scientific community called respond pandemic respiratory disease spread impressive rate among people world new coronavirus called sarscov<NUMBER> related disease indicated covid<NUMBER> reports positive patients world increased <NUMBER> <NUMBER> ascertained deaths <NUMBER> april <NUMBER> <NUMBER> <NUMBER> confirmed deaths <NUMBER> june <NUMBER> less <NUMBER> months due covid<NUMBER> complications also appears numbers might smaller number real cases due inability quantifying rescued asymptomatic people limit death rate sarscov<NUMBER> spread needs develop vaccine identify new small molecules able prevent treat covid<NUMBER> complications well prepare new quick diagnosis kits able quantify real number people exposed sarscov<NUMBER> among main actors sarscov<NUMBER> infection sarscov<NUMBER> spike proteins rnadependent rna polymerases proteases deserve mentioned indeed rnadependent rna polymerase become one main targets nucleoside analog antiviral drug remdesivir already used reducing complications due ebola dengue merscov infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> time viral protease inhibitors <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> investigation ability preventing virus protein cleavage specific reference spike protein cleavage <NUMBER> leading fusion virus proteins host cell membranes also antiinflammatory antibodiesdrugs combination anticoagulant molecules investigation limiting coagulopathies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine signaling impressively triggered sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> finally sarscov<NUMBER> spike protein become investigated target due ability forming interactions human ace<NUMBER> receptor causing fusion events make possible virus penetrate host human cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> crucial role played spike protein also due possibility use recombinant sarscov<NUMBER> spike protein triggering immune response working vaccine may help preventing treating covid <NUMBER> similarly recently proposed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> clarifying sarscov<NUMBER> infection mechanisms several research groups recently solved structure entire sarscov<NUMBER> spike protein <NUMBER>vsbpdb <NUMBER> <NUMBER>vxx pdb <NUMBER>vybpdb <NUMBER> prefusion conformation sarscov<NUMBER> spike rbd domain complex human ace<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb light available cited crystallizedcryoem solved structures propose strategy identifyingdrawing new sarscov<NUMBER> therapeutic antibodies directed rbd sarscov<NUMBER> spike protein could used contrasting sarscov<NUMBER> infection aiming prevent prepostfusion spike conformation interconversion responsible virus invasion provide molecular structural context studying new diagnosis kits based interactions engineered antibodies human sarscov<NUMBER> spike rbd covspike ace<NUMBER> homologous proteincrystallized structures searched using folding recognition methods implemented pgenthreader itasser aim amino acid sequence sarscov<NUMBER> spike protein monomer fasta sequence monomer taken <NUMBER>vsbpdb chain ace<NUMBER> fasta sequence monomer taken <NUMBER>m<NUMBER>pdb chain b used query sequences running pgenthreader httpbioin fcsuclacukpsipr ed itasser https zhang labccmbmedumich eduitasse r screen pdb searching similar deposited crystallized structures <NUMBER> <NUMBER> <NUMBER> <NUMBER> sequences retrieved <NUMBER> crystallized structures reference crystallized structures indicated certain high confidence level pgenthreader output aligned using clustalw <NUMBER> implemented jalview package <NUMBER> <NUMBER>d coordinates <NUMBER> crystallized structures superimposed using super command available pymol <NUMBER> super command allows aligning selected proteins investigation performing comparative structural analysis due ability providing sequenceindependent structurebased pairwise alignment notably super command robust align command successfully performs also superimposition proteins lower sequence similarity <NUMBER> <NUMBER> proteinprotein proteinligand binding regions highlighted selecting residues within <NUMBER> Ã¥ proteinprotein interface investigated ligands superimposed structures generated <NUMBER>d allatom models energetically minimized using yasara minimization server <NUMBER> rosetta relax application within rosetta scoring prep tools https wwwroset tacom mons orgdemos lates ttutor ialsscori ngandprepscori ngand prep <NUMBER> <NUMBER> <NUMBER> independently <NUMBER>d comparative model sarscov<NUMBER> spike trimer postfusion conformation built multitemplate modeling using modeller <NUMBER> detail human sarscov<NUMBER> spike protein sequence aligned sequences available entire postfusion conformation murine coronavirus spike protein <NUMBER>b<NUMBER>opdb <NUMBER> remaining available crystallized subdomains coronavirus spike proteins postfusion conformations <NUMBER>yl<NUMBER>pdb <NUMBER> <NUMBER>wyypdb <NUMBER> <NUMBER>wdfpdb <NUMBER> sequences cited crystallized structure fragments used query sequences sampling corresponding entire spike monomer sequences reciprocalblastp aligned sequences investigated structures comparative purposes obtained msa used driving multitemplate modeling complex <NUMBER>d model representing prefusion spike trimer interacting three ace<NUMBER> functional receptor units built superimposing recently solved cryoem prefusion structure sarscov<NUMBER> spike trimer complex <NUMBER>vsbpdb <NUMBER> <NUMBER>vybpdb <NUMBER>vxxpdb <NUMBER> sarscov<NUMBER> spike rbd crystallized complex human ace<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb sarscov<NUMBER> spike trimer interacting one ace<NUMBER> functional receptor conformations <NUMBER> <NUMBER>acgpdb <NUMBER>acjpdb <NUMBER>ackpdb <NUMBER> <NUMBER>cs<NUMBER>pdb <NUMBER> sarscov<NUMBER> spikerbd crystallized complex human ace<NUMBER> <NUMBER>ajfpdb <NUMBER> investigating prepostfusion conformation interconversion superimposed prefusion available crystallized structures sarscov<NUMBER> spike proteins generated <NUMBER>d models prefusion conformation spike trimer complex three ace<NUMBER> units obtained <NUMBER>d model postfusion conformation generated <NUMBER>d allatom models energetically minimized using yasara minimization server <NUMBER> rosetta relax application within rosetta scoring prep tools https wwwroset tacom monsorgdemos lates ttutor ialsscori ngandprepscori ngandprep <NUMBER> <NUMBER> <NUMBER> independently starting <NUMBER>d atomic coordinates crystallized neutralizing antibodies m<NUMBER> <NUMBER>dd<NUMBER>pdb <NUMBER> s<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> complexed sarscov<NUMBER> spike rbd domain modelled interactions m<NUMBER> s<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> sarscov<NUMBER> spike rbd domain superimposing fragment antigenbased fab portions m<NUMBER> <NUMBER>dd<NUMBER>pdb <NUMBER> s<NUMBER> <NUMBER>nb<NUMBER> pdb <NUMBER> sarscov<NUMBER> spike rbd domain complexed ace<NUMBER> <NUMBER>vw<NUMBER>pdb using pymol creating specific antibody directed sarscov<NUMBER> spike rbd replaced residues cdr regions m<NUMBER> crystallized fab portion residues may complement fulfill better sarscov<NUMBER> rbd surface also based interactions observed crystallized structures sarscov<NUMBER>rbdace<NUMBER> protein complex mutagenesis analyses modeling incomplete residues within crystallized structures performed using spdbv <NUMBER> andor pymol <NUMBER> proposed complete igg chimeric antibodies obtained superimposing abovecited m<NUMBER> resulting engineered fab portions complex sarscov<NUMBER> rbd <NUMBER>d atomic model crystallized igg available pdb <NUMBER>igtpdb <NUMBER> using spdbv pymol detail m<NUMBER> engineered fab portions superimposed pymol super command fab portions crystallized structure igg <NUMBER>igtpdb starting structural alignment backbones possible model missing residues located fabfc interface solving clashes breaks backbone <NUMBER> <NUMBER> <NUMBER> using spdbv glycosylation ladder coming crystal structures investigated <NUMBER>igtpdb <NUMBER>dd<NUMBER>pdb <NUMBER>nb<NUMBER>pdb alternatively retained within generated structural models superimposition operations allowing backbone connections renumbered atoms residues present resulting final pdb file using inhouse developed perl script generated <NUMBER>d allatom models energetically minimized using yasara minimization server <NUMBER> rosetta relax application within rosetta scoring prep tools https wwwroset tacom monsorgdemos lates ttutor ialsscori ngandprepscori ng andprep <NUMBER> <NUMBER> <NUMBER> independently obtained final models examined vmd pymol spdbv visual inspection searching putative unsolved clashes <NUMBER> <NUMBER> foldx analysecomplex assay performed determine interaction energy four generated antibodies rbd domains sarscov<NUMBER> spike proteins also determining interaction energy ace<NUMBER> interacting spike rbds comparative purposes way foldx analysecomplex operates unfolding selected targets determining stability remaining molecules subtracting sum individual energies global energy negative energies indicate better binding positive energies indicate binding <NUMBER> <NUMBER> energy calculated crystallized m<NUMBER>sarscov<NUMBER> rbd protein complex used reference value rosetta applications combine several tools model analyze macromolecular structures https wwwroset tacom monsorgdocslates thome chose use residueenergybreakdown interfaceanalyzer applications https wwwroset tacom monsorgdemos lates ttutor ialsscori ngandprepscori ngandprep rosetta scoring prep tools analyzing sarscov<NUMBER> spike rbdace<NUMBER> interface interactions rosetta residueenergybreakdown application used examine contribution protein residue score lowest energy backbone relaxed structures whereas rosetta interfaceanalyzer application used evaluating interactions across antibodyreceptor interface <NUMBER> <NUMBER> <NUMBER> <NUMBER> main event allows virus envelop fusion host human cell plasma membrane concerns conformational change occurring sarscov<NUMBER> spike protein converts prefusion conformation postfusion conformation interactions ace<NUMBER> spike protein cleavage sarscov<NUMBER> spike protein trimer resolved cryoem <NUMBER>vsbpdb <NUMBER> <NUMBER>vxxpdb <NUMBER>vyb pdb <NUMBER> postfusion conformation available yet according <NUMBER> coutard et al protein cleavage site s<NUMBER>s<NUMBER> s<NUMBER>â² produces division spike protein two subdomains ie nter si ectodomain containing rbd interacting ace<NUMBER> cter sii membraneanchored subdomain form sarscov<NUMBER> spike protein postfusion conformation able trigger fusion viral envelope host cell plasma membrane determining host cell invasion modelling <NUMBER>d postfusion conformation sarscov<NUMBER> spike protein searched sarscov<NUMBER> spike protein homologous structures found <NUMBER> crystallized structures included poses whole sarscov<NUMBER> spike proteins protein domains sarscov<NUMBER> spike proteins complex protein interactors ie ace<NUMBER> several prefusion conformations coronavirus spike proteins one spike protein postfusion conformation three protein subdomains spike proteins postfusion conformation supplementary table <NUMBER> thus built msa aligning sequence human sarscov<NUMBER> spike protein sequence available whole postfusion conformation spike protein <NUMBER>b<NUMBER>opdb <NUMBER> sequences remaining crystallized subdomains virus spike proteins postfusion conformations <NUMBER>yl<NUMBER>pdb <NUMBER> <NUMBER>wyypdb <NUMBER> <NUMBER>wdfpdb <NUMBER> together complete counterpart sequences sampled reciprocalblastp fig <NUMBER> provided msa fig <NUMBER> possible observe conserved s<NUMBER>s<NUMBER> s<NUMBER>â² cleavage sites according <NUMBER> sequence cterminal domain resulting cleavage furthermore also possible observe several clusters conserved residues fig <NUMBER> used anchor points proposed sarscov<NUMBER> spike sequence multitemplatestructure alignment building <NUMBER>d model monomer sarscov<NUMBER> spike protein postfusion conformation fig <NUMBER> among conserved protein regions six clusters residues host conserved cysteine residues fig <NUMBER> forming disulfide bridges crucial stabilizing prefusion postfusion sarscov<NUMBER> spike protein conformation <NUMBER> modelled sarscov<NUMBER> spike postfusion conformation consists residues <NUMBER> <NUMBER> yp<NUMBER> residues numbering resulting protein cleavage <NUMBER> protein fragments main constituents postfusion conformation also fragments modelled using protein template uniquegreatest existing solved postfusion conformation structure sequencestructure related spike protein <NUMBER>b<NUMBER>opdb amino acids <NUMBER> <NUMBER> np<NUMBER>b<NUMBER>opdb residues numbering <NUMBER> trimer sarscov<NUMBER> spike protein postfusion conformation obtained duplicating two times obtained monomer superimposing resulting three sarscov<NUMBER> spike protein monomers three spike protein monomers reported <NUMBER>b<NUMBER>opdb fig <NUMBER> releaxed <NUMBER>d comparative model sarscov<NUMBER> spike protein trimer built multitemplate comparative modeling showed rmsd lower <NUMBER> Ã¥ available spike protein postfusion conformation <NUMBER>b<NUMBER>opdb resulting model fig <NUMBER> appeared elongated narrow respect prefusion conformation according observed fragments spike proteins crystallized postfusion conformations whose sequences reported fig <NUMBER> whose pdbids listed supplementary table <NUMBER> resulting sarscov<NUMBER> spike postfusion spike conformation obtained following loss cited nterminal domain residues <NUMBER> black cartoon yp<NUMBER> residues numbering fig <NUMBER> middle protein portion residues <NUMBER> black cartoon resulting postfusion structure shows regions underwent conformational changes respect prefusion structure ie see residues <NUMBER> yellow cartoon <NUMBER> red cartoon <NUMBER> magenta cartoon yp<NUMBER> residues numbering fig <NUMBER> hand important conformational changes observed regions <NUMBER> <NUMBER> appears related loss nterminal portion residues <NUMBER> black cartoon causes reorientation <NUMBER> peptide involved perturbation <NUMBER> protein region reorient cyan boxes indicate cluster residues conserved sampled sequences maintained postfusion conformation considered anchor points preparing <NUMBER>b<NUMBER>opdb based sarscov<NUMBER> spike sequencestructure alignment used building <NUMBER>d comparative model sarscov<NUMBER> spike protein postfusion conformation amino acids s<NUMBER>a<NUMBER> see amino acids l<NUMBER>s<NUMBER> see b yp<NUMBER> residues numbering free space due nterminal missing residues similarly important conformational changes observed <NUMBER> protein region fig <NUMBER> appears due loss middle protein region residues <NUMBER> black cartoon fig <NUMBER> whose removal causes reorientation relaxation <NUMBER> amino acid protein region green cartoon fig <NUMBER> may occupy space previously occupied cleaved nterminal region <NUMBER> residues black cartoon notably stabilization postfusion conformation depends reorientation cterminal <NUMBER> protein region orange cyan cartoon fig <NUMBER> indeed cterminal portion specific reference residues <NUMBER> monomer deeply involved intermonomer hydrophilic ionic interactions residues <NUMBER> reoriented amino acid protein region specific reference residues <NUMBER> close monomers notably <NUMBER> protein region solved prefusion structure fig <NUMBER> previous protein segment ie residues <NUMBER> showed completely different orientation available prefusion structures among sampled crystallized structures possible observe three pdbids entire sarscov<NUMBER> spike proteins two sarscov<NUMBER> spike rbd protein interacting human ace<NUMBER> supplementary table <NUMBER> furthermore possible highlight several crystallized structures sarscov<NUMBER> merscov spike proteins single proteins complex receptors dedicated antibodies supplementary table <NUMBER> notably among sampled structures also four entries used building <NUMBER>d comparative model postfusion conformation considered supplementary table <NUMBER> modeling main interactions occurring sarscov<NUMBER> spike proteins ace<NUMBER> thanks high percentage identical residues shared spike rbd several cov strains fig <NUMBER> possible structurally align three objects consisting human ace<NUMBER>sarscov<NUMBER> spikerbd protein complex <NUMBER>ajfpdb human ace<NUMBER>sarscov<NUMBER> spikerbd protein complex <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb sarscov<NUMBER> spike protein trimer <NUMBER>vsbpdb <NUMBER>vxxpdb <NUMBER>vybpdb detail superimposition performed using pymol led structural alignment rbd ace<NUMBER>sarscov<NUMBER> <NUMBER>ajfpdb ace<NUMBER>sarscov<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb spike proteins fig <NUMBER> followed structure alignment sarscov<NUMBER> spike protein trimer <NUMBER>vsbpdb <NUMBER>vxxpdb <NUMBER>vybpdb notably obtained efficient superimposition two rbd domains rmsd lower <NUMBER> Ã¥ human sarscov<NUMBER> sarscov<NUMBER> spike proteins also due high percentage identical residues <NUMBER> possible superimpose crystallized sarscov<NUMBER> spike protein prefusion conformation modelled sarscov<NUMBER> spike protein trimers postfusion conformation showing deep conformational changes occurring along conformation interconversion fig <NUMBER> indeed known rbd subunits mobile able exhibit multiple conformational states modulate accessibility rbds triggering interactions receptor proteins host cell plasma membranes <NUMBER> proposed conformational changes reported scheme fig <NUMBER> sarscov<NUMBER> spike protein goes closed state rbd residues interacting ace<NUMBER> accessible fig <NUMBER>a g partially open state one fig <NUMBER>b h two fig <NUMBER>c rbd accessible subunits till final open state rbd residues interacting ace<NUMBER> rbd subunits accessible ready establish interactions ace<NUMBER> fig <NUMBER>d j established fig <NUMBER>e k known anchored plasma membrane involved internalization events <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> available crystallized structures obtained <NUMBER>d structure models possible highlight sarscov<NUMBER> spike rbd <NUMBER>ajfpdb sarscov<NUMBER> spike rbd residues <NUMBER> involved binding human colors residues numbering reflect localization sarscov<NUMBER> spike protein sequence reported protein domain <NUMBER>d structures yp<NUMBER> residues numbering uh upstream helix fp region hosting fusion peptide hr<NUMBER> heptad repeat <NUMBER> ch central helix bh Î²hairpin region cd connector domain hr<NUMBER> heptad repeat <NUMBER> according <NUMBER> f lateral views sarscov<NUMBER> spike protein trimer prepostfusion conformation respectively reported colored cartoon representation b g lateral views sarscov<NUMBER> spike monomer prepostfusion conformation respectively reported colored cartoons c h indicate zoomed views q<NUMBER>k<NUMBER> protein region greenred cartoon representation indicate zoomed views m<NUMBER>d<NUMBER> protein region magentaorange cartoon representation e j indicate zoomed views s<NUMBER>i<NUMBER> protein region yellow cartoon representation yellow sticks e j indicate disulfide bridges residue labels indicate residues used reference identifying quickly cited protein region terminal portions cysteine residues involved disulfide bridges notably yellow magenta red cartoon indicate monomer regions involved conformational changes whereas green orange cartoon indicate regions involved large conformational changes black cartoon portions b indicate protein regions lost cleavage events andor available crystallized structures cyan cartoon portion g indicates <NUMBER> protein region obtained comparative modeling using protein template available sarscov<NUMBER> spike protein solved structure corresponding protein region postfusion conformation observed <NUMBER>b<NUMBER>opdb notably corresponding protein region solved none investigated crystallized spike proteins prefusion conformations supplementary table <NUMBER> ace<NUMBER> fig <NUMBER> supplementary table <NUMBER> notably ionpair interactions observed sarscov<NUMBER> spike rbd human ace<NUMBER> also observed sarscov<NUMBER> spike rbd human ace<NUMBER> reported data represent updatedintegrated analysis similar one reported <NUMBER> light recently deposited sarscov<NUMBER> spike rbd complex human ace<NUMBER> <NUMBER>vw<NUMBER>pdb rbd sarscov<NUMBER> crystallized complex fab domain two different antibodies namely m<NUMBER> <NUMBER>dd<NUMBER>pdb <NUMBER> s<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> show high affinity sarscov<NUMBER> spike rbd <NUMBER> <NUMBER> nevertheless show different peculiarities mechanism action indeed s<NUMBER> binding rbd similarly ace<NUMBER> trigger sarscov spike transition postfusion conformation clarified yet viruscell fusion may triggered s<NUMBER> also s<NUMBER>rbd interactions occur close surface host cell plasma membrane protein targets sarscov<NUMBER> <NUMBER> variance s<NUMBER> m<NUMBER> antibody appears able prevent sarscov<NUMBER> spikeace<NUMBER> interactions sarscov<NUMBER> spike prepostfusion conformation transition neutralizing virus attack <NUMBER> thanks high percentage identical residues <NUMBER> sarscov<NUMBER> sarscov<NUMBER> spike rbd domains highly similar tertiary structure observed rmsd <NUMBER> Ã¥ coordinates rbds sarscov<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> <NUMBER>dd<NUMBER>pdb <NUMBER> sarscov<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER> <NUMBER>vsb pdb <NUMBER> spike proteins possible evaluate interactions m<NUMBER> sarscov<NUMBER> spike rbd propose sequencestructure ideal fab m<NUMBER>based fig <NUMBER> chimeric antibody targeting sarscov<NUMBER> spike rbd domain preventing fusion events ace<NUMBER> thus following infection aim first highlighted different rbd portions bound known antibodies superimposed sarscov<NUMBER> rbd sarscov<NUMBER> rbd highlighting differences residues involved direct interactions m<NUMBER> cdr regions s<NUMBER> cdr regions fig <NUMBER> table <NUMBER> due uncertain data concerning fusion events mechanism action s<NUMBER> antibody built new sarscov<NUMBER> rbddirected antibody focusing starting analysis monomermonomer interface interactions observed m<NUMBER> antibody crystallized complex sarscov<NUMBER> rbd <NUMBER> superimposed sarscov<NUMBER> spike rbdace<NUMBER> complex <NUMBER>ajfpdb comparing monomermonomer interface interactions observed modelled m<NUMBER> antibody complex sarscov<NUMBER> rbd superimposed sarscov<NUMBER> rbdace<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb protein complex fig <NUMBER> highlighted m<NUMBER> cdr residues table <NUMBER> replacing aiming increase m<NUMBER> affinity versus sarscov<NUMBER> spike rbds residues mutated replaced chosen according spacerestraints chemical needs better complementing sarscov<NUMBER> spike rbd surface based available sarscov<NUMBER> rbd structures complex ace<NUMBER> aiming produce something resembled ace<NUMBER> surface tables <NUMBER> <NUMBER> proposed mutated residues table <NUMBER> surely allowed already observed corresponding sites known antibodies according chotiakabat rules httpwwwbioin forgukabschoth iahtml <NUMBER> residue replacement directly performed newly generated <NUMBER>d model hosting interacting m<NUMBER>sarscov<NUMBER> spike rbd similarly complex modified m<NUMBER> antibody interacting sarscov<NUMBER> rbd also created m<NUMBER> cdr mutated residues reported table <NUMBER> furthermore mutated residues within m<NUMBER> cdr interacting sarscov<NUMBER> spike rbd residues observed fig <NUMBER> engineered fab portions thus aligned superimposed fab portion crystallized igg <NUMBER>igt pdb <NUMBER> sequence chimeric antibodies observed supplementary fig <NUMBER> whereas complete structure observed supplementary fig <NUMBER> interaction energies calculated sarscov<NUMBER> spike rbd domain m<NUMBER> native antibody fab portion give negative value table <NUMBER> confirming might binding interaction m<NUMBER> native antibody fab portion sarscov<NUMBER> spike rbd result encouraging also due indirect validation obtained getting similar interaction energies crystallized sarscov<NUMBER> rbd complex m<NUMBER> <NUMBER>d<NUMBER>pdb sarscov<NUMBER> sarscov<NUMBER> spike rbd domains crystallized complex ace<NUMBER> <NUMBER>ajfpdb <NUMBER>vw<NUMBER> pdb respectively table <NUMBER> furthermore strong interaction terms interaction energies calculated foldx analyse complex assay also predicted sarscov<NUMBER> spike rbd also sarscov<NUMBER> spike rbd modified m<NUMBER> antibody see table <NUMBER> suggesting engineered m<NUMBER> might efficient native m<NUMBER> binding sarscov<NUMBER> sarscov<NUMBER> spike rbd rosetta relax application used relaxing energetically investigated crystallized structures <NUMBER>d models rosetta force field relaxation run table <NUMBER> residueenergybreakdown tool confirmed m<NUMBER>sarscov<NUMBER> spike rbd complex might number interchain interactions comparable observed interface crystallized m<NUMBER>sarscov<NUMBER> spike rbd complex supplementary tables <NUMBER> <NUMBER> furthermore proposed mutations favor new interactions interface m<NUMBER>based mutated antibody sarscov<NUMBER> spike rbds level proposed ten mutations neighborhoods supplementary tables <NUMBER> investigated crystallized structures <NUMBER>d models analysed rosetta interfaceanalyzer application estimating interchain binding energies fab antibodies see colors c super zoomed rotated views crystallized sarscov<NUMBER> spike rbd residues interacting s<NUMBER> ab e f super zoomed rotated views sarscov<NUMBER> spike rbd predicted residues interacting s<NUMBER> ab g h super zoomed rotated views crystallized sarscov<NUMBER> spike rbd residues interacting m<NUMBER> ab j super zoomed rotated views sarscov<NUMBER> spike rbd predicted residues interacting m<NUMBER> ab cj residues rbdab interface <NUMBER> Ã¥ distance range reported sticks representation white sticks indicate rbd residues orange blue sticks indicate m<NUMBER> ab residues yellow pink sticks indicate s<NUMBER> ab residues analyses provided negative binding energies see dgseparated parameter table <NUMBER> investigated structures indicating binding interaction m<NUMBER> native antibody fab portion sarscov<NUMBER> spike rbd comparable terms binding energy ones calculated crystallized sarscov<NUMBER> spike rbdm<NUMBER> protein complex notably resulting binding energies obtained <NUMBER>d models hosting investigated m<NUMBER> m<NUMBER>based modified antibodies complex sarscov<NUMBER> spike rbd domains comparable see dgseparated parameter table <NUMBER> binding energies calculated <NUMBER>d models hosting crystallized sarscov<NUMBER> spike rbd domains complex ace<NUMBER> <NUMBER>ajfpdb <NUMBER>vw<NUMBER>pdb respectively table <NUMBER> supplementary tables <NUMBER> indicated pipeline allowed set molecular framework hosting sarscov<NUMBER> spike protein ace<NUMBER> receptor different antibodies pdb session could handled different molecular visualizers molecular framework possible study predict molecular level interactions different pieces framework may help understanding virus invasion mechanisms developing new vaccines antibodies identifying small molecules high affinity viral proteins establishing quicksafe diagnosis selectivespecific kits indeed scientific community focused development new weapons containing sarscov<NUMBER> spread covid<NUMBER> complications could observed enormous effort developing new vaccines based virus proteinnucleic acid portion able induce efficient specific immunogenic response <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> developing neutralizing therapeutic antibody highly specific sarscov<NUMBER> spike rbd <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> maybe starting antibodies isolated hyperimmune plasma convalescent patients <NUMBER> identifying chemicals high affinity sarscov<NUMBER> crucial proteins <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> maybe chosen also among repositories inhibitors proteases rnadependent polymerases <NUMBER> <NUMBER> <NUMBER> notably needs develop trustable titer serologic assay kits table <NUMBER> list sarscov<NUMBER> sarscov<NUMBER> spike rbd residues interacting reported ace<NUMBER> residues bold black residues delimited borders indicate pair cluster residues involved polar interprotein interactions normal black residues indicate residues spikerbdvsace<NUMBER> protein interface distant less <NUMBER> Ã¥ longest chains chosen within crystallized structures multiple chains highlighting listed interacting residues ace<NUMBER>interactingresidueswith sarscov<NUMBER>rbd <NUMBER>ajfpdb ace<NUMBER>interactingresidueswith sarscov<NUMBER>rbd <NUMBER>vw<NUMBER>pdb establishing level antibodies different biological samples indeed important question ie ones real number people exposed virus clear answer yet <NUMBER> <NUMBER> <NUMBER> <NUMBER> within presented molecular framework highlighted set possible efficient interactions crystallized m<NUMBER> antibody sarscov<NUMBER> spike rbd raising question possibility test directly m<NUMBER> cultured cells exposed virus hopefully patients starting observation also proposed set modifications m<NUMBER> cdr residues resulting higher specific antibody expressed tested cultured cells along development antibody engineering modeling session important paper published another revision support hypothesis table <NUMBER> list sarscov<NUMBER> rbd residues within <NUMBER> Ã¥ s<NUMBER>m<NUMBER> antibody residues bold residues indicate sarscov<NUMBER> residues interacting alternatively ace<NUMBER> andor m<NUMBER>s<NUMBER> crystallized available structures distance range <NUMBER> Ã¥ bold underlined residues indicate sarscov<NUMBER> residues interacting ace<NUMBER> predicted interact m<NUMBER> distance range <NUMBER> Ã¥ <NUMBER> <NUMBER> foldx rosetta analyses employed independently monitoring binding energies antibody receptor interface provided coherent results strengthening hypothesis original m<NUMBER> antibody might high affinity also sarscov<NUMBER> spike protein indicated calculated negative binding energy see foldx interaction energy parameter rosetta dgseparated parameter furthermore employed tools indicate local break structural energy correspondence proposed mutated sites antibodyreceptor complex interfaces reflecting increased affinity terms newly established interactions among investigated m<NUMBER>based mutated antibodies sarscov<NUMBER> spike rbds although calculated binding energies cannot considered absolute estimation real affinity investigated proteins binding energies obtained analysed crystallized structures <NUMBER>d engineered models order magnitude suggesting original m<NUMBER> m<NUMBER>based modified antibody might efficient binding sarscov<NUMBER> well sarscov<NUMBER> spike rbd also possible pose proposed molecular framework recent proposed sarscov<NUMBER> spike rbd directed cr<NUMBER> fab antibody <NUMBER>ylapdb <NUMBER>w<NUMBER>pdb <NUMBER> showing binds different site rbd protrudes towards central cavity spike protein trimer data shown appears rbdantibody interaction table <NUMBER> energy calculations crystallized structures <NUMBER>d comparative models investigated protein complexes pdbchain indicates chain pdb used within indicated analyses cited crystallized structures models obtained superimposition indicated chains longest chains chosen interaction energy analyses crystallized structures multiple chains chain e f indicate rbd chain within investigated pdbids chain b indicate ace<NUMBER> chain within investigated pdbids chain h l indicate heavy light chain investigated antibody wild type engineered variants according indicated pdbid premin postmin refer models prior energy minimization performed yasara minimization server bold numbers indicate interdomain interaction energies energetically relaxed complexes pdbchains used analyses rosetta indicated table <NUMBER> list energy terms taken https www roset tacom monsorgdocslates troset tabasic sscori ngscore types https wwwroset tacom monsorgdocslates tappli catio ndocum entat ion analy sisinter faceanaly zer follows energy terms obtained relaxscorejd<NUMBER> app dslffa<NUMBER> indicates disulfide geometry potential faatr indicates lennardjones attractive atoms different residues fadun indicates internal energy sidechain rotamers faelec indicates coulombic electrostatic potential distancedependent dielectric faintrarep indicates lennardjones repulsive atoms residue farep indicates lennardjones repulsive atoms different residues fasol indicates lazaridiskarplus solvation energy hbondbbsc indicates sidechainbackbone hydrogen bond energy hbondlrbb indicates backbonebackbone hbonds distant primary sequence hbondsc indicates sidechainsidechain hydrogen bond energy hbondsrbb indicates backbonebackbone hbonds close primary sequence proclose indicates proline ring closure energy energy psi angle preceding residue rama indicates ramachandran preferences ref indicates reference energy amino acid energy terms obtained interfaceanalyzer app complexnormalized indicates average energy residue entire complex dgseparated reported bold characters indicates change rosetta energy interface forming chains separated binding energy versus complexed dsasaint indicates solvent accessible area buried interface square angstroms dgseparateddsasax<NUMBER> separated binding energy per unit interface area Ã <NUMBER> make units fit score file scaling dsasa controls large interfaces energy deltaunsathbonds indicates number buried unsatisfied hydrogen bonds interface hbondefraction indicates amount interface energy dgseparated accounted cross interface hbonds hbondsint indicates total crossinterface hydrogen bonds found nresall indicates total number residues entire complex nresint indicates number residues interface perresidueenergyint indicates average energy residue interface side<NUMBER>score indicates energy one side interface side<NUMBER>score indicates energy side interface side<NUMBER> normalized indicates average perresidue energy one side interface side<NUMBER>normalized indicates average perresidue energy side interface rosetta energy terms expressed rosetta energy units reu according https wwwroset tacom monsorg docslates troset tabasic sunits inroset ta <NUMBER> dedicated studies necessary understanding steric hindering problems might arise using whole antibody deepening comprehension competitive mechanism would observed cr<NUMBER> rbd presence ace<NUMBER> receptor studying cited interactions pdbmolecular session allowed highlighting crucial ace<NUMBER> portions involved direct interactions sarscov<NUMBER> rbd suggesting administration recombinant rbd spike monomer entire spike trimer correctly folded might result efficient triggering antibody production plasma bcells reducing covid<NUMBER> complications supporting recently proposed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> time ace<NUMBER>rbd interaction estimated molecular framework strengthened hypothesis use recombinant ace<NUMBER> limiting covid<NUMBER> infection complications according recently proposed <NUMBER> <NUMBER> molecular framework like ones proposed also help studying putative role ace inhibitors perturbing ace<NUMBER>rbd interactions indeed recently proposed patients treated ace inhibitors might exposed sarscov<NUMBER> infection <NUMBER> although ace<NUMBER> refseq accession number np<NUMBER> representing main target ace inhibitors ace<NUMBER> np<NUMBER> testis isoform np<NUMBER> somatic isoform among studied isoforms share <NUMBER> identical residues uncertain data ace inhibitors possible greater selectivity ace<NUMBER> versus ace<NUMBER> effect ace<NUMBER> expression regulation available literature <NUMBER> <NUMBER> structural comparison observed rmsd crystallized native ace<NUMBER> coordinates <NUMBER>r<NUMBER>pdb <NUMBER> ace<NUMBER> coordinates <NUMBER>o<NUMBER>a pdb <NUMBER> lower <NUMBER> Ã¥ notably presence ace inhibitors captopril enalaprilat <NUMBER>uzepdb <NUMBER> <NUMBER>c<NUMBER>ppdb <NUMBER> lisinopril <NUMBER>o<NUMBER>pdb <NUMBER> produces rmsd lower <NUMBER> Ã¥ atomic coordinates cited crystallized structures reference native ace<NUMBER> <NUMBER>r<NUMBER>pdb <NUMBER> conversely cannot establish slightly higher rmsd observed native ace<NUMBER> <NUMBER>r<NUMBER>pdb ace<NUMBER> complexed sarscov<NUMBER> spike rbd <NUMBER> Ã¥ <NUMBER>ajfpdb sarscov<NUMBER> spike rbd <NUMBER> Ã¥ <NUMBER>vw<NUMBER>pdb attributed exclusively interactions sarscov<NUMBER> spike rbds observed rmsds order magnitude experimental resolution investigated crystallized structures however also admitting ace<NUMBER> inhibitors employed dosage would target ace<NUMBER> efficiency observed versus ace<NUMBER> presence inhibitors ace<NUMBER> binding cavity able induce important conformational change ace<NUMBER> might favor greater affinity ace<NUMBER> versus sarscov<NUMBER> spike rbd thus mechanism patients treated ace inhibitors would exposed sarscov<NUMBER> would rely positive feedback induced ace inhibitors ace<NUMBER> expression nevertheless pieces evidence support hypothesis need deepened <NUMBER> <NUMBER> along manuscript revisions couple interesting papers published concern showing patients treated ace inhibitors show slightly less severe set complications due covid<NUMBER> patients use ace inhibitors <NUMBER> <NUMBER> conclusion presented analysis highlights importance use fold recognition tools along approach drug design problem according rational protocol similar previously reported <NUMBER> <NUMBER> <NUMBER> like ones presented indeed case fold recognition tools helped us identifying crystallized structures ace<NUMBER> sarscov spike proteins similar investigation <NUMBER> days furthermore performing structural comparative analysis allowed us identify possible good starting point like ones represented m<NUMBER> already crystallized complex sarscov<NUMBER> spike rbd building proposed antibodies weeks strategy might promptly applied also future infections researchers involved drawing new antibodies andor developing new vaccines ie dealing future coronaviruses outbreaks best knowledge reported sarscov<NUMBER> spike protein trimer <NUMBER>d model first model describing possible conformational change leading reliable sarscov<NUMBER> spike protein postfusion conformation proposed model based available spike protein <NUMBER>b<NUMBER>opdb crystallized postfusion conformation help understanding mechanism allowing virus envelop fusion host cell plasma membranes following interactions ace<NUMBER> notably possible propose <NUMBER>d model main states reached sarscov<NUMBER> spike protein cited conformational changes leading postfusion conformation closed state rbd residues interacting ace<NUMBER> accessible partially open state one two rbd accessible subunits final open state rbd residues interacting ace<NUMBER> rbd subunits accessible ready establish interactions ace<NUMBER> postfusion conformation already described merscov <NUMBER>nb<NUMBER>pdb <NUMBER>nb<NUMBER>pdb sarscov<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER>nb<NUMBER>pdb <NUMBER>b<NUMBER>opdb spike proteins <NUMBER> <NUMBER> considering ace<NUMBER> works dimer spike protein consists trimer might even speculated fusion complete mechanism might involve three ace<NUMBER> dimers two spike trimers simultaneously notably since <NUMBER> may <NUMBER> three crystallized structures sarscov<NUMBER> spike protein closed conformation accessible rbd subunits partially open conformations one two accessible rbd subunits without ace<NUMBER> interacting subunits deposited <NUMBER>x<NUMBER>apdb <NUMBER>x<NUMBER>bpdb <NUMBER>x<NUMBER>cpdb coherent proposed corresponding models indeed rmsd coordinates crystallized <NUMBER>x<NUMBER>c pdb closed state starting crystallized structures <NUMBER>vsbpdb <NUMBER>vxxpdb depicting possible closed state sarscov<NUMBER> spike protein lower <NUMBER> Ã¥ furthermore rmsd coordinates crystallized partially open states sarscov<NUMBER> spike protein <NUMBER>x<NUMBER>bpdb showing two accessible rbds <NUMBER>x<NUMBER>apdb showing one accessible rbd corresponding <NUMBER>d models showing two one accessible rbds lower <NUMBER> Ã¥ cases analysis provided <NUMBER>d model postfusion conformation coherently crystallized <NUMBER>d structure sarscov<NUMBER> spike protein prefusion conformation confirms presence stability sort channel interface three monomers could represent good target site virtual screening chemicaldrug library aiming identify small molecule peptide high affinity central region spike protein trimer able block conformational changes leading postfusion conformation indeed recently observed peptide named ek<NUMBER> <NUMBER>zvm pdb <NUMBER> showing high affinity <NUMBER> protein region yp<NUMBER> residues numbering able prevent conformational changes postfusion conformation stabilization screening drugpeptide library would help identifying already approved drugpeptide maybe structurally related ek<NUMBER> high affinity spike trimer central channel might immediately translated patient bedside successful silico analyses context drugrepositioning approaches <NUMBER> <NUMBER> notably provided molecular framework investigatingdrawing new antibodies based spacerestraints needs would used setup new antibodies based available tissuespecific immunoglobulin structures proposed igg<NUMBER>a <NUMBER>igtpdb <NUMBER> specialized antibodies already optimized targeting specific cells receptors ie<NUMBER>hzhpdb <NUMBER> also among may successfully target respiratory tract <NUMBER>r<NUMBER>pdb <NUMBER> <NUMBER>qtjpdb <NUMBER> <NUMBER>ue<NUMBER>pdb <NUMBER> might administered even aerosol <NUMBER> <NUMBER> time already preclinical level administered vaccines based administration entire sarscov<NUMBER> spike protein <NUMBER> <NUMBER> <NUMBER> administration single sarscov<NUMBER> spike rbd induce production specific antibodies might sequenced modelled silico concern provided molecular network help quantifying interactions sarscov<NUMBER> spike rbd also cases different rbd variants <NUMBER> newly investigated antibodies ie lower calculated binding energy modelled complex higher likelihood obtain strong rbdantibody interactions would result efficient treatments discovered antibodies highest affinity spike rbd might also implemented antibody titer serologic kit diagnosis aiming early identification quantification sarscov<NUMBER> sera also asymptomatic people conversely new diagnosis kit could also based native rbd modified synthetic rbd greater affinity detected human antibodies directed sarscov<NUMBER> spike rbd protein determining real number healthy people already exposed virus population quantifying antisarscov<NUMBER> antibodies seraplasma rescued patients andor asymptomatic peoples lacking knowledge real number people exposed virus including asymptomatic people people mild symptoms rescued people never needed hospitalization quarantine important data still miss without data real number people exposed virus population coming back normal life extremely slow scientific community called respond pandemic respiratory disease spread impressive rate among people world new coronavirus called sarscov<NUMBER> related disease indicated covid<NUMBER> reports positive patients world <NUMBER> <NUMBER> april <NUMBER> th <NUMBER> ascertained died people due covid<NUMBER> complications also appears numbers might smaller number real cases due inability quantifying rescued asymptomatic people order limit death rate sarscov<NUMBER> spread needs develop vaccine identify new small molecules able prevent treat covid<NUMBER> complications well prepare new quick diagnosis kits able quantify real number people exposed sarscov<NUMBER> among main actors sarscov<NUMBER> infection sarscov<NUMBER> spike proteins rna dependent rna polymerases proteases deserve mentioned indeed rna dependent rna polymerase become one main targets nucleoside analog antiviral drug remdesivir already used reducing complications due ebola dengue merscov infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> time viral protease inhibitors <NUMBER> <NUMBER> <NUMBER> <NUMBER> investigation ability preventing virus protein specific reference spike proteins cleavage <NUMBER> leading fusion virus proteins host cell membranes also antiinflammatory antibodiesdrugs combination anticoagulant molecules investigation limiting coagulopathies <NUMBER> <NUMBER> <NUMBER> <NUMBER> cytokine signaling impressively triggered sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> finally sarscov<NUMBER> spike protein become investigated target due ability forming interactions human ace<NUMBER> receptor causing fusion events make possible virus penetrate host human cells <NUMBER> <NUMBER> <NUMBER> crucial role played spike protein also due possibility use recombinant sarscov<NUMBER> spike protein triggering immune response working vaccine may help preventing treating covid <NUMBER> similarly proposed recently <NUMBER> <NUMBER> <NUMBER> clarifying sarscov<NUMBER> infection mechanisms several research groups recently solved crystallized structure entire sarscov<NUMBER> spike protein <NUMBER>vsbpdb <NUMBER> <NUMBER>vxxpdb <NUMBER>vybpdb <NUMBER> prefusion conformation andor sarscov<NUMBER> spike rbd domain complex human ace<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb light available cited crystallizedcryoem solved structures propose strategy identifyingdrawing new sarscov<NUMBER> antibodies directed rbd sarscov<NUMBER> could used contrasting sarscov<NUMBER> infection aiming prevent prepostfusion spike conformation interconversion responsible virus invasion provide molecular structural context studying new diagnosis kits based interactions engineered antibodies human sarscov<NUMBER> spike rbd covspike ace<NUMBER> homologus proteincrystallized structures searched using folding recognition methods implemented pgenthreader itasser according validated protocols <NUMBER> <NUMBER> <NUMBER> <NUMBER> sequences retrieved <NUMBER> crystallized structures reference crystallized structures indicated certain high confidence level pgenthreader output aligned using clustalw <NUMBER> implemented jalview package <NUMBER> <NUMBER>d coordinates <NUMBER> crystallized structures superimposed comparative purposes using pymol <NUMBER> according validated protocols <NUMBER> <NUMBER> proteinprotein proteinligand binding regions highlighted selecting residues within <NUMBER> Ã¥ proteinprotein interface investigated ligands superimposed structures generated <NUMBER>d atom models energetically minimized using yasara minimization server <NUMBER> <NUMBER>d comparative model sarscov<NUMBER> spike trimer postfusion conformation built multitemplate modeling using modeller <NUMBER> detail human sarscov<NUMBER> spike protein sequence aligned sequences available entire post fusion conformation murine coronavirus spike protein <NUMBER>b<NUMBER>o <NUMBER> remaining available crystallized subdomains coronavirus spike proteins post fusion conformations <NUMBER>yl<NUMBER>pdb <NUMBER> <NUMBER>wyypdb <NUMBER> <NUMBER>wdf <NUMBER> sequences cited crystallized structure fragments used query sequences sampling corresponding entire spike monomer sequences reciprocalblastp aligned sequences investigated structures comparative purposes obtained msa used driving multitemplate modeling complex <NUMBER>d model representing prefusion spike trimer interacting three ace<NUMBER> functional receptor units built superimposing recently solved cryoem prefusion structure sarscov<NUMBER> spike trimer complex <NUMBER>vsbpdb <NUMBER> <NUMBER>vybpdb <NUMBER>vxxpdb <NUMBER> sarscov<NUMBER> spike rbd crystallized complex human ace<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb sarscov<NUMBER> spike trimer interacting one ace<NUMBER> functional receptor conformations <NUMBER> <NUMBER>acgpdb <NUMBER>acjpdb <NUMBER>ackpdb <NUMBER> <NUMBER>cs<NUMBER>pdb <NUMBER> sarscov<NUMBER> spikerbd crystallized complex human ace<NUMBER> <NUMBER>ajfpdb <NUMBER> investigating prepostfusion conformation interconversion superimposed prefusion available crystallized structures sarscov<NUMBER> spike proteins generated <NUMBER>d models prefusion conformation spike trimer complex three ace<NUMBER> units obtained <NUMBER>d model post fusion conformation generated <NUMBER>d atom models energetically minimized using yasara minimization server <NUMBER> starting <NUMBER>d atomic coordinates crystallized neutralizing antibodies m<NUMBER> <NUMBER>dd<NUMBER>pdb <NUMBER> s<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> directed sarscov<NUMBER> spike rbd domain modelled interactions m<NUMBER> s<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> sarscov<NUMBER> spike rbd domain superimposing fragment antigen based fab portions m<NUMBER> <NUMBER>dd<NUMBER>pdb <NUMBER> s<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> complexed sarscov<NUMBER> rbd sarscov<NUMBER> spike rbd domain complexed ace<NUMBER> <NUMBER>vw<NUMBER>pdb using pymol creating specific antibody directed sarscov<NUMBER> spike rbd replaced residues cdr regions m<NUMBER> crystallized fab portion residues may complement fulfill better sarscov<NUMBER> rbd surface mutagenesis analyses modeling incomplete residues within crystallized structures performed using spdbv <NUMBER> andor pymol <NUMBER> proposed complete igg chimeric antibodies obtained superimposing cited m<NUMBER> resulting engineered fab portions complex sarscov<NUMBER> rbd <NUMBER>d atomic model crystallized igg available pdb <NUMBER>igtpdb <NUMBER> using spdbv pymol according validated protocols <NUMBER> <NUMBER> <NUMBER> allow model missing residues solving clashes breaks backbone glycosylation ladder coming crystal structures investigated <NUMBER>igtpdb <NUMBER>dd<NUMBER>pdb <NUMBER>nb<NUMBER>pdb alternatively retained within generated structural models superimposition operations allowing backbone connections renumbered atoms residues present resulting final pdb file using inhouse developed perl script obtained final models examined vmd pymol spdbv according protocols <NUMBER> <NUMBER> generated <NUMBER>d atom models energetically minimized using yasara minimization server <NUMBER> foldx analysecomplex assay performed determine interaction energy four generated antibodies rbd domains sarscov<NUMBER> spike proteins also determining interaction energy ace<NUMBER> interacting spike rbds comparative purposes way foldx analysecomplex operates unfolding selected targets determining stability remaining molecules subtracting sum individual energies global energy negative energies indicate better binding positive energies indicate binding <NUMBER> <NUMBER> energy calculated crystallized m<NUMBER>sarscov<NUMBER> rbd protein complex used reference value main event allows virus envelop fusion host human cell plasma membrane concerns conformational change occurring sarscov<NUMBER> spike protein converts prefusion conformation postfusion conformation interactions ace<NUMBER> spike protein cleavage sarscov<NUMBER> spike protein trimer resolved cryoem <NUMBER>vsbpdb <NUMBER> <NUMBER>vxxpdb <NUMBER>vybpdb <NUMBER> postfusion conformation available yet according <NUMBER> coutard et al protein cleavage site s<NUMBER>s<NUMBER> s<NUMBER> produces division spike protein two subdomains ie nter si ectodomain containing rbd interacting ace<NUMBER> cter sii membrane anchored subdomain forming sarscov<NUMBER> spike protein post fusion conformation able trigger fusion viral envelope host cell plasma membrane determining host cell invasion provided msa fig <NUMBER> possible observe conserved s<NUMBER>s<NUMBER> s<NUMBER> cleavage sites according <NUMBER> sequence cterminal domain resulting cleavage starting cited multitemplate sequence alignment according validated protocols multitemplate <NUMBER>d modeling <NUMBER> <NUMBER> built <NUMBER>d model monomer sarscov<NUMBER> spike protein post fusion conformation fig <NUMBER> modelled sarscov<NUMBER> spike postfusion conformation consists residues <NUMBER> <NUMBER> yp<NUMBER> residues numbering resulting protein cleavage <NUMBER> also protein fragments solved structure <NUMBER>b<NUMBER>opdb aligned aminoacids <NUMBER> <NUMBER> np<NUMBER>b<NUMBER>opdb residues numbering counterpart <NUMBER> trimer sarscov<NUMBER> spike protein post fusion conformation obtained duplicating two times obtained monomer superimposing three sarscov<NUMBER> spike protein monomers three sarscov<NUMBER> spike protein monomers reported <NUMBER>b<NUMBER>opdb fig <NUMBER> <NUMBER>d comparative model sarscov<NUMBER> spike protein trimer built multitemplate comparative modeling showed rmsd lower <NUMBER> Ã¥ murine coronavirus spike protein postfusion conformation <NUMBER>b<NUMBER>opdb resulting model fig <NUMBER> appeared elongated narrow according observed fragments spike proteins crystallized postfusion conformations whose sequences reported fig <NUMBER> whose pdbid listed supp tab <NUMBER> modeling main interactions occurring sarscov<NUMBER> spike proteins ace<NUMBER> thanks high percentage identical residues shared spike rbd several cov strains fig <NUMBER> possible structurally align three objects consisting human ace<NUMBER>sarscov<NUMBER> spikerbd protein complex <NUMBER>ajfpdb human ace<NUMBER>sarscov<NUMBER> spikerbd protein complex <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb sarscov<NUMBER> spike protein trimer <NUMBER>vsbpdb <NUMBER>vxxpdb <NUMBER>vybpdb detail superimposition performed using pymol leaded structural alignment rbd ace<NUMBER>sarscov<NUMBER> <NUMBER>ajfpdb ace<NUMBER>sarscov<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb spike proteins fig <NUMBER> followed structure alignment sarscov<NUMBER> spike protein trimer <NUMBER>vsbpdb <NUMBER>vxxpdb <NUMBER>vybpdb notably obtained efficient superimposition two rbd domains rmsd lower <NUMBER> Ã¥ human sarscov<NUMBER> sarscov<NUMBER> spike proteins also due high percentage identical residues <NUMBER> possible superimpose crystallized sarscov<NUMBER> spike protein prefusion conformation modelled sarscov<NUMBER> spike protein trimers postfusion conformation showing deep conformational changes occurring along conformation interconversion fig <NUMBER> apparently postfusion conformation appears elongated narrower prefusion conformation top portion postfusion conformation locates beyond ace<NUMBER> receptors fig <NUMBER> known anchored plasma membrane involved internalization events <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> available crystallized structures obtained <NUMBER>d structure models possible highlight sarscov<NUMBER> spike rbd <NUMBER>ajfpdb sarscov<NUMBER> spike rbd residues <NUMBER> involved binding human ace<NUMBER> fig <NUMBER> supp tab <NUMBER> notably ion pair interactions observed sarscov<NUMBER> spike rbd human ace<NUMBER> also observed sarscov<NUMBER> spike rbd human ace<NUMBER> reported data represents updatedintegrated analysis similar ones reported <NUMBER> light recently deposited sarscov<NUMBER> spike rbd complex human ace<NUMBER> <NUMBER>vw<NUMBER>pdb tab <NUMBER> list sarscov<NUMBER> sarscov<NUMBER> rbd residues ace<NUMBER> bold black residues delimited borders indicate pair cluster residues involved polar interprotein interactions normal black residues indicate residues spikerbdvsace<NUMBER> protein interface distant less <NUMBER> Ã¥ longest chains chosen within crystallized structures multiple chains highlighting listed interacting residues rbd sarscov<NUMBER> crystallized complex fab domain two different antibodies namely m<NUMBER> <NUMBER>dd<NUMBER>pdb <NUMBER> s<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> show high affinity sarscov<NUMBER> spike rbd able block attachment ace<NUMBER> <NUMBER> <NUMBER> nevertheless show different peculiarities mechanism action indeed s<NUMBER> binding rbd similarly ace<NUMBER> able trigger sarscov spike transition postfusion conformation clarified yet viruscell fusion may triggered s<NUMBER> also s<NUMBER>rbd interactions occurs close surface cells target sarscov<NUMBER> <NUMBER> variance s<NUMBER> m<NUMBER> antibody appears able prevent sarscov<NUMBER> spikeace<NUMBER> interactions sarscov<NUMBER> spike prepostfusion conformation transition neutralizing virus attack <NUMBER> thanks high percentage identical residues <NUMBER> sarscov<NUMBER> sarscov<NUMBER> spike rbd domains highly similar tertiary structure observed rmsd <NUMBER> Ã¥ coordinates rbds sarscov<NUMBER> <NUMBER>nb<NUMBER>pdb <NUMBER> <NUMBER>dd<NUMBER>pdb <NUMBER> sarscov<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER> <NUMBER>vsbpdb <NUMBER> spike proteins possible evaluate interactions m<NUMBER> sarscov<NUMBER> spike rbd propose sequencestructure ideal fab m<NUMBER>based chimeric antibody targeting sarscov<NUMBER> spike rbd domain preventing fusion events ace<NUMBER> thus following infection aim firstly highlighted different rbd portions bound known antibodies superimposed sarscov<NUMBER> rbd sarscov<NUMBER> rbd highlighting differences residues involved direct interactions m<NUMBER> cdr regions s<NUMBER> cdr regions fig <NUMBER> due uncertain data concerning fusion events mechanism action s<NUMBER> antibody built new sarscov<NUMBER> rbd directed antibody starting analysis monomermonomer interface interactions observed m<NUMBER> antibody crystallized complex sarscov<NUMBER> rbd <NUMBER> superimposed sarscov<NUMBER> spike rbd ace<NUMBER> complex <NUMBER>ajfpdb comparing monomermonomer interface interactions observed modelled m<NUMBER> antibody complex sarscov<NUMBER> rbd superimposed sarscov<NUMBER> rbdace<NUMBER> <NUMBER>vw<NUMBER>pdb <NUMBER>lzgpdb protein complex fig <NUMBER> <NUMBER> residues replacement directly performed newly generated <NUMBER>d model hosting interacting m<NUMBER>sarscov<NUMBER> spike rbd similarly complex modified m<NUMBER> antibody interacting sarscov<NUMBER> rbd also created m<NUMBER> cdr mutated residues reported tab <NUMBER> furthermore mutated residues within m<NUMBER> cdr interacting sarscov<NUMBER> spike rbd residues observed fig <NUMBER> engineered fab portions thus aligned superimposed fab portion crystallized igg <NUMBER>igtpdb <NUMBER> sequence chimeric antibodies observed supp interaction energies calculated sarscov<NUMBER> spike rbd domain m<NUMBER> native antibody fab portion gives negative value tab <NUMBER> confirming might binding interaction m<NUMBER> native antibody fab portion sarscov<NUMBER> spike rbd result encouraging also due indirect validation obtained getting similar interaction energies crystallized sarscov<NUMBER> rbd complex m<NUMBER> <NUMBER>d<NUMBER>pdb sarscov<NUMBER> sarscov<NUMBER> spike rbd domains crystallized complex ace<NUMBER> <NUMBER>ajfpdb <NUMBER>vw<NUMBER>pdb respectively tab <NUMBER> furthermore strong interaction terms interaction energies calculated foldx analyse complex assay also predicted sarscov<NUMBER> spike rbd also sarscov<NUMBER> spike rbd modified m<NUMBER> antibody see tab <NUMBER> suggesting engineered m<NUMBER> might efficient native m<NUMBER> binding sarscov<NUMBER> sarscov<NUMBER> spike rbd indicated pipeline allowed setup molecular framework hosting sarscov<NUMBER> spike protein ace<NUMBER> receptor different antibodies pdb session could handled different molecular visualizers molecular framework possible study predict molecular level interactions different pieces framework help molecular framework like ones proposed also help studying putative role ace inhibitors perturbing ace<NUMBER>rbd interactions indeed recently proposed patients treated ace inhibitors might exposed sarscov<NUMBER> infection <NUMBER> although ace<NUMBER> refseq accession number np<NUMBER> representing main target ace inhibitors ace<NUMBER> np<NUMBER> testis isoform np<NUMBER> somatic isoform among studied isoforms share <NUMBER> identical residues uncertain data ace inhibitors possible greater selectivity ace<NUMBER> versus ace<NUMBER> effect ace<NUMBER> expression regulation available literature <NUMBER> <NUMBER> structural comparison observed rmsd crystallized native ace<NUMBER> coordinates <NUMBER>r<NUMBER>pdb <NUMBER> ace<NUMBER> coordinates <NUMBER>o<NUMBER>apdb <NUMBER> lower <NUMBER> Ã¥ notably presence ace inhibitors captopril enalaprilat <NUMBER>uzepdb<NUMBER> <NUMBER>c<NUMBER>ppdb <NUMBER> lisinopril <NUMBER>o<NUMBER>pdb <NUMBER> produces rmsd lower <NUMBER> Ã¥ atomic coordinates cited crystallized structures reference native ace<NUMBER> <NUMBER>r<NUMBER>pdb <NUMBER> conversely cannot establish slightly higher rmsd observed native ace<NUMBER> however also admitting ace<NUMBER> inhibitors employed dosage would target ace<NUMBER> efficiency observed versus ace<NUMBER> presence inhibitors ace<NUMBER> binding cavity able induce important conformational change ace<NUMBER> might favour greater affinity ace<NUMBER> versus sarscov<NUMBER> spike rbd thus mechanism patients treated ace inhibitors would exposed sarscov<NUMBER> would rely positive feedback induced ace inhibitors ace<NUMBER> expression nevertheless evidences support hypothesis need deepened <NUMBER> <NUMBER> conclusion presented analysis highlights importance use fold recognition tools along approach drug design problem according rational protocol similar previously reported <NUMBER> <NUMBER> <NUMBER> like ones presented high affinity spike channel might immediately tested bedside context drugrepositioning approaches <NUMBER> <NUMBER> notably provided molecular framework investigatingdrawing new antibodies based spacerestraints needs would used setup new antibodies based available tissuespecific immunoglobulin structures proposed igg<NUMBER>a <NUMBER>igtpdb <NUMBER> specialized antibodies already optimized targeting specific cells receptors ie<NUMBER>hzhpdb <NUMBER> also among may successfully target respiratory tract <NUMBER>r<NUMBER>pdb <NUMBER> <NUMBER>qtjpdb <NUMBER> <NUMBER>ue<NUMBER>pdb <NUMBER> might administered even aerosol <NUMBER> <NUMBER> time already preclinical level administered vaccines based administration entire sarscov<NUMBER> spike protein <NUMBER> <NUMBER> <NUMBER> administration single sarscov<NUMBER> spike rbd induce production specific antibodies might sequenced modelled silico concern provided molecular network help quantifying interactions sarscov<NUMBER> rbd also cases different rbd variants <NUMBER> newly investigated antibodies ielower calculated binding energy modelled complex higher likelihood success investigated vaccinesantibodies discovered antibodies highest affinity rbd might also implemented diagnosis kit aiming early identification sarscov<NUMBER> sera also asymptomatic people conversely new diagnosis kit could also based native rbd modified synthetic rbd greater affinity detected human antibodies directed sarscov<NUMBER> spike rbd protein determining real number healthy people already exposed virus population lacking knowledge real number people exposed virus including asymptomatic people people mild symptoms rescued people never needed hospitalization quarantine important data still miss without data real number people exposed virus population coming back normal life extremely slower detailed instructions setup shown molecular framework provided manuscript nevertheless also provide free assistance academic analyses upon request also provide dedicated technical support analyses requested private companies browser srl spinoff case please write infobrowserbioinfcom clp cc coronaviruses covs responsible several outbreaks past two decades including sarscov <NUMBER> merscov <NUMBER> <NUMBER> current covid<NUMBER> pandemic caused sarscov<NUMBER> began late <NUMBER> <NUMBER> scale covid<NUMBER> pandemic led unprecedented efforts research community rapidly identify test therapeutics vaccines understand molecular basis sarscov<NUMBER> entry pathogenesis immune targeting february may <NUMBER> large number sarscov<NUMBER> protein structures released protein data bank pdb <NUMBER> <NUMBER> spike glycoprotein structures <NUMBER> main protease structures <NUMBER> structures sarscov<NUMBER> proteins including nucleocapsid rna dependent rna polymerase target drug remdesivir highresolution protein structures immense importance understanding viral assembly aid rational vaccine therapeutic design first structures sarscov<NUMBER> trimeric spike glycoproteins major target sarscov<NUMBER> vaccines antibody therapeutics reported february early march <NUMBER> <NUMBER> <NUMBER> previously determined spike glycoprotein structures enabled advances including rational stability optimization sarscov merscov spikes yielding improved protein expression immunogenicity <NUMBER> given rapid rate coronavirus protein structural determination deposition likely continue simple updated resource detailing structures would provide useful reference describe new database experimentally determined coronavirus protein structures cov<NUMBER>d cov<NUMBER>d updated automatically weekly basis new structures released ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> main components cov<NUMBER>d database interrelated tables datasets tools coronavirus protein structures spike glycoprotein sequences schematic cov<NUMBER>d input organization contents shown figure <NUMBER> structure portion database includes dedicated pages tables â¢ spike glycoprotein structures addition table known structures cov spike proteins interactions cov<NUMBER>d provides viewer sarscov<NUMBER> spike rbd interactions antibodies ace<NUMBER> receptor superposed rbd common reference frame figure <NUMBER>a viewer permits users assess overlapping shared rbd binding modes among antibodies ace<NUMBER> one antibody interest s<NUMBER> human antibody cloned individual infected sarscov <NUMBER> potently neutralizes sarscov<NUMBER> <NUMBER> comparing rbd binding ace<NUMBER> rbd interaction viewer figure <NUMBER>a highlights s<NUMBER> engages rbd distinct site ace<NUMBER> accordance lack ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> observed rbd binding competition <NUMBER> epitope targeted s<NUMBER> dominated rbd residues <NUMBER> circled figure <NUMBER>a cov<NUMBER>d sequence logo generator page users enter spike residue ranges generate sequence logos represent positional residue propensities conservation regions interest based sets cov spike sequences sequence logo generated reference set spike proteins <NUMBER> sarslike covs figure <NUMBER>b shown figure <NUMBER>c indicating conservation nglycosylation site nxsnxt sequon position <NUMBER> amino acid variability position <NUMBER> glutamic acid e sarscov<NUMBER> n<NUMBER> glycan e<NUMBER> side chain directly engaged s<NUMBER> recently determined complex structure <NUMBER> cov<NUMBER>d provides easily accessible information identified sarscov<NUMBER> spike polymorphisms mapping onto spike glycoprotein structures sequences users navigate spike polymorphisms table shown observed single multiple substitutions spike glycoprotein along counts sequences containing d<NUMBER>g variant currently prevalent occurrences reference sequence represented current spike glycoprotein structures <NUMBER> sequences versus <NUMBER> sequences may <NUMBER> <NUMBER> viewing position substitution spike glycoprotein provide indication possible structural functional impact clicking view next substitution users visualize position substitution showing located spike surface located within adjacent receptor binding domain rbd figure <NUMBER>a however site closer rbd site another less prevalent sarscov<NUMBER> spike variant t<NUMBER>i figure <NUMBER>b ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> example usage visualizing modeled glycosylation nglycosylation viral glycoproteins play key role masking glycoprotein immune system affecting function <NUMBER> experimentally reported protein structures often lack nglycans large portions thereof due limitations resolution intrinsic glycan dynamics heterogeneity enable visualization additional analysis modeling glycosylated spike glycoproteins cov<NUMBER>d includes sets structures modeled nglycans predicted glycosylation sites nglycans built onto glycoprotein structures refined using new tools rosetta based rosettacarbohydrates <NUMBER> examples glycosylated structures visualized cov<NUMBER>d shown figure <NUMBER> downloaded directly users processing permits users view features nglycosylation present ace<NUMBER> surface figure <NUMBER>a relatively high glycosylation spike glycoprotein stem bottom figure <NUMBER>b presently structures include uniform oligomannose glycoforms found prevalent sarscov spike based previous mass spectroscopy analysis <NUMBER> five branched mannose sugars future plan include spike structures modeled glycans include glycoforms reflect recent mass spectroscopy experimental characterization sarscov<NUMBER> spike <NUMBER> constructed cov<NUMBER>d database reference research community providing simple updated interface coronavirus <NUMBER>d structures integrated molecular viewers useful features allow researchers identify analyze new coronavirus protein structures released particularly sarscov<NUMBER> allowing ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> insights sequence features polymorphisms well glycosylation recent study combining coronavirus structural sequence analysis revealed insights regarding determinants ace<NUMBER> recognition <NUMBER> recent sarscov<NUMBER> spikeantibody complex structures shown mechanisms crossreactive cov spike targeting neutralization <NUMBER> <NUMBER> <NUMBER> importantly new spikeantibody structures continue delineate determinants effective immune recognition spike glycoprotein update multistructure viewer include structures facilitate comparison previously determined ones explore adding annotations including structurebased classification spikeantibody interactions based features database helpful virologists computational biologists immunologists interested learning targeting sarscov<NUMBER> proteins small molecules antibodies well engaged vaccine design cov<NUMBER>d implemented using flask web framework httpsflaskpalletsprojectscom sqlite database engine httpswwwsqliteorg structures identified pdb weekly basis using ncbi blast command line tools <NUMBER> coronavirus protein reference sequences sarscov merscov sarscov<NUMBER> queries spike glycoprotein reference sequences genbank identification <NUMBER> structural visualization performed using ngl viewer <NUMBER> nglycans modeled onto spike glycoprotein structures using glycan modeling refinement protocol rosetta <NUMBER> example command line rosetta script glycan modeling protocol provided supplemental information sarscov<NUMBER> spike glycoprotein sequences sequence information downloaded ncbi virus <NUMBER> followed filtering sequences missing residues sequence polymorphism information obtained blast search using reference sarscov<NUMBER> spike glycoprotein sequence qhd<NUMBER> develop spike glycoprotein alignments betacoronavirus spike glycoprotein sequences downloaded ncbi virus <NUMBER> aligned clustal omega <NUMBER> seaview <NUMBER> sequences redundant <NUMBER> similarity contained missing residues removed remaining <NUMBER> sequences forming panbetacoronavirus alignment subset <NUMBER> sequences panbetacoronavirus alignment used generate sarslike sequence alignment contains every sequence panbetacoronavirus alignment <NUMBER> sequence similarity sarscov<NUMBER> spike sequence logos generated dynamically userspecified residue ranges using commandline version weblogo <NUMBER> phylogenetic trees representing spike reference sequences generated using clustalx <NUMBER> visualized using ape package <NUMBER> r wwwrprojectorg <NUMBER> sarscov membrane protein peptide complex human major histocompatibility complex mhc protein hlaa<NUMBER> pdb code <NUMBER>i<NUMBER>k <NUMBER> also shown sequence logo generated cov<NUMBER>d spike glycoprotein subsequence <NUMBER> ace<NUMBER> pdb code <NUMBER>lzg <NUMBER> cov<NUMBER>d spike colored magenta s<NUMBER> cyan ace<NUMBER> green interacting region interest rbd residues <NUMBER> circled reference clarity s<NUMBER>rbd region s<NUMBER>spike complex structure shown b unrooted phylogenetic tree generated using <NUMBER> reference spike sequences sarslike covs used cov<NUMBER>d sequence logo generator figure generated using ape package r <NUMBER> scale bar shown lower left representing <NUMBER> sequence divergence c cov<NUMBER>d sequence logo generation interface logo spike residues <NUMBER> logo generated using <NUMBER> sarsrelated spike glycoprotein reference sequences commandline version weblogo <NUMBER> copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint substitution polymorphisms shown context prefusion spike structure <NUMBER> pdb code <NUMBER>vsb gray sites spacefill representations wildtype residue spike trimer subunit colored atom type cyan carbon blue nitrogen red oxygen receptor binding domains residues <NUMBER> shown magenta red dashed circles denote mutation sites reference rbdace<NUMBER> complex <NUMBER> pdb code <NUMBER>lzg rbd ace<NUMBER> shown red blue cartoons respectively modeled nglycans shown gray red blue spheres one nglycan modeled spike rbd six modeled ace<NUMBER> b trimeric spike structure rbdclosed conformation <NUMBER> pdb code <NUMBER>vxx spike shown gray surface modeled nglycans shown gray red blue spheres <NUMBER> modeled nglycans present spike structure ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint coronaviruses covs responsible several outbreaks past two decades pandemic caused sarscov<NUMBER> began late <NUMBER> <NUMBER> scale covid<NUMBER> pandemic led unprecedented efforts research community rapidly identify test therapeutics vaccines understand molecular basis sarscov<NUMBER> entry pathogenesis immune targeting since february <NUMBER> large number sarscov<NUMBER> protein structures released protein data bank pdb <NUMBER> june <NUMBER>th <NUMBER> includes <NUMBER> spike glycoprotein structures <NUMBER> main protease structures <NUMBER> structures sarscov<NUMBER> proteins highresolution protein structures immense importance understanding viral assembly aid rational vaccine therapeutic design first structures sarscov<NUMBER> trimeric spike glycoproteins major target sarscov<NUMBER> vaccines antibody therapeutics reported february early march <NUMBER> <NUMBER> <NUMBER> previously determined spike glycoprotein structures enabled advances including rational stability optimization sarscov merscov spikes yielding improved protein expression immunogenicity <NUMBER> given rapid rate coronavirus protein structural determination deposition likely continue simple updated resource detailing structures would provide useful reference describe new database experimentally determined coronavirus protein structures cov<NUMBER>d cov<NUMBER>d updated automatically weekly basis new structures released pdb structures classified cov protein well bound molecule monoclonal antibody receptor small molecule ligand enable insights spike glycoprotein also include information sarscov<NUMBER> residue polymorphisms overall coronavirus sequence diversity betacoronaviruses mapped onto spike glycoprotein structures structures spike glycoproteins modeled glycans reference subsequent modeling resource aid efforts rational vaccine design targeting immunotherapies biologics small molecules basic research coronavirus structure recognition cov<NUMBER>d publicly available httpscov<NUMBER>dibbrumdedu cov<NUMBER>d implemented using flask web framework httpsflaskpalletsprojectscom sqlite database engine httpswwwsqliteorg structures identified pdb weekly basis using ncbi blast command line tools <NUMBER> visualization performed using ngl viewer <NUMBER> nglycans modeled onto spike glycoprotein structures using glycan modeling refinement protocol rosetta <NUMBER> example command line rosetta script glycan modeling protocol provided supplemental information rootmeansquare distances rmsds pairs full cov spike glycoprotein chains computed using fast structure alignment program <NUMBER> resultant distance matrix input r wwwrprojectorg used perform hierarchical clustering dendrogram generated using dendextend r package <NUMBER> spike chains classified two clusters based analysis corresponding open closed spike states sarscov<NUMBER> spike glycoprotein sequences downloaded ncbi virus <NUMBER> followed filtering sequences missing residues sequence polymorphism information obtained blast search using reference sarscov<NUMBER> spike glycoprotein sequence qhd<NUMBER> develop spike glycoprotein alignments betacoronavirus spike glycoprotein sequences downloaded ncbi virus <NUMBER> aligned clustal omega <NUMBER> seaview <NUMBER> sequences redundant <NUMBER> similarity contained missing residues removed remaining <NUMBER> sequences forming panbetacoronavirus alignment subset <NUMBER> sequences panbetacoronavirus alignment used generate sarslike sequence alignment contains every sequence panbetacoronavirus alignment <NUMBER> sequence similarity sarscov<NUMBER> spike sequence logos generated dynamically userspecified residue ranges using commandline version weblogo <NUMBER> phylogenetic trees representing spike reference sequences generated using clustalx <NUMBER> visualized using ape package <NUMBER> r wwwrprojectorg main components cov<NUMBER>d database interrelated tables datasets tools coronavirus protein structures spike glycoprotein sequences schematic cov<NUMBER>d input organization contents shown figure <NUMBER> structure portion database includes dedicated pages tables â¢ spike glycoprotein structures addition table known structures cov spike proteins interactions cov<NUMBER>d provides viewer sarscov<NUMBER> spike rbd interactions antibodies ace<NUMBER> receptor superposed rbd common reference frame figure <NUMBER>a viewer permits users assess overlapping shared rbd binding modes among antibodies ace<NUMBER> one antibody interest s<NUMBER> human antibody cloned individual infected sarscov <NUMBER> potently neutralizes sarscov<NUMBER> <NUMBER> comparing rbd binding ace<NUMBER> rbd interaction viewer figure <NUMBER>a highlights s<NUMBER> engages rbd distinct site ace<NUMBER> accordance lack observed rbd binding competition <NUMBER> epitope targeted s<NUMBER> dominated rbd residues <NUMBER> circled figure <NUMBER>a cov<NUMBER>d sequence logo generator page users enter spike residue ranges generate sequence logos represent positional residue propensities conservation regions interest based sets cov spike sequences sequence logo generated reference set spike proteins <NUMBER> sarslike covs shown figure <NUMBER>b indicating conservation nglycosylation site nxsnxt sequon position <NUMBER> amino acid variability position <NUMBER> glutamic acid e sarscov<NUMBER> n<NUMBER> glycan e<NUMBER> side chain directly engaged s<NUMBER> recently determined complex structure <NUMBER> nglycosylation viral glycoproteins play key role masking glycoprotein immune system affecting function <NUMBER> experimentally reported protein structures often lack nglycans large portions thereof due limitations resolution intrinsic glycan dynamics heterogeneity enable visualization additional analysis modeling glycosylated spike glycoproteins cov<NUMBER>d includes sets structures modeled nglycans predicted glycosylation sites nglycans built onto glycoprotein structures refined using new tools rosetta based previously developed glycan functionality <NUMBER> examples glycosylated structures visualized cov<NUMBER>d shown figure <NUMBER> downloaded directly users processing permits users view features nglycosylation present ace<NUMBER> surface figure <NUMBER>a relatively high glycosylation spike glycoprotein stem bottom figure <NUMBER>b presently structures include uniform oligomannose glycoforms found prevalent sarscov spike based previous mass spectroscopy analysis <NUMBER> five branched mannose sugars future plan include spike structures modeled glycans possibly include glycoforms reflect mass spectroscopy experimental characterization sarscov<NUMBER> spike <NUMBER> constructed cov<NUMBER>d database reference research community providing simple updated interface coronavirus <NUMBER>d structures integrated molecular viewers structural classification variety useful features allow researchers identify new coronavirus protein structures released particularly sarscov<NUMBER> enabling insights spike glycoprotein antibody recognition sequence features polymorphisms glycosylation recently released sarscov<NUMBER> spikeantibody complex structures revealed mechanisms crossreactive cov spike targeting neutralization <NUMBER> <NUMBER> <NUMBER> many ongoing antibody identification characterization studies likely result many antibodyspike structures near future cov<NUMBER>d facilitates use growing structural datasets analysis modeling structurebased design efforts collecting annotating structures conformations providing inline structural viewing single multiple complexes suggestions institute bioscience biotechnology research computing facility staff including christian presley provided resources assistance server implementation web hosting work supported part nih r<NUMBER> gm<NUMBER> bgp coronaviruses covs responsible several outbreaks past two decades pandemic caused sarscov<NUMBER> began late <NUMBER> <NUMBER> scale covid<NUMBER> pandemic led unprecedented efforts research community rapidly identify test ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint therapeutics vaccines understand molecular basis sarscov<NUMBER> entry pathogenesis immune targeting since february <NUMBER> large number sarscov<NUMBER> protein structures released protein data bank pdb <NUMBER> june <NUMBER>th <NUMBER> includes <NUMBER> spike glycoprotein structures <NUMBER> main protease structures <NUMBER> structures sarscov<NUMBER> proteins highresolution protein structures immense importance understanding viral assembly aid rational vaccine therapeutic design first structures sarscov<NUMBER> trimeric spike glycoproteins major target sarscov<NUMBER> vaccines antibody therapeutics reported february early march <NUMBER> <NUMBER> <NUMBER> previously determined spike glycoprotein structures enabled advances including rational stability optimization sarscov merscov spikes yielding improved protein expression immunogenicity <NUMBER> given rapid rate coronavirus protein structural determination deposition likely continue simple updated resource detailing structures would provide useful reference describe new database experimentally determined coronavirus protein structures cov<NUMBER>d cov<NUMBER>d updated automatically weekly basis new structures released pdb structures classified cov protein well bound molecule monoclonal antibody receptor small molecule ligand enable insights spike glycoprotein also include information sarscov<NUMBER> residue polymorphisms overall coronavirus sequence diversity betacoronaviruses mapped onto spike glycoprotein structures structures spike glycoproteins modeled glycans reference subsequent modeling resource ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint aid efforts rational vaccine design targeting immunotherapies biologics small molecules basic research coronavirus structure recognition cov<NUMBER>d publicly available httpscov<NUMBER>dibbrumdedu cov<NUMBER>d implemented using flask web framework httpsflaskpalletsprojectscom sqlite database engine httpswwwsqliteorg structures identified pdb weekly basis using ncbi blast command line tools <NUMBER> visualization performed using ngl viewer <NUMBER> nglycans modeled onto spike glycoprotein structures using glycan modeling refinement protocol rosetta <NUMBER> example command line rosetta script glycan modeling protocol provided supplemental information ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint rootmeansquare distances rmsds pairs full cov spike glycoprotein chains computed using fast structure alignment program <NUMBER> resultant distance matrix input r wwwrprojectorg used perform hierarchical clustering dendrogram generated using dendextend r package <NUMBER> spike chains classified two clusters based analysis corresponding open closed spike states sarscov<NUMBER> spike glycoprotein sequences downloaded ncbi virus <NUMBER> followed filtering sequences missing residues sequence polymorphism information obtained blast search using reference sarscov<NUMBER> spike glycoprotein sequence qhd<NUMBER> develop spike glycoprotein alignments betacoronavirus spike glycoprotein sequences downloaded ncbi virus <NUMBER> aligned clustal omega <NUMBER> seaview <NUMBER> sequences redundant <NUMBER> similarity contained missing residues removed remaining <NUMBER> sequences forming panbetacoronavirus alignment subset <NUMBER> sequences panbetacoronavirus alignment used generate sarslike sequence alignment contains every sequence panbetacoronavirus alignment <NUMBER> sequence similarity sarscov<NUMBER> spike sequence logos generated dynamically userspecified residue ranges using commandline version weblogo <NUMBER> phylogenetic trees representing spike reference sequences generated using clustalx <NUMBER> visualized using ape package <NUMBER> r wwwrprojectorg ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint main components cov<NUMBER>d database interrelated tables datasets tools coronavirus protein structures spike glycoprotein sequences schematic cov<NUMBER>d input organization contents shown figure <NUMBER> structure portion database includes dedicated pages tables â¢ spike glycoprotein structures unsupervised clustering based spike rootmeansquare distances rmsds automatically classifies spike structures two broad clusters figure <NUMBER> corresponding open closed conformations also referred conformations forms relevant receptor binding vaccine design <NUMBER> <NUMBER> annotations states based addition table known structures cov spike proteins interactions cov<NUMBER>d provides viewer sarscov<NUMBER> spike rbd interactions antibodies ace<NUMBER> receptor superposed rbd common reference frame figure <NUMBER>a viewer permits users assess overlapping shared rbd binding modes among antibodies ace<NUMBER> one antibody interest s<NUMBER> human antibody cloned individual infected sarscov <NUMBER> potently neutralizes sarscov<NUMBER> <NUMBER> comparing rbd binding ace<NUMBER> rbd interaction viewer figure <NUMBER>a highlights s<NUMBER> engages rbd distinct site ace<NUMBER> accordance lack observed rbd binding competition <NUMBER> epitope targeted s<NUMBER> dominated rbd ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint residues <NUMBER> circled figure <NUMBER>a cov<NUMBER>d sequence logo generator page users enter spike residue ranges generate sequence logos represent positional residue propensities conservation regions interest based sets cov spike sequences sequence logo generated reference set spike proteins <NUMBER> sarslike covs shown figure <NUMBER>b indicating conservation nglycosylation site nxsnxt sequon position <NUMBER> amino acid variability position <NUMBER> glutamic acid e sarscov<NUMBER> n<NUMBER> glycan e<NUMBER> side chain directly engaged s<NUMBER> recently determined complex structure <NUMBER> nglycosylation viral glycoproteins play key role masking glycoprotein immune system affecting function <NUMBER> experimentally reported protein structures often lack nglycans large portions thereof due limitations resolution intrinsic glycan dynamics heterogeneity enable visualization additional analysis modeling glycosylated spike glycoproteins cov<NUMBER>d includes sets structures modeled nglycans predicted glycosylation sites nglycans built onto glycoprotein structures refined using new tools rosetta based previously developed glycan functionality <NUMBER> examples glycosylated structures visualized cov<NUMBER>d shown figure <NUMBER> downloaded directly users processing permits users view features nglycosylation present ace<NUMBER> surface figure <NUMBER>a relatively high glycosylation spike glycoprotein stem bottom figure <NUMBER>b presently structures include uniform oligomannose glycoforms found prevalent sarscov spike based previous mass spectroscopy analysis <NUMBER> five branched ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint mannose sugars future plan include spike structures modeled glycans possibly include glycoforms reflect mass spectroscopy experimental characterization sarscov<NUMBER> spike <NUMBER> constructed cov<NUMBER>d database reference research community providing simple updated interface coronavirus <NUMBER>d structures integrated molecular viewers structural classification variety useful features allow researchers identify new coronavirus protein structures released particularly sarscov<NUMBER> enabling insights spike glycoprotein antibody recognition sequence features polymorphisms glycosylation recently released sarscov<NUMBER> spikeantibody complex structures revealed mechanisms crossreactive cov spike targeting neutralization <NUMBER> <NUMBER> <NUMBER> many ongoing antibody identification characterization studies likely result many antibodyspike structures near future cov<NUMBER>d facilitates use growing structural datasets analysis modeling structurebased design efforts collecting annotating structures conformations providing inline structural viewing single multiple complexes ccbynd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint whereas merscov spike protein attaches dipeptidyl peptidase <NUMBER> dpp<NUMBER> <NUMBER> <NUMBER> recently several structures sarscov<NUMBER> spike protein complexed human ace<NUMBER> resolved pdbids <NUMBER>lzg <NUMBER>vw<NUMBER> <NUMBER>m<NUMBER> highlighting critical residues involved intermolecular interactions viral spike protein receptor <NUMBER> virus transmitted humans bats intermediate hosts considerable work conducted explore sequence structural variations spike proteins animal host ace<NUMBER> receptors <NUMBER> <NUMBER> <NUMBER> shown variations viral spike protein host ace<NUMBER> sequences may act barrier viral infection across species <NUMBER> <NUMBER> <NUMBER> turn raises two interesting possibilities first natural genetic polymorphism human ace<NUMBER> gene andor protein influence attachment sarscov<NUMBER> spike protein second genetic variants ace<NUMBER> benign could considered evolutionary tradeoff variation trait may bring advantage disadvantage fitness organism study aims explore possibilities battery sequence structure analysis tools findings provide interesting insights potential relationship natural genetic variants human ace<NUMBER> susceptibility andor resistance covid<NUMBER> infection human ace<NUMBER> q<NUMBER>byf<NUMBER> retrieved ncbi uniprot respectively structures proteins identified pdbblast retrieved rcsb protein data bank <NUMBER> data genetic variants allele frequencies obtained ensembl genome browser <NUMBER> gnomad <NUMBER> appropriate filters employed limit data coding region variants ace<NUMBER> gene coding variants ace<NUMBER> corresponding critical binding sites ace<NUMBER>sarscov <NUMBER> ace<NUMBER>sarscov<NUMBER> pdbid <NUMBER>lzg reported show impaired binding coronavirus spike protein vitro mutation analysis <NUMBER> selected investigations table s<NUMBER> effect amino acid substitution protein ace<NUMBER> stability predicted <NUMBER>Â°c <NUMBER>Â°c using imutant<NUMBER> <NUMBER> program predicts change free energy Î´Î´g sequence variants compared wild type increase decrease protein stability indicated negative positive Î´Î´g values respectively functional impact selected allelic variants ace<NUMBER> predicted using sorting intolerant tolerant sift <NUMBER> polyphen<NUMBER> <NUMBER> combined annotationdependent depletion cadd <NUMBER> rare exome variant ensemble learner revel <NUMBER> total <NUMBER> ace<NUMBER> coding region allelic variants identified correspond critical interaction points ace<NUMBER> receptorbinding domain rbd coronavirus spike protein structural models variants generated using atomic coordinates pdbid <NUMBER>ajfa wildtype ace<NUMBER> template sarscov<NUMBER> spike glycoprotein <NUMBER> aminoacidlong structural protein located outer envelope virus protein two main functional subunits long nterminal s<NUMBER> subunit relatively short cterminal s<NUMBER> subunit <NUMBER> aminoacidlong rbd stationed within s<NUMBER> subunit spike protein mainly involved interaction ace<NUMBER> receptor <NUMBER> human ace<NUMBER> <NUMBER> aminoacidlong protein two functional domains nterminal peptidase m<NUMBER> domain cterminal collectrin domain partial structure ace<NUMBER> resolved pdbid <NUMBER>r<NUMBER> comprising peptidase m<NUMBER> domain structurally peptidase domain two catalytic subdomains active site sandwiched two subdomains <NUMBER> cocrystal structures sarscov<NUMBER> spike protein complexed human ace<NUMBER> pdbid <NUMBER>lzg sarscov human ace<NUMBER> <NUMBER> vitro mutation analysis human ace<NUMBER> <NUMBER> identified critical residues underpin interaction rbd viral spike protein ace<NUMBER> peptidase domain study among <NUMBER> <NUMBER> natural ace<NUMBER> coding variants identified ensembl genome browser gnomad respectively <NUMBER> found positions shown important binding ace<NUMBER> viral spike protein table s<NUMBER> allele frequencies variants range <NUMBER>eâ<NUMBER> rs<NUMBER> <NUMBER>eâ<NUMBER> rs<NUMBER> predict potential pathological consequences rendered ace<NUMBER> alleles changes free energy ace<NUMBER> variants estimated results showed amino acid substitutions three alleles rs<NUMBER> s<NUMBER>p rs<NUMBER> k<NUMBER>e rs<NUMBER> m<NUMBER>i may adversely affect stability encoded protein compared wild type table <NUMBER> however date pathogenic consequences reported relation variants humans moreover except rs<NUMBER> s<NUMBER>p predicted damaging polyphen<NUMBER> different prediction tools designed assess functional impact mutations andor singlenucleotide polymorphisms reveal ensuing pathogenicity rendered variants table <NUMBER> conversely rs<NUMBER> d<NUMBER>n rs<NUMBER> p<NUMBER>h predicted detrimental sift polyphen<NUMBER> whereas rs<NUMBER> m<NUMBER>t predicted damaging sift polyphen<NUMBER> revel prediction tools nevertheless report functional impact found literature allelic variants ace<NUMBER> well explore structural changes protein encoded figure <NUMBER>c many interactions also reported previously resolved structure sarscov spike proteinace<NUMBER> complex pdbid <NUMBER>ajf <NUMBER> representation comparison interactions different ace<NUMBER> alleles shown figure <NUMBER>d briefly conserved intermolecular interactions hydrogen bonds different ace<NUMBER> variants sarscov<NUMBER> spike protein found y<NUMBER> h<NUMBER> y<NUMBER> k<NUMBER> ace<NUMBER> spike protein <NUMBER> therefore likely rs<NUMBER> s<NUMBER>p s<NUMBER>p rs<NUMBER> e<NUMBER>g therefore findings investigation provide clues screen frequencies candidate alleles different populations predict prognosis covid<NUMBER> httporcidorg<NUMBER>x recently world health organization httpswwwwhoint declared outbreak spread novel coronavirus severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> causes <NUMBER> million reported cases <NUMBER> hundred thousand deaths <NUMBER> countries coronaviruses cause mild <NUMBER> respiratory distress <NUMBER> <NUMBER> however three coronaviruses namely severe acute respiratory syndrome coronavirus sarscov sarscov<NUMBER> middle east respiratory syndrome coronavirus merscov found far highly pathogenic transmitted animal human <NUMBER> sarscov <NUMBER> brings <NUMBER> case fatality rate cfr mers presented cfr <NUMBER> <NUMBER> <NUMBER> <NUMBER> cfr novel coronavirus cannot stated moment pandemic yet although <NUMBER> estimated one thing apparent transmission rate infection higher previous outbreaks <NUMBER> sarscov<NUMBER> causes mainly severe acute respiratory distress attacking lung cells complications heart kidney brain spleen ultimately succumbed disastrous effect coronavirus afflicted patients <NUMBER> hour crisis available effective standardofcare present treat coronavirus affected patients makes urgent need find agents get control pandemic scientists globally make effort best come effective therapeutic agents design drug virus first see indispensable processes virus help survive replicates copy number genome virus showed sequence similarity <NUMBER> batcov ratg<NUMBER> <NUMBER> sarscov <NUMBER> <NUMBER> sarscov<NUMBER> enveloped singlestranded positivesense rna genome containing viruses rna consists <NUMBER> nucleotides transcribed <NUMBER> orfs translated around <NUMBER> identified nonstructural structural proteins ncbi reference sequence nc<NUMBER> <NUMBER> sarscov<NUMBER> enters host cells containing ace<NUMBER> lung oral nasal mucosa glycosylated spike protein <NUMBER> human ace<NUMBER> interacts sarscov<NUMBER> spike proteins facilitates sarscov<NUMBER> entry target cells <NUMBER> <NUMBER> viral glycosylated spike protein composed s<NUMBER> s<NUMBER> subunits coronaviruses enables access host cell rbd s<NUMBER> subunit sarscov<NUMBER> attaches ace<NUMBER> led shed s<NUMBER> subunit subsequently triggers cleavage s<NUMBER> subunit host protease protein tmprss<NUMBER> cleave s<NUMBER>s<NUMBER> protease cleavage site <NUMBER> cleavage changes conformation allowing hr<NUMBER> hr<NUMBER> form <NUMBER>hb facilitates membrane fusion virus releases payload rna cytoplasm first translation product rna genome polyprotein pp<NUMBER>a pp<NUMBER>ab subsequently <NUMBER>cl protease <NUMBER>clpro papainlike protease plpro cleave pp<NUMBER>a pp<NUMBER>ab functional proteins required genome amplification structural proteins produced host ergolgi system assembles releases mature virus infected cells <NUMBER> <NUMBER> current understanding strongly recommends targeting surface protein viral particle possibly prevents entering host cell sarscov<NUMBER> spike protein trimeric protein rbd subunit two types conformations one conformation conformation viral spike protein could smoothly interact human ace<NUMBER> protein otherwise inaccessible <NUMBER> comparing structure sarscov<NUMBER> sarscov spike protein similar amino acid sequences functions <NUMBER> however rbd sarscov<NUMBER> spike protein conformation n packs tightly n terminal domain ntd neighboring protomer whereas sarscov<NUMBER> conformation angled closer central cavity trimer additionally binding affinity sarscov<NUMBER> spike protein ace<NUMBER> protein stronger sarscov even <NUMBER> folds <NUMBER> therefore deduce structure sarscov<NUMBER> similar sarscov <NUMBER> drug discovery development time taking costly complex process usually takes years effort get clinically successful <NUMBER> however virtual screening authentic databases use advanced bioinformatics cheminformatics reduce time come best drug match selected target process virtual screening become gold standard method preliminary phase drug designing discover potential hits sarscov<NUMBER> screened essential entry pathway targeting virus penetration cells study aims find potential hit compounds taiwan database extracts compounds tdec httpstdeckmuedutw sarscov<NUMBER> spike protein focus screen hit compounds interact viral spike protein spikeace<NUMBER> complex protein leading prevention viral payload host cytoplasm selected target mainly rbd spike proteins viral host cell interactions tdec academic scientific platform investigators different fields share research information includes much information compounds structures physicochemical properties biological activities etc pure natural isolates crude extracts synthesized extract plants microbes marine organisms chinese herbal medicines present study attempt made virtually screen candidates tdec selected target high throughput bioinformatics cheminformatics analysis get insight interaction spike protein hits <NUMBER> protein superimposition performed pymol software version <NUMBER>rc<NUMBER> compare conformation spike proteins two states <NUMBER> one spike protein prefusion ace<NUMBER>free conformation rbd spike protein ace<NUMBER>bound conformation study simulated structure rbd spike protein prefusion ace<NUMBER>free conformation constructed homology modeling using structure experimental structure ace<NUMBER>free spike protein resolved cryogenic electron microscopy cryoem modeling template s<NUMBER>a fig simulated spike protein able obtained swiss model website s<NUMBER>b fig <NUMBER> <NUMBER> rbd spike protein bound ace<NUMBER> protein experimental protein structure resolved xray crystallography able downloaded protein data bank pdb httpswwwrcsborg s<NUMBER>c fig <NUMBER> protein superimposition calculations analyzed shown pymol software virtual screenings molecular docking calculations performed autodock vina version <NUMBER> program within pyrx version <NUMBER> software discover potential compounds binding viral spike protein compound database <NUMBER> <NUMBER> <NUMBER> structures compounds downloaded may <NUMBER> <NUMBER> tdec collected compounds together save sdf format file discovery studio <NUMBER> visualizer software ds <NUMBER> <NUMBER> subsequently structures compounds optimized energy minimization steepest descent algorithm using mmff<NUMBER> force field translated <NUMBER> divided <NUMBER> individual pdbqt format files open babel program within pyrx software <NUMBER> experimental structure spikeace<NUMBER> complex protein resolved xray crystallography obtained protein data bank pdb id <NUMBER>m<NUMBER>j simulated structure prefusional spike protein downloaded swiss model website <NUMBER> <NUMBER> <NUMBER> substrates including ligands metal ions water molecules existed protein structures removed atoms residues protein structures modified added polar hydrogens partial charges using ds <NUMBER> software charm force field moreover discover potential compounds binding rbd spike protein prefusion conformation site connective interface spikeace<NUMBER> complex protein database virtual screening dimensions docking search spaces respectively set big enough contain residues ace<NUMBER> binding site rbd spike proteins therefore size docking sites respectively set follows experimental spikeace<NUMBER> complex protein previous report shown rbd sarscov<NUMBER> spike protein bound human ace<NUMBER> protein assist virus entry cells <NUMBER> recently <NUMBER>d protein structure viral spike protein resolved cryoem technique <NUMBER> however found structure spike protein resolved cryoem incomplete lacked parts residues rbd spike protein s<NUMBER>a fig therefore structure spike protein complete amino acid sequences prefusion conformation needed constructed simulation fortunately useful trusted simulated structure sarscov<NUMBER> spike protein prefusion conformation constructed homology modeling could easily downloaded swissmodel website s<NUMBER>b fig additionally viral rbd spike protein bound human ace<NUMBER> protein spikeace<NUMBER> complex protein also recently resolved xray crystallography s<NUMBER>c fig investigate whether conformation rbd spike proteins ace<NUMBER>free state ace<NUMBER>bound state differences protein superimposition performed pymol software using structural aligning method data showed value root mean square rms two conformations <NUMBER> Ã¥ <NUMBER>Ã¥ meant superimposition rbd spike proteins good fig <NUMBER> however comparing rbd regions spike proteins simulation models significantly different structural conformation blue ring fig <NUMBER> simulation showed position receptorbinding motif rbm regional structure prefusion conformation close rbd core fusion conformation besides pose rbm regional structure fusional conformation close ace<NUMBER> protein prefusion conformation generally sarcov<NUMBER> rbm contains many contacting residues binding human ace<NUMBER> protein <NUMBER> concluded conformation changing rbm regional structure spike protein might affect spike protein binding behavior human ace<NUMBER> protein study reported cterminal domain ctd sarscov spike protein bound ace<NUMBER> protein different kinds angles conformations poses would changed well fit conformation dynamic ace<NUMBER> protein ace<NUMBER> unboundup conformation ace<NUMBER>bound conformation ace<NUMBER> unbounddown conformation <NUMBER> additionally observed conformation rbd sarscov<NUMBER> spike protein prefusional state different fusional state fig <NUMBER> words speculate conformation dynamic rbd sarscov<NUMBER> spike protein would change well bind fit dynamic ace<NUMBER> protein therefore could design strategy two potential hitting sites could set compound docking sites prevent spike protein bind ace<NUMBER> protein one compounds docked rbd spike protein prevent spike protein bind human ace<NUMBER> protein compounds docked site connective interface spikeace<NUMBER> complex protein influence affinity binding dynamic viral spike protein dynamic human ace<NUMBER> protein cause nonfunctional changing structural conformation prevent viral spike protein cleaved human proteases study aim going discover compounds bind rbd spike protein prefusion conformation also bind site connective interface spikeace<NUMBER> complex protein discover potential compounds virtual screening molecular docking calculation performed autodock vina program within pyrx software molecular structures prepared virtual screening downloaded tdec website results showed numbers docked compounds binding energy <NUMBER> kcalmol prefusion rbd spike protein spikeace<NUMBER> complex protein respectively <NUMBER> <NUMBER> among compounds numbers overlapped compounds nonoverlapped compounds respectively <NUMBER> <NUMBER> binding energies properties <NUMBER> overlapped compounds respectively shown fig <NUMBER> s<NUMBER> fig s<NUMBER> table subsequently value screening threshold raised limited <NUMBER> kcalmol compounds tdec<NUMBER>cn<NUMBER> thioflexibilolide tdec<NUMBER>cn<NUMBER> candidine reached condition amino acid his<NUMBER> interactive distance <NUMBER>Ã¥ fig <NUMBER>d data also showed candidine could dock prefusional rbd spike protein cyan cartoon value binding energy <NUMBER> kcalmol fig <NUMBER>a also formed many interactions amino acids prefusional rbd amino acid leu<NUMBER> interactive distances respectively <NUMBER>Ã¥ <NUMBER>Ã¥ <NUMBER>Ã¥ <NUMBER>Ã¥ moreover also formed pipi tshaped interaction pinking purple dashed line amino acid phe<NUMBER> interactive distance <NUMBER>Ã¥ fig <NUMBER>b candidine docked site near connective interface <NUMBER> rbd spikeace<NUMBER> complex protein value binding energy <NUMBER> kcalmol fig <NUMBER>c besides also formed many interactions amino acids space near connective interface rbd spikeace<NUMBER> complex protein results showed formed electrostatic hydrogenbonding interaction green dashed line amino acid glu<NUMBER> interactive distance <NUMBER>Ã¥ besides also formed hydrophobic pisigma interaction dark purple dashed line amino acid asn<NUMBER> interactive distance <NUMBER>Ã¥ fig <NUMBER>d vaccines coronaviruses <NUMBER> <NUMBER> predictions obtained virtual screening binding energy possible flexibility conformation still useful lead way drug discovery drug repurposing represented fig <NUMBER> started <NUMBER> compounds taken tdec applied filters get compound bind target structures high affinity notably got two natural products thioflexibilolide candidine passed filters applied strong binding energy respectively <NUMBER> kcalmol <NUMBER> kcalmol prefusion spike protein <NUMBER> kcalmol <NUMBER> kcalmol spikeace<NUMBER> complex protein fig <NUMBER> fig <NUMBER> compounds listed s<NUMBER> phenotypic assay among hit compounds able influence interaction viral rbd spike protein human ace<NUMBER> protein two dynamic proteins besides also found among <NUMBER> compounds dioscin actinomycin saikosaponin c reported antivirus activity others virus s<NUMBER> table although compounds discovered database may potential ability prevent binding viral spike protein human ace<NUMBER> protein efficacy compounds still needed verified bioassay thioflexibilolide candidine natural products respectively isolated soft coral sinularia flexibilis phaius mishmensis <NUMBER> <NUMBER> chemical structure structure candidine solid thioflexibilolide might caused rbm spike protein major composed chain type structure rather Î±helix Î²sheet structure s<NUMBER> fig besides also deduce two compounds bind side face respectively rbm ace<NUMBER>free spike protein connective interface spikeace<NUMBER> complex protein probably affect affinity binding viral spike protein human ace<NUMBER> protein influence conformation changing prevent spike protein cleaved host protease like tmprss<NUMBER> fig <NUMBER> fig <NUMBER> rapidly develop useful drugs sarscov<NUMBER> computeraid drug screening performed many studies sarscov spike protein homology proteins greater <NUMBER> similar sequences function binding ace<NUMBER> however previous report also showed binding affinity sarscov<NUMBER> spike protein ace<NUMBER> higher sarscov spike protein approximately <NUMBER> folds <NUMBER> <NUMBER> reports suggested highly similar partial structure conformation spike proteins sarscov<NUMBER> sarscov moreover spikeace<NUMBER> complex protein constructed proteinprotein docking may good enough directly exhibit proteinprotein binding situation fact recently rbd sarscov<NUMBER> spike protein prefusion conformation pdb id <NUMBER>vsb complex protein sarscov<NUMBER> spike proteins rbd bound ace<NUMBER> protein already resolved pdb id <NUMBER>m<NUMBER>j respectively cryoem xray crystallography high resolution <NUMBER> <NUMBER> therefore two new resolving protein structures likely close structural situations fact words could raise accuracy structurebased virtual screening docking calculation structures resolved high resolution study developing viral spike antibody one good strategies fight sarscov<NUMBER> could bind rbd spike protein neutralize sarscov<NUMBER> reported <NUMBER> <NUMBER> however concerned inducing antibodydependent enhancement ade <NUMBER> herein reported <NUMBER> potential compounds sarscov<NUMBER> spike protein may advantage avoiding induce ade ace<NUMBER> type transmembrane protein functioned carboxypeptidase mediate homeostasis reninangiotensin system ras blood volume lung cardiovascular regulating functions cleaving angiotensin ii ang ii ang<NUMBER> <NUMBER> ace<NUMBER> higher expressed small intestine kidneys testicles adipose tissue thyroid moderate lungs liver adrenal glands rectum lower blood blood vessels spleen brain muscle bone marrow <NUMBER> <NUMBER> hand gender age characters could affect ace<NUMBER> expression inflammatory conditions skin lung brain thyroid <NUMBER> recent studies also showed gender could affect sarscov<NUMBER> infection susceptibility virus clearance <NUMBER> besides another report also pointed covid<NUMBER> patients symptoms including dysfunctions diarrhea taste smell injuries liver kidney heart may close relationship ace<NUMBER> expression <NUMBER> herein results showed <NUMBER> potential compounds could prevent binding viral spike protein human ace<NUMBER> protein silico <NUMBER> speculated potential compounds could fight covid<NUMBER> lower expression symptoms humans natural products proved beneficial due contribution long time develop effective drugs several diseases <NUMBER> therefore tried endemic tdec rich diverse natural product resources derived traditional medicine domestic microbes marine organisms thioflexibilolide wellknown neuroprotective antiinflammatory activities derived soft corals whereas gravicycle reported nontoxic vitro toxicity assessment cell <NUMBER> results reporting compounds screened employing virtual screening molecular docking approach database disabling sarscov<NUMBER> spike proteins rbd interaction ace<NUMBER> receptor host cell first kind far possibly know compounds perform well get filter potential drug candidate screening process strongly recommend compound vitro vivo investigation study carried intending come potential drugs covid<NUMBER> therapy piece work virtually screened <NUMBER> drugs target spike proteins rbd data mining filtering unfitted compounds finally found two compounds named thioflexibilolide candidine done molecular docking check whether binds target strong affinity per result found two compounds bind strong affinity selected target viral protein believed two compounds could potential drugs sarscov<NUMBER> two <NUMBER> s<NUMBER> sinularia flexibilis <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> phaius mishmensis <NUMBER> <NUMBER> tdec<NUMBER>ca<NUMBER> <NUMBER> <NUMBER> tripterygium wilfordii <NUMBER> tdec<NUMBER>ca<NUMBER> <NUMBER> <NUMBER> dioscorea nipponica <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> solanum torvum <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> sinularia crassa <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> streptomyces sindenensis <NUMBER> tdec<NUMBER>ca<NUMBER> <NUMBER> <NUMBER> bupleurum chinense <NUMBER> tdec<NUMBER>ca<NUMBER> <NUMBER> <NUMBER> cunninghamia lanceolata <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> sinularia brassica <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> sinularia brassica <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> annona montana <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> paraminabea acronocephala <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> paraminabea acronocephala <NUMBER> tdec<NUMBER>cn<NUMBER> <NUMBER> <NUMBER> sapindus mukorossi <NUMBER> s<NUMBER> <NUMBER> <NUMBER> recent outbreak coronavirus disease <NUMBER> caused novel severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> affected walks life genomic studies established sarscov<NUMBER> belong betacoronavirus genus also includes sarscov merscov associated previous outbreaks relatively smaller scale <NUMBER> <NUMBER> <NUMBER> coronaviruses attach host cell aid spike glycoprotein present envelope coronavirus spike glycoprotein composed two subunits s<NUMBER> subunit important binding host cell receptor s<NUMBER> subunit responsible fusion virus host cells membrane angiotensin converting enzyme <NUMBER> ace<NUMBER> enzyme located outer surface wide variety cells primary host cell target spike protein sarscov sarscov<NUMBER> associates <NUMBER> <NUMBER> <NUMBER> receptor binding domain rbd s<NUMBER> subunit viruses binds outer surface claw like structure ace<NUMBER> <NUMBER> sequence similarity rbd region sarscov sarscov<NUMBER> spike protein <NUMBER> <NUMBER> <NUMBER> fourteen residues sarscov spike protein rbd reported interact human ace<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> leu<NUMBER> leu<NUMBER> asn<NUMBER> tyr<NUMBER> asn<NUMBER> gly<NUMBER> tyr<NUMBER> thr<NUMBER> thr<NUMBER> gly<NUMBER> tyr<NUMBER> <NUMBER> <NUMBER> eight residues conserved sarscov<NUMBER> <NUMBER> equivalent conserved residues sarscov<NUMBER> tyr<NUMBER> tyr<NUMBER> asn<NUMBER> tyr<NUMBER> gly<NUMBER> thr<NUMBER> gly<NUMBER> tyr<NUMBER> leu<NUMBER> phe<NUMBER> phe<NUMBER> gln<NUMBER> gln<NUMBER> asn<NUMBER> substituted atomic level threedimensional structure several sarscov<NUMBER> proteins determined <NUMBER> <NUMBER> <NUMBER> <NUMBER> xray crystallography based structures provide remarkable insights macromolecular structure intermolecular interactions however molecular recognition binding dynamic processes molecular dynamics md simulation often complement traditional structural studies looking dynamics processes atomic level <NUMBER> <NUMBER> simulations provide insights structural stability macromolecular complexes flexibility interacting subunits interactions residues interface report stability binding dynamics sarscov<NUMBER> spike rbd bound ace<NUMBER> compare dynamics sarscov spike rbd running multiple <NUMBER> ns allatom md simulations high resolution xray crystal structures sarscov<NUMBER> spike rbd bound ace<NUMBER> illustrate fourteen positions associated interaction sarscovsarscov<NUMBER> ace<NUMBER> primary objective study identify similarities dissimilarities dynamics interactions sarscovsarscov<NUMBER> ace<NUMBER> identify key residues could vital integrity interface would provide insights residues could targeted disrupting interface md simulations sarscov<NUMBER>ace<NUMBER> sarscovace<NUMBER> complexes <NUMBER> ns md simulations sarscovace<NUMBER> complex pdb id <NUMBER>m<NUMBER>j sarscovace<NUMBER> complex pdb <NUMBER>ajf performed triplicate one <NUMBER> ns simulations sarscov<NUMBER>ace<NUMBER> complex extended <NUMBER> Âµs ensure interactions faithfully retained longer duration additionally triplicate <NUMBER> ns simulations second sarscov<NUMBER>ace<NUMBER> structure pdb id <NUMBER>lzg also performed ensure results biased single structure overall structural integrity stimulations sarscov<NUMBER>ace<NUMBER> complex retained cÎ± root mean square deviation rmsd starting structure less <NUMBER> Ã¥ case sarscovace<NUMBER> simulations one simulations cÎ± rmsd <NUMBER> Ã¥ oscillating rmsd simulation characteristic closingopening motion ace<NUMBER> claw like structure <NUMBER> figures <NUMBER>a figure <NUMBER>b two sarscovace<NUMBER> simulations higher rmsd associated detachment spike protein one end interface figure <NUMBER>b interestingly end remained attached evident specific contacts retained throughout simulations protein secondary structure composition compactness indicated radius gyration ace<NUMBER> spike protein structures also preserved throughout simulations supplementary figure <NUMBER> included salt bridges hydrogen bonds ÏÏ cationÏ interactions supplementary table <NUMBER> interactions persistent others residues sarscov<NUMBER>sarscov spike rbd interacted ace<NUMBER> consistently shown figures <NUMBER>a <NUMBER>b interfaces dynamics salient ones along length simulation trajectories shown figure <NUMBER> supplementary figures <NUMBER> <NUMBER> table <NUMBER> likelihood interaction gln<NUMBER> sarscov<NUMBER> lys<NUMBER> residue ace<NUMBER> reported recently <NUMBER> next backbone gly<NUMBER> sarscov consistently interacted lys<NUMBER> ace<NUMBER> three simulations gly<NUMBER> equivalent location sarscov<NUMBER> formed sustained interactions lys<NUMBER> ace<NUMBER> one simulation figures <NUMBER>a <NUMBER>b additionally side chain gln<NUMBER> backbone gly<NUMBER> sarscov<NUMBER> spike rbd formed sustained interactions three two simulations respectively lys<NUMBER> ace<NUMBER> interaction absent equivalent residues sarscov figures <NUMBER>a <NUMBER>b suggests sarscov<NUMBER> sarscov differs target basic lys<NUMBER> lys<NUMBER> residues ace<NUMBER> tyr<NUMBER> tyr<NUMBER> two conserved residues sarscov<NUMBER> spike rbd consistently interacted asp<NUMBER> gln<NUMBER> ace<NUMBER> multiple simulations tyr<NUMBER> tyr<NUMBER> observed interact his<NUMBER> gln<NUMBER> respectively ace<NUMBER> least <NUMBER> one simulation figures <NUMBER>a <NUMBER>b corresponding residues sarscov appear form sustained interactions except tyr<NUMBER> consistently interacted gln<NUMBER> two simulations furthermore gln<NUMBER> gln<NUMBER> sarscov<NUMBER> showed sustained interactions glu<NUMBER> asp<NUMBER> respectively corresponding asn<NUMBER> tyr<NUMBER> sarscov exhibited extremely weak interactions figures <NUMBER>a <NUMBER>b agreement recent work shows likely existence tyr<NUMBER>asp<NUMBER> tyr<NUMBER>his<NUMBER> tyr<NUMBER>gln<NUMBER> gln<NUMBER>glu<NUMBER> interactions sarscov<NUMBER> spike rbd ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> three residues mutated sarscov<NUMBER> ala<NUMBER> lys<NUMBER> gly<NUMBER> interacted ace<NUMBER> residues gln<NUMBER> asp<NUMBER> gln<NUMBER> interactions observed corresponding residues sarscov figures <NUMBER>a <NUMBER>b supplementary table <NUMBER> significantly strong salt bridge established sustained lys<NUMBER> sarscov<NUMBER> spike rbd asp<NUMBER> ace<NUMBER> nearly full duration simulations notably salt bridge absent sarscov since equivalent residue val<NUMBER> incapable forming interaction figures <NUMBER>a <NUMBER>b gly<NUMBER> maintained interaction gln<NUMBER> ace<NUMBER> majority one simulation figure <NUMBER>a ala<NUMBER> exhibited weak interactions gln<NUMBER> simulations look dynamics interface interactions maintained least <NUMBER> total simulation time three simulations two complexes evaluated four interfacial residues sarscov<NUMBER> lys<NUMBER> gln<NUMBER> tyr<NUMBER> gln<NUMBER> two sarscov thr<NUMBER> gly<NUMBER> maintained interactions four asp<NUMBER> glu<NUMBER> asp<NUMBER> lys<NUMBER> two lys<NUMBER> asp<NUMBER> residues ace<NUMBER> respectively figures <NUMBER>a <NUMBER>b hence noteworthy differences two viral spike proteins interact ace<NUMBER> larger number sustained interactions sarscov<NUMBER> spike protein could associated higher binding affinity sarscov<NUMBER> additionally similar dynamics interacting residues also observed triplicate <NUMBER> ns simulations another complex structure sarscov<NUMBER>ace<NUMBER> pdb <NUMBER>lzg simulated ensure results biased one structure recent studies based models sarscov<NUMBER> spike protein rbd indicated leu<NUMBER> phe<NUMBER> ser<NUMBER> asn<NUMBER> sarscov<NUMBER> important binding ace<NUMBER> via interaction met<NUMBER> tyr<NUMBER> lys<NUMBER> tyr<NUMBER> residues <NUMBER> however simulations weak ÏÏ interaction observed phe<NUMBER> tyr<NUMBER> supplementary table <NUMBER> leu<NUMBER> ser<NUMBER> asn<NUMBER> observed form significant interactions ace<NUMBER> water molecules play important role many intermolecular interfaces instance six conserved water sites found interface ace<NUMBER> sarscov<NUMBER> spike rbd watermediated indirect interactions formed ace<NUMBER>lys<NUMBER> spikephe<NUMBER>leu<NUMBER> ace<NUMBER>asp<NUMBER> spikegly<NUMBER> ace<NUMBER>asn<NUMBER>his<NUMBER>glu<NUMBER>asp<NUMBER> spikearg<NUMBER> figure <NUMBER> could also play role stabilizing interface study provides insight stability interactions define sarscovace<NUMBER> sarscov<NUMBER>ace<NUMBER> interfaces using extended md simulations xray crystal structures complexes firstly interactions shared sarscov<NUMBER>ace<NUMBER> sarscovace<NUMBER> complexes assessed sarscov<NUMBER> spike protein rbd consistently interacted ace<NUMBER> three clusters one end gln<NUMBER> gln<NUMBER> formed sustained hydrogen bonds glu<NUMBER> lys<NUMBER> ace<NUMBER> end tyr<NUMBER> formed hydrogen bond asp<NUMBER> ace<NUMBER> middle lys<NUMBER> formed strong stable salt bridge asp<NUMBER> ace<NUMBER> additionally several intermittent interactions sarscov<NUMBER> could permit bind stably sarscov figures <NUMBER>b <NUMBER>a supplementary table <NUMBER> findings also supported results two different structures sarscov<NUMBER>ace<NUMBER> complex supplementary figure <NUMBER> supplementary table <NUMBER> loop regions residues <NUMBER> sarscov<NUMBER> fluctuated less bound ace<NUMBER> compared sarscov stabilized formation sustained interactions gln<NUMBER> gln<NUMBER> sarscov<NUMBER> glu<NUMBER> lys<NUMBER> ace<NUMBER> respectively figures <NUMBER>a supplementary figure <NUMBER> unlike sarscov<NUMBER> sarscov region middle devoid stable interactions ace<NUMBER> however two ends different set residues sarscov formed interactions ace<NUMBER> figure <NUMBER>d therefore apparent several similarities differences structure dynamics interactions sarscov<NUMBER> sarscov ace<NUMBER> hence antibodies antiviral treatment modalities target spike protein sarscov expected produce similar effect sarscov<NUMBER> recent studies failed inhibit binding sarscov<NUMBER> rbd ace<NUMBER> support findings <NUMBER> <NUMBER> secondly two charged virus binding hot spots human ace<NUMBER> lys<NUMBER> lys<NUMBER> essential binding sarscov studied extensively <NUMBER> <NUMBER> charge neutralization hot spot lysines shown important binding coronavirus ace<NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> sarscov utilizes unique strategies achieve interestingly sarscov<NUMBER> residues formed sustained interactions lys<NUMBER> ace<NUMBER> absent sarscov indicating adaptation stronger interface figure <NUMBER>a figure <NUMBER>b <NUMBER>d strength sustained salt bridge lys<NUMBER> asp<NUMBER> could contribute substantially different binding affinity sarscov<NUMBER> ace<NUMBER> receptor compared sarscov <NUMBER> <NUMBER> notably previously reported residues leu<NUMBER> phe<NUMBER> tyr<NUMBER> phe<NUMBER> ser<NUMBER> asn<NUMBER> suggested enhance binding affinity sarscov<NUMBER> observed simulations <NUMBER> <NUMBER> <NUMBER> conclusion sarscov<NUMBER> sarscov spike rbd bind region ace<NUMBER> share several similarities interact ace<NUMBER> number differences dynamics interactions one salient difference presence stable salt bridge lys<NUMBER> sarscov<NUMBER> spike protein asp<NUMBER> ace<NUMBER> well three stable hydrogen bonds tyr<NUMBER> gln<NUMBER> gln<NUMBER> sarscov<NUMBER> asp<NUMBER> glu<NUMBER> lys<NUMBER> ace<NUMBER> observed sarscovace<NUMBER> interface stable viral binding host receptor crucial virus entry thus special consideration given stable interactions designing potential drugs treatment modalities target disrupt interface coordinates three dimensional xray crystal structures sarscov sarscov<NUMBER> rbd complex ace<NUMBER> obtained protein data bank pdb pdb ids structure used <NUMBER>m<NUMBER>j <NUMBER>lzg sarscov<NUMBER> spike protein rbd bound ace<NUMBER> <NUMBER>ajf sarscov spike protein rbd bound ace<NUMBER> schrÃ¶dinger maestro <NUMBER> schrÃ¶dinger llc new york ny used visualize prepare protein structures simulations structures first preprocessed using protein preparation wizard schrÃ¶dinger llc new york ny protein preparation stage included proper assignment bond order adjustment ionization states orientation disorientated groups creation disulfide bonds removal unwanted water molecules metal cofactors capping termini assignment partial charges addition missing atoms side chains case sarscov structure loop residues <NUMBER> missing pdb structure modeled using schrÃ¶dinger prime <NUMBER> hydrogen atoms incorporated standard protonation state ph <NUMBER> used structures spike protein rbd bound ace<NUMBER> placed orthorhombic boxes size <NUMBER> Ã¥ Ã <NUMBER> Ã¥ Ã <NUMBER> Ã¥ solvated single point charge spc water molecules using desmond system builder schrÃ¶dinger llc new york ny box size <NUMBER> Ã¥ Ã <NUMBER> Ã¥ Ã <NUMBER> Ã¥ used simulations spike rbd structures isolated pdb structures <NUMBER>m<NUMBER>j <NUMBER>ajf simulation systems neutralized counterions salt concentration <NUMBER>m nacl maintained md simulations performed using desmond <NUMBER> opls forcefield used calculations systems subjected desmonds default eight stage relaxation protocol start production run <NUMBER> ns simulations performed triplicate different set initial velocities simulations involving <NUMBER>m<NUMBER>j <NUMBER>lzg <NUMBER>ajf one <NUMBER> ns simulation run isolated spike protein structures one <NUMBER> ns simulations sarscov<NUMBER>ace<NUMBER> complex extended <NUMBER> Âµs ensure interactions retained longer period simulations isotropic martynatobiasklein barostat nosehoover thermostat used maintain pressure <NUMBER> atm temperature <NUMBER> k respectively <NUMBER> shortrange cutoff set <NUMBER> Ã¥ longrange coulombic interactions evaluated using smooth particle mesh ewald method pme <NUMBER> timereversible reference system propagator algorithm respa integrator employed inner time step <NUMBER> fs outer time step <NUMBER> fs <NUMBER> simulation data analyzed using packaged house scripts plotted using r <NUMBER> httpswwwrprojectorg emergence sarscov<NUMBER> marks seventh coronavirus isolated humans third cause severe diseasenamed covid<NUMBER>after severe acute respiratory syndrome sars middle east respiratory syndrome mers rapid spread sarscov<NUMBER> grave risk poses global health prompted world health organization declare <NUMBER> january <NUMBER> covid<NUMBER> outbreak public health emergency international concern <NUMBER> march <NUMBER> pandemic zhou et al <NUMBER> <NUMBER> march <NUMBER> nearly <NUMBER> sarscov<NUMBER> infections <NUMBER> associated deaths reported across least <NUMBER> countries rapidly evolving epidemiology pandemic absence licensed prophylactics therapeutics disease accelerated need elucidate molecular biology novel coronavirus although sarscov<NUMBER> newly identified virus shares genetic morphologic features others coronaviridae family particularly betacoronavirus genus genome recently isolated sarscov<NUMBER> shares <NUMBER> nucleotide identity human sarscov <NUMBER> bat sarslikecovzxc<NUMBER> spike glycoprotein particular bears significant structural homology sarscov compared coronaviruses merscov like sarscov surface spike glycoprotein sarscov<NUMBER> binds host receptor ace<NUMBER> mediate cell entry letko et al <NUMBER> yan et al <NUMBER>a sa class fusion proteinis also critical determinant viral host range tissue tropism primary target host immune response li <NUMBER> coronavirus vaccine candidates based one subcomponents coronavirus glycoproteins contain three segments large ectodomain singlepass transmembrane anchor short intracellular tail ectodomain consists receptorbinding subunit s<NUMBER> contains two subdomains one nterminus cterminus latter comprises receptorbinding domain rbd serves vital function attaching virus host receptor triggering conformational change protein results fusion host cell membrane s<NUMBER> subunit recently molecular structure recombinant fulllength sarscov<NUMBER> spike protein solved stabilized prefusion state single particle cryoelectron microscopy cryoem resolution <NUMBER> Ã¥ wrapp et al <NUMBER> despite comprehensive structural characterization spike protein whole movement rbd conformational states prevented complete modeling rbd domains subsequent cryoem investigations sarscov<NUMBER> provided detail rbd particularly sites contact human ace<NUMBER> receptor yan et al <NUMBER>a report first high resolutionless <NUMBER> Ã¥sarscov<NUMBER> rbd additionally present antigenicity recombinant rbd particularly interest given equipoise literature regarding binding affinities sarscov antibodies sarscov<NUMBER> rbd early reports described human sarscov antibody cr<NUMBER> able bind sarscov<NUMBER> rbd present study verify binding subsequently solved structure sarscov<NUMBER> rbd complex cr<NUMBER> novel cryptic epitope sarscov<NUMBER> rbd residues <NUMBER> cterminal histag expressed <NUMBER>f cells purified ninta affinity sizeexclusion chromatography crystallization condition screening identified <NUMBER> jeffamine d<NUMBER> <NUMBER> jeffamine m<NUMBER> <NUMBER> nacl <NUMBER>m mes ph <NUMBER> diffraction quality crystal growth crystals diffracted <NUMBER> Ã¥ group p <NUMBER> <NUMBER> <NUMBER> complete dataset <NUMBER> Ã¥ could scaled processed table <NUMBER> structure refined rfree <NUMBER> rwork <NUMBER> ramachandran outliers residues <NUMBER> clearly interpretable electron density map dual conformation loop containing residues <NUMBER> <NUMBER> clearly visible electron density map figure <NUMBER> structure comparison unliganded rbd structure presented stabilized prefusion sarscov<NUMBER> spike s<NUMBER>p molecule structure determined cryoem pdb id <NUMBER>vsb wrapp et al <NUMBER> shows high structural similarity rmsd <NUMBER> <NUMBER> <NUMBER> spike protomers structure s<NUMBER>p molecule s<NUMBER>p wrapp et al <NUMBER> <NUMBER> <NUMBER> <NUMBER> amino acids aa within protomer rbd modeled including <NUMBER> ace<NUMBER> receptor binding site measured buried surface area bsa yan et al <NUMBER>b sarscov rbd<NUMBER> compared liganded pdb id <NUMBER>ajf unliganded pdb id <NUMBER>ghv sarscov rbd structures shows high structural similarity except residues <NUMBER> figure <NUMBER> chimeric sarscov<NUMBER> rbd structure pdb id <NUMBER>vw<NUMBER> <NUMBER> aa differences compared sarscov<NUMBER> complex human ace<NUMBER> recently released pdb comparisons previously published structures sarscov<NUMBER> rbd highlight residues <NUMBER> area significant structural plasticity rbd structure study observe electron density two conformations <NUMBER> loop one conformations highly similar ligand bound form rbd second conformation would clash ace<NUMBER> receptor structural detail unliganded rbd comparison previously described rbd structures indicates area rbd structurally malleable implications antibody small molecule therapeutics design effort identify antibodies could bind sarscov<NUMBER> screened set sarscov tripp et al <NUMBER> mers cov wang et al <NUMBER> wang et al <NUMBER> rbdreactive antibodies binding sarscov<NUMBER> rbd demonstrated sarscov mouse antibody <NUMBER>cd tripp et al <NUMBER> nanomolar nm affinity sarscov<NUMBER> rbd significantly block ace<NUMBER> receptor binding figure <NUMBER> cr<NUMBER>a sarscov neutralizing antibody tian et al <NUMBER> identified human phagedisplay library ter meulen et al <NUMBER> also bound sarscov<NUMBER> rbd nm affinity figure <NUMBER>b assessed competition binding <NUMBER>cd cr<NUMBER> show antibodies crosscompete binding sarscov<NUMBER> rbd figure <NUMBER>c <NUMBER>d sarscov<NUMBER> likely zoonotic origin horseshoe bats implicated natural reservoirs sarscov sarscov<NUMBER> menachery et al <NUMBER> zhou et al <NUMBER> next explored antibody crossreactivity glycoproteins two bat sarsrelated covs sarsrcov rs<NUMBER> ge et al <NUMBER> yang et al <NUMBER> rs<NUMBER> hu et al <NUMBER> closely related progenitor sarscov retain ability utilize human ace<NUMBER> cr<NUMBER> able recognize recombinant spike glycoproteins generated bat sarsrcov rs<NUMBER> <NUMBER>cd mouse generated monoclonal antibodies mixed recognition phenotype figure <NUMBER>f antigenic crossreactivity set antibodies precipitated investigation molecular recognition determinants potential relevance human antibody motivated investigation prioritize studies cr<NUMBER> sequence available ter meulen et al <NUMBER> cr<NUMBER> heavy chain encoded ighv<NUMBER> contains <NUMBER>aa cdr h<NUMBER> <NUMBER> v geneencoded residues altered somatic hypermutation cr<NUMBER> light chain encoded igkv<NUMBER> <NUMBER> v geneencoded residue altered somatic hypermutation <NUMBER>aa cdr l<NUMBER> extended data figure <NUMBER>a provide atomiclevel understanding structure cr<NUMBER> antibody crystallized antigenbinding fragment fab cr<NUMBER> crystals diffracted <NUMBER> Ã¥ resolution space group p <NUMBER> table <NUMBER> overall structure cr<NUMBER> fab revealed relatively flat antigencombining site exception extended protruding <NUMBER>aa cdr l<NUMBER> loop figure s<NUMBER>a determine structure cr<NUMBER> complex sarscov<NUMBER> rbd carried crystallization conditions screening crystals cr<NUMBER>rbd complex forming <NUMBER>m succinic acid <NUMBER>m hepes ph <NUMBER> <NUMBER> peg mme<NUMBER> determined crystal structure xray diffraction <NUMBER> Ã¥ table <NUMBER> complex structure solved molecular replacement using refined cr<NUMBER> sarscov<NUMBER> rbd structures search models refined rworkrfree <NUMBER> table <NUMBER> cr<NUMBER> bound rbd epitope centered glycoprotein residues <NUMBER> total buried surface area <NUMBER> Ã¥ figure <NUMBER> figure s<NUMBER> table s<NUMBER> region highly conserved sarscov sarscov<NUMBER> figure s<NUMBER> comparison cr<NUMBER> epitope site previously described antibodycomplex structures sarscov merscov indicates cr<NUMBER> describes novel recognition site figure <NUMBER> figs s<NUMBER> s<NUMBER> sequence analysis epitope indicates epitope conserved betacoronavirus clade <NUMBER>b also similarity clade <NUMBER>d fig s<NUMBER> confirm site also shared <NUMBER>cd produced rbd knockout mutant introducing glycan sequon position <NUMBER> biolayer interferometry show cr<NUMBER> <NUMBER>cd binding rbd eliminated introduction glycan site fig s<NUMBER>d epitope conservation within clade explains antigenic crossreactivity human sarscov bat sars related cov date extensive structural characterization sarscov merscov spike molecule domains provides framework understanding novel sarscov<NUMBER> spike molecule table s<NUMBER> context coronavirus trimeric glycoproteins rbd displays two prototypical conformations either position implications receptor binding cell entry table s<NUMBER> analyze conformations modeled cr<NUMBER> binding trimeric structures sarscov<NUMBER> sarscov merscov cr<NUMBER> epitope occluded adjacent spike protomers rbd conformation becomes accessible spike open conformation multiple rbd molecules conformation figure <NUMBER> still clash antibody fc<NUMBER> region ntd protomer rbd adjacent protomer modeled using static structure understand whether cr<NUMBER> could bind sarscov glycoproteins measured binding stabilized s<NUMBER>p nonstabilized versions figure <NUMBER> observed robust binding nonstabilized glycoprotein binding sars s<NUMBER>p trimer low treated sars s<NUMBER>p trimer trypsin andor incubation ace<NUMBER> receptor assess whether minimal proteolytic action receptor binding could increase availability cryptic cr<NUMBER> epitope incubation stabilized s<NUMBER>p trimer human ace<NUMBER> dramatically affect cr<NUMBER> binding contrast trypsin treatment s<NUMBER>p protein resulted increased binding akin unstabilized glycoprotein binding level binding titratable increasing amounts s<NUMBER>p resulting higher cr<NUMBER> binding given prior neutralization protection studies utilizing cr<NUMBER> ability complement potent neutralizing antibodies likely cr<NUMBER> epitope represents cryptic epitope becomes exposed processes viral cell entry summary data represents detailed structural information sarscov<NUMBER> rbd date first structure sarscov<NUMBER> complex human antibody presence cryptic protective epitopes influenza bangaru et al <NUMBER> ebola viruses west et al <NUMBER> previously described identification novel cryptic epitope betacoronaviruses including sarscov sarscov<NUMBER> highlight novel viral vulnerability harnessed combination ace<NUMBER> receptor site targeting monoclonal antibodies vaccine therapeutic countermeasure development work supported funding defense health agency well cooperative agreement cr<NUMBER> sarscov<NUMBER> rbd measured biolayer interferometry kinetic constants determined calculated using minimum four dilutions rbd fitted using <NUMBER> binding model cd competition binding antibodies cr<NUMBER> <NUMBER>cd sarscov<NUMBER> rbd cr<NUMBER> control antibody allowed bind sarscov<NUMBER> prior binding <NUMBER>cd viceversa e sarscov<NUMBER> rbd sequentially bound antibodies cr<NUMBER> <NUMBER>cd followed soluble human ace<NUMBER> receptor f sarscov reactive antibodies assessed binding bat sarsrelated cov rs<NUMBER> rs<NUMBER> glycoproteins cov<NUMBER> rbdcr<NUMBER> complex sarscov s<NUMBER>p structure rbdcr<NUMBER> structure aligned sarscov trimer structure surface representation pdb id <NUMBER>cs<NUMBER> two rbd molecules located conformation static structure fc<NUMBER> region cr<NUMBER> ribbon representation clashes ntd protomer however epitope fully accessible one rbd representation b biolayer interferometry measurement cr<NUMBER> binding sars proteins trypsin treatment ace<NUMBER> receptor binding c cr<NUMBER> binding serial dilution sars s<NUMBER>p protein following trypsin treatment shanghai public health clinical center school public health collaboration central hospital wuhan huazhong university science technology wuhan center disease control prevention national institute communicable disease control prevention chinese center disease control university sydney sydney australia released sequence coronavirus genome case respiratory disease wuhan january <NUMBER> th available recombinomicscotopic<NUMBER>wuhancoronavirus<NUMBER>ncovsequences sequence also deposited genbank accession mn<NUMBER> gisaid epiisl<NUMBER> dna encoding sarscov<NUMBER> rbd residues <NUMBER> synthesized genscript cterminal his<NUMBER> purification tag cloned cmvr plasmid protein expressed transient transfection <NUMBER>f cells six days sarscov<NUMBER> rbdhis protein purified cell culture supernatant using ninta qiagen affinity column dna encoding protein ectodomains residues <NUMBER> bat sarsrelated cov isolates rs<NUMBER> rs<NUMBER> ref hu et al <NUMBER> synthesized genscript cterminal t<NUMBER>foldon domain cterminal gcn domain respectively followed factor xa cleavage sites streptactin purification tags bat sarsrcov genes cloned modified pcdna<NUMBER> expression plasmid chan et al <NUMBER> protein initially expressed transient transfection <NUMBER>f cells six days serial cloned select stably expressing cell lines yan l submission rs<NUMBER>t<NUMBER> rs<NUMBER>gcn proteins purified cell culture supernatant using streptactin affinity column oligomeric structure proteins selected size exclusion chromatography geakta trimeric proteins confirmed nativepage sars s<NUMBER>p produced previously described streptactin affinity chromatography followed gel filtration using <NUMBER> superdex<NUMBER> purification column purification purity glycoproteins assessed sdspage sequences cr<NUMBER> variable regions heavy light chains available genbank accession numbers dq<NUMBER> dq<NUMBER> respectively ter meulen et al <NUMBER> sequences synthesized genscript cloned cmvr expression vectors nih aids reagent program murine ig leader genbank dq<NUMBER> constant regions human igg<NUMBER> genbank aaa<NUMBER> igÎº genbank akl<NUMBER> plasmids encoding heavy light chains cotransfected expi<NUMBER>f cells thermofisher according manufacturers instructions <NUMBER> days antibodies purified cleared culture supernatants protein agarose thermofisher using standard procedures buffer exchanged phosphatebuffered saline pbs quantified using calculated e a<NUMBER> measurements fab fragment antibody cr<NUMBER> prepared digestion fulllength igg using enzyme lysc roche digestion reaction allowed proceed <NUMBER> hours <NUMBER>Â°c digestion assessed sdspage upon completion reaction mixture passed proteing beads <NUMBER> ml beads <NUMBER> times final flow assessed sdspage purity fab fragment mixed purified sarscov<NUMBER> rbd complex allowed form <NUMBER> hour room temperature expi<NUMBER>f thermofisher scientific a<NUMBER> <NUMBER>f cell lines utilized study crystallization sarscov<NUMBER> rbd <NUMBER> mgml <NUMBER> mgml pbs buffer screened crystallization conditions using art robbins gryphon crystallization robot <NUMBER> ul drops set <NUMBER> crystallization conditions crystal drops observed using jan scientific uvexps automated uv brightfield drop imaging robot crystals sarscov<NUMBER> rbd grew <NUMBER> hours multiple conditions molecular dimensions midas crystal screen diffractionquality crystals seen conditions b<NUMBER> g<NUMBER> f<NUMBER> h<NUMBER> cr<NUMBER> fab screened crystallization <NUMBER> mgml <NUMBER> mgml concentrations pbs diffraction quality crystals grew <NUMBER> hours <NUMBER>m imidazole ph <NUMBER> <NUMBER> <NUMBER>propanol <NUMBER> peg <NUMBER> complex cr<NUMBER> fab sarscov<NUMBER> rbd mixed <NUMBER> molar ratio crystallization drops setup <NUMBER> <NUMBER> mgml concentrations pbs buffer described crystals grew crystallization condition containing <NUMBER>m succinic acid <NUMBER>m hepes ph <NUMBER> <NUMBER> peg mme<NUMBER> rbd alone cr<NUMBER> fabrbd complex crystals harvested cryocooled respective crystallization conditions plus <NUMBER> glycerol single crystals transferred mother liquor containing <NUMBER> glycerol cryocooled liquid nitrogen prior data collection diffraction data sarscov<NUMBER> rbd collected advanced photon source aps argonne national laboratory necat id<NUMBER>c beamline measured using dectris eiger <NUMBER>m pixel detector crystals grown midas condition b<NUMBER> <NUMBER> jeffamine d<NUMBER> <NUMBER> jeffamine m<NUMBER> <NUMBER> nacl <NUMBER>m mes ph <NUMBER> provided highest resolution diffraction spots visible <NUMBER> Ã¥ complete dataset could processed <NUMBER> Ã¥ space group p<NUMBER> cr<NUMBER> fab crystals diffracted <NUMBER> Ã¥ necat id<NUMBER>c beamline diffraction data could scaled p<NUMBER> space group <NUMBER> completeness diffraction data cr<NUMBER> sarscov<NUMBER> rbd complex collected necat id<NUMBER>c beamline advanced photon source aps measured using dectris eiger <NUMBER>m pixel detector diffraction data multiple crystals merged scaled together achieve final resolution <NUMBER> Ã¥ overall completeness <NUMBER> data collection statistics reported table <NUMBER> phenix xtriage used analyze scaled diffraction data produced hkl<NUMBER> xds data analyzed completeness matthews coefficient twinning pseudotranslational pathology structure sarscov<NUMBER> rbd determined molecular replacement using phaser search model sars rbd pdb id <NUMBER>ajf molecule c cr<NUMBER> fab crystal structure determined molecular replacement using coxsackievirus a<NUMBER> neutralizing antibody <NUMBER>d<NUMBER> pdb id <NUMBER>xs<NUMBER> search model cr<NUMBER>rbd complex structure determined molecular replacement using refined cr<NUMBER> sarscov<NUMBER> rbd structures search models refinement carried using phenix refine positional global isotropic b factor refinement defined tls groups iterative cycles manual model building using coot structure quality assessed molprobity final refinement statistics structures reported table <NUMBER> structure figures generated using epitope sites correspond antigen sites contact antibody antigenantibody complex ie sites nonhydrogen atoms within <NUMBER> Ã¥ antibody given epitope site weight characterizes interaction epitope site antibody improved based bai et al <NUMBER> defined nc number contacts antibody ie number nonhydrogen antibody atoms within <NUMBER> Ã¥ site nnb number neighboring antibody residues â© âª mean number contacts nc â© âª mean number neighboring antibody residues nnb across epitope sites weight <NUMBER> attributed average interaction across epitope sites neighboring residue pairs identified delaunay tetrahedralization sidechain centers residues cï¡ counted side chain atom pairs <NUMBER> Ã¥ excluded quickhull barber <NUMBER> used tetrahedralization biopython pdb hamelryck manderick <NUMBER> handle protein structure sarscov<NUMBER> sarscov<NUMBER> rbd comparison residues considered similar following residues pairs rk rq kq qe qn ed dn ts sa vi il lm fy octet red<NUMBER> instrument fortÃ©bio reference subtraction binding kinetic constants determined least <NUMBER> concentrations fab fitting curves <NUMBER> langmuir binding model using data analysis software <NUMBER> fortÃ©bio antibodies loaded <NUMBER> ugml onto ahc probe <NUMBER> followed baseline incubation <NUMBER> assess antibody competition either <NUMBER>cd cr<NUMBER> nonspecific control antibody cr<NUMBER> incubated sarscov<NUMBER> rbd prior assessment binding cr<NUMBER> <NUMBER>cd antibody concentration <NUMBER> ugml assess binding human ace<NUMBER> receptor presence absence antibodies cr<NUMBER> <NUMBER>cd rbd loaded onto probe rbd sequentially incubated either cr<NUMBER> <NUMBER>cd control antibody cr<NUMBER> prior incubation human ace<NUMBER> receptor cr<NUMBER> loaded onto ahc probe <NUMBER>s prior incubation sarscov glycoproteins <NUMBER> ugml alone preincubated ace<NUMBER> protein sars s<NUMBER>p protein treated <NUMBER> bovine pancreas trypsin <NUMBER> minutes prior binding binding measurements sars spike protein provided bei resources lot <NUMBER>p<NUMBER> binding cr<NUMBER> also carried series concentrations sars s<NUMBER>p treated <NUMBER> ww bovine pancreatic trypsin associated accession numbers coordinates structure factors reported paper deposited pdb potential conflict interest reported authors sarscov<NUMBER> rbd measured biolayer interferometry kinetic constants determined calculated using minimum four dilutions rbd fitted using <NUMBER> binding model cd competition binding antibodies cr<NUMBER> <NUMBER>cd sarscov<NUMBER> rbd cr<NUMBER> control antibody allowed bind sarscov<NUMBER> prior binding <NUMBER>cd viceversa e sarscov<NUMBER> rbd sequentially bound antibodies cr<NUMBER> <NUMBER>cd followed soluble human ace<NUMBER> receptor f sarscov reactive antibodies assessed binding bat sarsrelated cov rs<NUMBER> rs<NUMBER> glycoproteins identification cr<NUMBER> epitope cryptic epitope structural alignment sarscov<NUMBER> rbdcr<NUMBER> complex sarscov s<NUMBER>p structure rbdcr<NUMBER> structure aligned sarscov trimer structure surface representation pdb id <NUMBER>cs<NUMBER> two rbd molecules located conformation static structure fc<NUMBER> region cr<NUMBER> ribbon representation clashes ntd protomer however epitope fully accessible one rbd representation b biolayer interferometry measurement cr<NUMBER> binding sars proteins trypsin treatment ace<NUMBER> receptor binding c cr<NUMBER> binding serial dilution sars s<NUMBER>p protein following trypsin treatment sarscov<NUMBER>spike setkctlksftvekgiyqtsnfrvqptesivrfpnitnlcpfgevfnatrfasvyawnrk <NUMBER> batrs<NUMBER>spike aelkcsvksfeidkgiyqtsnfrvapskevvrfpnitnlcpfgevfnattfpsvyawerk <NUMBER> batwiv<NUMBER>spike aelkcsvksfeidkgiyqtsnfrvapskevvrfpnitnlcpfgevfnattfpsvyawerk <NUMBER> sarscovspike aelkcsvksfeidkgiyqtsnfrvvpsgdvvrfpnitnlcpfgevfnatkfpsvyawerk <NUMBER> sarscov<NUMBER>spike risncvadysvlynsasfstfkcygvsptklndlcftnvyadsfvirgdevrqiapgqtg <NUMBER> batrs<NUMBER>spike risncvadysvlynstsfstfkcygvsatklndlcfsnvyadsfvvkgddvrqiapgqtg <NUMBER> batwiv<NUMBER>spike risncvadysvlynstsfstfkcygvsatklndlcfsnvyadsfvvkgddvrqiapgqtg <NUMBER> sarsspike kisncvadysvlynstffstfkcygvsatklndlcfsnvyadsfvvkgddvrqiapgqtg <NUMBER> sarscov<NUMBER>spike kiadynyklpddftgcviawnsnnldskvggnynylyrlfrksnlkpferdisteiyqag <NUMBER> batrs<NUMBER>spike viadynyklpddflgcvlawntnskdsstsgnynylyrwvrrsklnpyerdlsndiyspg <NUMBER> batwiv<NUMBER>spike viadynyklpddftgcvlawntrnidatqtgnynykyrslrhgklrpferdisnvpfspd <NUMBER> sarsspike viadynyklpddfmgcvlawntrnidatstgnynykyrylrhgklrpferdisnvpfspd <NUMBER> analysis cr<NUMBER> footprint across betacoronaviruses cr<NUMBER> epitope sarscov<NUMBER> chinawuhan<NUMBER>dec<NUMBER> rbd compared across betacoronaviruses epitope numbered according wuhan reference strength interaction ab spike protein indicated height color histogram bars sequence alignment sequences ordered based phylogenetic relationships based maximum likelihood phylogenetic tree derived amino acid rbd sequences rbd structure shown surface representation depicts mutations sarscov<NUMBER> sarscov<NUMBER> red cr<NUMBER> epitope outlined white contact residues shown stick representation coronaviruses covs group enveloped positivestranded rna viruses cause respiratory intestinal central nervous system infections humans animals <NUMBER> <NUMBER> six strains coronaviruses able infect humans identified <NUMBER> <NUMBER> among four human coronaviruses including hcovoc<NUMBER> hcov<NUMBER>e hcovnl<NUMBER> hcovhku<NUMBER> highly pathogenic cause mild respiratory diseases <NUMBER> however two coronaviruses severe acute respiratory syndrome coronavirus sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> caused two largescale pandemics resulted <NUMBER> cases including nearly <NUMBER> related deaths <NUMBER> cases including <NUMBER> related deaths respectively outbreaks sarscov merscov indicated coronaviruses highly pathogenic transmit animals humans <NUMBER> <NUMBER> <NUMBER> therefore urgent develop antiviral treatments vaccines targeting highrisk coronaviruses like sarscov merscov efficient antiviral drugs vaccines developed sarscov merscov another outbreak pneumonia caused novel coronavirus sarscov<NUMBER> emerged wuhan since december <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> march <NUMBER> sarscov<NUMBER> caused <NUMBER> confirmed cases including <NUMBER> related deaths globally <NUMBER> fulllength genome sequence sarscov<NUMBER> soon determined zhang group <NUMBER> revealed sarscov<NUMBER> probable bat study investigated rbdace<NUMBER> complex spike protein free rbd systems sarscov genbank id np<NUMBER> sarscov<NUMBER> genbank id mn<NUMBER> sarscov rbdace<NUMBER> complex structure directly downloaded protein data bank pdb entry <NUMBER>sci <NUMBER> water molecules removed complex structure free rbd structure obtained removing ace<NUMBER> protein rbdace<NUMBER> complex structure trimeric spike protein sarscov also downloaded pdb pdb entry <NUMBER>acd <NUMBER> sarscov<NUMBER> three dimensional <NUMBER>d rbd structure modeled based rbd structure sarscov using modeller program <NUMBER> sequence alignment performed using clustalw program <NUMBER> <NUMBER> complex structure sarscov<NUMBER> rbd protein human ace<NUMBER> predicted proteinprotein docking approach <NUMBER> <NUMBER> <NUMBER> <NUMBER>d structure trimeric spike protein sarscov<NUMBER> constructed based spike protein structure sarscov pdb entry <NUMBER>acd using modeller complex structure sarscov<NUMBER> rbd protein human ace<NUMBER> molecule predicted using hybrid proteinprotein docking algorithm hdock <NUMBER> <NUMBER> <NUMBER> <NUMBER> specifically given individual structures sarscov<NUMBER> rbd protein human ace<NUMBER> molecule hdock globally samples possible binding modes two proteins fast fourier transform fftbased search strategy <NUMBER> sampled binding modes evaluated iterative knowledgebased scoring function itscorepp <NUMBER> last binding modes ranked according binding energy scores top ten binding modes provided users docking calculation default parameters used namely grid spacing set <NUMBER> Ã¥ <NUMBER>d translational search angle interval set <NUMBER> â¢ rotational sampling <NUMBER>d euler space binding interface information pdb automatically applied templatebased modeling individual structures web server version hdock algorithm freely accessed web site httphdockphyshusteducn <NUMBER> amber suite used md simulations <NUMBER> simulations missing residues middle chain added using modeller program <NUMBER> simulations ff<NUMBER>sb force field selected <NUMBER> explicit solvent model used time step set <NUMBER> fs langevin dynamics used temperature control program pmemdcuda used simulation engine simulations performed gpu compute node <NUMBER> specifically system following four stages md simulations performed production simulation <NUMBER> <NUMBER>step simulation first run minimize solvated protein system weakly restraints backbone atoms <NUMBER> system heated <NUMBER> k <NUMBER>step ie <NUMBER> ps simulation weakly restraints backbone atoms <NUMBER> next another <NUMBER>step ie <NUMBER> ps constant pressure simulation conducted equilibrating density system <NUMBER> k <NUMBER> system equilibrated <NUMBER>step ie <NUMBER> ps constant pressure simulation <NUMBER> k finally two <NUMBER>step production simulations run record trajectories system <NUMBER> k coordinates written every <NUMBER> steps ie <NUMBER> ps resulting total <NUMBER> ns simulation <NUMBER> recorded trajectories simulations mmpbsapy used calculate free energies systems mmgbsa model <NUMBER> cpptraj used analyze coordinate trajectories <NUMBER> check statistical significance difference two means ttest performed obtain p value using two average free energies standard deviations rbd proteins sarscov<NUMBER> sarscov exhibit high sequence similarity <NUMBER> sequence identity <NUMBER> high homology resulted accurate <NUMBER>d rbd model sarscov<NUMBER> small rmsd <NUMBER> Ã¥ experimental sarscov rbd structure sarscov<NUMBER> rbd model experimental human ace<NUMBER> structure performed proteinprotein docking predict binding mode using hdock approach <NUMBER> <NUMBER> <NUMBER> figure <NUMBER>a shows predicted complex structure human ace<NUMBER> molecule sarscov<NUMBER> rbd protein seen figure predicted sarscov<NUMBER> rbdace<NUMBER> complex structure close experimentally determined sarscov rbdace<NUMBER> complex structure interface root mean square deviation rmsd two complexes <NUMBER> Ã¥ demonstrating rbds sarscov<NUMBER> sarscov bind site human ace<NUMBER> receptor figure <NUMBER>a results also understood comparing residues rbdace<NUMBER> binding interface sarscov<NUMBER> sarscov binding sites rbd proteins sarscov<NUMBER> sarscov conserved corresponding residues show high sequence similarity <NUMBER> figure <NUMBER>b c among hydrophobic residues important proteinprotein interactions especially conserved rbd sarscov<NUMBER> <NUMBER> hydrophobic residues binding site comparable <NUMBER> hydrophobic residues sarscov figure <NUMBER>b recently cryoem structure sarscov<NUMBER> rbdace<NUMBER> complex determined zhou group <NUMBER> comparing experimental structure predicted model showed two complexes close small interface rmsd <NUMBER> Ã¥ figure <NUMBER>a interface difference mainly due conformational changes rbd especially around loop residues <NUMBER> figure <NUMBER>b backbone rmsd two ace<NUMBER> monomers <NUMBER> Ã¥ flexible loop residues <NUMBER> rbd excluded interface rmsd predicted experimental complexes would small <NUMBER> Ã¥ results suggested accuracy predicted sarscov<NUMBER> rbdace<NUMBER> complex structure sarscov<NUMBER> rbd colored magenta interacting ace<NUMBER> colored blue sarscov rbd colored green interacting ace<NUMBER> colored red respectively b binding site residues rbd within <NUMBER> Ã¥ form ace<NUMBER> hydrophobic residues sarscov<NUMBER> rbd highlighted red c part sequence alignment spike proteins sarscov<NUMBER> sarscov rbd residues highlighted yellow residues binding site highlighted magenta respectively run longtime md simulation generate trajectories rbdace<NUMBER> complex system sarscov<NUMBER> sarscov binding free energies calculated using mmgbsa model mmpbsapy script amber package table <NUMBER> shows comparison rbdace<NUMBER> binding free energies sarscov<NUMBER> sarscov seen table binding free energy sarscov<NUMBER> rbdace<NUMBER> interaction â<NUMBER> kcalmol significantly lower binding free energy sarscov rbdace<NUMBER> interaction â<NUMBER> kcalmol words sarscov<NUMBER> binds human ace<NUMBER> significantly higher affinity sarscov recently experiment study also suggested sarscov<NUMBER> could bind human ace<NUMBER> higher affinity sarscov <NUMBER> may provide one possible reasons sarscov<NUMBER> much infectious sarscov though factors like human activities pathogen persistence also critical impact spread sarscov<NUMBER> examination binding free energy contributions reveals higher binding affinity sarscov<NUMBER> sarscov mostly attributed solvation energy contribution âg solv <NUMBER> vs <NUMBER> kcalmol whereas sarscov<NUMBER> higher binding free energy vacuum âg gas sarscov â<NUMBER> vs â<NUMBER> words sarscov<NUMBER> tends bind human ace<NUMBER> better sarscov water sarscov would bind human ace<NUMBER> better sarscov<NUMBER> gas investigation needed reveal impact binding preferences human infection table <NUMBER> binding free energies calculated molecular dynamics md simulations rbdace<NUMBER> interactions sarscov<NUMBER> sarscov âg gas interaction energy change gas âg solv solvation energy change upon binding solvent respectively units reported kcalmol ttest conducted check statistical significance difference two sets free energies pvalue <NUMBER> indicates difference statistically significant <NUMBER> confidence interval spike protein coronavirus envelope trimeric protein protein critical vitality coronaviruses important component virus particle also plays crucial role attaching host cells fusing membranes <NUMBER> addition spike protein also determines solubility coronavirus particles thus viral infectivity spike protein largest protein located coronavirus envelope surface therefore spike protein directly related stability functionality coronaviruses run lengthy md simulation study trimeric spike proteins sarscov<NUMBER> sarscov table <NUMBER> gives comparison free energies spike proteins sarscov<NUMBER> sarscov seen table spike protein sarscov<NUMBER> significantly lower total free energy g total â<NUMBER> kcalmol spike protein sarscov g total â<NUMBER> kcalmol table <NUMBER> results suggest sarscov<NUMBER> stable able survive significantly higher temperature sarscov may partly explain higher infection ability sarscov<NUMBER> sarscov sarscov<NUMBER> would higher persistence sarscov temperature table <NUMBER> free energies calculated md simulations spike proteins sarscov<NUMBER> sarscov g gas interaction energy gas g solv solvation energy solvent respectively units reported kcalmol ttest conducted check statistical significance difference two sets free energies pvalue <NUMBER> indicates difference statistically significant <NUMBER> confidence interval lower free energy sarscov<NUMBER> spike protein may result virus evolution adaption hosts sarslike coronaviruses normally originate bats known higher body temperature humans <NUMBER> <NUMBER> <NUMBER> words sarscov<NUMBER> sarslike coronaviruses would evolved achieve lower free energy spike proteins recombination mutations survive hightemperature animals like bats <NUMBER> addition free energy decomposition also shows lower free energy sarscov<NUMBER> spike protein sarscov spike protein mainly attributed free energy vacuum g gas â<NUMBER> vs â<NUMBER> kcalmol whereas solvation energies g solv comparable â<NUMBER> vs â<NUMBER> kcalmol table <NUMBER> may reflect evolution trend sarslike coronaviruses ie favoring internal interactions residues instead solvation energy kind evolution would also beneficial persistence coronaviruses kinds coronaviruses lower internal energy would robust able survive air solvent <NUMBER> free rbd sarscov<NUMBER> temperaturesensitive sarscov coronaviruses use spike protein attach host cells binding host cell receptor therefore receptor binding domain rbd spike protein critical coronaviruses infect host cells run lengthy md simulations investigate dynamic properties rbd proteins sarscov<NUMBER> sarscov table <NUMBER> shows comparison free energies free rbd proteins sarscov<NUMBER> sarscov similar findings spike protein detailed last section table <NUMBER> rbd protein sarscov<NUMBER> also shows significantly lower free energy sarscov â<NUMBER> vs â<NUMBER> kcalmol table <NUMBER> may also understood evolution pressure coronaviruses due hightemperature host environment however unlike spike protein free energy difference sarscov<NUMBER> sarscov mostly attributed interresidue interactions vacuum g gas rbd protein free energy difference sarscov<NUMBER> sarscov comes free energies vacuum g gas â<NUMBER> vs â<NUMBER> kcalmol solvation energy g solv â<NUMBER> vs â<NUMBER> kcalmol table <NUMBER> lower solvation energy sarscov<NUMBER> rbd sarscov rbd may understood rbd must move away spike protein water order bind human ace<NUMBER> <NUMBER> words sarscov<NUMBER> would evolved soluble move bind ace<NUMBER> easily better solubility sarscov<NUMBER> rbd sarscov rbd may also contribute part higher infection ability sarscov<NUMBER> sarscov table <NUMBER> free energies calculated md simulations rbd proteins sarscov<NUMBER> sarscov g gas interaction energy gas g solv solvation energy solvent respectively units reported kcalmol ttest conducted check statistical significance difference two sets free energies pvalue <NUMBER> indicates difference statistically significant <NUMBER> confidence interval protein flexibility critical factor binding may change binding interface two proteins also important contribution entropy penalty upon binding therefore investigated protein flexibility rbd domains sarscov<NUMBER> sarscov analyzing coordinate trajectories figure <NUMBER> shows two ensembles selected trajectories period <NUMBER> ns simulations rbd proteins sarscov<NUMBER> sarscov figure also gives comparison root mean square fluctuations rmsf rough measurement protein flexibility rbds sarscov<NUMBER> sarscov seen figure rbd sarscov<NUMBER> shows significantly higher rmsf sarscov words sarscov<NUMBER> rbd much flexible sarscov rbd flexibility especially higher loop residues <NUMBER> near binding site regions figure <NUMBER>a means sarscov<NUMBER> must overcome much entropy penalty sarscov binding human ace<NUMBER> know binding free energy two proteins expressed âg âe â tâs âe interaction energy âs entropy loss upon binding temperature system âs negative binding free energy become higher binding become weaker increasing temperature therefore rbdace<NUMBER> binding affinity sarscov<NUMBER> expected decrease much faster sarscov temperature increases words sarscov<NUMBER> much temperaturesensitive sarscov terms rbdace<NUMBER> binding namely sarscov<NUMBER> decrease infection ability much faster sarscov temperature rises therefore expected sarscov<NUMBER> would become less infectious compared sarscov disease prevention control sarscov<NUMBER> may get easier weather gets warmerhotter although drug vaccine development targeting rbd protein may challenging high protein flexibility near binding site previous studies showed sarscov<NUMBER> highly homologous human sarscov attaches host cells binding spike protein angiotensinconverting enzyme ii ace<NUMBER> however molecular mechanisms sarscov<NUMBER> binding human ace<NUMBER> evolution sarscov<NUMBER> remain unclear study extensively studied rbdace<NUMBER> complex spike protein free rbd protein systems sarscov<NUMBER> sarscov proteinprotein docking md simulations found sarscov<NUMBER> bind human ace<NUMBER> higher binding affinity sarscov may partly explain sarscov<NUMBER> much infectious sarscov spike protein sarscov<NUMBER> shows lower free energy sarscov suggesting sarscov<NUMBER> may stable able survive higher temperature sarscov may also provide insights bat origin sarscov<NUMBER> bats higher bodytemperature humans addition sarscov<NUMBER> rbd exhibits significantly higher flexibility sarscov rbd especially near binding site means sarscov<NUMBER> must overcome higher entropy penalty order bind ace<NUMBER> thus temperaturesensitive sarscov human infection therefore rising temperature sarscov<NUMBER> expected decrease infection ability much faster become much less infectious sarscov would make disease prevention control sarscov<NUMBER> easier results together one may infer unlike sarscov gone <NUMBER> sarscov<NUMBER> might survive hightemperature environment like summer virus activeinfectious due high flexibility rbd become infectious temperature low winter results may farreaching implication disease prevention control well drug vaccine development sarscov<NUMBER> devastating impact covid<NUMBER> infections caused sarscoronavirus <NUMBER> sarscov<NUMBER> stimulated unprecedented international activity discover effective vaccines drugs pathogenic coronaviruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> also raised important questions mechanisms zoonotic transfer viruses animals humans questions whether companion animals used commercial purposes act reservoirs infection reasons large variations sarscov<NUMBER> susceptibility across animal species <NUMBER> <NUMBER> <NUMBER> understanding viruses move species may help us prevent minimize pathways future elucidating molecular basis different susceptibilities species may also shed light differences susceptibilities different subgroups humans recently shi et al published results experiments determine susceptibility sarscov<NUMBER> ferrets cats dogs domesticated animals <NUMBER> showed sarscov<NUMBER> virus replicates poorly dogs pigs chickens ducks ferrets cats permissive infection studies reported susceptibility animal species sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> susceptible species macaques hamsters ferrets used animal models sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> absence purified isolated ace<NUMBER> relevant animal species could used measure molecular affinities spike protein experimentally computational methods offer considerable promise determining rank order affinities across species method impute species may permissive sarscov<NUMBER> show computational chemistry methods structurebased drug design used determine relative binding affinities sarscov<NUMBER> spike protein receptor angiotensin converting enzyme ace<NUMBER> critical initiating event sarscov<NUMBER> infection across multiple common exotic animal species <NUMBER> <NUMBER> <NUMBER> aim studies better understand speciesspecific nature interaction see could help elucidate origin sarscov<NUMBER> mechanisms zoonotic transmission construct threedimensional structure sarscov<NUMBER> spike protein sequence retrieved ncbi genbank database accession number yp<NUMBER> psiblast search pdb database template selection performed xray structure sars coronavirus spike template refcode <NUMBER>acc selected <NUMBER> sequence similarity sarscov<NUMBER> spike protein protein sequences ace<NUMBER> proteins different species summarized table <NUMBER> full sequence alignment supplementary figure <NUMBER> phylogenetic tree ace<NUMBER> proteins selected animal species illustrated supplementary figure <NUMBER> <NUMBER>dstructures built using modeller <NUMBER> httpssalilaborgmodeller <NUMBER> quality generated models evaluated using ga<NUMBER> score dope scores models assessed using swissmodel structure assessment server httpsswissmodelexpasyorgassess <NUMBER> xray crystal structures human ace<NUMBER> recode <NUMBER>sci human sars spike protein refcode <NUMBER>xlr retrieved protein data bank protein preparation removal nonessential nonbridging water molecules docking studies performed using ucsf chimera package httpswwwcglucsfeduchimera <NUMBER> modelled structures docked sarscov<NUMBER> spike protein structure using hdock server httphdockphyshusteducn <NUMBER> <NUMBER> molecular docking performed homology modelled sarscov<NUMBER> spike protein human animal ace<NUMBER> proteins sarscov spike protein also docked human ace<NUMBER> protein obtain docking pose binding energy calculations docking poses ranked using energybased scoring function docked structures analyzed using ucsf chimera software final models optimized using amber<NUMBER>sbildn force field gromacs<NUMBER> httpwwwgromacsorg <NUMBER> docked complexes sarscov<NUMBER> spike human ace<NUMBER> human sarscov spike human ace<NUMBER> sarscov<NUMBER> spike bat ace<NUMBER> etc used starting geometries md simulations simulations carried using gpu accelerated version program amber<NUMBER>sbildn force field periodic boundary conditions oracle cloud server docked complexes immersed truncated octahedron box tip<NUMBER>p water molecules solvated box neutralized na clâ counter ions using tleap program particle mesh ewald pme employed calculate longrange electrostatic interactions cutoff distance longrange van der waals vdw energy term <NUMBER> Ã¥ whole system minimized without restraint steps applied <NUMBER> cycles steepest descent minimization followed <NUMBER> cycles conjugate gradient minimization system optimization md simulations initiated gradually heating system nvt ensemble <NUMBER> <NUMBER> k <NUMBER> ps using langevin thermostat coupling coefficient <NUMBER>ps force constant <NUMBER> kcalmolÂ·Ã¥<NUMBER> complex finally production run <NUMBER> ns md simulation performed constant temperature <NUMBER> k npt ensemble periodic boundary conditions system md procedure shake algorithm applied constraint covalent bonds involving hydrogen atoms time step set <NUMBER> fs structural stability complex monitored rmsd rmsf values backbone atoms entire protein finally free energies binding calculated simulated docked structures calculations also performed <NUMBER> ns human ace<NUMBER> ensure <NUMBER>ns sufficiently long convergence duplicate production runs starting different random seeds also run allow estimates binding energy uncertainties determined strongest binding ace<NUMBER> structures binding free energies proteinprotein complexes evaluated two ways traditional method calculate energies solvated sarscov<NUMBER> spike ace<NUMBER> proteins bound complex proteins derive binding energy subtraction Î´g binding aq Î´g complex aq Î´g spike aq Î´g ace<NUMBER> aq also calculated binding energies using molecular mechanics poisson boltzmann surface area mmpbsa tool gromacs derived nonbonded interaction energies complex <NUMBER> <NUMBER> method also widely used method binding free energy calculations binding free energies protein complexes analyzed equilibrium phase output files <NUMBER> ns md simulations gmmpbsa tool gromacs used molecular dynamics simulations output files obtained used postprocess binding free free energy decomposition analyses also performed mmpbsa decomposition get detailed insight interactions ligand residue binding site binding interaction ligandresidue pair includes three terms van der waals contribution electrostatic contribution solvation contribution another estimate strength interaction proteinprotein complex obtained nonbonded interaction energy complex gromacs ability decompose shortrange nonbonded energies number defined groups compute interaction energies part analysis reran trajectory files obtained simulation recompute energies using rerun command interaction energy combination short range coulombic interaction energy coulsrproteinprotein shortrange lennardjones energy ljsrproteinprotein see table <NUMBER> paper prepared paper guterres im described substantial improvement proteinligand docking results using highthroughput md simulations <NUMBER> employed docking using autodock vina followed md simulation using charmm parameters advocated similar used study proteins solvated box tip<NUMBER>p water molecules extending <NUMBER> Ã¥ beyond proteins particlemesh ewald method used electrostatic interactions nonbonded interactions <NUMBER> <NUMBER> Ã¥ truncated systems minimized <NUMBER> steps using steepest descent method followed <NUMBER> ns equilibration nvt setting proteinligand complex ran <NUMBER> Ã <NUMBER> ns production runs initial structure using different initial velocity random seeds integration step size <NUMBER> fs ancestry sarscov<NUMBER> traces back human civet bat sarscov strains use ace<NUMBER> proteins cellular entry <NUMBER> <NUMBER> <NUMBER> similarities variations sequences sarscov<NUMBER> spike protein sars spike protein determined sequences retrieved ncbi genbank databank aligned using clustalw spike protein receptor binding domain rbd region showed <NUMBER> identity two viruses figure <NUMBER> conserved regions black nonconserved residues red blue threedimensional structure sarscov<NUMBER> spike protein figure ramachandran scores modeled ace<NUMBER> structures selected species summarized table <NUMBER> actual predicted ace<NUMBER> structures ramachandran plots selected species shown supplementary figure <NUMBER> figure <NUMBER> modelled structures assessed quality control using ramachandran plot molprobity scores swissmodel structure assessment ramachandran plot checks stereochemical quality protein analyzing residuebyresidue geometry overall structure geometry also way visualize energetically allowed regions backbone dihedral angles Ï Ï amino acid residues protein structure ramachandran score sarscov<NUMBER> spike protein <NUMBER> binding region molprobity scores provide evaluation model quality global local level <NUMBER> ace<NUMBER> modelled structures selected species also assessed using swiss model structure assessment ramachandran score percentage amino acid residues falling energetically favored region species ranged <NUMBER> table <NUMBER> ramachandran molprobity scores show built structures good quality suitable use studies ramachandran graphs presented supplementary figure <NUMBER> receptor binding domain rbd sarscov<NUMBER> spike protein docked ace<NUMBER> receptor various species using hdock server interacting residues ace<NUMBER> sarscov<NUMBER> spike protein depicted table <NUMBER> found certain key amino acids receptor binding motif rbm accordance previous studies <NUMBER> certain amino acids including phe<NUMBER> asn<NUMBER> asp<NUMBER> arg<NUMBER> conserved ace<NUMBER> selected species observed take part interaction spike protein tyr<NUMBER> lys<NUMBER> ala<NUMBER> arg<NUMBER> also interacted spike protein residues highly conserved across species except bat mouse ferret pangolin respectively spike protein interacting residues ophiophagus hannah king cobra least common amongst ace<NUMBER> species included study consistent low sequence similarity human ace<NUMBER> homo sapiens human molecular dynamics simulation complexes sarscov<NUMBER> spike protein ace<NUMBER> receptors various species performed <NUMBER>ns complexes became stable simulation rmsd fluctuations converging range <NUMBER> <NUMBER> nm original position calculated binding energies interactions sarscov<NUMBER> ace<NUMBER> species studied presented table <NUMBER> table <NUMBER> also includes observational vivo data sarscov<NUMBER> infectivity disease symptoms species reported although bats carry many coronaviruses including sarscov relative sarscov<NUMBER> direct evidence existence sarscov<NUMBER> bats found highlighted data binding strength sarscov<NUMBER> bat ace<NUMBER> considerably lower human ace<NUMBER> suggesting even sarscov<NUMBER> originally arise bat precursor must later adapted spike protein optimise binding human ace<NUMBER> current explanation might happened instances direct human infection coronaviruses bat viruses rare transmission typically involving intermediate host example lyssaviruses hendra periodically transmitted bats horses humans contact infected horse similarly sarscov shown transmitted bats civet cats humans date virus identical sarscov<NUMBER> identified bats nonhuman species making origins unclear date closely related coronavirus sarscov<NUMBER> bat coronavirus batcov ratg<NUMBER> <NUMBER> wholegenome identity sarscov<NUMBER> <NUMBER> hence genetic factors could underlie apparent lack susceptibility dogs covid<NUMBER> clinical infection known gain function gof mutations occur viruses lead pandemics gof means viruses gain new property eg influenza virus gof associated acquisition new function mammalian transmissibility increased virulence humans evasion existing host immunity <NUMBER> conditioning viruses humans pandemics progress well recognized however sarscov<NUMBER> structures sequences employed viruses collected early pandemic therefore clear sarscov<NUMBER> could developed high affinity human ace<NUMBER> notably higher putative zoonotic sources sarscov<NUMBER> unless previously selected human ace<NUMBER> ace<NUMBER> another species bearing closely homologous spike protein binding domain interestingly pangolin ace<NUMBER> bears similarities sbd human ace<NUMBER> marries fact pangolincov shares highly similar rbd sarscov<NUMBER> although remaining sequence <NUMBER> similarity could consistent process convergent evolution whereby human pangolin coronaviruses infecting via ace<NUMBER> come solution respect evolving optimal spike rbd binding either human pangolin ace<NUMBER> respectively data indicate humans might permissive pangolin covs use ace<NUMBER> cell entry fact needs borne mind respect future potential coronavirus pandemic sources however mean pangolin ace<NUMBER> receptor sarscov<NUMBER> spike protein rbd initially selected strength binding pangolin ace<NUMBER> lower binding human ace<NUMBER> makes unlikely pangolins missing intermediate host sarscov<NUMBER> spike selected pangolin ace<NUMBER> given higher affinity sarscov<NUMBER> human ace<NUMBER> bat ace<NUMBER> sarscov<NUMBER> would circulated pangolins long period time evolution selection occur date evidence sarscov<NUMBER> like virus circulating pangolins another possibility would short term evolutionary step pangolin recently coinfected bat ancestor sarscov<NUMBER> time infected pangolin cov allowing recombination event occur whereby spike rbd pangolin virus inserted bat cov thereby conferring bat cov high binding pangolin human ace<NUMBER> recombination events known occur rna viruses explain creation pandemic influenza strains <NUMBER> nevertheless events necessity rare require coinfection one host exactly time importantly recombination event occurred pangolins might expected similarly triggered epidemic spread new highly permissive sarscov<NUMBER> like virus among pangolin populations see occurring across human population currently evidence pangolin sarscov<NUMBER> like outbreak making whole scenario less likely indeed pangolins might protected sarscov<NUMBER> infection due existence crossprotective spike rbd neutralising antibodies induced exposure pangolin cov given rbd similarity two viruses another possibility still cannot excluded sarscov<NUMBER> created recombination event occurred inadvertently consciously laboratory handling coronaviruses new virus accidentally released local human population given seriousness ongoing sarscov<NUMBER> pandemic imperative efforts made identify original source sarscov<NUMBER> virus particular important establish whether covid<NUMBER> due completely natural chance occurrence presumed bat virus transmitted humans via intermediate animal host whether covid<NUMBER> alternative origins information paramount importance help prevent similar human coronavirus outbreak future rapid viral replication ensues celltocell spread acute inflammation begins mount uncontrolled viral replication dysregulated host immune responses may leading cause fatality sarscov<NUMBER> despite many studies underpinnings high virus infectivity remain poorly understood therefore essential dissect genomic control sarscov<NUMBER> infectivity virulence rational designing therapeutic agents genome genomic constitution sarscov<NUMBER> appear unique background disease pathology merscov share <NUMBER> genome sequence identity sarscov sarscov<NUMBER> two Î² human coronaviruses hcovs hcovhku<NUMBER> hcovoc<NUMBER> also share <NUMBER> genome identity sarscov sarscov<NUMBER> yet cause common cold instead acute respiratory distress human Î±coronavirus nl<NUMBER> <NUMBER>e strains even diverged Î²hcov genomes also cause common cold even essential genes like rna dependent rna polymerase rdrp diverged example rdrp sarscov<NUMBER>sarscov <NUMBER> identical merscov table s<NUMBER> therefore gene genomic features distinguishes virus important consideration understanding infectivity spread across hosts spike among coronaviruses spike key gene determines infectivity due established role initiating virushost attachment fusion entry celltocell fusion post replication <NUMBER> expressed protein executes function trimeric quaternary structure monomer segmented s<NUMBER> s<NUMBER> domains s<NUMBER> consists nterminal domain ntd cterminal domain ctd s<NUMBER> also known fusion domain consists fusion peptides fps central helix ch heptad repeat regions hr<NUMBER> hr<NUMBER> transmembrane domain tm followed cytoplasmic tail cp fig <NUMBER>a ntd ctd embeds receptorbinding domain rbd depending individual virus sarscov<NUMBER> ctd embeds rbd rbd recognizes hostcell mediates virushost attachment s<NUMBER> domain drives viral entry host cell celltocell fusion catalyzing virushost membrane fusion process tm anchors protein viral membrane fps contribute trigger drives virushost membrane fusion process transition pathway proposed proceed prehairpin intermediate structure followed prebundle hemifusion membraneassociated structure bundle structure eventual postfusion structure <NUMBER> remarkable despite similarity function Î²coronavirus spike proteins widely diverged rbd diverging <NUMBER> pairwise sequence identity explained part diversity host receptor targets like human ace<NUMBER> sarscov sarscov<NUMBER> dpp<NUMBER> merscov <NUMBER>oacsia hcovoc<NUMBER> hcovhku<NUMBER> s<NUMBER> domain also diverged comparatively less <NUMBER> overall pairwise sequence identitythe heptad repeat regions conserved fig <NUMBER>b pertinent ask features spike sequence structure determine virus fusogenicity infectivity spike glycosylation densely glycosylated spike protein suggested prime reason high sarscov<NUMBER> infectivity <NUMBER> extensive glycosylation s<NUMBER> domain driven intracellular nterminal signaling peptide transport retention endoplasmic reticulum see fig <NUMBER>b multiple sequence alignment <NUMBER> bottom panel however signal sequence absent fellow murine Î²coronavirus mhva<NUMBER> spike protein <NUMBER> indicating limited glycosylation yet mhva<NUMBER> aggressively infects mouse liver brain upon intracranial inoculation mice cause acute stage meningoencephalitis myelitis chronic stage demyelination axonal loss <NUMBER> <NUMBER> <NUMBER> infects neurons profusely spread neuron neuron propagation grey matter neuron white matter release nerve ends infect oligodendrocytes celltocell fusion <NUMBER> robust mechanisms evade immune responses induce chronic stage progressive neuroinflammatory demyelination concurrent axonal loss absence functional virions <NUMBER> <NUMBER> therefore high infectivity mhva<NUMBER> spike appear contingent glycosylation one argue sarscov<NUMBER> spike glycosylation may marginally raise basal fusion efficiency surface glycosylation thus may contributing factor host cell binding although successive virustocell celltocell fusion may alltogether play important role higher virus infectivity suggested enhanced virustocell infection propelled increased number hydrogenbonded contacts sarscov<NUMBER> rbd ace<NUMBER> receptor leading higher affinity improved host targeting compared sarscov <NUMBER> <NUMBER> however proposition weak rbds hcovs diverse including sarscov minimal rbd <NUMBER> <NUMBER> residues shares <NUMBER> sequence identity sarscov<NUMBER> fig s<NUMBER> besides significantly higher affinity ace<NUMBER> sarscov<NUMBER> experimentally corroborated <NUMBER> also sarscov<NUMBER> spike may interact receptors dcsign dcsignr sarscov increase tropism <NUMBER> viral spread therefore direct consequence ace<NUMBER> recognition infectivity unless virus entry realized however rbds interact ace<NUMBER> large numbers acute stage infection may modulate host immune response downregulating hydrolysis proinflammatory angiotensin ii antiinflammatory angiotensin <NUMBER> reninangiotensin signaling pathway <NUMBER> alter immune response increase infectivity effects manifest beyond early stage infection happen efficiency viral entry ratelimiting step spike cleavage cleavage spike protein said prime virushost membrane fusion process essential virus fusogenicity infectivity important consideration spike cleavage potentially removes situ covalent noncovalent constraints s<NUMBER> domain may impose s<NUMBER> domain impeding conformational transition facilitates virus entry comparison s<NUMBER>s<NUMBER> cleavage signal sequence shows sarscov<NUMBER> rrars furin recognition site similar mhva<NUMBER> spikes rrahr required activity <NUMBER> fig <NUMBER>b contrast canonical cleavage recognition sequence missing sarscov single arginine present regular cleavage site reported cleavage trypsin shown activate virus independent ph cleavage site signal s<NUMBER> highly conserved across hcovs contrast s<NUMBER>s<NUMBER> cleavage signal fig <NUMBER>b importance region aptly corroborated s<NUMBER> site cleavage studies sarscov <NUMBER> besides also possible spike activated low ph environment protonation residues internalizes endosome post interaction host receptor contrary fusion processes known happen mhva<NUMBER> spike without cleavage well <NUMBER> therefore sarscov<NUMBER> spike appears competent access multiple pathways priming enhances infection capability including possibility infect without cleavage well among components fusion apparatus spike s<NUMBER> domain fps least studied although suggested contribute trigger drives virushost fusion process initiating proteinhost membrane contacts limited experimental information available shows mutation fp sarscov spike significantly perturb fusion efficiency <NUMBER> much <NUMBER> <NUMBER> studies fp regions used synthetic peptides fusion assay system understand membrane perturbing capabilities <NUMBER> <NUMBER> <NUMBER> <NUMBER> ca <NUMBER> ions may interact peptides modulate fusion <NUMBER> interestingly fps also contains central proline <NUMBER> several viruses avian sarcomaleucosis virus <NUMBER> ebola virus <NUMBER> vesicular stomatitis virus <NUMBER> hepatitis c virus <NUMBER> important role investigated mutation studies location coronavirus fps proximal nterminal s<NUMBER> domain reminiscent fps hiv<NUMBER> influenza virus paramyxoviruses suggested head prehairpin intermediate structure <NUMBER> predicted current model class viral fusion proteins given fps believed early initiators protein host membrane contact still consensus location example fusion peptide sarscov<NUMBER> spike cited <NUMBER> position xia et al <NUMBER> compared <NUMBER> wrap et al <NUMBER> inferred alignment sarscov spike two additional fp segments <NUMBER> position <NUMBER> proposed based experimental studies ou et al <NUMBER> guillÃ©n et al <NUMBER> respectively reality four spike fusion domain segments fpi fpiv fig <NUMBER>b mentioned identified simple windowbased analysis using interfacial hydrophobicity scales wimley white <NUMBER> given fp<NUMBER> fpiii contiguous sequence whole segment spanning beginning fp<NUMBER> end fpiii termed together fusion loop fig <NUMBER>a fps loop act synergistically trigger membrane fusion process understood yet spike receptor binding fusion peptide structural perspective understand synergy fps trigger process important understand structure spike protein proper context fpi fpiii surface exposed contiguous space seen threedimensional structures spike fusion domain fig <NUMBER> cartoon diagrams fpi fpiii always surface exposed fulllength fpiv deeply buried interface virus membrane therefore fpi fpiii always available early contacts host membrane fpiv participate process post conformational transition may expose interaction host membrane understand guarantees fp surfaces make initial proteinhost membrane contact one must look possible modes virushost attachment spike example three rbds trimeric structure finds host receptor attain tripod binding mode fig <NUMBER>a recent structure trimeric spike complexed host receptor reveals precise geometry ceacam<NUMBER> binding rbd spike mhva<NUMBER> <NUMBER> however tripod binding requires receptor molecules host membrane preavailable specific arrangement high expression receptor molecules host cell surface expected increase probability tripod binding existing information whether precise arrangement present host surface suitable interaction trimeric rbd moreover membrane bilayer structure contain feature direct regular host receptor arrangement may noted tripod arrangement prehairpinprebundle helices fusion domain expected interact headon host membrane nterminal segment s<NUMBER> domain interact early proteinmembrane contact situation existing model structural transition follow <NUMBER> fpi fpii located middle cylinderlike spike s<NUMBER> structure fig <NUMBER>a conformational transition needed place near head cylinder fp<NUMBER> expected make early hostmembrane contact cleavage s<NUMBER>s<NUMBER> site fpii cleavage s<NUMBER> site see fig <NUMBER>a fpiii region limited scope make early contact due farthest position host membrane surface tripod binding mode virus membrane still <NUMBER>Ã¥ away three hr<NUMBER> regions need fold back bind hydrophobic grooves hr<NUMBER> trimer antiparallel manner bridge gap form hemifusion structure host membrane <NUMBER> spike fusion peptide trigger alternately one two rbds bind receptor vertical anchoring spike fusion domain relative host surface feasible based simple structural considerations also recent trimeric structure sarscov<NUMBER> spike shown single rbd open conformation <NUMBER> state interaction open rbd host fig <NUMBER>b expected stabilize spike anchoring specific orientation relative host due weak interaction fusion domain postcleaved s<NUMBER> domain expected interact sideon membrane surface belly landing trigger fusion process fig <NUMBER>c noted shape trimeric s<NUMBER> domain proper cylinder bulge midsegment call belly fpii fpi surfaces located crest bulge able make initial contact host membrane structural constraints guarantee belly landing understood overall geometry spike fig <NUMBER>d relative location ntd spike form three vertices triangle fpi fiii located midpoint sides forming vertices inner triangle receptor attachment two rbd locations s<NUMBER> landing close midpoint two vertices outer triangle coincident fp surfaces even onelegged attachment contact must always directed towards midpoint two ntds allows maximum contact surface formed spike stably rest host surface contact membranotropic segment fusion loop spanning fps expected engage host membrane fusogenic conformational change case fp sites proximal virus membrane surface hemifusion membrane structures initiated early comparison tripodbinding mode requires intermediate prehairpin structure formed also noted weak rbd binding s<NUMBER> domain disintegration spike trimer post tripod binding mimic oneor twolegged binding mode physicochemical property fusion loop synergy fps therein critical rapid initiation transition hemifusion stage membrane fusion process reorganization fusion loop formation eventual sixhelix bundle would sideface making maximum possible interface contacting host surface since exerted force conformation transition tangential host surface orthogonal frictional forces may allow efficient scything action based physiochemical nature contact engaged fusion loop nature initial surfaces fusion loop obtained electrostatic potential fpi fpiii surface patches <NUMBER> fig <NUMBER> surface diagrams among six spike proteins considered study sarscov<NUMBER> hydrophobicneutral electrostatic fp patches white colored suitable membrane disruption also least amount highly negative electrostatic surface red colored patches repel attachment s<NUMBER> domain host membrane due repelling hydrophilic surface outer membrane composed negatively charged fatty acid groups hand positive electrostatic surface blue colored patches may allow protein surface tightly attach membrane exterior charge attraction presence interfacial ion like ca <NUMBER> cap negative charge fp surface assist fusion trigger consistent membrane charge compatibility requirements disruption efficiency surface patches therefore likely highest hydrophobicneutral followed positive negative electrostatic potential unless modulated interfacial cation like ca <NUMBER> one may argue large patches negative electrostatic surface potential red color hcovhku<NUMBER> hcovoc<NUMBER> spike fusion domain may explain mild nature viruses aside electrostatics physical rigidity fusion loop spike prime importance virus fusogenicity spike fusion domain metastable local alteration rigidity global implications molecule alluded mutation studies fusion peptide central prolines <NUMBER> <NUMBER> <NUMBER> <NUMBER> criticality recently revealed comprehensive studies centrally located consecutive prolines mhva<NUMBER> spike fusion peptide <NUMBER> proline iminoacid unique structure restricted torsional freedom turn restricts torsional freedom protein backbone located <NUMBER> two consecutive prolines located rigidity protein backbone enhanced among six spike proteins study three single central proline fpi two centrally located consecutive prolines occur sarscov<NUMBER> spike fp<NUMBER> central prolines fpii single conserved central proline fpiv consecutive prolines exist central location hcovhku<NUMBER> hcovoc<NUMBER> mhva<NUMBER> fpiii spikes understand intrinsic flexibilityrigidity surface exposed fps set <NUMBER> ns molecular dynamics simulations <NUMBER> using charmm forcefield <NUMBER> fig <NUMBER> starting structures fpi fragments devoid stable secondary structures helices sheets dominated turns irregular structures indicating region prefers loop conformation true even mhva<NUMBER> spike flexible experimentally evidenced lack coordinate electron density map complete fpi pdb file <NUMBER>jcl comparison fpiis cases dominated helical conformation nterminal fp segments always helical state true fpiii region fragments well given irregular structure effect proline dramatic fpi region contrast fps fpii fpiii already stabilized hydrogen bonds helices fps fpi region although local secondary structures induced simulation lowest rootmeansquare fluctuation rmsf residue achieved sarscov<NUMBER> consecutive proline containing fp also confirmed energy landscape plot created molecular dynamics simulation trajectory fig s<NUMBER> compact single conformational well among fpis look fpiii regions consecutive proline containing fps exist hcovoc<NUMBER> lowest rmsf sarscov<NUMBER> fpiii segment central proline contains unique thrilethr segment constituted three consecutive Î²branched sidechain residues impart substantial rigidity based steric considerations <NUMBER> much consecutive prolines confirmed energy landscape plot shows single compact conformational well contrast fpiiis fig s<NUMBER> observations consistent previous comparative molecular dynamics studies <NUMBER> mhva<NUMBER> fpiii single central proline containing fpiii another parental nonneurotropic strain murine hepatitis virus mhv mhv<NUMBER> found fpiii former became rigid latter methanolic conditions compared water additionally nmr studies mhva<NUMBER> fpiii fragment revealed unique ability form cispeptide central pp peptide bond <NUMBER> cistrans isomerization membrane fusion process potential expose hydrophobic residues efficiently around isomerizedpeptide neighborhood enhancing fusion trigger potential structural role proline cannot discounted stabilizing interactions also dominate fps among formation aromatichydrophobic clusters relevance fusion process see fig s<NUMBER> examples observed packing loops combination aromatic valileleu side chains pack tightly exclude water regions become exposed conformational transition would enhance hydrophobic interaction protein surface membrane s<NUMBER> domains however fpiii regions part masked fpi segment evident relative solvent accessible surface area sasa values indicated fig <NUMBER> fpiii region get fully exposed post cleavage s<NUMBER> site dislodges sheathing fpi segment site gets progressively exposed conformational transition amidst fusion process experimental corroboration additional evidence rigidity imparted proline critical virus fusogenicity infectivity pathogenicity obtained previous vitro vivo studies <NUMBER> generated spike containing two consecutive prolines <NUMBER> smhva<NUMBER>pp fpiii proline deletion Î´<NUMBER> mutant smhva<NUMBER>p isogenic recombinant strain mhva<NUMBER> rsa<NUMBER> <NUMBER> spike protein proline deleted mutant spike gene construct smhva<NUMBER>p show slower trafficking cell surface significantly less fusogenicity established differential properties proline deletion spike construct generated proline deleted targeted recombinant mutant strain rsa<NUMBER>p contains smhva<NUMBER>p compared two consecutive prolinecontaining parental isogenic strain rsa<NUMBER> containing smhva<NUMBER>pp proline deleted mutant rsa<NUMBER>p infection neuronal cell line demonstrated less aggressive fewer syncytia formation one order lower viral titers postinfection vitro based vitro differential properties proline deletion spike construct generated proline deleted targeted recombinant mutant strain rsa<NUMBER>p contains smhva<NUMBER>p compared two consecutive proline containing parental isogenic strain rsa<NUMBER> containing smhva<NUMBER>pp vivo studies mice parallels vitro studies demonstrating significantly reduced viral replication consecutive disease pathologies like less severity meningitis encephalitis demyelination inability infect retina induce loss retinal ganglion cells <NUMBER> nonneurotropic strain mhv<NUMBER> sharing <NUMBER> genome identity mhva<NUMBER> <NUMBER> pairwise spike sequence identity single central proline fpiii causes meningitis unable invade brain parenchyma computational studies s<NUMBER> fusion domains smhva<NUMBER>pp mhv<NUMBER> spike involving molecular dynamics confirmed former rigid containing residues regular secondary structure <NUMBER> target therapy study brings importance fusion loop region could legitimate target design vaccine synthetic agents therapy covid<NUMBER> s<NUMBER> domain serves better therapeutic target s<NUMBER> due higher evolutionary conservation attempts made mainly focussed attention heptad repeat regions <NUMBER> two important features also make fusion loop attractive therapeutic target accessibility due surface exposure fulllength spike relatively high conservation residues fusion loop especially around fpii region increases scope pancoronavirus target cater future pandemic threats well mimetic peptides designed bind fusion loop inhibit fusogenic conformational transition s<NUMBER> domain impairment fusion trigger would direct bearing fusogenicity virus contribute reduction lung invasion damage clinically results acute pneumonia systematic studies identify minimal motif fusion loop serving fusogenic determinant improve selection potential therapeutic target prevent celltocell fusion subsequent pathogenesis interplay outlined physicochemical features determines virusentry process become efficient local global stability s<NUMBER> domain important since s<NUMBER> domain undergoes conformational transition local stability means reasonably rigid moving parts global stability means welldefined conformational transition pathway metastable stable state local global stability requirement could attributed physicochemical efficiency needed disturbing host membrane secondly electrostatic potential fusion peptide derived surface patches must neutral positive able engage host membrane presence glycosylation sites adds hydrophobicity s<NUMBER> domain surface small fraction available surface interaction host membrane fusogenic conformational transition requires optimal synergy physical chemical properties fusion loop allow concurrent scything action rapidly facilitate transition hostvirus hemifusion membrane state freeenergy available conformational transition s<NUMBER> relaxed helical bundle available disrupt host membrane overcome kinetic barrier bring host virus membrane lipid bilayers together prehairpin s<NUMBER> intermediate suggested exist many researchers may one many conformational states interacting host membrane priming spike cleavage important facilitating fusion process therefore part synergy play however open conformation rbd seen pdb id <NUMBER>vsb sarscov<NUMBER> suggests flexible linker segments loosely connect rbd back fusion domain leaving relatively free unfettered conformational transition therefore multifarious options prime trigger appear available sarscov<NUMBER> viral entry contributes increased infectivity preventing trigger inhibiting fusion loop therefore suitable target therapy given importance extensive study sarscov<NUMBER> spike protein mechanistic hypothesis described therefore warranted sequences used study downloaded ncbi database urlhttpwwwncbinlmnihgov multiple sequence alignments performed using tcoffee webserver httptcoffeecrgcat default parameter values alignment available server used server combines several methods come optimal multiple sequence alignment <NUMBER> protein threedimensional structures downloaded protein data bank httpwwwrcsborg pdb ids downloaded structures hcovhku<NUMBER> <NUMBER>i<NUMBER> mhva<NUMBER> <NUMBER>jcl <NUMBER>vsj hcovoc<NUMBER> <NUMBER>nzk merscov <NUMBER>q<NUMBER> sarscov<NUMBER> <NUMBER>vxx <NUMBER>vsb sarscov <NUMBER>xlr structures highest resolution preferred one model available coordinates files extracted obtaining starting models fps used molecular dynamics simulations whenever missing coordinates modeled extended structure fp sasa calculated program nacess httpwolfbmsumistacuknaccess residues atom coordinates present pdb file considered fully exposed solvent calculating relative sasa values secondary structure calculated secstr program procheck suite httpswwwebiacukthorntonsrvsoftwareprocheck electrostatic surface potential calculated using apbs plugin <NUMBER> inside pymol software httppymolorg default parameters used calculations cartoon diagrams surfaces rendered pymol software molecular dynamics simulations performed gromacs software <NUMBER> httpwwwgromacsorg simulations performed using charmm <NUMBER> forcefield cmap <NUMBER> fp placed cubic box solvated water spc model solvent molecules randomly replaced na cl â neutralize system bring final concentration nacl <NUMBER> periodic boundary conditions enforced three directions system minimized maximum force system reached <NUMBER> kj mol â<NUMBER> nm â<NUMBER> systems equilibrated <NUMBER> ns nvt ensemble followed equilibration <NUMBER> ns npt ensemble <NUMBER> atm <NUMBER> k production run executed <NUMBER> ns saving output every <NUMBER> ps yielding <NUMBER> frames analysis analysis trajectory performed using gromacs utilities diagrams created using inhouse software electrostatic surface fusion domain shown adjacent structure corresponding fusion peptide regions marked arrow orientation cartoon structure electrostatic surface aligned among note one face electrostatic surface visible repeated side due symmetry arising trimeric quaternary structure fusion domain structures shown cyan helices strands red loops magenta please refer fig <NUMBER> sequence alignment legend pdb id files used draw structures note part fpi surface absent mhva<NUMBER> hcovhku<NUMBER> due unavailable atom coordinates pdb file true small section fpii sarscov<NUMBER> residue details please refer fig <NUMBER> fpi regions least one asnlinked site sarscov<NUMBER> sarscov hcovhku<NUMBER> site fpii hcovoc<NUMBER> hcovhku<NUMBER> fpiii contiguous fpiii heptad repeat regions glycosylation sequence conservation among spike highest spike mhva<NUMBER> shares <NUMBER> overall sequence identity hcovhku<NUMBER> oc<NUMBER> <NUMBER> identity corresponding s<NUMBER> domains similar match sarscov merscov sarscov<NUMBER> <NUMBER> pairwise sequence identity fig <NUMBER> schematic diagrams explaining mode binding spike protein host receptor putative orientation relative host membrane surface virushost attachment cartoon diagram created using pdb id <NUMBER>vsj spike protein mhva<NUMBER> complex ceacam<NUMBER> receptor mouse since three subunits spike rbd attach receptor allows virus anchor tripod mode approximate length spike longer dimension indicated along fp locations b cartoon diagram created using pdb id <NUMBER>vsb one rbds shown open conformation receptor molecule ace<NUMBER> drawn show putative attachment onelegged mode twolegged mode may also possible similarly c s<NUMBER> domain sarscov<NUMBER> spike protein shown bellylanding orientation approximate length spike longer dimension indicated along marked fp locations ribbon diagram trimeric spike proteins six coronaviruses used study two triangles marked structure relative locations protruding ntds appear near outer triangle vertices fpi fpii fpiii colored surfaces located near inner triangle vertices triangles marked bring relative positions ntds fp surfaces spike structure oriented rbd appears closest eye followed ntd fps yaxis scales provide values sasa rmsf sidebyside standard deviation sasa simulation indicated shaded background around sasa curve xaxis indicates residues fp fragment central proline residues marked bold residues atom coordinates absent pdb file marked red residues corresponding secondary structures indicated present fulllength protein symbols mean follows hÎ±helix h Î±helix termini g <NUMBER>helix g <NUMBER>helix termini b Î²bridge e Î²strand e Î²strand termini hydrogenbonded turn hydrogenbonded turn termini bend space irregular secondary structure first second third columns indicated labels ii iii corresponding fpi fpii fpiii spike protein given virus respectively relative sasa value whole fp fragment s<NUMBER> domain expressed percentage indicated bold top part plot sarscorona virus cov<NUMBER> newest member large group viruses coming order nidovirales family coronaviridae genera beta coronavirus group <NUMBER>b<NUMBER> sarscov<NUMBER> consists four basic structural proteins club shape trimeric âspike protein sâ âmembrane proteinâ âenvelop e proteinâ helically symmetrical ânucleocapsid protein nâ<NUMBER> molecular basis transmission coronavirus cov already explained previous systematic review<NUMBER> infection process starts binding spike protein s<NUMBER>domain human host cell receptor angiotensinconverting enzyme <NUMBER> aces leads conformational change s<NUMBER> s<NUMBER> domain spike protein changes expose âfusion peptideâ s<NUMBER>domain mediates fusion viral host cell membranes rna genome virus subsequently released host cell virus uses hostcell machinery start translation process synthesize necessary polyproteins pp<NUMBER>a pp<NUMBER>ab processed proteases release nonstructural viral proteins nsps structural proteins spike e n protein translated respective location viral genome synthesized structural proteins nonstructural proteins rna genome assembles transported outside cell exocytosis<NUMBER> coming presently available pharmacotherapeutic options treatment covid<NUMBER> chloroquine hydroxychloroquine<NUMBER> interferonÎ± ribavirin corticosteroids<NUMBER> plasma therapy<NUMBER> intravenous immuneglobulins<NUMBER> lopinavirritonavir etc mainstream treatment options however agents used without major clinical evidence efficacy safety although many therapeutic options evaluation different settings example silico vitro preclinical clinical studies however definite evidence efficacy agents clinical settings still clear<NUMBER> sarscov<NUMBER> <NUMBER>â<NUMBER> similar sarscov genomic level<NUMBER> recent studies highlighted many important genomic variations sarscov<NUMBER> example absence <NUMBER>a protein changes number amino acid <NUMBER>c <NUMBER>b protein<NUMBER> spike protein also modified homologous recombination process<NUMBER> compared sarscov mutation n<NUMBER>t spike protein sarscov<NUMBER> confers higherbinding affinity sarscov<NUMBER> ace<NUMBER> receptor<NUMBER> better understanding viral life cycle terms structural biology perspectives help us identifying druggable targets approached drug design perspective systematically reviewed available target protein structures sarscov<NUMBER> relation viral life cycle drugdesign perspective included peerreviewed published studies evaluating target protein threedimensional <NUMBER>d structure nuclear magnetic resonance xray crystallography cryoelectron microscopy structure without bound ligand structures deposited published rcsborg among unpublished studies structure published rcsborg included inhibitor bound structures reviewing full text articles could find published papers <NUMBER>d structures four targets spike protein main protease also known main protease mpro <NUMBER>clpro rnadependent rnapolymerase rdrp nsp<NUMBER> sars cov<NUMBER> spike proteins trimeric fusion proteins two main domains s<NUMBER> s<NUMBER> domain structure spike protein sarscov<NUMBER> around <NUMBER> conserved compared sarscov<NUMBER> root mean square deviation rmsd sarscov receptorbinding domain rbd sarscov<NUMBER> rbd around <NUMBER> angstrom rmsd receptorbinding motif rbm sarscov rbm sarscov<NUMBER> around <NUMBER> angstrom implicating high similarity two structures<NUMBER> affinity interaction ectodomain sarscov<NUMBER> ace<NUMBER> high <NUMBER>â<NUMBER> fold compared sarscov thus contributes high infectivity sarscov<NUMBER> spike proteins considered class<NUMBER> viral fusionprotein requires twostep protease cleavages activation site s<NUMBER> s<NUMBER> location priming cleavage however activation cleavage occurs solely s<NUMBER> different protease example transmembrane protease serine protease<NUMBER> tmprss<NUMBER> tmprss<NUMBER> human airway trypsin hat like protease cathepsins etc involved proteolytic activation process cellbased experiments <NUMBER>hace<NUMBER> cells expression different tmprss isoforms enhanced sarscov<NUMBER> spike proteinmediated cellcell fusion<NUMBER> s<NUMBER>rbdmediated recognition attachment host receptor ace<NUMBER> primeinitiating event leads viral hostcell fusion subsequent events highlights importance detailed understanding interactions s<NUMBER> domain spike protein ace<NUMBER> rbd s<NUMBER>spike protein sarscov<NUMBER> consists core region receptorbinding motif rbm<NUMBER> core region consists <NUMBER> betapleated sheets <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> organized antiparallel mode rbm consists two short betapleated sheets Î²<NUMBER> Î²<NUMBER> loops alpha helices alpha <NUMBER> <NUMBER> total three cysteine residue pairs provide stability core another cysteine residue pair helps connecting distal end rbm<NUMBER> however interacting surface s<NUMBER> rbd ace<NUMBER> quite huge total buried surface area <NUMBER> angstraon<NUMBER> around <NUMBER> Ã¥ s<NUMBER> rbd side ace<NUMBER> side<NUMBER> compared sarscov many variations seen sarscov rbd region example n terminal variations arg<NUMBER> asn <NUMBER> tyr<NUMBER> gln<NUMBER> thr<NUMBER> asn<NUMBER> observed sarscov novel sarscov<NUMBER> ace<NUMBER> also serves chaperone amino acid transporter boat<NUMBER> slc<NUMBER>a<NUMBER> full length structure ace<NUMBER>boat<NUMBER> complex already reported complex represent homodimer <NUMBER>Ã ace<NUMBER>boat<NUMBER> two heterodimers ace<NUMBER>boat<NUMBER> exhibit closed open conformation due shift peptidase domain pd ace<NUMBER> however homodimerization mediated collectrin like domain cld<NUMBER> interestingly open close conformation complex governed state peptidase domain ace<NUMBER> peptidase domain also binds s<NUMBER> domain spike protein dimeric ace<NUMBER> complex accommodate two proteins together interactions may play important role membrane invagination endocytosis however ace<NUMBER> may stay homodimer even absence bo at<NUMBER> pdb <NUMBER>m<NUMBER> represents cryoem structure ace<NUMBER> amino acids <NUMBER> presence transporter b<NUMBER>at<NUMBER> without rbd âsarscov<NUMBER>spike proteinâ resolution <NUMBER> angstroms<NUMBER> structure âspikeprotein rbdâ complex âace<NUMBER>boat complexâ shown figure <NUMBER> pd ace<NUMBER> main region responsible interaction spike protein dissociation constant kd <NUMBER> nm<NUMBER> major interactions h bond rbd gln<NUMBER> thr<NUMBER> asn<NUMBER> n terminal ace<NUMBER> tyr<NUMBER> gln<NUMBER> lys<NUMBER> arg<NUMBER> tyr<NUMBER> lys<NUMBER> rbd region bind middle bridge region ace<NUMBER> asp<NUMBER> his<NUMBER> hydrogen bond forms gln<NUMBER> residues rbd gln<NUMBER> residues c terminal ace<NUMBER> phe<NUMBER> rbd shows vander waal force interaction met <NUMBER> ace<NUMBER> s<NUMBER> subunit key role membrane fusion<NUMBER> homology s<NUMBER> segments sarscov sarscov<NUMBER> around <NUMBER> fusion process initiated initial interactions rbd spike s<NUMBER> domain sarscov<NUMBER> pd ace<NUMBER> process followed interaction heptad repeat<NUMBER> hr<NUMBER> heptad repeat<NUMBER> hr<NUMBER> domain s<NUMBER> form six helix bundle fusion core fuses host cell membrane<NUMBER> compared sarscov<NUMBER> eight residue sequence fusion region s<NUMBER> sarscov<NUMBER> imparts stability six helix bundle core<NUMBER> already established pan cov inhibitor ek<NUMBER> also found useful sarscov<NUMBER> conjugating cholesterol ek<NUMBER> new molecule designed ek<NUMBER>c<NUMBER> showed potent inhibitory action sarscov<NUMBER> compared sarscov host membrane fusion ability higher case sarscov<NUMBER> mutated amino acids hr<NUMBER> results enhanced interaction hr<NUMBER> domain<NUMBER> details interaction hr<NUMBER> hr<NUMBER> s<NUMBER> visualized pdb <NUMBER> lxt<NUMBER> s<NUMBER> domain contains two heptad repeats hr<NUMBER> hr<NUMBER> one fusion peptide case sarscov critical cleavage r<NUMBER> may expose viral fusion peptide<NUMBER> fusion peptideassociated fusion platform bipartite alters membrane integrity presence calcium<NUMBER> proteolytic cleavage s<NUMBER> exposes fusion peptide virology fusion peptides used mediators fusion process help lipid membranes fuse permeabilize case sarscov<NUMBER> two fusion peptides recognized sarswwi sarswwii n terminal region spike protein ncov however among sarswwi peptide robustly divided membranes large unilamellar vesicles induced fusion lipid vesicles causing vesicular aggregation induced leakage lipid vesicles indicator propensity perturb membrane integrity<NUMBER> another experiment treatment bafilomycin ammonium chloride decreased sarscoventry <NUMBER>hace<NUMBER> cells indicating endocytosis possible route establishment cellular infection phosphoinositides may play important role endocytosis process example phosphatydleinositol <NUMBER>phosphate <NUMBER> kinase pipkin plays major role synthesis phosphotydilinositol <NUMBER> bis phosphate early endosome inhibiting pipkin apilimod resulted decreased entry sarscov<NUMBER> spike pseudovirion <NUMBER>hace<NUMBER> cells however downstream tcp<NUMBER> found another major determinant sarscov<NUMBER> endocytosis process<NUMBER> searching rcsb database could find eight structures spike protein s<NUMBER> s<NUMBER> domain respective study also published peer reviewed journal however could find structures details available peer reviewed domain however among structures could find one structure pdb <NUMBER>w<NUMBER> rbd s<NUMBER> sarscov<NUMBER> cocrystallized neutralizing antibody isolated convalescent sarscov patients<NUMBER> pdb <NUMBER>vw<NUMBER> represents sarscov<NUMBER> chimeric rbd crystallization structure complex<NUMBER> structures <NUMBER>vxx <NUMBER>vyb represent sarscov<NUMBER> ectodomain trimer closed open states pdb <NUMBER>vsb represents highresolution structure cryo em spike protein <NUMBER> Ã¥ sequence length <NUMBER> amino acids<NUMBER> pdb <NUMBER>m<NUMBER>j represents crystal structure rbd region spike protein bound ace<NUMBER> receptor resolution <NUMBER> Ã¥<NUMBER> polyclonal antibodies spike protein sarscov also neutralized satrscov<NUMBER> indicating conserved regions epitopes targeted developing vaccine<NUMBER> however three sarscov specific antibodies failed bind spike protein sarscov<NUMBER> replicase gene sarscov<NUMBER> encodes two polyproteins pp<NUMBER>a pp<NUMBER>ab necessary replicationtranscription process virus<NUMBER> main protease papainlike protease two major proteases processes two polyproteins release <NUMBER> nonstructural proteins nsps polyproteins results translation viral rna<NUMBER> structure typically contains two protomers protomer ii consisting <NUMBER> domains domain ii iii around <NUMBER> amino acids domain substratebinding site residues gap ii domain one interesting feature substrate binding site highly conserved among sarscov main protease variable domain helical domain iii<NUMBER> domain iii five helices cluster located implicated dimerization mpro salt bridge interaction arg<NUMBER> one protomer glu<NUMBER> protomer catalytic activity dimerization necessary nfinger protomer interacts protomer interaction residues glu<NUMBER> thus helps form shape substrate binding site<NUMBER> structure main protease represented figure <NUMBER> pro ability cleave larger pp<NUMBER>ab particular <NUMBER> sites recognition site leuglnseralagly cases<NUMBER> mpro crystal structure inhibitor n<NUMBER> already reported pdb <NUMBER> lu<NUMBER> structure sarscov<NUMBER> mpro reported Î±ketoamide inhibitor pdb <NUMBER>y<NUMBER>e<NUMBER>y<NUMBER>g<NUMBER>y<NUMBER>f<NUMBER> genomic organization covid<NUMBER> contains <NUMBER> utr orf<NUMBER>ab e n gene utr <NUMBER> among orf<NUMBER>ab cover largest part viral genome responsible coding <NUMBER> nsp nonstructuralproteins <NUMBER> nsp<NUMBER> nsp <NUMBER> encodes âpapain like protease pl proâ âchymotrypsinlike protease cl pro proâ respectively nsp<NUMBER> shows endoribonulease activity<NUMBER> orf<NUMBER>b encoded nsps <NUMBER>â<NUMBER> involved rna replicationtranscription process nsps eg rdrp helicase complex comprises replication transcription complex rtc<NUMBER> rtc typically anchored endoplasmic reticulum er originated double membrane containing vesicles integrated convoluted membranes network modified er membrane<NUMBER> among sarscov<NUMBER> nsp available crystalstructure nsp<NUMBER> pdb <NUMBER>vww <NUMBER> amino acid <NUMBER> Ã¥<NUMBER> however none structures nsp <NUMBER> inhibitor bound nsp<NUMBER> belongs endoribonuclease endou family<NUMBER> play role rna processing nsp<NUMBER> essential element coronavirus life cycle<NUMBER> nsp<NUMBER> endoribonuclease nidoviral rna uridylatespecific nendou belonging endou family cterminalnendou domain responsible catalyticfunction nsp<NUMBER> active site present <NUMBER> b sheet comprises six conserved residues his<NUMBER> ly<NUMBER> his<NUMBER> thr<NUMBER> ser<NUMBER> tyr<NUMBER> nendou activity nsp<NUMBER> induce proteininterference innateimmune response however effect may independent endonuclease activity also nsp<NUMBER> necessary element life cycle coronavirus<NUMBER> nsp<NUMBER> also known rdrp key component viral life cycle plays essential role synthesis viral rna transcriptionreplication nsp<NUMBER> nsp<NUMBER> act required cofactors machinery<NUMBER> nsp<NUMBER> structures comprises niran domain towards n terminal end rdrp domain toward c terminal end<NUMBER> niran domain polymerase domain linked interface domain<NUMBER> complex structure rdrp depicted figure <NUMBER> nsp<NUMBER> thought primary target nucleotide analogues remdesvir antiviral inhibitor ability treat sarscov<NUMBER> viral infection<NUMBER> cryo em structure nsp<NUMBER> remdesvir reported complex triphosphate form remdesvir nsp<NUMBER> nsp<NUMBER> pdb <NUMBER>bv<NUMBER> <NUMBER>Ã¥ resolution<NUMBER> presence absence dtt<NUMBER> nil conflicts interest spike proteins located surface coronaviruses serve entry proteins infection xu et al <NUMBER> spike molecules form trimers must cleaved cellular proteases fusion peptide facilitate fusion virus membrane infected cells proteases generate s<NUMBER> s<NUMBER> subunits spike molecules s<NUMBER> subunit contains critical receptorbinding domain bind ace<NUMBER> receptor host cells receptorbinding motif receptorbinding domain rich tyrosine forms direct contacts ace<NUMBER> fusion virus host cells involves several critical structures spike protein including central helix heptad repeat <NUMBER> <NUMBER> domains spike glycoproteins major targets vaccine design antibodybased therapies coronaviruses including middle east respiratory syndrome coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> caused multicountry outbreak <NUMBER> sarscov<NUMBER> responsible pandemic beginning <NUMBER> several antibodies targeting spike proteins sarscov<NUMBER> shown promising efficacy preclinical trials berry et al <NUMBER> bian et al <NUMBER> greenough et al <NUMBER> et al <NUMBER> et al <NUMBER> hwang et al <NUMBER> ishii et al <NUMBER> miyoshiakiyama et al <NUMBER> pak et al <NUMBER> prabakaran et al <NUMBER> rockx et al <NUMBER> sui et al <NUMBER> sui et al <NUMBER> ter meulen et al <NUMBER> traggiai et al <NUMBER> van den brink et al <NUMBER> zhu et al <NUMBER> furthermore structural studies suggest domains crucial receptorbinding domain also potential targets antibody binding include fusion peptide heptad repeat <NUMBER> central helix domains yuan et al <NUMBER> table si coronaviruses spike glycoproteins densely glycosylated <NUMBER> predicted sites nglycosylation function glycans immune evasion virus remains unknown study analyzed recombinant sarscov<NUMBER> spike protein expressed insect cells acquired tandem mass spectrometry msms spectrums glycopeptides generated sequential digestion using trypsin chymotrypsin analyzed cryogenic electron microscopy structures spike proteins identify surfaceexposed epitopes antibody recognition vaccine design total <NUMBER> nglycosylation sites found recombinant spike protein sarscov<NUMBER>secreted btitn<NUMBER>b<NUMBER> insect cells figure <NUMBER> <NUMBER> nglycosites confirmed fragment ions glycan moieties characteristic ions derived peptide backbones supplemental figure <NUMBER> <NUMBER> among eight located nterminal domain twon<NUMBER> n<NUMBER> located receptorbinding domain outside receptorbinding motif limited amino acids <NUMBER> three located rest s<NUMBER> subunit nine located s<NUMBER> subunit glycosylation pattern spike protein highly conserved sarscov<NUMBER> sarscov<NUMBER> middle east respiratory syndrome coronavirus nterminal heptad repeat <NUMBER> domains densely glycosylated fusion peptide domain neighbored nglycosite n<NUMBER> contrast receptorbinding motif central helix domain heptad repeat <NUMBER> domain free glycosylation majority nglycan moieties highmannose type table sii consistent glycosylation pathway btitn<NUMBER>b<NUMBER> insect cell line used produce recombinant spike protein evaluate efficiency glycosylation every nglycosite calculated relative ion abundance glycopeptide nonglycosylated sequences generated trypsin chymotrypsin digestion <NUMBER> nglycosylation sites occupied nglycans table siii <NUMBER> <NUMBER> nglycosites <NUMBER> ions glycosylated peptides nglycosites <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ions glycosylated peptides also searched oglycosylated glycopeptides table siv preliminary analysis indicated ion abundance oglycopeptide sequences less <NUMBER> compared nonglycosylated sequences predicted oglycosites t<NUMBER> t<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> cryogenic electron microscopy structure modeling protein data bank pdb <NUMBER>x<NUMBER> sarscov<NUMBER> spike protein <NUMBER> sites nglycosylation observed asnglcnac groups identified reducing end glycans atomic resolution pdb <NUMBER>x<NUMBER> <NUMBER> Ã¥ density maps extending glycan chains still visible although density relatively weak figure <NUMBER>a b c receptorbinding domain region sarscov<NUMBER>spike protein densely covered glycans except fspdgkpctppalncywplndygfytttgigyq overlaps previously identified achilles heel ie vulnerable spot antibody binding berry et al <NUMBER> spike protein sarscov<NUMBER> contains <NUMBER> nglycosylation sites yellow figure <NUMBER>d trimer structures protein sarscov<NUMBER> sarscov<NUMBER> aligned rootmeansquare deviation<NUMBER> single chain structures similar except loops nterminal nterminal domain supplemental figure <NUMBER> sequence alignment structure comparison revealed predicted glycosylation sites highly conserved fourteen <NUMBER> sites observed cryogenic electron microscopy sarscov<NUMBER> protein predicted sites sarscov<NUMBER> located similarly sarscov<NUMBER> figure <NUMBER>e receptorbinding domains overall highly conserved sequence identity <NUMBER> structure rootmeansquare deviation<NUMBER>Ã¥ two identical glycosylation sites near nterminal figure <NUMBER>f sequence specificity epitopes remained unique regions tables ii similar surfacedexposed region achilles heel yqagstpcngvegfncyfplqsygfqptngvgyq identified receptorbinding domain sarscov<NUMBER> interestingly achilles heel regions sarscov<NUMBER> sarscov<NUMBER> also free glycosylation whereas neighboring fragments covered interacting glycosylation region free glycosylation favorable ace<NUMBER> protein binding figure <NUMBER>g accessible surface area profiling used predicting epitopes monoclonal antibodies mabs supplemental figure <NUMBER> candidate epitopes listed table figure <NUMBER> addition receptorbinding domains multiple potential candidate epitopes found amino acid sequences fusion peptide heptad repeat <NUMBER> central helix domains similar sites found receptorbinding domains central helix domains viruses figure <NUMBER> however unique sites also found virus example unique epitope existing sarscov<NUMBER> sarscov<NUMBER> rarr <NUMBER> site furin recognition supplemental figure <NUMBER> evaluate conservation spike epitopes structural level aligned epitopes sarscov<NUMBER> sarscov<NUMBER> based cryogenic electron microscopy structures eleven predicted epitope pairs found receptorbinding domain heptad repeat <NUMBER> central helix table ii figure <NUMBER> supplemental figure <NUMBER> two structurally conserved epitope pairs ah<NUMBER>ah<NUMBER> ah<NUMBER>ah<NUMBER> predicted achilles heel region interacts ace<NUMBER> table ii also identified two conserved epitope pairs located surface receptorbinding domain outside ace<NUMBER>binding region ii iiii epitope pair iiii proven target recognition mab s<NUMBER> pinto et al <NUMBER> potent neutralization antibody halfmaximal inhibitory concentration ic<NUMBER> <NUMBER> ngml neutralizing antibodies toward spike proteins critical protective immunity traggiai et al reported spikespecific mabs isolated patient recovered sarscov<NUMBER> infection vitro neutralizing activity ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> traggiai et al <NUMBER> several groups reported mabs targeting spike berry et al <NUMBER> bian et al <NUMBER> greenough et al <NUMBER> et al <NUMBER> et al <NUMBER> ishii et al <NUMBER> miyoshiakiyama et al <NUMBER> rockx et al <NUMBER> sui et al <NUMBER> sui et al <NUMBER> ter meulen et al <NUMBER> van den brink et al <NUMBER> zhu et al <NUMBER> spike protein also focus vaccine development example mice vaccinated dna subunit vaccines composed spike proteins receptorbinding domain spike proteins adjuvants high titers immunoglobulin g antibodies protected sarscov<NUMBER> middle east respiratory syndrome coronavirus infection du et al <NUMBER> du et al <NUMBER> hondaokubo et al <NUMBER> iwatayoshikawa et al <NUMBER> li et al <NUMBER> lu et al <NUMBER> sekimukai et al <NUMBER> yang et al <NUMBER> zhao et al <NUMBER> tolllike receptor ligands delta inulin monophosphoryl lipid reported effective adjuvants combined subunit vaccines however avoid use adjuvant inactivated sarscov<NUMBER> recombinant adenoassociated virus encoding receptorbinding domain sarscov<NUMBER> spike protein also studied induced potent protective antibody responses infection du et al <NUMBER> okada et al <NUMBER> see et al <NUMBER> spruth et al <NUMBER> safety efficacy antibody therapeutics vaccines human clinical trials remain studied well mechanisms specific vaccine components formulations example pulmonary pathology reported alum used adjuvant spike protein subunit vaccine tseng et al <NUMBER> antibodyinduced lung injury also reported macaque model sarscov<NUMBER> infection liu et al <NUMBER> highlights importance avoiding antibodymediated inflammation receptorbinding domain major focus antibody vaccine studies three antibodies<NUMBER>r m<NUMBER> f<NUMBER>g<NUMBER> complexed receptorbinding domain sarscov<NUMBER> cocrystalized hwang et al <NUMBER> pak et al <NUMBER> prabakaran et al <NUMBER> three antibodies recognize noncontinuous conformational epitopes table si several mab clones recognize linear continuous peptide sequences also reported <NUMBER>d<NUMBER> <NUMBER>h<NUMBER> f<NUMBER>g<NUMBER> <NUMBER> although cocrystal structures available yet study identified accessible surface area profiling receptorbinding domain sarscov<NUMBER> found vulnerable region yqagstpcngvegfncyfplqsygfqptngvgyq previously structural counterpart region termed achilles heel sarscov<NUMBER> berry et al <NUMBER> mostly overlaps interface ace<NUMBER> protein figure <NUMBER>g sarscov<NUMBER> multiple mabs targeting achilles heel generated including f<NUMBER>g<NUMBER> <NUMBER>d<NUMBER>cr<NUMBER>m<NUMBER>fm<NUMBER>cr<NUMBER>f<NUMBER>g<NUMBER>and <NUMBER>r table si antibody vaccine development ongoing studies focusing epitopes achilles heel sarscov<NUMBER> especially ah<NUMBER> ah<NUMBER> sites listed table ii figure <NUMBER> directly interact ace<NUMBER> however neutralizing antibodies directly compete ace<NUMBER> binding also exist recovered sarscov<NUMBER> sarscov<NUMBER> patients example cr<NUMBER> mab neutralizes sarscov<NUMBER> sarscov<NUMBER> yuan et al <NUMBER> s<NUMBER> mab isolated sarscov<NUMBER> patient neutralizes sarscov<NUMBER> sarscov<NUMBER> structural analysis revealed epitope glycopeptide sequence located n<NUMBER> glycosite notably exactly structurally conserved regions predicted iiii epitope pair table ii clearly epitope pairs predicted study candidate targets isolate neutralizing antibodies well well known predicted epitopes protein antigens may masked glycosylation complex datasets algorithms spatial epitope prediction protein antigens seppa <NUMBER> developed based training parameters related interactions glycans surrounding amino acids kong et al <NUMBER> however experimental data available effect glycosylation sites epitope surfaces recent breakthrough highresolution cryogenic electron microscopy many glycoproteins solved modeled glycosylation sites directly exploit experimental data sarscov<NUMBER> spike protein highresolution cryogenic electron microscopy screened epitopes sarscov<NUMBER> spike protein accessible surface area profiling based homologymodeled structures approach identified achilles heel sarscov<NUMBER> well <NUMBER> multiple surfaceexposed epitopes within outside receptorbinding domain example nterminal domain ntd domain sarscov<NUMBER>spike protein mabs specific linear epitopes reported table si greenough et al <NUMBER> mabs specific regions s<NUMBER> s<NUMBER> subunits sarscov spike proteins also reported miyoshiakiyama et al <NUMBER> summarized table promising antibody binding sites within outside receptorbinding domain identified sarscov<NUMBER> future investigations focus vaccination studies validate function neutralizing epitopes preventive therapeutic effects virus challenge experiments dense glycosylation glycoproteins wellknown strategy used viruses conceal surface peptide epitopes would otherwise elicit antibody responses exemplified env protein human immunodeficiency virus <NUMBER> however decades effort mabs bind conformational epitopes surface env protein identified garces et al <NUMBER> kong et al <NUMBER> kong et al <NUMBER> antibodies bind nglycan portion neighboring peptide epitopes whereas antibodies mab <NUMBER>anc<NUMBER> evolved recognize peptide epitopes dependence glycan binding kong et al <NUMBER> antibodies specific spike glycoproteins data available whether recognition hindered glycosylation spike however antibodies bind peptide sugar portions spike glycopeptides exist mab s<NUMBER> binds glycopeptide epitope n<NUMBER> glycosylation site pinto et al <NUMBER> propose snake catching model snakelike epitope elusive difficult antibody catch highly mobile wiggly sugar chains hide peptide portion therefore overcome sugar barrier minimum length peptide portion either conformational linear continuous must first clamped paratope clamping effect may either strengthened sugars close peptide epitope hindered sugar modification clearly surfaceexposed glycopeptide motifs critical vaccine design summary study clearly identified ms <NUMBER> nglycosites sarscov<NUMBER> spike protein identified list linear surfaceexposed candidate epitopes spike proteins sarscov<NUMBER> sarscov<NUMBER> demonstrated advantages studying effects glycosylation real cryogenic electron microscopy data candidate epitopes critical screening mab therapeutics treat sarscov<NUMBER> well mechanistic studies vaccine development spike proteins sarscov<NUMBER>genbank accession number mn<NUMBER>sarscov<NUMBER> ab<NUMBER>and middle east respiratory syndrome virus km<NUMBER> predicted netnglyc sequence identity spike proteins sarscov<NUMBER> sarscov<NUMBER> high <NUMBER> sufficient build accurate homolog model sequence mn<NUMBER> submitted swissmodel structural model built available homolog structures templates one stable conformation trimer structure models sarscov<NUMBER> close spike protein structure sarscov<NUMBER>pdb <NUMBER>x<NUMBER> rootmeansquare deviation single protein chain approximately <NUMBER>Ã¥ two structures superimposed compared pymol figure <NUMBER>d e protein precipitated trichloroacetic acid solution <NUMBER>n protein pellet subsequently dissolved <NUMBER> urea <NUMBER>mm trishcl ph <NUMBER> tris<NUMBER>carboxyethylphosphine <NUMBER> mm added incubated <NUMBER> minutes room temperature reduce protein iodoacetamide <NUMBER>mm subsequently added incubated <NUMBER> minutes alkylate protein protein mixture digested chymotrypsin wako richmond va <NUMBER> ratio <NUMBER>Â°c followed trypsin promega <NUMBER> ratio ww <NUMBER>Â°c reaction terminated adding formic acid peptide mixture desalted monospin c<NUMBER> column gl sciences desalted peptide mixture loaded onto homemade <NUMBER>cm analytical column reprosilpur c<NUMBER>aq <NUMBER>Î¼m resin dr maisch gmbh <NUMBER>Î¼m odÃ <NUMBER>Î¼m id connected easynlc acquired msms ms data interpreted analyzed described liu et al <NUMBER> using pglyco <NUMBER> version <NUMBER> httppfindictaccnsoftwarepglycoindexhtml glycopeptide identification using byologic v<NUMBER> quantification parameters database search intact glycopeptides follows mass tolerance precursors fragment ions set Â± <NUMBER> Â±<NUMBER> ppm respectively enzymes trypsin chymotrypsin maximal missed cleavage <NUMBER> fixed modification carbamidomethylation cys residues c <NUMBER> da variable modifications contained oxidation met <NUMBER> da nglycosylation sequon nxst x â  p modified changing n j two shared mass glycan database extracted glycome db wwwglycomedborg identified spectra could automatically annotated displayed software tool glabel embedded pglyco<NUMBER> facilitates manual verification parameter settings byonic pglyco<NUMBER> except builtin nglycan database nglycan <NUMBER> insect glycan used database searching oglycan database homemade according previously reported glycan structures gaunitz et al lindberg et al <NUMBER> identified nglycopeptides examined manually verify accuracy identification glycopeptides quantified byologic based extracted ion chromatogram area curve glycosylation sites solved determined highresolution cryogenic electron microscopy density maps nacetyldglucosamine asnglcnac determined represent whole glycan due glycan flexibility disorder thesarscov<NUMBER>spike protein structure pdb<NUMBER>x<NUMBER> together asnglcnac sites applied molecular interface calculation pisa httpwwwccp<NUMBER>acukpisa amino acids linking interacting asnglcnac selected excluded epitope prediction besides interaction asnglcnac amino acids effects larger structure glycans extending every asnglcnac may also need considered shown figure <NUMBER>c although electron densities weak aforementioned molecular interface calculation procedure applied calculate accessible surface area screen corresponding antigen epitopes except glycosylation effect could measured structure yet available glycosylation sites conserved due high similarity two spike proteins could predict glycosylation site effects sarscov<NUMBER> spike structure well predicted epitopes coincided amino acid residues interacting asnglcnac removed candidates crossreference sarscov<NUMBER> data authors declare conflict interest dapeng zhou chao peng wen zhang designed study dapeng zhou xiaoxu tian ruibing qi chao peng wen zhang contributed collection analysis interpretation data dapeng zhou wen zhang wrote manuscript authors read approved final manuscript greenough et al <NUMBER> hwang et al <NUMBER> pak et al <NUMBER> prabakaran et al <NUMBER> page <NUMBER> <NUMBER> banerjee et al j transl med <NUMBER> <NUMBER> lives <NUMBER> infected persons globally <NUMBER> outbreak started wuhan province china spread <NUMBER> countries adverse effects china italy iran spain united states france germany britain several countries type therapeutic strategies starting blocking viral entry inhibition spike proteins association host ace<NUMBER> angiotensin converting enzyme type <NUMBER> modulations interfering kinase activity inactivation viral genome expressionpackaging vaccination virus demand present situation regarding vaccination strategies assumed frequent mutation results anomalies surfacespike proteins <NUMBER> <NUMBER> mostly resembling features sars cov global outbreak <NUMBER> https wwwwhointcsrsarsen virus unlikely manifested extremely high grade virulence spreading capability stability across geographical barrier specifically colder place aged persons specific genders yet clarified <NUMBER> positive selective pressure could account stability clinical features virus compared sars bat sarslike cov <NUMBER> stabilizing mutation falling endosomeassociatedproteinlike domain nsp<NUMBER> protein could account covid<NUMBER> high ability contagious destabilizing mutation nsp<NUMBER> proteins could suggest potential mechanism differentiating covid<NUMBER> sars cov <NUMBER> nevertheless nutritional immunological statuses also important factors screening therapeutic strategies affected sensitive persons possible medications immunizations existing drugs infusion convalescent plasma conducted utmost care covid <NUMBER> patients <NUMBER> advanced precautionary steps therapeutic interventions formulated taking account several personal community factors <NUMBER> development successful reproducible vaccination protocol human trial may take longer time issues mutation large number glycan shield epitope masking sars cov <NUMBER> proteins <NUMBER> series medication regimen <NUMBER> at<NUMBER>r blockers used reducing severity mortality sarscov<NUMBER> virus infections <NUMBER> chloroquine hydroxychloroquine prescribed somewhere fight covid<NUMBER> time <NUMBER> <NUMBER> human coronaviruses influenza viruses resulted epidemic last <NUMBER> decade different parts world anomalies severity spreading origin site china parts world european north america countries might indication common human covs may annual peaks circulation winter months us individual human covs may show variable circulation year year <NUMBER> colder climate prior exposure human coronaviruses influenza flu viruses possible vaccination might develop antibody dependent enhancement ade immunological responses recent sars cov<NUMBER> exposure ade might modulated immune response could elicit sustained inflammation lymphopenia andor cytokine storm <NUMBER> <NUMBER> possibly could one reasons history exposure covs beside weaker immune system older people affected present sars cov<NUMBER> moreover helper cells suppressor cells patients covid<NUMBER> normal levels novel coronavirus might mainly act lymphocytes especially lymphocytes <NUMBER> strong inflammatory events could initiator collapsing environment covid<NUMBER> infection death cases covid<NUMBER> infections acute respiratory failure followed organs like kidney anomalies cases inflammatory outburst might worsened infection post viralincubation situations <NUMBER> <NUMBER> recent studies experimentally infected animal strongly suggest crucial role virusinduced immunepathological events causing fatal pneumonia human cov infections <NUMBER> combined antiviral antiinflammatory treatment might beneficial cases <NUMBER> sarsbased available immunetherapeutic prophylactic modalities revealed poor efficacy neutralize protect infection targeting novel spike protein <NUMBER> background critical screening spike sequence structure sars cov<NUMBER> energetic ic<NUMBER> based immuneinformatics analysis may help develop suitable vaccine current study intended analyze spike proteins sars cov mers cov sars cov <NUMBER> four earlier outbreaking human corona virus strains critically compared sars cov sars cov <NUMBER> spikeproteins domains motifs screened several epitopes based energetics ic<NUMBER> antigenicity employing several bioimmuunoinformatics software regard possible glycosylation mhcparatope binding effects present work might helpful urgent development suitable vaccination regimen spike glycoprotein sequences four human coronavirus hku<NUMBER> nl<NUMBER> <NUMBER>e oc<NUMBER> mars coronavirus nc<NUMBER> sers coronavirus nc<NUMBER> retrieved virusite integrated database viral genomics <NUMBER> tertiary structures selected coronavirus cov spike proteins predictedvalidated using phyre<NUMBER> protein homologyanalogy recognition engine v <NUMBER> <NUMBER> swissmodel <NUMBER> phyre<NUMBER> structures predicted <NUMBER> experimentally designed protein folds predicted structures subjected analysis swissmodel qmean zscore calculation includes cumulative zscore cÎ² atoms solvation torsion values prediction rampage ramachandran plot analysis server <NUMBER> used protein <NUMBER>d structures quality assessment summation number residues favored regions additionally allowed regions considered percent quality assessment predicted tertiary structures visualized aligned using pymol molecular visualization system pymol assigns secondary structure using secondary structure alignment algorithm called dss sequences two structures aligned first structures aligned visualization molecules highspeed raytracer molecular graphics system used secondary structural analysis <NUMBER>d folding patterns analyzed form topology using profunc protein function predicting server using protein <NUMBER>d structures <NUMBER> protein classification topology analysis plays independent effective alternative traditional structural prediction topological differences two structures indicated differences protein folding flexibility sequence comparisons among selected cov spike glycoproteins conducted multiple sequence alignment using clustal x<NUMBER> <NUMBER> conserved motifs identified using meme suite httpmemesdscedu memecgibinmastcgi server meme suite represents ungapped conserved sequences frequently present group related sequences <NUMBER> motif number defined current study motif finding whereas glam<NUMBER>scan tools used identification gapped motifs within related sequences conserved motifs represented logo using glam<NUMBER>scan tools meme suite server identified motifs subjected annotation using protein blast https blast ncbinlmnihgovblast cgiprogr amblast ppagetypeblast searc hlinklocblast home finally functional gene ontology based conserved domain identification conducted using interpro classification protein families interactive database <NUMBER> conserved epitopes sars cov<NUMBER> spike glycoprotein identified using svmtrip tool predicts linear antigenic epitopes <NUMBER> svmtrip predicts linier antigenic epitopes feeding support vector machine tripeptide similarity propensity scores different preanalyzed epitope data annotation predicted epitopes performed protein blast svmtrip gained <NUMBER> sensitivity <NUMBER> precision value five fold crossvalidation epitope prediction <NUMBER> amino acid lengths selected major histocompatibility complex mhc binding efficiency predicted epitopes performed using immune epitope database iedb analysis resource <NUMBER> total <NUMBER> dpa <NUMBER> dqa <NUMBER> drb alleles mhc class ii screened detection best interactive alleles basis highest consensus percentile rank lowest ic<NUMBER> value analyses performed human class ii allele using frequently occurring alleles frequency <NUMBER> peptide length <NUMBER>mers selected consensus percentile rank â¤ <NUMBER> used selection peptides antigenecity predicted epitopes determined using vaxigen v<NUMBER> protective antigen tumour antigens subunit vaccines prediction server <NUMBER> vaxigen v<NUMBER> uses auto cross covariance acc transformation selected protein sequences based unique amino acid properties sequence used find <NUMBER> known antigen <NUMBER> nonantigens identified sequences tested antigenecity leaveoneout crossvalidation overall external validation prediction accuracy <NUMBER> structure mhc class ii hladra drb molecule pdb id <NUMBER>q<NUMBER>w <NUMBER>jlz fully glycosylated covid <NUMBER> spike protein structure pdb id <NUMBER>svb retrieved protein data bank pdb docking performed using hawkdock <NUMBER> zdock <NUMBER> server generating <NUMBER> docking solutions among best <NUMBER> analyzed based docking scores binding free energy value calculation initially seven preselected spike glycoprotein sequences including recent outbreaking strain sars cov<NUMBER> covid <NUMBER> subjected tertiary structure prediction table <NUMBER> ramachandran plot data structural alignment data suggests sars cov sars cov<NUMBER> covid<NUMBER> higher degree alignment figs <NUMBER> <NUMBER> position specific multiple sequence alignment also showed highest similarity covid <NUMBER> sars cov fig <NUMBER> although sequential diversity selected spike glycoproteins showed stretches conserved sequences fig <NUMBER> position nterminal cterminal found similar sars cov covid<NUMBER> topology analysis hand drastic difference observed mers cov arrangement secondary structures tertiary region fig <NUMBER> based alignment pattern selected sequences subjected analysis different conserved motifs protein sequences total <NUMBER> conserved motifs analyzed fig <NUMBER> remarkably selected spike glycoprotein sequences shown <NUMBER> motif sequences similar pattern conserved motif position represented fig <NUMBER> identified conserved motifs individually subjected protein blast functional annotation motif <NUMBER> <NUMBER> <NUMBER> <NUMBER> showed similarity spike protein human bat coronavirus origin motif <NUMBER> shared similarities spike structural protein mouse coronavirus origin motif <NUMBER> showed similarity spike glycoprotein sars cov motif <NUMBER> spike glycoprotein mers cov table <NUMBER> highest percent identity <NUMBER> observed motif <NUMBER> functional gene ontology based conserved domain identification within <NUMBER> identified motifs predicted interpro database ipr<NUMBER> coronas<NUMBER> pf<NUMBER> coronas<NUMBER> domains found within motif <NUMBER> <NUMBER> <NUMBER> similar domains also observed motif <NUMBER> <NUMBER> <NUMBER> extra domain ssf<NUMBER> coronavirus s<NUMBER> glycoprotein domains observed motif <NUMBER> identified domains predicted membrane fusion function go<NUMBER> receptormediated virion attachment host cell go<NUMBER> whereas detected viral envelope go<NUMBER> integral component membrane go<NUMBER> epitope probing conducted covid <NUMBER> spike glycoprotein sequence structure sequence analysis <NUMBER> different locations found also showed similarity sars cov sars covid <NUMBER> spike glycoprotein protein blast fig <NUMBER> also motif positions within spike glycoprotein monomer represented fig <NUMBER> epitopes <NUMBER> <NUMBER> <NUMBER> represented covid <NUMBER> spike glycoproteins found embedded within virus envelop among others epitopes <NUMBER> <NUMBER> <NUMBER> <NUMBER> found interior location spike glycoprotein monomer epitopes <NUMBER> <NUMBER> <NUMBER> found surface structure proper type major histocompatibility complex mhc selection identified covid <NUMBER> epitope performed enlisted table <NUMBER> epitopes individually screened <NUMBER> dpa <NUMBER> dqa <NUMBER> drb alleles mhc class ii best fit analysis analyzed spike glycoprotein covid <NUMBER> infectious particle transmit one infected individual another alleles mhc class ii selected viral epitope specificity analysis hladrb<NUMBER> observed bind <NUMBER>b <NUMBER>b <NUMBER>b <NUMBER>b <NUMBER>b <NUMBER>b epitope sequences identified basis ic<NUMBER> value among sequence iiaytmslgaensva epitope <NUMBER>b shown lowest ic<NUMBER> value <NUMBER> hand hladrb<NUMBER> found sequence timlccmtsccsclk epitope <NUMBER>a siiaytmslgaensv epitope <NUMBER>a highest consensus percentile rank basis highest value <NUMBER> found motif <NUMBER> similarly hladrb<NUMBER> observed sequences vrdpqtleilditpc epitope <NUMBER>a highest <NUMBER> vsvitpgtntsnqva epitope <NUMBER>a <NUMBER> consensus percentile rank value individual mhc class ii molecules found others table <NUMBER> threshold value highest consensus percentile rank selected <NUMBER> whole highest consensus percentile rank value <NUMBER> observed sequence qqliraaeirasanl epitope <NUMBER>a lowest ic<NUMBER> value <NUMBER> observed sequence iiaytmslgaensva epitope <NUMBER>b antigenic property identified target sequences epitopes also predicted basis threshold value <NUMBER> threshold value sequence considered nonantigenic sequences value antigenic nature total <NUMBER> antigenic sequences detected table <NUMBER> among two sequences aaeirasanlaatkm epitope <NUMBER>b itpgtntsnqvavly epitope <NUMBER>b found higher threshold value <NUMBER> <NUMBER> respectively coronavirus spike protein masking nacetyl glucosamine nag different locations comparative analysis glycosylated nonglycosylated protein revealed structural modification epitope locations among identified epitopes <NUMBER>b sequence itpgtntsnqvavly <NUMBER> found n linked glycosylation <NUMBER> position structural modification epitope analyzed using nonglycosylated protein structure covid <NUMBER> acc nc<NUMBER> glycosylated covid <NUMBER> protein pdb id <NUMBER>vsb effect glycosylation protein structures revealed glycosylated conformation organized fig <NUMBER>a nonglycosylated one fig <NUMBER>b secondary structural comparison two epitopes showed organized structure attached nag residue fig <NUMBER>d whereas shorter Î²sheet structure observed nag removed structure fig <NUMBER>c peptide interactive site <NUMBER>b epitope blocked due nag attachment result antibody binding antigen may hamper nag residue directly binds n asn amino acid residue fig <NUMBER>e removal nag spike glycoprotein structure difficult structural distortion glycosylated nonglycosylated epitope <NUMBER>b tertiary level indicated removal nag may distort structure epitope fig <NUMBER>f may hamper proper antigenantibody binding section energetics epitope attachment mhc class ii hladra drb determined presence absence nag <NUMBER>b epitope structure molecular docking fig <NUMBER> fig <NUMBER> amino acid attachment differences clearly indicated fig <NUMBER>b fig <NUMBER>c structural stabilization hydrogen bond networking noticed bindings less nag residue attached <NUMBER>f result indicated attachment nag epitope also made difficult mhc class ii molecules proper representation epitope though epitope <NUMBER> b also present surface spike glycoprotein found wrapped short segment igaehvnnsyecd <NUMBER> carrying glycosylation n residue position <NUMBER> fig <NUMBER>a result antibody accessibility epitope may also difficult whereas surface epitope <NUMBER> sequence vrdpqtleilditpc <NUMBER> showed highest antigenecity <NUMBER> table <NUMBER> highest consensus percentile rank <NUMBER> found free direct indirect nag attachment pattern fig <NUMBER>b basis analyzed mhc ii hladrb<NUMBER> pdb id <NUMBER>jlz binding molecular docking among best <NUMBER> docking posture <NUMBER> th found desired position mhc molecule fig <NUMBER>c best position <NUMBER> represented table <NUMBER> effort made epitope based peptide vaccine development searching mhci ii classes compatible sites results yet come <NUMBER> current study energetic inhibition concentration<NUMBER> based selection sars cov<NUMBER> spike epitope possible glycosylation effectstructuralhindrance evaluated may help urgent vaccination strategies current disastrous situation predicted structures analyzed quality assessment according qmean values two sars strains â <NUMBER> â <NUMBER> respective models table <NUMBER> good quality observed qmean values indicated degree native nature predicted structures universal scale <NUMBER> good quality structures indicated qmean zscore closest zero qmean indicated overall zscore cÎ² atoms solvation torsion values according ramachandran plot table <NUMBER> quality predicted structures <NUMBER> indicating good structural prediction structural alignment sets revealed sars cov<NUMBER> highly similar sars cov rather mers sequential structural point view higher degree similarity sars cov sars cov<NUMBER> might indicate help therapeutic vaccination strategies reference current global situation however absolute higher degree virulence spreading nature sars cov<NUMBER> great concern present scenario predicted conserved motifs showed functional similarity different coronavirus sequences analysis indicated identified motifs specific coronavirus could used markers common coronavirus infection detection irrespective covid <NUMBER> among selected epitopes motifs <NUMBER> <NUMBER> <NUMBER> found surface structure could used immunological targets proper diagnosis treatment covid <NUMBER> important issue epitope finalization could confronted factor possible transition prefusion postfusion spike structural distortion specific mutant structure designed tested resistant conformational change ace<NUMBER> binding protease cleavage s<NUMBER>s<NUMBER> site <NUMBER> may indicative searching suitable epitope may remain unhindered preto postfusion state transition covid<NUMBER> specific epitope designing <NUMBER> different sequences found different structural location among location <NUMBER>b interior <NUMBER>b could used potent antigen according epitope locations fig <NUMBER> antigenic nature sequences like <NUMBER>ab <NUMBER>ab could target also coronavirus spike proteins glycosylated nature nacetyl glucosamine nag main component glycan shielding possible epitope masking hcovnl<NUMBER> observed may barrier proper immunogenic responses <NUMBER> hand glycosylation showed direct effect proper structural packaging viral spike glycoprotein fig <NUMBER>a whereas non glycosylation removal glycosylation may distort structure proper mhc class ii binding representation may hamper among selected epitopes epitope <NUMBER> sequence vrdpqtleilditpc <NUMBER> showed highest antigenecity <NUMBER> consensus percentile rank <NUMBER> table <NUMBER> found direct indirect glycosylation pattern fig <NUMBER>b epitope <NUMBER> also formed rigid bonds mhc ii hladrb<NUMBER> pdb id <NUMBER>jlz could target covid<NUMBER> vaccine development modifications spike proteins structure receptor mediated host cell entry prediction postfusion events may result success vaccination strategies blocking entry host protease processing viral entry different lineage b viruses recombine gain entry human cells points also noted <NUMBER> sars cov<NUMBER> induced severe often lethal lung failure caused due inhibition ace<NUMBER> expression <NUMBER> keeping ace<NUMBER> normal functioning blocking viral entry challenging issue right possible suitable epitope screened current study may helpful global pandemic situation history last movement generates conformations <NUMBER> <NUMBER> <NUMBER> betacoronaviruses like sarscov merscov distantly related alphacoronavirus porcine epidemic diarrhea virus pedv also apparently stochastic rbd movement <NUMBER> <NUMBER> combination rbd updown rearrangement may lead s<NUMBER>head trimeric prefusion spike protein coronavirus adopt different possible conformations <NUMBER>down ii <NUMBER>up<NUMBER>down iii <NUMBER>up<NUMBER>down iv <NUMBER>up fig <NUMBER>c among <NUMBER>down <NUMBER>up symmetric conformers <NUMBER>up<NUMBER>down <NUMBER>up<NUMBER>down asymmetric conformers singleparticle cryoelectron microscopy cryoem determined symmetric asymmetric structures referred receptorbinding inactive state receptorbinding active state respectively <NUMBER> asymmetric structure one rbds rotates thought less stable sarscov <NUMBER> comparison recent cryoem study found three rbds <NUMBER>up<NUMBER>down conformation predominant arrangement prefusion state <NUMBER>ncov trimer <NUMBER> arrangement apparently appears legitimate sarscov<NUMBER> order explain higher affinity <NUMBER>up<NUMBER>down ace<NUMBER> receptor sarscov however cannot rule possibility <NUMBER>up<NUMBER>down conformation functional state may provide even stronger binding ace<NUMBER> considering fact ace<NUMBER> dimeric receptor <NUMBER> <NUMBER> hypothesis consistent recent crystallographic study demonstrating cr<NUMBER> neutralizing antibody isolated convalescent sars patients targets rbd least two rbd trimeric spike protein conformation <NUMBER> assembling experimental results high time understand molecular mechanism s<NUMBER>head coordination trimeric sarcov<NUMBER> identify important interaction regulating spike updown conformations schematic receptorbound spike protein including receptorbinding subunit s<NUMBER> membranefusion subunit s<NUMBER> coronavirus shown b side top views homotrimeric structure sarscov<NUMBER> spike protein one rbd s<NUMBER> subunit head rotated conformation c rbd updown movement expected lead s<NUMBER> heads trimeric spike protein attain following possible conformers <NUMBER> ii <NUMBER>up<NUMBER>down iii <NUMBER>up<NUMBER>down iv <NUMBER>up analogue demonstration spike protein topview ntds represented colored ovals rbds represented flexible sticks s<NUMBER> domains represented filled circles major challenge simulating gigantic structure fulllength trimeric spike associated largescale conformational transition indeed daunting task explore full conformational landscape atomic lengthscale overcome structurebased coarsegrained molecular dynamic simulation approach adopted <NUMBER> simulation started fulllength homotrimeric spike protein structure generated homology modeling involves alignment target sequence template structure pdb <NUMBER>vsb <NUMBER> <NUMBER> also helped build missing loops domainspecific residuerange fulllength trimeric sarscov<NUMBER> given fig <NUMBER>a s<NUMBER> head coordination trimeric spike programmed developing supersymmetric topologybased modeling framework fig <NUMBER>b described method pipeline supplementary material molecular machine ready swing s<NUMBER> head conformations movie s<NUMBER> s<NUMBER> number cryoem structures captured conformations rbd domain spike proteins coronaviruses including sarscov<NUMBER> s<NUMBER> subunit undergoes hingelike conformational movement prerequisite receptor binding fig <NUMBER>c <NUMBER> <NUMBER> <NUMBER> <NUMBER> apart hingeresponsive rbdcleft interaction study interchain interactions found assist rbdup rbddown conformations shown fig <NUMBER>d <NUMBER>e movie s<NUMBER> interactions identified impact breathing rbd sarscov<NUMBER> makes early referred rbdupdown conformations slightly different s<NUMBER>headupdown conformation trimeric sarscov<NUMBER> former regulated intrachain interactions latter regulated intra interchain interactions fig s<NUMBER> identifying unique intra interchain contacts <NUMBER> <NUMBER> extracted corresponding s<NUMBER>headup s<NUMBER>headdown conformations supersymmetric contact map generated follows development structurebased model hamiltonian materials methods supplementary based energy landscape theory protein folding <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> approach potentiates trimeric spike adopt c<NUMBER> symmetric <NUMBER>up <NUMBER>down states also break symmetry thermodynamically governed way fig s<NUMBER>s<NUMBER> <NUMBER> <NUMBER> residueresidue native contact map identifying unique intra interchain contactpairs formed single monomer s<NUMBER>head s<NUMBER>head states c within intrachain contacts unique contacts drive hinge motion leading rbdup rbddown states highlighted structure well contact map interchain unique contacts rbd ntd domains upholding s<NUMBER>headup state e interchain unique contacts responsible connecting rbd chaina s<NUMBER>stalk chainb s<NUMBER> stalk chainc monitor transition s<NUMBER>headup s<NUMBER>headdown states monomer trimeric interactions large pool unbiased longtime trajectories generated multiple occurrences states monomer sampled employ reaction coordinate q fraction native contact <NUMBER> <NUMBER> corresponding interchain contacts associated s<NUMBER>headup s<NUMBER>headdown states typical trajectory plot q extracted equilibrium simulation trimeric prefusion spike clearly shows hopping different conformational states hypothesized earlier fig <NUMBER>a furthermore dynamic transitions two major asymmetric states <NUMBER>up<NUMBER>down q s<NUMBER>headdown â<NUMBER> <NUMBER>updown q s<NUMBER>headdown â<NUMBER> evident qtrajectory analysis simulations yields <NUMBER>d free energy landscape trimeric spike protein sarscov<NUMBER> fig <NUMBER>b possible conformations conformations corresponding minima free energy landscape shown fig<NUMBER>c temperature dependence conformational transition indicates configurational entropy enthalpy compensation results enhanced population asymmetric <NUMBER>up<NUMBER>down <NUMBER>up<NUMBER>down conformations fig s<NUMBER> predominant population <NUMBER>up<NUMBER>down state consistent recent cryoem data <NUMBER> movie s<NUMBER> s<NUMBER> asymmetric structure <NUMBER>up<NUMBER>down emerges best binding epitope cr<NUMBER> antibody collected convalescent sars patients according recent antibody recognition study sarscov<NUMBER> <NUMBER> conformational transition sarscov<NUMBER> spike protein prefused state fraction native contact q dynamics counting interchains contactpairs formed s<NUMBER>headup state s<NUMBER>headdown state b twodimensional free energy landscape conformational transition function interchain contacts supporting s<NUMBER>headdown xaxis s<NUMBER>headup state yaxis explores possible conformations c representative structure corresponding minimum free energy landscape designated follows <NUMBER>up ii <NUMBER>up<NUMBER>down iii <NUMBER>up<NUMBER>down iv <NUMBER>down state shown onedimension population distribution plot unique interchain interactions formed rbd one chain ntd adjacent chain stabilizing s<NUMBER>headup conformation sarscov<NUMBER> pdb<NUMBER>vsb interchain domain closure analyzed interchain prolineproline distance measurement distance measured following spikes b sarscov spike pdb<NUMBER>x<NUMBER>b c merscov spike pdb <NUMBER>x<NUMBER>f rbd updown hinge dynamics triggered interchain rbdntd domain interaction e absence rbdntd interchain interaction hinge motion rbd hindered populating rbddown conformations allows sample rbdup conformation rarely stochastic manner study sequence interaction level fig s<NUMBER> fig s<NUMBER> comparison made cryoem structure sarscov<NUMBER> pdb <NUMBER>vsb sarscov pdb<NUMBER>x<NUMBER>b merscov pdb <NUMBER>x<NUMBER>f <NUMBER> <NUMBER> comparison results sarscov<NUMBER> ntdrbd domain association proline residue chaina forms chÐ¿ type interaction tyrosine residue <NUMBER> hydrophobic interaction another proline chainb fig <NUMBER>a fig s<NUMBER> interchain prolineproline distance measurement shows corresponding rbdntd domains far away case sarscov fig <NUMBER>b away case merscovs fig <NUMBER>c measurement involves respective cryoem structures despite relatively high degree sequence similarity sarscov<NUMBER> sarscov also spike protein bat coronavirus ratg<NUMBER> single histidine residue relevant rbdntd domain interface found unique vase sarscov<NUMBER> fig s<NUMBER> <NUMBER> imidazole ring histidine pointing towards hydrophobic assembly aforesaid prolinetyrosine juxtaposition rbds<NUMBER> hinge region interchain rbdntd connection thus found impact rbd hinge interaction upregulating rbdup conformation fig <NUMBER>d absence interchain interaction rbd mostly stays conformation allowing rbd break symmetry rarely stochastic manner fig <NUMBER>e absence interchain rbdntd connection also appears impact sarscov rbd hinge interaction opening rbds<NUMBER> cleft significantly less sarscov<NUMBER> respective s<NUMBER>headup state fig s<NUMBER> assistance interchain rbds<NUMBER>stalk related interfacial contacts also found modulate population dynamics rbddown conformation fig s<NUMBER> influence interchain rbds<NUMBER>stalk interaction also observed early cryoem analyses two proline mutations top s<NUMBER> stalk inferring rbds<NUMBER> interchain connection helped stabilize conformers sarscov <NUMBER> synergy internal rbdhinge interactions interchain interactions allows trimeric sarscov<NUMBER> adopt unique dynamical feature coronavirus spikes appears interchain interactions driven rapid symmetry breaking strategy potentiates spike machine turn highinfectivity energy landscape framework used study indeed helps unify compare different spike protein interactions present coronaviruses current situation develop diagnostics antiviral therapies utmost priority present structurebased model derived information microscopic interaction level might provide deep insight design effective decoys antibodies fight <NUMBER>ncov infection movies s<NUMBER> s<NUMBER> method pipeline building supersymmetric contact map sarscov<NUMBER> prefusion spike protein coarsegrained structurebased simulations performed fulllength trimetric sarscov<NUMBER> spike protein structurebased hamiltonians different simulations derived processing recent cryoem structure pdb<NUMBER>vsb thorough swiss model complete missing loops present structure <NUMBER> <NUMBER> generates homotrimeric sarscov<NUMBER> spike initial structure important components terms intra interchain contacts interaction leading s<NUMBER>headup s<NUMBER>headdown conformation protomer prevalent trimeric variant one monomer adopts s<NUMBER>headup two adopts s<NUMBER>headdown conformation characteristic intrachain contacts cause receptorbinding domain perform hingemotion resulting rbdup rbd conformations driven intra c defined pipeline method contact calculation performed using shadow criterion <NUMBER> interesting components interchain contacts residing interface dimer two categories interactive dimeric interfaces asymmetricdimer interface symmetricdimer interface chaina s<NUMBER>headup adjacent chainb s<NUMBER>headdown represent asymmetric dimer unit similarly chainb s<NUMBER>headdown adjacent chainc s<NUMBER>headdown represent symmetric dimer unit asymmetricdimer interface rbddomain chaina forms unique contacts ntd domain adjacent chainb shown cycled interfaces making interfaces dynamically capable inducing s<NUMBER>head movement developing structurebased hamiltonian trimeric spike protein simulation structurebased hamiltonian trimeric spike protein sarcov<NUMBER> derived using supersymmetric contact map current structurebased model amino acids represented single beads location cÎ± atom <NUMBER> <NUMBER> <NUMBER> <NUMBER> coarsegrained structurebased model wellestablished model comprehends novel way investigate mechanisms associated protein folding function <NUMBER> <NUMBER> <NUMBER> current context decoding virus entry mechanism model successfully characterized classi viral fusion protein dynamics including conformational rearrangement viral surface glycoprotein influenza hemagglutinin ha prefusion postfusion states <NUMBER> <NUMBER> described pipeline method complete hamiltonian comprises two terms intra shared first nonlocal term hamiltonian used abc intra h represents nonbonded interaction potential form <NUMBER> lennardjones potential used describe interactions stabilize native contacts <NUMBER> native contact defined pair residues j present native state using shadow criteria iâj<NUMBER> Î´ ij defined way j residues belong intra c Î´ ij <NUMBER> turning <NUMBER> lennardjones potential otherwise Î´ ij <NUMBER> nonnative pairs Î´ ij <NUMBER> repulsive potential Ï <NUMBER>Ã¥ used interaction coefficients used potential given table s<NUMBER> described method pipeline inter h include nonlocal interchain contacts residing interface dimer comprises accounting asymmetricdimer similar early approach Î´ ij defined j residues belong inter c Î´ ij <NUMBER> turning <NUMBER> lennardjones potential otherwise Î´ ij <NUMBER> inter begin every simulation initial structure energetically minimized structurebased hamiltonian using steepest descent algorithm atomic coordinates energy minimized structure evolved using langevin dynamics time step <NUMBER> r ï´ used underdamped condition rapid sampling <NUMBER> explicit particles reduced mass <NUMBER> r ï­ drag coefficient temperatures mentioned reduced units temperature dependence conformational transition performed several temperatures three representative reduced temperaturedependent t<NUMBER>t r t<NUMBER>t r t<NUMBER>t r analyses shown clarity fig s<NUMBER> population distribution function fraction native interchain contacts formed s<NUMBER>headdown state monitored temperatures four states emerge indicated fig <NUMBER>b fig s<NUMBER> temperature increases population shifts towards s<NUMBER>headup state t<NUMBER>t r population <NUMBER>up<NUMBER>down state appears predominant population conformational landscape correlates well recent cryoem data <NUMBER> performed simulations consistent selected temperature rmsd analyses ensure correctness simulation progress emergence correct structure fig s<NUMBER> population shifts towards s<NUMBER>headup state conformations temperature increases suggests s<NUMBER>headup states dynamic entropically stable note dynamical transition <NUMBER>up<NUMBER>down <NUMBER>up<NUMBER>down states may tolerate wide range temperatures population shift mechanism far examined tolerates temperature range t<NUMBER>t r t<NUMBER>t r temperature dependence rbd hinge motion also studied fig s<NUMBER> population distribution function fraction native intrachain hingeregion contacts formed rbd different temperatures monitored bimodal distribution reflects population rbdup rbddown states individual chain trimeric spike temperature increases rbdup states start enhance populations free energy calculation system state described reaction coordinate x case fraction native contact separated another state b described reaction coordinate x b finite barrier free energy transition b expressed b p x probability find system state b reaction coordinate q b holds p x finite set unbiased simulations trimeric spike protein complete thermodynamic description obtained probability distributions obtained sampling configurational space running <NUMBER> molecular dynamics simulation sets fig s<NUMBER> interchain interaction s<NUMBER>headup s<NUMBER>headdown states sarscov<NUMBER> spike interchain rbdntd domain closure s<NUMBER>headup state domain closure mediated double hydrogen bonds connecting arg chaina asn cys residue chainb b interchain rbds<NUMBER> domain closure s<NUMBER>headdown state s<NUMBER> stalk connection rbd mediated proline residue chaina formation chÐ¿ type interaction tyrosine hydrophobic interaction another proline chainb fig s<NUMBER> structural alignment two chains s<NUMBER>headdown state chainb orange chainc green s<NUMBER>headdown state extracted cryoem structure pdb<NUMBER>vsb trimeric spike low rmsd two chains suggests contact information extracted chains equivalent supports contact map generation shown method pipeline fig s<NUMBER> rms deviation chain initial state typical simulation progress initial state chain trimeric spike s<NUMBER>headup state chain bc s<NUMBER>headdown state b lower rmsd chain corresponds chain headup state c lower rmsd chain b corresponds chain b headdown state lower rmsd chain c corresponds chain cs headdown state rmsd analyses ensure correctness simulation progress emergence correct structure fig s<NUMBER> temperature dependence s<NUMBER>head updown transition rbd openclose breathing transition population distribution function native interchain contacts formed s<NUMBER>headdown state shown fig s<NUMBER> four states emerge shown fig <NUMBER>b temperature increases population shifts towards s<NUMBER>headup state conformations indicating s<NUMBER>headup states dynamic entropically stablenote dynamical transition <NUMBER>up<NUMBER>down <NUMBER>up<NUMBER>down states may tolerate wide range temperatures population shift mechanism b population distribution function fraction native intrachain hingeregion contacts formed rbd bimodal distribution reflects rbdup rbddown states individual chain trimeric spike temperature increases rbdup started populating temperature analysis helps choose intermediate temperature obtain correct population distribution fig s<NUMBER> sequence alignment sarscov<NUMBER> spike pdb <NUMBER>vsb sarscov spikepdb<NUMBER>x<NUMBER>b merscov spike pdb <NUMBER>x<NUMBER>f ratg<NUMBER> spike rbd highlighted green unique histidine residue highlighted yellow rbd sarscov<NUMBER> noted identical residues denoted beneath consensus position multiple sequence alignment continued next page fig s<NUMBER> opening rbds<NUMBER> cleft s<NUMBER>headup state sarscov<NUMBER> differs sarscov opening measured characteristic distance serine proline residues two edges cleft sarscov<NUMBER> distance <NUMBER> nm sarscovs <NUMBER>nm appears interchain rbdntd connection influences sarscov rbd hinge motion significantly cleft opening supported interchain interactions fig s<NUMBER> free energy landscape presence absence interchain rbds<NUMBER> contacts presence interchain rbds<NUMBER> contacts enhanced population <NUMBER>up<NUMBER>down compared <NUMBER>up<NUMBER>down b absence interchain rbds<NUMBER> contacts population shifts <NUMBER>up<NUMBER>down state <NUMBER>up<NUMBER>down state movie s<NUMBER> conformational dynamics fulllength trimeric sarscov<NUMBER> spike protein showing rapid symmetry breaking movie s<NUMBER>conformational dynamics fulllength trimeric sarscov<NUMBER> spike protein showing rapid symmetry breaking movie ntd domains shown better demonstration rbd movement movie s<NUMBER> conformational dynamics monomer fulllength sarscov<NUMBER> showing rbd hinge motion recent pandemic covid<NUMBER> third outbreak diseases caused beta coronavirus humans following severe acute respiratory syndrome sars middle eastern respiratory syndrome mers cui et al <NUMBER> <NUMBER>th march <NUMBER> <NUMBER> million global population infected mortality rate <NUMBER> closed cases covid<NUMBER> situation report<NUMBER> genetically etiological agent covid<NUMBER> sarscov<NUMBER> closely related sarscov compared merscov wu et al <NUMBER> similarly like sarscov angiotensin converting enzyme<NUMBER> ace<NUMBER> identified primary receptor sarscov<NUMBER> spike protein li <NUMBER> lan et al <NUMBER> whereas merscov spike protein interacts dipeptidyl peptidase <NUMBER> dpp<NUMBER> first site attachment host cell li <NUMBER> spike protein sarscov<NUMBER> <NUMBER> amino acid long protein two functionally distinct regions s<NUMBER> s<NUMBER> involved attachment entry virus respectively sarscov<NUMBER> entry host cell mediated proteolytic cleavage spike protein process dubbed priming recently human transmembrane protease serine <NUMBER> tmprss<NUMBER> shown carry priming sarscov<NUMBER> spike protein generating two distinct fragments viral spike protein s<NUMBER>s<NUMBER> s<NUMBER> hoffman et al recently cocrystal structure sarscov<NUMBER> spike protein complexed ace<NUMBER> receptor resolved unraveling finer details intermolecular interactions lan et al <NUMBER> however complex structure sarscov<NUMBER> spike protein tmprss<NUMBER> resolved date moreover molecular structure human tmprss<NUMBER> protein also known resultantly structural details intermolecular interactions sarscov<NUMBER> tmprss<NUMBER> largely unknown although like many protease inhibitors zhang et al <NUMBER> tmprss<NUMBER> inhibitor suggested andor shown antagonize entry virus host cells hoffman et al <NUMBER> study aims investigate interaction points tmprss<NUMBER> sarscov<NUMBER> spike protein using array bioinformatic tool findings provide structurefunction relationship tmprss<NUMBER> humans also predict sites interactions tmprss<NUMBER> sarscov<NUMBER> spike protein could lead development andor directed screening disruptor andor inhibitor molecules protein sequence human tmprss<NUMBER> o<NUMBER> retrieved uniprot subjected human tmprss<NUMBER> <NUMBER> amino acid long protein three functional domains nterminal ldlreceptor class domain <NUMBER> followed srcr <NUMBER> finally cterminal peptidase s<NUMBER> domain spanning <NUMBER> <NUMBER> amino acid figure <NUMBER>a till molecular structure protein resolved xtalpred analysis showed least possibility molecule crystalized potentially due high percentage coiled structure isoelectric point surface hydrophobicity figure <NUMBER>b may reason therefore used multiple approaches develop full length molecular model tmprss<NUMBER> finally selected refined model tmprss<NUMBER> <NUMBER> residues within allowed regions ramachandran plot acceptable considering nterminal portion protein predicted intrinsically disordered secondly demonstrated rather frequently many resolved structures proteins usp<NUMBER> pdb id <NUMBER>f<NUMBER>z <NUMBER> residues outside allowed region ramachandran plot moreover gibbs free energy values <NUMBER> kkmol prosa z score <NUMBER> suggest structural reliability model figure <NUMBER>cd full length molecular models tmrpss<NUMBER> considerable structural homology template molecule pdb <NUMBER>z<NUMBER>g deviation cÎ± back bone model template found <NUMBER>Ã¥ figure <NUMBER>e f three domains ldlreceptor class srcr peptidase s<NUMBER> formed distinct structural units molecular model nterminal region ldlreceptor class tmprss<NUMBER> found less unstructured figure <NUMBER>g h putative ca <NUMBER> biding residues asp<NUMBER> his<NUMBER> asp<NUMBER> glu<NUMBER> ile<NUMBER> found entry sarscov<NUMBER> host cell driven proteolytic cleavage spike protein resulting formation two fragments s<NUMBER>s<NUMBER> s<NUMBER> hoffman et al <NUMBER> precise positioning proteolytic cleavage sites mapped sequence comparison found junction arg<NUMBER>ser<NUMBER> arg<NUMBER>ser<NUMBER> cleavage later site results production s<NUMBER>s<NUMBER> s<NUMBER> fragments necessary viral entry table <NUMBER> figure <NUMBER>d whereas second cleavage site arg<NUMBER>ser<NUMBER> three residues catalytic triad his<NUMBER> ser<NUMBER> established hydrogen bond interactions pro<NUMBER> lys<NUMBER> ser<NUMBER> sarscov<NUMBER> spike protein table <NUMBER> figure <NUMBER>d ser<NUMBER> also formed hydrogen bond hydrophobic interaction ser<NUMBER> substrate binding site his<NUMBER> catalytic site tmprss<NUMBER> respectively table <NUMBER> figure <NUMBER>d since functionally important residues table <NUMBER> order explore druggability interacting residues tmprss<NUMBER> cleavage site sarscov<NUMBER> spike protein assessed volume area drug score consistent molecular docking simulations intermolecular interactions tmprss<NUMBER> arg<NUMBER>ser<NUMBER> sarscov<NUMBER> spike protein appeared suitable target drug designing development figure <NUMBER>e f <NUMBER>ef human tmprss<NUMBER> <NUMBER>kda protein member large superfamily serine protease mainly expressed prostate colon stomach salivary gland vaarala et al <NUMBER> prostate gland expression regulated androgens found overexpressed prostate carcinoma afar et al <NUMBER> physiologically protein important functioning epithelial sodium transport donaldson et al <NUMBER> angiogenesis aimes et al <NUMBER> therefore present study could also advanced relation explore effect natural polymorphism found human tmprss<NUMBER> priming sarscov<NUMBER> spike protein authors declare conflict interest novel coronavirus diseases outbreak coronavirus disease<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> probably biggest threat mankind today countries many <NUMBER> countries become victims pandemic viral infection <NUMBER> hitherto <NUMBER> lacs death recorded alongside <NUMBER> lacs individuals infected covid<NUMBER> throughout globe <NUMBER> first evidence recent outbreak covid<NUMBER> diagnosed causing pneumonia amongst infected individuals wuhan china end <NUMBER> <NUMBER> covid<NUMBER> considered Î² coronavirus <NUMBER>b group phylogenetic studies revealed covid<NUMBER> belongs family coronaviridae order nidovirales <NUMBER> alike flucausing viruses covid<NUMBER> also rna containing virus protein corecapsid surrounding rna genome comprising positivesense singlestranded rna <NUMBER> <NUMBER> <NUMBER> virus transmits humantohuman via sneeze cough respiratory droplets <NUMBER> <NUMBER> actual mechanistic insight pathogenesis sars cov<NUMBER> yet unclear due dearth knowledge virus selected human principal host virus escapes human innate immune system especially interaction viral antigens human tolllike receptors tlrs well mechanistic insights cytokine storm affecting multiple human organs particularly unknown however pathophysiology covid<NUMBER> typically involves entry virus respiratory droplets respiratory system principally alveoli lungs airways <NUMBER> viral glycoprotein capsid typically termed spike protein binds angiotensinconverting enzyme<NUMBER> ace<NUMBER> receptor rna genome enters host cell mostly alveolar cells via receptormediated endocytosis <NUMBER> entering host cell viral rna replicase formed messenger rna results rapid replication viral rna necessary structural proteins <NUMBER> hand interaction viral antigens host immune cells results induction proinflammatory responses trigger vasodilation increase vascular permeability accumulation humoral factors factors cumulatively cause fever majorly interrupts gaseous exchange cause breathing difficulty <NUMBER> lack complete understanding pathogenesis immunological peculiarity virus made situation alarming mankind currently specific drug vaccine available challenge myriad threat recent studies suggested combination hydroxychloroquine azithromycin drugs used conventional antiretroviral therapy remdesivir could effective treating patients covid <NUMBER> <NUMBER> several studies attempted present epitopebased vaccine candidates speedy emergence effective vaccine covid<NUMBER> <NUMBER> <NUMBER> considering current scenario covid<NUMBER> pandemic present study aims add novel dimension existing knowledge covid<NUMBER> biology presented comparative picture phylogeny antigenicity structural insights major infective protein spike glycoprotein sarscov<NUMBER> sarscov middle east respiratory syndromerelated coronavirus merscov well cognate receptor ace<NUMBER> different animals silico analyses addition also explored involvement possible pattern recognition receptors likely recognize viral spike protein involved hostpathogen interaction sarscov<NUMBER> infection human though biocomputational approach study proteinprotein interaction <NUMBER>d structure wildtype sarscov<NUMBER> spike glycoprotein pdb id <NUMBER>vyb retrieved rcsb protein data bank actually determined de novo using cryoelectron microscopic technique resolution <NUMBER> Ã¥ <NUMBER> spike glycoprotein sequences selected organisms first subjected multiple sequence alignment using clustalw algorithm using mega x software suite ver <NUMBER> <NUMBER>bit windows thereafter alignments used constructing phylogenetic tree neighborjoining method mega platform furthermore phylogenetic reconstruction performed using bootstrapping analyses <NUMBER> replications assess confidence developed phylogenetic tree study spike proteinace interaction homology modeling used model structure ace<NUMBER> receptors using retrieved amino acid sequences using software modeller <NUMBER> stereochemical quality built models evaluated plotting ramachandran plots using structural assessment tool provided swissmodel web server httpsswissmodelexpasyorg retrieved sequences ace<NUMBER> receptors organisms horseshoe bat malayan pangolin human used determine hydrophobicity based kytedoolittle algorithm using protscale web server httpswebexpasyorgprotscale server also employed construct plots percent accessible residues ace<NUMBER> receptor protein furthermore antigenic propensity proteins also predicted plotted kolaskar tongaonkar algorithm antigenic peptides finder tool immunomedicine group server httpimedmeducmes vadar volume area dihedral angle reporter server also used assess structural contents ace<NUMBER> protein phylogenetic relationship amongst spike protein sarscov<NUMBER> homologs described figure <NUMBER>a phylogenetic reconstruction generated unrooted phylogenetic tree resembles close phylogenetic relation sarscov<NUMBER> bat cov ratg<NUMBER> found share monophyletic group figure <NUMBER>a supported high bootstrap value bv value <NUMBER> also found spike protein sarscov share clade mers cov therefore phylogenetically distantly related viruses figure <NUMBER>a studying phylogenetic distance among major strains coronavirus studied sequence divergence ace<NUMBER> receptor protein major receptor sarscov<NUMBER> herein phylogenetic relationship revealed ace<NUMBER> protein distinct character amongst different genus animal kingdom figure <NUMBER>a example human gorilla closely related mammals minimum change genome phylogeny ace<NUMBER> receptor also supports figure <NUMBER>a since clade supported low bv <NUMBER> inferred receptor protein human could followed different ancestor gorilla interestingly ace<NUMBER> bat found comparatively closer human ace<NUMBER> pangolin javanica found distantly related one phylogenetic analysis revealed close relationship amongst spike proteins sarscov<NUMBER> infecting human bat coronavirus side ace<NUMBER> receptor found distinct characteristics studied molecular characteristics ace<NUMBER> human bat pangolin separately figure <NUMBER> analyses homology model corresponding pangolin bat human ace<NUMBER> suggested human bat possess similar content <NUMBER> alphahelices native structure ace<NUMBER> pangolinace<NUMBER> contains <NUMBER> proportion betasheet <NUMBER>d structures ace<NUMBER> bat human pangolin <NUMBER> <NUMBER> <NUMBER> respectively relative proportions random coils ace<NUMBER> structures found <NUMBER> <NUMBER> <NUMBER> respectively ace<NUMBER> protein bat human pangolin origin figure <NUMBER>a assumption biochemical biophysical characteristic theoretically designed protein structure dependent stereochemical quality herein ramachandran plot ace<NUMBER> organism demonstrated residues present favored region hence possess good stereochemical stability figure <NUMBER>b percentage accessible residues human ace<NUMBER> found close bat different pangolin figure <NUMBER>c considering plots percentage accessible residues choudhury mukherjee <NUMBER> figure <NUMBER>c clear ace<NUMBER> receptor r sinicus much accessible residues near ligandbinding region compared two hydrophobicity also considered important property receptor protein presented pattern hydrophobicity ace<NUMBER> three different organisms studied figure <NUMBER>d pattern hydrophobicity ace<NUMBER> human also found follow similar trend bat pangolin fact hydrophobicity plot bat r sinicus showed deeper peaks <NUMBER> midline compared plots two organisms current debate origin pathogenic transformation coronavirus origin virus may connection bat pangolin investigate postulation conducted molecular docking spike protein sarscov<NUMBER> ace<NUMBER> receptor human bat pangolin figure <NUMBER> observed different degrees binding interactions spike protein receptor ace<NUMBER> human two suspected zoonotic hostsreservoirs figure <NUMBER> order strength binding spike proteinbat ace<NUMBER> spike proteinhuman ace<NUMBER> spike proteinpangolin ace<NUMBER> table <NUMBER> interaction spike protein sarscov<NUMBER> bat ace<NUMBER> found strongest table <NUMBER> interacting surface spike protein ace<NUMBER> majorly consisting hydrogen bonding hydrophobic interaction depicted table <NUMBER> interestingly interacting surface ace<NUMBER> human also found similar bat figure <NUMBER> table <NUMBER> upon close examination observed receptorbinding domain sarscov<NUMBER> spike protein majorly comprises leu glu ser asn phe pro asp ligandbinding region ace<NUMBER> receptors bat human consisted glu pro asn ala val figure <NUMBER> table <NUMBER> binding potential spike protein also supported antigenicity sarscov<NUMBER> reveals increasing abundance antigenic peptides sarscov<NUMBER> comparison two strains coronavirus sarscov merscov table s<NUMBER> sarscov<NUMBER> pathogenesis principally involves disruption physiochemical barriers immunopathological consequences f g u r e <NUMBER> phylogeny spike protein cognate receptor ace<NUMBER> phylogenetic tree depicting relationship amongst different coronaviruses b unrooted phylogenetic tree depicting evolutionary route human ace<NUMBER> receptor values indicated tree depict corresponding bv value ace<NUMBER> angiotensinconverting enzyme<NUMBER> bv bootstrap value human majorly involve respiratory inflammation <NUMBER> extracellular domains surface tlrs found interact spike protein docked protein complexes figure <NUMBER> binding interfaces tlrs spike protein consisted hydrogen bonding hydrophobic interactions table <NUMBER> interestingly fine high valued antigenic peaks found antigenicity plot spike protein majorly detected interacting face spike protein tlrbinding region figure s<NUMBER> table s<NUMBER> asn<NUMBER> asn<NUMBER> ser<NUMBER> thr<NUMBER> his<NUMBER> ser<NUMBER> gln<NUMBER> thr<NUMBER> ser<NUMBER> tyr<NUMBER> gln<NUMBER> hydrogen bond phe<NUMBER> ile<NUMBER> leu<NUMBER> leu<NUMBER> val<NUMBER> pro<NUMBER> pro<NUMBER> val<NUMBER> ala<NUMBER> leu<NUMBER> hydrophobic interactions asn<NUMBER> ala<NUMBER> tyr<NUMBER> tyr<NUMBER> his<NUMBER> ser<NUMBER> asn<NUMBER> asn<NUMBER> thr<NUMBER> tyr<NUMBER> ser<NUMBER> asn<NUMBER> tyr<NUMBER> cys<NUMBER> thr<NUMBER> gln<NUMBER> hydrogen bond bat rhinolophus sinicus â<NUMBER> leu<NUMBER> ala<NUMBER> phe<NUMBER> phe<NUMBER> ile<NUMBER> pro<NUMBER> met<NUMBER> met<NUMBER> leu<NUMBER> pro<NUMBER> pro<NUMBER> hydrophobic interactions his<NUMBER> ser<NUMBER> thr<NUMBER> asn<NUMBER> asn<NUMBER> asn<NUMBER> tyr<NUMBER> ser<NUMBER> gln<NUMBER> thr<NUMBER> gln<NUMBER> val<NUMBER> hydrogen bond ala<NUMBER> ala<NUMBER> ile<NUMBER> phe<NUMBER> ala<NUMBER> pro<NUMBER> leu<NUMBER> ile<NUMBER> leu<NUMBER> abbreviation ace<NUMBER> angiotensinconverting enzyme<NUMBER> tremendous ability infection transmission producing fatal outcomes <NUMBER> considerable debates currently going among scientific communities regarding emergence covid<NUMBER> present study data suggest spike protein sarscov<NUMBER> phylogenetically closer bat sarscov pangolin sarscov distantly related mers described figure <NUMBER> previous studies direction indicated sarscov<NUMBER> genome rna shares <NUMBER> homology bat coronavirus <NUMBER> sarscov <NUMBER> present study corroborated indicated close relationship bat sarscov human sarscov<NUMBER> higher bv <NUMBER> indicated wellestablished monophyletic group <NUMBER> <NUMBER> moreover spike protein sarscov<NUMBER> contains antigenic peptides sarscov table <NUMBER> present study therefore suggesting spike protein expression virome sarscov<NUMBER> closely related bat cov ratg<NUMBER> forms virus might originated common ancestor moreover data also hypothesized human sarscov<NUMBER> naturally modified version bat sarscov interestingly also observed cognate receptor spike protein ace<NUMBER> phylogenetically close human bat inference also verified determining relative structural content binding efficacy spike protein human bat pangolin ace<NUMBER> receptor figures <NUMBER> <NUMBER> structural contents hydrophobicity proportion accessible residues ace<NUMBER> close bat human molecular docking studies revealed spike protein sarscov<NUMBER> binds strongly bat human pangolin moreover interaction zone spike proteinace<NUMBER> complex bat human also found comprising similar residues could possible reason behind choosing human host sarscov<NUMBER> moreover abundance human bat might promoted pathogenic transformation select human speedy transmission therefore studied involvement human innate immune receptors tlrs understand rationale choosing human host sarscov<NUMBER> immunological point view immunopathology covid infection reported caused due elevated inflammatory response constitutes abundant expression proinflammatory cytokines like interleukin<NUMBER> tumor necrosis factoralpha <NUMBER> two cytokines products tlr signaling pathway <NUMBER> data indicated tlr<NUMBER> possesses strong binding affinity spike protein following tlr<NUMBER> tlr<NUMBER> figure <NUMBER> table <NUMBER> tlr<NUMBER> efficient innate immune receptor induces proinflammatory responses binding pathogenic ligand <NUMBER> therefore interaction tlr<NUMBER> spike protein could one reasons behind immunopathological manifestation covid<NUMBER> interaction could useful developing drugs using tlr<NUMBER> antagonists anticorona therapeutics since used native conformations spike protein tlrs computed likely interactions however actual proteinprotein interaction study using surface plasmon resonance reveal actual strength binding binding constant intriguingly seen positive energy values tlr <NUMBER> <NUMBER> <NUMBER> indicate complex interaction needs examined future however recent study bhattacharya et al <NUMBER> revealed vaccine candidate sarscov<NUMBER> spike protein interacts tlr<NUMBER> since vaccine peptide much shorter actual protein length helical structure much exposed tlr whole protein complex native configuration aimed study finally data mutability indicated strongest mutability sarscov<NUMBER> sarscov merscov evidence collectively support earlier studies <NUMBER> <NUMBER> <NUMBER> indicated origin sarscov<NUMBER> animals strengthen view origin viral strain bat however experimental validations particularly needed establish inferences present silico studies indicated close relationship bat sarscov sarscov<NUMBER> level phylogeny major infective protein spike protein receptor ace<NUMBER> well proteinprotein interaction two zoonotic origin sarscov<NUMBER> bat therefore supported study spike protein sarscov<NUMBER> found bind surface tlrs tlr<NUMBER> <NUMBER> <NUMBER> especially strongly tlr<NUMBER> therefore selective targeting tlr<NUMBER>spike protein interaction designing competitive tlr<NUMBER>antagonists could pave new way treat covid<NUMBER> taken together study expected improve understanding biology sarscov<NUMBER> findings contribute fundamental knowledge could useful adopting accurate intervention strategy near future <NUMBER> novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> emerged global pandemic taking <NUMBER> date <NUMBER> th june <NUMBER> httpscovid<NUMBER>whoin life world rapid spread high mortality rate <NUMBER> <NUMBER> <NUMBER> cov sarscov<NUMBER> use homotrimer spike glycoprotein comprising s<NUMBER> s<NUMBER> subunit spike protein bind cellular receptors induce dissociation s<NUMBER> s<NUMBER> subunit also triggers cascade events transition s<NUMBER> metastable prefusion state stable postfusion state fusion cell viral membrane etc <NUMBER> <NUMBER> <NUMBER> s<NUMBER> subunit contains receptorbinding domain rbd binds peptidase domain pd human angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> recognition spike protein ace<NUMBER> enzyme first step virus lifecycle entry host cell reasons cov spike protein key target developing new vaccines therapeutic antibodies new drug molecules recent vitro studies also indicate rbd domain s<NUMBER> subunit plays key functional role binding sarscov ace<NUMBER> <NUMBER> crystal well cryoem structures complexes spikehace<NUMBER> reveal key information interactions rbds hace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> superposition rbd domains sarscov sarscov<NUMBER> shows similar structural fold root mean square deviation rmsd <NUMBER> Ã¥ <NUMBER> pairs cÎ± atoms <NUMBER> knowing binding ace<NUMBER> receptor triggers virial lifecycle also important understand binding affinity sarscov<NUMBER> differs sarscov experimental results reveal binding affinity values sarscov sarscov<NUMBER> hace<NUMBER> fall similar range <NUMBER> specifically equilibrium dissociation constant kd shows slightly higher value <NUMBER> nm sarscov<NUMBER> sarscov <NUMBER> nm <NUMBER> however recent publication shows <NUMBER> fold increased binding affinity trimeric spike protein ace<NUMBER> receptor sarscov<NUMBER> sarscov <NUMBER> nevertheless well established sarscov<NUMBER> slightly better binding affinity towards hace<NUMBER> sarscov high binding affinity suggests novel coronavirus evolved towards better binder human ace<NUMBER> receptor thus comparison rbd domains sarscov sarscov<NUMBER> utmost importance migh give us clue sarscov<NUMBER> deadlier sarscov similar experiments several computational studies performed binding affinity rbds sarscov sarscov<NUMBER> hace<NUMBER> <NUMBER> <NUMBER> earlier results based homology modeled structure sarscov<NUMBER> global fold spike protein correct atomic level scoring function predicting binding affinity accurate thus earlier results predicted lower binding affinity sarscov<NUMBER> <NUMBER> <NUMBER> also implies sidechain packing modeled structure accurate enough recent binding free energy calculations performed crystal structure rbdhace<NUMBER> sarscov<NUMBER> predicts high binding affinity sarscov <NUMBER> another study uses rosetta interface analyzer <NUMBER> concludes viruses similar binding affinity <NUMBER> thus insilico perspective still fully understood sarscov<NUMBER> better binder sarscov<NUMBER> results inconclusive hence atomisticlevel comparison needed two viruses recent study found hydrogen bonding network hydrophobic interactions major dominating forces responsible enhanced binding sarscov<NUMBER> <NUMBER> till studies focus search new vaccines drug molecules covid<NUMBER> little attention paid atomistic label description dynamics interfacial domain spike protein hace<NUMBER> receptor dynamic interactions rbd hace<NUMBER> may reveal crucial points accessible crystal structures work first assess atomistic level description rbds spike protein hace<NUMBER> receptor crystal structures identify key contact residues responsible binding rbd domain hace<NUMBER> also critically analyze differences interfacial residues sarscov sarscov<NUMBER> binding affinity two domains sarscov sarscov<NUMBER> next allatom molecular dynamics simulations rbd domains spike protein complexed human ace<NUMBER> <NUMBER> receptor sarscov sarscov<NUMBER> performed extract dynamics complexes focus study interfacial region rbds hace<NUMBER> provide atomistic picture interactions importance contact residues also highlighted thorough comparison made sarscov sarscov<NUMBER> till insilico work spikeace<NUMBER> complex done design new antibodies drug molecules whereas little attention paid atomistic level description dynamics spikeace<NUMBER> complex hence study focuses interfacial region rbd ace<NUMBER> domains simulation results reveal interfacial water molecules play important role regarding binding rbds ace<NUMBER> domain particularly bridge water connecting two domains spike protein hace<NUMBER> crystal structure sarscov<NUMBER> rbdace<NUMBER> pdb id <NUMBER>vw<NUMBER> sarscovrbdace pdb id <NUMBER>ajf taken protein database subjected md simulations two proteinprotein complexes contain notable structural elements special care taken preparing system like nglycosylation various asparagine residues disulfide bridges various pairs cysteine presence zinc finger amino acids require proper protonation states systems prepared using charmmgui web <NUMBER> server <NUMBER> parameter files equilibration files taken server simulations performed using software gromacs version <NUMBER> <NUMBER> <NUMBER> using charmm<NUMBER> forcefield <NUMBER> system solvated tip<NUMBER>p <NUMBER> water kcl salt added neutralize systems salt concentration <NUMBER> mm system solvated rectangular box dimensions l x <NUMBER> Ã¥ l <NUMBER> Ã¥ l z <NUMBER> Ã¥ distance appropriate avoid finitesize effects due longrange electrostatic interactions among neighboring simulation boxes simulation complexes carried <NUMBER>k <NUMBER> atm pressure treat longrange electrostatic interactions particle mesh ewald pme <NUMBER> method used cutoff <NUMBER> Ã¥ constrain hydrogen bond lincs algorithm <NUMBER> applied system minimized <NUMBER> steps steepest descent algorithm eliminate bad contacts system minimization equilibration simulation performed nvt ensemble <NUMBER> k nvt simulation npt equilibration performed <NUMBER> ns <NUMBER> atm pressure temperature maintained <NUMBER> k equilibration period position restrained applied heavy atoms protein velocity rescale thermostat parinnellorahman barostat <NUMBER> applied maintain temperature pressure respectively proteinprotein binding affinity calculations foldx software <NUMBER> used different visualizing trajectory analysis software packages ucsf chimera <NUMBER> vmd visual molecular dynamics <NUMBER> used qzyme workbenchâ¢ <NUMBER> inhouse enzyme engineering platform used calculations performed discussed results earlier published results highlighted differences rbd domains two spike proteins spike protein sarscov sarscov<NUMBER> share <NUMBER> sequence similarity structural fold almost identical whereas rbd domains sequence similarity <NUMBER> <NUMBER> figure <NUMBER> shows superposition sarscov sarscov<NUMBER> inset highlight key residues changed sarscov sarscov<NUMBER> crystal structure sarscov sarscov<NUMBER> significant proteinprotein contacts seen identified key residues important <NUMBER> stabilization spike protein hace<NUMBER> receptor figure s<NUMBER> supporting information displayed residues interfacial region rbd domain bound ace<NUMBER> domain distance cutoff <NUMBER> Ã¥ <NUMBER> residues rbd contact <NUMBER> residues ace<NUMBER> domain similar analysis sarscov<NUMBER> shows <NUMBER> residues rbd contact <NUMBER> residues ace<NUMBER> receptor among <NUMBER> ace<NUMBER> residues interacting two rbds <NUMBER> found common residues interacting residues ace<NUMBER> receptor located near nterminal helix analysis manifests surface area interfacial domain ace<NUMBER> rbds almost also corroborates earlier findings surface area <NUMBER> Ã¥ <NUMBER> <NUMBER> Ã¥ <NUMBER> sarscov<NUMBER> sarscov <NUMBER> within <NUMBER> Ã¥ cutoff <NUMBER> hydrophobic residues leu<NUMBER> phe<NUMBER> ala<NUMBER> phe<NUMBER> <NUMBER> hydrophilic ie hydrophobic residues arg<NUMBER> thr<NUMBER> tyr<NUMBER> tyr<NUMBER> gly<NUMBER> asn<NUMBER> tyr<NUMBER> gln<NUMBER> gly<NUMBER> gln<NUMBER> thr<NUMBER> asn<NUMBER> gly<NUMBER> tyr<NUMBER> near interface spike protein sarscov<NUMBER> whereas <NUMBER> hydrophobic residues leu<NUMBER> leu<NUMBER> ile<NUMBER> <NUMBER> hydrophilic residues arg<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> asn<NUMBER> tyr<NUMBER> asn<NUMBER> gly<NUMBER> tyr<NUMBER> thr<NUMBER> thr<NUMBER> gly<NUMBER> tyr<NUMBER> present near interface spike protein sarscov interesting note interface rbd domain enriched tyrosine glycine residues sarscov<NUMBER> <NUMBER> tyrosine <NUMBER> glycine <NUMBER> residues well sarscov <NUMBER> tyrosine <NUMBER> glycine <NUMBER> residues counted residues cutoff value <NUMBER> Ã¥ get estimation buried residues rbd domains found <NUMBER> <NUMBER> residues coming contact ace<NUMBER> domain sarscov sarscov<NUMBER> respectively table s<NUMBER> supporting information see effect interfacial residues overall binding affinity hace<NUMBER> performed computational alanine scanning interfacial residues see extent impact binding affinity due alanine substitution crystal structure sarscov<NUMBER> <NUMBER> hydrogen bonds rbd domain ace<NUMBER> domain however sarscov lesser number hydrogen bonds rbd ace<NUMBER> domain sarscov <NUMBER> hydrogen bonds two domains fewer hydrogen bonds sarscov expect rbdace<NUMBER> complex sarscov<NUMBER> stable sarscov calculate binding free energy spikehace<NUMBER> complex prodigy web server <NUMBER> well foldx software <NUMBER> binding free energy calculated crystal structures dimer <NUMBER> values <NUMBER> <NUMBER> kcalmol sarscov sarscov<NUMBER> respectively foldx calculations show binding energy <NUMBER> <NUMBER> kcalmol sarscov sarscov<NUMBER> respectively though values obtained prodigy foldx range trend suggests sarscov<NUMBER> binds effectively hace<NUMBER> evolved better binder human receptor discussed previous section interfacial residues rbd domain critical stabilizing proteinprotein complex performed computational alanine scanning contact residues rbd domain highlight importance residues mutated interfacial residues alanine calculate binding free energy ace<NUMBER> domain alanine scanning performed identify residues make significant contribution binding affinity hace<NUMBER> result reveals figure <NUMBER> residues lower binding affinity mutated alanine except n<NUMBER> slight increase binding affinity observed sarscov<NUMBER> decrease binding affinity suggests sarscov<NUMBER> sarscov optimized rbd domain bind human ace<NUMBER> receptor alanine scanning results observe y<NUMBER> l<NUMBER> f<NUMBER> y<NUMBER> g<NUMBER> v<NUMBER> found critical stabilizing overall complex compared sarscov<NUMBER> alanine mutation doesnt lower binding affinity residues sarscov result points fact sarscov<NUMBER> optimized interfacial residues manner binding hace<NUMBER> enhanced context would like discuss changes happened sarscov sarscov<NUMBER> mutations like tyr<NUMBER>âgln<NUMBER> thr<NUMBER>âasn<NUMBER> tyr<NUMBER>âleu<NUMBER> leu<NUMBER>âphe<NUMBER> leu<NUMBER>âphe<NUMBER> asn<NUMBER>âgln<NUMBER> show significant changes binding affinity particular position mutated alanine noted gln<NUMBER> gly<NUMBER> inserted near interfacial domain rbd sarscov<NUMBER> though two residues directly interacting ace<NUMBER> form intramolecular hydrogen bonds two give stability loop like gln<NUMBER> interacts gly<NUMBER> gly<NUMBER> interacts cys<NUMBER> alanine mutation two residues change binding affinity significantly next section discuss results obtained molecular dynamics simulations <NUMBER> ns molecular dynamics simulations adducts spikehace<NUMBER> sarscov sarscov<NUMBER> found stable figure s<NUMBER> molecular dynamics simulation trajectories extracted different components interaction energy ie electrostatics vanderwaals vdw interaction terms rbd spike protein hace<NUMBER> receptor figure <NUMBER> probability different rbd hace<NUMBER> significance overall binding affinity proteinprotein interaction <NUMBER> key observation made simulation trajectories minimum distance cÎ± atoms rbd ace<NUMBER> domain varies significantly sarscov sarscov<NUMBER> figure <NUMBER> minimum cÎ± distance gives idea relative separation two domains observed average cÎ± distance sarscov well known watermediated interactions one major driving forces protein folding proteindrug recognition processes <NUMBER> <NUMBER> <NUMBER> <NUMBER> previous section observed almost <NUMBER> Ã¥ gap spikhace<NUMBER> proteinprotein complex possibility interfacial domain gap region hydrated water molecules interfacial water molecules might play significant role stabilizing spike protein hace<NUMBER> receptor indeed simulations observed water molecules gradually populate interfacial domain spike protein hace<NUMBER> receptors <NUMBER> ns simulation period observed interfacial domain forms rich hydrogenbonded network stabilize overall proteinprotein complex simulations analyze water molecules come within <NUMBER> Ã¥ near spike protein hace<NUMBER> domain fluctuation number water molecules interfacial region ace<NUMBER> domain shows high water content sarscov sarscov<NUMBER> figure <NUMBER>a average water molecules near ace<NUMBER> domain <NUMBER>Â±<NUMBER> <NUMBER>Â±<NUMBER> sarscov<NUMBER> sarscov respectively though ace<NUMBER> interface almost sarscov sarscov<NUMBER> higher number water molecules near ace<NUMBER> interfaces probability plot figure <NUMBER> b shows clear difference number water molecules sarscov sarscov<NUMBER> similar result observed rbd domain spike protein greater number water molecules seen near sarscov spike domain sarscov<NUMBER> spike domain figure <NUMBER>a b high occupancy near interfacial domain sarscov attributed fluctuation rbd hace<NUMBER> domain larger gap two domains finally calculated bridgewater molecules hydrogenbonded ace<NUMBER> rbd domains time calculate number water molecules simultaneously forming hydrogen bonds rbd ace<NUMBER> domain figure <NUMBER> display number bridge water molecules <NUMBER> ns molecular dynamics simulations figure <NUMBER> b show one bridge water molecule hydrogenbonded rbd gln<NUMBER> well ace<NUMBER>glu<NUMBER> domain time simulation trajectories several multiwater bridge water molecules observed rbd hace<NUMBER> domains bridge water molecules seen slightly higher number bridge water molecules <NUMBER> sarscov<NUMBER> sarscov bridging water molecules play significant role stabilizing two domains complex expect bridge water molecules play significant role stabilizing spikeace<NUMBER> domain want highlight one key point crystal structure sarscov<NUMBER> gln<NUMBER> engaged hydrogen bond glu<NUMBER> whereas md simulation observed water molecules enter interfacial region connected two residues idea rbd ace<NUMBER> domains interacting water molecules calculate watermediated hydrogen bonds rbd hace<NUMBER> domains case hace<NUMBER> interfacial residues making almost number hydrogen bonds water molecules sarscov sarscov<NUMBER> expected ace<NUMBER> receptor viruses small changes attributed fluctuation hace<NUMBER> domain figure <NUMBER> finally calculated interaction energy electrostatic van der waals interfacial rbd ace<NUMBER> domain water molecules figure <NUMBER>ab observe interaction b figure <NUMBER> total interaction energy coulombic van der waals water molecules hace<NUMBER> rbd domains energy water molecules hace<NUMBER> domain viruses almost means surface topology hace<NUMBER> behaves similarly md simulations viruses difference seen rbd sarscov sarscov<NUMBER> interaction water molecules preferred sarscov sarscov<NUMBER> water molecules make greater number hydrogen bonds rbd domain enhanced water interaction rbd sarscov reduces direct interaction hace<NUMBER> receptor summary elucidate similarities differences sarscov sarscov<NUMBER> using molecular dynamics simulation approaches structural point view rbd spike protein shares significant similarity terms threedimensional structure fold however significant differences observed two viruses bind hace<NUMBER> receptor found improvement hydrophobic contacts leads enhanced van der waals interactions rbd hace<NUMBER> receptor affects high binding affinity sarscov<NUMBER> important information found study involvement water molecules interfacial domain rbd ace<NUMBER> receptor observed sarscov sarscov<NUMBER> interfacial domain spontaneously hydrated significant number water molecules populate gap rbd ace<NUMBER> domain found bridge water molecules play significant role stabilizing proteinprotein binary complex kind watermediated interaction sarscov sarscov<NUMBER> observe previous study present study unravels many structural dynamical features proteinprotein dimer complexes help us understand virus interacts human cell viral membrane fusion proteins responsible binding cellular receptors subsequent fusion viral cellular membranes paradigm class fusion proteins consists two heptad repeat regions hydrophobic fusion peptide <NUMBER> motif present sarscov <NUMBER> coronaviruses <NUMBER> well hemagglutinin ha influenza <NUMBER> gp<NUMBER> human tcell leukemia virus type <NUMBER> <NUMBER> gp<NUMBER> hiv <NUMBER> gp<NUMBER> ebola virus <NUMBER> <NUMBER> fusion protein paramyxovirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> class viral fusion proteins also divided two subtypes whose fusion mechanism low phdependent influenza ha phindependent like retroviral fusion proteins retroviruses receptor binding trigger fusion temperature redox conditions also influencing fusion mechanism <NUMBER> <NUMBER> sars spike appears insensitive redox conditions <NUMBER> sarscov proposed virus internalized cell endocytosis exposed low ph environment postulated proteolytic cleavage s<NUMBER> s<NUMBER> domains initiates membrane fusion process <NUMBER> although factors trigger fusion endocytosis ph sensitivity single receptor vs primary coreceptor binding redox change differ amongst diverse virus families viral fusion proteins thought share basic fusion mechanism <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> notable feature sars spike large mass <NUMBER> kd per trimer striking clubshaped appearance endon appears like threebladed propeller radius <NUMBER> Ã¥ <NUMBER> despite structural differences sars spike performs fundamental task viral entry host cell class viral fusion proteins influenza ha <NUMBER> kd per trimer sars spike subdivided four structural domains n c terminus two large external domains s<NUMBER> s<NUMBER> largely responsible receptor binding membrane fusion respectively many class viral fusion proteins analogous peptides generated proteolysis spike precursor maturation process host cell resulting two peptides fusion peptide nterminus s<NUMBER> sarscov s<NUMBER>s<NUMBER> assignment given based sequence homology viral fusion proteins however peptide cleavage maturation final two small domains comprised transmembrane domain carboxyterminal cytoplasmic domain principally anchor spike viral envelope cellsurface molecule ace<NUMBER> receptor sars spike protein <NUMBER> relatively large macromolecule diameter <NUMBER> Ã¥ comparison receptor influenza ha sialic acid much smaller <NUMBER> Ã¥ diameter precise mechanisms class viral fusion proteins gain access host cell remain unknown hypothetical entry process includes several steps take place sequence receptor binding fusion core rearrangement fusion peptide insertion host cell membrane refolding heptad repeats membrane fusion finally viral nucleocapsid transfer <NUMBER> structures ace<NUMBER> bound fragment sars spike containing receptorbinding domain preand postfusion configurations fusion core heptad repeats spike solved atomic resolution <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> addition atomic resolution structures two neutralizing antibodies bound sars spike receptorbinding domain solved <NUMBER> <NUMBER> showing blocking receptor binding domain preventing attachment virions cellsurface ace<NUMBER> likely mechanism virus neutralization antibodies aim present study delineate possible structural changes sars spike accompanied receptorbinding precisely localize receptor binding domains <NUMBER> total mass spike within overall structure employing cryoem image processing intact virions bound soluble ace<NUMBER> demonstrate structural dynamics accompany spikereceptor binding may involved triggering membrane fusion study structure spikeace<NUMBER> complex infected vero e<NUMBER> cells sarscov purified supernatant virus iodoxanol density gradient centrifugation previously shown specimens could cirradiated sufficient dose <NUMBER>mrad viral inactivation still preserving protein antigenicity inactivation verified passage cell culture testing quantitative pcr <NUMBER> purified cirradiated sarscov preparations fusogenic activity added vero e<NUMBER> cells high multiplicity <NUMBER> virions per cell causing formation syncytia absence replication cytopathic effects figure <NUMBER>a syncytia identical morphology observed cytopathic studies sarscov tissues tissue cultured cells syncytia also observed upon expression coronavirus protein following addition cells expressing sprotein cells surfaceexpressed ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> inactivated cirradiated virus preparations incubated human ace<NUMBER>human fc chimeric protein analysis complex cryoem <NUMBER>d image processing immunoelectron microscopy immunoem figure <NUMBER> movie s<NUMBER> ace<NUMBER>fc construct selected since soluble dimeric anticipated additional mass would beneficial locating receptor attached spike immunoem confirmed recombinant ace<NUMBER> protein bound virions binding affinity affected cirradiation figure <NUMBER>b observe structural changes associated prior irradiation image averaging suppressed possible random radiation induced structural changes cryoem coupled <NUMBER>d single particle image analysis employed investigate binding ace<NUMBER> spike sarscov although sarscov approximately spherical observed cryoem size shape vary slightly thus amenable singleparticle averaging techniques however individual spikes surface envelope virus provide repetitive structure ideal single particle techniques spikes surface virus particles readily imaged cryoem frozenhydrated state figure <NUMBER>c threedimensional image processing carried <NUMBER> selected spike images taken various defocus levels using routine singleparticle image processing <NUMBER> <NUMBER> resolution final <NUMBER>d structure evaluated fourier shell correlation <NUMBER> <NUMBER> Ã¥ figure <NUMBER> structure unbound spike compared spikeace<NUMBER> complex figures <NUMBER>e <NUMBER>f <NUMBER> movie s<NUMBER> cases spike portion <NUMBER>d structure fairly similar indicating ace<NUMBER> binding result fundamental structural unfolding spike however overall height spike reduced <NUMBER> Ã¥ <NUMBER> Ã¥ following ace<NUMBER> binding viewed endon perspective spike undergoes rotation <NUMBER>u following binding movie s<NUMBER> mass center axis symmetry distal end spike redistributes one small central blob three blobs nubs figure <NUMBER> precise location ace<NUMBER> binding distal end spike centered <NUMBER> Ã¥ central axis spike <NUMBER> Ã¥ gap axis symmetry ace<NUMBER> one ace<NUMBER> molecule bound three propellerlike blades spike making structure <NUMBER> Ã¥ high figure <NUMBER>f density ace<NUMBER> molecules high <NUMBER>d density map indicating high occupancy binding sites addition structure shows binding one ace<NUMBER> spike would sterically hinder binding additional ace<NUMBER> molecules two propellerblades trimer cryoem <NUMBER>d structures spike spikeace<NUMBER> complex combined atomic resolution structures sars spike receptorbinding domainace<NUMBER> complex <NUMBER> heptad repeat preand postfusion cores <NUMBER> <NUMBER> interpret cryoem structure receptorbinding domainace<NUMBER> data docked correlation score <NUMBER> using situs software package figure <NUMBER> <NUMBER> expected receptorbinding domain docked distal end spike ace<NUMBER> filling extra mass spike shown color violet figure <NUMBER> empty upper region mass likely composed fc component chimeric protein although chimeric molecule dimeric one leg ace<NUMBER> able bind three receptor binding domains trimer anticipate mass distal hinge region flexible therefore components blurred averaging process leaving portion additional mass <NUMBER>d map cterminus docked ace<NUMBER> location consistent interpretation previously modeled putative location receptorbinding domain ace<NUMBER> cryoem structure unbound spike using solely receptorbinding domain atomic resolution data <NUMBER> present study shown previous prediction location receptorbinding domain partially correct actual location receptor binding domain ace<NUMBER> fact shifted <NUMBER> Ã¥ towards <NUMBER>fold axis corresponding <NUMBER> diameter ace<NUMBER> results present study aid precise location future atomic resolution structure fragments sars spike well structural mapping neutralizing antibodybinding epitopes progress coordinates three dimensional reconstruction sars spike emd<NUMBER> sars spikeace<NUMBER> complex emd<NUMBER> deposited macromolecular database httpwwwebiacuk msd cryoem results demonstrate structural transition spike occurs upon receptor binding figure <NUMBER> movie s<NUMBER> overall height spike reduced <NUMBER> Ã¥ due shift mass s<NUMBER> domain figure <NUMBER> di three s<NUMBER> blades spike twist <NUMBER>u along axis symmetry distal end spike small blob feature replaced three small nubs appear radially figure <NUMBER> fj propose structural rearrangement represents initial priming spike membrane fusion brings cellular viral membranes <NUMBER> Ã¥ closer facilitate fusion coronavirus protein known mediate virioncell membrane fusion intercellular membrane fusion <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> present study shown purified inactivated virions also fusioncompetent show addition sarscov virions cultured cells express ace<NUMBER> induce fusion presumably fusion activity spikes virions bridging neighboring cells similar observations induction fusionfromwithout made cells surfaceexpressing spike protein mixed cells expressing ace<NUMBER> <NUMBER> trigger initiates membrane fusion varies amongst class fusion proteins activated receptor binding others ph others redox conditions proposed models membrane fusion postulated s<NUMBER> domain analogous receptor binding domains dissociate spike membrane fusion process dynamic process demonstrated influenza ha kemble et al <NUMBER> investigation engineered intermonomer disulfide bonds ha s<NUMBER> subunits result fusion activity impaired however could restored reducing conditions likely sars spike shares similar mechanism structural changes detected represent initial step process analogy class viral fusion proteins anticipate fusion core sars spike must undergo similar structural rearrangements fusion receptorbinding domain localized position distal end molecule closer <NUMBER>fold axis anticipated yet still position would impede structural rearrangements putative mechanisms class viral fusion proteins achieve membrane fusion proposed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> complete structural evidence role intermediate structures mechanisms yet obtained structural biology process best characterized influenza hemagglutinin paramyxovirus fusion f protein prefusion membrane fusion ph structures determined xray crystallography <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> subsequent models class viral fusion proteins based structural data two fusion proteins drawback models based recombinant ectodomains proven exist component complete molecule lack membraneinteracting residues lipids <NUMBER> cryoem structures presented investigation intact sars spike bound native virion lipid envelopes cryoem data instructive atomic resolution fragments docked within overall molecule especially entire sars spike proven difficult subject xray crystallography atomic resolution data exist fragments sars spike cryoem results show possible spike attach three ace<NUMBER> receptors may serve hold host membrane like tripod accurately orientate fusion core addition <NUMBER> Ã¥ gap axis symmetry ace<NUMBER> provides sufficient space fusion core rearrangement damico et al <NUMBER> demonstrated kinetics binding rous sarcoma virus envelope protein receptor suggested binding spike molecule multiple receptor monomers occurred may therefore possible structurally homologous viral envelope proteins also bind multiple receptors may general adaptation provides correct temporal spatial arrangement bring membrane fusion observation sars spike could bind three soluble ace<NUMBER> receptors provides three possible binding states one two three membranebound receptors attached spike one two receptors bound spike virus wide range movement possible whereas case three bound receptors spike fusion core arranged perpendicular cell surface minimal movement possible interesting note binding three receptors minimum number binding events required achieve perpendicular orientation three dimensional space observation matches conserved trimeric structures class fusion proteins common amongst enveloped viruses thus indicating possible conserved structuralfunctional relationship may exist another line reasoning oligomerisation favors better chance successful receptor binding subsequent insertion fusion peptide host membrane according model oligomeric multiples higher three would favored whereas tripod model receptor binding favors conserved trimeric structures class viral fusion proteins figure <NUMBER> presented ace<NUMBER>sars structures solved cryoem investigation fusion proteins like influenza ha<NUMBER> hiv gp<NUMBER> modeled rearrangements upon membrane fusion dramatic involving shedding mentioned domains investigation detected structural movement s<NUMBER> upon ace<NUMBER> binding could represent initial phase dramatic process followed fusion core rearrangement fusion peptide insertion host cell membrane refolding heptad repeats finally membrane fusion analyzing structure spikereceptor complex essential understanding viruses adapt utilize receptors different species may evolve gain specificity new receptor types rna viruses high rate mutation recombination <NUMBER> sars coronaviruses spike able retain specific binding affinity ace<NUMBER> one host species rapid evolution gain specificity novel ace<NUMBER> species demonstrated <NUMBER> <NUMBER> structure large size spike coronaviruses appears adaptation related utilization large host cellsurface molecules ace<NUMBER> specific receptors amongst coronavirus family specific cell surface receptors spike protein range <NUMBER> kd <NUMBER> large host receptor molecules turn functionally constrained thus conserved across species barriers utilizing binding large receptor molecule may important spike s<NUMBER> domain also acts spacer arm holding receptor far enough away threefold axis symmetry spike s<NUMBER> domain permit fusion core rearrangement subsequent membrane fusion property necessitates large spike molecule moreover multiple receptor binding may functional significance enhancing binding entry viruses crosslinking adjacent host receptor molecules could increase affinity virus target cell well improving kinetics fusion sars spikeace<NUMBER> complex ideal model system investigation class viral fusion protein dynamics utilizing cryoem investigate fusion protein binding structural changes native state within virion membranes fusogenic presence common cell fusion mechanism shared diverse virus families holds prospect developing broadspectrum antivirals target conserved mechanisms well potential use fusogenic proteins drug delivery systems sarscov tor<NUMBER> strain inoculated onto vero e<NUMBER> cells grown dulbeccos modified eagle medium supplemented <NUMBER> foetal bovine serum <NUMBER> uml penicillin <NUMBER> mgml streptomycin <NUMBER> mgml lglutamine <NUMBER>uc <NUMBER> co <NUMBER> cell supernatant harvested <NUMBER> ml sarscov tcid <NUMBER> titre <NUMBER> <NUMBER> ml virus pelleted using beckman sw<NUMBER> rotor <NUMBER> rpm <NUMBER> minutes virus pellet resuspended pbs buffer layered onto <NUMBER> iodoxanol gradient optiprep centrifuged sw<NUMBER> rotor <NUMBER> rpm <NUMBER> hours fractions <NUMBER> ml collected gradient auto densiflow gradient collector labcono dialyzed pbs sarscovenriched fractions checked sdspage western blotting rendered noninfectious irradiation gamma cell dry ice <NUMBER>mrad exposure <NUMBER> minutes irradiated specimens tested infectivity inoculation onto vero e<NUMBER> cells examined cytopathogenic effects <NUMBER> days followed blind passage cells testing growth sarscov pcr <NUMBER> test spike fusogenic activity vero e<NUMBER> cells cultured <NUMBER> well plates corning cells confluent medium removed well <NUMBER> ml gamma irradiated sarscov containing <NUMBER> <NUMBER> pfuml diluted <NUMBER> <NUMBER> culture media virus dilutions incubated cells <NUMBER> hour <NUMBER>uc incubation plates washed three times fresh culture medium remove unbound virus vero e<NUMBER> cells observed light microscopy <NUMBER> <NUMBER> days post treatment presence syncytia virus growth detected either dilution irradiated virus cytopathic effect observed presence nucleic acid syncytia investigated propidium iodide staining observation fluorescence microscopy human ace<NUMBER>fc human igg<NUMBER> recombinant protein adipogen initial concentration <NUMBER> mgml pbs diluted <NUMBER> pbs incubation sarscov remainder document referred ace<NUMBER> <NUMBER> ml sarscov injected <NUMBER> ml pbs formvarcarbon coated <NUMBER>mesh nickel grid incubated <NUMBER> minute incubations carried <NUMBER>uc grids washed pbs six times <NUMBER> minute followed <NUMBER>minute block pbsgbsa pbs ph<NUMBER> <NUMBER> glycine <NUMBER> bsa grids washed pbsg pbs ph<NUMBER> <NUMBER> glycine six times <NUMBER> minute followed <NUMBER>hour incubation <NUMBER> ml drop ace<NUMBER> grids washed pbsg pbs ph<NUMBER> <NUMBER> glycine six times <NUMBER> minute followed <NUMBER>hour incubation rabbit antihuman ace<NUMBER> polyclonal igg adipogen diluted <NUMBER> pbs grids washed pbsg pbs ph<NUMBER> <NUMBER> glycine six times <NUMBER> minute followed <NUMBER> minute incubation goat antirabbit igg conjugated <NUMBER> nm gold sigma diluted <NUMBER> pbs grids washed pbsg pbs ph<NUMBER> <NUMBER> glycine three times <NUMBER> minute grids fixed <NUMBER> minutes <NUMBER> paraformaldehyde <NUMBER> glutaraldehyde pbs washed deionised water negatively stained <NUMBER> methylamine tungstate nanoprobes observed transmission electron microscopy tecnai <NUMBER> g<NUMBER> transmission electron microscope fei operated <NUMBER> kv digital images collected using amt advantage xr<NUMBER> digital camera sarscov incubated ace<NUMBER> one hour <NUMBER> ml samples applied glowdischarged holey carbon films supported <NUMBER>mesh copper grids blotting immediately <NUMBER> seconds filter paper grids plunged liquid ethane cooled liquid nitrogen using custom built gravityoperated freezing device specimens transferred tecnai <NUMBER> g<NUMBER> transmission electron microscope fei operated <NUMBER> kv equipped gatan <NUMBER>dh lowtemperature specimen holder observations made temperatures <NUMBER>uc images recorded <NUMBER> magnification kodak so<NUMBER> electron image film dose <NUMBER> electronsÃ¥ <NUMBER> exposure <NUMBER> seconds film developed kodak d<NUMBER> <NUMBER> minutes room temperature rinsed <NUMBER> minutes water fixed <NUMBER> minutes kodak fixer exact magnification microscope sarscov imaged determined <NUMBER> using calibration grid pelco international images sarscov digitized nikon super coolscan <NUMBER> ed scanner pixel size <NUMBER>Ã¥ processing carried using eman spiderweb image processing program packages <NUMBER> <NUMBER> sgi fuel tezro workstations running irix <NUMBER> dell pe<NUMBER> <NUMBER>way <NUMBER>bit xeon dual core <NUMBER> ghz cpus <NUMBER>gb ram running linux fedora core <NUMBER> images corrected contrast transfer function ctf using ctfit function eman software package estimates defocus corrects ctf phaseflipping data set composed images centred spikesace<NUMBER> n <NUMBER> recorded <NUMBER> Ã¥ defocus processed using spider projection matching approach <NUMBER> incorporated threefold symmetry search function reconstruction procedure refinement cycle new reference volume either theresholded segmented using floodfill function situs software package <NUMBER> select spikeace<NUMBER> structure minimize influence neighbouring spikes reference structure used subsequent iteration projection match alignment initial reference model used procedure structure sars spike previously solved cryoelectron microscopy <NUMBER> population spike images composed side view projections well endon projections latter easily identified images greater defocus values highdefocusendon images essential eliminate missing cone reconstruction resolution cryoem reconstruction estimated fourier shell correlation <NUMBER>Ã¥ using <NUMBER> fsc criteria structures prefusion hr<NUMBER> domain ace<NUMBER>receptorbinding domain docked cryoem reconstruction using floodfill colores functions situs software package resultant docking generated one distinct location ace<NUMBER>receptorbinding domain placed ace<NUMBER> additional mass present reconstruction spike alone docking entire <NUMBER>fxppdb <NUMBER> structure previously conducted <NUMBER> threedimensional cryoem reconstructions atomic resolution structures <NUMBER>ajfpdb <NUMBER> <NUMBER>fxppdb <NUMBER> visualized using ucsf chimera computer graphics laboratory university california san francisco supported nih p<NUMBER> rr<NUMBER> <NUMBER> spike component spikeviral envelope reconstruction segmented entire reconstruction using floodfill algorithm situs software package movie s<NUMBER> rotating sars spikeace<NUMBER> complex generated silicon graphics workstation using ucsf chimera mediarecorder mediaconvert software provided silicon graphics irix <NUMBER> operating system movie s<NUMBER> showing morphing spike sars spike sars spikeace<NUMBER> complex generated using ucsf chimera software package morph map morphing tool plugin reconstructions masked cylindrical mask applied masked peripheral boundaries sarscov envelope reconstructions movie s<NUMBER> threedimensional reconstruction sars spikeace<NUMBER> complex movie supplements figs <NUMBER> <NUMBER> showing reconstruction spikeace<NUMBER> complex well location docked atomic structures movie starts showing spikeace<NUMBER> complex viewed endon perspective reconstruction tilts <NUMBER>o followed <NUMBER>o rotation along threefold axis symmetry spike second section movie cryoem reconstruction becomes transparent revealing location docked atomic structures followed final rotation <NUMBER>o back initial endon perspective following color scheme used cryoem surface ace<NUMBER> violet spike green stalk blue envelope beige nucleocapsid red atomic structures pdb id code <NUMBER>ajf sars spike receptorbinding domain red ace<NUMBER> white ace<NUMBER> cterminus blue pdb id code <NUMBER>fxp hr<NUMBER> fusion core yellow found doi<NUMBER>journalpone<NUMBER>s<NUMBER> <NUMBER> mb mov movie s<NUMBER> threedimensional morphing sars spike ace<NUMBER> bound structures movie supplements figs <NUMBER> <NUMBER> showing putative structural rearrangement spike binds ace<NUMBER> movie starts showing sars spike gradually morphs sars spikeace<NUMBER> complex back sars spike morphing reconstruction shown side endon perspectives mass attributed nucleocapsid presented without morphing one watches move play back forth done selecting loop quicktime player one see spike twist <NUMBER>o viewed endon perspective spike becomes squatter <NUMBER> x<NUMBER>c<NUMBER> viewed side perspective following color scheme used cryoem surface ace<NUMBER> violet spike green stalk blue envelope beige nucleocapsid red transmembrane cov sprotein spike trimer composed interwoven protomers include nterminal receptor binding s<NUMBER> domain cterminal s<NUMBER> domain contains fusion elements figure <NUMBER>a b <NUMBER> s<NUMBER> domain subdivided nterminal domain ntd followed receptor binding domain rbd two structurally conserved subdomains sd<NUMBER> sd<NUMBER> together domains cap s<NUMBER> domain protecting conserved fusion machinery several structures soluble ectodomain constructs retain complete s<NUMBER> domain surface exposed s<NUMBER> domain determined include sars<NUMBER> <NUMBER> sars <NUMBER> mers <NUMBER> <NUMBER> human <NUMBER> murine <NUMBER> Î²cov spike proteins structures revealed remarkable conformational heterogeneity sprotein spikes especially rbd region within single protomer rbd could adopt closed state figure <NUMBER>a rbd covers apical region s<NUMBER> protein near cterminus first heptad repeat hr<NUMBER> open state rbd dissociated apical central axis s<NUMBER> ntd cryoem structures strongly suggest large degree domain flexibility states ntd rbd structures provided essential information identify relative arrangement domains degree conformational heterogeneity may altered via mutation natural evolution virus vaccine immunogen design context remains determined study quantified variability s<NUMBER> s<NUMBER> geometric arrangements reveal important regions flexibility consider target structurebased immunogen design based analyses designed mutations alter conformational distribution domains sprotein visualized effect designs using structural determination pipeline relying first single particle analysis negative stain electron microscopy nsem rapid lowcost assessment spike ectodomains low resolution followed cryoem highresolution information changes introduced mutations results reveal heterogeneous conformational landscape sarscov<NUMBER> spike highly susceptible modification introduction mutations sites contact s<NUMBER> s<NUMBER> domains also present data modified sars<NUMBER> ectodomain constructs stabilized conformations yet seen current available structures great interest direct application vaccine design detailed structural schema defining geometry internal rearrangements movable domains sars<NUMBER> spike characterize unique arrangement distinct domains Î²cov spike first aimed develop precise quantitative definition relative positions examination available sars mers sprotein structures revealed <NUMBER> ntd rbd subdomains internal s<NUMBER> domain move rigid bodies <NUMBER> domains display remarkable array relative shifts domains s<NUMBER> region s<NUMBER> regions Î²sheet motif connector domain cd figure <NUMBER>bf order quantify movements analyzed relevant regions motion structural disposition available Î²cov ectodomain spike structures including <NUMBER> sars <NUMBER> <NUMBER> mers <NUMBER> hku<NUMBER> <NUMBER> oc<NUMBER> <NUMBER> murine Î²cov three sars<NUMBER> <NUMBER> structures figures <NUMBER>ef <NUMBER> protomer structures displaying asymmetric updown rbd states examined independently yielding dataset <NUMBER> structural states ntd split primary nterminal section secondary cterminal section based upon visual inspection region various Î²cov structures figures <NUMBER>bc <NUMBER> next analyzed sprotein geometry using vectorbased approach specifically vectors connecting regions cÎ± centroids generated used define relative dispositions domains figure <NUMBER>c <NUMBER> vector magnitudes select angles dihedrals used identify breadth differences domain positioning compare strains results indicated Î²cov spike proteins various strains differ markedly one another considerable variability domain arrangements within strains exists especially sars ectodomains figures <NUMBER>ef <NUMBER>ah particular <NUMBER> É¸<NUMBER> figure <NUMBER>ab describing angle sd<NUMBER> sd<NUMBER> sd<NUMBER> rbd vectors well sd<NUMBER> rbd dihedral respectively effectively report configurations indicating substantial differences sars mers states angular disposition ntd elements indicated differences sars mers particularly marked shift examined Î²cov spikes murine structure figure <NUMBER>e additional s<NUMBER> differences observed vectors involving sd<NUMBER> disposition s<NUMBER> domain relative s<NUMBER> defined dihedral vector connecting sd<NUMBER> s<NUMBER> cd differs markedly merssars<NUMBER> sars well angle vectors connecting ntd sd<NUMBER> sd<NUMBER> cd demonstrating shift sars<NUMBER> finally disposition cd inner portion s<NUMBER> measured angle vector connected interior s<NUMBER> Î²sheet motif vector connecting cd sd<NUMBER> indicates sars differs mers sars<NUMBER> interestingly mers disposition appears respond rbd triggering displaying bimodal distribution results demonstrate individual domain architectures overall arrangements conserved figure <NUMBER>d important differences domains exists strains suggesting subtle differences interdomain contacts could play major role determining distributions thereby alter surface antigenicity propensity domains access rbd states identification sites differential stabilization sars<NUMBER> ectodomain spike rbd orientation based observed variability geometric analysis Î²cov spikes asked whether propensity rbd display states could modified via mutations without altering exposed antigenic surfaces end identified protomer protomer interactive sites amenable modification selected mutations sites using schrÃ¶dinger biologics suite <NUMBER> <NUMBER> <NUMBER> effort eliminate exposure receptor binding site rbd examined potential disulfide linkages rbd contact s<NUMBER> near cterminus hr<NUMBER> prevent rbd exposure identified double cysteine mutant s<NUMBER>c d<NUMBER>c rbd s<NUMBER> double mutant rs<NUMBER>d supplemental figure s<NUMBER> candidate achieving goal transition state state involves shifts rbd ntd contacts therefore effort prevent shifts identified site rbd groove adjacent ntd prepared triple mutant d<NUMBER>l s<NUMBER>l e<NUMBER>l rbd ntd triple mutant rnt supplemental figure s<NUMBER> sd<NUMBER> acts hinge point rbd updown transitions figures <NUMBER>ac <NUMBER>ij hypothesized enhanced hydrophobicity sd<NUMBER> s<NUMBER> interface might shift position sd<NUMBER> thus influencing hinge potentially propensity rbd triggering double mutant n<NUMBER>i a<NUMBER>l subdomain <NUMBER> s<NUMBER> double mutant u<NUMBER>s<NUMBER>d supplemental figure s<NUMBER> well quadruple mutant a<NUMBER>l t<NUMBER>i f<NUMBER>y n<NUMBER>i subdomain <NUMBER> s<NUMBER> quadruple mutant u<NUMBER>s<NUMBER>q identified purpose finally asked whether linking sd<NUMBER> s<NUMBER> would alter conformational distribution rbds double cysteine mutant g<NUMBER>c t<NUMBER>c subdomain <NUMBER> s<NUMBER> double mutant u<NUMBER>s<NUMBER>d supplemental figure s<NUMBER> identified purpose mutants prepared context previously published sars<NUMBER> ectodomain construct <NUMBER> assess quality purified spike proteins obtain low resolution visualization structures performed nsem analysis micrographs showed reasonably uniform distribution particles consistent size shape sars<NUMBER> spike ectodomain figure <NUMBER> <NUMBER>d class averages showed spike populations well resolved domain features data subjected <NUMBER>dclassification followed homogeneous refinement unmutated construct resolved two classes roughly equal proportions two classes differed position rbd domains one class displayed three rbds positions whereas class displayed one rbd position consistent published cryoem results <NUMBER> described <NUMBER> ratio <NUMBER>up states sars<NUMBER> spike ectodomain mutant spikes analyzed using similar workflow unmutated spike mutants displayed wellformed spikes micrographs well <NUMBER>d class averages following <NUMBER>d classification rs<NUMBER>d construct observed conformation <NUMBER>rbd state seen unmutated spike found dataset u<NUMBER>s<NUMBER>q mutant presented another striking finding observed new conformational state <NUMBER> rbds position <NUMBER>rbd state reported mers cov spike ectodomain <NUMBER> observed thus far either sars sars<NUMBER> spikes based nsem analysis selected rs<NUMBER>d u<NUMBER>s<NUMBER>q constructs high resolution analysis cryoem visualize mutations effect structure spike collected cryoem datasets search open state spikes dataset unable find states confirming sars<NUMBER> spike locked conformation rs<NUMBER>d mutant rs<NUMBER>d disulfidelinked density mutation site confirmed disulfide formation double mutant rs<NUMBER>d figure <NUMBER> comparison domain arrangements construct unmutated closed state structure indicated protein structure otherwise unperturbed supplemental figure s<NUMBER>a contrast rs<NUMBER>d design u<NUMBER>s<NUMBER>q design displayed widespread rearrangement s<NUMBER> domains supplemental figure s<NUMBER>b state structure density mutated s<NUMBER> position remained configuration observed unmutated construct n<NUMBER>i f<NUMBER>y residue loop close proximity s<NUMBER> residue l<NUMBER> s<NUMBER> residue p<NUMBER> suggested mutations little impact observed shifts however s<NUMBER>interactive sd<NUMBER> displayed rigid body movement relative rs<NUMBER>d unmutated constructs <NUMBER> É¸<NUMBER> displacements <NUMBER>Â° <NUMBER>Â° respectively figure <NUMBER>a relatively small contact area s<NUMBER> s<NUMBER> subunits observed suggested despite relatively low mutation rate dramatic changes sprotein structure may occur mutations indeed recent evidence mutation sd<NUMBER> s<NUMBER> contact region suggests potential fitness gain acquisition interfacial residues <NUMBER> based upon results mutant d<NUMBER>g may indeed alter conformational landscape sarscov<NUMBER> sprotein immunogen provides platform induce nonrbd responses may needed protect evasion second area interest concerns cryptic pocket targeting antibodies proven effective neutralization sars antibodies target epitope presented state rbds appear require two rbd configuration <NUMBER> current stabilized ectodomain construct wide use sarscov<NUMBER> clinical trials demonstrated previously recapitulated nsem display one rbd states however u<NUMBER>s<NUMBER>q sd<NUMBER>s<NUMBER> targeting design developed display prominent two rbd state distribution compatible crypticepitope targeting mabs suggests capable inducing antibodies complicating factors potential vaccine enhancement may favor use truncated single domain constructs may display fewer potentially weakly nonneutralizing epitopes along designs presented allow detailed characterization vaccine immunogenicity also antigenicity paving way next generation vaccines novel sarscov<NUMBER> eventual development broadly neutralizing Î²cov vaccine thus previous generation stabilizing mutations ensure well folded trimer rational design approach developed provides means precisely controlling rbd orientation distribution thus allowing exploratory efforts understand role conformational dynamics perspective vaccine drug development initial cryoem data collected titan krios shared materials instrumentation datasets generated andor analyzed study available corresponding authors reasonable request code developed study available corresponding author reasonable request vector analysis performed using available cryoem structures sars<NUMBER> <NUMBER> <NUMBER> <NUMBER> vector magnitudes angles dihedrals centroids determined used subsequent analysis vector analysis performed using vmd <NUMBER> tcl interface principal component analysis performed r vector data centered scaled <NUMBER> structures sars pdb id <NUMBER>x<NUMBER> <NUMBER> mers pdb id <NUMBER>q<NUMBER> <NUMBER> sarscov<NUMBER> pdb id <NUMBER>vxx <NUMBER> prepared maestro <NUMBER> using protein preparation wizard <NUMBER> followed silico mutagenesis using schrÃ¶dingers cysteine mutation <NUMBER> residue scanning <NUMBER> tools residue scanning first performed individual selected sites allowing mutations leu ile trp tyr val followed scanning combinations yielded negative overall score scores visual inspection used selection prepared constructs sarscov<NUMBER> ectodomain constructs produced purified described previously ref wrapp et al mclellan briefly gene encoding residues <NUMBER>â<NUMBER> sarscov<NUMBER> genbank mn<NUMBER> proline substitutions residues <NUMBER> <NUMBER> gsas substitution furin cleavage site residues <NUMBER> cterminal t<NUMBER> fibritin trimerization motif hrv<NUMBER>c protease cleavage site twinstreptag <NUMBER>xhistag synthesized cloned mammalian expression vector pÎ±h mutants introduced background expression plasmids encoding ectodomain sequence used transiently transfect freestyle<NUMBER>f cells using turbo<NUMBER> speedbiosystems protein purified sixth day posttransfection filtered supernatant using streptactin resin iba purified sarscov<NUMBER> spike preparations diluted concentration <NUMBER> mgml <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> <NUMBER> Âµl protein deposited cf<NUMBER> grid glow discharged <NUMBER> seconds pelco easiglowâ¢ glow discharge cleaning system <NUMBER> incubation <NUMBER> humidity excess protein blotted away <NUMBER> seconds plunge frozen liquid ethane using leica em gp<NUMBER> plunge freezer leica microsystems frozen grids imaged titan krios thermo fisher equipped k<NUMBER> detector gatan data acquired using leginon system <NUMBER> dose fractionated <NUMBER> raw frames collected <NUMBER>ms framerate dataset energyfiltered slit width <NUMBER> ev individual frames aligned doseweighted ctf estimation particle picking <NUMBER>d classifications ab initio model generation heterogeneous refinements homogeneous <NUMBER>d refinements carried cryosparc <NUMBER> structures state pdb id <NUMBER>vxx single rbd state pdb id <NUMBER>vyb previously published sarscov<NUMBER> ectodomain used fit cryoem maps chimera <NUMBER> <NUMBER> rbd state generated pymol using single rbd state structure mutations made pymol <NUMBER> coordinates fit manually coot <NUMBER> followed iterative refinement using phenix <NUMBER> real space refinement subsequent manual coordinate fitting coot structure map analysis performed using pymol chimera supplemental figure s<NUMBER> alignment rs<NUMBER>d u<NUMBER>s<NUMBER>q designs unmutated construct structure rs<NUMBER>d dark blue aligned unmutated construct pdb id <NUMBER>vxx red b structure u<NUMBER>s<NUMBER>q green aligned unmutated construct pdb id <NUMBER>vxx red c u<NUMBER>s<NUMBER>q green mutation sites compared unmutated form red transmembrane cov sprotein spike trimer composed interwoven protomers include nterminal receptor binding s<NUMBER> domain cterminal s<NUMBER> domain contains fusion elements figure <NUMBER>a b <NUMBER> s<NUMBER> domain subdivided nterminal domain ntd followed receptor binding domain rbd two structurally conserved subdomains sd<NUMBER> sd<NUMBER> together domains cap s<NUMBER> domain protecting conserved fusion machinery several structures soluble ectodomain constructs retain complete s<NUMBER> domain surface exposed s<NUMBER> domain determined include sars<NUMBER> <NUMBER> sars <NUMBER> mers <NUMBER> <NUMBER> human <NUMBER> murine <NUMBER> Î²cov spike proteins structures revealed remarkable conformational heterogeneity sprotein spikes especially rbd region within single protomer rbd could adopt closed state figure <NUMBER>a rbd covers apical region s<NUMBER> protein near cterminus first heptad repeat hr<NUMBER> open state rbd dissociated apical central axis s<NUMBER> ntd cryoem structures strongly suggest large degree domain flexibility states ntd rbd structures provided essential information identify relative arrangement domains degree conformational heterogeneity may altered via mutation natural evolution virus vaccine immunogen design context remains determined study quantified variability s<NUMBER> s<NUMBER> geometric arrangements reveal important regions flexibility consider target structurebased immunogen design based analyses designed mutations alter conformational distribution domains sprotein visualized effect designs using structural determination pipeline relying first single particle analysis negative stain electron microscopy nsem rapid lowcost assessment spike ectodomains low resolution followed cryoem highresolution information changes introduced mutations results reveal heterogeneous conformational landscape sarscov<NUMBER> spike highly susceptible modification introduction mutations sites contact s<NUMBER> s<NUMBER> domains also present data modified sars<NUMBER> ectodomain constructs stabilized conformations yet seen current available structures great interest direct application vaccine design ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi biorxiv preprint detailed structural schema defining geometry internal rearrangements movable domains sars<NUMBER> spike characterize unique arrangement distinct domains Î²cov spike first aimed develop precise quantitative definition relative positions examination available sars mers sprotein structures revealed <NUMBER> ntd rbd subdomains internal s<NUMBER> domain move rigid bodies <NUMBER> domains display remarkable array relative shifts domains s<NUMBER> region s<NUMBER> regions Î²sheet motif connector domain cd figure <NUMBER>bf order quantify movements analyzed relevant regions motion structural disposition available Î²cov ectodomain spike structures including <NUMBER> sars <NUMBER> <NUMBER> mers <NUMBER> hku<NUMBER> <NUMBER> oc<NUMBER> <NUMBER> murine Î²cov three sars<NUMBER> <NUMBER> structures figures <NUMBER>ef <NUMBER> protomer structures displaying asymmetric updown rbd states examined independently yielding dataset <NUMBER> structural states ntd split primary nterminal section secondary cterminal section based upon visual inspection region various Î²cov structures figures <NUMBER>bc <NUMBER> next analyzed sprotein geometry using vectorbased approach specifically vectors connecting regions cÎ± centroids generated used define relative dispositions domains figure <NUMBER>c <NUMBER> vector magnitudes select angles dihedrals used identify breadth differences domain positioning compare strains results indicated Î²cov spike proteins various strains differ markedly one another considerable variability domain arrangements within strains exists especially sars ectodomains figures <NUMBER>ef <NUMBER>ah particular <NUMBER> É¸<NUMBER> figure <NUMBER>ab describing angle sd<NUMBER> sd<NUMBER> sd<NUMBER> rbd vectors well sd<NUMBER> rbd dihedral respectively effectively report configurations indicating substantial differences sars mers states angular disposition ntd elements indicated differences sars mers particularly marked shift examined Î²cov spikes murine structure figure <NUMBER>e additional s<NUMBER> differences observed vectors involving sd<NUMBER> disposition s<NUMBER> domain relative s<NUMBER> defined dihedral vector connecting sd<NUMBER> s<NUMBER> cd differs markedly merssars<NUMBER> sars well angle vectors connecting ntd sd<NUMBER> sd<NUMBER> cd demonstrating shift sars<NUMBER> finally disposition cd inner portion s<NUMBER> measured angle vector connected interior s<NUMBER> Î²sheet motif vector connecting ccbyncnd <NUMBER> international license certified peer review authorfunder made available cd sd<NUMBER> indicates sars differs mers sars<NUMBER> interestingly mers disposition appears respond rbd triggering displaying bimodal distribution results demonstrate individual domain architectures overall arrangements conserved figure <NUMBER>d important differences domains exists strains suggesting subtle differences interdomain contacts could play major role determining distributions thereby alter surface antigenicity propensity domains access rbd states identification sites differential stabilization sars<NUMBER> ectodomain spike rbd orientation based observed variability geometric analysis Î²cov spikes asked whether propensity rbd display states could modified via mutations without altering exposed antigenic surfaces end identified protomer protomer interactive sites amenable modification selected mutations sites using schrÃ¶dinger biologics suite <NUMBER> <NUMBER> <NUMBER> effort eliminate exposure receptor binding site rbd examined potential disulfide linkages rbd contact s<NUMBER> near cterminus hr<NUMBER> prevent rbd exposure identified double cysteine mutant s<NUMBER>c d<NUMBER>c rbd s<NUMBER> double mutant rs<NUMBER>d supplemental figure s<NUMBER> candidate achieving goal transition state state involves shifts rbd ntd contacts therefore effort prevent shifts identified site rbd groove adjacent ntd prepared triple mutant d<NUMBER>l s<NUMBER>l e<NUMBER>l rbd ntd triple mutant rnt supplemental figure s<NUMBER> sd<NUMBER> acts hinge point rbd updown transitions figures <NUMBER>ac <NUMBER>ij hypothesized enhanced hydrophobicity sd<NUMBER> s<NUMBER> interface might shift position sd<NUMBER> thus influencing hinge potentially propensity rbd triggering double mutant n<NUMBER>i a<NUMBER>l subdomain <NUMBER> s<NUMBER> double mutant u<NUMBER>s<NUMBER>d supplemental figure s<NUMBER> well quadruple mutant a<NUMBER>l t<NUMBER>i f<NUMBER>y n<NUMBER>i subdomain <NUMBER> s<NUMBER> quadruple mutant u<NUMBER>s<NUMBER>q identified purpose finally asked whether linking sd<NUMBER> s<NUMBER> would alter conformational distribution rbds double cysteine mutant g<NUMBER>c t<NUMBER>c subdomain <NUMBER> s<NUMBER> double mutant u<NUMBER>s<NUMBER>d supplemental figure s<NUMBER> identified purpose mutants prepared context previously published sars<NUMBER> ectodomain construct <NUMBER> assess quality purified spike proteins obtain low resolution visualization structures performed nsem analysis micrographs showed reasonably uniform distribution particles consistent size shape sars<NUMBER> spike ectodomain figure <NUMBER> <NUMBER>d class averages showed spike populations well resolved domain features data subjected <NUMBER>dclassification followed homogeneous refinement unmutated construct resolved two classes roughly equal proportions two classes differed position rbd domains one class displayed three rbds positions whereas class displayed one rbd position consistent published cryoem results <NUMBER> described <NUMBER> ratio <NUMBER>up states sars<NUMBER> spike ectodomain mutant spikes analyzed using similar workflow unmutated spike mutants displayed wellformed spikes micrographs well <NUMBER>d class averages following <NUMBER>d classification rs<NUMBER>d construct observed conformation <NUMBER>rbd state seen unmutated spike found dataset u<NUMBER>s<NUMBER>q mutant presented another striking finding observed new conformational state <NUMBER> rbds position <NUMBER>rbd state reported mers cov spike ectodomain <NUMBER> observed thus far either sars sars<NUMBER> spikes based nsem analysis selected rs<NUMBER>d u<NUMBER>s<NUMBER>q constructs high resolution analysis cryoem visualize mutations effect structure spike collected cryoem datasets copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint arrangements construct unmutated closed state structure indicated protein structure otherwise unperturbed supplemental figure s<NUMBER>a contrast rs<NUMBER>d design u<NUMBER>s<NUMBER>q design displayed widespread rearrangement s<NUMBER> domains supplemental figure s<NUMBER>b state structure density mutated s<NUMBER> position remained configuration observed unmutated construct n<NUMBER>i f<NUMBER>y residue loop close proximity s<NUMBER> residue l<NUMBER> s<NUMBER> residue p<NUMBER> suggested mutations little impact observed shifts however s<NUMBER>interactive sd<NUMBER> displayed rigid body movement relative rs<NUMBER>d unmutated constructs <NUMBER> É¸<NUMBER> displacements <NUMBER>Â° <NUMBER>Â° respectively figure <NUMBER>a b resulted displacement a<NUMBER>lt<NUMBER>i containing loop unmutated position resides near s<NUMBER> l<NUMBER> residue figure <NUMBER>b supplemental figure s<NUMBER>c s<NUMBER> contact disruption accompanied angular shift ntd away primary trimer axis owing sd<NUMBER> ntd contacts yielding <NUMBER> <NUMBER> structural details presented indicate locking state rbd unmutated position little impact overall configuration s<NUMBER> altering disposition sd<NUMBER> wide ranging impacts consistent observed straintostrain differences geometric analysis described figures <NUMBER> <NUMBER> conformational plasticity hallmark envelopedvirus fusionprotein structure owing necessity protecting conserved viral fusion elements host immune responses retaining sufficiently steep freeenergy gradient enable host cell fusion <NUMBER> exposed elements generally well conditioned permissive responsive mutations genetic drift host immune adaptation conformational plasticity however presents important difficulty context vaccine drug design indeed lessons learned continued effort produce broadly protective hiv<NUMBER> vaccine demonstrated importance detailed understanding control fusion protein dynamics <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> novel sarscov<NUMBER> likely exception regard indeed conformational plasticity sars<NUMBER> sprotein appeared greater hiv<NUMBER> env aimed develop quantitative understanding Î²cov structural states strains within rbd state configuration wide breadth domain arrangements along relatively small contact area s<NUMBER> s<NUMBER> subunits observed suggested despite relatively low mutation rate dramatic changes sprotein structure may occur mutations indeed recent evidence mutation sd<NUMBER> s<NUMBER> contact region suggests potential fitness gain acquisition interfacial residues <NUMBER> based upon results mutant d<NUMBER>g may indeed alter conformational landscape sarscov<NUMBER> sprotein datasets generated andor analyzed study available corresponding authors reasonable request code developed study available corresponding author reasonable request vector analysis performed using available cryoem structures sars<NUMBER> <NUMBER> structures sars pdb id <NUMBER>x<NUMBER> <NUMBER> mers pdb id <NUMBER>q<NUMBER> <NUMBER> sarscov<NUMBER> pdb id <NUMBER>vxx <NUMBER> prepared maestro <NUMBER> using protein preparation wizard <NUMBER> followed silico mutagenesis using schrÃ¶dingers cysteine mutation <NUMBER> residue scanning <NUMBER> tools residue scanning first performed individual selected sites allowing mutations leu ile trp tyr val followed scanning combinations yielded negative overall score scores visual inspection used selection prepared constructs sarscov<NUMBER> ectodomain constructs produced purified described previously ref wrapp et al mclellan briefly gene encoding residues <NUMBER>â<NUMBER> sarscov<NUMBER> genbank mn<NUMBER> proline substitutions residues <NUMBER> <NUMBER> gsas substitution furin cleavage site residues <NUMBER> cterminal t<NUMBER> fibritin trimerization motif hrv<NUMBER>c protease cleavage site twinstreptag <NUMBER>xhistag synthesized cloned mammalian expression vector pÎ±h mutants introduced background expression plasmids encoding ectodomain sequence used transiently transfect freestyle<NUMBER>f cells using turbo<NUMBER> speedbiosystems protein purified sixth day posttransfection filtered supernatant using streptactin resin iba purified sarscov<NUMBER> spike preparations diluted concentration <NUMBER> mgml <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> <NUMBER> Âµl protein deposited cf<NUMBER> grid glow discharged <NUMBER> seconds pelco easiglowâ¢ glow discharge cleaning system <NUMBER> incubation <NUMBER> humidity excess protein blotted away <NUMBER> seconds plunge frozen liquid ethane using leica em gp<NUMBER> plunge freezer leica microsystems frozen grids imaged titan krios thermo fisher equipped k<NUMBER> detector gatan data acquired using leginon system <NUMBER> ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint dose fractionated <NUMBER> raw frames collected <NUMBER>ms framerate dataset energyfiltered slit width <NUMBER> ev individual frames aligned doseweighted ctf estimation particle picking <NUMBER>d classifications ab initio model generation heterogeneous refinements homogeneous <NUMBER>d refinements carried cryosparc <NUMBER> structures state pdb id <NUMBER>vxx single rbd state pdb id <NUMBER>vyb previously published sarscov<NUMBER> ectodomain used fit cryoem maps chimera <NUMBER> <NUMBER> rbd state generated pymol using single rbd state structure mutations made pymol <NUMBER> coordinates fit manually coot <NUMBER> followed iterative refinement using phenix <NUMBER> real space refinement subsequent manual coordinate fitting coot structure map analysis performed using pymol chimera ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> figure s<NUMBER> sites identified differential stabilization sarscov<NUMBER> sprotein single protomer colored according figure <NUMBER> remaining two protomers color according s<NUMBER> light blue s<NUMBER> grey spheres indicate candidate mutation sites ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint supplemental figure s<NUMBER> alignment rs<NUMBER>d u<NUMBER>s<NUMBER>q designs unmutated construct structure rs<NUMBER>d dark blue aligned unmutated construct pdb id <NUMBER>vxx red b structure u<NUMBER>s<NUMBER>q green aligned unmutated construct pdb id <NUMBER>vxx red c u<NUMBER>s<NUMBER>q green mutation sites compared unmutated form red ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint recent pandemic caused sarscov<NUMBER> covid<NUMBER> posed challenging global health sanitation concern twentyfirst century <NUMBER> confirmed cases infected <NUMBER> confirmed fatalities world health organization updated june <NUMBER>th <NUMBER> <NUMBER> moreover pandemic caused widespread lockdown affecting <NUMBER> <NUMBER> individuals world virus responsible covid<NUMBER> sarscov<NUMBER> emerged late <NUMBER> region wuhan china <NUMBER> sarscov<NUMBER> belongs family coronaviridae characterized large enveloped positivestranded rna viruses potentially cause gastrointestinal nervous system respiratory distress <NUMBER> family also includes sarscov merscov <NUMBER> despite several similarities present interesting differences sarscov<NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> merscov sarscov use envelope protein termed spike protein gain access host cells <NUMBER> <NUMBER> protein displays highest degree genetic variability virus genome <NUMBER> additionally sarscov<NUMBER> protein exhibits greater affinity ace<NUMBER> receptor respect analogs sarscov merscov <NUMBER> <NUMBER> sarscov<NUMBER> protein shares <NUMBER> sequence similarity bat sarslike ratg<NUMBER> protein indicating natural origin virus <NUMBER> <NUMBER> due crucial role first stage viral infection several studies <NUMBER>â<NUMBER> point protein elective target develop coronaviruses therapies vaccines protein also main target neutralizing antibodies <NUMBER>â<NUMBER> protein belongs viral fusion class proteins <NUMBER> trimeric crownlike shape protrudes virus envelope targets diverse host cell receptors different species see table <NUMBER> ref <NUMBER> sars sarslike mers sarscov<NUMBER> coronaviruses target angiotensinconvertingenzyme <NUMBER> ace<NUMBER> present pneumocytes enterocytes respiratory system susceptible cells eg intestinal mucosal renal tubular epithelial cerebral neurons immune cells <NUMBER> sace<NUMBER> interaction occurs first stage viral entry initiate viral fusion host cell <NUMBER> <NUMBER> hallmark sarscov<NUMBER> protein optimized ace<NUMBER> binding <NUMBER> protein comprises two subunits termed s<NUMBER> s<NUMBER> cleaved first stage viral infection s<NUMBER> subunit responsible interaction protein host receptor ace<NUMBER> s<NUMBER> promotes viral fusion <NUMBER> receptor binding domain rbd resides residues <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> sarscov <NUMBER> development therapeutics targeting sace<NUMBER> complex requires comprehensive study complex interface associated dynamics <NUMBER> thus investigating allosteric nature sace<NUMBER> complex help understand quantify extent protein binds ace<NUMBER> therefore molecular basis virus infectivity identification allosteric modulation regions amrs allows design testing allosteric drugs ie drugs targeting different site complex interface enhanced bioactivity respect orthosteric drugs targeting proteinâprotein interaction interface <NUMBER> often tightly packed scarcely accessible field allosteric drugs rapidly developing field drug discovery may play crucial role therapeutic strategy sarscov<NUMBER> <NUMBER>â<NUMBER> study adopted multifaceted computational approach identify promising druggable allosteric sites viral protein first applied method protein contact networks pcns sace<NUMBER> complex sarscov<NUMBER> sarscov previous studies adopted method investigate proteinâprotein interactions <NUMBER>â<NUMBER> allosteric nature binding <NUMBER> <NUMBER> work application pcns clearly highlighted region sarscov sarscov<NUMBER> protein acts putative locus allosteric modulation amr amr investigated terms relevance stability complex ability transmit modulating signals binding site means independent computational approaches specifically adopted monomerbased approach <NUMBER> predict affinity protein ligand step ensembles ground state structures produced using anisotropic network model anm approach <NUMBER> moreover adopted unsupervised blind procedure predict possible interaction sites proteins affinities tentative partners using softnessbased prediction intersubunits affinity sepas addition dynamical difference rbd proteins two virus strains suggested may different binding allosteric properties also provided biophysical evidence based elastic network modeling enm approach combined perturbationresponse scanning prs <NUMBER> amrs viruses acted mediator intermolecular allostery protein ace<NUMBER> three methods converged allosteric character residues amr complexes allowed us state residues amr sarscov<NUMBER> amr susceptible allosteric drug targeting sarscov recent study <NUMBER> suggested many residues amr may one efficient epitopes antibody recognition preliminary docking studies individuated molecules bind amr hepcidin independently shown exhibit strong sequence similarities amr <NUMBER> analyzed structures consist following complex sarsspike glycoproteinhuman ace<NUMBER> complex stabilized variant ace<NUMBER>bound particles pdb code <NUMBER>cs<NUMBER> <NUMBER> termed sarscov sace<NUMBER> complex sarscov<NUMBER> analogous spike glycoproteinhuman ace<NUMBER> complex <NUMBER> purposed software used transform full structural information pdb files protein contact network pcn network nodes amino acid residues represented Î±carbons links nodes residues exist mutual distance residues centered Î±carbons range <NUMBER> <NUMBER> Ã¥ thus including significant <NUMBER> Ã¥ noncovalent <NUMBER> Ã¥ bonds discarding obliged contacts due proximity along sequence adjacency matrix mathematically represented pcn terms undirected unweighted network defined topological role nodes residues addressed functional role corresponding residues based value network descriptors method widely discussed elsewhere <NUMBER> basic network descriptor node degree k defined detect allosteric sites generally functional regions activating upon binding adopted method based network spectral clustering <NUMBER> <NUMBER> spectral clustering based laplacian matrix spectral decomposition laplacian matrix l defined degree matrix ie diagonal matrix whose diagonal degree vector spectral clustering based eigenvalue decomposition laplacian l sign fiedler vector eigenvector corresponding second minor eigenvalue used binary partition network parted two clusters turn could parted four outlined refs <NUMBER> <NUMBER> previously demonstrated network clusters group residues correspond functional regions protein <NUMBER> network nodes protein residues parted given number clusters independent userdefined parameter clustering software possible define participation coefficient p k si degree ith residue computed cluster belongs ie accounting links nodes pertaining cluster network descriptor demonstrated represent functional role residues binding stability <NUMBER> <NUMBER> <NUMBER> <NUMBER> residues high p value responsible communication clusters functional regions thus addressed via role allosteric communication <NUMBER> study participation coefficient maps projected onto ribbon protein structures heat maps highlight activating hotspots spikeace<NUMBER> complex participation coefficient maps visualized pymol httpspymolorg<NUMBER> characterized spike proteinace<NUMBER> interface means descriptors stemming structural information network analysis described â¢ interchain degree k ic defined node degree computed contacts nodes residues belonging different chains interface roughness qr <NUMBER> defined chain participating interface q number chain residues interface r sequence range chain residues interface â¢ interface amino acid range <NUMBER> iar rn n total number residues chain â¢ interface energy matrix e defined elastic network models enms provide efficient methods investigating intrinsic dynamics allosteric communication pathways proteins adopted two elastic network models <NUMBER> anisotropic network model anm <NUMBER> gaussian network model gnm anm <NUMBER> interaction potential protein n residues anm <NUMBER>n Ã <NUMBER>n hessian matrix h determined systems dynamics x z represented cartesian components ith residue v potential energy system selected r c <NUMBER> Ã¥ anms provide information amplitudes well direction residue fluctuations similarity two anm modes u k v l evaluated proteins two different conformations quantified terms inner product eigenvectors gnm <NUMBER> based description protein structure network c Î± connected springs uniform force constant Î³ located within cutoff distance r c gnm interaction potential protein n residues r ij <NUMBER> r ij equilibrium instantaneous distance residues j Î³ n Ã n kirchhoff matrix thus square fluctuations <NUMBER> normal modes extracted eigenvalue decomposition matrix Î³ uÎ»u u orthogonal matrix whose kth column u k kth mode eigenvector Î» diagonal matrix eigenvalues Î» k perturbation response scanning prs approach based linear response theory allowed evaluation residue displacements response external forces <NUMBER> study performed prs analysis based gnm constructing inverse laplacian matrix Î³ â<NUMBER> ndimensional vector Î´r node displacements response application perturbation ndimensional force vector f obeys hookes law f h â¢ Î´r purpose prs exert force given magnitude network one residue time f residues perturbed equal zero thus force exerted residue expressed <NUMBER> resulting response Î´r ndimensional vector described deformation residues response f metric response residue k magnitude â¨â¥Î´r k â¥ <NUMBER> â© kth block Î´r averaged multiple f expressed ikth element n Ã n prs matrix prs elements prs referred unit uniform perturbing force response unit deformation perturbation site obtained dividing row diagonal value k j j j j j j j j j j j z z z z z z z z z z z average effect perturbed effector site residues computed averaging sensors receivers residues j expressed â¨Î´r <NUMBER> â© sensor effector profile â¨Î´r <NUMBER> â© effector described average effect local perturbation effector site residues maxima along effector sensor profiles corresponded functional mobile residues underwent allosteric structural change crystallized structure presented one snapshot protein dynamic life bottom potential well created trajectory protein dynamics ground state setting rmsd cutoff <NUMBER> Ã¥ using anm <NUMBER> approach implemented prody <NUMBER> predict possible protein binding patches pbps spike proteins utilized ispred predict interface residues <NUMBER> ispredpredicted interface residues acted seed create possible pbp based procedure previously described <NUMBER> predictions monomerbased affinities based mechanical softness pbps performed utilizing sepas ver <NUMBER> <NUMBER> introduced ala mutations covidspike using foldx suite <NUMBER> computed general interface properties spike ace<NUMBER> complex using pisa software <NUMBER> figure <NUMBER>b chains also shown highlight chains participate two clusters figure <NUMBER>a interface fusion peptide ace<NUMBER> ectodomain strong terms number contacts viral host proteins clustering partition algorithm recognized fusionace<NUMBER> region single cluster even though comprised sequences belonging different chains map participation coefficient projected onto ribbon structure sarscovace<NUMBER> complex figure <NUMBER>c shows active region p <NUMBER> junction fusion peptide trimeric bulk phase spike protein active residues shown greater detail red figure <NUMBER>d previously demonstrated participation coefficient describes attitude residues toward participating intercommunication clusters thus putative score involvement residues allosteric communication therefore region good candidate intervene allosteric regulation complex formation value investigating allosteric drugs target portion protein figure <NUMBER> refers analogous analysis sarscov<NUMBER> sace<NUMBER> complex similar active region appeared junction fusion peptide body spike protein however active region sars cov sace<NUMBER> compact sarscov<NUMBER> sace<NUMBER> active regions complexes characterized two Î²sheets unfolded traits could thus targeted peptides due flexibility region absence pocket bind small organic molecules <NUMBER> table <NUMBER> reports values participation coefficient p residues p <NUMBER> located chain carrying fusion peptides sarscov sace<NUMBER> chain b cyan figure <NUMBER>a sarscov<NUMBER> sace<NUMBER> chain c magenta figure <NUMBER>a complexes sars cov sace<NUMBER> sarscov<NUMBER> sace<NUMBER> complexes accounted <NUMBER> <NUMBER> active residues respectively average value similar two distributions <NUMBER> sars cov sace<NUMBER> <NUMBER> sarscov<NUMBER> sace<NUMBER> however absolute values higher p residues <NUMBER> higher covid<NUMBER> sace<NUMBER> indicative corresponding larger reactivity active region characterization sace<NUMBER> interface table <NUMBER> reports properties interface sace<NUMBER> two complexes interface area absolute value energy sars cov sace<NUMBER> complex higher corresponding area sarscov<NUMBER> sace<NUMBER> complex however specific values unit area single residues higher sarscov<NUMBER> sace<NUMBER> indicating efficient yet less stable interface implied optimized complex formation ace<NUMBER> sarscov<NUMBER> observed ref <NUMBER> helped explain rapid kinetics infection mediated faster complex formation main receptor ace<NUMBER> rbds two proteins reported wide peptide comprised approximately <NUMBER> residues structures however limited core region termed receptor binding motif rbm claimed actively participate complex formation spike protein receptor ace<NUMBER> independently identified residues spike protein sarscov sarscov<NUMBER> using method pcns position value interchain degree reported table <NUMBER> complexes two residues two structures highest value interface degree <NUMBER>g sarscov <NUMBER>g sarscov<NUMBER> respectively two residues could considered hotspots ppi interface sace<NUMBER> complex glycine residues likely due high steric adaptability small glycine residues tightly packed region sace<NUMBER> interface confirmed high density interface extremely scarce accessibility small molecules targeting region also suggested need interfere ace<NUMBER> interface allosteric regulation previous sections amrs sace<NUMBER> complexes identified sarscov<NUMBER> sarscov using pcns approach table <NUMBER> amr accessible binding odds pbd one critical property protein complexes intersubunit affinity therefore besides sace<NUMBER> stability predicted affinity amr incomingdesigned molecule peptide molecules designed affect function amr crucial step provide independent proofofconcept allosteric features amr definition allosteric site must sense microenvironment druggability predicted amr reviewed need complete <NUMBER>d knowledge ace<NUMBER> complex means recently introduced method predict intersubunit affinity protein complexes using protein binding patch pbp single subunit computing pbp mechanical softness <NUMBER> alleviate static presentation protein structure crystallized state created ensembles protein complexes ground state using anm approach first step predicted affinity sarscov<NUMBER> sarscov proteins ace<NUMBER> compared predicted affinity protein ace<NUMBER> protein monomeric trimeric state obtain hints effect adjacent subunits affinity spike ligand figure <NUMBER> subunits chains denoted sa sb sc manage potential states spike protein propose different forms pbps protein â¢ sa subunit alone waiting partner left column figure <NUMBER> suppose sa may interact ace<NUMBER> using pbps similar ensemble ace<NUMBER> dimeric state first row figure <NUMBER> using pbps similar ones sa displays trimer spike ace<NUMBER> ensemble second row figure <NUMBER> â¢ subunit sa finds ace<NUMBER> binds directly right column figure <NUMBER> sa binds ace<NUMBER> via pbps displays either sb subunit available first row figure <NUMBER> association sb monomers second row figure <NUMBER> computations suggested sarscov<NUMBER> sa dark blue curves figure <NUMBER> sensitive presence sb subunit sarscov sa red curves figure <NUMBER> result suggested approaches potentially disrupted sasb association may provide efficient therapeutic route observed higher affinity ace<NUMBER> sarscov<NUMBER> sarscov observation may explain higher infectivity sarscov<NUMBER> interested predicting affinities possible pbps spike proteins tentative protein partners case know pbps spike proteins resolved <NUMBER>d structures possible protein complexes spike protein natural synthesized partners predicted seed interface residues spike surface using ispred approach <NUMBER> expanding selection radius defining pbp region <NUMBER> many possible pbps generated sarscov<NUMBER> sarscov spike proteins using sepas affinities generated pbps unknown partners predicted affinities averaged whole presented figure <NUMBER>a b sarscov<NUMBER> sarscov spikes respectively average affinities mapped surface spike proteins reported supporting information figures <NUMBER> <NUMBER> predicted regions affinity â<NUMBER> kcalmol resided interface region spike subunits residues proposed pbps belonged amr indicated red triangles figure <NUMBER> meant amr could act distinct pbp partners suggesting targeting amr may good choice drug design thus considering amr distinct pbp able <NUMBER> predict affinities amr unknown druglike protein partners simply using <NUMBER>d structure amr spike subunit different ensembles monomer case c figure <NUMBER>a <NUMBER> account effect ace<NUMBER> binding amr affinity possible partners assumed spike monomer association ace<NUMBER> predicted affinity amr possible partners dimer case dc figure <NUMBER>a <NUMBER> address effect sb spike chains affinity amr sa spike chain partners feeding sepas trimeric state spikes trimer case abc figure <NUMBER>a <NUMBER> analyze condition trimer spike ace<NUMBER> terms holocomplex sace<NUMBER> complex case abcd figure <NUMBER>a results indicated amr sarscov<NUMBER> spike exhibited higher affinity generic peptides amr sarscov spike interestingly affinity amr partners increased upon binding ace<NUMBER> suggested interplay two distant regions ace<NUMBER>binding site spike amr last result could considered another proofofconcept allosteric character amr predicted affinities spikes ace<NUMBER> presented affinity sarscov <NUMBER> spike blue curve sarscov spike red curve ace<NUMBER> predicted using sarscov <NUMBER>sarsxcby summarized state spike proteins affinity prediction x denotes number chain predictions x <NUMBER> means s<NUMBER> protein monomer form considered x <NUMBER> means s<NUMBER> ace<NUMBER> complex x <NUMBER> means whole spike complex ace<NUMBER> notes considered pbp computations <NUMBER> means pbps residues s<NUMBER> s<NUMBER>ace<NUMBER> complex used predict affinity <NUMBER> means pbps residues s<NUMBER> whole spike proteinsace<NUMBER> complex used predict affinity s<NUMBER> ace<NUMBER> horizontal axis presents predicted affinity kcalmol normalized density denotes yaxis journal proteome research pubsacsorgjpr article investigate effect induced structural perturbation amr binding affinity spike protein ace<NUMBER> introduced two sets ala mutations amr one set amr residues play major role allosteric modulation p <NUMBER> table <NUMBER> mutated ala set residues amr sarscov<NUMBER> sa mutated ala simulate sa perturbation used ensemble structures generated using anm approach setting rmsd cutoff <NUMBER> Ã¥ selecting normal mode states global perturbation distorts ace<NUMBER>binding site sa less <NUMBER> Ã¥ figure <NUMBER>b reported wildtype sa exhibits shoulder affinity density curve high affinity region observations suggested structural perturbation amr due ala mutation native residues decreased affinity sa ace<NUMBER> confirmation allosteric properties amr order explore amr druggability started recognizing strict structural similarity amr region hepcidin crucial protein iron regulation moreover recent preprint reported distant albeit relevant sequence similarity hepcidin sarscov<NUMBER> spike protein <NUMBER> established proof similarity hydrophobicity spectra ligandâ receptor pairs fostered observed sequence similarity hepcidin sarscov<NUMBER> sprotein <NUMBER> <NUMBER> moreover hepcidin strictly involved interleukin <NUMBER> il<NUMBER> regulation <NUMBER> given il<NUMBER> main actor associated cytokine storm linked fatalities provoked sarscov<NUMBER> infection <NUMBER> preliminary docking analysis showed perfect fit hepcidin amr region however must considered first step prioritize different peptides allosteric effectors addition characterization sace<NUMBER> interface comparison rbd dynamics sarscov sarscov<NUMBER> also important understand functional mechanism sace<NUMBER> interaction aim overlapping values slowest anm modes eigenvectors calculated compare intrinsic dynamics rbds proteins eq <NUMBER> materials methods figure <NUMBER>a dot products overlap values plotted map rbds sarscov versus sarscov<NUMBER> first <NUMBER> anm modes map upper limit <NUMBER> indicated perfect overlap red correspondent perfectly shared dynamics <NUMBER> indicated overlap blue figure <NUMBER> affinity possible pbps s<NUMBER> subunit spike tentative proteins predicted possible pbps defined s<NUMBER> subunit affinity pbps sarscov<NUMBER> sarscov b s<NUMBER> protein possible partners presented left vertical axis points averaged predicted affinity kcalmol proposed pbps right vertical axis denotes p metric table <NUMBER> amr participat residues xaxis notes residue pbps central residue red triangles represent position amr residues s<NUMBER> protein sequence figure <NUMBER> affinity amr tentative protein partners effect amr perturbation ace<NUMBER> affinity presented affinity kcal mol amr possible partners predicted s<NUMBER> monomer state c s<NUMBER> associated ace<NUMBER> stade dc s<NUMBER> accompanied two s<NUMBER> subunits state abc whole spike binds ace<NUMBER> state abcd b affinity s<NUMBER> ace<NUMBER> predicted amr intact wt residues amr p <NUMBER> mutated ala p <NUMBER> amr residues mutated ala p <NUMBER> affected region affinity density curve marked vertical gray arrow xaxis notes predicted affinity kcalmol vertical axis presents normalized density affinities indicating showed independent dynamics although rbds two complexes showed high structural similarity rmsd <NUMBER> Ã¥ overlap first <NUMBER> anm modes two rbds exhibited differences overlap values â¼<NUMBER> first three modes indicated weaker dynamical overlap even lowest frequencies endowed important functional meaning understand relative motions dynamics interface structures anm motions first mode two rbds shown figure <NUMBER>b c anm <NUMBER> interfacial residues stable blue peripheral loop exhibited highest fluctuation red relevant dynamical difference two systems referred loop motion sarscov rbd highest fluctuations point residues <NUMBER>d <NUMBER> k sarscov<NUMBER> rbd displayed higher flexibilities <NUMBER>g <NUMBER>p orange beads loop found located c terminal Î±<NUMBER> helix rbd interacting ace<NUMBER> van der waals forces hereinafter referred interfacial c loop suppose difference dynamics interfacial c loop may caused amino acid mutations respective interfaces ace<NUMBER> ie <NUMBER>y <NUMBER>l <NUMBER>l f <NUMBER>f <NUMBER>y <NUMBER>n <NUMBER>q sarscovrbd sarscov<NUMBER>rbd <NUMBER> thus mapped interfacial mutations onto structures yellow beads thus lower fluctuations mutations sarscov<NUMBER>rbd may account higher affinity interface accordingly despite overall structural similarity rbds two proteins showed different dynamics especially sace<NUMBER> interfaces differences dynamics may also indicate two sace<NUMBER> interfaces achieved activities including substrate binding allosteric regulation performed perturbation response scanning prs based gnm quantify allosteric properties amrs identify key residues perturbation provokes structural dynamical changes long distance first prs map provided information regarding sensitivity effectiveness given residue transmitting signals column matrix corresponding single residue eg r<NUMBER>v described wellconnected residue within amr region likely relevance transmitting allosteric signals distal parts sace<NUMBER> complex adapted method probe allosteric response amr region upon perturbation residues p <NUMBER> pcn prediction table <NUMBER> sace<NUMBER> complex sarscov dynamical changes residues amr red arrows figure <NUMBER>a caught due close distance space addition amr residues allosteric effects interfacial c loop high fluctuation effectiveness three residues p <NUMBER> almost identical reported figure <NUMBER>a case perturbation <NUMBER>s highest p value <NUMBER> appreciated three residues <NUMBER>v <NUMBER>n <NUMBER>s displayed longrange allosteric effects particular regions ace<NUMBER> sace interface residues relative amr sarscov<NUMBER> could classified three types according allosteric character first class included residues including <NUMBER>q <NUMBER>p <NUMBER>t <NUMBER>e <NUMBER>n <NUMBER>t <NUMBER>p upon perturbation residues exerted moderate dynamical effect amr residues relatively weak sensible intramolecular allosteric effect residues sace<NUMBER> interface especially highly flexible c loop perturbation amr residues largely affected dynamics ace<NUMBER> stronger longrange allosteric communications perturbation second type <NUMBER>n <NUMBER>l residues provokes large intermolecular allosteric effect rbd including peaks interfacial c loop figure <NUMBER>c addition perturbation weakened intermolecular communications amr ace<NUMBER> last type included <NUMBER>t exhibited similar dynamical effects three regions amr rbd ace<NUMBER> via longrange communications accordingly prs analysis provided important insight amr allostery among findings <NUMBER> residues sarscov amr <NUMBER> residues sarscov<NUMBER> amr predicted wideranging allosteric effects ace<NUMBER> protein result conjunction statistically significant higher effectiveness sarscov<NUMBER> amr perturbation si figure <NUMBER> suggested allosteric character stronger amr sarscov notably complexes interfacial c loop formed bridge transmit signal amr ace<NUMBER> reported rbdace<NUMBER> interfacial mutations sarscov sarscov<NUMBER> close interfacial c loop therefore propose different allosteric properties amr residues due mutations sace<NUMBER> interface figure s<NUMBER> box plot shows amr sarscov<NUMBER> statistically higher effectiveness sarscov pvalue <NUMBER> Ã <NUMBER> â<NUMBER> wilcoxon signedranked test application pcns sepas affinity flexibility prs based elastic network modes two complexes spike protein receptor ace<NUMBER> generated highly consistent results integrated computational approach disclosed active zones sarscov sarscov<NUMBER> complexes ace<NUMBER> ectodomain active zones demonstrated previous studies <NUMBER> <NUMBER> <NUMBER> present research convergence among different approaches extremely high probability acting allosteric sites modulate spikeace<NUMBER> protein binding regions worthy investigation perspective drug vaccine development indicated preliminary docking simulation methodological perspective results highlighted need identify convergence different simulation methods arising independent theoretical premises order obtain reliable picture associated biomolecular systems supporting information available free charge httpspubsacsorgdoi<NUMBER>acsjproteome<NUMBER>c<NUMBER> figure s<NUMBER> affinity sarscov sace<NUMBER> complex figure s<NUMBER> affinity sarscov<NUMBER> sace<NUMBER> complex figure s<NUMBER> wilcox test effectiveness pdf coronaviruses covs caused major outbreak human fatal pneumonia since beginning <NUMBER>st century severe acute respiratory syndrome coronavirus sarscov broke spread five continents <NUMBER> lethal rate <NUMBER> <NUMBER> <NUMBER> merscov broke arabian peninsula <NUMBER> fatality rate <NUMBER> <NUMBER> <NUMBER> sarscov merscov zoonotic viruses hosts batcivet dromedary respectively <NUMBER> <NUMBER> date specific therapeutic drug vaccine approved treatment human coronavirus therefore covs considered kind viruses outbreak poses huge threat humans wuhan viral pneumonia cases discovered end <NUMBER> coronavirus named <NUMBER> novel coronavirus <NUMBER>ncov world health organization january <NUMBER> <NUMBER> <NUMBER> <NUMBER> since <NUMBER>ncov highly homologous sarscov considered close relative sarscov international virus classification commission ictv classified <NUMBER>ncov severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> february <NUMBER> <NUMBER> time named disease caused <NUMBER>ncov covid<NUMBER> common symptoms person infected coronavirus include respiratory symptoms fever cough shortness breath dyspnea severe cases infection cause pneumonia severe acute respiratory syndrome kidney failure even death currently specific medicine treatment diseases caused sarscov<NUMBER> <NUMBER> covs enveloped viruses positive rna genome belonging coronaviridae family order nidovirales divided four genera Î± Î² Î³ Î´ sarscov<NUMBER> belongs Î² genus covs contain least four structural proteins spike protein envelope e protein membrane protein nucleocapsid n protein <NUMBER> among spike promotes host attachment viruscell membrane fusion virus infection therefore spike determines extent host range potential anticoronavirus therapies divided two categories depending target one acting human immune system human cells coronavirus terms human immune system innate immune system response plays important role controlling replication infection coronavirus interferon expected enhance immune response <NUMBER> blocking signal pathways human cells required virus replication may show certain antiviral effect addition viruses often bind receptor proteins surface cells order entering human cells example sars virus binds angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> mers binds dpp<NUMBER> receptor <NUMBER> <NUMBER> therapies acting coronavirus include preventing synthesis viral rna acting genetic material virus inhibiting virus replication acting critical enzymes virus blocking virus binding human cell receptors inhibiting viruss selfassembly process acting structural proteins fight coronavirus scientists come three strategies developing new drugs <NUMBER> first strategy test existing broadspectrum antivirals <NUMBER> interferons ribavirin cyclophilin inhibitors used treat coronavirus pneumonia fall category advantages therapies metabolic characteristics dosages used potential efficacy side effects clear approved treating viral infections disadvantage therapies broadspectrum cannot kill coronaviruses targeted manner side effects underestimated second strategy use existing molecular databases screen molecules may therapeutic effect coronavirus <NUMBER> <NUMBER> highthroughput screening makes strategy possible new functions many drug molecules found strategy example discovery antihiv infection drug lopinavirritonavir third strategy directly based genomic information pathological characteristics different coronaviruses develop new targeted drugs scratch theoretically drugs found therapies would exhibit better anticoronavirus effects research procedure new drug might cost several years even <NUMBER> years <NUMBER> development medicines treating sarscov<NUMBER> fastest way find potential molecules marketed drugs efficacy determined approved green channel approved hospital ethics committee rapid clinical treatment patients herein bioinformatics analysis proteins encoded novel coronavirus genes systematically conducted proteins sarscov<NUMBER> compared coronaviruses sarscov merscov conducted homology modeling build possible protein structures including viral papain like protease plpro main protease <NUMBER>clpro also named <NUMBER>chymotrypsinlike protease rnadependent rna polymerase rdrp helicase spike etc used proteins human relative proteins human ace<NUMBER> typeii transmembrane serine protease tmprss<NUMBER> enzymes targets screen zinc u food drug administration fdaapproved drug database zinc drug database zdd database traditional chinese medicine natural products including reported common antiviral components traditional chinese medicine database commonly used antiviral drugs <NUMBER> compounds virtual ligand screening method study predicts variety compounds may inhibit novel coronaviruses provides scientists information compounds may effective subsequent validation antiviral effects vitro vivo provide useful information clinical treatment novel coronavirus pneumonia complete genome wuhanhu<NUMBER> nc<NUMBER> downloaded ncbi nucleotide database nucleotide sequences aligned whole database using blastn search homology viral genomes alogorithm parameters max target sequences <NUMBER> expect threshold <NUMBER> obtained sarscov<NUMBER> genome gene bank genome sequence wuhanhu<NUMBER> aligned whole database using blastn search homology viral genomes phylogenetic analysis sequence alignment <NUMBER> coronaviruses various species found three coronaviruses bat <NUMBER> <NUMBER> <NUMBER> batcov ratg<NUMBER> batslcovzxc<NUMBER> batslcovzc<NUMBER> respectively highest genome sequence identity sarscov<NUMBER> fig <NUMBER>a moreover shown fig helicase new coronavirus structure biology study proteins still early stage one crystal structure <NUMBER>clpro deposited pdb pdb code <NUMBER>lu<NUMBER> order acquire threedimensional structure information proteins new coronaviruses subsequent drug screening aligned protein sequences sarscov<NUMBER> sequences pdb<NUMBER> database fold function assignment system supporting information figs s<NUMBER>s<NUMBER> fortunately proteins found high homology proteins threedimensional structure homology <NUMBER> supporting information table s<NUMBER> pdb codes labeled corresponding sequences fig <NUMBER>b unsurprisingly proteins highest homology sars nevertheless proteins still high homologous database prediction transmembrane helices proteins carried tmhmm server expected found proteins transmembrane proteins except nsp<NUMBER> supporting information figs s<NUMBER>s<NUMBER> far found much structural information viral proteins possible provides basis subsequent homology modeling drug screening homology modeling proteins sequences aligned model sequences derived sarscov predicted secondary structure time fig <NUMBER>a table s<NUMBER> interestingly shown fig <NUMBER>a important antivirus drug target protein like <NUMBER>clpro plpro rdrp highly conserved two human coronaviruses especially functional region shown table s<NUMBER> potential drug target proteins homologously modeled generated protein models provided pdb files supporting information coordinates targetscreening hit complexes provided upon request order verify accuracy homologous modeling aligned computational structure sarscov<NUMBER> <NUMBER>clpro modeled sarscov <NUMBER>clpro crystal structure sarscov<NUMBER> <NUMBER>clpro <NUMBER>lu<NUMBER> solved released manuscript prepared sequence sarscov<NUMBER> sarscov <NUMBER> fig <NUMBER>c recent researches speculated sarscov<NUMBER> could also bind ace<NUMBER> verified computational docking elisa measurement <NUMBER> <NUMBER> moreover homology spikerbd sequence sarscov<NUMBER> batcov ratg<NUMBER> high <NUMBER> despite high homology ratg<NUMBER> sarscov<NUMBER> spike sequence analysis found four among five important amino acids l<NUMBER> l<NUMBER> y<NUMBER> d<NUMBER> h<NUMBER> bind ace<NUMBER> <NUMBER> batcov ratg<NUMBER> differ sarscov<NUMBER> fig <NUMBER>c related research literature whether batcov ratg<NUMBER> infect human yet also performed homology modeling batcov ratg<NUMBER> spike rbd supporting information fig s<NUMBER> three spike rbd structures docked human ace<NUMBER> among conformations resemble crystal structure sars rbdace<NUMBER> complex <NUMBER> binding free energy sarscov<NUMBER> spike rbd human ace<NUMBER> <NUMBER> kcalmol supporting information fig s<NUMBER> sarscov spike rbd ace<NUMBER> <NUMBER> kcalmol supporting information fig s<NUMBER> batcov ratg<NUMBER> spike rbd ace<NUMBER> <NUMBER> kcalmol supporting information fig s<NUMBER> therapies act coronavirus divided several categories based specific pathways <NUMBER> acting enzymes functional proteins critical virus preventing virus rna synthesis replication <NUMBER> acting structural proteins virus blocking virus binding human cell receptors inhibiting viruss selfassembly process <NUMBER> producing virulence factor restore hosts innate immunity <NUMBER> acting hosts specific receptors enzymes preventing virus entering hosts cells related target proteins include nsp<NUMBER> nsp<NUMBER> nsp<NUMBER>b nsp<NUMBER>c plpro nsp<NUMBER>e based homology models <NUMBER> viral proteins <NUMBER> models <NUMBER> human targets resorted structurebased virtual ligand screening method using icm <NUMBER> modeling software molsoft llc screen potential smallmolecule compounds zinc drug database <NUMBER> compounds small inhouse database traditional chinese medicine natural products including reported common antiviral components traditional chinese medicine derivatives <NUMBER> compounds compounds lower calculated binding energies expressed scores mfscores considered higher binding affinities target protein  plpro responsible cleavages nterminus replicase polyprotein release nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> essential correcting virus replication <NUMBER> plpro also confirmed significant antagonize hosts innate immunity <NUMBER> <NUMBER> <NUMBER> indispensable enzyme process coronavirus replication infection host plpro popular target coronavirus inhibitors valuable targeting plpro treat coronavirus infections inhibitor approved fda marketing screening results table <NUMBER> antiviral drug ribavirin predicted bind plpro low binding energy scores<NUMBER> generated docking model ribavirin bound active site enzyme reported sarsplpro inhibitors pdb code <NUMBER>e<NUMBER>s hydrogen bonds predicted gly<NUMBER> gln<NUMBER> tyr<NUMBER> asp<NUMBER> compound also ÏÏ stacking found tyr<NUMBER> triazolering compound fig <NUMBER>a b strong hydrogen bonding hydrophobic interaction ribavirin enzyme imply may potent plpro inhibitor <NUMBER>clpro also known nsp<NUMBER> first automatically cleaved polyproteins produce mature enzymes cleaves downstream nsps <NUMBER> sites release nsp<NUMBER>nsp<NUMBER> <NUMBER> <NUMBER>clpro directly mediates maturation nsps essential life cycle virus detailed investigation structure catalytic mechanism <NUMBER>clpro makes <NUMBER>clpro attractive target anticoronavirus drug development inhibitors targeting sarscov <NUMBER>clpro mainly include peptide inhibitors smallmolecule inhibitors <NUMBER> <NUMBER>clpro monomer three domains domain residues <NUMBER> domain ii residues <NUMBER> domain iii residues <NUMBER> long loop residues <NUMBER> connects domains ii iii active site <NUMBER>clpro located gap domains ii cyshis catalytic dyad cys<NUMBER> his<NUMBER> <NUMBER> shown table <NUMBER> supporting excel file <NUMBER>clproxlsx antibacterial drugs lymecycline demeclocycline doxycycline oxytetracycline antihypertensive drugs nicardipine telmisartan conivaptan treating hyponatremia show highest binding affinity <NUMBER>clpro several natural compounds derivatives antivirus antiinflammatory effects also exhibited high binding affinity <NUMBER>clpro table <NUMBER> supporting excel file <NUMBER>clpronpxlsx including series andrographolide derivatives chrysin<NUMBER>oÎ²glucuronide scutellaria baicalensis betulonal cassine xylocarpa <NUMBER>Î²hydroxy<NUMBER>secofriedelolactone<NUMBER>oic acid isodecortinol cerevisterol viola diffusa hesperidin neohesperidin citrus aurantium kouitchenside deacetylcentapicrin plants swertia genus results suggest smallmolecule compounds might potential <NUMBER>clpro inhibitors could probably used treating sarscov<NUMBER> worth mentioning antiasthmatic drug montelukast also showed low binding energy <NUMBER>clpro shown fig <NUMBER>a montelukast well fitted active pocket <NUMBER>clpro lots hydrophobic amino acids like thr<NUMBER> leu<NUMBER> his<NUMBER> phe<NUMBER> cys<NUMBER> his<NUMBER> met<NUMBER> pro<NUMBER> his<NUMBER> compose relatively hydrophobic environment contain compound stabilize conformation hydrogen bonding predicted asn<NUMBER> carbonyl group compound fig <NUMBER>b dna rna along <NUMBER>â²<NUMBER>â² direction ntpdependent manner <NUMBER> importantly reported sarsnsp<NUMBER> sequence conserved indispensable necessary component replication coronavirus therefore identified target antiviral drug discovery reports nsp<NUMBER> inhibitors <NUMBER> <NUMBER> based structure modeling helicase protein antibacterial drugs lymecycline cefsulodine rolitetracycline antifungal drug itraconazole antihuman immunodeficiency virus<NUMBER> hiv<NUMBER> drug saquinavir anticoagulant drug dabigatran diuretic drug canrenoic acid predicted helicase inhibitors high mfscores virtual ligand screening natural products many flavanoids different sources Î±glucosyl hesperidin hesperidin rutin quercetagetin <NUMBER>oÎ²dglucopyranoside homovitexin showed high binding affinity target besides targets nonstructural proteins including nsp<NUMBER>b nsp<NUMBER>e nsp<NUMBER>nsp<NUMBER> complex nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> also play important role virus rna synthesis replication suggesting proteins may useful targets antiviral drug discovery virtual screening results showed many antibacterial antiviral antiinflammatory drugs zinc drug database inhouse natural productsderivatives database displayed potential good affinity targets detailed information virtual screening results shown supporting excel files zdd screening results file names targetxlsx natural products screening results file names targetnpxlsx spike main structural protein coronavirus assembles special corolla structure surface virus trimer spike main protein interacts host binding host cell receptors mediate virus invasion determine viral tissue host tropism <NUMBER> spike cleaved s<NUMBER> s<NUMBER> host cell protease like tmprss<NUMBER> etc main function s<NUMBER> bind host cell surface receptors however compounds predicted bind binding interface spikeace<NUMBER> complex compound could target binding interface spike ace<NUMBER> hesperidin shown fig <NUMBER>a hesperidin predicted lie middle shallow pit surface rbd spike dihydroflavone part compound went parallel Î²<NUMBER> sheet rbd sugar part inserted shallow pit direction away ace<NUMBER> hydrophobic amino acids including tyr<NUMBER> try<NUMBER> leu<NUMBER> phe<NUMBER> phe<NUMBER> try<NUMBER> try<NUMBER> tyr<NUMBER> form relatively hydrophobic shallow pocket contain compound fig <NUMBER>b hydrogen bonding predicted tyr<NUMBER> compound superimposing ace<NUMBER>rbd complex hesperidinrbd complex distinct overlap hesperidin interface ace<NUMBER> could observed fig <NUMBER>c suggesting hesperidin may disrupt interaction ace<NUMBER> rbd except spike protein e protein echannel possesses important biological functions structural integrity coronavirus host virulence nrbd crbd coronavirus n protein needed n proteins host cells bind coronavirus rna efficiently therefore e protein n protein nrbd crbd domains used targets discovery antiviral drugs virtual screening many antibacterial antiviral antitumor antiasthmatic antiinflammatory drugs etc zinc database inhouse natural productsderivatives database found display relatively good affinity targets detailed results virtual screening given supplementary excel files three coronavirus virulence factors nsp<NUMBER> nsp<NUMBER>c orf<NUMBER>a related interfering hosts innate immunity assisting coronavirus immune escape nsp<NUMBER> interacts host <NUMBER>s ribosomal subunit induces specifically host mrna degradation <NUMBER> also inhibits typei interferon production <NUMBER> nsp<NUMBER>c ability bind hosts adpribose help coronavirus resist host innate immunity <NUMBER> bone marrow matrix antigen <NUMBER> bst<NUMBER> inhibit release newlyassembled coronavirus host cells sarscov orf<NUMBER>a directly binds bst<NUMBER> inhibits activity blocking glycosylation bst<NUMBER> <NUMBER> evidences suggest nsp<NUMBER> nsp<NUMBER>c orf<NUMBER>a may potential targets antiviral drug discovery detailed screening results nsp<NUMBER> nsp<NUMBER>c orf<NUMBER>a showed series clinical drugs natural products antibacterial antiinflammatory effects exhibited relatively high binding affinity three target proteins piperacillin cefpiramide streptomycin lymecycline tetracycline platycodin platycodon grandifloras wogonoside scutellaria baicalensis vitexin vitex negundo andrographolide derivatives xanthones swertia genus detailed results virtual screening shown supporting excel files host ace<NUMBER> proved many studies specific receptor spike rbd sarscov <NUMBER> latest research shows host receptor sarscov<NUMBER> consistent sarscov exhibiting spike rbd sequence sarscov<NUMBER> similar sarscov rbd important interactions several key amino acid residues rbd receptorbinding motif ace<NUMBER> <NUMBER> based current research progress ace<NUMBER> considered host target treatment coronavirus infection block sarscov<NUMBER> entering host cells based virtual screening results ace<NUMBER> protein antidiabetes drug troglitazone antihypertensive drug losartan analgesia drug ergotamine antibacterial drug cefmenoxime hepatoprotective drug silybin etc predicted bind ace<NUMBER> low energy natural products phyllaemblicin g<NUMBER> phyllanthus emblica xanthones plants swertiagenus neohesperidin hesperidin citrus aurantium exhibited potentially high binding affinity ace<NUMBER> protein however none ace<NUMBER> binding compounds predicted target ace<NUMBER>rbd interface addition tmprss<NUMBER> known cut spike trigger infection sarscov merscov studies shown inhibiting enzyme activity tmprss<NUMBER> prevent coronaviruses entering host cells <NUMBER> possible target antiviral drug discovery virtual screen results shown supporting excel files predicted many antibacterial drugs pivampicillin hetacillin cefoperazone clindamycin antivirus natural compounds phyllaemblicin g<NUMBER> neoandrographolide kouitchenside etc potential tmprss<NUMBER> inhibitors order verify screening results zinc drug database utilize current resource antiviral drugs immediately constructed database <NUMBER> antiviral drugs deep calculation including compounds already market currently undergoing clinical trials treat sarscov<NUMBER> infections rdrp inhibitor gpcn<NUMBER> <NUMBER> binding pocket remdesivir bottom rna template channel position acceptor template nucleotide fig <NUMBER>a b compound well fitted shape pocket formed three hydrogen bonds asn<NUMBER> arg<NUMBER> asp<NUMBER> addition hydrophobic interactions leu<NUMBER> ala<NUMBER> tyr<NUMBER> may direct favorite conformation remdesivir fig <NUMBER>c interestingly remdesivir predicted bind target tmprss<NUMBER> low binding energy score mfscore shown fig <NUMBER>a remdesivir bound relatively positivelycharged allosteric pocket far away enzyme active center asn<NUMBER> arg<NUMBER> formed two hydrogen bonds phosphate groups compound weak hydrophobic interaction pyrrolotriazine ring remdesivir tyr<NUMBER> try<NUMBER> side chains polar amino acids may stabilize compound conformation fig <NUMBER>b also performed longitudinal analysis drugs <NUMBER> targets results showed tenofovir disoproxil fumarate beclabuvir may bind nsp<NUMBER> fewer compounds predicted act targets nsp<NUMBER> nsp<NUMBER>e nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nrbd crbd orf<NUMBER>a tmprss<NUMBER> showing selected antiviral drugs unlikely acting targets new coronavirus provides meaningful reference future research targets nsp<NUMBER>b nsp<NUMBER>c nsp<NUMBER>nsp<NUMBER> complex nsp<NUMBER> nsp<NUMBER> plpro <NUMBER>clpro rdrp helicase echannel spike ace<NUMBER> antiviral drugs predicted bind especially echannel rdrp <NUMBER>clpro plpro indicating targets likely useful discovery sarscov<NUMBER> therapeutic drugs known antivirals focus subsequent research ongoing sarscov<NUMBER> epidemic makes us painfully realize current targets difficult find direct inhibitors nondruggable targets like nsp<NUMBER> nsp<NUMBER>b nsp<NUMBER>c echannel etc currently popular protac technology may good strategy degrade proteins inhibit virus potential binding compounds found study targets might good start point spike protein found one compound natural hesperidin targeting binding spike rbd human ace<NUMBER> however like ace<NUMBER> binding compounds noninterface binding compound may still meaningful applications considering fusion covs membrane host cell membrane need big conformational change remained spike part rbd removal <NUMBER> small molecule bound spike time may interfere refolding spike therefore inhibits viral infection process furthermore small molecule target part spike protein may good start point design protac based therapy also dock existing antiviral drugs targets analyze possible targets antiviral drug horizontally analyze drugs may interact <NUMBER> targets vertically analyzed <NUMBER> targets based docking results found nsp<NUMBER>b nsp<NUMBER>c nsp<NUMBER>nsp<NUMBER> complex nsp<NUMBER> nsp<NUMBER> plpro <NUMBER>clpro rdrp helicase echannel spike ace<NUMBER> likely therapeutic targets antiviral drugs three targets nsp<NUMBER>b nsp<NUMBER>c echannel screened antiviral drugs may due model problem flexible small protein nsp<NUMBER>b nsp<NUMBER>c partial model echannel whether screened antiviral drugs really work targets needs verification also recommend application new coronavirus pneumonia compounds target predicted triphosphate nucleotide product remdesivir remdesivirtp competes rdrp substrate atp interfere viral rna synthesis docking results show remdesivirtp binds sarscov<NUMBER> rdrp score <NUMBER> docking results consistent original antiviral mechanism think remdesivir may good treating sarscov<NUMBER> pneumonia addition remdesivir also predicted bind human tmprss<NUMBER> protein facilitating virus infection new discovery provides ideas subsequent research chloroquine phosphate shown better antisarscov<NUMBER> effects recent studies drug clear target action docking results chloroquine phosphate predicted possibly combine nsp<NUMBER>b echannel need experiments verify conclusion  coronaviruses covs caused major outbreak human fatal pneumonia since beginning <NUMBER>st century severe acute respiratory syndrome coronavirus sarscov broke spread five continents <NUMBER> lethal rate <NUMBER> <NUMBER> middle east respiratory syndrome coronavirus merscov broke arabian peninsula <NUMBER> fatality rate <NUMBER> <NUMBER> <NUMBER> sarscov merscov zoonotic viruses hosts batcivet dromedary respectively <NUMBER> <NUMBER> date specific therapeutic drug vaccine approved treatment human coronavirus therefore covs considered kind viruses outbreak poses huge threat humans novel coronavirus found end <NUMBER> named <NUMBER> novel coronavirus <NUMBER>ncov world health organization january <NUMBER> <NUMBER> <NUMBER> <NUMBER> since <NUMBER>ncov highly homologous sarscov considered close relative sarscov international virus classification commission ictv classified <NUMBER>ncov severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> february <NUMBER> <NUMBER> time named disease caused <NUMBER>ncov covid<NUMBER> common symptoms person infected coronavirus include respiratory symptoms fever cough shortness breath dyspnea severe cases infection cause pneumonia severe acute respiratory syndrome kidney failure even death currently specific medicine treatment diseases caused sarscov<NUMBER> <NUMBER> covs enveloped viruses positive rna genome belonging coronaviridae family order nidovirales divided four genera b g sarscov<NUMBER> belongs b genus covs contain least four structural proteins spike protein envelope e protein membrane protein nucleocapsid n protein <NUMBER> among spike promotes host attachment virusecell membrane fusion virus infection therefore spike determines extent host range potential anticoronavirus therapies divided two categories depending target one acting human immune system human cells coronavirus terms human immune system innate immune system response plays important role controlling replication infection coronavirus interferon expected enhance immune response <NUMBER> blocking signal pathways human cells required virus replication may show certain antiviral effect addition viruses often bind receptor proteins surface cells order entering human cells example sars virus binds angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER>e<NUMBER> mers binds dpp<NUMBER> receptor <NUMBER> <NUMBER> therapies acting coronavirus include preventing synthesis viral rna acting genetic material virus inhibiting virus replication acting critical enzymes virus blocking virus binding human cell receptors inhibiting viruss selfassembly process acting structural proteins fight coronavirus scientists come three strategies developing new drugs <NUMBER> first strategy test existing broadspectrum antivirals <NUMBER> interferons ribavirin cyclophilin inhibitors used treat coronavirus pneumonia fall category advantages therapies metabolic characteristics dosages used potential efficacy side effects clear approved treating viral infections disadvantage therapies broadspectrum cannot kill coronaviruses targeted manner side effects underestimated second strategy use existing molecular databases screen molecules may therapeutic effect coronavirus <NUMBER> <NUMBER> highthroughput screening makes strategy possible new functions many drug molecules found strategy example discovery antihiv infection drug lopinavirritonavir third strategy directly based genomic information pathological characteristics different coronaviruses develop new targeted drugs scratch theoretically drugs found therapies would exhibit better anticoronavirus effects research procedure new drug might cost several years even <NUMBER> years <NUMBER> development medicines treating sarscov<NUMBER> fastest way find potential molecules marketed drugs efficacy determined approved green channel approved hospital ethics committee rapid clinical treatment patients herein bioinformatics analysis proteins encoded novel coronavirus genes systematically conducted proteins sarscov<NUMBER> compared coronaviruses sarscov merscov conducted homology modeling build possible protein structures including viral papain like protease plpro main protease <NUMBER>clpro also named <NUMBER>chymotrypsinlike protease rnadependent rna polymerase rdrp helicase spike etc used proteins human relative proteins human ace<NUMBER> typeii transmembrane serine protease tmprss<NUMBER> enzymes targets screen zinc u food drug administration fdaapproved drug database zinc drug database zdd database traditional chinese medicine natural products including reported common antiviral components traditional chinese medicine database commonly used antiviral drugs <NUMBER> compounds virtual ligand screening method study predicts variety compounds may inhibit novel coronaviruses provides scientists information compounds may effective subsequent validation antiviral effects vitro vivo provide useful information clinical treatment novel coronavirus pneumonia complete genome sarscov<NUMBER>whu<NUMBER> mn<NUMBER> downloaded ncbi nucleotide database thenucleotide sequences aligned whole database using blastn search homology viral genomesalogorithm parameters max target sequences <NUMBER> expect threshold <NUMBER> nucleotide sequence editing conducted using bioedit dnaman sequence alignment conducted using dnaman clustaiw evolutionary history inferred using neighborjoining method mega seven software package percentage replicate trees associated taxa clustered together bootstrap test determined <NUMBER> replicates protein sequence management analysis carried using snap gene view sequence alignment performed using clustalw method jalview software second structure protein sequences predicted jpred<NUMBER> homology model prediction carried searching pdb<NUMBER> database included fold function assignment system ffasgodziklaborg <NUMBER> prediction transmembrane helices proteins carried tmhmm server v <NUMBER> online httpwwwcbsdtudkservicestmhmm <NUMBER>d structure structures aligned pymol structure alignment tool approved drug database subset zinc database zdd zinc drug database containing <NUMBER> compounds <NUMBER> natural products database constructed containing <NUMBER> chemicals separated traditional chinese herbals laboratory naturally occurring potential antiviral components derivatives antiviral compounds library contains <NUMBER> known antiviral drugs reported antiviral compounds literature search corresponding homology models predicted fold function assignment system server target protein downloaded protein data bank wwwrcsborg alignment two protein sequences subsequent homology modeling performed bioinformatics module icm <NUMBER> modeling software intel i<NUMBER> <NUMBER> processor molsoft llc san diego ca usa structurebased virtual screening ligands continuously resiliently made dock target represented potential energy maps icm <NUMBER> software identify possible drug candidates <NUMBER>d compounds database scored according internal coordinate mechanics internal coordinate mechanics icm <NUMBER> based monte carlo method stochastic global optimization procedure pseudobrownian positionaltorsional steps position intrinsic molecular optimized visually inspecting compounds outside active site well weakly fitting active site eliminated compounds scores less Ã <NUMBER> mfscores less Ã <NUMBER> generally represents strong interactions priority selected proteineprotein docking followed manual icm software obtained sarscov<NUMBER> genome gene bank genome sequence sarscov<NUMBER>whu<NUMBER> aligned whole database using blastn search homology viral genomes phylogenetic analysis sequence alignment <NUMBER> coronaviruses various species found three coronaviruses bat <NUMBER> <NUMBER> <NUMBER> batcov ratg<NUMBER> batslcovzxc<NUMBER> batslcovzc<NUMBER> respectively highest genome sequence identity sarscov<NUMBER> fig <NUMBER>a moreover shown fig <NUMBER>b batcov ratg<NUMBER> exhibited closest linkage sarscov<NUMBER> among coronaviruses human sarscov <NUMBER> exhibited highest genome sequence identity sarscov<NUMBER> mersisolate nl<NUMBER> also <NUMBER> identity sarscov<NUMBER> sarscov clearly studied one among viruses according previous literatures structure function genome encoded proteins elucidated recent years study high genome identity sarscov<NUMBER> sarscov structure function prediction sarscov<NUMBER> genome encoded protein mainly based researches homology protein sarscov sarscov<NUMBER> genome <NUMBER> open reading frames fig <NUMBER>a orf<NUMBER>ab encodes replicase polyprotein <NUMBER> ab cleaved two proteases replicase proteins showed multifunction involved transcription replication viral rnas orf<NUMBER> encodes viral structural proteins n e proteins auxiliary proteins e proteins involved formation viral coat n protein involved packaging rna genome fig <NUMBER>c aligning amino acid sequence sars pp<NUMBER>ab analyzing characteristics restriction cleavage sites recognized <NUMBER>clpro plpro speculated <NUMBER> specific proteolytic sites <NUMBER>clpro plpro sarscov<NUMBER> pp<NUMBER>ab fig <NUMBER>b plpro cleaves three sites <NUMBER>e<NUMBER> <NUMBER>e<NUMBER> <NUMBER>e<NUMBER> nterminus <NUMBER>clpro cuts <NUMBER> sites cterminus forming <NUMBER> nonstructural proteins among nsp<NUMBER> contains multiple domains including segment sars unique domain deubiquitination proteolytic enzyme plpro nsp<NUMBER> <NUMBER>clpro nsp<NUMBER> rdrp analysis therapeutic targets sarscov<NUMBER> nsp<NUMBER> helicase new coronavirus structure biology study proteins still early stage one crystal structure <NUMBER>clpro deposited pdb pdb code <NUMBER>lu<NUMBER> order acquire threedimensional structure information proteins new coronaviruses subsequent drug screening aligned protein sequences sarscov<NUMBER> sequences pdb<NUMBER> database fold function assignment system supporting information figs s<NUMBER>es<NUMBER> fortunately proteins found high homology proteins threedimensional structure homology <NUMBER>e<NUMBER> supporting information table s<NUMBER> pdb codes labeled corresponding sequences fig <NUMBER>b unsurprisingly proteins highest homology sars nevertheless proteins still high homologous database prediction transmembrane helices proteins carried tmhmm server expected found proteins transmembrane proteins except nsp<NUMBER> supporting information figs s<NUMBER>es<NUMBER> far found much structural information viral proteins possible provides basis subsequent homology modeling drug screening homology modeling proteins sequences aligned model sequences derived sarscov predicted secondary structure time fig <NUMBER>a table s<NUMBER> interestingly shown fig <NUMBER>a important antivirus drug target protein like <NUMBER>clpro plpro rdrp highly conserved two human coronaviruses especially functional region shown table s<NUMBER> potential drug target proteins homologously modeled generated protein models provided pdb files supporting information coordinates targetscreening hit complexes provided upon request order verify accuracy homologous modeling aligned computational structure sarscov<NUMBER> <NUMBER>clpro modeled sarscov <NUMBER>clpro crystal structure sarscov<NUMBER> <NUMBER>clpro <NUMBER>lu<NUMBER> solved released manuscript prepared computational model sarscov<NUMBER> <NUMBER>clpro showed ca rmsd <NUMBER> Ã¥ overall structure compared sarscov<NUMBER> <NUMBER>clpro structure fig <NUMBER>b whats ca rmsd substrate binding regions <NUMBER> Ã¥ showing subtle difference ace<NUMBER> molecule known human entry receptor spike facilitates crossspecies transmission sequence alignment results show homology spikereceptor binding domain rbd sequence sarscov<NUMBER> sarscov <NUMBER> fig <NUMBER>c recent researches speculated sarscov<NUMBER> could also bind ace<NUMBER> verified computational docking elisa measurement <NUMBER> <NUMBER> moreover homology spikerbd sequence sarscov<NUMBER> batcov ratg<NUMBER> high <NUMBER> despite high homology ratg<NUMBER> sarscov<NUMBER> spike sequence analysis found four among five important amino acids l<NUMBER> l<NUMBER> y<NUMBER> d<NUMBER> h<NUMBER> bind ace<NUMBER> <NUMBER> batcov ratg<NUMBER> differ sarscov<NUMBER> fig <NUMBER>c related research literature whether batcov ratg<NUMBER> infect human yet also performed homology modeling batcov ratg<NUMBER> spike rbd supporting information fig s<NUMBER> three spike rbd structures docked human ace<NUMBER> among conformations resemble crystal structure sars rbdeace<NUMBER> complex <NUMBER> binding free energy sarscov<NUMBER> spike rbd human ace<NUMBER> Ã <NUMBER> kcalmol supporting information fig s<NUMBER> sarscov spike rbd ace<NUMBER> Ã <NUMBER> kcalmol supporting information fig s<NUMBER> batcov ratg<NUMBER> spike rbd ace<NUMBER> Ã <NUMBER> kcalmol supporting information fig s<NUMBER> therapies act coronavirus divided several categories based specific pathways <NUMBER> acting enzymes functional proteins critical virus preventing virus rna synthesis replication <NUMBER> acting structural proteins virus blocking virus binding human cell receptors inhibiting viruss selfassembly process <NUMBER> producing virulence factor restore hosts innate immunity <NUMBER> acting hosts specific receptors enzymes preventing virus entering hosts cells related target proteins include nsp<NUMBER> nsp<NUMBER> nsp<NUMBER>b nsp<NUMBER>c plpro nsp<NUMBER>e nsp<NUMBER>nsp<NUMBER> complex nsp<NUMBER>ensp<NUMBER> nsp<NUMBER>ensp<NUMBER> <NUMBER>clpro echannel e protein orf<NUMBER>a spike ace<NUMBER> cterminal rna binding domain crbd nterminal rna binding domain nrbd helicase rdrp tmprsss<NUMBER> based homology models <NUMBER> viral proteins <NUMBER> models two human targets resorted structurebased virtual ligand screening method using icm <NUMBER> modeling software molsoft llc screen potential smallmolecule compounds zinc drug database <NUMBER> compounds small inhouse database traditional chinese medicine natural products including reported common antiviral components traditional chinese medicine derivatives <NUMBER> compounds compounds lower calculated binding energies expressed scores mfscores considered higher binding affinities target protein significant functional proteins coronavirus nsps involved rna transcription translation protein synthesis plpro responsible cleavages nterminus replicase polyprotein release nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> essential correcting virus replication <NUMBER> plpro also confirmed significant antagonize hosts innate immunity <NUMBER>e<NUMBER> indispensable enzyme process coronavirus replication infection host plpro popular target coronavirus inhibitors valuable targeting plpro treat coronavirus infections inhibitor approved fda marketing screening results table <NUMBER> supporting excel file plproxlsx showed series antivirus drugs ribavirin valganciclovir thymidine antibacterial drugs chloramphenicol cefamandole tigecycline muscle relaxant drug chlorphenesin carbamate antitussive drug levodropropizine may high binding affinity plpro natural products table <NUMBER> supporting excel file plpronpxlsx platycodin platycodon grandiflorus baicalin scutellaria baicalensis sugetriol<NUMBER>diacetate cyperus rotundus phaitanthrin <NUMBER>di <NUMBER>indolyl<NUMBER>indolone isatis indigotica catechin compounds eepigallocatechin gallate <NUMBER> <NUMBER>tetrol exhibited high binding affinity plpro protein suggesting potential utility compounds treatment sarscov<NUMBER> antiviral drug ribavirin predicted bind plpro low binding energy scores z e<NUMBER> generated docking model ribavirin bound active site enzyme reported sarsplpro inhibitors pdb code <NUMBER>e<NUMBER>s hydrogen bonds predicted gly<NUMBER> gln<NUMBER> tyr<NUMBER> asp<NUMBER> compound also pep stacking found tyr<NUMBER> triazolering compound fig <NUMBER>a b strong hydrogen bonding hydrophobic interaction ribavirin enzyme imply may potent plpro inhibitor <NUMBER>clpro also known nsp<NUMBER> first automatically cleaved polyproteins produce mature enzymes cleaves downstream nsps <NUMBER> sites release nsp<NUMBER>ensp<NUMBER> <NUMBER> <NUMBER>clpro directly mediates maturation nsps essential life cycle virus detailed investigation structure catalytic mechanism <NUMBER>clpro makes <NUMBER>clpro attractive target anticoronavirus drug development inhibitors targeting sarscov <NUMBER>clpro mainly include peptide inhibitors smallmolecule inhibitors <NUMBER> <NUMBER>clpro monomer three domains domain residues <NUMBER>e<NUMBER> domain ii residues <NUMBER>e<NUMBER> domain iii residues <NUMBER>e<NUMBER> long loop residues <NUMBER>e<NUMBER> connects domains ii iii active site <NUMBER>clpro located gap domains ii cyshis catalytic dyad cys<NUMBER> his<NUMBER> <NUMBER> shown table <NUMBER> supporting excel file <NUMBER>clproxlsx antibacterial drugs lymecycline demeclocycline doxycycline oxytetracycline antihypertensive drugs nicardipine telmisartan conivaptan treating hyponatremia show highest binding affinity <NUMBER>clpro several natural compounds derivatives antivirus antiinflammatory effects also exhibited high binding affinity <NUMBER>clpro table <NUMBER> supporting excel file <NUMBER>clpronpxlsx including series andrographolide derivatives chrysin<NUMBER>obglucuronide baicalensis betulonal cassine xylocarpa <NUMBER>bhydroxy<NUMBER>secofriedelolactone<NUMBER>oic acid isodecortinol cerevisterol viola diffusa hesperidin neohesperidin citrus aurantium kouitchenside deacetylcentapicrin plants swertia genus results suggest smallmolecule compounds might potential <NUMBER>clpro inhibitors could probably used treating sarscov<NUMBER> worth mentioning antiasthmatic drug montelukast also showed low binding energy <NUMBER>clpro shown fig <NUMBER>a montelukast well fitted active pocket <NUMBER>clpro lots hydrophobic amino acids like thr<NUMBER> leu<NUMBER> his<NUMBER> phe<NUMBER> cys<NUMBER> his<NUMBER> met<NUMBER> pro<NUMBER> his<NUMBER> compose relatively hydrophobic environment contain compound stabilize conformation hydrogen bonding predicted asn<NUMBER> carbonyl group compound fig <NUMBER>b nsp<NUMBER> conserved protein coronavirus rnadependent rna polymerase rdrp vital enzyme coronavirus replicationtranscription complex rdrp domain polymerase located cterminus conserved seraspasp motif <NUMBER> nsp<NUMBER> de novo synthesize six nucleotides length used primer nsp<NUMBER>rdrp rna synthesis nsp<NUMBER>nsp<NUMBER> complex increases binding nsp<NUMBER> rna enhances rdrps enzyme activity nsp<NUMBER> <NUMBER> research sarscov merscov inhibitors nsp<NUMBER>rdrp used important drug target principle targeted inhibition nsp<NUMBER>rdrp could cause significant toxicity side effects host cells specific inhibitors found <NUMBER> virtualscreeningresultsofrdrpdemonstratedsomedrugsmightbe potentialinhibitorswith mfscoreslowerthanÃ <NUMBER>suchasseveralantifungal drug itraconazole antibacterial drug novobiocin gallstonedissolving drug chenodeoxycholic acid antiallergic drug cortisone antitumor drug idarubicin hepatoprotective drug silybin muscle relaxant drug pancuronium bromide chronic enteritis anticoagulant drug dabigatran etexilate table <NUMBER> supporting excel file rdrpxlsx natural products derivatives antivirus antiinflammation antitumor effects exhibited high binding affinity rdrp betulonal c xylocarpa gnidicin gniditrin gnidia lamprantha <NUMBER>b<NUMBER>bdihydroxy<NUMBER>secofriedelolactone<NUMBER>lactone v diffusa <NUMBER>deoxy<NUMBER>didehydroandrographolide andrographis paniculata <NUMBER>dihydroxy<NUMBER>methoxyxanthone swerti apseudochinensis theaflavin <NUMBER> <NUMBER> diogallate camellia sinensis andrographolide derivative r<NUMBER>r<NUMBER>as<NUMBER>r<NUMBER>as <NUMBER>adimethyl<NUMBER>methylene<NUMBER>oxo<NUMBER>e <NUMBER>oxo<NUMBER>dihydrofuran<NUMBER>ylethenyldecahydro<NUMBER>hbenzo cazepin<NUMBER>analysis therapeutic targets sarscov<NUMBER> ylmethyl <NUMBER>amino<NUMBER>phenylpropanoate table <NUMBER> supporting excel file rdrpnpxlsx helicase nsp<NUMBER> multifunctional protein include nterminal metal binding domain mbd helicase domain hel nterminal structure contains <NUMBER> cysteine residues form zn <NUMBER>Ã¾ binding domain helicase domain conserved motif cterminus nsp<NUMBER> unravel doublestranded ds dna rna along <NUMBER> <NUMBER> e<NUMBER> <NUMBER> direction ntpdependent manner <NUMBER> importantly reported sarsnsp<NUMBER> sequence conserved indispensable necessary component replication coronavirus therefore identified target antiviral drug discovery reports nsp<NUMBER> inhibitors <NUMBER> <NUMBER> based structure modeling helicase protein antibacterial drugs lymecycline cefsulodine rolitetracycline antifungal drug itraconazole antihuman immunodeficiency virus<NUMBER> hiv<NUMBER> drug saquinavir anticoagulant drug dabigatran diuretic drug canrenoic acid predicted helicase inhibitors high mfscores virtual ligand screening natural products many flavanoids different sources aglucosyl hesperidin hesperidin rutin besides targets nonstructural proteins including nsp<NUMBER>b nsp<NUMBER>e nsp<NUMBER>nsp<NUMBER> complex nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> also play important role virus rna synthesis replication suggesting proteins may useful targets antiviral drug discovery virtual screening results showed many antibacterial antiviral antiinflammatory drugs zinc drug database inhouse natural productsderivatives database displayed potential good affinity targets detailed information virtual screening results shown supporting excel files zdd screening results file names targetxlsx natural products screening results file names targetnpxlsx spike main structural protein coronavirus assembles special corolla structure surface virus trimer spike main protein interacts host binding host cell receptors mediate virus invasion determine viral tissue host tropism <NUMBER> spike cleaved s<NUMBER> s<NUMBER> host cell protease like tmprss<NUMBER> etc main function s<NUMBER> bind host cell surface receptors s<NUMBER> subunit mediates virusecell cellecell membrane fusion spike structural integrity cleavage activation play key role virus invasion virulence <NUMBER> therapeutic strategies block coronavirus entering host cells targeting spike proteins specific receptors host surface valuable development antiviral drugs basis virtual screening results smallmolecule compounds spike protein drugs showed high analysis therapeutic targets sarscov<NUMBER> <NUMBER> model binding affinity mfscoree<NUMBER> scoree<NUMBER> antihypertensive drugs rescinnamine iloprost prazosin antifungal drugs posaconazole itraconazole antibacterial drug sulfasalazine azlocillin penicillin cefsulodin anticoagulant drug dabigatran etexilate natural flavanoids licoflavonol glycyrrhiza uralensis cosmosiin baicalensis neohesperidin c aurantium mangostin garcinia mangostana kouitchenside swertia kouitchensis excoecariatoxin excoecaria agallocha phyllaemblicin g<NUMBER> p emblica piceatannol vitis vinifera exhibited high binding affinity detailed virtual screening results shown supporting excel files however compounds predicted bind binding interface spikeeace<NUMBER> complex compound could target binding interface spike ace<NUMBER> hesperidin shown fig <NUMBER>a hesperidin predicted lie middle shallow pit surface rbd spike dihydroflavone part compound went parallel b<NUMBER> sheet rbd sugar part inserted shallow pit direction away ace<NUMBER> hydrophobic amino acids including tyr<NUMBER> try<NUMBER> leu<NUMBER> phe<NUMBER> phe<NUMBER> try<NUMBER> try<NUMBER> tyr<NUMBER> form relatively hydrophobic shallow pocket contain compound fig <NUMBER>b hydrogen bonding predicted tyr<NUMBER> compound superimposing ace<NUMBER>erbd complex hesperidinerbd complex distinct overlap hesperidin interface ace<NUMBER> could observed fig <NUMBER>c suggesting hesperidin may disrupt interaction ace<NUMBER> rbd except spike protein e protein echannel possesses important biological functions structural integrity coronavirus host virulence nrbd crbd coronavirus n protein needed n proteins host cells bind coronavirus rna efficiently therefore e protein n protein nrbd crbd domains used targets discovery antiviral drugs virtual screening many antibacterial antiviral antitumor antiasthmatic antiinflammatory drugs etc zinc database inhouse natural productsderivatives database found display relatively good affinity targets detailed results virtual screening given supplementary excel files three coronavirus virulence factors nsp<NUMBER> nsp<NUMBER>c orf<NUMBER>a related interfering hosts innate immunity assisting <NUMBER> also inhibits typei interferon production <NUMBER> nsp<NUMBER>c ability bind hosts adpribose help coronavirus resist host innate immunity <NUMBER> bone marrow matrix antigen <NUMBER> bst<NUMBER> inhibit release newlyassembled coronavirus host cells sarscov orf<NUMBER>a directly binds bst<NUMBER> inhibits activity blocking glycosylation bst<NUMBER> <NUMBER> evidences suggest nsp<NUMBER> nsp<NUMBER>c orf<NUMBER>a may potential targets antiviral drug discovery detailed screening results nsp<NUMBER> nsp<NUMBER>c orf<NUMBER>a showed series clinical drugs natural products antibacterial antiinflammatory effects exhibited relatively high binding affinity three target proteins piperacillin cefpiramide streptomycin lymecycline tetracycline platycodin platycodon grandifloras wogonoside baicalensis vitexin vitex negundo andrographolide derivatives xanthones swertia genus detailed results virtual screening shown supporting excel files host ace<NUMBER> proved many studies specific receptor spike rbd sarscov <NUMBER> latest research shows host receptor sarscov<NUMBER> consistent sarscov exhibiting spike rbd sequence sarscov<NUMBER> similar sarscov rbd important interactions several key amino acid residues rbd receptorbinding motif ace<NUMBER> <NUMBER> based current research progress ace<NUMBER> considered host target treatment coronavirus infection block sarscov<NUMBER> entering host cells based virtual screening results ace<NUMBER> protein antidiabetes drug troglitazone antihypertensive drug losartan analgesia drug ergotamine antibacterial drug cefmenoxime hepatoprotective drug silybin etc predicted bind ace<NUMBER> low energy natural products phyllaemblicin g<NUMBER> p emblica xanthones plants swertia genus neohesperidin hesperidin c aurantium exhibited potentially high binding affinity ace<NUMBER> protein however none ace<NUMBER> binding compounds predicted target ace<NUMBER>erbd interface addition tmprss<NUMBER> known cut spike trigger infection sarscov merscov studies shown inhibiting enzyme activity tmprss<NUMBER> prevent coronaviruses entering host cells <NUMBER> possible target antiviral drug discovery virtual screen results shown supporting excel files predicted many antibacterial drugs pivampicillin hetacillin cefoperazone clindamycin antivirus natural compounds phyllaemblicin g<NUMBER> neoandrographolide kouitchenside etc potential tmprss<NUMBER> inhibitors order verify screening results zinc drug database utilize current resource antiviral drugs immediately constructed database <NUMBER> antiviral drugs deep calculation including compounds already market currently undergoing clinical trials treat sarscov<NUMBER> infections compounds docked <NUMBER> constructed targets sarscov<NUMBER> two human targets predict possible targets also search possible binding partners certain important targets special attentions paid drugs currently clinical trials results calculated docking scores listed supporting excel file antiviralsvstargetsscores significant scores scoree<NUMBER> mfscoree<NUMBER> highlighted brighten yellow remdesivir gs<NUMBER> nucleoside analogue rdrp inhibitor inhibit virus inhibiting synthesis viral nucleic acid yet approved marketing country january <NUMBER> year new england journal medicine reported diagnosis treatment first sarscov<NUMBER> patient united states <NUMBER> remdesivir showed potential treatment first patient novel coronavirus infection vero e<NUMBER> cells ec <NUMBER> remdesivir sarscov<NUMBER> <NUMBER> mmoll selection index si greater <NUMBER> <NUMBER> remdesivir currently undergoing randomized doubleblind controlled phase iii clinical study china molecular docking results show potential targets remdesivir nsp<NUMBER>b score z e<NUMBER> rdrp mfscores z e<NUMBER> echannel mfscore z e<NUMBER> tmprss<NUMBER> score z e<NUMBER> mfscores z e<NUMBER> rdrp generated docking model remdesivir could bind rnabinding channel sarscov<NUMBER> rdrp binding mode site highly similar coxsackievirus b<NUMBER> cvb<NUMBER> rdrp inhibitor gpcn<NUMBER> <NUMBER> binding pocket remdesivir bottom rna template channel position acceptor template nucleotide fig <NUMBER>a b compound well fitted shape pocket formed three hydrogen bonds asn<NUMBER> arg<NUMBER> asp<NUMBER> addition hydrophobic interactions leu<NUMBER> ala<NUMBER> tyr<NUMBER> may direct favorite conformation remdesivir fig <NUMBER>c interestingly remdesivir predicted bind target tmprss<NUMBER> low binding energy score mfscore shown fig <NUMBER>a remdesivir bound relatively positivelycharged allosteric pocket far away enzyme active center asn<NUMBER> arg<NUMBER> formed two hydrogen bonds phosphate groups compound weak hydrophobic interaction pyrrolotriazine ring remdesivir tyr<NUMBER> try<NUMBER> side chains polar amino acids may stabilize compound conformation fig <NUMBER>b lopinavir ritonavir marketed china mainly used treat hiv<NUMBER> infection adults children <NUMBER> years age vitro studies shown lopinavir ritonavir inhibit replication merscov sarscov exert antiviral effects drug listed recommended drug antiviral drugs section new coronavirus infected pneumonia diagnosis treatment program molecular docking results showed ritonavirs possible target nsp<NUMBER>c echannel mfscores Ã <NUMBER> Ã <NUMBER> respectively lopinavirs possible target nsp<NUMBER>b nsp<NUMBER>c helicase nrbd echannel mfscores Ã <NUMBER> Ã <NUMBER> Ã <NUMBER> Ã <NUMBER> Ã <NUMBER> respectively arbidol broadspectrum antiviral drug mainly treatment upper respiratory tract infections caused influenza b viruses etc recent years many studies proven effectiveness sarscov merscov arbidol hydrochloride block virus replication inhibiting fusion lipid membrane virus host cells compared untreated control group arbidol effectively inhibit coronavirus <NUMBER> times concentration <NUMBER>e<NUMBER> mmoll significantly inhibit viruss pathological effects cells docking results arbidol possible drug targets new coronavirus showed may interact nsp<NUMBER>nsp<NUMBER> complex nsp<NUMBER> nsp<NUMBER> echannel spike mfscores Ã <NUMBER> Ã <NUMBER> Ã <NUMBER> Ã <NUMBER> Ã <NUMBER> respectively darunavir hiv<NUMBER> protease inhibitor selectively inhibits cleavage hivencoded gagpol polyprotein virally infected cells thereby preventing formation mature infectious virus particles concentration <NUMBER> mmoll darunavir significantly inhibit virus replication inhibition efficiency <NUMBER> times compared untreated group docking results showed possible targets darunavir nsp<NUMBER>c plpro echannel spike proteins mfscores Ã <NUMBER> Ã <NUMBER> Ã <NUMBER> Ã <NUMBER> respectively favipiravir broadspectrum antiviral drug used treat flu shenzhen health commission initiated clinical studies use favipiravir treat sarscov<NUMBER> infections scores favipiravir docking targets virtual screening relatively low chloroquine phosphate used treatment malaria since <NUMBER>s later rheumatoid arthritis chloroquine reported earlier studies direct antiviral effects inhibiting flavivirus retrovirus hiv many coronaviruses recent study showed ec <NUMBER> <NUMBER> mmoll si greater <NUMBER> chloroquine effectively inhibit sarscov<NUMBER> cell level efficiency human body sarscov<NUMBER> infection yet clinically proven chloroquine phosphate turned chloroquine body play therapeutic effect docking results showed possible target chloroquine nsp<NUMBER>b echannel docking mfscores Ã <NUMBER> Ã <NUMBER> respectively also performed longitudinal analysis drugs <NUMBER> targets results showed tenofovir disoproxil fumarate beclabuvir may bind nsp<NUMBER> fewer compounds predicted act targets nsp<NUMBER> nsp<NUMBER>e nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> nrbd crbd orf<NUMBER>a tmprss<NUMBER> showing selected antiviral drugs unlikely acting targets new coronavirus provides meaningful reference future research targets nsp<NUMBER>b nsp<NUMBER>c nsp<NUMBER>nsp<NUMBER> complex nsp<NUMBER> nsp<NUMBER> plpro <NUMBER>clpro rdrp helicase echannel spike ace<NUMBER> antiviral drugs predicted bind especially echannel rdrp <NUMBER>clpro plpro indicating targets likely useful discovery sarscov<NUMBER> therapeutic drugs known antivirals focus subsequent research progressed early preclinical stage date sars virus <NUMBER> years ago current sarscov<NUMBER> emerging coronaviruses future may continue pose threat global public health therefore finding broadspectrum inhibitors may reduce effects human coronavirus infection remains challenging research focus given timeconsuming nature antiviral drug development registration existing treatments diseases may fastest treatment option emerging infectious diseases drugs prepared medication sufficient experience dosage safety adme situation well known study based results bioinformatics analysis <NUMBER> homology structures <NUMBER> sarscov<NUMBER> proteins one human protein built plus human ace<NUMBER> structure totally <NUMBER> targets setup high throughput virtual ligand screening special double scoring system icmpro soft allowed us evaluate docking results accurately score icm software calculated overall empirical function predicted physical interaction whiles mfscore mean force score computed knowledgebased potential functions derived statistics ligandereceptor complex pdb <NUMBER> <NUMBER> proteineprotein docking results deduce sarscov<NUMBER> spike protein strong binding affinity human ace<NUMBER> although weaker sarscov spike protein unexpectedly batcov ratg<NUMBER> spike protein slightly weaker binding affinity ace<NUMBER> compared sarscov<NUMBER> speculated virus may capable infecting humans directly close sarscov<NUMBER> evolved batcov ratg<NUMBER> may one two host evolutions involved published articles directly related intermediate hosts yet according recent research paper clinical characteristics sarscov<NUMBER> infection <NUMBER> sarscov<NUMBER> spread rapidly humantohuman transmission consistent observed proteineprotein docking results sarscov<NUMBER> spike rbd human ace<NUMBER> previous prediction <NUMBER> however fast growing incidents sarscov<NUMBER> pneumonia related deaths implied weaker binding sarscov<NUMBER> spike human ace<NUMBER> compared sars spike may fully explained current situation epidemic must receptors sarscov<NUMBER> infection facilitating mechanisms human host sarscov<NUMBER> spikerbd may take lower energy binding conformation different current sarscov spikerbd conformation found crystal structure probably induce fitting need investigated search potential coronavirus therapeutic drugs soon possible first screened potential compounds zinc drug database <NUMBER> compounds small inhouse database natural products <NUMBER> compounds series clinical drugs natural products antiviral antibacterial antiinflammatory effects exhibited high binding affinity different target proteins indicating potential utility treating sarscov<NUMBER> identified number compounds might antiviral activity approved drugs library antivirus drugs ribavirin valganciclovir thymidine antibacterial drugs cefpiramide sulfasalazine phenethicillin lymecycline demeclocycline doxycycline oxytetracycline tigecycline antiasthmatic drugs montelukast fenoterol reproterol hepatoprotective drug silybin original pharmacological actions drugs could helpful therapy viral infection pneumonia natural products flavanoids like compounds major components might meaningful treatment sarscov<NUMBER> infections ace<NUMBER> target although several compounds could bind ace<NUMBER> virtual screening studies compound found bind contact surface ace<NUMBER>espike complex suggesting compounds inhibitors ace<NUMBER> enzyme activities rather inhibitors ace<NUMBER> driven virus infections like described recently published research <NUMBER> selected compounds also unable bind contact surface ace<NUMBER>espike complex actually potential ace<NUMBER> inhibitors may suitable use drugs treating sarscov<NUMBER> infection poor prognosis would induced inhibition ace<NUMBER> enzyme activities ace<NUMBER> considered protective factor lung injury <NUMBER> targets difficult find direct inhibitors nondruggable targets like nsp<NUMBER> nsp<NUMBER>b nsp<NUMBER>c echannel etc currently popular protac technology may good strategy degrade proteins inhibit virus potential binding compounds found study targets might good start point spike protein found one compound natural hesperidin targeting binding spike rbd human ace<NUMBER> however like ace<NUMBER> binding compounds noninterface binding compound may still meaningful applications considering fusion covs membrane host cell membrane need big conformational change remained spike part rbd removal <NUMBER> small molecule bound spike time may interfere refolding spike therefore inhibits viral infection process furthermore small molecule target part spike protein may good start point design protac based therapy also dock existing antiviral drugs targets analyze possible targets antiviral drug horizontally analyze drugs may interact <NUMBER> targets vertically analyzed <NUMBER> targets based docking results found nsp<NUMBER>b nsp<NUMBER>c nsp<NUMBER>nsp<NUMBER> complex nsp<NUMBER> nsp<NUMBER> plpro <NUMBER>clpro rdrp helicase echannel spike ace<NUMBER> likely therapeutic targets antiviral drugs three targets nsp<NUMBER>b nsp<NUMBER>c echannel screened antiviral drugs may due model problem flexible small protein nsp<NUMBER>b nsp<NUMBER>c partial model echannel whether screened antiviral drugs really work targets needs verification also recommend application new coronavirus pneumonia compounds target predicted triphosphate nucleotide product remdesivir remdesivirtp competes rdrp substrate atp interfere viral rna synthesis docking results show remdesivirtp binds sarscov<NUMBER> rdrp score Ã <NUMBER> docking results consistent original antiviral mechanism think remdesivir may good treating sarscov<NUMBER> pneumonia addition remdesivir also predicted bind human tmprss<NUMBER> protein facilitating virus infection new discovery provides ideas subsequent research chloroquine phosphate shown better antisarscov<NUMBER> effects recent studies drug clear target action docking results chloroquine phosphate predicted possibly combine nsp<NUMBER>b echannel need experiments verify conclusion response recently reported antiaids drugs lopinavir ritonavir tablets poor effect treatment novel coronavirus pneumonia toxic side effects analyzed conjunction docking results molecular docking results show ritonavirs possible target nsp<NUMBER>c echannel lopinavirs possible target nsp<NUMBER>b nsp<NUMBER>c helicase nrbd echannel targets nsp<NUMBER>b nsp<NUMBER>c echannel may false positives due model inaccuracy small flexible protein partial model lopinavir ritonavir observe possible binding major targets like <NUMBER>clpro plpro rdrp docking result implies lopinavir ritonavir tablets may suitable treatment sarscov<NUMBER> infections results entire article based computer virtual screening conduct vivo vitro antiviral experiments yet want share results scientists antisarscov<NUMBER> research soon possible subsequent research try solve threedimensional structures <NUMBER> proteins sarscov<NUMBER> drug complexes providing target information drug intervention longterm drug design perform vivo vitro evaluations candidate drugs obtained study prepare clinical trial applications analysis therapeutic targets sarscov<NUMBER> <NUMBER> global pandemic developing december <NUMBER> strain severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> cause coronavirus disease <NUMBER> disease emergent variant adds additional coronavirus strains infect humans including human coronavirus oc<NUMBER> hcovoc<NUMBER> human coronavirus hku<NUMBER> hcovhku<NUMBER> sarscov human coronavirus <NUMBER>e hcov<NUMBER>e human coronavirus nl<NUMBER> hcovnl<NUMBER> human coronavirus nl<NUMBER> hcovnl<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronaviruses covs positivesense enveloped singlestranded rna viruses classified taxonomically family coronavirdiae order nidovirales <NUMBER> four genera covs including Î±cov Î²cov Î´cov Î³cov Î´covs Î³covs target avians whilst Î±covs Î²covs infect rodents bats <NUMBER> <NUMBER> <NUMBER> severe acute respiratory syndrome cov sarscov outbreaks also emerged previously creating epidemic <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> although mortality merscov sarscov sarscov<NUMBER> substantial preventative vaccines drugs available treat patients infected virus <NUMBER> <NUMBER> <NUMBER> current public health emergency international concern pheic world health organization declared sarscov<NUMBER> covid<NUMBER> novel Î²cov pandemic threat data obtained <NUMBER>may<NUMBER> suggest virus caused <NUMBER> infections <NUMBER> deaths affected <NUMBER> countries open reading frame <NUMBER>ab orf<NUMBER>ab sarscov<NUMBER> encodes three proteins broadly recognized drug targets since key components infections disease progression sarscov<NUMBER> protease <NUMBER> <NUMBER> rnadependent rna polymerase rdrp <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> spike glycoprotein <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> protease processes polyproteins translated viral rna heavily studied using small molecules inhibitors <NUMBER> penetrate host sarscov<NUMBER> makes use homotrimeric class glycosylated fusion spike protein <NUMBER> <NUMBER> <NUMBER> fusion viral host cell membranes facilitated spike glycoprotein undergoes significant conformational change upon fusion <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> studies suggest <NUMBER> <NUMBER> <NUMBER> spike glycoprotein functions homotrimer recognition subsequent fusion viral cellular membranes triggered s<NUMBER> subunit spike protein binds host cell receptor angiotensin converting enzyme<NUMBER> ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several insights structural biology consistent role domain affecting infection rate virus hostvirus interaction mediated receptor binding domain rbd domain s<NUMBER> subunit sarscov<NUMBER> spike glycoprotein forms hingelike conformation <NUMBER> <NUMBER> ie states represents host cell receptorinaccessible receptoraccessible <NUMBER> receptoraccessible conformation exists highly fluctuating state <NUMBER> <NUMBER> <NUMBER> <NUMBER> binding host target destabilizes prefusion homotrimer sheds s<NUMBER> subunit allows transition s<NUMBER> subunit highly stable postfusion conformation <NUMBER> interestingly proteinmediated cellcell fusion assays suggest sarscov<NUMBER> spike protein displays elevated plasma membrane fusion capacity compared sarscov <NUMBER> <NUMBER> several studies aimed define mechanism binding sarscov<NUMBER> host cell receptor <NUMBER> molecular dynamics simulations spike rbdace<NUMBER> complex <NUMBER> ns indicated spikerbdace<NUMBER> binding free energy sarscov<NUMBER> better sarscov <NUMBER> similarly studies shown sarscov<NUMBER> spike protein better binding affinity ace<NUMBER> two different angles rbd domain sarscov <NUMBER> structural features spikeace<NUMBER> interface suggest residues q<NUMBER> p<NUMBER> spike rbd domain responsible maintaining proteinprotein stability <NUMBER> using virtual highthroughput screening approach smallmolecules identified interact rbd domain sarscov<NUMBER> spike protein <NUMBER> natural compounds present curcuma sp citrus sp alpiniagalanga caesalpiniasappan could also target rbd domain sarscov<NUMBER> spike glycoprotein protease domain pd ace<NUMBER> sarscov<NUMBER> protease <NUMBER> set b cell cell epitopes derived spike nucleocapsid proteins map identically sarscov<NUMBER> proteins identified potential vaccine candidates <NUMBER> applying integrative antiviral drug repurposing methodology interplay covhost interactome drug targets human proteinprotein interaction network defined <NUMBER> bioinformatics methodologies used identify neutralizing antibodies might interact interfaces formed spike glycoprotein ace<NUMBER> host cell receptor <NUMBER> targeting rbd domain spike protein using docking experiments kanishka et al identified small molecule inhibitors <NUMBER> majority studies common strategy focused targeting interface formed sarscov<NUMBER> spike glycoprotein ace<NUMBER> host cell receptor ie spikerbdace<NUMBER> currently robust drugs widespread dissemination available coronaviruses including sarscov<NUMBER> virus due relatively rapid spread current outbreak relatively high mortality rate <NUMBER> rapid development new repurposed antiviral drugs high value although majority drug discovery programs target classically druggable enzymes encoded virus viral rna polymerase inhibited remdesivir <NUMBER> <NUMBER> <NUMBER> paucity information concerning regions spike glycoprotein outwith ace<NUMBER>binding domains especially domains interacting viral membrane sarscov<NUMBER> spike protein homotrimer composed three monomers chains b c figure <NUMBER>a monomeric protein contains nterminal ace<NUMBER> binding domain receptor binding domain rbd central helixheptad repeat cterminal region interacts plasma membrane <NUMBER> homotrimer spike protein assembly monomeric forms rate limiting cells suggesting possible space intervention viral life cycle <NUMBER> current study focuses understanding variability trimer spike glycoprotein sarscov<NUMBER> respect genomes coronavirus strains identifying changes molecular properties due conformational flexibility spike protein analysis suggests residues s<NUMBER> subunit less variable compared regions addition molecular dynamics simulations mds identified residues rbd domain obtained substantial flexibility may obstacle finding active hits contrast residues s<NUMBER> subunit trimer cavity showed least flexibility representing novel binding region ligands information used identify potentially novel drug pockets active site regions specifically oligomeric sarscov<NUMBER> spike glycoprotein performed md simulations monomeric trimeric form sarscov<NUMBER> spike glycoprotein developed virtual screening using food drug administration fda approved chemical library identified focused apparent cavity formed three subunits homotrimer simulations suggest mediate dynamic movements mimic bouncing spring sarrus linkage converting circular motion linear motion vice versa interacting ace<NUMBER> host cell receptor motion might important fusion virion host cell membrane hypothesized cavity formed three monomers subunits spike protein ie chains b c might form acceptor small molecules asked whether small molecules could identified relatively high binding energy identified several known compounds predicted binding energy gbviwsa dg generalizedborn volume integralweighted surface area â<NUMBER> â<NUMBER> kcalmol already proposed clinical trials including mtor mammalian target rapamycin pathway inhibitor sirolimus rapamycin macrolide type nct<NUMBER> yet recruiting <NUMBER> <NUMBER> <NUMBER> ritonavir openlabel trial hospitalized adults severe covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recent study screened hundreds approved molecules sarscov<NUMBER> assay using artificial intelligenceenabled phenomic assays <NUMBER> also identified sirolimus rapamycin promising candidate addition macrolides one top hits identified chitosan recently reported derivative inhibiting sarscov<NUMBER> coronavirus replication cell lines <NUMBER> <NUMBER> previous study also shown chitosan derivatives interact spike protein block interaction host receptor <NUMBER> data suggest mechanism whereby chitosan possibly derivatives well macrolide type molecules might bind pocket formed spike protein trimer provide novel domain focus future drug discovery projects <NUMBER> <NUMBER> c receptor binding domain rbd illustrating open pdb id <NUMBER>vsb <NUMBER> closed pdb id <NUMBER>vxx <NUMBER> conformation total <NUMBER> viral genome sequences downloaded global initiative sharing influenza data platform gisaid <NUMBER> order define evolutionary variability different domains spike glycoprotein genomes high coverage complete sequences selected filtering applied obtain complete sequences targeted domains reduced total number strains <NUMBER> total protein sequences acquired <NUMBER> frame translation using transeq tool emboss european molecular biology open software suite package version <NUMBER> european bioinformatics institute emblebi hinxton cambridge uk <NUMBER> amino acid chains spike glycoprotein aligned reference protein pdb id <NUMBER>vsb <NUMBER> <NUMBER> using muscle <NUMBER> variations amino acid residue changes scanned entire spike protein sequence along two areas interest multiple alignment file focusing subset s<NUMBER> subunit hr<NUMBER> ch cd domains rbd domain figure <NUMBER> tables s<NUMBER>s<NUMBER> cryoem cryogenic electron microscopy homotrimer structure sarscov<NUMBER> spike glycoprotein retrieved protein data bank database httpwwwrcsborgpdb pdb id <NUMBER>vsb figure <NUMBER> <NUMBER> <NUMBER> addition missing amino acid residues range <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coordinates structure sarscov<NUMBER> spike glycoprotein built using swissmodel figure <NUMBER> <NUMBER> molecular dynamics simulations carried model systems per standardized pipelines <NUMBER> <NUMBER> <NUMBER> detailed method explained supplementary materials file s<NUMBER> gromacs <NUMBER> <NUMBER> program gromacs groningen machine chemical simulations university groningen groningen netherlands used perform md calculations assigning charmm<NUMBER> forcefield <NUMBER> performed <NUMBER> ns molecular dynamics simulations two systems monomeric form ii homotrimer form spike protein analysis md simulations dynamics monomeric form spike protein serves control homotrimer functional unit initially model systems energy minimized provides baseline model structure resolves poorlyresolved conformations often found crystal structures <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> simulation box solvent atoms added enhance simulation realism following using npt number particles n system pressure p temperature isobaricisothermal thermodynamic ensemble equilibration systems performed adjust solvent molecules counter ions simulation box <NUMBER> equilibrated systems subsequently used perform final md production runs <NUMBER> ns results analyzed using gromacs <NUMBER> biovia discovery studio dassaultsystÃ¨mes biovia corp san diego ca usa chimera visual molecular dynamics vmd tools <NUMBER> <NUMBER> <NUMBER> structurebased virtual screening sbvs application silico methods identify promising lead molecules chemical libraries databases methods computational counterparts experimental biological evaluation methods highthroughput screening hts fda approved drug libraries retrieved target molecule corp targetmol wwwtargetmolcom selleck chemicals selleckchem wwwselleckchemcom vendors sbvs sarscov<NUMBER> spike glycoprotein performed using molecular operating environment moe chemical computing group inc montreal qc canada package <NUMBER> <NUMBER> receptorligand binding docking using charmm<NUMBER> forcefield <NUMBER> evaluated using gbviwsa âg scoring function <NUMBER> compounds showing best energies spike protein selected analysis gbviwsa âg forcefield based scoring function determines free energy binding ligand given position <NUMBER> addition also selected compounds showed comparatively stable interactions homotrimer spike protein applying triangle matcherplacement method receptorligand docking performed defining receptor rigid ligands flexible <NUMBER> <NUMBER> interested define evolutionary variance sarscov<NUMBER> spike protein understanding regions high low variance identify domains may functionally conserved potentially important virus life cycle positive evolutionary pressure whose selection might avoid immune system examining variability spike protein sarscov<NUMBER> different domains total <NUMBER> genome viral sequences retrieved gisaid <NUMBER> global view mutation space virus presented figure <NUMBER>a represents amino acid substitutions bins <NUMBER> aminoacids across spike glycoprotein hotspots variation mostly confined ntd rbd domains figures <NUMBER>b <NUMBER>b investigated variability entire sequence spike protein focusing regions showed lowvariability structure figure <NUMBER> investigating variations residue changes across entire spike protein sequence regions lower variability figure <NUMBER>a table s<NUMBER> s<NUMBER> subunit exhibited lowest sequence variability residue range <NUMBER> figures <NUMBER>b <NUMBER>c moreover previous studies identified active site region spike protein located rbd domain interacts ace<NUMBER> host cell receptor <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> comparing variability rbd domain s<NUMBER> subunit domains rbd domain shown contain mutations region compared s<NUMBER> subunit hr<NUMBER> ch cd domains figure <NUMBER>b c tables s<NUMBER>s<NUMBER> data suggest mutation natural selection viralhost arms race might operate frequently rbd domain contrast s<NUMBER> subunit conservation suggestive important core function mutations cannot tolerated findings prompted focus s<NUMBER> subunit important region investigate identifying potentially novel druggable pockets next traced dynamics different domains spike protein using md simulations figure <NUMBER>b simulated model systems spike protein monomer homotrimer forms first processed check stability protein stability simulated spike protein forms solvent environment traced rmsds root mean square deviation time dependent change nonhydrogen atoms figure <NUMBER>a rmsd plots figure <NUMBER>a suggest trimer form spike protein stable compared monomer form addition chain trimer higher rmsd <NUMBER> Ã¥ compared two chains consequence fact ace<NUMBER>active conformation <NUMBER> induces flexibility since monomer form higher rmsds compared trimer figure <NUMBER>a performed independent triplicates mds repeated three times md simulation monomer form figure s<NUMBER> findings replicates indicate monomer form higher rmsd compared trimer spike protein figure <NUMBER>a figure s<NUMBER> root mean square fluctuations rmsf computed cÎ± atoms residue spike protein order trace flexibility thereby define motions different domains figure <NUMBER>b rmsf findings forms monomer trimer indicated amino acids rbd domain residue range <NUMBER> highly fluctuating figures <NUMBER>b <NUMBER>b addition triplicate md simulations monomer form also suggests rbd domain higher rmsf three simulation replicates figure s<NUMBER> analyses correlate previous studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> particularly amino acids ranging <NUMBER> responsible interacting ace<NUMBER> highly fluctuating furthermore examining regions spike protein suggests s<NUMBER> subunit domains residue range <NUMBER> hr<NUMBER> ch cd showed least fluctuations within entire protein sequence figure <NUMBER>b correlates cryoem studies performed spike protein s<NUMBER> subunit stable <NUMBER> compared rbd domain subunit responsible highly stable postfusion conformation spike protein <NUMBER> <NUMBER> perspective designing drugs stable less flexible region within protein accurately trace better hit molecule case spike protein rmsf findings guided us towards focusing s<NUMBER> subunit figure <NUMBER>b moreover tracing residues involved hbond interactions two monomers ie chains ab ac bc homotrimer observed rbd domain residues also involved intermolecular interactions high occupancy suggests intermolecular interactions chains homotrimer might equilibrate spike protein might stimulate conversion conformation rbd domain interacts ace<NUMBER> receptor figure s<NUMBER> table s<NUMBER> structural dynamics time course spike protein monomer homotrimer form monitored md simulations figure <NUMBER>cd monomeric spike protein solvent environment exhibited movement active state towards inactive state rbd domain figure <NUMBER>c figure <NUMBER>c movie s<NUMBER> correlate previous findings rbd domain form two different conformations ie states represents host cell receptorinaccessible receptoraccessible respectively <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> spike protein better binding affinity ace<NUMBER> receptor two different angles rbd domain compared sarscov <NUMBER> figure <NUMBER>c movie s<NUMBER> describes conformational change regions spike protein rbd domain moves towards state monomeric form <NUMBER>d movie s<NUMBER> represents dynamics homotrimer spike protein suggesting rbd domain chain opens widely state domains hr<NUMBER> ch cd close viral transmembrane exhibited least movement figure <NUMBER>d md simulations addition exploration structural orientation s<NUMBER> subunit domains figure <NUMBER>d movie s<NUMBER> suggests form large pocket cavity using three chains monomers homotrimer spike protein slight movement observed homotrimer md simulation cavity movies s<NUMBER> s<NUMBER> structural orientation suggest could work bouncing spring sarrus linkage one may postulate spike protein interacts ace<NUMBER> receptor bouncing spring sarrus linkage movement may important fusion virion host membrane additionally cavity spike protein could work platform design development new drug leads protein figure <NUMBER>d molecules might alter trimer stability upon viral entry upon viral coat assembly several studies performed design drugs specific sarscov<NUMBER> spike protein <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however focused rbd domain addition md simulation variability analysis figures <NUMBER> <NUMBER> rbd domain highly flexible variable therefore drugging variable site may obstacle finding active hit molecules targeting less variable s<NUMBER> region cavity formed homotrimer figures <NUMBER> <NUMBER>d suggest might novel approach develop small molecule drug leads next investigated targetability trimer cavity formed s<NUMBER> subunit hr<NUMBER> ch cd domains spike protein figures <NUMBER> <NUMBER> using moe chemical computing group inc package <NUMBER> <NUMBER> using highthroughput virtual screening sbvs using library fda approved drugs alpha shapes construction <NUMBER> <NUMBER> geometric method used compute possible residues considered ligand docking trimer cavity spike protein figure <NUMBER>a highthroughput virtual screening powerful computational approach increasingly used drug discovery process silico identification novel hits large compound databases <NUMBER> applied sbvs approach dock molecules trimer cavity check feasibility target ligand binding cavity might reduce increase bouncing spring movement spike protein observed md simulations figure <NUMBER> movies s<NUMBER> s<NUMBER> perturbation might affect interactions host cell receptor hinge movement rbd domain compounds exhibit relatively high binding affinity towards sarscov<NUMBER> spike glycoprotein trimer cavity binding affinity â<NUMBER> â<NUMBER> kcalmol gbviwsa dg recorded list ligands showing best binding compounds already validated suggested becan active sarscov<NUMBER> virus includes chitosan <NUMBER> <NUMBER> <NUMBER> rapamycin <NUMBER> <NUMBER> <NUMBER> everolimus rad<NUMBER> <NUMBER> paclitaxel <NUMBER> ritonavir <NUMBER> <NUMBER> <NUMBER> <NUMBER> selameerin selamectin <NUMBER> danoprevir <NUMBER> table <NUMBER> among molecules rapamycin everolimus drugs previously identified mtor pathway inhibitors <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> antibacterial antiparasitic drugs list chitosan <NUMBER> selameerin selamectin <NUMBER> respectively paclitaxel found previously target bcl<NUMBER> microtubule associated functions <NUMBER> <NUMBER> addition fda approved drugs target protease ritonavir <NUMBER> danoprevir itmn<NUMBER> <NUMBER> docking known drugs within trimer cavity spike protein relative selectivity cavity suggests majority higheraffinity drugs molecular weight mw â¥<NUMBER> gmol table <NUMBER> figure s<NUMBER> however certainty compounds high mw form interactions spike protein addition finding highlights possibility trimer cavity occupy large ligands deep inside binding pocket figure <NUMBER>a particularly specific class ligands mostly macrolide type found exhibit better fit trimer cavity figure <NUMBER>a example rapamycin <NUMBER> <NUMBER> <NUMBER> everolimus rad<NUMBER> <NUMBER> paclitaxel <NUMBER> selameerin selamectin <NUMBER> figure <NUMBER>a intermolecular interactions spike protein compounds suggest residues three monomers chains b c actively involved binding drugs addition placement compounds inside trimer cavity suggests make use pocket space forming different conformation form stable interactions spike protein figure <NUMBER>a ligands found interacting homotrimer cavity high binding affinity also docked interface formed spike proteins rbd domain pdb id <NUMBER>lzg <NUMBER> interact ace<NUMBER> receptor sbvs structurebased virtual screening order check selectivity ligands trimer cavity docked subset table <NUMBER> rbd domain viral spike protein figure <NUMBER>b pdb id <NUMBER>lzg <NUMBER> rbd domain involved interacting ace<NUMBER> host cell receptor <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> docking suggests compounds table <NUMBER> better binding affinity trimer cavity compared rbd domain addition chitosan <NUMBER> <NUMBER> <NUMBER> <NUMBER> linear polysaccharide â<NUMBER> kcalmol could form linear conformation structure binding tothe rbd domain figure <NUMBER>b table <NUMBER> whilst ligand due molecular structural nature form slightly folded shape shown <NUMBER>ddiagram figure <NUMBER>a within trimer cavity contrast everolimus <NUMBER> macrolide type exhibits high affinity trimer pocket little selectivity rbd domain table <NUMBER> moreover ligands figure <NUMBER>b interact rbd domain overlap region bound cr<NUMBER> neutralizing antibody isolated convalescent sars patient interacts receptor binding domain sarscov<NUMBER> spike protein <NUMBER> sarscov<NUMBER> virus causing covid<NUMBER> disease uses fusion spike glycoprotein penetrate host cell therefore detailed understanding protein forms critical intervention point viral lifecycle interrogated spike protein diversity computational approaches first variability spike protein <NUMBER> different viral genome sequences evaluated residues s<NUMBER> subunit residue range <NUMBER> hr<NUMBER> ch cd domains found less evolutionarily variable compared regions domains contrast residues h<NUMBER>y q<NUMBER>k v<NUMBER>f v<NUMBER>a s<NUMBER>p k<NUMBER>p v<NUMBER>p found common amino acid substitutions spike protein related viruses secondly md simulations revealed residues rbd domain residue range <NUMBER> flexible compared residues s<NUMBER> subunit making complicated drug design strategies examination less variable regions revealed hr<NUMBER> ch cd domains s<NUMBER> subunit located close viral transmembrane formed large cavity pocket formed three spike monomers md simulation traced active state inactive state spike protein monomer form slight movement trimer cavity within structural orientation suggests could work bouncing spring sarrus linkage interacting host cell receptor conversion states monomer form spike protein using silico methods defined md field relatively fast nevertheless different structural isoforms identified spike protein using different experimental methods virus strains indicates although conversion may quick structural endpoints stable using recent cryoem structure sarscov<NUMBER> spike protein <NUMBER> asymmetric hingelike movement observed one three rbd domains s<NUMBER> subunit also observed merscov sarscov <NUMBER> <NUMBER> however also structures three rbd domains conformation <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data suggest physiological relevance due heterogeneous protein conformational dynamics example asymmetric conformational flexibility might functional role perhaps evading exposure bcell epitopes one rbd domain conformation andor optimized interaction ace<NUMBER> receptor depending virus strain addition bouncing spring mechanism communication trimer pocket rbd domain conformation possible different spike protein conformational isoforms provide another avenue develop drug discovery programs exploit andor circumvent dynamics investigation genomic variation within virus strains well findings md simulations identified conserved trimer cavity pocket formed s<NUMBER> subunit spike protein findings suggest novel target trimer cavity formed spike protein oligomerization may suitable manipulate viruses class targeting trimer pocket might identify new functional class drugs protein applying sbvs approach docked drug libraries trimer cavity hypothesis ligand might perturb predicted bouncing spring movement homotrimer formation proteinligand docking identified severalhits already published proposed inhibit sarscov<NUMBER> virus cell systems example studies suggest action mechanism molecules chitosan macrolide types eg rapamycin based sequence variability coronavirus including findings md simulations spike protein conserved trimer cavity hr<NUMBER> ch cd domains feature spike protein coronaviruses consistent previous work shown molecule ek<NUMBER> exhibited potent inhibitory activity human coronaviruses hcovs tested binding cterminal hr<NUMBER> domain <NUMBER> additionally conformations rbd domain observed md simulations supports concept spike protein also target possible igg therapeutic <NUMBER> list top compounds identified dock trimer cavity already validated suggested sarscov<NUMBER> virus inhibitors cells including chitosan derivative <NUMBER> <NUMBER> <NUMBER> rapamycin <NUMBER> <NUMBER> <NUMBER> everolimus rad<NUMBER> <NUMBER> paclitaxel <NUMBER> ritonavir <NUMBER> <NUMBER> <NUMBER> <NUMBER> selameerin selamectin <NUMBER> danoprevir <NUMBER> among modified polymeric version chitosan drug top hit analysis recently shown inhibit cov replication evidence molecule inhibits binding viral spike protein host ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> proteinprotein interaction map networkbased methodologies <NUMBER> <NUMBER> suggest sirolimus rapamycin emerges common potential drug lead repurposing covid<NUMBER> rapamycin mtor inhibitor drug found previously disrupt larp<NUMBER> larelated protein <NUMBER> mtorc<NUMBER> mammalian target rapamycin complex <NUMBER> binding shown reduce mers infection by<NUMBER> vitro <NUMBER> postulated geroprotectors sirolimus rapamycin close derivative rapalog everolimus rad<NUMBER> decreased infection rates small sample elderly patients <NUMBER> moreover drugs sirolimus rapamycin ritonavir currently clinical trials repurposing covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> sirolimus rapamycin registered clinical trial nct<NUMBER> yet recruiting designed evaluate adjunctive use sirolimus rapamycin oseltamivir patients hospitalized influenza <NUMBER> <NUMBER> ritonavir hiv protease inhibitor openlabel trial hospitalized adults severe covid<NUMBER> <NUMBER> <NUMBER> data smallsample clinical study showed danoprevir boosted ritonavir safe well tolerated patients <NUMBER> selamectin potential drug treating covid<NUMBER> found active pangolin coronavirus gxp<NUMBER>v workable model sarscov<NUMBER> research <NUMBER> antitumor drug paclitaxel increases cellular methylglyoxal virucidal levels providing rationale repurposing doxorubicin paclitaxel covid<NUMBER> treatment <NUMBER> nevertheless whether hit molecules identified dock trimer cavity impact virus life cycle requires orthogonal validation hope findings study help understand function highly conserved spike disease named covid<NUMBER> world health organization caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> recognized responsible pneumonia outbreak started december <NUMBER> wuhan city hubei china <NUMBER> spread february milan lombardy italy <NUMBER> becoming pandemic april <NUMBER> virus infected <NUMBER> people <NUMBER> countries sarscov<NUMBER> positivesense singlestranded rna virus shares similarities betacoronavirus severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov <NUMBER> bats identified primary host sarscov sarscov<NUMBER> <NUMBER> intermediate host linking sarscov<NUMBER> humans still unknown although recent report indicates pangolins could involved <NUMBER> coronaviruses use speciesspecific proteins mediate entry host cell spike protein activates infection human respiratory epithelial cells sarscov merscov sarscov<NUMBER> <NUMBER> spike assembled trimer contains around <NUMBER> amino acids within unit <NUMBER> <NUMBER> receptor binding domain rbd spike contains around <NUMBER> amino acids mediates binding angiotensinconverting enzyme ace<NUMBER> attacking respiratory cells another region upstream rbd present merscov sarscov involved adhesion sialic acid could play key role regulating viral infection <NUMBER> <NUMBER> present molecular details available sarscov<NUMBER> interactions human host mediated specific rna elements <NUMBER> study rna structural content used cross <NUMBER> previously developed investigate large transcripts human immunodeficiency virus hiv<NUMBER> <NUMBER> cross predicts structural profile rna molecules single doublestranded state singlenucleotide resolution using sequence information performed sequence structural alignments among <NUMBER> sarscov<NUMBER> strains identified conservation specific elements spike region provides clues evolution domains involved binding ace<NUMBER> sialic acid highly structured regions rna molecules strong propensity form stable contacts proteins <NUMBER> promote assembly specific complexes <NUMBER> <NUMBER> sarscov<NUMBER> domains enriched doublestranded content expected establish interactions within host cells important replicate virus <NUMBER> investigate interactions sarscov<NUMBER> rna human proteins employed catrapid <NUMBER> <NUMBER> catrapid <NUMBER> estimates binding potential specific protein rna molecule van der waals hydrogen bonding secondary structure propensities allowing identification interaction partners high confidence <NUMBER> unbiased analysis <NUMBER> protein interactions sarscov<NUMBER> rna reveals <NUMBER> sarscov<NUMBER> strong propensity bind human proteins involved viral infection especially reported associated hiv infection comparison sarscov hiv reveals indeed similarities <NUMBER> relationship sarscov<NUMBER> hiv still unexplored interestingly hiv sarscov<NUMBER> sarscov merscov furincleavage site occurring spike protein could explain spread velocity sarscov<NUMBER> compared sarscov merscov <NUMBER> <NUMBER> yet many processes related sarscov<NUMBER> replication unknown study aims suggest relevant protein interactions investigation hope largescale calculations structural properties binding partners sarscov<NUMBER> useful identify mechanisms virus replication within human host structured elements within rna molecules attract proteins <NUMBER> reveal regions important interactions host <NUMBER> indeed gene expressed sarscov<NUMBER> preceded conserved transcriptionregulating sequences act signal transcription complex synthesis rna minus strand promote strand transfer leader region resume synthesis process named discontinuous extension minus strand variant similarityassisted template switching operates viral rna recombination <NUMBER> analyze sarscov<NUMBER> structure reference wuhan strain mn<NUMBER> employed cross <NUMBER> predict doubleand singlestranded content rna genomes hiv<NUMBER> <NUMBER> found highest density doublestranded regions <NUMBER> nucleotides <NUMBER> membrane protein nucleotides <NUMBER> spike protein nucleotides <NUMBER> nucleocapsid n protein nucleotides <NUMBER> fig <NUMBER> <NUMBER> lowest density doublestranded regions observed nucleotides <NUMBER> <NUMBER> correspond regions nonstructural proteins nsp<NUMBER> nsp<NUMBER> upstream region spike surface protein fig <NUMBER> <NUMBER> addition maximum corresponding nucleotides <NUMBER> structural content spike protein shows minima around nucleotides <NUMBER> <NUMBER> fig <NUMBER> used vienna method <NUMBER> investigate rna secondary structure specific regions identified cross <NUMBER> employing <NUMBER> nucleotide window centered around cross maxima minima found good match cross scores vienna free energies fig <NUMBER> strong agreement also observed cross vienna positional entropy indicating regions highest structural content also lowest structural diversity analysis suggests presence structural elements sarscov<NUMBER> evolved interact specific human proteins <NUMBER> observation based assumption structured regions intrinsic propensity recruit proteins <NUMBER> supported fact structured transcripts act scaffolds protein assembly <NUMBER> <NUMBER> employed crossalign <NUMBER> study structural conservation sarscov<NUMBER> different strains materials methods analysis compared wuhan strain mn<NUMBER> around <NUMBER> coronaviruses data ncbi human fig <NUMBER> hosts supp fig <NUMBER> comparing sarscov<NUMBER> human coronaviruses <NUMBER> strains including sarscov merscov found conserved region falls inside spike genomic locus fig <NUMBER> precisely conserved region nucleotides <NUMBER> <NUMBER> exhibits intricate stable better investigate sequence conservation sarscov<NUMBER> compared <NUMBER> strains isolated different countries pandemic including china usa japan taiwan india brazil sweden australia data ncbi vipr wwwviprbrcorg materials methods analysis aims determine relationship structural content sequence conservation using clustal w multiple sequence alignments <NUMBER> observed general conservation coding regions fig <NUMBER>a <NUMBER> <NUMBER> show high variability due experimental procedures sequencing discarded analysis <NUMBER> one highly conserved region nucleotides <NUMBER> <NUMBER> spike genomic locus sequences upand downstream variable red bars fig <NUMBER>a used crossalign <NUMBER> compare structural content materials methods high variability structure observed <NUMBER> <NUMBER> nucleotides <NUMBER> <NUMBER> well <NUMBER> <NUMBER> associated region red bars fig <NUMBER>a rest regions significantly conserved structural level pvalue <NUMBER> fishers test compared protein sequences coded spike genomic locus ncbi reference qhd<NUMBER> found sequence fig <NUMBER>a structure fig <NUMBER> nucleotides <NUMBER> <NUMBER> highly conserved region corresponds amino acids <NUMBER> contact host receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> <NUMBER> promoting infection provoking lung injury <NUMBER> <NUMBER> contrast region upstream binding site receptor ace<NUMBER> located correspondence minimum structural profile around nucleotides <NUMBER> fig <NUMBER> highly variable <NUMBER> indicated tcoffee multiple sequence alignments <NUMBER> fig <NUMBER>a part spike region corresponds amino acids <NUMBER> merscov binds sialic acids regulating infection cellcell membrane fusion fig <NUMBER>b see related manuscript e milanetti et al <NUMBER> <NUMBER> <NUMBER> analysis suggests structural region nucleotides <NUMBER> <NUMBER> spike region conserved among coronaviruses fig <NUMBER> binding site ace<NUMBER> poor variation human sarscov<NUMBER> strains fig <NUMBER>b contrast region upstream propensity bind sialic acids <NUMBER> <NUMBER> <NUMBER> showed poor structural content high variability fig <NUMBER>b order obtain insights virus replicates human cells predicted sarscov<NUMBER> interactions whole rnabinding human proteome following protocol study structural conservation viruses <NUMBER> first divided wuhan sequence <NUMBER> fragments <NUMBER> nucleotides moving <NUMBER> <NUMBER> calculated proteinrna interactions fragment catrapid omics <NUMBER> canonical putative rnabinding proteins rbps total <NUMBER> interactions <NUMBER> proteins polypyrimidine tractbinding protein <NUMBER> ptbp<NUMBER> uniprot p<NUMBER> showed highest interaction propensity zscore materials methods <NUMBER> others heterogeneous nuclear ribonucleoprotein q hnrnpq o<NUMBER> showed highest interaction propensity <NUMBER> agreement previous studies coronaviruses fig <NUMBER>a <NUMBER> fragment predicted significant interactions filtering according z score used three different thresholds ascending order stringency z Â³ <NUMBER> <NUMBER> <NUMBER> respectively removed list proteins predicted interact promiscuously one fragment fragment <NUMBER> corresponds <NUMBER> contacted rbps around <NUMBER> zÂ³<NUMBER> highconfidence interactions fig <NUMBER>b agreement observation highly structured regions attract large number proteins <NUMBER> indeed <NUMBER> contains multiple stem loop structures control rna replication transcription <NUMBER> <NUMBER> contrast <NUMBER> fragment <NUMBER> spike still structured lesser extent attract fewer proteins <NUMBER> <NUMBER> respectively fragment <NUMBER> orf<NUMBER>ab spike predicted unstructured binding partners interactome fragment analysed using clevergo tool gene ontology go enrichment analysis <NUMBER> proteins interacting fragments <NUMBER> <NUMBER> <NUMBER> associated annotations related viral processes fig <NUMBER>c supp table <NUMBER> considering three thresholds applied materials methods found <NUMBER> viral proteins fragment <NUMBER> <NUMBER> proteins fragment <NUMBER> <NUMBER> proteins fragment <NUMBER> fig <NUMBER>d among highconfidence interactors fragment <NUMBER> discovered rbps involved positive regulation viral processes viral genome replication doublestranded rnaspecific editase <NUMBER> adarb<NUMBER> uniprot p<NUMBER> <NUMBER> <NUMBER>oligoadenylate synthase <NUMBER> oas<NUMBER> p<NUMBER> <NUMBER>adependent ribonuclease rnasel q<NUMBER> interestingly <NUMBER>oligoadenylate synthase <NUMBER> oas<NUMBER> reported upregulated human alveolar adenocarcinoma a<NUMBER> cells infected sarscov<NUMBER> log fold change <NUMBER> pvalue <NUMBER> <NUMBER> qvalue <NUMBER> <NUMBER> <NUMBER> doublestranded rnaspecific adenosine deaminase adar p<NUMBER> absent library due length meet catrapid omics requirements <NUMBER> omixcore extension algorithm specifically developed large molecules <NUMBER> attributes binding propensity adarb<NUMBER> adar thus indicating interactions might occur materials methods moreover experimental works indicate family adar deaminases active bronchoalveolar lavage fluids derived sarscov<NUMBER> patients <NUMBER> upregulated a<NUMBER> cells infected sarscov<NUMBER> log fold change <NUMBER> pvalue <NUMBER> <NUMBER> qvalue <NUMBER> <NUMBER> <NUMBER> also identified proteins related establishment integrated proviral latency including xray repair crosscomplementing protein <NUMBER> xrcc<NUMBER> p<NUMBER> xray repair crosscomplementing protein <NUMBER> xrcc<NUMBER> p<NUMBER> fig <NUMBER>b <NUMBER>e accordance calculations comparison a<NUMBER> cells responses sarscov<NUMBER> respiratory syncytial virus indicates upregulation xrrc<NUMBER> sarscov<NUMBER> log foldchange <NUMBER> pvalue <NUMBER> qvalue <NUMBER> <NUMBER> nucleolin ncl p<NUMBER> protein known involved coronavirus processing also predicted bind tightly <NUMBER> supp table <NUMBER> <NUMBER> importantly found proteins related defence response viruses atpdependent rna helicase ddx<NUMBER> q<NUMBER> involved negative regulation viral genome replication dnabinding proteins cyclint<NUMBER> ccnt<NUMBER> o<NUMBER> zinc finger protein <NUMBER> znf<NUMBER> q<NUMBER>y<NUMBER> prospero homeobox protein <NUMBER> prox<NUMBER> q<NUMBER> included could potential rnabinding ability fig <NUMBER>e <NUMBER> fragment <NUMBER> found two canonical rbps simple scaffold elements gag proteins versatile elements bind viral host proteins traffic cell membrane supp table <NUMBER> <NUMBER> analysis functional annotations carried genemania <NUMBER> revealed proteins interacting <NUMBER> sarscov<NUMBER> rna associated regulatory pathways involving notch<NUMBER> myc max previously connected viral infection processes fig <NUMBER>e <NUMBER> <NUMBER> interestingly proteins including ddx<NUMBER> ccnt<NUMBER> znf<NUMBER> fragment <NUMBER> trim<NUMBER> fragment <NUMBER> shown necessary hiv functions replication inside cell recently gordon et al reported list human proteins binding open reading frames orfs translated sarscov<NUMBER> <NUMBER> identified affinity purification followed mass spectrometry quantification <NUMBER> proteins hek<NUMBER>t cells interact viral orf peptides selecting <NUMBER> proteins binding <NUMBER> z score Â³<NUMBER> supp table <NUMBER> <NUMBER> exclusively interacting fragment <NUMBER> fig <NUMBER>b found <NUMBER> also reported list gordon et al <NUMBER> indicates significant enrichment representation factor <NUMBER> pvalue <NUMBER> hypergeometric test human proteome background fact list protein rna binding partners contains elements identified also proteinprotein network analysis surprising ribonucleoprotein complexes evolve together <NUMBER> components sustain different types interactions <NUMBER> note <NUMBER> interactions <NUMBER> rbps reported uniprot <NUMBER> represents considerable fraction ie <NUMBER> considering around <NUMBER> rbps human proteome ie <NUMBER> fully justified fact involve association viral rna comparing rbps present gordon et al <NUMBER> table <NUMBER> interestingly srp<NUMBER> larp<NUMBER> larp<NUMBER>b proteins assemble stress granules <NUMBER> <NUMBER> <NUMBER> targeted rna viruses <NUMBER> speculate sequestration elements orchestrated viral program aiming recruit host genes <NUMBER> protein kinase radixin rdx p<NUMBER> addition mentioned supp table <NUMBER> list <NUMBER> proteins binding <NUMBER> fragment <NUMBER> z score â¥<NUMBER> found <NUMBER> hits associated hiv supp table <NUMBER> q<NUMBER> rna polymeraseassociated protein rtf<NUMBER> homologue q<NUMBER> supp table <NUMBER> contrast significant enrichments found viruses instance ebola <NUMBER> among targets addition hvbrelated targets nuclear receptor subfamily <NUMBER> group member <NUMBER> nr<NUMBER>a<NUMBER> chembl<NUMBER> interferoninduced doublestranded rnaactivated protein kinase eif<NUMBER>ak<NUMBER> chembl<NUMBER> srsf protein kinase <NUMBER> srpk<NUMBER> chembl<NUMBER> hope list starting point pharmaceutical studies number proteins identified catrapid calculations previously reported coalesce large ribonucleoprotein assemblies stress granules among proteins found doublestranded rnaactivated protein kinase eif<NUMBER>ak<NUMBER> p<NUMBER> nucleolin ncl p<NUMBER> atpdependent rna helicase ddx<NUMBER> q<NUMBER> cyclint<NUMBER> ccnt<NUMBER> o<NUMBER> signal recognition particle subunit srp<NUMBER> o<NUMBER> larp<NUMBER> q<NUMBER>g<NUMBER>j<NUMBER> larelated protein <NUMBER>b heterogeneous nuclear ribonucleoprotein q hnrnpq o<NUMBER> <NUMBER> investigate propensity proteins phase separate stress granules used catgranule algorithm materials methods <NUMBER> found <NUMBER> proteins binding <NUMBER> fragment <NUMBER> z score â¥<NUMBER> highly prone accumulate stressgranules <NUMBER> proteins lowest z score used comparison pvalue<NUMBER> kolmogorovsmirnoff fig <NUMBER>g supp table <NUMBER> finding particularly relevant rna viruses known antagonize stress granules formation <NUMBER> indeed role stress granules processing bodies translation suppression rna decay impact virus replication <NUMBER> spreading using advanced computational approaches investigated structural content sarscov<NUMBER> rna predicted human proteins bind employed cross <NUMBER> <NUMBER> compare structural properties <NUMBER> coronaviruses identified elements conserved sarscov<NUMBER> strains regions containing highest amount structure <NUMBER> well glycoproteins spike membrane found spike protein domain encompassing amino acids <NUMBER> highly conserved across sarscov<NUMBER> strains result suggests spike must evolved specifically interact host partner ace<NUMBER> <NUMBER> mutations increasing binding affinity highly infrequent nucleic acids encoding region enriched doublestranded content speculate structure might attract host regulatory elements thus constraining variability fact spike region highly conserved among analysed sarscov<NUMBER> strains suggests specific drug designed prevent interactions within host contrast highly variable region amino acids <NUMBER> spike protein corresponds binding site sialic acids merscov see manuscript e milanetti et al <NUMBER> <NUMBER> <NUMBER> could play role infection <NUMBER> fact binding region changes different strains might indicate variety binding affinities sialic acids could provide clues specific responses human population interestingly sialic acid binding site absent sarscov present merscov represents important difference diseases sequence structural analyses spike protein indicate high conservation among coronaviruses suggest human engineering sarscov<NUMBER> highly unlikely using catrapid <NUMBER> <NUMBER> computed <NUMBER> protein interactions sarscov<NUMBER> found previously reported interactions polypyrimidine tractbinding protein <NUMBER> ptbp<NUMBER> heterogeneous nuclear ribonucleoprotein q hnrnpq nucleolin ncl <NUMBER> addition discovered highly structured region <NUMBER> largest number protein partners including atpdependent rna helicase ddx<NUMBER> previously reported essential hiv<NUMBER> coronavirus ibv replication <NUMBER> doublestranded rnaspecific editases adar adarb<NUMBER> catalyse hydrolytic deamination adenosine inosine <NUMBER> predicted interactions xrcc<NUMBER> xrcc<NUMBER> members hdprnp complex associating atpdependent rna helicase dhx<NUMBER> <NUMBER> well <NUMBER>adependent ribonuclease rnasel <NUMBER>oligoadenylate synthase <NUMBER> oas<NUMBER> control viral rna degradation <NUMBER> <NUMBER> interestingly ddx<NUMBER> xrcc<NUMBER> oas<NUMBER> upregulated human alveolar adenocarcinoma cells infected sarscov<NUMBER> <NUMBER> agreement predictions recent experimental work indicates family adar deaminases active bronchoalveolar lavage fluids derived sarscov<NUMBER> patients <NUMBER> significant overlap exists list protein interactions reported gordon et al <NUMBER> among candidate partners identified akap<NUMBER>l involved deadhbox rna helicase binding protein involved hiv infection <NUMBER> general proteins associated retroviral replication expected play different roles sarscov<NUMBER> sarscov<NUMBER> massively represses host gene expression <NUMBER> hypothesize virus hijacks host pathways recruiting transcriptional posttranscriptional elements interacting polymerase ii genes splicing factors instance akinase anchor protein <NUMBER>like akap<NUMBER>l larelated protein <NUMBER> larp<NUMBER> upregulated human alveolar adenocarcinoma cells infected sarscov<NUMBER> <NUMBER> link proteins previously studied context hiv viruses confirmed fro particularly relevant repurposing existing drugs <NUMBER> idea sarscov<NUMBER> sequesters different elements transcriptional machinery particularly intriguing supported fact large number proteins identified screening found stress granules <NUMBER> indeed stress granules protect host innate immunity hijacked viruses favour replication <NUMBER> moreover coronaviruses transcription uses discontinuous rna synthesis involves highfrequency recombination <NUMBER> possible pieces viruses resulting mechanism called defective interfering rnas <NUMBER> could act scaffold attract host proteins <NUMBER> <NUMBER> predicted secondary structure transcripts using cross computational recognition secondary structure <NUMBER> <NUMBER> cross developed perform highthroughput rna profiling algorithm predicts structural profile singleand doublestranded state singlenucleotide resolution using sequence information without sequence length restrictions scores <NUMBER> indicate double stranded regions used vienna method <NUMBER> investigate rna secondary structure minima maxima identified cross <NUMBER> used crossalign <NUMBER> algorithm based dynamic time warping dtw check evaluate structural conservation different viral genomes <NUMBER> crossalign previously employed study structural conservation <NUMBER> hiv genomes sarscov<NUMBER> fragments <NUMBER> nt overlapping searched inside complete genomes using obe open begin end module order search small profile inside larger one lower structural distance higher structural similarities minimum <NUMBER> almost identical secondary structure profiles significance assessed original publication <NUMBER> fasta sequences complete genomes sarscov<NUMBER> downloaded virus pathogen resource vipr wwwviprbrcorg total <NUMBER> strains regarding overall coronaviruses sequences downloaded ncbi selecting complete genomes total <NUMBER> genomes reference wuhan sequence available annotation epiisl<NUMBER> downloaded global initiative sharing influenza data gisaid httpswwwgisaidorg interactions fragment target sequence human proteome predicted using catrapid omics <NUMBER> <NUMBER> algorithm estimates binding propensity proteinrna pairs combining secondary structure hydrogen bonding van der waals contributions used clustal w <NUMBER> <NUMBER> sarscov<NUMBER> strains alignments tcoffee <NUMBER> spike proteins alignments variability spike region measured computing shannon entropy translated rna sequences shannon entropy computed follows sa sumi pai log pai correspond amino acid position pai frequency certain aminoacid position sequence low entropy indicates poorly variability pax <NUMBER> one <NUMBER> rest sx <NUMBER> contrast frequencies amino acids equally distributed entropy reaches maximum possible value catgranule <NUMBER> employed identify proteins assembling biological condensates scores <NUMBER> indicate protein prone phase separate structural disorder nucleic acid binding propensity amino acid patterns arginineglycine phenylalanineglycine key features combined computational approach <NUMBER> fig <NUMBER> c oronaviruses categorized order nidovirales family coronaviridae subfamily coronavirinae large group viral pathogens wide host range <NUMBER> infections humans mammals birds cause respiratory hepatic enteric neurological diseases varying severity <NUMBER> zoonotic transmission novel coronaviruses humans poses severe threats global health evidenced severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov sarscov<NUMBER> causing ongoing pandemic covid<NUMBER> world <NUMBER> meantime coronaviruses infecting domestic animals also bring substantial economic losses <NUMBER> example swine acute diarrhea syndrome coronavirus sadscov also known seacov peav isolated <NUMBER> caused outbreaks severe watery diarrhea suckling piglets mortality <NUMBER> several commercial pig farms guangdong province china <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sadscov Î±coronavirus representative members Î±genus porcine epidemic diarrhea virus pedv porcine transmissible gastroenteritis coronavirus tgev porcine respiratory coronavirus prcv feline infectious peritonitis virus fipv human nl<NUMBER> <NUMBER>e coronaviruses hcovnl<NUMBER> hcov<NUMBER>e <NUMBER> representative members three genera include mouse hepatitis coronavirus mhv bovine coronavirus bcov sarscov sarscov<NUMBER> merscov hcovoc<NUMBER> hcovhku<NUMBER> Î²genus avian infectious bronchitis virus ibv Î³genus porcine deltacoronavirus pdcov Î´genus <NUMBER> crossspecies transmission promoted genetic recombination andor mutations underlies host range expansion coronaviruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> bats natural reservoir <NUMBER> different Î±and Î²coronaviruses great potential interspecies transmission recombination andor mutation <NUMBER> <NUMBER> <NUMBER> <NUMBER> data genetic evolution receptor binding pathogenesis demonstrated human sarscov merscov likely originate bats <NUMBER> palm civets dromedary camels intermediate hosts sarscov merscov bats humans respectively <NUMBER> newly identified porcine sadscov isolates also found sharáº½ <NUMBER> sequence identity rhinolophus bat coronavirus hku<NUMBER> stressed severe results coronavirus spillover bats domestic animals <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however molecular mechanisms underlying transmission sadscov bats pigs still unknown need explored recently shown sadscov able infect cells broad range species including mouse chicken pig monkey human indicating high potential sadscov interspecies transmission <NUMBER> spike glycoprotein coronaviruses mediates viral entry binding host receptor s<NUMBER> subunit fusing viral cellular membranes s<NUMBER> subunit thereby determining viral host range tissue tropism <NUMBER> <NUMBER> class viral fusion protein spike exists envelope virion homotrimer monomer contains <NUMBER> amino acid residues cleaved s<NUMBER> s<NUMBER> subunits <NUMBER> coronaviruses nterminal domain ntd s<NUMBER> subunit recognizes cellsurface carbohydrates cterminal domain ctd specifically binds cellular protein receptors <NUMBER> <NUMBER> <NUMBER> sarscov sarscov<NUMBER> hcovnl<NUMBER> utilize ctd bind human receptor ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> merscov utilizes ctd bind human receptor dpp<NUMBER> <NUMBER> <NUMBER> tgev prcv <NUMBER>e utilize ctd bind receptor apn <NUMBER> <NUMBER> <NUMBER> hcovoc<NUMBER> utilizes ntd recognize glycans <NUMBER> one exception mhv utilizes ntd bind mouse receptor ceacam<NUMBER>a <NUMBER> <NUMBER> therefore s<NUMBER> subunit especially ntd ctd variable region spike responsible different tropisms coronaviruses comparison s<NUMBER> subunit containing fusion peptide fp heptad repeats hr<NUMBER> hr<NUMBER> membrane fusion conserved sequence structure <NUMBER> <NUMBER> sadscov receptor analysis indicated none known coronavirus protein receptors including ace<NUMBER> dpp<NUMBER> apn essential cell entry <NUMBER> <NUMBER> also reports regarding recognition glycans ntd sadscov structural studies spike binding glycans protein receptors provided important insights origin evolution interspecies transmission coronaviruses cryoem structures spike trimer four coronavirus genera reported Î±coronavirus spike structures determined hcovnl<NUMBER> <NUMBER> hcov<NUMBER>e <NUMBER> pedv <NUMBER> fipv <NUMBER> Î²coronavirus spike structures determined mhv <NUMBER> <NUMBER> <NUMBER> hcovhku<NUMBER> <NUMBER> hcovoc<NUMBER> <NUMBER> sarscov <NUMBER> merscov <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> Î³coronavirus spike structure determined ibv <NUMBER> Î´coronavirus spike structure determined pdcov <NUMBER> <NUMBER> cryoem structures bat coronavirus spike trimers reported crystal structures ctd hku<NUMBER> <NUMBER> hku<NUMBER> <NUMBER> hku<NUMBER> <NUMBER> determined spikes sadscov <NUMBER> amino acid residues hku<NUMBER> <NUMBER> amino acid residues among shortest coronavirus spike glycoproteins <NUMBER> amino acid identities known coronavirus spikes lower <NUMBER> indicating spikes hku<NUMBER> sadscov unique <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> study report cryoem structures sadscov hku<NUMBER> spike trimers <NUMBER> <NUMBER> Ã¥ resolution respectively hku<NUMBER> spike trimer structure first one bat coronavirus analyze hku<NUMBER> sadscov trimer structures also compare ntd ctd sd<NUMBER> sd<NUMBER> domains s<NUMBER> subunit s<NUMBER> subunit hku<NUMBER> spikes Î± Î² Î³ Î´coronaviruses results strongly support hku<NUMBER> sadscov preserve primitive structural features spikes close evolutionary relationship Î²coronavirus spikes provide insights evolution crossspecies transmission coronaviruses protein expression structure determination cdnas encoding hku<NUMBER> spike yp<NUMBER> sadscov spike avm<NUMBER> synthesized codons optimized insect cell expression hku<NUMBER> ectodomains residues <NUMBER> sadscov ectodomains residues <NUMBER> separately cloned pfastbacdual vector invitrogen cterminal foldon tag strep tag expression hi<NUMBER> insect cells purification homogeneity cryoem images two spike ectodomains recorded using fei titan krios microscope operating <NUMBER> kv gatan k<NUMBER> summit direct electron detector supplementary fig <NUMBER> <NUMBER> particles hku<NUMBER> spike <NUMBER> particles sadscov spike subjected <NUMBER>d classification total <NUMBER> particles hku<NUMBER> spike <NUMBER> particles sadscov spike selected subjected <NUMBER>d refinement c<NUMBER> symmetry generate density maps supplementary fig <NUMBER> table <NUMBER> overall structures hku<NUMBER> sadscov spikes overall structures hku<NUMBER> sadscov spikes determined resemble previously reported prefusion structures coronaviruses spikes spike trimers mushroomlike shape <NUMBER> Ã¥ height and<NUMBER> Ã¥ width fig <NUMBER>a consisting cap mainly formed Î²sheets s<NUMBER> subunit central stalk mainly formed Î±helices s<NUMBER> subunit root formed twisted Î²sheets loops s<NUMBER> subunit fig <NUMBER>a trimer c<NUMBER> axis along central stalk fig <NUMBER>a amino acid identity hku<NUMBER> sadscov spikes <NUMBER> two spike structures quite similar root mean square deviation rmsd <NUMBER> Ã¥ <NUMBER> aligned cÎ± atoms monomer <NUMBER> Ã¥ <NUMBER> aligned cÎ± atoms trimer due high structural similarity use hku<NUMBER> structure present features spikes subsequent description whereas significant differences pointed necessary s<NUMBER> subunit hku<NUMBER> spike comprises two major domains ntd ctd followed two subdomains <NUMBER> <NUMBER> sd<NUMBER> sd<NUMBER> connecting s<NUMBER> subunit fig <NUMBER>b c s<NUMBER> subunits three monomers form cap spike three ctds inner part apex sitting top central stalk three ntds located outside ctds surrounding central stalk fig <NUMBER>a ntd ctd sd<NUMBER> sd<NUMBER> s<NUMBER> subunit mainly composed Î² strands fig <NUMBER>c contrast upstream helix uh fp connecting region cr heptad repeat <NUMBER> hr<NUMBER> central helix ch s<NUMBER> subunit mainly composed helices whereas Î²hairpin bh subdomain <NUMBER> sd<NUMBER> bottom part s<NUMBER> subunit mainly consist Î² strands loops fig <NUMBER>c moreover residues sd<NUMBER> contain heptad repeat <NUMBER> hr<NUMBER> resolved hku<NUMBER> sadscov spike structures well reported coronavirus spike structures prefusion state sd<NUMBER> sd<NUMBER> s<NUMBER> subunit s<NUMBER> subunit highly similar amino acid sequence <NUMBER> <NUMBER> <NUMBER> identities structure cÎ± rmsd less <NUMBER> Ã¥ hku<NUMBER> sadscov spikes supplementary fig <NUMBER> ntd lowest sequence identity <NUMBER> among domains structural superimposition also gave higher cÎ± rmsd value <NUMBER> Ã¥ two ntds core Î²sheet structure structurally conserved conformational variations reside loops supplementary fig <NUMBER>a ctd sequence identity hku<NUMBER> sadscov spikes <NUMBER> cÎ± rmsd two ctds <NUMBER> Ã¥ also indicating structural variations ctd comparison highly conserved sd<NUMBER> sd<NUMBER> s<NUMBER> subunit ntd ctd s<NUMBER> subunit commonly utilized coronaviruses binding cellsurface carbohydrates protein receptors cell attachment <NUMBER> therefore sequence andor structural variations indicate hku<NUMBER> sadscov would also bind different host receptors ntd andor ctd s<NUMBER> subunit although receptors bat pig unknown receptorbinding sites spike defined ntd structure comparisons ntd hku<NUMBER> three layers antiparallel Î²sheet top one consisting six strands middle one consisting five strands bottom one consisting three strands bottom sheet short Î±helix fig <NUMBER>a top middle Î²sheets form galectinlike Î²sandwich fold inserted two strands bottom sheet fig <NUMBER>a supplement three disulfide bonds detected hku<NUMBER> ntd structure c <NUMBER> c <NUMBER> connecting nterminus ntd upper loop c <NUMBER> c <NUMBER> connecting Î²<NUMBER> Î²<NUMBER> strands top sheet c <NUMBER> c <NUMBER> connecting bottom helix bottom sheet fig <NUMBER>a although ntds coronaviruses adopt similar overall architecture ntd hku<NUMBER> highest structural similarity ntd<NUMBER> named domain <NUMBER> previous reports Î±coronavirus hcovnl<NUMBER> rmsd <NUMBER> Ã¥ <NUMBER> aligned cÎ± atoms fig <NUMBER>b supplementary fig <NUMBER>d ntd<NUMBER> Î±coronavirus pedv completely modeled spike trimer structure however partial model still fits well ntd hku<NUMBER> rmsd <NUMBER> Ã¥ <NUMBER> aligned cÎ± atoms hcovnl<NUMBER> pedv second ntd ntd<NUMBER> also named domain previous reports ntd hku<NUMBER> structurally less similar ntd<NUMBER> rmsd <NUMBER> Ã¥ hcovnl<NUMBER> ntd<NUMBER> <NUMBER> Ã¥ pedv ntd<NUMBER> fig <NUMBER>b supplementary fig <NUMBER>d recent structural represented ntd hcov<NUMBER>e ntd<NUMBER>s hcovnl<NUMBER> pedv fig <NUMBER>b c although sharing overall architecture two ntd subtypes structural difference galectinlike Î²sandwich fold containing top middle sheets stacked together hydrophobic interactions two Î²sheets well aligned galectinlike domain subtype whereas alignment shift galectinlike domain subtype ii fig <NUMBER>b notable difference distribution signature disulfide bonds signature disulfide bond c <NUMBER> c <NUMBER> numbered hku<NUMBER> connecting Î²<NUMBER> Î²<NUMBER> strands top sheet conserved subtype ntds fig <NUMBER>b subtype ii ntds two signature disulfide bonds first one c <NUMBER> c <NUMBER> numbered hcov<NUMBER>e connecting Î²<NUMBER> Î²<NUMBER> strands second one c <NUMBER> c <NUMBER> numbered hcov<NUMBER>e connecting Î²<NUMBER> neighbor loop fig <NUMBER>c besides c <NUMBER> c <NUMBER> numbered hku<NUMBER> connecting bottom helix bottom sheet conserved subtype subtype ii ntds fig <NUMBER>b c ntds Î²coronaviruses including bcov hcovhku<NUMBER> hcovoc<NUMBER> merscov sarscov mhv resemble subtype rather subtype ii ntd topology distribution disulfide bonds fig <NUMBER>d Î²coronavirus ntds additional loops nterminus Î²<NUMBER> Î²<NUMBER> strands Î²<NUMBER> Î²<NUMBER> strands numbered hku<NUMBER> structure forming extensive ceilinglike structure top galectinlike fold fig <NUMBER>d found evolvement ceilinglike structure functional outcomes immune evasion receptor binding <NUMBER> ntd Î³coronavirus ibv also resemble subtype ntd topology although disulfide bond positions conserved subtype ntd fig <NUMBER>e note ntd Î´coronavirus pdcov resemble subtype ii ntd topology distribution disulfide bonds fig <NUMBER>f ibv pdcov ntds also additional insertions including loops short helices galectinlike fold compared two subtypes ntd Î±coronaviruses fig <NUMBER>e f ctd structure comparisons ctd hku<NUMBER> twisted fivestranded antiparallel Î²sheet core connecting loops strands fig <NUMBER>a contains four disulfide bonds c <NUMBER> c <NUMBER> c <NUMBER> c <NUMBER> nterminus c <NUMBER> c <NUMBER> cterminus last one c <NUMBER> c <NUMBER> connecting Î²<NUMBER> Î²<NUMBER> strands core Î²sheet fig <NUMBER>a interestingly ctd core hku<NUMBER> high structural similarity conserved ctd core Î²coronaviruses disulfide bonds ctd hku<NUMBER> except c <NUMBER> c <NUMBER> also detected Î²coronavirus ctds fig <NUMBER>b ctds core one twisted Î²sheet name onelayer ctd subtype fig <NUMBER>a b Î²coronavirus ctds always insertion consisting loops andor strands Î²<NUMBER> Î²<NUMBER> strands core fig <NUMBER>b sarscov <NUMBER> sarscov<NUMBER> <NUMBER> merscov <NUMBER> hku<NUMBER> <NUMBER> hku<NUMBER> <NUMBER> receptorbinding motif rbm insertion region responsible binding respective protein receptors ctd hku<NUMBER> one short loop Î²<NUMBER> Î²<NUMBER> strands core twisted Î²sheet fig <NUMBER>a although members Î±genus hku<NUMBER> sadscov ctd structures significantly different Î±coronaviruses hcovnl<NUMBER> hcov<NUMBER>e pedv tgev prcv contain two layers Î²sheets fig <NUMBER>c named ctds twolayer ctd subtype available twolayer ctd structures well aligned cÎ± rmsd range <NUMBER> Ã¥ twolayer ctds contain two highly conserved disulfide bonds c <NUMBER> c <NUMBER> c <NUMBER> c <NUMBER> numbered pedv ctd fig <NUMBER>c c <NUMBER> c <NUMBER> conserved among coronaviruses whereas c <NUMBER> c <NUMBER> conserved Î±coronaviruses except hku<NUMBER> sads Î´coronavirus pdcov fig <NUMBER>c ctd Î´coronavirus pdcov core two Î²sheets belonging twolayer ctd subtype fig <NUMBER>c Î³coronavirus ibv core ctd also similar typical twolayer ctd fig <NUMBER>c however several Î² strands replaced loops disulfide bonds different positions twolayer ctd fig <NUMBER>c ibv ctd also extra region loops reminiscent extra domain ctds Î²coronaviruses fig <NUMBER>c sd<NUMBER> sd<NUMBER> structures comparisons sd<NUMBER> sd<NUMBER> two subdomains following ctd s<NUMBER> subunit linking ctd s<NUMBER> subunit hku<NUMBER> sd<NUMBER> partial Î² barrel consisting five Î² strands disulfide bond c <NUMBER> c <NUMBER> connecting cterminus Î²<NUMBER> strand fig <NUMBER>a fivestranded Î² barrel linking disulfide bond conserved among four genera coronavirus fig <NUMBER>a hku<NUMBER> sd<NUMBER> structure two layers Î²sheet additional short Î±helix top sheet fig <NUMBER>b additional Î±helix top sheet linked disulfide bond c <NUMBER> c <NUMBER> another disulfide bond c <NUMBER> c <NUMBER> links cterminal loop bottom sheet fig <NUMBER>b twolayer core structure second disulfide bond conserved among genera coronavirus however additional Î±helix first linking disulfide bond distinct feature Î²coronaviruses plus Î±coronavirus hku<NUMBER> sadscov fig <NUMBER>b additional helix appears insertion Î²<NUMBER> Î²<NUMBER> strands sd<NUMBER> retained evolution Î²coronaviruses quaternary packing ntd ctd spike observed coronaviruses two types quaternary packing mode s<NUMBER> subunits trimer intrasubunit packing crosssubunit packing <NUMBER> actually mainly caused different positioning interaction ntd ctd spike monomer hku<NUMBER> s<NUMBER> subunit similar Î±coronaviruses hcovnl<NUMBER> hcov<NUMBER>e pedv Î´coronavirus pdcov inward ctd contacts ntd fig <NUMBER>a three structural ntdctd modules cap region spikes composed ntd ctd monomer forming intrasubunit packing spike trimer fig <NUMBER>a s<NUMBER> subunits coronaviruses Î²and Î³genera including mhv sarscov merscov hcovoc<NUMBER> ibv outward ctd far away ntd fig <NUMBER>b therefore three structural ntdctd modules cap region spikes ntd one monomer ctd adjacent monomer forming crosssubunit packing spike trimer fig <NUMBER>b interestingly found outward ctds always insertion core structure Î²coronavirus ctds Î³coronavirus ibv ctd fig <NUMBER>b contrast inward ctds onelayer twolayer core structure without obvious inserted region conserved s<NUMBER> subunit distinct cr sequence analysis suggested s<NUMBER>s<NUMBER> protease cleavage site boundary s<NUMBER> s<NUMBER> subunits r<NUMBER>m<NUMBER> hku<NUMBER> spike r<NUMBER>m<NUMBER> sadscov spike <NUMBER> <NUMBER> <NUMBER> compared s<NUMBER> subunit topology structure s<NUMBER> subunit highly conserved coronavirus spikes hku<NUMBER> s<NUMBER> subunit contains <NUMBER>helix uh residues <NUMBER> fp helix residues <NUMBER> cr residues <NUMBER> <NUMBER>helix hr<NUMBER> residues <NUMBER> ch residues <NUMBER> twisted bh residues <NUMBER> Î²sandwich like sd<NUMBER> residues <NUMBER> figs <NUMBER>b <NUMBER>a like coronavirus spikes prefusion state model hr<NUMBER> sd<NUMBER> built structure due poor density five disulfide bonds s<NUMBER> detected two c <NUMBER> c <NUMBER> c <NUMBER> c <NUMBER> stabilize folded helices uh c <NUMBER> c <NUMBER> bends cr c <NUMBER> c <NUMBER> links ch bh c <NUMBER> c <NUMBER> within sd<NUMBER> fig <NUMBER>a first four disulfide bonds conserved coronaviruses last one sd<NUMBER> different positions different spikes specifically links Î²<NUMBER> Î²<NUMBER> strands sd<NUMBER> spikes hku<NUMBER> sadscov merscov numbered merscov coronavirus spikes links Î²<NUMBER> strand cterminal loop sd<NUMBER> numbered merscov supplementary fig <NUMBER> coronavirus spikes s<NUMBER>â² protease site upstream fp s<NUMBER> subunit essential proteolytic fusion activation spike receptor binding cleavage s<NUMBER>â² site promote largescale conformational changes fp cr hr<NUMBER> hr<NUMBER> allowing insertion fp host cell membrane formation sixhelix bundle fp cr often well totally resolved coronavirus spike structures clearly modeled hku<NUMBER> spike due atomic resolution map supplementary fig <NUMBER> typical cr s<NUMBER> subunit contains three helices one short strand disulfide bond bending first second helix form turn fig <NUMBER>b hku<NUMBER> second helix replaced short strand <NUMBER> third helix replaced loop <NUMBER> therefore two short strands one helix hku<NUMBER> cr fig <NUMBER>c conserved disulfide bond c <NUMBER> c <NUMBER> makes first helix cr hku<NUMBER> spike turn upside s<NUMBER>â² cleavage site r<NUMBER> s<NUMBER> covered reversed cr helix loops r<NUMBER> interacts e<NUMBER> loop k<NUMBER> k<NUMBER> helix <NUMBER> fig <NUMBER>c coronaviruses taking mhv s<NUMBER> example helix <NUMBER> cover s<NUMBER>â² site r<NUMBER> s<NUMBER> r<NUMBER> loosely interacts t<NUMBER> helix <NUMBER> fig <NUMBER>b dissociation s<NUMBER> subunit triggered receptor binding exposure s<NUMBER>â² site cleavage prerequisite proteolytic activation coronavirus spike mediate membrane fusion buried s<NUMBER>â² site indicates hku<NUMBER> spike compared coronavirus spikes would require conformational changes around s<NUMBER>â² site exposure porcine coronavirus sadscov also named seacov peav reports recently identified suckling piglets diarrhea southern china genome sequence identical <NUMBER> identity rhinolophus bat Î±coronavirus hku<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sadscov hku<NUMBER> phylogenetically located sublineage closely related proposed Î±coronavirus group<NUMBER>b lineage complete genome level <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however phylogenetic analysis based spike glycoprotein indicated members separate lineage clustered within Î²coronavirus supplementary fig <NUMBER>a suggesting hku<NUMBER> sadscov probably resulted recombination Î±coronavirus unrecognized Î²coronavirus gene <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> results together lower <NUMBER> amino acid identities known coronavirus glycoproteins strongly indicate spike glycoproteins hku<NUMBER> sadscov unique <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> study determined cryoem structures hcov<NUMBER>e s<NUMBER> pdcov s<NUMBER> intrasubunit packing ibv s<NUMBER> mhv s<NUMBER> sarscov s<NUMBER> crosssubunit packing <NUMBER> quaternary packing ntd ctd Î±coronavirus s<NUMBER> Î´coronavirus s<NUMBER> use intrasubunit packing pattern ntd ctd first monomer colored blue second colored red third colored magenta pdb codes hcov<NUMBER>e <NUMBER>u<NUMBER>h pdcov <NUMBER>b<NUMBER>n b Î²coronavirus s<NUMBER> Î³coronavirus s<NUMBER> use crosssubunit packing pattern ntd ctd first monomer colored blue second colored red third colored magenta extra loop ibv extra domains Î²covs colored yellow labeled ex pdb codes mhv <NUMBER>jcl ibv <NUMBER>cv<NUMBER> sars <NUMBER>xlr hku<NUMBER> sadscov spike glycoproteins atomic resolutions pairwise comparisons demonstrated nearly identical overall structures differences mainly locate loops ntd ctd s<NUMBER> subunit spikes hku<NUMBER> sadscov supplementary fig <NUMBER> series structural analysis comparisons also performed domain level hku<NUMBER> spike coronavirus spikes determined structures results show hku<NUMBER> sadscov spikes maintain primitive structural features especially ntd ctd provide insights evolution coronaviruses hku<NUMBER> sadscov one ntd s<NUMBER> subunit structures similar ntd<NUMBER> ntd<NUMBER> Î±coronaviruses hcovnl<NUMBER> pedv whereas ntd hcov<NUMBER>e structurally similar ntd<NUMBER> ntd<NUMBER> fig <NUMBER> therefore suggest Î±coronaviruses two subtypes ntd evolution relationship clear yet suggested presence two ntds hcovnl<NUMBER> result gene duplication <NUMBER> however sequence identity two ntds <NUMBER> hcovnl<NUMBER> <NUMBER> pedv considering hku<NUMBER> sadscov hcov<NUMBER>e one ntd belonging either subtype subtype ii plausible evolution way ntd Î±coronaviruses recombination two separate primitive domains genome resulting presence two ntds s<NUMBER> subunit Î±coronaviruses including hcovnl<NUMBER> pedv note two ntd subtypes may represent primitive structures could evolutionary ancestors ntds genera coronaviruses example current available spike structures ntds Î²coronavirus similar hku<NUMBER> ntd representing subtype architecture disulfide bond positions Î²coronavirus ntds also additional loop ceiling top sheet functionally facilitating immune evasion protein receptor binding mhv <NUMBER> <NUMBER> ntd Î³coronavirus ibv also architecturally similar subtype although disulfide bond positions conserved fig <NUMBER>e contrast Î´coronavirus pdcov ntd similar hcov<NUMBER>e ntd representing subtype ii architecture disulfide bond positions fig <NUMBER>f previous study ibv spike proposed Î±coronavirus ntds probably ancestral ntds four genera form evolutionary spectrum order Î± Î´ Î³ Î²genus <NUMBER> proposal similar previous one point two ntd subtypes Î±coronaviruses may represent primitive structures could evolutionary ancestors ntds however article argue evolution pathways may order Î± Î´ Î³ Î²genus plausible pathway Î² Î³ Î´coronavirus ntds may evolve independently parallelly subtype Î²and Î³coronavirus ntds subtype ii Î´coronavirus ntds supplementary fig <NUMBER>b hku<NUMBER> sadscov ctd structure onelayer core consisting twisted fivestranded antiparallel Î²sheet interestingly Î²coronavirus ctds also similar onelayer core structure three strictly conserved disulfide bonds also present core hku<NUMBER> ctd currently identified rbm Î²coronavirus ctds within inserted domain two strands core sheet insertion responsible receptor binding Î²coronaviruses replaced short loop hku<NUMBER> ctd result firstly indicates hku<NUMBER> ctd represent primitive structure onelayer ctd family inserted domain Î²coronaviruses results recombinant event evolution supplementary fig <NUMBER>c second indication hku<NUMBER> sadscov may utilize ctd bind protein receptors identified yet different receptor usage may determined ntd harbors almost <NUMBER> residue difference note ctds Î±coronaviruses Î³coronavirus ibv Î´coronavirus pdcov belong twolayer subtype consisting two layers Î²sheets although structural variations different viruses results confirmed previous phylogenetic analysis suggesting hku<NUMBER> sadscov probably resulted recombination Î±coronavirus genomic backbone unrecognized Î²coronavirus spike gene <NUMBER> <NUMBER> <NUMBER> contrast ntd ctd unique structural features sd<NUMBER> sd<NUMBER> s<NUMBER> subunit s<NUMBER> subunits hku<NUMBER> sadscov structurally conserved coronaviruses evolutionary aspect surprising region either connects ctd s<NUMBER> subunit sd<NUMBER> sd<NUMBER> mediates membrane fusion s<NUMBER> subunits whereas ntd ctd key factors determining tissue tropism host range coronaviruses <NUMBER> even highly conserved overall structure s<NUMBER> subunit hku<NUMBER> sadscov still secondary structure arrangement cr fp resulting buried s<NUMBER>â² cleavage site fig <NUMBER>c indicates although membrane fusion mechanism highly conserved dynamic fusion procedures hku<NUMBER> sadscov may still unique features need addressed future ongoing covid<NUMBER> pandemic caused sarscov<NUMBER> raised worldwide alert <NUMBER> <NUMBER> <NUMBER> compared domain structures hku<NUMBER> sarscov<NUMBER> proteins supplementary fig <NUMBER> ntd sarscov<NUMBER> two conserved disulfide bonds subtype ctd core sarscov<NUMBER> one layer Î²sheets sd<NUMBER> sd<NUMBER> sarscov<NUMBER> disulfide bonds hku<NUMBER> although additional helix sd<NUMBER> built sarscov<NUMBER> model owing poor density region sarscov<NUMBER> typical Î²coronavirus structural features domain inserted rbm ctd could major impetus crossspecies transmission bats human comparing structures hku<NUMBER> sadscov spikes coronavirus spikes observed additional ntds could recombined ceiling loops could inserted ntd core extra domain containing rbm could inserted ctd core structure phenomena indicate subdomains gradually recruited s<NUMBER> subunit evolution recruitments required crossspecies transmission adapting different host range responding updating host immune system provides vivid example coevolution virus host expression purification hku<NUMBER> sadscov spike ectodomains cdnas encoding hku<NUMBER> spike yp<NUMBER> sadscov spike avm<NUMBER> synthesized codons optimized insect cell expression hku<NUMBER> ectodomains <NUMBER> sadscov ectodomains <NUMBER> separately cloned pfastbacdual vector invitrogen cterminal foldon tag trimerization strep tag purification frame ph promoter expressed hi<NUMBER> insect cell using bactobac baculovirus system invitrogen briefly construct transformed dh<NUMBER>bac competent cells extracted bacmid transfected sf<NUMBER> cell using cellfectin ii reagent invitrogen baculoviruses harvested <NUMBER> days hightiter viruses generated one amplification used infect hi<NUMBER> cells density <NUMBER> Ã <NUMBER> <NUMBER> ml <NUMBER> h culture cell medium containing spike ectodomains concentrated exchanged binding buffer <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl spike ectodomains purified streptactin beads iba purified gelfiltration chromatography using superose <NUMBER> gel filtration column ge healthcare preequilibrated hbs buffer <NUMBER> mm hepes ph <NUMBER> <NUMBER> mm nacl purified ectodomains concentrated electron microscopy analysis cryoelectron microscopy aliquots spike ectodomains <NUMBER> Î¼l <NUMBER> mgml buffer containing <NUMBER> mm hepes ph <NUMBER> <NUMBER> mm nacl applied glowdischarged holey carbon grids quantifoil grid au <NUMBER> mesh r<NUMBER> grids blotted plungefrozen liquid ethane using fei vitrobot system fei images recorded using fei titan krios microscope operating <NUMBER> kv gatan k<NUMBER> summit direct electron detector gatan inc tsinghua university automated software autoemation used collect <NUMBER> movies hku<NUMBER> <NUMBER> movies sadscov Ã<NUMBER> magnification defocus range <NUMBER> <NUMBER> Î¼m movie total accumulate exposure <NUMBER> e â Ã¥ <NUMBER> fractionated <NUMBER> frames <NUMBER> ms exposure data collection statistics summarized table <NUMBER> whole frames movie corrected beaminduced motion using motionco<NUMBER> <NUMBER> final image bin averaged give pixel size <NUMBER> Ã¥ parameters contrast transfer function ctf estimated micrograph using gctf <NUMBER> particles automatically picked using gautomatch httpwww mrclmbcamacukkzhang extracted using relion <NUMBER> initially<NUMBER> particles hku<NUMBER> and<NUMBER> particles sads subjected <NUMBER>d classification two three additional <NUMBER>d classifications best class consisting<NUMBER> particles hku<NUMBER> and<NUMBER> particles sadscov applied creating <NUMBER>d initial model <NUMBER>d refinement <NUMBER>d classification total <NUMBER> particles hku<NUMBER> <NUMBER> particles sadscov best classes selected subjected <NUMBER>d refinement c<NUMBER> symmetry generate density map reported resolutions based goldstandard fsc cutoff <NUMBER> criterion <NUMBER> Ã¥ hku<NUMBER> spike <NUMBER> Ã¥ sadscov spike relion post processing local resolution variations estimated using resmap <NUMBER> data processing statistics summarized table <NUMBER> model building refinement hku<NUMBER> spike model building initial model hku<NUMBER> s<NUMBER> ntd generated using swissmodel <NUMBER> fit map using ucsf chimera <NUMBER> part hku<NUMBER> spike ectodomains obtained using map model phenix suit <NUMBER> sadscov spike model building initial model obtained fit hku<NUMBER> s<NUMBER> ntd ctd separately map using ucsf chimera <NUMBER> manual model rebuilding carried using coot <NUMBER> refined phenix realspace refinement <NUMBER> quality final model analyzed molprobity <NUMBER> emringer <NUMBER> validation statistics structural models summarized table <NUMBER> reporting summary information research design available nature research reporting summary linked article atomic coordinates hku<NUMBER> spike sadscov spike deposited worldwide protein data bank accession codes <NUMBER>m<NUMBER> <NUMBER>m<NUMBER> respectively corresponding maps deposited electron microscopy data bank accession codes emd<NUMBER> emd<NUMBER> respectively received <NUMBER> february <NUMBER> accepted <NUMBER> may <NUMBER> many human viral diseases consequence zoonotic event diseases caused zoonotic events affected millions people around world resulted high rates morbiditymortality humans changes viral proteins function ligands host receptor may promote spillover species recent zoonotic events caused ongoing epidemic high magnitude covid<NUMBER> epidemics caused sarscov<NUMBER> aim study determine mutations sequence spike protein sarscov<NUMBER> might favoring human human transmission silico approach performed changes detected s<NUMBER> subunit receptorbinding domain spike observed changes significant effect sarscov<NUMBER> spikeace<NUMBER> interaction produce reduction binding energy compared one batcov receptor data presented study suggest higher affinity sarscov<NUMBER> spike protein human ace<NUMBER> receptor compared one batcov spike ace<NUMBER> could cause rapid viral spread sarscov<NUMBER> humans role changes sarscov<NUMBER> spike protein interaction human ace<NUMBER> receptor silico analysis severe acute respiratory syndrome coronavirus sarscov middle eastern respiratory syndrome coronavirus merscov recently identified novel coronavirus sarscov<NUMBER> belong coronaviridae family genus betacoronavirus related important epidemiological outbreaks enveloped viruses positivesense singlestrand rna around <NUMBER> kb viral particles contain four main structural proteins spike membrane envelope protein nucleocapsid spike protein protrudes envelope virion plays pivotal role receptor host selectivity cellular attachment strong scientific evidence showed sars sarscov<NUMBER> spike proteins interact angiotensinconverting enzyme <NUMBER> ace<NUMBER> chen et al <NUMBER> also cellular receptors play secondary role viral attachment ctype lectin cd<NUMBER>l dcsign binds sarscov however ace<NUMBER> appears key functional receptor sarscov coutard et al <NUMBER> satija lal <NUMBER> probably sarscov<NUMBER> walls et al <NUMBER> interaction viral protein cell membrane receptor critical step replication cycle furthermore efficiency viral infection strongly dependent process several physicochemical factors associated proteinprotein interactions factors determined nature residues type chemical interactions occurring ligand receptor thus presence residues produce energetically favored interaction lower free energy may drive binding kinetics finally lead fusion event based study aimed evaluate energetic profile interaction sarscov<NUMBER> spike protein human cell receptor ace<NUMBER> sequences analyzed individually retrieved genbank accession numbers shown phylogenetic tree see figure <NUMBER> sequence used modeling process construct spike protein model sarscov<NUMBER> obtained protein database correspond <NUMBER>acc sars spike protein <NUMBER>acd batspike protein homology structural models viral spike protein sarscov<NUMBER> qho<NUMBER> batcov aaz<NUMBER> built using tools swissmodel modeling server deepviewswisspdbviewer <NUMBER> software arnold et al <NUMBER> several models obtained quality structure evaluated best model sarscov<NUMBER> spike obtained using crystal structure sarscov spike protein pdb code <NUMBER>acc hand batcov best model obtained using template crystal structure pdb code <NUMBER>acd models subjected protein structure optimization hydrogen atoms added partial charges assigned energy refinement protein model embedded <NUMBER> Ã¥ water box energy minimization performed applying constraints protein backbone preserve global folding optimizing relative position water molecules protein obtained systems underwent md simulations using namd described ortega et al <NUMBER> md simulations described study performed namd <NUMBER> phillips et al <NUMBER> vega zz <NUMBER> pedretti et al <NUMBER> charmm force field vanommeslaeghe et al <NUMBER> gasteiger charges used obtained structures represent lowest energy frame md simulations quality models established prosa wiederstein sippl <NUMBER> procheck programs laskowski et al <NUMBER> crystal structure sarscov spike pdb code <NUMBER>ack ace<NUMBER> pdb code <NUMBER>r<NUMBER> downloaded protein data bank also homology model sarscov<NUMBER> spike assayed protein preparation carried described binding patterns affinity estimations interaction viral spike ace<NUMBER> receptor performed using molecular docking process performed two steps first blind docking ligand spike protein receptor ace<NUMBER> performed using zdock software pierce et al <NUMBER> resulting docking data processed analyzed using tools prodigy software xue et al <NUMBER> finally results clustered analyzed considering binding energies main interacting residues complex phylogenetic analysis spike protein sequences sarscov<NUMBER> batcovs sarscov shown figure <NUMBER> results agreement recent reports independent introduction sarscov<NUMBER> batcov different spillover led introduction sarscov batcov rhinolophus affinis probable ancestor new virus wong et al <NUMBER> indeed sequences whole spike batcov sarscov<NUMBER> share <NUMBER> identity figure <NUMBER> divergence found however s<NUMBER> subunit particularly receptor binding domain rbd different spike proteins sarscov batcov rhinolophus sinicus originally signaled closely related virus sarscov<NUMBER> exhibit several amino acid substitutions deletions rbd compared sarscov<NUMBER> rbd batcov rhinolophus affinis although closely related one sascov<NUMBER> also displayed several amino acid substitutions figure <NUMBER> crystal structures spike protein sarscov homology models batcov accession number mg<NUMBER> batcov rhinolophus sinicus sarscov<NUMBER> interacting putative binding domain site human ace<NUMBER> analyzed interaction pattern three viral spikes quite similar main region interaction putative cellular receptor counterpart formed fifteen residues ordered betasheet conformation surrounded two capping loops figure <NUMBER> supplementary figure <NUMBER> interestingly sequence comparison sarscov<NUMBER> sarscov revealed residues pre sent receptorinteracting motive highly conserved <NUMBER> identity sharing nine residues viruses sarscov rbd present residues allowed interspecies infection known y<NUMBER> l<NUMBER> n<NUMBER> d<NUMBER> t<NUMBER> lu et al <NUMBER> however sarscov<NUMBER> slight modification residues could improve interaction human cellular receptor l<NUMBER> f<NUMBER> q<NUMBER> n<NUMBER> sarscov two main residues <NUMBER> <NUMBER> associated recognition human ace<NUMBER> receptor lu et al <NUMBER> residues suffered punctual mutation civet human k<NUMBER>n s<NUMBER>t li <NUMBER> sarscov<NUMBER> residues corresponding n<NUMBER> correspond q<NUMBER> t<NUMBER> n<NUMBER> changes sarscov<NUMBER> represent energetically favorable changes interaction receptor local environment present ace<NUMBER> receptor allows mutations produce significant number electrostatic stabilizing interactions table <NUMBER> furthermore mentioned previously presence two capping loops binding domain likely producing stabilization effect interaction cellular receptor models showed capping loops appear humaninfecting viruses absent bat virus data showed strongly suggest capping loops produce increase electrostatic interactions spike protein cellular receptor sarscov residues present capping loops showing direct interaction receptor r<NUMBER> s<NUMBER> t<NUMBER> y<NUMBER> p<NUMBER> d<NUMBER> s<NUMBER> n<NUMBER> sarscov<NUMBER> v<NUMBER> y<NUMBER> y<NUMBER> q<NUMBER> a<NUMBER> e<NUMBER> g<NUMBER> f<NUMBER> n<NUMBER> counterpairs located ace<NUMBER> receptor shown table <NUMBER> altogether higher number proteinprotein contacts table <NUMBER> longer capping loops could explain increase binding affinities sarscov<NUMBER> <NUMBER> kcalmol comparison sarscov <NUMBER> kcalmol table <NUMBER> thus loops could play important role together punctual mutations interesting clue determine host receptor specificity viral spike protein several amino acid substitutions rbd identified sarscov<NUMBER> rbd compared batsarscovs sarscov mutations spike protein could change tropism virus including new hosts increasing viral pathogenesis hiv infection good model change viral tropism mutations envelope proteins mutations switch coreceptor use ccr<NUMBER> cxcr<NUMBER> increasing viral pathogenesis mosier <NUMBER> interestingly data showed changes related ability interaction human ace<NUMBER> receptor also improving receptor recognition presence two loops around rbd sarscov<NUMBER> might promoting interaction ace<NUMBER> receptor improving binding receptor increasing number atoms involved tables <NUMBER> <NUMBER> amino acid substitutions longer capping loops could explain increase binding affinities sarscov<NUMBER> compared sarscov table <NUMBER> higher affinity values might related dynamic infection rapid spread observed virus origin sarscov<NUMBER> fully elucidated study course another study wong et al <NUMBER> showed high similarity protein level rbd among coronaviruses isolated recent outbreak sarscov<NUMBER> isolated pangolin rhinolophus affinis ratg<NUMBER> authors also suggest pangolin might intermediate host <NUMBER> identity human virus receptor binding motif bat human spike model ratg<NUMBER> quite similar obtained sarscov sarscov<NUMBER> loops rbd also present data shown protein sequence receptor binding motif <NUMBER> important amino acids comparing sequence sarscov<NUMBER> isolated viruses pangolin rhinolophus affinis <NUMBER> <NUMBER> differences observed respectively amino acids considered key union ace<NUMBER> yan et al <NUMBER> wong et al <NUMBER> differences mean slightly less favorable binding energies viruses ace<NUMBER> compared sarscov<NUMBER> shown study thus loops observed spike protein sarscov<NUMBER> could play important role together amino acid substitutions interesting clue determine host receptor specificity viral spike protein altogether structural changes residues composition viral spike protein could associated increased infection kinetics viral spreading comparative studies determine impact vitro mutation loops rbd sarscov sarscov<NUMBER> required order predict possible zoonotic event future wuhan hubei province china december <NUMBER> death toll rose <NUMBER> among <NUMBER> confirmed cases around globe april <NUMBER> <NUMBER> <NUMBER> virus causing covid<NUMBER> named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> based phylogenetic studies sarscov<NUMBER> categorized member genus betacoronavirus lineage includes sars coronavirus sarscov <NUMBER> caused sars severe acute respiratory syndrome china <NUMBER> <NUMBER> recent studies showed sarscov<NUMBER> close relationship bat sarslike covs <NUMBER> <NUMBER> <NUMBER> interestingly glycoprotein characterized critical determinant viral entry host cells consists two functional subunits namely s<NUMBER> s<NUMBER> s<NUMBER> subunit recognizes binds host receptor receptorbinding domain rbd whereas s<NUMBER> responsible fusion host cell membrane <NUMBER> <NUMBER> <NUMBER> merscov uses dipeptidyl peptidase<NUMBER> dpp<NUMBER> entry receptor <NUMBER> whereas sarscov sarscov<NUMBER> utilize ace<NUMBER> angiotensin converting enzyme<NUMBER> <NUMBER> abundantly available lung alveolar epithelial cells enterocytes suggesting glycoprotein potential drug target halt entry sarswith remarkable properties like glutaminerich <NUMBER> aa long exclusive molecular signature dsqqtvgqqdgsednqtttiqtivevqpqlemeltpvvqtie position <NUMBER> polyprotein <NUMBER>ab pp<NUMBER>ab <NUMBER> diversified receptorbinding domain rbd unique furin cleavage site prrarâsv s<NUMBER>s<NUMBER> boundary glycoprotein could play roles viral pathogenesis diagnosis treatment <NUMBER> date genomic variations sarscov<NUMBER> reported <NUMBER> <NUMBER> growing evidence spike protein <NUMBER> amino acid long glycoprotein multiple domains possibly plays major role sarscov<NUMBER> pathogenesis viral entry host cell initiated receptorbinding domain rbd s<NUMBER> head upon receptorbinding proteolytic cleavage occurs s<NUMBER>s<NUMBER> cleavage site two heptad repeats hr s<NUMBER> stalk form sixhelix bundle structure triggering release fusion peptide comes close proximity transmembrane anchor tm tm domain facilitates membrane destabilization required fusion virushost membranes <NUMBER> <NUMBER> insights sequence variations glycoprotein among available genomes key understanding biology sarscov<NUMBER> infection developing antiviral treatments vaccines study analyzed <NUMBER> genomic sequences sarscov<NUMBER> identify mutations available genomes followed amino acid variations glycoprotein foresee impact viral entry host cell structural biology viewpoint analysis ncbi reference sequence sarscov<NUMBER> glycoprotein accession number yp<NUMBER> used canonical sequence analyses spike protein variants variant analyses sarscov<NUMBER> genomes performed genome detective coronavirus typing tool version <NUMBER> specially designed virus dataset aligned muscle <NUMBER> entropy hx plot nucleotide variations sarscov<NUMBER> genome constructed using bioedit <NUMBER> mega x version <NUMBER> used construct msas phylogenetic tree using pairwise alignment neighborjoining methods clustalw <NUMBER> <NUMBER> tree structure validated running analysis <NUMBER> bootstraps <NUMBER> replications dataset evolutionary distances calculated using poisson correction method <NUMBER> variant sequences sarscov<NUMBER> modeled swissmodel <NUMBER> using cryoem spike protein structure sarscov<NUMBER> pdb id <NUMBER>vsb <NUMBER> template overall quality models assessed rampage server <NUMBER> generating ramachandran plots supplementary table <NUMBER> pymol biovia discovery studio used structure visualization superpose <NUMBER> <NUMBER> j u r n l p r e p r f <NUMBER> results multiple sequence alignment available <NUMBER> genomes sarscov<NUMBER> performed <NUMBER> variations found throughout <NUMBER> bp long sarscov<NUMBER> genome total <NUMBER> variations utr region <NUMBER> synonymous variations cause amino acid alteration <NUMBER> nonsynonymous variations causing change amino acid residue <NUMBER> indels <NUMBER> variations noncoding region supplementary table <NUMBER> among <NUMBER> variations <NUMBER> variations <NUMBER> synonymous <NUMBER> nonsynonymous mutations one deletion observed region orf encodes glycoprotein responsible viral fusion entry host cell <NUMBER> notable sarscov<NUMBER> genome sequences deposited usa <NUMBER> china <NUMBER> supplementary fig <NUMBER> positional variability sarscov<NUMBER> genome calculated msa <NUMBER> sarscov<NUMBER> whole genomes measure entropy value hx <NUMBER> excluding <NUMBER>â² <NUMBER>â² utr ten hotspot hypervariable position identified seven located orf<NUMBER>ab <NUMBER>ct <NUMBER>ct <NUMBER>ct <NUMBER>ct <NUMBER>ct <NUMBER>ag <NUMBER>ct one orf <NUMBER>ag orf<NUMBER>a <NUMBER>gt orf<NUMBER> <NUMBER>tc respectively variability position <NUMBER> <NUMBER> found highest among hotspots fig <NUMBER> phylogenetic analysis total <NUMBER> sequences <NUMBER> unique sarscov<NUMBER> <NUMBER> different coronavirus glycoprotein sequences performed evolutionary distances showed sarscov<NUMBER> spike proteins cluster node phylogenetic tree confirming sequences similar refseq yp<NUMBER> fig <NUMBER> bat coronaviruses close evolutionary relationship different strains found nearest outgroups clades bat coronavirus bm<NUMBER> bat hpbeta coronavirus bat coronavirus hku<NUMBER> conferring j u r n l p r e p r f journal preproof coronavirus vast geographical spread bat prevalent host fig <NUMBER> clades clusters speculated different hosts may describe evolutionary changes surface glycoprotein due cross species transmission viral hosts reported different spots different times indicative possible recombination glycoprotein sequences sarscov<NUMBER> retrieved ncbi virus variation resource repository aligned using clustalw position sarscov<NUMBER> spike protein domains measured aligning sarscov spike protein fig <NUMBER> <NUMBER> <NUMBER> sequence identity matrix <NUMBER> unique variants among unique sarscov<NUMBER> spike glycoprotein sequences identified <NUMBER> substitutions deletion fig <NUMBER>a supplementary table <NUMBER> <NUMBER> sequences found identical sarscov<NUMBER> protein reference sequence yp<NUMBER> <NUMBER> sequences identical variation d<NUMBER>g supplementary table <NUMBER> respectively due substitution amino acid differs charge remaining <NUMBER> variants mutated amino acids similar charge fig <NUMBER> sarscov<NUMBER> spike protein variants superposed cryoelectron microscopic structure sarscov<NUMBER> spike protein <NUMBER> fig <NUMBER> s<NUMBER> subunit spike protein especially heptad repeat region <NUMBER> fusion peptide domain transmembrane domain cytoplasmic tail found highly conserved sarscov sarscov<NUMBER> variants s<NUMBER> subunit diverse specifically nterminal domain ntd receptorbinding domain rbd spatial distribution protein sequences different variation time reveals variants <NUMBER> <NUMBER> glycoprotein sequences reported us j u r n l p r e p r f journal preproof followed <NUMBER> <NUMBER> sequences including y<NUMBER> deletion <NUMBER> <NUMBER> sequences india china respectively fig <NUMBER> one variant found one available sequence repository sweden australia south korea peru interestingly sequences unique among countries sequence reported except d<NUMBER>g found us peru fig <NUMBER> moreover also analyzed sequences brazil italy nepal pakistan spain taiwan vietnam variation glycoprotein sequence found compared refseq yp<NUMBER> covid <NUMBER> one contagious pandemics world ever <NUMBER> confirmed cases date april <NUMBER> <NUMBER> cases increased high <NUMBER> times less month <NUMBER> phylogenetic analysis showed sarscov<NUMBER> unique coronavirus presumably related bat coronavirus bm<NUMBER> hpbetacoronavirus study <NUMBER> <NUMBER> <NUMBER> likewise number studies targeting sarscov<NUMBER> spike protein undertaken therapeutic measures <NUMBER> unique structural functional details sarscov<NUMBER> spike protein still scrutiny also found variant r<NUMBER>i receptor binding domain rbd mutated positively charged arginine residue neutral smaller sized isoleucine residue fig <NUMBER> change might alter interaction viral rbd host receptor r<NUMBER> residue sarscov<NUMBER> known interact ace<NUMBER> receptor viral entry <NUMBER> similarly alterations rbd g<NUMBER>s v<NUMBER>a h<NUMBER>q a<NUMBER>s also could affect interaction sarscov<NUMBER> spike protein molecules j u r n l p r e p r f require investigations qia<NUMBER> qis<NUMBER> variants found alteration alanine valine a<NUMBER>v aspartic acid tyrosine d<NUMBER>y respectively alpha helix hr<NUMBER> domain previous reports indicated hr<NUMBER> domain plays significant role viral fusion entry forming helical bundles hr<NUMBER> mutations including alanine substitution valine a<NUMBER>v hr<NUMBER> region predominantly responsible conferring resistance mouse hepatitis coronaviruses hr<NUMBER> derived peptide entry inhibitors <NUMBER> study hypothesizes mutation a<NUMBER>v found sarscov<NUMBER> might also role emergence drugresistance virus strains also mutation d<NUMBER>h found heptad repeat <NUMBER> hr sarscov<NUMBER> could play vital role viral pathogenesis moreover found <NUMBER> variants including one deletion <NUMBER> located within s<NUMBER> especially within ntd rbd region glycoprotein fig <NUMBER>a region responsible preliminary interaction host cell receptor ace<NUMBER> indicates ntd rbd prone mutations however ntd rbd portions harbour potential epitopes might serve potential peptide vaccine candidates sarscov<NUMBER> reported different studies <NUMBER> <NUMBER> <NUMBER> reason behind choosing sequences protein domain ntd rbd situated outer surface virus could accessible immune system fig <NUMBER>c variations reported herein within outer domains glycoprotein could help design effective epitopebased vaccines antivirals sarscov<NUMBER> protein contains additional furin protease cleavage site prrars s<NUMBER>s<NUMBER> domain conserved among <NUMBER> sequences revealed study supplementary fig <NUMBER> unique signature thought make sarscov<NUMBER> virulent sarscov regarded novel features viral pathogenesis <NUMBER> according previous reports host cell protease process coronavirus accelerate viral tropism accordingly influenza virus <NUMBER> <NUMBER> <NUMBER> <NUMBER> apart could also promote viruses escape antiviral therapies targeting transmembrane protease j u r n l p r e p r f tmprss<NUMBER> clinicaltrialsgov nct<NUMBER> well reported protease cleave s<NUMBER>s<NUMBER> glycoprotein <NUMBER> comparative analyses sarscov sarscov<NUMBER> spike glycoprotein showed <NUMBER> similarity diverse region recent severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> outbreak posed great challenge human health past <NUMBER> decades encountered outbreak many deadly viruses ebola <NUMBER> zika <NUMBER> nipah <NUMBER> <NUMBER> well evolution various strains coronaviruses cov mainly sarscov <NUMBER> merscov <NUMBER> resulted high morbidity mortality almost <NUMBER> years deadly influenza virus h<NUMBER>n<NUMBER> spanish flu pandemic millions deaths worldwide approximately <NUMBER> million <NUMBER> <NUMBER> recent outbreak novel cov sarscov<NUMBER> left entire world helplessness misery clinical spectrum covid<NUMBER> ranges mild fever cough shortness breath severe clinical conditions characterized respiratory failure <NUMBER> <NUMBER> old age together preexisting conditions lung heart disease diabetes compromised immune system expedite infection time severity <NUMBER> <NUMBER> multiple recent reviews <NUMBER> <NUMBER> could briefup statistical dynamics covid<NUMBER> cases worldwide structurally cov largest known rna genome <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> kb among known viruses characterized nonsegmented positivesense singlestranded rna genome encodes four major structural proteins virus including nucleocapsid n envelope e membrane spike proteins <NUMBER> <NUMBER> membrane envelope proteins associated virus assembly spike protein plays main role facilitating virus entry via mediating interaction transmembrane surface receptor host cells <NUMBER> <NUMBER> spike protein directly interacts peptidase domain pd angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> <NUMBER> technically marks virus entry inside cells <NUMBER> sarscov<NUMBER> shares around <NUMBER> sequence identity sarscov genome suggesting similarity host interacting functions <NUMBER> <NUMBER> like sarscov spike protein sarscov<NUMBER> contains s<NUMBER> s<NUMBER> subunits jointly responsible fusion entry virus <NUMBER> <NUMBER> <NUMBER> inside host cells receptorbinding domain rbd s<NUMBER> subunit initiates direct binding ace<NUMBER> pd whereas s<NUMBER> subunit contains basic elements needed membrane fusion <NUMBER> <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> singlepass type transmembrane metallocarboxypeptidase enzyme primarily involved maturation peptide hormone angiotensin ang turn regulates vasoconstriction blood pressure <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> primarily expressed alveolar epithelial type ii cells serves viral receptor <NUMBER> <NUMBER> besides alveolar epithelial type ii cells also expressed several extrapulmonary tissues including heart kidney intestine <NUMBER> <NUMBER> fulllength structure ace<NUMBER> consists two main domainsthe nterminal pd collectrinlike domain cld cterminal end <NUMBER> <NUMBER> <NUMBER> <NUMBER> fact spike glycoprotein sarscov<NUMBER> binds homodimer ace<NUMBER> facilitates virus entry host cells <NUMBER> <NUMBER> addition studies conducted association ace<NUMBER> amino acid transporter b<NUMBER>at<NUMBER> slc<NUMBER>a<NUMBER> sarscov<NUMBER> may bind ace<NUMBER>b<NUMBER>at<NUMBER> complex <NUMBER> <NUMBER> ace<NUMBER> interaction b<NUMBER>at<NUMBER> could aid producing antivirals vaccine block cov infection targeting ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current epidemiology sarscov<NUMBER> vaccine might considered highly anticipated therapy however given vaccine development production highly challenging timeconsuming task need hour develop potent therapeutic agents could effectively curb infection early stages several approaches decoysoluble ace<NUMBER> proteins antibodies serum infected patients epitopebased vaccines repurposing drugs designing blocking peptides underway <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> peptides possess several attractive features compared small molecules protein therapeutics including high structural compatibility target proteins ability disrupt proteinprotein interfaces etc computational tools ease way reach therapeutic solution covid<NUMBER> currently computational analysis structural differences human ace<NUMBER> impact binding sarscov<NUMBER> spike protein thereby lays foundation design development ace<NUMBER>based peptide inhibitors sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> current study used computational biology tools develop therapeutic strategy utilizing novel peptide exploiting sarscov<NUMBER>ace<NUMBER> interaction protein sequence sarscov<NUMBER> retrieved rcsb protein data bank pdb id <NUMBER>m<NUMBER> peptide design development initially stretch <NUMBER> amino acid residues glu<NUMBER> leu<NUMBER> taken ace pd pdb <NUMBER>m<NUMBER> saved pdb using build structure module discovery studio visualizer biovia ds <NUMBER> <NUMBER> sequence optimized geometry using minimize functionality ucsf chimera software <NUMBER> performed alanine scanning better understand individual roles residues within <NUMBER>amino acid peptide binding sarscov<NUMBER> alanine substitution residue performed using biovia discovery studio <NUMBER> software <NUMBER> peptide modeled energy minimized using ucsf chimera software <NUMBER> also truncated five residues nterminal end <NUMBER>amino acid <NUMBER>aa peptide get shorter <NUMBER>amino acids peptide phe<NUMBER> leu<NUMBER> peptide energy minimized using method described crystal structure sarscov<NUMBER> spike proteinace<NUMBER> pdb id <NUMBER>m<NUMBER> complex retrieved protein data bank https wwwrcsborg used starting point docking studies molecular docking performed using pydock https lifebscespidpydoc kweb <NUMBER> haddock <NUMBER> <NUMBER> zdock <NUMBER> servers validate results program turn mutually correlated docking results analyzed using chimera <NUMBER> ds visualizer programs <NUMBER> results obtained analyzed binding energies peptide conformations sarscov<NUMBER> spike protein binding interface molecular dynamics md simulations performed <NUMBER> ns modeled protein coordinates structure stored examined utilizing analytical tool gromacs <NUMBER> package <NUMBER> toxicity relevant molecular mechanistic values peptides electrostatics desolation van der waals vdw force predicted using toxinpred server https crddosddnetragha vatoxin pred <NUMBER> toxinpred insilico method developed predict design toxicnontoxic peptides main dataset used method consists <NUMBER> toxic peptides â¤ <NUMBER> residues physiochemical characteristics peptide sequences determined using protparam tool https webexpas yorgprotp aram expasy database server <NUMBER> fig <NUMBER> crystal structure sarscov<NUMBER> spike protein ace<NUMBER> pd domain pdb id <NUMBER>m<NUMBER> retrieved protein data bank https wwwrcsborg interface residues sarscov<NUMBER> spike protein ace<NUMBER> pd domain visualized interpreted using ucsf chimera software <NUMBER> detailed analysis interface residues small stretch ace<NUMBER> pd nterminal region <NUMBER>amino acids glu<NUMBER> leu<NUMBER> found interacting majorly sarscov<NUMBER> spike protein fig <NUMBER> table <NUMBER> furthermore evaluated whether <NUMBER>amino acid chain alone without remainder ace<NUMBER> pd domain could bind sarscov<NUMBER> spike protein hence <NUMBER>aa sequence taken ace<NUMBER> pd domain docked sarscov<NUMBER> spike protein <NUMBER>m<NUMBER> using pydock program <NUMBER> perform nonbiased analysis performed blind docking run whereby specify binding site docking simulations obtained results clustered analyzed comparing binding energies docked conformations peptide within sarscov<NUMBER> spike protein table <NUMBER> interestingly found peptide binds sarscov<NUMBER> spike protein exactly place original ace<NUMBER> pd domain interacts shows <NUMBER>amino acid sequence independently potential inhibit interaction sarscov<NUMBER> spike protein ace<NUMBER> complex docking analysis sarscov<NUMBER>ace<NUMBER> peptide interface determined critical interacting amino acids identified ace<NUMBER> pd domainderived peptide involved binding sarscov<NUMBER> spike protein table <NUMBER> computational alanine scanning performed identify critically important amino acids <NUMBER>aa peptide inhibitor involved binding sarscov<NUMBER> spike protein approach alanine scanning contributes estimating binding energy residue total binding energy original peptide <NUMBER> process involves substitution amino acid alanine records resulting binding energy changes molecular docking substituted threedimensional structure peptide substitution alanine results significant drop overall free binding energy residues considered critically important residues binding <NUMBER> hence performed alanine scanning <NUMBER>aa peptide determine significance residue inhibitory potential independently interacting ace<NUMBER> binding region srascov<NUMBER> spike protein amino acids peptide independently mutated alanine using biovia discovery studio <NUMBER> software <NUMBER> alaninesubstituted peptides modeled minimized using ucsf chimera program <NUMBER> fig <NUMBER> however mutated residues f<NUMBER>a f<NUMBER>a h<NUMBER>a f<NUMBER>a y<NUMBER>a l<NUMBER>a found critically important binding stabilizing peptidesarscov<NUMBER> spike protein complex fig <NUMBER> observed change â <NUMBER> kcalmol â <NUMBER> drop total binding score fig <NUMBER> furthermore deleted nonsignificant identified alanine scanning residues found deletion residue f<NUMBER> l<NUMBER> would make unstable structure hence removed five residues e<NUMBER> q<NUMBER> a<NUMBER> k<NUMBER> t<NUMBER> nterminal region peptide retained residues f<NUMBER> l<NUMBER> resulting final <NUMBER>aa peptide addition molecular mechanistic values electrostatics table <NUMBER> vdw usually weak force type intermolecular force enhancing attraction binding ligand receptor vdw forces involved maintenance stabilization drugreceptor complex replacing respective amino acids f<NUMBER> f<NUMBER> h<NUMBER> f<NUMBER> y<NUMBER> l<NUMBER> alanine significantly reduces binding score either directly losing interaction changing peptide conformation becomes less compatible sarscov<NUMBER> spike protein hence based results alanine scanning peptide shortened extreme nterminus due dispensability sarscov<NUMBER> binding final peptide derivative f<NUMBER> l<NUMBER> d<NUMBER> k<NUMBER> f<NUMBER> n<NUMBER> h<NUMBER> e<NUMBER> a<NUMBER> e<NUMBER> d<NUMBER> l<NUMBER> f<NUMBER> y<NUMBER> q<NUMBER> s<NUMBER> s<NUMBER> l<NUMBER> docked analyzed validate binding efficiency utilized three stateoftheart programs pydock <NUMBER> zdock <NUMBER> haddock <NUMBER> <NUMBER> validate docking studies top poses retrieved software package resulted conformations close original <NUMBER>amino acid peptide thereby validating efficacy potent sarscov<NUMBER> inhibitor fig <NUMBER> final <NUMBER>aa peptide molecular weight <NUMBER> amino acid composition ala <NUMBER> asn n <NUMBER> asp <NUMBER> gln q <NUMBER> glu e <NUMBER> h <NUMBER> leu l <NUMBER> lys k <NUMBER> phe f <NUMBER> ser <NUMBER> tyr <NUMBER> total number negatively charged residues four asp glu table <NUMBER> interacting residues <NUMBER> interface sarscov<NUMBER> docked <NUMBER> aa peptide <NUMBER> interface sarscov<NUMBER> docked <NUMBER> aa peptide <NUMBER> interface sarscov<NUMBER> blue docked <NUMBER> aa peptide red underlined bold residues making strong interactions peptides sarscov<NUMBER> spike protein sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> ace<NUMBER> angiotensinconverting enzyme <NUMBER> pd peptidase domain total number positively charged residues two lys extinction coefficient calculated units â<NUMBER> cm â<NUMBER> <NUMBER> nm measured water found <NUMBER> Â± <NUMBER> useful estimation coefficient spectrophotometrically following protein purifying halflife prediction time takes half amount protein cell disappear synthesis cell presently used expasy tool protparam relies nend rule relates halflife protein identity nterminal residue prediction given three model organisms human yeast escherichia coli considering nterminal sequence considered f phe estimated halflife <NUMBER> <NUMBER> h mammalian reticulocytes vitro instability index ii computed <NUMBER> classifies protein unstable physical stability peptides influenced intrinsic external factors prediction peptide stability suggests precautionary steps taken make therapeutically potent unstable peptides stable certain biochemical analysis predicted aliphatic index peptide found <NUMBER> grand average hydropathicity gravy â <NUMBER> toxinpred used predict toxicity <NUMBER>aa peptide desired toxicity mutating minimum number amino acids <NUMBER> toxinpred tool allows us submit query peptide fasta format optimize peptide sequence obtain maximumminimumdesired toxicity based quantitative matrixbased positionspecific scores comparing toxicnontoxic data set insilico predicted toxinpred toxicity results <NUMBER>aa peptide indicate nontoxic compared mutated peptides a<NUMBER> f<NUMBER> l<NUMBER> f<NUMBER> e<NUMBER> a<NUMBER> l<NUMBER> f<NUMBER> y<NUMBER> q<NUMBER> s<NUMBER> s<NUMBER> l<NUMBER> sarscov<NUMBER> r<NUMBER> d<NUMBER> e<NUMBER> r<NUMBER> q<NUMBER> g<NUMBER> k<NUMBER> i<NUMBER> y<NUMBER> r<NUMBER> l<NUMBER> f<NUMBER> v<NUMBER> e<NUMBER> g<NUMBER> f<NUMBER> n<NUMBER> c<NUMBER> y<NUMBER> q<NUMBER> y<NUMBER> g<NUMBER> respective docked complexes <NUMBER>aa <NUMBER>aa peptides target protein subjected md simulation studies analysing stability terms root mean square deviation rsmd potential interactions <NUMBER> ns stability two proteinpeptide complexes analyzed using rmsd backbone atoms calculated average rmsd complexes range <NUMBER> nm <NUMBER> nm <NUMBER>aa <NUMBER>aa peptide complexes respectively fig <NUMBER> end <NUMBER> ns timescale simulation proteinpeptide complexes attained stable conformations fig <NUMBER> lower rmsd values obtained comparing initial final peptide complex conformations fig <NUMBER>b revealed docked complexes stable hence much difference conformations course dynamics simulation several advantages peptides including ease synthesis modifications low toxicity high target specificity selectivity led us design potential therapeutic candidate covid<NUMBER> present insilico study first step towards designing inhibitory peptides block sarscov<NUMBER> entry host cell peptide could inhibit binding sarscov<NUMBER> spike protein ace<NUMBER> pd domain earliest stage sarscov<NUMBER> infection findings study suggest peptide <NUMBER>amino acids could considered selective therapeutic candidate covid<NUMBER> study conducted han kral shows similar aspects towards designing peptide inhibitor <NUMBER> identification <NUMBER> interacting residues ace<NUMBER> pd rbd sarscov<NUMBER> spike protein <NUMBER> Ã¥ region crystal structure pdb <NUMBER>m<NUMBER> agreement findings han kral <NUMBER> however comparison structurally stable <NUMBER>aa peptide inhibitor comprising ace<NUMBER> pd residues ranging positions <NUMBER> inhibitor <NUMBER> peptide comprising residues <NUMBER> structurally unstable nonspecific hence made multiple modifications thereby changes properties well similarity peptide total <NUMBER> interacting residues ace<NUMBER> pd <NUMBER> residues stretch q<NUMBER> l<NUMBER> utilizing fact study residue <NUMBER> stretch <NUMBER>aa peptide ace<NUMBER> pd estimated functional significance structural stability based binding energy conformational stability contrast inhibitor <NUMBER> obtained stable <NUMBER>aa peptide inhibitor nonsignificant residues truncated noninteracting residues within <NUMBER>aa peptide interfacial site found important binding stability peptide hence inhibitor <NUMBER> han kral differs structural stability composition specificity due presence nonsignificant residues leading deformity helical structure provision experimental investigations desired synthesized peptide combination computational studies needed confirm complete study recommended compare computational results designed peptides vitro vivo eventually clinical studies time writing new coronavirus also known sarscov<NUMBER> causes severe acute respiratory syndrome <NUMBER> <NUMBER> caused approximately death approximately <NUMBER> infection <NUMBER> people covid<NUMBER> outbreak represents serious threat public health <NUMBER> world health organization officially declared pandemic date <NUMBER> coronavirus strains known infect humans approved therapies vaccine available <NUMBER> past two decades addition sarscov<NUMBER> two Î²coronavirus caused three severe epidemics worldwide sarscov <NUMBER> <NUMBER> merscov <NUMBER> respectively cause severe acute respiratory syndrome sars middle east respiratory syndrome mers characteristics interactions viruses human cell receptors carefully studied shed light diffusion speed mortality rate differences sarscov<NUMBER> others special regard sarscov indeed sarscov spread across <NUMBER> countries six continents caused total <NUMBER> cases <NUMBER> deaths <NUMBER> <NUMBER> incubation period <NUMBER> <NUMBER> days <NUMBER> side demonstrated latency sarscov<NUMBER> varies <NUMBER> days average <NUMBER> days <NUMBER> thus average latency sarscov<NUMBER> slightly longer sarscov <NUMBER> moreover estimated epidemiological data individuals infected sarscov<NUMBER> conta authors contributed equally present work â  corresponding author edoardomilanettiuniroma<NUMBER>it gious beginning incubation period incubation period end infection infected individual transmits infection <NUMBER> people <NUMBER> sarscov<NUMBER> similarly sarscov merscov attacks lower respiratory system thus causing viral pneumonia however infection also affect gastrointestinal system heart kidney liver central nervous system <NUMBER> <NUMBER> <NUMBER> face emergency epidemic essential shed light interaction mechanisms virus human cell receptors well characterized sarscov infection mediated highaffinity interactions receptorbinding domain rbd spike glycoprotein humanhost angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> spike protein located virus envelope promotes attachment host cell fusion virus cellular membrane <NUMBER> <NUMBER> recently also proven several critical residues sarscov<NUMBER>s rbd provide favorable interactions human ace<NUMBER> consistent sarscov<NUMBER>s capability infect cell <NUMBER> <NUMBER> experimental side also confirmed vivo experiments sarscov<NUMBER>s entry mediated lung cell ace<NUMBER> receptors <NUMBER> importantly structure spikeace<NUMBER> receptor complex recently determined crioem <NUMBER> conclusion understood sarscov<NUMBER> binds ace<NUMBER> receptor infect host cell using spike proteins rbd even likely evolved sarscov independently <NUMBER> since ace<NUMBER> molecule known human entry receptor understanding molecular mechanisms interaction ace<NUMBER> receptor spike protein virus key factor designing new drug compounds aim computational methods based sequence structure studies proteins represent powerful tool <NUMBER> indeed development effective computational methods predicting binding sites proteins improve understanding many molecular mechanisms <NUMBER> <NUMBER> <NUMBER> several methods analyze protein interaction used protein surface information <NUMBER> <NUMBER> <NUMBER> <NUMBER> promising strategy study molecular interaction determine using deep learning methods chemicophysical features molecular surface <NUMBER> method allows efficiently detect binding sites unfortunately drawbacks deep learning approach requires definition training several parameters creation sufficiently large training test database method also requires analysis possible orientations relative positions binding sites work present new general method efficiently describe shape molecular surfaces apply study interactions spike proteins corresponding receptors involved sarscov merscov sarscov<NUMBER> infection mechanisms method proposed first time describes regions molecular surface <NUMBER>d zernike formalism indeed local patch <NUMBER>d protein molecule represented surface <NUMBER>d square grid retaining distance angular information respect specific reference system applying zernike expansion compute completely unsupervised numerical descriptors summarize patch geometry use compute structural similarity two patches zernike descriptors rotationally invariant ensuring method high efficiency low computational cost since avoids necessity preliminary structure orientation overall operations substantially reduce search space dimensionality thus allowing method able explore several protein regions compared previous methods first apply method large dataset proteinprotein complexes proteinprotein dataset test ability method detect interacting regions noninteracting regions use definition complementarity method recognizes interactions large proteinprotein database good precision furthermore thanks low computational cost building invariant description blindly sample entire surfaces <NUMBER> interacting proteins retrieve binding sites use formalism study interaction spike protein membrane receptors comparing sarscov<NUMBER> sarscov mers demonstrate actual region binding spike protein ace<NUMBER> human sarscov sarscov<NUMBER> higher complementarity respect randomly sampled exposed receptor regions furthermore also analyze detail structural properties mers spike protein like several proteins belonging coronaviruses family interact sialic acids <NUMBER> among coronaviruses bovine coronavirus bcov two human coronaviruses oc<NUMBER> hku<NUMBER> employ sialoglycanbased receptors <NUMBER>oacetylated sialic acid <NUMBER>oacsia key component <NUMBER> viruses bind cell surface components containing nacetyl<NUMBER>oacetylneuraminic acid interaction essential initiation infection <NUMBER> particular propose possible alternative mechanism sarscov<NUMBER> cellular infection spike protein interaction sialic acid receptors upper airways similarly shown mers spike protein <NUMBER> indeed highlight surface region nterminal domain sarscov<NUMBER> spike similar mers spike sialic acidbinding region present compatible charge observations suggest two pockets potentially share analogous function second infection mechanism sarscov<NUMBER> could explain high diffusion speed last decade <NUMBER>d zernike formalism widely applied characterization molecular interactions <NUMBER> <NUMBER> <NUMBER> <NUMBER> work adopted new representation based <NUMBER>d zernike polynomials allows quantitative characterization protein surface regions shown fig<NUMBER> computational protocol associates molecular patch ordered set numbers expansion coefficients describes shapes compact description possible analyze similarity <NUMBER> different regions suggesting example similar ligand <NUMBER> binding regions study complementarity <NUMBER> interacting surfaces validate method firstly collected large structural dataset proteinprotein complexes characterize binding sites <NUMBER>d zernike test method ability recognize higher complementarity observed pairs interacting surfaces compared lower complementarity found <NUMBER> surfaces noninteracting thus analyze detail interactions sarscov<NUMBER> spike protein membrane receptors comparing sarscov<NUMBER> properties sarscov merscov selected structural dataset composed <NUMBER> experimentally determined proteinprotein com b selected patch points fitted plane reoriented way zaxis passes centroid points orthogonal plane point c along zaxis defined largest angle perpendicular axis secant connecting c surface point equal <NUMBER> finally point distance r point c evaluated c point surface projected fit plane binned square grid pixel average r values points inside pixel associated resulting <NUMBER>d projection patch represented set <NUMBER>d zernike invariant descriptors ef given proteinprotein complex pdb code <NUMBER>b<NUMBER>f example surface vertex select patch centered compute zernike descriptors blindly identify two binding sites sampled patch compared patches molecular partner vertex associated minimum distance patch patches molecular partner associated g smoothing process surface point values applied highlight signal regions characterized mostly low distance values high shape complementarity plexes recent paper presented state art patch recognition computational method <NUMBER> complex selected interacting regions characterized <NUMBER>d zernike invariant descriptors therefore binding site associated onedimensional vector allowing us easily compare shape protein regions euclidean distance zernike descriptors two regions complementary characterized low distance corresponding zernike vectors <NUMBER> test ability method recognize two interacting regions compared much distance zernike descriptors see methods pair interacting binding sites smaller distances random patches particular define random patch set set <NUMBER> patches randomly extracted <NUMBER> biggest protein dataset <NUMBER> patches protein proteinprotein complex define real distance distance interacting surfaces random ones values observed comparisons binding site one protein random patch set unsupervised method excellent ability recognizing binding regions respect random patches area roc curve <NUMBER> note state art supervised method described <NUMBER> shape descriptors considered achieves auc <NUMBER> patches comparable sizes meaning approach clearly overcome performances shape complementarity recognition furthermore much lower computational time needed calculation <NUMBER>d zernike descriptors allows extensive sampling surfaces pair proteins complex centering surface point molecular patch generate protein high number zernike descriptors comparing patches two proteins label surface point binding propensity maximum complementarity recorded zernike descriptors patch others belonging molecular partner surface real binding region expected demarcated mostly composed elements high complementarity make binding region high complementarity evident smooth signal attributing vertex surface average value vertices closer <NUMBER>Ã¥ see method example fig<NUMBER> report result method specific case pdb code <NUMBER>b<NUMBER>f procedure clearly identifies binding regions two proteins subset <NUMBER> proteinprotein complexesthe smallest terms number surface vertices perform blind search interacting regions results promising since average value auc corresponding roc <NUMBER> fourteen forty proteins auc higher <NUMBER> comparison complementarity sarscov sarscov<NUMBER> spike protein human ace<NUMBER> receptor excellent promising results found large dataset encouraged us investigate pressing problem coronavirus interaction host cell first analyzed shape complementarity spike proteins sarscov sarscov<NUMBER> complex human ace<NUMBER> receptor <NUMBER> <NUMBER> interesting notice contact spike ace<NUMBER> receptor sarscov sarscov<NUMBER> occurs two separate interacting regions see fig <NUMBER> meaning need investigate two interacting regions separately comparing two raw distances found ace<NUMBER>sarscov distance smaller ace<NUMBER>sarscov<NUMBER> one even complexes complementarity much higher one would find random regions complexes see figure <NUMBER> note appropriate comparison need define suitable ensemble random patches indeed random regions sampled molecular surface spike protein imposing center two patches distance binding region observed experimental complex real spike binding region ensemble <NUMBER> sampled regions compared receptor binding sites results analysis shown fig <NUMBER> show distance distribution random regions report distance real binding regions ace<NUMBER>sarscov ace<NUMBER>sarscov<NUMBER> complex method works recognizing interacting patches real binding regions show higher complementarity lower distance randomly sampled regions furthermore analysis shows ace<NUMBER> receptor slightly higher shape complementarity sarscov sarscov<NUMBER> spike protein however results quite comparable among accordance experimental data <NUMBER> although currently known spike protein sarscov<NUMBER> binds ace<NUMBER> receptor host cells <NUMBER> <NUMBER> investigation possible infection mechanism key factor study disease specifically work <NUMBER> authors underline necessity elucidate whether sarscov<NUMBER> spike protein could acquired ability bind sialic acid merscov recently shown besides usual receptor dipeptidylpeptidase <NUMBER> receptor merscov spike protein interacts sialic acid molecules <NUMBER> using wellidentified pocket nterminal region protein makes virus able interact high airways reach low airway cells <NUMBER> recognition spike sialic acids occurs via conserved groove plays key role merscovmediated attachment sialosides entry human airway epithelial cells <NUMBER> since interaction merscov spike sialic acids caused mainly hydrogen bonds shape complementarity <NUMBER> method particularly suitable find sarscov<NUMBER> spike surface region similar one involved binding sialic acid merscov spike using experimental structure merscov spike sialic acid molecules complexes <NUMBER> extract binding region describe zernike descriptors sample corresponding domains sarscov sarscov<NUMBER> spike building molecular patch surface point characterizing corresponding zernike descriptors region sampled spike proteins <NUMBER> viruses compared merscov spike binding gion looking similar region mediate interaction similar ligand fig <NUMBER> show results analysis particular selecting region similar merscov binding site identified one region sarscov sarscov<NUMBER> spike protein interestingly best region sarscov<NUMBER> spike exhibits higher similarity pocket selected sarscov spike moreover calculate electrostatic potential involved surfaces efsurf webserver <NUMBER> shown fig <NUMBER> cartoon representation region found molecular surface sarscov<NUMBER> spike similar mers spike region interacting sialic acid terms shape electrostatic similarity differently region identified sarscov spike exhibit electrostatic clearly dissimilar sialic binding site merscov spike making unlikely interaction sialic acid region addition fig<NUMBER> propose multiple sequence alignment software clustal omega <NUMBER> three spike proteins importantly proposed sarscov<NUMBER> binding site besides structurally surface region bordering corresponding mers pocket composed set consecutive residues sequence number <NUMBER> constituting insertion respect sarscov spike sequence thus insertion adomain spike protein could confer sarscov<NUMBER> capability infecting human cells dual strategy making possible high diffusion speed virus blind prediction interaction regions molecules still open challenge despite great steps made however need fast reliable theoretical computational tools capable guide speedup experiments becomes especially important face emergencies like present one emergency caused novel sarscov<NUMBER> human infection spreading impressive rate world health organization officially declared pandemic indeed last months seen extensive studies virushost interactions focusing particular various stages cell internalization mechanism recent works found analogy case sarscov sarscov<NUMBER> uses spike protein bind ace<NUMBER> receptors mostly associated lower respiratory ways experimental investigations highlighted comparable receptor binding affinity novel coronavirus older sarscov even binding regions display certain degree variability <NUMBER> modest difference binding affinity seems insufficient explain higher humanhuman transmission rate respect sarscov overall sequence variability suggest sarscov<NUMBER> may optimized directions acquiring ability binding receptors <NUMBER> work present new fast computational method compactly summarizes morphological properties surface region protein testing unsupervised method large dataset proteinprotein interactions proved excellent ability correctly recognize high shape complementarity occurring interacting surfaces analyzing newly available experimental structures sarscov<NUMBER> spike protein complex human ace<NUMBER> found binding region presents indeed comparable slightly slower shape complementarity analogous complex sarscov minimal difference enforces hypothesis apparent higher fitness sarscov<NUMBER> lie elsewhere particular looking members large coronavirus family one finds many members developed ability bind two distinct receptors one binding site cterminal domain sprotein generally binds proteinlike receptors like ace<NUMBER> sarscov sarscov<NUMBER> situated nterminal region usually able bind sugarlike receptors particular merscov found able bind sialic acid receptors camel human bat cells applying method sialic acidbinding region recently determined experimentally merscov found exceptionally similar region corresponding region sarscov<NUMBER> spike region similar structure merscov correspondent one absent sarscov see figure <NUMBER> could able mediate lowaffinity highavidity interaction sialic acid interestingly sequence variability spike protein recently studied considering sarscov<NUMBER> sequences belonging <NUMBER> different strains <NUMBER> shows high conservation level ace<NUMBER> binding site highest variability located region indicate potentially involved sialic acid biding evidence confirm importance region regulating hostcell infection <NUMBER> conclusion propose dual cell entry mechanism explain high diffusion speed virus exhibits strongly encourage accurate investigation observation dataset proteinprotein complexes experimentally solved xray crystallography taken <NUMBER> selected pair interactions regarding chains <NUMBER> residues proteinprotein dataset therefore composed <NUMBER> complexes â¢ complex sarscov spike protein human ace receptor pdb code <NUMBER>acj â¢ complex sarscov<NUMBER> spike protein human ace receptor pdb code <NUMBER>m<NUMBER> â¢ complex mers spike protein sialic acid pdb code <NUMBER>q<NUMBER> â¢ unbound sarscov spike protein pdb code <NUMBER>crv â¢ unbound sarscov<NUMBER> spike protein modeled itasser server <NUMBER> use dms <NUMBER> compute solvent accessible surface proteins structure given xray structure pdb format <NUMBER> using density <NUMBER> points per <NUMBER> water probe radius <NUMBER>Ã¥ unit normals vector point surface calculated using flag ân putative sialic acidbinding region sarscov<NUMBER> predicted zernikebased method left right projected region putative interaction sarscov sialic acid electrostatic potential surface cartoon representation sarscov spike protein highlighted binding site c b sarscov spike protein given molecular surface described set point threedimensional cartesian space region interest surface define surface patch Ï intersection region interest surface principle region interest arbitrary shape work chose use spherical region radius r <NUMBER>Ã¥ one point surface center see figure <NUMBER>a patch selected fit plane passes points Ï reorient patch way zaxis perpendicular plane going center plane given point c zaxis define angle Î¸ largest angle perpendicular axis secant connecting c point surface Ï c set order Î¸ <NUMBER> â¢ r distance c surface point build square grid associate pixel mean r points inside <NUMBER>d function zernike invariant descriptors invariant rotation space next section provide brief summary main features zernike basis several good reviews like <NUMBER> offer detailed discussions schematic representation procedure shown figure <NUMBER>b given function f r Ï polar coordinates defined inside region r <NUMBER> unitary circle possible represent function zernike basis  expansion coefficients zernike polynomials complex functions composed radial angular part radial part certain couple indexes n given general couple polynomials one finds z nm z n Ï n <NUMBER> Î´ nn Î´ mm <NUMBER> ensures polynomials form basis knowing set complex coefficients c nm allows univocal reconstruction original image resolution depends order expansion n maxn found n <NUMBER> corresponds number coefficients <NUMBER> allows good visual reconstruction original image taking modulus coefficient z nm c nm set descriptors obtained remarkable feature invariant rotations around origin unitary circle shape similarity two patches assessed comparing zernike invariants associated <NUMBER>d projections particular similarity patch j measured euclidean distance invariant vectors ie comparing patches relative orientation patches projection unitary circle must evaluated intuitively search similar regions must compare patches orientation projected <NUMBER>d plane ie solventexposed part surface must oriented direction patches example positive zaxis instead want assess complementarity two patches must orient patches contrariwise ie one patch solventexposed part toward positive zaxis toward negative zaxis velocity procedure patch <NUMBER>d surface produces set invariant descriptors allows vast screening couples surfaces look similar also complementary regions order identify binding region given couple proteins associate point one surface vector zernike invariants associate patch point center another set invariants point surface orientation point say protein <NUMBER> compute euclidean distance points surface associated protein <NUMBER> associate point minimum found distance viceversa protein <NUMBER> see figure <NUMBER>e f smoothing process surface point values applied order highlight signal regions characterized mostly low distance values high shape complementarity time writing new coronavirus also known sarscov<NUMBER> causes severe acute respiratory syndrome <NUMBER> <NUMBER> caused approximately death approximately <NUMBER> infection <NUMBER> people covid<NUMBER> outbreak represents serious threat public health <NUMBER> world health organization officially declared pandemic date <NUMBER> coronavirus strains known infect humans approved therapies vaccine available <NUMBER> past two decades addition sarscov<NUMBER> two Î²coronavirus caused three severe epidemics worldwide sarscov <NUMBER> <NUMBER> merscov <NUMBER> respectively cause severe acute respiratory syndrome sars middle east respiratory syndrome mers characteristics interactions viruses human cell receptors carefully studied order shed light diffusion speed mortality rate differences sarscov<NUMBER> others special regard sarscov indeed sarscov spread across <NUMBER> countries six continents caused total <NUMBER> cases <NUMBER> deaths <NUMBER> <NUMBER> incubation period <NUMBER> <NUMBER> days <NUMBER> side demonstrated latency sarscov<NUMBER> varies <NUMBER> days average <NUMBER> days <NUMBER> thus average latency sarscov<NUMBER> slightly longer sarscov <NUMBER> moreover estimated epidemiological data individuals infected sarscov<NUMBER> contagious beginning incubation period incubation period end infection infected individual transmits infection <NUMBER> people <NUMBER> sarscov<NUMBER> similarly sarscov merscov attacks lower respiratory system thus causing viral pneumonia however infection also affect gastrointestinal system heart kidney liver central nervous system <NUMBER> <NUMBER> <NUMBER> face emergency epidemic essential shed light interaction mechanisms virus human cell receptors well characterised sarscov infection mediated highaffinity interactions receptorbinding domain rbd spike glycoprotein humanhost angiotensin converting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> spike protein located virus envelope promotes attachment host cell fusion viral cellular membrane <NUMBER> <NUMBER> recently also proven several critical residues sarscov<NUMBER>s rbd provide favorable interactions human ace<NUMBER> consistent sarscov<NUMBER>s capability infect cell <NUMBER> <NUMBER> experimental side also confirmed vivo experiments sarscov<NUMBER>s entry mediated lung cell ace<NUMBER> receptors <NUMBER> importantly structure spikeace<NUMBER> receptor complex recentely determined crioem <NUMBER> conclusion understood sarscov<NUMBER> binds ace<NUMBER> receptor infect host cell using spike proteins rbd even likely evolved sarscov independently <NUMBER> since ace<NUMBER> molecule known human entry receptor understanding molecular mechanisms interaction ace<NUMBER> receptor spike protein virus key factor designing new drug compounds aim computational methods based sequence structure studies proteins represent powerful tool <NUMBER> indeed development effective computational methods predicting binding sites proteins improve understanding many molecular mechanisms <NUMBER> <NUMBER> <NUMBER> several methods analyze protein interaction used protein surface information <NUMBER> <NUMBER> <NUMBER> <NUMBER> promising strategy study molecular interaction determine using deep learning methods chemicophysical features molecular surface <NUMBER> method allows efficiently detect binding sites unfortunately drawbacks deep learning approach requires definition training several parameters creation sufficiently large training test database method also requires analysis possible orientations relative position binding sites work present new general method efficiently describe shape molecular surfaces apply study interactions spike proteins corresponding receptors involved sarscov merscov sarscov<NUMBER> infection mechanisms method proposed first time describes regions molecular surface <NUMBER>d zernike formalism indeed local patch <NUMBER>d protein molecule represented surface <NUMBER>d square grid retaining distance angular information respect specific reference system applying zernike expansion compute completely unsupervised numerical descriptors summarize patch geometry use compute structural similarity two patches zernike descriptors rotationally invariant ensuring method high efficiency low computational cost since avoids necessity preliminary structure orientation overall operation substantially reduces search space dimensionality thus allowing method able explore several protein regions compered previous methods firstly apply method large dataset proteinprotein complexes proteinprotein dataset test ability method detect interacting regions noninteracting regions use definition complementarity method recognize interactions large proteinprotein database good precision furthermore thanks low computational cost building invariant description blindly sample entire surfaces <NUMBER> interacting proteins retrieve binding sites use formalism study interaction spike protein membrane receptors comparing sarscov<NUMBER> sarscov mers demonstrate actual region binding spike protein ace<NUMBER> human sarscov sarscov<NUMBER> higher complementarity respect randomly sampled exposed receptor region furthermore also analize detail structural properties mers spike protein like several proteins belonging coronaviruses family able interact sialic acids <NUMBER> among coronaviruses bovine coronavirus bcov two human coronaviruses oc<NUMBER> hku<NUMBER> employ sialoglycanbased receptors <NUMBER>oacetylated sialic acid <NUMBER>oacsia key component <NUMBER> viruses bind cell surface components containing nacetyl<NUMBER>oacetylneuraminic acid interaction essential initiation infection <NUMBER> particular propose possible alternative mechanism sarscov<NUMBER> cellular infection spike protein interaction sialic acid receptors upper airways similarly shown mers spike protein <NUMBER> indeed highlights surface region nterminal domain sarscov<NUMBER> spike similar mers spike sialic acid binding region present compatible charge observations suggest two pockets potentially share analogous function second infection mechanism sarscov<NUMBER> could explain high diffusion speed last decade <NUMBER>d zernike formalism widely applied characterization molecular interactions <NUMBER> <NUMBER> <NUMBER> <NUMBER> work adopted new representation based <NUMBER>d zernike polynomials allows quantitative characterization protein surface regions shown fig<NUMBER> computational protocol associates molecular patch ordered set numbers expansion coefficients describes shapes compact description possible analyze similarity <NUMBER> different regions suggesting example similar ligand <NUMBER> binding regions study complementarity <NUMBER> interacting surfaces validate method firstly collected large structural dataset proteinprotein complexes characterize binding sites <NUMBER>d zernike test method ability recognize higher complementarity observed pairs interacting surfaces compared lower complementarity found <NUMBER> surfaces noninteracting thus analyze detail interactions sarscov<NUMBER> spike protein membrane receptors comparing sarscov<NUMBER> properties sarscov merscov selected structural dataset composed <NUMBER> experimentally determined proteinprotein com b selected patch points fitted plane reoriented way zaxis passes centroid points orthogonal plane point c along zaxis defined largest angle perpendicular axis secant connecting c surface point equal <NUMBER> finally point distance r point c evaluated c point surface projected fit plane binned square grid pixel average r values points inside pixel associated resulting <NUMBER>d projection patch represented set <NUMBER>d zernike invariant descriptors ef given proteinprotein complex pdb code <NUMBER>b<NUMBER>f example surface vertex select patch centered compute zernike descriptors blindly identify two binding sites sampled patch compared patches molecular partner vertex associated minimum distance patch patches molecular partner associated g smoothing process surface point values applied order highlight signal regions characterized mostly low distance values high shape complementarity plexes recent paper presented state art patch recognition computational method <NUMBER> complex selected interacting regions characterized <NUMBER>d zernike invariant descriptors therefore binding site associated one dimensional vector allowing us easily compare shape protein regions euclidean distance zernike descriptors two regions complementary characterized low distance corresponding zernike vectors <NUMBER> test ability method recognize two interacting regions compared much distances zernike descriptors see methods pair interacting binding sites smaller distances <NUMBER> random patches particular proteinprotein complex define real distance distance interacting surfaces random set formed comparison binding site one protein binding sites extracted complexes dataset unsupervised method good ability recognize true pair binding regions respect random patches auc roc <NUMBER> comparing patches r <NUMBER>Ã¥ note state art supervised method described <NUMBER> achieves auc <NUMBER> considered shape descriptors similar patches <NUMBER> â <NUMBER>Ã¥ geodedic lenght furthermore much lower computational time needed calculation <NUMBER>d zernike descriptors allows extensive sampling surfaces pair proteins complex centering surface point molecular patch generate protein high number zernike descriptors comparing patches two proteins label surface point binding propensity maximum complementarity recorded zernike descriptors patch others belonging molecular partner surface real binding region expected demarcated mostly composed elements high complementarity make binding region high complementarity evident smooth signal attributing vertex surface average value vertices closer <NUMBER>Ã¥ see method example fig<NUMBER> report result method specific case pdb code <NUMBER>b<NUMBER>f procedure clearly identify binding regions two proteins subset <NUMBER> proteinprotein complexesthe smallest terms number surface vertices perform blind search interacting regions results promising since average value auc corresponding roc <NUMBER> fourteen forty proteins auc higher <NUMBER> comparison complementarity sarscov sarscov<NUMBER> spike protein human ace<NUMBER> receptor excellent promising results found large dataset encouraged us investigate pressing problem coronavirus interaction host cell first analyzed shape complementarity spike proteins sarscov sarscov<NUMBER> complex human ace<NUMBER> receptor <NUMBER> <NUMBER> interesting notice contact spike ace<NUMBER> receptor sarscov sarscov<NUMBER> occurs two separate interacting regions see fig <NUMBER> meaning need investigate two interacting regions separately comparing two raw distances found ace<NUMBER>sarscov distance smaller ace<NUMBER>sarscov<NUMBER> one even complexes complementarity much higher one would find random regions complexes see figure <NUMBER> note appropriate comparison need define suitable ensemble random patches indeed random regions sampled molecular surface spike protein imposing center two patches distance binding region observed experimental complex real spike binding region ensemble <NUMBER> sampled regions compared receptor binding sites results analysis shown fig <NUMBER> show distances distribution random regions report distance real binding regions ace<NUMBER>sarscov ace<NUMBER>sarscov<NUMBER> complex method works recognizing interacting patches real binding regions show higher complementarity lower distance randomly sampled regions furthermore analysis shows ace<NUMBER> receptor slightly higher shape complementarity sarscov sarscov<NUMBER> spike protein however results quite comparable among accordance experimental data <NUMBER> although currently known spike protein sarscov<NUMBER> binds ace<NUMBER> receptor host cells <NUMBER> <NUMBER> investigation possible infection mechanism key factor study disease specifically work <NUMBER> authors underline necessity elucidate whether sarscov<NUMBER> spike protein could acquired ability bind sialic acid merscov fact recently shown besides usual receptor dipeptidylpeptidase <NUMBER> receptor merscov spike protein interacts sialic acid molecules <NUMBER> using well identified pocket nterminal region protein makes virus able interact high airways reach low airway cells <NUMBER> recognition spike sialic acids occurs via conserved groove plays key role merscovmediated attachment sialosides entry human airway epithelial cells <NUMBER> since interaction merscov spike sialic acids caused mainly hydrogen bonds shape complementarity <NUMBER> method particularly suitable find sarscov<NUMBER> spike surface region similar one involved binding sialic acid merscov spike using experimental structure merscov spike sialic acid molecules complexes <NUMBER> extract binding region describe zernike descriptors sample corresponding domains sarscov sarscov<NUMBER> spike building molecular patch surface point characterizing corresponding zernike descriptors region sampled spike proteins <NUMBER> viruses compared merscov spike binding region looking similar regions mediate interaction similar ligand fig <NUMBER> show results analysis partic ular selecting region similar merscov binding site identified one region sarscov sarscov<NUMBER> spike protein interestingly best region sarscov<NUMBER> spike exhibits higher similarity pocket selected sarscov spike moreover calculate electrostatic potential involved surfaces efsurf webserver <NUMBER> shown fig <NUMBER> cartoon representation region found molecular surface sarscov<NUMBER> spike similar mers spike region interacting sialic acid terms shape electrostatic similarity differently region identified sarscov spike exhibit electrostatic clearly dissimilar sialic binding site merscov spike making unlikely interaction sialic acid region addition fig<NUMBER> propose multiple sequence alignment software clustal omega <NUMBER> three spike proteins importantly proposed sarscov<NUMBER> binding site besides structurally surface region bordering corresponding mers pocket composed set consecutive residues sequence number <NUMBER> constituting insertion respect sarscov spike sequence thus insertion adomain spike protein could confer sarscov<NUMBER> capability infecting human cells dual strategy making possible high diffusion speed virus putative sialic acid binding region sarscov<NUMBER> predicted zernikebased method left right projected region putative interaction sarscov sialic acid electrostatic potential surface cartoon representation sarscov spike protein highlighted binding site c b sarscov spike protein blind prediction interaction regions molecules still open challenge despite great steps made however need fast reliable theoretical computational tools capable guide speedup experiments becomes especially important face emergencies like present one emergency caused novel sarscov<NUMBER> human infection spreading impressive rate world health organization officially declared pandemic indeed last months seen extensive studies virushost interactions focusing particular various stages cell internalization mechanism recent works found analogy case sarscov sarscov<NUMBER> uses spike protein bind ace<NUMBER> receptors mostly associated lower respiratory ways experimental investigations highlighted comparable receptor binding affinity novel coronavirus older sarscov even binding regions display certain degree variability <NUMBER> binding affinity seems insufficient explain higher humanhuman transmission rate respect sarscov overall sequence variability suggest sarscov<NUMBER> may optimized directions acquiring ability binding receptors <NUMBER> work present new fast computational method compactly summarizes morphological properties surface region protein testing unsupervised method large dataset proteinprotein interactions proved ability correctly recognize high shape complementarity occurring interacting surfaces analizing newly available experimental structures sarscov<NUMBER> spike protein complex human ace<NUMBER> found binding region presents indeed comparable slightly slower shape complementarity analogous complex sarscov minimal difference enforces hypothesis apparent higher fitness sarscov<NUMBER> lie elsewhere particular looking members large coronavirus family one finds many members developed ability bind two distinct receptors one binding site cterminal domain sprotein like ace<NUMBER> sarscov sarscov<NUMBER> situated nterminal region usually able bind sugarlike molecules particular merscov found able bind sialic acid receptors camel human bat cells applying method sialic acid binding region recently determined experimentally merscov found exceptionally similar region corresponding region sarscov<NUMBER> spike speculate region similar structure merscov one absent sarscov see figure <NUMBER> could able mediate lowaffinity highavidity interaction sialic acid conclusion propose dual cell entry mechanism explain high diffusion speed virus exhibits strongly encourage accurate investigation observation dataset proteinprotein complexes experimentally solved xray crystallography taken <NUMBER> selected pair interactions regarding chains <NUMBER> residues proteinprotein dataset therefore composed <NUMBER> complexes â¢ complex sarscov spike protein human ace receptor pdb code <NUMBER>acj â¢ complex sarscov<NUMBER> spike protein human ace receptor pdb code <NUMBER>m<NUMBER> â¢ complex mers spike protein sialic acid pdb code <NUMBER>q<NUMBER> â¢ unbound sarscov spike protein pdb code <NUMBER>crv â¢ unbound sarscov<NUMBER> spike protein modeled itasser server <NUMBER> use dms <NUMBER> compute solvent accessible surface proteins structure given xray structure pdb format <NUMBER> using density <NUMBER> points per <NUMBER> water probe radius <NUMBER>Ã¥ unit normals vector eac point surface calculated using flag ân given molecular surface described set point three dimensional cartesian space region interest surface define surface patch Ï intersection region interest surface principle region interest arbitrary shape work chose use spherical region radius r one point surface center see figure <NUMBER>a patch selected fit plane passes though points Ï reorient patch way zaxis perpendicular plane going center plane given point c zaxis define angle Î¸ largest angle perpendicular axis secant connecting c point surface Ï c set order Î¸ <NUMBER> â¢ r distance c surface point build square grid associate pixel mean r points inside <NUMBER>d function expanded basis zernike polynomials norm coefficients expansion constitute zernike invariant descriptors invariant rotation space next section provide brief summary main features zernike basis several good reviews like <NUMBER> offer detailed discussions schematic representation procedure shown figure <NUMBER>b given function f r Ï polar coordinates defined inside region r <NUMBER> unitary circle possible represent function zernike basis c nm n <NUMBER> Ï z nm f n <NUMBER> Ï <NUMBER> <NUMBER> drr <NUMBER>Ï <NUMBER> dÏz nm r Ïf r Ï <NUMBER> expansion coefficients zernike polynomials complex functions composed radial angular part radial part certain couple indexes n given general couple polynomials one finds z nm z n Ï n <NUMBER> Î´ nn Î´ mm <NUMBER> ensures polynomials form basis knowing set complex coefficients c nm allows univocal reconstruction original image resolution depends order expansion n maxn found n <NUMBER> corresponds number coefficient <NUMBER> allows good visual reconstruction original image taking modulus coefficient z nm c nm set descriptors obtained remarkable feature invariant rotations around origin unitary circle shape similarity two patches assessed comparing zernike invariants associated <NUMBER>d projections particular similarity patch j measured euclidean distance invariant vectors ie comparing patches relative orientation patches projection unitary circle must evaluated intuitively search similar regions must compare patches orientation projected <NUMBER>d plane ie solvent exposed part surface must oriented direction patches example positive zaxis instead want assess complementarity two patches must orient patches contrariwise ie one patch solventexposed part toward positive zaxis toward negative zaxis velocity procedure patch <NUMBER>d surface produces set invariant descriptors allows vast screening couples surfaces order look similar also complementary regions order identify binding region given couple proteins associate point one surface vector zernike invariants associate patch point center another set invariants point surface orientation point say protein <NUMBER> compute euclidean distance points surface associated protein <NUMBER> associate point minimum found distance viceversa protein <NUMBER> see figure <NUMBER>e f smoothing process surface point values applied order highlight signal regions characterized mostly low distance values high shape complementarity conformations also observed coronaviruses <NUMBER> closed conformation three rbds buried interface three protomers whereas open conformation one rbds rotates therefore primed binding ace<NUMBER> addition wrapp et al demonstrate open conformation represents predominant state spike protein trimer <NUMBER> rbd sarscov<NUMBER> spike protein binds human receptor ace<NUMBER> studies shang et al lan et al yan et al illuminate atomicresolution details interaction <NUMBER> <NUMBER> <NUMBER> fig <NUMBER>c note ace<NUMBER> normally functions promote maturation angiotensin hormone controls blood pressure aberrant ace<NUMBER> levels linked cardiovascular diseases <NUMBER> may play role disease severity observed covid<NUMBER> patients comorbid conditions heart blood lung diseases diabetes yan et al describe cryoem structure complex full length human ace<NUMBER> rbd sarscov<NUMBER> spike protein suggest two spike protein trimers simultaneously bind ace<NUMBER> dimer <NUMBER> precise binding interface sarscov<NUMBER> spike rbd ace<NUMBER> dissected crystal structures complex determined shang et al lan et al <NUMBER> <NUMBER> fig <NUMBER>d analyzing structure shang et al uncovered several hotspots distinguish binding sarscov<NUMBER> sarscov <NUMBER> authors found overall rbdace<NUMBER> interface sarscov<NUMBER> complex larger binding interface sarscov complex rbd sarscov<NUMBER> forms contacts ace<NUMBER> including three additional intermolecular salt bridges involving q<NUMBER> g<NUMBER> rbd k<NUMBER> e<NUMBER> k<NUMBER> ace<NUMBER> dashed lines fig <NUMBER>d receptorbinding ridge rbd sarscov<NUMBER> complex adopts compact conformation allowing adjacent loop move closer ace<NUMBER> f<NUMBER> rbd insert hydrophobic pocket ace<NUMBER> structural differences could account <NUMBER>to <NUMBER>fold increase binding affinity sarscov<NUMBER> spike rbd toward ace<NUMBER> compared sarscov observed independently several groups <NUMBER> analysis crystal structures rbd sarscov spike protein complex established sarscov neutralizing human m<NUMBER> <NUMBER>r antibodies reveals antibodies bound binding site ace<NUMBER> <NUMBER> implying neutralizing mechanism direct blockage receptor binding lan et al estimate <NUMBER> <NUMBER> epitope residues m<NUMBER> <NUMBER> <NUMBER> epitope residues <NUMBER>r conserved rbd sequences sarscov sarscov<NUMBER> may explain lack appreciable crossreactivity antibodies <NUMBER> interestingly recent structure rbd sarscov<NUMBER> spike protein bound another antibody isolated sars patient cr<NUMBER> determined yuan et al shows cr<NUMBER> targets epitope distal ace<NUMBER>binding site may provide crossreactivity needs thoroughly evaluated <NUMBER> therapeutic targets beyond receptorbinding domain sarscov<NUMBER> spike protein proteolytic cleavage sarscov<NUMBER> spike protein human serine protease tmprss<NUMBER> critical step virus entry plasma membrane fusion mechanism fig <NUMBER> shown hoffmann et al <NUMBER> authors demonstrate camostat mesylate clinically proven serine protease inhibitor halts tmprss<NUMBER> activity blocks sarscov<NUMBER> infection lung cells <NUMBER> following binding ace<NUMBER> disassociation ace<NUMBER>bound <NUMBER> subunit <NUMBER> subunit spike proteinstill attached virus envelope cterminal transmembrane domain additionally cleaved <NUMBER> â² siteinserts cleaved terminus host cell plasma membrane thus physically links viral cell membranes allows heptad repeats hr<NUMBER> hr<NUMBER> <NUMBER> subunit interact assemble sixhelix bundle needed bring membranes closer final fusion xia et al show ek<NUMBER>c<NUMBER> lipopeptide targets heptad repeats potent inhibitor sarscov<NUMBER> fusion cellular assays mouse model <NUMBER> using human clinicalgrade recombinant soluble ace<NUMBER> monteil et al reduced sarscov<NUMBER> viral growth <NUMBER> <NUMBER>fold vero cells suppressed infection engineered human blood vessel organoids kidney organoids <NUMBER> addition targeting components viral attachment membrane fusion machinery strategies eliminate sarscov<NUMBER> include impeding virus entry host cell endosomal pathway disrupting activities viral proteins ou cathepsin l apilimod tetrandrine sid <NUMBER> respectively reduces host cell entry <NUMBER> inside host cell viral rna uses host ribosomal machinery produce important life cycle proteins also serve attractive targets development antisarscov<NUMBER> therapeutics one proteins sarscov<NUMBER> main protease pro required processing polyproteins translated viral rna inhibition pro activity impedes viral replication crystal structure sarscov<NUMBER> pro complex Î±ketoamide inhibitor provides mechanistic details necessary advance direction <NUMBER> speed structural information sarscov<NUMBER> virus collected astonishing structural approaches likely contribute drug discoveries validation aid development vaccines reduce eventually eliminate ongoing public health emergency outbreak novel coronavirus severe acute respiratory syndrome cov<NUMBER> sars cov<NUMBER> covid <NUMBER> infection threatening humanity globally occurring last week december <NUMBER> result massive loss human health status global economy becoming unaccountable current situation sars cov<NUMBER> claimed <NUMBER> lives <NUMBER> infected persons globally <NUMBER> outbreak started wuhan province china spread <NUMBER> countries adverse effects china italy iran spain united states france germany britain several countries type therapeutic strategies starting blocking viral entry inhibition spike proteins association host ace<NUMBER> angiotensin converting enzyme type <NUMBER> modulations interfering kinase activity inactivation viral genome expressionpackaging vaccination virus demand present situation regarding vaccination strategies assumed frequent mutation results anomalies surface spike proteins <NUMBER> <NUMBER> mostly resembling features sars cov global outbreak <NUMBER> httpswwwwhointcsrsarsen virus unlikely manifested extremely high grade virulence spreading capability stability across geographical barrier specifically colder place aged persons specific genders yet clarified <NUMBER> positive selective pressure could account stability clinical features virus compared sars bat sarslike cov <NUMBER> stabilizing mutation falling endosomeassociatedproteinlike domain nsp<NUMBER> protein could account covid<NUMBER> high ability contagious destabilizing mutation nsp<NUMBER> proteins could suggest potential mechanism differentiating covid<NUMBER> sars cov <NUMBER> nevertheless nutritional immunological statuses also important factors screening therapeutic strategies affected sensitive persons possible medications immunizations existing drugs infusion convalescent plasma conducted utmost care covid <NUMBER> patients <NUMBER> advanced precautionary steps therapeutic interventions formulated taking account several personal community factors <NUMBER> development successful reproducible vaccination protocol human trial may take longer time issues mutation large number glycan shield epitope masking sars cov <NUMBER> proteins <NUMBER> series medication regimen <NUMBER> at<NUMBER>r blockers used reducing severity mortality sarscov<NUMBER> virus infections <NUMBER> chloroquine hydroxychloroquine prescribed somewhere fight covid<NUMBER> time <NUMBER> <NUMBER> human coronaviruses influenza viruses resulted epidemic last <NUMBER> decade different parts world anomalies severity spreading origin site china parts world european north america countries might indication common human covs may annual peaks circulation winter months us individual human covs may show variable circulation year year <NUMBER> colder climate prior exposure human coronaviruses influenza flu viruses possible vaccination might develop antibody dependent enhancement ade immunological responses recent sars cov<NUMBER> exposure ade might modulated immune response could elicit sustained inflammation lymphopenia andor cytokine storm <NUMBER> <NUMBER> possibly could one reasons history exposure covs beside weaker immune system older people affected present sars cov<NUMBER> moreover helper cells suppressor cells patients covid<NUMBER> normal levels novel coronavirus might mainly act lymphocytes especially lymphocytes <NUMBER> strong inflammatory events could initiator collapsing environment covid<NUMBER> infection death cases covid<NUMBER> infections acute respiratory failure followed organs like kidney anomalies cases inflammatory outburst might worsened infection post viralincubation situations <NUMBER> <NUMBER> recent studies experimentally infected animal strongly suggest crucial role virusinduced immunopathological events causing fatal pneumonia human cov infections <NUMBER> combined antiviral antiinflammatory treatment might beneficial cases <NUMBER> sarsbased available immunetherapeutic prophylactic modalities revealed poor efficacy neutralize protect infection targeting novel spike protein <NUMBER> background critical screening spike sequence structure sars cov<NUMBER> energetic ic<NUMBER> based immunoinfrmatics analysis may help develop suitable vaccine current study intended analyze spike proteins sars cov mers cov sars cov <NUMBER> four earlier outbreaking human corona virus strains critically compared sars cov sars cov <NUMBER> spikeproteins domains motifs screened several epitopes based energetics ic<NUMBER> antigenicity employing several bioimmuuno informatics software regard possible glycosylation mhcparatopic binding effects present work might helpful urgent development suitable vaccination regimen tertiary structures selected coronavirus cov spike proteins predicted validated using phyre<NUMBER> protein homologyanalogy recognition engine v <NUMBER> <NUMBER> swissmodel <NUMBER> phyre<NUMBER> structures predicted <NUMBER> experimentally designed protein folds predicted structures subjected analysis swissmodel qmean zscore calculation includes cumulative zscore cÎ² atoms solvation torsion values prediction rampage ramachandran plot analysis server <NUMBER> used protein <NUMBER>d structures quality assessment summation number residues favored regions additionally allowed regions considered percent quality assessment predicted tertiary structures visualized aligned using pymol molecular visualization system pymol assigns secondary structure using secondary structure alignment algorithm called dss sequences two structures aligned first structures aligned visualization molecules highspeed raytracer molecular graphics system used secondary structural analysis <NUMBER>d folding patterns analyzed form topology using profunc protein function predicting server using protein <NUMBER>d structures <NUMBER> protein classification topology analysis plays independent effective alternative traditional structural prediction topological differences two structures indicated differences protein folding flexibility sequence comparisons among selected cov spike glycoproteins conducted multiple sequence alignment using clustal x<NUMBER> <NUMBER> conserved motifs identified using meme suite httpmemesdscedumemecgibinmastcgi server meme suite represents ungapped conserved sequences frequently present group related sequences <NUMBER> motif number defined current study motif finding whereas glam<NUMBER>scan tools used identification gapped motifs within related sequences conserved motifs represented logo using glam<NUMBER>scan tools meme suite server identified motifs subjected annotation using protein blast httpsblastncbinlmnihgovblastcgiprogramblastppagetypeblastsearchlinkloc blasthome finally functional gene ontology based conserved domain identification conducted using interpro classification protein families interactive database <NUMBER> conserved epitopes sars cov<NUMBER> spike glycoprotein identified using svmtrip tool predicts linear antigenic epitopes <NUMBER> svmtrip predicts linier antigenic epitopes feeding support vector machine tripeptide similarity propensity scores different preanalyzed epitope data annotation predicted epitopes performed protein blast svmtrip gained <NUMBER> sensitivity <NUMBER> precision value five fold crossvalidation epitope prediction <NUMBER> amino acid lengths selected major histocompatibility complex mhc binding efficiency predicted epitops performed using immune epitope database iedb analysis resource <NUMBER> total <NUMBER> dpa <NUMBER> dqa <NUMBER> drb alleles mhc class ii screened detection best interactive alleles basis highest consensus percentile rank lowest ic<NUMBER> value analyses performed human class ii allele using frequently occurring alleles frequency <NUMBER> peptide length <NUMBER>mers selected consensus percentile rank â¤ <NUMBER> used selection peptides antigenecity predicted epitopes determined using vaxigen v<NUMBER> protective antigen tumour antigens subunit vaccines prediction server <NUMBER> vaxigen v<NUMBER> uses auto cross covariance acc transformation selected protein sequences based unique amino acid properties sequence used find <NUMBER> known antigen <NUMBER> nonantigens identified sequences tested antigenecity leaveoneout crossvalidation overall external validation prediction accuracy <NUMBER> structure mhc class ii hladra drb molecule pdb id <NUMBER>q<NUMBER>w <NUMBER>jlz fully glycosylated covid <NUMBER> spike protein structure pdb id <NUMBER>svb retrieved protein data bank pdb docking performed using hawkdock <NUMBER> zdock <NUMBER> server generating <NUMBER> docking solutions among best <NUMBER> analyzed based docking scores binding free energy value calculation higher degree similarity sars cov sars cov<NUMBER> might indicate help therapeutic vaccination strategies reference current global situation however absolute higher degree virulence spreading nature sars cov<NUMBER> great concern present scenario based alignment pattern selected sequences subjected analysis different conserved motifs protein sequences total <NUMBER> conserved motifs analyzed epitope designing conducted covid <NUMBER> spike glycoprotein sequence structure sequence analysis <NUMBER> different locations found also showed similarity sars cov sars covid <NUMBER> spike glycoprotein protein blast figure <NUMBER> also motif positions within spike glycoprotein monomer represented figure <NUMBER> epitopes <NUMBER> <NUMBER> <NUMBER> represented covid <NUMBER> spike glycoproteins found embedded within virus envelop among others motifs <NUMBER> <NUMBER> <NUMBER> <NUMBER> found interior location spike glycoprotein monomer motifs <NUMBER> <NUMBER> <NUMBER> found surface structure could used immunological targets proper diagnosis treatment covid <NUMBER> important issue epitope finalization could confronted factor possible transition prefusion postfusion spike structural distortion specific mutant structure designed tested resistant conformational change ace<NUMBER> binding protease cleavage s<NUMBER>s<NUMBER> site <NUMBER> may indicative searching suitable epitope may remain unhindered preto postfusion state transition proper type major histocompatibility complex mhc selection identified covid <NUMBER> epitope performed enlisted table <NUMBER> threshold value highest consensus percentile rank selected <NUMBER> whole highest consensus percentile rank value <NUMBER> observed sequence qqliraaeirasanl epitope <NUMBER>a lowest ic<NUMBER> value <NUMBER> observed sequence iiaytmslgaensva epitope <NUMBER>b antigenic property identified target sequences epitopes also predicted basis threshold value <NUMBER> threshold value sequence considered nonantigenic sequences value antigenic nature total <NUMBER> antigenic sequences detected table <NUMBER> among two sequences aaeirasanlaatkm epitope <NUMBER>b itpgtntsnqvavly epitope <NUMBER>b found higher threshold value <NUMBER> <NUMBER> respectively location <NUMBER>b interior <NUMBER>b could used potent antigen according epitope locations figure <NUMBER> antigenic nature sequences like <NUMBER>ab <NUMBER>ab could target also coronavirus spike proteins glycosylated nature nacetyl glucosamine nag main component glycan shielding possible epitope masking hcovnl<NUMBER> observed may barrier proper immunogenic responses <NUMBER> comparative analysis glycosylated nonglycosylated protein revealed structural modification epitope locations among identified epitopes <NUMBER>b sequence itpgtntsnqvavly <NUMBER> found n linked glycosylation <NUMBER> position structural modification epitope analyzed using nonglycosylated protein structure covid <NUMBER> acc nc<NUMBER> gltcosylated covid <NUMBER> protein pdb id <NUMBER>vsb effect glycosylation protein structures revealed glycosylated conformation organised figure <NUMBER>a nonglycosylated one figure <NUMBER>b secondary structural comparison two epitopes showed organised structure attached nag residue figure <NUMBER>d whereas shorter Î²sheet structure observed nag removed structure figure <NUMBER>c peptide interactive site <NUMBER>b epitope blocked due nag attachment result antibody binding antigen may hamper nag residue directly binds n asn amino acid residue figure <NUMBER>e removal nag spike glycoprotein structure difficult structural distortion glycosylated nonglycosylated epitope <NUMBER>b tertiary level indicated removal nag may distort structure epitope figure <NUMBER>f may hamper proper antigenantibody binding section energetics epitope attachment mhc class ii hladra drb determined presence absence nag <NUMBER>b epitope structure molecular docking figure <NUMBER> docking results showed without nag binding efficiency <NUMBER>b though epitope <NUMBER> b also present surface spike glycoprotein found wrapped short segment igaehvnnsyecd <NUMBER> carrying glycosylation n residue position <NUMBER> figure <NUMBER>a result antibody accessibility epitope may also difficult whereas surface epitope <NUMBER> sequence vrdpqtleilditpc <NUMBER> showed highest antigenecity <NUMBER> table <NUMBER> recombine gain entry human cells points also noted <NUMBER> sars cov<NUMBER> induced severe often lethal lung failure caused due inhibition ace<NUMBER> expression <NUMBER> keeping ace<NUMBER> normal functioning blocking viral entry challenging issue right possible suitable epitope screened current study may helpful global pandemic situation history last two decades outbreak types virus much evident present situation justifies advanced studies proper infrastructure fundresources facilities global scale eradicate current possible future outbreak position epitope <NUMBER> covid <NUMBER> spike protein direct indirect nag attachment pdb id <NUMBER>svb b among <NUMBER> best docking positions <NUMBER> found epitope presenting site mhc ii hladrb<NUMBER> pdb id <NUMBER>jlz c best docking posture epitope <NUMBER> mhc ii hladrb<NUMBER> specific interaction pattern e early december <NUMBER> sudden dramatic outbreak new coronavirus strain named sarscov<NUMBER> emerged continental chinese area wuhan quickly diffused throughout country date several cases viruses reported europe us sarscov<NUMBER> strongly infectious <NUMBER> infected people around <NUMBER> deaths reported within three months virus appearance update <NUMBER>th april <NUMBER> milion confirmed cases <NUMBER> thousands deaths reported rapid spread new virus reveals mechanism diffusion somehow different filoviridae ie ebolavirus <NUMBER> viral pathogenesis results symptoms like fever acute pneumonia eventually respiratory failure death rate long time needed full recovery comorbidity associated viral infection ie advanced age particular life stages pregnancy result major threat global health <NUMBER> scenario need cure appears extremely urgent main strategy diffusion viruses represented development specific vaccines however complexity viruses ability mutate adapt new host organisms belonging species also led different therapeutic approaches aimed interfere viral life cycle processes essential membrane fusion replication <NUMBER> <NUMBER> furthermore computational chemistry represents fundamental tool screening applicable drugs <NUMBER> computational approach also represent tool physicians healthcare professionals operate first decision best therapy administrate first instance coronaviruses singlestranded rna enveloped viruses <NUMBER> <NUMBER> whose genes encode among others trimeric structural spike protein homodimeric cysteine proteinase <NUMBER> rna polymerase several nonstructural proteins httpswwwncbinlmnihgovnuccorenc<NUMBER> <NUMBER> phylogenetic point view genetic similarities shared sarscov<NUMBER> <NUMBER> sars coronavirus strain sarscov belong socalled beta cov group batisolated coronaviruses strains already underlined <NUMBER> gene identity <NUMBER> <NUMBER> <NUMBER> alignment spike protein protease showed analogy primary sequences <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> proteases spike proteins targets choice inhibition sars mers <NUMBER> <NUMBER> <NUMBER> <NUMBER> several efforts made develop inhibitors activities using virtual screening experimental methods <NUMBER> <NUMBER> work present results obtained sarscov<NUMBER> spike protein <NUMBER>clike protease molecular docking several inhibitors originally developed antiviral therapy viruses hepatitis c virus hcv human immunodeficiency virus hiv thirteen proteinase inhibitors antihiv antihcv drugs investigated along three different compounds spike protein inhibition despite different viral strains drugs originally developed aim investigate whether could also affinity sarscov<NUMBER> use antivirals already available therapy new virus would huge advantage fight battle first step eventually arise bioinformatic analysis could provide information potential effectiveness indeed silico data suggest effective interaction occurs tested molecules results represent promising starting point antiviral therapies alternative coadjuvant vaccination strategy protein sequences obtained curated genomic sequence deposited gene database id number nc<NUMBER> verified sarscov id nc<NUMBER> <NUMBER> <NUMBER>clike protease id yp<NUMBER> envelope spike protein id yp<NUMBER> rnadependent rnapolymerase id yp<NUMBER> nucleocapsid phosphoprotein id yp<NUMBER> selected set antiviral drugs taken influenza research database fludborg potential inhibitors sarscov<NUMBER> protease identified among antiprotease drugs mentioned database asunaprevir db<NUMBER> nelfinavir db<NUMBER> simeprevir db<NUMBER> faldaprevir db<NUMBER> indinavir db<NUMBER> ritonavir db<NUMBER> amprenavir db<NUMBER> tipranavir db<NUMBER> atazanavir db<NUMBER> saquinavir db<NUMBER> darunavir db<NUMBER> fosamprenavir db<NUMBER> lopinavir db<NUMBER> furthermore three molecules chosen spike protein umifenovir db<NUMBER> enfuvirtide db<NUMBER> pleconaril db<NUMBER> software openbabel <NUMBER> used convert smiles code molecule <NUMBER>d structural file threedimensional structure enfuvirtide taken available crystallographic structure pdb id <NUMBER>h<NUMBER> chain homology model performed itasser server giving input sequences obtained sarscov<NUMBER> genomic sequence model structures energy minimized docking protocol performing short vacuum <NUMBER> step steepestdescent optimization potential energy using gromacs tools <NUMBER> autodock vina <NUMBER> used perform molecular docking antiviral drugs onto sarscov<NUMBER> protease envelope protein regarding protease residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> set flexibles binding mode search <NUMBER> <NUMBER>clike protease binding box centered coordinates residue met<NUMBER> volume fully encompassed whole binding pocket spike envelope glycoprotein box used search binding modes centered position center mass val<NUMBER> sidechain restrained area extracellular head trimeric protein prefusion conformation following paragraphs analyze discuss key properties putative target proteins sarscov<NUMBER> comparison homologs sarscov focus particular four proteins main <NUMBER>clike protease spike envelope glycoprotein rnadependent rnapolymerase rdrp nucleocapsid protein <NUMBER>clike protein main protease sarscov<NUMBER> plays fundamental role rna translation thus already underlined essential viral replication <NUMBER> mature form found dimer monomer formed three structural pseudodomains domain residues <NUMBER> domain ii residues <NUMBER> share antiparallel Î²barrel structure domain iii residues <NUMBER> contains fivefold antiparallel Î±helix cluster <NUMBER> <NUMBER> binding site substrates located cleft region domains ii catalytic region formed dyad his<NUMBER>cys<NUMBER> highly conserved among coronavirus proteases also reminiscent trypsinlike serine proteases <NUMBER> importantly <NUMBER>cpro<NUMBER> sarscov<NUMBER> shares high similarity sarscov homolog <NUMBER> residues substituted respect sars counterpart thr<NUMBER>val ala<NUMBER>ser ser<NUMBER>ala lys<NUMBER>asn ala<NUMBER>ser thr<NUMBER>ala residues distant protease active site unlikely related selectivity protease figure <NUMBER>a nonetheless two mutations lys<NUMBER>asn ala<NUMBER>ser located deep hydrophobic pocket active site loop region flanking entrance active site although available crystallographic structure lys<NUMBER>asn results located far directly contribute ligand binding presence extends hydrophobic inner region conversely ser<NUMBER> seems relatively distant his<NUMBER> active site <NUMBER> Ã¥ may role ligand recruitment figure <NUMBER>b although crystallographic structure <NUMBER>clike protease sarscov<NUMBER> complex peptidelike inhibitor pdb id <NUMBER>lu<NUMBER> made recently available protein data bank structure clearly shows closed binding pocket around inhibitor useful identify residues involved inhibitory action configuration well suited molecular docking may limit effectiveness pose searching methods reason preferred model threedimensional structure protease using homology modeling protocol excluding complexed covid<NUMBER> protease among target structures structure obtained itasser server showed good alignment score tmscore <NUMBER> apo structure sarscov main protease pdb id <NUMBER>b<NUMBER>o interestingly rootmeansquared deviation rmsd model structure available crystallographic structure sarscov<NUMBER> protease low <NUMBER> Ã¥ mostly due differences binding pocket loop conformations main results obtained docking protocol shown table <NUMBER> protease drug recognitions usually driven hydrophobic interactions <NUMBER> <NUMBER> figure <NUMBER> clearly shows four best scoring ligands indeed thoroughly fill hydrophobic pockets flank catalytic dyad surprisingly wellknown hcv ns<NUMBER>a protease inhibitor simeprevir <NUMBER> identified best scoring drug significant difference respect promising inhibitors sarscov<NUMBER> protease identified lopinavir <NUMBER> nelfinavir <NUMBER> simeprevir fully fills two hydrophobic pockets flanking catalytic dyad his<NUMBER>cys<NUMBER> macrocyclic compound fits pocket formed residues range phe<NUMBER>phe<NUMBER> acyl sulfonamide cyclopropyl moiety points towards region encompassing leu<NUMBER> pro<NUMBER> val<NUMBER> pose induces opening catalytic dyad indeed his<NUMBER>cys<NUMBER> changes <NUMBER> Ã¥ apo configuration <NUMBER> Ã¥ inhibited form simeprevir binding sarscov<NUMBER> protease also sustained three hydrogen bonds anchor ligand binding pocket two link amide backbone glu<NUMBER> gly<NUMBER> carbonyl macrocycle acyl sulfonamide cyclopropyl moiety respectively third hydrogen bond formed n asn<NUMBER> side chain ether group detailed structural representation interacting residues shown figure <NUMBER>a findings may appear rather surprising hcv main protease shares low similarity sarscov<NUMBER> homolog <NUMBER> nonetheless two proteases share similar topology active site except hydrophobic loop phe<NUMBER>phe<NUMBER> structurally absent hcv protease figure <NUMBER>b socalled spike protein protein sarscov<NUMBER> present within envelope homotrimer like case enveloped viruses monomer features ectodomain transmembrane domain cytoplasmic tail inhibitors typically designed interact upper part protein interfere host membrane binding fusogenic activity protein several experimentally obtained structures multimeric conformation sarscov spike protein available pdb <NUMBER>wrg <NUMBER> Ã <NUMBER> <NUMBER>xlr homology model structure sarscov<NUMBER> spike protein obtained itasser server global pairwise sequence alignment indicated sarscov<NUMBER> spike protein shares <NUMBER> primary sequence sarscov homolog overall similarity <NUMBER> differences project slightly different negativepositive residue ratio <NUMBER> sarscov <NUMBER> sarscov<NUMBER> slightly less acidic pi <NUMBER> sarscov <NUMBER> sarscov<NUMBER> interestingly work progress electron microscopy structure sarscov<NUMBER> spike protein oligomeric prefusion inactive structure single receptorbinding domain made available another group pdb id <NUMBER>vsb <NUMBER> unfortunately thorough direct comparison model structure experimental data impaired different global configuration two trimeric structures downinactive vs upactive conformations however experimental structure shows one monomer upstate comparison performed monomerbased manner rmsd downstate monomers two structures low <NUMBER> Ã¥ residues secondary structure assignments <NUMBER> Ã¥ overall worth noting prefusion state inactive conformation significantly stable upconformations <NUMBER> <NUMBER> <NUMBER> findings confirm quality homology model suitability docking studies visual inspection electrostatic potential downinactive conformation sarscov<NUMBER> spike protein figure <NUMBER>ab shows inner part protein proximal viral envelope negatively charged protein head clearly characterized positive electrostatic potential picture rather different one sarscov figure <NUMBER>cd thus suggests important property tailor future inhibitors docking three different inhibitors performed spike protein inhibitors expected block membrane binding limited docking search region area around protein head prefusion configuration moreover due large size protein limit computational cost performed rigid docking inhibitors target multimeric protein autodock vina used identify best binding pose three different drugs umifenovir db<NUMBER> enfuvirtide db<NUMBER> pleconaril db<NUMBER> results shown table <NUMBER> interestingly upon binding enfuvirtide interacts spike protein whose cap mainly positively charged negatively charged amino acids several glutamate residues opposed enfuvirtide figure <NUMBER>a inhibits viral spike protein action upon host membrane interposing avoiding contact protein cellular membrane two drugs docked entrance central channel pore formed trimeric structure figure <NUMBER>bc viral polymerases share seven highly conserved motifs essentially involved nucleotidebinding catalysis rna replication huge complex structures act association several nonstructural proteins <NUMBER> global pairwise sequence sarscov<NUMBER> rdrp sarscov counterpart shows large sequence identity shared two proteins <NUMBER> also high similarity <NUMBER> analysis rdrp rna primer complex displays rnainteracting residues conserved sarscov sarscov<NUMBER> red figure <NUMBER>a viral nucleocapsid protein n protein interacts viral genome forms ribonucleoprotein core wellknown protein plays different roles viral infection involved synthesis viral rna transcription genomic rna translation viral proteins <NUMBER> coronavirus nucleocapsid proteins share general structural pattern composed three distinct domains nterminal domain <NUMBER> residues suggested bind rna central domain <NUMBER> residues also predicted recognize rna finally cterminal domain drives protein dimerization although complete structure nucleocapsid protein available sarscov local structural comparison performed structure superposition sarscov<NUMBER> model structure nterminal central domain sars counterparts figure <NUMBER> sequence pairwise alignment sarscov<NUMBER> n protein sarscov homolog shows high identity primary structure <NUMBER> overall similarity <NUMBER> modeling superimposition protease structure homologous sars virus protease show little differences although pivotal function residues different sarscov<NUMBER> protease assimilate protein sort sitedirected mutant sars protease figure <NUMBER> spike protein structure shows upper trimeric cap supported stem domain remarkable differences terms charge mainly positive ectodomain strongly negative stem domain figure <NUMBER> respect stimulated important results clinical trials patients treated antiretroviral agents <NUMBER> <NUMBER> extended investigation computational inspection many different drugs chose selection common antiviral drugs display probable molecular reasons efficacy combined antiviral therapy drugs examined include hiv<NUMBER> protease inhibitors mostly used combination antiviral drugs treatment hiv adults children moreover antiviral drugs included screening show activity hepatitis c virus good oral bioavailability one antiviral drugs tested sarscov<NUMBER> envelope protein enfuvirtide hiv fusion inhibitor used combination therapy treatment hiv<NUMBER> infection <NUMBER> second molecule tested umifenovir antiviral agent activity influenza aand bviruses <NUMBER> last one pleconaril <NUMBER> used prevention asthma exacerbations common cold symptoms asthmatic subjects exposed respiratory infections pleconaril orally bioavailable active picornaviridae viruses docking shows <NUMBER> <NUMBER> protease inhibitors reported highscore thermodynamic terms proteindrug complex <NUMBER> table <NUMBER> may selected future core new antiviral drugs specific sarscov<NUMBER> protease intriguingly docking spike protein shows interesting results three drugs tested notably enfuvirtide placed interface two monomers position molecule could impair transition closed open state figure <NUMBER> finally worth mentioning currently drugs reported table <NUMBER> used satisfying results therapies treatment sarscov<NUMBER> rnadependent rnapolymerase rdrp one important proteins involved genetic information replication transmission coronavirus family viruses function accomplished multimeric complex rdrp nonstructural proteins favoring sort wrappingandscrolling viral genome rdrp similar homologous sars figure <NUMBER> nprotein promotes package viral genome helical ribonucleocapsid virion assembly also interacting membrane protein consequently nprotein plays important role viral rna transcription well viral replication dimerization domains sarscov sarscov<NUMBER> share high similarity figure <NUMBER> differences protein structure level sars closest phylogenetic virus intriguing contribute characterize peculiarity sarscov<NUMBER> coronavirus influenza virus belonging oldscenario virology taxonomy worth mentioning several groups working antiviralbased strategies fight new big threat represented sarscov<NUMBER> cases patients treated molecules chosen studies ie ritonavir lopinavir umifenovir <NUMBER> <NUMBER> <NUMBER> <NUMBER> data strongly support corroborate results work exacerbation covid<NUMBER> diffusion stimulated researchers medical personnel find solution treatment compatible arsenal antiviral drugs currently available time closing present manuscript numbers <NUMBER> confirmed cases around <NUMBER> deaths sensible increase recovered people <NUMBER> <NUMBER> according coronavirus covid<NUMBER> global cases johns hopkins csse interactive map updated <NUMBER>th april <NUMBER> milion confirmed cases <NUMBER> thousands deaths reported first line strategy isolation dramatic quarantine measurements clinical treatments may reasonable positive warrant limit spread virus four proteins taken account interesting molecular targets medicinal chemistry mainly protease envelope spike protein antiviral drug therapy effective firststage approach treating covid<NUMBER> infections present work could contribute suggest physicians choice combination antivirals administer patients alongside hospitalization obviously knowledge terms general organization structure virus particle limited proteins like protease spike primary molecular targets drug discovery development near future availability xray crystal structures majority proteins allow exhaustive docking calculation different classes drugs eg antiparasitic drugs peptides structural computational studies analysis subordinate helpful comprehension virus molecular elements right way help scientific community long process leading developing vaccine coronaviruses covs enveloped singlestranded positive sense rna viruses belong family coronaviridae basis genomic organization phylogenetic relationship coronaviruses classified subfamily coronavirinae consists four genera alphacoronavirus Î±cov betacoronavirus Î²cov gammacoronavirus Î³cov deltacoronavirus Î´cov cui et al <NUMBER> evolutionary trend analysis coronaviruses revealed Î±cov Î²cov originated bats rodents Î³cov Î´cov found originated avian species ge et al <NUMBER> ability covs cross species barrier resulted pathogenic covs hku<NUMBER> nl<NUMBER> oc<NUMBER> <NUMBER>e covs associated mild symptoms humans whereas severe acute respiratory syndrome cov sarscov middle east respiratory syndrome cov merscov known cause severe disease fehr perlman <NUMBER> <NUMBER> <NUMBER> sarscov emerged china <NUMBER> clinical cases <NUMBER> deaths since <NUMBER> merscov caused persistent epidemics arabian peninsula viruses found originate bats transmitted intermediate mammalian host civets case sarscov camels case merscov eventually infected humans song et al <NUMBER> sarscov<NUMBER> declared pandemic <NUMBER> confirmed cases <NUMBER> deaths globally <NUMBER>th april <NUMBER> world health organization <NUMBER> characterize novel coronavirus bronchoalveolar lavage fluid throat swabs collected nine patients visited wuhan seafood market initial outbreak special pathogenfree human airway epithelial hae cells used virus isolation collected samples inoculated hae cells apical surfaces hae cells monitored cytopathic effects supernatant collected perform rtpcr assays apical samples collected next generation sequencing three passages wholegenome sequences sarscov<NUMBER> generated combination sanger illumina oxford nanopore sequencing lu et al <NUMBER> phylogenetic analysis revealed bats might source sarscov<NUMBER> andersen et al <NUMBER> additionally studies suggested origin sarscov<NUMBER> associated pangolins shereen et al <NUMBER> decipher mechanism replication development effective preventive therapeutic strategies understanding structure sarscov<NUMBER> genome organization replication crucial therefore chapter focuses morphology structure genomic organization replication cycle sarscov<NUMBER> sarscov<NUMBER> isolated nasopharyngeal oropharyngeal samples inoculated vero cells order identify sarscov<NUMBER> inoculated cells prefixed using <NUMBER> paraformaldehyde <NUMBER> glutaraldehyde transmission electron microscopy performed structure sarscov<NUMBER> observed examining infected cells <NUMBER> days post infection electron microscopy revealed coronavirusspecific morphology sarscov<NUMBER> virus particle sizes ranging <NUMBER> <NUMBER> nm observed wide variety intracellular organelles specifically vesicles park et al <NUMBER> due high sequence similarity structure sarscov<NUMBER> speculated sarscov kumar et al <NUMBER> surface viral protein spike membrane envelope coronavirus embedded host membranederived lipid bilayer encapsulating helical nucleocapsid comprising viral rna fig <NUMBER> <NUMBER> finlay et al <NUMBER> structure spike protease sarscov<NUMBER> zhang et al <NUMBER> resolved provides opportunity develop newer class drugs treatment covid<NUMBER> size coronavirus genome range <NUMBER> <NUMBER> kb comprise <NUMBER> open reading frames orfs encoding <NUMBER> amino acid polyproteins first orf comprises approximately <NUMBER> genome encodes <NUMBER> nonstructural proteins nsps whereas remaining orfs encode accessory structural proteins genome sarscov<NUMBER> lacks hemagglutininesterase gene however comprises two flanking untranslated regions utrs <NUMBER> <NUMBER> end <NUMBER> <NUMBER> <NUMBER> end <NUMBER> nucleotides sequence variation among sarscov<NUMBER> sarscov revealed significant difference orfs nsps nsps includes two viral cysteine proteases including papainlike protease nsp<NUMBER> chymotrypsinlike <NUMBER>clike main protease nsp<NUMBER> rnadependent rna polymerase nsp<NUMBER> helicase nsp<NUMBER> others likely involved transcription replication sarscov<NUMBER> chan et al <NUMBER> addition nsps four major structural proteins spike surface glycoprotein membrane nucleocapsid protein n envelope e accessory proteins encoded orfs nterminal glycosylated ectodomain present nterminal end protein comprises three transmembrane domains tm long cterminal ct domain fig <NUMBER> e proteins required virus morphogenesis assembly budding whereas glycoprotein fusion viral protein comprising two subunits s<NUMBER> s<NUMBER> s<NUMBER> subunit shares <NUMBER> sequence identity bat sarslike covs human sarscov comprises signal peptide nterminal domain ntd receptorbinding domain rbd walls et al <NUMBER> differences found external subdomain primarily responsible interaction spike ace<NUMBER> receptor ectodomain spike protein <NUMBER> amino acid residues cloned expressed crystallize solve spike glycoprotein structure sarscov<NUMBER> structure spike glycoprotein structure sarscov<NUMBER> resembles spike protein sarscov rmsd <NUMBER> Ã¥ first orf comprises approximately <NUMBER> genome encodes <NUMBER> nonstructural proteins nsps whereas remaining orfs encode accessory structural proteins nsps includes two viral cysteine proteases including papainlike protease nsp<NUMBER> chymotrypsinlike <NUMBER>clike main protease nsp<NUMBER> rnadependent rna polymerase nsp<NUMBER> helicase nsp<NUMBER> others likely involved transcription replication sarscov<NUMBER> addition nsps genome encodes four major structural proteins including spike surface glycoprotein membrane nucleocapsid protein n envelope e accessory proteins like orfs study also reveals receptorbinding region rbd exhibited highest structural divergence wrapp et al <NUMBER> s<NUMBER> subunit shares <NUMBER> sequence identity bat sarslike covs human sarscov comprises two heptad repeat regions known hrn hrc form coiledcoil structures surrounded protein ectodomain protein found exhibit furin cleavage site prrarsv interface s<NUMBER> s<NUMBER> subunits processed biogenesis coutard et al <NUMBER> entry coronaviruses host target cells depends binding spike glycoprotein cellular receptor priming protein host cell proteases like sarscov sarscov<NUMBER> uses ace<NUMBER> receptor internalization tmprss<NUMBER> serine proteases protein priming hoffmann et al <NUMBER> similar sarscov extrapulmonary spread sarscov<NUMBER> may seen due widespread tissue expression ace<NUMBER> receptor addition studies revealed spike protein sarscov<NUMBER> exhibits <NUMBER> times higher affinity compared sarscov wrapp et al <NUMBER> binding spike protein ace<NUMBER> receptor results conformational changes spike protein leads fusion viral envelop protein host cell membrane following entry via endosomal pathway coutard et al <NUMBER> matsuyama taguchi <NUMBER> event followed release viral rna host cytoplasm undergoes translation generates replicase polyproteins pp<NUMBER>a pp<NUMBER>b cleaved virus encoded proteinases small proteins replication coronavirus involves ribosomal frame shifting translation process generates genomic multiple copies subgenomic rna species discontinuous transcription encodes relevant viral proteins assembly virion takes place via interaction viral rna protein endoplasmic reticulum er golgi complex virions subsequently released cells via vesicles fig <NUMBER> <NUMBER> hoffmann et al <NUMBER> pathological findings sarscov<NUMBER> infected patients highly resemble sarscov merscov infected patients flow cytometric analysis peripheral blood samples showed significant reduction cd<NUMBER> cd<NUMBER> cell counts status found hyperactivated higher proportion dual positive hladr cd<NUMBER> seen rapid progression pneumonia seen chest xray images differences right left lung histopathological investigation lung liver heart tissue performed lung biopsy showed cellular fibromyxoid exudates bilateral diffuse alveolar damage right lung showed prominent desquamation pneumocytes formation hyaline membrane indicating signs acute respiratory distress syndrome ards whereas left lung showed pulmonary edema formation hyaline membrane addition lungs found exhibit interstitial mononuclear patchy inflammatory infiltrates dominated specifically lymphocytes tian et al <NUMBER> intraalveolar spaces characterized multinucleated syncytial cells atypical enlarged pneumocytes showing virusinduced cytopathic effect liver biopsy patients infected sarscov<NUMBER> showed moderate microvesicular steatosis mild portal lobular activity suggesting injury might caused virus drug induced interstitial mononuclear inflammatory infiltrates observed heart tissue pathological changes may provide new insights pathogenesis pneumonia induced sarscov<NUMBER> may help clinicians effectively deal covid<NUMBER> patients phylogenetic analysis revealed sarscov<NUMBER> might originated bats pangolins structural investigations virusinfected cells reveal coronavirusspecific morphology sarscov<NUMBER> size virus <NUMBER> nm size sarscov<NUMBER> genome ranges <NUMBER> <NUMBER> kb comprises <NUMBER> orfs lacks hemagglutininesterase gene however comprises <NUMBER> <NUMBER> <NUMBER> <NUMBER> flanking untranslated regions utrs spike glycoprotein structure sarscov<NUMBER> resembles spike protein sarscov rmsd <NUMBER> Ã¥ like sarscov sarscov<NUMBER> uses ace<NUMBER> receptor internalization tmprss<NUMBER> serine proteases protein priming histopathological investigation tissues sarscov<NUMBER> infected patients showed virusinduced cytopathic effect signs acute respiratory distress syndrome lung cells sarscov<NUMBER> recently emerged declared pandemic world health organization based genomic sequences submitted ncbi database scientific community analyzed samples suggested preventive therapeutic strategies therefore investigation genomic diversity collected specimens around globe needs conducted order design common effective therapies vaccines addition genomic characterization helps us accurately identify origin evolution virus deciphering mechanism sarscov<NUMBER> replication various cellbased models may help us understand pathogenesis identify specific targets develop effective antiviral drugs numerous promising therapeutic <NUMBER> <NUMBER> vaccine <NUMBER> <NUMBER> research efforts underway covid<NUMBER> yet therapeutic vaccine currently available traditional drug biologic development experimentdriven typically executed via largescale screening vitro vivo traditional approaches led many effective safe therapeutics require years complete therefore cannot alone relied upon support rapid response novel pathogens <NUMBER> <NUMBER> <NUMBER> datadriven machine learning methods increasingly explored rapid therapeutic development <NUMBER> <NUMBER> potentially offering promise rapid design phase however purely datadriven machine learning system would limited rapid response scenarios due inevitable insufficiency available data novel emerging pathogens theorydriven computational methods molecular dynamics simulations provide virtually limitless amounts data target systems still require experimental validation lawrence livermore national laboratory llnl glaxosmithkline gsk vaccines research developed combined computationalexperimental platform vaccine antigen design last two years combined platform combines experimentdriven datadriven theorydriven approaches leverage strength approach mitigating limitations initial predictions platform driven computational component based integrating existing experimental data structural biologybioinformatic modeling molecular dynamics simulations highperformance computing systems active machine learning model aims optimize binding behavior iteratively proposing mutations amino acid sequence initial antigen proposed mutant antigens evaluated existing computational binding estimation tools using known estimated antibodyantigen structures platform leverages feature representation threedimensional antigenantibody interface bayesian optimization algorithm propose computational evaluation mutants high predicted performance mutants improve machine learning model computational platform improves predictions proposing designs evaluated high throughput experimental evaluation component results incorporated machine learning model feedback loop combined computationalexperimental antigen design platform results generated described greater detail future joint publication gsk including details machine learning model response covid<NUMBER> pandemic modified used computational components antigen design platform propose mutations sarscov<NUMBER> neutralizing antibodies achieve optimize binding receptor binding domain rbd sarscov<NUMBER> spike protein approach motivated enabled knowledge existing antibodies specific rbd sarscov<NUMBER> spike protein prevent sarscov<NUMBER> binding human ace<NUMBER> receptor entering cell thus neutralizing virus <NUMBER> <NUMBER> high similarity sarscov<NUMBER> sarscov<NUMBER> including rbd <NUMBER> suggest approach could produce efficacious therapeutic antibodies <NUMBER> days <NUMBER> demonstrated platform could generate antibody designs using sarscov<NUMBER> sequence information support antibodyantigen structures previously experimentally determined sarscov<NUMBER> executed entire workflow constructing homologybased structural model experimentally determined structures sarscov<NUMBER> sprotein available absence known sarscov<NUMBER> spike protein structure characterized sarscov<NUMBER> surface glycoprotein sequence yp<NUMBER> <NUMBER> constructing homologybased structural model using as<NUMBER>ts protein modeling system <NUMBER> structures spike proteins sarscov<NUMBER> protein data bank pdb entries <NUMBER>x<NUMBER> <NUMBER> <NUMBER>nb<NUMBER> <NUMBER> <NUMBER>dd<NUMBER> <NUMBER> <NUMBER>bgf <NUMBER> identified closest complete pdb structural templates use modeling resolutions <NUMBER> <NUMBER> <NUMBER> <NUMBER> Ã¥ respectively four templates last three provide experimentally solved complexes three antibodies s<NUMBER> m<NUMBER> f<NUMBER>g<NUMBER> main focus constructed homology models achieve highest possible accuracy rbdfab antigenbinding fragment interfaces used additional pdb templates refine models corresponding regions example pdb template <NUMBER>ghw <NUMBER> used improve accuracy modeled interface rbd fab neutralizing antibody <NUMBER>r cryoemderived structure sarscov<NUMBER> spike protein became available feb <NUMBER> <NUMBER> publicly released feb <NUMBER> <NUMBER> <NUMBER> httpswwwrcsborgstructure<NUMBER>vsb xray crystal structures receptorbinding domain became available starting march <NUMBER> <NUMBER> httpwwwrcsborgstructure<NUMBER>vw<NUMBER> published comparison homology models indicates estimated structures completed jan <NUMBER> <NUMBER> publicly available beginning feb <NUMBER> <NUMBER> accurate especially fab antigenbinding fragment <NUMBER> antibody interfaces figure <NUMBER> table <NUMBER> show residue deviations sarscov<NUMBER> homology models sarscov<NUMBER> cryoem structures sarscov<NUMBER> structures using sarscov<NUMBER> xray structure <NUMBER>w<NUMBER>c reference two regions indicated rectangular boxes residues <NUMBER> <NUMBER> part loop regions local conformations deviate note regions part interface selected antibodies figure <NUMBER> depicts homologybased model superimposed cryoem structure m<NUMBER> antibody structure provided indicate fabrbd interface region note regions deviations <NUMBER> Ã¥ outside interface region lga <NUMBER> global distance calculation gdc <NUMBER> xray structures listed descending order lga type rmsd sequence identity lga gdc details computationalexperimental platform described greater detail future publication including details active machine learning model feature space used represent three dimensional antigenantibody interface antibody optimization pipeline overall generate initial <NUMBER> antibodies executed following steps <NUMBER> obtain structures experimentallydetermined atomic coordinates previously deposited pdb several sarscov<NUMBER>neutralizing antibodies complex sarscov<NUMBER> sprotein obtain sequences sarscov<NUMBER> sprotein <NUMBER> map public sarscov<NUMBER> spike protein sequences structures estimated <NUMBER> costructures involving <NUMBER> antibodies completed jan <NUMBER> <NUMBER> made publicly available feb <NUMBER> <NUMBER> used two antibodies m<NUMBER> s<NUMBER> subsequent calculations <NUMBER> define set residues modification starting sarscov<NUMBER>neutralizing antibodies via automatic contact estimation <NUMBER> use machine learning module computational design platform iteratively propose mutations original antibody m<NUMBER> perform free energy calculations using foldx <NUMBER> llnl highperformance computing hpc maximize estimated affinities sarscov<NUMBER> spike protein homology model feb <NUMBER> <NUMBER> evaluated <NUMBER> mutant antibodies selected design space <NUMBER> <NUMBER> <NUMBER> amino acids <NUMBER> positions primary template structure pdb <NUMBER>dd<NUMBER> <NUMBER> use hpc perform additional free energy calculations <NUMBER> selected antibody sequences performing free energy calculations using rosetta <NUMBER> <NUMBER> antibodies molecular dynamics simulations <NUMBER> assess sequences statium energy prediction tool <NUMBER> completed feb <NUMBER> <NUMBER> <NUMBER> assess developability <NUMBER> selected antibody sequences using <NUMBER> developability metrics therapeutic antibody profiler <NUMBER> used machine learning module computational design platform iteratively propose mutations original antibody m<NUMBER> run foldx <NUMBER> calculations llnl hpc estimate free energies sarscov<NUMBER> spike protein homology model foldx binding calculations estimate change free energy ddg antibodyantigen protein complex resulting proposed mutations m<NUMBER> used calculation part objective function drive antibody optimization via machine learning model evaluated <NUMBER> mutants foldx course search improved antibodies estimated ddg values ranging <NUMBER> <NUMBER> kcalmole figure <NUMBER> plots improvements foldxestimated ddg values course machine learningdriven optimization process results indicate machine learning model effective searching combinatorial space possible antibody mutants perform design optimization identify increasingly improved predicted antibody designs selected subset antibody mutants additional calculations using rosetta <NUMBER> statium <NUMBER> molecular dynamics calculations <NUMBER> well antibody developability estimates via therapeutic antibody profiler <NUMBER> see methods section silico calculations performed used select <NUMBER> first round antibodies molecular mechanicsgeneralized born solvent accessible surface area mmgbsa molecular dynamics calculations <NUMBER> described methods section considered accurate estimate mmgbsa calculates antibodyantigen interaction free energies using fully solvated molecular dynamics md conformational sampling protein complex estimates free energy computationally less expensive implicit solvent model gbsa m<NUMBER> starting template design known neutralize sarscov<NUMBER> binding rbd preventing virus binding entering human ace<NUMBER> receptor mmgbsa calculations m<NUMBER> complex sarscov<NUMBER> spike protein yield <NUMBER> kcalmole Â±<NUMBER> m<NUMBER> known bind sarscov<NUMBER> spike protein <NUMBER> yields <NUMBER> sarscov<NUMBER> results suggest m<NUMBER>derived antibody mutants potentially bind neutralize sarscov<NUMBER> starting jan <NUMBER> <NUMBER> used two highperformance computers llnl course <NUMBER> days support <NUMBER> cpu hours <NUMBER> gpu hours performing <NUMBER> silico free energy calculations candidate antibodies complex sarscov<NUMBER> rbd performed work using sarscov<NUMBER> sequence previously published neutralizing antibody structures sarscov<NUMBER> predicted structures sarscov<NUMBER> proved accurate within targeted rbd region compared experimentally derived structures published weeks later predicted sarscov<NUMBER> structures used silico design platform evaluate <NUMBER> mutant antibodies iteratively proposing mutations sarscov<NUMBER> neutralizing antibodies optimize binding within sarscov<NUMBER> rbd selected <NUMBER> initial antibody sequences predicted target sarscov<NUMBER> rbd starting baseline free energy <NUMBER> kcalmol Â± <NUMBER> <NUMBER> selected first round antibody structures predicted improved interaction sarscov<NUMBER> rbd free energies ranging low <NUMBER> kcalmole baseline sarscov<NUMBER> antibody complex sarscov<NUMBER> rbd calculated free energy <NUMBER> kcalmole neutralizes virus preventing binding entering human ace<NUMBER> receptor results suggest predicted antibody mutants may bind sarscov<NUMBER> rbd therefore potentially neutralize virus additionally antibody mutants score well according multiple antibody developability metrics via therapeutic antibody profiler <NUMBER> antibody designs expressed experimentally tested binding sarscov<NUMBER> spike protein provide invaluable feedback improve machine learningdriven designs also continually improving platform performing additional silico calculations included future updates document addition currently <NUMBER> performing higher fidelity molecular dynamics calculations increase accuracy predictions using <NUMBER> <NUMBER> <NUMBER> investigating binding hotspots via single point mutation computational analysis <NUMBER> exploring potential impacts glycosylation rbd site supplementary materials document include <NUMBER> <NUMBER> homologybased structural models developed sarscov<NUMBER> complex sarscov<NUMBER> neutralizing antibodies <NUMBER> antibody mutant sequences silico free energy calculations performed <NUMBER> mutant antibodies derived m<NUMBER> sarscov<NUMBER> neutralizing antibody used select first round <NUMBER> candidate antibodies experimental evaluation absence known sarscov<NUMBER> spike protein structure characterized surface glycoprotein sequence yp<NUMBER> <NUMBER> constructing homologybased structural model using as<NUMBER>ts system <NUMBER> sarscov<NUMBER> assess regions sequencestructure conservation variability sarscov<NUMBER> sarscov<NUMBER> sequence similarity<NUMBER> created set initial structural models using available templates comparative analysis constructed models available templates pdb performed using stralsv algorithm <NUMBER> identifies protein fragments exhibit structural similarities despite low primary amino acid sequence similarity regions structure conformation uncertainties observed used results searches modeling missing loop regions assessment possible structure conformation diversity preliminary models constructed final models conformation sidechain atoms predicted using scwrl <NUMBER> residueresidue correspondences match residues identical template sarscov<NUMBER> spike protein copied templates onto models structural stereochemical quality models checked using contactdot algorithm molprobity software package <NUMBER> final constructed models finished relaxation using ucsf chimera <NUMBER> figures <NUMBER> <NUMBER> show two constructed structural models sarscov<NUMBER> spike protein complex fab s<NUMBER> m<NUMBER> figs <NUMBER> <NUMBER> respectively sarscov<NUMBER> neutralizing antibody set provided models constructed help assessment possible different conformations spikeantibody complexes ddg foldx calculations <NUMBER> mutant antibodies complex rbd started structure minimization using minimize structure procedure available ucsf chimera <NUMBER> process followed <NUMBER> iterations repairpdb function foldx performed ddg calculations defined list mutations using buildmodel procedure estimates stability dg defined free energy protein used <NUMBER> runs procedure check calculated rotamers specified mutations converged optimal trapped solution first set ddg estimates calculated difference free energy dg mutant wildtype labeled foldx ddg average supplementary materials additional ddg estimates calculated using analysecomplex algorithm used wildtype mutated models calculate ddg based energy changes interface within rbdfab complexes labeled foldx ddg interface supplementary materials estimate ddg values using rosetta started structure minimization using relax procedure proteinfab complex model made <NUMBER> relaxed structures chose representative model lowest free energy structures calculated ddg estimates change stability using ddgmonomer algorithm <NUMBER> iterations settings described <NUMBER> labeled rosetta ddg total energy supplementary materials additional ddg estimates calculated using flexddg protocol <NUMBER> evaluates energy changes focusing interfaces within rbdfab complexes labeled rosetta ddg flex supplementary materials addition rosetta calculations total energy flex performed possible singlepoint mutations <NUMBER> locations selected mutation <NUMBER> amino acid mutation possibilities <NUMBER> locations <NUMBER> total rosetta singlepoint mutation calculations used molecular mechanicsgeneralized born solvent accessible surface area mmgbsa calculations antibodyantigen interaction free energies <NUMBER> mmgbsa uses fully solvated molecular dynamics conformational sampling protein complex estimates free energy computationally cheaper implicit solvent model gbsa molecular dynamics simulations performed openmm <NUMBER> toolkit molecular simulation using amber force field <NUMBER> positional constraints <NUMBER> kcalmoleÃ¥ <NUMBER> place backbone atoms c n ca heating system system heated <NUMBER> k increments <NUMBER> ps temperature system <NUMBER> k constraints removed equilibration performed <NUMBER> ns ten individual <NUMBER> ns dynamics simulations performed equilibrated system conformational sampling last <NUMBER> ns dynamics <NUMBER> ps increments simulations used mmgbsa calculation <NUMBER> total structures mmgbsa calculations performed using mmpbsapy part amber suite programs bioinformatic heuristic computed number mutations considered unlikely labeled number unconventional mutations dataset provided supplementary materials mutant antibody considered heuristic describes mutations low probability mutational probability distribution derived blosum<NUMBER> substitution matrix <NUMBER> mutational probability distribution gives substitutions higher probabilities eg <NUMBER> lower eg aw <NUMBER> total probabilities <NUMBER> destination amino acids <NUMBER> given point mutation given probability <NUMBER> ie less <NUMBER>th mutation declared unconventional count incremented one example alanine <NUMBER> <NUMBER> mutations unconventional heuristic outbreak new betacoronavirus <NUMBER>ncov formally named sarscov<NUMBER> represents worldwide epidemic threat causing major disruptions societies economies <NUMBER> reasons new virus internationally declared public health emergency context structural knowledge proteins virus provide important information develop strategies infection ranging diagnosis therapy general coronaviruses use protein localized envelope bind cell receptors binding series molecular events lead fusion viral membrane host cell eventually leading virus entry invasion one necessary steps mechanism binding spike protein receptor binding domain rbd cell receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> indeed knock ace<NUMBER> hela cells shown prevent infection reasons development antibodies target spike rbd coronaviruses block interaction ace<NUMBER> disrupting fundamental infection mechanism represent attractive therapeutic solutions monoclonal antibodies high affinities previously developed spike rbd sarscov however despite correlations two viruses rbdtargeted sarscov monoclonal antibodies shown ability bind neutralize <NUMBER>ncov recent publication cryoem structure <NUMBER>ncov spike trimer <NUMBER> Ã¥ resolution provide useful basis link observations molecular causes guide design sarscov<NUMBER> specific antibodies possibly suggest basis molecules able block cell viral entry carry comparative analysis spike protein rbds sarscov<NUMBER> sarscov reveal key properties surfaces reconnected observed differences antibody ab receptor binding starting atomic resolution information available solved structures two proteins mlce matrix low coupling energies method applied identify subsets surface residues defined interacting mlce analysis protein energetics accounts interactions residue establishes residues protein belongs correlation parameter structural properties protein thus highlights substructures preorganized interact potential partner cell receptor antibody mlce analyzes interaction energies amino acids protein particular computes nonbonded part potential van der waals electrostatic interactions solvent effects via mmgbsa calculation obtaining protein composed n residues n Ã n symmetric interaction matrix mij eigenvalue decomposition matrix highlights regions strongest weakest couplings fragments surface contiguous space weakly coupled protein core define potential interaction regions words putative interacting patches assumed characterized frustrated intramolecular interactions actual interaction partner actually occur favorable interactions determine lower free energy bound unbound state <NUMBER> <NUMBER> indeed minimal energetic coupling rest protein allows substructures undergo conformational changes recognized binding partner antibodies receptors properties hallmarks antibody binding epitopes ppi substructures mlce method prediction proteinprotein interaction regions antibody binding epitopes validated several previous studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> took advantage recent publication structures sarscov<NUMBER> spike protein prefusion state doiorg<NUMBER>scienceabb<NUMBER> known structure sarscov spike protein comparatively apply interaction epitope prediction method mlce application mlce receptor binding domain rbd aa <NUMBER> sarscov<NUMBER> spike protein pdb code <NUMBER>vsb doi <NUMBER>pdb<NUMBER>vsbpdb <NUMBER> sarscov spike protein pdb code <NUMBER>x<NUMBER> doi <NUMBER>pdb<NUMBER>x<NUMBER>pdb figure <NUMBER> shows two protein regions contain potential interaction regionsabbinding epitopes share topological localization two opposite ends <NUMBER>d structures figure <NUMBER> however trait appears common one linear sequences correspond predicted interacting epitope regions reported table <NUMBER> importantly predicted epitopes sarscov spike rbd show good degree overlap epitopes mapped neutralizing ab <NUMBER>r <NUMBER> s<NUMBER> <NUMBER> m<NUMBER> <NUMBER> providing relevant validation approach however spite high degree structural similarity two spike proteins mabs failed bind sarscov<NUMBER> rbd probably due low degree sequence conservation regions contacted antibodies fact sarscovdirected mabs reactive novel betacoronavirus highlights need discover specific epitopes sarscov<NUMBER> actually except common topological localization predicted abbinding epitopes differ two proteins sequence <NUMBER>d structural organization table <NUMBER> <NUMBER> figure <NUMBER> cases linear sequences spanning distant segments primary structure come together threedimensional structure form extended substructures potentially preorganized binding particularly true conformational epitope nand cterminal region sarscov<NUMBER> rbd interacting region spans large part welldefined betasheet subdomain table <NUMBER> <NUMBER> figure <NUMBER> tempting suggest expression subdomain isolation could give rise highly immunoreactive molecule <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> rbd knowledge substructures representing potential conformational epitopes may helpful guiding development peptidebased immunogens able elicit antibodies specifically target cognate protein predicted epitopes belong figure <NUMBER> simply speaking termini linear segments making conformational epitopes could aptly bridged number gly residues sufficient approximate distance experimental structure table <NUMBER> antibodies raised molecules recapitulate main determinants immunoreactivity full protein could useful applications therapeutic setting <NUMBER> <NUMBER> <NUMBER> furthermore information potentially specific sarscov<NUMBER> spike rbdspecific epitopes specific sarscov<NUMBER> rbd epitope sequences structures identified thus used design new molecular probes immunoprobes facile synthetic accessibility potential function antigenmimicking baits target virusspecific antibodies patients fluids immunogens generate new abs able detect relevant antigens <NUMBER> <NUMBER> importantly ran predictions sarscov<NUMBER> rbd crystal structures domain complex cellular receptor protein ace<NUMBER> reported lan et al aa <NUMBER> <NUMBER> yan et al <NUMBER> note one predicted interaction region almost completely overlaps substructure spike protein rdb engaged binding ace<NUMBER> <NUMBER> tpcngvegf <NUMBER> synthetic mimicry sequence could aptly generate high priority candidates aimed disrupting ppis sarscov<NUMBER> rbd cell receptor ace<NUMBER> molecules could used block viral entry cells similarly approach also predicts patch sarscov spike rbd partly involved binding ace<NUMBER> see <NUMBER> overall two rbd proteins likely evolved common ancestor share common fold characterized different sequences physicochemical properties determined sequence differences efficaciously unveiled mlce reverberate modulation networks intraprotein interactions underlie preorganization regions potential recognition binding partners cell receptors antibodies results represent best knowledge one first molecular physicalchemistry based rationalization reasons tested sarscov rbd monoclonal abs appreciable crossreactivity sarscov<NUMBER> rbd <NUMBER> despite fact two domains recently reported display affinity ace<NUMBER> kd values <NUMBER> nm <NUMBER> nm sarscov<NUMBER> sarscov respectively <NUMBER> complex scenario predictions help disentangle issues related betacoronavirues infectivity immunological response acknowledgement acknowledge funding regione lombardia project ready regional network developing diagnostic methods rapid response emerging epidemics bioemergencies coordinates proteins analyzed text downloaded pdb missing residues belonging highly flexible loops solved structure spike protein modeled homology using swissmodel web server httpsswissmodelexpasyorg retrieved structure sarscov <NUMBER>x<NUMBER> best template structures used input epitope prediction using matrix local coupling energies method mlce combines analysis structural determinants given protein energetic properties <NUMBER> <NUMBER> approach allows identify nonoptimized lowintensity energetic interactionnetworks corresponding substructures prone establish interactions antibodies suitably recognized binding partners briefly contiguous ath eigenvalue ith component corresponding eigenvector eigenvector negative correspondent eigenvalue contains interaction information stabilizing interaction system approximated interaction matrix thus given structure protein known one estimate contact matrix assuming two amino acids contact distance two heavy atoms smaller threshold hadamard product two matrices gives us matrix local coupling energies â¢ select possible interacting zones sets close residues show weak frustrated interactions analysis energetic properties surface residues based mlce method basically perform mmgbsa analysis structure force field obtaining symmetric perresidue interaction matrix keeping nonbonded interaction ie electrostatic van der waals solvation contributions diagonalize matrix obtaining set eigenvectors sorted following increasing value eigenvectors number amino acids sequence thus write original matrix ij <NUMBER> k <NUMBER> <NUMBER> shown first eigenvector alone used build approximate interaction matrix ij Î» recapitulates interactions relevant stabilization certain conformation defined protein protein substructure mmgbsa made amber <NUMBER> software ff<NUMBER>sb forcefield tables <NUMBER> <NUMBER> highlighted colors figure <NUMBER> space filling regions indicate possible conformational epitopes sarscov<NUMBER> formed juxtapositions sequences reports table <NUMBER> region binding ace<NUMBER> correctly predicted also highlighted severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causes covid<NUMBER> coronavirus closely related sarscov middle east respiratory syndrome mers coronaviruses <NUMBER> covid<NUMBER> manifest adults severe interstitial pneumonia hyperinflammation severe respiratory manifestations rare children <NUMBER> <NUMBER> <NUMBER> recently however multisystem inflammatory system children misc recognized patients either tested positive covid<NUMBER> pcr serology epidemiological links covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> initial reports uk <NUMBER> many cases reported europe <NUMBER> <NUMBER> new york usa cdc however cases reported china japan south korea also severely impacted covid<NUMBER> pandemic ecdc misc manifests persistent fever hyperinflammation multi organ system involvement including cardiac gastrointestinal renal hematologic dermatologic neurologic symptoms <NUMBER> highly reminiscent toxic shock syndrome tss <NUMBER> <NUMBER> table <NUMBER> rather kawasaki disease due marked demographic clinical laboratory differences <NUMBER> similarities tss association misc covid<NUMBER> led us hypothesize sarscov<NUMBER> may possess superantigenic fragments induce inflammatory cascade perhaps also contribute hyperinflammation cytokine storm features observed severe adult covid<NUMBER> cases <NUMBER> <NUMBER> question raised sarscov<NUMBER> possess superantigenic fragments could elicit reactions upon binding proteins involved host cell cytotoxic adaptive immune response reaction observed sarscov pandemic <NUMBER> shortly sars<NUMBER> unique sarscov<NUMBER> recent mutations sarscov<NUMBER> may promoted increased virulence although children largely spared severe covid<NUMBER> disease rare hyperinflammatory syndrome described europe east coast united states termed multisystem inflammatory syndrome children misc symptoms diagnostic lab values misc resemble toxic shock typically caused pathogenic superantigens stimulating excessive activation adaptive immune system show sarscov<NUMBER> spike sequence structure motif highly similar bacterial superantigens may directly bind cell receptors sequence motif present coronaviruses may explain unique potential sarscov<NUMBER> cause misc cytokine storm observed adult covid<NUMBER> patients cd<NUMBER> cd<NUMBER> cells ability sags bypass antigen specificity tcrs results broad activation cells cytokine storm leading toxic shock <NUMBER> <NUMBER> notably sags bind major antigenic peptide binding groove mhcii instead bind regions well Î±Î²tcrs directly early studies showed bacterial sags activate cells binding Î²chain dimeric tcrs variable domain v <NUMBER> <NUMBER> <NUMBER> recent studies revealed bind either Î±or Î²chains <NUMBER> question sarscov<NUMBER> possess superantigenic fragmentsdomains could bind Î±Î²tcrs used computational modelling determine whether sarscov<NUMBER> possesses sag activity demonstrate insert present sarscov<NUMBER> absent sars<NUMBER> mers mediates high affinity nonspecific binding tcr notably motif <NUMBER> amino acids enclosing insert unique sarscov<NUMBER> among beta coronaviruses sequence structure features highly similar seb toxin furthermore analysis indicates sarscov<NUMBER> mutation detected european strain may enhance tcr binding suggesting mutations may account geographical differences misc occurrence finding important implications management treatment covid<NUMBER> sarscov<NUMBER> spike harbors high affinity site tcr Î²chain binding contains insertion p<NUMBER>rra<NUMBER> unique sars<NUMBER> first examined whether sarscov<NUMBER> could bind Î±Î²tcr aim constructed sarscov<NUMBER> structural model based cryoem structure resolved spike glycoprotein <NUMBER> used xray structure Î±Î²tcr resolved ternary complex seh mhcii <NUMBER> generated series structural models possible sarscov<NUMBER> glycoprotein tcr complex formation using cluspro <NUMBER> simulations led binding pose presented fig <NUMBER>a one probable mechanisms complex formation described detail supplemental information si supplementary fig s<NUMBER> therein tcr binds interface s<NUMBER> s<NUMBER> subunits spike protein near s<NUMBER>s<NUMBER> cleavage site closeup view interface spike tcrvÎ² domain fig <NUMBER>b reveals several strong interatomic interactions involving residues s<NUMBER>r<NUMBER> spike r<NUMBER>e<NUMBER> q<NUMBER> d<NUMBER> respective cdrs <NUMBER> <NUMBER> vÎ² overall closeup b views complex interfacial interactions b spike monomers colored white ice blue spectrally blue nterminal domain red displayed surface representation better visualization spike trimer oriented receptor binding domains rbds bottom tcr Î±and Î²chains red cyan ribbons b segment s<NUMBER>pprar<NUMBER> including prra insert highly conserved cleavage site r<NUMBER> shown van der waals representation black labels nearby cdr residues tcrvÎ² domain labeled bluewhite see additional information supplementary fig s<NUMBER> note tcrvÎ²binding epitope sarscov<NUMBER> centered around sequence motif p<NUMBER>rra<NUMBER> shortly prra hereafter sequential spatial neighbors comparison sarscov<NUMBER> betacoronavirus spike protein sequences showed <NUMBER> sarscov<NUMBER> distinguished existence fourresidue insertion prra preceding furin cleavage site r<NUMBER>s<NUMBER> peptide bond subunits s<NUMBER> s<NUMBER> protomer fig <NUMBER>a structural comparison trimeric proteins sarscov sarscov<NUMBER> shows close structural similarity general except rbd engaged specific interfacial interactions <NUMBER> two spikes significantly differ near prrars motif unique sarscov<NUMBER> exposed extracellular medium fig <NUMBER>b examination motif near prra reveals close structural similarity seb superantigen well sequence similarities neurotoxins viral sag insertion prra together sequentially preceding seven amino acids succeeding arg fully conserved among Î²coronaviruses pointed form motif y<NUMBER>qtqtnsprrar<NUMBER> homologous neurotoxins ophiophagus cobra bungarus genera well neurotoxinlike regions three rabv strains <NUMBER> fig <NUMBER>c noticed segment bears close similarity hiv<NUMBER> glycoprotein gp<NUMBER> superantigenic motif f<NUMBER>v<NUMBER> gp<NUMBER> sag motif <NUMBER> last row sarscov<NUMBER> trimer composed s<NUMBER> subunits protomers colored orange red gray displayed van der waals format protruding motifs e<NUMBER>r<NUMBER> highlighted white green red blue representing hydrophobic hydrophilic acidic basic residues close sequence similarity bacterial viral sags support potential superantigenic character amino acid stretch y<NUMBER>r<NUMBER> sarscov<NUMBER> directed us analyze local sequence structural properties analysis led interesting sequence similarity partially overlapping fragment t<NUMBER>q<NUMBER> spike seb superantigenic peptide y<NUMBER>nkkkatvqeld<NUMBER> fig <NUMBER>a dodecapeptide sequence within seb shows strong conservation among broad range staphylococcal streptococcal sags <NUMBER> <NUMBER> note sequentially aligned segment sars<NUMBER> s<NUMBER>k<NUMBER> bears minimal similarity seb sag fig <NUMBER>a left even interesting sarscov<NUMBER> motif showed palindromic behavior respect superantigenic seb sequence sense broader stretch e<NUMBER> r<NUMBER> could aligned superantigen peptide reverse direction well fig <NUMBER>a right brings attention versatility high propensity sarscov<NUMBER> tcrvÎ²binding site residues potentially act superantigenic fragment significantly structures two peptides exhibit remarkable similarity fig <NUMBER>bc including salt bridge stabilizing structural motif e<NUMBER>k<NUMBER> seb e<NUMBER>r<NUMBER> sarscov<NUMBER> relative orientations three positively charged residues k<NUMBER>k<NUMBER>k<NUMBER> seb r<NUMBER>r<NUMBER>r<NUMBER> sarscov<NUMBER> Î²hairpin apparently serves scaffold may supported sars coronavirus potential disulfide bond c<NUMBER>c<NUMBER> former two features absent sars<NUMBER> spike fig <NUMBER>d analysis overall indicates segment t<NUMBER>nsprrar<NUMBER> forms putatively superantigenic core consistently aligned various bacterial viral sags figs <NUMBER>c <NUMBER>ac without participation adjoining amino acids however combined broader sequence structure analysis fig <NUMBER> panels right bc reveals even compelling feature putative sag core structurally consolidated spatial proximity conserved acidic segment e<NUMBER>cd<NUMBER> forms highly stable salt bridge polybasic segment prrar sarscov<NUMBER> much way salt bridge observed seb sars<NUMBER> note seb superantigen peptide y<NUMBER>nkkkatvqeld<NUMBER> reported bind cd<NUMBER> <NUMBER> cell receptor provides costimulatory signals required cell activation survival cd<NUMBER> tcrv domains share immunoglobulin fold fig <NUMBER>e binding mechanism shown fig <NUMBER>b likely adopted minor rearrangements enabling binding seb cd<NUMBER> finally homologous superantigenic segment seb binding cd<NUMBER> also tested potential binding sars<NUMBER> spike e<NUMBER>r<NUMBER> onto cd<NUMBER> considering possibility target sars<NUMBER> spike superantigenic segment might cd<NUMBER> simulations indicated segment equally bind cd<NUMBER> supporting strong propensity fragment stimulate cell activation existence potential superantigenic toxic intercellularadhesion molecule icamlike sequence fragments sars<NUMBER> thoroughly examined li et al following <NUMBER> pandemic <NUMBER> led identification nine sequence stretches including three botulinum neurotoxin type g precursors two motifs high similarity intercellular adhesion molecule <NUMBER> icam<NUMBER> comparative analysis sarscov<NUMBER> spike sequence revealed seven sequence motifs conserved sarscov sarscov<NUMBER> supplementary fig s<NUMBER> among note y<NUMBER>nengtitdavdcaldplsetkc<NUMBER> icam<NUMBER> cd<NUMBER>like motif also participates association sarscov<NUMBER> spike bound Î±Î²tcr see fig <NUMBER> note icam<NUMBER> involvement critical mediating immune inflammatory responses observed interaction icam<NUMBER>like motif sarscov<NUMBER> tcrvÎ± tandem interaction discussed putative sag motif around insert prra tcrvÎ± likely strengthen association virus cell ensuing activation precisely n<NUMBER>e<NUMBER>n<NUMBER> t<NUMBER> belonging icamlike fragment closely interact tcrvÎ± cdrs mainly t<NUMBER> spike makes close contacts s<NUMBER> cdr<NUMBER> e<NUMBER> spike forms hydrogen bond t<NUMBER> cdr<NUMBER> n<NUMBER> n<NUMBER> spike closely associate r<NUMBER> fig <NUMBER>d rare mutation d<NUMBER>ye recently observed sars<NUMBER> strain europe contributes stabilizing interaction tcr interestingly sarscov<NUMBER> spike binding region harbors three residues recently reported mutated new strains europe usa <NUMBER> <NUMBER> d<NUMBER>g a<NUMBER>v d<NUMBER>yne former two may potentially interact mhcii latter d<NUMBER> european strain located close tcrvÎ² strongly interacts n<NUMBER> fig <NUMBER>a c supplementary figs s<NUMBER> s<NUMBER>a substitution glutamate mutant d<NUMBER>e increases strength intermolecular thereby virust cell association supplementary fig s<NUMBER>c even stronger interactions spike tcrvÎ² observed upon replacing d<NUMBER> tyrosine illustrated supplementary fig s<NUMBER>d interfacial interactions case stabilized hydrogen bond y<NUMBER> d<NUMBER> aromatic polarÏ interaction y<NUMBER> n<NUMBER> well possible electrostatic interactions k<NUMBER> s<NUMBER> quantitative evaluation change binding affinity spike tcr upon mutating d<NUMBER> e n yields Î´Î´gdây <NUMBER>kcal mol <NUMBER> Î´Î´gdâe <NUMBER>kcal mol <NUMBER> Î´Î´gdân <NUMBER>kcal mol <NUMBER> respectively see supplementary table s<NUMBER> details thus d<NUMBER>yne mutations would expected strengthensupport described association superantigenic prracontaining segment tcrvÎ² understanding immunopathology leading severe manifestations covid<NUMBER> adults children critical importance effective management treatment disease misc shows remarkable similarity pediatric tss <NUMBER> using silico modeling analysis found sarscov<NUMBER> encodes superantigen motif near s<NUMBER>s<NUMBER> cleavage site region highly similar structure seb sag motif interacts tcr cd<NUMBER> <NUMBER> mediates tss seb enables largescale cell activation proliferation <NUMBER> resulting massive production proinflammatory cytokines including ifnÎ³ tnfÎ± il<NUMBER> cells well il<NUMBER> tnfÎ± apcs <NUMBER> cytokine storm leads multiorgan tissue damage similar observed misc therefore propose misc observed covid<NUMBER> patients may mediated superantigen activity sarscov<NUMBER> protein date misc mostly observed europe east coast north america described asia despite sizeable outbreaks covid<NUMBER> <NUMBER> cdc ecdc show mutation d<NUMBER> found european strain sarscov<NUMBER> enhances binding affinity sag motif tcr could least partly explain geographical skewing misc areas european strain endemic identification strainspecific mutations may help predict future outbreak misc may occur findings raise exciting possibility immunomodulatory therapeutic options used tss may also effective misc including ivig steroids indeed initial published unpublished reports suggest misc patients respond well ivig without steroids <NUMBER> ivig recognizes seb epitopes <NUMBER> thus may function part neutralization superantigen given structural similarities seb protein sag motif potential crossreactivity immunoglobins explaining least part response misc cases ivig fdaapproved antiinflammatory drugs tested models seb tss may also effective including ctla<NUMBER>ig inhibit cd<NUMBER> costimulation <NUMBER> mtor inhibitor rapamycin <NUMBER> already use covid<NUMBER> addition humanized monoclonal antiseb abs described <NUMBER> could also potential therapeutic benefit misc patients notably shown mouse model tss lethal seb superantigen challenge prevented short peptide mimetics superantigen motif <NUMBER> would interesting examine whether short peptide mimetics sarscov<NUMBER> spike superantigen region might employed preventattenuate inflammatory cytokine gene induction toxic shock misc patients present majority antibody therapies investigation designed target sarscov<NUMBER> receptor binding domains rbds <NUMBER> <NUMBER> simulations also indicated rbd might potentially interact tcrs however compared rbds relatively fewer mutations found sag region sarscov<NUMBER> notably prra insert unique sarscov<NUMBER> retained among isolates sequenced date <NUMBER> <NUMBER> might constructive design antibodies drugs targeting sag region block cleavage essential enabling viral entry <NUMBER> <NUMBER> also modulate saginduced inflammatory cytokine gene induction <NUMBER> fortunately severe respiratory manifestations covid<NUMBER> children well development misc rare may due trained immunity <NUMBER> crossviral immunity coronavirus strains <NUMBER> b cells play important role antiviral response cd<NUMBER> cd<NUMBER> cells convalescent covid<NUMBER> patients recognize range sars<NUMBER> epitopes protein represents major target <NUMBER> interestingly cells unexposed individuals also respond protein epitopes sarscov<NUMBER> supports hypothesis crossviral immunity coronavirus strains <NUMBER> however fraction infected children develop misc unclear possible poor initial antibody response virus fails neutralize sag leading immune enhancement following exposure certain hla types permissive binding sag indeed hla shown play role covid susceptibility <NUMBER> nine cases initially reported uk six afrocaribbean descent also suggests potential genetic component susceptibility <NUMBER> interesting note approximately third fewer misc patients tested positive sarscov<NUMBER> majority serologic evidence infection history exposure covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> may suggest sarscov<NUMBER> sag causes delayed hyperinflammation response certain children sags implicated autoimmunity triggering selfreactive cells <NUMBER> antibodymediated enhancement upon reexposure virus may also contribute uncontrolled infection inflammation <NUMBER> also possible despite negative nasopharyngeal pcr test virus may still present gastrointestinal tract <NUMBER> misc patients demonstrate unusually severe gi symptoms abdominal pain vomiting diarrhea addition severe myocardial dysfunction cardiac shock <NUMBER> severe gi symptoms also frequently associated sag <NUMBER> summary made three major observations prrar sequential neighbors interact tcrvÎ² residues d<NUMBER> r<NUMBER> e<NUMBER> cdrs association closely resembles seb sag tcrvÎ² b nearby d<NUMBER> participates interaction mutation tyrosine would strengthen association tcrvÎ² c sequence motif n<NUMBER>t<NUMBER> typical icam<NUMBER> interacts tcrvÎ± stabilizingenhancing association viral spike host cell tcr binding pose tcr respect spike allows simultaneously three associations first important <NUMBER> nd significant european strain <NUMBER> rd may imparting stronger hostvirus adhesion therefore strategies used treatment sebmediated toxic shock approaches block interaction protein tcr may reduce hyperinflammatory manifestations covid<NUMBER> adults children sarscov<NUMBER> p<NUMBER>dtc<NUMBER> sarscov cvhsap<NUMBER> spike models generated using swissmodel <NUMBER> based resolved spike glycoprotein structures sarscov<NUMBER> pdb <NUMBER>vsb sarscov <NUMBER> pdb <NUMBER>acdthe missing loops crystal structures built using libraries backbone fragments <NUMBER> constraint space de novo reconstruction backbone segments <NUMBER> two mutants associated european covid<NUMBER> patients <NUMBER> constructed using charmmgui <NUMBER> one main strain mutant d<NUMBER>g contains four mutations including q<NUMBER>k a<NUMBER>v d<NUMBER>g d<NUMBER>y two sarscov<NUMBER> spike mutants together sarscov<NUMBER> p<NUMBER>dtc<NUMBER> originally taken wuhan used investigate binding Î±Î²tcr mhcii pdb <NUMBER>xn<NUMBER> <NUMBER> using cluspro <NUMBER> prodigy <NUMBER> see details si sarscov<NUMBER> spike model prefusion state generated using swissmodel <NUMBER> based resolved cryoem structure protein data bank pdb <NUMBER>vsb <NUMBER> spike glycoprotein one receptor binding domains rbds conformation structure cell receptor tcr containing tcrÎ± tcrÎ² chains taken crystal structure ternary complex human tcr staphylococcal enterotoxin h seh human major histocompatibility complex class ii mhcii molecule <NUMBER> using proteinprotein docking software cluspro <NUMBER> constructed silico series binary complexes sarscov<NUMBER> spike tcr obtained <NUMBER> clusters conformations spiketcr binary complexes upon clustering <NUMBER> models generated cluspro clusters rankordered cluster size recommended <NUMBER> analyzed models found majority <NUMBER> showed tcr bound spike via constant domain given constant domain proximal cell membrane tcr employs variable domain binding superantigens andor antigenmhc complexes <NUMBER> added restraints docking simulations prevent binding tcr constant domain filter conformers variable domain would bind spike led <NUMBER> clusters based set <NUMBER> models cluspro interestingly <NUMBER> models showed binding tcr near region prra insert <NUMBER> models showed binding tcr within multiple rbds thus identified two hot spots tcr binding within sarscov<NUMBER> spike one near prra insert within rbd representative members belonging topranking clusters presented fig s<NUMBER> structure human mhcii taken crystal structure ternary complex <NUMBER> pdb <NUMBER>xn<NUMBER> human tcr seh mhcii first performed docking simulations generate binary complexes mhcii sarscov<NUMBER> spike six representative mhciispike binary complexes selected explore docking tcr form ternary complex analyzed predicted ternary complex models mhciispiketcr potential tertiary mhciispiketcr complex models selected following three filtering criteria <NUMBER> tcr either binds near prra insert region rbd <NUMBER> binding regions involve homologous superantigen toxin binding motifs predicted sarscov fig s<NUMBER> <NUMBER> mhcii tcr close proximity filters led mhciispiketcr complex model illustrated fig s<NUMBER>a interestingly sarscov<NUMBER> spike binding region harbors three residues recently reported mutated new strains europe usa <NUMBER> fig s<NUMBER>b d<NUMBER>g a<NUMBER>v d<NUMBER>yne exclude possible occurrence potential tertiary complexes especially involving rbds focus complex shown fig s<NUMBER> uniquely satisfied three aforementioned criteria mutated d<NUMBER> sarscov<NUMBER> spike silico asparagine glutamic acid tyrosine line aforementioned mutant d<NUMBER>yne observed new strain europe aim used pymol mutagenesis tool <NUMBER> evaluated change local conformation energetics complex formed tcr probable rotamers selected energetically minimized presence bound tcr conformation shown fig <NUMBER> using openmm <NUMBER> binding affinities Î´g dissociation constants kd obtained full complex intact spike entire tcr interactors ii single spike subunit tcrvÎ² d<NUMBER>yne mutation spike <NUMBER> Â°c using prodigy server <NUMBER> tables table s<NUMBER> binding affinities predicted interactions Î±Î²tcr sarscov<NUMBER> spike beforeafter point mutation d<NUMBER>yne Î´g kcal mol <NUMBER> kd nm Î´g kcal mol <NUMBER> kd nm Î´g kcal mol <NUMBER> kd nm Î´g kcal mol <NUMBER> kd nm severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causes covid<NUMBER> coronavirus closely related sarscov middle east respiratory syndrome mers coronaviruses <NUMBER> covid<NUMBER> manifest adults severe interstitial pneumonia hyperinflammation severe respiratory manifestations rare children <NUMBER> <NUMBER> <NUMBER> recently however multisystem inflammatory system children misc recognized patients either tested positive covid<NUMBER> pcr serology epidemiological links covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> initial reports uk <NUMBER> many cases reported europe <NUMBER> <NUMBER> new york usa cdc however cases reported china japan south korea also severely impacted covid<NUMBER> pandemic ecdc misc manifests persistent fever hyperinflammation multi organ system involvement including cardiac gastrointestinal renal hematologic dermatologic neurologic symptoms <NUMBER> highly reminiscent toxic shock syndrome tss <NUMBER> <NUMBER> table <NUMBER> rather kawasaki disease due marked demographic clinical laboratory differences <NUMBER> similarities tss association misc covid<NUMBER> led us hypothesize sarscov<NUMBER> may possess superantigenic fragments induce inflammatory cascade perhaps also contribute hyperinflammation cytokine storm features observed severe adult covid<NUMBER> cases <NUMBER> <NUMBER> question raised sarscov<NUMBER> possess superantigenic fragments could elicit reactions upon binding proteins involved host cell cytotoxic adaptive immune response reaction observed sarscov pandemic <NUMBER> shortly sars<NUMBER> unique sarscov<NUMBER> recent mutations sarscov<NUMBER> may promoted increased virulence tss caused two types superantigens sags bacterial viral bacterial sags broadly studied include proteins secreted staphylococcus aureus streptococcus pyogenes induce inflammatory cytokine gene induction toxic shock typical examples tss toxin <NUMBER> tsst<NUMBER> staphylococcal enterotoxins b seb h seh highly potent cell activators bind mhc class ii mhcii molecules andor tcrs cd<NUMBER> cd<NUMBER> cells ability sags bypass antigen specificity tcrs results broad activation cells cytokine storm leading toxic shock <NUMBER> <NUMBER> notably sags bind major antigenic peptide binding groove mhcii instead bind regions well Î±Î²tcrs directly early studies showed bacterial sags activate cells binding Î²chain dimeric tcrs variable domain v <NUMBER> <NUMBER> <NUMBER> recent studies revealed bind either Î±or Î²chains <NUMBER> question sarscov<NUMBER> possess superantigenic fragmentsdomains could bind Î±Î²tcrs used computational modelling determine whether sarscov<NUMBER> possesses sag activity demonstrate insert present sarscov<NUMBER> absent sars<NUMBER> mers mediates high affinity nonspecific binding tcr notably motif <NUMBER> amino acids enclosing insert unique sarscov<NUMBER> among beta coronaviruses sequence structure features highly similar seb toxin furthermore analysis indicates sarscov<NUMBER> mutation detected european strain may enhance tcr binding suggesting mutations may account geographical differences misc occurrence finding important implications management treatment covid<NUMBER> sarscov<NUMBER> spike harbors high affinity site tcr Î²chain binding contains insertion p<NUMBER>rra<NUMBER> unique sars<NUMBER> first examined whether sarscov<NUMBER> could bind Î±Î²tcr aim constructed sarscov<NUMBER> structural model based cryoem structure resolved spike glycoprotein <NUMBER> used xray structure Î±Î²tcr resolved ternary complex seh mhcii <NUMBER> generated series structural models possible sarscov<NUMBER> glycoprotein tcr complex formation using cluspro <NUMBER> simulations led binding pose presented fig <NUMBER>a one probable mechanisms complex formation described detail supplemental information si supplementary fig s<NUMBER> therein tcr binds interface s<NUMBER> s<NUMBER> subunits spike protein near s<NUMBER>s<NUMBER> cleavage site closeup view interface spike tcrvÎ² domain fig <NUMBER>b reveals several strong interatomic interactions involving residues s<NUMBER>r<NUMBER> spike r<NUMBER>e<NUMBER> q<NUMBER> d<NUMBER> respective cdrs <NUMBER> <NUMBER> vÎ² overall closeup b views complex interfacial interactions b spike monomers colored white ice blue spectrally blue nterminal domain red displayed surface representation better visualization spike trimer oriented receptor binding domains rbds bottom tcr Î±and Î²chains red cyan ribbons b segment s<NUMBER>pprar<NUMBER> including prra insert highly conserved cleavage site r<NUMBER> shown van der waals representation black labels nearby cdr residues tcrvÎ² domain labeled bluewhite see additional information supplementary fig s<NUMBER> note tcrvÎ²binding epitope sarscov<NUMBER> centered around sequence motif p<NUMBER>rra<NUMBER> shortly prra hereafter sequential spatial neighbors comparison sarscov<NUMBER> betacoronavirus spike protein sequences showed <NUMBER> sarscov<NUMBER> distinguished existence fourresidue insertion prra preceding furin cleavage site r<NUMBER>s<NUMBER> peptide bond subunits s<NUMBER> s<NUMBER> protomer fig <NUMBER>a structural comparison trimeric proteins sarscov sarscov<NUMBER> shows close structural similarity general except rbd engaged specific interfacial interactions <NUMBER> two spikes significantly differ near prrars motif unique sarscov<NUMBER> exposed extracellular medium fig <NUMBER>b examination motif near prra reveals close structural similarity seb superantigen well sequence similarities neurotoxins viral sag insertion prra together sequentially preceding seven amino acids succeeding arg fully conserved among Î²coronaviruses pointed form motif y<NUMBER>qtqtnsprrar<NUMBER> homologous neurotoxins ophiophagus cobra bungarus genera well neurotoxinlike regions three rabv strains <NUMBER> fig <NUMBER>c noticed segment bears close similarity hiv<NUMBER> glycoprotein gp<NUMBER> superantigenic motif f<NUMBER>v<NUMBER> <NUMBER> well hiv<NUMBER> gp<NUMBER> sag motif <NUMBER> last row sarscov<NUMBER> trimer composed s<NUMBER> subunits protomers colored orange red gray displayed van der waals format protruding motifs e<NUMBER>r<NUMBER> highlighted white green red blue representing hydrophobic hydrophilic acidic basic residues close sequence similarity bacterial viral sags support potential superantigenic character amino acid stretch y<NUMBER>r<NUMBER> sarscov<NUMBER> directed us analyze local sequence structural properties analysis led interesting sequence similarity partially overlapping fragment t<NUMBER>q<NUMBER> spike seb superantigenic peptide y<NUMBER>nkkkatvqeld<NUMBER> fig <NUMBER>a dodecapeptide sequence within seb shows strong conservation among broad range staphylococcal streptococcal sags <NUMBER> <NUMBER> note sequentially aligned segment sars<NUMBER> s<NUMBER>k<NUMBER> bears minimal similarity seb sag fig <NUMBER>a left even interesting sarscov<NUMBER> motif showed palindromic behavior respect superantigenic seb sequence sense broader stretch e<NUMBER> r<NUMBER> could aligned superantigen peptide reverse direction well fig <NUMBER>a right brings attention versatility high propensity sarscov<NUMBER> tcrvÎ²binding site residues potentially act superantigenic fragment ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint significantly structures two peptides exhibit remarkable similarity fig <NUMBER>bc including salt bridge stabilizing structural motif e<NUMBER>k<NUMBER> seb e<NUMBER>r<NUMBER> sarscov<NUMBER> relative orientations three positively charged residues k<NUMBER>k<NUMBER>k<NUMBER> seb r<NUMBER>r<NUMBER>r<NUMBER> sarscov<NUMBER> Î²hairpin apparently serves scaffold may supported sars coronavirus potential disulfide bond c<NUMBER>c<NUMBER> former two features absent sars<NUMBER> spike fig <NUMBER>d analysis overall indicates segment t<NUMBER>nsprrar<NUMBER> forms putatively superantigenic core consistently aligned various bacterial viral sags figs <NUMBER>c <NUMBER>ac without participation adjoining amino acids however combined broader sequence structure analysis fig <NUMBER> panels right bc reveals even compelling feature putative sag core structurally consolidated spatial proximity conserved acidic segment e<NUMBER>cd<NUMBER> forms highly stable salt bridge polybasic segment prrar sarscov<NUMBER> much way salt bridge observed seb sars<NUMBER> note seb superantigen peptide y<NUMBER>nkkkatvqeld<NUMBER> reported bind cd<NUMBER> <NUMBER> cell receptor provides costimulatory signals required cell activation survival cd<NUMBER> tcrv domains share immunoglobulin fold fig <NUMBER>e binding mechanism shown fig <NUMBER>b likely adopted minor rearrangements enabling binding seb cd<NUMBER> finally homologous superantigenic segment seb binding cd<NUMBER> also tested potential binding sars<NUMBER> spike e<NUMBER>r<NUMBER> onto cd<NUMBER> considering possibility target sars<NUMBER> spike superantigenic segment might cd<NUMBER> simulations indicated segment equally bind cd<NUMBER> supporting strong propensity fragment stimulate cell activation existence potential superantigenic toxic intercellularadhesion molecule icamlike sequence fragments sars<NUMBER> thoroughly examined li et al following <NUMBER> pandemic <NUMBER> led identification nine sequence stretches including three botulinum neurotoxin type g precursors two motifs high similarity intercellular adhesion molecule <NUMBER> icam<NUMBER> comparative analysis sarscov<NUMBER> spike sequence revealed seven sequence motifs conserved sarscov sarscov<NUMBER> supplementary fig s<NUMBER> among note y<NUMBER>nengtitdavdcaldplsetkc<NUMBER> icam<NUMBER> cd<NUMBER>like motif also participates association sarscov<NUMBER> spike bound Î±Î²tcr see fig <NUMBER> note icam<NUMBER> involvement critical mediating immune inflammatory responses observed interaction icam<NUMBER>like motif sarscov<NUMBER> tcrvÎ± tandem interaction discussed putative sag motif around insert prra tcrvÎ± likely strengthen association virus cell ensuing activation precisely n<NUMBER>e<NUMBER>n<NUMBER> t<NUMBER> belonging icamlike fragment closely interact tcrvÎ± cdrs mainly t<NUMBER> spike makes close contacts s<NUMBER> cdr<NUMBER> e<NUMBER> spike forms hydrogen bond t<NUMBER> cdr<NUMBER> n<NUMBER> n<NUMBER> spike closely associate r<NUMBER> fig <NUMBER>d rare mutation d<NUMBER>ye recently observed sars<NUMBER> strain europe contributes stabilizing interaction tcr interestingly sarscov<NUMBER> spike binding region harbors three residues recently reported mutated new strains europe usa <NUMBER> <NUMBER> d<NUMBER>g a<NUMBER>v d<NUMBER>yne former two may potentially interact mhcii latter d<NUMBER> european strain located close tcrvÎ² strongly interacts n<NUMBER> fig <NUMBER>a c supplementary figs s<NUMBER> s<NUMBER>a substitution glutamate mutant d<NUMBER>e increases strength intermolecular thereby virust cell association supplementary fig s<NUMBER>c even stronger interactions spike tcrvÎ² observed upon replacing d<NUMBER> tyrosine illustrated supplementary fig s<NUMBER>d interfacial interactions case stabilized hydrogen bond y<NUMBER> d<NUMBER> aromatic ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint polarÏ interaction y<NUMBER> n<NUMBER> well possible electrostatic interactions k<NUMBER> s<NUMBER> quantitative evaluation change binding affinity spike tcr upon mutating d<NUMBER> e n yields Î´Î´gdây <NUMBER>kcal mol <NUMBER> Î´Î´gdâe <NUMBER>kcal mol <NUMBER> Î´Î´gdân <NUMBER>kcal mol <NUMBER> respectively see supplementary table s<NUMBER> details thus d<NUMBER>yne mutations would expected strengthensupport described association superantigenic prracontaining segment tcrvÎ² understanding immunopathology leading severe manifestations covid<NUMBER> adults children critical importance effective management treatment disease misc shows remarkable similarity pediatric tss <NUMBER> using silico modeling analysis found sarscov<NUMBER> encodes superantigen motif near s<NUMBER>s<NUMBER> cleavage site region highly similar structure seb sag motif interacts tcr cd<NUMBER> <NUMBER> mediates tss seb enables largescale cell activation proliferation <NUMBER> resulting massive production proinflammatory cytokines including ifnÎ³ tnfÎ± il<NUMBER> cells well il<NUMBER> tnfÎ± apcs <NUMBER> cytokine storm leads multiorgan tissue damage similar observed misc therefore propose misc observed covid<NUMBER> patients may mediated superantigen activity sarscov<NUMBER> protein date misc mostly observed europe east coast north america described asia despite sizeable outbreaks covid<NUMBER> <NUMBER> cdc ecdc show mutation d<NUMBER> found european strain sarscov<NUMBER> enhances binding affinity sag motif tcr could least partly explain geographical skewing misc areas european strain endemic identification strainspecific mutations may help predict future outbreak misc may occur findings raise exciting possibility immunomodulatory therapeutic options used tss may also effective misc including ivig steroids indeed initial published unpublished reports suggest misc patients respond well ivig without steroids <NUMBER> ivig recognizes seb epitopes <NUMBER> thus may function part neutralization superantigen given structural similarities seb protein sag motif potential crossreactivity immunoglobins explaining least part response misc cases ivig fdaapproved antiinflammatory drugs tested models seb tss may also effective including ctla<NUMBER>ig inhibit cd<NUMBER> costimulation <NUMBER> mtor inhibitor rapamycin <NUMBER> already use covid<NUMBER> addition humanized monoclonal antiseb abs described <NUMBER> could also potential therapeutic benefit misc patients notably shown mouse model tss lethal seb superantigen challenge prevented short peptide mimetics superantigen motif <NUMBER> would interesting examine whether short peptide mimetics sarscov<NUMBER> spike superantigen region might employed preventattenuate inflammatory cytokine gene induction toxic shock misc patients present majority antibody therapies investigation designed target sarscov<NUMBER> receptor binding domains rbds <NUMBER> <NUMBER> simulations also indicated rbd might potentially interact tcrs however compared rbds relatively fewer mutations found sag region sarscov<NUMBER> notably prra insert unique sarscov<NUMBER> retained among isolates sequenced date <NUMBER> <NUMBER> might constructive design antibodies drugs targeting sag region block cleavage essential enabling viral entry <NUMBER> <NUMBER> also modulate saginduced inflammatory cytokine gene induction <NUMBER> fortunately severe respiratory manifestations covid<NUMBER> children well development misc rare may due trained immunity <NUMBER> crossviral immunity coronavirus strains <NUMBER> b cells play important role antiviral response cd<NUMBER> cd<NUMBER> cells convalescent covid<NUMBER> patients recognize range sars<NUMBER> epitopes protein represents major target <NUMBER> interestingly cells unexposed individuals also respond protein epitopes sarscov<NUMBER> supports hypothesis crossviral immunity coronavirus strains <NUMBER> however fraction infected children develop misc unclear possible poor initial antibody response virus fails neutralize sag leading immune enhancement following exposure certain hla types permissive binding sag indeed hla shown play role covid susceptibility <NUMBER> nine cases initially reported uk six afrocaribbean descent also suggests potential genetic component susceptibility <NUMBER> interesting note approximately third fewer misc patients tested positive sarscov<NUMBER> majority serologic evidence infection history exposure covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> may suggest sarscov<NUMBER> sag causes delayed hyperinflammation response certain children sags implicated autoimmunity triggering selfreactive cells <NUMBER> antibodymediated enhancement upon reexposure virus may also contribute uncontrolled infection inflammation <NUMBER> also possible despite negative nasopharyngeal pcr test virus may still present gastrointestinal tract <NUMBER> misc patients demonstrate unusually severe gi symptoms abdominal pain vomiting diarrhea addition severe myocardial dysfunction cardiac shock <NUMBER> severe gi symptoms also frequently associated sag <NUMBER> summary made three major observations prrar sequential neighbors interact tcrvÎ² residues d<NUMBER> r<NUMBER> e<NUMBER> cdrs association closely resembles seb sag tcrvÎ² b nearby d<NUMBER> participates interaction mutation tyrosine would strengthen association tcrvÎ² c sequence motif n<NUMBER>t<NUMBER> typical icam<NUMBER> interacts tcrvÎ± stabilizingenhancing association viral spike host cell tcr binding pose tcr respect spike allows simultaneously three associations first important <NUMBER> nd significant european strain <NUMBER> rd may imparting stronger hostvirus adhesion therefore strategies used treatment sebmediated toxic shock approaches block interaction protein tcr may reduce hyperinflammatory manifestations covid<NUMBER> adults children sarscov<NUMBER> p<NUMBER>dtc<NUMBER> sarscov cvhsap<NUMBER> spike models generated using swissmodel <NUMBER> based resolved spike glycoprotein structures sarscov<NUMBER> pdb <NUMBER>vsb sarscov <NUMBER> pdb <NUMBER>acdthe missing loops crystal structures built using libraries backbone fragments <NUMBER> constraint space de novo reconstruction backbone segments <NUMBER> two mutants associated european covid<NUMBER> patients <NUMBER> constructed using charmmgui <NUMBER> one main strain mutant d<NUMBER>g contains four mutations including q<NUMBER>k a<NUMBER>v d<NUMBER>g d<NUMBER>y two sarscov<NUMBER> spike mutants together sarscov<NUMBER> p<NUMBER>dtc<NUMBER> originally taken wuhan used investigate binding Î±Î²tcr mhcii pdb <NUMBER>xn<NUMBER> <NUMBER> using cluspro <NUMBER> prodigy <NUMBER> see details si current pandemic potentially lethal novel coronavirus named sarscov<NUMBER>covid<NUMBER> caused major impact millions peoples health global economy <NUMBER> httpswwwcdcgovcoronavirus<NUMBER>ncov date <NUMBER> deaths nearly two million confirmed positive cases reported globally making sarscov<NUMBER> urgent public health concern along side using using neutralizing antibodies targeting spike glycoproteins involved host cell adhesion <NUMBER> several antiviral drugs drugs hydroxychloroquine also evaluated repurpose possible treatments sarscov<NUMBER> <NUMBER> different classes antivirals evaluation include <NUMBER>cl protein inhibitors ribavirin lopinavirritonavir rna synthesis inhibitors remdesivir tenofovir disoproxil fumaratetdf <NUMBER>tc neuraminidase inhibitors tamiflu peramivir <NUMBER> small molecule drugs target ability sarscov<NUMBER> interact host cells ace<NUMBER> inhibitors <NUMBER> <NUMBER> however potential drug target mechanism several candidate drugs remains elusive warrants structural biophysical studies unravel potential antiviral drugs bind impact sarscov<NUMBER> among clinically advancing several random drugs trails sarscov<NUMBER> arbidol umifenovir fig <NUMBER>a also screening sarscov<NUMBER> <NUMBER> however drug target viral protein mechanism action arbidol sarscov<NUMBER> elusive essential understand drug action mechanism develop better therapeutics considering current public health crisis aimed unravel potential drug target molecular interactions address mechanism action arbidol sarscov<NUMBER> foremost interesting us know arbidol known drug influenza <NUMBER> <NUMBER> thats binds haemagglutinin ha protein raises intriguing question sequence structural similarities sarscov<NUMBER> spike glycoprotein influenza virus h<NUMBER>n<NUMBER> ha protein could resulted positive drug effect comparative protein sequence analysis shows short region sarscov<NUMBER> spike glycoprotein trimerization domain s<NUMBER> aa<NUMBER> aa<NUMBER> resembles h<NUMBER>n<NUMBER> ha fig s<NUMBER>a outer membrane spike glycosylation protein sarscov<NUMBER> essential host cell adhesion via human ace<NUMBER> cd<NUMBER> receptors <NUMBER> <NUMBER> trimerization imperative host membrane fusion raises intriguing question whether arbidol could also bind similar way ha sarscov<NUMBER> spike glycoprotein finding potential arbidol antiviral drug binding target structural studies unravel mechanism interaction great implications essential current global public health emergency could open arena developing new potential therapeutics end performed molecular dynamics structureguided drug binding analysis screen arbidol binding sites sarscov<NUMBER> spike glycoprotein though two independent servers haddock<NUMBER> httpshaddockscienceuunl ii swissdock httpswissdockchdocking reliability using sarscov<NUMBER> spike glycoprotein trimer pdb <NUMBER>vsb <NUMBER> servers predictions consistent provide six possible positions arbidol could potentially interact spike glycoprotein fig s<NUMBER>b s<NUMBER>c among obtained six clusters arbidol binding sites notice single false positive c<NUMBER> single true site c<NUMBER> four unimportantsurface binding regions c<NUMBER> clusters assessed corroborated based solvent accessibility surface area sasa cscore confidence score zscore clash score binding location exposed residues sarscov<NUMBER> spike glycoprotein refinement completed using coot wwwmrcimbcamuk ensure appropriate docking clashes side chain residues binding free energies taken consideration selecting best possible docked site final model aribidol docked homotrimer structure sarscov<NUMBER> spike glycoprotein fig <NUMBER>b visualised pymol unravel arbidol binding mode mechanism action first looked possible amino acid residues spike glycoprotein involved establishing interaction arbidol found k<NUMBER> e<NUMBER> k<NUMBER> e<NUMBER> r<NUMBER> s<NUMBER> n<NUMBER> l<NUMBER> t<NUMBER> s<NUMBER> trimerization domain makes interaction arbidol either via van der waals forces hydrogen bonding fig <NUMBER>d fig s<NUMBER>e specifically arbidol sandwiched trimerization helices two protomers k<NUMBER> r<NUMBER> n<NUMBER> l<NUMBER> t<NUMBER> chain e<NUMBER> k<NUMBER> e<NUMBER> s<NUMBER> l<NUMBER> chain b fig <NUMBER>c <NUMBER>d total buried interface <NUMBER>Ã¥ <NUMBER> three arbidol binding regions <NUMBER>Ã¥ <NUMBER> arbidol calculated pisa server httpswwwebiacukpdbepisa next looked arbidol interacts h<NUMBER>n<NUMBER> ha protein pdb <NUMBER>t<NUMBER>n <NUMBER> interestingly noticed arbidol interaction influenza ha protein also mediated via arg lys leu glu key interacting residues r<NUMBER> e<NUMBER> k<NUMBER> l<NUMBER> e<NUMBER> l<NUMBER> l<NUMBER> fig <NUMBER>e <NUMBER>f furthermore arbidol sandwiched two trimerization helices two protomers chain b fig <NUMBER>f furthermore found position h<NUMBER>n<NUMBER> ha binding residues e<NUMBER> r<NUMBER> e<NUMBER> l<NUMBER> l<NUMBER> k<NUMBER> t<NUMBER> k<NUMBER> similar sarscov<NUMBER> spike glycoprotein residues k<NUMBER> <NUMBER> e<NUMBER> r<NUMBER> l<NUMBER> y<NUMBER> furthermore compare exact structural similarities sarscov<NUMBER> h<NUMBER>n<NUMBER> trimerization domains involved abridol binding superimposed arbidol binding regions sarscov<NUMBER> h<NUMBER>n<NUMBER> superimposes rmsd <NUMBER>Ã¥ cï¡ atoms also suggests possible structural similarities drug binding region spike glycoprotein influenza virus sarscov<NUMBER> accentuates influenza virus drug could potential drug sarscov<NUMBER> infections sequence structural similarities binding sites arbidol solved simulated seems promising suggests arbidol efficacy combating sarscov<NUMBER> based molecular dynamics structural studies corroborate spike glycoprotein sarscov<NUMBER> drug target arbidol incites drug binding mode key interacting residues mechanism arbidol effectively block impede trimerization spike glycoprotein essential cell adherence entry <NUMBER> blocking trimerization spike glycoprotein also leads formation naked unmatured virus least infectious although study significant implications repurposing knowing drug target understanding mechanism viral inhibition efficacy safety arbidol sarscov<NUMBER> still requires clinical investigation current drug options focused inhibitors ace<NUMBER> viral rna polymerase potential drugs impede viral spike protein trimerization also equally essential combination drugs profound effect combating viral infection study also accenture development new therapeutics sarscov<NUMBER> based arbidol using structureguided drug designing sarscov merscov considered highly pathogenic known transmitted bats humans via intermediate host palm civets <NUMBER> dromedary camels <NUMBER> fulllength structure sarscov<NUMBER> spike glycoprotein simulated itasser server online tool <NUMBER> spikeace<NUMBER> binding model predicted using prism <NUMBER> <NUMBER> spike protein ace<NUMBER> structure files analyzed using pymol software pymol v<NUMBER> sarscov<NUMBER> encodes least <NUMBER> proteins including <NUMBER> nonstructural proteins <NUMBER> structural proteins <NUMBER> auxiliary proteins <NUMBER> spike glycoprotein structural protein located outer envelope virion binds hostreceptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> glycoprotein sarscov merscov sarscov<NUMBER> <NUMBER> <NUMBER> amino acids contains amino nterminal s<NUMBER> subunit carboxyl cterminal s<NUMBER> subunit <NUMBER> figure <NUMBER> s<NUMBER> subunit receptorbinding domain rbd spanning <NUMBER> residues consists two subdomains core external subdomains <NUMBER> <NUMBER> rbd core subdomain responsible formation trimer particles <NUMBER> external subdomain contains two exposed loops surface bind ace<NUMBER> <NUMBER> investigating evolutionary relationship rbd sequence spike protein helpful understanding virus origin trends f g u r e <NUMBER> structural diagrams spike glycoproteins sarscov merscov sarscov<NUMBER> spike proteins coronaviruses contain s<NUMBER> subunit s<NUMBER> subunit divided cleavage sites fp fusion peptide hr heptad repeat <NUMBER> heptad repeat <NUMBER> rbd receptorbinding domain contains core binding motif external subdomain sp signal peptide phylogenetic reconstruction determines evolutionary relationship host selection spike glycoproteins humanclose beta coronaviruses better understand host selection beta coronaviruses relationship spike glycoprotein sarscov<NUMBER> closely related beta coronaviruses analyzed result showed bat sarslike cov ratg<NUMBER> <NUMBER> overall genome sequence identity <NUMBER> inner joint neighbor sarscov<NUMBER> figure <NUMBER> october <NUMBER> reported sendai virus coronavirus dominant viruses virome data malayan pangolins <NUMBER> noteworthy sarscov widely distributed coronavirus pangolin samples blasted sarscov<NUMBER> reads found spike protein sequence present pangolin sarslike cov numbered srr<NUMBER> protein pangolin sarslike cov srr<NUMBER> marked red star possesses <NUMBER> similarity sarscov<NUMBER> partly <NUMBER> residues s<NUMBER> subunit read virome data removing lost sequences still <NUMBER> similarity sarscov<NUMBER> data shown fulllength sequence spike protein pangolin sarslike cov sarscov<NUMBER> seems little different temporal tree showed divergence time spike sequence bat sarslike ratg<NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> bat sarslike ratg<NUMBER> sarscov<NUMBER> cluster figure s<NUMBER> global expansion deep sequencing work led increased amount sarscov<NUMBER> genotype studying selective stress may helpful assessing variability potential host changes sarscov<NUMBER> based report <NUMBER> selective pressure analysis showed genes orf<NUMBER> orf<NUMBER>a greater selective pressure spike average pressure relative whole genome figure s<NUMBER> spike rbdreceptor interaction key factor determining host range coronaviruses rbd sequences spike protein sarscov bat pangolin sarslike cov sarscov<NUMBER> aligned figure <NUMBER> deletions <NUMBER> <NUMBER> residues bat sarslike cov located external subdomain seems viruses infect humans naturally given direct evidence showing bat sarslike cov ever infected humans interestingly sarscov<NUMBER> rbd sequence <NUMBER> <NUMBER> possesses <NUMBER> identity pangolin sarslike cov srr<NUMBER> higher <NUMBER> similarity bat sarslike cov ratg<NUMBER> residues k<NUMBER> s<NUMBER> civet sarscov effectively recognize civet ace<NUMBER> bind human ace<NUMBER> much less efficiently <NUMBER> residue thr<NUMBER> rbd binds tyr<NUMBER> lys<NUMBER> human ace<NUMBER> van der waals contacts <NUMBER> table <NUMBER> mouse dog also multiple â¥<NUMBER> substitutions cat hamster contain three mutations region showed lys<NUMBER> tyr<NUMBER> lys<NUMBER> mutations substantially interfere s<NUMBER>ig association <NUMBER> study provides information possibilities like snakes pangolins turtles c picta bellii c mydas p sinensis may also act potential intermediate hosts transmitting sarscov<NUMBER> human although much needs confirmed semn <NUMBER> flanked untranslated regions ends rep gene codes nonstructural protein membrane envelope protein essential viral assembly nucleocapsid protein important rna synthesis <NUMBER> spike protein responsible attachment virus host cell subsequent entry <NUMBER> <NUMBER> <NUMBER> recently mutations orf<NUMBER> orf<NUMBER> n region sarscov<NUMBER> observed <NUMBER> mutations nonstructural proteins nsp <NUMBER> nsp <NUMBER> could reasons unique mechanism action compared sars presence glutamine serine proline various positions sequence sarscov<NUMBER> believed affect properties shown table <NUMBER> table <NUMBER> table <NUMBER> <NUMBER> <NUMBER> variability seen genome sequence sarscov<NUMBER> strain coronavirus obtained bats ie ratg<NUMBER> thereby indicating <NUMBER> similarity two genomes sarscov<NUMBER> seen expressed two types strains cov namely l type recently genomes <NUMBER> patients infected sarscov<NUMBER> analysed wherein <NUMBER> showed linkage polymorphism single nucleotide among <NUMBER> expressed l type named due involvement leucine codon <NUMBER> strains showed type named due involvement serine codon change observed site <NUMBER> <NUMBER> sequence <NUMBER> similar studies sarscov<NUMBER> genome analysis showed type type ii sarscov<NUMBER> genotypes differed sites <NUMBER> <NUMBER> <NUMBER> <NUMBER> shown figure <NUMBER> sarscov<NUMBER> genome types ancestral genome b obtained mutations c<NUMBER>t t<NUMBER>c type c obtained mutation g<NUMBER>t type b <NUMBER> full genome sequencing various sarscov<NUMBER> isolates shown multiple variations different orfs corresponding sequence sarscov<NUMBER> obtained bat ratg<NUMBER> shows virus spread globally evolved numerous mutations <NUMBER> shown supplementary table <NUMBER> could place medical fraternity even alarming situation structural proteins sarscov<NUMBER> envelope coronavirion contains protruding projections surface called large surface glycoproteins spike proteins responsible recognizing hosts receptor followed binding fusing membrane <NUMBER> due crownshaped appearance projections named coronavirus coronaa crown latin <NUMBER> amino acid sequence sarscov<NUMBER> spike protein <NUMBER> homology sarscov spike protein <NUMBER> findings reported <NUMBER> similarity s<NUMBER> subunit <NUMBER> similarity s<NUMBER> subunit sarscov<NUMBER> sarscov <NUMBER> molecular weight <NUMBER> kda contains <NUMBER> amino acids <NUMBER> generally coronavirus particle may contain <NUMBER> timers spikes <NUMBER> spike protein consists ectodomain element transmembrane moiety short intracellular c fragment viral ectodomain inherits two subunits namely s<NUMBER> facilitates receptor binding s<NUMBER> facilitates membrane fusion structured like clove built three s<NUMBER> subunits s<NUMBER> stem formed trimer <NUMBER> shown figure <NUMBER>a genomic sequence spike amino acids shown figure <NUMBER>b functional components spike protein mapped according amino acid positions shown table <NUMBER> spike proteins also help promoting adhesion infected cells adjacent noninfected cells enhance spreading virus <NUMBER> additional <NUMBER> nucleotides towards arginine cleaving site correlate cleavage site similar furin site known cleaved virus activation <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> type ii transmembrane serine protease tmprss<NUMBER> coexpressed type ii pneumocytes tmprss<NUMBER> initiates cleavage followed activation spike protein promotes membrane fusion viral entry cells also transmission infection neighbouring cells specifically conditions low ph <NUMBER> spike protein sarscov<NUMBER> undergoes structural transformation binding viral membrane host membrane occur receptor binding domain rbd present s<NUMBER> subunit recognizes binds human ace<NUMBER> <NUMBER> times affinity sarscov domain <NUMBER> possibly due polymorphism <NUMBER>t thus enhancing receptor spike interactions promoting infectivity <NUMBER> unique feature seen s<NUMBER> ad s<NUMBER> sites sarscov<NUMBER> sites form prolonged loop lies towards outer end trimer thus rendering sarscov<NUMBER> proteolytic interaction proteases host cells <NUMBER> s<NUMBER> subunit occurs prefusion trimer phase however upon binding host cell receptor destabilizes sheds causes s<NUMBER> subunit transform stable postfusion state spike protein display upward phase available receptor downward phase unavailable receptorin downward phase ncov rbd lies near trimers central pocket <NUMBER> s<NUMBER> subunit comprises single fusion peptide fp additional proteolytic site internal fusion peptide prior transmembrane domain two heptadrepeat <NUMBER> recent analysis suggested four novel inserts spike protein unique sarscov<NUMBER> s<NUMBER> subunit insert hints n terminal domain c terminal domain implicated insert ii insert iii junction subdomain <NUMBER> subdomain <NUMBER> s<NUMBER> subunit lies insert iv interestingly inserts ii iii shown remarkable homology hiv<NUMBER> gp<NUMBER> insert iv gag proteins <NUMBER> another study revealed characteristic features certain amino acid protein rendered sarscov<NUMBER> high affinity ace receptor presence glutamine <NUMBER> asparagine <NUMBER> leucine <NUMBER> phenylalanine <NUMBER> serine <NUMBER> amino acids shown provide boost ace<NUMBER> binding <NUMBER> therefore protein plays crucial role viral entry host cells structural abilities newly discovered sarscov<NUMBER> boost intended actions fact protruding spikes first point contact host receptors therapeutic strategies applied prevent binding target receptors prevent actions n protein abundant viral protein expressed host samples early stages infection known bind viral rna form core ribonucleoprotein helps host cell entry interaction cellular processes following fusion virus <NUMBER> sequence sarscov<NUMBER> n protein shows <NUMBER> similarity n protein sarscov <NUMBER> rtc ie replication transcription complexes formed nonstructural proteins nsp play essential part viral genome synthesis <NUMBER> linker region sandwiched n terminal domain ntd c terminal domain ctd shown figure <NUMBER> n protein sarscov caused activation cyclooxygenase<NUMBER> cox<NUMBER> enhancer causing expression cox<NUMBER> causes inflammation lungs <NUMBER> also involved inhibition phosphorylation b<NUMBER> phosphoprotein essential progression cell cycle duplication centrosome <NUMBER> n protein interacts p<NUMBER> proteasome subunit known degrade viral proteins <NUMBER> also showed inhibit type interferon ifn causing restrictions immune responses generated body due viral infections <NUMBER> cell line studies showed due inhibitory action n protein cyclincyclindependent kinase complex ccdk progression sphase reduced <NUMBER> another cell line study showed reduced proliferation cells due inhibition cytokinesis protein translation due n proteininduced aggregation translation factor named human elongation factor <NUMBER> Î± hef<NUMBER> Î± <NUMBER> viral rna synthesis known increase n protein seen interact heterogeneous nuclear ribonucleoprotein hnrnpa<NUMBER> <NUMBER> structural elucidation sarscov<NUMBER> n protein ntd showed single asymmetric confirmation four n protein ntd depicted structural alignment orthorhombic crystal basically looks like wrist made acidic moieties palm basic components core Î² sheet extending like fingers <NUMBER> ntd n protein known bind rna genome sequencing different ordered disordered regions n protein showed rna binding occurs n<NUMBER> region exists monomer <NUMBER> also reported presence amino acids arginine position <NUMBER> tyrosine <NUMBER> might essential binding sarscov rna <NUMBER> studies proved combination linker region ntd even ctd n protein essential enhanced binding capacity viral rna latter showed <NUMBER> times binding performance earlier ctd dimeric nature <NUMBER> disordered regions around compared single disordered region around ntd <NUMBER> central linker region rich serine arginine residues sr region possessing essential phosphorylation sites may regulate n protein functioning <NUMBER> site forms major phosphorylation site enhances interactions proteins localization linker proteins within cell mediates desired activity higher alanine substitutions reduced amount n protein phosphorylation <NUMBER> linker region interactions sr moieties central region lead formation dimers n proteins essential activity <NUMBER> ctd hydrophobic nature rich helix also known domain dimerization occurs reason contains residues form homodimers selfassociation <NUMBER> structurally every single asymmetric moiety ctd consists four individual homodimers joined form octamer arrangement moieties appears shape letter x forms symmetric fold structures one perpendicular another perpendicular midpoint structure due positive charges region n terminus appears basic could hint site binding nucleic acid <NUMBER> domain components possess large forces repulsion prevents interactions within domains provides electrostatically larger binding surface prevents oligomer nucleocapsid formation therefore nucleic acid binds causes neutralization charges causing accumulation protein molecules come closer oligomerize thus forming nucleocapsids <NUMBER> n protein showcases various activities essential functioning proliferation virus thus another essential component spike proteins along n shows promising area field developing effective therapeutics prevent proliferation viral progenies e protein tiny integral membrane protein composed ntd hydrophobic domain chain c terminal <NUMBER> <NUMBER> amino acids <NUMBER> <NUMBER> kda size <NUMBER> n terminal stretches <NUMBER> st <NUMBER> th amino acids hydrophobic region ranges <NUMBER> th <NUMBER> th position c terminal <NUMBER> th <NUMBER> th position structural sequence <NUMBER> amino acids <NUMBER> position present virion hydrophobic tail towards cytoplasm<NUMBER> hydrophobic region forms oligomers form ionic pore across membranes structural elucidation protein shows pentameric form containing <NUMBER> Î±helical regions <NUMBER> looped regions structures showed randomized movements modulated normal activity ion channels thus enhancing viral pathogenicity <NUMBER> contrast interactions within c terminal domain may affect pentameric conformation <NUMBER> novel feature seen <NUMBER> th position e protein sequence sarscov<NUMBER> arginine replaced alanine glutamine aspartate compared similar coronaviruses also positions <NUMBER> threonine valine identified <NUMBER> translation e undergo palmitoylation cysteine residues n mediated glycosylation aspartate amino acid may necessary virus like particles vlp formation <NUMBER> protein form viroporins proteins hydrophobic nature small architecture viroporins essential viral assembly along release also mediate pathogenic processes induce cytotoxicity <NUMBER> interactions nsp<NUMBER> nsp<NUMBER> heterotypically essential inducing desired curvature endoplasmic reticulum er membrane e coexpression facilitates production spherical virulent particles <NUMBER> tail sarscov e protein lies cytoplasm targets cisgolgi complex region help proline residues incorporated n terminal e protein also contains additional golgi complex associating elements due mutations tail region affect golgi complex targeting process <NUMBER> ionic gradient may dissipated ergic golgi compartment e may lead exit virion <NUMBER> final four amino acids present c terminal e protein hosts motif named postsynaptic density proteindisc largezonula occludans<NUMBER> pdz binding motif pdm therefore e protein may facilitate disruption epithelium lungs due binding protein associated caenorhabditis elegans lin<NUMBER> protein <NUMBER> pals<NUMBER> pdm <NUMBER> protein present high amount proteins coronaviruses <NUMBER> length spans <NUMBER> amino acids short length n terminal domain attached triple transmembrane domains connected carboxylterminal domain belong nlinked glycosylated proteins conserved domain <NUMBER> amino acids <NUMBER> structural analysis protein shows exists two forms namely long compact form two forms originally homodimers n terminal ectodomain c terminal endodomain different conformation endodomain may undergo elongation compression due named long compact form spike protein seen forms predominantly longform may suggest form promotes spike installation tyrosine reduces <NUMBER> may essential instability long form form bends membrane creates spherical structure encircling ribonucleoprotein <NUMBER> protein organized <NUMBER>d lattice provides scaffold viral assembly <NUMBER> undergo translation polysomes bound membranes fused er carried towards golgi complex interact e proteins generate virions three tdm first one capable enough encourage selfassociation proteins improved membrane affinity retention golgi <NUMBER> proline expected create steric bulk rigorousness due structure sarscov<NUMBER> may undergo change conformation <NUMBER> xx running title sarscov<NUMBER> structural proteins outbreak sarscov<NUMBER> related disease covid<NUMBER> caused <NUMBER> million infections <NUMBER> million deaths globally sarscov<NUMBER> spike protein exhibits two notable features receptorbinding domain rbd optimized bind human cell receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> subunit spike protein trimer polybasic cleavage site <NUMBER> given structural similarity spike proteins sarscov<NUMBER> close relative sarscov <NUMBER> rbd sarscov<NUMBER> quickly recognized targeting ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> required subsequent viral entry atomic structures contact region sarscov<NUMBER> rbd ace<NUMBER> experimentally obtained different groups <NUMBER> <NUMBER> <NUMBER> owing crucial role sarscov<NUMBER> rbd numerous vaccine drug candidates proposed target rbd inhibit rbdace<NUMBER> binding <NUMBER> <NUMBER> <NUMBER> however research beginning show mutations distal rbd nonrbd mutations sarscov<NUMBER> also influence transmissibility instance walls et al <NUMBER> found mutating t<NUMBER>nsprrar<NUMBER> residues distributed around <NUMBER> nm sarscov<NUMBER> rbd variant t<NUMBER>ilr<NUMBER> transduction efficiency decreased human ace<NUMBER>expressing baby hamster kidney cells mutant d<NUMBER>g single change genetic code aspartic acid g glycine sarscov<NUMBER> spike protein began spreading europe february displayed stronger transmissibility <NUMBER> d<NUMBER> g<NUMBER> residues located <NUMBER> <NUMBER> nm sarscov<NUMBER> rbd surprisingly yuan et al <NUMBER> found antibody cr<NUMBER> isolated recovered sarscov patient targeted highly conserved epitope sarscov<NUMBER> sarscov also distal rbds antibody cr<NUMBER> directly bind spike protein rbd works support significance nonrbd mutations nonrbdtargeting vaccine drug design remains elusive thus far present work large scale allatom explicit solvent molecular dynamics md simulations reveal spike protein polybasic cleavage sites distributed approximately <NUMBER> nm away rbd enhance binding affinity sarscov<NUMBER> rbd ace<NUMBER> information used design negatively charged tetrapeptide glugluleuglu targets polybasic cleavage sites negatively charged glutamic acids glu introduced charge neutralize polybasic cleavage sites nonpolar leucine leu included increase hydrophobicity tetrapeptide favors binding polybasic cleavage site tetrapeptide glugluleuglu found bind one specific polybasic cleavage site resulting remarkable weakening <NUMBER> spike proteinace<NUMBER> binding energy work provides guidelines design therapeutic peptides inhibit sarscov<NUMBER> rbdace<NUMBER> binding subunit sarscov<NUMBER> trimeric spike protein one polybasic cleavage site r <NUMBER>rar<NUMBER> <NUMBER> polybasic cleavage sites r <NUMBER>rar<NUMBER> reported sarscov lineage b coronaviruses therefore thought unique sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> comparison extensive studies carried sarscov<NUMBER> rbd polybasic cleavage sites thus far widely investigated function remains elusive believed related viral transmissibility sarscov<NUMBER> <NUMBER> <NUMBER> moreover found essential spike proteindriven viral entry lung cells <NUMBER> elucidate influence polybasic cleavage sites wild type wt spike proteinace<NUMBER> complex investigated along two mutants figure <NUMBER> sarscov<NUMBER> spike proteinace<NUMBER> complex downloaded zhangserver <NUMBER> contains full length wild type sarscov<NUMBER> spike protein bound ace<NUMBER> receptor spike proteinace<NUMBER> complex solvated water box length <NUMBER>Ã<NUMBER>Ã<NUMBER> nm <NUMBER> <NUMBER> nacl included allatom md simulation conducted equilibrate system using charmm <NUMBER>m force field <NUMBER> preserve spike proteinace<NUMBER> binding structure nonhydrogen atoms spike protein trimer ace<NUMBER> restrained removed following simulations wt spike protein subsequently mutated mutant <NUMBER> n<NUMBER>sprra<NUMBER> residues removed three subunits spike protein trimer mutant similar variant experimentally investigated t<NUMBER>ilr<NUMBER> <NUMBER> case mutant <NUMBER> r<NUMBER>r<NUMBER> residues changed e <NUMBER>e<NUMBER> three subunits trimeric spike protein e stands negatively charged glutamic acid three systems wt mutants <NUMBER> <NUMBER> allatom explicit solvent simulations performed duration <NUMBER> ns five parallel runs carried based simulation configurations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ns see methods section five parallel simulations employed calculate binding energy table s<NUMBER> supporting information intermolecular hydrogen bonds sarscov<NUMBER> rbd ace<NUMBER> figure <NUMBER>a final simulation snapshot wild type spike proteinace<NUMBER> complex polybasic cleavage sites located <NUMBER> <NUMBER> nm away rbd three systems sarscov<NUMBER> rbd stayed bound ace<NUMBER> figure <NUMBER>bd nevertheless potential energy rbd ace<NUMBER> summation intermolecular shortrange coulomb lennardjones interactions exhibited remarkable differences figure <NUMBER>e rbdace<NUMBER> binding energy wt spike protein <NUMBER> Â± <NUMBER> kjmol removal n<NUMBER>sprra<NUMBER> compromises rbdace<NUMBER> interaction <NUMBER> <NUMBER> Â± <NUMBER> kjmol supporting mutant <NUMBER> heavily depresses binding affinity rbd ace<NUMBER> line experimental finding mutation <NUMBER>nsprrar<NUMBER> variant t<NUMBER>ilr<NUMBER> murine leukemia virus decreased transduction efficiency human ace<NUMBER>expressing baby hamster kidney cells <NUMBER> meanwhile mutation r<NUMBER>r<NUMBER> e<NUMBER>e<NUMBER> decreased rbdace<NUMBER> binding energy <NUMBER> <NUMBER> Â± <NUMBER> kjmol therefore mutants greatly destabilized rbdace<NUMBER> binding comparison wt spike protein note ace<NUMBER> highly negatively charged <NUMBER> e leads highly negatively charged extracellular membrane surface coulomb interactions favor adsorption positively charged species instance arginine residues also note due positively charged nature arginine found enhance cellular uptake peptides <NUMBER> promote therapeutic delivery peptides across bloodbrain barrier alzheimers disease <NUMBER> therefore observed drops rbdace<NUMBER> binding energy mutants <NUMBER> <NUMBER> could primarily ascribed change longrange coulomb interactions ace<NUMBER> spike protein table s<NUMBER> even though polybasic cleavage sites around <NUMBER> nm away rbd ace<NUMBER> moreover substitution positively charged arginine negatively charged glutamic acid increases protein hydration table s<NUMBER> consistent fact negatively charged amino acids exhibit stronger hydration positively charged ones <NUMBER> <NUMBER> <NUMBER> analysis intermolecular hydrogen bonds rbd ace<NUMBER> demonstrated similar influence mutants figure <NUMBER>f wt spike protein exist <NUMBER> Â± <NUMBER> hydrogen bonds rbd ace<NUMBER> good agreement experimental finding <NUMBER> eight rbdace<NUMBER> intermolecular polar interactions suggested based cryoem structure mutant <NUMBER> number rbdace<NUMBER> intermolecular hydrogen bonds decreased <NUMBER> <NUMBER> Â± <NUMBER> <NUMBER> <NUMBER> Â± <NUMBER> mutant <NUMBER> results support mutants weaken rbdace<NUMBER> binding affinity line calculated rbdace<NUMBER> intermolecular interaction energy visualization distribution rbdace<NUMBER> intermolecular hydrogen bonds figure <NUMBER>bd suggested balanced hydrogen bonds ends rbdace<NUMBER> contact region play crucial role stabilizing rbdace<NUMBER> binding specifically number intermolecular hydrogen bonds decreases termini wt spike protein mutant <NUMBER> mutant <NUMBER> interestingly preparing work antibody cr<NUMBER> <NUMBER> reported bind nonrbd region spike protein explore possibility inhibit sarscov<NUMBER> rbdace<NUMBER> binding neutralizing polybasic cleavage sites end designed oligopeptide tetrapeptide glugluleuglu eele negatively charged glutamic acids glu included neutralize positively charged arginine residues polybasic cleavage sites hydrophobic leucine leu residue introduced decrease hydration test simulation tetrapeptide eeee showed eeee became quickly dissolved within <NUMBER> ns owing high hydration negatively charged amino acids <NUMBER> <NUMBER> <NUMBER> potential energy number hydrogen bonds rbd ace<NUMBER> c averages standard deviations five parallel runs figure <NUMBER> three eele molecules initially put next three polybasic sites trimeric spike protein system equilibrated using process simulations absence tetrapeptide one typical configuration presented figure <NUMBER>a inclusion tetrapeptide eele still preserve spike proteinace<NUMBER> complex figure <NUMBER>a b nevertheless rbdace<NUMBER> intermolecular potential energy figure <NUMBER>c remarkably dropped <NUMBER> <NUMBER> Â± <NUMBER> kjmol without eele <NUMBER> Â± <NUMBER> kjmol presence eele similarly number rbdace<NUMBER> intermolecular hydrogen bonds dropped <NUMBER> therefore presence eele greatly lessened rbdace<NUMBER> binding note one subunit trimeric spike protein directly binds ace<NUMBER> receptor consequently three polybasic cleavage sites different distances ace<NUMBER> receptor distinct local environment furthermore ace<NUMBER> receptor tetrapeptide eele negatively charged <NUMBER>e ace<NUMBER> <NUMBER>e eele effects collectively lead observation three tetrapeptides exhibited different binding behavior neighboring polybasic cleavage sites specifically polybasic cleavage site distributed farthest ace<NUMBER> stably binds tetrapeptide eele whole simulation duration <NUMBER> ns figure <NUMBER>a contrast two polybasic cleavage sites closer ace<NUMBER> form weaker interactions neighboring tetrapeptides eele became unbound around <NUMBER> ns <NUMBER> ns experimentally design polybasic cleavage sitetargeting clinical therapeutic peptides increase oligopeptide hydrophobicity required elevate stability sarscov<NUMBER> spike proteinoligopeptide binding determine binding polybasic cleavage sites reduces rbdace<NUMBER> overall binding energy even meanwhile delivery therapeutic peptides known challenging concerning short halflife due rapid proteolytic degradation short circulation time due low molecular weight <NUMBER> <NUMBER> could potentially overcome covalently grafting oligopeptides side chains peptide brush polymers <NUMBER> integrating onto peptide amphiphiles <NUMBER> pegylation <NUMBER> using largescale allatom explicit solvent simulations investigated impact sarscov<NUMBER> polybasic cleavage sites distributed approximately <NUMBER> nm away rbd binding affinity rbd ace<NUMBER> found comparison wild type sarscov<NUMBER> spike protein mutant deletion n<NUMBER>sprra<NUMBER> mutant substitution r<NUMBER>r<NUMBER> e<NUMBER>e<NUMBER> lessen binding strength sarscov<NUMBER> rbd ace<NUMBER> mutationdriven difference ascribed electrostatic interactions spike proteins wild type mutants ace<NUMBER> hydration line recent experimental findings <NUMBER> <NUMBER> work supports distal mutations impact sarscov<NUMBER> rbdace<NUMBER> binding affinity design tetrapeptide glugluleuglu binds polybasic cleavage site sarscov<NUMBER> demonstrates polybasic cleavage site target neutralizing sarcov<NUMBER> rbdace<NUMBER> binding supports recent finding nonrbd region sarscov<NUMBER> targetted antibody <NUMBER> work besides shedding light mechanism sarscov<NUMBER> spike protein binds human cells suggests therapeutic peptides design target polybasic cleavage sites inhibit sarscov<NUMBER> rbd binding ace<NUMBER> allatom explicit solvent molecular dynamics md simulations performed using package gromacs version <NUMBER> <NUMBER> charmm <NUMBER>m potential <NUMBER> employed proteins na clions recommended charmm tip<NUMBER>p water model <NUMBER> employed structures constrained using settle algorithm <NUMBER> sarscov<NUMBER> spike proteinace<NUMBER> binding structure downloaded zhangserver <NUMBER> spike proteinace<NUMBER> complex reconstructed using citasser model <NUMBER> based protein identification number qhd<NUMBER> <NUMBER> spike protein subunit trimeric spike protein included residues <NUMBER> t<NUMBER> net charge <NUMBER>e ace<NUMBER> residues s<NUMBER> d<NUMBER> net charge <NUMBER>e e elementary charge spike proteinace<NUMBER> complex first solvated simulation box edge length <NUMBER>Ã<NUMBER>Ã<NUMBER> nm <NUMBER> figure <NUMBER> <NUMBER> nacl added along <NUMBER> na counterions spike protein ace<NUMBER> system composition listed table s<NUMBER> supporting information energy simulation box first minimized followed simulation <NUMBER> ps using canonical ensemble constant number particles volume temperature nvt integration time step <NUMBER> fs employed hydrogeninvolved covalent bonds constrained using lincs algorithm <NUMBER> <NUMBER> another simulation <NUMBER> ps subsequently conducted using isothermalisobaric ensemble constant number particles pressure temperature npt velocity rescale temperature coupling employed along berendsen pressure coupling following equilibration simulation <NUMBER> ns nosÃ©hoover temperature coupling applied along parrinellorahman pressure coupling <NUMBER> equilibration simulations coordinates nonhydrogen atoms spike protein trimer ace<NUMBER> restrained using force constant <NUMBER> kjmolnm <NUMBER> preserve spike proteinace<NUMBER> binding structure parameters production simulation spike proteinace<NUMBER> complex solvated simulation box <NUMBER> nacl b spike protein trimer colored cyan silver blue respectively ace<NUMBER> orange na clions displayed using small blue cyan beads respectively water omitted display polybasic cleavage sites r<NUMBER>rar<NUMBER> highlighted bigger blue beads system equilibrated c wt spike protein mutated removing n <NUMBER>sprra<NUMBER> mutant <NUMBER> r<NUMBER> purple changing r<NUMBER>r<NUMBER> e<NUMBER>e<NUMBER> mutant <NUMBER> e<NUMBER>ear<NUMBER> red e simulation lasted <NUMBER> ns c e five parallel runs <NUMBER> ns performed based configurations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ns process applied system eele tetrapeptides f production simulation figure <NUMBER>c periodic boundary conditions employed three dimensions neighbor searching conducted <NUMBER> Ã¥ using verlet particlebased method updated every <NUMBER>time steps lennardjones lj <NUMBER> interactions switched <NUMBER> <NUMBER> Ã¥ via potentialswitch method gromacs shortrange coulomb interactions truncated cutoff distance <NUMBER> Ã¥ longrange interactions calculated using smooth particle mesh ewald pme algorithm <NUMBER> <NUMBER> temperatures proteins ions water separately coupled using nosÃ©hover algorithm reference temperature <NUMBER>k characteristic time <NUMBER> ps isotropic parrinellorahman barostat employed reference pressure <NUMBER> bar characteristic time <NUMBER> ps compressibility <NUMBER>Ã<NUMBER> <NUMBER> bar <NUMBER> covalent bonds constrained supported integration time step <NUMBER> fs parameters recommended accurate reproduction original charmm simulation lipid membrane system <NUMBER> system around <NUMBER> atoms computationally expensive performance around <NUMBER> nsday <NUMBER> highperformance computing nodes <NUMBER> cpu cores intel haswell e<NUMBER> <NUMBER> ghz <NUMBER> Ã <NUMBER> gts intelÂ® qpi <NUMBER> mhz shortrange coulomb lj interaction energies table s<NUMBER> supporting information calculated using gromacs program gmx energy intermolecular hydrogen bonds calculated using gromacs program gmx hbond structural criteria hydrogen bond applied donor acceptor distance r da â¤ <NUMBER> Ã¥ hydrogenâdonorâacceptor angle Î¸hda â¤ <NUMBER>Â° <NUMBER> <NUMBER> based equilibrated structure wild type spike protein mutated mutant <NUMBER> n<NUMBER>sprra<NUMBER> residues deleted three subunits spike protein trimer mimic experimentally reported mutant walls et al <NUMBER> residues t<NUMBER>nsprrar<NUMBER> wild type spike protein sarscov<NUMBER> mutated t<NUMBER>ilr<NUMBER> accordingly six clions distributed next six arginine residues r <NUMBER>r<NUMBER> removed neutralize system system equilibrated relax mutated region followed production simulations simulation parameters simulation wild type spike protein similarly five parallel simulations carried based production simulation <NUMBER> ns figure <NUMBER>d mutant <NUMBER> r<NUMBER>r<NUMBER> residues changed e<NUMBER>e<NUMBER> three subunits spike protein trimer accordingly six clions distributed next six arginine residues r<NUMBER>r<NUMBER> replaced na ions neutralize system simulation parameters simulation wild type spike protein production simulation lasted <NUMBER> ns five parallel simulations performed figure <NUMBER>e three tetrapeptides glugluleuglu eele included initially put next three polybasic cleavage sites r<NUMBER>rar<NUMBER> trimeric wild type spike protein figure <NUMBER>f spike proteinace<NUMBER> complex tetrapeptide eele solved simulation box edge length <NUMBER>Ã<NUMBER>Ã<NUMBER> nm <NUMBER> <NUMBER> nacl added along <NUMBER> na counterions eele <NUMBER> na counterions spike protein ace<NUMBER> table s<NUMBER> supporting information equilibration productions whose wild type spike protein absence tetrapeptide calculated rbdace<NUMBER> intermolecular coulomb lennardjones interactions presented table s<NUMBER> supporting information following files available free charge httppubsacsorgdoixxx last two decades zoonotic coronaviruses severe acute respiratory syndrome coronavirus sars cov <NUMBER> <NUMBER> coronaviruses novel sars cov<NUMBER> appears spreading rapidly readily posing challenging task administrative scientific communities sars identified camel human transmission saudi arabia <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronaviruses crossed species resulted causing human infections leading mortality reported civet sars cov also infect humans <NUMBER> viral rna stores genetic information also serves translate structural nonstructural proteins nsps sars cov<NUMBER> sars cov uses angiotensin converting enzyme<NUMBER> ace<NUMBER> receptor entry human epithelial cells <NUMBER> cause infection virus infectivity studies hela cells shown sars cov<NUMBER> also uses ace<NUMBER> receptor cellular entry <NUMBER> reported first sars cov<NUMBER> infection wuhan china caused original host bats <NUMBER> less <NUMBER> months transmitted among human populations entire world initial contact sars covcov<NUMBER> human host via recognition heavily glycosylated cell envelope spike protein virus ace<NUMBER> receptor human host resulting infection order understand specificity estimate extent similarities variations sars cov<NUMBER> spike proteins required binding host receptor analyzed representative spike protein sequences order estimate evolutionary progression bat sars cov genome able adapt human host novel coronavirus causing covid<NUMBER> analyzed complete genomes bat civet human sars cov human sars cov<NUMBER> carried computational analyses nucleotide protein sequences generating multiple sequence alignments msas constructing phylogenetic trees analyzing threedimensional structures spike proteins address article protected copyright rights reserved spike proteins retrieved ncbi database using sequence similarity search blast program <NUMBER> considered analyses redundancy dataset removed using cdhit program <NUMBER> nucleotide protein sequence homology analyses based msa reveals substitutions deletions insertions position understand evolutionary relationships members msas processed generate phylogenetic trees pictorial representation evolutionary relationships related members various sequences analyzed msas phylogenetic trees spike proteins complete genomes generated using next generation phylogenyfr web service available httpsngphylogenyfr <NUMBER> protocol takes sequences nucleotide protein input fasta file format generates msa phylogenetic tree ngphylogeny server selected fastme <NUMBER> program infers phylogenies using distance approach since capable handling large datasets <NUMBER> based input fasta sequences msa generated adopts multiple alignment sars cov sars cov<NUMBER> spike proteins retrieved various host sources sequence length ranging <NUMBER> <NUMBER> amino acids structurally spike protein characterized three regions <NUMBER> nterminal extracellular domain <NUMBER> transmembrane anchor domain <NUMBER> intracellular segment nterminal extracellular domain comprises receptor binding subunit s<NUMBER> membranefusion subunit s<NUMBER> s<NUMBER> subunit comprises two domains ntd rbd sequence analyses spike proteins various host sources shown msa supplementary figure s<NUMBER> phylogenetic tree figure <NUMBER> figure <NUMBER> observed paralogous proteins individual host sources associated distinct clade spike proteins human sars cov<NUMBER> share highest sequence similarity according least pairwise distances also orthologous spike proteins host species highly similar according low pairwise distances therefore intriguing see despite high sequence identity spike proteins various host sources sars cov sars cov<NUMBER> able bind human host ace<NUMBER> receptor order understand analyzed msa spike proteins supplementary figure s<NUMBER> observed nterminal <NUMBER> amino acids comprising s<NUMBER> subunit vary moderate extent among host sources relative later receptor <NUMBER> structures superimposed amino acid residues within <NUMBER> Ã¥ distance ace<NUMBER> receptor identified highlighted pairwise sequence alignment rbd figure <NUMBER>b despite amino acid mutations regions proteins structures highly superimposable location corresponding deletions two sequence regions bat sars cov respect human sars cov<NUMBER> match ace<NUMBER> binding region figure <NUMBER>c second insertion sequence region ie cov<NUMBER> stabilized disulfide bond <NUMBER>c <NUMBER>c figure <NUMBER>c disulfide bond conserved spike proteins comprise insertion sequence regions rbd bat sars cov spike proteins position equivalent <NUMBER>c replaced conserved glycine residue therefore disulfide bond absent interestingly bat sars cov spike protein qhr<NUMBER> acquired insertion sequences rbd also possesses disulfide bond believe presence sequence regions rbd disulfide bond stabilizes conformation extended loop required recognition human ace<NUMBER> sequence regions identified work serve potential candidate epitopes design antibodies specific human sars cov<NUMBER> recognition analyses suggest bat spike protein qhr<NUMBER> undergone significant evolutionary changes resembles human sars cov<NUMBER> spike protein bat sars cov may led transmission sars cov bat human novel sars cov<NUMBER> results also suggest bat sars cov spike proteins avp<NUMBER> avp<NUMBER> progression acquiring mutations towards becoming sars cov<NUMBER>like proteins phylogenetic tree figure <NUMBER> showing proteins qhr<NUMBER> avp<NUMBER> avp<NUMBER> close human sars cov<NUMBER> support hypothesis representative complete genomes nucleotide sequences bat civet human cov human cov<NUMBER> analyzed msa shown figure s<NUMBER> phylogenetic tree article protected copyright rights reserved figure <NUMBER> figure <NUMBER> observed human sars cov<NUMBER> genomes cluster one clade pairwise distance lower <NUMBER> revealing high identity suggest two sequence regions mesefr syltpg ntd spike protein human sars cov<NUMBER> two sequence regions vggny eiyqagstpcngv rbd interact ace<NUMBER> may exploited potential candidates antibody design accepted article article protected copyright rights reserved little research initiated enlighten nigerians pathogenesis targets drug development newly discovered severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection way forward achieve longlasting future treatment disease also many citizens country aware deadliness disease coronavirus disease <NUMBER> covid<NUMBER> kind viral infection causing pneumonialike symptoms first reported wuhan china december <NUMBER> disease caused sarscov<NUMBER> <NUMBER> <NUMBER> outbreak declared pandemic <NUMBER> th january <NUMBER> regarded third introduction highly pathogenic virus human population severity virus causes infection human population age immune status dependent shorter among patients greater <NUMBER>years old compared age <NUMBER> early symptoms include fever cough fatigue symptoms include sputum production headache haemoptysis dyspnoea lymphopenia figure <NUMBER> <NUMBER> clinical features unmask chest computer tomography ct scan presented pneumonia however also abnormal features rnaaemia acute respiratory distress syndrome acute cardiac injury incidence groundglass opacities lead death <NUMBER> unfortunately use interferon inhalation treatment cases show clinical progress worsen condition lead pulmonary opacities <NUMBER> besides patients infected sarscov<NUMBER> also developed gastrointestinal associated symptoms like diarrhea <NUMBER> <NUMBER> minimize transmission sarscov<NUMBER> health care workers patients important develop methods identification various modes viral transmission fecal urine samples <NUMBER> genome sequencing virus five patients pneumonia hospitalized december <NUMBER> december <NUMBER> <NUMBER> showed presence previously unknown Î² coronavirus Î²cov strain <NUMBER> upon isolation sequencing Î²cov shows <NUMBER> identity sequence two batderived severe acute respiratory syndromes sarslike coronaviruses batslcovzc<NUMBER> batslcovzxc<NUMBER> <NUMBER> identity sequence middle east respiratory syndrome coronavirus merscov <NUMBER> similarities genome sequences sarscov<NUMBER> minimum number ten open reading frames orfs genome sequences covs merscov sarscov first orf making twothird sarscov<NUMBER> rna undergoes translation two polyproteins comparison merscov sarscov two polyproteins pp<NUMBER>a pp<NUMBER>ab processed posttranslational modification <NUMBER> nonstructural proteins nsps nsp<NUMBER> nsp<NUMBER> <NUMBER> nsps translocated rough endoplasmic reticulum doublemembrane vesicles replication transcription virus occurred <NUMBER> <NUMBER> remaining orfs sarscov<NUMBER> localized onethird remaining genome responsible encoding nonreplicating participating accessory proteins unknown functions structural proteins membrane nucleocapsid n envelope e spike proteins investigation scientists china revealed sarscov requires angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor binding invasion host also binding significant determination disorders caused sarscov<NUMBER> infection j u r n l p r e p r f pathogenesis infection caused sarscov <NUMBER> nevertheless dipeptidyl peptidase <NUMBER> receptor required merscov invasion <NUMBER> predict specificity zoonotic coronaviruses infection humans adaptation possibility better understanding proteases action receptor binding essential therefore development therapeutics treatment sarscov<NUMBER> highly warranted <NUMBER> however review aims discuss molecular pathogenesis sarscov<NUMBER> target drug development enlighten nigerians deadliness disease way forward achieve future treatment current pandemic molecular pathogenesis sarscov<NUMBER> poorly understood date nevertheless merscov sarscov mechanisms shed light pathogenesis sarscov<NUMBER> essential protein sarscov<NUMBER> mediates binding human cell spike protein protein involved first step infection protein composed s<NUMBER> s<NUMBER> subunit according cryogenic electron microscopy cryoem studies receptorbinding domain rbd <NUMBER>d structure size <NUMBER>kda localized s<NUMBER> subunit vibrational movement rbd examined characterization structure related merscov sarscov found mechanism action sarscov<NUMBER> interestingly similarities structure sarscov<NUMBER> sarscov spike glycoprotein structural difference rbd sarscov<NUMBER> rbd angle closer central cavity trimer conformation sarscov rbd packs tightly domain nterminal neighboring protomer conformation <NUMBER> binding affinity two viruses investigated using surface plasmon resonance showed even though sarscov sarscov<NUMBER> share binding receptor ace<NUMBER> binding affinity sarscov<NUMBER> <NUMBER>nm almost <NUMBER> fold higher sarscov binding ace<NUMBER> receptor reason sarscov<NUMBER> easily transmitted human human whereas complex formed sarscov<NUMBER> sectodomain ace<NUMBER> studied using highresolution cryoem revealed complex similar sarscov complex spike structural protein mediates entry sarscov<NUMBER> human cells trimetric protein class <NUMBER> fusion protein metastable prefusion conformation undergoes structural rearrangement human cell membrane fusion rearrangement activated upon binding rbd s<NUMBER> subunit host cell receptor ace<NUMBER> <NUMBER> destabilization prefusion trimer take place upon receptor binding viral membrane host cell membrane lead shedding s<NUMBER> s<NUMBER> subunit transition stable postfusion conformation rbd s<NUMBER> pass hingelike movement leading transient hiding conformation receptor inaccessible state exposing confirmation ie receptor accessible state receptor binding determinant therefore mechanism engaging host cell receptor sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> entry human cells merscov binds dipeptidyl peptidase<NUMBER> dpp<NUMBER> receptor sarscov binds ace<NUMBER> receptor membrane fusion viral infectivity coronavirus occurred proteolytic cleavage s<NUMBER> position protein occurred sarscov pathogenesis use twostep furin activation essential fusion mers host membrane <NUMBER> entry sarscov also mediated clathrindependent independent endocytosis <NUMBER> <NUMBER> sarscov<NUMBER> binds angiotensinconverting enzyme receptor ace<NUMBER> results entry host virus releases rna cytoplasm orf<NUMBER>a orfab rna translated polyprotein <NUMBER>a pp<NUMBER>a polyprotein ab ppab orf<NUMBER>a encodes enzyme protease cleaves polyproteins nonstructural proteins nsps form rna replicasetranscriptase complex needed structural protein synthesis replicase complex executes formation negativesense rna upon fragmentation negativesense rna subgenomic rna discontinuous transcription fragments encode j u r n l p r e p r f spike membrane nucleocapsid envelope protein formed structural proteins synthesized rough endoplasmic reticulum pass endoplasmic reticulumgolgi intermediate compartment ergic golgi apparatus sortation assembly take place finally viral protein genomic rna assembled virion endoplasmic reticulum golgi released outside cell vesicle <NUMBER> <NUMBER> <NUMBER> <NUMBER> invasion cells sarscov<NUMBER> antigen attached antigenpresenting cells central antiviral immunity finally major histocompatibility complex mhc human leukocyte antigen hla humans present antigenic peptides cytotoxic lymphocytes specific sarscov recognized viral antigen therefore pathogenesis mechanism figure <NUMBER> sarscov help understanding drug development strategies sarscov<NUMBER> infection upon presentation antigen antigenpresenting cells cellular humoral immunity body stimulated virusspecific b cells therefore igm igg common antibody profile sarscov <NUMBER> weeks marked time taken igm sarscov disappear igg lasting longer <NUMBER> researches cellular immunity coronavirus carried updated report reveals number cd<NUMBER>Ã¾ cd<NUMBER>Ã¾ cells peripheral blood sarscov<NUMBER> infected patients significantly reduced <NUMBER> acute phase sarscov infection decrease cd<NUMBER>Ã¾ cd<NUMBER>Ã¾ cells interestingly sarscov recovered patients four years cell memory cells undergo ifng production delayedtype hypersensitivity dth response proliferation even without antigen <NUMBER> also cell memories sarscov persist six years infection recovered patients <NUMBER> therefore understanding immunology sarscov<NUMBER> help development vaccine <NUMBER> j u r n l p r e p r f figure <NUMBER> overview sarscov<NUMBER> pathogenesis virus binds ace<NUMBER> receptor enter human cell rna got translated structural proteins spike nucleocapsid membrane envelope proteins essential invasion infection human cell pathological events associated sarscov<NUMBER> sarscov merscov infection called acute respiratory distress syndrome ard <NUMBER> mechanism acute respiratory distress syndrome ards effector immune cell uncontrollably released deadly systemic proinflammatory cytokines ifna ifng il<NUMBER>b il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> tnfa tgfb etc also chemokines ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> cxcl<NUMBER> etc <NUMBER> <NUMBER> cytokine chemokine release effector cells lead organ failure death happened severe case sarscov<NUMBER> infection <NUMBER> better survival mers cov sarscov invaded host example pattern recognition receptor responsible recognizing pathogenassociated molecule however mers sars viruses develop way producing doublemembrane vesicle without pattern recognition receptor allows viral genome replicate without control immune system <NUMBER> inhibited mers accessory protein activation melanoma differentiated associated protein gene <NUMBER> mda<NUMBER> interaction doublestranded directly <NUMBER> <NUMBER> <NUMBER> elaborate nuclear transport ifn regulatory protein activation ifn b promoter blocked merscov orf<NUMBER>a orf<NUMBER>b orf<NUMBER> membrane proteins <NUMBER> since coronaviruses mers destabilize immune system altering antigen presentation cells downregulation gene expression therefore important drug development develop strategy destroying immune evasion sarscov<NUMBER> <NUMBER> drug development scratch take least decade following repositioning existing antiviral drugs effective sarscov<NUMBER> might solution current pandemic sudden infectious diseases human innate immunes system plays crucial role replication coronaviruses together use interferon boost immune response counteracting coronaviruses <NUMBER> sarscov sarscov<NUMBER> bind ace<NUMBER> merscov binds protease receptors called dpp<NUMBER> entry human cell therapeutics acting coronaviruses either blocking virus association human cell inhibition viral selfassembly inhibition structural protein blocking rna synthesis viral genetic material inhibition blocking critical enzymes virus inhibit replication <NUMBER> three strategies coronavirus drug development introduced scientists strategy testing broadspectrum existing antiviral drugs <NUMBER> drugs ribavirin cyclophilin inhibitors interferons used treat coronavirus associated symptoms pneumonia considered fall category therefore known metabolic characteristics dosage efficacy side effect approval viral treatment major advantage associated therapeutic strategy major problems drugs killing coronaviruses targeted manner broadspectrum therefore bettertargeted therapeutics indeed needed second strategy involved use existing molecular databases screen find molecules therapeutic potential effective coronaviruses <NUMBER> availability high throughput techniques makes possible screening potential therapeutics aid finding function new molecules instance discovery drugs lopinavirritonavir antihiv third strategy development new targeted drugs scratch based coronaviruses pathological features genetic information perceived drug development strategy exhibit efficacy virus however might cost several years drug development clinical trials estimated drug development take seven years even <NUMBER> years <NUMBER> recommended research initiated drug development scratch highly contiguous viruses prepare future pandemics based molecular targets four major strategies sarscov<NUMBER> drug development discussed also targets used develop new drugs scratch based pathological genomic characteristics new sarscov<NUMBER> <NUMBER> therapeutics acting protein enzymes critical growth virus preventing replication synthesis rna nonstructural proteins nsps involved protein synthesis translation rna transcription processing modification virus replication host infection therefore nsps considered significant functional protein coronaviruses coronavirus main proteinase <NUMBER>clpro papainlike proteinase plpro rna dependent rna polymerase rdrp helicase superior molecular targets small inhibitory molecule drug development result wellunderstood enzyme active sites biological functions example papainlike proteinase plpro protein cleaves replicase polyprotein nterminus leading release nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> indispensable replication control corrections <NUMBER> also plpro antagonize immunity infected patient <NUMBER> <NUMBER> group enzymes necessary replication viral infection popular target <NUMBER>clpro otherwise called nsp<NUMBER> protein cleaved automatically polyprotein form mature enzyme cleaved downstream <NUMBER> sites leads release nsp<NUMBER> nsp<NUMBER> interestingly maturation nsps directly mediated <NUMBER>clpro life cycle virus depends maturation <NUMBER>clpro studies structure catalytic mechanism <NUMBER>clpro make promising drug development target covid<NUMBER> therefore antibacterial drugs lymecycline antihypertensive drugs nicardipine known block activity <NUMBER>clike main protease rnadependent rna polymerase rdrp otherwise known nsp<NUMBER> protein conserved coronaviruses forms vital enzyme viral replication transcriptional complex rdrp conserved amino acid serine <NUMBER> aspartic acid therefore nsp<NUMBER> used important target sars mers drug development even though specific inhibitor nsp<NUMBER>rdrp found targeted inhibition result significant side effects toxicity host cell strengthening research target lead therapeutic development sarscov infection <NUMBER> <NUMBER> <NUMBER> however natural products exhibit antivirus antitumor antiinflammation effects exert binding affinity rdrp molecules betulonal cassine xylocarpa gnidicin gniditrin gnidia lamprantha bind inhibit rdrp coronaviruses helicase nsp<NUMBER> multifunctional protein n terminal metalbinding domain helicase domain structure n terminal contains <NUMBER> cysteine residues make zinc binding domain c terminus conserved motif helicase also necessary component replication coronavirus therefore helicase identified target antiviral drug discovery less research helicase inhibitors drugs antibacterial lymecycline cefsulodine rolitetracycline antifungal itraconazole antihiv drug saquinavir anticoagulant drug dabigatran diuretic drug canrenoic acid shown potent inhibitors helicase <NUMBER> <NUMBER> also studies shown myricetin scutellarein potentially inhibit sarscov<NUMBER> helicase protein vitro affecting atpase activity unwinding activity nsp<NUMBER> <NUMBER> inhibiting selfassembly core structural protein coronavirus gathered form special corolla like structure viral surface like trimer called spike protein binds host cell receptor using rbd results invasion host host cell protease cleaves spike protein s<NUMBER> s<NUMBER> s<NUMBER> binds surface receptor host s<NUMBER> mediates virus cell fusion cell cell fusion cleavage activation structural integrity crucial invasion virulence activity mediated spike protein <NUMBER> strategies block spike protein means preventing coronavirus entering host regarded valuable development antiviral drugs <NUMBER> <NUMBER> natural flavonoids licoflavonol glycyrrhiza uralensis therapeutics anticoagulant drug dabigatran etexilate antifungal drugs posaconazole itraconazole antihypertensive drugs rescinnamine iloprost prazosin antibacterial drug sulfasalazine azlocillin penicillin cefsulodin inhibit coronavirus binding receptor cell surface human cell <NUMBER> rdb located s<NUMBER> spike protein sarscov<NUMBER> also target development therapeutic monoclonal antibodies despite fact structural homology sarscov<NUMBER> sarscov cryoem studies monoclonal antibody originally developed target sarscov rbd tested sarscov<NUMBER> rbd sd<NUMBER> fragment antibody show binding affinity sarscov<NUMBER> say amino acids involved interaction rbd spike protein ace<NUMBER> receptor sarscov<NUMBER> sarscov supported <NUMBER> modeling sarscov<NUMBER> rdb interaction ace<NUMBER> revealed sequence amino acids important interaction ace<NUMBER> rbd spike glycoprotein less clarity actual sequence involved interaction therefore need new monoclonal antibody development rbd sarscov<NUMBER> hence knowledge spike protein sarscov<NUMBER> atomic level using cryoem enable scientists carry protein engineering design development effective inhibitory molecules monoclonal antibodies <NUMBER> virulence factors coronavirus interferes innate immunity infected cells nsp<NUMBER> nsp<NUMBER>c orf<NUMBER>a nsp<NUMBER> induces degradation host mrna interferon type <NUMBER> production upon binding <NUMBER>s ribosomal subunit <NUMBER> nsp<NUMBER>c binds nucleotide host adpribose gives coronavirus ability resist innate immunity instance bone marrow matrix antigen <NUMBER> blocks assembled coronavirus host cell also sarscov orf<NUMBER>a interacts bst <NUMBER> blocks glycosylation results termination orf<NUMBER>a activity <NUMBER> therefore aforementioned virulence factors potential drug discovery targets coronavirus example antibacterial antiinflammatory natural products bind inhibit virulence factors also drugs platycodin streptomycin tetracycline piperacillin cefpiramide lymecycline platycodon grandifloras potentially inhibit coronavirus virulence factors <NUMBER> <NUMBER> receptor spike rna binding domain sarscov ace<NUMBER> receptor since sarscov interact angiotensin receptor blocking receptor target therapeutics development sarscov<NUMBER> infection therefore antihypertensive drugs losartan antibacterial cefmenoxime hepatoprotective silybin antidiabetes troglitazone analgesia ergotamine bind high affinity angiotensin <NUMBER> receptor <NUMBER> rna dependent rna polymerase nsp<NUMBER> promising molecular target sarscov<NUMBER> drug development current state finding treatment sarscov<NUMBER> drug repositioning drug targeted treatment ebola virus called remdesivir showed efficacy sarscov<NUMBER> replication therefore rna dependent rna polymerase inhibitor rdrpscalled remdesivir developed gilead science inc mimic structure adenosine regarded nucleotide analog developed originally inhibit ebola virus replication even though drug pass phase <NUMBER> clinical trial ebola virus studies shown promising treatment covid<NUMBER> <NUMBER> also drug reported promising sarscov<NUMBER> replication inhibition result structural similarities rdrps various viruses remdesivir serve broad antiviral drug studies also shown drug effective merscov interestingly usa china commence phase <NUMBER> clinical trial remdesivir sarscov<NUMBER> <NUMBER> even though drugs broadspectrum antibiotics antiviral drugs interferonsa nebulization used reduction viral load remdesivir promising impact sarscov<NUMBER> controversy efficacy drugs used treatment sarscov merscov ribavirin corticosteroids lopinavirritonavir interferon makes investigated treatment sarscov<NUMBER> infection satisfactory result achieved trial remdesivir mice model treatment mice day infection coronavirus decrease viral load improvement mice pulmonary function however remdesivir administration viral load reaches maximum peak infection cannot improve symptoms patient remdesivir improve patient symptoms virus reaches maximum peak treatment rhesus monkey remdesivir <NUMBER> hours infection promising reduction symptoms associated merscov infection within <NUMBER> hours administration <NUMBER>g remdesivir rhesus monkey results peripheral blood mononuclear blood distribution drug followed drug activation nucleotide triphosphate <NUMBER> according j u r n l p r e p r f new england journal medicine patient recent travel wuhan china diagnosed covid<NUMBER> returning washington january <NUMBER> <NUMBER> even though improvement patient symptoms upon remdesivir treatment viral load got decreased treatment say viral infection selflimiting immune system might started fighting infection therefore clear whether improvement symptoms patient due drug patients natural immunity however remdesivir expected specific drug targets rdrp sarscov<NUMBER> <NUMBER> great zealot chinese combat pandemic initiated research covid<NUMBER> drugs remdesivir approved clinical trial passing stringent ethical review <NUMBER> th february <NUMBER> launched trial chinas compassionate use reported remdesivir immediate drug treatment severe covid<NUMBER> proven effective brought remdesivir stage clinical trial safety good pharmacokinetics <NUMBER> remdesivir vitro inhibition research carried wuhan research institute find drug block replication virus ec<NUMBER> <NUMBER> Î¼m cc<NUMBER> <NUMBER> Î¼m si <NUMBER> low micromolar concentration infectedvero e<NUMBER> cells studies shown effective treatment sarscov<NUMBER> infection achieved combinational treatment chloroquine remdesivir result blockage viral replication recovery patient disease <NUMBER> chloroquine increases endosomal ph cell well affecting glycosylation cellular receptor result blockage sarscov<NUMBER> infection <NUMBER> <NUMBER> effect chloroquine sarscov<NUMBER> investigated <NUMBER> reported chloroquine function entry postentry virus addition antiviral activity also chloroquine modulate immune system turn result enhancement antiviral activity also inhibit replication coronavirus epithelial cells lungs cellular receptor glycosylation interference authorization use chloroquinehydroxychloroquine treatment sarscov<NUMBER> infection granted fda usa hence chloroquine function blocking virus fusion cell membrane <NUMBER> <NUMBER> widely distribution chloroquine blood lungs upon administration orally another interesting future use chloroquine establishing treatment sarscov<NUMBER> infection recommended covid<NUMBER> patients mild moderate severe symptoms take <NUMBER>mg chloroquine twice day prescription shown decrease length stay hospital improved symptoms hydroxychloroquine activity chloroquine identical mechanism action <NUMBER> moreover intensive research needed unravel potential receptors drug discovery development sarscov<NUMBER> besides <NUMBER> reported synthetic mrna called modernas mrna<NUMBER> used vaccine protection sarscov<NUMBER> infection upon intramuscular administration evoke antiviral effect directed spike protein say synthetic mrna encodes prefused spike protein sarscov<NUMBER> use mrna elicit antiviral activity need use virus unlike conventional vaccines clinical trial phase <NUMBER> mrna<NUMBER> currently taking place vaccine promising efficacy investigated immediately sum rna dependent rna polymerase spike protein sarscov<NUMBER> promising targets sarscov<NUMBER> vaccine drug development therapeutics repositioning <NUMBER> drug development viral pathogens longterm process however drug repositioning taking place treatment reduction peak covid<NUMBER> pandemic also imperative identify promising targets drug development longlasting future treatment disease also indepth understanding sarscov<NUMBER> pathogenesis atomic studies using cryoem understand amino acid involved interaction rbd spike protein ace<NUMBER> human cells essential effective vaccine drug development nigerian government initiate research clinical trial antiviral drugs inhibit sarscov<NUMBER> infection j u r n l p r e p r f current pandemic claiming health lives people world highly important initiate expand researches study pathogenesis drug targets sarscov<NUMBER> help developing treatment vaccine also prepare world prepare future reoccurrence disease research also initiated development bispecific inhibitors sarscov<NUMBER> achieve effective inhibition coronavirus activity author declares conflicts interest j u r n l p r e p r f study investigated sarscov<NUMBER> molecular targets enzymes receptors proteins drug development promising targets based drug repositioning novel drug monoclonal antibody mrna vaccine development establish scientific discoveries nigeria towards fighting present pandemic evidence study little research initiated nigeria towards development treatment drug repositioning sarscov<NUMBER> infection therefore motivates nigerian scientists initiate research drug repurposing studies molecular targets sarscov<NUMBER> therapeutics development scratch nigeria play crucial role fighting present pandemic helping identification novel molecular targets new drug development sarscov<NUMBER> infection help country develop new treatments locally repurpose existing antiviral drugs initiate clinical trials could beneficial fighting pandemic prevention future reoccurrence disease proteins associated sarscov<NUMBER> infection explore drug vaccine development molecular targets critical sarscov<NUMBER> replication rna synthesis papainlike proteinase plpro <NUMBER>clike main protease <NUMBER>clpro rnadependent rna polymerase rdrp nsp<NUMBER> helicase nsp<NUMBER> spike protein important binding ace<NUMBER> receptor one great targets drug repositioning monoclonal antibody vaccine development also virulence factors nsp<NUMBER> nsp<NUMBER>c orf<NUMBER>a explored sarscov<NUMBER> drug development based drug repositioning remdesivir targeting rna dependent rna polymerase chloroquinehydroxychloroquine affecting activity spike protein binding ace<NUMBER> receptor clinical trial yielding positive results however unless molecular targets well studied potential could unraveled study reveals wide variety enzymes proteins receptors explored development novel therapeutics scratch repurposing existing antiviral drugs treatment sarscov<NUMBER> infection suggested extensive research carried rna dependent rna polymerase spike protein develop novel therapeutics apart repositioning chloroquinehydroxychloroquine remdesivir strategy prepare future reoccurrence disease longlasting future treatment background studies fusioninhibitory peptides derived heptad repeat <NUMBER> <NUMBER> hr<NUMBER> hr<NUMBER> regions hiv<NUMBER> envelope glycoprotein gp<NUMBER> provided crucial information viral fusogenic mechanism used similar approach study fusogenic mechanism severeacuterespiratorysyndromeassociated coronavirus sarscov methods tested inhibitory activity infection two sets peptides corresponding sequences sarscov spike protein hr<NUMBER> hr<NUMBER> regions investigated interactions hr<NUMBER> hr<NUMBER> peptides surface plasmon resonance sedimentation equilibration analysis circular dichroism native polyacrylamidegel electrophoresis size exclusion highperformance liquid chromatography computeraided homology modelling molecule docking analysis findings one peptide cp<NUMBER> derived hr<NUMBER> region inhibited sarscov infection micromolar range cp<NUMBER> bound high affinity peptide hr<NUMBER> region np<NUMBER> cp<NUMBER> alone low â£helicity selfassociated form trimer phosphate buffer ph <NUMBER>Â·<NUMBER> cp<NUMBER> np<NUMBER> mixed equimolar concentrations formed sixhelix bundle similar fusogenic core structure hiv<NUMBER> gp<NUMBER> interpretation binding target cell transmembrane spike protein might change conformation association hr<NUMBER> hr<NUMBER> regions form oligomeric structure leading fusion viral targetcell membranes prefusion intermediate state cp<NUMBER> could bind hr<NUMBER> region interfere conformational changes resulting inhibition sarscov fusion target cells cp<NUMBER> might modifiable increase antisarscov activity could developed antiviral agent treatment prophylaxis sarscov infection global outbreak severe acute respiratory syndrome sars <NUMBER> seriously threatened public health socioeconomic stability disorder caused novel coronavirus sarsassociated coronavirus sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> angiotensinconverting enzyme <NUMBER> functional receptor virus <NUMBER> mechanism sarscov enters target cells unclear elucidation fusogenic mechanism provide important information development antiviral drugs vaccines treatment prevention sars sarscov could originated wild animals similar coronavirus isolated animals himalayan palm civets <NUMBER> coronavirus shares genetic structural properties others including murine hepatitis virus bovine coronavirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> example sarscov also expresses abundant spike glycoprotein surface trimeric dimeric structure forming spikes <NUMBER> nm long <NUMBER> nm wide bulbous end <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> spike protein sarscov involved virus binding fusion entry typical class viral fusion protein similar transmembrane glycoproteins many enveloped viruses <NUMBER> therefore information obtained studies enveloped viruses hiv<NUMBER> could useful investigation fusogenic mechanism mediated sarscov spike protein early <NUMBER>s wild coworkers group discovered potent hiv<NUMBER> fusioninhibitory peptides derived gp<NUMBER> heptad repeat <NUMBER> <NUMBER> hr<NUMBER> hr<NUMBER> regions designated npeptides cpeptides respectively <NUMBER> <NUMBER> <NUMBER> one cpeptides t<NUMBER> trimeris research triangle park nc usa recently approved us food drug administration first new class antihiv drugsfusion inhibitors studies mechanism action antihiv<NUMBER> peptides provided important information elucidate fusogenic mechanism mediated hiv<NUMBER> gp<NUMBER> <NUMBER> <NUMBER> <NUMBER> binding gp<NUMBER> cd<NUMBER> coreceptor gp<NUMBER> changes interaction heptad repeat <NUMBER> <NUMBER> regions spike protein sarsassociated coronavirus implications virus fusogenic mechanism identification fusion inhibitors occurrence group seven aminoacids many times protein sequence seven aminoacids labelled g generally hydrophobic others hydrophilic method measuring protein molecular masses solution studying interactions proteins including associative states heterogeneity thermodynamic properties complex formed six rodlike structures rod consists peptide â£helical conformation like spring three peptides form central trimeric core three peptides pack grooves surface central trimeric core personal use reproduce permission lancet publishing group aminoacid sequences peptides derived hr<NUMBER> hr<NUMBER> regions sarscov spike protein similar hiv<NUMBER> gp<NUMBER> hr<NUMBER> hr<NUMBER> regions figure <NUMBER> similarity suggests two transmembrane envelope glycoproteins share common mechanism mediating fusion viral targetcell membranes similar approach used studying hiv<NUMBER> gp<NUMBER> designed synthesised series peptides corresponding sequences sarscov spike protein hr<NUMBER> hr<NUMBER> regions used peptides probes study fusogenic mechanism virus identify antiviral peptides peptides synthesised applied biosystems pioneer peptide synthesiser abi framingham usa standard fmoc<NUMBER>hbenzotriazole<NUMBER>yl<NUMBER>tetramethyluronium hexafluorophosphate hbtu methods purified homogeneity highperformance liquid chromatography hplc agilent technologies palo alto ca usa characterised maldi tof mass spectrometer abi voyager de foster city ca peptide sequences shown table <NUMBER> biotinylated cp<NUMBER> np<NUMBER> prepared addition biotin hbtu ntermini peptides synthesis inhibitory activity synthetic peptides sarscov infection vero e<NUMBER> cells assessed previously described <NUMBER> <NUMBER> tcid <NUMBER> <NUMBER> tissueculture infectious dose sarscov whu strain accession number ay<NUMBER> mixed equal volume peptide graded concentrations incubated <NUMBER>Â°c <NUMBER> min mixture added monolayers vero e<NUMBER> cells <NUMBER>well tissueculture plates incubation <NUMBER>Â°c <NUMBER> h supernatants removed fresh medium added day <NUMBER> infection cytopathic effect recorded concentrations peptides resulting <NUMBER> inhibition ic <NUMBER> calculated measure binding affinity kinetic dissociation constant sarscov related peptides used surface plasmon resonance optical biosensor model bia <NUMBER> biacore inc piscataway nj usa biotinylated cp<NUMBER> <NUMBER> moll immobilised streptavidin sensor chips biacore surface reference biotinylated cp<NUMBER> bound included analysis derivatised sensor chips washed equilibrated phosphatebuffered saline ph <NUMBER>Â·<NUMBER> <NUMBER> lmin peptides tested introduced five serial dilutions running buffer phosphatebuffered saline ph <NUMBER>Â·<NUMBER> <NUMBER>Â·<NUMBER> p<NUMBER> <NUMBER> l injection volumes flow rate <NUMBER> lmin conformation via hr<NUMBER> hr<NUMBER> interaction form fusogenic hexameric core structure brings viral targetcell membranes close proximity resulting fusion intermediate state cpeptide bind viral gp<NUMBER> hr<NUMBER> region block formation sixhelix bundle thus inhibiting virus fusion target cell <NUMBER> discovery hiv<NUMBER> fusioninhibitory peptides launched new line investigation viral fusogenic mechanisms identification antiviral peptides infection many enveloped virusessimian <NUMBER> feline <NUMBER> immunodeficiency viruses ebola virus <NUMBER> newcastle disease virus <NUMBER> respiratory syncytial virus <NUMBER> similarly hiv<NUMBER> gp<NUMBER> s<NUMBER> domain sarscov spike protein contains hr<NUMBER> hr<NUMBER> sequences tend form coiledcoil structure figure <NUMBER> association followed <NUMBER> min dissociation sensogram response data analysed commercial software biaevaluation version <NUMBER> kinetic dissociation constant calculated experiment done least three times secondary structure peptides determined circulardichroism spectroscopy previously described <NUMBER> isolated peptides peptide mixtures diluted phosphate buffer <NUMBER> mmoll sodium phosphate ph <NUMBER>Â·<NUMBER> final concentration <NUMBER> moll circulardichroism spectra acquired spectropolarimeter model j<NUMBER> jasco inc japan <NUMBER>Â°c bandwidth <NUMBER>Â·<NUMBER> nm resolution <NUMBER>Â·<NUMBER> nm path length <NUMBER>Â·<NUMBER> cm response time <NUMBER>Â·<NUMBER> scanning speed <NUMBER> nmmin thermal denaturation monitored <NUMBER> nm application thermal gradient <NUMBER>Â°cmin spectra corrected subtraction blank corresponding solvent melting curve smoothed midpoint thermal unfolding transition tm values calculated jasco software utilities previously described <NUMBER> apparent molecular masses peptides peptide mixtures measured sedimentation equilibrium analysis beckman coulter optima xli analytical ultracentrifuge equipped realtime videobased dataacquisition system rayleigh optics peptides run three initial concentrations <NUMBER> moll <NUMBER> moll <NUMBER> moll <NUMBER> mmoll sodium phosphate ph <NUMBER>Â·<NUMBER> containing <NUMBER> mmoll sodium chloride <NUMBER> mmoll tris<NUMBER>carboxyethylphosphine hydrochloride sample volumes <NUMBER> l used sixsector cells equipped quartz windows experiments done <NUMBER>Â°c sedimentation equilibrium data collected <NUMBER> <NUMBER> rpm <NUMBER> <NUMBER>Ï«g np<NUMBER> <NUMBER> <NUMBER> rpm <NUMBER> <NUMBER>Ï«g cp<NUMBER> <NUMBER> <NUMBER> rpm <NUMBER> <NUMBER>Ï«g cp<NUMBER>np<NUMBER> complex sedimentation equilibrium profiles edited program reedit jeff lary national analytical ultracentrifuge center storrs ct usa analysed nonlinear leastsquares method program winnonlin <NUMBER> values partial specific volumes peptides calculated aminoacid composition program sednterp david hayes magdalen college oxford uk tom laue university new hampshire durham nh usa john philo amgen thousand oaks ca usa native polyacrylamidegel electrophoresis npage done previously described <NUMBER> isolated peptides peptide mixtures indicated concentrations mixed trisglycine native sample buffer invitrogen carlsbad ca usa ratio one one loaded <NUMBER> l well <NUMBER>Ï«<NUMBER> cm trisglycine precast gel <NUMBER> gel electrophoresis carried constant <NUMBER> v room temperature <NUMBER> h gel stained coomassie blue image taken fluorchem <NUMBER> imaging system alpha innotech corp san leandro ca usa another set experiments mixtures np<NUMBER> biotinylated cp<NUMBER> analysed npage described peptides gel transferred nitrocellulose membrane amersham pharmacia biotech inc piscataway nj usa blocked <NUMBER> nonfat milk <NUMBER>Âºc overnight followed incubation streptavidinconjugated horseradish peroxidase room temperature <NUMBER> h extensive washing membrane stained <NUMBER>Ñdiaminobenzidine dye image taken described biosil sec <NUMBER> column <NUMBER>Ï«<NUMBER>Â·<NUMBER> mm biorad hercules ca usa used sizeexclusion hplc sehplc assess oligomer formation <NUMBER> hr<NUMBER>derived peptide incubated hr<NUMBER>derived peptide final concentration peptide <NUMBER> moll <NUMBER>Âºc <NUMBER> min <NUMBER> l sample injected column connected hplc system waters delta <NUMBER> milford usa phosphatebuffered saline ph <NUMBER>Â·<NUMBER> used mobile phase flow rate <NUMBER>Â·<NUMBER> mlmin ultraviolet absorbance <NUMBER> nm recorded photodiode array detector waters <NUMBER> biorad gelfiltration r<NUMBER> processor sgi mountain view ca usa models optimised refine <NUMBER> option modeller uses conjugated gradient together molecular dynamics simulated annealing techniques five models run built model lowest objective function selected protein geometry verified quanta protein health check resulting model evaluated stereochemical properties procheck software <NUMBER> used docking program gramm <NUMBER> model interactions np<NUMBER> cp<NUMBER> peptides docking algorithm predicts structure protein peptide complex maximising geometric match images two protein peptide molecules details docking approach described elsewhere <NUMBER> role funding source funding source role study design collection analysis interpretation data writing report decision submit publication analysed spike protein sarscov strain tor<NUMBER> <NUMBER> predictprotein program <NUMBER> protein consists sarscov spike protein analysed probability forming â£helical coiledcoil structures use program multicoil <NUMBER> sequences submitted httpjurawimiteducgibinmulticoilmulticoilpl predict conformation np<NUMBER>cp<NUMBER> complex homology modelling docking techniques first looked sequence alignment np<NUMBER> cp<NUMBER> peptides corresponding npeptides cpeptides hiv<NUMBER> gp<NUMBER> analysis showed <NUMBER> sequence similarity figure <NUMBER> used xray crystal structure gp<NUMBER> core structure pdb code <NUMBER>env build model interaction sarscov np<NUMBER> cp<NUMBER> peptides described aligned hiv<NUMBER> npeptide n<NUMBER> sarscov npeptide np<NUMBER> hiv<NUMBER> cpeptide c<NUMBER> sarscov cpeptide cp<NUMBER> use program clustalx <NUMBER> insertions deletions manually adjusted avoid gaps helix regions homology models peptide built automated software <NUMBER> transmembrane domain residues <NUMBER> intracellular domain residues <NUMBER> signal peptide residues <NUMBER> aminoterminus observed obvious fusogenic peptide sequence identified spike proteins coronaviruses except porcine transmissible gastroenteritis virus feline infectious peritonitis virus cleavable cellular proteases yield s<NUMBER> receptor binding s<NUMBER> virus fusion subunits <NUMBER> sarscov spike protein contain typical cleavage site basic aminoacid sequenceeg rrfrr grhrr krrsrr <NUMBER> therefore boundary s<NUMBER> s<NUMBER> domains cannot accurately identified present coronavirus spike proteins s<NUMBER> domain conserved sequence s<NUMBER> domain latter compact globular structure predicted predictprotein program globe prediction globularity s<NUMBER> domain contains hr<NUMBER> residues <NUMBER> hr<NUMBER> residues <NUMBER> similar class viral fusion proteins <NUMBER> <NUMBER> <NUMBER> analysis multicoil program <NUMBER> showed sequences hr<NUMBER> hr<NUMBER> regions tendency form trimeric dimeric helix bundles consistent observation coronavirus spike proteins homotrimers homodimers <NUMBER> thus regions may take part oligomerisation conformational changes spike protein viruscell fusion events spike protein sarscov <NUMBER> pairwise aminoacid identity corresponding proteins coronaviruses consistent observation rota colleagues <NUMBER> however identity hr<NUMBER> hr<NUMBER> sequences much higher table <NUMBER> suggests sequences hr<NUMBER> hr<NUMBER> regions conserved sequences spike protein alignments peptides derived hr<NUMBER> hr<NUMBER> regions sarscov spike protein hiv<NUMBER> gp<NUMBER> revealed high sequence similarity hiv<NUMBER> npeptide n<NUMBER> sarscov npeptide np<NUMBER> hiv<NUMBER> cpeptide c<NUMBER> sarscov cpeptide cp<NUMBER> <NUMBER> <NUMBER> respectively figure <NUMBER> thus hr<NUMBER> hr<NUMBER> regions sarscov spike protein hiv<NUMBER> gp<NUMBER> may share certain structural functional features also noticed residues located positions helical wheels hydrophobic figure <NUMBER> grey boxes conserved b c f positions hydrophilic figure <NUMBER> white boxes feature suggests helices form homologous oligomers hydrophobic association knobsintoholes packing interactions positions way similar interactions nhelices hiv<NUMBER> gp<NUMBER> core <NUMBER> residues b c f positions form hydrophilic face towards solution making oligomeric bundles water soluble since hr<NUMBER> hr<NUMBER> sequences sarscov spike protein highly similar hiv<NUMBER> gp<NUMBER> hypothesised hr<NUMBER> hr<NUMBER> domains similar functions hiv<NUMBER> gp<NUMBER>ie participating viral fusion process <NUMBER> therefore designed synthesised six peptides overlapping sequences hr<NUMBER> hr<NUMBER> regions table <NUMBER> figure <NUMBER> peptides range <NUMBER> <NUMBER> aminoacid residues length table <NUMBER> molecular masses isolated peptides np<NUMBER> cp<NUMBER> np<NUMBER>cp<NUMBER> complex measured sedimentation equilibrium ph <NUMBER>Â·<NUMBER> np<NUMBER> npeptides random coil structure solution np<NUMBER> mixed cp<NUMBER> equimolar concentrations â£helicity increased figure <NUMBER> however â£helicity change np<NUMBER> mixed cp<NUMBER> cp<NUMBER> mixed peptides hr<NUMBER> findings suggest np<NUMBER> cp<NUMBER> associate form complex â£helical conformation helical complex relatively stable phosphate buffer tm <NUMBER>Â°c figure <NUMBER> gp<NUMBER> cpeptides interacts site hr<NUMBER> region interferes conformational change spike protein viral fusion process identify cp<NUMBER> binding site hr<NUMBER> immobilised biotinylated cp<NUMBER> streptavidin sensor chips searched cp<NUMBER>binding peptides hr<NUMBER> region determined surface plasmon resonance biacore cp<NUMBER> strongly bound np<NUMBER> high binding affinity kinetic dissociation constant <NUMBER>Â·<NUMBER>Ï«<NUMBER> <NUMBER> moll figure <NUMBER> whereas peptides derived hr<NUMBER> region low binding activity cp<NUMBER> data shown cp<NUMBER> tenresidue shift towards cterminus cp<NUMBER> figure <NUMBER> table <NUMBER> bind np<NUMBER> suggests nterminal residues cp<NUMBER> important interaction np<NUMBER> cp<NUMBER> cterminal residues cp<NUMBER> interfere binding np<NUMBER> cp<NUMBER> circulardichroism spectroscopic analysis showed peptide cp<NUMBER> low content â£helicity minima <NUMBER> nm <NUMBER> nm phosphate buffer previously shown npage hiv<NUMBER> gp<NUMBER> peptides n<NUMBER> c<NUMBER> interact form sixhelix bundle <NUMBER> similar approach investigated whether cp<NUMBER> also forms oligomeric complex peptides derived hr<NUMBER> region exception np<NUMBER> npeptides showed bands gel figure <NUMBER> carried net positive charges native electrophoresis conditions table <NUMBER> could therefore migrated gel np<NUMBER> migrate gel net zero charge showed two bands perhaps differing conformations peptide cp<NUMBER> showed band lower part gel mixture np<NUMBER> cp<NUMBER> showed two bands lower one position isolated cp<NUMBER> upper one expected higher order oligomeric complex formed np<NUMBER> cp<NUMBER> confirm whether band indeed represents complex formed np<NUMBER> cp<NUMBER> analysed mixture np<NUMBER> biotinylated cp<NUMBER> different ratios npage two gels one stained coomassie blue figure <NUMBER> middle gel peptides complex another gel transferred nitrocellulose membrane stained streptavidinconjugated horseradish peroxidase substrate figure <NUMBER> lower gel increasing concentrations np<NUMBER> intensity upper bands increased lower bands decreased suggests formation upper band depends concentration np<NUMBER> confirms band represent aggregates cp<NUMBER> since migration speed molecule complex npage depends size net charge molecule complex method cannot used measure exactly molecular mass np<NUMBER>cp<NUMBER> complex gel find whether lower band cp<NUMBER> monomer oligomer therefore analysed apparent molecular masses peptides np<NUMBER> cp<NUMBER> np<NUMBER>cp<NUMBER> complex sedimentation equilibration successfully used find mass sixhelix bundle formed hiv<NUMBER> gp<NUMBER> npeptides cpeptides <NUMBER> isolated np<NUMBER> monomer molecular mass obtained cp<NUMBER> corresponded trimer phosphatebuffered saline table <NUMBER> hplcpurified mixture np<NUMBER> cp<NUMBER> showed complex molecular mass <NUMBER> <NUMBER> da figure <NUMBER> close calculated molecular mass trimer dimers results confirmed sehplc np<NUMBER> showed single peak monomer cp<NUMBER> major peak corresponding trimer whereas mixture np<NUMBER> cp<NUMBER> showed three peaks corresponding np<NUMBER> monomer cp<NUMBER> trimer np<NUMBER>cp<NUMBER> trimer heterodimer hexamer figure <NUMBER> findings suggest np<NUMBER> monomeric structure cp<NUMBER> trimeric conformation phosphatebuffered saline mixed equimolar concentration interact form sixhelix bundle consisting three molecules np<NUMBER> three cp<NUMBER> notion consistent biophysical properties hiv<NUMBER> gp<NUMBER> npeptides cpeptides shown sedimentation equilibration sehplc <NUMBER> <NUMBER> <NUMBER> alignments np<NUMBER> cp<NUMBER> peptides corresponding hiv<NUMBER> gp<NUMBER> npeptides cpeptides revealed reasonable sequence similarities gave us confidence homology model np<NUMBER> cp<NUMBER> association could built basis xray crystal structure hiv<NUMBER> gp<NUMBER> core formed gp<NUMBER> npeptides cpeptides <NUMBER> <NUMBER> np<NUMBER> showed typical coiledcoil structure figure <NUMBER> cp<NUMBER> â£helical conformation exception kink middle structure structure possible complex two peptides investigated use specialised proteindocking software <NUMBER> residues positions np<NUMBER> cp<NUMBER> hydrophobic complex structure formed docking technique also shows hydrophobic interactions two peptides eg l<NUMBER> i<NUMBER> f<NUMBER> i<NUMBER> i<NUMBER> np<NUMBER> interact well l<NUMBER> v<NUMBER> l<NUMBER> i<NUMBER> i<NUMBER> cp<NUMBER> respectively owing lack crystal coordinates sequence beyond nterminus hiv<NUMBER> gp<NUMBER> peptide c<NUMBER> <NUMBER> corresponding nterminal sequence residues <NUMBER> cp<NUMBER> could modelled interaction corresponding region cterminus np<NUMBER> could predicted discovery peptidic hiv<NUMBER> fusion inhibitors <NUMBER> <NUMBER> <NUMBER> elucidation mechanism action <NUMBER> <NUMBER> <NUMBER> provided important information explain fusogenic mechanism hiv<NUMBER> enveloped viruses <NUMBER> antisarscov peptide cp<NUMBER> peptides derived hr regions spike protein used probes investigate roles hr<NUMBER> hr<NUMBER> regions process sarscov entry target cells biophysical studies showed peptides derived regions sarscov spike proteins similar properties derived hiv<NUMBER> gp<NUMBER> hr<NUMBER> hr<NUMBER> regions respectively example like hiv<NUMBER> gp<NUMBER> npeptides cpeptides np<NUMBER> cp<NUMBER> sarscov interact form highorder oligomeric helices may important roles fusion sarscov target cells basis results study knowledge hiv<NUMBER> gp<NUMBER> viral transmembrane proteins <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> propose model elucidate fusogenic mechanism mediated sarscov spike protein mechanism cp<NUMBER> inhibits sarscov infection figure <NUMBER> native state spike proteins virus surface could oligomeric form selfassociation partly helical hr<NUMBER> regions form stems spikes sarscov hr<NUMBER> regions may random coil conformation covered s<NUMBER> domain binding s<NUMBER> domain receptor eg angiotensinconverting enzyme <NUMBER> <NUMBER> target cell receptorbinding state s<NUMBER> domain changes conformation forming â£helices extending inserting inert fusion peptide targetcell membrane exposing hr<NUMBER> hr<NUMBER> regions intermediate prehairpin state hr<NUMBER>s form trimer hr<NUMBER> trimer dissociates monomers subsequently hr<NUMBER> monomers pack onto grooves hr<NUMBER> trimer form sixhelix bundle fusionactive core structure brings viral targetcell membranes close proximity resulting fusion membranes formation fusion pores allow virus genome enter target cell cpeptide cp<NUMBER> present intermediate state could bind hr<NUMBER> region block hexamer formation thereby inhibiting fusion however direct evidence needed validate model nevertheless information obtained coronaviruses provide indirect evidence support hypothesis luo colleagues <NUMBER> shown spike protein murine hepatitis virus like hiv<NUMBER> gp<NUMBER> <NUMBER> <NUMBER> contains hr<NUMBER> hr<NUMBER> regions may important roles spikeproteinmediated cellcell fusion virus entry double alanine substitutions four middle heptadic leucine isoleucine residues within hr<NUMBER> region lead significant reduction fusion activity defects spike oligomerisation bosch coworkers <NUMBER> reported structural functional characterisation fusion core complex formed hr<NUMBER> hr<NUMBER> regions murine hepatitis virus spike protein although group worked independently distinct coronaviruses different approaches obtained surprisingly similar results first peptides derived hr<NUMBER> region hr<NUMBER> region antiviral activity second hr<NUMBER> peptides derived murine hepatitis virus sarscov spike proteins antiviral activity micromolar range third fragments involving interaction hr<NUMBER> hr<NUMBER> spike proteins viruses located regions findings suggest murine hepatitis virus sarscov common fusogenic mechanism may shared coronaviruses peptides derived hr<NUMBER> regions sarscov murine hepatitis virus spike proteins much less potent inhibitory activity hiv<NUMBER> gp<NUMBER> cpeptides eg c<NUMBER> t<NUMBER> activity nanomolar range <NUMBER> <NUMBER> sarscov murine hepatitis virus may therefore fusogenic mechanism different hiv<NUMBER> however peptides derived hr<NUMBER> regions many enveloped viruses including ebola virus <NUMBER> newcastle disease virus <NUMBER> parainfluenza virus <NUMBER> respiratory syncytial virus <NUMBER> inhibit corresponding virus infection also micromolar range viruses similar fusogenic mechanisms hiv<NUMBER> <NUMBER> two major factors affect potency fusioninhibitory peptide sensitivity virus corresponding antiviral peptides sequence conformation inhibitory peptide sensitivity hiv<NUMBER> fusioninhibitory peptide t<NUMBER> correlates fusion kinetics envelopecoreceptor affinity receptor density <NUMBER> figure <NUMBER> illustration conformational changes sarscov spike protein process fusion virus targetcell membranes insights viral fusogenic mechanism gained studies peptidic hiv<NUMBER> fusion inhibitors sarscov spike glycoprotein contains heptad repeat <NUMBER> <NUMBER> hr<NUMBER> hr<NUMBER> sequences similar hiv<NUMBER> envelope glycoprotein gp<NUMBER> similarity might help elucidate mechanism sarscov enters target cells thus could implications treatment paper assesses ability synthesised peptides derived sarscov hr<NUMBER> hr<NUMBER> regions inhibit cytopathic effect tissue culture investigates interactions hr<NUMBER> hr<NUMBER> peptides cp<NUMBER> peptide derived hr<NUMBER> region strong inhibitory activity tissue culture cp<NUMBER> np<NUMBER> peptide derived hr<NUMBER> region interacted form sixhelix structure similar fusogenic core structure hiv<NUMBER> gp<NUMBER> findings confirm carboxyl terminal portion spike glycoprotein sarscov type <NUMBER> fusion glycoprotein possible fusogenic mechanism involves cp<NUMBER> binding hr<NUMBER> region thereby interfering conformational changes lead fusion viral targetcell membranes lancet â¢ vol <NUMBER> â¢ march <NUMBER> <NUMBER> â¢ wwwthelancetcom viruses might different sensitivity corresponding inhibitory peptides antiviral activity peptidic fusion inhibitors depends optimum peptide sequences conformations changes sequences conformations could substantially affect antiviral activity stability complexes form <NUMBER> <NUMBER> <NUMBER> however optimisation peptide sequence conformation could improve antiviral activity therefore cp<NUMBER> used lead designing potent antisarscov peptides drug development use peptides treatment sars better application antihiv peptides chemotherapy aids doses needed treat individual acute sarscov infection chronic sars reported whereas hivinfected individual might use t<NUMBER> one expensive antihiv drugs life furthermore antisarscov peptides might also used prophylactically nasal spray inhalation formulations protect atrisk populations working travelling sarsendemic areas peptides derived hr<NUMBER> hr<NUMBER> regions sarscov spike protein could used establish highthroughput assays screening nonpeptidic sarscov fusion inhibitors successfully developed several assays hiv<NUMBER> gp<NUMBER> npeptides cpeptides identification smallmolecule hiv<NUMBER> fusion inhibitors <NUMBER> <NUMBER> <NUMBER> compounds block hr<NUMBER>hr<NUMBER> interaction could used leads development virus fusion inhibitors contributors jiang planned directed executed project liu carried npage circular dichroism sehplc analysis g xiao virus inhibition assay liu g xiao made equal contributions chen h xiong carried surface plasmon resonance analysis coordinated study j niu j farmar synthesised peptides c r escalante carried sedimentation equilibration analysis k debnath molecular modelling docking study p tien supervised virus inhibition assay sarscov<NUMBER> cause covid<NUMBER> pandemic swept across globe reminded like live rampant infectious disease without effective drugs vaccines researchers piled quest provide rational designs structural biology community exception structures sarscov<NUMBER> proteins emerging unprecedented speed one main focuses viral spike glycoprotein binds receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> allowing virus entry discuss recent papers structural characterization spike highlight might guide structurebased approaches develop effective spikebased vaccine coronavirus spikes trimeric molecules present receptorbinding domains rbds distal tips rbds recognize receptors allowing virus enter cells entry spike undergoes large conformational rearrangement prefusion postfusion state driving viral fusion cell membrane coronavirus spikes structurally characterized particular sarscov merscov two related viruses caused epidemics respiratory disease crucial question whether sarscov<NUMBER> resembled either related viruses would exciting news years study viruses could applied quest sarscov<NUMBER> vaccine using cryoelectron microscopy number studies including walls et al <NUMBER> determined reviewed ref <NUMBER> suggest effective neutralizing responses due antibodies target small domain ensuring induce best antibodies also reduces risk producing dangerous antibodies help virus entry antibodydependent enhancement whether future holds stabilized spikes rbds new spike structures revealed knowledge sarscov also applicable sarscov<NUMBER> good news must hope quest design rational vaccines based knowledge quickly realized structural studies research community work together fight global pandemic oxford uk â email underthelensbiochoxacuk structures spike resembled closely structure sarscov spike seen coronaviruses two conformations visualizeda closed state rbds docked trimeric core open conformation single rbd raised position <NUMBER> studies also showed like sarscov sarscov<NUMBER> uses ace<NUMBER> human cell entry <NUMBER> crystal structure soon followed showing rbd binds ace<NUMBER> ref <NUMBER> shortly first structure neutralizing antibody bound rbd spike glycoprotein showed sarscovreactive antibodies could neutralize new virus <NUMBER> polyclonal antibody sera sarscov also proved effective <NUMBER> many ways structural studies showed new virus resembles virus causes sars true sarscov<NUMBER> mean design vaccine two spikebased vaccinedesign strategies developed sarscov applicable first approach relies stabilization spike generate effective neutralizing antibody responses vaccinated individuals generate antibodies prefusion spike thus preventing ace<NUMBER> binding cell entry reason structureguided mutations designed fix sarscov spike prefusion state <NUMBER> stabilized sarscov<NUMBER> spikes designed using method therefore promising vaccine need whole spike second approach design vaccine contains rbd number studies spike beat covid<NUMBER> nature reviews ic robiology coronaviruses covs group enveloped positivestranded rna viruses cause respiratory intestinal central nervous system infections humans animals <NUMBER> last year six strains coronaviruses able infect humans identified <NUMBER> <NUMBER> among four human coronaviruses including hcovoc<NUMBER> hcov<NUMBER>e hcovnl<NUMBER> hcovhku<NUMBER> highly pathogenic cause mild respiratory diseases <NUMBER> however two coronaviruses severe acute respiratory syndrome coronavirus sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> caused two largescale pandemics resulted <NUMBER> cases including nearly <NUMBER> related deaths <NUMBER> cases including <NUMBER> related deaths respectively outbreaks sarscov merscov showed coronaviruses highlypathogenic viruses transmit humans animals <NUMBER> therefore urgent develop antiviral treatments vaccines targeting highrisk coronaviruses like sarscov merscov efficient antiviral drugs vaccines developed sarscov merscov another outbreak pneumonia caused new coronavirus <NUMBER>ncov emerged wuhan since december <NUMBER> february <NUMBER> <NUMBER> <NUMBER>ncov caused <NUMBER> cases china nearly <NUMBER> cases around world <NUMBER> related deaths <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> fulllength genome sequence <NUMBER>ncov soon determined zhang group <NUMBER> revealed <NUMBER>ncov probable bat origin <NUMBER> identical wholegenome level bat sarslike coronavirus <NUMBER> addition <NUMBER>ncov also closely related sarslike coronaviruses shares <NUMBER> sequence identify sarscov <NUMBER> encoded proteins like coronavirus main proteinase <NUMBER>clpro papainlike protease plpro rnadependent rna polymerase rdrp sequence identity even higher high <NUMBER> <NUMBER>ncov sarscov <NUMBER> therefore thought <NUMBER>ncov would function similar way sarscov humaninfection pathogenic mechanism <NUMBER> <NUMBER> <NUMBER> coronaviruses uses surface spike glycoprotein envelope attach host cells mediate host cell membrane viral membrane fusion infection <NUMBER> spike protein includes two regions s<NUMBER> s<NUMBER> s<NUMBER> host cell receptor binding s<NUMBER> membrane fusion s<NUMBER> region also includes nterminal domain ntd three cterminal domains ctd<NUMBER> ctd<NUMBER> ctd<NUMBER> <NUMBER> sarscov receptor binding domain rbd located ctd<NUMBER> s<NUMBER> region sarscov attaches human host cells binding rbd protein angiotensinconverting enzyme ii ace<NUMBER> <NUMBER> therefore interaction rbd ace<NUMBER> prerequisite human infection sarscov given high homology sarscov <NUMBER>ncov expected <NUMBER>ncov would also use ace<NUMBER> molecule receptor entry human cells <NUMBER> hypothesis experimentally confirmed virus infectivity studies shi group <NUMBER>ncov able use ace<NUMBER> proteins humans chinese horseshoe bats civet entry receptor ace<NUMBER>expressing cells cells without ace<NUMBER> <NUMBER> xu et al used moe calculate binding free energies rbd spike protein human ace<NUMBER> showing binding free energy <NUMBER>ncov human ace<NUMBER> â<NUMBER> kcalmol whereas sarscov human ace<NUMBER> â<NUMBER> kcalmol <NUMBER> recently cryoem structure <NUMBER>ncov spike protein prefusion conformation determined <NUMBER> biophysical structural evidence suggested <NUMBER>ncov binds ace<NUMBER> higher affinity sarscov <NUMBER> although seems clear <NUMBER>ncov infects human cells binding rbd domain human ace<NUMBER> receptor <NUMBER> <NUMBER> <NUMBER> <NUMBER> molecular mechanism binding rbd protein ace<NUMBER> receptor still unknown many questions remain answered example previous studies showed binding affinity <NUMBER>ncov human ace<NUMBER> weaker sarscov human ace<NUMBER> <NUMBER> however reality <NUMBER>ncov resulted many cases seems infectious sarscov study extensively investigated spike proteinhuman ace<NUMBER> protein systems <NUMBER>ncov sarscov using proteinprotein docking molecular dynamics md simulations specifically extensively studied free energies dynamics rbdace<NUMBER> binding spike protein free rbd systems given spike protein potential drug target also virus antigen present study beneficial drug design vaccine development disease prevention <NUMBER>ncov study investigated rbdace<NUMBER> complex spike protein free rbd systems sarscov genbank id np <NUMBER> <NUMBER>ncov genbank id mn<NUMBER> sarscov rbdace<NUMBER> complex structure directly downloaded protein data bank pdb entry <NUMBER>sci <NUMBER> water molecules removed complex structure free rbd structure obtained removing ace<NUMBER> protein rbdace<NUMBER> complex structure trimeric spike protein sarscov also downloaded pdb pdb entry <NUMBER>acd <NUMBER> <NUMBER>ncov three dimensional <NUMBER>d rbd structure modeled based rbd structure sarscov using modeller program <NUMBER> sequence alignment performed using clustalw program <NUMBER> <NUMBER> complex structure <NUMBER>ncov rbd protein human ace<NUMBER> predicted proteinprotein docking approach <NUMBER> <NUMBER> <NUMBER> <NUMBER>d structure trimeric spike protein <NUMBER>ncov constructed based structure sarscov spike protein using modeller complex structure <NUMBER>ncov rbd protein human ace<NUMBER> molecule predicted using hybrid proteinprotein docking algorithm hdock <NUMBER> <NUMBER> <NUMBER> <NUMBER> specifically given individual structures spike rbd protein human ace<NUMBER> molecule hdock globally sample possible binding modes two proteins fast fourier transform fft search strategy <NUMBER> sampled binding modes evaluated iterative knowledgebased scoring function <NUMBER> last binding modes ranked according binding energy scores top ten binding modes provided users docking calculation default parameters used namely grid spacing set <NUMBER>Ã¥ <NUMBER>d translational search angle interval set <NUMBER> â¢ rotational sampling <NUMBER>d euler space binding interface information pdb automatically applied modeling individual structures web server version hdock algorithm freely accessed web site httphdockphyshusteducn <NUMBER> amber suite used md simulations <NUMBER> simulations missing residues middle chain added using modeller <NUMBER> simulations ff<NUMBER>sb force field selected <NUMBER> explicit solvent model used time step set <NUMBER> fs langevin dynamics used temperature control program pmemdcuda used simulation engine simulations performed gpu compute node <NUMBER> specifically system following four stages md simulations performed production simulation <NUMBER> <NUMBER>step simulation first run minimize solvated protein system weakly restraints backbone atoms <NUMBER> system heated <NUMBER>k <NUMBER>step ie <NUMBER>ps simulation weakly restraints backbone atoms <NUMBER> next another <NUMBER>step ie <NUMBER>ps constant pressure simulation conducted equilibrating density system <NUMBER> k <NUMBER> system equilibrated <NUMBER>step ie <NUMBER>ps constant pressure simulation <NUMBER>k finally two <NUMBER>step production simulations run record trajectories system <NUMBER>k coordinates written every <NUMBER> steps ie <NUMBER>ps resulting total <NUMBER>ns simulation <NUMBER> recorded trajectories simulations mmpbsapy used calculate free energies systems using mmgbsa model <NUMBER> cpptraj used analyze coordinate trajectories <NUMBER> rbd proteins <NUMBER>ncov sarscov exhibit high sequence similarity <NUMBER> sequence identity <NUMBER> high homology resulted accurate <NUMBER>d rbd model <NUMBER>ncov small rmsd <NUMBER>Ã¥ experimental sarscov rbd structure experimental human ace<NUMBER> structure <NUMBER>ncov rbd model performed proteinprotein docking predict binding mode using hdock approach <NUMBER> <NUMBER> <NUMBER> figure <NUMBER>a shows predicted complex structure human ace<NUMBER> molecule <NUMBER>ncov rbd protein seen figure predicted rbdace<NUMBER> complex structure <NUMBER>ncov close experimentally determined rbdace<NUMBER> complex structure sarscov interface rootmeansquaredeviation rmsd two complexes <NUMBER>Ã¥ showing rbds <NUMBER>ncov sarscov bind site human ace<NUMBER> receptor figure <NUMBER>a results also understood comparing residues rbdace<NUMBER> binding interface <NUMBER>ncov sarscov binding sites rbd proteins <NUMBER>ncov sarscov conserved corresponding residues show high sequence similarity <NUMBER> figures <NUMBER>b c among hydrophobic residues important proteinprotein interactions especially conserved rbd <NUMBER>ncov <NUMBER> hydrophobic residues binding site comparable <NUMBER> hydrophobic residues sarscov figure <NUMBER>b run longtime md simulation generate trajectories rbdace<NUMBER> complex system <NUMBER>ncov sarscov binding free energies calculated using mmgbsa model mmpbsapy script amber package table <NUMBER> shows comparison rbdace<NUMBER> binding free energies <NUMBER>ncov sarscov seen table binding free energy rbdace<NUMBER> interaction <NUMBER>ncov â<NUMBER> kcalmol significantly lower binding free energy rbdace<NUMBER> interaction sarscov â<NUMBER> kcalmol words <NUMBER>ncov binds human ace<NUMBER> significantly higher affinity sarscov result consistent current fact <NUMBER>cov much infectious sarscov recently experimental studies also showed <NUMBER>cov could bind human ace<NUMBER> higher affinity sarscov <NUMBER> examination binding free energy contributions reveals higher binding affinity <NUMBER>ncov sarscov mostly attributed solvation energy contribution âg solv <NUMBER> vs <NUMBER> kcalmol whereas <NUMBER>ncov higher binding free energy vacuum âg gas sarscov <NUMBER> vs <NUMBER> words <NUMBER>ncov tends bind human ace<NUMBER> better sarscov water sarscov would bind human ace<NUMBER> better <NUMBER>ncov gas investigation needed confirm binding differences spike protein coronavirus envelope trimeric protein protein critical vitality coronaviruses important component virus particle also plays crucial role attaching host cells fusing membranes <NUMBER> addition spike protein also determines solubility coronavirus particles thus viral infectivity spike protein largest protein located membrane surface therefore spike protein directly related stability functionality coronaviuses run lengthy md simulation study trimeric spike proteins <NUMBER>ncov sarscov table <NUMBER> gives comparison free energies spike proteins <NUMBER>ncov sarscov seen table spike protein <NUMBER>ncov significantly lower total free energy g total â<NUMBER> kcalmol spike protein sarscov g total â<NUMBER> kcalmol table <NUMBER> results suggest <NUMBER>ncov stable survive significantly higher temperature sarscov may also partly explain higher infectivity <NUMBER>ncov sarscov <NUMBER>ncov would higher virus vitality sarscov temperature lower free energy <NUMBER>ncov spike protein may result virus evolution sarscov sarslike coronaviruses normally originate bats known higher body temperature humans words <NUMBER>ncov sarslike coronavirus would evolved achieve lower free energy spike proteins recombination mutations survive hightemperature animals like bats <NUMBER> addition free energy decomposition also shows lower free energy <NUMBER>ncov spike protein sars table <NUMBER> may reflect evolution trend sarslike coronaviruses ie favoring internal interactions residues instead solvation energy kind evolution would also beneficial kinds coronaviruses would robust able survive air solvent coronaviruses uses spike protein attach host cells binding host cell receptor therefore receptor binding domain rbd spike protein critical coronaviruses infect host cells run lengthy md simulations investigate structural properties rbd proteins <NUMBER>ncov sarscov table <NUMBER> shows comparison free energies rbd proteins <NUMBER>ncov sarscov similar findings spike protein detailed last section table <NUMBER> rbd protein <NUMBER>ncov also shows significantly lower free energy sarscov <NUMBER> vs <NUMBER> kcalmol table <NUMBER> may also understood evolution pressure hightemperature host environment however unlike spike protein free energy difference <NUMBER>ncov sarscov mostly attributed interresidue interactions vacuum g gas rbd protein free energy difference <NUMBER>ncov sarscov comes free energy vacuum g gas <NUMBER> vs <NUMBER> kcalmol solvation energy g solv <NUMBER> vs <NUMBER> <NUMBER> kcalmol table <NUMBER> lower solvation energy <NUMBER>ncov sarscov rbd may understood rbd must move away spike protein water order bind human ace<NUMBER> <NUMBER> words <NUMBER>ncov would evolved soluble move bind ace<NUMBER> easily better solubility rbd <NUMBER>ncov sarscov may also contribute part higher infectivity <NUMBER>ncov sarscov protein flexibility critical factor binding may change binding interface two proteins also important contribution entropy penalty upon binding figure <NUMBER>a means <NUMBER>ncov must overcome much entropy penalty sarscov binding human ace<NUMBER> know binding free energy two proteins expressed âg âe â âs âe interaction energy âs entropy temperature system âs negative binding free energy become higher binding become weaker increasing temperature therefore rbdace<NUMBER> binding affinity <NUMBER>ncov expected decrease much faster sarscov temperature increases words <NUMBER>ncov much temperaturesensitive sarscov namely <NUMBER>ncov decrease infection ability much faster sarscov temperature rises therefore expected <NUMBER>ncov become less infectious compared sarscov disease prevention control <NUMBER>ncov get easier weather gets warmerhotter although drug vaccine development targeting rbd protein challenging protein flexibility binding site study extensively studied rbdace<NUMBER> complex spike protein free rbd protein systems <NUMBER>ncov sarscov proteinprotein docking md simulations found <NUMBER>ncov higher binding affinity human ace<NUMBER> sarscov explaining fact <NUMBER>cov much infectious sarscov spike protein <NUMBER>ncov also shows lower free energy sarscov suggesting <NUMBER>ncov stable may able survive higher temperature sarscov may also explain bat origin <NUMBER>ncov bats higher bodytemperature humans addition rbd <NUMBER>ncov exhibits significantly higher flexibility sarscov especially near binding site indicates <NUMBER>ncov must overcome higher entropy penalty order bind ace<NUMBER> thus temperaturesensitive sarscov therefore rising temperature <NUMBER>ncov expected decrease infection ability much faster become much less infectious sarscov would make disease prevention control <NUMBER>ncov easier taking results together unlike sarscov gone <NUMBER> <NUMBER>ncov might survive hightemperature environment like summer virus activeinfectious due high flexibility rbd become infectious temperature low winter findings farreaching implication disease prevention control well drug vaccine development <NUMBER>ncov emergence highly pathogenic novel coronavirus <NUMBER> sarscov <NUMBER> became pandemic posed global health emergency coronaviridae family viruses mostly hosted animals found pathogenic humans though viruses pathogenic humans caused mild moderate symptoms lu et al <NUMBER> however severe acute respiratory syndrome sars <NUMBER> mers middle east respiratory syndrome <NUMBER> caused sarscov cov infected larger populations showed significant fatalities december <NUMBER> another betacoronavirus identified group people admitted severe pneumonia symptoms wuhan china named sarscov <NUMBER> ncov lu et al <NUMBER> muralidharan et al <NUMBER> peeri et al <NUMBER> umesh et al <NUMBER> wahedi et al <NUMBER> short span time infection rate increased <NUMBER> million people infected <NUMBER> million deaths <NUMBER> th may <NUMBER> throughout world <NUMBER> continuing many countries adopted social distancing lock precautions decrease rate ncovid<NUMBER> infections human human lack vaccines targeted therapies aanouz et al <NUMBER> elfiky <NUMBER>a kumar et al <NUMBER> phylogenetic analysis states sarscov <NUMBER> ncov closely related bat derived coronavirus batslcovzc<NUMBER> batslcovzxc<NUMBER> han et al <NUMBER> lan et al <NUMBER> lu et al <NUMBER> known different coronaviruses start infection binding spike glycoprotein subunit specific receptors human cells instance merscov binds cd<NUMBER> nterminal end sarscov spike protein receptor binding domain rbd binds angiotensin converting enzyme <NUMBER> ace<NUMBER> receptors abdelli et al <NUMBER> alkhafaji et al <NUMBER> hasan et al <NUMBER> khan jha et al <NUMBER> lan et al <NUMBER> peeri et al <NUMBER> yan et al <NUMBER> ace<NUMBER> interaction promotes spike protein subunit s<NUMBER> membrane perfusion dissociation receptor binding domain rbd subunit s<NUMBER> interaction ace<NUMBER> boopathi et al <NUMBER> hasan et al <NUMBER> cov structure includes matrix protein mprotein small envelop protein eprotein gupta et al <NUMBER> spike glycoprotein nucleocapsid protein nprotein elfiky <NUMBER>b proteins like chymotrypsin elmezayen et al <NUMBER> papain like proteases joshi et al <NUMBER> khan zia et al <NUMBER> sarma et al <NUMBER> spike protein initiates binding host cell receptor system nprotein plays crucial role rna replication host cells enayatkhani et al <NUMBER> lobogalo et al <NUMBER> sarma et al <NUMBER> structural similarity sarscov ncov strengthens binding ncov spike protein ace<NUMBER> receptor possibilities adeoye et al <NUMBER> lan et al <NUMBER> however antibodies raised sarscov recovered people able neutralize ncovid<NUMBER> symptoms lan et al <NUMBER> signifies structural differences ncov cov recently published crystal structure pdb id <NUMBER>m<NUMBER>j elucidates structural interactions spike protein rbd ncov considering extended mutations present ncov sequence comes rbd sinha et al <NUMBER> shown ace<NUMBER> interacting residues present ncov spike protein rbd cov lan et al <NUMBER> pant et al <NUMBER> important understand hot spot amino acids interactions far interactions stable allowing membrane perfusion virus host cell current silico study focuses highlighting ace<NUMBER> spike protein rbd amino acid interactions strength hot spot amino acid interactions studied molecular dynamic simulations period <NUMBER> ns deviations fluctuations made ace<NUMBER>rbd complex along energies clarify understanding stability ncov spike protein rbd interaction ace<NUMBER> receptor comparison sarscov entire computational work performed using schrodinger suite applications employed present study mapping protein rbd sequences cov ncov performed using multiple sequence viewer tool prime application schrodinger suite crystal structures retrieved protein databank prepared using protein preparation wizard tool parameters used refining structure addition hydrogens creating disulphide bonds maintaining zero order bonds selenomethionines methionines conversion import process tab refine tab optimizing hydrogen bonds repair finally minimized structure force field opls<NUMBER> using superimposition tool maestro complexes cov ncovace<NUMBER> individual sprotein rbd cov ncov structurally superimposed rmsd root mean square deviations calculated jorgensen et al <NUMBER> sastry et al <NUMBER> molecular dynamic simulations mds complexes performed using desmond software initially complex imported system builder application desmond module default parameters like spc simple pointcharge solvent model orthorhombic periodic boundary box box size distances Ã¥ a<NUMBER> Ã¢ b<NUMBER> Ã¢ c<NUMBER> angles a<NUMBER> Ã¢ b<NUMBER> Ã¢ c<NUMBER> minimizing volume model system generated simulations continuing ions tab system builder application na Ã¾ ions added based total charge salt concentration <NUMBER> also added neutralize system second step simulations protocol minimization complex obtained system builder relaxed setting maximum iterations number <NUMBER> remaining parameters set default finally minimized complex subjected molecular dynamic simulations setting ensemble parameter npt isothermalisobaric ensemble number particles n pressure p temperature <NUMBER> k temperature <NUMBER> bar pressure simulation run time set <NUMBER> ns islam et al <NUMBER> relaxed using default relation protocol guo et al <NUMBER> veeramachaneni et al <NUMBER> protein binding analysis performed using protein interaction analysis application schrodinger suite spike protein sprotein sequence sarscov cov sarscov <NUMBER> ncov retrieved uniprot databank sequence ids p<NUMBER> p<NUMBER>dtc<NUMBER> respectively multiple sequence alignment performed using clustal omega web server emblebi services alignment results displayed <NUMBER> identity figure <NUMBER> sequences previous studies aydin et al <NUMBER> reported receptor binding domain rbd cov spike protein ranging <NUMBER> <NUMBER> specific residues <NUMBER> related binding motif played crucial role binding human ace<NUMBER> receptor viral admittance ncov residues aligned <NUMBER> <NUMBER> positions respectively spike protein rbd cov ncov shared <NUMBER> identity alignment displayed <NUMBER> mutations <NUMBER> residues found mutated spike protein rbd region ncov among <NUMBER> mutations related binding motif predicted crucial amino acids based correlation analysis done spike protein binding motif cov considering binding region major criterion cov ncov receptor binding domains analyzed structural changes resulting mutations continue structural analysis receptor binding regions reported pdb structures sarscov pdb id <NUMBER>sci sarsncov pdb id <NUMBER>m<NUMBER>j retrieved protein databank fchain sequences relates spike protein rbd virus achain represents ace<NUMBER> receptor prior analysis rbd sequences retrieved pdb cross validated corresponding full length uniprot sequences many structural modifications observed ncov rbd spike protein mutations occurred course time compared cov overview mutational changes secondary structure cov ncov spike protein receptor binding region aligned figure <NUMBER> cov majority spike protein rbd <NUMBER>d structure made loops <NUMBER> helices <NUMBER> sheets <NUMBER>d structure ncov spike protein rbd comprised <NUMBER> helices <NUMBER> sheets interconnecting loops figure <NUMBER> b lan et al <NUMBER> detailed information regarding residues involved helices sheets proteins tabulated table <NUMBER> major structural changes recorded seen residues ranging <NUMBER> <NUMBER> cov loop region corresponding residues ncov ie <NUMBER> framed two helices three sheets helix observed cov protein <NUMBER> absent corresponding ncov <NUMBER> residues residues sited loop region extra sheets ncov protein tyr <NUMBER>gln <NUMBER> cys <NUMBER>tyr <NUMBER> val <NUMBER>cys <NUMBER> absent cov residues shaped loops complex ace<NUMBER> receptor rbd cov ncov spike protein crystal structures retrieved prepared using protein preparation wizard application schrodinger suite series steps explained methodology part prepared complexes subjected protein interaction analysis application available suite investigate interactions occurring receptor spike protein rbd superimposition cov ncov without ace<NUMBER> receptor resulted <NUMBER> Ã¥ rmsd figure <NUMBER>c complex ace<NUMBER> receptor superimposed complexes displaying <NUMBER> Ã¥ deviations rmsd figure <NUMBER>a cov rbdace<NUMBER> complex maintained <NUMBER> hydrogen bonds <NUMBER> pipi interaction <NUMBER> salt bridge figure <NUMBER> b concurrently ncov spike protein rbdace<NUMBER> receptor complex displayed <NUMBER> hydrogen bonds <NUMBER> salt bridge figure <NUMBER>c interactions like hydrogen bond pipi stacking salt bridge made cov ncov spike protein ace<NUMBER> receptor reported along closest residues distance also solvent accessible surface area sasa table <NUMBER> complexes residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> virus rbd maintained hydrogen bond interaction profiles residues <NUMBER> <NUMBER> <NUMBER> ace<NUMBER> receptor respectively primemmgbsa based bindingfree energy calculated considering ncov cov ligands ace<NUMBER> receptor bindingfree energies calculated Ã <NUMBER> kcalmol ncov Ã <NUMBER> kcalmol cov comparing two complexes binding interaction profiles ncov found binding rigidly ace<NUMBER> receptor cov number h bonds binding free energy calculations also found inline supporting interaction analysis results confirming ncov binding stringency human ace<NUMBER> receptor compared cov molecular dynamic simulation analysis ace<NUMBER>cov sprotein rbd ace<NUMBER>ncov sprotein rbd deviations graph ace<NUMBER> receptor cov sprotein rbd b rmsd graphs ace<NUMBER> receptor ncov sprotein rbd c rmsf graph ace<NUMBER> receptor cov sprotein rbd ace<NUMBER> receptor ncov sprotein rbd residues fluctuation graph crystal structures subjected molecular dynamic simulation studies period <NUMBER> ns understand stability complexes hydrogen bond interactions rootmeansquare deviation rmsd rootmeansquare fluctuation rmsf made cov ncov ace<NUMBER> receptor complex state binding profiles analyzed average total energy potential energy complexes also calculated evaluate rigidity complexes using trajectories complex deviations made two spike proteins reported individually deviations made ace<NUMBER> receptor spike protein rbd cov complex <NUMBER>sci displayed figure <NUMBER>a initial simulation period <NUMBER> ns ace<NUMBER> receptor deviations found inclined state thereafter protein maintained stable deviations till end simulation run time <NUMBER> ns deviation range <NUMBER> <NUMBER> Ã¥ majority deviations around <NUMBER> Ã¥ spike protein rbd inclined deviations observed throughout simulation run time deviations range <NUMBER> Ã¥ ace<NUMBER> ncov spike protein rbd complex <NUMBER>m<NUMBER>j ace<NUMBER> receptor made deviations <NUMBER> <NUMBER> Ã¥ majority deviations maintained around <NUMBER> Ã¥ <NUMBER> ns simulation run time steady state deviations small fluxes observed till end <NUMBER> ns figure <NUMBER>b based acceptable deviation range ie <NUMBER> Ã¥ deviations made ace<NUMBER> receptor reflects stability receptor complex form deviations made ncov spike protein rbd low raging <NUMBER> <NUMBER> Ã¥ stability deviations figure <NUMBER> hydrogen bond energies reported ace<NUMBER>cov sprotein rbd <NUMBER>sci ace<NUMBER>ncov sprotein rbd <NUMBER>m<NUMBER>j simulations hydrogen bonds graph maintained receptor protein simulation run b ace<NUMBER> receptor sprotein rbd ncov complex hydrogen bonds graph simulations studies c average energy potential energies graph ace<NUMBER>cov sprotein rbd complex average energy potential energies graph ace<NUMBER>ncov sprotein rbd complex attained <NUMBER> ns run time maintained pace till end simulation run comparing two complexes based rmsd results ace<NUMBER>ncov found stable compared ace<NUMBER>cov complex spike protein rbd cov ncov deviations difference <NUMBER> Ã¥ higher compared ace<NUMBER> receptor change around <NUMBER> Ã¥ receptor made deviations almost similar complexes difference deviations made cov ncov spike protein rbd could attributed mutations structural changes fluctuations made ace<NUMBER> receptor cov spike protein rbd depicted figure <NUMBER>c range ace<NUMBER> receptor residues fluctuation cov <NUMBER> <NUMBER> Ã¥ majority residues fluctuated <NUMBER> <NUMBER>Ã¥ interestingly residues ace<NUMBER> receptor complex ncov spike protein rbd also produced similar type fluctuation range ie <NUMBER> Ã¥ figure <NUMBER>d cov spike protein rbd showed fluctuations ranging <NUMBER> Ã¥ average fluctuations around <NUMBER> Ã¥ ncov spike protein rbd fluctuations reported <NUMBER> <NUMBER> Ã¥ majority residues fluctuated around <NUMBER> Ã¥ tail end residue fluctuations also observed expected conclusion considering fluctuations made spike protein rbd complexes ncov residues fluctuations range low leading stability rigidity complex using trajectories simulation event analysis number hydrogen bonds formed complexes simulation runs calculated ace<NUMBER>cov spike protein rbd complex pdb <NUMBER>sci hydrogen bond range <NUMBER> mean value average number hydrogen bonds <NUMBER> figure <NUMBER>a similarly ace<NUMBER>ncov spike protein rbd complex pdb <NUMBER>m<NUMBER>j range <NUMBER> mean value <NUMBER> figure <NUMBER>b using simulation quality analysis tool total potential energies two complexes calculated cov complex reported Ã <NUMBER> Ã <NUMBER> kcalmol total potential energy whereas ncov showed Ã <NUMBER> Ã <NUMBER> kcalmol respectively figure <NUMBER>c values state ncov complex stable compared cov complex justifying increase average number hydrogen bond main aim interaction profile study elucidate residues hotspots receptor table <NUMBER> list important residues identified ace<NUMBER> receptor hydrogen bond interactions sustained <NUMBER> ns simulation run time mds run time ns ace<NUMBER> receptor residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> glu <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tyr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> asp <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lys <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> glu <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lys <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> asp <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> gln <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> gln <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thr <NUMBER> <NUMBER> <NUMBER> <NUMBER> tyr <NUMBER> <NUMBER> <NUMBER> ser <NUMBER> <NUMBER> asp <NUMBER> <NUMBER> ala <NUMBER> table <NUMBER> identified important residues ncov sprotein rbd hydrogen bond interactions sustained <NUMBER> ns simulation run time mds run time ns ncov spike protein rbd residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> gln <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> gln <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> asn <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tyr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lys <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> thr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tyr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> asn <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tyr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ala <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> leu <NUMBER> <NUMBER> <NUMBER> <NUMBER> gly <NUMBER> <NUMBER> <NUMBER> <NUMBER> phe <NUMBER> <NUMBER> <NUMBER> gly <NUMBER> <NUMBER> <NUMBER> glu <NUMBER> <NUMBER> gly <NUMBER> <NUMBER> arg <NUMBER> tyr <NUMBER> protein interactions using trajectory file every <NUMBER> ns simulation run time interval poses considered binding analysis study total <NUMBER> frames retrieved residues involved hydrogen bond formation ace<NUMBER> receptor spike protein rbd ncov identified table <NUMBER> simulation run residues involved hydrogen bonding initial time intervals failed continue bond succeeding intervals later found retaining interactions end simulation simultaneously residues failed produce hydrogen bond initial time frames later found establishing continuing established hydrogen bond end simulation run based results <NUMBER> amino acids ncov spike protein <NUMBER> residues ace<NUMBER> receptor identified showing stable hydrogen bond formation table <NUMBER> hydrogen bonds characterized strong <NUMBER> Ã¥ moderate <NUMBER> Ã¥ weak <NUMBER> Ã¥ based distance donor acceptor jeffrey jeffrey <NUMBER> khan jha et al <NUMBER> based majority reported hydrogen bonds ace<NUMBER> receptor residues ncov spike protein rbd moderate category interaction percentage <NUMBER> correlating hydrogen bond sustainability selected <NUMBER> frames ace<NUMBER> receptor residues ncov spike protein rbd glu <NUMBER> <NUMBER> preserved hydrogen bond interaction selected frames tyr <NUMBER> asp <NUMBER> <NUMBER> three residues lys <NUMBER> glu <NUMBER> <NUMBER> <NUMBER> followed lys <NUMBER> asp <NUMBER> <NUMBER> gln <NUMBER> gln <NUMBER> <NUMBER> remaining five residues reported <NUMBER> hydrogen bond sustainability table <NUMBER> corresponding ncov amino acid residues involved hydrogen bonding receptor simulation studies also identified table <NUMBER> residue gln <NUMBER> showed <NUMBER> hydrogen bonding throughout simulation residues hydrogen bond interaction percentage gln <NUMBER> <NUMBER> asn <NUMBER> tyr <NUMBER> lys <NUMBER> <NUMBER> followed tyr <NUMBER> asn <NUMBER> tyr <NUMBER> ala <NUMBER> apart remaining nine residues reported <NUMBER> hydrogen bonding interaction percentage simulations hydrogen bonds ncov sprotein rbd ace<NUMBER> receptor residues intact throughout run time certain residues showed shift hydrogen bonds interestingly top listed residue gln <NUMBER> ncov sprotein glu <NUMBER> receptor maintained hydrogen throughout simulation addition gln <NUMBER> also maintained another hydrogen bond lys <NUMBER> receptor hence based observations gln <NUMBER> reported crucial residue ncov binding residue gln <NUMBER> seen maintaining overall <NUMBER> hydrogen bond interaction shared asp <NUMBER> <NUMBER> intervals shifted lys <NUMBER> <NUMBER> third residue ncov sprotein rbd asn <NUMBER> maintained <NUMBER> interaction profile tyr <NUMBER> simultaneously shift h bond also found among residues like lys <NUMBER> receptor forming hydrogen bonds phe <NUMBER> leu <NUMBER> glu <NUMBER> sprotein entire simulation period changes could attributed flexibility nature receptor sprotein course simulations run cov sprotein rbd residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previously reported hotspots several studies han et al <NUMBER> wan et al <NUMBER> present study comparing hotspots cov ncov stated hotspots cov replicated ncov among two residues asn <NUMBER>thr <NUMBER> cov found mutated gln <NUMBER>asn <NUMBER> ncov mutated animo acid residues found h bond interactions gln<NUMBER> <NUMBER> asn <NUMBER> simulations profoundly influenced binding sprotein rbd ace<NUMBER> receptor important hot spots identified ace<NUMBER> receptor ncov sprotein rbd simulation studies displayed figure <NUMBER> along hydrogen interactions hydrophobic interactions ncov sprotein rbd ace<NUMBER> receptor also analyzed time frames defined tina et al <NUMBER> based analysis leu <NUMBER> met <NUMBER> tyr <NUMBER> phe <NUMBER>of ace<NUMBER> receptor phe <NUMBER> tyr <NUMBER> ncov protein rbd found involved hydrophobic interactions conclusion study reports hotspot amino acid residues involved binding ncov spike protein rbd human ace<NUMBER> receptor overall mutations identified ncov spike protein receptor binding domain led structural changes additional sheets helices rbd structure facilitating h bond interactions ace<NUMBER> receptor spike protein hotspot residues interactions listed rmsd rmsf <NUMBER> ns simulation run confirms stability rigidity interactions energy calculations reiterate binding efficiency ncov comparison cov considering hotspot amino acid residues blockers could designed inhibiting binding ncov spike protein rbd human ace<NUMBER> receptor thereby stopping entry virus host cells pandemic covid<NUMBER> caused highly transmittable pathogen sarscov<NUMBER> infected millions people worldwide <NUMBER> <NUMBER> date infected <NUMBER> million people resulting <NUMBER> deaths varied incidence mortality rates across globe <NUMBER> usa european countries recorded large number infections associated higher mortality compared asian countries variations could due differences virulence pathogenicity viral strains host factors including genetic makeup sarscov<NUMBER> use spike glycoprotein host cells adhesion nterminal s<NUMBER>subunit interact receptor ace<NUMBER> also known sarscov<NUMBER> sprotein gets activated host proteases <NUMBER> <NUMBER> evidences also shown corona viruses proteins cleaved host cell proteases furin s<NUMBER>s<NUMBER> cleavage site exposing s<NUMBER> serine protease tmprss<NUMBER> activate fusion membranes viral entry <NUMBER> <NUMBER> however lack structural molecular studies concerning tmprss<NUMBER> interaction sprotein limits understanding key priming action tmprss<NUMBER> host cell entry sprotein great therapeutic implications aid whole exome sequencing discover report functionally relevant variants ace<NUMBER> tmprss<NUMBER> human genome contribute differences covid<NUMBER> infection rates employing structural mutation studies molecular dynamics show variant v<NUMBER>m decreased stability plausible role viral entry furthermore first time demonstrate structural interactions tmprss<NUMBER> s<NUMBER> subunit sarscov<NUMBER> spike protein also report structural interactions clinically approved protease inhibitors block tmprss<NUMBER> interaction s<NUMBER> subunit spike protein establish specificity precision study group recruited obtaining informed consent study protocol approved institutional ethics committee whole blood <NUMBER>ml collected <NUMBER> healthy individuals general population indian ethnicity whole exome data generated <NUMBER> individuals variants identified ace<NUMBER> tmprss<NUMBER> replicated <NUMBER> <NUMBER> individuals respectively shown supplementary fig s<NUMBER> study subjects considered healthy based selfreported disease normal bmi ultrasound laboratory parameters found clinically healthy analysis dna isolated whole blood complete exonic regions amplified sequenced next generation sequencer ion proton life technologies usa functionally relevant variants identified using polyphen sift scores genotypes interpreted using genome lab gexp software v<NUMBER> protocols conformed standard kit instructions methodology given supplementary information better understand structure tmprss<NUMBER> including position organization catalytic site substrate processing modelled monomer structure human tmprss<NUMBER> employing swissmodel itasser structure ensure residues placed ramachandran favored positions using coot wwwmrcimbcamuk validated model used previously published validated model structure full length sarscov<NUMBER> spike glycoprotein <NUMBER> molecular docking haddock <NUMBER> cluspro interaction studies performed activated form post furin cleavage sarscov<NUMBER> spike glycoprotein s<NUMBER> domain modelled validated tmprss<NUMBER> aa<NUMBER>aa<NUMBER> template structures binding free energies taken consideration selecting best possible models ensured residues occupied ramachandran favored positions using coot wwwmrcimbcamuk final model complex structure activated sarscov<NUMBER> spike glycoprotein homotrimer tmprss<NUMBER> visualized pymol tmprss<NUMBER> potent protease inhibitors chemostat upmoastat nafamostat bromhexine hydrochloride docked simulated individually molecular docking dynamics studies protein protease inhibitors prepared docking ensuring presence hydrogen atoms water molecules least <NUMBER> Ã¥ around binding site catalytic pocket using mastero package program <NUMBER> binding corroborated based solvent accessibility surface area sasa cscore confidence score zscore clash score jelly body refinement done ccp<NUMBER> program suite <NUMBER> coot wwwmrcimbcamuk ensure appropriate docking steric hindrance clashes side chain residues binding free energies taken consideration selecting best possible docked site whole exome sequencing next generation sequencer yielded <NUMBER> gb data <NUMBER> variants per sample across genome identified <NUMBER> variants ace<NUMBER> <NUMBER> tmprss<NUMBER> applying relevant filters fig <NUMBER> <NUMBER> variants rs<NUMBER> ace<NUMBER> rs<NUMBER> tmprss<NUMBER> genes replicated minor allele frequency tmprss<NUMBER> variant <NUMBER> ace<NUMBER> variant <NUMBER> compare allelic frequencies indians ethnicities sequenced flanking regions variants ace<NUMBER> tmprss<NUMBER> study subjects representative electropherogram tmprss<NUMBER> genotypes shown fig <NUMBER> genes whole exome sequencing data complete data first filtered quality minor allele frequency variants genes b representative electropherogram depicting three genotypes variant rs<NUMBER> tmprss<NUMBER> gene minor allele sequence forward strand reverse strands arrows indicate variant c genotype frequencies healthy individuals overall structure tmprss<NUMBER> aa<NUMBER>aa<NUMBER> fig <NUMBER>a measures <NUMBER> Ã¥ length <NUMBER> Ã¥ diameter comprising nterminal aa<NUMBER>aa<NUMBER> activation domain cterminal aa<NUMBER>aa<NUMBER> proteolytic catalytic domain mapped catalytic sitepocket tmprss<NUMBER> residues h<NUMBER> s<NUMBER> k<NUMBER> w<NUMBER> q<NUMBER> found highly conserved ttps type ii transmembrane serine proteases based available literature addressing serine protease target sites mapped two potential tmprss<NUMBER> binding sites sprotein t<NUMBER> aa<NUMBER> aa <NUMBER> t<NUMBER> aa <NUMBER> aa<NUMBER> located s<NUMBER> domain region fig <NUMBER> structure sproteins s<NUMBER> s<NUMBER> domains shown fig <NUMBER>b tmprss<NUMBER> variant rs<NUMBER> current epidemiological reports showing lower sarscov<NUMBER> infection rate indian ethnic background raises intriguing question correlation infection valine <NUMBER> wildtype protein v<NUMBER> located nterminal srcs domain scavenger receptor cysteine rich paired three antiparallel Î²sheets aa<NUMBER>aa<NUMBER> structurally replacement v<NUMBER>m accommodate met due topology charge limit fig <NUMBER>a performed molecular dynamics simulation studies know mutant protein characteristics found undergone structural deformation due complete shift motif fig<NUMBER>c corroborated overall increase bfactor stability factor tmprss<NUMBER> v<NUMBER>m mutation fig <NUMBER> e f observations reiterate v<NUMBER>m variant tmprss<NUMBER> decreases stability protein observed tmprss<NUMBER> potentially interacting t<NUMBER> t<NUMBER> sites s<NUMBER> domain spike glycoprotein overall complex structure shows tmprss<NUMBER> binds t<NUMBER> site sarscov<NUMBER> spike glycoprotein homotrimer adopts typical protease binding mode interacts higher affinity <NUMBER> kcal suggests bonafide tight interaction tmprss<NUMBER> protease spike glycoprotein active catalytic pocket tmprss<NUMBER> made residues q<NUMBER> h<NUMBER> e<NUMBER> k<NUMBER> p<NUMBER> k<NUMBER> k<NUMBER> e<NUMBER> k<NUMBER> l<NUMBER> s<NUMBER> q<NUMBER> w<NUMBER> residues h<NUMBER> s<NUMBER> k<NUMBER> q<NUMBER> highly conserved among several serine proteases tmprss<NUMBER> catalytic pocket cuplike architecture accommodates interacts linker region connecting Î±<NUMBER>Î±<NUMBER> Î±<NUMBER>Î±<NUMBER> s<NUMBER> domain spike protein fig <NUMBER>a <NUMBER>b respect tmprss<NUMBER> interaction t<NUMBER> site activated s<NUMBER> domain sarscov<NUMBER> spike glycoprotein extended wellexposed loop region g<NUMBER> n<NUMBER> adopts peptide binding mode tmprss<NUMBER> entire sshape loop region t<NUMBER> site k<NUMBER> i<NUMBER> s<NUMBER> domain pass canyonlike crevice cuplike structure tmprss<NUMBER> catalytic pocket fig <NUMBER>d among residues k<NUMBER> y<NUMBER> d<NUMBER> c<NUMBER> l<NUMBER> d<NUMBER> i<NUMBER> r<NUMBER> r<NUMBER> key interacting residues also well positioned towards catalytic pocket tmprss<NUMBER> fig <NUMBER> e explore specificity validate precision catalytic pocket performed molecular docking refinement dynamic studies four potential tmprss<NUMBER> protease inhibitors chemostat upamostat nafmostat bromhexine hydrochloride fig <NUMBER> af expected observed specific binding location drugs directed catalytic pocket tmprss<NUMBER> main drug binding region structurally linked binding t<NUMBER> t<NUMBER> sites s<NUMBER> domain spike glycol proteins binding energy <NUMBER> kcal identified missense variant rs<NUMBER> tmprss<NUMBER> gene shown confer decreased stability protein homology model tmprss<NUMBER> mutant v<NUMBER>m identified interaction sites sarscov<NUMBER> sprotein first time binding clinically proven protease inhibitors precision specificity interaction sites suggest site targeted developing newer drugs treatment sarscov<NUMBER> infection till drugs tested patients therapeutically current covid clinics intriguing note although viral strain emerged china spread various regions world significant differences incidence mortality rates cannot also identified interactions tmprss<NUMBER> spike glycoprotein using model complex validated model structure fulllength sarscov<NUMBER> spike glycoprotein <NUMBER> available structures pdb lack furin tmprss<NUMBER> recognition cleavage sites <NUMBER> based available literature target sites serine proteases <NUMBER> <NUMBER> along sequence analysis identified two prime tmprss<NUMBER> recognition sites sarscov<NUMBER> spike glycoprotein two identified sites span part heptad region<NUMBER> hr<NUMBER> six helix bundle sarscov<NUMBER> near fusion peptide recently reported heptad regions hr<NUMBER> hr<NUMBER> aid bringing fusion peptide close proximity transmembrane domain facilitating membrane fusion <NUMBER> <NUMBER> <NUMBER> convincing speculate furin protease acts first spike glycoprotein s<NUMBER>s<NUMBER> region cleaves spike protein s<NUMBER> ace<NUMBER> cd<NUMBER> binding region s<NUMBER> trimerization domain resulting complete exposure s<NUMBER> domain tmprss<NUMBER> recognition sites elucidated earlier <NUMBER> <NUMBER> model fits well normal genotype tmprss<NUMBER> whether genetic variant tmprss<NUMBER> protease physiological role sarscov<NUMBER> infection activation spike glycoprotein elusive insilico studies suggested decreased stability protein variant free energy change less <NUMBER> k calmol present important domain protein <NUMBER> <NUMBER> molecular dynamics simulation confirm structural distortions due complete shift motif leading changes quaternary structure protein concomitant increase b factor v<NUMBER>m variant reiterates fact although v<NUMBER>m located catalytic pocket tmprss<NUMBER> decrease stability protein might hamper sarscov<NUMBER> viral entry however needs confirmed order assess binding efficiency tmprss<NUMBER> identified cleavage sites s<NUMBER> subunit spike protein tested clinically proven protease inhibitors camostat nafamostat upamostat bromhexine hydrochloride bhh camostat used therapeutically unrelated clinical conditions shown inhibit influenza viral replication <NUMBER> nafamostat potent inhibitor mers sprotein mediated membrane fusion <NUMBER> bhh hand fda approved mucolytic agent specific inhibitor tmprss<NUMBER> <NUMBER> <NUMBER> upamostat another serine protease inhibitor consideration clinical trials <NUMBER> four drugs bind active site tmprss<NUMBER> high precision specificity fig <NUMBER> supplementary fig s<NUMBER> demonstrate camostat upamostat bhh preferentially bind specific location catalytic pocket tmprss<NUMBER> nafamostat binds <NUMBER> additional binding residues two modesfurthermore potential tmprss<NUMBER> inhibitors also share interaction via several polar charged hydrophobic interactions supplementary fig s<NUMBER> specific binding drugs high precision confirms could potentially bind impede interaction spike glycoprotein tmprss<NUMBER> study identified interaction sites drugs tmprss<NUMBER> therefore conserved epitope targeted developing vaccines therapeutic drugs based findings propose model interaction tmprss<NUMBER> s<NUMBER> subunit spike protein sarscov<NUMBER> fig <NUMBER> limitation study shown association v<NUMBER>m variant infectivity covid<NUMBER> patients instability protein shown silico approaches studies needed covid<NUMBER> patients explore association functional assays gain mechanical insights role variant human diseases incidence severity progression therapeutic response genetic predisposition susceptibility covid<NUMBER> may also predisposition although age sex comorbidities shown associate varied incidence severity disease host genetic predisposition explored study reports first time host factor genetics molecular structure tmprss<NUMBER> cleavage sites s<NUMBER> subunit spike glycoprotein interesting note significant proportion variant carriers india lesser incidence covid<NUMBER> compared ethnicities including usa european countries lower variant carriers higher incidence report importance host genetic factors first time covid<NUMBER> host genetics initiative httpswwwcovid<NUMBER>hgorg reiterate need study role human genome explaining covid<NUMBER> severity susceptibility coronavirus commonly found nature infects mammals birds <NUMBER> among <NUMBER> species seven humansusceptible <NUMBER> <NUMBER> aside sarscov merscov cause deadly pneumonia humans crossing species barrier <NUMBER> sarscov<NUMBER> bringing global pandemic respiratory disease within six months first case confirmed wuhan city china <NUMBER> identified novel coronavirus member Î²coronavirus family coronaviridae positive singlestranded rna virus protein envelope <NUMBER> date covid<NUMBER> caused sarscov<NUMBER> results six million people infected <NUMBER> thousand deaths worldwide compared sarscov merscov sarscov<NUMBER> spreads rapidly highly infectious humans <NUMBER> <NUMBER> <NUMBER> crucial understand origin coronavirus strategy adapting human hosts efficiently moreover apply knowledge controlling pandemic developing effective therapeutics vaccines covid<NUMBER> reconstructing phylogenomic relationships among various coronavirus <NUMBER> showed around <NUMBER> genome sequence similarity sarscov <NUMBER> closely related bat coronavirus ratg<NUMBER> spike gene <NUMBER> given closely related sarslike coronaviruses genome structure sarscov<NUMBER> similar betacoronaviruses composed order <NUMBER>replicase orf<NUMBER>absenvelopeemembranemn<NUMBER> numbers open reading frames orfs function resembles sarscov <NUMBER> noted ratg<NUMBER> highly similar sarscov<NUMBER> especially genes differed crucial genomic structures one notable features polybasic furin cleavage site insertion prra residue junction two subunits s<NUMBER> s<NUMBER> protein <NUMBER> <NUMBER> <NUMBER> <NUMBER> although studies show bats could reservoir host many coronaviruses including sarscov reservoir host sarscov<NUMBER> remains unclear <NUMBER> <NUMBER> <NUMBER> given global spread epidemic draws lot attention reveal origins pandemic event evolutionary sarscov<NUMBER> may explain infectiousness transmissibility among different animal hosts provide evidence whether virus natural artificial spike glycoprotein surface sarscov<NUMBER> key enter target cells forms homotrimers protruding surface recognize host cell receptor cause membrane fusion <NUMBER> spike protein contains s<NUMBER> s<NUMBER> subunits receptorbinding domain rbd exists s<NUMBER> bind peptidase domain pd angiotensinconverting enzyme <NUMBER> ace<NUMBER> s<NUMBER> responsible membrane fusion viral infection <NUMBER> <NUMBER> sarscov rbd spike protein diverse part whole genome six amino acid y<NUMBER> l<NUMBER> n<NUMBER> d<NUMBER> t<NUMBER> y<NUMBER> found play key role binding ace<NUMBER> receptor transmissibility across species boundary <NUMBER> similar sarscov rbd mutations acquired adaption different host cells along transmission also observed sarscov<NUMBER> thus dissection key mutations spike protein rbd affect binding ace<NUMBER> receptor would important understanding molecular mechanism sarscov<NUMBER> infect human cells recent studies show ace<NUMBER> receptor host cells would mediate entry ability sarscov<NUMBER> interacting spike protein binding capacity spike protein sarscov<NUMBER> determines transmissibility coronavirus across species particularly among humans <NUMBER> <NUMBER> present study intends <NUMBER> reveal phylogenetic relationship sarscov<NUMBER> identified different population genomic level provide genetic evidence based structural proteincoding genes n e identifying nucleotide variations sarscov<NUMBER> collected different regions amid covid<NUMBER> pandemic <NUMBER> provide prediction revealing adaptive mutations spike protein sarscov<NUMBER> based specific variation gene finding differences stability spike protein mutants affinities human ace<NUMBER> receptors <NUMBER> explore whether variants ace<NUMBER> different populations may affect infectivity covid<NUMBER> end analyzed variants ace<NUMBER> large cohort including <NUMBER> chinese local people human populations identified polymorphisms may influent binding ace<NUMBER> spike protein coronaviruses furthermore predicted affinities spike protein binding ace<NUMBER> variants understand whether changes would render individuals resistant susceptible sarscov<NUMBER> molecular level herein study could explain part origin sarscov<NUMBER> phylogenetic level based whole genome multiple key genes allow elucidation population risk profiles also help advance therapeutics rationally designed soluble ace<NUMBER> receptor management covid<NUMBER> carried kimura two factor correction method nucleic acid level calculation avoid prediction error caused selection outgroups far evolutionary relationship complex outgroup adopted study sequence merscov sarscov selected outgroups predict genetic relationship maximum likelihood ml phylogenic trees constructed based <NUMBER> genome sequences sarscov<NUMBER> sarscov merscov selected outgroups figure <NUMBER> alignment merged identical sequences one clade labels kept one genomic tree showed sarscov<NUMBER> closely related sarslike virus found horseshoe bat yunnan ratg<NUMBER> coronavirus pangolin collected guangdong province sister taxon ratg<NUMBER> closer virus bat pangolins guangxi sarscov<NUMBER> related closely sarscov nucleic level australia european countries usa case document showed patient confirmed sevenday trip italy didnt show symptoms journey branches poorly supported bootstrap values exhibited polytomies indicated sarscov<NUMBER> adapting human hosts globally hard determine origin sarscov<NUMBER> solely based nucleic data furthermore genomic tree multiple genes sequences sarscov<NUMBER> divergent outgroups detected mutations according gene sequences comparison figure <NUMBER> shown figure <NUMBER> extracted aligned gene sequences sars coronavirus different hosts one pangolin closer sarscov<NUMBER> ratg<NUMBER> horseshoe bat rhinolophus spp found big fragment shift genes pangolin less similar sarscov<NUMBER> compared ratg<NUMBER> insertions exhibited pangolin indicated potential recombination spike protein coronavirus would occur crossspecies hosts manumission according gene sequences different strains found similarity sarscov<NUMBER> sarscovbat <NUMBER> higher compared coronavirus pangolins <NUMBER> showed solved phylogenetic tree based gene fig <NUMBER> compared trees based genomic sequences multiple genes nevertheless phylogeny reconstructed based genome gene multiple genes indicate sarscov<NUMBER> closely related ratg<NUMBER> virus isolated pangolin gene studied key gene sarscov<NUMBER> binding host cells receptor gene shows less conserved compared genome sequence sarscov<NUMBER> studies suggest high divergence found spike protein rbd specifically direct bonding sites ace<NUMBER> receptor play important role sarscov<NUMBER> adapting different animal hosts populations different regions combined phylogeny based gene also detected mutationson gene binding capacity ace<NUMBER> receptor human beings <NUMBER> point mutations predicted significantly influence affinity stability spike protein fig <NUMBER> among <NUMBER> polymorphisms exhibited increased affinity stability <NUMBER> ones showed decreased affinity stability table <NUMBER> analysis outcomes <NUMBER> polymorphisms spike protein shown supplementary table <NUMBER> figure <NUMBER> table <NUMBER> showed missense mutation spike protein rbd significant changes cutoff <NUMBER> affinity stability ace<NUMBER> receptors interestingly residues l<NUMBER> q<NUMBER> n<NUMBER> would two potential mutations leading contrary affinities including increased affinity leucine changed methionine aa<NUMBER> glutaurine changed tryptophan aa<NUMBER> asparagine changed tyrosine aa<NUMBER> reduced affinity leucine changed alanine glutamine changed alanine asparagine changed glycine polymorphisms residue causing two opposite effects affinity suggested mutations positions may lead different adaptation directions sarscov<NUMBER> fit different hosts furthermore phe<NUMBER> gln<NUMBER> phe<NUMBER> showed two mutations result affinity reduction stability spike protein different mutations showed table <NUMBER> found <NUMBER> mutants increased stability spike protein including g<NUMBER>w g<NUMBER>a q<NUMBER>w n<NUMBER>y g<NUMBER>y consistent affinity match mutations spike protein reported sarscov<NUMBER> database china national center bioinformation httpsbigdbigaccnncov predictions total <NUMBER> polymorphisms spike protein collected database <NUMBER> missense variants selected run analysis affinity stability binding ace<NUMBER> supplementary table <NUMBER> focused <NUMBER> missense variants region t<NUMBER>c<NUMBER> spike protein <NUMBER> variants bring significant changes affinity ace<NUMBER> figure <NUMBER>a moreover <NUMBER> variants cause structural stability changes spike protein rbd figure <NUMBER>b calculated population frequency <NUMBER> missense variants ace<NUMBER> collected gnomad supplementary table <NUMBER> local population table <NUMBER> analysis stability affinity spike protein sarscov<NUMBER> performed study results showed significant differences affinity stability revealing evolutionary origin sarscov<NUMBER> great value understand transmission pathway crossspecies provide guide longterm infection prevention zoonotic coronavirus since novel coronavirus extremely limited morphological information sarscov<NUMBER> could used phylogenic analysis genomic data sarscov<NUMBER> nowadays provide helpful approach identify divergence along transmission among sarscoronavirus <NUMBER> <NUMBER> gene divergent coronavirus genetic level relative genes <NUMBER> along adapting human host cellular environment mutations occur spike protein enable enhance binding affinity stability spike proteinhace<NUMBER> complex enhancement would increase transmissibility sarscov<NUMBER> among human bring severe disease <NUMBER> table <NUMBER> <NUMBER> variants spike protein rbd causing significantly higher lower affinity ace<NUMBER> stability focused study cutoff set three determining significance table <NUMBER> among <NUMBER> mutations highly enhance binding spike protein ace<NUMBER> residue g<NUMBER> figure <NUMBER> also reported cdc date combined <NUMBER> variants <NUMBER> missense mutations total spike protein sarscov<NUMBER> reported cdc found affinity stability analysis outcomes among <NUMBER> missense variants locate region t<NUMBER>c<NUMBER> five variants spike protein enhance affinity binding hace<NUMBER> table <NUMBER> three increase stability spikehace<NUMBER> complex table <NUMBER> additionally collected genome sequences sarscov<NUMBER> harbor variants spike protein found variants v<NUMBER>a occurs <NUMBER> strains usa v<NUMBER>f occurs <NUMBER> strains hong kong australia european countries variant g<NUMBER>v highly enhance affinity identified strain australia supplementary table <NUMBER> mapped strains onto genomic phylogenetic tree found dispersed distributed position close sarsbat sarspangolin covid<NUMBER> widespread globally several studies tried find novel coronavirus came reports analyze origin sarscov<NUMBER> according divergent pattern spike protein study multiple variants spike protein found different countries clustered ancestral direction phylogeny might suggest sarscov<NUMBER> infection start occur multiple sites wuhan city however due limited detection capability restricted availability samples infected animals variants available national database uncompleted data needs collected studies furthermore since sarscov<NUMBER> strains variants spike protein relative reference sequence sarscov<NUMBER> nc<NUMBER> found divergence phylogenetic position closer sarsbat sarspangolin might indicate consensus evolution occurred gene enable sarscov<NUMBER> adapt human hosts well however since difficult determine exact time zero patient got infected sarscov<NUMBER> date sample collection data extracted could mislead results believe clinical information countries would needed research global concern requires cooperation collaboration political games constant blames shared analysis <NUMBER> variants spike protein study help world tracking mutations sarscov<NUMBER> also useful select potential druggable targets neutral inhibitors prevent damages may brought pandemic covid<NUMBER> aside mutations spike protein adapting new hosts hace<NUMBER> also represents polymorphisms binding region hostvirus interaction time makes natural selection virus host cells <NUMBER> therefore variants hace<NUMBER> receptor would also play role sarscov<NUMBER> infection cao colleagues <NUMBER> <NUMBER> researchers found three unique variants hace<NUMBER> italian population might corresponding high fatality including p<NUMBER>h w<NUMBER>c l<NUMBER>v <NUMBER> compared unique variants found local italian population mapping hace protein structure figure <NUMBER> found italian ones closer binding region local ones silico simulation indicated none change affinity stability spike protein sarscov<NUMBER> hace<NUMBER> complex table <NUMBER> generally find variants ace<NUMBER> would significantly increase decrease affinity stability spike ml phylogeny tree different strains sarscov<NUMBER> various region around world partial full tree found supplementary figure <NUMBER> bootstrap values mapped branch long colors annotated clades ml phylogeny tree n n gene sequences sarscov<NUMBER> various strains partial full tree found supplementary figure <NUMBER> bootstrap values mapped branch long colors annotated clades alignment gene different sars virus phylogenetic tree based gene partial full tree presented supplementary figure <NUMBER> bootstrap values mapped branch well colors annotated clades identified polymorphism spike protein rbd mapped structure spike protein sarscov<NUMBER> complex ace<NUMBER> humans cyan spike protein orangeace<NUMBER> direct bounding spike protein <NUMBER> point mutations causing affinity significant change direct bounding spike protein sarscov<NUMBER> blue presents decreasing affinity purple shows increasing reported polymorphism spike protein rbd mapped structure spike protein sarscov<NUMBER> complex ace<NUMBER> humans cyan spike protein orangeace<NUMBER> blue presents decreasing affinity stability red shows increasing ones affinity b stability residue g<NUMBER> variants documents cdc g<NUMBER>v prediction g<NUMBER>w spike protein polymorphous points local population italy citation italian ones marked green local ones marked red world health organization declared global emergency pandemic coronavirus disease covid<NUMBER> actively spreading around globe covid<NUMBER> caused virus sarscov<NUMBER> cause symptoms fever cough pneumonia nausea fatigue sarscov<NUMBER> reached <NUMBER> countries around globe <NUMBER> cases confirmed march <NUMBER> <NUMBER> <NUMBER> epidemiological background virus thought stem seafood market wuhan china <NUMBER> however true epicenter initial transfer humans still unknown currently <NUMBER> complete genome sequences known ncbi genbank <NUMBER> countries variation sequences less <NUMBER> virus closely related sarscov allows utilization known protein structures quickly build model drug discovery new sarscov<NUMBER> <NUMBER> traditional methods drug discovery could take years approach taken search possible medications sarscov<NUMBER> silico docking models variable proteins sarscov<NUMBER> spike glycoprotein sarscov<NUMBER> <NUMBER>cl main protease cov spike protein binds host cell membrane receptormediated interaction allows entrance host cell computationally determined sarscov<NUMBER> similar mechanism sars virus receptor highest affinity ace<NUMBER> angiotensinconverting enzyme <NUMBER> <NUMBER> structural similarities sarscov<NUMBER> spike protein sars spike protein conservation <NUMBER> variability host cell interaction region protein currently crystal structure available sarscov<NUMBER> spike protein employed homology modeling sarscov<NUMBER> utilizing sars spike protein pdb <NUMBER>ghv template second silico docking model <NUMBER>cl pro main protease responsible controlling several major functions virus highly conserved catalytic domain sars virus <NUMBER> functions include replication processes virus makes ideal target drug development <NUMBER> sarscov<NUMBER> main protease determined ref <NUMBER> pdb <NUMBER>lu<NUMBER> proteins spike protease essential transmission virulence virus inhibiting anyone two proteins higher active therapy severity infection reduced efforts placed competitively inhibiting binding natural substrates library known bioactive compounds run several sites spike protein catalytic site sarscov<NUMBER> main protease utilizing approved compound database quick trials compounds minimal effort approval food drug agencies could carried chosen run zinc<NUMBER> database classified zinc<NUMBER> <NUMBER> approved drugs major jurisdictions including fda ie drugbank approved database covers major bioactive pharmaceutical compounds utilized around globe currently <NUMBER> entries molecular docking calculations completed using schrodingerÂ® docking suits schrÃ¶dinger maestro new york ny usa version <NUMBER> mmshare version <NUMBER> release <NUMBER> platform windowsx<NUMBER> using virtual screening workflow workflow utilized three docking precisions htvs sp xp yielded top <NUMBER> hits binding site proteins prepared restrained minimization using force field opls<NUMBER>e grid sites created using glideÂ® receptor grid generator docking length <NUMBER> Ã¥ grids centers determined active resides target protein ligands prepared using force field opls<NUMBER>e possible states generated ph <NUMBER> Â± <NUMBER> docking scores reported kcalmol negative number better binding surface glycoprotein wuhan seafood market pneumonia virus sequence id yp<NUMBER> structure modeled using modbase <NUMBER> utilized modeller <NUMBER> structural modeling sequence ncbi accession yp<NUMBER> uploaded modbase interface run template sars spike protein receptor binding domain pdb <NUMBER>ghv chain e sequence identity found <NUMBER> fig <NUMBER>a calculation completed imported schrÃ¶dinger maestroÂ® structure minimized using force field opls<NUMBER>e overlay pre post minimized structure seen fig s<NUMBER> sequencing revealed sarscov<NUMBER> similar sarscov virus allows genomic proteomic homology comparison using homology modeling able develop model spike glycoprotein fig <NUMBER> model allowed us perform docking calculations utilizing database known bioactive approved compounds modeller modbase programs able use homologue sars spike protein pdb <NUMBER>ghv original sarscov<NUMBER> sequence genbank mn<NUMBER> construct sarscov<NUMBER> spike protein protein run restriction minimization process utilizing schrodinger docking suitsÂ® protein preparation allows side chains placed energetically favorable conformation fig <NUMBER>b effort stop spikeace<NUMBER> interaction several sites determined targeted spike protein docking studies three sites located interaction points specifically hydrogen bonding calculated main intermolecular force spikeace<NUMBER> interaction fourth allosteric site determined surface mapping protein locations binding sites chosen would cause destruction ace<NUMBER> interactions sites labeled site <NUMBER> information sites seen supplemental table s<NUMBER> fig s<NUMBER> results sarscov<NUMBER> spike glycoprotein reported table <NUMBER> structural alignments revealed sarscov<NUMBER> protease highly conserved sars pdb <NUMBER>lvo main protease <NUMBER> id <NUMBER> <NUMBER>cl pro main protease run restriction minimization process utilizing schrodinger docking suitsÂ® fig s<NUMBER>a previous studies revealed sars protease mutation residue his<NUMBER> renders enzyme inactive sarscov<NUMBER> homologous residue his<NUMBER> site <NUMBER> center x â<NUMBER> <NUMBER> z <NUMBER> fig s<NUMBER>b used central point molecular docking calculations active site also revealed second histidine center his<NUMBER> site <NUMBER> center x â<NUMBER> <NUMBER> z <NUMBER> fig s<NUMBER>c seems play role interactions bound ligand <NUMBER>lu<NUMBER> structure targeted second center point molecular docking calculations results sarscov<NUMBER> <NUMBER>cl protease reported table <NUMBER> molecular docking employed search possible medications contained approved bioactive compound database hit compounds reported potential inhibit sarscov<NUMBER> spike protein <NUMBER>cl pro main protease guaranteed activity however lays groundwork computational drug discovery new compounds reduce transmission symptoms sarscov<NUMBER> used structural homology modeling determine dockable target sarscov<NUMBER> spike protein utilized newly characterized <NUMBER>cl pro main protease docking models several exciting hits <NUMBER>cl pro main proteinase zanamivir approved medication treatment influenza b viruses <NUMBER> indinavir saquinavir shown treat prevent hiv remdesivir antiviral compound experimental stages shown activity sarscoronavirus ebola virus possibly sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> also exciting uncover flavin adenine dinucleotide fad adeflavin b<NUMBER> deficiency medicine coenzyme coenzyme may also potentially used treatment sarscov<NUMBER> infections novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> associated current pandemic outbreak covid<NUMBER> virus emerged wuhan china transmitted person person <NUMBER> patients visited local seafood market selling various live animals zoonotic disease suspected spread <NUMBER> also suggested snake <NUMBER> pangolin <NUMBER> mammals birds <NUMBER> genome sarscov<NUMBER> contains two open reading frames orfs orf<NUMBER> orf<NUMBER> encoding two polyproteins responsible viral genome maintenance cleavage also set socalled structural proteins spike glycoproteins envelope protein membrane proteins nucleocapsid one structural proteins spike surface glycoprotein spike glycoprotein one primary therapeutic targets protein plays important role binding receptors host cell fusion host viral membranes target antibodies reviewed fung liu <NUMBER> study examined <NUMBER> genomes establish relationship spike glycoproteins different coronaviruses done combination phylogenetic tree analysis reconstructed translated sequences comparison structural models phylogenetic study confirmed close relatedness sarscov<NUMBER> bats coronaviruses contrast comparison structural models found yak bos grunniens betacoronavirus closest match recently released complete genome sequences downloaded analysis ncbi listed table s<NUMBER> furthermore spike glycoprotein orfs nucleotide protein sequences retrieved ncbi orffinder httpswwwncbinlmnihgovorffinder conserved domains checked cdsearch ncbi respectively complete translated orfs used multiple sequence alignments performed using muscle tests substitution models phylogenetic analysis carried using mega x software <NUMBER> neighborjoining method jtt substitution models selected assuming estimated proportion invariant sites <NUMBER>gammadistributed rate categories account rate heterogeneity across sites gamma shape parameter estimated directly data reliability internal branch assessed using bootstrapping method <NUMBER> bootstrap replicates two spike glycoproteins gammacoronaviruses used outgroup structural models spike glycoproteins table s<NUMBER> marked built using swissmodel <NUMBER> predicted structures refined online tool <NUMBER>drefine httpsysbiornetmissouriedu<NUMBER>drefine verified using qmean httpsswissmodelexpasyorgqmean ipba web server used pdb structure alignment httpswwwdsimb insermfrdsimbtoolsipbaindexphp quality structure alignments evaluated using root mean square deviation normalized score chimera software <NUMBER> used structure visualization table s<NUMBER> four conserved domains identified spike glycoprotein nterminal domain pfam<NUMBER> spike receptorbinding domain pfam<NUMBER> coronavirus s<NUMBER> glycoprotein pfam<NUMBER> coronavirus s<NUMBER> glycoprotein pfam<NUMBER> listed nterminal cterminal direction figure s<NUMBER> surprisingly none analyzed genomes exhibited domain architecture known example viruses studied earlier top line figures s<NUMBER> s<NUMBER> common feature noticed alphacoronaviruses gammacoronaviruses share domain architecture represented two domains coronavirus s<NUMBER> glycoprotein along coronavirus s<NUMBER> glycoprotein contrast analyzed betacoronaviruses full partial spike receptorbinding domain interestingly betacoronaviruses humans yaks hosts spike glycoprotein nterminal domain absent analyzed hosts gain insight phylogenetic relationships spike glycoproteins alphacoronaviruses betacoronaviruses gammacoronaviruses different hosts robust phylogenetic tree multiple alignments <NUMBER> extracted sequences figure s<NUMBER> furthermore better understand relationships spike glycoproteins structural level built protein models homologybased server swissmodel <NUMBER> table s<NUMBER> marked obtained models evaluated verified table s<NUMBER> next step ipba web server local backbone conformation comparison similarity algorithm used match human hostdelivered sarscov<NUMBER> mers spike glycoproteins models delivered coronaviruses hosts table <NUMBER> mers betacoronavirus used control data set wellstudied hosts human camel close genetic relationship wellcharacterized <NUMBER> expected human hostdeliveredmers showed highest similarity camels sarscov<NUMBER>s spike glycoprotein contrary shown highest similarity yakdelivered betacoronavirus table <NUMBER> figure <NUMBER>b proper domain classification identification remain matter discussion earlier papers refer spike glycoprotein cleaved middle forming s<NUMBER> s<NUMBER> domains subdividing nterminal cterminal domains <NUMBER> based current conserved domain database cdd output concluded nterminal s<NUMBER> corresponds spike glycoprotein also wish emphasize importance investigations evolution spike glycoprotein work could render positive impact current sarscov<NUMBER> transmission prevent zoonotic disease outbreaks type future late <NUMBER> novel pathogenic coronavirus sarscov<NUMBER> entered human population since spread throughout world number people suffering associated disease continues rise increasing need effective therapeutic interventions sarscov<NUMBER> sarscov<NUMBER> spike proteins highly homologous <NUMBER> sequence identity similar sarscov<NUMBER> interaction sarscov<NUMBER> spike protein angiotensinconverting enzyme <NUMBER> ace<NUMBER> human cells critical viral entry host cells gralinski menachery <NUMBER> tai et al <NUMBER> wu et al <NUMBER> sarscov<NUMBER> spike obligate trimer ace<NUMBER> presents dimer cell surface chen liu guo <NUMBER> several highresolution structures sarscov<NUMBER> spike receptor binding domain spikerbd bound ace<NUMBER> published lan et al <NUMBER> yan et al <NUMBER> however writing structures sarscov<NUMBER> spike trimer complex either dimeric monomeric form ace<NUMBER> reported resulting incomplete understanding nature interaction structural studies trimeric sarscov<NUMBER> sarscov<NUMBER> spike protein demonstrate spikerbds coronaviruses undergo hingelike movements transition conformations host ace<NUMBER> receptor interact rbd conformation whereas conformation inaccessible ace<NUMBER> wrapp vlieger et al <NUMBER> rbds sarscov<NUMBER> spike rotate away position different angles position gui et al <NUMBER> several cryoem structures report approximately half sarscov<NUMBER> <NUMBER> spike particles threedown closed conformation half oneup open conformation song gui wang xiang <NUMBER> walls et al <NUMBER> another cryoem study sarscov<NUMBER> spike reported <NUMBER> spike twoup conformation <NUMBER> threeup conformation kirchdoerfer et al <NUMBER> different conformations spike observed cryoem studies may affected andor limited properties grid sample preparation conditions may also reflect differences sarscov<NUMBER> <NUMBER> thus remains unknown many rbds sarscov<NUMBER> accessible within trimeric spike bind ace<NUMBER> physiological conditions thus degree intraspike avidity plays interaction ace<NUMBER> sarscov<NUMBER> spike recombinant ace<NUMBER> engineered dimeric ace<NUMBER>fc fusion shown several studies neutralize sarscov<NUMBER> virus lei et al <NUMBER> li et al <NUMBER> monteil et al <NUMBER> however remains unknown whether dimeric form ace<NUMBER> offers affinity enhancements avidity compared monomer understanding role mechanism intraspike avidity binding important engineering tight binding antagonists neutralize virus infection elucidate nature interaction dimeric ace<NUMBER> trimeric sarscov<NUMBER> spike performed thorough characterization binding interactions different multimeric forms spikerbd ace<NUMBER> figure <NUMBER>a results reveal ace<NUMBER> monomer ace<NUMBER>fc dimer bind isolated spikerbd ace<NUMBER>fc dimer bind tightly trimeric spike ectodomain flspike interestingly affinity ace<NUMBER>fc dimer much higher rbdfc dimer flspike suggesting although intramolecular avidity plays role interactions effect compromised context flspike consistent find ace<NUMBER> associates slowly flspike indicates rbds flspike protein readily accessible ace<NUMBER> probe conformational landscape rbds flspike engineered ace<NUMBER>fc splitnanoluciferase nanoluc reporters found proportion flspike interact multiple ace<NUMBER>fc molecules simultaneously indicating one rbd domain spike trimer adopt conformation using pseudotyped sarscov<NUMBER> virus neutralization assays show ace<NUMBER>fc dimer much potent neutralizing virus ace<NUMBER> monomer findings extend biochemical insight spike trimer binds ace<NUMBER> dimer important implications multimeric therapeutic molecules dimeric ace<NUMBER> antibodybased biologics effectively target sarscov<NUMBER> study interaction ace<NUMBER> sarscov<NUMBER> spike constructed panel spike ace<NUMBER> proteins various multimeric formats figure <NUMBER>a trimeric sarscov<NUMBER> spike ectodomain aa <NUMBER> flspike expressed purified described amanat et al <NUMBER> construct generously provided f krammer lab furin cleavage site removed pair stabilizing mutations cterminal t<NUMBER> trimerization motif followed <NUMBER>xhis tag added modifications widely used structural analysis gui et al <NUMBER> kirchdoerfer et al <NUMBER> song et al <NUMBER> walls et al <NUMBER> wrapp wang et al <NUMBER> designed dimeric form spike receptor binding domain aa <NUMBER> spikerbdfc containing tevcleavable fcfusion molecule cterminal avi tag biotinylation czajkowsky hu shao pleass <NUMBER> also generated monomeric form spikerbd aa <NUMBER> spikerbdmonomer cterminal tev<NUMBER>xhisavi human ace<NUMBER> ectodomain contains nterminal peptidase domain aa <NUMBER> cterminal dimerization domain aa <NUMBER> designed monomeric form ace<NUMBER> aa <NUMBER> ace<NUMBER>monomer cterminal tev<NUMBER>xhisavi tag dimeric form ace<NUMBER> aa <NUMBER> ace<NUMBER>fc tevcleavable fcfusion molecule cterminal avi tag czajkowsky et al <NUMBER> ace<NUMBER> spike proteins expressed biraerexpressing expi<NUMBER> cells howarth et al <NUMBER> martinko et al <NUMBER> fcfusion molecules purified protein affinity chromatography spikerbdmonomer flspike ninta affinity chromatography figure <NUMBER>b <NUMBER>c however ace<NUMBER> monomer express generated instead tev release ace<NUMBER>fc figure <NUMBER>a <NUMBER>b proteins except ace<NUMBER> monomer <NUMBER> biotinylated expression understand oligomerization affects spikeace<NUMBER> interaction determined affinity binding kinetics different spikerbd ace<NUMBER> proteins biolayer interferometry bli figure <NUMBER> spikerbdmonomer spikerbdfc flspike immobilized streptavidin ninta sensors allowed bind ace<NUMBER> monomer ace<NUMBER>fc solution fourfold avidity effect observed spikerbdmonomerace<NUMBER>fc interaction kd <NUMBER> nm figure <NUMBER>d compared spikerbdmonomerace<NUMBER>monomer interaction kd <NUMBER> nm figure <NUMBER>a contrast spikerbdfcace<NUMBER>fc interaction kd <NUMBER> <NUMBER> figure <NUMBER>e showed <NUMBER>fold increase binding affinity compared spikerbdfcace<NUMBER>monomer interaction kd <NUMBER> nm figure <NUMBER>b dramatic increase affinity driven massive decrease rate little change rate indicates strong intramolecular twoontwo avidity spikerbdfc ace<NUMBER>fc next tested binding ace<NUMBER> monomer ace<NUMBER>fc flspike determine affinity avidity effect surprisingly found binding interaction ace<NUMBER> monomer flspike weak could measured accurately figure <NUMBER>c contrast ace<NUMBER>fc interacts flspike kd <NUMBER> nm similar affinity isolated spikerbdmonomer figure <NUMBER>f suggests presence two ace<NUMBER> molecules close proximity ace<NUMBER>fc essential productive interaction flspike single ace<NUMBER> monomer sufficient bind rbd flspike however affinity flspikeace<NUMBER>fc interaction substantially less spikerbdfcace<NUMBER>fc interaction kd <NUMBER> <NUMBER> figure <NUMBER>e suggesting highavidity twoontwo interaction compromised context flspike could due geometricsteric constraints unique conformations rbds flspike context flspike loaded much higher density bli sensor load <NUMBER> nm probed ace<NUMBER>fc see avidity recovered supplementary figure s<NUMBER>a indicates spike presented high density ace<NUMBER>fc arms engage two rbds neighboring spike trimers close enough contrast monomeric ace<NUMBER> bind flspike strongly even flspike loaded saturation demonstrating importance ace<NUMBER> dimerization interacting flspike supplementary figure s<NUMBER>b interestingly kon flspikeace<NUMBER>fc interaction figure <NUMBER>c <NUMBER>f <NUMBER>fold lower interactions spikerbdmonomer spikerbdfc ace<NUMBER> ace<NUMBER>fc figure <NUMBER>a <NUMBER>b <NUMBER>d <NUMBER>e koff also <NUMBER>to <NUMBER>fold lower decreased kon suggests rbds flspike protein may undergo conformational change binding ace<NUMBER> previous cryoem studies sarscov<NUMBER> flspike show approximately half particles three rbd domains conformation conformations states rbd angle lower <NUMBER>Â° body trimer inaccessible ace<NUMBER> peng et al <NUMBER> data supports significant proportion rbds flspike protein closed partially closed state inaccessible ace<NUMBER> rbd open allow binding ace<NUMBER> decreased koff hand suggests presence multiple rbds within context flspike could slow dissociation ace<NUMBER>fc investigate rbd conformational landscape flspike designed splitnanoluc system orthogonally probe spikeace<NUMBER> interaction splitnanoluc enzymes particular nanobit promega broadly used detect proteinprotein interactions study analyte concentrations dixon et al <NUMBER> nanobit system composed lgbit smbit smbit <NUMBER> amino acid peptide low intrinsic affinity lgbit kd <NUMBER> Âµm smbit lgbit close proximity two subunits assemble form active luciferase enzyme interrogate interaction ace<NUMBER> spike engineered ace<NUMBER>fc reporter molecules smbit lgbit fused ctermini figure <NUMBER>a constructs expressed high yield purity figure <NUMBER>b <NUMBER>c functionally validate split reporter system immobilized spikerbdfc streptavidin magnetic beads highdensity incubation <NUMBER> nm ace<NUMBER>fcsmbit ace<NUMBER>fclgbit <NUMBER> nm smbitace<NUMBER>fc lgbitace<NUMBER>fc substrate showed dosedependent luminescence signal consistent assembled functional split enzyme reporter intermolecular proximity figure <NUMBER>d <NUMBER>e found nterminal fusion reporter pair showed higher sensitivity compared cterminal fusion reporter pair supplementary figure s<NUMBER> suggesting increased entropy flexible linker fc domain reduces productive luciferase reconstitution next used split reporters interrogate soluble flspike trimer figure <NUMBER>f <NUMBER>g smbitlgbitace<NUMBER>fc followed addition substrate smbitlgbitace<NUMBER>fc reporters showed dosedependent increase luminescence signal <NUMBER> nm flspike result suggests although flspike cannot form highavidity twoontwo interaction arms ace<NUMBER>fc time proportion flspike proteins twoup perhaps even threeup rbds simultaneously interact multiple ace<NUMBER>fc molecules cannot resolve twoup threeup conformations present prior ace<NUMBER> binding appear ace<NUMBER> binding induces conformational change enables two rbd domains engage binding second ace<NUMBER>fc domain translate studies cells compared ability ace<NUMBER> monomer ace<NUMBER>fc neutralize sarscov<NUMBER> pseudotyped virus infect cells pseudotyped hiv<NUMBER> particles carry wildtype sarscov<NUMBER> spike protein capable delivering nanoluc luciferase reporter gene ace<NUMBER>expressing hek<NUMBER>t cells cells pseudovirus preincubated serially diluted ace<NUMBER>fc monomeric ace<NUMBER> luciferase activity measured cell lysates <NUMBER> hours post infection ace<NUMBER>fc neutralized sarscov<NUMBER> pseudotyped particles ic<NUMBER> <NUMBER> Âµgml <NUMBER> nm ace<NUMBER> monomer substantially neutralize concentrations tested <NUMBER> Âµgml <NUMBER> nm figure <NUMBER>a <NUMBER>b stark difference efficacy monomeric dimeric ace<NUMBER> confirms ace<NUMBER> monomer binds poorly spike tested ability ace<NUMBER>fc ace<NUMBER> monomer neutralize sarscov<NUMBER> virus sarscov<NUMBER> live virus preincubated <NUMBER> nm ace<NUMBER>fc ace<NUMBER> monomer prior infecting veroe<NUMBER> cells monkey kidney epithelial cell line broadly used studying viral infectivity <NUMBER> hours post infection cells lysed intercellular viral host rna isolated converted cdna quantified qpcr consistent pseudotyped virus neutralization results ace<NUMBER>fc neutralized sarscov<NUMBER> much potently ace<NUMBER> monomer figure <NUMBER>a <NUMBER>b worldwide efforts currently underway develop effective fastacting clinical interventions control spread mortality sarscov<NUMBER> clear interaction ace<NUMBER> spikerbd plays crucial role viral entry current understanding insufficient design maximally effective therapeutic options work systematically interrogated ace<NUMBER> dimer interacts sarscov<NUMBER> spike trimer understand fundamental avidity properties spikeace<NUMBER> interaction results bli experiments split reporter assays virus neutralization assays provide important insight conformational landscape rbds sarscov<NUMBER> spike summarized figure <NUMBER>a decreased kon ace<NUMBER>fc suggests majority rbds flspike ace<NUMBER>inaccessible conformation requires opening binding ace<NUMBER> figure <NUMBER>a poor binding monomeric ace<NUMBER> figure <NUMBER>b strong binding dimeric ace<NUMBER>fc figure <NUMBER>c indicate intraspike avidity ace<NUMBER> rebinding plays important role promoting interaction however observed highly productive avidity effect spikerbdfcace<NUMBER>fc interaction observe massive twoontwo avidity flspikeace<NUMBER>fc interaction figure <NUMBER>d weaker interaction could due rbd conformations spike suboptimal geometry two proteins highavidity binding nonetheless show two rbd domains conformation allowing binding two ace<NUMBER>fc one spike trimer figure <NUMBER>e evidenced bli experiment bound flspike presence rbds slows dissociation ace<NUMBER>fc figure <NUMBER>f comparison <NUMBER>d shown splitnanoluc reporter experiments ace<NUMBER> domains two separate ace<NUMBER>fc splitreporters simultaneously bind spike trimer generate active luciferase figure <NUMBER> together results indicate trimeric sarscov<NUMBER> spike interacts ace<NUMBER> limited important intraspike avidity addition intraspike avidity interspike avidity could contribute improved affinity ace<NUMBER>fc especially intact virus possible ace<NUMBER>fc could bridge two spike molecules viral surface bind increased avidity similar observed highdensity loading bli experiment supplementary figure <NUMBER>a previous structural studies sarscov<NUMBER> shows spike proteins densely distributed lin et al <NUMBER> <NUMBER> spike molecules displayed viral particle diameter <NUMBER> nm beniac andonov grudeski booth <NUMBER> neuman et al <NUMBER> using values studies estimate interspike distance <NUMBER> Ã¥ structure native ace<NUMBER> dimer pdb <NUMBER>m<NUMBER> shows two ace<NUMBER> arms <NUMBER> Ã¥ apart would able span predicted interspike distance ace<NUMBER> monomer fused fc flexible linker ace<NUMBER>fc may sufficient bridge two spikes <NUMBER> Ã¥ apart structural studies iggs shown antigen binding sites fab arms flexiblehinge region fc roughly <NUMBER> Ã¥ apart sosnick et al <NUMBER> would still fall short interspike distance however estimates based rigid membrane spike proteins uniformly distributed also account heterogeneity spike presentation across viral particles may case coronaviruses enveloped virus fluid lipid membrane allows spike protein mobility clustering potentially enable interspike binding ace<NUMBER> dimers iggs indeed cryoem images sarscov<NUMBER> show irregularity lack symmetry spike distribution coronavirus envelope beniac et al <NUMBER> direct reports interspike avidity dimeric ace<NUMBER> experiments needed thoroughly examine spikeace<NUMBER> interaction viral surface cryoem structural studies date sarscov<NUMBER> spike identified closed oneup rbd conformation cao et al <NUMBER> pinto et al <NUMBER> walls et al <NUMBER> wrapp wang et al <NUMBER> split reporter assay identified population spike twoup threeup conformation relative population rbd conformers whether exist ace<NUMBER>unbound state emerge upon ace<NUMBER> binding remains unknown figure <NUMBER>f previous studies suggested ace<NUMBER> binding could lead conformational change sarscov<NUMBER> <NUMBER> spike song et al <NUMBER> yuan et al <NUMBER> molecular dynamic simulation sarscov<NUMBER> spike bound ace<NUMBER> found significant flexibility rbd conformation peng et al <NUMBER> em study sarscov<NUMBER> spike reported distribution rbd conformers different ace<NUMBER>bound structure compared unbound structure kirchdoerfer et al <NUMBER> accordance studies results support model ace<NUMBER> binding induces conformational change spike enables two rbds conformation figure <NUMBER>f complex dynamic nature spikeace<NUMBER> interaction likely play key role biology sarscov<NUMBER> infection anticipate characterization interaction sarscov<NUMBER> spike native ace<NUMBER> elucidate exact nature binding furthermore findings important ramifications developing successful protein therapeutic covid<NUMBER> recombinant ace<NUMBER> proteins antibodies block host ace<NUMBER>viral spike interaction promising antisarscov<NUMBER> therapeutics much higher potency ace<NUMBER>fc comparison ace<NUMBER> monomer observed live virus neutralization assays suggest monovalent therapeutics ace<NUMBER> monomers fab domains likely much less effective multimeric formats dimeric ace<NUMBER> ectodomain monteil et al <NUMBER> ace<NUMBER>fc lei et al <NUMBER> yan et al <NUMBER> igg figure <NUMBER>g finally results highlight importance understanding ace<NUMBER>spike interaction context flspike trimer also hope spike ace<NUMBER> constructs generated useful tools greater research community enable better understanding sarscov<NUMBER> biology thank members wells lab particularly working covid<NUMBER> project efforts contributions also thank dr john pak chan zuckerberg initiative biohub authors declare competing interests plasmids constructed standard molecular biology methods flspike plasmid generous gift pak lab chan zuckerberg initiative biohub krammer lab icahn smbit tag ace<NUMBER>fcsmbit fusion plasmids generated overlapextension pcr also <NUMBER>amino acid nterminal fusion <NUMBER>amino acid cterminal fusion linker ace<NUMBER> fc domains cterminal avitag removed ace<NUMBER>fc reporter plasmids complete plasmid sequences available upon request ace<NUMBER> spike proteins expressed purified expi<NUMBER> bira cells according established protocol manufacturer thermo fisher scientific briefly <NUMBER> Âµg pfuse invivogen vector encoding protein interest transiently transfected <NUMBER> million expi<NUMBER> bira cells using expifectamine kit thermo fischer scientific enhancer added <NUMBER> h transfection cells incubated total <NUMBER> <NUMBER> Â°c <NUMBER> co<NUMBER> environment supernatants harvested centrifugation fcfusion proteins purified protein affinity chromatography histagged proteins purified ninta affinity chromatography purity integrity assessed sdspage purified protein buffer exchanged pbs stored <NUMBER> Â°c aliquots histagged recombinant tev protease <NUMBER> mg purified ace<NUMBER>fc protein mixed reaction tube rotated <NUMBER> Â°c <NUMBER> minutes cleavage reaction incubated washed beads rotating <NUMBER> Â°c <NUMBER> minutes incubation occurred additional <NUMBER> Âµl magnetic protein beads <NUMBER> Âµl ninta beads prepared described supernatant first bead clearance transferred newly prepared beads allowed incubate additional <NUMBER> minutes <NUMBER> Â°c remove beads protein supernatant reaction mixture spin filtered <NUMBER> g <NUMBER> min washed additional <NUMBER> ul pbs<NUMBER> mm imidazole histagged tev biotinylated fc uncut ace<NUMBER>fc remained beads monomeric ace<NUMBER> isolated flowthrough purity monomeric ace<NUMBER> confirmed sdspage electrophoresis purified protein buffer exchanged pbs store <NUMBER> Â°c aliquots assess stability proteins measured melting temperature tm differential scanning fluorimetry dsf method described previously hornsby et al <NUMBER> briefly purified protein diluted <NUMBER> Âµm <NUMBER> Âµm dsf buffer containing sypro orange <NUMBER>x invitrogen pbs <NUMBER> Âµl reaction mixture transferred one well <NUMBER>well pcr plate duplicate prepared needed roche lc<NUMBER> lightcycler reaction heated <NUMBER>Â°c <NUMBER>Â°c ramp rate <NUMBER>Â°c per <NUMBER> sec intensities fluorescent signal <NUMBER> nm <NUMBER> nm excitation emission wavelengths continuously collected curve peak corresponds melting temperature protein data processed tm calculated using roche lc<NUMBER> lightcycler software biolayer interferometry data measured using octet red<NUMBER> fortebio biotinylated spike spike rbd protein immobilized streptavidin sa biosensor fortebio blocking biotin purified ace<NUMBER> proteins solution used analyte pbs <NUMBER> tween<NUMBER> <NUMBER> bsa used diluents buffers <NUMBER> monovalent binding model used fit kinetic parameters kon koff spikefc magnetic bead assay magnetic beads prepared taking <NUMBER> Âµl streptavidin magnesphere paramagnetic particles promega incubated <NUMBER> Âµm spikefcavitag <NUMBER> minutes rotating room temperature following beads blocked <NUMBER> um biotin <NUMBER> minutes beads washed three times pbs <NUMBER> tween <NUMBER> bsa <NUMBER> Âµl <NUMBER>fold dilutions beads incubated <NUMBER>Âµl premixed <NUMBER> nm ace<NUMBER>fcsmbit ace<NUMBER>fclgbit fusions sample incubated shaking room temperature <NUMBER> minutes nanoglo lucfierase substrate promega diluted nanoglo luciferase buffer added well <NUMBER> Âµl luminescence measured tecan m<NUMBER> plate reader <NUMBER> minutes flspike detection <NUMBER> Âµl flspike dilutions combined <NUMBER> Âµl premixed <NUMBER> nm smbitace<NUMBER>fc lgbitace<NUMBER>fc samples incubated substrate luminescence detected described hek<NUMBER>t cells overexpressing fulllength ace<NUMBER> carrying two inactivating mutations catalytic domain h<NUMBER>n h<NUMBER>n generated using standard lentivirus transduction cells maintained dmem gibco <NUMBER> heatinactivated fetal bovine serum gentamycin <NUMBER> Âµgml blasticidin pseudotyped hiv<NUMBER> particles expressing sarscov<NUMBER> spike glycoprotein nanoluc luciferase reporter generated transfection hek<NUMBER>t cells pnl<NUMBER>denvnanoluc psarscov<NUMBER>strunc pnl<NUMBER>denvnanoluc derived pnl<NUMBER> adachi et al <NUMBER> inserting <NUMBER> bp deletion vpu stopcodon resulting loss envexpression nanoluc luciferase reporter gene nluc promega inserted place bp <NUMBER> nefframe psarscov<NUMBER>strunc generated insertion humancodon optimized gene encoding <NUMBER> aas cterminally truncated sarscov<NUMBER> spike geneart pcr<NUMBER> supernatants containing virus harvested filtered <NUMBER> hr post transfection used infection ace<NUMBER>overexpressing <NUMBER>t cells pseudotyped virus preincubated serially diluted ace<NUMBER>fc ace<NUMBER> monomer <NUMBER> Â°c <NUMBER> hr addition cells cells washed twice pbs <NUMBER> hr post infection lysed luciferase cell culture lysis <NUMBER>x reagent promega relative luminescence units normalized derived cells infected sarscov<NUMBER> pseudotyped virus absence ace<NUMBER>fcace<NUMBER> monomer half maximal inhibitory concentration ic<NUMBER> determined using <NUMBER>parameter nonlinear regression graphpad prism concentration ace<NUMBER>fcace<NUMBER> monomer tested duplicate reported average standard deviation experiment two biological replicates ace<NUMBER>fc treatment obtained exp <NUMBER> exp <NUMBER> handling experiments using sarscov<NUMBER> conducted biosafety level <NUMBER> containment approved bua protocols sarscov<NUMBER> clinical isolate <NUMBER>ncovusawa<NUMBER> obtained bei resources harcourt et al <NUMBER> prior experiments virus passed vero e<NUMBER> cells create working stocks titers measured plaque formation assay experiments vero e<NUMBER> cells cultured minimal essential media mem <NUMBER> fetal bovine serum fbs <NUMBER> penstrep seeded <NUMBER>well culture plates <NUMBER>e<NUMBER> cellswell day prior infection sarscov<NUMBER> performed using moi <NUMBER> virus incubated infection media emem <NUMBER> fbs containing <NUMBER> nm monomeric ace<NUMBER> <NUMBER> nm dimeric ace<NUMBER>fc blocker <NUMBER> hour <NUMBER> Â°c culture media removed vero e<NUMBER> cells <NUMBER> Âµl blockervirus inoculum added <NUMBER> hour <NUMBER> Â°c subsequently <NUMBER> ml cell culture media added cells incubated <NUMBER> Â°c additional <NUMBER> hours rna harvest viral entry cells cellular transcription viral genes measured qpcr cellular rna isolated converted cdna using rnaeasy rna extraction kit qiagen quantitect reversetranscriptase kit qiagen according manufacturer instructions qpcr reactions prepared using sybr select master mix thermo following conditions n gene e gene hgusb gene primer cross reactive cercopithecus aethiops concentration <NUMBER> nm annealing temperature <NUMBER> Â°c hactb gene primer biolayer interferometry bli data ace<NUMBER> monomer ace<NUMBER>fc dimer binding immobilized spike rbdmonomer rbdfc dimer trimeric flspike ectodomain spike variants loaded onto sensors binding <NUMBER> nm ace<NUMBER> monomer ace<NUMBER>fc used analytes solution concentrations ranging <NUMBER> nm <NUMBER> nm although ace<NUMBER> monomer bound spikerbdmonomer spikerbdfc kd <NUMBER> <NUMBER> nm respectively bind flspike strongly ac contrast ace<NUMBER>fc dimer bound forms affinities <NUMBER> nm <NUMBER> pm <NUMBER> nm df although ace<NUMBER>fc bind spikerbdfc strong intramolecular avidity <NUMBER>on<NUMBER> interaction present context flspike indicating one arm ace<NUMBER>fc engage rbd flspike decreased kon koff ace<NUMBER>fc context flspike f compared spikerbdmonomer indicates conformational changes rbd context spike trimer important interaction ace<NUMBER>fc flspike nterminal ace<NUMBER> nanobit system able detect spikerbdfc bound magnetic beads better sensitivity cterminal fusions supplementary figure s<NUMBER> f cartoon depiction nterminal ace<NUMBER> nanobit sensor system detect flspike solution g nterminal ace<NUMBER> nanobit system able detect flspike solution indicating one rbd flspike trimer conformation two ace<NUMBER>fc molecules bind reconstitute split enzyme assays luminescence signal normalized nobead control average standard deviation plotted n<NUMBER> majority flspike proteins closed partially closed conformation opening rbd spike necessary ace<NUMBER> binding b monomeric ace<NUMBER> binds poorly trimeric spike c ace<NUMBER>fc binds much stronger spike monomer indicating rebinding intraspike avidity contribute significantly highaffinity nature interaction dimeric ace<NUMBER>fc interact flspike full twoontwo intramolecular avidity e one rbd conformation enabling engagement separate ace<NUMBER> molecules twoup conformation shown rbd conformations also possible f proposed model ace<NUMBER> binding may induce conformational change spike resulting twoup threeup rbd conformations h dimeric molecules ace<NUMBER>fc igg potent monomeric inhibitor neutralizing sarscov<NUMBER> virus panels rbd open conformation colored green rbd closed formation colored grey viral infections constitute serious public health social problem worldwide especially recent covid<NUMBER> pandemic caused betacoronavirus sarscov<NUMBER> <NUMBER> virus utilizes glycosylated spike protein bind host angiotensinconverting enzyme <NUMBER> ace<NUMBER> tmprss<NUMBER> <NUMBER> <NUMBER> initial crucial infection steps different carbohydratemediated interactions playing key roles hostpathogen interface shown many viruses hiv<NUMBER> influenza viruses ebolavirus sarscov <NUMBER> <NUMBER> viral proteins often highly glycosylated recognized different carbohydratebinding proteins host triggering simultaneously immuneresponses facilitate inhibit viral entry dissemination <NUMBER> contrast pathogens rare exceptions viruses glycosylation machinery exploit host intracellular glycosylation machinery viral intracellular replication due high evolutionary pressure glycosylation profiles various humaninfecting viruses different classic hostglycosylated protein described example surface proteins hiv<NUMBER> ebolavirus mers sarscov siv <NUMBER> <NUMBER> glycans viral proteins important proper folding modulating accessibility host proteases neutralizing antibodies <NUMBER> virus exploited hostglycosylation machinery camouflage strategy hiding hypothetical immunogenic epitopes well using host carbohydrate binding receptors entry mechanisms example described ebolavirus <NUMBER> hiv<NUMBER> <NUMBER> addition low affinity antibodies viral glycoproteins reported increase viral infection <NUMBER> scenario glycosylation profiles spike glycoprotein sarscov<NUMBER> recently described <NUMBER> <NUMBER> <NUMBER> nglycosylation profile sarscov<NUMBER> spike protein expressed human embryonic kidney <NUMBER> cells hek<NUMBER> showed combination high mannoses complextype oligosaccharides including highly processed sialylated complextype glycans fucosylated glycans different glycosylation sites <NUMBER> <NUMBER> <NUMBER> interestingly nglycosylation profile sarscov<NUMBER> spike protein shows also difference compared sarscov spike protein <NUMBER> addition olinked glycan residues predicted <NUMBER> described <NUMBER> apparently three adjacent predicted olinked glycans seem unique sarscov<NUMBER> spike protein hostimmune system evolutionary conserved class carbohydratebinding proteins lectins able sense different glycanepitopes triggering innate responses carbohydratedependent manner <NUMBER> frame ctype lectins dendritic cellspecific intercellular adhesion molecule<NUMBER>grabbing nonintegrin dcsign langerin described wellknown receptor dendritic cells used many viruses entry mechanism hiv<NUMBER> <NUMBER> <NUMBER> ebolavirus <NUMBER> macrophage galactose binding lectin mgl mannose receptor mr play role influenza virus infection <NUMBER> sialic acidbinding immunoglobulintype lectins siglecs<NUMBER> involved hiv<NUMBER> trans infection ebolavirus uptake <NUMBER> <NUMBER> context sarscov<NUMBER> infection investigated interactions glycosylated viral spike protein expressed hek<NUMBER> cells host immune lectins via solidphase immunoassays screened library different human ctype lectins expressed myeloid cells antigenpresenting cells like dendritic cells macrophages dcsign langerin mgl mr dectin<NUMBER> macrophage inducible calcium dependent lectin receptor mincle soluble mbl bind sarscov<NUMBER> spike protein used coating agent elisa experiments figure <NUMBER> clearly shows binding sarscov<NUMBER> spike protein human lectin receptors dcsign mgl binding dcsign langerin mr mbl suggests interactions specific fucosylated glycans present n<NUMBER> core Î±<NUMBER> fucose lex type structures <NUMBER> particular conformation highmannoses able discriminate dcsign langerin binding sarscov<NUMBER> spike protein mgl fits presence oglycans thr<NUMBER> ser<NUMBER> spike protein <NUMBER> specificity mgl described Î± Î² galgalnac containing glycoconjugates <NUMBER> surprisingly mgl dcsign receptors found tolerogenic macrophagesdendritic cells carbohydratebinding shown hijack myeloid function keeping macrophages immunesilent induction antiinflammatory cytokines induction cell apoptosisexhaustion <NUMBER> although oligomannosidescontent spike protein reported around <NUMBER> man<NUMBER>glcnac<NUMBER> described predominant oligomannosetype glycan n<NUMBER> n<NUMBER> <NUMBER> see binding langerin mr mbl bona fide lectins able recognize mannosides despite fact mr mannosebinding evolved separately ctype lectins mbl mr close similarity mannosebinding profiles <NUMBER> however human lectins able bind positive controls experiment illustrating sensitivity assay lectins bind carbohydrate structures see figure s<NUMBER> specific binding dcsign langerin shown also marburg virus marv <NUMBER> viruses like hiv<NUMBER> binds receptors <NUMBER> fact sarscov<NUMBER> spike protein binds dcsign langerin mr mbl may indicate highmannoses accessible preferential specificity different fucosylated residues context core fucosylation terminal lewis antigens spike protein line finding lectins bind spike protein confirming poor accessibility spike protein highmannoses immune system expected lectin mincle dectin<NUMBER> recognising mostly mycobacterial glycolipids betaglucans respectively used control bind spike protein full figure positive controls shown figure s<NUMBER> binding sarscov<NUMBER> spike protein human ctype lectins human ctype lectins elisa results wells coated viral spike protein binding different ctype lectins evaluated calciumcontaining buffer experiment performed three times duplicate similar results data normalized signal bsacoated wells error bars indicate standard deviations od optical density since sarscov<NUMBER> spike protein described express highly processed sialylated complexglycans n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> <NUMBER> investigated whether glycans could signature sialicacid binding lectins siglecs family carbohydrate receptors immunereceptor tyrosinebased inhibition motif itim known immune inhibitory signaling properties <NUMBER> using solidphase immunoassay screeningsystem library different siglecs siglec<NUMBER> siglec<NUMBER> siglec<NUMBER> siglec<NUMBER> siglec<NUMBER> explored binding activity sarscov<NUMBER> spike protein siglecs expressed almost immune cells including b cells monocytes eosinophils macrophages <NUMBER> although siglecs bona fide sialicacids binding proteins literature consistent assigning specific sialylated pattern siglec notwithstanding human siglec<NUMBER> siglec<NUMBER> prevalence interact Î±<NUMBER> linked sialic acids siglec<NUMBER> prevalence interact Î±<NUMBER> linked sialic acids context cases fucosylated sulfated oligosaccharides siglec<NUMBER> highly expressed macrophages monocytes siglec<NUMBER> monocytes neutrophils conventional dendritic cells nk cells siglec<NUMBER> b cells monocytes eosinophils <NUMBER> different siglecs implicated cellmediated tolerance alter b cell function inhibitory siglec<NUMBER> siglec<NUMBER> upregulated tumorinfiltrating cd<NUMBER> cd<NUMBER> cells contributing exhaustion tumor cell responses <NUMBER> shown figure <NUMBER> observed specific interaction sarscov<NUMBER> spike protein siglec<NUMBER> siglec<NUMBER> siglec<NUMBER> results clearly suggest presence Î±<NUMBER> Î±<NUMBER> linked sialic acids viral spike protein well roles immunomodulatory siglecs sarscov<NUMBER> infection probably altering modulating bcells neutrophil eosinophils monocytes macrophages function full figure positive controls shown figure s<NUMBER> experiment performed three times duplicate similar results data normalized signal blocking buffercoated wells error bars indicate standard deviations od optical density data illustrate heterogeneous glycanrepertoire expressed sarscov<NUMBER> spike protein modulate binding different carbohydratebinding receptors expressed host immune cells particular speculate spike protein could target repertoire immune inhibiting glycan binding receptors dcsign mgl siglec<NUMBER> siglec<NUMBER> siglec<NUMBER> also illustrates enormous potential sarscov<NUMBER> modulate host immune system multiple levels next explored different angle carbohydratemediated interactions sarscov<NUMBER> studying interactions lung microbiota components may contribute disease severity various viruses influenza viruses hiv<NUMBER> coronavirus oc<NUMBER> mers described interact host sialicacids containing structures <NUMBER> <NUMBER> interact sulfated glycosaminoglycans suggesting carbohydraterecognition activity different viral proteins <NUMBER> context recently glycosaminoglycan heparin described interact sarscov<NUMBER> spike protein inducing conformation changes <NUMBER> heparan sulfate showed binding spike protein length dependent manner <NUMBER> starting evidences chose study interaction sarscov<NUMBER> spike protein different glycoconjugates lung microbiota mechanism underlying interactions lung microbiota viruses currently fully understood known lung resident microbiota modulates viral infections yielding beneficial outcomes conferring protection viral infection harmful outcomes since virus use resident bacteria spread host direct indirect mechanisms <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover viruses perturb integrity commensal microbiota modified viral infections age smoke turn influences virus infectivity morbidity <NUMBER> looking closely bacteria occupying lung upperrespiratory microbiota covered extremely complex library glycoconjugates mostly form bacterial capsularpolysaccharides cps lipopolysaccharides lps outer layer may contribute intimate interactions sarscov<NUMBER> lung microbiota could help understanding mechanistically viral entry also supporting therapies prognosisdiagnosis markers clinical perspective data suggest microbiota composition upperrespiratory tract acute respiratory syncytial virus infection differs healthy controls <NUMBER> covid<NUMBER> pandemic well past viral outbreaks respiratory viral infections associated coinfections streptococcus pneumoniae sp recently reported <NUMBER> covid<NUMBER> patients died also showed secondary bacterial infections fungal coinfections <NUMBER> thus proofofconcept designed solidphase immunoassay coating plates library seven structurally different cps pneumoniae seven abundant serotypes worldwide well ones included pneumococcal conjugatevaccines pcv sp<NUMBER> sp<NUMBER> sp<NUMBER>b sp<NUMBER> sp<NUMBER>c sp<NUMBER>f sp<NUMBER>f determined binding sarscov<NUMBER> spike protein fcconstruct assay quantify potential interactions surprisingly analyzing binding spike protein structurally different sp cps assay observed strong binding spike protein sp<NUMBER>f sp<NUMBER>f figure <NUMBER> spike protein able strongly recognize cps sp<NUMBER>f sp<NUMBER>f somewhat weaker interaction observed sp<NUMBER>c sp<NUMBER>b cps sp<NUMBER> sp<NUMBER> poorly bound sarscov<NUMBER> spike protein csp sp<NUMBER> recognized looking structural rationale sp<NUMBER>f sp<NUMBER>f sp<NUMBER>c sp<NUMBER>b common presence following glycan epitope glc gal <NUMBER> <NUMBER> <NUMBER> linked rham rha stands rhamnose glc glucose gal galactose interestingly sp<NUMBER> sp<NUMBER> sp<NUMBER> rhamnose structures rhamnose deoxy sugar present humans highly abundant example bacteria mycobacteria bacterial rhamnosylated glycoconjugates evolutionary conserved patterns coevolved host immune system triggering example mammals conserved abundant class naturallyacquired antirhamnose antibodies <NUMBER> despite fact see differential binding sarscov<NUMBER> spike protein different capsules sure equal amounts coated plates increase concentrations different cps showed improvement binding different monoclonal antibodies reported cps tested experimental conditions showed equal coating different cps following observation binding sarscov<NUMBER> spike protein different sp cps aimed studying also interactions lung microbiota glycoconjugates designed another elisa experiment prove spike protein binding different lps expressed surface antigens different gramnegative bacteria small library different lps pseudomonas aeruginosa salmonella typhimurium shigella flexneri tested elisa assay spike protein p aeruginosa typical widespread human opportunistic pathogen cause severe often deadly lung infections particularly immunocompromised patients increasingly resistant large number antibiotics <NUMBER> chose compare p aeruginosa two bacteria interesting lungs namely typhimurium <NUMBER> flexneri <NUMBER> enteric pathogens capable invading disseminating intestinal epithelium specific interaction spike protein lps p aeruginosa compared lps gutassociated pathogens typhimurium flexneri indeed clear showed figure <NUMBER> structural considerations mentioned sp cps might done lps intestinal pathogens tested salmonella shigella express rhamnosylatedepitopes p aeruginosa strain analysed addition opportunistic pathogen able occupy lung ecosystem p aeruginosa expresses lps containing coreantigen glc <NUMBER>rha epitope <NUMBER> also case proved different parallel experiments lectins binding three tested lps coating elisa wells similar way together results bacterial glycoconjugates suggest context sarscov<NUMBER> infection bacteria serotypes lung harbor rhamnosylatedepitopes could facilitate binding virus epithelial cells subsequent dissemination observations could trigger design new therapeutic approaches bacterial coinfections covid<NUMBER> patients unreported results indicate lung microbiota cps lps play role accelerating viral infection addition due high prevalence bacterial pneumonia covid<NUMBER> patients results could also help evaluating impact pcv vaccination covid<NUMBER> patients already suggested viral infections <NUMBER> well identify specific sp serotypes able modulate viral infection conclusion identified different carbohydratemediated interactions sarscov<NUMBER> spike protein interactions could impact drive infection severity corresponding uncontrolled immune responses inflammation processes <NUMBER> proved glycanheterogeneity sarscov<NUMBER> spike protein cause multiple interactions host lectins showed spike protein recognized specifically ctype lectins dcsign mgl different siglecs siglec<NUMBER> siglec<NUMBER> siglec<NUMBER> interestingly connects new ace<NUMBER> independent infection pathways hypothetical immune suppression monocytes macrophages dendritic cells b cells binding dcsign mgl siglec<NUMBER> siglec<NUMBER> indicates presence accessibility immune system fucosylated sialylated structures well clear presence oglycans spike glycoprotein also proved totally unexplored behavior viral proteins showing specific binding sarscov<NUMBER> different glycoconjugates expressed bacteria able colonize lungs results may implications control understand bacterial coinfections better understanding disease severity add risk factors covid<NUMBER> patients together data aim adding different carbohydratemediated interactions complex holistic picture sarscov<NUMBER> infection implications optical density od measured <NUMBER> nm elisa reader added wells <NUMBER>h room temperature gentle shaking <NUMBER> rotmin wells washed hbss <NUMBER>x<NUMBER>Âµl <NUMBER> Âµl antihuman horseradish peroxidase <NUMBER> Âµgml goat antihuman igghrp jacksonimmuno added <NUMBER> min room temperature wells washed hbss <NUMBER>x<NUMBER>Âµl finally <NUMBER> Âµl substrate solution <NUMBER>â²<NUMBER>â²tetramethylbenzidine tmb citricacetate buffer ph<NUMBER> h<NUMBER>o<NUMBER> added max <NUMBER> min incubation room temperature reaction stopped <NUMBER> Âµl h<NUMBER>so<NUMBER> <NUMBER> optical density od measured <NUMBER> nm elisa reader experiment performed three times similar results duplicate data normalized signal <NUMBER> nm carbofree blocking solutioncontaining wells polyacrylamide polymers paa functionalized different glycans purchased lectinity mw approx <NUMBER> kda carbohydrate content around <NUMBER> mol neu<NUMBER>acÎ±<NUMBER>lacc<NUMBER>paa <NUMBER>apa paasia <NUMBER> neu<NUMBER>acÎ±<NUMBER>lacglypaa <NUMBER>pa paasia <NUMBER> galÎ²och<NUMBER>ch<NUMBER>ch<NUMBER>nh<NUMBER> <NUMBER>pa paagal used concentration <NUMBER>Î¼gml paaglycoconjugates coat elisa wells spike protein bacterial glycoconjugates elisa solution <NUMBER> Âµl different bacterial glycoconjugates pneumoniae cps provided finlay vaccine institute cuba lps pseudomonas aeruginosa serotype <NUMBER> shigella flexneri strain m<NUMBER>t salmonella typhimurium sh<NUMBER> provided department chemical sciences university naples federico ii italy <NUMBER> Âµgml cps <NUMBER> Âµgml lps pbs <NUMBER>mm ph<NUMBER> used coat nunc maxisorp plate <NUMBER>h <NUMBER>Â°c discarding washing <NUMBER>x<NUMBER>Âµl pbs <NUMBER>mm ph<NUMBER> wells blocked <NUMBER> Âµl carbofree blocking solution vector laboratories catalog nonc<NUMBER> <NUMBER>Â°c <NUMBER> min blocking solution discarded <NUMBER>Âµl sarscov earliest coronavirus isolates identified mammalian avian sources <NUMBER>s <NUMBER>s beaudette hudson <NUMBER> doyle hutchings <NUMBER> cheevers daniels <NUMBER> time electron microscopy revealed prominent large spikes surface virions whose resulting crownlike appearance gave rise name coronavirus fig <NUMBER> coronaviruses <NUMBER> structural proteins including spike protein envelope protein e membrane protein nucleocapsid protein n members coronavirus phylogenetic subgroup <NUMBER>a shorter protein called hemagglutinin esterase sarscov genome unusually large at<NUMBER> kb encodes <NUMBER> open reading frames several proteins marra et al <NUMBER> rota et al <NUMBER> interior lipid envelope sarscov appears gap observed low density threedimensional <NUMBER>d structures fig <NUMBER> <NUMBER> dense layer presumably surface nucleocapsid comprising mainly n protein details nucleocapsid organized clear however n protein presumably anchored cytoplasmic side virion envelope via protein low abundance protein may account gap low density envelope nucleocapsid electron microscopic examination shows evidence supercoiled rna seen paramyxoviruses interior appears amorphous cryoelectron microscopy cryoem hence arrangement whereby rna may bound nucleocapsid protein clear striking feature sarscov spike huge mass <NUMBER> kd per trimer however despite size differences sarscov spike performs fundamental task viral entry host cell smaller type <NUMBER> viral fusion proteins influenza hemagglutinin ha <NUMBER> kd per trimer sarscov spike subdivided four structural domains n c terminus two large external domains s<NUMBER> s<NUMBER> largely responsible receptor binding membrane fusion respectively type <NUMBER> viral fusion proteins analogous peptides generated proteolysis spike precursor maturation process host cell yielding two peptides fusion peptide n terminus s<NUMBER> sarscov s<NUMBER>s<NUMBER> assignment given based sequence homology viral fusion proteins although appears peptide cleavage final two small domains comprised transmembrane domain carboxyterminal cytoplasmic domain cellsurface molecule angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor sarscov protein relatively large macromolecule diameter <NUMBER> Ã¥ comparison receptor influenza ha sialic acid much smaller <NUMBER> Ã¥ diameter one challenges achieving structural molecular studies native sarscov classified biological safety level <NUMBER> organism requiring handling containment however shown specimens could girradiated sufficient dose <NUMBER> mrad viral inactivation still preserving protein structure possible carry cryoem intact virions obtain <NUMBER>d structure native unfixed virions spike using single particle image processing averaging multiple images containing booth et al <NUMBER> beniac et al <NUMBER> immunolabeling showed virions intact antigenically well structurally fig <NUMBER> still able bind sarscov receptor ace<NUMBER> cryoem coupled <NUMBER>d singleparticle image analysis used determine structure sarscov spike positioning binding ace<NUMBER> spike beniac et al <NUMBER> beniac et al <NUMBER> spikes surface virus particles readily imaged cryoem frozenhydrated native state fig <NUMBER>e <NUMBER>d image processing carried selected spikes using singleparticle image processing penczek et al <NUMBER> frank et al <NUMBER> beniac et al <NUMBER> structures spike spikeace<NUMBER> complex solved <NUMBER> Ã¥ resolution figs <NUMBER> <NUMBER> beniac et al <NUMBER> beniac et al <NUMBER> spike shows striking structure <NUMBER> Ã¥ diameter three distinct lobes domains <NUMBER> Ã¥ thick subunit trimer similar appearance blades propeller thin stalk connecting spike viral envelope blades twisted angle of<NUMBER> axis symmetry almost certainly composed spike s<NUMBER> domain atomic resolution structures docked within sarscov spikeace<NUMBER> <NUMBER>d reconstruction pdb id code <NUMBER>ajf ace<NUMBER> blue receptorbinding domain red <NUMBER>fxp yellow arrow points c terminus ace<NUMBER> color scheme ace<NUMBER> violet spike green stalk blue envelope beige nucleocapsid red scale bar <NUMBER> Ã¥ ace<NUMBER> binding result fundamental structural unfolding spike however overall height spike reduced <NUMBER> Ã¥ <NUMBER> Ã¥ following binding viewed endon spike undergoes rotation of<NUMBER> following binding mass center axis symmetry distal end spike redistributes redistributions mass identified difference maps two reconstructions fig <NUMBER> upon ace<NUMBER> binding spike undergoes decondensation mass around central axis fig <NUMBER>b g blue region putative location s<NUMBER> domain difference map bound spike fig <NUMBER> <NUMBER>di shows changes ace<NUMBER> component purple outer edges three blades s<NUMBER> domain green precise location ace<NUMBER> binding distal end spike centered <NUMBER> Ã¥ central axis spike <NUMBER> Ã¥ gap axis symmetry ace<NUMBER> one ace<NUMBER> molecule bind three propellerlike blades spike making structure <NUMBER> Ã¥ high fig <NUMBER> <NUMBER>b binding one ace<NUMBER> spike one two propeller blades trimer possible hence binding one ace<NUMBER> molecule stearically hinder binding additional ace<NUMBER> molecules cryoem <NUMBER>d structures spike spikeÃ ace<NUMBER> complex combined atomic resolution structures sarscov spike receptorbinding domain ace<NUMBER> complex li et al <NUMBER>a heptad repeat preand postfusion cores supekar et al <NUMBER> hakanssonmcreynolds et al <NUMBER> show receptorbinding domain docks distal end spike ace<NUMBER> fig <NUMBER> cryoem reconstruction sarscov spike af subtracted sarscov spikeace<NUMBER> complex ej positive component attributed sarscov spike bg indicates rearrangement s<NUMBER> core positive component attributed sarscovace<NUMBER> complex shows addition ace<NUMBER> exterior rearrangement s<NUMBER> di net difference map presented ch structures presented side perspective ae endon perspective fj arrows f j illustrate mass reorganization occurs central axis spike one small central blob splits three nubs af region spike adjacent ace<NUMBER> corresponds receptorbinding domain highlighted dotted line colored purple color scheme fig <NUMBER> <NUMBER> scale bar <NUMBER> Ã¥ filling extra mass spike shown color violet fig <NUMBER> <NUMBER> empty upper region mass appears components second ace<NUMBER> fc component chimeric protein location cterminus docked ace<NUMBER> consistent interpretation viral membrane fusion proteins responsible binding cellular receptors subsequent fusion viral cellular membranes paradigm type <NUMBER> fusion proteins consists two heptad repeat regions hydrophobic fusion peptide dutch et al <NUMBER> motif present sarscov hakanssonmcreynolds et al <NUMBER> coronaviruses xu et al <NUMBER> well hemagglutinin ha influenza skehel wiley <NUMBER> gp<NUMBER> human tcell leukemia virus type <NUMBER> kobe et al <NUMBER> gp<NUMBER> hiv weissenhorn et al <NUMBER> gp<NUMBER> ebola weissenhorn et al <NUMBER> malashkevich et al <NUMBER> fusion protein paramyxovirus zhao et al <NUMBER> chen et al <NUMBER> type <NUMBER> viral fusion proteins also divided two subtypes whose fusion mechanism low phdependent influenza ha phindependent like retroviral fusion proteins retroviruses receptor binding trigger fusion temperature redox conditions also influencing fusion mechanism hernandez et al <NUMBER> damico et al <NUMBER> sarscov spike appears insensitive redox conditions fenouillet et al <NUMBER> although factors trigger fusion endocytosis ph sensitivity single receptor vs primary coreceptor binding redox change differ amongst diverse virus families viral fusion proteins thought share basic fusion mechanism baker et al <NUMBER> skehel wiley <NUMBER> dutch et al <NUMBER> colman lawrence <NUMBER> dimitrov <NUMBER> hofmann pohlmann <NUMBER> precise mechanisms type <NUMBER> viral fusion proteins gain access host cell remain unknown hypothetical entry process includes several steps take place sequence receptor binding fusion core rearrangement fusion peptide insertion host cell membrane refolding heptad repeats membrane fusion finally viral nucleocapsid transfer earp et al <NUMBER> proposed models membrane fusion postulated s<NUMBER> domain analogous receptorbinding domains dissociate spike membrane fusion process dynamic process demonstrated influenza ha kemble et al <NUMBER> investigation engineered intermonomer disulfide bonds ha s<NUMBER> subunits result fusion activity impaired however could restored reducing conditions probable sarscov spike shares similar mechanism structural changes detected cryoem representing initial step process analogy type <NUMBER> viral fusion proteins fusion core sarscov spike thought undergo similar structural rearrangements fusion receptorbinding domain localized position distal end molecule closer <NUMBER>fold axis anticipated yet still position would impede structural rearrangements putative mechanisms type <NUMBER> viral fusion proteins achieve membrane fusion proposed baker et al <NUMBER> skehel wiley <NUMBER> dutch et al <NUMBER> colman lawrence <NUMBER> dimitrov <NUMBER> complete structural evidence role intermediate structures mechanisms yet obtained structural biology process best characterized influenza ha paramyxovirus fusion protein f prefusion membrane fusion ph structures determined xray crystallography sauter et al <NUMBER> bullough et al <NUMBER> skehel wiley <NUMBER> yin et al <NUMBER> yin et al <NUMBER> fig <NUMBER> <NUMBER> inset subsequent models type <NUMBER> viral fusion proteins based structural data two fusion proteins drawback models based recombinant ectodomains proven exist component complete molecule lack membraneinteracting residues lipids skehel wiley <NUMBER> cryoem structures intact sarscov spike bound native virion lipid envelopes instructive atomic resolution fragments docked within overall molecule especially entire sarscov spike proven difficult subject xray crystallography atomic resolution data exist fragments sarscov spike structural data modeled scheme propose mechanism sarscov spikemediated membrane fusion figs <NUMBER> <NUMBER> initial step receptorbinding domain spike attaches human receptor ace<NUMBER> point fusion core prefusion configuration three heptad <NUMBER> repeats hr<NUMBER> forming coiledcoil symmetric trimer center stalk spike hakanssonmcreynolds et al <NUMBER> next step membrane fusion process virus internalized cell endocytosis exposed low ph environment may undergo proteolytic cleavage s<NUMBER> s<NUMBER> domains simmons et al <NUMBER> next step fusion core rearrangement fusion peptide fp inserts host cell membrane fig <NUMBER> <NUMBER> initial process illustrated models m<NUMBER>m<NUMBER> based atomic structure hr<NUMBER> prefusion core begins collapse upon model m<NUMBER> manner similar occurs influenza ha skehel wiley <NUMBER> inset fig <NUMBER> <NUMBER> illustrates process ha coloring segments s<NUMBER> illustrate rearrangement m<NUMBER> m<NUMBER> takes place process propose receptorbinding domain still holds ace<NUMBER> fully extended fusion peptide positioned penetrate host membrane cryoem results show possible spike attach three ace<NUMBER> receptors may serve hold host membrane like tripod accurately orientate fusion core fig <NUMBER> addition <NUMBER> Ã¥ gap axis symmetry ace<NUMBER> provides sufficient space fusion core rearrangement damico et al <NUMBER> demonstrated kinetics binding rous sarcoma virus envelope protein ectodomain liposomes linear respect receptor concentration suggested activation trimeric ectodomain favored binding multiple receptor monomers one therefore infer structurally homologous viral envelope proteins also bind multiple receptors may general adaptation provides correct temporal spatial arrangement bring membrane fusion observation sarscov spike could bind three soluble ace<NUMBER> receptors provides three possible binding states one two three membranebound receptors attached spike fig <NUMBER> <NUMBER> present three states one receptor bound spike virus wide range movement possible whereas two receptors bound movement cryoem docked ace<NUMBER>receptorbinding domain prefusion core m<NUMBER> postfusion core m<NUMBER> structures provided start end points modeling spike rearrangement five intermediate models illustrate jackknife mechanism fusion core following color scheme used cryoem surface fig <NUMBER> <NUMBER> ribbon structures ace<NUMBER> white c terminus blue spike receptorbinding domain red hr<NUMBER> pink hr<NUMBER> yellow cylindrical models fp red hr<NUMBER> pink hr<NUMBER> yellow scale bar <NUMBER> Ã¥ greatly restricted motion one plane case three bound receptors spike fusion core arranged perpendicular cell surface minimal movement possible present demonstrated membrane fusion requires fusion core oriented perpendicular host cell membrane function however one hypothesize based orientation ace<NUMBER> distal end sarscov spike interesting note binding three receptor molecules minimum number binding events required achieve perpendicular orientation <NUMBER>d space observation matches conserved trimeric structures type <NUMBER> fusion proteins common amongst enveloped viruses thus indicating possible conserved structuralfunctional relationship may exist several steps involved viral entry broken least six components b receptor targeting c viral attachment fusion core rearrangement fusion peptide insertion e fusion core refolding f membrane fusion g nucleocapsid transfer bg host membrane represented using shaded blue line color scheme used figs <NUMBER> <NUMBER> scale bar <NUMBER> Ã¥ next step membrane fusion process involves refolding fusion core back upon adopt postfusion configuration supekar et al <NUMBER> fig <NUMBER> models m<NUMBER>m<NUMBER> configuration three heptad <NUMBER> repeats hr<NUMBER> form parallel coiledcoil trimer three hr<NUMBER> pack antiparallel fashion hydrophobic grooves hr<NUMBER> trimer result fp transmembrane regions spike brought close proximity resulting host viral membranes close contact sarscov virion average <NUMBER> spikes beniac et al <NUMBER> density several spikes would close enough together act concert disrupt plasma membrane induce pore formation viral cellular membranes opening pores would allow sarscov nucleocapsid enter host cell cytoplasm shown model fig <NUMBER> <NUMBER> multiple sarscov spike trimers may involved formation fusion pore similar situation influenza suggested three six ha trimers may involved production fusion pore skehel wiley <NUMBER> figs <NUMBER> <NUMBER> presented ace<NUMBER>sarss<NUMBER> domains fig <NUMBER> binding sarscov spike multiple receptors presented three <NUMBER> orthographic views x z axes one receptor bound wide range motion possible binding two receptors freedom movement greatly reduced motion one plane b three receptors bound spike positioned way movement restrained fusion core perpendicular host cell membrane c host membrane represented using shaded blue surface fig <NUMBER> color scheme used sarscov spike fig <NUMBER> <NUMBER> scale bar <NUMBER> Ã¥ solved cryoem investigation model membrane fusion present fusion proteins like influenza ha<NUMBER> hiv gp<NUMBER> modeled rearrangements upon membrane fusion dramatic involving shedding abovementioned domains cryoem investigations detected structural movement s<NUMBER> upon ace<NUMBER> binding could represent initial phase dramatic process postulated occur course membrane fusion analysis structure spikereceptor complex demonstrates sarscov adapt utilize receptors different species may evolve gain specificity new receptor types redundancy great deal protein mass accommodate evolutionary changes rna viruses high rate mutation recombination moya et al <NUMBER> sarscov spike able retain specific binding affinity ace<NUMBER> one host species rapid evolution gain specificity novel ace<NUMBER> species demonstrated li et al <NUMBER>b li et al <NUMBER> large size spike coronaviruses may related use large host cellsurface molecules ace<NUMBER> specific receptors amongst coronavirus family specific cellsurface receptors protein range <NUMBER> kd wentworth holmes <NUMBER> large host receptor molecules course functionally constrained turn relatively well conserved across species barriers utilizing binding large receptor molecule spike s<NUMBER> domain also acts spacer arm holding receptor far enough away threefold axis symmetry spike s<NUMBER> domain permit fusion core rearrangement subsequent membrane fusion property necessitates large spike molecule moreover multiple receptor binding functional significance enhancing binding entry viruses crosslinking adjacent host receptor molecules could increase affinity virus target cell well improving kinetics fusion sarscov spike useful model system investigation type <NUMBER> viral fusion protein dynamics utilizing system research may lead possibility developing broadspectrum antivirals target conserved cell fusion mechanisms shared diverse virus families outbreak new type severe pneumonia covid<NUMBER> started december <NUMBER> <NUMBER> going worldwide caused <NUMBER> fatalities infected <NUMBER> individuals globally although earlier infected cases mainly found china march <NUMBER> particularly hubei province confirmed covid<NUMBER> cases reported <NUMBER> countries territories end march <NUMBER> still increasing rapidly one urgent desire coping global crisis develop discover drugs treat diseases caused novel coronavirus sarscov<NUMBER> also known <NUMBER>ncov<NUMBER> according genome comparative studies sarscov<NUMBER> belongs genus betacoronavirus nucleotide sequence identity <NUMBER> compared closest bat coronavirus ratg<NUMBER> <NUMBER> compared two bat sarslike viruses batslcovzc<NUMBER> batslcovzxc<NUMBER> <NUMBER> compared sarscov <NUMBER> furthermore sarscov<NUMBER> spike protein protein sequence identity <NUMBER> receptor binding domain rbd sarscov rbd denoted sarsrbd following sarscov sarscov<NUMBER> utilize human angiotensin converting enzyme <NUMBER> protein ace<NUMBER> initiate spike protein binding facilitate fusion host cells <NUMBER> <NUMBER>residue rbd sarscov spike protein found sufficient bind human ace<NUMBER> <NUMBER> based fact rbd sarscov<NUMBER> becomes critical protein target drug development treat covid<NUMBER> study started neither crystal structure sarscov<NUMBER> spike protein rbd segment determined homology modeling approach applied construct model sarscov<NUMBER> spike rbd complex human ace<NUMBER> binding domain denoted cov<NUMBER>rbdace<NUMBER> following similar approach applied predict complex structure estimate binding energies <NUMBER> high sequence similarity cov<NUMBER>rbd sarsrbd predicted structure found highly consistent resolved crystal structures <NUMBER> see another crystal structure httpnmdccnncov entrynmdcs<NUMBER> pdbid <NUMBER>lzg structures laid foundation dynamics investigation cov<NUMBER>rbdace<NUMBER> complex using computational simulation method predicted cov<NUMBER>rbdace<NUMBER> model subjected allatom molecular dynamics md simulations study binding interactions although crystal structure predicted model cov<NUMBER>rbdace<NUMBER> complex provide important information binding interactions molecular interfaces md simulations extend knowledge dynamics regime fully solvated environment importance ace<NUMBER> residues investigated simulating complexes ace<NUMBER> mutants partial dissociation ace<NUMBER> observed within <NUMBER> ns simulations control simulations sarsrbdace<NUMBER> complexes allowed detailed comparison receptor binding two different types viruses results showed wild type cov<NUMBER>rbdace<NUMBER> complex stable <NUMBER> ns simulations especially welldefined binding interface hand mutations helix<NUMBER> k<NUMBER> ace<NUMBER> alter binding revealing new binding poses reduced contacts compared crystal structures analysis interaction energy showed binding enhanced adjusting conformations form favorable interactions simulation progressed consistent increased hydrogen bonding patterns furthermore analysis also showed sarsrbd cov<NUMBER>rbd comparable binding affinities ace<NUMBER> former slightly stronger latter dynamic information obtained study shall useful understanding sarscov<NUMBER> host interaction designing inhibitors block cov<NUMBER>rbd binding computer model sarscov<NUMBER> spike rbd complex human ace<NUMBER> spike rbd sarscov<NUMBER> genbank mn<NUMBER> <NUMBER> comprises cys<NUMBER>gly<NUMBER> residues according sequence homology analysis sarscov spike rbd predicted threedimensional structure model residues obtained swissmodel server <NUMBER> predicted sarscov<NUMBER> rbd model subsequently superimposed xray structure sarscov rbd complex human ace<NUMBER> pdb code<NUMBER>ajf chain <NUMBER> finally computer model sarscov<NUMBER> rbd human ace<NUMBER> cov<NUMBER>rbdace<NUMBER> obtained simulations analysis based analysis predicted model sequence alignment literature survey two systems containing mutations human ace<NUMBER> prepared subject md simulation studies mutant construct based fact rat ace<NUMBER> markedly diminishes interactions sars spike protein <NUMBER> proposed rat ace<NUMBER> likely reduced binding affinity cov<NUMBER>rbd <NUMBER> investigate roles critical residues ace<NUMBER> created two mutants human ace<NUMBER> see table <NUMBER> <NUMBER> mutant muth<NUMBER> ace<NUMBER> nterminal residue <NUMBER> mutated residues rat ace<NUMBER> <NUMBER> mutant k<NUMBER>h highly conserved k<NUMBER> mutated histidine corresponding amino acid rat mouse ace<NUMBER> proteins focus impact two binding sites rest ace<NUMBER> kept human ace<NUMBER> predicted model cov<NUMBER>rbdace<NUMBER> complex used starting models md simulations spike protein rbd domain composed <NUMBER> residues <NUMBER> ace<NUMBER> protein contains <NUMBER> residues nterminal domain simulation parameterization equilibration prepared complex structures including mutant systems using charmmgui webserver <NUMBER> system solvated tip<NUMBER>p water sodium chloride ions neutralize systems salt concentration <NUMBER> mm approximately system composed <NUMBER> atoms parametrized charmm<NUMBER> force field <NUMBER> energy minimization using steepest descent algorithm system equilibrated human body temperature <NUMBER> k maintained nosehoover scheme three independent trajectories starting random velocities based maxwell distributions simulated cov<NUMBER>rbdace<NUMBER> sarsrbdace<NUMBER> complex systems wild types simulations time step <NUMBER> fs used pme particle mesh ewald <NUMBER> applied longrange electrostatic interactions van der waals interactions evaluated within distance cutoff <NUMBER> Ã¥ hydrogen atoms constrained using lincs algorithm <NUMBER> human ace<NUMBER> mutants complex cov<NUMBER>rbd constructed described previously mutant complex model simulated two independent trajectories furthermore crystal structure cov<NUMBER>rbdace<NUMBER> complex became available two additional simulations carried using crystal structure starting model crossvalidate simulation results based homology model trajectory propagated <NUMBER> ns following protocol wild type cov<NUMBER>rbdace<NUMBER> complex simulations analyses carried tools gromacs rmsd rmsf energy pairdist examine system properties overall stability local residue general structure fluctuations simulations gmmpbsa program <NUMBER> applied extract molecular mechanics energy emm lennard jones electrostatic interactions ace<NUMBER> rbd spike proteins vmd chimera applied analyze hydrogen bonds molecular binding interface water distributions visualization rending model images <NUMBER> <NUMBER> homology structure cov<NUMBER>rbdace<NUMBER> compared sarsrbdace<NUMBER> crystal structure newly resolved crystal structure cov<NUMBER>rbdace<NUMBER> results indicated homology model accurate especially binding interface md simulations refined side chain orientations improve model quality simulation data revealed stable binding cov<NUMBER>rbd ace<NUMBER> spite conformational changes ace<NUMBER> relative movement cov<NUMBER>rbd ace<NUMBER> mainly exhibited swinging motion pivoted binding interface simulations also revealed roles water molecules binding rbd ace<NUMBER> receptor md simulation complex ace<NUMBER> mutants suggested mutation ace<NUMBER> helix<NUMBER> k<NUMBER> alter binding modes binding affinity predicted cov<NUMBER>rbdace<NUMBER> complex structure highly similar sarsrbdace<NUMBER> shown figure <NUMBER> rbd domain rmsd <NUMBER> Ã¥ aligned residues <NUMBER> Ã¥ <NUMBER> residue pairs indicating homology model cov<NUMBER>rbd good agreement sarsrbd ace<NUMBER> residues near binding interface within <NUMBER> Ã¥ rbd rmsd smaller <NUMBER> Ã¥ compared sarsrbdace<NUMBER> complex superposed structures revealed rbdace<NUMBER> interfaces almost identical two complexes figure <NUMBER>c retrospective comparison predicted complex structure superposed newly resolved crystal models see figure <NUMBER>d detailed comparison interface results indicated homology model accurate especially binding interface residues near cov<NUMBER>rbdace<NUMBER> interface defined combined set ace<NUMBER> residues within <NUMBER> Ã¥ rbd rbd residues within <NUMBER> Ã¥ ace<NUMBER> exhibited difference <NUMBER> Ã¥ rmsd comparable difference two independently reported crystal models rmsd <NUMBER> Ã¥ comparison rmsd <NUMBER> Ã¥ residues extended region within <NUMBER> Ã¥ binding interface rbd domain spike protein showed overall rmsd values less <NUMBER> Ã¥ ace<NUMBER> domain rmsd <NUMBER> Ã¥ predicted model crystal structures three simulations cov<NUMBER>rbdace<NUMBER> systems binding interface highly stable exhibiting small conformational changes especially interfacing residues ace<NUMBER> protein rmsd residues rbd binding interface <NUMBER>Ã¥ <NUMBER>Ã¥ average side chain atom positions refined form favorable interactions figure <NUMBER>d one outstanding example k<NUMBER> sidechain pointed wrong orientation predicted structure quickly refined correct orientation consistent crystal structure right panel figure <NUMBER>d terms collective conformational changes cov<NUMBER>rbdace<NUMBER> complex showed two interesting movements <NUMBER> loop l<NUMBER> Î²<NUMBER> Î²<NUMBER> residues s<NUMBER> g<NUMBER> particular cov<NUMBER>rbd found expand interactions nterminal helix helix<NUMBER> ace<NUMBER> figure <NUMBER>a pointed away helix<NUMBER> predicted crystal structures figure <NUMBER>d left <NUMBER> tilting movement rbd relative ace<NUMBER> observed depicted swinging motion binding interface pivot see figure <NUMBER> illustration predicted crystal structures cov<NUMBER>rbdace<NUMBER> complex l<NUMBER> form close contacts ace<NUMBER> analysis crystal packing revealed loop participated interaction another asymmetric unit see supplemental information interestingly simulation data suggested l<NUMBER> could move towards ace<NUMBER> form contacts helix<NUMBER> potentially enhance binding reflected change interaction energies crystal structure c<NUMBER> c<NUMBER> rbd crosslinked via disulfide bond reduces flexibility l<NUMBER> region limiting access ace<NUMBER> hand reported binding sarsrbd ace<NUMBER> insensitive redox states cysteines high extend <NUMBER> based simulation results hypothesize reduced form c<NUMBER> c<NUMBER> also exist virus invasion host cells reduced cysteines potentially enhance binding ace<NUMBER> two simulation trajectories found l<NUMBER> remained conformations similar crystal structure cysteines c<NUMBER> c<NUMBER> close enough disulfide bond formation examining binding interface cov<NUMBER>rbd ace<NUMBER> found polar charged residues account large fraction therefore electrostatic interactions play critical roles complex formation based distances two proteins key residues binding interface identified summarized table <NUMBER> three representative models see figure <NUMBER> majority residues conserved three models except model<NUMBER> figure <NUMBER>a additional contacts ace<NUMBER> residues l<NUMBER> region highlighted green color table <NUMBER> shown figure <NUMBER> l<NUMBER> remained starting position two representative models figure <NUMBER>bc simulations carried sarsrbdace<NUMBER> complex serving comparative system interestingly sarsrbd counterpart l<NUMBER> cov<NUMBER>rbd form close contacts ace<NUMBER> three simulations worthwhile mention sequence identity cov<NUMBER>rbd sarsrbd low loop region suggesting loop region might partially responsible difference receptor binding hydrogen bonds cov<NUMBER>rbd ace<NUMBER> extracted using vmd based statistics three simulation trajectories cov<NUMBER>rbdace<NUMBER> complex <NUMBER> hydrogen bonds subunits average stringent criteria comparison sarsrbdace<NUMBER> <NUMBER> hydrogen bonds average see supplementary information statistics hydrogen bonds suggest slightly weaker binding cov<NUMBER>rbd ace<NUMBER> relative sarsrbdace<NUMBER> complex also noteworthy point important roles water molecules complex interface cov<NUMBER>rbdace<NUMBER> complex instant time approximately <NUMBER> water molecules binding interface simultaneously located within <NUMBER> Ã¥ cov<NUMBER>rbd ace<NUMBER> figure <NUMBER> water molecules function bridges forming hydrogen bonds residues rbd ace<NUMBER> dwelling time water molecules interface nanoseconds revealed md simulations results also consistent crystal structure <NUMBER> water molecules interface figure <NUMBER>c discoveries emphasize role water molecules desires detailed quantification understand interactions rbd ace<NUMBER> demonstrated ace<NUMBER> several mammalian species possess high sequence similarities yet binding sarsrbd differs significantly particular binding sarsrbd rat ace<NUMBER> much weaker discovered experiments <NUMBER> inspired information two mutants cov<NUMBER>rbdace<NUMBER> constructed <NUMBER> ace<NUMBER>muth<NUMBER> mutating nterminal helix<NUMBER> rat ace<NUMBER> <NUMBER> ace<NUMBER>k<NUMBER>h mutating k<NUMBER> histidine amino acid wild type rat ace<NUMBER> two <NUMBER>ns md simulations carried mutant system simulation showed mutations ace<NUMBER>muth<NUMBER> reduced interaction cov<NUMBER>rbd helix<NUMBER> ace<NUMBER>k<NUMBER>h showed weaker binding cov<NUMBER>rbd Î²hairpin centered h<NUMBER> using clustering analysis representative structures identified simulation trajectory figure <NUMBER> although overall topology similar wild type complex structure pronounced differences ace<NUMBER>muth<NUMBER> system cov<NUMBER>rbd tilted away ace<NUMBER> helix<NUMBER> one simulation figure <NUMBER>a cov<NUMBER>rbd lost contact helix<NUMBER> g<NUMBER> n<NUMBER> another simulation ace<NUMBER>k<NUMBER>h figure <NUMBER>c wild type ace<NUMBER> k<NUMBER> hydrogen donor mutant h<NUMBER> cannot form hydrogen bond cov<NUMBER>rbd wild type cov<NUMBER>rbdace<NUMBER> complex number contacting residue pairs significantly reduced ace<NUMBER>k<NUMBER>h mutant system line report k<NUMBER> critical residues hydrophobic neighborhood enables positively charged residue high selectivity rbd <NUMBER> physical interactions rbd ace<NUMBER> quantified simulated structures considered molecular mechanics energy emm composed van der waals electrostatic interactions furthermore number residue contacts nc rbd ace<NUMBER> extracted simulated structures emm nc indicate rbd interactions ace<NUMBER> comparable cov<NUMBER> sars spike proteins figure <NUMBER> simulations would like point energy emm physical interaction rbd ace<NUMBER> rather binding energy requires accurately incorporating solvation energy entropy furthermore standard deviations emm <NUMBER> kjmol <NUMBER> kjmol two complexes therefore infer binding affinities comparable cov<NUMBER>rbdace<NUMBER> sarsrbdace<NUMBER> simulations started predicted crystal models yielded similar results purple triangles line recent study authors showed similar binding affinity human ace<NUMBER> sarscov<NUMBER> sarscov spike proteins <NUMBER> found association rate constants kon <NUMBER>x<NUMBER> m<NUMBER>s<NUMBER> sarscov spike protein showed faster dissociation rate constant koff <NUMBER>x<NUMBER> s<NUMBER> <NUMBER> times larger sarscov<NUMBER> spike protein koff <NUMBER>x<NUMBER> s<NUMBER> similar kon values equilibrium dissociation constants kd nanomolar range reported studies sarscov<NUMBER> spike protein rbd binding human ace<NUMBER> interestingly mutation impacts reflected emm nc analysis ace<NUMBER>muth<NUMBER> likely reduce binding ace<NUMBER> due tilting movement cov<NUMBER>rbd making ace<NUMBER> helix<NUMBER> blue triangle symbol lower right see figure <NUMBER>a representative structure simulation trajectory cov<NUMBER>rbdace<NUMBER>muth<NUMBER> complex blue triangle left upper corner largest nc observed among simulations simulations complex ace<NUMBER>k<NUMBER>h mutants green diamonds number contacts reduced compared wild type system one simulation contacts cov<NUMBER>rbd helix<NUMBER> ace<NUMBER> completely lost see figure <NUMBER>c consistent less favorable interactions reflected increase emm sarsrbd interaction ace<NUMBER>muth<NUMBER> simulations revealed fewer contacts compared wild type sarsrbdace<NUMBER> complex purple stars figure <NUMBER> homology modeling cov<NUMBER>rbdace<NUMBER> complex yielded highly consistent models compared crystal structures allatom molecular dynamics simulations carried study dynamic interactions cov<NUMBER>rbd human ace<NUMBER> results compared sarsrbdace<NUMBER> system human ace<NUMBER> mutants also constructed mimic rat ace<NUMBER> investigate roles critical residues possible binding modes mammals observed md simulations improved structure binding interface strengthened interactions subunits structure complex interface highly stable simulations cov<NUMBER>rbdace<NUMBER> complex wild type loop region Î²<NUMBER> Î²<NUMBER> potentially form contacts ace<NUMBER> observed one simulation trajectory simulations results also reveal interactions cov<NUMBER>rbd ace<NUMBER> mediated water molecules interfaces stressing necessity accounting explicit water molecules quantifying binding affinity interactions rbd ace<NUMBER> quantified physical interaction energies molecular mechanics energy number contacting residues detailed comparison results suggest cov<NUMBER>rbd sarsrbd bind human ace<NUMBER> comparable affinity comparison sarsrbdace<NUMBER> cov<NUMBER>rbdace<NUMBER> complexes former forms fewer contacts latter figure <NUMBER> yet exhibiting stronger interactions decomposition emm van der waals electrostatic interactions revealed major difference attributed electrostatic interactions furthermore compared major contacting residues found sarsrbd two charged residues r<NUMBER> d<NUMBER> cov<NUMBER>rbd one charged residue k<NUMBER> complex interface polar hydrophobic residues comparable two rbds consistent statistics hydrogen bonds complex interfaces study started structure predicted using homology modeling method later found highly consistent crystal structure demonstrating potentiality structure prediction dynamics simulation revealing molecular details availability high resolution experimental information furthermore interactions cov<NUMBER>rbd ace<NUMBER> mutants mimicking rat ace<NUMBER> protein investigated results provide valuable information atomic level reduced binding affinity recent report sarscov<NUMBER> infection dog <NUMBER> remark muth<NUMBER> t<NUMBER>l q<NUMBER>k k<NUMBER>e t<NUMBER>s d<NUMBER>n h<NUMBER>q f<NUMBER>s l<NUMBER> n<NUMBER> q<NUMBER> s<NUMBER> conserved rat mouse k<NUMBER>h k<NUMBER>h h<NUMBER> conserved rat mouse table <NUMBER> contact residues cov<NUMBER>rbd ace<NUMBER> green color denotes new interaction observed crystal structure model<NUMBER> t<NUMBER> f<NUMBER> d<NUMBER> k<NUMBER> h<NUMBER> e<NUMBER> e<NUMBER> d<NUMBER> y<NUMBER> q<NUMBER> m<NUMBER> y<NUMBER> n<NUMBER> k<NUMBER> g<NUMBER> d<NUMBER> r<NUMBER> k<NUMBER> y<NUMBER> l<NUMBER> f<NUMBER> q<NUMBER> a<NUMBER> g<NUMBER> s<NUMBER> t<NUMBER> g<NUMBER> f<NUMBER> n<NUMBER> y<NUMBER> q<NUMBER> y<NUMBER> g<NUMBER> q<NUMBER> t<NUMBER> n<NUMBER> g<NUMBER> y<NUMBER> s<NUMBER> q<NUMBER> t<NUMBER> f<NUMBER> d<NUMBER> k<NUMBER> h<NUMBER> e<NUMBER> d<NUMBER> y<NUMBER> q<NUMBER> l<NUMBER> m<NUMBER> y<NUMBER> n<NUMBER> k<NUMBER> g<NUMBER> d<NUMBER> r<NUMBER> k<NUMBER> g<NUMBER> y<NUMBER> y<NUMBER> l<NUMBER> f<NUMBER> a<NUMBER> f<NUMBER> n<NUMBER> y<NUMBER> q<NUMBER> y<NUMBER> g<NUMBER> q<NUMBER> t<NUMBER> n<NUMBER> g<NUMBER> y<NUMBER> q<NUMBER> t<NUMBER> f<NUMBER> d<NUMBER> k<NUMBER> h<NUMBER> e<NUMBER> e<NUMBER> d<NUMBER> y<NUMBER> q<NUMBER> m<NUMBER> y<NUMBER> n<NUMBER> k<NUMBER> g<NUMBER> d<NUMBER> r<NUMBER> k<NUMBER> g<NUMBER> y<NUMBER> y<NUMBER> l<NUMBER> f<NUMBER> a<NUMBER> f<NUMBER> n<NUMBER> y<NUMBER> q<NUMBER> y<NUMBER> g<NUMBER> q<NUMBER> t<NUMBER> n<NUMBER> g<NUMBER> y<NUMBER> table s<NUMBER> contact residues sarscovrbdace<NUMBER> interface traj <NUMBER> traj<NUMBER> traj <NUMBER> ace<NUMBER> cov ace<NUMBER> cov ace<NUMBER> cov s<NUMBER> q<NUMBER> t<NUMBER> k<NUMBER> h<NUMBER> e<NUMBER> d<NUMBER> y<NUMBER> q<NUMBER> l<NUMBER>l l<NUMBER>l m<NUMBER> y<NUMBER> q<NUMBER> e<NUMBER> n<NUMBER> k<NUMBER> g<NUMBER> d<NUMBER> r<NUMBER> r<NUMBER> y<NUMBER> y<NUMBER> y<NUMBER> l<NUMBER> d<NUMBER> l<NUMBER> n<NUMBER> y<NUMBER> n<NUMBER> g<NUMBER> y<NUMBER> t<NUMBER> t<NUMBER> g<NUMBER> i<NUMBER> y<NUMBER> q<NUMBER> t<NUMBER> d<NUMBER> k<NUMBER> h<NUMBER> e<NUMBER> d<NUMBER> y<NUMBER> q<NUMBER> l<NUMBER>l l<NUMBER>l m<NUMBER> y<NUMBER> q<NUMBER> e<NUMBER> n<NUMBER> k<NUMBER> g<NUMBER> d<NUMBER> r<NUMBER> r<NUMBER> y<NUMBER> y<NUMBER> y<NUMBER> l<NUMBER> p<NUMBER> d<NUMBER> g<NUMBER> l<NUMBER> n<NUMBER> y<NUMBER> n<NUMBER> g<NUMBER> y<NUMBER> t<NUMBER> t<NUMBER> g<NUMBER> i<NUMBER> y<NUMBER> q<NUMBER> t<NUMBER> k<NUMBER> h<NUMBER> e<NUMBER> d<NUMBER> y<NUMBER> q<NUMBER> l<NUMBER>l l<NUMBER>l m<NUMBER> y<NUMBER> q<NUMBER> e<NUMBER> n<NUMBER> k<NUMBER> g<NUMBER> d<NUMBER> r<NUMBER> r<NUMBER> y<NUMBER> y<NUMBER> l<NUMBER> p<NUMBER> d<NUMBER> g<NUMBER> p<NUMBER> l<NUMBER> n<NUMBER> y<NUMBER> l<NUMBER> n<NUMBER> g<NUMBER> y<NUMBER> t<NUMBER> t<NUMBER> g<NUMBER> i<NUMBER> y<NUMBER> m<NUMBER> t<NUMBER> k<NUMBER> k<NUMBER> y<NUMBER> e<NUMBER> m<NUMBER> t<NUMBER> k<NUMBER> k<NUMBER> y<NUMBER> e<NUMBER> fig<NUMBER> cov<NUMBER>rbdace<NUMBER> sarsrbdace<NUMBER> superposed b c fig<NUMBER> b c severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> emerged late <NUMBER> rapidly spread causing global pandemic severe acute respiratory syndrome sars coronavirus<NUMBER> sarscov<NUMBER> utilizes heavily glycosylated spike protein bind host receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> mediate cell entry fusion <NUMBER> protein trimeric class fusion protein composed two functional subunits responsible receptor binding s<NUMBER> subunit membrane fusion s<NUMBER> subunit <NUMBER> <NUMBER> surface virally encoded protein covered hostderived glycans trimer encoding <NUMBER> nlinked glycosylation sites <NUMBER> viral fusion proteins spike proteins diverse coronaviruses hiv<NUMBER> envelope env influenza hemagglutinin ha typically covered high mannose complex glycans <NUMBER> <NUMBER> viruses rely host glycosylation machinery synthesize express glycans cover surface proteins exposed virus shield conserved neutralization epitopes immune surveillance genetic somatic diversities preclude targeting protein epitopes broadspectrum neutralization viruses may display common carbohydrate moieties targeted glycan binding agents indeed targeting glycan moieties proposed general strategy broadspectrum virus neutralization <NUMBER> <NUMBER> <NUMBER> one concern general concept glycan targeting agents may unfavorable crossreactivity human tissue binding host carbohydrate moieties heavily glycosylated viral proteins hiv<NUMBER> env example significant population unprocessed oligomannosetype glycans usually observed high abundance secreted mammalian glycoproteins <NUMBER> <NUMBER> divergence host cell glycosylation nonself nature oligomannose glycans represent immunogenic targets indeed number antihiv<NUMBER> broadly neutralizing antibodies bnabs isolated specifically target gp<NUMBER> glycans part epitope <NUMBER> <NUMBER> <NUMBER> sitespecific glycan analysis sarscov<NUMBER> spike protein demonstrated <NUMBER> oligomannosetype glycans protein surface <NUMBER> raised hypothesis glycan shield sarscov<NUMBER> spike protein targeted hiv<NUMBER> glycanreactive antibodies tested sarscov<NUMBER> protein binding hiv<NUMBER> bnab <NUMBER>g<NUMBER> binds glycanonly epitope hiv<NUMBER> env <NUMBER> <NUMBER> <NUMBER> well panel fabdimerized glycanreactive fdg antibodies recently demonstrated fdg antibodies common hiv<NUMBER> uninfected b cell repertoire bound high mannose glycans hiv<NUMBER> env yeast environmental antigens <NUMBER> companion manuscript <NUMBER> described highly prevalent fdg antibodies target high mannose glycan shield hiv<NUMBER> env test members category antibodies binding sarscov<NUMBER> spike protein sarscov<NUMBER> protein ectodomain construct incorporating residues <NUMBER> sarscov<NUMBER> protein harboring two stabilizing proline mutations s<NUMBER> domain foldon trimerization domain well cterminal twin streptactin tags expressed purified described previously hek<NUMBER>f cells figure s<NUMBER> <NUMBER> tested three different groups fdg antibodies <NUMBER> fdg antibodies isolated shivinfected macaques shown broadly neutralize hiv<NUMBER> isolates dh<NUMBER> dh<NUMBER> dh<NUMBER> <NUMBER> fdg precursor antibodies isolated hiv naÃ¯ve human dh<NUMBER> shiv infected dh<NUMBER> dh<NUMBER> hiv env vaccinated dh<NUMBER> dh<NUMBER> dh<NUMBER> macaques <NUMBER> antibody <NUMBER>g<NUMBER> forms subcategory variable heavy vh domainswapped fdg antibody known date antibody <NUMBER>g<NUMBER> bnab neutralizes heterologous hiv<NUMBER> isolates binds conformational glycan cluster hiv<NUMBER> env <NUMBER> <NUMBER> <NUMBER> test whether fdg antibodies bind hiv<NUMBER> env glycan shield also recognize sarscov<NUMBER> spike performed elisa spr assays figures <NUMBER> s<NUMBER>s<NUMBER> positive control elisa assays included antibody d<NUMBER> see methods binds receptor binding domain rbd sarscov<NUMBER> sarscov<NUMBER> negative control antibody ch<NUMBER> <NUMBER> binds influenza hemagglutinin observed binding protein rbddirected antibody d<NUMBER> whereas binding observed negative control antibody ch<NUMBER> fdg antibodies tested bound sarscov<NUMBER> spike varying degrees figures <NUMBER> s<NUMBER> s<NUMBER> determine antibodies targeting glycan epitopes sarscov<NUMBER> protein tested binding antibodies protein presence highmannose glycan dmannose figures <NUMBER> s<NUMBER> gain insight epitope sarscov<NUMBER> spike ectodomain targeted fdg antibodies chose <NUMBER>g<NUMBER> structural determination complex sars<NUMBER> spike ectodomain nondomainswapped fdg antibodies exist mixtures yand ishaped forms <NUMBER> vh domainswapped <NUMBER>g<NUMBER> presents <NUMBER> ishaped population separated intermolecular dimer form size exclusion chromatography <NUMBER> digested using papain yield stable domainswapped fab dimer amenable structural studies figure s<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER>g<NUMBER> fab obtained papain digestion <NUMBER>g<NUMBER> igg figure s<NUMBER> bound sarscov<NUMBER> spike affinity <NUMBER> nm figure s<NUMBER> onand offrates <NUMBER> x <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> x <NUMBER> <NUMBER> <NUMBER> respectively fdg antibodies figure <NUMBER> well hiv<NUMBER> bnab <NUMBER>g<NUMBER> tested sarscov<NUMBER> plaque reduction neutralization assay negative starting <NUMBER> Âµgml data shown importantly none assays enhanced numbers viral plaques seen addition fdg antibodies visualize epitope <NUMBER>g<NUMBER> bound sarscov<NUMBER> spike determined cryoem structure <NUMBER>g<NUMBER> fab bound stabilized sarscov<NUMBER> ectodomain construct <NUMBER> figures <NUMBER> s<NUMBER> s<NUMBER> table s<NUMBER> cryoem dataset obtained <NUMBER> micrographs showed considerable compositional heterogeneity revealing populations unliganded spike well spike bound <NUMBER>g<NUMBER> <NUMBER> <NUMBER> <NUMBER> binding sites figure s<NUMBER> <NUMBER>g<NUMBER>bound spike <NUMBER> total population obtained cryoem reconstructions sarscov<NUMBER> protein bound single <NUMBER>g<NUMBER> fab <NUMBER> Ã¥ <NUMBER> particles protein bound two <NUMBER>g<NUMBER> fabs <NUMBER> Ã¥ resolution <NUMBER> particles figure s<NUMBER> also observed smaller population <NUMBER> particles showed occupancy three binding sites although <NUMBER>g<NUMBER> density one sites substantially weaker two even upon extensive <NUMBER>d classification population weaker density third site remained suggesting weak density due flexibility bound <NUMBER>g<NUMBER> rather partial occupancy maximize resolution <NUMBER>g<NUMBER> interface sarscov<NUMBER> spike performed <NUMBER>d refinement combining <NUMBER>g<NUMBER>bound particles using mask focused refinement protein one <NUMBER>g<NUMBER> fab obtained <NUMBER> Ã¥ reconstruction <NUMBER>g<NUMBER> fab bound sarscov<NUMBER> spike figures <NUMBER> s<NUMBER> table s<NUMBER> fitting map coordinates sarscov<NUMBER> spike pdb <NUMBER>vxx <NUMBER> <NUMBER>g<NUMBER> fab<NUMBER> pdb <NUMBER>n<NUMBER> <NUMBER> followed iterative coordinate refinement model building <NUMBER> <NUMBER> yielded model <NUMBER>g<NUMBER> fab<NUMBER> bound sarscov<NUMBER> spike used analysis local resolutions cryoem reconstruction spanned range <NUMBER> vh domain swapped configuration <NUMBER>g<NUMBER> fabdimer fab<NUMBER> welldefined electron density bound <NUMBER>g<NUMBER> figure <NUMBER>a b unique domainswapped architecture described previously number highresolution structures solved using xray crystallography cryoem <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> results creation two secondary binding sites either side vhvh interface addition primary binding site vhvl interface <NUMBER> cryoem reconstruction fab<NUMBER> fragment <NUMBER>g<NUMBER> bound sarscov<NUMBER> spike revealed quaternary epitope <NUMBER>g<NUMBER> s<NUMBER> subunit sarscov<NUMBER> spike glycans different protomers clustered together form <NUMBER>g<NUMBER> epitope figures <NUMBER> three protein glycans primary contributors <NUMBER>g<NUMBER> binding epitope glycans <NUMBER> <NUMBER> one protomer glycan <NUMBER> adjacent protomer figures <NUMBER> <NUMBER>g<NUMBER> fab<NUMBER> interaction sarscov<NUMBER> spike buried <NUMBER> Ã¥ <NUMBER> area interface epitope composed entirely nlinked glycans primary binding sites one vhvl interfaces contacting glycans positions n<NUMBER> n<NUMBER> figures <NUMBER>a<NUMBER>c see figure s<NUMBER> glycan nomenclature one two secondary binding sites created result vhvh domain swapping contacted glycan positions n<NUMBER> figures <NUMBER> <NUMBER> glycanonly epitopes expected mobile protein epitope investigated extent disorder motion position <NUMBER>g<NUMBER> bound protein heterogeneous <NUMBER>d classification performed cryoem dataset using mask including <NUMBER>g<NUMBER> density s<NUMBER> density excluding s<NUMBER> hr<NUMBER> regions revealed two distinct <NUMBER>g<NUMBER> orientations related <NUMBER>degree angular displacement hinge glycan <NUMBER> figure <NUMBER>a b test importance residue appeared pivot point bound <NUMBER>g<NUMBER> n<NUMBER>a glycan deletion mutant expressed purified confirmed nsem contain welldispersed properly folded spike particles figure s<NUMBER> deletion glycan position <NUMBER> resulted abrogation <NUMBER>g<NUMBER> fab binding thus confirming glycan <NUMBER> critical binding <NUMBER>g<NUMBER> sarscov<NUMBER> spike figure <NUMBER>c next tested binding panel nondomainswapped fdg antibodies n<NUMBER>a glycandeleted mutant spr assay n<NUMBER> glycan deletion either abrogated substantially reduced binding fdg iggs tested figures <NUMBER>d s<NUMBER> thus suggesting common epitope sarscov<NUMBER> spike recognized fdg antibodies vh domainswapped <NUMBER>g<NUMBER> shown bind isolated man<NUMBER> glycans hiv<NUMBER> env study demonstrate <NUMBER>g<NUMBER> also bind sarscov<NUMBER> protein figure <NUMBER>a <NUMBER> <NUMBER> <NUMBER>g<NUMBER> recognize free mannose nondomainexchanged form binds hiv<NUMBER> glycan shield domainexchanged thus highlighting importance avidity interactions glycan clusters <NUMBER> structure <NUMBER>g<NUMBER> bound hiv<NUMBER> env revealed binding sites <NUMBER> hiv<NUMBER> env glycans <NUMBER>g<NUMBER> <NUMBER> <NUMBER> one two primary binding sites vhvl interface two secondary sites vhvh interface created result domainswapping figures <NUMBER>b consistent glycanonly epitope <NUMBER>g<NUMBER> binding soluble hiv<NUMBER> env construct inhibited dmannose figure <NUMBER>d structure <NUMBER>g<NUMBER> fab<NUMBER> bound sarscov<NUMBER> protein <NUMBER> glycan binding sites <NUMBER>g<NUMBER> occupied spike glycans figure <NUMBER>c <NUMBER>g<NUMBER> showed robust glycandependent binding sarscov<NUMBER> protein binding weaker hiv<NUMBER> env figure <NUMBER>d another noteworthy difference binding <NUMBER>g<NUMBER> hiv<NUMBER> env versus binding sarscov<NUMBER> hiv<NUMBER> env binding glycans come single gp<NUMBER> monomer hiv<NUMBER> env trimer whereas sarscov<NUMBER> protein binding site quaternary <NUMBER>g<NUMBER>binding glycans site contributed two three protomers making one first examples quaternary epitope spanning multiple protomers sarscov<NUMBER> protein <NUMBER> first s<NUMBER> domain paper demonstrated category prevalent glycanreactive antibodies termed fdg antibodies bind high mannose glycans surface sarscov<NUMBER> spike protein fdg antibodies bind isolated high mannose glycans <NUMBER> <NUMBER> well high mannose glycans hiv<NUMBER> fungal pathogens candida albicans cryptococcus neoformans <NUMBER> <NUMBER> hiv<NUMBER> infection humans shiv infection macaques fdg antibodies affinity matured achieve heterologous breadth <NUMBER>g<NUMBER> hiv<NUMBER> broadly neutralizing antibody vh domain swapped architecture <NUMBER> architecture unique <NUMBER>g<NUMBER> antibody kind known long time however recently discovered nondomainswapped fdg antibodies dimerize without vh domain swapping capable broad hiv<NUMBER> broad neutralization shown dh<NUMBER> igg clonal lineage antibodies <NUMBER> show addition <NUMBER>g<NUMBER> binding vh domain swapping also required fdg antibody recognition sarscov<NUMBER> spike protein demonstrated binding nondomainswapped fdg antibodies hiv<NUMBER> envreactive fdg antibodies tested study neutralize sarscov<NUMBER> demonstration common epitope fdg antibodies exists surface sarscov<NUMBER> spike raises hypothesis sarscov<NUMBER> infection may enjoin fdg precursors select fdg affinity matured antibodies evolve capacity neutralize sarscov<NUMBER> via glycan recognition fdg precursors common human b cell repertoire demonstrates deleted due immune tolerance mechanisms <NUMBER> previously postulated <NUMBER>g<NUMBER> glycanreactive hiv<NUMBER> antibodies rare due reactivity selfglycans <NUMBER> regard select hiv<NUMBER> glycan reactive antibodies shown react surface immune cell subsets <NUMBER> whether immune tolerance mechanisms limit affinity maturation fdg antibodies potently neutralize sarscov<NUMBER> yet unknown data along companion paper describing category fdg antihiv<NUMBER> antibodies raise hypothesis preexisting antibodies raised high mannosecontaining environmental antigens fungi host molecules coopted hiv<NUMBER> env become hiv<NUMBER> broadly neutralizing antibodies propose set fdg precursor antibodies might able targeted protein sarscov<NUMBER> setting covid<NUMBER> disease vaccination induce sarscov<NUMBER> neutralizing antibodies interest determine fdg category sproteinreactive antibodies neutralize sarscov<NUMBER> isolated covid<NUMBER> infected vaccinated individuals regard ng et al demonstrated preexisting s<NUMBER> igg antibodies sarscov<NUMBER> sprotein likely induced human covs cause common cold syndromes sera able neutralize sarscov<NUMBER> <NUMBER> however remains unknown preexisting s<NUMBER>protein antibodies glycan reactive summary demonstrate reactivity pool glycanreactive antibodies quaternary epitope sarscov<NUMBER> spike protein key study determine fdg antibodies recruited vaccination develop antibodies play preventive role protection sarscov<NUMBER> infection sarscov<NUMBER> ectodomain constructs produced purified described previously <NUMBER> briefly gene encoding residues <NUMBER>â<NUMBER> sarscov<NUMBER> genbank mn<NUMBER> proline substitutions residues <NUMBER> <NUMBER> gsas substitution furin cleavage site residues <NUMBER> cterminal t<NUMBER> fibritin trimerization motif hrv<NUMBER>c protease cleavage site twinstreptag <NUMBER>xhistag synthesized cloned mammalian expression vector pÎ±h mutants introduced background expression plasmids encoding ectodomain sequence used transiently transfect freestyle<NUMBER>f cells using turbo<NUMBER> speedbiosystems protein purified sixth day post transfection filtered supernatant using streptactin resin iba figure s<NUMBER> affinity purified protein run superose <NUMBER> increase column purified protein flashfrozen liquid nitrogen stored <NUMBER>Â° c rhesus fdg mabs dh<NUMBER> dh<NUMBER> dh<NUMBER> dh<NUMBER> dh<NUMBER> dh<NUMBER> dh<NUMBER> dh<NUMBER> human fdg antibody dh<NUMBER> expressed previously described <NUMBER> antibody <NUMBER>g<NUMBER> obtained three sources either produced two sources described original sequence <NUMBER> sugar sarscov<NUMBER> trimeric spike protein captured streptavidin individual wells <NUMBER>well plate serially diluted mabs tested binding elisa binding assays optimized use sarscov<NUMBER> spike protein aliquotted frozen upon production desired aliquots frozen spike protein thawed <NUMBER> stored overnight room temperature sarscov<NUMBER> spike protein man<NUMBER>v<NUMBER> aglycone v<NUMBER> peptides captured via streptavidin nuncabsorb elisa plates using pbsbased buffers assay conditions previously described <NUMBER> <NUMBER> hiv<NUMBER> ch<NUMBER>tf sosip trimer commerciallyobtained constructs sarscov<NUMBER> spike ectodomain s<NUMBER>s<NUMBER> ecd s<NUMBER> ecd rbd sino biological inc cat <NUMBER>v<NUMBER>b<NUMBER> <NUMBER>v<NUMBER>b respectively rbd genescript cat z<NUMBER> captured using mouse antiavitag mab avidity llc aurora co brief coated <NUMBER>ng streptavidin <NUMBER>Âµl <NUMBER>Âµgml <NUMBER> ng mouse antiavitag mab <NUMBER>Âµl <NUMBER>Âµgml per well <NUMBER>well nuncabsorb elisa plate sealed incubated overnight <NUMBER> c sarscov<NUMBER> spike protein <NUMBER>Âµgml added streptavidin <NUMBER>Âµl per well <NUMBER>well plate one hour room temperature facilitate protein capture hiv<NUMBER> ch<NUMBER>tf sosip trimer sarscov<NUMBER> s<NUMBER>s<NUMBER> ecd s<NUMBER> ecd rbd spike proteins <NUMBER> Âµgml added antiavi mab <NUMBER>Âµl per well <NUMBER>well plate one hour room temperature facilitate elisas using superblock previously described <NUMBER> moreover whereas <NUMBER>g<NUMBER> polymun bound protein surface plasmon reasonance less potent recombinantly expressed <NUMBER>g<NUMBER> antibodies bind well elisa commercial <NUMBER>g<NUMBER> polymun provided maltose mannose buffer neutralization assays performed using sarscov<NUMBER> isolate usawa<NUMBER> rvu lot nr<NUMBER> source material supplied bei resources catalog number nr<NUMBER> data reported prnt<NUMBER> <NUMBER> reduction foci count relative back titer input verification endpoint titer given dilution series reported concentration lowest continuous dilution foci count less equal <NUMBER> neutralization cutoff experimental samples assayed least duplicate dilution series virus input internal assay controls within accepted tolerances <NUMBER> Âµgml final concentration spike made <NUMBER> ratio <NUMBER> glutaraldehyde hbs ph <NUMBER> <NUMBER>mm hepes <NUMBER>mm nacl <NUMBER> glycerol hbs ph <NUMBER> <NUMBER> min incubation tris ph <NUMBER> added <NUMBER>m stock final concentration <NUMBER>m quench glutaraldehyde incubated <NUMBER>min carbon coated grids cf<NUMBER>cu ems glow discharged <NUMBER>sec <NUMBER>ma <NUMBER> Âµl sample incubated grid <NUMBER> sec blotted stained <NUMBER> uranyl formate antibodies diluted <NUMBER> ruthenium red hbs ph <NUMBER> <NUMBER>min incubation <NUMBER> Âµl droplet loaded glow discharged carbon coated grid briefly rinsed dh<NUMBER>o stained <NUMBER> uranyl formate images obtained philips em<NUMBER> electron microscope operated <NUMBER> kv <NUMBER>Ã magnification <NUMBER> Ã¥ pixel size relion program used perform class averaging singleparticle images binding fdg antibodies sarscov<NUMBER> spike assessed surface plasmon resonance biacore t<NUMBER> gehealthcare <NUMBER>Â°c hbsep <NUMBER> mm hepes ph <NUMBER> <NUMBER> mm nacl <NUMBER> mm edta <NUMBER> surfactant p<NUMBER> running buffer binding measured two different formats first format figures s<NUMBER> s<NUMBER>a sarscov<NUMBER> spike captured sa chip binding response measured flowing igg solutions surface regenerated injections flowing <NUMBER>m nacl <NUMBER>mm naoh solution <NUMBER>s flow rate <NUMBER>Âµlmin second format figure s<NUMBER>b data fit <NUMBER> langmuir binding model purified sarscov<NUMBER> spike preparations diluted final concentration <NUMBER> mgml <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> mixed <NUMBER>fold molar excess <NUMBER>g<NUMBER> fab incubated <NUMBER> hours room tempearture <NUMBER> ul protein deposited cf discharge cleaning system <NUMBER> incubation <NUMBER> humidity excess protein blotted away <NUMBER> seconds plunge frozen liquid ethane using leica em gp<NUMBER> plunge freezer leica microsystems cryoem imaging performed fei titan krios microscope thermo fisher scientific operated <NUMBER> kv data acquired gatan k<NUMBER> detector operated counting mode using leginon system k<NUMBER> experimental parameters <NUMBER> ms exposure <NUMBER> frames <NUMBER> ms framerate total dose <NUMBER> ea<NUMBER> pixel size <NUMBER>Ã¥px system also energyfiltered slit width <NUMBER> ev total <NUMBER> images collected cryoem image quality monitored onthefly data collection using automated processing routines individual frames aligned doseweighted using motioncor<NUMBER> <NUMBER> implemented within appion pipeline <NUMBER> data processing performed within cryosparc <NUMBER> including particle picking multiple rounds <NUMBER>d classification ab initio reconstruction heterogeneous homogeneous map refinements nonuniform map refinements heterogenous classifications performed within relion <NUMBER> using masks produced chimera structure state pdb id <NUMBER>vxx previously published sarscov<NUMBER> ectodomain structure <NUMBER>g<NUMBER> fab bound man<NUMBER> pdb id <NUMBER>n<NUMBER> used fit cryoem maps chimerax coordinates fit manually coot <NUMBER> following iterative refinement using isolde <NUMBER> subsequent manual coordinate fitting coot structure map analysis performed using pymol chimerax <NUMBER> cryoem maps fitted coordinates process deposited electron microscopy database emdb rcsb protein data bank respectively sequences fdg antibody heavy light chain genes deposited genbank previously described <NUMBER> <NUMBER> seriallydiluted mabs tested binding also see figure s<NUMBER> s<NUMBER> mouse antirhesus goat antihuman igghrp secondary antibodies used detect binding rhesus human mabs respectively binding measured absorbance od <NUMBER>nm whereas binding titers log area curve reported figure s<NUMBER> principle new infectious agent challenges totally susceptible population little immunity able totally infect population causing pandemics pandemics rapidly spread affecting large part people causing plenty deaths significant social disruption economic loss however look even worst pandemics human history realize ethnic geographical differences susceptibility disease actually exist spite infectious sources transmission routes individuals <NUMBER> current sars covid<NUMBER> shortened form coronavirus disease <NUMBER> epidemic spread appears similarly influenced ethnical geographical factors initial spread china pandemic progressing accelerating rate western europe united states america <NUMBER> regions causative agent severe acute respiratory syndrome corona virus <NUMBER> sarscov<NUMBER> spreading incredibly quickly people due newness one earth immunity sars covid<NUMBER> transmission route yet regions world kinetics diffusion mortality seem less impressive although world become highly interconnected result huge growth trades travels <NUMBER> multitude factors may concur explain ethnic geographical differences pandemic progression severity including cultural social economic inequality well health care system organization climate also mostly considerable individual differences genetic susceptibility diseases may involved <NUMBER> genomic predisposition major concept modern medicine understanding molecular bases genetic predisposition help find prevention treatment strategies corresponding diseases <NUMBER> sars covid<NUMBER> even subtle interindividual genetic differences may affect sarscov<NUMBER> viral life cycle host innate acquired immune response sarscov<NUMBER> enveloped positivestranded rna virus replicates cytoplasm uses envelope spike projections key enter human airway cells <NUMBER> coronaviruses spike glycoproteins forms homotrimers protruding viral surface primary determinant cell tropism pathogenesis host interspecies transmission spike glycoproteins comprise two major functional domains nterminal domain s<NUMBER> binding host cell receptor cterminal domain s<NUMBER> responsible fusion viral cellular membranes <NUMBER> following interaction host receptor internalization viral particles host cells accomplished complex mechanisms culminate activation fusogenic activity spike consequence major conformational changes general may triggered receptor binding low ph exposure proteolytic activation <NUMBER> coronaviruses spike glycoproteins cleaved furin golgiresident protease boundary s<NUMBER> s<NUMBER> domains resulting s<NUMBER> s<NUMBER> subunits remain noncovalently bound prefusion conformation important consequences fusogenicity <NUMBER> notably variance sarscov sarslike cov spike glycoproteins sarscov<NUMBER> spike glycoprotein contain furin cleavage site s<NUMBER>s<NUMBER> boundary cleaved viral biogenesis <NUMBER> may affect major entry route viruses host cell <NUMBER> productive entry coronaviruses harbor noncleaved spike glycoproteins sarscov rely endosomal proteases suggesting entry accomplished hijacking host endocytic machinery <NUMBER> indeed reported sarscov infection inhibited lysomotropic agents inhibition lowphactivated protease cathepsin l <NUMBER> however sarscov also able fuse directly cell membrane presence relevant exogenous proteases entry route believed much efficient compared endocytic route <NUMBER> fact proteases respiratory tract belonging transmembrane proteaseserine subfamily tmprss tmprss<NUMBER> hat tmprss<NUMBER>d able induce sarscov spike glycoprotein fusogenic activity <NUMBER> first cleavage s<NUMBER>s<NUMBER> boundary r<NUMBER> facilitates second cleavage position r<NUMBER> releasing fusogenic s<NUMBER> subdomain <NUMBER> hand also evidence cleavage ace<NUMBER> cterminal segment tmprss<NUMBER> enhance spike glycoproteindriven viral entry <NUMBER> notably recently demonstrated also sarscov<NUMBER> cell entry depends tmprss<NUMBER> blocked protease inhibitors <NUMBER> sarscov<NUMBER> respiratory syndrome corona virus sarscov spike proteins share high phylogenetic similarities <NUMBER> indeed viruses exploit human cell receptor namely angiotensinconverting enzyme <NUMBER> ace<NUMBER> transmembrane enzyme whose expression dominates lung alveolar epithelial cells <NUMBER> <NUMBER> <NUMBER> receptor <NUMBER>amino acid long captoprilinsensitive carboxypeptidase <NUMBER>amino acids nterminal signal peptide cterminal membrane anchor catalyzes cleavage angiotensin angiotensin <NUMBER> angiotensin ii vasodilator angiotensin <NUMBER> thus playing key role systemic blood pressure homeostasis counterbalancing vasoconstrictive action angiotensin ii generated cleavage angiotensin catalyzed ace <NUMBER> although ace<NUMBER> mrna expressed ubiquitously ace<NUMBER> protein expression dominates lung alveolar epithelial cells enterocytes arterial venous endothelial cells arterial smooth muscle cells <NUMBER> evidence ace<NUMBER> may serve chaperone membrane trafficking amino acid transporter b<NUMBER>at<NUMBER> also known slc<NUMBER>a<NUMBER> mediates uptake neutral amino acids intestinal cells sodium dependent manner <NUMBER> recently <NUMBER> Ã¥ resolution cryoem structure fulllength human ace<NUMBER> complex b<NUMBER>at<NUMBER> presented structural modelling suggests ace<NUMBER>b<NUMBER>at<NUMBER> bind two spike glycoproteins simultaneously <NUMBER> <NUMBER> hypothesized presence b<NUMBER>at<NUMBER> may block access tmprss<NUMBER> cutting site ace<NUMBER> <NUMBER> <NUMBER> b<NUMBER>at<NUMBER> also known slc<NUMBER>a<NUMBER> expressed high variability normal human lung tissues shown analysis data available oncomine work weiss et al <NUMBER> notably wide range genetic polymorphic variation characterizes ace<NUMBER> gene maps x chromosome polymorphisms significantly associated occurrence arterial hypertension diabetes mellitus cerebral stroke coronary artery disease heart septal wall thickness ventricular hypertrophy <NUMBER> <NUMBER> <NUMBER> association ace<NUMBER> polymorphisms blood pressure responses cold pressor test led hypothesis different polymorphism distribution worldwide may consequence genetic adaptation different climatic conditions <NUMBER> <NUMBER> study used combination silico tools analyze possible impact ace<NUMBER> singlenucleotide polymorphisms snps interaction sarscov<NUMBER> spike glycoprotein results seem suggest ace<NUMBER> polymorphism contribute ethnic geographical differences sars covid<NUMBER> spreading across world <NUMBER> <NUMBER>lzg sarscov<NUMBER> spike rbd ace<NUMBER> complex <NUMBER> <NUMBER>m<NUMBER>j sarscov<NUMBER> spike rbd ace<NUMBER> complex <NUMBER> <NUMBER>vw<NUMBER> chimeric sarscovsarscov<NUMBER> spike rbd ace<NUMBER> complex <NUMBER> <NUMBER>m<NUMBER> sarscov<NUMBER> spike rbd ace<NUMBER>b<NUMBER>at<NUMBER> complex <NUMBER> fig <NUMBER>a clustalo alignments human ace<NUMBER> amino acid sequences models similar sarscov rbm sarscov<NUMBER> rbm forms concave surface houses convexity formed two helices exposed surface ace<NUMBER> strong network hbond salt bridge interactions mediate receptorligand binding global energy several distinctive features <NUMBER>d models without glycosylation reported supplementary table <NUMBER> contact residues classified permanent predicted binding residues <NUMBER> models stable predicted binding residues <NUMBER> <NUMBER> <NUMBER> models unstable predicted binding residues <NUMBER> <NUMBER> <NUMBER> models hyperunstable <NUMBER> <NUMBER> models <NUMBER> twentyseven substitutions predicted influence ace<NUMBER>spike interface least one different <NUMBER>d pdb models fifteen seventeen predicted affect ace<NUMBER>b<NUMBER>at<NUMBER> ace<NUMBER>ace<NUMBER> interfaces respectively residues described uniprot database httpswwwuniprotorguniprotq<NUMBER>byf<NUMBER> important interaction spike ace<NUMBER> permanent contact residues predicted binding nonpolymorphic fig <NUMBER>b contrast polymorphic residues stable unstable hyperunstable list <NUMBER> snps dbsnp s<NUMBER>p i<NUMBER>t i<NUMBER>v e<NUMBER>k a<NUMBER>t k<NUMBER>e k<NUMBER>r t<NUMBER>a e<NUMBER>d e<NUMBER>k e<NUMBER>k s<NUMBER>r e<NUMBER>g m<NUMBER>i g<NUMBER>e e<NUMBER>g g<NUMBER>v d<NUMBER>n predicted affect ace<NUMBER>spike interface used analysis snps possibly affecting ace<NUMBER> glysosylation supplementary table <NUMBER> illustrates amino acid glycosylation sites structure glycosidic chains inferred different ace<NUMBER>spike complex pdb models putative polymorphic sites q<NUMBER>r n<NUMBER>h n<NUMBER>d n<NUMBER>s dbsnp database may affect ace<NUMBER> glycosylation also reported one amino acid variations n<NUMBER>d rather common south asia supplementary table <NUMBER> firedock <NUMBER> used estimate effects removal glycosidic residues chains ace<NUMBER> interaction sarscov<NUMBER> spike rbd calculating Î´g values data indicated removal glycosidic chains results either increased decreased Î´g values depending pdb model fig <NUMBER>c particular removal glycosidic moieties apparently strengthened ace<NUMBER>spike interaction sarscov spikeace<NUMBER> <NUMBER>ajf model appeared weaken interaction sarscov<NUMBER> spike ace<NUMBER> <NUMBER>vw<NUMBER> model cases effect mostly due removal terminal betamannose bma fig <NUMBER>c predicted decorate glycosidic chain attached aspartic amino acid residue position <NUMBER> maps helix involved interaction spike shown fig <NUMBER>d noteworthy <NUMBER>vw<NUMBER> model bma involved two hbonds one pseudobond fig <NUMBER>e bonds lost nonglycosylated models contrast <NUMBER>ajf model bma forms one hbond removal terminal bma thr<NUMBER> acquires grads binding thereby strengthening interaction ace<NUMBER> results seem suggest ace<NUMBER> glycosylation may play different role modulating interaction sarscov spike sarscov<NUMBER> spike among diffused snps worldwide two snps able potentially affect interaction ace<NUMBER> sarscov spike sarscov<NUMBER> spike supplementary table <NUMBER> particular s<NUMBER>p snp rather common african people frequency <NUMBER> k<NUMBER>r snp frequent european people frequency <NUMBER> supplementary table <NUMBER> firedock <NUMBER> results indicated s<NUMBER>p substitution decreased affinity ace<NUMBER> spike <NUMBER>ajf <NUMBER>vw<NUMBER> models fig <NUMBER>c similar results obtained models moreover amino acid substitution seems also affect ace<NUMBER> nterminal cleavage site fig <NUMBER>d firedock <NUMBER> simulations carried ace<NUMBER> alternative cleavage site effects s<NUMBER>p snp much impressive fig <NUMBER> c contrast k<NUMBER>r less common k<NUMBER>e substitutions appeared increase affinity ace<NUMBER> sarscov<NUMBER> spike <NUMBER>ajf model slightly decrease affinity ace<NUMBER> sarscov spike <NUMBER>vw<NUMBER> <NUMBER>m<NUMBER> models fig <NUMBER>a <NUMBER>vw<NUMBER> generated chimeric sarscovsarscov<NUMBER> spike support results performed additional simulation challenging ace<NUMBER> structure <NUMBER>vw<NUMBER> spike structures generated different models fig <NUMBER>b results confirmed shown fig <NUMBER>a noteworthy receptorligand interactions much weaker <NUMBER>m<NUMBER> sarscov<NUMBER> spike rbd ace<NUMBER>b<NUMBER>at<NUMBER> complex respect models confirming inhibitory function b<NUMBER>at<NUMBER> however model lower energy values effects k<NUMBER>re substitutions much evident shows ace<NUMBER> computed using <NUMBER>d pdb model <NUMBER>m<NUMBER> input file characterized high deformation tract located immediately upstream transmembrane domain fig <NUMBER>b whereas cterminal tail characterized high fluctuation fig <NUMBER>c suggest hydrophobic domain alone highly unstable membrane confirming chaperone required correct topology maintenance function assigned moonlighting amino acid transporter b<NUMBER>at<NUMBER> <NUMBER> investigate dynamic properties ace<NUMBER> globular head transmembrane helix conserved domains firstly mapped <NUMBER>d structure dynamut <NUMBER> simulation carried ace<NUMBER> using <NUMBER>wv<NUMBER> pdb model without transmembrane domain fig <NUMBER>ab results indicate residues ace<NUMBER> interface involved interaction sarscov<NUMBER> spike glycoprotein actually fluctuate fig <NUMBER>cd dynamic properties sarscov<NUMBER> sarscov spike proteins also investigated two helices betasheet residues betasheet illustrated supplementary fig <NUMBER>d fig <NUMBER>a supplementary fig <NUMBER> supplementary table <NUMBER> <NUMBER> amino acid residues reported polymorphic dbsnp analyzed women probably prone infection often present less severe disease although higher incidence cardiac respiratory metabolic comorbidities probably responsible severe form infection men estrogeninduced upregulation ace<NUMBER> expression would explain increased susceptibility women less severe often asymptomatic form disease furthermore ace<NUMBER> gene located xp<NUMBER> area genes reported escape xinactivation explaining higher expression females <NUMBER> <NUMBER> hand hypothesized regardless sex pharmacological antihypertensive drugs ace inhibitors sartans environmental factors no<NUMBER> pollution capable inducing overexpression ace<NUMBER> could responsible increased susceptibility infection andor greater severity <NUMBER> ace<NUMBER> plays essential role reninangiotensinaldosterone system loss function due massive binding viral particles internalization could constitute essential element pathophysiology pulmonary cardiac damage covid<NUMBER> infection <NUMBER> <NUMBER> context underlined ace<NUMBER> probably plays dual role dynamic infection disease course beginning ace<NUMBER> overexpression may increase entry virus cell replication consequent viralinduced loss function results unopposed accumulation angiotensin ii aggravates acute lung injury response viral infection indeed rodent blockade reninangiotensinaldosterone system limits acute lung injury induced sarscov<NUMBER> spike protein <NUMBER> suggesting ace<NUMBER> function preserved increased baseline expression especially seen premenopausal women clinical course infection might less severe suggested polymorphisms ace<NUMBER> gene could reduce spike affinity subsequent lower susceptibility infection hypothesis geographical ethnical distribution could explain strong discrepancies infection rate andor lethality observed worldwide <NUMBER> effectively showed network plot nonmetric multidimensional scaling snps diffused worldwide affect significantly interaction ace<NUMBER> sarscov<NUMBER> spike s<NUMBER>p one rare polymorphisms able potentially affect interaction lowering affinity polymorphism frequent african populations diffusion <NUMBER> remains low explain except minimal part reduced death toll allowed authors predict hamsters could infected experimentally confirmed underlining reliability silico modelingand could subsequently origin interanimal transmission however hamsters although developing clinical signs infection relative histopathological changes die <NUMBER> speculate lethality may related spikeace<NUMBER> affinity hand lower affinity bat could explain besides better immune controlwhy animals carriers without dying study chan colleagues <NUMBER> modestly snpdetermined lower affinity spike ace<NUMBER> seem explain differences distribution lethality disease humans hypothesize question addressed specular way perhaps polymorphisms responsible higher affinity responsible higher severity disease especially high affinity receptors overexpressed mentioned environmental pharmacological factors obviously underlying diseases would contribute even severe course disease intense viral replication capable infecting turn large number persons including individuals similar ace<NUMBER> polymorphisms silico models allowed us identify k<NUMBER>r k<NUMBER>e snps possible increase spikeace<NUMBER> affinity k<NUMBER>r snp relatively frequent european people frequency <NUMBER> would correspond potential target population <NUMBER> people european union level addition firedock <NUMBER> <NUMBER> simulations led predict possible effects s<NUMBER>p k<NUMBER>r k<NUMBER>e ace<NUMBER> snps dynamut <NUMBER> encom <NUMBER> tools used compare dynamic features ace<NUMBER> polymorphic variants order analyze possible indirect effects binding interfaces snps located outside interfaces snps i<NUMBER>v v<NUMBER>a a<NUMBER>t identified common snps may produce indirect effects dynamic models although precise effects snps interaction ace<NUMBER> sarscov<NUMBER> sarscov spike proteins determined detail nevertheless desirable use dynamic modeling unmask indirect effects snps seems necessary confirm vivo among patients serious disease andor fatal outcome polymorphisms responsible high spikeace<NUMBER> affinity frequent among patients less severeasymptomatic disease even general population obviously impact polymorphisms severity outcome weighted appropriate demographic clinical factors differences confirmed would pave way identification population scale healthy individuals whose molecular phenotypes would responsible serious disease apart usual social distancing measures could reinforced cases targeted drug prevention strategies could evaluated could logical assess pharmacological prophylactic interventions proposed categories healthy people particular risk exposure caregivers particular chloroquine interfering nterminal glycosylation ace<NUMBER> could lower affinity spike thus representing interesting candidate silico model found removal glycosidic moieties weakened interaction sarscov<NUMBER> spike ace<NUMBER> serine protease inhibitor camostat mesylate approved japan treat unrelated diseases shown block tmprss<NUMBER> activity <NUMBER> <NUMBER> thus another interesting candidate hand identification broader categories people lower risk developing severe disease could allow safer exit lockdown phase facilitating establishment faster herd immunity waiting reliable serological tests effective vaccines basis silico study speculate infection mortality databases <NUMBER>d structures proteins downloaded pdb rcsb protein data bank <NUMBER> focused analysis <NUMBER>ajf sarscov <NUMBER> <NUMBER> <NUMBER> used identity ace<NUMBER> receptor snps select diffused ones functional information acquired uniprot database <NUMBER> chimera <NUMBER> used tool image generation <NUMBER>d mapping pdb managing analyze results binding interface characterization selected pdb models analyzed structural point view using chimera software order identify glycosylation sites secondary structures proteins involved binding ace<NUMBER> spike protein receptor binding domain rbd estimate effect glycosylations implemented static model chimera used remove glycosydic residues firedock <NUMBER> used compute global energy scores native structures deglycosylated models side starting entire list snps ssipe evoef <NUMBER> used identify residues involved binding interfaces second step carried ssipe ssipe <NUMBER> aimed estimating effects single snps generate mutant models different snps lists obtained compared used identify stable binding amino acid residues ssipe analysis performed pdb model <NUMBER>m<NUMBER> used map ace<NUMBER>spike protein interaction interface ace<NUMBER> ace<NUMBER> dimerization interface b<NUMBER>at<NUMBER>ace<NUMBER> interaction interface model contains ace<NUMBER> dimeric form hydrophobic domains b<NUMBER>at<NUMBER> others models transmembrane domains ace<NUMBER> ace<NUMBER> interface b<NUMBER>at<NUMBER>ace<NUMBER> interface absent spike models reported study ligands similar manner static models ssipe used models estimate variation terms free energy related polymorphisms map ace<NUMBER> dimerization interface ace<NUMBER>b<NUMBER>at binding interface legends figures fig <NUMBER> <NUMBER>d oscillation plot distance ace<NUMBER> amino acid residues mapping two helices involved binding spike proteins b <NUMBER>d images regions containing amino acid residues shown panel c variance distance ace<NUMBER> amino acid residues mapping two helices involved binding spike proteins de oscillation plot distance two helices betasheet residues betasheet e fg variance distance amino acid residues two helices betasheet f residues betasheet g showing results snps mapping outside ace<NUMBER> interfaces severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> causative agent coronavirus disease <NUMBER> emerged <NUMBER> rapidly spread infecting millions overwhelming healthcare systems impacting economies worldwide cucinotta vanelli <NUMBER> respond global effort initiated develop vaccines therapeutic agents covid<NUMBER> vaccine development reviewed callaway <NUMBER> trimeric sarscov<NUMBER> spike type <NUMBER> fusion machine facilitates viruscell entry interaction ace<NUMBER> receptor hoffmann et al <NUMBER> ou et al <NUMBER> lead target antibodies block virus entry sarscov<NUMBER> neutralizing antibodies far isolated target receptor binding domain rbd spike protein brouwer et al <NUMBER> cao et al <NUMBER> chen et al <NUMBER> chi et al <NUMBER> ju et al <NUMBER> liu et al <NUMBER> pinto et al <NUMBER> robbiani et al <NUMBER> rogers et al <NUMBER> seydoux et al <NUMBER> wang et al <NUMBER>a wrapp et al <NUMBER>a zeng et al <NUMBER> zost et al <NUMBER> sites nterminal domain s<NUMBER> stem domain also associated neutralizing activity betacoronaviruses pallesen et al <NUMBER> wang et al <NUMBER>b virusneutralizing antibodies sought therapeutic prophylactic agents cao et al <NUMBER> reviewed graham et al <NUMBER> zhou zhao <NUMBER> biotinlabeled molecular probes comprising sarscov<NUMBER> spike well discrete domains accelerate development vaccines therapeutic antibodies vaccine development probes used track humoral responses longitudinally liu et al <NUMBER> yongchen et al <NUMBER> quantify elicited responses spike domains correlating responses neutralization provide crucial insight sites spike vulnerability antibody identification probes used b cell sorting identify b cells <NUMBER> encoding antibodies capable recognizing spike particular spike domains well characterization antibody binding affinities surface plasmon resonance spr biolayer interferometry bli analyses describe structurebased design molecular probes encompassing sarscov<NUMBER> spike domains first designed construct allowed tagbased purification oncolumn biotinylation next incorporated sarscov<NUMBER> spike ectodomain prefusion stabilizing mutations cterminal trimerization motif expressed biotinylated purified characterized including cryoem based structuredefined spikedomain organization wrapp et al <NUMBER>b also created characterized separate molecular probes comprising nterminal domain ntd receptorbinding domain rbd rbd spike domain <NUMBER> rbdsd<NUMBER> also used structure rbd ace<NUMBER> lan et al <NUMBER> wang et al <NUMBER>b yan et al <NUMBER>a define mutations could inhibit ace<NUMBER> interaction incorporated mutant rbd probes ace<NUMBER>recognition ablated finally characterized properties devised probes including degree biotinylation antibodybinding specificity use sorting yeast cells expressing sarscov<NUMBER> spikebinding antibodies b cells covid<NUMBER> convalescent donor overall findings demonstrate structurebased design used develop molecular probes sarscov<NUMBER> spike facilitate purification biotinylation devised probe construct using constant portion antibody fc nterminal purification tag fc expresses folds <NUMBER> efficiently effectively captured protein resins jager et al <NUMBER> prevent intermolecular dimer formation fctag used single chainfc scfc knobinhole feature ridgway et al <NUMBER> knob comprising protruding tyrosine t<NUMBER>y incorporated nterminalhalf fcinterface followed <NUMBER>residuelinker ggggs <NUMBER> hole comprising recessed threonine y<NUMBER>t incorporated cterminalhalf fcinterface kabat antibody residue numbering johnson wu <NUMBER> figure <NUMBER>a scfc target region interest figure <NUMBER>b added cleavage site human rhinovirus <NUMBER>c hrv<NUMBER>c protease cordingley et al <NUMBER> highly specific protease recognizes sequence levlfqgp cleaving q leaving gp dipeptide start target allowed us remove target protein protein acapture resin protease treatment avoiding low ph elution known alter conformations type <NUMBER> fusion machine could potentially alter conformation probe target sequence interest incorporated <NUMBER>residue linker followed biotin ligasespecific sequence <NUMBER>lnqqavi construct design enabled capture protein oncolumn biotinylation figure <NUMBER>b buffers biotinylation hrv<NUMBER>c cleavage compatible entire process biotinylation hrv<NUMBER>c cleavage purification could principle accomplished single column though generally added polishing size exclusion chromatography step ensure size homogeneity obtain molecular probe sarscov<NUMBER> spike incorporated stabilizing mutations spike target protein residues <NUMBER> <NUMBER> wrapp et al <NUMBER>b replacing <NUMBER> rrar s<NUMBER>s<NUMBER> cleavage site gsas kv domains hr<NUMBER> ch pp figure <NUMBER> table s<NUMBER> adding t<NUMBER>phage fibritin trimerization domain foldon cterminus efimov et al <NUMBER> miroshnikov et al <NUMBER> construct hereafter referred s<NUMBER>p expressed transient mammalian cell transfection observed cleavage hrv<NUMBER>c protease impeded glutathionestransferasetagged histagged version protease suggesting partial steric constraints access hrv<NUMBER>c site overall could obtain <NUMBER> mg purified s<NUMBER>p probe per liter cell culture <NUMBER> h incubation <NUMBER> Â°c histagged hrv<NUMBER>c proteaseliberated probe sarscov<NUMBER> s<NUMBER>p ran primarily single peak sizeexclusion chromatography major band sdspage figure <NUMBER>a b appeared homogeneous negativestain em figure <NUMBER>c recognized rbdbinding antibody cr<NUMBER> tian et al <NUMBER> yuan et al <NUMBER> also characterized binding three antibodies sars<NUMBER> convalescent donor s<NUMBER> s<NUMBER> recognizes rbd s<NUMBER> recognizes epitope s<NUMBER> s<NUMBER> recognizes ntd three antibodies bound well s<NUMBER>p probe ace<NUMBER> receptor soluble cd<NUMBER> d<NUMBER>d<NUMBER>scd<NUMBER> antibody vrc<NUMBER> wu et al <NUMBER> bound control probe encompassing hiv<NUMBER> envelope glycoprotein trimer bg<NUMBER> dssosip figure <NUMBER>d note iggs cr<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER>s<NUMBER> showed stronger binding corresponding antigenbinding fragment fab potentially due avidity properties suggested sarscov<NUMBER> s<NUMBER>p probe good biological mimic prefusion sarscov<NUMBER> spike ectodomain provide atomiclevel insight mimicry spike probe determined cryoem structure biotinylated sarscov<NUMBER> s<NUMBER>p probe figures <NUMBER>e s<NUMBER> table s<NUMBER> cryoem grids frozen biotinylated sarscov<NUMBER> s<NUMBER>p probe pbs ph <NUMBER> observed two distinct conformations one three rbds position displaying c<NUMBER> symmetry one rbd position two rbds position c<NUMBER>symmetric observed particles <NUMBER> <NUMBER> rbds conformation contributed <NUMBER> Ã¥ resolution map whereas <NUMBER> rbd state <NUMBER> <NUMBER> particles <NUMBER>d reconstruction achieved overall resolution <NUMBER> Ã¥ two final atomic models similar published cryoem spikeectodomain structures wrapp et al <NUMBER>b c<NUMBER>symmetric structure included residues <NUMBER> residues <NUMBER> modeled c<NUMBER>symmetric structure cases regions could modeled intrinsic flexibility five additional residues cterminal region <NUMBER> visible reconstruction density rbds structure similar published structures wrapp et al <NUMBER>b cterminal region s<NUMBER> domain case rest probe sufficiently ordered modeled two structures similar except single rbd position c<NUMBER> symmetry structure excluding single rbd rmsd <NUMBER> Ã¥ two probe structures <NUMBER> aligned cÎ± atoms domain structure sarscov<NUMBER> spike clearly evident cryoem structure consistent published accounts wrapp et al <NUMBER>b based structures created constructs incorporating ntd rbd rbdsd<NUMBER> regions <NUMBER> separate molecular probes figure <NUMBER> transient transfection yield constructs greater <NUMBER> mgl ntd rbd eluted single peak sizeexclusion chromatography exhibited single band sdspage figure <NUMBER>a b rbdsd<NUMBER> eluted two peaks sec disulfidebonded dimer monomer figure <NUMBER>a b chose monomeric form studies biological basis higher association receptor recognition domain probes specific construct ace<NUMBER> binding rbd rbdsd<NUMBER> probes ntd probe figure <NUMBER>c left similarly antibodies cr<NUMBER> s<NUMBER> recognized rbd rbdsd<NUMBER> s<NUMBER> showed binding two probes figure <NUMBER>c right antibody s<NUMBER> recognized ntd probe results indicate truncated domain probes folded properly retained native conformation fulllength s<NUMBER>p probe structural information define domain boundaries also biological interfaces based structure rbd domain ace<NUMBER> lan et al <NUMBER> figure <NUMBER>a designed constructs ace<NUMBER>interface residues mutated arg knockout ace<NUMBER> affinity figure <NUMBER>b expressed purified two doublearg mutants rbdl<NUMBER>ra<NUMBER>ravi rbdl<NUMBER>rg<NUMBER>ravi one triplearg mutant rbdl<NUMBER>ra<NUMBER>rg<NUMBER>ravi three eluted single peak sizeexclusion chromatography exhibited single band sdspage figure <NUMBER>c three mutants completely ablated ace<NUMBER> binding designed figure <NUMBER>e left contrast cr<NUMBER> recognition three mutants mostly retained epitope cr<NUMBER> ace<NUMBER>binding site located different locations rbd s<NUMBER> rbdl<NUMBER>ra<NUMBER>rg<NUMBER>ravi reduced detectable level indicating potential epitope overlapping g<NUMBER> region similar observations s<NUMBER>pavi rbdavi rbdsd<NUMBER>avi s<NUMBER> fab recognition three mutants substantially reduced figure <NUMBER>e right results indicated ace<NUMBER>interfacemutant probes used specifically distinguish antibodies targeting ace<NUMBER>binding site epitopes rbd assess molecular probes quality function first performed kinetic analyses ace<NUMBER> receptor antibodies binding probes spr figure <NUMBER>a purified biotinylated probes immobilized streptavidin sensor chip surface ace<NUMBER> antibodies mobile phase ace<NUMBER> bound fulllength ectodomain probe s<NUMBER>p k <NUMBER> nm affinity isolated rbd domain probe somewhat lower k <NUMBER> nm found s<NUMBER>p probe sensitive chip regeneration required remove antibody used singlecycle kinetics analyze interaction fabs antibodies cr<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> bound sarscov<NUMBER> s<NUMBER>p probe high affinity figure <NUMBER>a top row interestingly binding onrates three antibodies comparable offrates varied cr<NUMBER> antibody known bind rbd neutralize sarscov<NUMBER> virus bound sarscov<NUMBER> s<NUMBER>p lower affinity ace<NUMBER> <NUMBER> vs <NUMBER> nm respectively although cr<NUMBER> higher affinity rbd probe <NUMBER> nm s<NUMBER>p <NUMBER> nm another rbdbinding nonneutralizing antibody s<NUMBER> bound rbd s<NUMBER>p probes <NUMBER> <NUMBER> nm respectively antibody s<NUMBER> also nonneutralizing bind ntd rbd probes figure <NUMBER>c <NUMBER> <NUMBER> bind s<NUMBER>p probe k <NUMBER> nm consistent s<NUMBER> directed ntdspecific antibody s<NUMBER> neutralizing capacity bound ntd s<NUMBER>p probes <NUMBER> <NUMBER> nm respectively results confirm biotinylated probes binding specificity receptor antibodies functioning properly expected next tested probes sorting antigenspecific yeast cells displaying sarscov depending initial level antigenspecific antibodies present one two rounds sorting enrichment could increase antigenspecific cells several orders magnitude indicating substantial utility probes cell sorting demonstrate utility probes sorting human b cells obtained overall designed probes found functional spr sorting yeast cells b cells spikereactive antibodies molecular probes comprising key targets sarscov<NUMBER> spike domains broad utility vaccine development probes used define monitor elicited responses antibody characterization probes serve critical molecular tags facilitating identification highly effective antibodies could used passive therapy cao et al <NUMBER> reviewed casadevall et al <NUMBER> graham ambrosino <NUMBER> walker burton <NUMBER> diagnostics employed assess sera reactivity provide sensitive markers infection perera et al <NUMBER> yan et al <NUMBER>b zhao et al <NUMBER> pathogenesis assist delineating susceptible cells virus might infect tracking viral variants including might selective advantages korber et al <NUMBER> show structurebased design coupled incorporation purificationtag based construct ii sequencespecific protease iii sequencespecific biotin ligase enable streamlined probe development <NUMBER> <NUMBER> probe construction used process incorporating cutandpaste assembly necessary components employing nterminal purification tag sequence stretches targeted sequencespecific enzymes hrv<NUMBER>c protease biotin ligase sequencespecific cleavage sites thrombin could incorporated control presence components surrounding target protein interest proteasespecific cleavage however lead addition residual amino acids resultant nand ctermini protease cleavage note context nterminal hrv<NUMBER>c site appends dipeptide glypro nterminus liberated target importantly structure target protein define domain boundaries allowing separate probes specific domains domain combinations structurebased methods describe probe construction may allow assessment immune responses type <NUMBER> fusion machines previously created hemagglutinin trimer probes y<NUMBER>f mutation whittle et al <NUMBER> used identify broadly neutralizing antibodies influenza joyce et al <NUMBER> also created ebolavirus trimer probes could used identify protective neutralizing antibodies sudan outbreak ebolavirus strain gaudinski et al <NUMBER> misasi et al <NUMBER> previously used biotinylated envelope sosip probe identify broadly neutralizing fusion peptidedirected antibodies hiv<NUMBER> kong et al science <NUMBER> overall cutandpaste structurebased design described easily adapted streamlined development molecular probes pathogens also emerging pathogens shown sarscov<NUMBER> authors declare competing interest <NUMBER> <NUMBER> â¢ key resources information requests resources reagents directed fulfilled peter kwong pdkwongnihgov plasmids sarscov<NUMBER> probes avi tag generated study available upon request noncommercial research purposes cryoem maps biotinylated sarscov<NUMBER> s<NUMBER>p deposited emdb accession codes emd<NUMBER> rbds emd<NUMBER> rbd fitted coordinates deposited pdb accession codes <NUMBER>xf<NUMBER> <NUMBER>xf<NUMBER> respectively expi<NUMBER>f freestyle <NUMBER>f cells purchased thermo fisher scientific cells used directly commercial sources following manufacturer suggestions described detail construction expression plasmids sarscov<NUMBER> probes dna sequences coding sarscov<NUMBER> spike domains cloned pvrc<NUMBER>based expression vector geneimmune gene interest placed dna sequence encoding nterminus single chain human fc knobinhole mutations ggsggggsgg linker hrv<NUMBER>c protease cleavage site purification protein column oncolumn cleavage dna sequence encoding cterminus ggglvpqqsg <NUMBER> <NUMBER> linker named<NUMBER>lnqq avi tag placed gene interest biotinylation table s<NUMBER> scfcsarscov<NUMBER> s<NUMBER>pavi construct cloned insertion included spike protein residues <NUMBER> <NUMBER> gsas replacing rrar s<NUMBER>s<NUMBER> cleavage site k<NUMBER>p v<NUMBER>p stabilization mutations gsg linker t<NUMBER>phage fibritin trimerization domain foldon described wrapp colleagues wrapp et al <NUMBER>b model <NUMBER>lnqq linker avi tag obtained pepfold server shen et al <NUMBER> thevenet et al <NUMBER> show location cterminal addition figure s<NUMBER> single chain fc tagged sarscov<NUMBER> probes produced transient transfection <NUMBER> freestyle cells previously described wrapp et al <NUMBER>b one liter cells transfected <NUMBER> mg sarscov<NUMBER> probe plasmid premixed <NUMBER> ml turbo<NUMBER> transfection reagent cells allowed grow <NUMBER> days <NUMBER> rpm <NUMBER> Â°c <NUMBER> co <NUMBER> supernatant harvested centrifugation filtered cleared supernatant incubated <NUMBER>ml pbsequilibrated protein resin two hours resin synthesized subcloned pvrc<NUMBER> vector described previously wu et al <NUMBER> expi<NUMBER>f cells thermo fisher using turbo<NUMBER> transfection reagent speed biosystems day <NUMBER> post transfection culture supernatant harvested loaded protein column washing pbs <NUMBER> column volumes igg eluted igg elution buffer pierce immediately neutralized addition one tenth volume <NUMBER>m trishcl ph <NUMBER> fab fragments generated overnight endoproteinase lysc new england biolabs digestion <NUMBER> c lyscigg ratio <NUMBER> ww passed protein column remove uncut igg fc fragments fortÃ©bio octet htx instrument fortÃ©bio used analyze biotinylation level antigenicity receptor recognition molecular probes assays performed <NUMBER>Â°c tilted black <NUMBER>well plates geiger bioone pbs <NUMBER> tween<NUMBER> <NUMBER> bsa <NUMBER> sodium azide agitation set <NUMBER> rpm biotinylated sarscov<NUMBER> spike <NUMBER> Î¼gml ntd <NUMBER> Î¼gml rbd <NUMBER> Î¼gml rbdsd<NUMBER> <NUMBER> Î¼gml rbdl<NUMBER>ra<NUMBER>r <NUMBER> Î¼gml rbdl<NUMBER>rg<NUMBER>r <NUMBER> Î¼gml rbdl<NUMBER>ra<NUMBER>rg<NUMBER>r <NUMBER> Î¼gml hiv env <NUMBER> Î¼gml loaded streptavidin biosensors <NUMBER> seconds binding biotinylated probes measured dipping immobilized probes solutions receptors antibodies <NUMBER> nm <NUMBER> seconds receptor antibody binding assessed triplicate parallel correction subtract systematic baseline drift carried subtracting measurements recorded loaded sensor dipped buffer control well reference corrected response values reported averages maximum signal association step surface plasmon resonance spr binding experiments performed using biacore t<NUMBER> biosensor equipped either series sa chip fab binding assays series cm<NUMBER> chip immobilized neutravidin ace<NUMBER> binding assays measurements performed <NUMBER>Â°c running buffer <NUMBER> mm hepes ph <NUMBER> <NUMBER> mm nacl <NUMBER> vv tween<NUMBER> biotinylated spike rbd ntd captured independent flow cells <NUMBER> ru <NUMBER> ru <NUMBER> ru respectively ace<NUMBER>analyte samples prepared running buffer concentration range <NUMBER>nm using threefold dilution series binding spike rbd ntd surfaces well neutravidin reference surface tested <NUMBER>s followed <NUMBER>s dissociation phase <NUMBER>Î¼lmin blank buffer cycles performed throughout experiment injecting running buffer instead ace<NUMBER> subtract systematic noise binding signal data processed fit <NUMBER> binding model using scrubber <NUMBER> biologic software avoid need surface regeneration arises low offrate fabs used singlecycle kinetics fab binding experiments fab tested analyte concentrations <NUMBER>nm prepared running buffer using threefold dilution series binding spike rbd surface ntd surface s<NUMBER> monitored <NUMBER>s followed dissociation phase <NUMBER>s<NUMBER>s depending interaction four blank buffer single cycles performed injecting running buffer instead fab remove systematic noise binding signal data processed fit <NUMBER> single cycle model using scrubber <NUMBER> biologic software negativestain electron microscopy <NUMBER> <NUMBER> purified sarscov<NUMBER> samples diluted approximately <NUMBER> mgml buffer containing <NUMBER> mm hepes ph <NUMBER> <NUMBER> mm nacl <NUMBER>Âµl drop diluted sample applied glowdischarged carboncoated copper grid grid washed buffer adsorbed protein molecules negatively stained <NUMBER> uranyl formate micrographs collected nominal magnification <NUMBER>x pixel size <NUMBER> nm using serialem mastronarde <NUMBER> fei tecnai t<NUMBER> electron microscope operated <NUMBER> kv equipped eagle ccd camera particles picked automatically using inhouse written software yt unpublished referencefree <NUMBER>d classification performed relion <NUMBER> scheres <NUMBER> biotinylated sarscov<NUMBER> spike probe diluted final trimer concentration <NUMBER> mgml pbs ph <NUMBER> sample <NUMBER> Âµl applied glowdischarged carboncoated copper grid cf <NUMBER> vitrified using vitrobot mark iv wait time <NUMBER> seconds blot time <NUMBER> seconds data collected using leginon software suloway et al <NUMBER> installed titan krios electron microscope operating <NUMBER> kv equipped gatan k<NUMBER>bioquantum direct detection device total dose fractionated <NUMBER> <NUMBER> raw frames motion correction ctf estimation particle picking extraction <NUMBER>d classification ab initio model generation <NUMBER>d refinements local resolution estimation carried cryosparc <NUMBER> punjani et al <NUMBER> <NUMBER>d reconstructions performed using c<NUMBER> symmetry rbds map c<NUMBER> symmetry applied <NUMBER> rbd map local refinement beta c<NUMBER> symmetry performed rbds map using mask focused cterminal <NUMBER> <NUMBER> helices included bottom s<NUMBER> subunit spanning residue <NUMBER> c terminus overall resolution <NUMBER> Ã¥ rbds map <NUMBER> Ã¥ <NUMBER> rbd map <NUMBER> Ã¥ rbds local refinement map confirmed providing half maps resolve cryo em phenix adams et al <NUMBER> coordinates sars cov<NUMBER> spike ectodomain structures pdb entries <NUMBER>vxx <NUMBER>vyb employed initial models fitting cryoem map rbds <NUMBER> rbd conformation respectively structures rbds position modeled using crystallographic structure rbd complex cr<NUMBER> fab pdb entry <NUMBER>w<NUMBER> template rbd position map quality allow visualization side chains modeled polyala consistent observed <NUMBER>vyb manual automated model building iteratively performed using coot emsley cowtan <NUMBER> real space refinement phenix respectively order accurately fit coordinates electron density map half maps provided resolve cryo em tool phenix support manual model building emringer barad et al <NUMBER> molprobity davis et al <NUMBER> used validate geometry check structure quality iteration step ucsf chimera pettersen et al <NUMBER> used mapfitting cross correlation calculation fitinmap tool figure preparation probe conjugation <NUMBER> <NUMBER> biotinylated sarscov<NUMBER> spike probes conjugated using either allophycocyanin apc phycoerythrin pe bv<NUMBER> bv<NUMBER> bv<NUMBER>labeled streptavidin reactions prepared <NUMBER> molecular ratio protein streptavidin every monomer labeled labeled streptavidin added increments incubations <NUMBER>Â°c rotating <NUMBER> minutes addition yeast display analysis using monoclonal yeast created expressed analyzed previously published wang et al <NUMBER>a briefly vh vl regions s<NUMBER> s<NUMBER> s<NUMBER> codon optimized yeast expression synthesized cloned pctvhvlk<NUMBER> pctvhvll<NUMBER> yeast expression vectors genscript yeast display vectors linearized saccharomyces cerevisiae strain awy<NUMBER> matÎ± aga<NUMBER>gal<NUMBER>aga<NUMBER>ura<NUMBER> pdi<NUMBER>gapdhpdi<NUMBER>leu<NUMBER> ura<NUMBER> trp<NUMBER> leu<NUMBER>Î´<NUMBER> his<NUMBER>Î´<NUMBER> pep<NUMBER>his<NUMBER> prb<NUMBER>Î´<NUMBER>r can<NUMBER> gal transformed yeast cells maintained ypd medium <NUMBER> gl dextrose <NUMBER> gl peptone <NUMBER> gl yeast extract library transformation yeast cells maintained sdcaa medium <NUMBER> gl dextrose <NUMBER> gl yeast nitrogen base <NUMBER> gl casamino acids <NUMBER> gl nah<NUMBER>po<NUMBER>Â·h<NUMBER>o <NUMBER> gl na<NUMBER>hpo<NUMBER>Â·<NUMBER>h<NUMBER>o fab display induced incubating yeast sgdcaa medium sdcaa <NUMBER> gl galactose <NUMBER> gl dextrose two days induction <NUMBER>x<NUMBER> yeast incubated staining buffer phosphate buffered saline <NUMBER> bsa <NUMBER>mm edta containing antiflag fluorescein isothiocyanate antibody <NUMBER> Âµgml clone m<NUMBER> sigmaaldrich probes <NUMBER> minutes ice prior washing <NUMBER> times ice cold staining buffer fab expressing yeast flag analyzed capacity bind indicated probes using facs aria ii bd biosciences single probe stain experiments yeast incubated kapa biosystems generate <NUMBER>bp vhvl products library cloning yeast display <NUMBER> ng natively paired cdna amplified primers containing not<NUMBER> asci restriction sites cloning bidirectional yeast display plasmids wang et al <NUMBER>a libraries transformed amplification e coli followed plasmid dna extraction subcloning galactoseinducible bidirectional promoter resulting native fab display libraries cotransformed electrocompetent awy<NUMBER> ascinoti digested pct vector yeast cells passaged twice screening wang et al <NUMBER>a samples collected bd facsaria iii analyzed flowjo v<NUMBER> statistical analyses bli assessment probeantibody binding performed using graphpad prism spr data processed fit <NUMBER> binding model using scrubber <NUMBER> biologic software mwm run alongside probe c negative stain em sarscov<NUMBER> s<NUMBER>p probe <NUMBER>dclass averages shown widefield raw em image <NUMBER>fold magnification biotinylation antigenicity receptor recognition sarscov<NUMBER> s<NUMBER>p probe level biotinylation evaluated capture probes <NUMBER> Î¼gml onto streptavidin biosensors biotinylated hiv<NUMBER> env stabilized prefusion closed conformation dssosip mutations containing <NUMBER>lnqqavi tag cterminus used comparison binding assessed using <NUMBER> Î¼gml s<NUMBER>p probe <NUMBER> Î¼gml hiv env receptors antibodies <NUMBER> nm error bars represent standard deviation triplicate measures low level nonspecific binding fab s<NUMBER> hiv<NUMBER> env observed e cryoem structures biotinylated sarscov<NUMBER> s<NUMBER>p probe domains colored figure <NUMBER>c sequence cterminal residues <NUMBER> plus foldon <NUMBER>lnqqavi tag biotin visible electron density see also figure s<NUMBER> table s<NUMBER> b sdspage ntd rbd rbdsd<NUMBER> molecular probes rbdsd<NUMBER> peak <NUMBER> appeared partially disulfide linked therefore removed analysis rbdsd<NUMBER> thus refers monomeric peak <NUMBER> c receptor binding left antibody binding right rbd rbdsd<NUMBER> probes bound ace<NUMBER> receptor antibody s<NUMBER> ntd probe interacted antibody s<NUMBER> binding assessed using <NUMBER> Î¼gml probe <NUMBER> nm receptor antibody error bars represent standard deviation triplicate measures low level nonspecific binding s<NUMBER> fab rbd rbdsd<NUMBER> observed see also figure s<NUMBER> e receptor antibody binding mutant rbd probes knockout mutations abolished rbd binding ace<NUMBER> receptor retaining binding cr<NUMBER> s<NUMBER> antibodies binding assessed using <NUMBER> Î¼gml rbdl<NUMBER>ra<NUMBER>r <NUMBER>Î¼gml rbdl<NUMBER>rg<NUMBER>r <NUMBER>Î¼gml rbdl<NUMBER>ra<NUMBER>rg<NUMBER>r account varying biotinylation levels among mutants receptor antibodies <NUMBER> nm error bars represent standard deviation triplicate measures see also figure s<NUMBER> table s<NUMBER> presort round <NUMBER> presort round <NUMBER> conversion postfusion form s<NUMBER> subunit engages host membrane whilst dispensing s<NUMBER> <NUMBER> neutralising human monoclonal antibodies recognise ace<NUMBER> receptor binding site sarscov<NUMBER> sarscov<NUMBER> generally crossreactive two viruses susceptible escape mutation <NUMBER> indeed natural mutation y<NUMBER>n already identified site gisaid <NUMBER> accession id epiisl<NUMBER> wieneckebaldacchino et al contrast cr<NUMBER> derived sarscov<NUMBER> patient crossreacts strongly sarscov<NUMBER> methods fig <NUMBER> shown recognise cryptic conserved epitope rbd distinct binding epitope ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> uncommon sarscov<NUMBER> antibodies suggested similar observations <NUMBER>d<NUMBER> <NUMBER> isolate sarscov<NUMBER> spikereactive monoclonal antibodies cloned antibody genes bloodderived plasmablasts covid<NUMBER> patient convalescent phase one ey<NUMBER>a shown elisa bind s<NUMBER> sarscov<NUMBER> cross react sarscov<NUMBER> fig <NUMBER> binding ey<NUMBER>a sarscov<NUMBER>infected cells detected immunofluorescence fig <NUMBER> surface plasmon resonance spr measurements ey<NUMBER>a fab showed high affinity binding immobilised sarscov<NUMBER> rbd kd <NUMBER> nm although value immobilised ey<NUMBER>a igg somewhat higher derived kinetic data methods extended data fig <NUMBER> extended data table <NUMBER> spr studies showed interdependence ey<NUMBER>a cr<NUMBER> binding varied depending component immobilised sensor chip ace<NUMBER> blocking assays confirmed somewhat asymmetric blocking effect extended data fig <NUMBER> rbd stably expressed <NUMBER> mdcksiat<NUMBER> cells mdckrbd ey<NUMBER>a block binding ace<NUMBER> rbd whereas ace<NUMBER> stably expressed mdcksiat<NUMBER> cells mdckace<NUMBER> ey<NUMBER>a blocked interaction rbd ace<NUMBER> assay ey<NUMBER>a exhibits around <NUMBER> times stronger ace<NUMBER> blocking cr<NUMBER> <NUMBER> ey<NUMBER>a ic<NUMBER> <NUMBER> nm cr<NUMBER> ic<NUMBER> <NUMBER> nm equivalent ace<NUMBER> inhibition compared ace<NUMBER>fc ic<NUMBER> <NUMBER> nm vhh<NUMBER>fc ic<NUMBER> <NUMBER> nm <NUMBER> observations suggestive indirect effect ey<NUMBER>a bound rbd consistent allosteric weak direct interaction supported spr competition assay immobilised cr<NUMBER> binds distant ace<NUMBER> binding site extended data fig <NUMBER> <NUMBER> showed complete competition ey<NUMBER>a rbd binding suggesting recognise overlapping epitopes indicated ey<NUMBER>a binds sarscov<NUMBER> rbd tightly two independent neutralisation tests using live wild type sarscov<NUMBER> showed strong neutralisation neutralisation test ey<NUMBER>a based quantitative pcr detection virus supernatant bathing infected vero e<NUMBER> cells <NUMBER> days culture showed <NUMBER>fold reduction virus signal methods extended data fig <NUMBER> indicating highly neutralising corroborated plaque reduction neutralisation test prnt phe porton methods extended data table <NUMBER> using sarscov<NUMBER> virus ey<NUMBER>a gave nd<NUMBER> <NUMBER> Âµgml <NUMBER> nm calculated according grist <NUMBER> separate prnt implementation oxford gave slightly higher nd<NUMBER> <NUMBER> Âµgml consistent shorter incubation time antibody virus lower temperature extended data fig <NUMBER> elucidate epitope ey<NUMBER>a determined crystal structures deglycosylated sarscov<NUMBER> rbd complex ey<NUMBER>a fab alone ternary complex incorporating nanobody nb shown compete ace<NUMBER> data closely related nb see huo <NUMBER> submitted crystallisation chaperone crystals binary complex diffracted <NUMBER> Ã¥ resolution methods extended data table <NUMBER> ternary complex <NUMBER> Ã¥ interaction ey<NUMBER>a rbd identical complexes extended data fig <NUMBER> higher resolution ternary complex showed interaction ey<NUMBER>a nb permitted full interpretation detailed interactions figs <NUMBER> <NUMBER> refined give rworkrfree <NUMBER> good stereochemistry methods extended data table <NUMBER> residues <NUMBER> rbd <NUMBER> <NUMBER> heavy chain <NUMBER> light chain ey<NUMBER>a <NUMBER> nb well defined fig <NUMBER>a b nb recognises epitope adjacent slightly overlapping ace<NUMBER> receptor binding site binds rbd orthogonally ey<NUMBER>a fig <NUMBER>bc ey<NUMBER>a binds essentially epitope cr<NUMBER> <NUMBER> <NUMBER> different pose corresponding rotation <NUMBER>Â° axis perpendicular rbd Î±<NUMBER> helix central epitopes fig <NUMBER>de fab complex interface buries <NUMBER> <NUMBER> Ã¥ <NUMBER> surface area cdrs heavy light chains respectively ey<NUMBER>a interaction mediated cdr loops h<NUMBER> h<NUMBER> h<NUMBER> l<NUMBER> l<NUMBER> contacting predominantly Î±<NUMBER> also Î±<NUMBER> Î²<NUMBER>Î±<NUMBER> Î±<NUMBER>Î±<NUMBER> Î±<NUMBER>Î²<NUMBER> loops rbd fig <NUMBER> extended data fig <NUMBER> total <NUMBER> residues heavy chain <NUMBER> light chain participate interface together <NUMBER> residues rbd heavy chain form potentially <NUMBER> hydrogen bonds single salt bridge d<NUMBER> h<NUMBER> k<NUMBER> rbd light chain interface residues contribute additional <NUMBER> hydrogen bonds hydrophobic interactions increase binding affinity fig <NUMBER> <NUMBER> residues involved interaction <NUMBER> conserved cr<NUMBER> ey<NUMBER>a epitopes fig <NUMBER> extended data fig <NUMBER> conformational changes introduced rbd binding ey<NUMBER>a Î±<NUMBER> residues <NUMBER> Î±<NUMBER> residues <NUMBER> helices extended data fig <NUMBER> similar seen cr<NUMBER> complex <NUMBER> comparison epitope residues ey<NUMBER>a cr<NUMBER> <NUMBER> vhh<NUMBER> <NUMBER> shows substantial overlap extended data fig <NUMBER> although bulk molecules extend different directions vhh<NUMBER> directly blocks ace<NUMBER> binding <NUMBER> first prefusion spike structures pdb ids <NUMBER>vsb <NUMBER> <NUMBER>vxx <NUMBER>vyb <NUMBER> residues <NUMBER> <NUMBER> linker two helices s<NUMBER> mutated propro sequence prevent conversion postfusion helical conformation rbds found either one two three configuration cases epitope inaccessible position packed another rbd trimer nterminal domain ntd neighbouring protomer recent publication wild type spike identifies closed form <NUMBER> s<NUMBER> portion spike tightened structure yet deposited however looked role epitope rather fully closed form broadly similar ey<NUMBER>a epitope packs tightly s<NUMBER> knuckle bearing propro mutations forming buried proteinprotein interface making epitope completely inaccessible assume closed form interaction even tighter probably responsible maintaining spike prefusion state even rbd configuration epitope remains largely inaccessible substantial movement rbd would required permit interaction unless one rbd conformation <NUMBER> investigate fab insinuates spike performed cryoem analysis spike ectodomain mixed <NUMBER>fold molar excess ey<NUMBER>a fab incubated room temperature <NUMBER> Â°c aliquot taken <NUMBER> hours applied cryoem grids frozen methods unbiased <NUMBER>d class averages revealed three major particle classes onethird comprising trimeric spikeey<NUMBER>a complex selfassociated methods extended data table <NUMBER> <NUMBER>Â° addition orientations vh domains relative associated rbds differ slightly crystal structure <NUMBER>Â° <NUMBER>Â° <NUMBER>Â° respectively quality density suggests likely samples selected continuous distribution extended data fig <NUMBER> majority remaining particles form either roughly <NUMBER>fold symmetric structure triangular association methods extended data table <NUMBER> figs <NUMBER> reconstructions particles anisotropic due preferential orientation particles grid somewhat mitigated collecting data <NUMBER>Â° tilt yield reconstructions <NUMBER> Ã¥ <NUMBER> Ã¥ respectively plane grid significantly worse resolution perpendicular grid extended data fig <NUMBER> reconstructions sufficiently clear allow unambiguous fitting ey<NUMBER>arbd complexes extended data fig <NUMBER> however density assume nterminal domains poor reconstructions attempt fit model structures likely represent residual wellstructured fragment unfolding prefusion state spike sds page analysis shows spike polypeptide remains largely uncleaved extended data fig <NUMBER> dimeric trimeric structures formed different lateral associations also differ seen similarly structurally degraded spikecr<NUMBER> complexes <NUMBER> extended data fig <NUMBER> convalescent serum shown promise patients severely ill covid<NUMBER> <NUMBER> <NUMBER> thus immunotherapeutics potential treating covid<NUMBER> even relatively late stage disease end desirable find combination antibodies neutralise virus different mechanisms mitigate immune evasion antibody dependent enhancement one neutralisation mechanism blocking receptor attachment propose attachment ey<NUMBER>a epitope major neutralisation mechanism support epitope recognised ey<NUMBER>a reported several antibodies <NUMBER> <NUMBER> <NUMBER> <NUMBER> nanobodies <NUMBER> raised sarscov<NUMBER> sarscov<NUMBER> mers sarscov<NUMBER> cr<NUMBER> also shown neutralise synergistically ace<NUMBER> blocking antibodies <NUMBER> despite spatial separation ey<NUMBER>a ace<NUMBER> epitopes find crosstalk two binding events ey<NUMBER>a epitope extremely unusual since completely inaccessible prefusion spike trimer raises question mechanism neutralisation might prefusion state ey<NUMBER>acr<NUMBER> epitope rests upon upper end helixturnhelix heptad repeat <NUMBER> hr<NUMBER> central helix ch s<NUMBER> essentially putting lid springloaded extension helix occurs conversion postfusion state vicinity mutations designed prevent conversion preand postfusion conformation <NUMBER> fig <NUMBER> residues epitope crucial proteinprotein interactions therefore highly conserved explaining date proved impossible generate mutations escape binding antibody <NUMBER> ey<NUMBER>a binding isolated rbd tight <NUMBER> nm roughly order magnitude tighter cr<NUMBER> remarkably binding pose top spike allows three fabs bind simultaneously around central axis whereas cr<NUMBER> fab cannot accommodated line major portion spike molecules incubated <NUMBER> h ey<NUMBER>a still intact prefusion state <NUMBER> converted simple modelling suggests similar packing could occur intact antibodies extended data fig <NUMBER> general would expect binders epitope neutralise displacing lid hr<NUMBER>ch turn reducing stability prefusion state therefore reducing barrier conversion stable postfusion trimer conversion hindered construct used presence proline mutations turn helices premature conversion would prevent later attachment cell block infectivity kinetics process determine effectiveness antibody neutralisation ultimately protection since rbd relatively small domain might also interplay separate epitopes thus saw allosteric effects ey<NUMBER>a ace<NUMBER> binding similarly vhh<NUMBER> binds overlapping epitope ey<NUMBER>a strongly inhibits ace<NUMBER> binding virtue different angle attack <NUMBER> reason crosstalk study designed isolate sarscov<NUMBER> antigenspecific human mabs peripheral plasmablasts humans natural sarscov<NUMBER> infection characterize antigenic specificity phenotypic activity sarscov<NUMBER> spikereactive mab determine structure antibody complex viral antigen fresh peripheral blood mononuclear cells pbmcs separated whole blood density gradient centrifugation cryopreserved pbmcs thawed pbmcs stained mix fluorescentlabelled antibodies cellular surface markers including anticd<NUMBER> bd biosciences usa anticd<NUMBER> bd biosciences usa anticd<NUMBER> bd biosciences usa anticd<NUMBER> bd biosciences usa anticd<NUMBER> bd biosciences usa antiigg bd biosciences usa antiigm bd biosciences usa plasmablasts selected gating cd<NUMBER>cd<NUMBER>cd<NUMBER>cd<NUMBER>hicd<NUMBER>hiiggigmevents isolated chamber single cell previously described <NUMBER> sorted single cells used produce human igg monoclonal antibodies previously described <NUMBER> expression vectors carry variable domains heavy light chains transfected <NUMBER>t cell line expression recombinant fulllength human igg monoclonal antibodies serumfree transfection medium determine individual gene segments employed vdj vj rearrangements number nucleotide mutations amino acid replacements variable domain sequences aligned germline gene segments using international immunogenetics imgt alignment tool httpwwwimgtorgimgtvquestinput ey<NUMBER>a igg used neutralisation making fab antibody expressed using nanobody derived naÃ¯ve library followed affinity maturation described deglycosylation rbd<NUMBER> Âµl endoglycosidase f<NUMBER> <NUMBER>mgml added rbd <NUMBER> mgml <NUMBER> ml incubated room temperature two hours rbd loaded superdex <NUMBER> hiload <NUMBER> gel filtration column ge healthcare purification using buffer <NUMBER> mm hepes ph <NUMBER> <NUMBER> mm nacl purified rbd concentrated using <NUMBER> kda ultrafiltration tube amicon <NUMBER> mgml  neutralization activity monoclonal antibodycontaining supernatant measured using sarscov<NUMBER> strain cdc<NUMBER> infection vero e<NUMBER> cells <NUMBER> briefly vero e<NUMBER> cells preseeded <NUMBER> well plate concentration <NUMBER> x <NUMBER> <NUMBER> cells per well following day monoclonal antibodycontaining supernatant mixed equal volume <NUMBER> tcid<NUMBER> virus preparation incubated <NUMBER> Â°c <NUMBER> hour mixture added seeded vero e<NUMBER> cells incubated <NUMBER> Â°c <NUMBER> days cell control virus control virus backtitration setup experiment day <NUMBER> culture supernatant harvested well viral rna extracted automatic labturbo system taigen taiwan following manufacturers instructions part except specimen pretreated proteinase k prior rna extraction realtime reverse transcription polymerase chain reaction performed <NUMBER>Âµl reaction containing <NUMBER> Âµl rna <NUMBER> sarscov<NUMBER> australiavic<NUMBER> <NUMBER> plaque reduction neutralization tests performed using passage <NUMBER> sarscov<NUMBER> victoria<NUMBER> <NUMBER> virus suspension appropriate concentrations dulbeccos modification eagles medium containing <NUMBER> fbs d<NUMBER> <NUMBER> Âµl mixed antibody <NUMBER> Âµl diluted d<NUMBER> final concentration <NUMBER> Âµgml <NUMBER> Âµgml <NUMBER> ugml <NUMBER> Âµgml triplicate wells <NUMBER> well tissue culture plate incubated room temperature <NUMBER> minutes thereafter <NUMBER> ml single cell suspension vero e<NUMBER> cells d<NUMBER> <NUMBER> x <NUMBER>ml added incubated <NUMBER> h <NUMBER> c overlain <NUMBER> ml d<NUMBER> supplemented carboxymethyl cellulose <NUMBER> cultures incubated <NUMBER> days <NUMBER> c plaques revealed staining cell monolayers amido black acetic acidmethanol purified deglycosylated rbd ey<NUMBER>a fab combined approximate molar ratio <NUMBER> concentration <NUMBER> mgml nb also combined ey<NUMBER>a<NUMBER>his fab rbd <NUMBER> molar ratio final concentration <NUMBER> mgml two complexes separately incubated room temperature one hour initial screening crystals performed crystalquick <NUMBER>well x plates greiner bioone cartesian robot using nanolitre sittingdrop vapour diffusion method previously described <NUMBER> <NUMBER> crystals soaked solution containing <NUMBER> glycerol <NUMBER> reservoir solution seconds mounted loops frozen liquid nitrogen prior data collection diffraction data collected <NUMBER> k beamline i<NUMBER> diamond light source uk diffraction images <NUMBER>Â° rotation recorded eiger<NUMBER> xe <NUMBER>m detector exposure time <NUMBER> per frame beam size <NUMBER>Ã<NUMBER> Âµm <NUMBER> beam transmission data indexed integrated scaled automated data processing program xia<NUMBER>dials <NUMBER> <NUMBER> data set binary complex <NUMBER>Â° collected single frozen crystal <NUMBER> Ã¥ resolution <NUMBER>fold redundancy crystal belongs space group p<NUMBER> unit cell dimensions b <NUMBER> Ã¥ c <NUMBER> Ã¥ structure determined molecular replacement phaser <NUMBER> using search models antibody cr<NUMBER> fab rbd rbdcr<NUMBER> fab complex pdb id <NUMBER>yla <NUMBER> three rbdey<NUMBER>a complexes crystal asymmetric unit resulting crystal solvent content <NUMBER> ternary complex data set <NUMBER>Â° rotation data extending <NUMBER> Ã¥ collected beamline i<NUMBER> diamond exposure time <NUMBER> per <NUMBER>Â° frame beam size <NUMBER>Ã<NUMBER> Âµm <NUMBER> beam transmission crystal also belongs space group r<NUMBER> unit cell dimensions b <NUMBER> Ã¥ c <NUMBER> Ã¥ one rbdey<NUMBER>anb complex asymmetric unit solvent content <NUMBER> one cycle refmac<NUMBER> <NUMBER> used refine atomic coordinates manual correction coot <NUMBER> protein sequence search model binary ternary complexes final refinement used phenix <NUMBER> resulting rwork <NUMBER> rfree <NUMBER> data <NUMBER> Ã¥ resolution binary complex rwork <NUMBER> rfree <NUMBER> data <NUMBER> Ã¥ resolution ternary complex well ordered density single glycan glycosylation site n<NUMBER> rbd data collection structure refinement statistics given extended data table <NUMBER> structural comparisons used shp <NUMBER> residues forming rbdfab interface identified pisa <NUMBER> figures prepared pymol pymol molecular graphics system version <NUMBER>r<NUMBER>pre schrÃ¶dinger llc spike protein following sec purification buffer exchanged <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> buffer using desalting column zeba thermo fisher final concentration <NUMBER> mgml incubated ey<NUMBER>a fab buffer <NUMBER> molar ratio fab trimeric spike room temperature <NUMBER> hrs control grids spike alone incubation room temperature <NUMBER> hrs also prepared grid prepared using <NUMBER> Âµl sample applied freshly glowdischarged high <NUMBER> grids screened titan krios microscope using serialem operating <NUMBER> kv thermo fisher movies collected k<NUMBER> detector titan krios operating <NUMBER> kv super resolution mode calibrated super resolution pixel size <NUMBER> apix <NUMBER>Â° <NUMBER>Â° tilt compensate poorer contrast tilted data necessary use higher dose rate latter dataset alignment motion correction performed using relion<NUMBER>s implementation motion correction <NUMBER> <NUMBER>by<NUMBER> patchbased alignment frames binned two resulting final calibrated pixel size <NUMBER> Ã¥pixel contrasttransferfunction ctf fulldose nonweighted micrographs estimated within cryosparc wrapper gctfv<NUMBER> <NUMBER> images manually inspected poor ctffits discarded particles picked unbiased blob picking cryosparc v<NUMBER> <NUMBER> subjected rounds <NUMBER>d classification spikeey<NUMBER>a dataset structure <NUMBER> spikelike particles used make template pick particles untilted dataset filtered <NUMBER>d classification <NUMBER> particles refined <NUMBER>d classification ab initio model set <NUMBER> Â° dataset <NUMBER> particles used template filtered <NUMBER>d classification set <NUMBER> particles refined unbiased <NUMBER>d classification two particle sets refined together final set <NUMBER> particles b c triangular ring dimeric form particles zero <NUMBER>Â° datasets combined similar manner spikeey<NUMBER>a dataset using exposure group utilities module cryosparc particle sets b <NUMBER> particles c <NUMBER> particles reclassified best class refined nonuniform refinement b c<NUMBER> symmetry imposed final refinement stage resulting appreciable improvement resolution indicated inspection goldstandard fsc <NUMBER> <NUMBER> versus <NUMBER> Ã¥ see extended data table <NUMBER> em density spikeey<NUMBER>a fitted structure closed form spike pdb id <NUMBER>vxx apart rbds ey<NUMBER>a fab fitted rbdey<NUMBER>a ternary crystal structure using coot <NUMBER> due lower resolution rbd ey<NUMBER>a fitted dimeric trimeric em density spikeey<NUMBER>a structure refined phenix <NUMBER> real space refinement first rigid body positional bfactor refinements rigid body refinement applied dimeric trimeric complexes statistics em data collection structure refinement shown extended data table <NUMBER> authors contributed equally dz hmed cpc ey<NUMBER>a binds s<NUMBER> subunit sarscov<NUMBER> cross react s<NUMBER> sarscov<NUMBER> b antibody cr<NUMBER> similarly binds s<NUMBER> subunit sarscov<NUMBER> cross react sarscov<NUMBER> s<NUMBER> lower affinity c convalescent serum covid<NUMBER> patient also included control case binding mers oc<NUMBER> spike proteins also investigated binding ey<NUMBER>a sarscov<NUMBER> infected cells immunofluorescence assay antiinfluenza h<NUMBER> mab bs <NUMBER>a included control sarscov<NUMBER> spike sarscov<NUMBER> s<NUMBER> sarscov<NUMBER> s<NUMBER> mers spike oc<NUMBER> spike novel coronavirus known severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> simply covid<NUMBER> seventh member coronavirus family <NUMBER> two viruses family infect humans severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov positivesense singlestrand enveloped rna viruses coronavirus particles contain four main structural proteins spike membrane envelope nucleocapsid <NUMBER> <NUMBER> spike protein protrudes envelope virion consists two subunits receptorbinding domain rbd interacts receptor proteins host cells second subunit facilitates fusion viral membrane host cell membrane recent studies showed rbd spike proteins sarscov sarscov<NUMBER> interact angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> belongs membranebound carboxydipeptidase family attached outer surfaces cells widely distributed human body particular higher expression ace<NUMBER> observed organs small intestine colon kidney heart ace<NUMBER> expression comparatively lower liver lungs <NUMBER> <NUMBER> role oxidative stress binding viral proteins host cell surface receptors relatively underexplored area biomedical research <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previous studies indicated entry viral glycoprotein impacted thioldisulfide balance cell surface <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> perturbations thioldisulfide equilibrium also found deter entry viruses target cells <NUMBER> first step viral entry involves binding viral envelop protein onto cellular receptor followed endocytosis conformational changes viral protein helps induction viral protein endosomal membrane finally releasing viral content cell conformational changes mediated ph changes well conversion disulfide thiol group viral spike protein <NUMBER> several cell surface oxidoreductases <NUMBER> regulate thioldisulfide exchange responsible conformational changes viral proteins needed virus entry host cells backdrop significant mortality rate sarscov<NUMBER> hereinafter referred cov<NUMBER> infection important know thioldisulfide balance plays role binding spike glycoprotein host cell receptor protein ace<NUMBER> recent study spike glycoprotein sarscov hereinafter referred cov exhibited complete redox insensitivity <NUMBER> despite reduction disulfide bridges cov thiols binding ace<NUMBER> remained unchanged <NUMBER> however study probe redox sensitivity ace<NUMBER> receptor thus present study computationally investigated redox state partners ace<NUMBER> covcov<NUMBER> binding affinities structure cov <NUMBER> <NUMBER> cov<NUMBER> <NUMBER> complexed ace<NUMBER> known noncovalent interactions proteinprotein interface <NUMBER> reported recently using reported structures molecular dynamics simulations electrostatic field calculations performed explore impact thioldisulfide balance covcov<NUMBER> ace<NUMBER> binding affinities structural dynamical changes due change redox states cysteines interacting proteins analyzed effects binding free energies studied molecular basis binding spike proteins ace<NUMBER> known xray crystallographic sarscov <NUMBER> cryoelectron microscopic sarscov<NUMBER> <NUMBER> studies sequence alignment cov cov<NUMBER> spike proteins showed high sequence identity <NUMBER> indicating binding ace<NUMBER> receptors similar fig <NUMBER> bound structures rbd cov cov<NUMBER> found complexed ace<NUMBER> fig <NUMBER> ace<NUMBER> cov<NUMBER> possess four disulfide bridges whereas cov subunit two disulfide linkages table <NUMBER> fig <NUMBER>a <NUMBER>b two large helices ace<NUMBER> form curved surface fig <NUMBER> illustrated dashed curved line interacts concave region cov cov<NUMBER> subunit structural change along trajectory cases simulation started equilibrated structure obtained minimizing neutralized solvated protein complex built experimentally determined structures evolution protein structure along md trajectory monitored calculating rootmeansquare deviation rmsd structure starting structure frame reference following standard procedure <NUMBER> briefly md simulation protein coordinates recorded every <NUMBER> ps interval rootmeansquaredeviation rmsd frame calculated average rootmeansquare displacement backbone c Î± atoms respect initial structure rmsd values averaged conformations stored <NUMBER> ns time plotted simulated time fig <NUMBER> compared starting structure moderate backbone fluctuation noted protein complexes <NUMBER> ns simulations maximum rmsd range <NUMBER> Ã¥ table <NUMBER> evolution smooth stability demonstrated standard deviation computed rmsds less <NUMBER> Ã¥ taken together results simulations showed unexpected structural deformation sarcovcov<NUMBER>âââace<NUMBER> complex reduced thiol groups oxidized disulfide bonds states table <NUMBER> table <NUMBER> however disulfides covcov<NUMBER> well ace<NUMBER> reduced thiols binding became thermodynamically unfavorable cases binding free study found reduction disulfides sulfydryl groups completely impairs binding sarscovcov<NUMBER> spike protein ace<NUMBER> evident positive gibbs energy binding â bind g obtained cov ox âââace<NUMBER> ox cov<NUMBER> ox âââace<NUMBER> ox complexes disulfides ace<NUMBER> reduced sulfydryl groups binding becomes weaker redox environment cell surface receptors regulated thioldisulfide equilibrium extracellular region <NUMBER> <NUMBER> maintained glutathione transporters <NUMBER> number oxidoreductases <NUMBER> including protein disulfide isomerase <NUMBER> several redox switches <NUMBER> oxidative stress extracellular environment becomes oxidationprone resulting disulfide formation protein surfaces <NUMBER> therefore severe oxidative stress cell surface receptor ace<NUMBER> rbd intruding viral spike protein likely present oxidized form predominantly disulfide linkages computational study shows oxidative stress lack reducing environment would result significantly favorable binding viral protein cell surface ace<NUMBER> terms energetics computational study demonstrates oxidized form proteins disulfide bridges would cause <NUMBER> kcalmol decrease gibbs binding free energy furthermore ace<NUMBER> viral spike proteins latch known key player remedial oxidative stress <NUMBER> binding viral protein prevent key catalytic function ace<NUMBER> converting angiotensin <NUMBER> strong activator oxidative stress angiotensin <NUMBER> thereby creating vicious circle enhanced viral attack summary present study demonstrates <NUMBER> <NUMBER> absence reduced oxidative stress would significant beneficial effect early stage viral infection preventing viral protein binding host cells computational setup setting protein systems structural manipulations carried using visual molecular dynamics vmd <NUMBER> disulfide groups modified thiols setting structures using standard vmd scripts molecular optimization dynamics md simulations carried using nanoscale molecular dynamics namd package using charmm<NUMBER> force field <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> md simulations electrostatic energy calculations carried using particle mesh ewald method <NUMBER> backbone rootmeansquaredeviation rmsd calculations performed using vmd proteinprotein interactions studied using adaptivebasis poisson boltzmann solver apbs <NUMBER> electrostatic field calculations performed using pdb<NUMBER>pqr program suit <NUMBER> molecular dynamics simulations simulations performed using structure ace<NUMBER> bound sarscov pdb entry <NUMBER>d<NUMBER>g <NUMBER> <NUMBER> scarcov<NUMBER> pdb entry <NUMBER>m<NUMBER>j <NUMBER> simulations setup protein complexes systems carried following protocols used previous studies lab <NUMBER> <NUMBER> briefly hydrogens added using hbuild module charmm ionic amino acid residues maintained protonation state corresponding ph <NUMBER> protonation state histidine residues determined computing pka using binding free energy calculations gibbs free energies binding ace<NUMBER> sars cov cov<NUMBER> proteins calculated using apbs using standardized method treecodeaccelerated boundary integral poissonboltzmann equation solver tabipb <NUMBER> method protein surface triangulated electrostatic surface potentials computed discretization surface potentials utilized compute net energy due solvation well electrostatic interactions two protein subunits outlined thermodynamic scheme scheme <NUMBER> following scheme <NUMBER> free energy binding two protein fragments water expressed sum two components eq <NUMBER> â coul g represents coulombic electrostatic interactions proteins occurring proteinprotein interface scheme <NUMBER> â â solv g difference solvation energies complex corresponding free proteins however solvation calculation used part entire spike protein well ace<NUMBER> therefore â bind g tabipb calibrated correcting â â solv g using experimentally known binding free energy ace<NUMBER>Â·Â·Â·cov<NUMBER> k experimental dissociation constant equal <NUMBER> nm <NUMBER> corrected free energy solvation using â g corr eq <NUMBER> corrected binding free energy â bind g protein complexes expressed shown eq <NUMBER> combination last two terms eq <NUMBER> equal â â solv g corr therefore eq <NUMBER> simplified figure <NUMBER> sequence alignment generated clustal omega <NUMBER> receptorbinding domain sarscov sarscov<NUMBER> proteins represents identical residues represents similar residues gap represents dissimilar residues cysteine residues highlighted yellow rvqptesivrfpnitnlcpfgevfnatrfasvyawnrkrisncvadysvlynsasfstfk <NUMBER> cov pfgevfnatkfpsvyawerkkisncvadysvlynstffstfk <NUMBER> cygvsptklndlcftnvyadsfvirgdevrqiapgqtgkiadynyklpddftgcviawns <NUMBER> cov cygvsatklndlcfsnvyadsfvvkgddvrqiapgqtgviadynyklpddfmgcvlawnt <NUMBER> mediumscale fluctuations shown green coronaviruses large family viruses may cause illness animals humans seven coronaviruses known cause respiratory infections ranging common cold severe diseases first two coronaviruses human cov<NUMBER>e hcov<NUMBER>e human covoc<NUMBER> hcovoc<NUMBER> discovered <NUMBER>s cause relatively mild respiratory symptoms human severe acute respiratory syndrome coronavirus sarsrcov identified <NUMBER> causes flulike symptoms atypical pneumonia worst cases fouchier et al <NUMBER> human coronavirus nl<NUMBER> hcovnl<NUMBER> identified <NUMBER> human covhku<NUMBER> hcovhku<NUMBER> described <NUMBER> woo et al <NUMBER> generally cause upper respiratory disease humans may progress lower respiratory infections van der hoek et al <NUMBER> recently pathogenic middle east respiratory syndrome merscov coronavirus appeared first time <NUMBER> identified sixth human coronavirus zaki et al <NUMBER> finally previously unknown coronavirus probably originated baths sarscov<NUMBER> identified december <NUMBER> wuhan china andersen et al <NUMBER> gorbalenya et al <NUMBER> sarscov<NUMBER> caused ongoing pandemic severe pneumonia named coronavirus disease <NUMBER> affected <NUMBER> million people worldwide caused <NUMBER> deaths may <NUMBER> <NUMBER> currently vaccine known coronaviruses approved coronavirus vaccines live attenuated inactivated viruses proteinbased vaccines dna mrna vaccines viral spike glycoprotein nucleocapsid n protein two main targets antibody production development vaccines antiviral drugs due ability trigger dominant longlasting immune response spike protein large type transmembrane protein approximately <NUMBER> amino acids protein attractive target vaccine development surface expression renders direct target host immune response spike proteins assemble trimers virion surface form distinctive crownlike structure mediate contact host cell binding ace<NUMBER> receptor process necessary virus entry protein contains <NUMBER> subunits s<NUMBER>nterminal domain responsible receptor binding s<NUMBER> cterminal domain responsible fusion s<NUMBER> subunit conserved one s<NUMBER> subunit differs even within species coronaviruses s<NUMBER> contains two subdomains nterminal cterminal show receptorbinding functions s<NUMBER> domain contains two heptad repeats hydrophobic residues responsible formation Î±helical coiledcoil structure participate virushost cell membrane fusion walls et al <NUMBER> nucleocapsid protein regulates viral genome transcription replication packaging essential viability n protein potential interest vaccine development highly immunogenic amino acid sequence highly conserved protein contains two structural domains nterminal domain acts putative rna binding domain cterminal domain acts dimerization domain tilocca et al <NUMBER> cellresponses n proteins shown immunogenic long lasting sarscov patients furthermore bcell antibody response n proteins also reported effective although shortlived compared cellresponse search tcell bcell epitopes stimulate specific immune response n proteins represents valuable strategy identify targets development sarscov<NUMBER> vaccine ahmed et al <NUMBER> previous study showed genes encoding n proteins tend evolve faster genes encoding matrix envelope proteins dilucca et al <NUMBER> result suggested higher divergence observed two genes could represent significant barrier development antiviral therapeutics sarscov<NUMBER> perform comprehensive analysis positionspecific rates evolution orderdisorder propensities spike glycoprotein nucleocapsid protein n sarscov<NUMBER> thus provide insilico survey major nucleocapsid protein spike protein epitopes identify subset wellconserved among homologues human coronaviruses could help design broadspectrum vaccines sarscov<NUMBER> complete coding genomic sequences sarscov<NUMBER> obtained ncbi viral databases accessed <NUMBER>may<NUMBER> study also considered six human coronaviruses human cov<NUMBER>e hcov<NUMBER>e human covoc<NUMBER> hcovoc<NUMBER>human severe acute respiratory syndrome coronavirus sarsrcov human coronavirus nl<NUMBER> hcovnl<NUMBER> human covhku<NUMBER> hcovhku<NUMBER> middle east respiratory syndrome coronavirus merscov severe acute respiratory syndromerelated coronavirus <NUMBER> sarscov<NUMBER> downloaded coding sequences coronaviruses national center biotechnological information ncbi available httpswwwncbinlmnihgov virus investigated evolutionary conservation structural disorder tendency protein n uniprot id p<NUMBER>dtc<NUMBER> uniprot id p<NUMBER>dtc<NUMBER> regarded important targets development vaccines antiviral drugs explore evolutionary relationships among proteins n seven human coronaviruses considered selected protein sequences aligned using clustal omega httpswwwebiacuktoolsmsaclustalo madeira et al <NUMBER> tool new multiple sequence alignment msa program uses seeded guide trees hmm profileprofile techniques generate alignments phylogenetic tree divergent sequences structural orderdisorder propensity protein predicted usingiupred<NUMBER>a httpsiupred<NUMBER>aeltehu mÃ©szÃ¡ros et al <NUMBER> using option long disordered regions briefly iupred<NUMBER>a fast robust sequenceonly predictor based energy estimation approach allows identify disordered protein regions key component calculations energy estimation matrix <NUMBER> <NUMBER> matrix whose elements characterize general preference pair amino acids contact derived globular proteins prediction associates score residue protein sequence ranging <NUMBER> strong propensity ordered structure <NUMBER> strong propensity disordered structure <NUMBER> cutoff classify residues either ordered disordered line original protocol dosztÃ nyi et al <NUMBER> positionspecific estimations structural orderdisorder propensity residue averaged window <NUMBER> residues average value assigned central residue window taking account limitations sides protein sequence calculated rate evolution per site sarscov<NUMBER>proteins n relative orthologs six human coronaviruses using rate<NUMBER>site httpsmtauacilitaymaycprate<NUMBER>sitehtml pupko et al <NUMBER> rate<NUMBER>site calculates evolutionary rate site msa using probabilisticbased evolutionary model allows taking account stochastic process underlying sequence evolution within protein families phylogenetic tree proteins family conservation score site msa corresponds sites evolutionary rate positionspecific estimations rate evolution residue averaged window <NUMBER> residues average value assigned central residue window taking account limitations sides protein sequence size window taken equal used section <NUMBER> aminoacidic sequences nucleocapsid n protein spike glycoprotein seven human coronaviruses considered sarscov<NUMBER> sarscov merscov hcov<NUMBER>e hcovoc<NUMBER> hcovnl<NUMBER> hcovhku<NUMBER> compared assess positionspecific rates evolution two proteins investigated relationships positionspecific rates evolution distribution epitopes previously suggested contribute immune response caused human sarscov<NUMBER> infections purpose considered sarscov<NUMBER>b cell cell epitopes derived n proteins ahmed et al ahmed et al <NUMBER> worth noting epitopes also considered another study aiming provide molecular structural rationale major nucleocapsid protein epitopes potential role conferring protection sarscov<NUMBER> infection tilocca et al <NUMBER> herein focused sarscov<NUMBER> n proteins two proteins main targets vaccines antiviral drugs due dominant longlasting immune response previously reported sarscov ahmed et al <NUMBER> aligned homologous protein sequences seven human coronaviruses used resulting alignment calculate conservation profile using software rate<NUMBER>site pupko et al <NUMBER> see materials methods fig <NUMBER> report profile obtained protein n together functional regionsdomains sarscov<NUMBER> derived b cell cell epitopes top report sarscov<NUMBER> derived b cell epitopes blue cell epitopes red ahmed et al ahmed et al <NUMBER> profile values greater less zero reflect faster slower evolution respectively note rnabinding domain region <NUMBER> dimerization domain region <NUMBER> correspond regions values less zero implying higher conservation respect rest sequence although general trend conservation profile hovers around <NUMBER> regions conservation score greater one indicating regions likely positive selection interestingly location regions corresponds presence b cell cell epitopes see fig s<NUMBER> specific location sequences epitope segments could display high amino acid variability amino acid diversity regions allows virus evade host immune system recognition thus conclude source variability regions likely host immune response however worth noting presence epitopes highly conserved regions spanning residues <NUMBER> <NUMBER> may potentially offer longlasting protection sarscov<NUMBER> similarly study conservation profile protein distribution associated epitopes fig <NUMBER> solid blue line represent positionspecific estimations rate evolution residue averaged window <NUMBER> residues around position taking account limitations sides protein sequence function distance start codon thin horizontal dotted line represent threshold value score characteristic disorder <NUMBER> rate<NUMBER>site bottom orange rectangles show receptorbinding domain receptor binding motif human ace<NUMBER> fusion peptide two heptad repeats top report sarscov<NUMBER> derived b cell epitopes blue cell epitopes red ahmed et al ahmed et al <NUMBER> bottom fig <NUMBER> endocytosis translocation virus enzyme endosomes located within cells wang et al <NUMBER> millet whittaker <NUMBER> interestingly receptorbinding motif ace<NUMBER> region <NUMBER> fusion peptide amino acids <NUMBER>iyktppikdfggfnfsqil sarscov<NUMBER> segment fusion protein inserts target lipid bilayer triggers viruscell membrane fusion characterized high rates evolution conversely heptad repeats <NUMBER> <NUMBER>which known play crucial role membrane fusion viral entry liu et al <NUMBER> show lower rates evolution moreover note large percentage b cell cell epitopes located cterminal region spike protein correspondence heptad repeats <NUMBER> <NUMBER> s<NUMBER> domain see fig s<NUMBER> details sequences epitopes location along sequence thus variance protein n note spike protein epitopes mainly located protein regions characterized lower rates evolution observation suggests immune system adapted recognize slowly evolving regions protein predicted structural orderdisorder propensity proteins n investigate relationship disordered structure spatial distribution sarscov<NUMBER> derived b cell cell epitopes estimate structural stability protein sequence without relying structure used energy estimation approach core iupred<NUMBER>a disorder prediction method see materials methods fig <NUMBER> show orderdisorder propensity profile protein n together sarscov<NUMBER> derived b cell cell epitopes solid blue line represent positionspecific estimations structural orderdisorder propensity residue averaged window <NUMBER> residues around position taking account limitations sides protein sequence function distance start codon thin horizontal dotted line represent threshold value score characteristic disorder <NUMBER> iupred<NUMBER>a top report sarscov<NUMBER> derived b cell epitopes blue cell epitopes red ahmed et al ahmed et al <NUMBER> two orange rectangles show rnabinding domain dimerization domain rationale understand results score residue protein sequence ranges <NUMBER> strong propensity ordered structure <NUMBER> strong propensity disordered structure particular residue sequence classified either ordered disordered depending whether iupred<NUMBER>a score <NUMBER> <NUMBER> respectively rnabinding domain dimerization domain predicted ordered large percentage residues vast majority b cell epitopes cell epitopes overlap two functional regions protein n see also fig s<NUMBER> details although disordered protein regions expected underrepresented epitopes due sensitive proteolysis mitiÄ et al <NUMBER> note presence large fraction bcell tcell epitopes predicted disordered regions similarly studied orderdisorder propensity profile protein fig <NUMBER> orderdisorder propensity profile sarscov<NUMBER> protein solid blue line represent positionspecific estimations structural orderdisorder propensity residue averaged window <NUMBER> residues around position taking account limitations sides protein sequence function distance start codon thin horizontal dotted line represent threshold value score characteristic disorder <NUMBER> iupred<NUMBER>a top report sarscov<NUMBER> derived b cell epitopes blue cell epitopes red ahmed et al ahmed et al <NUMBER> orange rectangles show receptorbinding domain receptor binding motif human ace<NUMBER> fusion peptide two heptad repeats <NUMBER> <NUMBER> spike protein predicted ordered along whole sequence receptor binding domain fusion peptide wellstructured also case observe vast majority sarscov<NUMBER> derived b cell cell epitopes located regions displaying reduced disorder tendency see also fig s<NUMBER> details characterization evolutionary structural properties spikesurface glycoprotein nucleocapsid n protein central development vaccines antiviral drugs ahmed et al <NUMBER> study performed systematic analysis rates evolution structural orderdisorder propensities protein n relation location sarscov<NUMBER>b cell cell epitopes derived n proteins ahmed et al ahmed et al <NUMBER> identification conserved epitopes strong interest help design broadspectrum vaccines present outbreak sarscov<NUMBER> indeed highaffinity neutralizing antibodies conserved epitopes could provide immunity sarscov<NUMBER> protection future pandemic viruses conservation score measures evolutionary conservation amino acid position protein based phylogenetic relationships observed amongst homologous sequences rate evolution constant among amino acid sites positions evolve slowly commonly referred conserved others evolve rapidly referred variable see fig <NUMBER> fig <NUMBER> rate variations correspond different levels purifying selection acting sites purifying selection result geometrical constraints folding protein <NUMBER>d structure constraints amino acid sites involved enzymatic activity ligand binding alternatively amino acid sites take part proteinprotein interactions used rate<NUMBER>site method infer rate evolution residue amino acid sequences protein n analyzed structural properties protein regions epitopes located studying orderdisorder propensity show presence conserved epitopes nonconserved epitopes terms rates evolution specifically vast majority sarscov<NUMBER> derived b cell epitopes cell epitopes nucleocapsid n protein located rnabinding dimerization domains case found epitopes ordered disordered regions although noted vast majority epitopes located regions high rates evolution also identified epitopes conserved protein regions similarly observed sarscov<NUMBER> derived b cell cell epitopes spike protein preferentially located protein regions predicted ordered conserved thus suggest immune targeting conserved epitopes may potentially offer protection novel coronavirus finally worth noting numerous sars sproteinspecific neutralizing antibodies reported recognize epitopes within receptor binding domain rbd ace<NUMBER> receptor sui et al <NUMBER> indeed rbd immunization induced specific antibodies may block recognition thus effectively prevent invasion virus however showed receptorbinding motif ace<NUMBER> region <NUMBER> fusion peptide region <NUMBER> characterized high rates evolution indicating tendency two regions mutate therefore overcome host immunity conclusion results suggest targeting conserved regions sarscov<NUMBER> spike nucleocapsid proteins less plasticity structural constraint broader utility antibodybased immunotherapy neutralization prevention escape variants novel coronavirus sarscov<NUMBER> spread widely rapidly since first identified wuhan china december <NUMBER> <NUMBER> <NUMBER> <NUMBER> associated disease covid<NUMBER> causes severe respiratory difficulties aged patients higher risk mortality <NUMBER> time writing <NUMBER> confirmed cases <NUMBER> deaths registered worldwide given dramatic public health emergency strong urgent need new antiviral agents block humantohuman transmission treat infected patients like coronaviruses sarscov<NUMBER> makes use densely glycosylated spike protein gain access host cells <NUMBER> <NUMBER> protein forms homotrimers protruding viral envelope binds high affinity host receptor ace<NUMBER> angiotensinconverting enzyme <NUMBER> mainly expressed epithelial cells respiratory tract <NUMBER> recently another human receptor cd<NUMBER> identified possible route viral entrance mediated protein <NUMBER> cd<NUMBER> also known basigin emmprin transmembrane glycoprotein belongs immunoglobulin superfamily involved many processes including tumor development plasmodium invasion virus infection <NUMBER> attachment human transmembrane protease serine <NUMBER> tmprss<NUMBER> cleaves activates protein thus allowing sarscov<NUMBER> enter host cells <NUMBER> compared sarscov additional protease possibly furin likely involved priming sarscov<NUMBER> since protein sarscov<NUMBER> contains four redundant furin cut proargargala motifs absent sarscov <NUMBER> protein contains two subunits s<NUMBER> s<NUMBER> s<NUMBER> comprises receptor binding domain rbd responsible recognizing binding cell surface receptor ace<NUMBER> <NUMBER> essential infection protein promising target antibodies vaccines <NUMBER> indeed preventing attachment protein either ace<NUMBER> cd<NUMBER> receptors would hamper infection early viral entry step based structural information available complex protein ace<NUMBER> receptor <NUMBER> engineered miniaturised mimic ace<NUMBER> named spikeplug miniprotein produced high yields highly soluble conformationally stable displays nanomolar binding affinity protein sarscov<NUMBER> given properties spikeplug promising molecule development treatments based inhibition viral entry different types coronavirus used available structural information interactions protein human ace<NUMBER> receptor design spike interactors analysis structure sarscov<NUMBER> complex ace<NUMBER> reveals hydrogen bonds protein ace<NUMBER> involve helix h<NUMBER> residues <NUMBER> cterminal part helix h<NUMBER> residues <NUMBER> ace<NUMBER> <NUMBER> outside region important interaction protein ace<NUMBER> mediated lys<NUMBER> ace<NUMBER> indeed presence histidine place lysine position <NUMBER> rat ace<NUMBER> disfavours viral binding <NUMBER> starting region h<NUMBER>h<NUMBER> ace<NUMBER> basic scaffold design spike interactor included number mutations increase stability solubility aim compensate missing interactions mediated residues outside helices h<NUMBER> h<NUMBER> important issue peptide small protein design conformational stability since peptides usually folded solution therefore stabilise scaffold included extra helix h<NUMBER> residues <NUMBER> naturally caps helices h<NUMBER> h<NUMBER> ace<NUMBER> structure cluster hydrophobic interactions involving val<NUMBER> leu<NUMBER> leu<NUMBER> h<NUMBER> phe<NUMBER> leu<NUMBER> phe<NUMBER> h<NUMBER> ala<NUMBER> h<NUMBER> therefore holding together two helices h<NUMBER> h<NUMBER> figure <NUMBER> addition noticed glu<NUMBER> important stabilise structure ace<NUMBER> receptor forming salt bridge interaction arg<NUMBER> hydrogen bond backbone n lys<NUMBER> figure <NUMBER>a however residue forms weak hydrogen bond tyr<NUMBER> considered outside receptor binding motif sarscov<NUMBER> <NUMBER> engaged contact complex ace<NUMBER> rbd protein sarscov <NUMBER> homologous sarscov<NUMBER> <NUMBER> rbd domain <NUMBER> therefore mutated glu<NUMBER> arginine residue energy minimised using gromacs <NUMBER> shown figure <NUMBER>a arg<NUMBER> side chain form hydrogen bonds main chain gly<NUMBER> protein figure <NUMBER>a conformation arg<NUMBER> also stabilised salt bridge asp<NUMBER> mimics interactions protein mediated lys<NUMBER> ace<NUMBER> figure <NUMBER>a <NUMBER> <NUMBER> engineered variant including two mutations leu <NUMBER> gln leu <NUMBER> gln improve protein solubility replacing hydrophobic hydrophilic residues hamper aggregation solution ace<NUMBER> two residues located opposite side sbinding region form hydrophobic interactions core ace<NUMBER> stabilise figure <NUMBER>b c mutation glutamine residues also motivated characteristics glutamine stabilize Î± helix structures recombinant miniprotein named spikeplug table <NUMBER> figure <NUMBER>c successfully overexpressed ecoli resulting high yield <NUMBER> mg pure protein one litre bacterial culture using faruv cd spectroscopy observed spectrum spikeplug typical wellstructured fold high Î±helical content figure <NUMBER>a typical minima <NUMBER> <NUMBER> nm figure <NUMBER> spectra also showed folding fully reversible cd spectrum refolding fully superimposable recorded <NUMBER>Â°c figure <NUMBER>a investigate heatinduced changes protein secondary structure thermal unfolding curves recorded following cd signal <NUMBER> nm function temperature thus providing melting temperature tm <NUMBER>Â°c figure <NUMBER>b microscale thermophoresis mst analysis performed measure binding affinity blocking first step sarscov<NUMBER> entry host cells hampering interaction protein cellular receptor represents highly promising therapeutic strategy covid<NUMBER> focused generating spike interactor resembles human ace<NUMBER> receptor argued type molecule would act known coronaviruses using receptor sarscov hcovnl<NUMBER> well coronavirues possibily emerging future several structures complex protein ace<NUMBER> receptor recently published based structural information designed miniprotein embeds important spikeinteracting residues ace<NUMBER> receptor miniaturised mimic ace<NUMBER> properly engineered stable solution enhance affinity protein indeed important issue peptideor proteinbased drugs conformational stability miniprotein spikeplug presents highly stable Î± helical conformation solution nanomolar binding affinity rbd domain glycosylated protein sarscov<NUMBER> dissociation constant kd determined using mst <NUMBER> nm range affinity measured protein ace<NUMBER> receptor <NUMBER> nm <NUMBER> currently designing additional variants improve binding affinity protein basic idea mimics host receptor great advantage drugs several reasons first novel coronavirus emerge able infect humans ace<NUMBER> receptor proteins recognised plugged receptor mimics figure <NUMBER> blocking viral entry importantly spikeplug large enough cover important interactions protein small enough bind simultaneously three chains protein thus increasing potential hamper interactions ace<NUMBER> receptor figure <NUMBER> another point considered research drug resistance pathogens easily mutate escape therapeutic treatments however virus mutates escape binding spikeplug also likely drop affinity natural ace<NUMBER> receptor resulting suicide action validity approach demonstrated development antiretroviral drug enfuvirtide blocks action hiv<NUMBER> gp<NUMBER> fusion protein thus preventing viral entry antiviral drugs also enfuvirtide select resistance mutations however shown resistance drug comes serious fitness cost virus since involves structural alterations essential component virushost cell fusion complex <NUMBER> hence targeting receptor binding domain sarscov<NUMBER> might also result high genetic barrier towards resistance last expect spikeplug well tolerated almost complete identity correspondent domains endogenous human protein conclusion believe spikeplug firstin class promising lead candidate development molecular targeted therapies sarscov<NUMBER> coronaviruses figure <NUMBER> cartoon representation plugged spike trimer structure protein pdb code <NUMBER>vxx <NUMBER> reported magenta prune blue position spikeplug molecules green surface representation protein determined upon superposition rbd domain minimised spikeplugrbd complex rbd domain entire protein pdb code <NUMBER>vxx b panels report side top views respectively molecular modelling initially performed using cryo em structure sarscov<NUMBER> protein pdb code <NUMBER>vsb <NUMBER> crystal structure complex ace<NUMBER> rbd domain sarscov protein pdb code <NUMBER>ajf <NUMBER> complete missing regions cryo em structure computed homology model sarscov<NUMBER> protein using modeller <NUMBER> structure <NUMBER>ajf template work progress crystal structure complex ace<NUMBER> rbd domain protein sarscov<NUMBER> pdb code <NUMBER>m<NUMBER>j released <NUMBER> structure interactions protein ace<NUMBER> conserved given high sequence identity rbd sarscov sarscov<NUMBER> <NUMBER> relied structures take also possible crystal packing bias account mutations basic scaffold generated using software coot <NUMBER> models energy minimised using gromacs package <NUMBER> figures generated pymol <NUMBER> gene encoding spikeplug synthesised codonoptimised e coli expression geneartÂ® gene synthesis company invitrogen subsequently subcloned petm<NUMBER> vector embl germany ncoi xhoi restriction sites plasmid endows placement histidinetag cterminal miniprotein expression level optimised carrying small scale expression screening using different e coli available strains screenings recombinant protein successfully overexpressed ecoli bl<NUMBER>de<NUMBER> cells resulting yield <NUMBER> mg pure protein one litre bacterial culture briefly overnight starting culture <NUMBER> ml prepared growth <NUMBER>l luria bertani lb medium containing <NUMBER>Âµg l â<NUMBER> kanamycin induced <NUMBER> mm iptg <NUMBER>Â°c approximately <NUMBER> h protein purified sonicating bacterial cells resuspended binding buffer <NUMBER>mm nacl <NUMBER>mm trishcl <NUMBER> mm imidazole <NUMBER> vv glycerol ph <NUMBER> containing proteaseinhibitor cocktail roche diagnostics lysate cleared centrifugation <NUMBER> rpm <NUMBER>Â°c supernatant loaded onto <NUMBER> ml ninta resin qiagen milan italy equilibrated binding buffer washing ten volumes binding buffer protein eluted adding <NUMBER> mm imidazole binding buffer fractions containing eluted protein pooled concentrated loaded onto superdex <NUMBER> hr <NUMBER> gelfiltration column ge healthcare equilibrated <NUMBER>mm nacl <NUMBER>mm trishcl <NUMBER> vv glycerol ph <NUMBER> purification step sample eluted single peak homogeneous judged <NUMBER> sdspage analysis protein concentrated using centrifugal filter merck millipore concentration determined uv absorbance using corresponding É values <NUMBER> cm <NUMBER> cd measurements carried using jasco j<NUMBER> cd spectropolarimeter equipped thermophoretic measurements performed using monolith nt<NUMBER> device red detection channel nanotemper technologies munich germany recombinant spikeplug produced laboratory sarscov<NUMBER> spike rbd purchased sino biological inc mst recording sarscov<NUMBER> spike rbd labelled fluorescent dye nt<NUMBER> using protocol suggested nanotemper thermophoretic experiments conducted using monolith nt<NUMBER> nanotemper technologies munich germany briefly <NUMBER> Âµl <NUMBER> Âµm solution sarscov<NUMBER> spike protein rbd labelling buffer <NUMBER> mm nahco<NUMBER> <NUMBER> mm nacl ph <NUMBER> mixed <NUMBER> Âµl <NUMBER> Âµm nt<NUMBER>nhydroxysuccinimide fluorophore nanotemper technologies incubated dark <NUMBER> min room temperature spike rbd concentration labelling nt<NUMBER>spike rbd measured using uvvis spectrophotometer labelling efficiency determined <NUMBER> mst experiment performed buffer containing <NUMBER> mm nacl <NUMBER>mm trishcl <NUMBER> coronaviruses covs enveloped single positive stranded rna viruses belong subfamily coronavirinae genomes covs within range <NUMBER> <NUMBER> kilobases length probably largest viral rna known cui et al <NUMBER> fehr perlman <NUMBER> one main features coronavirus spike projections stand virion surface resemble crown shape reason name covs considered causal agents several diseases birds mammals including bats bovines mice dogs cats civets camels fehr perlman <NUMBER> coronaviruses considered highly pathogenic virus severe acute respiratory syndrome sars found <NUMBER> <NUMBER> chinese province guangdong cui et al <NUMBER> one decade another highly pathogenic coronavirus emerged named middle east respiratory syndrome merscov affecting different countries middle east recently december <NUMBER> ji et al <NUMBER> novel cov identified pathogen causing outbreaks illness chinese city wuhan firstly named <NUMBER>ncov world health organization however later renamed sarscov<NUMBER> international committee taxonomy viruses ictv sarscov<NUMBER> belongs lineage b bcovs subgenus sarbecovirus ji et al <NUMBER> wang et al <NUMBER> covs four principal proteins structure spike glycoprotein membrane envelope e nucleocapside n fehr perlman <NUMBER> homotrimers protein constitute spike structure virus surface spike glycoprotein mediates binding receptor host rbd fehr perlman <NUMBER> <NUMBER> Ã¥ resolution cryoem structure sarscov<NUMBER> shows predominant state trimer one three rbds wrapp et al <NUMBER> worthy interest described receptors coronaviruses depend lineage therefore alpha lineage aminopeptidase n apn described receptor sarscov hcovnl<NUMBER> use angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor case merscov uses protein cd<NUMBER> host infecting epitelial bronchial non ciliated cells type ii pneumocytes cao et al <NUMBER> li et al <NUMBER> case sarscov<NUMBER> suggested could use enzyme ace<NUMBER> host despite presence mutations binding domain lu et al <NUMBER> additionally spike glycoprotein hydrophobic segment fusion loop fusion peptide considered class fusion protein fehr perlman <NUMBER> protein activation subjected diverse conformational changes insertion putative fusion peptide fp target membrane ou et al <NUMBER> thus study spike glycoprotein virus determination structural similarity binding domains receptor covs lu et al <NUMBER> well importance fusion process replication cycle relevant sarscov<NUMBER> infected lot people <NUMBER> countries june <NUMBER> st <NUMBER> oms reported <NUMBER> <NUMBER> <NUMBER> people infected sarscov<NUMBER> <NUMBER> deaths httpswwwwhointemergenciesdiseasenovelcoronavirus<NUMBER> indicating facing new pandemic nishiura et al <NUMBER> unfortunately treatment vaccines currently best preventive strategy treat diseases diverse pathogens vaccine application vaccine application prevent diseases pathogens currently one common strategies development peptide based vaccines immunogenic regions using inmunoinformatics tools calis et al <NUMBER> peptides better known epitopes form mhcepitope complexes driving activation immune response prevent infection major histocompatibility complex mhc class mhc class iidependent immune responses considered important class molecules mhci expressed nucleated cells interact cell receptors tcrs induce cytotoxic immune system lymphocytes mhcii molecules bind antigenic peptides generated endocytic pathway endosomes phagosomes professional apcs macrophages b lymphocytes dendritic cells present cd<NUMBER> Ã¾ cell receptor agudelo patarroyo <NUMBER> types molecules participate immune response eliminate antigens different mechanisms two mhc molecules show grooves peptides bound generally peptides within range <NUMBER> <NUMBER> amino acids size commonly bind mhci whereas peptides <NUMBER> amino acid size bind mhcii agudelo patarroyo <NUMBER> apostolopoulos et al <NUMBER> mhc allele set present chromosome called mhc haplotype work haplotype class hlaa Ã£ <NUMBER> hlaa Ã£ <NUMBER> haplotype class ii hladrb<NUMBER> Ã£ <NUMBER> hladrb<NUMBER> Ã£ <NUMBER> included due response viruses including neutralizing antibody cd<NUMBER>Ã¾ tcell mediated cd<NUMBER>Ã¾ tcell mediated antibodies humoral cellular immunity responses respectively furthermore work used bioinformatics tools find spike glycoprotein epitopes sarscov<NUMBER> possible immunogenic peptides could used possible vaccines future adequate selection epitopes bioinformatics tools help induce direct potent immune response using methodology considered epitopes features suggested works example promiscuity saraav et al <NUMBER> conservation doytchinova flower <NUMBER> sidney et al <NUMBER> exposure surface trimeric spike glycoprotein liang et al <NUMBER> consensus sequences spike glycoprotein sarscov<NUMBER> <NUMBER> protein <NUMBER> complete genome sequences reported sequences available may <NUMBER> th <NUMBER> downloaded covid <NUMBER> data hub complete genomes highcoverage ones regions clearly identified amino acids nucleotides nn xx sequences included study multiple alignments carried clustal x program employing default parameters provided program larkin et al <NUMBER> afterwards complete genome sequence alignment traduced protein sequences sequences following ids nc<NUMBER> yp<NUMBER> considered reference sequences refseq since available covid <NUMBER> data hub consensus sequence sarscov<NUMBER> spike glycoprotein hla supertypes molecules mhci mhcii proteins identified affinity peptides hlasupertype molecules determined employing following servers netmhc <NUMBER> netmhcii <NUMBER> netmhc <NUMBER> server used predict <NUMBER> mer peptides could affinity hla supertypes mhci proteins andreatta nielsen <NUMBER> whereas netmhcii <NUMBER> jensen et al <NUMBER> employed predict <NUMBER>mer peptides could show affinity hla sypertypes mhcii proteins time prepared manuscript crystal structure protein data bank rose et al <NUMBER> thus threedimensional <NUMBER>d model protein built employing molecular modeling techniques program swissmodel httpsswissmodelexpasyorg waterhouse et al <NUMBER> ncbi database primary sequence sarscov<NUMBER> spike glycoprotein id sequence yp<NUMBER> found sequence used build <NUMBER>d model sarscov<NUMBER> spike glycoprotein using swissmodel software process crystal structure pdb <NUMBER>acd sarscov spike glycoprotein structure employed template build sarscov<NUMBER> spike glycoprotein sarscov spike glycoprotein identity <NUMBER> sarscov<NUMBER> predictive <NUMBER>d model consensus sequence named scons represents structure sarscov<NUMBER> spike glycoprotein furthermore model validated using software pdbsum laskowski et al <NUMBER> additionally time preparing manuscript two crystal structures represent distinct conformational states spike glycoprotein released pdb id <NUMBER>vyb represents conformation whereas pdb id <NUMBER>vxx constitutes conformation crystals showed missing fragments thus completed employing molecular modeling techniques using program modeller <NUMBER> script segmentpy webb sali <NUMBER> process resultant models denoted <NUMBER>vxxfill <NUMBER>vybfill process epitope selection peptides showed following features promiscuity protein surface exposure conservation grade selected pdb database searched structures mhciii proteins hladrb<NUMBER> Ã£ <NUMBER> molecule crystal pdb id <NUMBER>bij hlaa Ã£ <NUMBER> used crystal structure pdb id <NUMBER>w<NUMBER>w hlaa Ã£ <NUMBER> used structure pdb id <NUMBER>xpg whereas hladrb<NUMBER> Ã£ <NUMBER> molecule find structure pdb modeled structure homology modeling using program modeller <NUMBER> webb sali <NUMBER> employed crystal structure pdb id <NUMBER>pdo template identity <NUMBER> alpha chain identity <NUMBER> beta chain three dimensional <NUMBER>d structures chosen epitopes built employing pepfold <NUMBER> server employs novo peptide structure prediction strategy based hidden markov model derived structural alphabet sa lamiable et al <NUMBER> mhciii proteins docked chosen epitopes using cluspro <NUMBER> server vajda et al <NUMBER> regards program epitopes considered ligands whereas molecules hladrb<NUMBER> Ã£ <NUMBER> hlaa Ã£ <NUMBER> hlaa Ã£ <NUMBER> hladrb<NUMBER> Ã£ <NUMBER> determined receptors cluspro server employs distinct algorithms permit evaluate millions predictive complexes taking account electrostatic energy well desolvation parameters larkin et al <NUMBER> subsequently mhcepitope complexes show highest affinity selected eleven molecular dynamics simulations mch ii epitopescomplexes carried means namd program using known inputs namd standard md simulations phillips et al <NUMBER> complexes solvated notal charge neutralized final concentration <NUMBER> nacl md simulations performed periodic boundary conditions pbc method partcilemesh ewald pme used calculation electrostatic potential energy bonded cutoff <NUMBER> Ã¥ switchdist <NUMBER> Ã¥ pairlistdist <NUMBER> Ã¥ implemented long range interactions equilibration step ntv constant volume temperature protocol applied production step ntp constant temperature pressure ensemble maintained langevin thermostat <NUMBER> k anisotropic langevin barostat <NUMBER> atm last two steps integration time step <NUMBER> femtosecond fs used bond lengths involved finally md simulations run <NUMBER> ns table <NUMBER> promiscuous epitopes table describes molecules hla supertype show affinity epitopes using netmhc <NUMBER> netmhcii <NUMBER> servers affinity indicated parenthesis either weak wb strong sb predicted alignment complete genome sequences <NUMBER> amino acid changes identified table s<NUMBER> figure <NUMBER> spike glycoprotein sarc cov<NUMBER> alignment protein sequences <NUMBER> amino acid changes found table s<NUMBER> figure <NUMBER>b results mutation snp d<NUMBER>g identified interestingly mutation presumably found possible region s<NUMBER>s<NUMBER> binding site near furin recognition site r<NUMBER> cleavage spike glycoprotein yin <NUMBER> sequence id yp<NUMBER> analyzed servers netmhc <NUMBER> server netmhcii <NUMBER> predict immunogenic regions could induce antibodies virus sarscov<NUMBER> servers mentioned predicted <NUMBER> regions could affinity either mhci mhcii proteins process selected <NUMBER> epitopes regions showed promising characteristics include promiscuity ebrahimi et al <NUMBER> saraav et al <NUMBER> conservation affinity hlasupertypes doytchinova flower <NUMBER> sidney et al <NUMBER> exposure surface trimeric spike glycoprotein liang et al <NUMBER> promiscuity affinity revealment hlasupertypes submitting peptides mentioned servers <NUMBER> epitopes table <NUMBER> showed affinity mhci mhcii molecules identified promiscuous since capable binding different molecules universal displayed affinity towards hlasupertype molecules thus epitopes would efficient different ethnic groups conservation grade epitopes also calculated two multiple sequence alignments described table <NUMBER> shows conserved epitopes highlighting e<NUMBER> change residue y<NUMBER>f e<NUMBER> change residue p<NUMBER>s e<NUMBER> changes residues a<NUMBER>t v<NUMBER>f e<NUMBER> change residues s<NUMBER>l a<NUMBER>s finally epitopes showed variations higher number reside changes e<NUMBER> e<NUMBER> exposure surface trimer spike glycoprotein figure <NUMBER> shows different trimers epitopes bound exhibited exposed scons consensus sequence <NUMBER>vxxfill conformation <NUMBER>vybfill conformation conformation <NUMBER>vybfill e<NUMBER> e<NUMBER> epitopes exposed however conformation <NUMBER>vxxfill model consensus sequence scons exposed surface sarscov<NUMBER> spike glycoprotein figure <NUMBER> also depicted figures <NUMBER> <NUMBER> epitopes exposed figure <NUMBER> docking e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> peptides hladrb<NUMBER> Ã£ <NUMBER> molecules structural coupling e<NUMBER> peptide lowest energy Ã <NUMBER> frequency <NUMBER> observed b e<NUMBER> green schematized lowest energy Ã <NUMBER> frequency <NUMBER> c observe blue color peptide e<NUMBER> interacting drb<NUMBER> Ã£ <NUMBER> complex peptide e<NUMBER> posed binding cavity ligand frequency <NUMBER> lowest energy Ã <NUMBER> e<NUMBER> peptide orange binds binding cavity frequency <NUMBER> lowest energy Ã <NUMBER> furthermore amino acids peptides interact amino acids cavity hladrb<NUMBER> Ã£ <NUMBER> models specifically e<NUMBER> epitope exposed chain b figure <NUMBER> c colored gray comparison conformations figure <NUMBER>a b figure <NUMBER> b shows conformation <NUMBER>vxxfill e<NUMBER> epitope exposed structure conformation scons based results suggest conformational state protein could influence exposure grade peptides surface structure molecules mhci mhcii molecules quite different cavity mhcii shows different pockets pocket<NUMBER> p<NUMBER> pocket <NUMBER> p<NUMBER> pocket <NUMBER> p<NUMBER> pocket <NUMBER> p<NUMBER> known crucial stability mhciiepitope complex may play role recognition amino acids agudelo patarroyo <NUMBER> case mhci complex six specificity pockets af found pocket b pb pocket f pf known relevant anchorage process molecules mhci molecules hinrichs et al <NUMBER> present work focused searching pockets could crucial stability mhcepitope complex following peptides e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> docked hladrb<NUMBER> Ã£ <NUMBER> molecule whereas epitope e<NUMBER> coupled hladrb<NUMBER> Ã£ <NUMBER> peptides e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> coupled hlaa Ã£ <NUMBER> allele liu et al <NUMBER> whereas peptide e<NUMBER> coupled hlaa Ã£ <NUMBER> allele worth mentioning chosen alleles identified frequent among ethnic groups side capability epitopes form covalent noncovalent interactions cavities alleles also evaluated highlighting interactions present pockets crucial stability mhciepitope complex figure <NUMBER> table <NUMBER> show results binding e<NUMBER> peptide hladrb<NUMBER> Ã£ <NUMBER> allele could observed peptide interacts residues involved p<NUMBER> p<NUMBER> p<NUMBER> p<NUMBER> pockets particularly residues q<NUMBER>b p<NUMBER> n<NUMBER>a p<NUMBER> p<NUMBER> n<NUMBER>a p<NUMBER> p<NUMBER> form hydrogen bonds specifically d<NUMBER>b p<NUMBER> able form hydrogen bonds generate saline bridge residue shows covalent interactions among p<NUMBER> p<NUMBER> p<NUMBER> pockets e<NUMBER> e<NUMBER> e<NUMBER> peptides form nonbonded interactions crucial pockets hladrb<NUMBER> Ã£ <NUMBER> hlaa Ã£ <NUMBER> depicted tables <NUMBER> <NUMBER> first peptide e<NUMBER> able bind p<NUMBER> p<NUMBER> p<NUMBER> p<NUMBER> pockets located hladrb<NUMBER> Ã£ <NUMBER> allele pb pf pockets display electrostatic interactions hydrogen bonds hlaa Ã£ <NUMBER> allele figures <NUMBER>a <NUMBER>c side e<NUMBER> peptide interacts allele hlaa Ã£ <NUMBER> figure <NUMBER> c table <NUMBER> complex hydrogen bonds saline bridges present crucial pockets pb pf thus suggesting e<NUMBER> peptide could form stable complexes hlaa Ã£ <NUMBER> hladrb<NUMBER> Ã£ <NUMBER> alleles affinity e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> complex attributed three hydrogen bonds p<NUMBER> p<NUMBER> p<NUMBER> pockets saline bridges sited p<NUMBER> p<NUMBER> pockets figure <NUMBER>d e<NUMBER>hlaa Ã£ <NUMBER> complex presence electrostatic interactions two hydrogen bonds located pocket b hlaa Ã£ <NUMBER> allele depicted figure <NUMBER>a figure <NUMBER> docking e<NUMBER> e<NUMBER> e<NUMBER> peptides mhcii e<NUMBER> peptide coupled hladrb<NUMBER> Ã£ <NUMBER> haplotype peptide recognition cavity frequency <NUMBER> lowest energy Ã <NUMBER> b section observe e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> complex peptide coupled lowest energy Ã <NUMBER> frequency <NUMBER> peptide binding cavity c e<NUMBER> peptide binds hladrb<NUMBER> Ã£ <NUMBER> haplotype <NUMBER> frequency lowest energy Ã <NUMBER> e<NUMBER> binds cavity frequency <NUMBER> lowest energy Ã <NUMBER> addition amino acids peptides interact amino acids mhcii molecule cavity shown e<NUMBER> peptide able form electrostatic interactions include four hydrogen bonds three located pf pb pockets e<NUMBER>hlaa Ã£ <NUMBER> complex figure <NUMBER> b figure <NUMBER> c shows e<NUMBER>hlahladrb<NUMBER> Ã£ <NUMBER> complex affinity mediated hydrogen bonds located p<NUMBER> p<NUMBER> p<NUMBER> pockets e<NUMBER> e<NUMBER> peptides situated rbd region corresponds binding domain ace<NUMBER> receptor wrapp et al <NUMBER> making even interesting e<NUMBER> peptide interacts within p<NUMBER> p<NUMBER> p<NUMBER> pockets hladrb<NUMBER> Ã£ <NUMBER> allele figure <NUMBER> b depicts presence <NUMBER> hydrogen bonds within p<NUMBER> p<NUMBER> p<NUMBER> pockets table <NUMBER> e<NUMBER> peptide interacts pb pf pockets hlaa Ã£ <NUMBER> molecule table <NUMBER> stability e<NUMBER>hlaa Ã£ <NUMBER> complex mainly due presence <NUMBER> hydrogen bonds figure <NUMBER>d <NUMBER> located pb pf pockets interestingly according immunoinformatic predictions e<NUMBER> peptide show affinity hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER> shows affinity hladrb<NUMBER> Ã£ <NUMBER> theoretical predictions could identified peptides bind p<NUMBER> p<NUMBER> p<NUMBER> pockets figure <NUMBER> c table <NUMBER> electrostatic interactions example <NUMBER> hydrogen bonds <NUMBER> saline bridges found five hydrogen bonds located p<NUMBER> p<NUMBER> p<NUMBER> pockets e<NUMBER>hlaa Ã£ <NUMBER> complex stable e<NUMBER> peptide able bind pb pf pockets hlaa Ã£ <NUMBER> allele table <NUMBER> figure <NUMBER>b complex shows noncovalent interactions example <NUMBER> hydrogen bonds <NUMBER> saline bridges additionally presence one hydrogen bond pb pocket figure <NUMBER> shows e<NUMBER> epitope binds hladrb<NUMBER> Ã£ <NUMBER> molecule noncovalent interactions three hydrogen bonds located p<NUMBER> p<NUMBER> pockets addition table <NUMBER> shows figure <NUMBER> docking peptides e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> mhc molecules peptide e<NUMBER> magenta binds cavity drb<NUMBER> Ã£ <NUMBER> frequency <NUMBER> lowest energy Ã <NUMBER> b e<NUMBER>drb<NUMBER> Ã£ <NUMBER> complex illustrated determined binding frequency ligand formation <NUMBER> lowest energy Ã <NUMBER> c section shown e<NUMBER> peptide binds cavity hlaa Ã£ <NUMBER> molecule frequency <NUMBER> lowest energy Ã <NUMBER> finally figure e<NUMBER> peptide binds hlaa Ã£ <NUMBER> frequency <NUMBER> lowest energy Ã <NUMBER> addition amino acids peptides interact amino acids mhc molecule cavity shown peptide binds crucial pockets e<NUMBER>hlaa Ã£ <NUMBER> complex figure <NUMBER> table <NUMBER> also binds crucial pockets pb pf binding mediated seven hydrogen bridges <NUMBER> distributed crucial pockets e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> epitopes interact p<NUMBER> p<NUMBER> p<NUMBER> pockets hladrb<NUMBER> Ã£ <NUMBER> allele affinity e<NUMBER> e<NUMBER> peptides due noncovalent interactions specifically hydrogen bonds four hydrogen bonds formed e<NUMBER> distributed p<NUMBER> p<NUMBER> p<NUMBER> p<NUMBER> pockets figure <NUMBER>b e<NUMBER> peptide forms <NUMBER> hydrogen bonds two found p<NUMBER> p<NUMBER> pockets figure <NUMBER>c binding force e<NUMBER> e<NUMBER> peptides mediated noncovalent interactions including hydrogen bonds saline bridges e<NUMBER> peptide forms <NUMBER> hydrogen bonds <NUMBER> positioned p<NUMBER> p<NUMBER> p<NUMBER> pockets <NUMBER> saline bridges <NUMBER> placed p<NUMBER> p<NUMBER> pockets figure <NUMBER>a e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> complex hydrogen bonds depicted p<NUMBER> p<NUMBER> pockets well saline bridges p<NUMBER> pocket figure <NUMBER>b two complexes e<NUMBER>hlaa Ã£ <NUMBER> e<NUMBER>hlaa Ã£ <NUMBER> bound peptides interact pb pf pockets show formation electrostatic interactions include hydrogen bonds saline bridges peptides mhci molecules figures <NUMBER>d <NUMBER> hydrogen bonds detected <NUMBER> positioned pb pf pockets well <NUMBER> saline bridges form e<NUMBER>hlaa Ã£ <NUMBER> complex e<NUMBER> peptide figure <NUMBER> could seen bound hlaa Ã£ <NUMBER> allele displaying <NUMBER> hydrogen bonds <NUMBER> sited pb pf pockets additionally <NUMBER> saline bridges found two placed pb pocket figure <NUMBER> docking e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> peptides molecule hlaa Ã£ <NUMBER> peptide e<NUMBER> binds binding cavity ligand frequency <NUMBER> lowest energy Ã <NUMBER> b shown section frequency e<NUMBER>hlaa Ã£ <NUMBER> complex <NUMBER> lowest energy Ã <NUMBER> c e<NUMBER> bound recognition cavity frequency <NUMBER> lowest energy Ã <NUMBER> e<NUMBER> binds hlaa Ã£ <NUMBER> cavity lowest energy Ã <NUMBER> frequency <NUMBER> studies focused mainly mhc ii molecule since widely described potential roles mhcii molecules inducing immune responses vaccination although mechanisms still unknown eunju et al <NUMBER> takenaka et al <NUMBER> two md simulations correspond alleles hladrb<NUMBER> hladrb<NUMBER> others mhciiepitopes complexes carried structural analysis <NUMBER> mhciiepitopes md simulations calculating root mean square deviation rmsd considering alpha carbon atoms mhcii molecules along <NUMBER> ns trajectories calculations performed using carma program glykos <NUMBER> figure <NUMBER> shows rmsd values protein structures stable <NUMBER> ns rmsd values mhcii molecules e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> fluctuate <NUMBER> <NUMBER> Ã¥ mhcii molecules e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> rmsd values fluctuate <NUMBER> <NUMBER> Ã¥ rmsd value mhcii molecule e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> oscillates <NUMBER> <NUMBER> Ã¥ finally mhcii molecules e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> show rmsd values <NUMBER> <NUMBER> Ã¥ table <NUMBER> shows binding free energy calculations mhciiepitopes complexes using mmpbsa method results could seen epitope lowest energy Ã <NUMBER> kcalmol corresponds e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> epitopes show low binding free energy values correspond e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> figure <NUMBER> docking e<NUMBER>hlaa Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hlaa Ã£ <NUMBER> e<NUMBER>hlaa Ã£ <NUMBER> complexes e<NUMBER> peptide binds cavity ligand bound frequency <NUMBER> lowest energy Ã <NUMBER> b observed frequency <NUMBER> lowest energy Ã <NUMBER> e<NUMBER>hlaa Ã£ <NUMBER> complex c e<NUMBER> peptide binds recognition site frequency <NUMBER> lowest energy Ã <NUMBER> e<NUMBER>hlaa Ã£ <NUMBER> complex binds cavity lowest energy Ã <NUMBER> frequency <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> e<NUMBER>hladrb<NUMBER> Ã£ <NUMBER> epitopes marked bold table currently immunoinformatics represents useful interface computer science experimental immunology work used computational tools permitted find spike glycoprotein epitopes sarscov<NUMBER> possible immunogenic peptides process selection epitopes considered different epitope features promiscuity conservation exposure surface trimeric spike glycoprotein liu et al <NUMBER> additionally e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> peptides display affinity towards hlaa Ã£ <NUMBER> allele expressed different ethnic groups amerindian arab asian aboriginal austronesina caucausoid hispanic jew melanesian mextizo mixed mixed ancestry mulatto oriental persian polynesian siberian gonzalezgalarza et al <NUMBER> overall peptides mentioned table <NUMBER> identified promiscuous showed affinity hlasupertype two properties peptides important recognized different proteins mchi mhcii families providing greater capacity generate antibodies addition mentioned databases frequency alleles investigated found hladrb<NUMBER> Ã£ <NUMBER> hlaa Ã£ <NUMBER> alleles distributed different ethnic groups therefore peptides could used base design new vaccines different human races ethnic groups important sarscov<NUMBER> china also distributed different countries immunoinformatics analysis could depicted e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> epitopes potential candidates immunogenic agents show four important features promiscuity universality hlasupertype exposure trimer conservation grade interestingly mentioned epitopes also showed lowest binding free energies mm pbsa calculations indicating also structural stability mhciiepitope complexes e<NUMBER> peptide showed mentioned features also region crucial receptor interaction target cells could also initiate infection process additionally structural alignments demonstrated amino acid leu<NUMBER> crucial affinity spike glycoprotein ace<NUMBER> protein hand epitope <NUMBER> located near peptide fusion ou et al <NUMBER> trimeric spike glycoprotein therefore could recognized antibodies could prevent structural changes necessary virus fuse endosome membrane release genome cycle replication suggest proposed epitopes using immunoiformatics tools could interfere functional regions spike glycoprotein crucial steps virus infection silico studies identified epitopes e<NUMBER> e<NUMBER> e<NUMBER> e<NUMBER> accomplish essential features promiscuity conservation grade exposure universality also also form stable complexes mhcii molecule observed binding free energy calculations mmpbsa whole characteristics could provide higher probability generate specific immune response epitope e<NUMBER> located functional region spike glycoprotein epitope e<NUMBER> located near region hand antibodies could potentially generated epitope e<NUMBER> could recognize rbm region avoiding formation spike glycoproteinace<NUMBER> complex could result interruption virus entry host cell finally immunoiformatics tools permitted us identify epitopes used potential vaccines pandemic events work proposed set epitopes could synthesized assayed animal model determine potential induce immunogenic responses even used future applications design new epitope vaccines sarscov<NUMBER> could also represent preventive strategy stop pandemic worldwide coronavirus disease <NUMBER> pandemic rapidly become international public health threat causing inconceivable loss lives severe socioeconomic instability worldwide severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> identified causal agent disease enveloped singlestranded positivesense rna virus assigned species severe acute respiratory syndromerelated coronavirus genus betacoronavirus family coronaviridae firstly identified cluster pneumonia cases wuhan china december <NUMBER> zhou et al <NUMBER> january <NUMBER> <NUMBER> world health organization declared coronavirus epidemic public health emergency international concern raised threat coronavirus epidemic world level high february <NUMBER> march <NUMBER> covid<NUMBER> officially declared worldwide pandemic march <NUMBER> stated europe becoming new epicentre pandemic main cause uncontainable spread disease lack specific antiviral medications though several groups world making lot effort trying speed research although production vaccines could powerful weapon sarscov<NUMBER> spread invasion take quite long time develop clinically test safety thus emergency measure would fundamental identify develop antiviral molecules treat covid<NUMBER> also prevent transmission although antiviral treatment yet approved several therapeutic approaches proposed based administration molecules developed treating diseases combination lopinavirritonavir chloroquine hydroxychloroquine kupferschmidt cohen <NUMBER> preclinical studies also suggested remdesivir rna polymerase inhibitor developed ebola could effective prophylaxis therapy human coronavirus infections suggested results obtained testing activity rhesus macaque model merscov infection de wit et al <NUMBER> finally investigation led istituto nazionale tumori fondazione pascale di napoli focused use tocilizumab humanized igg<NUMBER> monoclonal antibody directed il<NUMBER> receptor commonly used treatment rheumatoid arthritis prevent cytokine storm syndrome caused sarscov<NUMBER> infection clinicaltrialsgov identifier nct<NUMBER> available httpsclinicaltrialsgovct<NUMBER>shownct<NUMBER> however certain evidence treatments conclusive may also available developing countries confirmed sarscov<NUMBER> initiates entry host cells binding angiotensinconverting enzyme <NUMBER> ace<NUMBER> cell receptor via receptor binding domain rbd trimeric spike glycoprotein triggering mechanism mediates fusion host viral membranes zhou et al <NUMBER> protein trimeric class fusion protein exists metastable prefusion conformation undergoes substantial structural rearrangements fuse viral membrane host cell membrane bosch et al <NUMBER> li <NUMBER> protein subdivides two distinct functional subunits s<NUMBER> subunit involved host cell receptor recognition s<NUMBER> mediates viral fusion host cells fusion process triggered s<NUMBER> subunit binds specific cell receptor receptor binding destabilizes prefusion trimer resulting shedding s<NUMBER> subunit transition s<NUMBER> subunit stable postfusion conformation latter characterized assembly heptad repeats <NUMBER> hr<NUMBER> <NUMBER> hr<NUMBER> regions <NUMBER>helix bundle structure allows viral fusion entry host cells bosch et al <NUMBER> walls et al <NUMBER> complete threedimensional structure human sarscov<NUMBER> spike postfusion conformation yet published recently wrapp coworkers wrapp et al <NUMBER> determined first <NUMBER> Ã¥ resolution cryoelectron microscopy cryoem structure sarscov<NUMBER> trimer prefusion conformation study provides biophysical structural evidences sarscov<NUMBER> protein binds ace<NUMBER> receptor higher affinity closely related severe acute respiratory syndrome coronavirus sarscov protein additionally authors tested several published sarscov rbdspecific monoclonal antibodies found appreciable binding sarscov<NUMBER> protein suggesting antibody crossreactivity may limited rbds two viruses wrapp et al <NUMBER> crucial function protein sarscov<NUMBER> infection process structural component could represent target antibody smallmolecules mediated neutralization characterization prefusion structure allowed get atomiclevel information essential guide design development novel therapeutic molecules previous data obtained human respiratory syncytial virus hrsv f protein class viral fusion glycoprotein sharing structural similarities lower respiratory tract viruses fusion glycoproteins indicated newly generated escape mutations evaluated smallmolecule fusion inhibitors clustered inside central cavity f protein prefusion conformation battles mclellan <NUMBER> lopes et al <NUMBER> yan et al <NUMBER> crystallographic studies later confirmed smallmolecules bind within central cavity contacting j u r n l p r e p r f two three lobes trimeric binding pocket interacting residues fusion peptide second heptad repeat battles et al <NUMBER> functional studies involving soluble f proteins samuel et al <NUMBER> membranebound f proteins battles et al <NUMBER> demonstrated evaluated smallmolecules act antagonists prevent protein transition postfusion conformation date known smallmolecule fusion inhibitors bind pocket mechanism action devincenzo et al <NUMBER> stevens et al <NUMBER> data suggest also case sarscov<NUMBER> targeting central cavity spike glycoprotein prefusion conformation could valuable approach hindering prefusion postfusion transition consequently virus entry host cells paper used sarscov<NUMBER> trimer structure prefusion conformation wrapp et al <NUMBER> perform drug repurposing aim find suggest smallmolecule fusion inhibitors clinical use repurposing drugs already approved still clinical trial represents accelerated route drug discovery existing drugs already established clinical pharmacokinetic data carried virtual screening vs simulation using <NUMBER> fda drugs extracted drugbank database httpswwwdrugbankca wishart et al <NUMBER> structure spike glycoprotein wrapp et al <NUMBER> completed using modeling techniques used identification available compounds strongly interacting inside inner cavity fig <NUMBER> furthermore stability selected proteindrug complexes tested using classical molecular dynamics md simulations free energy interaction molecules finely evaluated molecular mechanics energies combined generalized born surface area continuum solvation mmgbsa method perresidue energy decomposition analysis genheden ryde <NUMBER> finally alignments sequence spike glycoprotein used study sequences betacoronavirus spike glycoproteins reported genbank database clark et al <NUMBER> including recently deposited sequences different sarscov<NUMBER> isolates carried evaluate presence variability within protein region analyzed simulation research result considering available scientific information selected set drugs suggested sarscov<NUMBER> fusion inhibitors hypothesis use compounds extended also related viruses cryoem structure sarscov<NUMBER> spike glycoprotein prefusion conformation obtained pdb database pdb id <NUMBER>vsb wrapp et al <NUMBER> trimer structure composed three identical monomers named b c completed modeling nonterminal missing loops using swissmodel webserver waterhouse et al <NUMBER> modeling procedure mainly involved regions s<NUMBER> subunit glycoprotein residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> monomer residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> monomer b residues <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> monomer c also two regions s<NUMBER> subunit residues <NUMBER> <NUMBER> monomers b c although modeled regions close central cavity spike glycoprotein rebuilt since possible accurately simulate analyze protein missing parts using classical md simulation fact simulation protein would subjected unnatural fluctuations misleading subsequent analyses drug library containing <NUMBER> compounds mol<NUMBER> format extracted drugbank database v <NUMBER> wishart et al <NUMBER> httpswwwdrugbankca spike glycoprotein receptor drug structure files converted pdbqt format using preparereceptor<NUMBER>py prepareligand<NUMBER>py tools mgltools software morris et al <NUMBER> sanner <NUMBER> seven drug structures excluded analysis since prepareligand could generate pdbqt files eight structures containing si atoms excluded due absence forcefield parameters <NUMBER> molecular docking simulations performed using inhouse parallelized version autodock vina <NUMBER> program trott olson <NUMBER> one docking simulation including ten docking runs carried drug docking simulation autodock vina program selects <NUMBER> binding poses representing cluster centroids different conformations generated run using lamarckian genetic algorithm box size x<NUMBER> Ã¥ y<NUMBER> Ã¥ z<NUMBER> Ã¥ placed hr<NUMBER> internal region residues <NUMBER> <NUMBER> spike j u r n l p r e p r f glycoprotein monomer <NUMBER> receptor residues sidechains around selected binding site considered flexible y<NUMBER> f<NUMBER> n<NUMBER> i<NUMBER> v<NUMBER> t<NUMBER> q<NUMBER> n<NUMBER> v<NUMBER> d<NUMBER> q<NUMBER> n<NUMBER> monomer r<NUMBER> e<NUMBER> f<NUMBER> monomer c virtual screening performed using <NUMBER> nodes enea hpc cluster cresco<NUMBER> ponti et al <NUMBER> docking simulation took <NUMBER> <NUMBER> topranking docked compounds binding energies reevaluated average best poses obtained three repeated molecular docking simulations two sequential molecular docking simulations performed phthalocyanine hypericin two topranking drugs order dock second third molecule compounds inside spike glycoprotein binding pocket best complexes obtained virtual screening first docking run used receptors converting structures pdbqt format using preparereceptor<NUMBER>py tool mgltools software morris et al <NUMBER> sanner <NUMBER> two molecular docking simulations including ten docking runs carried using autodock vina <NUMBER> program trott olson <NUMBER> box size x<NUMBER> Ã¥ y<NUMBER> Ã¥ z<NUMBER> Ã¥ centred hr<NUMBER> internal region spike glycoprotein monomer b selecting <NUMBER> residues sidechains around binding site flexible y<NUMBER> f<NUMBER> n<NUMBER> i<NUMBER> v<NUMBER> t<NUMBER> q<NUMBER> n<NUMBER> v<NUMBER> e<NUMBER> q<NUMBER> n<NUMBER> monomer b r<NUMBER> e<NUMBER> f<NUMBER> monomer finally box size x<NUMBER> Ã¥ y<NUMBER> Ã¥ z<NUMBER> Ã¥ placed hr<NUMBER> internal region belonging monomer c selecting <NUMBER> side chains flexible y<NUMBER> f<NUMBER> n<NUMBER> i<NUMBER> v<NUMBER> t<NUMBER> q<NUMBER> n<NUMBER> v<NUMBER> e<NUMBER> q<NUMBER> n<NUMBER> monomer c r<NUMBER> e<NUMBER> f<NUMBER> monomer b binding energies calculated average best poses obtained three repeated docking simulations sequential molecular docking simulations <NUMBER> top drugs obtained reevaluating compounds ranking performed first three docked compounds applying parameters already described <NUMBER> compounds molecular docking molecular docking fourth compound instead performed using box size x<NUMBER> Ã¥ y<NUMBER> Ã¥ z<NUMBER> Ã¥ centred hr<NUMBER> internal regions monomers b c selecting <NUMBER> receptor side chains flexible i<NUMBER> t<NUMBER> e<NUMBER> q<NUMBER> r<NUMBER> n<NUMBER> f<NUMBER> monomer b y<NUMBER> r<NUMBER> n<NUMBER> q<NUMBER> k<NUMBER> monomer c molecular docking simulations took <NUMBER> performed using enea hpc cluster cresco<NUMBER> ponti et al <NUMBER> two complexes obtained multiple docking phthalocyanine hypericin drugs simulated using classical molecular dynamics topologies coordinates files input structures generated using tleap module ambertools <NUMBER> package case et al <NUMBER> spike glycoprotein parametrized using ff<NUMBER>sb force field tian et al <NUMBER> parameters two topranking drugs generated using antechamber module ambertools <NUMBER> package case et al <NUMBER> general amber force field wang et al <NUMBER> spike glycoprotein complexed three drugs inserted rectangular box tip<NUMBER>p water molecules jorgensen et al <NUMBER> setting minimum distance <NUMBER> Ã¥ box sides neutralizing solution <NUMBER> moll nacl ions order remove unfavourable interactions structures subjected four minimization cycles composed <NUMBER> steps steepest descent minimization followed <NUMBER> steps conjugated gradient minimization starting restraint <NUMBER> kcalmol <NUMBER> Ã¥ <NUMBER> imposed protein ligand atoms subsequently reduced removed last minimization cycle systems gradually heated <NUMBER> <NUMBER> k nvt ensemble period <NUMBER> ns using langevin thermostat goga et al <NUMBER> imposing starting restraint <NUMBER> kcalmol <NUMBER> Ã¥ <NUMBER> protein ligand atom decreased every <NUMBER> ps order slowly relax system systems simulated isobaricisothermal npt ensemble <NUMBER> ns imposing pressure <NUMBER> atm using langevin barostat aoki et al <NUMBER> fixing temperature <NUMBER> k covalent bonds involving hydrogen atoms constrained using shake algorithm ryckaert et al <NUMBER> production run <NUMBER> ns performed systems timestep <NUMBER> fs using pmemdcuda module amber <NUMBER> software case et al <NUMBER> pme method used calculating longrange interactions cutoff <NUMBER> Ã¥ set shortrange interactions darden et al <NUMBER> system coordinates saved every <NUMBER> steps rmsd analysis spike glycoprotein performed using rms module gromacs <NUMBER> analysis tool abraham et al <NUMBER> hydrogen bond analyses carried j u r n l p r e p r f using hbonds plugin software vmd <NUMBER> humphrey et al <NUMBER> generalized born surface area continuum solvation mmgbsa analysis genheden ryde <NUMBER> perresidue energy decomposition analysis performed last <NUMBER> ns simulations using mmpbsapympi program implemented amber<NUMBER> software case et al <NUMBER> <NUMBER> nodes enea hpc cluster cresco<NUMBER> ponti et al <NUMBER> decomposition analysis performed residues surrounding drug located within cutoff distance <NUMBER> Ã¥ j u r n l p r e p r f virtual screening vs analysis drug repurposing set <NUMBER> structures approved experimental investigational drugs extracted drugbank database httpswwwdrugbankca wishart et al <NUMBER> performed order find compounds entering inner cavity protein blocking hr<NUMBER> conformational changes could act spike glycoprotein fusion inhibitors using inhouse parallelized version autodock vina software trott olson <NUMBER> evaluated binding affinity drug one three hr<NUMBER> internal regions spike glycoprotein residues <NUMBER> ten topranking compounds obtained vs analysis reported fig <NUMBER> table s<NUMBER> interestingly three compounds already reported possible antiviral agents targeting different types enveloped viruses particular compounds <NUMBER>hphthalocyanine simply referred phthalocyanine hypericin represent two appealing molecules fact show significantly high affinity hr<NUMBER> region additionally hypericin different phthalocyanine derivates already shown prevent human immunodeficiency virus hiv infections interfering surface glycoprotein gp<NUMBER> binding fusion host cell franÃ§ois et al <NUMBER> vzorov et al <NUMBER> furthermore two compounds derivatives also possess different antiviral activities towards viral species discussed section <NUMBER> hypericin also recently shown inhibit infectious bronchitis virus ibv avian coronavirus acting mechanism involving inhibition virusinduced cellular apoptosis chen et al <NUMBER>b considering trimeric structure spike glycoprotein propose inhibitory mechanism least three drug molecules could enter arrange inside inner cavity binding three hr<NUMBER> internal regions wrapp et al <NUMBER> concurrent binding three molecules could generate strong steric hindrance inside pocket preventing conformational changes hr<NUMBER> regions hence formation <NUMBER>helix bundle stabilizing postfusion conformation walls et al <NUMBER> order evaluate hypothesis starting top ranking complexes obtained vs procedure evaluated binding affinity two phthalocyanine two hypericin molecules two hr<NUMBER> internal regions spike glycoprotein average binding energies obtained molecule reported table <NUMBER> observed even binding affinities second third bound molecules lower obtained first due reduction conformational space inside pocket still remain particularly suitable establishing valuable interactions compounds contact high number residues within pocket hr<NUMBER> internal regions upward downward regions spike creating connection hr<NUMBER>s surrounding regions inner cavity fig <NUMBER> phthalocyanine molecules arrange symmetric orientation fig <NUMBER> ab facing inner cavity pocket establishing <NUMBER> hydrophobic interactions surrounding residues particular stacking interactions settled isoindole groups phthalocyanines aromatic sidechains protein fig <NUMBER> b three phthalocyanines also set hydrophobic interactions within increasing stability multiple complex fig <NUMBER> bc hypericin molecules hand bind hr<NUMBER> regions alternate orientation fig <NUMBER> de establishing <NUMBER> hydrophobic interactions <NUMBER> hydrogen bonds surrounding residues hypericin molecules also set contacts within interacting hydrogen bonds established hydroxyl groups fig <NUMBER> f however higher affinity showed phthalocyanine hr<NUMBER> regions suggests hydrophobic interactions drive formation extremely favourable associations inside pocket hypothesis supported presence many aromatic moieties compounds showing higher affinity internal cavity fig <NUMBER> difficult hypothesize location compounds might intermediate postfusion form spike since complete postfusion structures still available recently published incomplete structure spike postfusion core pdb id <NUMBER>lxt xia et al <NUMBER> found three key cavity residues involved interactions compounds present spike <NUMBER>helix bundle structure residues <NUMBER> nevertheless since aim prevent virus entry earlier phase directly blocking prefusion conformation potential interactions drugs structures conformational progress taken consideration since would add details improve model assess affinity top two drugs spike pocket performed <NUMBER> ns md simulations multiple docking complexes accurately evaluate mmgbsa method genheden ryde <NUMBER> interaction energies docked compounds receptor mmgbsa analysis confirmed high affinity drugs binding pocket table <NUMBER> showing presence three hypericin drugs leads increase hydrogen bonds network established within pocket fact molecules stably set <NUMBER> <NUMBER> hydrogen bonds fig s<NUMBER> lower panel mainly residues p<NUMBER> r<NUMBER> e<NUMBER> monomer n<NUMBER> e<NUMBER> q<NUMBER> monomer b p<NUMBER> monomer c well conversely polar interactions play minor role phthalocyanine drugs binding pocket since none three molecules established valuable hydrogen bonds simulation time fig s<NUMBER> upper panel perresidue energy decomposition analysis genheden ryde <NUMBER> also carried drug highlight independent contribution specific pocket residues binding dynamically describe compounds interactions within pocket table s<NUMBER> analysis showed drugs establish <NUMBER> <NUMBER> mediumto highaffinity contacts residues belonging internal hr<NUMBER> regions residues <NUMBER> surrounding residues j u r n l p r e p r f inside cavity evidence supports hypothesis drugs may act like anchors surrounding internal regions moreover results also confirmed interactions established three phthalocyanines mostly hydrophobic three hypericin molecules also set valuable electrostatic interactions contacted residues although hydrophobic contribution still much stronger md mmgbsa results mainly confirmed interaction patterns described molecular docking simulations indicating highly stable binding poses obtained molecules improve number hydrophobic interactions inside pocket creating nonpolar network establishment strong steric hindrance within cavity may likely hamper subsequent conformational changes leading formation postfusion conformation spike interestingly simulations also observed first second docked phthalocyanine hypericin molecules maintain starting binding poses interacting hr<NUMBER> internal regions monomer b third added phthalocyanine hypericin compound moves towards centre pocket simultaneously contacting hr<NUMBER> internal regions fig <NUMBER> ab arrangement compounds expected create hard impairment motion hr<NUMBER> regions contributing stabilization spike prefusion conformation conclusion results sustain hypothesis presence drugs inside pocket may block hr<NUMBER> regions preventing huge spike conformational changes permit sarscov<NUMBER> entry target cells ranking compounds obtained vs procedure table s<NUMBER> reweighted based literature retrieved compound table <NUMBER> fig s<NUMBER> s<NUMBER> particular conceived scoring method allowed us evaluate reformulated ranking based obtained binding energies b known side effects physiological effects compounds c previously identified antiviral properties briefly side effects classified using score ranging <NUMBER> <NUMBER> named sse particular compounds interfering drugs penalized compounds mild side effects assigned positive score compounds unknown effects received score <NUMBER> physiological effects compounds also received score ranging <NUMBER> <NUMBER> named spe according compounds unfavourable physiological activities negatively weighted compounds predicted evaluated antiviral antiinflammatory activity received value <NUMBER> <NUMBER> compounds unknown neutral physiological activities obtained value <NUMBER> drugs previously evaluated clinical trials positively weighted computing clinical trial score named strials follows n indicates number clinical trials compound evaluated antiviral action n number trials clinical targets n phaseii n phaseiii n phaseiv number trial experimental phase reported us national library medicine nlm clinical trials database httpsclinicaltrialsgov maximum value <NUMBER> <NUMBER> <NUMBER> allowed last three terms equation balance ranking maximum value <NUMBER> overall strials score compounds antiviral properties even directed towards viruses andor targets different one chosen research highly favoured final score property add extra value drugs assuming could affect sarscov<NUMBER> targets addition spike cavity furthermore particular case phthalocyanine antiviral activity experimentally observed specific viral targets completely understood vzorov et al <NUMBER> drug interaction within inner cavity could provide reason still undefined antiviral activity santiviral calculation compounds known antiviral activity assigned score <NUMBER> compounds activity hypothesized experimentally assessed assigned score <NUMBER> compound showed activity enveloped viruses <NUMBER> added score finally according confirmed data score <NUMBER> <NUMBER> given compounds reported inhibitory mechanism involved binding spike glycoproteins andor inhibition virus fusion host cells compound average binding energy named sbinding calculated three repeated molecular docking simulations summed obtained score finally <NUMBER> weight added best <NUMBER> compounds obtained vs procedure named svs reported table s<NUMBER> concluding final score compound computed using following equation reweighted ranking reported table <NUMBER> shows four top ranking compounds ie phthalocyanine hypericin tmc<NUMBER> quarfloxin evaluated combining analyzed data represent promising drugs suggested possible treatment sarscov<NUMBER> infection highlight clinical potential four selected compounds provide brief description drug strictly focused known hypothesized antiviral properties listed effects although directed towards sarscov<NUMBER> representing evidence interaction virus may contribute general antiviral properties drug cocktail phthalocyanines dye molecules commonly used optical electrical catalytic applications sorokin <NUMBER> wright <NUMBER> different phthalocyanine derivatives also evaluated efficacy virucidal agents fusion inhibitors franÃ§ois et al <NUMBER> vzorov et al <NUMBER> vzorov et al <NUMBER> given photochemical properties pththalocyanines also showed phototoxic virucidal action different enveloped viruses korneev et al <NUMBER> nikolaevaglomb et al <NUMBER> smetana et al <NUMBER> concerning safety molecule cell toxicity reported vivo study mice showed good toxicity profile tissue damage styczynski et al <NUMBER> hypericin natural naphthodiantrone compound mainly derived plants genus hypericum particularly hypericum perforatum st johns wort widely known antidepressant activity jendÅ¾elovskÃ¡ et al <NUMBER> karioti bilia <NUMBER> hypericin also shown specific antiviral activity wide variety enveloped viruses mainly related viral assembly release inhibition kubin et al <NUMBER> hypericin also reported act fusion inhibitor different viruses kubin et al <NUMBER> lenard et al <NUMBER> stevenson lenard <NUMBER> hypericin h perforatum extracts also shown inhibit cellular apoptosis induced avian coronavirus ibv attenuate pathological injuries caused virus trachea kidney chickens chen et al <NUMBER>a chen et al <NUMBER>b side effects reported st johns wort treatment include skin rash dizziness headache tiredness difficult sleep tmc<NUMBER> macrocyclic indole nonnucleoside inhibitor hepatitis c virus hcv ns<NUMBER>b rnadependent rna polymerase cummings et al <NUMBER> devogelaere et al <NUMBER> clinical trials highlighted promising antiviral properties hcv well good safety tolerability profiles limited toxicity offtarget activities combination tmc<NUMBER> protease inhibitor also known simeprevir ritonavir showed increased antiviral activity hcv well tolerated patients bourgeois et al <NUMBER> vijgen et al <NUMBER> quarfloxin also known cx<NUMBER> itarnafloxin fluoroquinolone derivative gquadruplexbinding compound clinically evaluated antineoplastic activity balasubramanian et al <NUMBER> drygin et al <NUMBER> compound well tolerated patients clinical trials showed good toxicity profile reaching phase ii discarded poor bioavailability action site balasubramanian et al <NUMBER> gquadruplex binding compounds shown exert antiviral activity different enveloped viruses interact gquadruplex regions viral genomes lavezzo et al <NUMBER> ruggiero richter <NUMBER> reason hypothesize quarfloxin could possess potential antiviral activity despite knowledge yet evaluated inhibition mechanism hypothesized research strictly depends interactions established compounds hr<NUMBER> internal residues pocket mechanism may consequently extended members betacoronavirus family depending sequence identity found region purpose sequence spike glycoprotein structure used study first checked high number sarscov<NUMBER> sequences deposited april <NUMBER> <NUMBER> genbank protein database clark et al <NUMBER> retrieved complete sarscov<NUMBER> spike glycoprotein protein sequences ncbi virus portal hatcher et al <NUMBER> performed similarity search using blastp suite blast altschul et al <NUMBER> selecting region spanning fusion peptide hr<NUMBER> region residues <NUMBER> <NUMBER> cryoem structure <NUMBER>residues long query sequence showed <NUMBER> identity towards <NUMBER> <NUMBER> evaluated spikeglycoprotein target sequences indicating region highly conserved sarscov<NUMBER> isolates sequenced date among <NUMBER> entries identity lower <NUMBER> two sequences showed one residue mismatch located outside internal cavity others contained undetermined residues match query explaining lower identity percentage obtained evaluated whether region also conserved among betacoronaviruses j u r n l p r e p r f ncbitxid<NUMBER> submitted query sequence showed <NUMBER> identity spike glycoprotein sequence bat coronavirus ratg<NUMBER> ncbitxid<NUMBER> genbank accession qhr<NUMBER> identity values ranging <NUMBER> <NUMBER> observed different sarscov isolates animal sarslike betacoronaviruses total <NUMBER> different entries particular internal hr<NUMBER> region specific target compounds completely conserved among <NUMBER> hit sequences except one residue mismatch observed within sequence palm civet sars coronavirus a<NUMBER> ncbitxid<NUMBER> genbank accession aav<NUMBER> hand spike glycoprotein sequences deposited middle east respiratory syndrome coronavirus merscov another concerning human pathogen showed <NUMBER> <NUMBER> sequence identity fusion peptidehr<NUMBER> sarscov<NUMBER> region identity <NUMBER> <NUMBER> internal hr<NUMBER> region alone results show selected compounds targeting highly conserved internal regions spike could represent broadspectrum treatment active sarscov<NUMBER> currently isolated variants overcoming concerning mutation potential virus furthermore high sequence structural identities sarscov sarscov<NUMBER> spike glycoproteins suggest compounds may represent efficient therapeutic strategy also towards sarscov virus finally low sequence identity evaluated sarscov<NUMBER> internal hr<NUMBER> region members betacoronavirus family completely exclude possibility drugs may also effectively bind within nonidentical pockets since different pattern interactions would established could perhaps enhance binding compounds instead preventing j u r n l p r e p r f results obtained research support hypothesis presence specific compounds inside inner cavity spike glycoprotein prefusion conformation fig <NUMBER> could block hr<NUMBER> regions preventing conformational changes allow sarscov<NUMBER> entry target cells fact hr<NUMBER> regions actively involved compounds recognition confirmed mmgbsa perresidue decomposition analysis table s<NUMBER> addition hypothesized inhibitory mechanism may explain unknown mechanisms phthalocyanine derivatives experimentally shown induce viral fusion inhibition impairment spike glycoproteins binding cell receptors vzorov et al <NUMBER> suggest optimal therapeutic strategy could involve simultaneous administration cocktail inhibitors could boost individual antiviral property based reweighted virtual screening results table <NUMBER> obtained though evaluation previous literature propose concurrent administration four compounds phthalocyanine hypericin tmc<NUMBER> quarfloxin used possible antiviral treatment sarscov<NUMBER> already observed antiviral properties although mostly assessed different targets viruses add important value drugs since could interfere sarscov<NUMBER> infection also mechanisms independent hypothesized inhibition spike glycoprotein fusion host cell evaluate feasibility simultaneous localization different compounds inside pocket also performed sequential molecular docking simulations four selected drugs fig s<NUMBER> results showed compounds could fit together inside pocket still maintaining high affinity hr<NUMBER> regions overall binding pocket evaluated interaction energies phthalocyanine <NUMBER> hypericin <NUMBER> tmc<NUMBER> <NUMBER> quarfloxin <NUMBER> kcalmol furthermore results obtained carrying sequence alignments strongly indicate hypothesized inhibition mechanism described work may extended identified sarscov<NUMBER> isolates closely related sarscov potentially even known members betacoronavirus family concluding hypotheses arising simulation research represent valid contribution international community modulation sarscov<NUMBER> infection could also useful enveloped viruses sharing infection mechanism authors declare potential conflicts interest disclose representations obtained drugbank database wishart et al <NUMBER> httpswwwdrugbankca drugs order follows table s<NUMBER> table <NUMBER> final virtual screening ranking obtained applying reweighting scoring function binding energies calculated average <NUMBER> repeated molecular docking simulations neutralizing antibody responses coronaviruses mainly target receptorbinding domain rbd trimeric spike characterized polyclonal iggs fabs covid<NUMBER> convalescent individuals recognition coronavirus spikes plasma iggs differed focus rbd epitopes recognition alphaand betacoronaviruses contributions avidity increased bindingneutralization iggs fabs using electron microscopy examined specificities polyclonal plasma fabs revealing recognition s<NUMBER> rbd epitopes sarscov<NUMBER> spike moreover <NUMBER>Ã¥ cryoem structure neutralizing monoclonal fabspike complex revealed epitope blocks ace<NUMBER> receptor binding modeling based structures suggested different potentials interspike crosslinking iggs viruses characterized iggs would affected identified newlyemergent betacoronavirus sarscov<NUMBER> resulted pandemic <NUMBER> causing respiratory disease covid<NUMBER> wu et al <NUMBER>b sarscov<NUMBER> third zoonotic betacoronavirus infect humans century following sarscov merscov middle east respiratory syndrome infections <NUMBER> <NUMBER> respectively de wit et al <NUMBER> addition four globallydistributed human coronaviruses hcovoc<NUMBER> hcovhku<NUMBER> betacoronaviruses hcovnl<NUMBER> hcov<NUMBER>e alphacoronaviruses contribute <NUMBER> common colds fung liu <NUMBER> neutralizing antibody response coronaviruses primarily directed trimeric spike glycoprotein viral membrane envelope serves machinery fuse viral host cell membranes fung liu <NUMBER> coronavirus proteins contain three copies s<NUMBER> subunit comprising s<NUMBER> s<NUMBER> domains mediates attachment target cells three copies s<NUMBER> subunit contains fusion peptide functions membrane fusion figure <NUMBER>a neutralizing antibody responses sarscov<NUMBER> sarscov merscov proteins often target receptorbinding domain rbd also called s<NUMBER> b domain hwang et al <NUMBER> pinto et al <NUMBER> prabakaran et al <NUMBER> reguera et al <NUMBER> rockx et al <NUMBER> walls et al <NUMBER> walls et al <NUMBER> widjaja et al <NUMBER> wrapp mclellan <NUMBER> wrapp et al <NUMBER> proteins sarscov<NUMBER> <NUMBER> residues strain wuhanhu<NUMBER> sarscov <NUMBER> residues strain urbani share <NUMBER> amino acid sequence identity proteins sarscov<NUMBER> merscov <NUMBER> residues strain emc<NUMBER> distantly related sharing <NUMBER> identity figure <NUMBER>b c sequence identities sarscov<NUMBER> common cold coronavirus proteins even lower varying <NUMBER> <NUMBER> phylogenetic analyses confirm sarscov<NUMBER> sarscov closely related human coronaviruses figure <NUMBER>b rbds<NUMBER> b domains show varying degrees sequence identity ranging <NUMBER> sarscov<NUMBER> hcovnl<NUMBER> <NUMBER> analyzed purified igg fabs plasmas <NUMBER> covid<NUMBER> convalescent individuals robbiani et al <NUMBER> binding trimeric monomeric rbds<NUMBER> b domains six human coronaviruses neutralization sarscov<NUMBER> pseudoviruses better understand recognition polyclonal antibodies characterized plasma fabs two individuals using negativestain electron microscopy polyclonal epitope mapping nsempem showing polyclonal landscape includes antibodies target epitopes sarscov<NUMBER> s<NUMBER> rbd domains addition solved <NUMBER> Ã¥ singleparticle cryoem structure trimer bound neutralizing monoclonal antibody mab targeted epitope rbd overlapped rbd epitope identified nsempem would sterically block ace<NUMBER> receptor binding epitopes found represent binding classes defined distinct vh gene segments suggesting recurring classes commonly represented neutralizing antibodies sarscov<NUMBER> providing criteria evaluating neutralizing antibodies raised infection vaccination finally used modeling suggest distinct binding orientations allow differential avidity effects demonstrating potential interspike crosslinking would increase effective affinities antis iggs sarscov<NUMBER> virions coronaviruses effects avidity convalescent plasma samples collected individuals recovered covid<NUMBER> rockefeller university hospital robbiani et al <NUMBER> isolated polyclonal iggs <NUMBER> convalescent plasmas figure <NUMBER> relatively high neutralizing titers robbiani et al <NUMBER> compared binding iggs purified proteins sarscov<NUMBER> sarscov merscov hcovoc<NUMBER> hcovnl<NUMBER> hcov<NUMBER>e figure s<NUMBER> elisa figure <NUMBER> figure s<NUMBER> purified plasma iggs recognized proteins coronaviruses evaluated weaker binding observed samples merscov figure <NUMBER>c common cold coronavirus proteins figure <NUMBER>d f amongst plasmas cov<NUMBER> cov<NUMBER> cov<NUMBER> chosen analysis based elisa ec <NUMBER> values neutralization potencies robbiani et al <NUMBER> iggs cov<NUMBER> cov<NUMBER> showed strongest binding proteins sarscov<NUMBER> sarscov elisas rbd s<NUMBER> b domain two common cold coronavirus proteins showed strongest binding sarscov<NUMBER> rbd cov<NUMBER> followed cov<NUMBER> cov<NUMBER> iggs proportion rbd versus binding cov<NUMBER> cov<NUMBER> cov<NUMBER> suggesting majority igg responses plasmas focused rbd often target neutralizing antibodies coronavirus infections hwang et al <NUMBER> pinto et al <NUMBER> prabakaran et al <NUMBER> reguera et al <NUMBER> rockx et al <NUMBER> walls et al <NUMBER> walls et al <NUMBER> widjaja et al <NUMBER> wrapp et al <NUMBER> appreciable reactivity sarscov merscov rbds exhibited cov<NUMBER> igg bound sarscov rbd figure <NUMBER>b although cannot determine whether iggs binding three proteins potential crossreactive binding sarscov antibodies demonstrated mab isolated sarsinfected individual shown recognize sarscov sarscov<NUMBER> rbds pinto et al <NUMBER> reactivity merscov rbd observed polyclonal iggs figure <NUMBER>c plasma iggs binding rbd substantially weaker binding counterpart protein exception strong cov<NUMBER> cov<NUMBER> responses sarscov<NUMBER> rbd plasma iggs exhibited stronger binding common cold s<NUMBER> b rbds counterpart protein trimers figure <NUMBER>d f assess degree crossreactive recognition contributed binding plasma iggs rbds<NUMBER> b domains repeated elisas adsorption sarscov<NUMBER> rbdcoupled resin control resin five plasma igg samples figure s<NUMBER> positive control purified plasma iggs incubated rbd resin showed little sarscov<NUMBER> rbd binding figure s<NUMBER>a binding sarscov rbd also reduced iggs remaining sarscov<NUMBER> rbd adsorption figure s<NUMBER>b suggesting crossreactive recognition consistent <NUMBER> sequence conservation structural homology sarscov<NUMBER> rbd sarscov rbd contrast adsorption plasma iggs sarscov<NUMBER> rbd resins modest effect binding common cold coronavirus rbds figure s<NUMBER>d f consistent little crossreactive antibody recognition likely due low conservation sarscov<NUMBER> rbd mild coronavirus rbds premkumar et al <NUMBER> also note iggs control plasmas collected individuals exposed sarscov<NUMBER> exhibited binding common cold coronavirus rbds affected sarscov<NUMBER> rbd adsorption figure s<NUMBER> consistent preexposure mild coronaviruses rather crossreactivity sarscov<NUMBER> rbd taken together results suggest binding strengths patterns different coronavirus protein recognition diverse across covid<NUMBER> individual plasma samples ii convalescent covid<NUMBER> individuals harbor antibodies sarscov<NUMBER> protein lesser extent rbds<NUMBER> b well reactivity coronaviruses likely represents previous exposure common cold viruses iii polyclonal iggs individual plasma samples bind proteins merscov andor sarscov may display crossreactive recognition since plasma donors unlikely infected either coronaviruses iv compared cov<NUMBER> cov<NUMBER> plasmas cov<NUMBER> igg response higher proportion iggs recognized sarscov<NUMBER> rbd evaluated degree avidity effects contributed strength binding plasma iggs proteins rbds comparing binding bivalent polyclonal iggs binding monovalent fabs prepared proteolytic cleavage purified polyclonal iggs figure <NUMBER>a c differential effects evident igg fab comparisons sarscov<NUMBER> antis response reduced least <NUMBER> case monovalent fabs plasmas except cov<NUMBER> figure <NUMBER>a recognition coronavirus proteins also diminished fabs compared intact iggs figure <NUMBER>b f three plasma iggs evaluated largest relative differences igg versus fab binding sarscov<NUMBER> protein observed cov<NUMBER> cov<NUMBER> igg versus fab binding difference cov<NUMBER> less pronounced figure <NUMBER>a notably sarscov<NUMBER> protein rbd elisas showed higher fraction cov<NUMBER> plasma iggs rbdspecific compared cov<NUMBER> iggs figure <NUMBER>a b robbiani et al <NUMBER> summary elisa data indicate iggs plasma samples differ degree focus upon epitopes within protein rbds<NUMBER> b domain relative amounts reactivity sarscov merscov common cold coronaviruses extent avidity effects contribute tighter binding polyclonal bivalent iggs compared monovalent fabs plasma iggs potent neutralizers plasma fabs investigate whether bivalent architecture larger size iggs compared fabs resulted increased neutralization potencies measured potencies purified plasma iggs fabs using vitro neutralization assays figure <NUMBER>g sarscov<NUMBER> pseudoviruses constructed described robbiani et al <NUMBER> concentrations iggs fabs <NUMBER> neutralization achieved ic <NUMBER> values calculated tested plasma iggs neutralized pseudoviruses lower molar concentrations fab counterparts increased potencies ranging <NUMBER>to <NUMBER>fold figure <NUMBER>h increased potency iggs compared fabs statistically significant p <NUMBER> even accounting two fabs per igg conclude bivalent iggs effectively neutralize sarscov<NUMBER> pseudoviruses monovalent fabs next used negative stain polyclonal electron microscopy nsempem bianchi et al <NUMBER> nogal et al <NUMBER> map epitopes fabs isolated convalescent covid<NUMBER> plasma iggs onto sarscov<NUMBER> protein method fabs bind antigenic target separated nonbinding fabs polyclonal mixture sizeexclusion chromatography sec fabantigen complexes imaged em <NUMBER>d<NUMBER>d classification used identify predominant epitopes bianchi et al <NUMBER> nogal et al <NUMBER> figure <NUMBER>ac typically fabs incubated <NUMBER>x ec <NUMBER> values calculated binding assays bianchi et al <NUMBER> nogal et al <NUMBER> covid<NUMBER> plasmas antis fab ec <NUMBER> values estimated <NUMBER> Âµgml figure s<NUMBER> purified polyclonal fabs cov<NUMBER> cov<NUMBER> plasmas approximate ec <NUMBER> ranging <NUMBER> Âµgml showed stable binding sec incubation sarscov<NUMBER> trimers figure <NUMBER>d <NUMBER>d class averages showed evidence bound fabs figure s<NUMBER> contrast purified fabs cov<NUMBER> ec <NUMBER> <NUMBER> Âµgml showed evidence binding sec data shown <NUMBER>d reconstruction figure <NUMBER>a order verify extra densities nsempem <NUMBER>d reconstructions corresponded bound fabs first solved <NUMBER>d reconstruction sarscov<NUMBER> alone revealing expected low resolution structure closed prefusion trimer figure <NUMBER>a <NUMBER>d reconstruction cov<NUMBER> fabs complexed showed recognizable density trimer single extending density apex trimer corresponding fab mixture fabs bound similar epitope figure <NUMBER>a density could fit trimer fab bound single rbd position using coordinates sarscov<NUMBER> trimer structures wrapp et al <NUMBER> consistent elisa results mapping cov<NUMBER> response sarscov<NUMBER> rbd figure <NUMBER>a complex structure position cov<NUMBER> fabs closely resembled structure sarscov bound fab s<NUMBER> mab isolated sarscovinfected individual whose epitope overlaps binding site ace<NUMBER> receptor figure <NUMBER>b interestingly s<NUMBER> binding shown functionally mimic ace<NUMBER> binding allowing cleavage sarscov protein promote fusogenic conformational rearrangements cov<NUMBER> fab complex reconstruction showed occupancy one sprotomer rbd position figure <NUMBER>a cov<NUMBER> fabs might also bind analogous s<NUMBER> fabsarscov complex classes trimer structures found two upone three rbd conformations moreover antibody s<NUMBER> whose binding orientation resembles position observed cov<NUMBER> fabs reconstruction figure <NUMBER>b appears member class recurrent antisars mabs belongs set <NUMBER> nonclonallyrelated vh<NUMBER>derived mabs isolated individual infected sarscov represented <NUMBER> clones isolated individual pinto et al <NUMBER> notably clones contained similar <NUMBER> amino acid light chain complementarity determining <NUMBER> cdrl<NUMBER> sequences consensus sequence mqgthwppt suggesting group mabs common mode binding partially dependent vh<NUMBER>derived features rbd residues <NUMBER> <NUMBER> contacted antibody heavy chain s<NUMBER> fabsarscov structure conserved sarscov sarscov<NUMBER> residues vicinity antibody heavy chain residues n<NUMBER> k<NUMBER> vh gene segments encoding n<NUMBER>k<NUMBER> pair vh<NUMBER> vh<NUMBER> vh<NUMBER> lefranc et al <NUMBER> mabs isolated single b cell sorting using sarscovalso found sequenced antibodies five donor plasmas robbiani et al <NUMBER> similarity binding orientation cov<NUMBER> fabs s<NUMBER> figure <NUMBER>b suggests cov<NUMBER> fabs may members s<NUMBER> recurrent class consistent hypothesis <NUMBER> <NUMBER> sequenced antibodies cov<NUMBER> donor derived vh<NUMBER> closelyrelated vh<NUMBER> vh<NUMBER> vh gene segments robbiani et al <NUMBER> cov<NUMBER> fabss structure also showed recognizable density trimer single bound fabs figure <NUMBER>c however complex trimer appeared closed rbds position fab density associated rbd rather one s<NUMBER> subunits complex fabs pointed downwards ie towards viral membrane rather upwards away viral membrane seen cov<NUMBER> fabs cov<NUMBER> fabs density vicinity loops s<NUMBER> domain disordered sarscov<NUMBER> trimer structures wrapp et al <NUMBER> flexibility could explain diffuse nature cov<NUMBER> fabs density reconstruction interestingly characterization cov<NUMBER> neutralization showed less correlation rbdspecific antibodies relative cov<NUMBER> robbiani et al <NUMBER> consistent elisas figure <NUMBER>a nsempem characterizations figure <NUMBER>c reported suggests targeting s<NUMBER> regions outside rbd may represent alternative modes potent neutralization sarscov<NUMBER> found neutralizing antibodies isolated vaccination merscov nonhuman primates fabss reconstruction although could resolve densities bound fabs cov<NUMBER>s nsempem reconstruction figure <NUMBER>a rbdbinding mabs isolated cov<NUMBER> individual potently neutralizing robbiani et al <NUMBER> determined <NUMBER> Ã¥ singleparticle cryoem structure complex one antibody c<NUMBER> ic <NUMBER> neutralization sarscov<NUMBER> pseudovirus <NUMBER> ngml robbiani et al <NUMBER> bound sarscov<NUMBER> protein using <NUMBER> Ã¥ crystal structure unbound c<NUMBER> fab fitting cryoem density figure <NUMBER> figures s<NUMBER> s<NUMBER> tables s<NUMBER>s<NUMBER> found two populations c<NUMBER> fabs complexes asymmetric trimer two rbds complexed fab state <NUMBER> <NUMBER> Ã¥ resolution symmetric trimer three rbds conformation rbd complexed fab state <NUMBER> <NUMBER> Ã¥ resolution figure <NUMBER>a subset complexes cryoem structure s<NUMBER> mab bound sarscov trimer also found three rbds bound three fabs although structure c<NUMBER>s structure majority complexes rbds two one configuration c<NUMBER>rbd interfaces similar across five examples state <NUMBER> state <NUMBER> complex structures figure s<NUMBER> thus describe interface one fabrbd complexes state <NUMBER> complex resolution interface improved performing focused local refinement punjani et al <NUMBER> c<NUMBER> fabrbd portion complex figure s<NUMBER> c<NUMBER> fab uses three heavy chain complementarity determining regions cdrh<NUMBER> cdrh<NUMBER> cdrh<NUMBER> two light chain cdrs cdrl<NUMBER> cdrl<NUMBER> rest receptorbinding ridge rbd figure <NUMBER>b c majority antibody contacts made cdrh<NUMBER> cdrh<NUMBER> cdrl<NUMBER> cdrh<NUMBER> cdrl<NUMBER> playing minor roles c<NUMBER> epitope overlaps cov<NUMBER> epitope defined nsempem also rests receptorbinding ridge rbd although fabs cov<NUMBER> reconstruction predicted adopt different angle approach figure <NUMBER>d interestingly c<NUMBER>rbd interaction closely resembles rbd interaction another covid<NUMBER> donorderived neutralizing mab b<NUMBER> figure <NUMBER>e reported recent fabrbd crystal structure wu et al <NUMBER>c heavy chains b<NUMBER> c<NUMBER> derived vh<NUMBER> gene segment whereas light chain gene segments differ kv<NUMBER> b<NUMBER> wu et al <NUMBER>c lv<NUMBER> c<NUMBER> robbiani et al <NUMBER> accordingly cdrh<NUMBER> cdrh<NUMBER> loops neutralizing antibodies share similar conformations contribute antibodyrbd interface cdrh<NUMBER> loops figure <NUMBER>b e common epitope c<NUMBER> b<NUMBER> overlaps binding site ace<NUMBER> figure <NUMBER>f rationalizing potent neutralizing activities robbiani et al <NUMBER> wu et al <NUMBER>c given cov<NUMBER> one potent neutralizing plasmas <NUMBER> collected robbiani et al <NUMBER> overlap c<NUMBER>b<NUMBER> neutralizing epitope nsempemdefined predominant cov<NUMBER> epitope suggests recognition cov<NUMBER> epitope s<NUMBER>like antibodies would also neutralizing <NUMBER> rbd neutralizing antibodies shared binding mode c<NUMBER> b<NUMBER> vh<NUMBER>derived mabs defines recurrent class antisarscov<NUMBER> mabs among large set n<NUMBER> cloned antisarscov<NUMBER> mabs rbd derived vh<NUMBER> vh<NUMBER> gene segments overrepresented robbiani et al <NUMBER> studies also reported antisarscov<NUMBER> mabs derived genes brouwer et al <NUMBER> cao et al <NUMBER> chi et al <NUMBER> ju et al <NUMBER> rogers et al <NUMBER> seydoux et al <NUMBER> wu et al <NUMBER>c zost et al <NUMBER> vh<NUMBER> vh<NUMBER> vh gene segments encode v regions differ one amino acid position cdr thus functionally equivalent terms vgenedetermined mab classes grouping vh<NUMBER> vh<NUMBER> overrepresentation vh<NUMBER>vh<NUMBER>derived mabs significant p <NUMBER> notable characteristic vh<NUMBER>vh<NUMBER>derived subset <NUMBER> mabs within <NUMBER> antirbd mabs robbiani et al <NUMBER> bias towards shorter cdrh<NUMBER>s defined imgt lefranc et al <NUMBER> <NUMBER> lengths <NUMBER> <NUMBER> residues significantly different human antibody repertoire entire set <NUMBER> antisarscov<NUMBER> rbd mabs two sample kolmogorovsmirnov test p <NUMBER> figure s<NUMBER>a superposition vh domains unrelated antibodies longer cdrh<NUMBER>s suggests rbd residues <NUMBER> andor <NUMBER> present steric barrier limiting cdrh<NUMBER> loop lengths compatible binding orientation figure s<NUMBER>b recent report identified clonallyunrelated group vh<NUMBER>vh<NUMBER> antisarscov<NUMBER> mabs based cdrh<NUMBER> sequence similarity antisarscov mab m<NUMBER> derived vh<NUMBER> structure sarscov rdb complex m<NUMBER> pdb code <NUMBER>dd<NUMBER> prabakaran et al <NUMBER> shows mab m<NUMBER> share b<NUMBER>c<NUMBER> binding mode suggest key feature vh<NUMBER>vh<NUMBER> mabs identified based cdrh<NUMBER> sequence similarity m<NUMBER> cdrh<NUMBER> length <NUMBER> residues mabs share c<NUMBER>b<NUMBER> binding mode m<NUMBER> binding mode identified mutations unlikely affect epitopes revealed nsempem singleparticle cryoem recent report suggested mutation protein d<NUMBER>g increases transmissibility sarscov<NUMBER> korber et al <NUMBER> speculated substitution others found different protein sequences could affect antibody recognition cryoem structures prefusion trimer wrapp et al <NUMBER> c<NUMBER>s complex figure <NUMBER> protein residue d<NUMBER> located s<NUMBER> makes contact adjacent protomer address whether d<NUMBER>g mutation could affect binding antibodies marked location d<NUMBER> residues residues reported mutate korber et al <NUMBER> cov<NUMBER> cov<NUMBER> nsempem reconstructions figure <NUMBER>a b c<NUMBER>s cryoem structure figure <NUMBER>c rbdbinding cov<NUMBER> fabs c<NUMBER> fab distant residue d<NUMBER> figure <NUMBER>a c therefore cov<NUMBER> reconstruction reflects predominant epitope cov<NUMBER> plasma unlikely antibodies elicited cov<NUMBER> individual would sensitive d<NUMBER>g substitution indeed absence large conformational changes antirbd antibodies including c<NUMBER> robbiani et al <NUMBER> b<NUMBER> wu et al <NUMBER>c would unaffected substitution mutations sarscov<NUMBER> rbd identified genome sequencing also include n<NUMBER>k v<NUMBER>a v<NUMBER>f tables s<NUMBER>s<NUMBER> affected residues within epitopes cov<NUMBER> fabs figure <NUMBER>a b c<NUMBER> fab figure <NUMBER>c residue <NUMBER> disordered unliganded protein structures wrapp et al <NUMBER> predominant epitope cov<NUMBER> fabs closer protein d<NUMBER> residue appears outside binding interface addition mutations s<NUMBER> domain identified genome sequencing tables s<NUMBER>s<NUMBER> reside outside cov<NUMBER> fabs epitope figure <NUMBER>a b thus absence major conformational changes induced mutation observed substitutions particularly d<NUMBER>g mutation unlikely affect antibodies elicited cov<NUMBER> cov<NUMBER> individuals rbdbinding mabs c<NUMBER> protein epitopes offer different possibilities avidity effects igg receptor binding iggs contain two identical antigenbinding fabs thus offering opportunity bind pathogens regularlyspaced antigenic sites using avidity effects either interspike crosslinking binding epitope adjacent spikes andor intraspike crosslinking binding epitope identical subunits single multimeric spike klein bjorkman <NUMBER> address whether interspike crosslinking antisarscov<NUMBER> iggs could occur modeled adjacent proteins virion membrane assuming minimum interspike separation distance <NUMBER> nm observed cryoelectron tomography analyses sarscov coronaviruses neuman et al <NUMBER> including bound fab trimer position cov<NUMBER> fabs nsempem reconstruction addressed whether fabs single igg could bind two adjacent trimers modeling predicts interspike crosslinking could occur cov<NUMBER> epitope figure <NUMBER>a contrast downwardpointing fabs cov<NUMBER>s nsempem reconstruction appear unlikely participate interspike crosslinking igg due fab orientations unable accommodate fc position could join two fabs figure <NUMBER>a predictions consistent elisa results demonstrating diminished binding cov<NUMBER> fabs compared igg counterparts less pronounced differences fab versus igg comparison cov<NUMBER> figure <NUMBER> also used modeling predict whether avidity effects could influence interaction ace<NUMBER> integral membrane protein dimerizes target cell surface viral trimers starting cryoem structure dimeric fulllength ace<NUMBER> associated integral membrane protein b at<NUMBER> bound monomeric sarscov<NUMBER> rbds modeled bound trimers cryoem structure sarscov trimers two rbds position kirchdoerfer et al <NUMBER> assuming adjacent ace<NUMBER>b at<NUMBER> complexes host cell membrane modeling predicts interspike crosslinking possible figure <NUMBER>b addition intraspike crosslinking could also occur rbds two upone trimer rotate figure <NUMBER>c thus trimers indeed crosslink adjacent ace<NUMBER> receptors bind single trimer ace<NUMBER> subunits ace<NUMBER> dimer could take advantage avidity effects bind tightly predicted affinity measurements involving interactions monomeric ace<NUMBER> ectodomains monomeric coronavirus rbds walls et al <NUMBER> wrapp et al <NUMBER> possibility avidity effects interactions sarscov<NUMBER> ace<NUMBER> dimers implications interpretation pseudovirus assays measure coronavirus infectivity presence absence potential inhibitors antibodies vitro neutralization assays sarscov<NUMBER> include pseudoviruses based hiv lentiviral particles crawford et al <NUMBER> ou et al <NUMBER> robbiani et al <NUMBER> wu et al <NUMBER>a murine leukemia virus retroviral particles pinto et al <NUMBER> quinlan et al <NUMBER> vesicular stomatitis virus hoffmann et al <NUMBER> nie et al <NUMBER> xiong et al <NUMBER> pseudovirus types could potentially incorporate different numbers spikes case overall spike density would alter sensitivity antibody avidity case effects avidity igg binding tethered antigen complicated mixture intrinsic fabantigen affinity kinetics input concentration incubation time klein bjorkman <NUMBER> wu et al <NUMBER> thus neutralization potencies iggs could affected vitro neutralization assays addition considering therapeutic applications convalescent plasma purified antibodies avidity effects would difficult predict given uncertainties antibody concentrations viral titers potentially different trimer spacings densities infectious virions results provide glimpse diverse antibody responses neutralizing plasmas donors recovered covid<NUMBER> characterized polyclonal plasma iggs exhibited different degrees crossreactive binding proteins sarscov<NUMBER> sarscov merscov showed plasma iggs also included noncrossreactive antibodies common cold virus rbds mapping sarscov<NUMBER> epitopes targeted convalescent plasma iggs observed expected targeting protein rbd also discovered s<NUMBER> epitope outside rbd may represent alternative binding site neutralizing antibodies rbdbinding fabs cov<NUMBER> plasma resembled binding s<NUMBER> vh<NUMBER> mab isolated sarscov patient blocks ace<NUMBER> receptor binding rockx et al <NUMBER> found another type ace<NUMBER> receptorblocking antisarscov<NUMBER> antibody analysis neutralizing mab derived cov<NUMBER> individual <NUMBER> cryoem structure sarscov<NUMBER> protein bound c<NUMBER> mab observed epitope rbd overlapped binding site cov<NUMBER> fabs closely resembled binding b<NUMBER> another mab isolated covid<NUMBER> patient wu et al <NUMBER>c like c<NUMBER> b<NUMBER> also derived vh<NUMBER> vh gene segment structural studies support hypothesis recurrent classes antisarscov<NUMBER> neutralizing antibodies derived vh<NUMBER>vh<NUMBER> vh<NUMBER> gene segments use distinct rbdbinding modes b<NUMBER>c<NUMBER> s<NUMBER> mabs respectively providing valuable information evaluating antibodies raised infection vaccination sequences alone finally rbd s<NUMBER> epitopes mapped nsempem singleparticle cryoem unlikely affected common mutations different sarscov<NUMBER> isolates offering hope antibody therapeutics andor vaccine might effective combatting current pandemic wrote paper contributions authors connection work rockefeller university filed provisional patent application dfr mcn inventors goddard et al <NUMBER> pettersen et al <NUMBER> displayed cartoons s<NUMBER> blue s<NUMBER> b red s<NUMBER> gray b cov<NUMBER> volume bestfitted pdb <NUMBER>vyb sarscov<NUMBER> one s<NUMBER> b conformation inset overlay pdb <NUMBER>nb<NUMBER> showed similarities s<NUMBER> b epitope targeting cov<NUMBER> fab orange human sarscov neutralizing antibody s<NUMBER> magenta cartoon c cov<NUMBER> fitted pdb <NUMBER>vxx closed prefusion conformation inset fab density green focused s<NUMBER> domain see also figure s<NUMBER> plasmas indicated numbers control plasmas indicated con adsorbed one two resins sarscov<NUMBER> rbd resin iggs remaining rbd adsorption light gray bars <NUMBER>g<NUMBER> mab control resin iggs remaining control adsorption dark gray bars iggs remaining adsorption evaluated elisas indicated rbd s<NUMBER> b domains binding iggs adsorption ioma antibody hiv<NUMBER> gristick et al <NUMBER> used control assay results presented area curve auc shown mean Â± sd experiments conducted duplicate workflow classification refinement selected particles briefly selection good <NUMBER>d class averages ab initio model generated homogeneously refined <NUMBER>d classification improve features sarscov<NUMBER> rbdc<NUMBER> fab interface particles states <NUMBER> <NUMBER> combined used nonuniform focused refinement yield state <NUMBER>like reconstruction fsc<NUMBER> resolution <NUMBER> Ã¥ wu et al <NUMBER>c cases one fab crystallographic asymmetric unit vh evaluated enumerated separately cdrh<NUMBER> clashes defined cdrh<NUMBER> atom within <NUMBER> Ã¥ atom rbd stringent criterion devised account allowing cdr flexibility different side chain rotamer conformations information requests reagents directed fulfilled lead contact pamela bjorkman bjorkmancaltechedu expression plasmids generated study human cov proteins c<NUMBER> fab shared upon request unique reagents generated study purified human plasma iggs sarscov<NUMBER> pseudoviruses available lead contact completed material transfer agreement table s<NUMBER> samples peripheral blood obtained upon written consent community participants protocols approved institutional review board rockefeller university dro<NUMBER> details demographics cohort provided robbiani et al <NUMBER> hek<NUMBER>t cells pseudovirus production hek<NUMBER>t ace<NUMBER> cells pseudovirus neutralization experiments cultured <NUMBER>Â°c <NUMBER> co <NUMBER> dulbeccos modified eagles medium dmem gibco supplemented <NUMBER> heatinactivated fetal bovine serum fbs sigmaaldrich <NUMBER> Âµgml gentamicin sigmaaldrich medium <NUMBER>t ace<NUMBER> cells additionally contained <NUMBER>Âµgml blasticidin gibco constitutive expression ace<NUMBER> <NUMBER>t cells cdna encoding ace<NUMBER> carrying two inactivating mutations catalytic site h<NUMBER>n h<NUMBER>n inserted csib kane et al <NUMBER> <NUMBER> sffv promoter robbiani et al <NUMBER> <NUMBER>t ace<NUMBER> cells generated transduction csib based virus followed selection <NUMBER> Âµgml blasticidin gibco expi<NUMBER>f cells gibco protein expression maintained <NUMBER>Â°c <NUMBER> co <NUMBER> expi<NUMBER> expression medium gibco transfected using expi<NUMBER> expression system kit gibco maintained shaking <NUMBER> rpm gender hek<NUMBER>t hek<NUMBER>t ace<NUMBER> expi<NUMBER>f cell lines female cell lines specifically authenticated e coli dh<NUMBER> alpha zymo research propagation expression plasmids cultured <NUMBER>Ëc lb broth sigmaaldrich shaking <NUMBER> rpm generate pseudotyped viral stocks hek<NUMBER>t cells transfected pnl<NUMBER>âenvnanoluc psarscov<NUMBER>s trunc robbiani et al <NUMBER> using polyethylenimine leading production hiv<NUMBER>based virions carrying sarscov<NUMBER> protein surface eight hours transfection cells washed twice phosphate buffered saline pbs fresh media added supernatants containing virions harvested <NUMBER> hours post transfection filtered stored <NUMBER>Â°c infectivity virions determined titration <NUMBER>t ace<NUMBER> cells convalescent healthy donor plasma samples collected processed described robbiani et al <NUMBER> convalescent plasma samples used nsempem residents state new york cov<NUMBER> <NUMBER>yearold male hispanic collection <NUMBER> days symptom onset cov<NUMBER> <NUMBER>yearold male caucasian collection <NUMBER> days symptom onset cov<NUMBER> <NUMBER>yearold female caucasian collection <NUMBER> days symptom onset analysis sarscov<NUMBER> genomes gisaid database sample collection dates march <NUMBER> contemporaneous infections individuals cov<NUMBER> cov<NUMBER> cov<NUMBER> performed identify viral spike mutations likely present sarscov<NUMBER> genomes new york state residents march <NUMBER> <NUMBER> <NUMBER> contained d<NUMBER>g mutation thus based statelevel mutant frequencies individuals likely infected d<NUMBER>gcontaining viruses spike mutations genomes frequency <NUMBER> participants provided written informed consent sample collection rockefeller university hospital study conducted accordance good clinical practice anticoagulated plasma heatinactivated <NUMBER>Ëc <NUMBER> hour prior shipment caltech stored <NUMBER>Ëc thereafter robbiani et al <NUMBER> sequence alignments proteins rbds<NUMBER> b domains made clustal omega sievers et al <NUMBER> phylogenetic trees calculated amino acid alignments using phyml <NUMBER> guindon et al <NUMBER> visualized presto httpwwwatgcmontpellierfrpresto codonoptimized nucleotide sequences encoding sarscov<NUMBER> ectodomain residues <NUMBER> early sarscov<NUMBER> sequence isolate genbank mn<NUMBER> asp position <NUMBER> include d<NUMBER>g mutation described possibly transmissible korber et al <NUMBER> sarscov residues <NUMBER> genbank aap<NUMBER> merscov residues <NUMBER> genbank jx<NUMBER> hcovoc<NUMBER> residues <NUMBER> genbank aat<NUMBER> hcovnl<NUMBER> residues <NUMBER> genbank aas<NUMBER> hcov<NUMBER>e residues <NUMBER> genbank aak<NUMBER> synthesized subcloned mammalian expression ptwistcmv betaglobin vector twist bioscience technologies proteins modified previously described briefly ectodomain constructs included nterminal muphosphatase signal peptide <NUMBER>p stabilizing mutations pallesen et al <NUMBER> cterminal extension gsgrenlyfqg tev protease site gggsgyipeaprdgqayvrkdgewvllstfl foldon trimerization motif ghhhhhhhh octahistidine tag glndifeaqkiewhe avitag sarscov<NUMBER> merscov hcovnl<NUMBER> hcovoc<NUMBER> mutations remove s<NUMBER>s<NUMBER> furin cleavage site introduced codonoptimized nucleotide sequences encoding receptor binding domain rbd sarscov<NUMBER> residues <NUMBER> sarscov residues <NUMBER> merscov residues <NUMBER> hcovnl<NUMBER> residues <NUMBER> corresponding s<NUMBER> b domains hcovoc<NUMBER> residues <NUMBER> hcov<NUMBER>e residues <NUMBER> synthesized subcloned mammalian expression ptwistcmv betaglobin vector twist bioscience technologies rbds<NUMBER> b constructs included nterminal human il<NUMBER> signal peptide dual cterminal tags ghhhhhhhh octahistidine glndifeaqkiewhe avitag protein rbds<NUMBER> analyzed sdspage fractions corresponding trimers monomeric rbds<NUMBER> b proteins pooled stored <NUMBER>Ëc purified covs trimers concentrated <NUMBER> mgml loaded onto superose <NUMBER> increase <NUMBER> gl column ge healthcare life sciences passed wyatt dawn coupled wyatt utrex differential refractive index detector wyatt technology data analyzed using astra <NUMBER> software wyatt technology determine glycoprotein molecular weights iggs purified plasma samples using <NUMBER> plasmids sarscov<NUMBER> rbd <NUMBER>xhistag constructs residues <NUMBER> genbank protocol control resin made using procedure covalently couple <NUMBER>g<NUMBER> hiv<NUMBER> mab described scharf et al <NUMBER> rbdabsorption elisa experiments evaluate binding purified polyclonal iggs cov s<NUMBER> b rbd proteins absorption sarscov<NUMBER> rbdspecific antibodies biotinylateds<NUMBER> b rbd proteins captured highcapacity streptavidin coated <NUMBER>well plates thermo scientific incubating <NUMBER> Âµl <NUMBER> Âµgml protein solution tbs overnight <NUMBER>Ëc plates washed <NUMBER>x washing buffer blocked described absorption rbdspecific antibodies <NUMBER> Âµl sarscov<NUMBER> rbdcoupled resin <NUMBER>g<NUMBER> control resin incubated <NUMBER> Âµl purified iggs diluted <NUMBER> mgml <NUMBER> h rt agitation incubation sarscov<NUMBER> rbdcoupled resin gently centrifuged <NUMBER> x g <NUMBER> min nonabsorbed iggs removed careful pipetting aqueous layer pelleted rbdcoupled resin unadsorbed absorbed igg samples assayed <NUMBER> Âµgml starting concentration seven <NUMBER>fold serial dilutions described pseudoviruses based hiv lentiviral particles prepared described robbiani et al <NUMBER> purified covs trimers adsorbed freshlyglow discharged purec <NUMBER> mesh carboncoated copper grids emd sciences <NUMBER> min followed <NUMBER> uranyl formate electron microscopy sciences staining micrographs recorded using digital micrograph software <NUMBER>kv fei tecnai t<NUMBER> equipped gatan ultrascan <NUMBER>k x <NUMBER>k ccd <NUMBER>x nominal magnification methods adapted bianchi et al <NUMBER> form polyclonal fabs complexes <NUMBER> Âµg sarscov<NUMBER> trimers incubated overnight rt <NUMBER> mgml fabs <NUMBER> Âµl total volume corresponding <NUMBER>x ec <NUMBER> values elisas using purified polyclonal fabs complexes purified sec superose <NUMBER> increase <NUMBER> gl column ge healthcare life sciences fractions containing complexes pooled concentrated <NUMBER> Âµgml passed <NUMBER> Âµm filter deposition <NUMBER> mesh carboncoated copper grids ted pella stained <NUMBER> wv uranyl formate electron microscopy sciences grids imaged <NUMBER> kev using titan krios transmission electron microscope thermo fisher operating rt equipped k<NUMBER> direct electron detector gatan using serialem <NUMBER> mastronarde <NUMBER> images processed cryosparc v <NUMBER> referencefree particle stack generated using gaussian blob picker punjani et al <NUMBER> particles corresponding sfab complexes identified extensive <NUMBER>d classification identify class averages displayed structural elements interpreted fab density also represented different views extracted particles used generate ab initio models cryosparc processed <NUMBER>d classification separate complexes trimer structures alone figures prepared using ucsf chimera goddard et al <NUMBER> pettersen et al <NUMBER> fab c<NUMBER> monoclonal igg expressed purified stored described scharf et al <NUMBER> schoofs et al <NUMBER> adams et al <NUMBER> cycles manual building coot emsley et al <NUMBER> table s<NUMBER> purified c<NUMBER> fab incubated sarscov<NUMBER> trimer <NUMBER> molar ratio per protomer ice <NUMBER> minutes prior purification sec superose <NUMBER> increase <NUMBER> gl column ge healthcare life sciences fabs complexes concentrated <NUMBER> mgml trisbuffered saline tbs immediately deposition onto <NUMBER> mesh <NUMBER> auultrafoil grid electron microscopy sciences freshly glowdischarged <NUMBER> min <NUMBER> using pelco easiglow ted pella <NUMBER> Âµl complex mixed <NUMBER> Âµl <NUMBER> wv octylmaltoside fluorinated solution anatrace samples vitrified <NUMBER> liquid ethane using mark iv vitrobot thermo fisher blotting <NUMBER> whatman <NUMBER> filter paper <NUMBER>Â°c <NUMBER> humidity c<NUMBER>s trimer complex micrographs collected titan krios transmission electron microscope thermo fisher operating <NUMBER> kv using serialem automated data collection software mastronarde <NUMBER> movies obtained gatan k<NUMBER> summit direct electron detector operating counting mode nominal magnification <NUMBER>x superresolution <NUMBER> Ã¥pixel using defocus range â<NUMBER> â<NUMBER> Âµm movies collected <NUMBER> exposure time rate <NUMBER> e pixs resulted total dose <NUMBER> eÃ¥ <NUMBER> <NUMBER> frames <NUMBER> cryoem movies patch motion corrected beaminduced motion including doseweighting within cryosparc v<NUMBER> punjani et al <NUMBER> binning super resolution movies <NUMBER> <NUMBER> Ã¥pixel nondoseweighted images used estimate ctf parameters using ctffind<NUMBER> rohou grigorieff <NUMBER> micrographs power spectra showed poor ctf fits signs crystalline ice discarded leaving <NUMBER> micrographs particles picked referencefree manner using gaussian blob picker cryosparc punjani et al <NUMBER> initial <NUMBER> particle stack extracted binned x<NUMBER> <NUMBER> Ã¥pixel subjected iterative rounds referencefree <NUMBER>d classification identify class averages corresponding intact strimer complexes welldefined structural features routine resulted new particle stack <NUMBER> particles unbinned <NUMBER> Ã¥pixel reextracted using <NUMBER> box size two ab initio volumes generated one class <NUMBER> particles revealing strimer complexed two c<NUMBER> fabs particles <NUMBER>d classified k<NUMBER> heterogeneously refined reveal two distinct states c<NUMBER>s trimer complex state <NUMBER> <NUMBER> particles displaying <NUMBER> rbd conformations bound <NUMBER> c<NUMBER> fabs state <NUMBER> <NUMBER> particles displayed <NUMBER> rbd conformations bound <NUMBER> c<NUMBER> fabs particles states <NUMBER> <NUMBER> separately refined using nonuniform <NUMBER>d refinement imposing either c<NUMBER> c<NUMBER> symmetry respectively final resolutions <NUMBER> Ã¥ state <NUMBER> <NUMBER> particles <NUMBER> Ã¥ state <NUMBER> <NUMBER> particles according goldstandard fsc bell et al <NUMBER> given rbd conformations c<NUMBER> fabs bound similar states <NUMBER> <NUMBER> improvements resolution rbdc<NUMBER> fab interface achieved combining entire particle stack <NUMBER>k particles focused nonuniform <NUMBER>d refinement soft mask generated state <NUMBER> volume <NUMBER>pixel extension <NUMBER>pixel soft cosine edge s<NUMBER> subunits c<NUMBER> fab variable domains efforts resulted modest improvement rbdc<NUMBER> fab interface figure s<NUMBER>d overall resolution <NUMBER> Ã¥ according goldstandard fsc initial coordinates generated docking individual chains reference structures cryoem density using ucsf chimera goddard et al <NUMBER> following coordinates used sarscov<NUMBER> trimer pdb code <NUMBER>vyb rbd conformations pdb code <NUMBER>bz<NUMBER> c<NUMBER> fab study initial models refined cryoem maps using one round rigid body refinement followed real space refinement sequenceupdated models built manually coot emsley et al <NUMBER> refined using iterative rounds refinement coot phenix adams et al <NUMBER> glycans modeled possible nlinked glycosylation sites pngss coot using blurred maps processed variety bfactors terwilliger et al <NUMBER> validation model coordinates performed using molprobity reported table s<NUMBER> structural figures made using pymol version <NUMBER> schrodinger llc ucsf chimera goddard et al <NUMBER> local resolution maps calculated using cryosparc v <NUMBER> punjani et al <NUMBER> elisas evaluate plasma igg binding human cov proteins average signals independent experiments plotted area curve auc using matlab r<NUMBER>a mathworks number replicates experiment described figure table legends statistical significance defined p <NUMBER> comparison neutralization potencies plasma iggs fabs n<NUMBER> performed using twotailed paired ttest frequency vh<NUMBER>vh<NUMBER> gene usage among cloned antisarscov<NUMBER> mabs <NUMBER> individuals compared human repertoire v gene usage using twotailed ttest unequal variances described robbiani et al <NUMBER> twosample kolmogorovsmirnov test compare cdrh<NUMBER> length distribution vh<NUMBER> vh<NUMBER> mabs together <NUMBER> set human repertoire performed using quest graphâ¢ kolmogorovsmirnov ks test calculator aat bioquest inc httpswwwaatbiocomtoolskolmogorovsmirnovkstestcalculator vh<NUMBER>vh<NUMBER> cdrh<NUMBER> length comparison <NUMBER> set also evaluated using twotailed mannwhitney u test indicated p <NUMBER> tables table s<NUMBER> crystallographic data collection refinement statistics c<NUMBER> fab structure related figure <NUMBER> <NUMBER> ssrl unit cell Ã¥ table s<NUMBER> cryoem data collection refinement statistics c<NUMBER>s complex structure related figure <NUMBER> table s<NUMBER> protein mutations found different sarscov<NUMBER> isolates related figure <NUMBER> list sarscov<NUMBER> spike mutations frequency â¥ <NUMBER> set <NUMBER> isolates downloaded global initiative sharing influenza data gisaid sarscov<NUMBER> sequence database <NUMBER> elbe bucklandmerrett <NUMBER> shu mccauley <NUMBER> genomes processed nextstrain augur pipeline httpsgithubcomnextstrainaugur hadfield et al <NUMBER> using mafft v<NUMBER> katoh standley <NUMBER> sequence alignment fasttree price et al <NUMBER> generate phylogenetic tree resulting data analyzed custom swift program supplemental table <NUMBER> protein mutations found different sarscov<NUMBER> isolates list sarscov<NUMBER> spike mutations frequency â¥ <NUMBER> set <NUMBER> isolates downloaded gisaid <NUMBER> coronaviruses enveloped viruses containing positivesense rna genomes four human <NUMBER> coronaviruses generally cause mild respiratory illness circulate annually however sars causative agent ongoing covid<NUMBER> pandemic <NUMBER> <NUMBER> may <NUMBER> <NUMBER> <NUMBER> reported <NUMBER> million cases <NUMBER> deaths worldwide effective vaccines therapeutic <NUMBER> antibodies smallmolecule inhibitors urgently needed development <NUMBER> interventions proceeding rapidly coronavirus virions decorated spike glycoprotein binds hostcell <NUMBER> receptors mediates cell entry via fusion host viral membranes <NUMBER> proteins <NUMBER> trimeric class fusion proteins expressed single polypeptide subsequently <NUMBER> cleaved s<NUMBER> s<NUMBER> subunits cellular proteases <NUMBER> <NUMBER> s<NUMBER> subunit contains receptor<NUMBER> binding domain rbd case sarscov<NUMBER> recognizes angiotensin<NUMBER> converting enzyme <NUMBER> ace<NUMBER> receptor hostcell surface <NUMBER> <NUMBER> <NUMBER> s<NUMBER> subunit mediates <NUMBER> membrane fusion contains additional protease cleavage site referred s<NUMBER>â² <NUMBER> adjacent hydrophobic fusion peptide binding rbd ace<NUMBER> triggers s<NUMBER> dissociation <NUMBER> <NUMBER> essential viral life cycle making protein primary target neutralizing antibodies <NUMBER> critical vaccine antigen <NUMBER> <NUMBER> stabilized prefusion conformation class fusion proteins desirable vaccine <NUMBER> development conformation found infectious virions displays <NUMBER> neutralizing epitopes targeted antibodies prevent entry process <NUMBER> <NUMBER> <NUMBER> employ structurebased design increase yield stability sars <NUMBER> cov<NUMBER> spike ectodomain prefusion conformation report multiple prolines disulfide <NUMBER> bonds salt bridges cavityfilling substitutions increase expression andor stability <NUMBER> <NUMBER> one common strategy stabilize class fusion proteins spike covalently link <NUMBER> region undergoes conformational change region via disulfide bond <NUMBER> instance q<NUMBER>cs<NUMBER>c substitution attempts link hr<NUMBER> central helix whereas <NUMBER> g<NUMBER>ca<NUMBER>c aims link hr<NUMBER> upstream helix two variants boosted protein <NUMBER> expression <NUMBER>fold <NUMBER>fold compared s<NUMBER>p respectively fig <NUMBER>b however size<NUMBER> exclusion chromatography sec traces variants showed leftward shift compared s<NUMBER> <NUMBER>p indicating proteins running larger expected agreed well <NUMBER> negative stain electron microscopy nsem results showed partially misfolded spike particles <NUMBER> fig s<NUMBER> contrast s<NUMBER>ca<NUMBER>c t<NUMBER>ca<NUMBER>c variants eluted sec volume <NUMBER> similar s<NUMBER>p wellfolded trimeric particles nsem fig <NUMBER>e variants link <NUMBER> Î±helix two different flexible loops pack neighboring protomer fig <NUMBER> <NUMBER> notably s<NUMBER>ca<NUMBER>c twofold higher expression s<NUMBER>p increased <NUMBER> thermostability fig <NUMBER>f <NUMBER> cavityfilling substitutions salt bridges also enhance protein stability without <NUMBER> disturbing overall fold cavity filling particularly helpful stabilizing prefusion <NUMBER> conformations rsv f hiv<NUMBER> env <NUMBER> found many cavityfilling salt bridge <NUMBER> designs improved protein expression compared s<NUMBER>p fig <NUMBER>g example l<NUMBER>f <NUMBER> t<NUMBER>d produced <NUMBER>fold increases protein yield maintained correct quaternary <NUMBER> structure fig <NUMBER>c <NUMBER>e although thermostability variants assessed <NUMBER> differential scanning fluorimetry dsf unchanged compared s<NUMBER>p fig <NUMBER>f <NUMBER> previous successes using proline substitutions inspired us investigate <NUMBER> individual <NUMBER> variants wherein proline substituted flexible loops ntermini helices <NUMBER> fusion peptide hr<NUMBER> region connecting cr table <NUMBER> fig <NUMBER>g expected <NUMBER> multiple proline variants boosted protein expression increased thermostability fig <NUMBER> <NUMBER>d <NUMBER>f two successful substitutions f<NUMBER>p a<NUMBER>p exhibited <NUMBER> <NUMBER> fold increases protein yield relative s<NUMBER>p respectively a<NUMBER>p substitution <NUMBER> increased melting temperature tm <NUMBER> Â°c variants appeared wellfolded <NUMBER> trimers nsem fig <NUMBER>e fig s<NUMBER> multisubstitution spike variants <NUMBER> next generated combination combo variants combined bestperforming <NUMBER> modifications initial screen combo variants containing two disulfide bonds <NUMBER> generally expressed <NUMBER>fold lower singledisulfide variants suggesting <NUMBER> interfered table s<NUMBER> adding one disulfide s<NUMBER>ca<NUMBER>c single proline <NUMBER> variant f<NUMBER>p also reduced expression level although quaternary structure spikes <NUMBER> well maintained table s<NUMBER> combo<NUMBER> beneficial effect disulfide bond <NUMBER> prominent combined l<NUMBER>f cavityfilling variant combo<NUMBER> s<NUMBER>ca<NUMBER>c <NUMBER> l<NUMBER>f higher protein yields either parental variants tm combo<NUMBER> <NUMBER> increase compared s<NUMBER>ca<NUMBER>c fig s<NUMBER>b addition mixing one cavityfilling <NUMBER> substitution one proline substitution combo<NUMBER> increased expression compared <NUMBER> l<NUMBER>f alone table s<NUMBER> <NUMBER> combining multiple proline substitutions resulted drastic increases <NUMBER> expression stability fig <NUMBER>a combo<NUMBER> containing a<NUMBER>p a<NUMBER>p <NUMBER>fold <NUMBER> increase protein yield compared a<NUMBER>p alone fig <NUMBER>b <NUMBER>c adding third proline <NUMBER> a<NUMBER>p increased thermostability <NUMBER> Â°c tm increase expression fig <NUMBER>c proline substitutions s<NUMBER>p hexapro expressed <NUMBER>fold higher s<NUMBER>p <NUMBER> Â°c increase <NUMBER> tm retained trimeric prefusion conformation fig <NUMBER>d fig s<NUMBER> focused <NUMBER> construct additional characterization fig <NUMBER>c <NUMBER>d <NUMBER> binding kinetics hexapro human ace<NUMBER> receptor comparable s<NUMBER>p <NUMBER> fig <NUMBER>e <NUMBER>f affinities <NUMBER> nm <NUMBER> nm respectively hexapro remained <NUMBER> folded prefusion conformation <NUMBER> cycles freezethaw <NUMBER> days incubation room <NUMBER> temperature <NUMBER> minutes <NUMBER> Â°c fig <NUMBER>g <NUMBER>h contrast s<NUMBER>p showed signs <NUMBER> aggregation <NUMBER> cycles freezethaw began unfolding <NUMBER> min <NUMBER> Â°c collectively data indicate hexapro promising candidate sarscov<NUMBER> vaccine <NUMBER> development confirm stabilizing substitutions lead unintended conformational <NUMBER> changes determined cryoem structure sarscov<NUMBER> hexapro single <NUMBER> dataset able obtain highresolution <NUMBER>d reconstructions two distinct conformations table s<NUMBER> q<NUMBER>cs<NUMBER>c substitution led partially misfolded spikes fig <NUMBER>b <NUMBER> interprotomer disulfides shown improve trimer integrity hiv<NUMBER> env <NUMBER> stability rsv f <NUMBER> interprotomeric t<NUMBER>cs<NUMBER>c substitution ablated expression <NUMBER> table s<NUMBER> contrast found stabilizing flexible loops located protomer <NUMBER> interfaces beneficial s<NUMBER>ca<NUMBER>c t<NUMBER>ca<NUMBER>c increased thermostability <NUMBER> expression resulted native trimer structures possible anchoring flexible loops <NUMBER> relatively rigid Î±helix favors protomer assembly introducing salt bridge hiv<NUMBER> gp<NUMBER>gp<NUMBER> interface boosted protein <NUMBER> expression also enhanced binding trimerspecific antibodies suggesting improved <NUMBER> retention native quaternary structure <NUMBER> based similar principle t<NUMBER>d <NUMBER> substitution introduced form electrostatic interaction arg<NUMBER> neighboring <NUMBER> protomer fig <NUMBER> likewise g<NUMBER>e substitution designed form interprotomeric <NUMBER> salt bridge arg<NUMBER> variants increased expression resembled wellfolded trimeric <NUMBER> spikes fig <NUMBER>e fig s<NUMBER> table s<NUMBER> addition salt bridges filling loosely packed copyright holder preprint version posted may <NUMBER> <NUMBER> substitution designed fill cavity formed part hr<NUMBER> fp Î²hairpin fig <NUMBER> <NUMBER> variant <NUMBER>fold increase expression fig <NUMBER>c appeared additive effects <NUMBER> paired disulfide proline substitutions table s<NUMBER> <NUMBER> among best singlesubstitution variants discovered f<NUMBER>p a<NUMBER>p fig hydrophobic residues near fusion peptide concern influenza ha stemonly <NUMBER> designs <NUMBER> similarly addressed issue replacing exposed phe<NUMBER> pro fig <NUMBER> <NUMBER>c a<NUMBER>p substitution imposes rigidity flexible loop connector region <NUMBER> hr<NUMBER> similar t<NUMBER>p substitution found helpful stabilizing ebola <NUMBER> gp <NUMBER> hexapro cryoem dataset observed third particles tworbdup <NUMBER> conformation previously observed sarscov<NUMBER> spikes recent <NUMBER> structure determined modified spike containing four hydrophobic substitutions <NUMBER> brought subdomain <NUMBER> closer s<NUMBER> <NUMBER> hypothesize stable s<NUMBER> hexapro allowed <NUMBER> us capture relatively unstable conformation may transiently exist prior triggering <NUMBER> dissociation s<NUMBER> similar observed structures merscov <NUMBER> s<NUMBER>p spike even <NUMBER>rbdup conformation could observed <NUMBER> additionally hexapro <NUMBER> spikes able retain prefusion state freezethaws room temperature storage <NUMBER> heat stress aid development hexapro spikes subunit vaccine antigens hexapro spikes may also improve dna mrnabased vaccines producing antigen table s<NUMBER> cryoem data collection refinement statistics ccbyncnd <NUMBER> international license certified peer review authorfunder made available sarscov<NUMBER> s<NUMBER>p variant used base construct subsequent designs <NUMBER> pairs residues cÎ² atoms less <NUMBER> Ã¥ apart considered disulfide bond designs <NUMBER> particularly targeted regions move drastically preto postfusion transition <NUMBER> fusion peptide connector region hr<NUMBER> salt bridge variants required <NUMBER> charged groups substituted residues predicted within <NUMBER> Ã¥ residues <NUMBER> loops slightly longer distance <NUMBER> Ã¥ allowed corefacing residues sidechains <NUMBER> adjacent preexisting internal cavity examined potential substitutions bulkier table s<NUMBER> <NUMBER> cryoem data processing <NUMBER> motion correction ctfestimation particle picking performed warp <NUMBER> particles side view trimeric sarscov<NUMBER> spike ectodomain prefusion conformation pdb id <NUMBER>vsb s<NUMBER> domains shown transparent molecular surface s<NUMBER> domain protomer shown ribbon diagram inset corresponds one four types spike modifications proline salt bridge disulfide cavity filling side chains inset shown red spheres proline yellow sticks disulfide red blue sticks salt bridge orange spheres cavity filling ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint table s<NUMBER> cryoem data collection refinement statistics coronaviruses enveloped viruses containing positivesense rna genomes four human <NUMBER> coronaviruses generally cause mild respiratory illness circulate annually however sars <NUMBER> cov merscov acquired humans via zoonotic transmission caused outbreaks <NUMBER> severe respiratory infections high casefatality rates <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> sarscov<NUMBER> novel betacoronavirus emerged wuhan china december <NUMBER> <NUMBER> causative agent ongoing covid<NUMBER> pandemic <NUMBER> <NUMBER> may <NUMBER> <NUMBER> <NUMBER> reported <NUMBER> million cases <NUMBER> deaths worldwide effective vaccines therapeutic <NUMBER> antibodies smallmolecule inhibitors urgently needed development <NUMBER> interventions proceeding rapidly <NUMBER> coronavirus virions decorated spike glycoprotein binds hostcell <NUMBER> receptors mediates cell entry via fusion host viral membranes <NUMBER> proteins <NUMBER> trimeric class fusion proteins expressed single polypeptide subsequently <NUMBER> cleaved s<NUMBER> s<NUMBER> subunits cellular proteases <NUMBER> <NUMBER> s<NUMBER> subunit contains receptor <NUMBER> binding domain rbd case sarscov<NUMBER> recognizes angiotensin <NUMBER> converting enzyme <NUMBER> ace<NUMBER> receptor hostcell surface <NUMBER> <NUMBER> <NUMBER> s<NUMBER> subunit mediates <NUMBER> membrane fusion contains additional protease cleavage site referred s<NUMBER>â² <NUMBER> adjacent hydrophobic fusion peptide binding rbd ace<NUMBER> triggers s<NUMBER> dissociation <NUMBER> allowing large rearrangement s<NUMBER> transitions metastable prefusion <NUMBER> conformation highly stable postfusion conformation <NUMBER> <NUMBER> rearrangement <NUMBER> fusion peptide inserted hostcell membrane cleavage s<NUMBER>â² two heptad <NUMBER> repeats protomer associate form sixhelix bundle brings together nand c <NUMBER> termini s<NUMBER> subunits well viral hostcell membranes attachment entry <NUMBER> essential viral life cycle making protein primary target neutralizing antibodies <NUMBER> critical vaccine antigen <NUMBER> <NUMBER> <NUMBER> stabilized prefusion conformation class fusion proteins desirable vaccine <NUMBER> development conformation found infectious virions displays <NUMBER> neutralizing epitopes targeted antibodies prevent entry process <NUMBER> <NUMBER> <NUMBER> wildtype spike ectodomains <NUMBER> used determine highresolution spike structures <NUMBER> cryoem <NUMBER> <NUMBER> <NUMBER> <NUMBER> importantly successful transplantation doubleproline substitution <NUMBER> sarscov<NUMBER> spike sarscov<NUMBER> s<NUMBER>p allowed rapid determination high<NUMBER> resolution cryoem structures accelerated development vaccine candidates <NUMBER> <NUMBER> however <NUMBER> even substitutions sarscov<NUMBER> s<NUMBER>p ectodomain unstable difficult <NUMBER> produce reliably mammalian cells hampering biochemical research development <NUMBER> subunit vaccines employ structurebased design increase yield stability sars cov<NUMBER> spike ectodomain prefusion conformation report multiple prolines disulfide <NUMBER> bonds salt bridges cavityfilling substitutions increase expression andor stability <NUMBER> <NUMBER> spike relative s<NUMBER>p base construct combining four proline substitutions single <NUMBER> construct termed hexapro stabilized prefusion state increased expression <NUMBER>fold <NUMBER> highresolution cryoem structure variant confirms proline substitutions adopt <NUMBER> designed conformations disrupt conformation s<NUMBER> subunit thus preserving <NUMBER> antigenicity work facilitate production prefusion spikes diagnostic kits <NUMBER> subunit vaccines broad implications nextgeneration coronavirus vaccine design generate prefusionstabilized sarscov<NUMBER> spike protein expresses higher levels <NUMBER> stable original s<NUMBER>p construct <NUMBER> analyzed sarscov<NUMBER> s<NUMBER>p cryoem <NUMBER> structure pdb id <NUMBER>vsb designed substitutions based upon knowledge class fusion <NUMBER> protein function general protein stability principles strategies included <NUMBER> introduction disulfide bonds prevent conformational changes pretopostfusion <NUMBER> transition salt bridges neutralize charge imbalances hydrophobic residues fill internal <NUMBER> cavities prolines cap helices stabilize loops prefusion state cloned <NUMBER> <NUMBER> single s<NUMBER>p variants characterized relative expression levels table s<NUMBER> <NUMBER> expressed well characterized monodispersity thermostability quaternary <NUMBER> structure given s<NUMBER> subunit undergoes largescale refolding pretopostfusion <NUMBER> transition exclusively focused efforts stabilizing s<NUMBER> substitutions category <NUMBER> identified increased expression maintaining prefusion conformation fig <NUMBER> <NUMBER> <NUMBER>a overall <NUMBER> <NUMBER> singlesubstitution variants higher expression s<NUMBER>p <NUMBER> table s<NUMBER> <NUMBER> singlesubstitution spike variants <NUMBER> <NUMBER> one common strategy stabilize class fusion proteins spike covalently link <NUMBER> region undergoes conformational change region via disulfide bond <NUMBER> instance q<NUMBER>cs<NUMBER>c substitution attempts link hr<NUMBER> central helix whereas <NUMBER> g<NUMBER>ca<NUMBER>c aims link hr<NUMBER> upstream helix two variants boosted protein <NUMBER> expression <NUMBER>fold <NUMBER>fold compared s<NUMBER>p respectively fig <NUMBER>b however size<NUMBER> exclusion chromatography sec traces variants showed leftward shift compared s<NUMBER> <NUMBER>p indicating proteins running larger expected agreed well <NUMBER> negative stain electron microscopy nsem results showed partially misfolded spike particles <NUMBER> fig s<NUMBER> contrast s<NUMBER>ca<NUMBER>c t<NUMBER>ca<NUMBER>c variants eluted sec volume <NUMBER> similar s<NUMBER>p wellfolded trimeric particles nsem fig <NUMBER>e variants link <NUMBER> Î±helix two different flexible loops pack neighboring protomer fig <NUMBER> <NUMBER> notably s<NUMBER>ca<NUMBER>c twofold higher expression s<NUMBER>p increased <NUMBER> thermostability fig <NUMBER>f <NUMBER> cavityfilling substitutions salt bridges also enhance protein stability without <NUMBER> disturbing overall fold cavity filling particularly helpful stabilizing prefusion <NUMBER> conformations rsv f hiv<NUMBER> env <NUMBER> found many cavityfilling salt bridge <NUMBER> designs improved protein expression compared s<NUMBER>p fig <NUMBER>g example l<NUMBER>f <NUMBER> t<NUMBER>d produced <NUMBER>fold increases protein yield maintained correct quaternary <NUMBER> structure fig <NUMBER>c <NUMBER>e although thermostability variants assessed <NUMBER> differential scanning fluorimetry dsf unchanged compared s<NUMBER>p fig <NUMBER>f <NUMBER> previous successes using proline substitutions inspired us investigate <NUMBER> individual <NUMBER> variants wherein proline substituted flexible loops ntermini helices <NUMBER> fusion peptide hr<NUMBER> region connecting cr table <NUMBER> fig <NUMBER>g expected <NUMBER> multiple proline variants boosted protein expression increased thermostability fig <NUMBER> <NUMBER>d <NUMBER>f two successful substitutions f<NUMBER>p a<NUMBER>p exhibited <NUMBER> <NUMBER> fold increases protein yield relative s<NUMBER>p respectively a<NUMBER>p substitution <NUMBER> increased melting temperature tm <NUMBER> Â°c variants appeared wellfolded <NUMBER> trimers nsem fig <NUMBER>e fig s<NUMBER> multisubstitution spike variants <NUMBER> next generated combination combo variants combined bestperforming <NUMBER> modifications initial screen combo variants containing two disulfide bonds <NUMBER> generally expressed <NUMBER>fold lower singledisulfide variants suggesting <NUMBER> interfered table s<NUMBER> adding one disulfide s<NUMBER>ca<NUMBER>c single proline <NUMBER> variant f<NUMBER>p also reduced expression level although quaternary structure spikes <NUMBER> well maintained table s<NUMBER> combo<NUMBER> beneficial effect disulfide bond <NUMBER> prominent combined l<NUMBER>f cavityfilling variant combo<NUMBER> s<NUMBER>ca<NUMBER>c <NUMBER> l<NUMBER>f higher protein yields either parental variants tm combo<NUMBER> <NUMBER> increase compared s<NUMBER>ca<NUMBER>c fig s<NUMBER>b addition mixing one cavityfilling <NUMBER> substitution one proline substitution combo<NUMBER> increased expression compared <NUMBER> l<NUMBER>f alone table s<NUMBER> <NUMBER> combining multiple proline substitutions resulted drastic increases <NUMBER> expression stability fig <NUMBER>a combo<NUMBER> containing a<NUMBER>p a<NUMBER>p <NUMBER>fold <NUMBER> increase protein yield compared a<NUMBER>p alone fig <NUMBER>b <NUMBER>c adding third proline <NUMBER> a<NUMBER>p increased thermostability <NUMBER> Â°c tm increase expression fig <NUMBER>c tm retained trimeric prefusion conformation fig <NUMBER>d fig s<NUMBER> focused <NUMBER> construct additional characterization binding kinetics hexapro human ace<NUMBER> receptor comparable s<NUMBER>p <NUMBER> fig <NUMBER>e <NUMBER>f affinities <NUMBER> nm <NUMBER> nm respectively hexapro remained <NUMBER> folded prefusion conformation <NUMBER> cycles freezethaw <NUMBER> days incubation room <NUMBER> temperature <NUMBER> minutes <NUMBER> Â°c fig <NUMBER>g <NUMBER>h contrast s<NUMBER>p showed signs <NUMBER> aggregation <NUMBER> cycles freezethaw began unfolding <NUMBER> min <NUMBER> Â°c collectively data indicate hexapro promising candidate sarscov<NUMBER> vaccine <NUMBER> development confirm stabilizing substitutions lead unintended conformational <NUMBER> changes determined cryoem structure sarscov<NUMBER> hexapro single <NUMBER> dataset able obtain highresolution <NUMBER>d reconstructions two distinct conformations table s<NUMBER> q<NUMBER>cs<NUMBER>c substitution led partially misfolded spikes fig <NUMBER>b <NUMBER> interprotomer disulfides shown improve trimer integrity hiv<NUMBER> env <NUMBER> stability rsv f <NUMBER> <NUMBER> interprotomeric t<NUMBER>cs<NUMBER>c substitution ablated expression <NUMBER> table s<NUMBER> contrast found stabilizing flexible loops located protomer <NUMBER> interfaces beneficial s<NUMBER>ca<NUMBER>c t<NUMBER>ca<NUMBER>c increased thermostability <NUMBER> expression resulted native trimer structures possible anchoring flexible loops <NUMBER> relatively rigid Î±helix favors protomer assembly introducing salt bridge hiv<NUMBER> gp<NUMBER>gp<NUMBER> interface boosted protein <NUMBER> expression also enhanced binding trimerspecific antibodies suggesting improved <NUMBER> retention native quaternary structure <NUMBER> based similar principle t<NUMBER>d <NUMBER> substitution introduced form electrostatic interaction arg<NUMBER> neighboring <NUMBER> protomer fig <NUMBER> likewise g<NUMBER>e substitution designed form interprotomeric <NUMBER> salt bridge arg<NUMBER> variants increased expression resembled wellfolded trimeric <NUMBER> spikes fig <NUMBER>e fig s<NUMBER> table s<NUMBER> addition salt bridges filling loosely packed <NUMBER> hydrophobic cores allow protein refold help stabilize prefusion state shown <NUMBER> previous cavityfilling substitutions rsv f hiv<NUMBER> env <NUMBER> <NUMBER> <NUMBER> l<NUMBER>f <NUMBER> substitution designed fill cavity formed part hr<NUMBER> fp Î²hairpin fig <NUMBER> <NUMBER> variant <NUMBER>fold increase expression fig <NUMBER>c appeared additive effects <NUMBER> paired disulfide proline substitutions table s<NUMBER> <NUMBER> among best singlesubstitution variants discovered f<NUMBER>p a<NUMBER>p fig <NUMBER> <NUMBER> combining a<NUMBER>p a<NUMBER>p substitutions generated highest hydrophobic residues near fusion peptide concern influenza ha stemonly <NUMBER> designs <NUMBER> similarly addressed issue replacing exposed phe<NUMBER> pro fig <NUMBER> <NUMBER>c a<NUMBER>p substitution imposes rigidity flexible loop connector region <NUMBER> hr<NUMBER> similar t<NUMBER>p substitution found helpful stabilizing ebola <NUMBER> gp <NUMBER> hexapro cryoem dataset observed third particles tworbdup <NUMBER> conformation previously observed sarscov<NUMBER> spikes recent <NUMBER> structure determined modified spike containing four hydrophobic substitutions <NUMBER> brought subdomain <NUMBER> closer s<NUMBER> <NUMBER> hypothesize stable s<NUMBER> hexapro allowed <NUMBER> us capture relatively unstable conformation may transiently exist prior triggering <NUMBER> dissociation s<NUMBER> similar observed structures merscov table s<NUMBER> cryoem data collection refinement statistics sarscov<NUMBER> s<NUMBER>p variant used base construct subsequent designs <NUMBER> pairs residues cÎ² atoms less <NUMBER> Ã¥ apart considered disulfide bond designs <NUMBER> particularly targeted regions move drastically preto postfusion transition <NUMBER> fusion peptide connector region hr<NUMBER> salt bridge variants required <NUMBER> charged groups substituted residues predicted within <NUMBER> Ã¥ residues <NUMBER> loops slightly longer distance <NUMBER> Ã¥ allowed corefacing residues sidechains <NUMBER> adjacent preexisting internal cavity examined potential substitutions bulkier table s<NUMBER> cryoem density reconstruction shown colored according local resolution central slice density shown right wellknown virus escape mechanism critical understand mechanism dynamics controlled structural studies Î²cov sprotein focused primarily soluble ectodomain construct without stabilizing proline mutations <NUMBER>p includes structures sars<NUMBER> <NUMBER> sars <NUMBER> mers <NUMBER> <NUMBER> human <NUMBER> murine <NUMBER> Î²cov ectodomains structures sars mers ectodomains revealed presence one two rbd states three rbd state observed mers ectodomain demonstrating breadth rbd configurations available spike interestingly states observed human Î²covs hku<NUMBER> oc<NUMBER> murine Î²cov suggesting mutations spike protein confer dramatic differences propensity rbd sample available conformational space quantitative examination available Î²cov sprotein structures recently revealed s<NUMBER> s<NUMBER> subunit domains different Î²cov viruses occupy diverse array configurations <NUMBER> based upon analysis predicted sprotein conformation particularly sensitive mutations interfaces domains subunits indeed mutations sites major impacts configuration protein especially rbd updown distribution <NUMBER> studies <NUMBER> <NUMBER> <NUMBER> demonstrated role proteinprotein contacts determining conformation sprotein influence rbd configuration glycosylation near interfacial domain regions poorly understood like class viral fusion proteins Î²cov sproteins heavily glycosylated obscuring spike surface limiting targetable area immune responses recent sitespecific analysis glycosylation patterns sars<NUMBER> sprotein revealed extensive variation glycan type indicating marked differences processing enzyme accessibility site <NUMBER> together wide variation spike conformation coupled presence glycans adjacent rbd suggests among many factors affecting rbd position glycosylation patterns may provide means control conformational equilibrium study investigated potential two sars<NUMBER> ntd glycans close proximity rbd influence conformational distribution rbd states analysis available sars<NUMBER> state structures suggested n<NUMBER> n<NUMBER> glycans may interact state rbd acting direct stabilizers state steric blocks transitions state combined binding studies surface plasmon resonance structural studies using negative stain electron microscopy nsem singleparticle cryoelectron microscopy cryoem define shifts updown state equilibrium glycandeleted mutants sars<NUMBER> spike ectodomain together results demonstrate rbd proximal glycans influence propensity sprotein adopt multiple configurations suggesting means viral escape therefore need consider nonrbd neutralizing responses vaccine design order establish whether glycans may indeed alter rbd orientation first examined sars<NUMBER> glycan density positions <NUMBER> <NUMBER> cryoem maps three previously published sars<NUMBER> structures <NUMBER> state n<NUMBER> glycan resides cleft formed ntd rbd supplemental figure <NUMBER>a state occupies region rbd state figure <NUMBER>a suggests solvated state configuration preferred must shifted order accommodate state presence glycan may act hinderance uptodown state transitions sterically hindering state limiting rbd ntd packing additional glycan n<NUMBER> residing toward apical position ntd close proximity rbd therefore may also influence rbd position unlike n<NUMBER> glycan position n<NUMBER> glycan presents apparent restriction rbd positioning state supplemental figure <NUMBER>b however clear density glycan observed occupying region rbd rest closed state potentially forming interactions state rbd figure <NUMBER>a suggests glycan may act stabilize rbd state alternatively presence near rbd state may confer degree stability fully closed state together observations combined recent results suggesting remarkable conformational sensitivity mutations suggest glycans may act stabilize observed rbd updown equilibrium next asked whether rbd proximal ntd glycans occur Î²covs highresolution structural data available examined structures mers sars oc<NUMBER> hku<NUMBER> murine Î²cov sprotein ectodomains pdb ids <NUMBER>w<NUMBER>h <NUMBER>crw <NUMBER>ohv <NUMBER>i<NUMBER> <NUMBER>jcl respectively identifying three mers n<NUMBER> n<NUMBER> n<NUMBER> two sars<NUMBER> synonymous sars n<NUMBER> n<NUMBER> one oc<NUMBER> n<NUMBER> two hku<NUMBER> n<NUMBER> n<NUMBER> glycosylation sites proximal respective rbds figure <NUMBER>b rbd adjacent glycosylation sites observed murine sprotein mers sars glycans display similar extensions rbd space one state lack state structures oc<NUMBER> hku<NUMBER> precludes examination rbd adjacent ntd glycans absence rbd however hku<NUMBER> n<NUMBER> oc<NUMBER> n<NUMBER> glycans extend upward away rbd suggesting glycans unlikely exert strong influence rbd conformation supplemental figure <NUMBER>c interestingly cryoem reconstructions sars<NUMBER> mers sars yield state rbds states reported oc<NUMBER> hku<NUMBER> murine datasets together observations suggest rbd proximal ntd glycans may indeed affect conformational distribution updown rbd states order examine extent n<NUMBER> n<NUMBER> glycans influence conformational distribution sprotein produced diproline <NUMBER>p stabilized <NUMBER> sprotein ectodomain <NUMBER> n<NUMBER>a n<NUMBER>a mutants protein yields streptactin purification <NUMBER> mg <NUMBER> mg per <NUMBER>l culture supernatant respectively n<NUMBER>a n<NUMBER>a mutant supplemental figures <NUMBER> <NUMBER> assess reactivity glycandeleted spike ectodomain mutants ace<NUMBER> receptor tested binding spike ace<NUMBER> ectodomain construct bearing cterminal mouse fc tag immobilized antifc surface spr binding assays showed n<NUMBER>a mutant displayed <NUMBER> increased binding levels unmutated construct n<NUMBER>a mutant showed decrease <NUMBER> figure <NUMBER>a supplemental figure <NUMBER>b ace<NUMBER> binding requires rbd position spr data suggests n<NUMBER>a mutant displays open states whereas n<NUMBER>a mutant displays closed states next examined updown state distribution mutants via negative stain electron microscopy nsem heterogenous classification n<NUMBER>a mutant particles revealed dramatic shift <NUMBER> v state distribution unmutated <NUMBER>p <NUMBER> ratio <NUMBER> state figure <NUMBER>a remarkably n<NUMBER>a mutant shifted distribution opposite direction displaying higher propensity adopt rbd states yielding <NUMBER> state state ratio <NUMBER> population <NUMBER>rbd class figure <NUMBER>a together ace<NUMBER> binding nsem results demonstrated ntd nglycan deletions distinct impacts rbd distribution highresolution cryoem structures nglycan deleted constructs indicates modest perturbation sprotein configuration next turned cryoem high resolution structure determination visualize impact glycan deletions local global configuration sprotein domains collected processed <NUMBER> <NUMBER> images n<NUMBER>a n<NUMBER>a mutant respectively yield particle stacks cleaned <NUMBER>d classification multiple rounds ab initio classification heterogenous refinement cryosparc <NUMBER> using <NUMBER> Ã¥ low pass filtered state state maps generated available sars<NUMBER> structures initial maps high resolution refinement generated sorted particles via ab initio reconstruction supplemental figures <NUMBER> <NUMBER> resulting particle distribution n<NUMBER>a mutant predominantly minor <NUMBER> state population n<NUMBER>a mutant <NUMBER> <NUMBER> one observed unmutated spike previously <NUMBER> <NUMBER> unable identify particle subset corresponding two state cryoem dataset updown state populations obtained via nsem unmutated <NUMBER> glutaraldehyde fixed sars<NUMBER> sprotein ectodomain match previously observed cryoem distribution <NUMBER> using approach find distributions dramatically differentially shifted mutation either n<NUMBER> n<NUMBER> alanine spr nsem cryoem distribution tracking direction exception n<NUMBER>a cryoem particles two rbd state observed considering concordance spr nsem results may due particle processing potential relatively disordered state rbds two state glycan deletion next examined highresolution details cryoem maps refinement n<NUMBER>a mutant state using c<NUMBER> symmetry resulted <NUMBER> Ã¥ map coordinates fit map yielding structure aligning unmutated <NUMBER>p structure pdb id <NUMBER>vxx <NUMBER> Ã¥ rmsd alignment s<NUMBER> subunit revealed structures nearly identical regions rmsd <NUMBER> Ã¥ examination ntd rbd interface using alignment revealed shift ntd toward rbd figure <NUMBER>ad weak density n<NUMBER> glycan observed suggestive overall similar position relative observed previously figure <NUMBER>b c one rbd state map refined <NUMBER> Ã¥ resolution using c<NUMBER> symmetry comparison one rbd state structure fit map unmutated counterpart pdb id <NUMBER>vyb suggests slight shift rbd n<NUMBER>a mutation figure <NUMBER>e f however limited resolution structure limits close examination movement nevertheless density n<NUMBER> glycan observed ntd adjacent figure <NUMBER>b shift observed either two ntds indicating ntd shift sensitive s<NUMBER> s<NUMBER> subunit arrangements supplemental figure <NUMBER>c <NUMBER>up rbd resides largely position unmutated spike minor differences due potentially lower relative resolution region figure <NUMBER>eh density n<NUMBER> glycan observed protomers consistent state map together results n<NUMBER>a n<NUMBER>a structural analysis results suggest two glycans play differential role influencing sarscov<NUMBER> rbd arrangement shifting ntd toward away adjacent rbds viral fusion proteins often heavily glycosylated sars<NUMBER> sprotein exception though decorated fewer glycans hiv<NUMBER> envelope protein <NUMBER> glycans per protomer <NUMBER> sars<NUMBER> spike well shielded immune surveillance sars<NUMBER> spike protein proven remarkably sensitive domaindomain interfacial mutations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> led us ask whether glycans near ntdrbd interface might also impact configuration spike investigated role two ntd context expected indeed recent report detergent solubilized fulllength sars<NUMBER> spike suggested greater stability state rbd <NUMBER> yet experimental results revealing role n<NUMBER> n<NUMBER> glycans modulating conformational landscape protein taken together findings computational analysis performed context fulllength spike <NUMBER> analysis rbdproximal ntd glycans diverse Î²covs figure <NUMBER> provides strong support role glycans controlling virion bound sprotein conformation dynamics differences glycosylation region different cov spikes could contributor determining receptor specificity thus transmission toward second question related utility vaccine design building upon previous study demonstrated conformational control rbd dynamics protein ectodomain modulating interdomain proteinprotein contacts expand tools achieving control glycanprotein interactions demonstrate rbd dynamics modulated targeting key glycans interdomain contacts create two new ectodomain constructs differential exposure immunodominant rbd use immunogens vaccination regimens taken together investigations demonstrate remarkable plasticity conformational machine suggest sprotein diverse landscape conformational escape mutations select genetic drift host immune pressures direct evolution cryoem reconstructions deposited electron microscopy data bank emdb accession codes tbd protein data bank pdb ids tbd sarscov<NUMBER> ectodomain constructs produced purified described previously <NUMBER> briefly gene encoding residues <NUMBER>â<NUMBER> sarscov<NUMBER> genbank mn<NUMBER> proline substitutions residues <NUMBER> <NUMBER> gsas substitution furin cleavage site residues <NUMBER> cterminal t<NUMBER> fibritin trimerization motif hrv<NUMBER>c protease cleavage site twinstreptag <NUMBER>xhistag synthesized cloned mammalian expression vector pÎ±h mutants introduced background expression plasmids encoding ectodomain sequence used transiently transfect freestyle<NUMBER>f cells using turbo<NUMBER> speedbiosystems protein purified sixth day posttransfection filtered supernatant using streptactin resin iba ace<NUMBER> gene cloned fusion protein mouse fc region attached cterminal end <NUMBER>x histag added cterminal end fc domain ace<NUMBER> mouse fc tag purified ninta chromatography ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint thermal shift assay performed using tycho nt <NUMBER> nanotemper technologies spike variants diluted <NUMBER> mgml ncov buffer <NUMBER>mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> sodium azide run duplicates capillary tubes intrinsic fluorescence recorded <NUMBER> nm <NUMBER> nm heating sample <NUMBER> Â°c rate <NUMBER> Â°cmin ratio fluorescence <NUMBER> nm ti calculated tycho nt <NUMBER> purified sarscov<NUMBER> spike preparations diluted concentration <NUMBER> mgml <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> <NUMBER> Âµl protein deposited cf<NUMBER> grid glow discharged <NUMBER> seconds pelco easiglowâ¢ glow discharge cleaning system <NUMBER> incubation <NUMBER> humidity excess protein blotted away <NUMBER> seconds plunge frozen liquid ethane using leica em gp<NUMBER> plunge freezer leica microsystems frozen grids n<NUMBER>a mutant imaged titan krios thermo fisher equipped k<NUMBER> detector gatan n<NUMBER>a mutant image titan krios equipped falcon <NUMBER>ec detector data acquired using leginon system <NUMBER> n<NUMBER>a epu software thermo fisher scientific n<NUMBER>a dose fractionated <NUMBER> raw frames collected <NUMBER>ms framerate dataset energyfiltered slit width <NUMBER> ev n<NUMBER>a mutant individual frames aligned doseweighted <NUMBER> ctf estimation particle picking <NUMBER>d classifications ab initio model generation heterogeneous refinements homogeneous <NUMBER>d refinements local resolution calculations carried cryosparc <NUMBER> structures state pdb id <NUMBER>vxx single rbd state pdb id <NUMBER>vyb previously published sarscov<NUMBER> ectodomain used fit cryoem maps chimera <NUMBER> mutations made pymol <NUMBER> coordinates fit maps first using isolde <NUMBER> followed iterative refinement using phenix <NUMBER> real space refinement subsequent manual coordinate fitting coot needed structure map analysis performed using pymol chimera <NUMBER> chimerax <NUMBER> ccbyncnd <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted june <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> causative pathogen covid<NUMBER> <NUMBER> induces fever severe respiratory illness pneumonia sarscov<NUMBER> utilizes extensively glycosylated spike protein protrudes viral surface bind angiotensinconverting enzyme <NUMBER> ace<NUMBER> host cell receptor mediate cell entry <NUMBER> protein trimeric class fusion protein composed two functional subunits responsible receptor binding s<NUMBER> subunit membrane fusion s<NUMBER> subunit remarkably surface virally encoded envelope spike dominated array hostderived glycans trimer displaying <NUMBER> nlinked glycosylation sites extensive glycosylation important implications vaccine design obligate parasites many viruses exploit hostcell machinery glycosylate proteins numerous viral envelope proteins including hiv<NUMBER> envelope env influenza hemagglutinin ha lassa virus glycoprotein complex gpc possess genetically encoded nlinked glycan sequons nxst motifs x amino acid except proline viral glycosylation wideranging roles viral pathobiology including mediating protein folding stability shaping viral tropism genetically encoded sequons significant selective pressure mechanism immune evasion shielding specific epitopes antibody neutralization however note currently reported low mutation rate sarscov<NUMBER> yet observed mutations nlinked glycosylation sites <NUMBER> surfaces unusually high density glycans also enable immune recognition <NUMBER> <NUMBER> <NUMBER> role glycosylation immune evasion camouflaging immunogenic protein epitopes well studied coronaviruses <NUMBER> principal antigen presented surface sarscov<NUMBER> virions protein key target vaccine design efforts apparent viral spike targeted full assortment vaccine strategies nucleicacid based approaches <NUMBER> whereby viral protein expressed vivo recombinant strategies whereby viral glycoproteins delivered appropriate adjuvants strategies aim elicit neutralizing adaptive immunity emphasis achieving antibody response sites viral entry understanding glycosylation recombinant viral spikes reveal fundamental features viral biology guide vaccine design strategies manufacturing glycans enzymatically elaborated golgi apparatus features processed socalled complextype glycosylation necessarily influenced <NUMBER> <NUMBER> <NUMBER> <NUMBER> however observations hybridand complextype glycans virally derived material suggests viral glycoproteins subjected golgi resident processing enzymes <NUMBER> <NUMBER> impaired glycan maturation sensitive reporter local viral protein architecture <NUMBER> detailed sitespecific analysis emerged indicator nativelike architecture increasingly used compare different immunogens monitoring manufacturing processes importantly addition structural insights presence oligomannosetype glycans viral spikebased immunogens also shown enhance trafficking glycoprotein germinal centers via interaction lectins mannosebinding lectin <NUMBER> therefore considerable importance understand glycosylation recombinant mimetics virus spike apply mass spectrometry understand sitespecific nlinked glycan composition degree sequon occupancy soluble nativelike sarscov<NUMBER> protein nativelike folding trimeric recombinant material recently revealed detailed structural analysis cryoelectron microscopy <NUMBER> <NUMBER> previously validated glycopeptide analysis methodology applied approach study range viral glycoprotein immunogens <NUMBER> enables crossviral comparisons glycosylation made report sitespecific glycosylation <NUMBER> nlinked glycan sites found sarscov<NUMBER> protomer observed viral glycoproteins elevation oligomannoseand hybridtype glycans compared hostderived glycoproteins although compared many viruses still large population complextype glycans displayed across trimer surface also report <NUMBER> glycan sites occupancy nearly fully complete means epitopes shielded ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint immune system virus also likely shielded immunogen sitespecific glycan analysis sarscov<NUMBER> immunogens help guide vaccine design manufacturing resolve sitespecific glycosylation sarscov<NUMBER> protein visualize distribution glycoforms across protein surface expressed purified recombinant soluble material identical manner used obtain highresolution cryoelectron microscopy cryoem structure albeit without glycan processing blockade using kifunensine <NUMBER> soluble recombinant variant protein contains <NUMBER> glycans sarscov<NUMBER> protein figure <NUMBER>a stabilization trimeric prefusion structure achieved using <NUMBER>p stabilizing mutations <NUMBER> residues <NUMBER> <NUMBER> addition cterminal trimerization motif ensures quaternary structure remains intact glycan processing case hiv env mimetics known influence glycosylation certain sites <NUMBER> <NUMBER> prior analysis supernatant containing recombinant sarscov<NUMBER> purified using cterminal streptag followed sizeexclusion chromatography ensure nativelike trimeric sarscov<NUMBER> protein analyzed figure <NUMBER>b trimeric conformation purified material validated using negative stain electron microscopy figure <NUMBER>c ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint trypsin chymotrypsin alphalytic protease employed generate three glycopeptide samples proteases cleave different sites selected order generate glycopeptides contain single nlinked glycan sequon glycopeptide pools analyzed lcms highenergy collisioninduced dissociation hcd ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint fragmentation glycan compositions site determined <NUMBER> nlinked glycan sites sarscov<NUMBER> protein figure <NUMBER> diverse range glycan compositions observed across different glycosylation sites order convey main processing features site abundances glycan summed oligomannose hybridand complextype glycosylation addition diverse signals arising heterogeneous complextype glycosylation simplified summation glycan intensities limited range structural categories three sites sarscov<NUMBER> predominantly oligomannosetype n<NUMBER> n<NUMBER> n<NUMBER> predominant structure observed site exception n<NUMBER> man<NUMBER>glcnac<NUMBER> demonstrates sites largely accessible ï¡<NUMBER>mannosidases poor substrates glcnacti gateway enzyme formation hybridand complextype glycans golgi apparatus stage processing impeded signature related density presentation glycans viral spike example densely glycosylated spikes hiv<NUMBER> env lassa virus gpc give rise numerous sites dominated man<NUMBER>glcnac<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly several sites possess significant populations hybridtype glycans notably n<NUMBER> phenomenon observed viral glycoproteins hiv<NUMBER> env <NUMBER> structures particularly prevalent mammalian glycoproteins <NUMBER> <NUMBER> hybridtype glycans shown targeted antihiv antibodies <NUMBER> could also important immunogen trafficking since mannoseterminating moieties <NUMBER> mixture oligomannosetype glycans complextype glycans found sites n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> figure <NUMBER> <NUMBER> sites protein <NUMBER> contain significant populations oligomannosetype glycans highlighting processing sarscov<NUMBER> glycans divergent host glycoproteins remaining <NUMBER> sites dominated processed complextype glycans predominant category complextype glycans observed protein fucosylated biantennary structures similar abundant mammalian glycoproteins feature interrogated using methodology extent unoccupancy glycosylation sites sequon present glycan attached hiv immunogen research holes generated unoccupied glycan sites shown immunogenic potentially give rise distracting epitopes <NUMBER> using cryoem structure trimeric sarscov<NUMBER> protein pdb id <NUMBER>vsb <NUMBER> generated model map glycosylation status coronavirus spike mimetic onto experimentally determined <NUMBER>d structure figure <NUMBER> combined mass spectrometric cryoem analysis reveals nlinked glycans occlude distinct regions across surface sarscov<NUMBER> spike glycans modelled onto site using predominant glycans observed figure <NUMBER> colored according prevalence oligomannosetype glycans shielding receptor binding sites sarscov<NUMBER> spike proximal glycosylation sites n<NUMBER> n<NUMBER> n<NUMBER> observed especially receptor binding domain conformation shielding receptor binding sites glycans common feature viral glycoproteins observed sarscov <NUMBER> hiv<NUMBER> env <NUMBER> influenza ha <NUMBER> lasv gpc <NUMBER> given functional constraints receptor binding sites subsequent low mutation rates residues likely selective pressure utilize nlinked glycans method camouflage one conserved potentially vulnerable areas respective glycoproteins <NUMBER> <NUMBER> interesting note absence specific glycan cluster responsible presence oligomannosetype glycans rather dispersion glycans across s<NUMBER> s<NUMBER> subunits significant contrast viral glycoproteins example density glycans clusters hiv even enabled structural classification different modes interaction <NUMBER> sarscov<NUMBER> oligomannosetype structures probably protected extent protein component exemplified n<NUMBER> glycan partially sandwiched nterminal receptorbinding domains figure <NUMBER> characterized nlinked glycans extended loop structures resolved cryoem maps <NUMBER> n<NUMBER> n<NUMBER> determined complextype glycans consistent inherent flexibility regions resulting accessibility residues glycan processing enzymes fig <NUMBER> oligomannosetype glycans comprise <NUMBER> total glycan pool hybridtype complextype glycans comprising <NUMBER> <NUMBER> respectively sup fig <NUMBER> despite potential impact different local protein structure glycan processing overall glycosylation sarscov<NUMBER> comparable sarscov<NUMBER> protein coronavirus proteins <NUMBER> <NUMBER> <NUMBER> <NUMBER> previously reported recombinant sarscov<NUMBER> mimetic also contained <NUMBER> oligomannosetype glycans showing remarkable conservation glycan processing across coronaviruses whilst oligomannosetype glycan content well observed typical host glycoproteins significantly lower found viral glycoproteins example one densely glycosylated viral spike proteins hiv<NUMBER> env contains <NUMBER> oligomannosetype glycans <NUMBER> <NUMBER> suggests sarscov<NUMBER> protein less densely glycosylated glycans form much less shield compared viral glycoproteins including hiv env lasv gpc may beneficial elicitation potent neutralizing antibodies addition oligomannosetype glycans processing complextype glycans important consideration immunogen engineering across <NUMBER> nlinked glycosylation sites <NUMBER> glycans contain least one sialic acid residue <NUMBER> fucosylated figure <NUMBER> data suggest high levels fucosylation low levels sialylation considering complex hybrid type glycans make <NUMBER> total glycans sarscov<NUMBER> understanding distribution glycan modifications across viral spike illustrates differential susceptibility different processing enzymes absolute levels heavily influenced cellular expression system utilized previously demonstrated hiv<NUMBER> env glycosylation processing complextype glycans driven producer cell levels oligomannosetype glycans largely independent expression system much closely related protein structure glycan density <NUMBER> fucosylation proteinproximal glcnac residue c terminal sialylation s<NUMBER> s<NUMBER> subunits colored light grey dark grey respectively glycosylation analysis sarscov<NUMBER> offers detailed benchmark sitespecific glycan signatures characteristic natively folded trimeric spike increasing number glycoproteinbased vaccine candidates developed detailed glycan analysis offers route comparing immunogen integrity also important monitor manufacturing processes scaled clinical use glycosylation therefore also important measure antigen quality manufacture serological testing kits particularly protein fragments may offer advantages terms production yield lack effective glycan mimicry natively folded trimeric spike lower levels mannose ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint terminating glycans sarscov<NUMBER> compared many viral spikes may indicate glycan engineering considered scenario firstgeneration glycoproteinbased vaccine candidates poorly immunogenic finally advent nucleotidebased vaccines important understand delivery mechanisms impact immunogen processing presentation express prefusion ectodomain gene encoding residues <NUMBER>â<NUMBER> sarscov<NUMBER> genbank mn<NUMBER> proline substitutions residues <NUMBER> <NUMBER> gsas substitution furin cleavage site residues <NUMBER> cterminal t<NUMBER> fibritin trimerization motif hrv<NUMBER>c protease cleavage site twinstreptag <NUMBER>xhistag synthesized cloned mammalian expression vector pÎ±h expression vector used transiently transfect freestyle<NUMBER>f cells thermo fisher using polyethylenimine protein purified filtered cell supernatants using streptactin resin iba subjected additional purification sizeexclusion chromatography using superose <NUMBER> <NUMBER> column ge healthcare <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> purified sarscov<NUMBER> spike diluted concentration <NUMBER> mgml using <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> applied plasma cleaned cf<NUMBER>cu grid electron microscopy sciences protein stained using methylamine tungstate nanoprobes allowed dry room temperature <NUMBER> minutes grid imaged talos tem thermo fisher scientific equipped ceta <NUMBER>m detector micrographs collected using tia v<NUMBER> software nominal magnification <NUMBER>Ã corresponding calibrated pixel size <NUMBER> Ã¥pix ctf estimation particle picking <NUMBER>d class averaging performed using cistem <NUMBER> three <NUMBER> Î¼g aliquots sarscov<NUMBER> protein denatured <NUMBER>h <NUMBER> mm trishcl ph <NUMBER> containing <NUMBER> urea <NUMBER> mm dithiothreitol dtt next protein reduced alkylated adding <NUMBER> mm iodoacetamide iaa incubated <NUMBER>h dark ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint followed <NUMBER>h incubation <NUMBER> mm dtt eliminate residual iaa alkylated env proteins bufferexchanged <NUMBER> mm trishcl ph <NUMBER> using vivaspin columns <NUMBER> kda digested separately overnight using trypsin chymotrypsin alpha lytic protease mass spectrometry grade promega ratio <NUMBER> ww next day peptides dried extracted using c<NUMBER> ziptip merckmilipore peptides dried resuspended <NUMBER> formic acid analyzed nanolcesi ms easynlc <NUMBER> thermo fisher glycopeptide fragmentation data extracted raw file using byonic tm version <NUMBER> byologic tm software version <NUMBER> protein metrics inc glycopeptide fragmentation data evaluated manually glycopeptide peptide scored truepositive correct b fragment ions observed along oxonium ions corresponding glycan identified ms data searched using protein metrics <NUMBER> nglycan library relative amounts glycan site well unoccupied proportion determined comparing extracted chromatographic areas different glycotypes identical peptide sequence charge states single glycopeptide summed precursor mass tolerance set <NUMBER> ppm <NUMBER> ppm fragments <NUMBER> false discovery rate fdr applied relative amounts glycan site well unoccupied proportion determined comparing extracted ion chromatographic areas different glycopeptides identical peptide sequence glycans categorized according composition detected hexnac<NUMBER>hex<NUMBER>â<NUMBER> classified m<NUMBER> m<NUMBER> hexnac<NUMBER>hex<NUMBER>â<NUMBER>x classified hybrid hexnac<NUMBER>fuc<NUMBER>x classified fhybrid complextype glycans classified according number processed antenna ccby <NUMBER> international license certified peer review authorfunder made available copyright holder preprint version posted march <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint fucosylation following compositions fucose assigned fa categories hexnac<NUMBER>hex<NUMBER>x assigned a<NUMBER> hexnac<NUMBER>x a<NUMBER>a<NUMBER>b hexnac<NUMBER>x a<NUMBER>a<NUMBER>b hexnac<NUMBER>x a<NUMBER>a<NUMBER>b fragmentation method provide linkage information compositional isomers group example triantennary glycan contains hexnac <NUMBER> biantennary glycans bisect glycan containing least one sialic acid counted sialylated structural models nlinked glycan presentation sarscov<NUMBER> created using electron microscopy structures pdb id <NUMBER>vsb along complex hybrid oligomannosetype nlinked glycans pdb id <NUMBER>byh <NUMBER>b<NUMBER>i <NUMBER>wah dominant glycoform presented site modelled nlinked carbohydrate attachment sites coot <NUMBER> severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> causative pathogen covid<NUMBER> <NUMBER> induces fever severe respiratory illness pneumonia sarscov<NUMBER> utilizes extensively glycosylated spike protein protrudes viral surface bind angiotensinconverting enzyme <NUMBER> ace<NUMBER> host cell receptor mediate cell entry <NUMBER> protein trimeric class fusion protein composed two functional subunits responsible receptor binding s<NUMBER> subunit membrane fusion s<NUMBER> subunit remarkably surface virally encoded envelope spike dominated array hostderived glycans trimer displaying <NUMBER> nlinked glycosylation sites extensive glycosylation important implications vaccine design obligate parasites many viruses exploit hostcell machinery glycosylate proteins numerous viral envelope proteins including hiv<NUMBER> envelope env influenza hemagglutinin ha lassa virus glycoprotein complex gpc possess genetically encoded nlinked glycan sequons nxst motifs x amino acid except proline viral glycosylation wideranging roles viral pathobiology including mediating protein folding stability shaping viral tropism genetically encoded sequons significant selective pressure mechanism immune evasion shielding specific epitopes antibody neutralization however note currently reported low mutation rate sarscov<NUMBER> yet observed mutations nlinked glycosylation sites <NUMBER> surfaces unusually high density glycans also enable immune recognition <NUMBER> <NUMBER> <NUMBER> role glycosylation immune evasion camouflaging immunogenic protein epitopes well studied coronaviruses <NUMBER> principal antigen presented surface sarscov<NUMBER> virions protein key target vaccine design efforts apparent viral spike targeted full assortment vaccine strategies nucleicacid based approaches <NUMBER> whereby viral protein expressed vivo recombinant strategies whereby viral glycoproteins delivered appropriate adjuvants strategies aim elicit neutralizing adaptive immunity emphasis achieving antibody response sites viral entry understanding glycosylation recombinant viral spikes reveal fundamental features viral biology guide vaccine design strategies manufacturing glycans enzymatically elaborated golgi apparatus features processed socalled complextype glycosylation necessarily influenced producer cellline however presence glycans typical early stages secretory pathway otherwise mature glycoproteins often closely relate fundamental features viral spike architecture high viral glycan density extensive packing glycan protein surface impair normal glycan maturation pathway steric interference host enzymes underprocessed oligomannoseand hybridtype glycans found majority viral envelope proteins hiv<NUMBER> env influenza ha lassa virus gpc <NUMBER> viral glycoproteins traffic secretory system glycosylation processing recombinant material often closely captures glycan maturation state virion particularly important viruses hiv<NUMBER> viral glycans also targeted neutralizing antibodies coronaviruses reported form virions budding lumen endoplasmic reticulumgolgi intermediate compartments ergic <NUMBER> <NUMBER> <NUMBER> <NUMBER> however observations hybridand complextype glycans virally derived material suggests viral glycoproteins subjected golgi resident processing enzymes <NUMBER> <NUMBER> impaired glycan maturation sensitive reporter local viral protein architecture <NUMBER> detailed sitespecific analysis emerged indicator nativelike architecture increasingly used compare different immunogens monitoring manufacturing processes importantly addition structural insights presence oligomannosetype glycans viral spikebased immunogens also shown enhance trafficking glycoprotein germinal centers via interaction lectins mannosebinding lectin <NUMBER> therefore considerable importance understand glycosylation recombinant mimetics virus spike apply mass spectrometry understand sitespecific nlinked glycan composition degree sequon occupancy soluble nativelike sarscov<NUMBER> protein nativelike folding trimeric recombinant material recently revealed detailed structural analysis cryoelectron microscopy <NUMBER> <NUMBER> previously validated glycopeptide analysis methodology applied approach study range viral glycoprotein immunogens <NUMBER> enables crossviral comparisons glycosylation made report sitespecific glycosylation <NUMBER> nlinked glycan sites found sarscov<NUMBER> protomer observed viral glycoproteins elevation oligomannoseand hybridtype glycans compared hostderived glycoproteins although compared many viruses still large population complextype glycans displayed across trimer surface also report <NUMBER> glycan sites occupancy nearly fully complete means epitopes shielded immune system virus also likely shielded immunogen sitespecific glycan analysis sarscov<NUMBER> immunogens help guide vaccine design manufacturing resolve sitespecific glycosylation sarscov<NUMBER> protein visualize distribution glycoforms across protein surface expressed purified recombinant soluble material identical manner used obtain highresolution cryoelectron microscopy cryoem structure albeit without glycan processing blockade using kifunensine <NUMBER> soluble recombinant variant protein contains <NUMBER> glycans sarscov<NUMBER> protein figure <NUMBER>a stabilization trimeric prefusion structure achieved using <NUMBER>p stabilizing mutations <NUMBER> residues <NUMBER> <NUMBER> addition cterminal trimerization motif ensures quaternary structure remains intact glycan processing case hiv env mimetics known influence glycosylation certain sites <NUMBER> <NUMBER> prior analysis supernatant containing recombinant sarscov<NUMBER> purified using cterminal streptag followed sizeexclusion chromatography ensure nativelike trimeric sarscov<NUMBER> protein analyzed figure <NUMBER>b trimeric conformation purified material validated using negative stain electron microscopy figure <NUMBER>c trypsin chymotrypsin alphalytic protease employed generate three glycopeptide samples proteases cleave different sites selected order generate glycopeptides contain single nlinked glycan sequon glycopeptide pools analyzed lcms highenergy collisioninduced dissociation hcd fragmentation glycan compositions site determined <NUMBER> nlinked glycan sites sarscov<NUMBER> protein figure <NUMBER> diverse range glycan compositions observed across different glycosylation sites order convey main processing features site abundances glycan summed oligomannose hybridand complextype glycosylation addition diverse signals arising heterogeneous complextype glycosylation simplified summation glycan intensities limited range structural categories three sites sarscov<NUMBER> predominantly oligomannosetype n<NUMBER> n<NUMBER> n<NUMBER> predominant structure observed site exception n<NUMBER> man<NUMBER>glcnac<NUMBER> demonstrates sites largely accessible ï¡<NUMBER>mannosidases poor substrates glcnacti gateway enzyme formation hybridand complextype glycans golgi apparatus stage processing impeded signature related density presentation glycans viral spike example densely glycosylated spikes hiv<NUMBER> env lassa virus gpc give rise numerous sites dominated man<NUMBER>glcnac<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> interestingly several sites possess significant populations hybridtype glycans notably n<NUMBER> phenomenon observed viral glycoproteins hiv<NUMBER> env <NUMBER> structures particularly prevalent mammalian glycoproteins <NUMBER> <NUMBER> hybridtype glycans shown targeted antihiv antibodies <NUMBER> could also important immunogen trafficking since mannoseterminating moieties <NUMBER> mixture oligomannosetype glycans complextype glycans found sites n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> n<NUMBER> figure <NUMBER> <NUMBER> sites protein <NUMBER> contain significant populations oligomannosetype glycans highlighting processing sarscov<NUMBER> glycans divergent host glycoproteins remaining <NUMBER> sites dominated processed complextype glycans predominant category complextype glycans observed protein fucosylated biantennary structures similar abundant mammalian glycoproteins feature interrogated using methodology extent unoccupancy glycosylation sites sequon present glycan attached hiv immunogen research holes generated unoccupied glycan sites shown immunogenic potentially give rise distracting epitopes <NUMBER> using cryoem structure trimeric sarscov<NUMBER> protein pdb id <NUMBER>vsb <NUMBER> generated model map glycosylation status coronavirus spike mimetic onto experimentally determined <NUMBER>d structure figure <NUMBER> combined mass spectrometric cryoem analysis reveals nlinked glycans occlude distinct regions across surface sarscov<NUMBER> spike glycans modelled onto site using predominant glycans observed figure <NUMBER> colored according prevalence oligomannosetype glycans shielding receptor binding sites sarscov<NUMBER> spike proximal glycosylation sites n<NUMBER> n<NUMBER> n<NUMBER> observed especially receptor binding domain conformation shielding receptor binding sites glycans common feature viral glycoproteins observed sarscov <NUMBER> hiv<NUMBER> env <NUMBER> influenza ha <NUMBER> lasv gpc <NUMBER> given functional constraints receptor binding sites subsequent low mutation rates residues likely selective pressure utilize nlinked glycans method camouflage one conserved potentially vulnerable areas respective glycoproteins <NUMBER> <NUMBER> interesting note absence specific glycan cluster responsible presence oligomannosetype glycans rather dispersion glycans across s<NUMBER> s<NUMBER> subunits significant contrast viral glycoproteins example density glycans clusters hiv even enabled structural classification different modes interaction <NUMBER> sarscov<NUMBER> oligomannosetype structures probably protected extent protein component exemplified n<NUMBER> glycan partially sandwiched nterminal receptorbinding domains figure <NUMBER> characterized nlinked glycans extended loop structures resolved cryoem maps <NUMBER> n<NUMBER> n<NUMBER> determined complextype glycans consistent inherent flexibility regions resulting accessibility residues glycan processing enzymes <NUMBER> oligomannosetype glycans comprise <NUMBER> total glycan pool hybridtype complextype glycans comprising <NUMBER> <NUMBER> respectively sup fig <NUMBER> despite potential impact different local protein structure glycan processing overall glycosylation sarscov<NUMBER> comparable sarscov<NUMBER> protein coronavirus proteins <NUMBER> <NUMBER> <NUMBER> <NUMBER> previously reported recombinant sarscov<NUMBER> mimetic also contained <NUMBER> oligomannosetype glycans showing remarkable conservation glycan processing across coronaviruses whilst oligomannosetype glycan content well observed typical host glycoproteins significantly lower found viral glycoproteins example one densely glycosylated viral spike proteins hiv<NUMBER> env contains <NUMBER> oligomannosetype glycans <NUMBER> <NUMBER> suggests sarscov<NUMBER> protein less densely glycosylated glycans form much less shield compared viral glycoproteins including hiv env lasv gpc may beneficial elicitation potent neutralizing antibodies addition oligomannosetype glycans processing complextype glycans important consideration immunogen engineering across <NUMBER> nlinked glycosylation sites <NUMBER> glycans contain least one sialic acid residue <NUMBER> fucosylated figure <NUMBER> data suggest high levels fucosylation low levels sialylation considering complex hybrid type glycans make <NUMBER> total glycans sarscov<NUMBER> understanding distribution glycan modifications across viral spike illustrates differential susceptibility different processing enzymes absolute levels heavily influenced cellular expression system utilized previously demonstrated hiv<NUMBER> env glycosylation processing complextype glycans driven producer cell levels oligomannosetype glycans largely independent expression system much closely related protein structure glycan density <NUMBER> fucosylation proteinproximal glcnac residue c terminal sialylation s<NUMBER> s<NUMBER> subunits colored light grey dark grey respectively glycosylation analysis sarscov<NUMBER> offers detailed benchmark sitespecific glycan signatures characteristic natively folded trimeric spike increasing number glycoproteinbased vaccine candidates developed detailed glycan analysis offers route comparing immunogen integrity also important monitor manufacturing processes scaled clinical use glycosylation therefore also important measure antigen quality manufacture serological testing kits particularly protein fragments may offer advantages terms production yield lack effective glycan mimicry natively folded trimeric spike lower levels mannoseterminating glycans sarscov<NUMBER> compared many viral spikes may indicate glycan engineering considered scenario firstgeneration glycoproteinbased vaccine candidates poorly immunogenic finally advent nucleotidebased vaccines important understand delivery mechanisms impact immunogen processing presentation express prefusion ectodomain gene encoding residues <NUMBER>â<NUMBER> sarscov<NUMBER> genbank mn<NUMBER> proline substitutions residues <NUMBER> <NUMBER> gsas substitution furin cleavage site residues <NUMBER> cterminal t<NUMBER> fibritin trimerization motif hrv<NUMBER>c protease cleavage site twinstreptag <NUMBER>xhistag synthesized cloned mammalian expression vector pÎ±h expression vector used transiently transfect freestyle<NUMBER>f cells thermo fisher using polyethylenimine protein purified filtered cell supernatants using streptactin resin iba subjected additional purification sizeexclusion chromatography using superose <NUMBER> <NUMBER> column ge healthcare <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> purified sarscov<NUMBER> spike diluted concentration <NUMBER> mgml using <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> applied plasma cleaned cf<NUMBER>cu grid electron microscopy sciences protein stained using methylamine tungstate nanoprobes allowed dry room temperature <NUMBER> minutes grid imaged talos tem thermo fisher scientific equipped ceta <NUMBER>m detector micrographs collected using tia v<NUMBER> software nominal magnification <NUMBER>Ã corresponding calibrated pixel size <NUMBER> Ã¥pix ctf estimation particle picking <NUMBER>d class averaging performed using cistem <NUMBER> three <NUMBER> Î¼g aliquots sarscov<NUMBER> protein denatured <NUMBER>h <NUMBER> mm trishcl ph <NUMBER> containing <NUMBER> urea <NUMBER> mm dithiothreitol dtt next protein reduced alkylated adding <NUMBER> mm iodoacetamide iaa incubated <NUMBER>h dark followed <NUMBER>h incubation <NUMBER> mm dtt eliminate residual iaa alkylated env proteins bufferexchanged <NUMBER> mm trishcl ph <NUMBER> using vivaspin columns <NUMBER> kda digested separately overnight using trypsin chymotrypsin alpha lytic protease mass spectrometry grade promega ratio <NUMBER> ww next day peptides dried extracted using c<NUMBER> ziptip merckmilipore peptides dried resuspended <NUMBER> formic acid analyzed nanolcesi ms easynlc <NUMBER> thermo fisher glycopeptide fragmentation data extracted raw file using byonic tm version <NUMBER> byologic tm software version <NUMBER> protein metrics inc glycopeptide fragmentation data evaluated manually glycopeptide peptide scored truepositive correct b fragment ions observed along oxonium ions corresponding glycan identified ms data searched using protein metrics <NUMBER> nglycan library relative amounts glycan site well unoccupied proportion determined comparing extracted chromatographic areas different glycotypes identical peptide sequence charge states single glycopeptide summed precursor mass tolerance set <NUMBER> ppm <NUMBER> ppm fragments <NUMBER> false discovery rate fdr applied relative amounts glycan site well unoccupied proportion determined comparing extracted ion chromatographic areas different glycopeptides identical peptide sequence glycans categorized according composition detected hexnac<NUMBER>hex<NUMBER>â<NUMBER> classified m<NUMBER> m<NUMBER> hexnac<NUMBER>hex<NUMBER>â<NUMBER>x classified hybrid hexnac<NUMBER>fuc<NUMBER>x classified fhybrid complextype glycans classified according number processed antenna fucosylation following compositions fucose assigned fa categories hexnac<NUMBER>hex<NUMBER>x assigned a<NUMBER> hexnac<NUMBER>x a<NUMBER>a<NUMBER>b hexnac<NUMBER>x a<NUMBER>a<NUMBER>b hexnac<NUMBER>x a<NUMBER>a<NUMBER>b fragmentation method provide linkage information compositional isomers group example triantennary glycan contains hexnac <NUMBER> biantennary glycans bisect glycan containing least one sialic acid counted sialylated structural models nlinked glycan presentation sarscov<NUMBER> created using electron microscopy structures pdb id <NUMBER>vsb along complex hybrid oligomannosetype nlinked glycans pdb id <NUMBER>byh <NUMBER>b<NUMBER>i <NUMBER>wah dominant glycoform presented site modelled nlinked carbohydrate attachment sites coot <NUMBER> pandemic corona virus disease <NUMBER> covid<NUMBER> caused severe acute <NUMBER> respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> urgent public health emergency <NUMBER> made serious impact global health economy <NUMBER> date <NUMBER> <NUMBER> deaths <NUMBER> million confirmed positive cases reported globally making <NUMBER> contagious pandemic last decade wwwcoronavirusgov since initial reports <NUMBER> <NUMBER> pneumoniacausing novel coronavirus sarscov<NUMBER> wuhan china mortality <NUMBER> morbidity increasing exponentially around globe despite several antiviral <NUMBER> antibody treatments <NUMBER> available neutralising antibodies use targeting sars<NUMBER> cov<NUMBER> spike glycoprotein essential host cell adhesion via ace<NUMBER> cd<NUMBER> <NUMBER> receptors <NUMBER> <NUMBER> infection control still insignificant meanwhile several antiviral drugs <NUMBER> ritonavir lopinavir chloroquine remdesivir others targeting different host viral <NUMBER> proteins clinically evaluating repurposing combat sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> drastic increasing number positive cases around world wwwcdcgov <NUMBER> moderate response antivirals clinical trials poor response antibodies targeting <NUMBER> spike sarscov<NUMBER> spike glycoprotein serious concern warrants detail understanding <NUMBER> molecular structural features sarscov<NUMBER> structural proteins native <NUMBER> condition postviral infection abet understanding dynamics <NUMBER> mechanism viral action human cell overall complex structure shows three furin proteases binding mid <NUMBER> equatorial region mid region s<NUMBER> s<NUMBER> domain s<NUMBER>s<NUMBER> sarscov<NUMBER> spike <NUMBER> glycoprotein homotrimer offcentric adjacent side spike trimer fig <NUMBER> r<NUMBER> w<NUMBER> q<NUMBER> <NUMBER> <NUMBER> fig <NUMBER> s<NUMBER> interestingly residues also well<NUMBER> positioned interact viral spike protein cleavage site complex structure <NUMBER> entire substratebinding pocket furin protease appears like canyonlike crevice <NUMBER> accommodate large portion target proteinpeptide results show <NUMBER> sarscov<NUMBER> spike glycoprotein amino acid residues n<NUMBER> q<NUMBER> prime interacting <NUMBER> residues furin protease position orientation unique residues <NUMBER> involved furin recognition well exposed organise flexible loop spike <NUMBER> protein residues n<NUMBER> n<NUMBER> e<NUMBER> y<NUMBER> t<NUMBER> n<NUMBER> s<NUMBER> r<NUMBER> r<NUMBER> r<NUMBER> s<NUMBER> <NUMBER> q<NUMBER> makes strong interaction furin protease fig <NUMBER>a interaction <NUMBER> viral spike glycoprotein furin protease mediated via several van der waals <NUMBER> hydrogen bonding furthermore entire cleavage loop viral spike protein fits <NUMBER> canyonlike substratebinding pocket furin protease quite interesting notice <NUMBER> none previously known coronaviruses novel furin protease cleavage site <NUMBER> spike glycoprotein accentuates novelty uniqueness sarscov<NUMBER> <NUMBER> addition previous reports glycosylation spike glycoprotein show furin <NUMBER> cleavage site sarscov<NUMBER> spike glycoprotein targeted glycosylation <NUMBER> hence cleavage loop completely solventexposed <NUMBER> corroborates <NUMBER> potential attack furin protease s<NUMBER>s<NUMBER> cleavage site sarscov<NUMBER> spike <NUMBER> glycoprotein based furin binding mode structural interaction propose <NUMBER> following supposition binding cleaving priming spike glycoprotein s<NUMBER>s<NUMBER> <NUMBER> region furin protease might cut spike glycoprotein nterminal s<NUMBER> domain <NUMBER> spike glycoproteins also could make ace<NUMBER> cd<NUMBER> inhibitors least effective <NUMBER> upon cleavage nterminal s<NUMBER> domains required cell penetration also <NUMBER> raises caution making neutralizing antibodies targeting sarscov<NUMBER> spike <NUMBER> glycoprotein cleavage activities need considered hence speculate <NUMBER> antibodies s<NUMBER> domain drugs targeting s<NUMBER> trimerization could promising q<NUMBER> two major ebola virus outbreaks africa <NUMBER> zika virus brazil <NUMBER> current severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> declared world health organization pandemic <NUMBER> <NUMBER> occurred past decade case strong sense dÃ©jÃ  vu scientists involved drug discovery lack available antivirals treat infected patients leads clamoring test anything available pharmaceutical companies charge offer drugs also seem see similar patterns response across outbreaks rush first sense priority might lead best even outcome patients always immediate proposal create vaccine pronouncements available short time end year actual outbreak question never happens within optimistic artificial deadlines experienced current outbreak ebola vaccine ready second outbreak approved <NUMBER> governments calm populations time needing seen something vanquish virus case sarscov<NUMBER> results pneumonia <NUMBER> shares aspects pathology pathogenesis severe acute respiratory syndrome sars middle east respiratory syndrome mers <NUMBER> sarscov<NUMBER> sarscov merscov belong family coronaviridae genus betacoronavirus several drug companies immediately made antivirals available example abbvie made hiv approved drug lopinavirritonavir combination available chinese government <NUMBER> drug previously suggested promising based combination study results marmoset study <NUMBER> publications already appeared describing use drug patient korea significantly decreasing viral load <NUMBER> simultaneously gilead made available remdesivir previously failed clinical trials ebola <NUMBER> recently shown activity mers rhesus macaques <NUMBER> remdesivir chloroquine several drugs tested vitro sarscov<NUMBER> table <NUMBER> shown active <NUMBER> researchers also suggested early january <NUMBER> treatment options might likely included lopinavirritonavir remdesivir favilavir arbidol well broad array nucleoside analogs neuraminidase inhibitors peptides rna synthesis inhibitors antiinflammatory drugs traditional chinese medicines <NUMBER> <NUMBER> <NUMBER> need treatment options important learn transmission <NUMBER> see increases number travelrelated infections <NUMBER> already past weeks seen rapid spread italy many countries including brazil beyond virus outbreaks greatly straining healthcare systems affected countries test every aspect infrastructure supply chains preparedness <NUMBER> raises question learn past drug discovery efforts attempt develop additional drugs sarscov<NUMBER> efficiently acceleration global sarscov<NUMBER> data generation effectively couple months remarkable however scientific information gaps impede progress toward smallmolecule treatments still perceived many persist first outlined ebola back <NUMBER> <NUMBER> thus make thenandnow comparisons see supplementary material figs s<NUMBER>s<NUMBER> table s<NUMBER> online well share experiences research virus outbreaks efforts ebola drug discovery initially started <NUMBER> computational pharmacophore analysis small number vitro ebola active compounds <NUMBER> followed identifying summarizing fdaapproved drugs could used virus <NUMBER> <NUMBER> highlighting various strategies next virus outbreak <NUMBER> steps preceded pivotal point us developing machine learning models ebola virus derived vitro data <NUMBER> <NUMBER> early drug <NUMBER> identified screens antimalarial amodiaquine subsequently shown associated decreased mortality <NUMBER> drug artesunate amodiaquine used malaria treatment ebola patients whereas others took different malaria medicine artemetherlumefantrine <NUMBER> ebola machine learning models used select three molecules vitro testing <NUMBER> identified pyronaridine tilorone quinacrine good vitro activity nm ebola virus <NUMBER> preliminary data enabled us obtain funding nih take one compounds vivo testing also leveraged nih support collaborator test two compounds well molecules tested mouse model ebola infection demonstrated significant efficacy <NUMBER> <NUMBER> <NUMBER> pyronaridine currently pursued larger animal models ebola virus infection working computational models vitro testing happened space months whereas took several years obtain funding first mouse studies means streamlined approach drug discovery cost effective amount data ultimately generated led revitalized interest molecules <NUMBER> pulled together team researchers brazil usa provide suggestions open drug discovery effort zika virus included various computational strategies repurpose molecules docking zika proteins <NUMBER> also described resources molecules could prioritized testing followed homology modeling every zika virus protein <NUMBER> weeks first crystal structures zika proteins released work performed open attracted attention ibm world community grid team requested submit proposal zika project using distributed computing facilities became openzika project led team brazil usa involved docking millions molecules zinc database zika virus related flavivirus protein crystal structures <NUMBER> since also performed modeling zika proteins <NUMBER> analysis first <NUMBER> years following outbreak <NUMBER> recent efforts led discovery inhibitor ns<NUMBER> helicase <NUMBER> learn openzika project streamline future open science projects would follows would pick fewer targets dock molecules openzika project created billions docking results tens targets take many years process would also suggest best work highresolution crystal structures versus homology models soon possible would also start library commercially available drugs antivirals would massively limit number molecules docked thousand found docking zinc library available time led compounds readily available focused libraries interesting options perform targetdirected virtual screening examples chemdiv <NUMBER> asinex <NUMBER> databases specific subsets protease inhibitors example facilitating accelerating experimental screening openzika learnt multiple biology labs committed testing vitro also important access experimental results quickly validate computational approach working ibm world community grid include funding found difficult obtain nih funding support project beginning computational also attempted small business grants academic collaborators without success even though leveraging massive computational resources world community grid would recommend open efforts like need funding vitro validation millions dollars invested nih fund zika research projects since <NUMBER> outbreak yet small molecule note drug discovery pipeline <NUMBER> still therefore unmet medical need treatments zika virus computational efforts could aid costeffective whole genome sequences sarscov<NUMBER> isolated patients several countries brazil canada china germany korea usa made rapidly available global initiative sharing influenza data gsaid platform <NUMBER> <NUMBER> genomes sampled december <NUMBER> february <NUMBER> samples found closely related mutations relative common ancestor preliminary genetic analysis indicates brazilian genome differs three mutations wuhan reference strain <NUMBER> two mutations shared closest sequencethe germany strain <NUMBER> space weeks acknowledgement latest coronavirus outbreak several laboratories started deposit homology models main viral protease <NUMBER> <NUMBER> sarscov<NUMBER> proteins using server itasser <NUMBER> others performed docking models <NUMBER> developed models understand virus enters cells modeling spike protein human angiotensinconverting enzyme <NUMBER> ace<NUMBER> protein interaction <NUMBER> time writing structures available sarscov<NUMBER> main protease complex inhibitor n<NUMBER> pdb id <NUMBER>lu<NUMBER> <NUMBER> s<NUMBER> s<NUMBER> subunits spike glycoprotein receptorbinding domain <NUMBER>vsb post fusion core subunit <NUMBER>lxt hr<NUMBER> domain <NUMBER>lvn <NUMBER> <NUMBER> useful overview provided searching entire virus sequence protein data bank pdb see supplementary material fig s<NUMBER> online comparison zika took several months beginning outbreak single protein available pdb <NUMBER> spike glycoprotein responsible fusion viral membrane hostcell membrane virus maturation cleaved subunits s<NUMBER> attaches virion cell membrane interacting host receptor s<NUMBER> mediates fusion virion cellular membranes recent study reports sarscov<NUMBER> spike protein binds ace<NUMBER> higher affinity sarscov <NUMBER> one cryoem structure sarscov<NUMBER> spike protein low resolution <NUMBER> Ã¥ without human ace<NUMBER> protein <NUMBER> time writing paper preferred build model homology modeling see supplementary material methods online using sarscov<NUMBER> spike protein model available sarscov spike protein crystal structure pdb <NUMBER>ajf aligned structures compare residues spikeace<NUMBER> interface residues viruses seen fig <NUMBER> residues sarscov asn<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> leu<NUMBER> tyr<NUMBER> asn<NUMBER> sarscov<NUMBER> asn<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> gln<NUMBER> phe<NUMBER> leu<NUMBER> gln<NUMBER> moreover sarscov<NUMBER> residues gln<NUMBER> phe<NUMBER> leu<NUMBER> gln<NUMBER> conserved physicalchemical features except residues sarscov<NUMBER> gln<NUMBER> polar sars tyr<NUMBER> hydrophobic fig <NUMBER> main protease pro coronaviruses cysteine protease participates viral replication cleaving polyprotein pro organized three domains active homodimer form <NUMBER> aligned crystal structures pro sarscov merscov sarscov<NUMBER> compare structures residues catalytic site catalytic site sarscov sarscov<NUMBER> his<NUMBER>cys<NUMBER> <NUMBER> whereas merscov his<NUMBER>cys<NUMBER> <NUMBER> fig <NUMBER> catalytic site localized interface domain residues <NUMBER> ii <NUMBER> third domain residues <NUMBER> cterminal consists loop region required dimerization <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently reported structures pro sarscov sarscov<NUMBER> high identity <NUMBER> <NUMBER> function structural equivalence pro sarscov merscov sarscov<NUMBER> demonstrate coronavirus proteases promising targets development broadspectrum antivirals viruses drug repurposing offers potentially faster approach identify drugs already approved uses might work disease interest <NUMBER> <NUMBER> <NUMBER> type strategy attempted merscov sarscov <NUMBER> <NUMBER> repurposing hostbased therapies also proposed coronaviruses <NUMBER> several studies screened hundred molecules tested activity merscov sarscov table <NUMBER> <NUMBER> <NUMBER> first screen <NUMBER> fdaapproved drugs identified four fdaapproved drugs including chloroquine chlorpromazine loperamide lopinavir <NUMBER> time second study screened <NUMBER> compounds identified <NUMBER> fdaand nonfdaapproved drugs including chloroquine among many hits <NUMBER> abl<NUMBER> kinase inhibitors imatinib impacts early stages infection internalization endosomal trafficking latter molecule appears work inhibiting fusion viral membrane <NUMBER> chloroquine widely used malaria loperamide used diarrhea represent drugs readily available many locations around world physicians also familiar sideeffect profile ligand datasets screens used apply machine learning methods produce predictive models used screen compound libraries suggest superposition sarscov sarscov<NUMBER> spike proteins highlighting spikeace<NUMBER> interface binding pocket zoom residues sarscov<NUMBER> spike s<NUMBER> asn<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> gln<NUMBER> phe<NUMBER> leu<NUMBER> gln<NUMBER> correspondent sarscov spike s<NUMBER> asn<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> leu<NUMBER> tyr<NUMBER> asn<NUMBER> superposition sarscov merscov sarscov<NUMBER> main proteases respective catalytic biding site sarscov pdb id <NUMBER>q<NUMBER>w sarscov<NUMBER> pdb id <NUMBER>lu<NUMBER> share residues catalytic site his<NUMBER>cys<NUMBER> merscov pdb id <NUMBER>wkl his<NUMBER> cys<NUMBER> situated domains ii fig <NUMBER> experimental details described supplementary material online bayesian models also available httpmodelscollabchemcom<NUMBER> advantage approach method fast require crystal structures enables smallmolecule structures scored many models simultaneously wellestablished principle sarscov<NUMBER> relevant enzyme assay proteinprotein interaction antagonism viral infectivity determination run collection approved drugs however neither trivial get definitive list structures silico prepared docking acquire physical collection ready screening even though various repurposing subsets available vendors notwithstanding approximation definitive approved set alternative screening every approved drug take one class compounds example taken opportunity dock fdaapproved hiv<NUMBER> protease inhibitors amprenavir atazanavir darunavir fosamprenavir indinavir lopinavir nelfinavir ritonavir saquinavir tipranavir hepatitis c ns<NUMBER>a protease inhibitors asunaprevir boceprevir grazoprevir paritaprevir simeprevir telaprevir pro structure sarscov<NUMBER> docking performed two different commercial docking software products biovia discovery studio schrÃ¶dinger glide <NUMBER> <NUMBER> <NUMBER> <NUMBER> best docking results compared see supplementary material table s<NUMBER> online results docking approaches indicated azatanavir lopinavir could interest vitro vivo testing fig <NUMBER> atazanavir interact pro hbonding cys<NUMBER> amide group aromatic ring atazanavir ligandfit score <NUMBER> also formed hydrophobic interactions residues cys<NUMBER> met<NUMBER> leu<NUMBER> tyr<NUMBER> cys<NUMBER> relation lopinavir ligandfit score <NUMBER> hbonds established residues cys<NUMBER> glu<NUMBER> nitrogen atoms carbamate groups similar hydrophobic interactions observed lopinavir fig <NUMBER> china south korea lopinavir <NUMBER> mg ritonavir <NUMBER> mg already used treatment covid<NUMBER> day lopinavirritonavir administration viral load started decrease detectable little coronavirus titers observed since <NUMBER> lopinavir coformulated ritonavir commercially available known kaletra<NUMBER> around worldit formularies hiv contrast atazanavir less commonly used kaletra<NUMBER> widely produced distributed quickly existing channels important ensure hiv patients lose access medications need also medication clinicians familiar terms side effects unlike less commonly used medications broader analysis fdaapproved drugs docked protease structure could point drugs worth testing also performed docking calculations sarscov<NUMBER> spike glycoprotein complexed host ace<NUMBER> protein fdaapproved drugs <NUMBER> molecules using schrÃ¶dinger glide software <NUMBER> <NUMBER> <NUMBER> <NUMBER> one cryoem structure sarscov<NUMBER> spike protein low resolution <NUMBER> Ã¥ without human ace<NUMBER> protein <NUMBER> time analysis preferred build model homology modeling lowerresolution structures <NUMBER> Ã¥ higher show basic contours protein chain atomic structure must inferred built sarscov<NUMBER> spike subunit s<NUMBER> model using swissmodel server <NUMBER> template used sarscov spike s<NUMBER> protein pdb id <NUMBER>ghv <NUMBER> resolution <NUMBER> Ã¥ <NUMBER> sequence identity sarscov<NUMBER> spike protein protein refinement added human ace<NUMBER> protein model based sarscov spikeace<NUMBER> structure pdb id <NUMBER>ajf <NUMBER> built full sarscov<NUMBER> spike s<NUMBER>ace<NUMBER> model see fig s<NUMBER> supplementary material online quality statistics intermolecular <NUMBER>d <NUMBER>d interactions atazanavir lopinavir b main protease structure sarscov<NUMBER> pdb id <NUMBER>lu<NUMBER> obtained docking <NUMBER>d representation left hbonds presented magenta dashed lines color code carbon oxygen nitrogen hydrogen atoms grey red blue white respectively <NUMBER>d interaction diagrams right hbonds presented magenta arrows pymol software <NUMBER> used visual inspection <NUMBER>d docking poses render <NUMBER>d molecular images <NUMBER>d <NUMBER>d intermolecular interactions rizatriptan dasabuvir b pravastatin c empagliflozin spikeace<NUMBER> interface light blue green respectively <NUMBER>d representation left hbonds presented magenta dashed lines color code carbon oxygen nitrogen hydrogen atoms grey red blue white respectively sarscov<NUMBER> spike s<NUMBER> subunit colored blue human ace<NUMBER> light blue <NUMBER>d ligandinteraction diagram right hbonds pp stacking pcation interactions presented magenta green red lines respectively glide software <NUMBER> <NUMBER> used dock ligands grid centered asn<NUMBER> tyr<NUMBER> tyr<NUMBER> tyr<NUMBER> gln<NUMBER> phe<NUMBER> leu<NUMBER> gln<NUMBER> residues wwwdrugdiscoverytodaycom <NUMBER> modeled sarscov<NUMBER> spikeace<NUMBER> good <NUMBER> residues lie favorable regions ramachandran plot molprobity score <NUMBER> sarscov<NUMBER> spikeace<NUMBER> model available see supplemental material pdb file online subsequently performed dockingbased virtual screening grid centered spikeace<NUMBER> interface seen table <NUMBER> docking scores indicated rizatriptan antimigraine agent glide score Ã <NUMBER> kcal mol Ã <NUMBER> dasabuvir antiviral hepatitis c glide score Ã <NUMBER> kcal mol Ã <NUMBER> pravastatin lipidlowering agent glide score Ã <NUMBER> kcal mol Ã <NUMBER> empagliflozin hypoglycemic agent glide score Ã <NUMBER> kcal mol Ã <NUMBER> could interest vitro testing details intermolecular interactions drugs interface spikeace<NUMBER> shown fig <NUMBER> summary drugs form pcation interactions lys<NUMBER>a pp interactions phe<NUMBER>b hbonds his<NUMBER>a asp<NUMBER>a gly<NUMBER>b ser<NUMBER>b good agreement results previous study suggests early high dose statin pravastatin could crucial surviving merscov infection <NUMBER> suggested molecules could validated future vitro experiments modern drug discovery efforts try eliminate inefficiency increasing knowledge extensive utilization generated data guide new experiments therefore also taken drug repurposing approach based polypharmacology using method called molecular biological signature <NUMBER> profiling approach guided artificial intelligence capable presenting complex relationships chemical substance molecular targets cells andor organs could create complete understanding multibiological profile caused drug analyzed response disease example applied drugs ritonavir <NUMBER> favipiravir ribavirin chloroquine scaffolds find new potential molecular biological signature profiles search nonobvious mechanismofactionbased associations drugs molecular targets diseases fig <NUMBER> supplementary material fig s<NUMBER> table s<NUMBER> online comparing molecular biological signature ritonavir drugs found drugs cobicistat carfilzomib ombitasvir presented highest matching scores <NUMBER> suggesting drugs could interest sarscov<NUMBER> molecular biological signature profiles generated ritonavir compared drugs using artificial intelligence create thousands decisionmakers mimic biological response interaction small molecule multiple enzyme targets offtargets vitro vivo endpoints drugs cobicistat carfilzomib ombitasvir presented higher matching scores <NUMBER> ritonavir although already several drugs assessed clinically sarscov<NUMBER> still need identify additional treatments alternatives offset drug shortages possibly discover molecules increased efficacy safety costeffectiveness previously proposed applied computational drug discovery approaches machine learning docking aid discovery new candidate molecules ebola zika respectively learnt efforts applied sarscov<NUMBER> demonstrated however research case moved much faster pace initially delivering first crystal structure weeks first public notification virus companies mobilized bring drugs patients clinicians used prior vitro research proposed compounds active merscov sarscov suggest treatments sarscov<NUMBER> currently clinically use broadspectrum antivirals usa would invaluable situations like sarscov<NUMBER> viruses identifying medications sideeffect profiles known clinicians already produced scale available local pharmacies around world allow patients treated especially travel restrictions quarantines could reduce production distribution certain drugs remain important need medications baseline hiv patients take ritonavirlopinavir able continue access medications need else risk poor clinical outcomes antiviral resistance patients although viruses flu might killed patients usa season far crippling financial impact sarscov<NUMBER> remains seen globally past ebola zikv merscov sarscov outbreaks anything go sarscov<NUMBER> pandemic far significant multiple effective treatments available sarscov<NUMBER> rapidly delivered patients could save lives also supplement treatments combination computational screening machine learning docking select additional drugs test proposed herein repeated future virus outbreaks sense dÃ©jÃ  vu probably repeated next virus outbreaks develop broaderspectrum antivirals time hope better prepared hope however save lives effective antiviral treatments need ready future novel coronavirus known severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> simply covid<NUMBER> seventh member coronavirus family <NUMBER> two viruses family infect humans severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov positivesense singlestrand enveloped rna viruses coronavirus particles contain four main structural proteins spike membrane envelope nucleocapsid <NUMBER> spike protein protrudes envelope virion consists two subunits receptorbinding domain rbd interacts receptor proteins host cells second subunit facilitates fusion viral membrane host cell membrane recent studies showed rbd spike proteins sarscov sarscov<NUMBER> interact angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> belongs membranebound carboxydipeptidase family attached outer surfaces cells widely distributed human body particular higher expression ace<NUMBER> observed organs small intestine colon kidney heart ace<NUMBER> expression comparatively lower liver lungs <NUMBER> <NUMBER> role oxidative stress binding viral proteins host cell surface receptors relatively underexplored area biomedical research <NUMBER>â<NUMBER> previous studies indicated entry viral glycoprotein impacted thiolâdisulfide balance cell surface <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> perturbations thiolâdisulfide equilibrium also found deter entry viruses target cells <NUMBER> first step viral entry involves binding viral envelop protein onto cellular receptor followed endocytosis conformational changes viral protein help induction viral protein endosomal membrane finally releasing viral content cell conformational changes mediated ph changes well conversion disulfide thiol group viral spike protein <NUMBER> several cell surface oxidoreductases <NUMBER> regulate thiolâdisulfide exchange responsible conformational changes viral proteins needed virus entry host cells backdrop significant mortality rate sarscov<NUMBER> hereinafter referred cov<NUMBER> infection important know thiolâdisulfide balance plays role binding spike glycoprotein onto host cell receptor protein ace<NUMBER> recent study spike glycoprotein sarscov hereinafter referred cov exhibited complete redox insensitivity <NUMBER> despite reduction disulfide bridges cov thiols binding ace<NUMBER> remained unchanged <NUMBER> however study probe redox sensitivity ace<NUMBER> receptor thus present study computationally investigated redox state partners ace<NUMBER> covcov<NUMBER> binding affinities structure cov <NUMBER> cov<NUMBER> <NUMBER> complexed ace<NUMBER> known noncovalent interactions proteinâprotein interface <NUMBER> reported recently using reported structures molecular dynamics simulations electrostatic field calculations performed explore impact thiolâdisulfide balance covcov<NUMBER> ace<NUMBER> binding affinities structural dynamical changes due alteration redox states cysteines interacting proteins analyzed effects binding free energies studied molecular basis binding spike proteins ace<NUMBER> known xray crystallographic sarscov <NUMBER> cryoelectron microscopic sarscov<NUMBER> <NUMBER> studies sequence alignment cov cov<NUMBER> spike proteins showed high sequence identity <NUMBER> indicating binding ace<NUMBER> receptors similar figure <NUMBER> bound structures rbd cov cov<NUMBER> found complexed ace<NUMBER> figure <NUMBER> ace<NUMBER> cov<NUMBER> possess four disulfide bridges whereas cov subunit two disulfide linkages table <NUMBER> figure <NUMBER>a b two large helices ace<NUMBER> form curved surface figure <NUMBER> illustrated dashed curved line interacts concave region cov cov<NUMBER> subunit <NUMBER> structural changes along trajectory cases simulation started equilibrated structure obtained minimizing neutralized solvated protein complex built experimentally determined structures evolution protein structure along molecular dynamics md trajectory monitored calculating rootmeansquare deviation rmsd structure starting structure frame reference following standard procedure <NUMBER> briefly md simulation protein coordinates recorded every <NUMBER> ps interval rmsd frame calculated average rootmeansquare displacement backbone c Î± atoms respect initial structure rmsd values averaged conformations stored <NUMBER> ns time plotted simulated time figure <NUMBER> compared starting structure moderate backbone fluctuation noted protein complexes <NUMBER> ns simulations maximum rmsd range <NUMBER>â<NUMBER> Ã¥ table <NUMBER> evolution dynamics smooth stability demonstrated standard deviation computed figure <NUMBER> sequence alignment generated clustal omega <NUMBER> receptorbinding domain sarscov sarscov<NUMBER> proteins represents identical residues represent strongly weakly similar residues respectively gap represents dissimilar residues cysteine residues highlighted yellow rmsds less <NUMBER> Ã¥ taken together results simulations showed unexpected structural deformation sarscovcov<NUMBER>Â·Â·Â·ace<NUMBER> complex reduced thiol groups oxidized disulfide bonds states table <NUMBER> <NUMBER> thermal fluctuations due cleavage disulfide bridges md simulation results indicated flexibility different structural elements interacting proteins altered upon cleavage disulfide bridges oxidized state producing sulfydryl thiol groups reduced state complex impact reduction disulfide bridges probed calculating residuelevel rootmeansquare fluctuations rmsf c Î± atoms respect average structure md simulation trajectory changes backbone flexibility due complete reduction disulfides thiols interacting proteins shown figure <NUMBER>a b backbone colorcoded indicate magnitude thermal fluctuations larger smaller backbone fluctuations shown red blue respectively whereas medium fluctuation regions shown green backbone fluctuation analysis demonstrated cleavage disulfide bridges indeed affected flexibility local regions became dynamic figure <NUMBER>b significant alteration backbone flexibility noticed interface cov ace<NUMBER> subunits proteins fully reduced states ie disulfides changed sulfydryl groups evident figure <NUMBER>b helix residues <NUMBER>â<NUMBER> ace<NUMBER> became mobile due rupture nearby c<NUMBER>c<NUMBER> disulfide second region belongs flexible loop consisting residues <NUMBER>â <NUMBER> cov subunit residues <NUMBER>â<NUMBER> cov<NUMBER> subunit interacts nterminal segment ace<NUMBER> cleavage disulfides c<NUMBER>c<NUMBER> cov c<NUMBER>c<NUMBER> cov<NUMBER> resulted higher thermal fluctuation <NUMBER> binding study computed gibbs binding free energy Î´ bind gÂ° protein complexes table <NUMBER> demonstrated binding cov cov<NUMBER> ace<NUMBER> occurs attractive electrostatic interactions individual subunits prevail desolvation due complexation complex formation results desolvation proteins surfaces proteinâprotein interface thereby producing positive Î´Î´ solv g corr protein systems table <NUMBER> formation stable proteinâprotein cysteine residues highlighted yellow disulfide bonds shown using black solid lines start end residues crystal structures numbered highlighted red gray highlighted residues missing crystal structure figure <NUMBER> rmsds averaged <NUMBER> ns md simulation protein complexes ace<NUMBER> sarscov sarscov<NUMBER> disulfidecontaining proteins referred oxidized shorthand notation ox thiol variants denoted red notation httppubsacsorgjournalacsodf article complex energy counterbalanced negative electrostatic interactions Î´ coul g interacting proteins disulfides rbd cov cov<NUMBER> reduced thiols impact reduction binding two proteins ace<NUMBER> different computed Î´ bind gÂ°for cov ox Â·Â·Â·ace<NUMBER> ox cov red Â·Â·Â·ace<NUMBER> ox â<NUMBER> â<NUMBER> kcalmol respectively table <NUMBER> indicating slightly tighter binding reduced cov rbd ace<NUMBER> experimentally known k value cov ox Â·Â·Â·ace<NUMBER> ox system <NUMBER> nm <NUMBER> corresponds Î´ bind gÂ°value â<NUMBER> kcalmol therefore computationally determined Î´ bind gÂ°f cov ox Â·Â·Â·ace<NUMBER> ox binding comparable experimental value although experimentally determined k available cov red Â·Â·Â·ace<NUMBER> ox system binding assay cov red rbd found redox sensitivity binding ace<NUMBER> <NUMBER> small favorability cov red Â·Â·Â·ace<NUMBER> ox binding observed computation indicates reduction cov much impact binding affinity ace<NUMBER> could explain experimentally observed redox insensitivity <NUMBER> case cov<NUMBER> binding ace<NUMBER> became less favorable disulfides rbd reduced thiols computed gibbs binding free energies increased â¼<NUMBER> kcalmol reduced cov<NUMBER> Î´ bind g cov<NUMBER> ox Â·Â·Â·ace<NUMBER> ox cov<NUMBER> red Â·Â·Â·ace<NUMBER> ox â<NUMBER> â<NUMBER> kcalmol respectively contrast reduction disulfides ace<NUMBER> impaired binding significantly cov cov<NUMBER> proteins gibbs binding free energies viral spike proteins cov cov<NUMBER> ace<NUMBER> red namely cov ox Â·Â·Â·ace<NUMBER> red cov<NUMBER> ox Â·Â·Â· ace<NUMBER> red â<NUMBER> â<NUMBER> kcalmol respectively Î´ bind gÂ°values â¼<NUMBER> <NUMBER> kcalmol positive observed oxidized forms ace<NUMBER> ie cov ox Â·Â·Â· ace<NUMBER> ox cov<NUMBER> ox Â·Â·Â·ace<NUMBER> ox table <NUMBER> however disulfides covcov<NUMBER> well ace<NUMBER> reduced thiols binding became thermodynamically unfavorable figure <NUMBER> fits concaveshaped loopÎ²sheetloop motif residues <NUMBER>â <NUMBER> cov residues <NUMBER>â<NUMBER> cov<NUMBER> rbd viral spike proteins loss disulfide bridges ace<NUMBER> strong impact junction two conjoined helices figure <NUMBER> cov red Â·Â·Â·ace<NUMBER> red region close disulfide bridge c<NUMBER>c<NUMBER> cleavage significant impact shape complementarity proteinâprotein interface similarly loss c<NUMBER>c<NUMBER> disulfide cov c<NUMBER>c<NUMBER> cov<NUMBER> resulted significant conformational change loop region displaced away proteinâprotein interface â¼<NUMBER> Ã¥ indicating reduced binding interaction confirmed binding free energy calculations conformational change well alteration backbone flexibility figure <NUMBER> must resulted impaired binding covcov<NUMBER> ace<NUMBER> study found reduction disulfides sulfydryl groups completely impairs binding sarscov cov<NUMBER> spike protein ace<NUMBER> evident positive gibbs energy binding Î´ bind gÂ° obtained cov red Â·Â·Â· ace<NUMBER> red cov<NUMBER> red Â·Â·Â·ace<NUMBER> red complexes disulfides ace<NUMBER> reduced sulfydryl groups binding becomes weaker Î´ bind gÂ°becomes less negative <NUMBER>â<NUMBER> kcalmol respect fully oxidized systems hand reduction disulfides rbd cov<NUMBER> comparatively less effect Î´ bind gÂ° reduction disulfides cov rbd impact binding ace<NUMBER> finding consistent observed redox insensitivity binding cov ace<NUMBER> <NUMBER> redox environment cell surface receptors regulated thiolâdisulfide equilibrium extracellular region <NUMBER> <NUMBER> maintained glutathione transporters <NUMBER> number oxidoreductases <NUMBER> including protein disulfide isomerase <NUMBER> several redox switches <NUMBER> oxidative stress extracellular environment becomes oxidationprone resulting disulfide formation protein surfaces <NUMBER> therefore severe oxidative stress cell surface receptor ace<NUMBER> rbd intruding viral spike protein likely present oxidized form predominantly disulfide linkages computational study shows oxidative stress lack reducing environment would result significantly favorable binding viral protein cell surface ace<NUMBER> terms energetics computational study demonstrates oxidized form proteins disulfide bridges would cause <NUMBER> kcalmol decrease gibbs binding free energy furthermore ace<NUMBER> viral spike proteins latch known key player remedial oxidative stress <NUMBER> binding viral protein prevent key catalytic function ace<NUMBER> converting angiotensin <NUMBER> strong activator oxidative stress angiotensin <NUMBER>â<NUMBER> thereby creating vicious circle enhanced viral attack summary present study demonstrates absence reduced oxidative stress would significant beneficial effect early stage viral infection preventing viral protein binding host cells <NUMBER> computational setup setting protein systems structural manipulations carried using visual molecular dynamics vmd <NUMBER> disulfide groups modified thiols setting structures using standard vmd scripts molecular optimization dynamics md simulations carried using nanoscale molecular dynamics namd package using charmm<NUMBER> force field <NUMBER>â<NUMBER> md simulations electrostatic energy calculations carried using particle mesh ewald method <NUMBER> backbone rootmeansquaredeviation rmsd calculations performed using vmd proteinâprotein interactions studied using adaptivebasis poissonâ boltzmann solver apbs <NUMBER> electrostatic field calculations performed using pdb <NUMBER>pqr program suit <NUMBER> <NUMBER> molecular dynamics simulations simulations performed using structure ace<NUMBER> bound sarscov pdb entry <NUMBER>d<NUMBER>g <NUMBER> sarscov<NUMBER> pdb entry <NUMBER>m<NUMBER>j <NUMBER> simulations set protein complex systems carried following protocols used previous studies lab <NUMBER> <NUMBER> briefly hydrogens added using hbuild module charmm ionic amino acid residues maintained protonation state corresponding ph <NUMBER> protonation state histidine residues determined computing pk using propka option pdb <NUMBER>pqr protein structures explicitly solvated water tip<NUMBER>p model neutralized adding <NUMBER> sodium atoms prepared solvated protein complexes dimensions <NUMBER> Ã¥ Ã <NUMBER> Ã¥ Ã <NUMBER> Ã¥ sarscov <NUMBER> Ã¥ Ã <NUMBER> Ã¥ Ã <NUMBER> Ã¥ sarscov<NUMBER> systems <NUMBER> systems subjected equilibration <NUMBER> ps following equilibration <NUMBER> ns md simulations performed system velocities positions atoms figure <NUMBER> comparison conformational change proteinâ protein interface cov ox Â·Â·Â·ace<NUMBER> ox left cov red Â·Â·Â·ace<NUMBER> red right cov ace<NUMBER> subunits complex shown blue red colors respectively center structural motif containing two helices ace<NUMBER> Î² sheet cov cov<NUMBER> monitored top bottom <NUMBER> ns md simulation left right panels show difference conformational changes oxidized form cov ox Â·Â·Â·ace<NUMBER> ox reduced form cov red Â·Â·Â·ace<NUMBER> red respectively httppubsacsorgjournalacsodf article dynamics calculated using velocity verlet integration algorithm <NUMBER> using time step <NUMBER> fs simulations run namd implementation langevin dynamics <NUMBER> constant temperature <NUMBER> k using periodic boundary conditions model nonbonding interactions switching function turned switchdist <NUMBER> Ã¥ cutoff <NUMBER> Ã¥ pairlistdist <NUMBER> Ã¥ <NUMBER> binding free energy calculations gibbs free energies binding ace<NUMBER> sarscov cov<NUMBER> proteins calculated using apbs standardized method treecodeaccelerated boundary integral poissonâ boltzmann tabipb equation solver <NUMBER> method protein surface triangulated electrostatic surface potentials computed discretization surface potentials utilized compute net energy due solvation well electrostatic interactions two protein subunits outlined thermodynamic scheme scheme <NUMBER> following scheme <NUMBER> free energy binding two protein fragments water expressed sum two components eq <NUMBER> Î´ coul g represents coulombic electrostatic interactions proteins occurring proteinâ protein interface scheme <NUMBER> Î´Î´ solv g difference solvation energies complex corresponding free proteins however solvation calculation used part entire spike protein well ace<NUMBER> therefore Î´ bind g tabipb calibrated correcting Î´Î´ solv g using experimentally known binding free energy ace<NUMBER>Â·Â·Â·cov<NUMBER> k <NUMBER> nm experimental dissociation constant <NUMBER> corrected free energy solvation shown eq <NUMBER> combination last two terms eq <NUMBER> equal Î´Î´ solv g corr therefore eq <NUMBER> simplified dialysed pbs sarscovenriched fractions checked sdspage western blotting rendered noninfectious irradiation gamma cell dry ice <NUMBER> mrad exposure <NUMBER> minutes dose chosen sufficient viral inactivation <NUMBER> retaining antibody <NUMBER> enzyme functional activities <NUMBER> previous studies indicated viral rna highly sensitive radiation viruses <NUMBER> mrad <NUMBER> even cooled minimize heat damage proteins whereas antigenicity viral proteins antibody binding titres maintained doses <NUMBER> mrad <NUMBER> <NUMBER> mrad <NUMBER> irradiated specimens tested infectivity inoculation onto vero e<NUMBER> cells examined cytopathogenic effects <NUMBER> days followed blind passage cells testing growth sarscov pcr <NUMBER> cryoelectron microscopy virus samples <NUMBER>Âµl applied glowdischarged holey carbon films supported <NUMBER>mesh copper grids blotting immediately <NUMBER> seconds filter paper grids plunged liquid ethane cooled liquid nitrogen using custom built gravityoperated freezing device specimens transferred tecnai <NUMBER> g<NUMBER> transmission electron microscope fei operated <NUMBER>kv equipped gatan <NUMBER>dh lowtemperature specimen holder observations made temperatures <NUMBER>Â°c images recorded <NUMBER>x magnification kodak <NUMBER> electron image film dose <NUMBER> electronsÃ¥ <NUMBER> exposure <NUMBER> seconds film developed kodak d<NUMBER> <NUMBER> minutes room temperature immunogold stained samples imaged room temperature tecnai <NUMBER> digital images collected using either gatan msc amt advantage xr<NUMBER> digital cameras image processing exact magnification microscope determined <NUMBER>x using calibration grid formvarcarbon coated <NUMBER>mesh nickel grids floated drops purified sarscov <NUMBER>Î¼l <NUMBER> minute incubations carried <NUMBER> Â°c grids washed pbs followed <NUMBER>minute block pbsgbsa pbs ph<NUMBER> <NUMBER> glycine <NUMBER> bsa washing pbsg pbs ph<NUMBER> <NUMBER> glycine grids incubated primary antibody diluted pbsgbsa convalescent patient serum diluted pbs followed washes pbsg incubated secondary antibody conjugated <NUMBER> <NUMBER> nm gold followed washing pbsg grids fixed <NUMBER> paraformaldehyde <NUMBER> glutaraldehyde pbs washed deionised water negatively stained either <NUMBER> uranyl acetate <NUMBER> methylamine tungstate nanoprobes yaphank ny case nucleocapsid labelling specimens permeabilised pretreatment <NUMBER> np<NUMBER> pbs ice experiments negative controls run included omission primary antibody test nonspecific binding keywords covid<NUMBER> sarscov<NUMBER> coronavirus receptorbinding domain receptor bindingmotif novel coronavirus emerged human population city wuhan china causing severe respiratory illness world health organization named <NUMBER> novel coronavirus disease pathogen named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> huang et al <NUMBER> li et al <NUMBER> since emergence december <NUMBER> viral infection already spread many chinese cities several countries world health organization declared public health emergency international concern end january <NUMBER> situation report <NUMBER> may <NUMBER> th <NUMBER> indicated <NUMBER> million confirmed cases reported globally nearly <NUMBER> cases usa alone total deaths caused disease reached <NUMBER> <NUMBER> cases mainly americas europe <NUMBER> <NUMBER> respectively httpswwwwhointdocsdefaultsourcecoronavirusesituationreports<NUMBER>covid<NUMBER>sitrep<NUMBER>pdfsfvrsn<NUMBER>ebbbe<NUMBER> coronaviruses belong family coronaviridae order nidovirales classified four genera alphacoronavirus betacoronavirus gammacoronavirus deltacoronavirus cui et al <NUMBER> perlman netland <NUMBER> enveloped positivestranded rna viruses containing largest genome among rna viruses ranging <NUMBER> <NUMBER> kb fehr perlman <NUMBER> release sarscov<NUMBER> genome sequence classified betacoronavirus closely related severe acute respiratory syndrome coronavirus sarscov emerged <NUMBER> ksiazek et al <NUMBER> peiris et al <NUMBER> coronaviruses spike protein forms large protrusions virus surface spikes giving viral particles appearance crowns hence name coronavirus j u r n l p r e p r f cui et al <NUMBER> perlman netland <NUMBER> zumla et al <NUMBER> spikes represent first contact host mediate virus entry host cells besides protein linked host tissue tropism du et al <NUMBER> li <NUMBER> structurally coronavirus spikes cloveshaped trimers protein asymmetric unit containing large ectodomain singlepass transmembrane anchor short intracellular tail kirchdoerfer et al <NUMBER> smith et al <NUMBER> ectodomain consists receptorbinding subunit s<NUMBER> membranefusion subunit s<NUMBER> s<NUMBER> subunit containing distinct nterminal cterminal domains s<NUMBER>ntd s<NUMBER>ctd beniac et al <NUMBER> walls et al <NUMBER> one major complexities coronaviruses receptor recognition pattern date several receptors found recognized different coronaviruses li <NUMBER> li <NUMBER> among receptors zinc peptidases angiotensinconverting enzyme <NUMBER> ace<NUMBER> hofmann et al <NUMBER> li et al <NUMBER> aminopeptidase n apn delmas et al <NUMBER> li et al <NUMBER> dipeptidyl peptidase <NUMBER> dpp<NUMBER> raj et al <NUMBER> yang et al <NUMBER> carcinoembryonic antigenrelated cell adhesion molecule <NUMBER> ceacam<NUMBER> dveksler et al <NUMBER> williams et al <NUMBER> sialic acidcontaining receptors schwegmannwessels herrler <NUMBER> report compared composition structural features protein receptorbinding domains sarscov<NUMBER> related viruses especially sarscov tried extrapolate findings shed light possible functioning protein new coronavirus especially receptorbinding domains total <NUMBER> sequences proteins sarscov<NUMBER> isolates <NUMBER> countries retrieved majority sequences usa <NUMBER> followed china <NUMBER> j u r n l p r e p r f supplementary file <NUMBER> sequence identity reference sequence yp<NUMBER> varied <NUMBER> <NUMBER> indicating thus high degree conservation nearly <NUMBER> sequences identical reference sequence <NUMBER> presented mostly single mutations one mutated position sequence mutated positions <NUMBER> total reported supplementary file <NUMBER> however mutated positions three shared several sequences position <NUMBER> thr mutated ile <NUMBER> taiwanese sequences position <NUMBER> ala mutated thr <NUMBER> sequences thailand importantly apparition gly instead asp position <NUMBER> <NUMBER> sequences note three positions located s<NUMBER> subunit protein sarscov<NUMBER> shares <NUMBER> amino acid similarity recently identified batcov ratg<NUMBER> isolate <NUMBER> bat sarslike cov <NUMBER> identity sarscov gz<NUMBER> isolate moreover compared s<NUMBER> subunit s<NUMBER> subunit proteins found conserved four strains figure <NUMBER> table <NUMBER> comparing segments <NUMBER>aa sarscov<NUMBER> protein three coronaviruses figure <NUMBER>a results indicated region spanning aa<NUMBER> protein similar new bat isolate <NUMBER> sarsor bat sarslike strains pronounced dissimilarity noted regions spanning aa<NUMBER> aa<NUMBER> correspond cterminal domain s<NUMBER> subunit s<NUMBER>ctd s<NUMBER>ntd sarscov<NUMBER> highly similar newly isolated bat coronavirus ratg<NUMBER> <NUMBER> shares roughly <NUMBER> <NUMBER> sarscov bat sarslike cov respectively table <NUMBER> structurally used dali server aligning s<NUMBER>ntd sarscov<NUMBER> coronaviruses different genera table <NUMBER> expected s<NUMBER>ntd sarsj u r n l p r e p r f cov<NUMBER> similar betacoronaviruses especially sarscov highest zscore highest sequence identity lowest rmsd however ntds aligned zscores ranging <NUMBER> <NUMBER> rmsds ranging <NUMBER> <NUMBER> similarity due galectinlike topology ntds core structures previously documented li <NUMBER> primary sequence alignment also revealed insertions shared sarscov<NUMBER> bat coronavirus ratg<NUMBER> sarscov located positions aa<NUMBER> aa<NUMBER> aa<NUMBER> aa<NUMBER> sarscov<NUMBER> protein figure <NUMBER> investigate structural role inserts searched protein data bank using largest insert <NUMBER>gtngtkr<NUMBER> <NUMBER> amino acids extensions nand cterminal sides leading <NUMBER>aa long segment <NUMBER>aihvsgtngtkrfdnpv<NUMBER> analyzed hits see whether aligned motifs engaged identified structural function searched protein databank using gtngtkr motif first hit structure mengo virus vp<NUMBER> protein figure <NUMBER>a aligned segment located vp<NUMBER> gh loop forms along vp<NUMBER> cterminal loop depression capsid associated receptor recognition binding kim et al <NUMBER> krishnaswamy rossmann <NUMBER> although depression described mengo virus capsid absent s<NUMBER>ntd sarscov<NUMBER> target motif <NUMBER>gtngtkrfdn<NUMBER> forms similarly exposed loop two neighboring loops containing <NUMBER>ssg<NUMBER> motif identified insert <NUMBER> nterminal loop <NUMBER>ltt<NUMBER> motif sides figure <NUMBER>b whether formation could play role mengo virus vp<NUMBER> vp<NUMBER> loops would turn allow sarscov<NUMBER> interact receptor need investigation moreover mengo virus found bind murine cellular receptor vascular cell adhesion molecule <NUMBER> vcam<NUMBER> enter infect cells huber <NUMBER> receptor molecule restricted endothelial cells subject upregulation cytokines stimulation hosokawa et al <NUMBER> singh et al <NUMBER> given high cytokine amounts stimulated sarscov<NUMBER> huang et al <NUMBER> preexisting heart disease hypertension coronary heart disease one major comorbidities fatality cases deng peng <NUMBER> interesting explore possibility sarscov<NUMBER> binding vcam<NUMBER> receptor via s<NUMBER>ntd mouse hepatitis coronavirus mhv also binds another cell adhesion molecule murine carcinoembryonic antigenrelated cell adhesion molecule <NUMBER>a mceacam<NUMBER>a using s<NUMBER>ntd peng et al <NUMBER> therefore next step compared mhv sarscov<NUMBER> s<NUMBER>ntds found receptorbinding motif mhv s<NUMBER>ntd also presents motif <NUMBER>ntngnk<NUMBER> similarity insert <NUMBER> <NUMBER>gtngtkr<NUMBER> sarscov<NUMBER> s<NUMBER>ntd however s<NUMBER>ntds compared quaternary structures proteins motifs seem occupy opposite positions figure <NUMBER>c besides peng et al identified four receptor binding motifs mhv s<NUMBER>ntd rbm<NUMBER> peng et al <NUMBER> comparing mhvreceptor interaction interface exposed amino acids receptorbinding surface sarscov<NUMBER> s<NUMBER>ntd found nterminal aa<NUMBER> segments adopt different conformations figure <NUMBER>d segment mhv rbm<NUMBER> contains three residues critical receptor binding affinity peng et al <NUMBER> therefore seems unlikely sarscov<NUMBER> would bind receptor however observation taken care since based predicted model sarscov<NUMBER> s<NUMBER>ntd taken together presence gtngtkr motif sarscov<NUMBER> s<NUMBER>ntd seems potentially evolutionary feature sarscov<NUMBER> acquired allow s<NUMBER>ntd bind protein receptors believe observations worth investigating another structure containing analyzed motif tail spike protein <NUMBER> bacteriophage cba<NUMBER> podoviridae chen et al <NUMBER> aligned motif gtngtk located within receptorbinding domain inverting region connecting subdomain d<NUMBER> d<NUMBER> interestingly unlike tail spike proteins sugarbinding sites located d<NUMBER> subdomain muller et al <NUMBER> steinbacher et al <NUMBER> xiang et al <NUMBER> d<NUMBER>d<NUMBER> inverting region cba<NUMBER> tail spike protein generates hole forms sugarbinding site chen et al <NUMBER> although target motif directly involved sugars interactions binding site hole formed opposite direction gtngtk loop quite similar orientation motif observed sarscov<NUMBER> s<NUMBER>ntd figure <NUMBER> besides could counterparts sugarbinding pocket cba<NUMBER> tail spike protein one two pockets formed sarscov<NUMBER> s<NUMBER>ntd first situated top part domain located Î²sandwich core opposite direction gtngtkr loop figure <NUMBER>c latter pocket also aligned sugarbinding site ntd bovine coronavirus bcov figure <NUMBER>a c peng et al peng et al <NUMBER> reported pocket Î²sandwich core sugarbinding site bcov ntd mutagenesis studies identified <NUMBER> residues critical ntdreceptor interaction y<NUMBER> e<NUMBER> w<NUMBER> h<NUMBER> binding stabilized loop <NUMBER> <NUMBER>ndlnkl<NUMBER> figure <NUMBER>c interestingly corresponding pocket sarscov<NUMBER> ntd also contains three amino acids e<NUMBER> f<NUMBER> y<NUMBER> orientation four key residues identified bcov ntd moreover positions e<NUMBER> y<NUMBER> j u r n l p r e p r f strikingly similar y<NUMBER> e<NUMBER> bcov ntd figure <NUMBER>d besides counterpart stabilizing loop <NUMBER> also present sarscov<NUMBER> ntd although shorter seems share nxxn motif observations suggest sarscov<NUMBER> ntd might recognize sugar receptor well likely neu<NUMBER>ac<NUMBER> bcov ntd binds peng et al <NUMBER> tngtrrf motif also present infectious bronchitis coronavirus ibv spike protein despite low primary sequence identity <NUMBER> pairwise structural alignment revealed sarscov<NUMBER> s<NUMBER>ntd shared relatively high structural similarity s<NUMBER>ntd ibv dali zscore <NUMBER> rmsd <NUMBER> <NUMBER> aligned residues table <NUMBER> aligned motif tngtrrf located within s<NUMBER>ctd ibv subdomain connecting s<NUMBER> s<NUMBER> shang et al <NUMBER> although functional features described subdomains s<NUMBER>ntds s<NUMBER>ctds coronaviruses spikes target motif found protruding surface trimer figure <NUMBER>a suggesting protrusion might interact surrounding environment aligned fragment also located cterminal mimivirus cyclophilin missing deposited structure thai et al <NUMBER> authors link structural function segment interest however note first virusencoded cyclophilin lacks peptidylprolyl isomerase activity several viruses human immunodeficiency virus type <NUMBER> sarscov exploit host cyclophilin chen et al <NUMBER> sorin kalpana <NUMBER> interestingly viral cyclophilin located surface mature mimivirus virions given absence catalytic activity authors suggested protein may play structural role yet identified mimivirus life cycle thai et al <NUMBER> since mimivirus cause j u r n l p r e p r f pneumonia humans la scola et al <NUMBER> saadi et al <NUMBER> exact position cyclophilin yet determined question could asked whether <NUMBER>ngtkrf<NUMBER> motif could play role virus pathogenesis could shared sarscov<NUMBER> besides viruses search functional gtngtkr motif deposited protein structures revealed similar motif folylpolyglutamate synthetase fpgs lactobacillus casei enzyme catalyzes mgatpdependent glutamylation folate coenzymes figure <NUMBER>b aligned motif <NUMBER>ihvtgtng<NUMBER> located putative nucleotidebinding p loop gtngkgs resembles consensus ploop sequence found many adenylate uridylate kinase smith rayment <NUMBER> sun et al <NUMBER> moreover Ï loop near p loop binding site also suggested play role activity fpgs especially serine residue interestingly similarly shaped loop also found sarscov<NUMBER> s<NUMBER>ntd adjacent gtngtkr loop formed insert <NUMBER> <NUMBER>sssg<NUMBER> also rich serine residues figure <NUMBER>c given severity widespread nature infection safe assume sarscov<NUMBER> efficient way penetrate infect cells besides based comparison sarscov<NUMBER> sarscov receptorbinding domains seems sarscov<NUMBER> evolved way allowed maintain enhance binding ace<NUMBER> receptor via s<NUMBER>ctd also acquired different s<NUMBER>ntd according analysis might bind receptors protein sugar receptor precisely acquisition gtngtkr motif found active sites structural nonstructural proteins viruses organisms might allow sarscov<NUMBER> recognize receptorscoreceptors besides ace<NUMBER> moreover results suggest apparition gtngtkr motif points toward evolutionary trait sarscov<NUMBER> rather hypothesis engineered virus functional constraints proteins tend evolve way tertiary structures could perform needed functions regardless changes primary sequences goldstein <NUMBER> siltbergliberles et al <NUMBER> worth et al <NUMBER> two main factors driving evolution proteins need better adaptation host receptors need evade immune system host ensure better infectivity li <NUMBER> li <NUMBER> therefore plausible assume sarscov<NUMBER> acquired gtngtkr motif evolutionary parkour functional constraints exact mechanism acquisition origin motif believe investigations needed context sarscov<NUMBER> infection pertinent motif viral proteins activity general total <NUMBER> sarscov<NUMBER> protein complete sequences available ncbi virus portal retrieved sequences sarscov gc<NUMBER> isolate ay<NUMBER> two bat isolates bat sarslike coronavirus mg<NUMBER> recently isolated ratg<NUMBER> bat coronavirus mn<NUMBER> also retrieved glycoproteins compared sarscov<NUMBER> refseq yp<NUMBER> first performed multiple alignment proteins <NUMBER> sarscov<NUMBER> strains see dissimilarities present analyzed occurrence mutations comparison reference sequence next compared similarity glycoprotein sarscov<NUMBER> refseq yp<NUMBER> selected <NUMBER> related coronaviruses strains mentioned <NUMBER> aligning fulllength proteins <NUMBER> stains j u r n l p r e p r f altogether <NUMBER> aligning fulllength sarscov<NUMBER> protein related strains separately <NUMBER> aligning portions <NUMBER>aa windows sarscov<NUMBER> protein related strains separately sequence alignments performed using muscle algorithm implemented megax software blastp suite us national library medicine search motifs similar gtngtkr motif protein data bank deposited structures blastp suite us national library medicine used adjusting parameters search short input sequence three crystal structures sarscov<NUMBER> spike protein containing s<NUMBER>ntd retrieved protein data bank pdb id <NUMBER>vyb <NUMBER>vxx <NUMBER>vsb since structures lacks fragments interest especially gtngtkr motif sequence glycoprotein sarscov<NUMBER> reference id yp<NUMBER> submitted itasser httpszhanglabccmbmedumicheduitasser swissmodel httpsswissmodelexpasyorg servers prediction complete <NUMBER>d structure models waterhouse et al <NUMBER> yang zhang <NUMBER> quality predicted <NUMBER>d structures evaluated using molprobity server httpmolprobitybiochemdukeedu williams et al <NUMBER> best models selected analysis structural alignments performed using dali server httpekhidna<NUMBER>biocenterhelsinkifidali holm <NUMBER> regions identified similarity analysis mapped sarscov<NUMBER> protein trimer predicted swissmodel server region aa<NUMBER> depicted blue region aa<NUMBER> depicted red region <NUMBER> depicted cyan region aa<NUMBER> depicted hot pink cterminal region starting aa<NUMBER> depicted yellow <NUMBER>h<NUMBER> b sarscov<NUMBER> s<NUMBER>ntd orientation bcov s<NUMBER>ntd <NUMBER>gtngtkr<NUMBER> far side colored red counterpart loop <NUMBER> conserved nxxn motif front also colored red c different orientations bcov sarscov<NUMBER> s<NUMBER>ntds obtained <NUMBER>Â° rotation xaxis b respectively key residues interactions sugar moieties bcov s<NUMBER>ntd possible counterparts sarscov<NUMBER> s<NUMBER>ntd shown red sticks c respectively j u r n l p r e p r f novel coronavirus sarscov<NUMBER> emerged unprecedented global pandemic <NUMBER> <NUMBER> <NUMBER> june <NUMBER> <NUMBER> nearly <NUMBER> million confirmed cases worldwide leading <NUMBER> deathswho infection sarscov<NUMBER> causes fever dry cough severe respiratory illness pneumonia disease recently named covid<NUMBER> <NUMBER> pathological studies revealed features diffuse alveolar damage dad excessive fluid lungs critically ill patients often need ventilators support oxygen furthermore frequent complication covid<NUMBER> blood clotted abnormally observed many hospitalized patients <NUMBER> therefore urgent need mechanistic understanding pathogenicity sarscov<NUMBER> concomitant complications able treat hospitalized patients sudden emergency rapid spread sarscov<NUMBER> global efforts identified human angiotensinconverting enzyme <NUMBER>ace<NUMBER> entry receptor new coronavirus <NUMBER> also entry receptor sarscov <NUMBER> <NUMBER> <NUMBER> structural studies revealed sarscov<NUMBER> spike glycoprotein binds ace<NUMBER> higher affinity <NUMBER>nm sarscov spike protein <NUMBER> <NUMBER> <NUMBER> <NUMBER> overall structure sarscov<NUMBER> resembles sarscov rbd domain one protomer spike protein trimer tightly interacting ace<NUMBER> extracellular enzymatic domain physiologically ace<NUMBER> zinc metalloprotease carboxypeptidase homolog dipeptidase angiotensinconverting enzyme ace different substrate specificity <NUMBER> ace cleaves cterminal dipeptide ang produce potent vasopressor octapeptide ang ii whereas ace<NUMBER> cleaves carboxylterminus produce ang <NUMBER> deactivate ang ii therefore ace ace<NUMBER> together play important roles regulating vasoconstriction vasodilatation renninangiotensin system ras meanwhile ace ace<NUMBER> plays critical role kininkallikrein system control vascular permeability vasodilatation <NUMBER> ace deactivates bradykinin nonapeptide ligand constitutively expressed bradykinin receptor b<NUMBER> bradykinin processed carboxypeptidase n form desarg<NUMBER>bradykinin potent ligand inflammationinducible bradykinin receptor b<NUMBER> <NUMBER> reninangiotensin kininkallikrein systems ace<NUMBER> also cleaves biological peptides apelin<NUMBER> activates apelin receptor cause vasodilatation however limited information level substrates sarscov<NUMBER> infection given fact ace<NUMBER> major entry receptor new coronavirus compared relatively low expression ace ace<NUMBER> predominantly expressed lung pneumocytes ii explains lung major organ infected sarscov<NUMBER> critical clinical observations showed covid<NUMBER> patients often dyspnea accumulation fluid lungs representing local angioedema clearly suggests pathological involvement vascular permeability vasodilatation sarscov<NUMBER> infection however direct assessment ace<NUMBER> enzymatic activity coronavirus infection examined binding sarscov<NUMBER> spike protein would affect intrinsic enzymatic activity ace<NUMBER> using one well characterized fluorogenic ace<NUMBER> substrate caspase<NUMBER> substrate mcayvadapkdnp <NUMBER> comparison ace substrate bradykinin analog mcarppgfsafkdnp also included enzymatic activity assessment <NUMBER> surprise sarscov<NUMBER> spike enhanced ace<NUMBER> proteolytic activity cleave mcayvadapkdnp mediated ace<NUMBER> binding rbd furthermore sarscov<NUMBER> rbd enhanced ace<NUMBER> activity hydrolyze bradykininanalog better sarscov rbd measurements kinetic constants also showed sarscov<NUMBER> spike protein altered binding affinity k ace<NUMBER> caspase<NUMBER> substrate bradykininanalog propose new line evidence sarscov<NUMBER> spike protein significantly alters ace<NUMBER> activity specificity could clinically relevant understanding pathogenesis covid<NUMBER> genetic analysis revealed sarscov<NUMBER> highly homologous severe acute respiratory syndrome coronavirus sarscov infected human cells angiotensinconverting enzyme <NUMBER>ace<NUMBER> receptor <NUMBER> <NUMBER> outbreak covid<NUMBER> ace<NUMBER> quickly identified entry receptor sarcov<NUMBER> well structural studies demonstrated sarscov<NUMBER> sarscov utilized rbd domain interact ace<NUMBER> similar binding mode however sarscov<NUMBER> spike protein displays much higher binding affinity ace<NUMBER> compared sarscov given nanomolar affinity ace<NUMBER> sarscov<NUMBER> spike protein wonder binding sarscov<NUMBER> spike protein ace<NUMBER> would affect enzymatic activity since ace<NUMBER> critical component renninangiotensin kininkallikrein system carboxypeptidase <NUMBER> <NUMBER> previously reported ace<NUMBER> efficiently hydrolyzes biological peptides consensus sequence prox<NUMBER> residuesprohydrophobic p<NUMBER>p<NUMBER> positions <NUMBER> cleavage proline hydrophobic residue exemplified ang ii drvyihpâf desarg <NUMBER> bk rppgfspâf ace<NUMBER> also cleaves peptides basic residue p<NUMBER> position dynorphin yggflrrirpklâk neurotensin <NUMBER>pelyenkpâr rapidly continuously assess enzyme activity fluorogenic peptide substrates normally used therefore monitored ace<NUMBER> proteolytic activity measuring degradation fluorogenic capase<NUMBER> substrate mcayvadapkdnp <NUMBER> addition bradykinin figure <NUMBER>a similarly sarscov<NUMBER> spike protein enhanced ace<NUMBER> cleavage bradykinin analog mcarppgfsafkdnpoh produce <NUMBER> times rfu within <NUMBER> hours figure <NUMBER>b previous enzymatic assays showed ace<NUMBER> activity increased concentrations nacl <NUMBER>m <NUMBER>m carried enzymatic assays increased concentration nacl consistently sarscov<NUMBER> spike protein enhanced ace<NUMBER> activity <NUMBER>m <NUMBER>m nacl enabled ace<NUMBER> cleave bradykininanalog well supplementary figure <NUMBER> indicating enhancement resulted interaction sarscov<NUMBER> spike protein ace<NUMBER> furthermore enhancement ace<NUMBER> activity sarscov<NUMBER> spike protein concentration dependent manner enzymatic assays added various concentrations sarscov<NUMBER> spike protein ranging <NUMBER>ugml <NUMBER>ugml dilution sarscov<NUMBER> spike protein assays gradually mitigated enhancement ace<NUMBER> activity clear transition <NUMBER>ugml <NUMBER>ugml sarscov<NUMBER> spike protein figure <NUMBER> c dose dependent enhancement ace<NUMBER> activity sarscov<NUMBER> spike protein line binding affinity ace<NUMBER> sarscov<NUMBER> spike protein reported <NUMBER>nm equivalent <NUMBER>ugml previous studies showed sarscov infection may lead internalization ace<NUMBER> receptor thus decrease cell surface level ace<NUMBER> <NUMBER> however examining lung tissue <NUMBER> days post infection sarscov<NUMBER> virus ace<NUMBER> transgenic mice showed colocalization sarscov<NUMBER> spike protein ace<NUMBER> receptor cell surface <NUMBER> <NUMBER> supporting sarscov<NUMBER> spike formed stable interaction ace<NUMBER> cell entry addition lasting interaction sarscov<NUMBER> spike ace<NUMBER> cell surface suggests observed enhancement ace<NUMBER> activity solution might happen vivo well sarscov<NUMBER> sarscov spike protein highly homologous prefusion trimeric architectures one receptor binding domain rbd ace<NUMBER> binding however sarscov<NUMBER> spike protein binds ace<NUMBER> <NUMBER> fold higher affinity sarscov spike <NUMBER> <NUMBER> determined whether rbd domain would sufficient boost ace<NUMBER> activity results showed sarscov<NUMBER> rbd sarscov rbd enhanced ace<NUMBER> cleavage caspase<NUMBER> substrate figure <NUMBER> b demonstrating sarscov<NUMBER> sarscov rbd alone sufficient enhance ace<NUMBER> activityace<NUMBER> enhancement ace<NUMBER> activity sarscov<NUMBER> rbd protein showed concentration dependent saturation half maximal enhancement <NUMBER>nm whereas sarscov rbd protein enhances ace<NUMBER> activity almost linearly <NUMBER>nm <NUMBER>nm half maximal enhancement <NUMBER>nm figure <NUMBER>e nevertheless sarscov<NUMBER> rbd sarscov rbd could increase cleavage mcarppgfsafkdnpoh ace<NUMBER> figure <NUMBER> c f recently reported sarscov<NUMBER> rbd bound ace<NUMBER> nanomolar affinities<NUMBER>nm sarscov rbd bound ace<NUMBER> submicromolar affinities<NUMBER>nm different capabilities sarscov<NUMBER> sarscov rbd proteins enhance ace<NUMBER> enzymatic activity suggested stable interaction rbd ace<NUMBER> necessary cleavage nonoptimal substrates bradykinin analog characterize efficiently ace<NUMBER> cleaves fluorogenic caspase<NUMBER> substrate bradykinin analog presence sarscov<NUMBER> spike protein determined kinetic constants ace<NUMBER> particularly physiological condition ph<NUMBER> <NUMBER>mm nacl measurements carried <NUMBER>ng ace<NUMBER> presence absence <NUMBER>ugml sarscov<NUMBER> spike protein hydrolysis limited <NUMBER> product formed initial velocity conditions michaelismenten plots showed sarscov<NUMBER> spike protein resulted <NUMBER> fold reduction k <NUMBER> showed higher activities <NUMBER>m nacl previously reported worth mention k cat k value ace<NUMBER> hydrolysis bradykinin analog mcarppgfsafkdnpoh presence sarscov<NUMBER> spike protein <NUMBER> x <NUMBER> <NUMBER> <NUMBER> <NUMBER> slightly higher ace<NUMBER> hydrolysis angiotensin decapeptide drvyihpfhâl biological substrate ace<NUMBER> <NUMBER> taken together sarscov<NUMBER> increased substrate binding affinities catalytic rate ace<NUMBER> measurements kinetic constants ace<NUMBER> revealed binding sarscov<NUMBER> spike protein altered substrate affinity k ace<NUMBER> also changed enzymatic efficiency presence sarscov<NUMBER> spike protein ace<NUMBER> cleaved bradykininanalog k <NUMBER>um previously reported ace<NUMBER> could also cleave desarg <NUMBER> bradykinin much higher k <NUMBER>um therefore wonder binding sarscov<NUMBER> spike protein would alter cleavage dynamics among different substrates designed substrate competition assays assess selectivity activity ace<NUMBER> upon binding sarscov<NUMBER> rbd enzymatic reactions utilized nonfluorogenic bk desbk ang ii peptide compete ace<NUMBER> cleavage fluorogenic substrates figure <NUMBER> absence sarscov<NUMBER> rbd binding ang ii bk desbk inhibited cleavage caspase<NUMBER> substrate mcayvadapkdnpoh <NUMBER> inhibition <NUMBER>um consistent low k <NUMBER>um ang ii high k desbk poor activity bk figure <NUMBER> b f h competitive ace<NUMBER> cleavage caspase<NUMBER> substrate resulted inhibition constant ki ang ii <NUMBER> Âµm <NUMBER> Âµm respectively absence presence sarscov<NUMBER> rbd suggesting sarscov<NUMBER> rbd enhanced ace<NUMBER> activity ang ii similarly bk desbk inhibited ace<NUMBER> cleavage ki <NUMBER> Âµm <NUMBER> Âµm respectively presence sarscov<NUMBER> rbd figure <NUMBER> c e g suggesting sarscov<NUMBER> also enhanced ace<NUMBER> binding bk desbk ace<NUMBER> cleavage bkanalog ang ii competed ki constant <NUMBER> Âµm <NUMBER> Âµm absence presence sarscov<NUMBER> rbd respectively supplement figure <NUMBER> similar caspase<NUMBER> substrate cleavage however bk desbk failed inhibit ace<NUMBER> cleavage bkanalog shown bkanalog bound endothelin converting enzyme<NUMBER> ece<NUMBER> much better bk due cterminal modification <NUMBER> likely bkanalog also bound better ace<NUMBER> bk new coronavirus sarscov<NUMBER> infects human cells via binding spike glycoprotein human angiotensinconverting enzyme<NUMBER> ace<NUMBER> examined influence high affinity binding sarscov<NUMBER> spike protein enzymatic activity ace<NUMBER> surprisingly enzymatic assay showed sarscov<NUMBER> spike protein significantly enhanced enzymatic activity ace<NUMBER> cleave yvadapk peptide suggesting ace<NUMBER> upon sarscov<NUMBER> binding would likely cleave efficiently substrates proline p<NUMBER> position ang ii drvyihpâf apelin<NUMBER>qrprlshkgpmpâf similarly binding sarscov<NUMBER> spike enhanced ace<NUMBER> cleave bradykinin analog rppgfsafk addition bradykinin rppgfspfr competed yvadapk peptide ace<NUMBER> cleavage similar extent desarg <NUMBER> bradykinin results showed sarscov<NUMBER> spike protein bound ace<NUMBER> entry receptor also hijacked enzymatic activities compared various structures ace<NUMBER> reveal structural changes ace<NUMBER> proteolytic domain might happen upon sarscov<NUMBER> spike binding affect enzymatic activity ace<NUMBER> native structure ace<NUMBER> extracellular proteolytic domain comprised two subdomains n terminal c terminal subdomain wide cleft substrate binding catalysis <NUMBER> rmsd less <NUMBER>Ã¥ figure <NUMBER> e however sarscov<NUMBER> rbd sarscov rbd binding caused hinge movement nand cterminal domains reminiscent closing clam assessed relative movement measuring angle formed asn<NUMBER> rim native ace<NUMBER> cterminal domain zinc atom catalytic center asn<NUMBER> superimposed ace<NUMBER> bound rbd sarscov<NUMBER> sarscov compared sarscov rbd binding <NUMBER>Â° angle upon sarscov<NUMBER> rbd binding increased <NUMBER>Â° particularly binding chimeric sarscov<NUMBER> rbd ace<NUMBER> <NUMBER> could cause significant movement <NUMBER>Â°of cterminal subdomain toward nterminal domain ace<NUMBER> figure <NUMBER>f furthermore angle caused inhibitor mln<NUMBER> binding <NUMBER>Â° form closed conformation ace<NUMBER> suggesting sarscov<NUMBER> spike binding initiated progressive conformational change energetically facilitate ace<NUMBER> catalysis comparison substrate binding pocket ace<NUMBER> showed residues f<NUMBER> h<NUMBER> f<NUMBER> h<NUMBER> y<NUMBER> y<NUMBER> sarscov<NUMBER>ace<NUMBER> complexes moved closer aligned ang ii mln<NUMBER> inhibitor suggesting sarscov<NUMBER> rbd binding ace<NUMBER> could increase substrate binding figure <NUMBER>g consistent kinetic constant measurement revealed k values ace<NUMBER> hydrolysis decrease upon sarscov<NUMBER> spike binding addition sarscov<NUMBER> rbd bound ace<NUMBER> h<NUMBER> residue proposed stabilize hybridized nitrogen upon catalysis adopted conformation bound inhibitor active conformation h<NUMBER> observed native sarscov rbd bound ace<NUMBER> structure suggesting tighter binding sarscov<NUMBER> rbd could also induce conformation change position ace<NUMBER> substrate pocket residues efficient catalysis increasing number confirmed cases worldwide major manifestation sarscov<NUMBER> mediated covid<NUMBER> disease complications generated critical concerns due lack highly effective antiviral drugs vaccines current analysis ace<NUMBER> enzymatic activity upon sarscov<NUMBER> spike protein binding would clinically relevant however limitation study could systemically measure levels various ace<NUMBER> substrates cleaved products covid<NUMBER> patients currently would propose ratios vasodilators vasoconstrictors would change sarscov<NUMBER> infection due high affinity interaction ace<NUMBER> sarscov<NUMBER> spike protein subsequently altered ace<NUMBER> enzymatic activity substrate selectivity compared previous outbreaks sarscov mers sarscov<NUMBER> contagious clinical symptoms covid<NUMBER> variable <NUMBER> addition accumulation fluid lung considerable fraction critically ill covid<NUMBER> patients developed deep venous thrombosis pulmonary embolism <NUMBER> clinical observations share common prognostic feature pointed cardiovascular system vasodilation vasoconstriction permeability essential components cardiovascular system regulated crosstalk many hormones biological active peptides among reninangiotensin system kininkellikrein system major effects upon cardiovascular systems <NUMBER> <NUMBER> importantly ace<NUMBER> catalyzes conversion regulatory peptides systems maintain homeostatic state among biological active substrates ace<NUMBER> cleaves among peptide components renninangiotensin system ace<NUMBER> could efficiently hydrolyze ang ii drvyihpâf partially cleave ang idrvyihpfhâl sarscov<NUMBER> infection enhancement ace<NUMBER> activity could produce cleaved products ang <NUMBER> ang <NUMBER> beside opposing effects ang ii ang <NUMBER> vasoconstriction vasodilatation regulated expression ace<NUMBER> several vivo vitro studies documented ang ii decreased expression ace<NUMBER> activation mapk pathways whereas ang <NUMBER> counteracted inhibitory effect ang ii boost expression ace<NUMBER> mapk phosphatase activation <NUMBER> <NUMBER> previous studies showed sarscov infection caused internalization ace<NUMBER> <NUMBER> however analyzing lung tissue ace<NUMBER> mice <NUMBER> days post sarscov<NUMBER> infection showed substantial expression ace<NUMBER> <NUMBER> importantly ace<NUMBER> expression increased lungs severe covid<NUMBER> patients comorbidities compared control individuals <NUMBER> <NUMBER> enhanced ace<NUMBER> activity cleave ang ii upon sarscov<NUMBER> spike binding might one mechanisms whereby sarscov<NUMBER> utilized boost expression ace<NUMBER> apelin <NUMBER>qrprlshkgpmpâf endogenous ligand angiotensin ii protein j receptor apjr homolog angiotensin receptor at<NUMBER> <NUMBER> apelin <NUMBER> nanomolar affinity apjr major effect apelin vivo nitric oxide dependent arterial dilatation counterbalance ang ii effects cleavage carboxylterminal phenylalanine apelin <NUMBER> cause loss critical interactions phe<NUMBER> large hydrophobic cavity apjr <NUMBER> resulting <NUMBER> fold decrease potency <NUMBER> enhancement ace<NUMBER> activity would accelerate metabolism apelin <NUMBER> dampening beneficial effects overall cardiac functions proteolysis bradykinin may particularly relevant covid<NUMBER> normally ace responsible hydrolysis bradykinin whereas ace<NUMBER> hydrolyzes desarg <NUMBER> bradykinin <NUMBER> bradykinin selectively binds b<NUMBER> receptors desarg <NUMBER> bradykinin selectively binds b<NUMBER> receptor compared constitutive expression b<NUMBER> receptor expression b<NUMBER> receptor upregulated inflammation addition previous studies showed reactions bradykinin degradation occurred normally production rate desarg <NUMBER> bradykinin accelerated fivefold blood clotted <NUMBER> results showed sarscov<NUMBER> spike protein enhanced bradykinin desarg <NUMBER> bradykinin binding ace<NUMBER> furthermore neuropeptides dynorphin <NUMBER>yggflrrirpklâk ï¢casomorphinypfvepâi good ace<NUMBER> substrate endogenous ligands opioid receptors antinociceptive effects <NUMBER> interestingly dynorphin <NUMBER> also implicated appetite stimulant <NUMBER> removal cterminal lysine residue dynorphin <NUMBER> resulted <NUMBER> loss potency <NUMBER> since symptoms covid<NUMBER> also include body aches loss taste would intriguing speculate altered ace<NUMBER> hydrolysis neuropeptides would affect homeostatic functions opioid receptors well collectively homeostatic regulation cardiovascular system controlled ace<NUMBER> would vector express prefusion ectodomain gene encoding residues <NUMBER> sarscov<NUMBER>genbank mn<NUMBER> kindly provided jason mclellan university texas austin protein expressed described previously <NUMBER> brief freestyle<NUMBER> f cells thermo fisher transiently transfected expression vector using polyethylenimine pei protein purified filtered cell supernatants using streptactin xt resin iba inc subsequently subjected purification size exclusion chromatography using superose <NUMBER> <NUMBER> column ge healthcare buffer <NUMBER>mm tris ph<NUMBER> <NUMBER>m nacl enzymatic assays sarscov<NUMBER> spike commercial rbd recombinant proteins dialyzed extensively <NUMBER>mm trisph<NUMBER> <NUMBER>m nacl reactions performed black microtiter plates ambient temperature <NUMBER>Â°c according manufacturers instruction well <NUMBER>ul <NUMBER> <NUMBER>ugml ace<NUMBER> assay buffer containing <NUMBER>mm trisph<NUMBER> plus nacl <NUMBER>m <NUMBER>m <NUMBER>m added respectively <NUMBER>ul dialysis buffer sarscov<NUMBER> spikerbd domain proteins various final concentrations ranging <NUMBER>ugml <NUMBER>ugml added wells incubated <NUMBER>min mixing shaking reactions initiated adding <NUMBER>ul fluorogenic peptides <NUMBER>um <NUMBER>fold serial dilutions ranging <NUMBER>um <NUMBER>um determine kinetic constants ace<NUMBER> hydrolysis relative fluorescence units rfu read excitation emission wavelengths <NUMBER>nm <NUMBER>nm top read respectively kinetic mode <NUMBER>minute intervals <NUMBER> hours calculate specific activity ace<NUMBER> substrate blank adjusted relative fluorescent units converted molarities according conversion factor synergy h<NUMBER> plate reader calibrated standard mcaproleuoh supplement figure <NUMBER> obtain kinetic constants hydrolysis limited â¤<NUMBER> product formed initial velocity conditions initial velocities plotted versus compare relative proteolytic activity ace<NUMBER> different substrates various concentrations nonfluorogenic bk desbk ang ii peptides added reaction mixture fluorogenic peptides competitive substrates mentioned <NUMBER>ul ace<NUMBER> <NUMBER>ugml preincubated buffers sarscov<NUMBER> rbd protein final concentration <NUMBER>nm <NUMBER>min subsequently <NUMBER>ul fluorogenic peptides <NUMBER>um supplemented serial dilution nonfluorogenic bk desbk ang ii peptides ranging <NUMBER>um <NUMBER>um added initiate enzymatic cleavage fluorescence changes measured <NUMBER>min intervals <NUMBER> hour <NUMBER> degree initial velocity conditions students ttest used determine statistical significance pair wise comparison experiment repeated least duplicates p<NUMBER> considered statistically significant p<NUMBER> p<NUMBER> p<NUMBER> p<NUMBER> target neutralizing antibodies <NUMBER> making understanding structure conformational states pertinent investigating antigenic surfaces designing vaccines sarscov s<NUMBER> subunit composed two distinct domains nterminal domain s<NUMBER> ntd receptorbinding domain s<NUMBER> rbd also referred s<NUMBER> ctd domain b domains implicated binding host receptors depending coronavirus question however coronaviruses known utilize s<NUMBER> ntd s<NUMBER> rbd viral entry <NUMBER> sarscov makes use s<NUMBER> rbd bind human angiotensinconverting enzyme <NUMBER> ace<NUMBER> host receptor <NUMBER> <NUMBER> recent examination using cryoelectron microscopy cryoem illuminated prefusion structures coronavirus spikes <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> initial examination hcovhku<NUMBER> showed receptorbinding site s<NUMBER> rbd occluded rbd conformation hypothesized conformational changes required access site <NUMBER> subsequent studies highly pathogenic human coronavirus proteins sarscov <NUMBER> <NUMBER> merscov <NUMBER> <NUMBER> showed viral s<NUMBER> rbd indeed sample conformation receptorbinding site accessible structural studies also located positions s<NUMBER> s<NUMBER> s<NUMBER>â² cleavage sites prefusion spike s<NUMBER>s<NUMBER> site lies within surface exposed loop second subdomain s<NUMBER> <NUMBER> however s<NUMBER>â² site lies closer base spike though region located surface spike cleavage site prevented surrounding protein elements <NUMBER> coronavirus transitions metastable prefusion state highly stable postfusion state part proteins role membrane fusion instability prefusion state presents significant challenge production protein antigens antigenic presentation prefusion antibody epitopes likely lead neutralizing responses recently presented design two proline mutations <NUMBER>p prefusion stabilization coronavirus proteins <NUMBER> stabilized merscov <NUMBER>p ectodomain shown maintain prefusion spike conformation similar antibody recognition wildtype possess higher immunogenicity used singleparticle cryoem determine structures prefusion stabilized sarscov <NUMBER>p ectodomain uncleaved s<NUMBER>s<NUMBER> cleaved ace<NUMBER>bound states threedimensional classification s<NUMBER> rbd positions corresponding atomic protein models revealed neither ace<NUMBER>binding trypsin cleavage s<NUMBER>s<NUMBER> boundary induced substantial conformational changes prefusion stabilized protein structural description sarscov <NUMBER>p ectodomain examine potential conformational differences sarscov <NUMBER>p compared unstabilized wildtype ectodomains <NUMBER> <NUMBER> determined structures sarscov <NUMBER>p ectodomain included <NUMBER> Ã¥ resolution c<NUMBER>symmetric reconstruction several asymmetric reconstructions <NUMBER> Ã¥ see fig <NUMBER> supplementary tables s<NUMBER> s<NUMBER> figs s<NUMBER> s<NUMBER> s<NUMBER> ntd s<NUMBER> rbd clearly present appear poorly resolved cryoem maps precluding de novo build regions reason available sarscov crystal structures <NUMBER> corresponding domains placed densities overall sarscov <NUMBER>p structure resembles coronaviruses particularly betacoronavirus genus <NUMBER> <NUMBER> <NUMBER> <NUMBER> previously published sarscov wildtype prefusion ectodomains <NUMBER> <NUMBER> s<NUMBER> domains surround helical s<NUMBER> subunits interdigitate <NUMBER> <NUMBER>x<NUMBER>pdb dark green prefusion stabilized sarscov <NUMBER>p ectodomain <NUMBER>crvpdb light green adopt identical conformations near <NUMBER>p mutation site coordinate models derived c<NUMBER> symmetry cryoem reconstructions shown c highly featured density region containing <NUMBER>p mutation site classification heterogeneity within s<NUMBER> rbd reveals distribution rbd configurations singleup conformation prevalent s<NUMBER> regions shown blue s<NUMBER> regions shown green membranedistal apex trimeric spike structure s<NUMBER> subunit appears highly conserved across coronavirus genera <NUMBER> <NUMBER> <NUMBER> sarscov prefusion wildtype <NUMBER>p structures nearly identical regions including regions proximal <NUMBER>p mutation site fig <NUMBER>bc although overall structures sarscov similar able build several s<NUMBER> protein regions excluded wildtype sarscov models including fusionpeptideadjacent region well additional amino acids s<NUMBER> cterminal connector domain region cterminal fusion peptide known fp<NUMBER> suggested act second part bipartite fusion peptide sarscov <NUMBER> comparison fp<NUMBER> region structures presented mhv <NUMBER> hcovhku<NUMBER> <NUMBER> merscov <NUMBER> <NUMBER> hcovnl<NUMBER> <NUMBER> porcine deltacoronavirus <NUMBER> structures indicates sarscov adopts unique conformation region fig <NUMBER> whereas coronaviruses possess two short Î±helices crosslinking disulfide bond sarscov similar disulfide bond bridges two strands betahairpin unique sarscov conformation fp<NUMBER> lack crossgroup sequence conservation beyond disulfide bond region suggest sarscov may use distinct mechanism fp<NUMBER> membrane insertion trimeric sarscov <NUMBER>p adopts two distinct conformations related s<NUMBER> rbd delineation two distinct conformations s<NUMBER> rbd consistent observations made merscov <NUMBER> well one studies wildtype sarscov <NUMBER> gui et al <NUMBER> however observed gradient conformations wildtype sarscov observed structural studies coronavirus spikes work presented possibilities different observations may differences spike expression system yielding alternate glycosylation patterns alternate protein constructs true source remains unclear conformation caps s<NUMBER> helices makes extensive contacts s<NUMBER> ntd conformation s<NUMBER> rbd exposes s<NUMBER> rbd receptorbinding site previously reported wildtype sarscov <NUMBER> particles contained three rbd conformations <NUMBER> contained single s<NUMBER> rbd conformation <NUMBER> examine conformation s<NUMBER> rbd among sarscov <NUMBER>p ectodomains used local masking image sutraction <NUMBER>d sorting strategy <NUMBER> accurately classify conformations either three s<NUMBER> rbd positions within trimer analysis revealed majority <NUMBER>p proteins singleup conformation <NUMBER> lesser amounts doubleand tripleup conformations <NUMBER> <NUMBER> respectively alldown conformation observed increased propensity adopt s<NUMBER> rbd conformation may indicate difference coronavirus containing <NUMBER>p mutations however differences sample preparation cannot fully ruled ace<NUMBER> s<NUMBER> cterminal domains examine structural consequences binding ace<NUMBER> stabilized sarscov <NUMBER>p combined sarscov <NUMBER>p ectodomain excess soluble human ace<NUMBER> subsequent purification sizeexclusion chromatography immediate cryoem specimen preparation supplementary fig s<NUMBER> initial sorting particle heterogeneity indicated spikes could split ace<NUMBER>bound <NUMBER> unbound <NUMBER> classes using similar masking <NUMBER>d sorting strategy sorted unbound class classes s<NUMBER> conformations one two s<NUMBER> rbds fig <NUMBER> supplementary tables s<NUMBER>s<NUMBER> figs s<NUMBER>s<NUMBER> observe alldown class three s<NUMBER> rbd class indicating low prevalence conformations among unbound <NUMBER>p proteins expanding <NUMBER>d sorting strategy classification heterogeneity within sarscov ace<NUMBER> complex reveals <NUMBER> particles bound ace<NUMBER> particles bound ace<NUMBER> configuration s<NUMBER> rbd observed classes containing triple conformation s<NUMBER> rbd poorly represented labeled description class begins lower rbd viewed membrane distal apex proceeds clockwise side views membranedistal top views shown reconstruction s<NUMBER> regions shown blue s<NUMBER> regions shown green soluble ace<NUMBER> shown orange classified ace<NUMBER>bound particles s<NUMBER> rbd position identified single double triple ace<NUMBER>bound able identify s<NUMBER> rbd conformations nonace<NUMBER> occupied rbd positions represent population s<NUMBER> rbd conformations among ace<NUMBER>bound hypothesized previous structural work <NUMBER> <NUMBER> <NUMBER> <NUMBER> s<NUMBER> rbd stabilized spike recognizes ace<NUMBER> s<NUMBER> rbd conformation proportion total s<NUMBER> rbd conformations within ace<NUMBER>bound unbound classes nearly identical within dataset <NUMBER> s<NUMBER> rbd strongly suggests binding single ace<NUMBER> receptor induce adjacent s<NUMBER> rbds transition conformation within context stabilized hence ace<NUMBER> likely bind already s<NUMBER> rbd rather inducing conformational changes required s<NUMBER> rbd become accessible ace<NUMBER> though proportion s<NUMBER> rbd ace<NUMBER> dataset <NUMBER> similar proportion s<NUMBER> rbd sars <NUMBER>p ectodomain dataset <NUMBER> large difference distributions one two conformational states datasets significance difference remains unclear despite prolonged coincubation excess ace<NUMBER> difficulties saturating s<NUMBER> rbd ace<NUMBER> context stabilized trimeric ectodomain poor saturation illustrated small proportion triplebound ace<NUMBER> majority spikes unbound receptor contrast isolated recombinant s<NUMBER> rbd easily binds ace<NUMBER> capable saturating ace<NUMBER> target cells block smediated entry <NUMBER> observed substoichiometric ace<NUMBER> binding trimeric spikes consistent difficulty using soluble ace<NUMBER> receptor neutralize sarscov pseudotyped onto vsv <NUMBER> reduced binding ace<NUMBER> trimeric spikes likely due incomplete exposure conformational flexibility s<NUMBER> rbd contrast mhv binds ceacam<NUMBER>a via s<NUMBER> ntd undergo conformational changes exhibits complete neutralization soluble receptor <NUMBER> <NUMBER> similar recently published merscov structures <NUMBER> ace<NUMBER>bound s<NUMBER> rbd sarscov <NUMBER>p adopts much extended rotated conformation compared s<NUMBER> rbd modeled previous wildtype sarscov structures <NUMBER> supplementary fig s<NUMBER> difference likely due poor density hinge regions s<NUMBER> rbd subdomain <NUMBER> sd<NUMBER> previous reconstructions <NUMBER> <NUMBER> rather presentation unique receptorbound conformation influence stabilizing mutations indeed bound ace<NUMBER> receptor s<NUMBER> rbd reconstructions show poorer density quality less mobile regions sarscov fig <NUMBER> improve density ace<NUMBER>bound s<NUMBER> rbd used focused refinement image subtraction region overcome flexibility domains relative rest sarscov <NUMBER>p yielded <NUMBER> Ã¥ resolution reconstruction improved local density quality fig <NUMBER>bc successfully placed crystal structure sarscov s<NUMBER> rbd bound ace<NUMBER> <NUMBER>ajfpdb <NUMBER> density rigid body indicating previously determined crystal structure accurately recapitulates conformation ace<NUMBER>bound s<NUMBER> rbd prefusion stabilized trimeric spike given s<NUMBER> rbd conformation well separated space sequence <NUMBER>p stabilizing mutations anticipate introduction prefusion stabilizing mutations influences molecular interactions s<NUMBER> rbd ace<NUMBER> beyond perhaps increasing prevalence s<NUMBER> rbd conformations noted indeed wildtype <NUMBER>pstabilized sarscov ectodomains demonstrate similar affinities ace<NUMBER> spr <NUMBER> <NUMBER> nm respectively supplementary fig s<NUMBER> ace<NUMBER>bound s<NUMBER> rbd extends upwards rotates away contacts nearby amino acids hence conformational changes induced receptor binding s<NUMBER> rbd likely caused absence s<NUMBER> rbd contacts conformation rather formation additional intraspike contacts receptorbound state supplementary fig s<NUMBER> indeed movement s<NUMBER> rbd conformation disrupts molecular interactions s<NUMBER> central Î±helices may play role receptorinduced conformational changes wildtype spikes observation hostreceptor engagement s<NUMBER> rbd disrupts interactions within spike manner independent direct receptorspike contacts suggests flexible mechanism different coronavirus spikes may bind diverse protein receptors s<NUMBER> rbd facilitate fusion host cells suggested binding host protein receptor coronavirus spikes induces conformational changes leading fusion exposure s<NUMBER>â² protease site cleavage <NUMBER> <NUMBER> comparison ace<NUMBER>bound <NUMBER>pstabilized spike structures wildtype sarscov <NUMBER>pstabilized sarscov indicate overall structures similar exhibit large conformational differences absence conformational changes includes regions near s<NUMBER>â² cleavage site fusion peptide s<NUMBER> heptad repeat <NUMBER> hr<NUMBER> however fine examination ace<NUMBER>bound structure revealed modest conformational change s<NUMBER> central helix s<NUMBER> uncapped receptorbound rbd wildtype <NUMBER> <NUMBER> <NUMBER>p unbound structures central helix presents Î±helix protomer trimer however ace<NUMBER>bound structure upper portion s<NUMBER> helix uncapped ace<NUMBER>bound s<NUMBER> rbd transitioned <NUMBER> <NUMBER> helix fig <NUMBER>de Î±to <NUMBER> <NUMBER> helix transition unique s<NUMBER> protomer uncapped ace<NUMBER>bound s<NUMBER> rbd observed two copies trimeric spike subtle transition may indicate conformational changes towards fusion initiated central helix nterminal central helix <NUMBER>p mutations stabilize spike prefusion conformation stabilizing mutations may block propagation conformational changes beyond subtle change short <NUMBER> <NUMBER> helix providing possible mechanism prefusion stabilizing effect unlike coronavirus spikes merscov sarscov lacks amino acid sequence capable recognition host furin proteases s<NUMBER>s<NUMBER> cleavage site however sarscov cleaved vitro exogenous trypsin equivalent site proposed similar cleavage event may occur vivo trypsinlike proteases viral entry <NUMBER> <NUMBER> moreover trypsin cleavage sarscov potentiates efficient membrane fusion <NUMBER> <NUMBER> merscov cleavage s<NUMBER>s<NUMBER> enables efficient receptor recognition <NUMBER> addition coronaviruses possess secondary cleavage site s<NUMBER> called s<NUMBER>â² <NUMBER> site thought cleaved host proteases receptor recognition <NUMBER> <NUMBER> <NUMBER> liberates viral fusion peptide insert host membranes s<NUMBER> prehairpin intermediate <NUMBER> s<NUMBER>â² cleavage proposed occur arginine residue conserved across coronavirus genera sarscov arg<NUMBER> <NUMBER> examine trypsin protease sensitivity prefusionstabilized coronavirus spikes carried limited proteolysis experiments wildtype <NUMBER>p sarscov ectodomains presence absence soluble ace<NUMBER> receptor time course proteolysis revealed four samples cleaved s<NUMBER> s<NUMBER> products equivalent rates similar sites supplementary fig s<NUMBER> nearing end time course additional lower molecular weight bands observed interpret degradation s<NUMBER> subunit regardless whether wildtype prefusionstabilized used whether ace<NUMBER> bound ectodomains prominent band corresponds s<NUMBER>â² cleavage product approximately <NUMBER> kda analyze cleavage products detail performed cryoem analysis trypsincleaved sarscov <NUMBER>p ectodomain using allparticles c<NUMBER> symmetry yielded reconstruction <NUMBER> Ã¥ resolution fig <NUMBER> supplementary tables s<NUMBER> s<NUMBER> fig s<NUMBER> short loop containing s<NUMBER>s<NUMBER> cleavage site disordered uncleaved <NUMBER>p reconstruction remains disordered <NUMBER>p trypsin cleaved reconstruction moreover examination structure models indicates significant differences trypsincleaved uncleaved sarscov <NUMBER>p fig <NUMBER>b fine sorting s<NUMBER> rbd positions trypsincleaved reveals similar distribution s<NUMBER> rbd conformations available receptor binding uncleaved samples although additionally observe small proportion s<NUMBER> rbd alldown conformation fig <NUMBER>c results indicate trypsincleavage s<NUMBER>s<NUMBER> impart large conformational changes prefusionstabilized sarscov <NUMBER>p justifies removal s<NUMBER>s<NUMBER> cleavage sites production homogeneous material vaccine immunogens agreement vitro limited proteolysis experiments s<NUMBER>â² site remains uncleaved trypsincleaved <NUMBER>p ectodomain structures arginine proposed s<NUMBER>â² cleavage site coronavirus spike structures published date presented blocked cleavage loop protruding nterminal fusion peptide nterminal helix s<NUMBER> hr<NUMBER> fig <NUMBER> exposure site cleavage present first structures trimeric coronavirus spike ectodomain bound protein receptor well first structures prefusion s<NUMBER>s<NUMBER> cleaved coronavirus spikes structures sarscov <NUMBER>p ectodomain bound soluble form human ace<NUMBER> receptor show conformational changes induced receptor binding likely due disruption proteinprotein interactions rather formation additional contacts s<NUMBER> rbd regions supplementary fig s<NUMBER> conformational change observe ace<NUMBER>sarscov <NUMBER>p structures transition short <NUMBER> <NUMBER> helix top s<NUMBER> central Î±helix uncapped receptorbound s<NUMBER> rbd suggesting extensive conformational changes may initiated <NUMBER> <NUMBER> helices hypothesized act intermediates coiltoÎ±helix transitions <NUMBER> transitions <NUMBER> <NUMBER> helices Î±helices also hypothesized voltage sensing domains potassium channels proposed transition plays role changing resting activated state relaxed state <NUMBER> though extensive changes likely drive conformational rearrangements accompanying membrane fusion <NUMBER>p prefusion stabilizing mutations adjacent short <NUMBER> <NUMBER> helix may block changes occurring however wildtype <NUMBER>p sarscov ectodomains bound ace<NUMBER> cleaved equally trypsin indicating least level trypsin protease susceptibility two receptorbound complexes appear equivalent strategies similar used employed stabilize hiv envelope glycoprotein env trimers prefusion conformation <NUMBER> <NUMBER> hiv env like sars cov also engages protein receptor cd<NUMBER> undergoes large conformational change viral surface upon binding <NUMBER> similarly soluble stabilized versions env undergo large conformational changes upon cd<NUMBER> binding <NUMBER> <NUMBER> <NUMBER> conversely ebola virus glycoprotein gp undergoes modest conformational changes upon binding receptor npc<NUMBER> <NUMBER> <NUMBER> thus class fusion machines likely fundamental differences fusion process requires study structural biochemical data show introduction <NUMBER>p prefusionstabilizing mutations interfere receptor binding recognition trypsinlike proteases structural examinations receptorbound trypsincleaved prefusionstabilized sarscov <NUMBER>p proteins indicate neither receptor binding trypsin cleavage induce large conformational changes stabilized spikes additionally structures accompanying limited proteolysis experiments show neither receptor binding trypsin cleavage expose s<NUMBER>â² cleavage site proteolysis within stabilized spike ectodomains work increases body knowledge surrounding prefusionstabilized spikes presenting native surfaces interactions host factors maintaining prefusion conformation mammaliancodonoptimized gene encoding sarscov tor<NUMBER> strain residues <NUMBER> cterminal t<NUMBER> fibritin trimerization domain hrv<NUMBER>c cleavage site <NUMBER>xhistag twinstreptag synthesized subcloned eukaryoticexpression vector pÎ±h prolinesubstituted variant harboring k<NUMBER>p v<NUMBER>p mutations generated based construct resulting plasmids designated sars wt sars <NUMBER>p respectively transfected <NUMBER> l freestyle <NUMBER>f cells life technologies <NUMBER>f cells used without validation tested mycoplasma three hours transfection kifunensine added final concentration <NUMBER> Î¼m cultures harvested <NUMBER> protein purified supernatant using streptactin resin iba hrv<NUMBER>c protease <NUMBER> wtwt added protein reaction incubated overnight <NUMBER> Â°c digested protein purified using superose <NUMBER> <NUMBER> column ge healthcare life sciences gene encoding human ace<NUMBER> residues <NUMBER> hrv<NUMBER>c cleavage site <NUMBER>xhistag twinstreptag synthesized subcloned eukaryoticexpression vector pÎ±h protein expressed described proteins hrv<NUMBER>c digested ace<NUMBER> protein purified using superdex <NUMBER> column ge healthcare life sciences make complexes sars <NUMBER>p soluble ace<NUMBER> two proteins combined <NUMBER> molar ratio prior overnight incubation sizeexclusion chromatography superose <NUMBER> increase <NUMBER> ge healthcare life sciences purified sarscov wt sarscov <NUMBER>p ectodomain captured nta sensor chip via <NUMBER>x histag level â¼<NUMBER> response units ru per cycle using biacore x<NUMBER> ge healthcare nta sensorchip regenerated cycles using <NUMBER> mm edta <NUMBER> mm naoh followed <NUMBER> mm nicl <NUMBER> sample containing <NUMBER> mm hepes ph <NUMBER> <NUMBER> mm sodium chloride <NUMBER> surfactant p<NUMBER> ge healthcare hbsp injected sarscov reference flow cells followed injections purified ace<NUMBER> serially diluted <NUMBER>fold <NUMBER> nm <NUMBER> nm hbsp duplication electron microscopy data collection <NUMBER> Âµl <NUMBER> mgml protein protein complexes mixed <NUMBER> Âµl <NUMBER> wv amphipol a<NUMBER> anatrace prior grid preparation <NUMBER> Âµl protein mixture final concentration <NUMBER> mgml spotted plasma cleaned cflat grids <NUMBER> Âµm<NUMBER> Âµm spacing grids blotted <NUMBER> seconds plunge freezing liquid ethane vitrobot grids loaded onto titan krios data collected using leginon <NUMBER> total dose <NUMBER> e â Ã¥ <NUMBER> frames aligned motioncor<NUMBER> ucsf <NUMBER> implemented appion workflow <NUMBER> particles selected using dog picker <NUMBER> images assessed particle picks masked using em hole punch <NUMBER> ctf image estimated using gctf <NUMBER> electron microscopy data processing initial particle stacks cleaned using multiple rounds <NUMBER>d classification relion <NUMBER> good particles selected resembling prefusion coronavirus spikes sars <NUMBER>p trypsintreated sars <NUMBER>p particles clean stacks used reconstruction c<NUMBER> symmetry datasets extensively sorted using <NUMBER>d classification examine heterogeneity s<NUMBER> rbds described previously <NUMBER> briefly <NUMBER>d masks defined encompass possible heterogeneity s<NUMBER> rbd position density within masks removed unfiltered unsharpened reconstructions used relionproject image subtraction create particle stack containing signal arising masked density finally used focused <NUMBER>d classification identify compositional conformational states s<NUMBER> rbd position <NUMBER>d reconstructions produced relion <NUMBER> final refinements performed sixpixel softedge solvent mask postprocessing applied reconstruction apply bfactor sharpening amplitude corrections well calculate local resolution maps coordinate models built several highresolution reconstructions using <NUMBER>i<NUMBER>pdb <NUMBER> <NUMBER>ajf pdb <NUMBER> <NUMBER>x<NUMBER>s pdb <NUMBER> template models reference recently published wildtype sars ectodomain <NUMBER>x<NUMBER> pdb <NUMBER> manual model building performed coot <NUMBER> coordinate refinement rosetta relax <NUMBER> realspace refinement phenix <NUMBER> final rounds coordinate refinement adp estimation performed phenix limited proteolysis <NUMBER> Âµg either sarscov <NUMBER>p sarscov wt ectodomains mixed soluble ace<NUMBER> <NUMBER> ratio incubated overnight <NUMBER> Â°c proteins digested <NUMBER> ww tpck trypsin room temperature sdspage analysis samples removed indicated time points immediately mixed sds loading buffer incubated <NUMBER> Â°c <NUMBER> minute em analysis proteolysis reaction stopped two hours using phenylmethylsulfonylfloride pmsf final concentration <NUMBER> mm immediately loaded onto superose <NUMBER> increase <NUMBER> sizeexclusion column sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd configuration sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd configuration sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd configuration ace<NUMBER> sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd configuration ace<NUMBER> sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd configuration ace<NUMBER> sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd configuration ace<NUMBER> sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd configuration ace<NUMBER> ace<NUMBER> sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd configuration ace<NUMBER> ace<NUMBER> sars <NUMBER>p ace<NUMBER> s<NUMBER> rbd incursion animal usually batderived coronaviruses human population caused several outbreaks severe disease starting severe acute respiratory syndrome sars <NUMBER> <NUMBER> menachery et al <NUMBER> late <NUMBER> highly infectious illness coldlike symptoms progressing pneumonia acute respiratory failure resulting estimated <NUMBER> overall death rate baud et al <NUMBER> higher mortality among elderly immunocompromised populations identified confirmed pandemic <NUMBER> th march <NUMBER> etiological agent novel coronavirus sarscov<NUMBER> belonging lineage b betacoronavirus sharing <NUMBER> sequence identity bat coronaviruses lu et al <NUMBER>a heavily glycosylated trimeric surface spike protein mediates viral entry host cell large type transmembrane glycoprotein ectodomain alone comprises <NUMBER> residues wrapp et al <NUMBER> made single polypeptide cleaved host proteases yield nterminal s<NUMBER> region cterminal s<NUMBER> region spike exists initially prefusion state domains s<NUMBER> cloak upper portion spike relatively small <NUMBER> kda s<NUMBER> rbd nestled tip rbd predominantly state receptor binding site inaccessible however appears stochastically flips hingelike motion transiently presenting ace<NUMBER> receptor binding site roy <NUMBER> song et al <NUMBER> walls et al <NUMBER> wrapp et al <NUMBER> ace<NUMBER> acts functional receptor sarscov sarscov<NUMBER> binding latter <NUMBER> <NUMBER>fold higher affinity k <NUMBER> nm possibly contributing ease transmission song et al <NUMBER> wrapp et al <NUMBER> <NUMBER> sequence identity rbds sarscov sarscov<NUMBER> figure s<NUMBER> ace<NUMBER> locks holds rbd destabilising s<NUMBER> cloak possibly favouring conversion postfusion form s<NUMBER> subunit massive conformational changes propels fusion domain upwards engage host membrane casting s<NUMBER> process song et al <NUMBER> wrapp et al <NUMBER> structural studies rbd complex ace<NUMBER> lan et al <NUMBER> wang et al <NUMBER>b yan et al <NUMBER> recognized extracellular peptidase domain pd ace<NUMBER> mainly polar interactions <NUMBER> protein attractive candidate vaccine development immunotherapy potent nanomolar affinity neutralising human monoclonal antibodies sarscov rbd identified attach ace<NUMBER> receptor binding site including m<NUMBER> cr<NUMBER> <NUMBER>r ter meulen et al <NUMBER> sui et al <NUMBER> zhu et al <NUMBER> example <NUMBER>r binds nanomolar affinity prevents binding ace<NUMBER> formation syncytia vitro inhibits viral replication vivo sui et al <NUMBER> however despite two viruses sharing ace<NUMBER> receptor ace<NUMBER> blocking antibodies bind sarscov<NUMBER> rbd wrapp et al <NUMBER> contrast cr<NUMBER> sarscovspecific monoclonal selected single chain fv phage display library constructed lymphocytes convalescent sars patient reconstructed igg<NUMBER> format ter meulen et al <NUMBER> reported crossreact strongly binding rbd sarscov<NUMBER> k <NUMBER> nm tian et al <NUMBER> whilst competing binding ace<NUMBER> ter meulen et al <NUMBER> furthermore although sarscov escape mutations could readily generated ace<NUMBER>blocking cr<NUMBER> escape mutations could generated cr<NUMBER> preventing mapping epitope ter meulen et al <NUMBER> furthermore natural mutation sarscov<NUMBER> detected residue <NUMBER> n gisaid shu mccauley <NUMBER> accession id epiisl<NUMBER> wieneckebaldacchino et al <NUMBER> forms part ace<NUMBER> binding epitope finally cr<NUMBER> cr<NUMBER> act synergistically neutralise sarscov extreme potency ter meulen et al <NUMBER> whilst work prepared publication paper reporting cr<NUMBER> neutralise sarscov<NUMBER> describing structure complex rbd <NUMBER> Ã¥ resolution published yuan et al <NUMBER> extend structure analysis significantly higher resolution using different neutralisation assay show cr<NUMBER> neutralise sarscov<NUMBER> via mechanism would detected method yuan et al yuan et al <NUMBER> use cryoem analysis interaction cr<NUMBER> full spike ectodomain confirm <NUMBER> mechanism taken together observations suggest cr<NUMBER> epitope major target therapeutic antibodies understand cr<NUMBER> works first investigated interaction cr<NUMBER> fab isolated recombinant sarscov<NUMBER> rbd alone presence ace<NUMBER> surface plasmon resonance spr measurements methods figure s<NUMBER> confirmed cr<NUMBER> binding rbd strong although weaker binding reported sarscov ter meulen et al <NUMBER> slight variation according whether cr<NUMBER> rbd used analyte k <NUMBER> nm <NUMBER> nm respectively derived kinetic data table s<NUMBER> independent measure using biolayer interferometry bli rbd analyte gave k <NUMBER> nm methods figure s<NUMBER> values quite similar reported tian et al tian et al <NUMBER> <NUMBER> nm whereas weaker binding k <NUMBER> nm reported recently yuan et al yuan et al <NUMBER> using spr perform competition assay revealed binding ace<NUMBER> rbd perturbed presence cr<NUMBER> figure s<NUMBER> presence ace<NUMBER> slows binding cr<NUMBER> rbd accelerates dissociation similarly release ace<NUMBER> rbd accelerated presence cr<NUMBER> observations suggestive allosteric effect ace<NUMBER> cr<NUMBER> plaque reduction neutralisation test using sarscov<NUMBER> virus cr<NUMBER> showed nd<NUMBER> <NUMBER> starting concentration <NUMBER>mgml calculated according grist grist <NUMBER> superior mers convalescent serum nd<NUMBER> <NUMBER> used nibsc <NUMBER> international standard positive control see methods table s<NUMBER> corresponds <NUMBER> neutralisation <NUMBER> nm <NUMBER> ugml similar neutralising concentration <NUMBER> neutralisation <NUMBER> ugml reported ter meulen et al ter meulen et al <NUMBER> sarscov however discussed apparent disagreement result reported recently yuan et al yuan et al <NUMBER> determined crystal structure sarscov<NUMBER> rbdcr<NUMBER> fab complex see methods table s<NUMBER> investigate relationship binding epitopes ace<NUMBER> cr<NUMBER> crystals grew rapidly consistently two crystal forms grew drop solvent content crystal form solved first unusually high ca <NUMBER> ace<NUMBER> binding site exposed large continuous solvent channels within crystal lattice figure s<NUMBER> crystals therefore offer promising vehicle crystallographic screening identify potential therapeutics could act block virus attachment current analysis crystal form <NUMBER> Ã¥ resolution avoid overfitting refinement used novel realspace refinement algorithm optimise phases vagabond hmg unpublished see methods together favourable observation parameter ratio resulting exceptionally high solvent content meant map high quality allowing reliable structural interpretation figure s<NUMBER> methods full interpretation detailed interactions cr<NUMBER> rbd enabled second crystal form diffracted high resolution <NUMBER> Ã¥ structure refined give rworkrfree <NUMBER> good stereochemistry methods table s<NUMBER> figure s<NUMBER> highresolution structure shown figure <NUMBER>a two complexes crystal asymmetric unit residues <NUMBER> one rbd <NUMBER> <NUMBER> rbd well defined whilst residues<NUMBER> cr<NUMBER> heavy chains disordered rbd similar structure seen complex sarscov<NUMBER> rbd ace<NUMBER> rmsd <NUMBER> ca atoms <NUMBER> Ã¥ <NUMBER> pdb <NUMBER>m<NUMBER>j lan et al <NUMBER> rmsd <NUMBER> Ã¥ <NUMBER> compared sars cov rbd pdb <NUMBER>ajf li et al <NUMBER> minor conformational changes introduced binding cr<NUMBER> residues <NUMBER> rbd deglycosylated methods leave single saccharide unit nlinked glycosylation sites clearly seen n<NUMBER> n<NUMBER> figure s<NUMBER> cr<NUMBER> attaches rbd surface orthogonal ace<NUMBER> receptor binding site overlap epitopes indeed fab ace<NUMBER> ectodomain bind without clashing figure <NUMBER>d tian et al <NUMBER> independence ace<NUMBER> binding site reported recently another sarscov<NUMBER> neutralising antibody <NUMBER>d<NUMBER> fab complex interface buries <NUMBER> Ã¥ <NUMBER> surface area <NUMBER> <NUMBER> Ã¥ <NUMBER> heavy light chains respectively figure <NUMBER>a figure s<NUMBER> somewhat rbdace<NUMBER> interface covers <NUMBER> Ã¥ <NUMBER> pdb <NUMBER>m<NUMBER>j lan et al <NUMBER> typical fab complex interaction mediated antibody cdr loops fit well rather sculpted surface rbd figure <NUMBER>b c heavy chain cdr<NUMBER> <NUMBER> <NUMBER> make contacts residues Î± <NUMBER> Î² <NUMBER> Î± <NUMBER> residues <NUMBER> two light chain cdrs <NUMBER> <NUMBER> interact mainly residues Î² <NUMBER>Î±<NUMBER> loop Î± <NUMBER> <NUMBER> Î± <NUMBER>Î²<NUMBER> loop <NUMBER> figures <NUMBER> s<NUMBER> s<NUMBER> total <NUMBER> residues heavy chain <NUMBER> light chain cement interaction <NUMBER> residues rbd heavy chain potentially form <NUMBER> hbonds <NUMBER> salt bridges latter d<NUMBER> e<NUMBER> cdr<NUMBER> k<NUMBER> rbd whilst light chain interface comprises <NUMBER> hbonds single salt bridge e<NUMBER> cdr<NUMBER> k<NUMBER> rbd binding consolidated number hydrophobic <NUMBER> interactions figure s<NUMBER>b <NUMBER> residues involved interaction <NUMBER> conserved sarscov sarscov<NUMBER> figure <NUMBER>b figure s<NUMBER> cr<NUMBER> epitope much conserved receptor blocking antisarscov antibody <NUMBER>r <NUMBER> <NUMBER> interacting residues conserved hwang et al <NUMBER> inline lack cross reactivity observed latter reason conservation cr<NUMBER> epitope becomes clear context complete prefusion structure pdb ids <NUMBER>vsb wrapp et al <NUMBER> <NUMBER>vxx <NUMBER>vyb walls et al <NUMBER> epitope inaccessible figure <NUMBER> rbd configuration cr<NUMBER> epitope packed tightly another rbd trimer nterminal domain ntd neighbouring protomer structure prefusion form trimeric spike majority rbds although presumably stochastically one may walls et al <NUMBER> wrapp et al <NUMBER> structure sarscov complex ace<NUMBER> ectodomain shows configuration competent bind receptor family orientations significantly different hinge angles song et al <NUMBER> however cr<NUMBER> epitope remains largely inaccessible even configuration modelling rotation rbd required enable fab interaction context spike trimer showed rotation corresponding <NUMBER>Â° declination central vertical axis required beyond observed previously walls et al <NUMBER> wrapp et al <NUMBER> figure <NUMBER>i although might partly mitigated complex movements rbd one rbd configuration requirement would relaxed somewhat since locking state receptor blocking antibodies thought destabilise prefusion state walls et al <NUMBER> binding cr<NUMBER> presumably introduces destabilisation leading premature conversion postfusion state inactivating virus cr<NUMBER> ace<NUMBER> blocking antibodies bind <NUMBER> independently induce conformation presumably explaining observed synergy binding two sites ter meulen et al <NUMBER> test cr<NUMBER> binding destabilises prefusion state spike ectodomain construct described previously wrapp et al <NUMBER> used produce glycosylated protein hek cells methods cryoem screening showed protein trimeric prefusion conformation spike mixed excess cr<NUMBER> fab incubated room temperature aliquots taken <NUMBER> minutes <NUMBER> hours aliquots immediately applied cryoem grids frozen methods <NUMBER> minutes incubation collection substantial amount data allowed unbiased particle picking <NUMBER>d classification revealed two major structural classes similar number prefusion conformation ii radically different conformation methods table s<NUMBER> figure s<NUMBER> detailed analysis prefusion conformation led structure nominal resolution <NUMBER> Ã¥ fsc <NUMBER> based broad distribution orientations revealed predominant rbd pattern one two previously seen wrapp et al <NUMBER> evidence cr<NUMBER> binding figure <NUMBER>a figure s<NUMBER> analysis major particle class revealed strong preferential orientation particles grid figure s<NUMBER>a despite reconstruction nominal resolution <NUMBER> Ã¥ within plane grid perhaps <NUMBER> Ã¥ resolution perpendicular direction figure s<NUMBER>b could produced allowed unambiguous fitting cr<NUMBER>rbd complex figure <NUMBER>b note addition less well defined density attached rbd suitable position correspond spike nterminal domain wrapp et al <NUMBER> structures longer trimeric rather two complexes associate form approximately symmetric dimer however application symmetry reconstruction process improve <NUMBER> <NUMBER> resolution interactions responsible dimerisation involve ace<NUMBER> binding site rbd elbow fab however interaction occur lowresolution crystal form therefore probably extremely weak biologically significant since conversion postfusion conformation leads dissociation s<NUMBER> includes nterminal domain rbd results confirm cr<NUMBER> destabilises prefusion spike conformation evidence provided analysis data collected <NUMBER> h incubation point intact trimers remaining heterogeneous range oligomeric assemblies appeared able interpret detail consistent lateral assembly fabrbd complexes figure s<NUMBER> note relatively slow kinetics representative events vivo conversion might accelerated elevated temperature absence mutations added construct stabilise prefusion state kirchdoerfer et al <NUMBER> pallesen et al <NUMBER> wrapp et al <NUMBER> documented mechanism neutralisation coronaviruses blocking receptor attachment case sarscov achieved presentation rbd spike conformation although yet confirmed sarscov<NUMBER> likely similar mechanism apply define second class neutralisers bind highly conserved epitope figure s<NUMBER> therefore act sarscov sarscov<NUMBER> cr<NUMBER> first identified neutralising antibody sarscov ter meulen et al <NUMBER> find binding cr<NUMBER> isolated rbd tight <NUMBER> nm crystal structure complex reveals atomic detail interaction despite spatial separation cr<NUMBER> ace<NUMBER> epitopes find allosteric effect two binding events role <NUMBER> <NUMBER> cr<NUMBER> epitope stabilising prefusion spike trimer explains date proved impossible generate mutations escape binding antibody ter meulen et al <NUMBER> whilst assay cr<NUMBER> neutralises sarscov<NUMBER> recent paper yuan et al <NUMBER> reported alternative assay detect neutralisation difference likely due removal antibodyvirus mix adsorption indicator cells incubating allow cytopathic effect cpe develop would inline distinction previously seen neutralisation tests influenza virus antibodies bind stem hemagglutinin therefore block receptor binding thomson et al <NUMBER> antibodies appear neutralising tested standard neutralisation assay similar protocol used adopted yuan et al inoculum virusantibody washed development cpe neutralisation observed however antibodies left assay incubation produce cpe analogy would expect antibodies rbd block attachment ace<NUMBER> behave similar way antibodies globular head ha whilst antibodies cr<NUMBER> neutralise alternative mechanism blocking receptor attachment may need present throughout incubation period indicator cells reveal neutralisation agrees observation absence ace<NUMBER> cr<NUMBER> fab destroys prefusionstabilised trimer <NUMBER> <NUMBER>h room temperature measured cryoem monoclonal antibodies recognised potential antivirals lu et al <NUMBER>b salazar et al <NUMBER> results suggest cr<NUMBER> may immediate utility since mechanism neutralisation unusually resistant virus escape contrast antibodies compete ace<NUMBER> whose epitope sarscov<NUMBER> reported already <NUMBER> <NUMBER> shown mutation residue <NUMBER> gisaid accession id epiisl<NUMBER> wieneckebaldacchino et al <NUMBER> shu mccauley <NUMBER> likely susceptible escape furthermore knowledge detailed structure epitope presented higher affinity version cr<NUMBER> might engineered alternatively since mechanism neutralisation likely used antibodies potent monoclonal antibody targeting epitope might found instance screening competition cr<NUMBER> additionally since epitope sterically functionally independent wellestablished receptorblocking neutralising antibody epitope considerable scope therapeutic synergy antibodies targeting two epitopes indeed type validate spr results k fab cr<NUMBER> rbd also measured biolayer interferometry kinetic assays performed octet red <NUMBER>e fortebio <NUMBER> â shake speed <NUMBER> rpm fab cr<NUMBER> immobilized onto amine reactive <NUMBER>nd generation ar<NUMBER>g biosensors fortebio serially diluted rbd <NUMBER>ï¼<NUMBER>ï¼<NUMBER>ï¼<NUMBER> <NUMBER> nm used analyte pbs ph <NUMBER> used assay buffer recorded data analysed using data analysis software ht v<NUMBER> fortebio global <NUMBER> fitting model neutralising virus titres measured serum samples heatinactivated <NUMBER> Â°c <NUMBER> minutes sarscov<NUMBER> strain victoria<NUMBER> cell passage <NUMBER> caly et al <NUMBER> diluted concentration <NUMBER>e<NUMBER> pfuml <NUMBER> pfu<NUMBER> Âµl mixed <NUMBER> <NUMBER> fcsmem containing <NUMBER> mm hepes buffer doubling serum dilutions <NUMBER> <NUMBER> <NUMBER>well vbottomed plate plate incubated <NUMBER> Â°c humidified box <NUMBER> hour allow antibody serum samples neutralise virus cr<NUMBER> ph<NUMBER> starting concentration <NUMBER> mgml diluted <NUMBER> <NUMBER> dilutions made <NUMBER>fold <NUMBER> neutralised virus transferred wells twice dpbswashed plaque assay <NUMBER>well plate seeded verohslam previous day <NUMBER>e<NUMBER> cells per well <NUMBER> fcsmem neutralised virus allowed adsorb <NUMBER> Â°c hour overlaid plaque assay overlay media <NUMBER>x mem<NUMBER> cmc<NUMBER> fcs final <NUMBER> days incubation <NUMBER> Â°c humified box plates fixed stained plaques counted dilutions controls performed duplicate median neutralising titres nd<NUMBER> determined using spearmankarber formula kÃ¤rber <NUMBER> relative virus control wells purified deglycosylated rbd cr<NUMBER> fab concentrated <NUMBER> mgml <NUMBER> mgml respectively mixed approximate molar ratio <NUMBER> crystallization screen experiments carried using nanolitre sittingdrop vapour diffusion method <NUMBER>well plates previously described walter et al <NUMBER> walter et al <NUMBER> transmission data indexed integrated scaled automated data processing program xia<NUMBER>dials winter <NUMBER> winter et al <NUMBER> data set <NUMBER>Â° collected single frozen crystal <NUMBER> Ã¥ resolution <NUMBER>fold redundancy crystal belongs space group p<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> unit cell dimensions b <NUMBER> Ã¥ c <NUMBER> Ã¥ structure determined molecular replacement phaser mccoy et al <NUMBER> using search models human germline antibody fabs <NUMBER>o<NUMBER> pdb id <NUMBER>kmt teplyakov et al <NUMBER> heavy chain ighv<NUMBER>igk<NUMBER> pdb id <NUMBER>i<NUMBER>d teplyakov et al <NUMBER> light chain rbd sarscov<NUMBER> rbdace<NUMBER> complex pdb id <NUMBER>m<NUMBER>j lan et al <NUMBER> one rbdcr<NUMBER> complex crystal asymmetric unit resulting crystal solvent content <NUMBER> optimization crystallization conditions second crystal form found grow condition similar morphology data set <NUMBER>Â° rotation data extending <NUMBER> Ã¥ collected beamline i<NUMBER> diamond one crystals exposure time <NUMBER> per <NUMBER>Â° frame beam size <NUMBER>Ã<NUMBER> Î¼ <NUMBER> beam transmission crystal also belongs space group p<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> significantly different unit cell dimensions b <NUMBER> Ã¥ c <NUMBER> Ã¥ two rbdcr<NUMBER> complexes asymmetric unit solvent content <NUMBER> initial structure determined using lower resolution data first crystal form data excluded resolution <NUMBER> Ã¥ fell beamstop shadow one cycle refmac<NUMBER> murshudov et al <NUMBER> used refine atomic coordinates manual correction coot emsley cowtan <NUMBER> figure s<NUMBER> final refined structure r work <NUMBER> r free <NUMBER> data <NUMBER> Ã¥ resolution structure later used determine structure second crystal form refined phenix liebschner et al <NUMBER> r work <NUMBER> r free <NUMBER> data <NUMBER> Ã¥ resolution refined model revealed presence one extra residue heavy chain nterminus <NUMBER> extra residues nterminus one rbd signal peptide well ordered density single glycan glycosylation sites n<NUMBER> n<NUMBER> one rbd one n<NUMBER> second rbd data collection structure refinement statistics given table s<NUMBER> structural comparisons used shp stuart et al <NUMBER> residues forming rbdfab interface identified pisa krissinel henrick <NUMBER> figures prepared pymol pymol molecular graphics system version <NUMBER>r<NUMBER>pre schrÃ¶dinger llc purified spike protein buffer exchanged <NUMBER> mm tris ph <NUMBER> <NUMBER> mm nacl <NUMBER> nan<NUMBER> buffer using desalting column zeba thermo fisher Î¼ nominal magnification x<NUMBER> corresponding calibrated pixel size <NUMBER> Ã¥pixel see table s<NUMBER> cryoem data processing <NUMBER> <NUMBER> <NUMBER> minute <NUMBER> h incubation datasets motion correction alignment <NUMBER>x binned superresolution movies performed using relion<NUMBER> ctfestimation gctf v<NUMBER> zhang <NUMBER> nontemplatedriven particle picking performed within cryosparc v<NUMBER>live followed multiple rounds <NUMBER>d classification punjani et al <NUMBER> <NUMBER> minutes dataset <NUMBER>d class averages structurea structureb used separately templatedriven classification rounds <NUMBER>d <NUMBER>d classification c<NUMBER> symmetry structures sharpened cryosparc data processing refinement statistics given table s<NUMBER> initial model spike structurea generated using pdb id <NUMBER>vyb walls et al <NUMBER> rigid body fitted final map using coot emsley cowtan <NUMBER> model refined real space phenix liebschner et al <NUMBER> resulted correlation coefficient <NUMBER> two copies rbdcr<NUMBER> fitted structureb manner strongly anisotropic resolution overall correlation coefficient vs model lower <NUMBER> <NUMBER> h incubation dataset particles extracted larger box size <NUMBER> pixels compared <NUMBER> pixels following multiple rounds <NUMBER>d classification <NUMBER>d class averages blobpicked particles showing signs complete flowerlike structures selected ab initio reconstruction <NUMBER> h data detailed fitting attempted te red negative blue positive mysterious pneumonia illness first reported late december <NUMBER> wuhan china rapidly spread dozen countries including united states thousands infected individuals hundreds deaths within month <NUMBER> scientists china isolated virus patients determined genetic code pathogen responsible epidemic new coronavirus designated <NUMBER>ncov world health organization <NUMBER>ncov belongs family viruses wellknown severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov killed hundreds people past <NUMBER> years coronaviruses consist large diverse family viruses classified four genera alpha beta gamma delta coronavirus <NUMBER> <NUMBER> representative alphacoronaviruses include human coronavirus nl<NUMBER> hcovnl<NUMBER> betacoronaviruses include bestknown sarscov merscov based nucleic acid sequence similarity newly identified <NUMBER>ncov betacoronavirus entry coronaviruses host cells mediated spike glycoprotein gives coronaviruses crownlike appearance forming spikes surface amino acid sequence spike glycoprotein consists large ectodomain singlepass transmembrane anchor short cterminal intracellular tail <NUMBER> ectodomain contains receptorbinding unit s<NUMBER> membranefusion unit s<NUMBER> electron microscopic imaging illustrated spike glycoprotein forms cloveshaped spike three s<NUMBER> heads trimeric s<NUMBER> stalk virus enter host cell s<NUMBER> binds specific cell surface receptor via receptorbinding domain rbd s<NUMBER> fuses host cell viral membranes enabling entry viral genomes host cells specific rbdreceptor binding determines cell animal infected also serves target therapeutic inventions treat diseases caused coronaviruses previous studies identified angiotensin converting enzyme <NUMBER> ace<NUMBER> functional receptor sarscov <NUMBER> <NUMBER> study analyzed structure spike glycoprotein rbd <NUMBER>ncov identified unique feature potentially allows high affinity binding ace<NUMBER> human cells discussed potential candidates natural hosts <NUMBER>ncov routes transmission strategies inhibit virus entry therapeutic applications genomic sequence <NUMBER>ncov deposited wang et al downloaded genbank database mn<NUMBER> dna protein sequences compared using blast program multiple sequence alignment performed using clustal omega program threedimensional structure analyzed using cn<NUMBER>d program ncbi protein structure simulation performed using swissmodel based cocrystal structure human ace<NUMBER> sarscov spike glycoprotein rbd <NUMBER> pdb id <NUMBER>ajf ace<NUMBER> rdb interaction analyzed molecular docking using patchdock firedock programs using initially reported sequence mn<NUMBER> blast search ncbi database revealed <NUMBER> inputs virus essentially identical sequences accession nc<NUMBER> mn<NUMBER> mn<NUMBER> mn<NUMBER> mn<NUMBER> mn<NUMBER> closest homolog <NUMBER>ncov sarslike coronavirus isolated bat mg<NUMBER> sequence identity <NUMBER> <NUMBER> coverage fig <NUMBER>a also shows <NUMBER> sequence identity sars coronavirus isolated human patients civet <NUMBER> coverage throughout entire <NUMBER>bp genome <NUMBER>ncov least conserved region encodes spike glycoprotein sequence identity <NUMBER>e<NUMBER> spike glycoprotein forms spikes surface coronaviruses responsible entrance viruses host cells rbd spike glycoprotein molecule directly binds receptors surface host cells <NUMBER> case sarscov batcivet sarslike cov receptor ace<NUMBER> exopeptidase catalyzes conversion angiotensin nonapeptide angiotensin<NUMBER> conversion angiotensin ii angiotensin<NUMBER> <NUMBER>e<NUMBER> protein level whole spike glycoprotein rbd share <NUMBER> <NUMBER> sequence identity sarscov respectively sarscov spike glycoprotein known glycosylated total <NUMBER> predicated nglycosylation sites found spike glycoprotein <NUMBER>ncov shared sarscov except latter contains extra glycosylation site n<NUMBER> detailed sequence alignment rbd sarscov spike glycoprotein closely related coronaviruses protein level shown fig <NUMBER>b crystal structure sarscov rbd complex receptor human ace<NUMBER> solved <NUMBER> performing molecular simulation obtained ternary structure rbd <NUMBER>ncov essentially superimposable sarscov fig <NUMBER>aec except noted structural variation loop loop <NUMBER> backbone deduced rbd structure consists <NUMBER> beta sheets peptide segments involved formation secondary structure highly conserved without presence secondary structure breakers four cysteinyl residues form disulfide bonds corresponding c<NUMBER>c<NUMBER> c<NUMBER>c<NUMBER> sarscov also conserved see also fig <NUMBER>b furthermore performed molecular docking examine binding rbd ace<NUMBER> deduced complex structure reveals similar mode extensive interaction seen sarscov favorable binding energy Ã <NUMBER> <NUMBER> vs Ã <NUMBER> kcalmol fig <NUMBER>def contact ace<NUMBER> rbd involves two bsheets three loops see figs <NUMBER>b <NUMBER>a <NUMBER> amino acid residues sarscov rbd directly contact ace<NUMBER> <NUMBER> conserved <NUMBER>ncov see fig <NUMBER>b presumably substituted amino acids either reduce enhance interaction define contribution variant amino acids rbd ace<NUMBER> interaction compare sequences rbd three sarscovassociated viruses fig <NUMBER>b include coronaviruses isolated patients short weak sars outbreak <NUMBER>e<NUMBER> denoted sarsv palm civets bats possible sources sarscov found humans <NUMBER>e<NUMBER> recombinant proteins containing rbd <NUMBER> viruses known bind human ace<NUMBER> <NUMBER> <NUMBER> comparison sarscov responsible major sras outbreak <NUMBER>e<NUMBER> binding sarsv civet rbds substantially weaker <NUMBER> quantitative binding affinity bat rbd determined <NUMBER> amino acid residues rbd ace<NUMBER> binding interface plays crucial role determining binding affinity among <NUMBER> amino acid residues rbd sars contact ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> shared sarsv civet bat <NUMBER>ncov respectively fig <NUMBER>b n<NUMBER> found sars viruses isolated human patients changed k r civet bat respectively earlier study demonstrated n<NUMBER> k substitution resulted significantly lower affinity <NUMBER>fold increase kd values <NUMBER> interestingly amino acid substituted similar amino acid glutamine q<NUMBER> <NUMBER>ncov also contains amide group extended position potentially carry similar functions comparison sarscov t<NUMBER> changed asparagine n<NUMBER> <NUMBER>ncov alanine serine viruses shown t<NUMBER> substitution increased kd <NUMBER>fold suggesting methyl group rather hydroxyl group threonine residue important interaction <NUMBER> hard predict n<NUMBER> amide group confer better interaction hydrophobic amino acid l<NUMBER> also important interaction rbd ace<NUMBER> interestingly substituted proline sarsv phenylalanine <NUMBER>ncov corresponding f<NUMBER> l<NUMBER> located loop formed disulfide bond c<NUMBER>c<NUMBER> interestingly loop ctppalnc sarscov replaced cngvegfnc <NUMBER>ncov containing one extra amino acid residue totally different amino acid compositions replacement two proline residues two flexible glycine residues converts rigid structure flexible one examination deduced rbdace<NUMBER> complex structure reveals unique phenylalanine f<NUMBER> flexible loop penetrate deep hydrophobic pocket ace<NUMBER> formed f<NUMBER> l<NUMBER> y<NUMBER> l<NUMBER> fig <NUMBER>f presence two aromatic amino acids pocket may provide additional binding force via pstacking interactions <NUMBER> taken together <NUMBER>ncov likely stronger binding ace<NUMBER> via spike glycoprotein glycosylation may also affect interaction rbd ace<NUMBER> among <NUMBER> glycosylation sites spike glycoprotein two rbd fig <NUMBER>b glycosylation detected one residues asn<NUMBER> <NUMBER> n<NUMBER> corresponds n<NUMBER> spike glycoprotein <NUMBER>ncov conserved glycosylation site since well separated rbdace<NUMBER> interaction interphase glycosylation site unlikely interfere interaction <NUMBER> noted another potential glycosylation site corresponding n<NUMBER> sarscov conserved <NUMBER>ncov substitution Ã¾<NUMBER> position lack glycosylation expected affect receptor binding <NUMBER>ncov outbreak thought initiated seafood market also carried many wild live animals including snakes birds various mammals interestingly study ji et al suggests snakes might serve likely reservoir novel ncov<NUMBER> based observation codon usage ncov<NUMBER> similar snakes potential hosts investigated <NUMBER> data premise debated sought address problem analyzing structure ace<NUMBER> different animals ace<NUMBER> widely expressed animal kingdom fish amphibians reptiles birds mammals remarkably structure highly conserved comparison human ace<NUMBER> civet paguma larvata aax<NUMBER> bat rhinolophus sinicus adn<NUMBER> bird nipponia nippon kfq<NUMBER> snake protobothrops mucrosquamatus xp<NUMBER> frog xenopus laevis xp<NUMBER> fish callorhinchus milii xp<NUMBER> revealed amino acid sequence identity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively fig <NUMBER> aligns parts ace<NUMBER> sequences contain interaction sites contact sarscov rbd according published cocrystal structure <NUMBER> interaction involved mainly two ahelices ace<NUMBER> <NUMBER> amino acid residues involved direct interaction <NUMBER> shared seven species animals analyzed study including f<NUMBER> supposedly interacts f<NUMBER> spike glycoprotein <NUMBER>ncov fig <NUMBER>f many remaining resides contact conserved replaced amino acids similar chemical properties interesting note bird ace<NUMBER> shares many conserved contacting amino acid residues bat civet ace<NUMBER> ace<NUMBER> molecules potential interact rbd <NUMBER>ncov high affinity therefore would surprise wild animals found primary secondary host <NUMBER>ncov sarscovlike coronaviruses found many bats considered natural reservoirs viruses may well host <NUMBER>ncov however possibility coldblooded animals like snakes serve host cannot ruled flexible interacting loop identified study may allow virus adapt coldblooded warmblooded hosts performing immunostaining earlies studies demonstrated expression ace<NUMBER> lung alveolar epithelial cells well arterial venous endothelial cells arterial smooth muscle cells renal tubular epithelium epithelia small intestine <NUMBER> <NUMBER> lung expression provides strong support infection sarscov <NUMBER>ncov airways lung however searching human protein atlas database found ace<NUMBER> mrna mainly detected small intestine colon duodenum kidney testis gallbladder expression level lung minimal fig <NUMBER> furthermore examining data two singlecell rnaseq studies <NUMBER> <NUMBER> identified <NUMBER> <NUMBER> <NUMBER> <NUMBER> lung epithelial cells expressed detectable level ace<NUMBER> wwwebiacukgxasc confirms overall expression ace<NUMBER> lung low may also suggest presence selected cells upregulated ace<NUMBER> expression certain conditions tissue expression pattern ace<NUMBER> suggests modes virus transmission may involve functions intestine kidney testis tissues particular attention paid intestines expressed highest level ace<NUMBER> earlier studies demonstrated diarrhea present <NUMBER> patients infected sarscov <NUMBER> importantly recent case report demonstrated presence <NUMBER>ncov feces patient initial diarrhea episode <NUMBER> finding noted reports tests feces urine samples presence <NUMBER>ncov warranted may help reveal alternative routes virus transmission since initial outbreak <NUMBER>ncov infection much contagious originally thought know virus capable spreading quickly human human people spread virus even become symptomatic <NUMBER> makes harder contain virus many concerned possibility new pandemic study suggests unique structural features spike glycoprotein rbd <NUMBER>ncov confers potentially higher affinity binding receptor found sarscov higher affinity binding capability number viruses required infect cell much reduced partly explains <NUMBER>ncov appears aggressive sarscov also reminds us lesserknown coronavirus hcovnl<NUMBER> also uses ace<NUMBER> also receptor hcovnl<NUMBER> initially isolated child bronchiolitis netherlands <NUMBER> belongs alphacoronavirus subfamily rbd sarscov shares structural homology sarscov recognizes region ace<NUMBER> however cocrystal structure reveals rbd nl<NUMBER>cov narrower contact ace<NUMBER> involving fewer amino acids <NUMBER> presumably results weaker interaction evidently nl<NUMBER>cov spread aggressively causes mild moderate respiratory infections <NUMBER> exact mode transmission <NUMBER>ncov firmly established sarscov thought transmitted respiratory droplets produced infected person coughs sneezes <NUMBER> respiratory droplets spread occur direct persontoperson contact close distance presumably <NUMBER>ncov transmitted respiratory droplets may also transmitted effectively air long distance airborne spread ways considering predominant expression ace<NUMBER> intestines kidney <NUMBER>ncov may infect cells tissues find way feces urine makes transmission fecaloral route bodyfluids urine possible presence <NUMBER>ncov feces supports notion <NUMBER> specific rbdreceptor binding determines cell animal infected also serves target therapeutic inventions treat diseases caused coronaviruses binding directly ace<NUMBER> surface host cells spike glycoprotein plays essential role virus infection obvious way stop virus infection block rbd ace<NUMBER> interaction achieved using antibodies small molecular inhibitors naturally antibodies inhibitors disrupt interaction rbd ace<NUMBER> therapeutic importance using molecular docking approach earlier study identified n<NUMBER>aminoethyl<NUMBER> aziridineethanamine novel ace<NUMBER> inhibitor effectively blocks sarscov rbdmediated cell fusion <NUMBER> provided potential candidate lead compound therapeutic drug development meanwhile biochemical cellbased assays established screen chemical compound libraries identify novel inhibitors hand many ace inhibitors currently used treat hypertension cardiovascular diseases <NUMBER> among captopril perindopril ramipril lisinopril benazepril moexipril although drugs primarily target ace homolog ace<NUMBER> <NUMBER> sequence identity <NUMBER> sequence similarity catalytic domain may effective toward ace<NUMBER> well <NUMBER> noted ace inhibitors bind catalytic center rather rbd binding site nonetheless enzymatic inhibitors may indirectly alter conformation rbd binding site thereby affect interaction ace<NUMBER> rbd certainly worthwhile test drugs ability block rbdace<NUMBER> interaction <NUMBER> coronavirus disease covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> spread globally since first outbreak wuhan china december <NUMBER> <NUMBER>â<NUMBER> common symptoms sarscov<NUMBER> infected patients involve fever cough fatigue estimated death rate <NUMBER>â<NUMBER> <NUMBER> already caused <NUMBER> million confirmed cases <NUMBER> deaths world time work written addition health concerns disease also brought severe economic social issues <NUMBER> situation wuhan stepped europe united states experiencing major epidemic thus crucial understand infection spreading process find measures mitigate epidemic situation sarscov<NUMBER> member betacoronavirus genus <NUMBER> also includes acute respiratory syndrome coronavirus sarscov middleeast respiratory syndrome virus mers sarscov<NUMBER> virus appears optimized binding human receptor ace<NUMBER> <NUMBER> binding patterns ace<NUMBER> sarscov<NUMBER> sarscov receptor binding domain rbd thought almost identical <NUMBER> specifically sarscov<NUMBER> shares <NUMBER>â<NUMBER> sequence identity sarscov whole protein <NUMBER>â<NUMBER> rbd <NUMBER> trimeric spike glycoprotein sarscov<NUMBER> comprised three s<NUMBER>s<NUMBER> units rbd locates s<NUMBER> one variation s<NUMBER>s<NUMBER> cleavage site sarscov<NUMBER> unique rrar furin recognition site <NUMBER> sarscov single arginine <NUMBER> three s<NUMBER>s<NUMBER> units undergo hingelike conformational switch states state rbd exposed able bind receptor state rbd hidden inaccessible receptor <NUMBER> sarscov spike trimer two one populated state <NUMBER> could likely case sarscov<NUMBER> knowledge experimental statistical measurement reported yet recent study pointed possibility two spike proteins binding ace<NUMBER> <NUMBER> binding receptor following cascade events triggered spike protein undergoes large conformational change s<NUMBER> receptor shed s<NUMBER> transformed stable postfusion state finally viral membrane fused cell membrane <NUMBER> <NUMBER> despite similarities structures binding patterns two viruses sarscov<NUMBER> spreads faster sarscov might due stronger binding ace<NUMBER>sarscov<NUMBER> complex <NUMBER> range experimental binding affinities two ace<NUMBER>virus wide reports <NUMBER> nm <NUMBER> <NUMBER>â<NUMBER> nm <NUMBER> ace<NUMBER>sarscov<NUMBER> ace<NUMBER>sarscov complexes respectively also reports <NUMBER> nm <NUMBER> nm <NUMBER> <NUMBER> nm <NUMBER> nm <NUMBER> systems respectively cases ace<NUMBER>sarscov<NUMBER> complex shows larger binding affinity ace<NUMBER>sarscov hand although sequences epitope studied extensively still unclear structuralenergetic basis difference two complexes moreover receptor binding crucial step drug antibody interference infection process thus work focus understanding detailed differences binding features two coronaviruses human receptor ace<NUMBER> recent works yielded highresolution structure sarscov<NUMBER> prefusion state <NUMBER> well complex rbd domain ace<NUMBER> <NUMBER> emerging structures provide opportunity use computational modeling investigate underlying mechanism behind differences binding strengths two ace<NUMBER>virus complexes however task challenging example recent theoretical work <NUMBER> analyzed number contacts interface area fluctuations concluded different viruses different strategy binding however work could obtain correct order binding affinity ace<NUMBER>sarscov<NUMBER> ace<NUMBER>sarscov complexes obviously main issue differences interaction free energies two types viruses receptor energy essential understanding binding process evaluating binding energy large protein complex enormous challenge fully atomistic models thus chose use coarsegrained cg model <NUMBER>â<NUMBER> study energetics complexes cg model consistently developed systematically calibrated account proper evaluation electrostatic free energies proteins membranes including course solvation hydrophobic effects model applied extensively many systems calculating proteinfolding free energies related properties <NUMBER>â<NUMBER> use model evaluate binding virus ace<NUMBER> analysis binding patterns found substitutions residues near rbd sarscov conversion sarscov<NUMBER> reason increase binding energy found major contribution actually comes body spike protein away rbd also found antibody sarscov show crossreactivity might partially due fact binding interface partially covered compare situation ace<NUMBER>sarscov<NUMBER> complex work used modeler <NUMBER> perform homology modeling constructing binding complexes ace<NUMBER>sarscov<NUMBER> m<NUMBER>sarscov<NUMBER> sarscov<NUMBER> structure taken recent cryoem study pdb id <NUMBER>vsb <NUMBER> incomplete receptor binding domain binding domain used crystal structure sarscov<NUMBER> rbd bound ace<NUMBER> pdb id <NUMBER>m<NUMBER>j <NUMBER> binding m<NUMBER> sarscov<NUMBER> modeled using m<NUMBER>sarscov structure template pdb id <NUMBER>dd<NUMBER> <NUMBER> subsequently utilized cg model calculate free energy structure relevant binding energies cg model focused electrostatic free energy protein involves solvation energy interactions charged polar residues full cg treatment includes membrane terms see si included present case since membrane system studied total cg energy defined follows <NUMBER> see also si terms right side chain van der waals energy main chain solvation energy main chain hydrogen bond energy side chain electrostatic energy side chain polar energy side chain hydrophobic energy main chainside chain electrostatic energy main chainside chain van der waals energy respectively scaling coefficients c <NUMBER> c <NUMBER> c <NUMBER> taking values <NUMBER> <NUMBER> <NUMBER> work evaluation free energy used monte carlo proton transfer mcpt method <NUMBER> determine charge configuration ionizable residues system mcpt approach mc procedure controls proton transfer moves ionizable residues one ionizable residue bulk acceptance probability move determined standard metropolis criteria see si calculations able get cg free energy protein configuration also electrostatic contribution residue either journal physical chemistry b pubsacsorgjpcb article ace<NUMBER>virus complex unbound state note cg already represents free energy system potential energy calculations simulations carried using molarisxg package <NUMBER> <NUMBER> details see si started trying evaluate binding energy differences two complexes ace<NUMBER>sarscov<NUMBER> ace<NUMBER>sarscov determine difference coming study utilized recently published cryoem structure sarscov<NUMBER> pdb id <NUMBER>vsb <NUMBER> crystal structure rbd ace<NUMBER> pdb id <NUMBER>m<NUMBER>j <NUMBER> performed homologymodeling order obtain structure ace<NUMBER>sarscov<NUMBER> complex structure ace<NUMBER>sarscov taken previous work pdb id <NUMBER>cs<NUMBER> <NUMBER> getting structures performed energy minimization molecular dynamics structural relaxation procedure followed mcpt algorithm <NUMBER> determines optimal charge distribution ionizable residues obtained cg energies ace<NUMBER>sarscov<NUMBER> ace<NUMBER>sarscov complexes treatment obtained cg energies ace<NUMBER> sarscov sarscov<NUMBER> monomers infinite distance separation ace<NUMBER>virus binding free energy calculated Î´g binding g complex â g ace<NUMBER> â g virus even though binding mode two ace<NUMBER>virus complexes figure <NUMBER>b argued almost identical <NUMBER> still obtained binding energy â<NUMBER> kcalmol ace<NUMBER>sarscov<NUMBER> â<NUMBER> ace<NUMBER>sarscov respectively expected major difference come electrostatic contributions point binding energy difference could either effect nonconserved residues change structures two complexes near outside rbds understand issue quantitative way evaluated electrostatic contributions residue total binding free energy two complexes see figure <NUMBER>a found residues give positive contributions others give negative contributions finding consistent results show interactions binding interface strengthen others weaken binding <NUMBER> see whether difference binding comes rbd classified free energy contributions based distances binding site thus plotted figure <NUMBER>b contributions residues within given range total free energy done according distances n<NUMBER> residue ace<NUMBER>sarscov<NUMBER> t<NUMBER> ace<NUMBER>sarscov surprise consider journal physical chemistry b pubsacsorgjpcb article residues within <NUMBER> Ã¥ binding site found ace<NUMBER>sarscov complex stronger binding affinity curve ace<NUMBER>sarscov<NUMBER> curve apparently residues <NUMBER> <NUMBER> Ã¥ residues switched trend result indicates binding receptor remote position binding site possibly leads stronger binding ace<NUMBER>sarscov<NUMBER> ace<NUMBER>sarscov interestingly three s<NUMBER>s<NUMBER> cleavage sites also locate within <NUMBER>â<NUMBER> Ã¥ range view conclusion tried examine whether finding longrange interactions coincidental thus tested influence effective dielectric constant cg model using constant <NUMBER> <NUMBER> also use function form Îµ eff <NUMBER> Îµâ²<NUMBER> â expâÎ¼r ij used Îµâ² <NUMBER> Î¼ <NUMBER> found trend stayed similar different dielectric constants still possible including effect ionic strength would reduce binding difference long distance sign unlikely change noted value overall calculated binding energy probably overestimate one missing effect entropy contribution separate parts complex equal two systems another missing effect abovementioned effect ionic strength would reduce electrostatic interaction illustrate contributions residue plot contributions figure <NUMBER>c figure assigns residue one color free energy contribution complexes residues relatively large energy changes near binding site red yellow colors according figure <NUMBER>b contributions negative ace<NUMBER>sarscov<NUMBER> however move outside rbd residues type appear thinner spike protein body sarscov<NUMBER> compared fatter spike protein body sarscov suggests ace<NUMBER>virus complexes residues rbd region strengthen binding others weaken figure <NUMBER>a however interactions change <NUMBER> <NUMBER> Ã¥ binding site makes binding affinity sarscov<NUMBER> stronger figure <NUMBER>b may indicate effective evolution spike protein body novel virus larger binding affinity might explain sarscov<NUMBER> spreads faster sarscov structural homology similar binding patterns several rbddirected monoclonal antibodies m<NUMBER> s<NUMBER> <NUMBER>r sarscov tested sarscov<NUMBER> none could show crossreactivity <NUMBER> <NUMBER> another antibody cr<NUMBER> obtained convalescent sarscov patient could bind sarscov<NUMBER> still could neutralize virus even concentration high <NUMBER> Î¼gml crossreactivity attributed high percentage targeted epitope residues <NUMBER> <NUMBER> work tried understand absence crossreactivity studying binding pattern sarscov<NUMBER> one sarscov antibody m<NUMBER> used homology modeling generate structure m<NUMBER>sarscov<NUMBER> complex sarscov<NUMBER> pdb id <NUMBER>vsb <NUMBER> m<NUMBER>sarscov rbd pdb id <NUMBER>dd<NUMBER> <NUMBER> structures antibodyvirus complexes used Î´g binding g complex â g m<NUMBER> â g virus figure <NUMBER>a shows overlapped structures ace<NUMBER>sarscov<NUMBER> m<NUMBER>sarscov<NUMBER> complexes aligned toward virus body visually m<NUMBER> antibody covers part ace<NUMBER>sarscov<NUMBER> binding interface analyzed distancedependent electrostatic energy contributions m<NUMBER>virus complex seen figure <NUMBER>b binding m<NUMBER> sarscov<NUMBER> result structuralenergetic differences lead increase interactions range <NUMBER> <NUMBER> Ã¥ observed ace<NUMBER>sarscov<NUMBER> complex energy contribution near rbd <NUMBER> Ã¥ also weaker comparison corresponding contribution ace<NUMBER>virus complex overall m<NUMBER> shows ineffective binding pattern misses part epitopes ace<NUMBER> could trigger following structural changes might also case antibodies show crossreactivity mimic ace<NUMBER>sarscov<NUMBER> binding pattern zhang et al synthesized <NUMBER>mer peptide fragment ace<NUMBER> peptidase domain Î±<NUMBER> helix <NUMBER> however binding affinity strong might effect instability small helix fragment structural analysis shows <NUMBER> key residues participate binding ace<NUMBER> sarscov <NUMBER> among eight conserved sarscov<NUMBER> six mutated six mutated residues n<NUMBER> r<NUMBER> sarscov<NUMBER>sarscov l<NUMBER>y<NUMBER> f<NUMBER>l<NUMBER> q<NUMBER>n<NUMBER> q<NUMBER>y<NUMBER> n<NUMBER>t<NUMBER> figure <NUMBER>a understand substituted residues would affect binding energy performed mutation calculations two ace<NUMBER>virus complexes residues ace<NUMBER>sarscov<NUMBER> table <NUMBER> mutated ace<NUMBER>sarscov<NUMBER> constructs less stable compared wildtype system mutated ace<NUMBER>sarscov shows opposite results consistent previous distancedependent binding energy contributions near rbd find ace<NUMBER> sarscov complex gives favorable binding pattern ace<NUMBER>sarscov<NUMBER> complex figure <NUMBER>b mutation calculation suggests effective binding novel virus might happen remote part current work explored structuralenergetic basis difference binding energy sarscov<NUMBER> ace<NUMBER> sarscovace<NUMBER> complexes found binding sarscov<NUMBER> favorable rbd optimized sarscov<NUMBER> glycoprotein trimer body evolved bind stronger distanced sites fact consider rbd sarscov favorable clear stronger binding converted conformational changes cleavage subsequent fusion events however case interesting explanation reason novel coronavirus spreads faster easier results also suggest use novel virus template drugantibody design whole spike protein binding template instead fraction rbd might neglect essential changes virus body size effect supporting information available free charge httpspubsacsorgdoi<NUMBER>acsjpcb<NUMBER>c<NUMBER> constructing assemblies energetics cg protein model figure protein complex construction done utilizing available experimental structures structure used work combination elements cryoem xray diffraction xrd structures receptor ace<NUMBER> structure comes cryoem ace<NUMBER>sarscov<NUMBER> complex pdb id <NUMBER>vsb <NUMBER> protein body novel virus sarscov<NUMBER> utilized two structures one virus body pdb <NUMBER>vsb however structure misses loop near binding domain another available structure xrd complex ace<NUMBER> receptor binding domain sarscov<NUMBER> structure loop near rbd complete pdb id <NUMBER>m<NUMBER>j <NUMBER> combined protein body pdb <NUMBER>vsb loops near rbd <NUMBER>m<NUMBER>j obtain complete sarscov<NUMBER> protein body entire ace<NUMBER>sarscov complex structure taken cryoem structure pdb id <NUMBER>cs<NUMBER> <NUMBER> sarscov antibody m<NUMBER> complex used xrd structure pdb id <NUMBER>dd<NUMBER> <NUMBER> binding patterns ace<NUMBER>sarscov<NUMBER> ace<NUMBER>sarscov m<NUMBER>sarscov directly obtained mentioned pdb structures binding pattern m<NUMBER> sarscov<NUMBER> obtained mimicking binding pattern m<NUMBER> sarscov homologymodelling done modeller <NUMBER> obtaining structures trim coarsegrained cg representation perform steepest decent energy minimization md relaxation eliminate unreasonable closed interactions potential energy converged next use monte carlo proton transfer mcpt procedure obtain cg free energies see simulations calculations done molarisxg package software <NUMBER> binding energy calculated following equations ace<NUMBER>virus complexes m<NUMBER>virus complexes development realistic cg models field slow partly due difficulties obtaining unique points calibration used relatively extensive benchmark folding experiments membrane insertion experiments cg model continuously developed refined group based solvation model ionizable residues emphasis keyrole electrostatic effects protein <NUMBER> cg model entire side chain represented cb fig s<NUMBER> total cg free energy given total cg folding free energy taken relative free energy unfolded system water zero allied potential two terms represent main chain side chain contributions third term accounts total protein side chain flexibility estimating overall conformational entropy main chain energy given contributions backbone solvation hydrogen bonds c<NUMBER> c<NUMBER> scaling coefficients <NUMBER> <NUMBER> respectively side chain term given first three terms electrostatic polar hydrophobic components respectively last term van der waals component side chain interactions c<NUMBER> scaling coefficient <NUMBER> focus placed electrostatic term computed sum change free energy associated chargecharge interactions ionizable side chains ââ â change solvation free energy residues specific environment ââ â inside protein water finally electrodes electrolytes presented another term added total energy last term cg representation effect external potential details see ref <NUMBER>a <NUMBER>b cg energy evaluation use monte carlo proton transfer mcpt algorithm obtain charge configuration system <NUMBER>a mcpt approach mc controls proton transfer ionizable residues one ionizable residue bulk acceptance possibility move determined standard metropolis criteria actual mcpt used time dependent study proton transport processes described ref <NUMBER>b however use approach obtained equilibrated ionization states cov epidemic saudi arabia similar manifestations detected acute lung injury often followed pulmonary renal failure dromedary camels involved infection thought common source transmission animal human nevertheless risk factors human remained unclear <NUMBER> <NUMBER> infection merscov virus spread france uk spain italy tunisia fatality rate merscov infected persons <NUMBER> <NUMBER> high fatality rates <NUMBER> <NUMBER> reported sarscov merscov respectively fortunately fatality rate sarscov<NUMBER> <NUMBER> reported significantly low <NUMBER> three pathogenic viruses belong genus betacoronavirus previously known coronaviruses infect human includes human coronavirus <NUMBER>e hcov<NUMBER>e oc<NUMBER> hcovoc<NUMBER> nl<NUMBER> hcovnl<NUMBER> hku<NUMBER> hcovhku<NUMBER> <NUMBER> metagenomics nextgeneration sequencing technology identified genetic material j u r n l p r e p r f highly conserved two overall identity <NUMBER> fact according homology sarscov<NUMBER> ratg<NUMBER> sarslike coronavirus bats <NUMBER> wholegenome level <NUMBER> depicting bat zoonotic source newly evolved sarscov<NUMBER> <NUMBER> sarscov<NUMBER> found enveloped virus particle size <NUMBER> nm diameter name suggests corona means crown crowned like projections seen electron microscopy <NUMBER> positive sense rna genetic material size <NUMBER> kb fig <NUMBER> roughly distributed among adenosines <NUMBER> cytosines <NUMBER> guanines <NUMBER> rest thymines <NUMBER> <NUMBER> genome compacted helical nucleocapsid often enclosed lipid bilayer also rna genome covs largest among rna viruses <NUMBER> nonstructural open reading frames also present <NUMBER> orf<NUMBER>ab largest gene sarscov<NUMBER> encoding polyprotein pp<NUMBER>ab another gene orf<NUMBER>a encodes polyprotein pp<NUMBER>a twothirds viral rna situated first orf orf<NUMBER>ab encodes <NUMBER> residues long polyprotein thus orf<NUMBER>a orf<NUMBER>ab translated produce pp<NUMBER>a pp<NUMBER>ab polyproteins cleaved proteases encoded orf<NUMBER>a yield <NUMBER> nonstructural proteins nsps sequence studies noted variations sarscov<NUMBER> sarscov lack <NUMBER>a gene variation number base pairs <NUMBER>b <NUMBER>c genes sarscov<NUMBER> <NUMBER> addition around <NUMBER> substitutions recognized within genome sarscov<NUMBER> compared previously known coronaviruses systemic study may affected functionality pathogenicity novel virus <NUMBER> said proteins extensively studied devising new antiviral agents covid<NUMBER> genome well <NUMBER>d structures indicate main drugbinding pockets probably conserved across sarscov<NUMBER> sars mers <NUMBER> coronaviruses entry found often biphasic nature means enter cell near cell surface late endosomal phase <NUMBER> addition characteristic coronavirus fusion peptide fragment fusion protein works calciumdependent manner employed membrane fusion different receptors identified nsp<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> receptor merscov <NUMBER> receptor hcov<NUMBER>e found aminopeptidase n aka cd<NUMBER> lung epithelial cells primary targets sarscov<NUMBER> binding takes place receptor binding domain class viral fusion protein called spike glycoprotein ace<NUMBER> receptor lung epithelial cells <NUMBER> fig <NUMBER> molecular interactions studies crystal structure analysis also confirms spike protein sarscov<NUMBER> binds human angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor readily infects ciliated bronchial cells type ii pneumocytes found lungs unfortunately sarscov<NUMBER> affinity ace<NUMBER> receptors sarscov due single n<NUMBER>t mutation protein sarscov<NUMBER> <NUMBER> aids transmission host host noteworthy expression level well allele frequency ace<NUMBER> receptors varies among populations factors may correlate disease susceptibility sequence polymorphism binding viral protein ace<NUMBER> induces negative feedback loop level ace<NUMBER> drops counterpart enzyme ace picks role converting substrate angiotensin angiotensin ii elevated levels angiotensin ii results profound binding receptor agtr<NUMBER>a resulting increased pulmonary vascular permeability <NUMBER> study <NUMBER> patients infected sarscov<NUMBER> showed females less susceptible infection males older males comorbidities j u r n l p r e p r f likely infected sarscov<NUMBER> highlighted insights role ace<NUMBER> sarscov<NUMBER> pandemic <NUMBER> <NUMBER> advance research field structural molecular biology shall reveal complexities molecular mechanism prompts coronavirus smediated membrane fusion sarscov<NUMBER> seventh member coronavirus family characteristic manifestation lower upper respiratory tracts symptoms like dry productive cough sore throat lassitude followed fever <NUMBER> sterility csection coupled isolation measures immediately rule possibility infection birth strongly raising suspicion utero transmission virus neonate needed external ventilator support twelve hours extubated put cpap outcome favourable require antibiotic support lab tests imaging found normal throughout <NUMBER> infected patients shown high leukocyte counts abnormal respiratory functioning boosted proinflammatory cytokines tnfÎ± mip<NUMBER>Î± interleukin<NUMBER> <NUMBER> <NUMBER> additionally creactive protein erythrocyte sedimentation rate ddimer formation also peaks infection <NUMBER> journal preproof j u r n l p r e p r f covid<NUMBER> showed unique clinical features include targeting lower airway evident symptoms like rhinitis sneezing sore throat fig <NUMBER> also patients infected covid<NUMBER> found developed intestinal symptoms like diarrhoea <NUMBER> mers sars patients diarrhoea <NUMBER> upon entering host sarscov<NUMBER> reported stay respiratory tract days asymptomatic period found virus persists <NUMBER> days severe cases <NUMBER> days nonsevere cases viral load profile found peak time onset symptoms transmissible easily early stage infection high viral load found severe cases potentially used marker case severity prognosis viral rna particle found faeces <NUMBER> days onset symptom persists <NUMBER> <NUMBER> weeks well total blood urine serum saliva <NUMBER> main mode transmission fomites respiratory droplets rates transmission appear similar asymptomatic symptomatic patients according data revealed european centre disease prevention control environmental sustainability active sarscov<NUMBER> <NUMBER> hours air aerosolization around <NUMBER> hours chipboard almost <NUMBER> days stainless steel plastic based assessment made chinese government indicated <NUMBER> j u r n l p r e p r f cterminal together comprise ed <NUMBER> crucial successful entry coronavirus host cell s<NUMBER> initiates first step viral entry contains receptorbinding domain s<NUMBER> later mediate fusion cell viral membranes critical step cleavage protein generally mediated host protein convertase allows fusion sequences exposed required fusion cleavage protein s<NUMBER>s<NUMBER> site mediates cellcell fusion essential step entry protein human lung cells vital step governed cellular protease furin performs cleavage sarscov<NUMBER> like merscov depends furinmediated precleavage proteins s<NUMBER>s<NUMBER> site activation protein tmprss<NUMBER> lung cells fail express robust levels cathepsin l inhibitors furin tmprss<NUMBER> serve possible therapeutic options covid<NUMBER> recent study reported inhibitor tmprss<NUMBER> blocks sarscov<NUMBER> infection <NUMBER> however interesting point noted furin needed normal development unlike tmprss<NUMBER> hence obstructing furin longer periods associated unwanted toxic effects <NUMBER> genomic analysis novel coronavirus revealed spike protein differs close bat cov relatives sense specific site gets activated j u r n l p r e p r f cleavage site expressed gain function allowed bat cov infect humans <NUMBER> also transmit different hosts gene recombination mutations receptorbinding domain leading higher mortality rate sarscov<NUMBER> virus enter human bronchial epithelia contact ace<NUMBER> receptors making virus highly hostspecific recently crystal structure spike proteins receptorbinding domain sarscov<NUMBER> complex human ace<NUMBER> released wang zhangs group <NUMBER> interestingly study conducted revealed ace<NUMBER> expression higher males females supporting notion <NUMBER> deaths reported males sample study carried new york additional findings suggest binding sarscov<NUMBER> ace<NUMBER> synergistic expression ace<NUMBER> <NUMBER> main components s<NUMBER> domain nterminal domain ntd cterminal domain ctd s<NUMBER> domain marked major antigen surface coronavirus receptor binding domain rbd head region s<NUMBER> recognizes host cell receptor ace<NUMBER> reported glutamine <NUMBER> lysine <NUMBER> key residues rbd ace<NUMBER> respectively involved interaction <NUMBER> initiating membrane fusion viral particles hosts receptor <NUMBER> residues ace<NUMBER> interact rbd contain <NUMBER> amino acids spike protein contact k<NUMBER> ace<NUMBER> r<NUMBER> residue rbd play important role <NUMBER> small section s<NUMBER> region formed <NUMBER> <NUMBER> amino acid residues plenty strong attachment peptidase domain ace<NUMBER> <NUMBER> according another report six rbd residues l<NUMBER> f<NUMBER> q<NUMBER> s<NUMBER> n<NUMBER> y<NUMBER> actively involved ace<NUMBER> receptor binding determining host range sarscov<NUMBER> <NUMBER> s<NUMBER> contains basic elements like hydrophobic fusion peptide needed membrane fusion fig <NUMBER> xray crystallographic analysis demonstrates hr<NUMBER> hr<NUMBER> domains combinedly form <NUMBER>hb fusion core s<NUMBER> subunit sarscov<NUMBER> structure crucial membrane fusion sarscov pro also called chymotrypsinlike protease <NUMBER>cl pro presence cyshis dyad active site responsible protease activity <NUMBER> commonly found recognition sequence pro leuglnâ¦seralagly â¦ denotes cleavage site <NUMBER> pro majorly involved cleavage pps generate nsps later compile replicasetranscriptase complex rtc <NUMBER> pro exists homodimer molecular mass <NUMBER> kda determined mass spectroscopy <NUMBER> <NUMBER> Ã¥ highresolution crystal structure reveals twofold symmetry pro molecule two subunits held together saltbridge interaction glu<NUMBER> one protomer arg<NUMBER> <NUMBER> fig <NUMBER> monomer three distinct domains domains â° â± display antiparallel Î²barrel structures whereas domain iii large antiparallel globular structure made <NUMBER> Î±helices arranged domains ii iii connected using long loop like segment domain iii substrate binds pocket created domains ii highly conserved among covs hand variable regions Î±helices surface loops domain iii <NUMBER> two monomers arranged perpendicular orientation domain ii one contact nh<NUMBER>terminal residues aka nfinger others dimerization essential formation substrate binding sites thus also affect catalytic efficiency protease thereby maintain shape substratebinding pocket s<NUMBER> protein <NUMBER> sarscov<NUMBER> mpro made <NUMBER> amino acid residues crystal structure analysis suggests thr<NUMBER> thr<NUMBER> leu<NUMBER> his<NUMBER> ser<NUMBER> met<NUMBER> tyr<NUMBER> phe<NUMBER> leu<NUMBER> asn<NUMBER> gly<NUMBER> cys<NUMBER> his<NUMBER> met<NUMBER> glu<NUMBER> leu<NUMBER> pro<NUMBER> phe<NUMBER> asp<NUMBER> gln<NUMBER> thr<NUMBER> ala<NUMBER> gln<NUMBER> found active site pocket <NUMBER> pl pro cleaves borderlines nsp<NUMBER> nsp<NUMBER> nsp<NUMBER> works association pro cleave poly protein nsps <NUMBER> pl pro catalytic core domain contains <NUMBER> amino acids responsible cleaving replicase substrates consensus sequence cleavage sites usually found lxgg <NUMBER> fig <NUMBER> major antiviral drugs designed pro pl pro proteases inhibiting activity enzymes could hamper viral replication many studies recently reported drugs targeting main protease possible therapeutics covid<NUMBER> recent literature used repurposing fda approved drugs identify potential leads inhibited sarscov<NUMBER> pro play key role covid<NUMBER> therapeutics <NUMBER> absence similar human protease makes pro easy target antiviral drug development <NUMBER> nonetheless care taken avoid chances host toxicity ensuring cleavage sequence host protease different <NUMBER> another approach could mutate ser<NUMBER> phe<NUMBER> positions crucial sites involved dimerization <NUMBER>clpro <NUMBER> j u r n l p r e p r f helicase unwinds doublestranded rna segment single strands hydrolysing ntps enzyme prefers atp datp dctp substrates due sequence conservation coronaviruses helicase easy target develop antiviral drugs <NUMBER> adp binding site nucleic acid binding site nsp <NUMBER> considered molecular docking studies designing inhibitors serious limitation nonspecificity inhibitors may cause host toxicity rdrp structurally conserved rna polymerase executes rna replication transcription help cofactors nsp<NUMBER> nsp<NUMBER> fig <NUMBER> complex forms largest <NUMBER> kda unit involved rna synthesis also possesses characteristic nidovirus nsp<NUMBER> nterminal domain kinaselike structural fold <NUMBER> j u r n l p r e p r f involved various steps central dogma novel coronavirus two main domains nterminal exoribonuclease exon domain important part play proofreading preventing fatal mutations cterminal domain act guaninen<NUMBER> methyltransferase n<NUMBER>mtase required mrna capping <NUMBER> one rnaprocessing enzymes encoded coronavirus genome forms sixunit endoribonuclease cleaves <NUMBER> end uridines <NUMBER> j u r n l p r e p r f acts cofactor forms assembly nsp<NUMBER> nsp<NUMBER> heterodimer conformation nsp<NUMBER> positioned nsp<NUMBER> monomer nsp <NUMBER> overall conserved structure comprising nterminus made two Î±helices central Î²sheet domain cterminus domain various loops helices <NUMBER> enzyme present localized envelope cov usually <NUMBER> <NUMBER> camostat mesylate serine protease inhibitor well known action tmprss<NUMBER> activity makes potential drug candidate test sarscov<NUMBER> <NUMBER> per centres diseases control prevention cdc two types tests available scan also employed testing covid<NUMBER> <NUMBER> currently approved treatment modalities consist supportive care teamed oxygen supplementation performed via noninvasive ventilation mechanical ventilation severe cases may also treated antibiotics bacterial infection vasopressor support clinicians usa italy reported several complications acute myocardial damage thromboembolic phenomena pe sudden death around <NUMBER> trials progress test possible treatments covid<NUMBER> wang et al wuhan institute virology screened fda approved antivirus antiinfection drugs found remdesivir chloroquine could effectively prevent viral growth cellbased assay ec<NUMBER> <NUMBER> <NUMBER> Î¼m respectively <NUMBER> repurposing drugs happens practical approach response rapidly increasing positive cases antiviral drugs monoclonal antibodies antibodyrich plasma recovered patients also trials ongoing therapies broadly classified two basis targets first approach targets virus entity blocking key enzyme responsible viral life processes replication translation etc preventing entry virus particle human cells approach stress immune system functioning j u r n l p r e p r f either boosting innatehumoral immunity inhibiting inflammatory response led pulmonary failure <NUMBER> <NUMBER> march announced launch solidarity coordinated effort collect scientific data rapidly study design kept simple even hospitals overwhelming number patients participate physician simply records date patient left hospital died duration entire stay whether patient required ventilation oxygen design blinded website randomizes patient one four drug regimes local standard care study chosen experimental antiviral remdesivir antimalarial drughydroxychloroquine combination antiretroviral drugs lopinavir ritonavir combination plus ifnÎ² kong et al recently introduced docking server docking small molecules peptides antibodies potential targets covid<NUMBER> useful researchers across world predicting targetligand interactions covid<NUMBER> <NUMBER> evolution novel coronavirus eventual outbreak covid<NUMBER> put burden medical fraternity scientific community identify components viral entity including genome replication cycle proteome well modes transmission achieved collaborative efforts backed advances molecular structural virology viral proteins identified potential targets since involved phase viral life cycle present review discussed structure function hostvirus interactions various sarscov<NUMBER> proteins based thorough review latest literature available hope review give useful groundwork devising new drugs covid<NUMBER> although many potential therapies clinical trial pharmaceutical products yet offered reliable well effective covid<NUMBER> <NUMBER> st march incursion animal usually batderived coronaviruses human population caused several outbreaks severe disease starting severe acute respiratory syndrome sars <NUMBER> menachery et al <NUMBER> late <NUMBER> highly infectious illness coldlike symptoms progressing pneumonia acute respiratory failure resulting estimated <NUMBER> overall death rate baud et al <NUMBER> higher mortality among elderly immunocompromised populations identified confirmed pandemic <NUMBER> th march <NUMBER> etiological agent novel coronavirus sarscov<NUMBER> belonging lineage b betacoronavirus sharing <NUMBER> sequence identity bat coronaviruses lu et al <NUMBER>a heavily glycosylated trimeric surface spike protein mediates viral entry host cell large type transmembrane glycoprotein ectodomain alone comprises <NUMBER> residues wrapp et al <NUMBER> made single polypeptide cleaved host proteases yield nterminal s<NUMBER> region cterminal s<NUMBER> region spike exists initially prefusion state domains s<NUMBER> cloak upper portion spike relatively small <NUMBER> kda s<NUMBER> rbd nestled tip rbd predominantly state receptor binding site inaccessible however appears stochastically flips hingelike motion transiently presenting ace<NUMBER> receptor binding site roy <NUMBER> song et al <NUMBER> walls et al <NUMBER> wrapp et al <NUMBER> ace<NUMBER> acts functional receptor sarscov<NUMBER> sarscov<NUMBER> binding latter <NUMBER> <NUMBER>fold higher affinity k <NUMBER> nm possibly contributing ease transmission song et al <NUMBER> wrapp et al <NUMBER> <NUMBER> sequence identity rbds sarscov<NUMBER> sarscov<NUMBER> figure <NUMBER> ace<NUMBER> locks holds rbd destabilising s<NUMBER> cloak possibly favouring conversion postfusion form s<NUMBER> subunit massive conformational changes propels fusion domain upwards engage host membrane casting s<NUMBER> process song et al <NUMBER> wrapp et al <NUMBER> structural studies rbd complex ace<NUMBER> lan et al <NUMBER> wang et al <NUMBER> yan et al <NUMBER> show recognised extracellular peptidase domain pd ace<NUMBER> mainly polar interactions spike protein attractive candidate vaccine development immunotherapy potent nanomolar affinity neutralising human monoclonal antibodies sarscov<NUMBER> rbd identified attach ace<NUMBER> receptor binding site including m<NUMBER> cr<NUMBER> <NUMBER>r ter meulen et al <NUMBER> sui et al <NUMBER> zhu et al <NUMBER> example <NUMBER>r binds nanomolar affinity prevents binding ace<NUMBER> formation syncytia vitro inhibits viral replication vivo sui et al <NUMBER> however despite two viruses sharing ace<NUMBER> receptor ace<NUMBER> blocking antibodies bind sarscov<NUMBER> rbd wrapp et al <NUMBER> contrast cr<NUMBER> sarscov<NUMBER>specific monoclonal selected single chain fv phage display library constructed lymphocytes convalescent sars patient reconstructed igg<NUMBER> format ter meulen et al <NUMBER> reported crossreact strongly binding rbd sarscov<NUMBER> k <NUMBER> nm tian et al <NUMBER> whilst competing binding ace<NUMBER> ter meulen et al <NUMBER> furthermore although sarscov<NUMBER> escape mutations could readily generated ace<NUMBER>blocking cr<NUMBER> escape mutations could generated cr<NUMBER> preventing mapping epitope ter meulen et al <NUMBER> furthermore natural mutation sarscov<NUMBER> detected residue <NUMBER> n gisaid shu mccauley <NUMBER> accession id epiisl<NUMBER> wieneckebaldacchino et al <NUMBER> forms part ace<NUMBER> binding epitope finally cr<NUMBER> cr<NUMBER> act synergistically neutralise sarscov<NUMBER> extreme potency ter meulen et al <NUMBER> whilst work prepared publication paper reporting cr<NUMBER> neutralise sarscov<NUMBER> describing structure complex rbd <NUMBER> Ã¥ resolution published yuan et al <NUMBER> report crystallographic analysis significantly higher resolution use different neutralisation assay show cr<NUMBER> neutralise sarscov<NUMBER> use cryoem analysis interaction cr<NUMBER> full spike ectodomain demonstrate mechanism neutralisation seen coronaviruses taken together observations suggest cr<NUMBER> epitope major target therapeutic antibodies understand cr<NUMBER> works first investigated interaction cr<NUMBER> fab isolated recombinant sarscov<NUMBER> rbd alone presence ace<NUMBER> surface plasmon resonance spr measurements methods figure s<NUMBER> confirmed cr<NUMBER> binding rbd strong although weaker binding reported sarscov<NUMBER> ter meulen et al <NUMBER> slight variation according whether cr<NUMBER> rbd used analyte k <NUMBER> nm <NUMBER> nm respectively derived kinetic data table s<NUMBER> independent measure using biolayer interferometry bli rbd analyte gave k <NUMBER> nm methods figure s<NUMBER> values quite similar reported tian et al tian et al <NUMBER> <NUMBER> nm whereas weaker binding k <NUMBER> nm reported recently yuan et al yuan et al <NUMBER> using spr perform competition assay revealed binding ace<NUMBER> rbd perturbed presence cr<NUMBER> figure s<NUMBER> presence ace<NUMBER> slows binding cr<NUMBER> rbd accelerates dissociation similarly release ace<NUMBER> rbd accelerated presence cr<NUMBER> observations suggestive allosteric effect ace<NUMBER> cr<NUMBER> plaque reduction neutralisation test using sarscov<NUMBER> virus cr<NUMBER> showed probit midpoint prnt <NUMBER> <NUMBER> <NUMBER> confidence interval <NUMBER> starting concentration <NUMBER>mgml calculated according grist grist <NUMBER> superior nibsc international standard positive control used public health england mers convalescent serum gives prnt <NUMBER> <NUMBER> <NUMBER> confidence interval <NUMBER> see methods figure <NUMBER> table s<NUMBER> corresponds <NUMBER> neutralisation <NUMBER> Âµgml <NUMBER> nm exceeding <NUMBER> Âµgml reported ter meulen et al ter meulen et al <NUMBER> sarscov<NUMBER> however discussed apparent disagreement result reported recently yuan et al yuan et al <NUMBER> light discrepancy neutralisation tests performed rule differences assay regard antibodyvirus contact time repeated prnt tests deliberately using three different batches cr<NUMBER> gave similar results table s<NUMBER> leaving virusantibody mix place throughout incubation plate removing antibody one hour also gave similar results prnt <NUMBER> values <NUMBER> <NUMBER> respectively methods figure s<NUMBER> summary results taking consideration different cr<NUMBER> starting concentrations within confidence levels following experiments commercial source antibody cr<NUMBER> creative biolabs tested using method date wash leave experiment starting concentration <NUMBER> mgml gave markedly weaker neutralisation prnt <NUMBER> <NUMBER> leaving antibody plate <NUMBER> washing note cases neutralisation slightly higher antibody washed although differences within confidence levels experiments possible reflects unbound virus remaining inoculum washed determined crystal structure sarscov<NUMBER> rbdcr<NUMBER> fab complex see methods table s<NUMBER> investigate relationship binding epitopes ace<NUMBER> cr<NUMBER> crystals grew rapidly consistently two crystal forms grew drop solvent content crystal form solved first unusually high ca <NUMBER> ace<NUMBER> binding site exposed large continuous solvent channels within crystal lattice figure s<NUMBER> crystals therefore offer promising vehicle crystallographic screening identify potential therapeutics could act block virus attachment current analysis crystal form <NUMBER> Ã¥ resolution avoid overfitting refinement used realspace refinement algorithm optimise phases vagabond hmg unpublished see methods together favourable observation parameter ratio resulting exceptionally high solvent content meant map high quality allowing reliable structural interpretation figure s<NUMBER> methods full interpretation detailed interactions cr<NUMBER> rbd enabled second crystal form diffracted high resolution <NUMBER> Ã¥ structure refined give rworkrfree <NUMBER> good stereochemistry methods table s<NUMBER> figure s<NUMBER> structure similar reported yuan et al <NUMBER> rmsd cÎ±s rbd <NUMBER> Ã¥ whilst cr<NUMBER> heavy chain <NUMBER> Ã¥ light chain <NUMBER> Ã¥ also differences overall interaction compared structure overlapping rbd angular differences variable domains <NUMBER> <NUMBER>Âº highresolution structure shown figure <NUMBER> two complexes crystal asymmetric unit residues <NUMBER> one rbd <NUMBER> <NUMBER> rbd well defined whilst residues <NUMBER> cr<NUMBER> heavy chains disordered rbd similar structure seen complex sarscov<NUMBER> rbd ace<NUMBER> rmsd <NUMBER> cÎ± atoms <NUMBER> Ã¥ <NUMBER> pdb <NUMBER>m<NUMBER>j lan et al <NUMBER> rmsd <NUMBER> Ã¥ <NUMBER> compared sars cov<NUMBER> rbd pdb <NUMBER>ajf li et al <NUMBER> minor conformational changes introduced binding cr<NUMBER> residues <NUMBER> rbd deglycosylated methods leave single saccharide unit nlinked glycosylation sites clearly seen n<NUMBER> n<NUMBER> figure s<NUMBER> cr<NUMBER> attaches rbd surface orthogonal ace<NUMBER> receptor binding site overlap epitopes indeed fab ace<NUMBER> ectodomain bind without clashing figure <NUMBER>d tian et al <NUMBER> independence ace<NUMBER> binding site reported recently another sarscov<NUMBER> neutralising antibody <NUMBER>d<NUMBER> okba et al <NUMBER> fab complex interface buries <NUMBER> Ã¥ <NUMBER> surface area <NUMBER> <NUMBER> Ã¥ <NUMBER> heavy light chains respectively figure <NUMBER> figure s<NUMBER> somewhat rbdace<NUMBER> interface covers <NUMBER> Ã¥ <NUMBER> pdb <NUMBER>m<NUMBER>j lan et al <NUMBER> typical fab complex interaction mediated antibody cdr loops fit well rather sculpted surface rbd figure <NUMBER>b c heavy chain cdr<NUMBER> <NUMBER> <NUMBER> make contacts residues Î±<NUMBER> Î²<NUMBER> Î±<NUMBER> residues <NUMBER> two light chain cdrs <NUMBER> <NUMBER> interact mainly residues Î²<NUMBER>Î±<NUMBER> loop Î±<NUMBER> <NUMBER> Î±<NUMBER>Î²<NUMBER> loop <NUMBER> figures <NUMBER> <NUMBER> <NUMBER> total <NUMBER> residues heavy chain <NUMBER> light chain cement interaction <NUMBER> residues rbd heavy chain potentially form <NUMBER> hbonds <NUMBER> salt bridges latter d<NUMBER> e<NUMBER> cdr<NUMBER> k<NUMBER> rbd light chain interface comprises <NUMBER> hbonds single salt bridge e<NUMBER> cdr<NUMBER> k<NUMBER> rbd binding consolidated number hydrophobic interactions figure <NUMBER> slight differences interactions reported yuan et al <NUMBER> instance contact area light chainrbd differs <NUMBER> two structures <NUMBER> residues involved interaction <NUMBER> conserved sarscov<NUMBER> sarscov<NUMBER> figures <NUMBER> <NUMBER> cr<NUMBER> epitope much conserved receptor blocking antisarscov<NUMBER> antibody <NUMBER>r <NUMBER> <NUMBER> interacting residues conserved hwang et al <NUMBER> inline lack cross reactivity observed latter reason conservation cr<NUMBER> epitope becomes clear context complete prefusion structure pdb ids <NUMBER>vsb wrapp et al <NUMBER> <NUMBER>vxx <NUMBER>vyb walls et al <NUMBER> epitope inaccessible figure <NUMBER> rbd configuration cr<NUMBER> epitope packed tightly another rbd trimer nterminal domain ntd neighbouring protomer structure prefusion form trimeric spike majority rbds although presumably stochastically one may walls et al <NUMBER> wrapp et al <NUMBER> structure sarscov<NUMBER> complex ace<NUMBER> ectodomain shows configuration competent bind receptor family orientations significantly different hinge angles song et al <NUMBER> however cr<NUMBER> epitope remains largely inaccessible even configuration modelling rotation rbd required enable fab interaction context spike trimer showed rotation corresponding <NUMBER>Â° declination central vertical axis required beyond observed previously walls et al <NUMBER> wrapp et al <NUMBER> figure <NUMBER>i although might partly mitigated complex movements rbd one rbd configuration requirement would relaxed somewhat since locking state receptor blocking antibodies thought destabilise prefusion state walls et al <NUMBER> binding cr<NUMBER> presumably introduces destabilisation leading premature conversion postfusion state inactivating virus cr<NUMBER> ace<NUMBER> blocking antibodies bind independently induce conformation presumably explaining observed synergy binding two sites ter meulen et al <NUMBER> test cr<NUMBER> binding destabilises prefusion state spike ectodomain construct described previously wrapp et al <NUMBER> used produce glycosylated protein hek cells methods cryoem screening showed protein trimeric prefusion conformation spike mixed excess cr<NUMBER> fab incubated room temperature aliquots taken <NUMBER> minutes <NUMBER> h aliquots immediately applied cryoem grids frozen methods <NUMBER> minutes incubation collection substantial amount data allowed unbiased particle picking <NUMBER>d classification revealed two major structural classes similar number prefusion conformation ii radically different structure methods table s<NUMBER> figure s<NUMBER> detailed analysis prefusion conformation led structure nominal resolution <NUMBER> Ã¥ fsc <NUMBER> based broad distribution orientations revealed predominant rbd pattern one two previously seen wrapp et al <NUMBER> evidence cr<NUMBER> binding figure <NUMBER>a analysis major particle class revealed strong preferential orientation particles grid figure s<NUMBER>c despite reconstruction nominal resolution <NUMBER> Ã¥ within plane grid perhaps <NUMBER> Ã¥ resolution perpendicular direction figure s<NUMBER>g could produced allowed unambiguous fitting cr<NUMBER>rbd complex figure <NUMBER>b note addition less well defined density attached rbd suitable position correspond spike nterminal domain wrapp et al <NUMBER> structures longer trimeric rather two complexes associate form approximately symmetric dimer however application symmetry reconstruction process improve resolution interactions responsible dimerisation involve ace<NUMBER> binding site rbd elbow fab however interaction occur lowresolution crystal form therefore probably extremely weak biologically significant since conversion postfusion conformation leads dissociation s<NUMBER> includes nterminal domain rbd results confirm cr<NUMBER> destabilises prefusion spike conformation evidence provided analysis data collected <NUMBER> h incubation point intact trimers remaining heterogeneous range oligomeric assemblies appeared able interpret detail consistent lateral assembly fabrbd complexes figure s<NUMBER> note relatively slow kinetics representative events vivo conversion might accelerated elevated temperature absence mutations added construct stabilise prefusion state kirchdoerfer et al <NUMBER> pallesen et al <NUMBER> wrapp et al <NUMBER> documented mechanism neutralisation coronaviruses blocking receptor attachment case sarscov<NUMBER> achieved presentation rbd spike conformation although yet confirmed sarscov<NUMBER> likely similar mechanism apply define second class neutralisers bind highly conserved epitope figure <NUMBER> therefore act sarscov<NUMBER> sarscov<NUMBER> cr<NUMBER> first identified neutralising antibody sarscov<NUMBER> ter meulen et al <NUMBER> find binding cr<NUMBER> isolated rbd tight <NUMBER> nm crystal structure complex reveals atomic detail interaction despite spatial separation cr<NUMBER> ace<NUMBER> epitopes find allosteric effect two binding events role cr<NUMBER> epitope stabilising prefusion spike trimer explains date proved impossible generate mutations escape binding antibody ter meulen et al <NUMBER> whilst assay cr<NUMBER> strongly neutralises sarscov<NUMBER> recent paper yuan et al <NUMBER> reported alternative assay detect neutralisation tested whether removal antibodyvirus mix adsorption indicator cells performed yuan et al incubating allow cytopathic effect cpe develop would explain difference would inline distinction previously seen neutralisation tests influenza virus antibodies bind stem hemagglutinin therefore block receptor binding thomson et al <NUMBER> antibodies appear neutralising tested standard neutralisation assay similar yuan et al inoculum virusantibody washed development cpe neutralisation observed however antibodies left assay incubation produce cpe performing sidebyside prnt experiments leaving antibodyvirus mix place washing however show significant difference fact neutralisation marginally stronger excess antibody virus washed check issues related reproducibility performed neutralisation tests three separate batches cr<NUMBER> gave essentially indistinguishable results table s<NUMBER> however tested commercially sourced cr<NUMBER> creative biolabs usa cat mro<NUMBER>lc neutralisation markedly reduced perhaps improperly folded antibody possible loss neutralisation ability commercial antibody may related report cr<NUMBER> neutralise sarscov<NUMBER> yuan et al <NUMBER> addition note prnt tests performed cr<NUMBER> appears give strong incomplete <NUMBER> plaque reduction neutralisation partial neutralisation reported antibodies ebola virus nonetheless confer profound protection rijal et al <NUMBER> saphire et al <NUMBER> given mechanism neutralisation rationalise arises kinetic limitation antibody binding spike destruction seen cryoem absence ace<NUMBER> cr<NUMBER> fab destroys prefusionstabilised trimer <NUMBER> <NUMBER>h room temperature might also lead slightly higher neutralisation antibody noninactivated virus washed cells one hour summary cr<NUMBER> neutralises sarscov<NUMBER> via unusual mechanism assays appear detect poorly observed yuan et al <NUMBER> important establish effective mechanism controlling viral infection monoclonal antibodies recognised potential antivirals lu et al <NUMBER>b qiu et al <NUMBER> salazar et al <NUMBER> results suggest cr<NUMBER> may immediate utility since mechanism neutralisation unusually resistant virus escape contrast antibodies compete ace<NUMBER> whose epitope sarscov<NUMBER> reported already shown mutation residue <NUMBER> gisaid accession id epiisl<NUMBER> wieneckebaldacchino et al <NUMBER> shu mccauley <NUMBER> likely susceptible escape furthermore knowledge detailed structure epitope presented higher affinity version cr<NUMBER> might engineered alternatively since mechanism neutralisation likely used antibodies potent monoclonal antibody targeting epitope might found instance screening competition cr<NUMBER> additionally since epitope sterically functionally independent wellestablished receptorblocking neutralising antibody epitope considerable scope therapeutic synergy antibodies targeting two epitopes indeed type synergy described sarscov<NUMBER> ter meulen et al <NUMBER> moreover reported wan et al <NUMBER> residue numbers sarscov<NUMBER> rbd conserved amino acids red background secondary structures labelled top sequence glycosylation site marked blue hexagon residues involved receptor binding marked magenta disks blue disks mark residues involved interactions cr<NUMBER> heavy chain vh cyan disks mark residues interacting cr<NUMBER> light chain vl green disks chains cr<NUMBER> starting concentration <NUMBER>mgml dilutions used <NUMBER> <NUMBER> probit midpoint <NUMBER> <NUMBER> confidence intervals <NUMBER> <NUMBER> information requests resources reagents directed fulfilled lead contact david stuart davestrubioxacuk plasmids generated study available lead contact completed materials transfer agreement high resolution lower resolution coordinates structure factors sarscov<NUMBER> rbdcr<NUMBER> complex available pdb accession codes <NUMBER>yla <NUMBER>ym<NUMBER> respectively httpswwwrcsborg em maps structure models deposited emdb pdb accession codes emd<NUMBER> <NUMBER>z<NUMBER> prefusion spike emd<NUMBER> <NUMBER>yor dimeric rbdcr<NUMBER> complex respectively httpswwwemdataresourceorg data support findings study available corresponding authors request validate spr results k fab cr<NUMBER> rbd also measured biolayer interferometry kinetic assays performed octet red <NUMBER>e fortebio <NUMBER> â shake speed <NUMBER> rpm fab cr<NUMBER> immobilized onto amine reactive <NUMBER>nd generation ar<NUMBER>g biosensors fortebio serially diluted rbd <NUMBER>ï¼<NUMBER>ï¼<NUMBER>ï¼<NUMBER> <NUMBER> nm used analyte pbs ph <NUMBER> used assay buffer recorded data analysed using data analysis software ht v<NUMBER> fortebio global <NUMBER> fitting model plate incubated <NUMBER> c humidified box <NUMBER> h allow neutralisation take place virusantibody mixture transferred wells twice dpbswashed <NUMBER>well plate containing confluent monolayers vero e<NUMBER> cells virus allowed adsorb onto cells <NUMBER> c hour humidified box overlaid mem containing <NUMBER> carboxymethylcellulose sigma dorset uk <NUMBER> vv fcs <NUMBER>mm hepes buffer <NUMBER> days incubation <NUMBER> c humidified box plates fixed overnight <NUMBER> formalinpbs vv washed tap water stained <NUMBER> crystal violet solution sigma plaques counted midpoint probit analysis written r programming language statistical computing graphics used determine dilution antibody required reduce sarscov<NUMBER> viral plaques <NUMBER> prnt<NUMBER> compared virus control n<NUMBER> script used r based source script johnson et al <NUMBER> antibody dilutions run duplicate internal positive control prnt assay also run duplicate using sample heatinactivated <NUMBER> â c <NUMBER> min human mers convalescent serum known neutralise sarscov<NUMBER> national institute biological standards control uk protocol repeated two experiments cr<NUMBER> different batch starting concentration <NUMBER> mgml compare leaving virusantibody mixture plate parallel washing addition overlay media purified deglycosylated rbd cr<NUMBER> fab concentrated <NUMBER> mgml <NUMBER> mgml respectively mixed approximate molar ratio <NUMBER> crystallization screen experiments carried using nanolitre sittingdrop vapour diffusion method <NUMBER>well plates previously described walter et al <NUMBER> walter et al <NUMBER> crystals initially crystals mounted loops frozen liquid nitrogen prior data collection diffraction data collected <NUMBER> k beamline i<NUMBER> diamond light source uk diffraction images <NUMBER>Â° rotation recorded eiger<NUMBER> xe <NUMBER>m detector exposure time either <NUMBER> <NUMBER> per frame beam size <NUMBER>Ã<NUMBER> Î¼m <NUMBER> beam transmission data indexed integrated scaled automated data processing program xia<NUMBER>dials winter <NUMBER> winter et al <NUMBER> data set <NUMBER>Â° collected single frozen crystal <NUMBER> Ã¥ resolution <NUMBER>fold redundancy crystal belongs space group p<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> unit cell dimensions b <NUMBER> Ã¥ c <NUMBER> Ã¥ structure determined molecular replacement phaser mccoy et al <NUMBER> using search models human germline antibody fabs <NUMBER>o<NUMBER> pdb id <NUMBER>kmt teplyakov et al <NUMBER> heavy chain ighv<NUMBER>igk<NUMBER> pdb id <NUMBER>i<NUMBER>d teplyakov et al <NUMBER> light chain rbd sarscov<NUMBER> rbdace<NUMBER> complex pdb id <NUMBER>m<NUMBER>j lan et al <NUMBER> one rbdcr<NUMBER> complex crystal asymmetric unit resulting crystal solvent content <NUMBER> optimisation crystallisation conditions second crystal form found grow condition similar morphology data set <NUMBER>Â° rotation data extending <NUMBER> Ã¥ collected beamline i<NUMBER> diamond one crystals exposure time <NUMBER> per <NUMBER>Â° frame beam size <NUMBER>Ã<NUMBER> Î¼m <NUMBER> beam transmission crystal also belongs space group p<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> significantly different unit cell dimensions b <NUMBER> Ã¥ c <NUMBER> Ã¥ two rbdcr<NUMBER> complexes asymmetric unit solvent content <NUMBER> initial structure determined using lower resolution data first crystal form data excluded resolution <NUMBER> Ã¥ fell beamstop shadow one cycle refmac<NUMBER> murshudov et al <NUMBER> used refine atomic coordinates manual correction coot emsley cowtan <NUMBER> data collection structure refinement statistics given table s<NUMBER> structural comparisons used shp stuart et al <NUMBER> residues forming rbdfab interface identified pisa krissinel henrick <NUMBER> figures prepared pymol pymol molecular graphics system version <NUMBER>r<NUMBER>pre schrÃ¶dinger llc purified spike protein buffer exchanged <NUMBER> table s<NUMBER> <NUMBER> minute <NUMBER> h incubation datasets motion correction alignment <NUMBER>x binned superresolution movies performed using relion<NUMBER> ctfestimation gctf v<NUMBER> zhang <NUMBER> nontemplatedriven particle picking performed within cryosparc v<NUMBER>live httpscryosparccom followed multiple rounds <NUMBER>d classification punjani et al <NUMBER> <NUMBER> minutes dataset <NUMBER>d class averages particle groups b used separately templatedriven classification rounds <NUMBER>d <NUMBER>d classification c<NUMBER> symmetry structures sharpened cryosparc data processing refinement statistics given table s<NUMBER> initial model spike group generated using pdb id <NUMBER>vyb walls et al <NUMBER> rigid body fitted final map using coot emsley cowtan <NUMBER> <NUMBER> h incubation dataset particles extracted larger box size <NUMBER> pixels compared <NUMBER> pixels following multiple rounds <NUMBER>d classification <NUMBER>d class averages blobpicked particles showing signs complete flowerlike structures selected ab initio reconstruction classes petals flowerlike particles missing figure s<NUMBER> <NUMBER> h data detailed fitting attempted spr kinetic data fitted using biacore t<NUMBER> evaluation software <NUMBER> wwwcytivalifesciencescom bli data analysed using data analysis software ht v <NUMBER> wwwfortebiocom prnt neutralisation data subjected midpoint probit authors declare competing interests binding affinity rbd cr<NUMBER> fab related star methods surface plasmon resonance biolayer interferometry ab surface plasmon resonance binding sensorgrams measured biacore t<NUMBER> biotinylated bio rbd immobilised ligand cr<NUMBER> fab used analyte five concentrations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nm cd cr<NUMBER> igg immobilised ligand rbdhis used analyte five concentrations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> nm data fitted <NUMBER> binding model using biacore t<NUMBER> evaluation software <NUMBER> average kinetic values two sets experiment listed extended table <NUMBER> table s<NUMBER> xray data collection refinement statistics related figure <NUMBER> star methods crystallisation data collection xray structure determination xray crystallographic refinement electron density map generation december <NUMBER> outbreak sarscov<NUMBER> infection brought back attention pathogenic coronavirus spotlight <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> spreading rapidly causing severe covid<NUMBER> symptoms lifethreatening diseases infected patients <NUMBER> numbers infected cases reached <NUMBER> less <NUMBER> months <NUMBER> prominent sequence differences crucial rbms sarscov<NUMBER> sarscov raise critical question whether binding affinity sarscov<NUMBER> spike protein human ace<NUMBER> comparable sarscov recent study computational modeling suggested sarscov<NUMBER> lower binding affinity human ace<NUMBER> result loss one hydrogen bond interactions <NUMBER> however another publication using structure analysis suggested similar binding affinities sarscov <NUMBER> using biolayer interferometry binding assay tian et al <NUMBER> measured sarscov<NUMBER> rbds binding affinity human ace<NUMBER> protein <NUMBER> nm comparable previously published affinity data sarscov spike protein <NUMBER> comparison spike proteins binding affinities human ace<NUMBER> sarscov<NUMBER> sarscov inconclusive indirect hence direct headtohead comparison desired understanding infectivity transmissibility sarscov<NUMBER> virus neutralizing antibody nab expected one promising treatments coronavirus infection among existing therapeutic options <NUMBER> <NUMBER> several nabs targeting sarscov exhibit significant vivo antivirus activities reducing virus titers lung tissues animal models <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however coronavirus singlestranded rna virus prone rapid mutations transmission nabs without crossreactivity broad spectrum viral mutants could lead treatment failure <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore highly potent crossprotective nabs prophylactic vaccines sarscov<NUMBER> urgent needs investigated optimized complex structure conformations rbds sarscov<NUMBER> wuhanivdchb<NUMBER> gisaid accession id epiisl<NUMBER> sarscov cuhkw<NUMBER> genbank accession id ay<NUMBER> ace<NUMBER> computational modeling binding free energy analysis also used recombinant s<NUMBER> proteins two viruses compare binding curves recombinant ace<NUMBER> protein ace<NUMBER> expressing cells studies confirm sarscov<NUMBER> sarscov similar binding affinities human receptor ace<NUMBER> due relatively low homology spike rbds sarscov<NUMBER> sarscov significant interest investigate whether sarscov neutralizing antibodies possess crossreactivity sarscov<NUMBER> sarscov polyclonal antibodies ace<NUMBER> blocking nonblocking nabs tested sarscov<NUMBER> pseudovirus psv cross neutralizing activities structure model sarscovrbdace<NUMBER> complex optimized based complexs crystal structure pdb id <NUMBER>ajf httpwwwrcsborg structure model sarscov<NUMBER> rbdace<NUMBER> complex constructed homology modeling using optimized sarscov rbdace<NUMBER> complex crystal structure template based <NUMBER> amino acid sequence homology two viruses rootmeansquare deviation rmsd cÎ± atoms two complex structures <NUMBER> Ã¥ indicating almost identical structural conformation figure<NUMBER>b subtle differences rbdace<NUMBER> interfaces sarscov<NUMBER> sarscov loop <NUMBER> numbered according sarscov rbd arising oneresidue insertion residue <NUMBER> figure <NUMBER>a hand interaction patterns complex structures interfaces somewhat different figure <NUMBER>a table s<NUMBER> four residues sarscov<NUMBER> rbd ie n<NUMBER> g<NUMBER> q<NUMBER> n<NUMBER> lost interactions ace<NUMBER> compared corresponding residues sarscov rbd ie r<NUMBER> d<NUMBER> y<NUMBER> t<NUMBER> four replacing residues sarscov<NUMBER> rbd ie k<NUMBER> v<NUMBER> e<NUMBER> f<NUMBER> form new interactions ace<NUMBER> absent sarscov rbd corresponding v<NUMBER> s<NUMBER> p<NUMBER> l<NUMBER> figure <NUMBER>ac noteworthy although strong saltbridge presented r<NUMBER> sarscov rbd e<NUMBER> ace<NUMBER> missing interaction involving sarscov<NUMBER> rbd however new strong saltbridge interaction e<NUMBER> sarscov<NUMBER> rbd k<NUMBER> ace<NUMBER> compensates loss rbdace<NUMBER> binding free energies sarscov sarscov<NUMBER> estimated <NUMBER> <NUMBER> reu rosetta energy unit respectively table s<NUMBER> rosetta interface analyzer <NUMBER> insignificant difference binding free energies suggests sarscov<NUMBER> sarscov viruses similar binding affinities human ace<NUMBER> recombinant s<NUMBER> protein sarscov<NUMBER> showed similar binding human ace<NUMBER> protein cellular forms compared sarscov rbd containing s<NUMBER> protein resulted cleavage spike protein virus membrane responsible binding virus human receptor cell membrane important viral infectivity <NUMBER> binding curves recombinant s<NUMBER> proteins sarscov<NUMBER> sarscov human ace<NUMBER> measured elisa results confirmed viruses similar s<NUMBER>ace<NUMBER> proteinprotein binding curves ec <NUMBER> figure <NUMBER>a binding curves s<NUMBER> protein ace<NUMBER> expressing <NUMBER>t cells assessed using facs similar binding curves ec <NUMBER> values obtained two viruses figure <NUMBER>b experimental results consistent structure modeling analysis indicates sarscov<NUMBER> virus likely infects human cells similar mechanisms sarscov virus binding human ace<NUMBER> comparable affinities hence may possess similar transmissibility serial diluted recombinant s<NUMBER> proteins sarscov<NUMBER> sarscov merscov coated <NUMBER> well plates incubated recombinant fctagged ace<NUMBER> ace<NUMBER>fc binding evaluation b recombinant s<NUMBER> proteins sarscov<NUMBER> sarscov incubated <NUMBER>tace<NUMBER> cells subjected facs evaluation binding coronavirus mutation emergence escape mutants neutralizing monoclonal antibodies vaccines major concern sarscov<NUMBER> sarscov two different coronaviruses modest level sequence homology spike proteins understanding whether antibodies raised sarscov spike protein immunization crossreactivity new sarscov<NUMBER> offer important insights guidance therapeutic antibody prophylactic vaccine development sarscov nabs generated immunizing mouse rabbit sarscov s<NUMBER> rbd protein two sarscov sprotein rabbit polyclonal antibodies table <NUMBER> four monoclonal antibodies table <NUMBER> analyzed crossreactivity sarscov<NUMBER> s<NUMBER> protein crossneutralizing activities sarscov<NUMBER> psv expected polyclonal antibodies showed weaker binding sarscov<NUMBER> s<NUMBER> protein ec <NUMBER> <NUMBER>ngml compared sarscov s<NUMBER> protein ec <NUMBER> <NUMBER>ngml neutralizing activities sarscov<NUMBER> psv lower twoorders magnitudes sarscov psv table <NUMBER> presenting pessimistic forecast probability identify highly potent crossreactive nabs sarscov<NUMBER> sarscov antibodies antibody libraries sarscov monoclonal nabs strong s<NUMBER> binding ec <NUMBER> <NUMBER>ngml k â¤<NUMBER>e<NUMBER> potent ace<NUMBER>blocking activities exhibited potent neutralizing activities sarscov minimum dose reach <NUMBER> neutralization <NUMBER>Î¼gml almost crossbinding sarscov<NUMBER> s<NUMBER> protein ec <NUMBER> <NUMBER>Î¼gml crossneutralizing activities sarscov<NUMBER> psv <NUMBER> neutralizing activity <NUMBER>Î¼gml figure<NUMBER> table <NUMBER> figure s<NUMBER> s<NUMBER> interestingly three ace<NUMBER>nonblocking monoclonal antibodies showed modest binding activities sarscov s<NUMBER> protein ec <NUMBER> <NUMBER>ngml neutralizing activities sarscov psv minimum dose reach <NUMBER> neutralization â¥ <NUMBER> Î¼gml although nabs less potent ace<NUMBER>blocking nabs sarscov could evidently crossbind sarscov<NUMBER> s<NUMBER> protein ec <NUMBER> <NUMBER>Î¼gml crossneutralize sarscov<NUMBER> psv <NUMBER> neutralizing activity <NUMBER>Î¼gml table <NUMBER> rp<NUMBER> polyclonal antibody rabbit immunized sarscov s<NUMBER> protein t<NUMBER> polyclonal antibody rabbit immunized sarscov rbd protein binding sars nabs sarscov s<NUMBER> protein tested elisa recombinant s<NUMBER> protein sarscov coated plates serial diluted nabs added binding recombinant s<NUMBER> protein b binding sars nabs sarscov<NUMBER> s<NUMBER> protein tested elsia recombinant s<NUMBER> protein sarscov<NUMBER> coated plates serial diluted nabs added binding recombinant s<NUMBER> protein c neutralization sarscov nabs sarscov<NUMBER> psv antibody competition sarscov rbd binding ace<NUMBER> recombinant sarscov rbd protein coated plates nabs recombinant ace<NUMBER> added rbd binding competition measurements suggested sarscov sarscov<NUMBER> rbd sequence alignment analysis figure <NUMBER>a <NUMBER> rbm sequence homology much less <NUMBER> rbd sequence homology structure similarity analysis confirms presence significant local structure differences rbm regions rest rbd regions significantly higher similarities figure <NUMBER> moreover three glycosylation sites sarscov rbd ie n<NUMBER> n<NUMBER> n<NUMBER> <NUMBER> conserved although one glycosylation sites n<NUMBER> may glycosylated corresponding residue sarscov<NUMBER> predicted netnglyc <NUMBER> taking two viruses rbd structure similarities glycosylation sites account predict two possible conserved regions rbd epitopes crossreactive neutralizing antibodies reside regions probably overlap ace<NUMBER> binding sites figure <NUMBER> speculate likely obtain crossreactive nonblocking neutralizing antibodies targeting conserved regions outside rbm region neutralization mechanism nonblocking crossreactive antibodies likely unrelated ace<NUMBER> blockage rbd shown spacefilled model colored surface ace<NUMBER> shown gray tube model three glycosylation sites sarscov labeled note n <NUMBER> st sarscov changed n <NUMBER> sa sarscov<NUMBER> different nxst pattern required glycosylation hence site likely unglycosylated two possible crossreactive regions marked yellow circles coronavirus spike protein shown responsible interacting host cell receptors initiate infection sarscov sarscov viruses use human ace<NUMBER> cell entry <NUMBER> due nature rna virus rapid mutation rates changes sproteins amino acid sequence especially rbds receptor binding motif could significant impact virus infectivity pathogenicity transmissibility crossprotection previous coronavirus infection well therapeutic antibody prophylactic vaccine development hence understanding differences sarscov sarscov<NUMBER> implications may offer significant scientific practical value though difficult assess virushostcell interactions real virion studied new sarscov<NUMBER> headtohead comparisons sarscov using multiple methods measurements recombinant sarscov<NUMBER> sarscov spike proteins recombinant ace<NUMBER> protein ace<NUMBER> expressing <NUMBER>t cells confirmed two coronaviruses similar binding affinities human ace<NUMBER> figure <NUMBER>ab provided direct molecular based evidences support possibly explain observation new sarscov<NUMBER> coronavirus similar transmissibility sarscov virus since sarscov<NUMBER> sarscov coronaviruses <NUMBER> sequence homology share human receptor ace<NUMBER> analyzing sarscovs antibodies crossreactivity sarscov<NUMBER> may provide useful information whether neutralizing epitopes conserved two coronaviruses two rabbit polyclonal antibodies produced sarscov s<NUMBER> rbd proteins potent binding neutralizing activities sarscov modest crossbinding crossneutralizing activities new sarscov<NUMBER> virus four highly potent ace<NUMBER> blocking sarscov monoclonal antibodies showed binding affinities sarscov s<NUMBER> protein range <NUMBER> nm <NUMBER> pm high neutralizing activities sarscov low <NUMBER> ugml nab lead <NUMBER> neutralization sarscov psv however virtually crossbinding cross neutralizing activities novel sarscov<NUMBER> virus detected four ace<NUMBER> blocking monoclonal antibodies screened nonace<NUMBER>blocking antibodies raised sarscov rbd neutralizing activities three monoclonal antibodies identified although binding affinities sarscov s<NUMBER> protein significantly lower ec <NUMBER> <NUMBER> <NUMBER> Î¼gml compared <NUMBER> <NUMBER> Î¼gml ec <NUMBER> four ace<NUMBER>blocking nabs significant crossbinding activities sarscov<NUMBER> s<NUMBER> protein modest crossneutralizing activities sarscov<NUMBER> psv detected observation three antibodies bind neutralize sarscov sarscov<NUMBER> without blocking ace<NUMBER> suggest following first epitope epitopes three antibodies conserved across two significantly different coronaviruses hence possible maybe challenging identify antibodies potent neutralizing activities sarscov sarscov<NUMBER> ideally mutant virus strains well second epitope epitopes three nabs likely located outside rbm motif due nonace<NUMBER> blocking features fact homology rbm motif two viruses significantly lower rest portion rbd analysis mutations rbd also conducted analyzed <NUMBER> sequences sarscov<NUMBER> variants gisaid found <NUMBER> variants mutations rbd one n<NUMBER>dd<NUMBER>y two v<NUMBER>f one f<NUMBER>l alignment <NUMBER> sarscov rbd sequences collected blast via ncbi website <NUMBER> used consurf analysis <NUMBER> shown figure <NUMBER> sarscov rbm region highly variable making challenging develop crossreactive antibodies broad spectrum neutralizing activities mutant strains hand significant portions rbd marked pink outside rbm motif highly conserved neutralizing antibodies targeting epitopes regions could potentially crossprotective activities different mutant strains also noteworthy three nonblocking antibodies neutralizing activities significantly lower four blocking antibodies due limited number antibodies obtained difficult conclude whether consistent pattern ace<NUMBER> blockage neutralizing potency one speculate neutralizing antibodies targeting conserved epitopes outside rbm region may crossprotective may also less potent due lack ace<NUMBER> blocking activities recent article <NUMBER> sarscov rbd neutralizing antibody cr<NUMBER> epitope outside rbm motif also shown nonblocking crossbinding sarscov<NUMBER> rbd relatively low k <NUMBER> nm neutralization mechanism nonblocking antibodies clear yet known antibodies targeting s<NUMBER> region could block s<NUMBER> proteins configuration change hence interfere virus entry host cells whether nonblocking rbd antibodies also interfere s<NUMBER> proteins configuration change remains investigated summary findings suggest sarscov<NUMBER> sarscov bind human ace<NUMBER> similar affinities hence may similar transmissibility antibodies targeting rbm regions may potent due ace<NUMBER> blocking activities crossprotecting antibodies targeting rbm regions may difficult obtain lower degree sequence conservation antibodies conserved regions outside rbm motif may possess crossprotective neutralizing activities may less potent due lack ace<NUMBER> blocking activities mechanism neutralization nonblocking rbd antibodies remains investigated developing potent crossprotective therapeutic antibodies vaccines possible could challenging rbd shown colored surface ace<NUMBER> shown gray cartoon three surface mutation sites ie n<NUMBER>d d<NUMBER>y v<NUMBER>f observed sarscov<NUMBER> rbd labeled mutation f<NUMBER>l buried shown recombinant s<NUMBER> proteins sarscov<NUMBER> cat <NUMBER> human embryonic kidney <NUMBER>t cell line catcrl<NUMBER> used pseudovirus psv packaging purchased atcc <NUMBER>tace<NUMBER> cells established transfection ace<NUMBER> expression plasmid <NUMBER>t cells <NUMBER>t <NUMBER>tace<NUMBER> cells grown dulbeccos modified eagles medium dmem containing <NUMBER> vv fbs indicated proteins coated <NUMBER> well plates using cbs buffer night <NUMBER>â bsa used blocking room temperature <NUMBER>h indicated corresponding proteins antibodies added incubated room temperature <NUMBER>h washing away unbound proteins antibodies secondary antibody hrp labeling added incubated another hour washed away developing buffer added incubated <NUMBER> min <NUMBER> h <NUMBER> <NUMBER> added stop reaction absorbance <NUMBER>nm detected microplate reader indicated concentrations s<NUMBER> proteins sarscov<NUMBER> sarscov incubated <NUMBER>tace<NUMBER> cells <NUMBER> min washing away unbound proteins cells incubated withpe labelled antihistag antibody <NUMBER> min went flow cytometer detection cellular binding flowjo graphpad softwares used data analysis recombinant sarscov s<NUMBER> protein biotinated loaded using sa sensor indicated antibodies added real time association dissociation analysis data analysis octet used data processing <NUMBER> hours transfection <NUMBER>t cells preplate t<NUMBER> flask dmem<NUMBER> fbs <NUMBER> cellscm <NUMBER> <NUMBER>Î¼g luciferaseexpressing hiv<NUMBER> lentiviral transfer genome pwpxlluc <NUMBER>Î¼g packaging plasmid psd <NUMBER>Î¼g expression plasmid encoding either sarscov<NUMBER>s protein pcmvwhcovspike sarss protein pcmvsarsspike cotransfected preplated <NUMBER>t cells using sinofection transfection reagent according procedure recommended manufacturer transfected cells incubated incubated <NUMBER>â <NUMBER> co <NUMBER> overnight followed medium exchange fresh dmem plus <NUMBER> fbs supernatant containing pseudovirus collected <NUMBER> hours filtered <NUMBER>Î¼m filter stored <NUMBER>â longtime storage <NUMBER>â short time storage <NUMBER>tace<NUMBER> cells plated <NUMBER>well plate <NUMBER> cellswell <NUMBER> Î¼ l dmem<NUMBER> fbs <NUMBER>Î¼l serially diluted antibody samples <NUMBER>Î¼l sarscov<NUMBER> sars psv mixed incubated <NUMBER>â <NUMBER> hour <NUMBER>Î¼lwell antibodypsv mixture added onto <NUMBER>tace<NUMBER> cell wells incubated <NUMBER>â <NUMBER> co <NUMBER> <NUMBER> hours infection luciferase luminescence rlu detected using luciferase assay system according procedure recommended manufacturer luminescence microplate reader antibodies inhibition calculated following inhibiton <NUMBER> antibodies neutralization titers presented <NUMBER> maximal inhibitory concentration ic <NUMBER> protein sequence alignments performed using clustal omega <NUMBER> sarscov rbdace<NUMBER> complex structure remodeled based pdb <NUMBER>ajf complete missing loop using discovery studio ds <NUMBER> complex structure optimized rosetta relax <NUMBER> sarscov<NUMBER> rbdace<NUMBER> complex structure constructed base optimized sarscov rbdace<NUMBER> complex structure using ds also optimized rosetta relax interface rbd ace<NUMBER> analyzed rosetta interface analyzer <NUMBER> ds software pymol used preparing structural figures <NUMBER> structural similarity analysis sarscov<NUMBER> sarscov carried discovery studio ds <NUMBER> structural conservation analysis sarscov rbd carried using consurf <NUMBER> alignment <NUMBER> sarscov rbd sequence used generation sequence conservation collected blast via ncbi website <NUMBER> structural conservation displayed pymol <NUMBER> <NUMBER> <NUMBER> packstat rosettas packing statistic score interface <NUMBER>bad <NUMBER>perfect faatr lennardjones attractive atoms different residues farep lennardjones repulsive atoms different residues faelec coulombic electrostatic potential distancedependent dielectric table s<NUMBER> rbd side chain interaction rbdace<NUMBER> interface distance nearest distance side chain rbd residue ace<NUMBER> sb saltbridge hb hydrogen bond piÏstack Ïanion interaction np nonpolar interaction figure s<NUMBER> realtime association dissociation monoclonal nabs detected octet system figure s<NUMBER> neutralization assays monoclonal nabs sarscov psv december <NUMBER> outbreak sarscov<NUMBER> infection brought back attention pathogenic coronavirus spotlight <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> spreading rapidly causing severe covid<NUMBER> symptoms lifethreatening diseases infected patients <NUMBER> numbers infected cases reached <NUMBER> less <NUMBER> months <NUMBER> prominent sequence differences crucial rbms sarscov<NUMBER> sarscov raise critical question whether binding affinity sarscov<NUMBER> spike protein human ace<NUMBER> comparable sarscov recent study computational modeling suggested sarscov<NUMBER> lower binding affinity human ace<NUMBER> result loss one hydrogen bond interactions <NUMBER> however another publication using structure analysis suggested similar binding affinities sarscov <NUMBER> using biolayer interferometry binding assay tian et al <NUMBER> measured sarscov<NUMBER> rbds binding affinity human ace<NUMBER> protein <NUMBER> nm comparable previously published affinity data sarscov spike protein <NUMBER> comparison spike proteins binding affinities human ace<NUMBER> sarscov<NUMBER> sarscov inconclusive indirect hence direct headtohead comparison desired understanding infectivity transmissibility sarscov<NUMBER> virus neutralizing antibody nab expected one promising treatments coronavirus infection among existing therapeutic options <NUMBER> <NUMBER> several nabs targeting sarscov exhibit significant vivo antivirus activities reducing virus titers lung tissues animal models <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however coronavirus singlestranded rna virus prone rapid mutations transmission nabs without crossreactivity broad spectrum viral mutants could lead treatment failure <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore highly potent crossprotective nabs prophylactic vaccines sarscov<NUMBER> urgent needs ace<NUMBER> computational modeling binding free energy analysis also used recombinant s<NUMBER> proteins two viruses compare binding curves recombinant ace<NUMBER> protein ace<NUMBER> expressing cells studies confirm sarscov<NUMBER> sarscov similar binding affinities human receptor ace<NUMBER> due relatively low homology spike rbds sarscov<NUMBER> sarscov significant interest investigate whether sarscov neutralizing antibodies possess crossreactivity sarscov<NUMBER> sarscov polyclonal antibodies ace<NUMBER> blocking nonblocking nabs tested sarscov<NUMBER> pseudovirus psv cross neutralizing activities structure model sarscovrbdace<NUMBER> complex optimized based complexs crystal structure pdb id <NUMBER>ajf httpwwwrcsborg structure model sarscov<NUMBER> rbdace<NUMBER> complex constructed homology modeling using optimized sarscov rbdace<NUMBER> complex crystal structure template based <NUMBER> amino acid sequence homology two viruses rootmeansquare deviation rmsd cÎ± atoms two complex structures <NUMBER> Ã¥ indicating almost identical structural conformation figure<NUMBER>b subtle differences rbdace<NUMBER> interfaces sarscov<NUMBER> sarscov loop <NUMBER> numbered according sarscov rbd arising oneresidue insertion residue <NUMBER> figure <NUMBER>a hand interaction patterns complex structures interfaces somewhat different figure <NUMBER>a table s<NUMBER> four residues sarscov<NUMBER> rbd ie n<NUMBER> g<NUMBER> q<NUMBER> n<NUMBER> lost interactions ace<NUMBER> compared corresponding residues sarscov rbd ie r<NUMBER> d<NUMBER> y<NUMBER> t<NUMBER> four replacing residues sarscov<NUMBER> rbd ie k<NUMBER> v<NUMBER> e<NUMBER> f<NUMBER> form new interactions ace<NUMBER> absent sarscov rbd corresponding v<NUMBER> s<NUMBER> p<NUMBER> l<NUMBER> figure <NUMBER>ac noteworthy although strong saltbridge presented r<NUMBER> sarscov rbd e<NUMBER> ace<NUMBER> missing interaction involving sarscov<NUMBER> rbd however new strong saltbridge interaction e<NUMBER> sarscov<NUMBER> rbd k<NUMBER> ace<NUMBER> compensates loss rbdace<NUMBER> binding free energies sarscov sarscov<NUMBER> estimated <NUMBER> <NUMBER> reu rosetta energy unit respectively table s<NUMBER> rosetta interface analyzer <NUMBER> insignificant difference binding free energies suggests sarscov<NUMBER> sarscov viruses similar binding affinities human ace<NUMBER> authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint recombinant s<NUMBER> protein sarscov<NUMBER> showed similar binding human ace<NUMBER> protein cellular forms compared sarscov rbd containing s<NUMBER> protein resulted cleavage spike protein virus membrane responsible binding virus human receptor cell membrane important viral infectivity <NUMBER> binding curves recombinant s<NUMBER> proteins sarscov<NUMBER> sarscov human ace<NUMBER> measured elisa results confirmed viruses similar s<NUMBER>ace<NUMBER> proteinprotein binding curves ec <NUMBER> figure <NUMBER>a binding curves s<NUMBER> protein ace<NUMBER> expressing <NUMBER>t cells assessed using facs similar binding curves ec <NUMBER> values obtained two viruses figure <NUMBER>b experimental results consistent structure modeling analysis indicates sarscov<NUMBER> virus likely infects human cells similar mechanisms sarscov virus binding human ace<NUMBER> comparable affinities hence may possess similar transmissibility serial diluted recombinant s<NUMBER> proteins sarscov<NUMBER> sarscov merscov coated <NUMBER> well plates incubated recombinant fctagged ace<NUMBER> ace<NUMBER>fc binding evaluation b recombinant s<NUMBER> proteins sarscov<NUMBER> sarscov incubated <NUMBER>tace<NUMBER> cells subjected facs evaluation binding authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint coronavirus mutation emergence escape mutants neutralizing monoclonal antibodies vaccines major concern sarscov<NUMBER> sarscov two different coronaviruses modest level sequence homology spike proteins understanding whether antibodies raised sarscov spike protein immunization crossreactivity new sarscov<NUMBER> offer important insights guidance therapeutic antibody prophylactic vaccine development sarscov nabs generated immunizing mouse rabbit sarscov s<NUMBER> rbd protein two sarscov sprotein rabbit polyclonal antibodies table <NUMBER> four monoclonal antibodies table <NUMBER> analyzed crossreactivity sarscov<NUMBER> s<NUMBER> protein crossneutralizing activities sarscov<NUMBER> psv expected polyclonal antibodies showed weaker binding sarscov<NUMBER> s<NUMBER> protein ec <NUMBER> <NUMBER>ngml compared sarscov s<NUMBER> protein ec <NUMBER> <NUMBER>ngml neutralizing activities sarscov<NUMBER> psv lower twoorders magnitudes sarscov psv table <NUMBER> presenting pessimistic forecast probability identify highly potent crossreactive nabs sarscov<NUMBER> sarscov antibodies antibody libraries sarscov monoclonal nabs strong s<NUMBER> binding ec <NUMBER> <NUMBER>ngml k â¤<NUMBER>e<NUMBER> potent ace<NUMBER>blocking activities exhibited potent neutralizing activities sarscov minimum dose reach <NUMBER> neutralization <NUMBER>Î¼gml almost crossbinding sarscov<NUMBER> s<NUMBER> protein ec <NUMBER> <NUMBER>Î¼gml crossneutralizing activities sarscov<NUMBER> psv <NUMBER> neutralizing activity <NUMBER>Î¼gml figure<NUMBER> table <NUMBER> figure s<NUMBER> s<NUMBER> interestingly three ace<NUMBER>nonblocking monoclonal antibodies showed modest binding activities sarscov s<NUMBER> protein ec <NUMBER> <NUMBER>ngml neutralizing activities sarscov psv minimum dose reach <NUMBER> neutralization â¥ <NUMBER> Î¼gml although nabs less potent ace<NUMBER>blocking nabs sarscov could evidently crossbind sarscov<NUMBER> s<NUMBER> protein ec <NUMBER> <NUMBER>Î¼gml crossneutralize sarscov<NUMBER> psv <NUMBER> neutralizing activity <NUMBER>Î¼gml table <NUMBER> rp<NUMBER> polyclonal antibody rabbit immunized sarscov s<NUMBER> protein t<NUMBER> polyclonal antibody rabbit immunized sarscov rbd protein authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint binding sars nabs sarscov s<NUMBER> protein tested elisa recombinant s<NUMBER> protein sarscov coated plates serial diluted nabs added binding recombinant s<NUMBER> protein b binding sars nabs sarscov<NUMBER> s<NUMBER> protein tested elsia recombinant s<NUMBER> protein sarscov<NUMBER> coated plates serial diluted nabs added binding recombinant s<NUMBER> protein c neutralization sarscov nabs sarscov<NUMBER> psv antibody competition sarscov rbd binding ace<NUMBER> recombinant sarscov rbd protein coated plates nabs recombinant ace<NUMBER> added rbd binding competition measurements suggested sarscov sarscov<NUMBER> rbd sequence alignment analysis figure <NUMBER>a <NUMBER> rbm sequence homology much less <NUMBER> rbd sequence homology structure similarity analysis confirms presence significant local structure differences rbm regions rest rbd regions significantly higher similarities figure <NUMBER> moreover three glycosylation sites sarscov rbd ie n<NUMBER> n<NUMBER> n<NUMBER> <NUMBER> conserved although one glycosylation sites n<NUMBER> may glycosylated corresponding residue sarscov<NUMBER> predicted netnglyc <NUMBER> taking two viruses rbd structure similarities glycosylation sites account predict two possible conserved regions rbd epitopes crossreactive neutralizing antibodies reside regions probably overlap ace<NUMBER> binding sites figure <NUMBER> speculate likely obtain crossreactive nonblocking neutralizing antibodies targeting conserved regions outside rbm region neutralization mechanism nonblocking crossreactive antibodies likely unrelated ace<NUMBER> blockage rbd shown spacefilled model colored surface ace<NUMBER> shown gray tube model three glycosylation sites sarscov labeled note n <NUMBER> st sarscov changed n <NUMBER> sa sarscov<NUMBER> different nxst pattern required glycosylation hence site likely unglycosylated two possible crossreactive regions marked yellow circles coronavirus spike protein shown responsible interacting host authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint cell receptors initiate infection sarscov sarscov viruses use human ace<NUMBER> cell entry <NUMBER> due nature rna virus rapid mutation rates changes sproteins amino acid sequence especially rbds receptor binding motif could significant impact virus infectivity pathogenicity transmissibility crossprotection previous coronavirus infection well therapeutic antibody prophylactic vaccine development hence understanding differences sarscov sarscov<NUMBER> implications may offer significant scientific practical value though difficult assess virushostcell interactions real virion studied new sarscov<NUMBER> headtohead comparisons sarscov using multiple methods measurements recombinant sarscov<NUMBER> sarscov spike proteins recombinant ace<NUMBER> protein ace<NUMBER> expressing <NUMBER>t cells confirmed two coronaviruses similar binding affinities human ace<NUMBER> figure <NUMBER>ab provided direct molecular based evidences support possibly explain observation new sarscov<NUMBER> coronavirus similar transmissibility sarscov virus since sarscov<NUMBER> sarscov coronaviruses <NUMBER> sequence homology share human receptor ace<NUMBER> analyzing sarscovs antibodies crossreactivity sarscov<NUMBER> may provide useful information whether neutralizing epitopes conserved two coronaviruses two rabbit polyclonal antibodies produced sarscov s<NUMBER> rbd proteins potent binding neutralizing activities sarscov modest crossbinding crossneutralizing activities new sarscov<NUMBER> virus four highly potent ace<NUMBER> blocking sarscov monoclonal antibodies showed binding affinities sarscov s<NUMBER> protein range <NUMBER> nm <NUMBER> pm high neutralizing activities sarscov low <NUMBER> ugml nab lead <NUMBER> neutralization sarscov psv however virtually crossbinding cross neutralizing activities novel sarscov<NUMBER> virus detected four ace<NUMBER> blocking monoclonal antibodies screened nonace<NUMBER>blocking antibodies raised sarscov rbd neutralizing activities three monoclonal antibodies identified although binding affinities sarscov s<NUMBER> protein significantly lower ec <NUMBER> <NUMBER> <NUMBER> Î¼gml compared <NUMBER> <NUMBER> Î¼gml ec <NUMBER> four ace<NUMBER>blocking nabs significant crossbinding activities sarscov<NUMBER> s<NUMBER> protein modest crossneutralizing activities sarscov<NUMBER> psv detected observation three antibodies bind neutralize sarscov sarscov<NUMBER> without blocking ace<NUMBER> suggest following first epitope epitopes three antibodies conserved across two significantly different coronaviruses hence possible maybe challenging identify antibodies potent neutralizing activities sarscov sarscov<NUMBER> ideally mutant virus strains well second epitope epitopes three nabs authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint likely located outside rbm motif due nonace<NUMBER> blocking features fact homology rbm motif two viruses significantly lower rest portion rbd analysis mutations rbd also conducted analyzed <NUMBER> sequences sarscov<NUMBER> variants gisaid found <NUMBER> variants mutations rbd one n<NUMBER>dd<NUMBER>y two v<NUMBER>f one f<NUMBER>l alignment <NUMBER> sarscov rbd sequences collected blast via ncbi website <NUMBER> used consurf analysis <NUMBER> shown figure <NUMBER> sarscov rbm region highly variable making challenging develop crossreactive antibodies broad spectrum neutralizing activities mutant strains hand significant portions rbd marked pink outside rbm motif highly conserved neutralizing antibodies targeting epitopes regions could potentially crossprotective activities different mutant strains also noteworthy three nonblocking antibodies neutralizing activities significantly lower four blocking antibodies due limited number antibodies obtained difficult conclude whether consistent pattern ace<NUMBER> blockage neutralizing potency one speculate neutralizing antibodies targeting conserved epitopes outside rbm region may crossprotective may also less potent due lack ace<NUMBER> blocking activities recent article <NUMBER> sarscov rbd neutralizing antibody cr<NUMBER> epitope outside rbm motif also shown nonblocking crossbinding sarscov<NUMBER> rbd relatively low k <NUMBER> nm neutralization mechanism nonblocking antibodies clear yet known antibodies targeting s<NUMBER> region could block s<NUMBER> proteins configuration change hence interfere virus entry host cells whether nonblocking rbd antibodies also interfere s<NUMBER> proteins configuration change remains investigated summary findings suggest sarscov<NUMBER> sarscov bind human ace<NUMBER> similar affinities hence may similar transmissibility antibodies targeting rbm regions may potent due ace<NUMBER> blocking activities crossprotecting antibodies targeting rbm regions may difficult obtain lower degree sequence conservation antibodies conserved regions outside rbm motif may possess crossprotective neutralizing activities may less potent due lack ace<NUMBER> blocking activities mechanism neutralization nonblocking rbd antibodies remains investigated developing potent crossprotective therapeutic antibodies vaccines possible could challenging authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint rbd shown colored surface ace<NUMBER> shown gray cartoon three surface mutation sites ie n<NUMBER>d d<NUMBER>y v<NUMBER>f observed sarscov<NUMBER> rbd labeled mutation f<NUMBER>l buried shown recombinant s<NUMBER> proteins sarscov<NUMBER> cat <NUMBER>v<NUMBER>h sarscov cat <NUMBER>v<NUMBER>b<NUMBER> merscov cat<NUMBER>v<NUMBER>h recombinant rbd protein sarscov cat <NUMBER>v<NUMBER>b<NUMBER> transfection reagent sinofection cat stf<NUMBER> mammalian expression plasmids full length rbd protein sarscov<NUMBER> cat vg<NUMBER>ut wuhanivdchb<NUMBER> sarscov cat vg<NUMBER>gn cuhkw<NUMBER> ace<NUMBER> cat hg<NUMBER>ut polyclonal antibodies sarscov rp<NUMBER> cat <NUMBER>rp<NUMBER> t<NUMBER> cat <NUMBER>t<NUMBER> purchased sino biological fetal bovine serum fbs cat sa <NUMBER> purchased lanzhou minhai bioengineering hygromycin cat v<NUMBER> purchased sigmaaldrich sarscov neutralizing antibodies generated mice m<NUMBER> m<NUMBER> rabbits r<NUMBER> r<NUMBER> r<NUMBER> r<NUMBER> r<NUMBER> r<NUMBER> immunized recombinant s<NUMBER> protein sarscov luciferase assay system cat e<NUMBER> purchased promega human embryonic kidney <NUMBER>t cell line catcrl<NUMBER> used pseudovirus psv packaging purchased atcc <NUMBER>tace<NUMBER> cells established transfection ace<NUMBER> expression plasmid <NUMBER>t cells <NUMBER>t <NUMBER>tace<NUMBER> authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint cells grown dulbeccos modified eagles medium dmem containing <NUMBER> vv fbs indicated proteins coated <NUMBER> well plates using cbs buffer night <NUMBER>â bsa used blocking room temperature <NUMBER>h indicated corresponding proteins antibodies added incubated room temperature <NUMBER>h washing away unbound proteins antibodies secondary antibody hrp labeling added incubated another hour washed away developing buffer added incubated <NUMBER> min <NUMBER> h <NUMBER> <NUMBER> added stop reaction absorbance <NUMBER>nm detected microplate reader indicated concentrations s<NUMBER> proteins sarscov<NUMBER> sarscov incubated <NUMBER>tace<NUMBER> cells <NUMBER> min washing away unbound proteins cells incubated withpe labelled antihistag antibody <NUMBER> min went flow cytometer detection cellular binding flowjo graphpad softwares used data analysis recombinant sarscov s<NUMBER> protein biotinated loaded using sa sensor indicated antibodies added real time association dissociation analysis data analysis octet used data processing pseudovirus production <NUMBER>t adherent cells <NUMBER> hours transfection <NUMBER>t cells preplate t<NUMBER> flask dmem<NUMBER> fbs <NUMBER> cellscm <NUMBER> <NUMBER>Î¼g luciferaseexpressing hiv<NUMBER> lentiviral transfer genome pwpxlluc <NUMBER>Î¼g packaging plasmid psd <NUMBER>Î¼g expression plasmid encoding either sarscov<NUMBER>s protein pcmvwhcovspike sarss protein pcmvsarsspike cotransfected preplated <NUMBER>t cells using sinofection transfection reagent according procedure recommended manufacturer transfected cells incubated incubated <NUMBER>â <NUMBER> co <NUMBER> overnight followed medium exchange fresh dmem plus <NUMBER> fbs supernatant containing pseudovirus collected <NUMBER> hours filtered <NUMBER>Î¼m filter stored <NUMBER>â longtime storage <NUMBER>â short time storage <NUMBER>tace<NUMBER> cells plated <NUMBER>well plate <NUMBER> cellswell <NUMBER> Î¼ l dmem<NUMBER> fbs <NUMBER>Î¼l serially diluted antibody samples <NUMBER>Î¼l sarscov<NUMBER> sars psv mixed incubated <NUMBER>â <NUMBER> hour <NUMBER>Î¼lwell antibodypsv mixture added onto <NUMBER>tace<NUMBER> cell wells incubated authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER>â <NUMBER> co <NUMBER> <NUMBER> hours infection luciferase luminescence rlu detected using luciferase assay system according procedure recommended manufacturer luminescence microplate reader antibodies inhibition calculated following inhibiton <NUMBER> antibodies neutralization titers presented <NUMBER> maximal inhibitory concentration ic <NUMBER> protein sequence alignments performed using clustal omega <NUMBER> sarscov rbdace<NUMBER> complex structure remodeled based pdb <NUMBER>ajf complete missing loop using discovery studio ds <NUMBER> complex structure optimized rosetta relax <NUMBER> sarscov<NUMBER> rbdace<NUMBER> complex structure constructed base optimized sarscov rbdace<NUMBER> complex structure using ds also optimized rosetta relax interface rbd ace<NUMBER> analyzed rosetta interface analyzer <NUMBER> ds software pymol used preparing structural figures <NUMBER> structural similarity analysis sarscov<NUMBER> sarscov carried discovery studio ds <NUMBER> structural conservation analysis sarscov rbd carried using consurf <NUMBER> alignment <NUMBER> sarscov rbd sequence used generation sequence conservation collected blast via ncbi website <NUMBER> structural conservation displayed pymol <NUMBER> authorfunder rights reserved reuse allowed without permission table s<NUMBER> rbd side chain interaction rbdace<NUMBER> interface distance nearest distance side chain rbd residue ace<NUMBER> sb saltbridge hb hydrogen bond piÏstack Ïanion interaction np nonpolar interaction authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint figure s<NUMBER> realtime association dissociation monoclonal nabs detected octet system figure s<NUMBER> neutralization assays monoclonal nabs sarscov psv authorfunder rights reserved reuse allowed without permission copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi biorxiv preprint coronaviruses large family viruses belongs coronaviridae family basis genomic structures phylogenetic relationship subfamily coronavirinae comprises four genera alphacoronavirus betacoronavirus gammacoronavirus deltacoronavirus <NUMBER> transmission alphacoronaviruses betacoronaviruses limited mammals causes respiratory illness humans sars coronavirus sarscov middle east respiratory syndrome coronavirus merscov whereas gammacoronaviruses deltacoronaviruses infect birds well infect mammals <NUMBER> coronaviruses largest rna genome swatantra kumar shailendra k saxena contributed equally work shailendra k saxena shailenkgmcindiaedu <NUMBER> kilobases kb positive sense genome encodes four major structural proteins including spike nucleocapsid n membrane envelope e required make complete virus particle <NUMBER> upon entry host cells viral genome translates two large precursor polyproteins namely pp<NUMBER>a pp<NUMBER>ab get processed <NUMBER> mature nonstructural proteins nsp<NUMBER>nsp<NUMBER> orf <NUMBER>aencoded viral proteinases <NUMBER>clike proteinases <NUMBER>clpro papainlike proteinase plpro nonstructural proteins nsps perform crucial function viral rna replication transcription <NUMBER> rna recombination without proofreading mechanism among existing coronaviruses mostly responsible evolution emergence novel coronaviruses <NUMBER> frequency recombination proposed higher gene codes viral spike glycoprotein <NUMBER>st january <NUMBER> chinese authorities confirmed around <NUMBER> human cases three deaths due novel coronavirus <NUMBER>ncov wuhan city china according world health organization <NUMBER>th february <NUMBER> total <NUMBER> cases confirmed <NUMBER> deaths case fatality rate <NUMBER> around <NUMBER> cases <NUMBER> deaths reported china alone addition china southeast asian countries including singapore thailand republic korea japan taiwan malaysia vietnam india philippines nepal sri lanka cambodia reported cases <NUMBER>ncov moreover countries like united arab emirates germany france united kingdom italy spain russia sweden finland belgium usa canada australia also reported <NUMBER>ncov cases <NUMBER> however route transmission <NUMBER>ncov yet identified average age patients reported <NUMBER>ncov infection <NUMBER> years <NUMBER> cases men health care professionals hospitalized patients highest risk <NUMBER>ncov transmission patients mainly reported pneumonia like symptoms fever fatigue dry cough lymphopenia elevated level lactate dehydrogenase prolonged prothrombin time addition patients difficulty breathing chest radiographs showing bilateral patchy shadows ground glass opacity patients including invasive pneumonic infiltrates cases <NUMBER> <NUMBER> <NUMBER>ncov china suspected emerge closely related predecessors sarscov may spread especially due ongoing yearly migration worldwide travelling characterize virus genetic material bronchoalveolar lavage performed patients collected fluid samples cultured viruses used nextgeneration sequencing samples found closely related bat sarslike betacoronavirus <NUMBER> sequenced virus wuhan seafood market pneumonia virus isolates wuhanhu<NUMBER> <NUMBER> bp ssrna accession number mn<NUMBER> available ncbi database <NUMBER> length <NUMBER>ncov encoded proteins found almost similar among <NUMBER>ncov bat sarslike coronaviruses however notable difference found longer spike protein <NUMBER>ncov compared bat sarslike coronaviruses sarscov <NUMBER> infection coronavirus initiated via interaction viral envelope host cellular membrane <NUMBER> internalization virus also depends upon potential glycosylation sites present viral glycoprotein viral envelope comprises three proteins spike membrane two major glycoproteins envelope e nonglycosylated protein protein comprises short nterminal glycosylated ectodomain three transmembrane domains tm long cterminal ct domain <NUMBER> e proteins required virus morphogenesis assembly budding glycoprotein type <NUMBER> fusion viral protein comprises two heptad repeat regions known hrc hrn forms coiledcoil structures surrounded protein ectodomain <NUMBER> protein cleaved two subunits s<NUMBER> s<NUMBER> s<NUMBER> comprises minimal receptorbinding domain <NUMBER> helps receptor binding s<NUMBER> facilitates membrane fusion <NUMBER> protein crucial receptor binding membrane fusion internalization virus tissue tropism host range therefore crucial targets vaccine development <NUMBER> therefore present study analyzed glycoprotein <NUMBER>ncov considering importance virus attachment host cell receptor compared predecessor reference sarscov strain sequence variation glycosylation pattern structural antigenic divergence better understanding viral pathogenesis antigenicity japanese encephalitis virus af<NUMBER> considered outlier phylogenetic analysis sequences used tree generated molecular evolutionary genetic analysis mega x software <NUMBER> tree generated upgma unweighted pair group method arithmetic mean method simple agglomerative hierarchical clustering method <NUMBER> comparison glycoprotein current circulating <NUMBER>ncov sarscov used wuhan seafood market pneumonia virus <NUMBER>ncov submitted ncbi wu f et al <NUMBER> jan <NUMBER> accession number qhd<NUMBER> sars coronavirus gd<NUMBER>t<NUMBER> sarscov submitted ncbi song h et al <NUMBER> dec <NUMBER> accession number ay<NUMBER> <NUMBER> analyzing variation among spike glycoprotein sequences aligned complete spike glycoprotein sequences <NUMBER>ncov sarscov standard singleletter abbreviations amino acids used collinear sequences aligned online use clustal omega httpswwwebiacuktoolsmsaclustalo data validated alignment using emboss needle pairwise sequence alignment tools eblosum<NUMBER> matrix gap penalty <NUMBER> extended penalty <NUMBER> <NUMBER> mismatches gaps identified small positive scores identified scores <NUMBER> identified identities identified addition specifically analyzed sequence variation minimal receptorbinding domain <NUMBER> glycoproteins determine differences viral attachment sites spike glycoproteins host cell surface glycosylation sites <NUMBER>ncov sarscov spike glycoproteins determined netnglyc <NUMBER> software httpswww cbsdtudkservicesnetnglyc <NUMBER> addition glycosylation sites validated another software nglyde httpsbioappiissinicaedutwnglydehelp html <NUMBER> antigenic variation among spike glycoproteins <NUMBER>ncov sarscov determined using netctl <NUMBER> server httpswwwcbsdtudkservices netctl <NUMBER> server predicts peptide mhc class binding proteasomal c terminal cleavage transporter associated antigen processing tap protein transport efficiency cytotoxic lymphocyte ctl epitopes two spike glycoproteins determined separately results compared epitopes score <NUMBER> ctl epitopes validated another software mhci binding predictions iedb analysis resource httpstoolsiedborgmhci <NUMBER> determine structural divergence protein homology modeling performed using spike glycoprotein sequences <NUMBER>ncov sarscov using hhpred server httpstoolkittuebingenmpgde toolshhpred <NUMBER> generated models glycoproteins <NUMBER>ncov pdba sarscov pdbb based cryoem structure sars coronavirus spike glycoprotein pdb id <NUMBER>acc generated models superimposed determine structural divergence using superpose version <NUMBER> httpswishartbiologyualbertaca superpose calculates protein superposition using modified quaternion approach deviation structural divergences calculated according local global rmsd values <NUMBER> phylogenetic analysis exhibits <NUMBER>ncov closely related bat sarslike coronavirus however <NUMBER>ncov bat sarslike coronavirus emerged sars coronavirus fig <NUMBER> suggesting <NUMBER>ncov newly spilled coronavirus humans china closely related sarscov complete sequence alignment data suggested spike glycoprotein sequences <NUMBER>ncov sarscov exhibits <NUMBER> identity <NUMBER> similarity <NUMBER> gaps fig <NUMBER>a data suggests spike glycoprotein <NUMBER>ncov exhibits higher sequence similarity <NUMBER> difference sarscov additionally looked sequence variation minimal receptorbinding domain rbd <NUMBER> <NUMBER> amino acids required interaction cellular receptors found spike glycoproteins exhibits <NUMBER> identity <NUMBER> similarity <NUMBER> gaps suggesting <NUMBER> difference tertiary structure minimal rbd shown fig <NUMBER>b significant variation minimal rbd sglycoprotein suggests <NUMBER>ncov may alteration virus binding capacity infectivity host cell receptor potential glycosylation sites among spike glycoproteins compared presented table <NUMBER> compared sarscov found spike glycoprotein <NUMBER>ncov exhibits novel glycosylation sites ngtk nfti nltt ntsn may results sequence variation addition also found <NUMBER>ncov spike glycoprotein exhibits common glycosylation sites also present sarscov nitn ngti nitn nfsq nesl nctf nntv table <NUMBER> glycosylation data suggests <NUMBER>ncov may interacts host receptor using novel glycosylation sites may affect internalization process associated pathogenesis antigenic variation spike glycoproteins <NUMBER>ncov sarscov compared determine antigenicity found ctl epitopes novel sarscov however six epitopes risncvady cvadysvly rsfiedllf rvdfcgkgy mtsccsclk vlkgvklhy found identical represented italics spike glycoproteins table <NUMBER> addition table shows comparison predicted nglycosylation sites spike glycoprotein wuhanhu<NUMBER> novel coronavirus <NUMBER>ncov sars coronavirus<NUMBER> sarscov strains nglycosylation potential <NUMBER> taken cutoff nglycosylation sites determined netnglyc <NUMBER> <NUMBER> validated nglyde server <NUMBER> italics indicates differences nglycosylation sites two spike glycoproteins structural glycosylation antigenic variation <NUMBER> novel coronavirus <NUMBER>ncov <NUMBER> table shows comparison predicted ctl epitopes spike glycoprotein wuhanhu<NUMBER> novel coronavirus <NUMBER>ncov sars coronavirus<NUMBER>sarscov strains epitopes generated netctl <NUMBER> <NUMBER> validated iedb analysis resource server <NUMBER> scores <NUMBER> shows highest sensitivity specificity towards mhc class italics indicates identical ctl epitopes italics showing common epitopes one amino acid change two spike glycoproteins epitopes identified change single amino acid represented italics antigenicity data suggested <NUMBER>ncov exhibits antigenic similarities sars coronavirus might associated similar antigenic response therefore considered one preventive strategies based glycoprotein peptide based vaccine designed sarscov addition novel epitopes may used design newer effective vaccines overall difference <NUMBER> glycoprotein sequences <NUMBER> difference minimal receptorbinding domain influenced us look structural divergence spike glycoproteins <NUMBER>ncov sarscov generated models compared structural divergence found two glycoproteins exhibits <NUMBER> local rmsd value angstrom fig <NUMBER> showed spite <NUMBER> variation sequences insignificant structural divergence among spike glycoproteins results suggests attachment inhibitors designed sarscov may used current choice therapy <NUMBER>ncov outbreak <NUMBER>novel coronavirus <NUMBER>ncov china raised alarm due associated global risk management <NUMBER>ncov human infections depends characteristics virus including transmission capability severity resulting infection availability vaccines medicines control impact coronavirus disease coronaviruses zoonotic nature means transmit animals humans <NUMBER> however exact source <NUMBER>ncov yet identified evolution <NUMBER>ncov may result rna recombination among viruses previously reported case sz<NUMBER> strain sarscov arose recombination existing rf<NUMBER> wiv<NUMBER> bat strains likewise wiv<NUMBER> bat strains generated likely two prevalent bat sarscov strains <NUMBER> frequent breakpoint recombination exist gene coronavirus encodes spike protein comprises minimalbinding domain orf<NUMBER> upstream encodes accessory protein <NUMBER> considering prevalence large genetic diversity existing coronaviruses close proximity frequent recombination expected emergence novel variants phylogenetic analysis revealed <NUMBER>ncov arises predecessors strains sarscoronaviruses present study shown sequence divergence differences similarity glycosylation sites antigenic variation spike glycoprotein <NUMBER>ncov compared sarscov strain amino acid sequence alignment data suggests significant variation <NUMBER> addition found <NUMBER> difference minimal receptorbinding domain glycoprotein significant variation minimal receptorbinding domain sglycoprotein suggests <NUMBER>ncov may alteration virus binding capacity infectivity host cell receptor <NUMBER> found novel glycosylation sites spike glycoprotein <NUMBER>ncov suggesting virus may utilize different glycosylation interact receptors also found glycosylation sites minimal receptorbinding domain exhibits similar sites coronaviruses <NUMBER> comparing antigenic sites found <NUMBER>ncov exhibits novel ctl epitopes may results distinct antigenic response compared sars coronavirus novel ctl epitopes may impart opportunities development peptide based vaccine prevention <NUMBER>ncov however epitopes found similar glycoproteins suggesting sarsassociated peptide based vaccine might used prevention <NUMBER>ncov current scenario regard found one ctl epitope rvdfcgkgy used design peptide based vaccine sarscov found effective various animal models <NUMBER> furthermore found insignificant structural divergence two glycoproteins suggests attachment inhibitors designed sarscov may used current choice therapy <NUMBER>ncov variation amino acid sequences distinctive antigenicity <NUMBER>ncov suggests although current virus infection severe potential become pandemic moreover identified insignificant structural divergence spike glycoproteins suggests although virus changed sequence structure remains data also suggests scope coronavirus specific attachment inhibitors choice therapy current pandemic situation collectively first time results exhibit emergence human <NUMBER>ncov closely related predecessor sarscov consequently renamed sarscov<NUMBER> owing pandemic potential declared public health emergency international concern earliest foremost data provide evidence <NUMBER>ncov uses various novel glycosylation sites sarscov may potential become pandemic owing antigenic discrepancy demonstration novel ctl epitopes may impart opportunities development peptide based vaccine prevention <NUMBER>ncov additionally revelation similar antigenic sites <NUMBER>ncov sars coronavirus suggests scope sarsassociated peptide based vaccine prevention <NUMBER>ncov similarity spike glycoprotein structures suggests use coronavirus specific attachment inhibitors current choice therapy <NUMBER>ncov world health organization informed pneumonia cases unknown etiology wuhan hubei province china <NUMBER> december <NUMBER> <NUMBER> novel coronavirus identified cause disease investigations <NUMBER> new virus related previously identified sarscov severe acute respiratory syndrome coronavirus named sarscov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> symptoms coronavirus disease <NUMBER> acute onset fever myalgia dyspnea cough evidence groundglass lung opacities currently effective vaccine treatment covid<NUMBER> patients continued research urgently needed address challenges posed pandemic transmembrane spike glycoprotein sarscov<NUMBER> interacts angiotensinconverting enzyme <NUMBER> ace<NUMBER> presented surface human cells mediates viral entry <NUMBER> <NUMBER> <NUMBER> viral spike human ace<NUMBER> hace<NUMBER> glycoproteins glycosylation affects interactions vaccine design covid <NUMBER> spike glycoprotein forms trimeric structure surface virus envelope <NUMBER> spike protein consists s<NUMBER> s<NUMBER> subunit s<NUMBER> subunit mediates binding virus ace<NUMBER> receptor s<NUMBER> subunit enables fusion virion cell membrane initiates viral entry sarscov<NUMBER> <NUMBER> <NUMBER> times higher affinity ace<NUMBER> receptor sarscov <NUMBER> may part related glycosylation proteins sarscov<NUMBER> glycoprotein carries <NUMBER> nglycosylation sequons <NUMBER> <NUMBER> least <NUMBER> sites mucintype oglycosylation predicted <NUMBER> yet observed experimentally latest analysis shows <NUMBER> <NUMBER> nglycosylation sequons occupied complex hybrid oligomannosidic structures sequons predominantly occupied oligomannose structures could influence trimeric structure studies also detected one oglycopeptide occupied sites distinct predicted furin cleavage site s<NUMBER>s<NUMBER> boundary <NUMBER> <NUMBER> <NUMBER> study report analysis sitespecific glycoforms focus resolution structural motifs identified oand nglycopeptides end used highresolution lcmsms hcd fragmentation modulated nce <NUMBER> study recombinant sarscov<NUMBER> fulllength protein expressed human embryonic kidney hek <NUMBER> cells analyses identified <NUMBER> occupied oglycopeptides <NUMBER> nglycopeptides resolved first time lacdinac polylacnac structural motifs associated nglycopeptides identified novel oglycopeptides including glycopeptide near furin cleavage site spike glycoprotein recombinant sarscov<NUMBER> spike r<NUMBER>a r<NUMBER>a histag protein expressed hek <NUMBER> cell line obtained acrobiosystems newark de usa trypsin gold gluc sequencing grade promega madison wi pngase f neuraminidase <NUMBER> <NUMBER> betagalactosidase new england biolabs ipswich aliquots sarscov<NUMBER> protein dissolved sodium bicarbonate buffer final concentration <NUMBER>mgml protein solution reduced <NUMBER> mm dtt <NUMBER> min <NUMBER> Â°c alkylated <NUMBER> mm iodoacetamide <NUMBER> min dark digested trypsin gold <NUMBER> ngÎ¼l <NUMBER>Â°c barocycler nep<NUMBER> pressure biosciences south easton <NUMBER> hour gluc pngase f neuraminidase beta galactosidase digests tryptic peptides carried described previously <NUMBER> <NUMBER> heat inactivation <NUMBER> Â°c <NUMBER> min prior addition enzyme digested proteins separated using <NUMBER>minute acn gradient <NUMBER> mm x <NUMBER> Î¼m c<NUMBER> pepmap column flow rate <NUMBER> Î¼lmin described previously <NUMBER> brief peptide glycopeptide separation achieved <NUMBER> min trappingwashing step using <NUMBER> solvent <NUMBER> acetonitrile <NUMBER> formic acid <NUMBER> Î¼lmin followed <NUMBER> min acetonitrile gradient glycopeptides analyzed using orbitrap fusion lumos mass spectrometer electrospray ionization voltage <NUMBER> kv capillary temperature <NUMBER>Â°c ms<NUMBER> scans performed mz <NUMBER> wide quadrupole isolation resolution <NUMBER> mz <NUMBER> rf lens <NUMBER> intensity threshold ms<NUMBER> set <NUMBER>e<NUMBER> selected precursors ms<NUMBER> charge state <NUMBER> dynamic exclusion <NUMBER>s datadependent hcd tandem mass spectra <NUMBER> collected resolution <NUMBER> orbitrap fixed first mass <NUMBER> <NUMBER> normalized collision energy <NUMBER> <NUMBER> <NUMBER> etd ethcd methods used calibrated charge dependent parameters hcd supplemental activation set <NUMBER> nce used chromatographic method instrument settings etd measurements described lcimmsms experiments performed waters select series cyclic ion mobility mass spectrometer acquity mclass solvent system tryptic peptides separated using <NUMBER> Âµm x <NUMBER> mm acquity beh c<NUMBER> column <NUMBER> cm symmetry c<NUMBER> trap peptides eluted <NUMBER> minutes prior electrospray ionization analysis positive mode glycoforms polybasic peptide isolated quadrupole fragmented trap region prior ion mobility separations ion mobility methods entailing five passes cyclic device previously optimized hexnachex hexnachexneuac oxonium ions used separate characterize oxonium ion fragments targeted glycopeptides traveling wave parameters within cyclic device kept default values <NUMBER> ms <NUMBER>v wave velocity wave height respectively calibration collisional cross section performed single pass <NUMBER>pass methods using major mix byonic software protein metric used identification summary formulas glycans associated glycopeptides independent searches performed data different collision energy ce settings spectra identified glycopeptides checked manually presence structurespecific fragments analysis ion mobility data performed using driftscope v<NUMBER> manual extraction retention ranges associated glycopeptides identified <NUMBER> tryptic nglycopeptides sarscov<NUMBER> spike protein occupied high mannose hybrid complex glycans determined site occupancy pngasef deglycosylation <NUMBER> water described <NUMBER> find majority sequons fully occupied table <NUMBER> found two sequons glycosylated n<NUMBER> n<NUMBER> n<NUMBER> almost exclusively occupied high mannose glycans remaining <NUMBER> sequons dominated complex glycans addition confirmed presence core fucosylation <NUMBER> occupied sequons table <NUMBER> used recently described workflows using modulation collision energy ce selective fragmentation glycopeptides <NUMBER> identify structural motifs nglycosylated peptides sarscov<NUMBER> protein identified lacdinac structural motif occupied sequons sarscov<NUMBER> expressed hek<NUMBER> cells table <NUMBER> table <NUMBER> resolved extensive fucosylation core well outerarms nglycopeptides described previously <NUMBER> presence core fucose confirmed <NUMBER> sequons confirmed presence outer arm fucosylation <NUMBER> <NUMBER> <NUMBER> sequons contrast previously published data <NUMBER> might result slight differences hek<NUMBER> expression systems used differences analytical methods example study analyzed modified fulllength protein cleaved convertases could potentially cause differences however likely energy optimized workflows improve structural resolution achieve complete assignment linkages quantification isobaric structures presence structural motifs frequently associated specific biological functions clearly established overall results show <NUMBER> glycopeptides carry polylacnac motifs sequons occupied complex glycans carry lacdinac degree lacdinac structures constitute majority <NUMBER> glycoforms n<NUMBER> n<NUMBER> may necessarily reflect nglycoforms virion hek<NUMBER> expression system commonly used functional studies glycoprotein production vaccine candidates means resolution structures highly relevant previously published data describes one oglycopeptide occupied s<NUMBER> t<NUMBER> <NUMBER> <NUMBER> identified oglycopeptides addition identified <NUMBER> oglycopeptides occupied core<NUMBER> core<NUMBER> structures table <NUMBER> occupancy sites varies <NUMBER> <NUMBER> <NUMBER> low least three glycopeptides however detect approximately <NUMBER> occupancy core<NUMBER> core<NUMBER> structures t<NUMBER> figure <NUMBER> <NUMBER> located near polybasic furin cleavage site s<NUMBER> s<NUMBER> subunits evolved sarscov<NUMBER> protein <NUMBER> relevant oglycans proximal convertase cleavage sites protein substrates regulate proteolysis <NUMBER> exoglycosidase digestion ethcd fragmentation used determine exact sites occupied glycans identified <NUMBER> oglycopeptides occupied oglycans table <NUMBER> figure <NUMBER> shows typical etdethcd fragmentation spectrum oglycopeptide case simplified nonspecific neuraminidase fragmentation shows t<NUMBER> major occupied site z<NUMBER> carries glycan z<NUMBER> thepeptide occupied core<NUMBER> figure <NUMBER>a well core<NUMBER> figure <NUMBER>b structures addition used combination neuraminidase Î²<NUMBER> Î²<NUMBER>galoctosidasesto resolve hexnac attachment oglycopeptide even hcd spectra supplemental figure <NUMBER> chose cims <NUMBER> oxonium ions determine structural features oglycopeptides sars cov<NUMBER> glycoprotein choose use cims fragment reduce influence peptide backbone structural resolution able confirm presence core<NUMBER> structures dihexnac fragment mz <NUMBER> hcd spectra using orbitrap fusion lumos figure <NUMBER>a inset tandem mass spectra obtained cims instrument preserve large oxonium ions intact detached glycan mz <NUMBER> figure <NUMBER> confirms hexasacharide occupies oglycopeptide agccamligaehvnndeasyeccamdipigagiccamasyqtqtnspr using beam type fragmentation could determine serine threonine occupied cannot fully exclude possibility contribution second glycan peptide neither etd hcd spectra show evidence another occupied site besides t<NUMBER> peptide also confirmed presence extended core<NUMBER> structure associated glycopeptide fragments <NUMBER> <NUMBER> observed spectra figure <NUMBER>b used cims separate isomeric oxonium ion fragments glycopeptides used mz <NUMBER> ion assign sialylation core<NUMBER> monosialylated structures used optimized procedure based hemopexin glycopeptide standard described previously <NUMBER> determined ccs fragment <NUMBER> figure <NUMBER> observed fragmentation glycopeptide sialylt antigen linkage Î±<NUMBER> ccs <NUMBER> fragmentation nglycopeptide sialyllacnac Î±<NUMBER> linkage ccs <NUMBER> data shown agreement previously published results linkages sialylated glycans <NUMBER> <NUMBER> resolved two major ims peaks cims fragment mz <NUMBER> using one pass method figure <NUMBER>a <NUMBER> passes first peak partially separated two analytes determined ccss <NUMBER> <NUMBER> Ã¥ <NUMBER> second peak ccs <NUMBER> Ã¥ <NUMBER> reproducible <NUMBER>hexnac containing structures supplemental figure <NUMBER> ccs first peak fits exactly previously observed ccs sialylated Î±<NUMBER> lacnac ccs second peak fits gal<NUMBER>sa monosialylated core<NUMBER> structure figure <NUMBER> panel used cims fragment mz <NUMBER> <NUMBER>hexnac<NUMBER>hex determine ratio core<NUMBER> structure extended core<NUMBER> structure obtained <NUMBER> major peaks using <NUMBER> passes cims data shown first peak drift time<NUMBER> ms ccs <NUMBER> Ã¥ <NUMBER> consistent core<NUMBER> structure second peak <NUMBER> ms ccs <NUMBER> Ã¥ <NUMBER> linear core<NUMBER> extended structure terminal galnac<NUMBER>gal described previously <NUMBER> ratio core<NUMBER> terminal galnac<NUMBER>gal core<NUMBER> structure <NUMBER>  research reported publication supported national institutes health awards s<NUMBER>od<NUMBER> u<NUMBER>ca<NUMBER> r<NUMBER>ca<NUMBER> rg content solely responsibility authors necessarily represent official views national institutes health authors declare conflict interest nonconserved regions spike glycoproteins merscov srascov sarscov<NUMBER> spike proteins sarscov<NUMBER> wuhan zhejiang guandong china countries united states france australia germany nearly <NUMBER> conserved supplementary fig <NUMBER> next alignment phylogenetic analysis amino acid sequences spike proteins sarscov<NUMBER> merscov sarscovs showed difference sequence conservancy fig <NUMBER>a supplementary fig <NUMBER> spike proteins five sarscovs approximately <NUMBER> homologous aa sequence supplementary fig <NUMBER> used sarsns<NUMBER> representative sarscov analysis currently bioinformatic approaches epitope analysis welldeveloped successfully proved identify weak strong epitopes might experimentally ignored <NUMBER> study using antibody epitope bioinformatic tools supplementary materials methods computed sequencebased antibody epitope scores spike proteins merscov sarscov sarscov<NUMBER> fig <NUMBER>b sarscov<NUMBER> significantly lower antibody epitope score compared merscov p <NUMBER> fig <NUMBER>c significantly higher antibody epitope score compared sarscov p <NUMBER> fig <NUMBER>c indicating spike proteins significantly variable antigenicity next conducted sequence alignment acquire conserved nonconserved regions spike proteins fig <NUMBER>d supplementary fig <NUMBER> compared conserved regions nonconserved regions significantly higher antibody epitope score fig <NUMBER>e f indicating nonconserved regions spike proteins antigenic surface accessibility epitope also important interaction antibody antigen evaluated surface epitope accessibility spike proteins fig <NUMBER>g significant difference observed total protein level fig <NUMBER>h however nonconserved regions showed significantly higher surface epitope accessibility score fig <NUMBER>i j indicating nonconserved regions spike proteins available antibody recognition furthermore identified antibody epitopes considering antibody epitope surface epitope accessibility scores fig <NUMBER>k supplementary materials methods antibody epitopes spike proteins compared merscov sarscov sarscov<NUMBER> fig <NUMBER>l unique shared public epitopes identified fig <NUMBER>m public epitope could found although five epitopes shared sarscov sarscov<NUMBER> apparent dominances unique epitopes srascov <NUMBER> srascov<NUMBER> <NUMBER> fig <NUMBER>n moreover among unique epitopes <NUMBER> derived nonconserved regions combinations conserved nonconserved regions fig <NUMBER>o indicating divergence spike proteins could lead major changes antibody epitopes next according cryoelectron microscopy structure sarscov spike protein complexed human ace<NUMBER> protein pdb accession <NUMBER>acj <NUMBER> used swissmodel bioinformatic tool <NUMBER> model threedimensional complex structure sarscov<NUMBER> spike protein binding host cell receptor novel antibody epitopes dominate antigenicity spike glycoprotein zheng l song ace<NUMBER> fig <NUMBER>p discovered sarscov<NUMBER> spike rbd interaction interface ace<NUMBER> fig <NUMBER>p rbd sarscov<NUMBER> spike protein found seven epitopes one conserved region homologous sarscov yet rest novel epitopes using combinations conserved nonconserved regions fig <NUMBER>q furthermore identified highscore epitopes high epitope surface accessibility score fig <NUMBER>r supplementary fig <NUMBER> finally found <NUMBER> highscore epitopes sarscov<NUMBER> <NUMBER> conserved region located outside rbd nevertheless identified two novel highscore epitopes located rbd fig <NUMBER>s might used block spikeace<NUMBER> interaction inhibit sarscov<NUMBER> infection summary study showed although sarscov<NUMBER> spike protein displayed high <NUMBER> homology toward sarscov novel epitopes contributed <NUMBER> antibody epitopes <NUMBER> rbd antibody epitopes <NUMBER> highscore antibody epitopes sarscov<NUMBER> implying remarkable alterations antigenicity notably results might explain antibodies srascov spike protein invalidated sarscov<NUMBER> previous study <NUMBER> indicate necessity develop new antibodies vaccines specific sarscov<NUMBER> importantly discovered novel highscore antibody epitopes sarscov<NUMBER> spike protein analyzed rbd locations potent specific targets developing antibody drugs vaccines sarscov<NUMBER> future taken together study found antigenicity sarscov<NUMBER> spike protein remarkably dominated altered novel antibody epitopes provides promising leads research development vaccine sarscov<NUMBER> fig <NUMBER> antibody epitope analysis spike proteins merscov sarscov sarscov<NUMBER> alignment phylogenetic analysis amino acid sequences spike proteins sarscov<NUMBER> merscov five representative sarscovs total sequence alignment supplementary fig <NUMBER> b antibody epitope scores spike proteins merscov sarscov sarscov<NUMBER> grey dashed lines indicate default threshold antibody epitope scores c density plot distributions antibody epitope scores spike proteins merscov sarscov sarscov<NUMBER> colors showing tail distribution probability grey dashed lines representing first second third quartiles respectively results considered statistically significant p <NUMBER> p <NUMBER> p <NUMBER> p <NUMBER> using kruskalwallis test illustration conserved nonconserved sequences e density plot distributions antibody epitope scores conserved nonconserved sequences comparison spike proteins sarscov sarscov<NUMBER> results considered statistically significant p <NUMBER> p <NUMBER> p <NUMBER> p <NUMBER> using wilcoxons signedrank test f distributions antibody epitope scores conserved nonconserved sequences comparison spike proteins merscov sarscov<NUMBER> using wilcoxons signedrank test g surface epitope accessibility scores spike proteins merscov sarscov sarscov<NUMBER> grey dashed lines indicate default threshold surface epitope accessibility scores h distributions surface epitope accessibility scores spike proteins merscov sarscov sarscov<NUMBER> using kruskalwallis test distributions surface epitope accessibility scores conserved nonconserved sequences comparison spike proteins sarscov sarscov<NUMBER> using wilcoxons signedrank test j distributions surface epitope accessibility scores conserved nonconserved sequences comparison spike proteins merscov sarscov<NUMBER> using wilcoxons signedrank test k illustration antibody epitope identification l venn plot antibody epitopes spike proteins merscov sarscov sarscov<NUMBER> illustration analyzing intersected epitopes unique shared public groups n plot number intersected epitopes spike proteins merscov sarscov sarscov<NUMBER> number shared unique epitopes conserved nonconserved combination conserved nonconserved regions spike proteins sarscov sarscov<NUMBER> color size cycles represent number epitopes Ã represents epitope could found p structural model sarscov<NUMBER> spike protein yellow complex human cell receptor ace<NUMBER> cyan model superimposed using structure sarscov spike protein ace<NUMBER> protein complex pdb accession <NUMBER>acj template gray shadow represents receptorbinding domain rbd q number epitopes located rbd nonrbd conserved nonconserved combination conserved nonconserved regions sarscov<NUMBER> spike protein color size cycles represent number epitopes Ã represents epitope could found r plot antibody epitope scores surface epitope accessibility scores epitopes dot represent epitope green dashed lines indicate medians respectively dot color represents source epitopes dot size represents amino acid length epitopes represents epitopes located rbd light green area shows highscore epitopes detail information highscore antibody epitopes sarscov<NUMBER> spike protein acquisition processing sequence data total <NUMBER> whole genome sequences sarscov<NUMBER> <NUMBER>ncov downloaded <NUMBER> january <NUMBER> gisaid database <NUMBER> multiple sequence alignment conducted spike protein sequences sarscov merscov sarscov<NUMBER> using clustal w <NUMBER> next pairwise scoring matrix distances computed using fitch similarity aligned sequences <NUMBER> based resulting scoring matrix phylogenetic tree constructed using neighborjoining method <NUMBER> sequencebased antibody epitopes score analyzed using bepipred<NUMBER> bioinformatic tool <NUMBER> antibody epitope candidates analyzed using default threshold value <NUMBER> surface epitope accessibility computed using emini surface accessibility scale method <NUMBER> next antibody epitope candidates filtered surface accessible epitopes score using default threshold value <NUMBER> fig <NUMBER>k <NUMBER>d cryoelectron microscopy structure sarscov spike protein complexed host cell receptor ace<NUMBER> protein derived protein data bank pdb accession <NUMBER>acj <NUMBER> next according sarscov<NUMBER> spike protein sequence swissmodel bioinformatic tool <NUMBER> used model <NUMBER>d complex structure sarscov<NUMBER> spike protein binding ace<NUMBER> statistical analyses performed using r v<NUMBER> wilcoxon signedrank two samples kruskalwallis test dunns multiple comparison test multiple samples performed using stats package appropriate statistical tests used <NUMBER> significance level p â¥ <NUMBER> considered significant ns p <NUMBER> coronaviruses covs typically cause mild severe respiratory intestinal infections mammals including humans <NUMBER> <NUMBER> belongs family coronaviridae comes order nidovirales <NUMBER> <NUMBER> covs classified four genera alphacoronavirus betacoronavirus gammacoronavirus deltacoronavirus first two genera ie alphaand betacoronavirus mainly infect mammals whereas gammacoronaviruses deltacoronaviruses foul avian species <NUMBER> years passed since identification first human cov hcov documented respiratory tract modulator <NUMBER> <NUMBER> december <NUMBER> several clusters epidemiologically associated seafood animal market wuhan china patients suffering fever illness severe respiratory tract infections pneumonia unknown origin reported <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> finally leaded isolation novel coronavirus <NUMBER>ncov disease recently named covid<NUMBER> world health organization already characterized covid<NUMBER> world pandemic <NUMBER> infection spread <NUMBER> countries territories <NUMBER> covid<NUMBER> outbreak six species hcovs reported association respiratory tract infections table <NUMBER> table <NUMBER> <NUMBER> seventh strain hcov novel coronavirus <NUMBER>ncov aka sarscov<NUMBER> taxonomically belongs betacoronavirus genre possesses high nucleotide sequence similarity sarscov merscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> positivesense singlestranded rna viruses surrounded envelope figure <NUMBER> sarscov<NUMBER> <NUMBER> bp singlestranded rna virus utilizes host cellular components accomplish physiological affairs viral entry assembly budding virions genomic replication protein synthesis subsequently executes pathological damage host <NUMBER> <NUMBER> <NUMBER> thus punctuating juncture viral life cycle small molecules peptides vaccines physical elements may potentially gain therapeutic benefit host depending several viral targets figure <NUMBER> related stages viral life cycle novel antiviral agents may designed discovered nonetheless different structurebased modeling techniques numerous ligandbased computational techniques may fruitful strategy design newer inhibitors sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> meanwhile hefty menace posed current outbreak covid<NUMBER> obvious scientific community looking effective drugs within plausible time coherent development well organised strategies remains hope triumph battle partially known sarscov<NUMBER> repurposing existing antiviral drugs based previous ground work closely related coronavirus rapid screening drug databases one strategic economic ways eradicate covid<NUMBER> pandemic <NUMBER> <NUMBER> <NUMBER> traditional bioinformatics chemoinformatics approaches readily generated new data sarscov<NUMBER> research explosive pace considering severity spread covid<NUMBER> study inline concept finding chemotypes expedite process antihcov drug discovery exquisite picture recent research including targetbased biological screening provided includes virtual silico well experimental vitro screening approaches response sarscov<NUMBER> reported april <NUMBER> main aim provide scientific community overview medicinal chemistry sarscov<NUMBER> allow rapid development antiviral agents work part rational drug design discovery <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> initiative pave way antisarscov<NUMBER> drug discovery paradigm could help facilitate global efforts fight covid<NUMBER> details structural biology sarscov<NUMBER> virus yet discovered contains <NUMBER> bp singlestranded positive sense rna genome encapsulated within membrane envelope figure <NUMBER> <NUMBER> <NUMBER> <NUMBER> recruits multisubunit replication machinery <NUMBER> genome sarscov<NUMBER> comprises <NUMBER> nucleotides ten open reading frames orfs <NUMBER>â² terminal regions encodes several structural proteins including spike membrane envelope e nucleocapsid n proteins figure <NUMBER> whereas <NUMBER>â² terminal orf<NUMBER>ab responsible two viral replicase polyproteins pp<NUMBER>a pp<NUMBER>b upon proteolytic cleavage two viral replicase polyproteins fabricate sixteen nonstructural proteins nsp figure <NUMBER> <NUMBER> table <NUMBER> may placed spike glycoprotein coronavirus main conciliator entry host cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> spike glycoprotein contains large ectodomain ii singlepass transmembrane anchor iii short cterminal intracellular tail <NUMBER> ectodomain consists receptorbinding unit s<NUMBER> membranefusion s<NUMBER> stalk basically receptorbinding unit s<NUMBER> binds specific cell surface receptor via receptor binding domain rbd whereas trimeric s<NUMBER> fuses viral membranes host cell enable entry viral genomes host cells figure <NUMBER> researchers already identified angiotensin converting enzyme <NUMBER> ace<NUMBER> functional receptor sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> crowned shaped spike glycoprotein covs binds directly ace<NUMBER> host cells surface plays critically virus infection ace<NUMBER> expressed widely conserved primary structures throughout animal kingdom ace<NUMBER> fish amphibians reptiles birds mammals potentially interact rbd sarscov<NUMBER> <NUMBER> therefore blocking rbd ace<NUMBER> interaction obvious therapeutic intervention treat diseases caused covs specific antibodies small molecular inhibitors disrupt interaction rbd ace<NUMBER> among set sixteen nonstructural proteins nsp<NUMBER> identified play pivotal role life cycle sarscov<NUMBER> replication well maturation figure <NUMBER> key component nsp<NUMBER> termed main protease mpro like rna viruses functional significance mpro chymotrypsinlike protease <NUMBER>clpro sarscov<NUMBER> emerges attractive drug target development antiviral agents recently <NUMBER>d structure <NUMBER>clpro sarscov<NUMBER> reported <NUMBER> like coronaviruses mpro also consists three domains domain comprising <NUMBER> amino acids ii rdrp active site appointing two successive aspartate residues projected betaturn structure making surface accessible nucleotide channel configured sarscov robson <NUMBER> performed preliminary bioinformatics studies propose synthetic vaccine peptidomimetic antagonist spike glycoprotein sarscov<NUMBER> author employed quel language perform bioinformatics approach krsfiedllfnkv identified well conserved sequence motif corresponds known cleavage sites sars virus sequence motif formed basis design specific synthetic vaccine epitope peptidomimetic agent <NUMBER> group scientists cairo university egypt predicted covid<NUMBER> spike binding site cellsurface receptor namely glucose regulated protein <NUMBER> grp<NUMBER> employing structural bioinformatics combination proteinprotein docking <NUMBER> notably region iv supposed pivotal driving force grp<NUMBER> binding predicted binding affinity <NUMBER> kcalmol prediction binding site sheds light mode envelope protein recognition grp<NUMBER> substratebinding domain future endeavours <NUMBER> molecular modeling study explore potential inhibitors rna binding n terminal domain ntd nucleocapsid protein n protein sarma et al <NUMBER> pointed two potential hits namely zinc<NUMBER> zinc<NUMBER> figure <NUMBER> authors employed two ntd structures n proteins namely <NUMBER>ofz <NUMBER>ssk firstly set diverse compounds asinex maybridge library docked <NUMBER> compounds targets prioritized significant docking scores mmgbsa binding free energy pharmacokinetic properties qikprop druglikeness swissadme molecular dynamics md studies performed screen compounds two potential hits one compound theophylline derivative since theophylline derivative commonly used bronchodilator hence author screened approved bronchodilators n protein <NUMBER> rna binding site covid<NUMBER> <NUMBER> approved bronchodilators showed mmgbsa binding affinity following order formeterol terbutaline ipratropium bromide tiotropium bromide theophylline salbutamol recently native nonnative proteinprotein interactions ppis emerged target structurebased screening small molecule may alternative drug design paradigm could accelerate antiviral drug discovery various pathogens <NUMBER> <NUMBER> <NUMBER> since orthostaticallosteric stabilization nonnative ppis sarscov<NUMBER> nucleocapsid protein results abnormal protein oligomerizaion finally leading loss viral activity scientists national chung hsing university taiwan acclaimed nonnative ppis nterminal domain merscov nucleocapsid protein merscov nntd <NUMBER> reported crystal structure merscov nntd nonnative dimeric configuration turned target virtual screening orthosteric stabilizers acros zinc drug databases finding provides valuable insight motivations design new antivirals based stabilizing nonnative protein interaction interface n protein <NUMBER> gupta coworkers <NUMBER> employed computational techniques explore best possible structure sarscov<NUMBER> e protein present pdb database author reported e protein sarscov<NUMBER> pentameric protein comprised <NUMBER> Î±helices <NUMBER> loops near <NUMBER> compounds docked whereas <NUMBER> compounds prioritized significant affinities docking scores docking study e protein sarscov<NUMBER> phytochemicals like belachinal macaflavanone e vibsanol divulged amino acids v<NUMBER> f<NUMBER> play crucially binding interactions functional behaviour e protein sarscov<NUMBER> <NUMBER>ns molecular dynamics studies revealed Î±helix loops e protein escapades random movement modulates normal ion channel activity succour pathogenesis human vertebrates unlikely random manoeuvre e protein sarscov<NUMBER> gets reduced binding inhibitors <NUMBER> khan et al <NUMBER> pinpointed three fdaapproved drugs remdesivir saquinavir darunavir two small molecules flavone coumarin derivatives possible inhibitors <NUMBER>clpro targetbased virtual screening number <NUMBER> compounds docked top <NUMBER> primary hits distinguished significant affinities docking scores binding interaction active site residue <NUMBER>clpro selected compounds extensively scrutinized using plif module moe md simulation binding free energy calculations recorded evaluate dynamic behaviour stability proteinligand contact binding affinity hit compounds <NUMBER> kandeel alnazawi <NUMBER> reported statistics pairwise sequence comparison matrix among main protease mpro covs high pairwise sequence alignment identity <NUMBER> found sarscov<NUMBER> sarscov<NUMBER> mpro whereas <NUMBER> identity exposed sarscov<NUMBER> merscov mpro consequence number amino acid differences sarscov<NUMBER> sarscov<NUMBER> mpro <NUMBER> <NUMBER> sarscov<NUMBER> merscov mpro early virtual screening vs study fda approved drugs retrieved selleckchem inc first resolved sarscov<NUMBER> mpro crystal structure pdb <NUMBER>lu<NUMBER> performed helps repurposing already approved drugs eradicate covid<NUMBER> <NUMBER> detailed scanning binding mode drugs sarscov<NUMBER> mpro conferred hydrophobic hydrogen bonding interactions main imperators binding interestingly telbivudine figure <NUMBER> antihepatitis b virus agent bind sarscov<NUMBER> mpro hydrogen bond interactions amino acid residues s<NUMBER> q<NUMBER> moreover broad spectrum antiviral agent ribavirin figure <NUMBER> interacted sarscov<NUMBER> mpro forming hydrogen bonds side chain amino acid residue q<NUMBER> backbone amino acid residue t<NUMBER> ribavirin officially approved respiratory syncytial virus rsv infection also used combination interferon Î±<NUMBER>b hepatitis c virus moreover also exhibited potency sarscov infection <NUMBER> study distinguish potential active herbs <NUMBER>ncov et al leading viral eradication <NUMBER> another study elfiky <NUMBER> reported sarscov<NUMBER> rdrp targeted molecular docking study antipolymerase drugs approved use various viruses surprisingly ribavirin remdesivir sofosbuvir galidesivir tenofovirexhibited promising binding affinity sarscov<NUMBER> rdrp results also consistence previous one <NUMBER> guanosine derivative idx<NUMBER> setrobuvir yak potential block sarscov<NUMBER> strain since drugs already passed adme toxicity measurements may used new therapeutic drug candidate sarscov<NUMBER> lung coworkers <NUMBER> identified theaflavin polyphenolic constituent present black tea hydrophobic interactions found driving force binding theaflavin formed hydrogen bonds d<NUMBER> r<NUMBER> r<NUMBER> sarscov<NUMBER> rdrp additionally Ïcation interaction found r<NUMBER> <NUMBER> calligari et al <NUMBER> autodockvina scoring â<NUMBER> kcalmol recognised best autodock vina scoring drug spite hcv main protease measure low identity sarscov<NUMBER> homolog <NUMBER> thus finding thunderbolt <NUMBER> therefore may inferred similar topology active site proteases main driving force binding simeprevir fitted well two hydrophobic pockets fringed catalytic dyad h<NUMBER>c<NUMBER> sarscov<NUMBER> mpro also fitted hydrophobic loop f<NUMBER>f<NUMBER> moreover binding simeprevir sarscov<NUMBER> protease anchored three hydrogen bonding interactions e<NUMBER> g<NUMBER> n<NUMBER> <NUMBER> article homology modelling sarscov<NUMBER> protein aid itasser server done using sarscov spike pdb <NUMBER>wrg <NUMBER> Ã <NUMBER> <NUMBER>xlr template global pairwise sequence alignment measured sarscov<NUMBER> protein shares <NUMBER> primary sequence homolog addition overall similarity <NUMBER> autodock vina molecular docking homology modelled structure protein predicted umifenovir db<NUMBER> enfuvirtide db<NUMBER> pleconaril db<NUMBER> potential inhibitors <NUMBER> study repurposing existing drugs current pandemic covid<NUMBER> wu et al <NUMBER> predicted potential drugs acting certain target multiple targets sarscov<NUMBER> bioinformatics based homology modelling utilised build possible targets viral mpro plpro rdrp helicase spike etc next modelled proteins human relative proteins including human ace<NUMBER> typeii transmembrane serine protease enzymes forwarded systematically analyse screen zinc drug database zdd along database traditional chinese medicine natural products database commonly used <NUMBER> antiviral drugs <NUMBER> study seems interesting due deep discussions vast target predictability lead candidates emerged study required vitro vivo studies conformations new drug discovery development takes five ten years investigations well cost billions dollars thus drug repositioning cheap strategy respond immediately fdaapproved drugs justify safe alternatives least modest antisarscov<NUMBER> activity achieved currently academia industry personnel involved testing approved drugs andor ii drug candidates clinical trials vitro screenings fda approved drugs well compounds currently clinical trials phases well documented <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> need vivo testing facilitate drug discovery efforts sarscov<NUMBER> nafamostat figure <NUMBER> potent membrane fusion inhibitor merscov <NUMBER> found inhibit <NUMBER>ncov infection ec <NUMBER> besides agent marketed antiprotozoal drug <NUMBER> also reported possess antiviral broad range viruses <NUMBER> article wang et al <NUMBER> remdesivir illustrated years ago <NUMBER> found effectively block sarscov<NUMBER> infection lowmicromolar concentration <NUMBER> exhibited halfmaximal effective concentration ec <NUMBER> <NUMBER> Î¼m <NUMBER>ncov vero e<NUMBER> cells half cytotoxic concentration cc <NUMBER> <NUMBER> Î¼m selectivity index si <NUMBER> remdesivir also inhibited virus infection sarscov<NUMBER> sensitive human liver cancer huh<NUMBER> cells <NUMBER> widelyused antimalarial drug chloroquine cq figure <NUMBER> used <NUMBER> years <NUMBER> found shows clinical potency covid<NUMBER> figure <NUMBER> may placed molecular mechanism chloroquine sarscov known <NUMBER> <NUMBER> recently wang et al <NUMBER> reported timeofaddition assay explained function cq ec <NUMBER> <NUMBER> Î¼m cc <NUMBER> <NUMBER> Î¼m si <NUMBER> entry well postentry stages novel corona virus infection vero e<NUMBER> cells group researches evaluated vitro antisarscov<NUMBER> effect hydroxychloroquine hcq figure <NUMBER> sulphate derivative cq comparison cq <NUMBER> hydroxychloroquine sulphate <NUMBER> introduced long first synthesized <NUMBER> <NUMBER> upon introduction hydroxyl group cq resulted <NUMBER> less toxic agent cq animals cq hcq weak bases restrict virus infection byi triggering endosomal ph essential viruscell fusion ii interfering glycosylation ace<NUMBER> receptor spike protein coronavirus <NUMBER> additionally cq hcq obstructed sarscov<NUMBER> transport early endosomes ees endolysosomes els interestingly exhibited distinct binding mode covalent peptidomimetic <NUMBER>clpro inhibitors <NUMBER> vitro screening <NUMBER> drugs screened hcovs infection <NUMBER> immunofluorescence analysis antibody specific viral n protein sarscov<NUMBER> scored drug treated cells doseresponse curve drc developed analysing confocal microscope images viral n protein cell nuclei remdesivir sarscov<NUMBER> ic <NUMBER> <NUMBER> Âµm lopinavir sarscov<NUMBER> ic <NUMBER> <NUMBER> Âµm chloroquine sarscov<NUMBER> ic <NUMBER> <NUMBER> Âµm used reference drugs consequently <NUMBER> drugs showed good activities ic <NUMBER> ranges <NUMBER> <NUMBER> Î¼m antihelminthic drug niclosamide corticosteroid used treat asthma allergic rhinitis ciclesonide emerged sarscov<NUMBER> inhibitors ic <NUMBER> <NUMBER> Î¼m <NUMBER> Î¼m respectively notably niclosamide reduces merscov replication inhibiting skp<NUMBER> activity leading enhancement autophagy <NUMBER> thus similar mechanism may introduced niclosamide hamper sarscov<NUMBER> infection <NUMBER> zhang et al <NUMBER> reported structurebased design synthesis activity assessment Î±ketoamides broadspectrum inhibitors coronavirus enterovirus replication showed good inhibitory properties isolated proteases viral replicons virusinfected huh<NUMBER> cells nearequipotency enteroviruses alphacoronaviruses betacoronaviruses observed upon optimization p<NUMBER> substituent Î±ketoamides cyclopentylmethyl cyclohexylmethyl p<NUMBER> substituent disposed lowmicromolar ec <NUMBER> values three virus genera cell cultures compound <NUMBER>r found promising merscov virusinfected huh<NUMBER> cells <NUMBER> dint high similarity among <NUMBER>clproteases coronavirus awaited compound <NUMBER>r expected display good antiviral activity covid<NUMBER> near future meanwhile clinical trial studies molecules started covid<NUMBER> mainly drug repurposing <NUMBER> depicted table <NUMBER> medicinal chemistry sarscov<NUMBER> infection still infancy target specific lead molecules yet identify study deals information currently available potential targets therapeutic invention screening new compounds drug repurposing sarscov<NUMBER> figure <NUMBER> <NUMBER>d structure sarscov<NUMBER> <NUMBER>clike protease bears <NUMBER> identity ortholog sarscov interestingly residues involved catalysis substrate binding dimerization <NUMBER>clpro <NUMBER> conserved addition polyprotein pp<NUMBER>ab sequences highly similar <NUMBER> identity depending upon alike substrate specificities high identities opinion previous progress specific sarscov inhibitors development undertaking course action design discovery inhibitors sarscov<NUMBER> group already explored structural properties important sarscov viral <NUMBER>clike protease inhibitors <NUMBER> recently collaborative work research team suggested implications naphthyl derivatives sarscov<NUMBER> plpro enzyme though indepth ligandreceptor interaction analysis <NUMBER> already predicted inhouse glutaminebased molecules use seed drug design optimization plpro sarscov<NUMBER> <NUMBER> fact antiviral drugs also taken consideration regards targetbased vs one important approaches used drug repurposing computational analyses subordinate right choice enrich basal knowledge long process leading drug development figure <NUMBER> clearcut treatment approach prescribed covid<NUMBER> use already approved drugs alternative strategy howbeit relatively limited computational resource biased silico screening may scattered linearity drug discovery novel coronavirus near future virtual hits may serve promising drug like molecule sarscov<NUMBER> details vitro vivo laboratory investigations moreover availability xray crystal structures important viral proteins trigger exhaustive docking calculation diverse chemotypes crystal clear prevention covid<NUMBER> requires strong sustainable global collaborative work <NUMBER> data sharing exigent fill knowledge gaps global pandemic progress scientific understanding regarding structural molecular biology sarscov<NUMBER> legitimate shape lead compounds achieve therapeutic goals development medicinal chemistry bioinformatics chemoinformatics studies remains indispensable bit savoir faire authors conflict interests sk abdul amin senior research fellow department pharmaceutical technology jadavpur university kolkata india working guidance tarun jha research area includes design synthesis small molecules anticancer antiviral properties computational chemical biology largescale structureactivity relationship analysis published sixty two researchreview articles different reputed peerreviewed journals three book chapters enjoys good conversation science regional history contemporary art books tarun jha professor department pharmaceutical technology jadavpur university kolkata india supervised <NUMBER> phd students guided nine research projects funded different organizations published <NUMBER> research articles different reputed peerreviewed journals research area includes design synthesis anticancer small molecules prof jha member academic advisory committee national board accreditation nba new delhi india early december <NUMBER> chinese health authorities reported several cases pneumonia unknown cause originated wuhan city hubei province china causative agent outbreak identified virus belonged sarbecovirus subgenus orthocoronavirinae subfamily previously referred interim name <NUMBER> novel coronavirus <NUMBER>ncov <NUMBER> <NUMBER> later named sarscov<NUMBER> <NUMBER> due rapid spread covid<NUMBER> world health organization declared global pandemic march <NUMBER> <NUMBER> midjune <NUMBER> <NUMBER> million cases confirmed across <NUMBER> countries resulting <NUMBER> deaths <NUMBER> unfortunately approved antiviral treatment preventive vaccine coronaviruses humans since supportive care recommended interim treatment imperative identify repurposable lead compounds treat covid<NUMBER> sarscov<NUMBER>specific drug vaccine developed although coronavirus genome consists numerous conserved druggable enzymes including papainlike protease plpro <NUMBER>clike protease <NUMBER>clpro nonstructural proteins rnadependent rna polymerase rdrp helicase development clinically approved antiviral therapies proven difficult task <NUMBER> surface structural spike glycoprotein key immunogenic cov antigen essential virus host cellreceptor interactions important target therapeutic development spike protein consists nterminal s<NUMBER> subunit receptor binding cterminal s<NUMBER> subunit membrane fusion s<NUMBER> subunit contains receptorbinding domain rbd attaches host membrane thus playing important role viral entry sarscov<NUMBER> utilizes ace<NUMBER> receptor entry transmembrane protease serine <NUMBER> tmprss<NUMBER> spike protein priming <NUMBER> crystallographic studies shown sarscov<NUMBER> binds ace<NUMBER> receptor binding mode nearly identical sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> binding affinity ace<NUMBER> receptor rbd sarscov<NUMBER> spike protein reported significantly higher compared sarscov <NUMBER> <NUMBER> based importance virus membrane fusion events viral life cycle infectivity spike protein sarscov<NUMBER> targeted drug screening study utilizes virtual compound screening methodology identify potential small molecule inhibitors specific rbd spike protein sarscov<NUMBER> primary objective screen existing fdaapproved drugs silico followed experimental validation identify repurposable drugs targeting clinical validation model sarscov<NUMBER> spike protein constructed using crystal structure <NUMBER>vsbchain correct missing residues amino acid sequence identity target sequence genbank qhd<NUMBER> template <NUMBER>vsbchain <NUMBER> sarscov<NUMBER> model showed rmsd <NUMBER> Ã¥ relative crystal structure <NUMBER>vsbchain structure assessment predicted model using ramachandran plot showed <NUMBER> residues favored regions <NUMBER> outliers none outliers contained residues present active site protein predicted model used insilico studies initial docking simulations resulted seven compounds three compounds antiviral<NUMBER> antiviral<NUMBER> antiviral <NUMBER> docking scores <NUMBER> <NUMBER> <NUMBER> kcalmol enamine antiviral library four compounds ponatinib imatinib ergotamine glecaprevir docking scores <NUMBER> <NUMBER> <NUMBER> <NUMBER> kcalmol zinc<NUMBER> fda library respectively libraries chosen help identify repurposable drug potentially inhibit sarscov<NUMBER> screened compounds highest affinities within respective sets one binding conformations ace<NUMBER> binding domain spike protein binding poses seven screened compounds rbd shown fig <NUMBER>a structures descriptions screened drugs given table s<NUMBER> supplementary data verification binding affinity compounds done via molecular dynamics md simulations stability md simulations evaluated using rmsd rmsf diagrams rmsd diagram protein rbdligands simulations provided fig s<NUMBER> showed simulations compounds remained stable <NUMBER>ns also rmsds seven simulations around <NUMBER> Ã¥ fig s<NUMBER> rmsf diagram showed structural fluctuations protein ligand binding site stable fig s<NUMBER> free energy calculations mmgbsa method fig <NUMBER>b indicated compounds fdaapproved drug library significantly lower binding free energies ie higher affinities drugs enamine library agreement docking scores ponatinib abl tyrosine kinase inhibitor used treat leukemia <NUMBER> displayed negative binding free energy <NUMBER> Â± <NUMBER> kcalmol imatinib glecaprevir ergotamine also show binding free energies within close range ponatinib high affinity screened compounds visible compared negative control dimethyl sulfoxide dmso ineffective coronaviruses <NUMBER> interactions binding free energies seven compounds spike protein provided fig s<NUMBER> table s<NUMBER> supplementary data among screened drugs abl tyrosine kinase inhibitor imatinib selected vitro studies since also shown inhibit sarscov merscov blocking endosomal fusion cellculture level <NUMBER> <NUMBER> <NUMBER> <NUMBER> shown fig <NUMBER>a inset md simulation video supplied supplementary information imatinib predicted bind strongly rbd spike protein forming hydrogen bonds pipi stacking interactions tyr <NUMBER> pipi stacking interactions tyr <NUMBER> critical interaction ace<NUMBER> <NUMBER> <NUMBER> suggested tyrosinekinase inhibitors affect cleavage spike protein inhibits spikemediated endosomal fusion <NUMBER> <NUMBER> <NUMBER> high affinity tyrosinekinase inhibitors towards spike protein deduced initial docking results imatinib ponatinib shown highly negative binding free energies based promising silico data initial viral plaque assay results fig s<NUMBER> imatinib chosen advanced experimental validation first evaluated toxicity imatinib incubating compound vero cells one hour eight hours experiments compound remained cells eight hours toxicity measured concentrations <NUMBER> Âµm <NUMBER> Âµm <NUMBER> Âµm <NUMBER> Âµm however <NUMBER>hour design toxicity observed next evaluated ability imatinib inhibit replication entry concentrations low <NUMBER> Âµm compound effective suppressing <NUMBER> plaque formation <NUMBER>hr design ic<NUMBER> value determined using linear regression <NUMBER> nm consistent toxicity data toxicity observed <NUMBER> <NUMBER> Âµm compound also showed efficacy <NUMBER>hour design higher ic<NUMBER> values data indicate imatinib inhibits virus replication vitro shown fig <NUMBER>a <NUMBER>b evaluate imatinib inhibits viral entry performed two fusion assays endosomal vero plasma membrane verotmprss<NUMBER> shown fig <NUMBER>c <NUMBER>d respectively based cytotoxicity concentrations <NUMBER> nm toxicity observed microscopically red arrow graph vsvg control revealed <NUMBER> infectivity cytopathic effect every concentration suggesting inhibitor affect vsvg entry vsvg particles cells carry spike proteins thus significant entry inhibition occurred suggesting entry inhibition likely mediated spike protein however effect verotmprss<NUMBER> cells less clear coronaviruses used compared vsvg control similar level toxicity observed cells worth noting toxicity probably result incubating cells imatinib <NUMBER> hours assay taken together evidence imatinib binds spike prevents viral entry possibly preventing endosomal entry binding kinetics imatinib rbd sarscov<NUMBER> spike protein evaluated using biolayer interferometry bli analysis showed imatinib binds sarscov<NUMBER> rbd protein onrate kon <NUMBER> Â± <NUMBER> Ã <NUMBER> <NUMBER> <NUMBER> <NUMBER> dissociates offrate koff <NUMBER> Â± <NUMBER> Ã <NUMBER> <NUMBER> <NUMBER> resulted equilibrium affinity constant kd <NUMBER> Â± <NUMBER> Âµm calculated ratio koff kon rates affinity values indicate <NUMBER> rbds surface spike glycoproteins occupied micromolar concentrations imatinib affinity imatinib sarscov<NUMBER> spike rbd protein still higher previously published values nanomolar range ligand id bdbm<NUMBER> <NUMBER> imatinib abl tyrosine kinase <NUMBER> range micromolar affinities imatinib srcfamily kinases frk fyn <NUMBER> indicating calculated binding affinity results realistic shown fig <NUMBER>e urgent need finding treatment current pandemic sarscov<NUMBER> health experts across globe trying use existing clinically approved drugs treat patients specific drug developed present study using combination computational techniques followed vitro studies identified imatinib fda approved anticancer drug potential treatment sarscov<NUMBER> infection data indicate inhibition sarscov<NUMBER> replication ic<NUMBER> <NUMBER> nm also docking experiments show imatinib forms strong interactions rbd sarscov<NUMBER> shown invitro inhibition results suggest imatinib prevents viral replication analogy studies using coronaviruses likely mode action imatinib via inhibition spike protein nevertheless cannot completely exclude inhibition tyrosine kinase also resulted significant inhibition virus replication <NUMBER> <NUMBER> therefore likely imatinib causes inhibition cellular kinase virus fusion resulting inhibition virus replication results provide evidence supporting recent clinical trials clinicaltrialsgov identifier nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> nct<NUMBER> covid<NUMBER> patients imatinib swissmodel server <NUMBER> used construct homology model sarscov<NUMBER> spike protein using crystal structure sarscov<NUMBER> spike protein pdb<NUMBER>vsbchain template <NUMBER> genome sequence wuhanhu<NUMBER> genbank mn<NUMBER> used representative sarscov<NUMBER> spike protein sequence genbank qhd<NUMBER> used target sequence <NUMBER> swissmodel structure assessment tool used validate quality predicted model around <NUMBER> compounds including <NUMBER> nucleosidelike compounds enamine targeted antiviral library enaminenet <NUMBER> food drug administration fdaapproved drugs zinc<NUMBER> database <NUMBER> used molecular docking molecules prepared obabel <NUMBER> sdf mol<NUMBER> format pdbqt format <NUMBER>d compound structures enamine library resolved obabel gen<NUMBER>d command docking file protein model prepared mgltools v<NUMBER> <NUMBER> molecules docked rbd spike protein via autodock vina <NUMBER> <NUMBER> grid box <NUMBER>Ã<NUMBER>Ã<NUMBER> size <NUMBER> Ã¥ spacing fixed around rbd thr<NUMBER>val<NUMBER> spike protein docking simulations done three replicates conformation highest binding score recorded batch processing docking data collection performed using inhouse script data analyzed statistically using r studio <NUMBER> graphs constructed ggplot r <NUMBER> ligandreceptor interactions studied using schrÃ¶dinger maestro <NUMBER> molecules high docking scores selected screening library studies stable conformations selected molecules docking simulations analyzed md simulations performed using schrÃ¶dingerdesmond <NUMBER> proteinligand complexes prepared schrÃ¶dingers protein preparation wizard <NUMBER> structures refined capping c n termini protein adding missing hydrogens optimizing hydrogen bonds finally minimized using opls<NUMBER>e force field <NUMBER> molecular dynamics system built processed ligandreceptor complexes system solvated orthorhombic box using spc solvent model buffer distance <NUMBER> Ã¥ system charge neutralized na clions using <NUMBER>m concentration nacl simulations performed using desmonds default relax protocol opls<NUMBER>e force field heavy atoms system initially minimized restraints <NUMBER> Â°k restrained increasing temperature <NUMBER> Â°k lastly relaxed <NUMBER> Â°k npt ensemble get equilibrium status system relaxation simulation systems performed <NUMBER> Â°k npt ensemble <NUMBER> bar pressure <NUMBER>ns trajectories related energy terms recorded interval <NUMBER> ps post simulation analysis including complex root mean square deviation rmsd ligandprotein root mean square fluctuation rmsf performed via schrÃ¶dinger simulation interaction diagrams molecular mechanismgeneral born surface area mmgbsa binding energies <NUMBER> calculated based last <NUMBER> ns simulation trajectories twentysix frames one every <NUMBER> frames selected <NUMBER> frames mmgbsa calculation molecule prime mmgbsa used vsgb <NUMBER> solvation model <NUMBER> opls<NUMBER>e force field free binding energy Î´g calculated equation codonoptimized merscov isolate emc vg<NUMBER>gn sarscov isolate cuhkw<NUMBER> vg<NUMBER>gn expression plasmids pcmv ordered sinobiological subcloned pcaggs using clai kpni sites last <NUMBER> amino acids sarscov spike protein deleted enhance pseudovirus production codonoptimized cdna encoding sarscov<NUMBER> glycoprotein isolate wuhanhu<NUMBER> cterminal <NUMBER> amino acid deletion synthesized cloned pcagss ecori bglii sites pvsvegfpdg <NUMBER> pmd<NUMBER>g <NUMBER> pcagvsvp <NUMBER> pcagvsvl <NUMBER> pcagvsvn <NUMBER> pcaggst<NUMBER>opt <NUMBER> ordered addgene expressing pcaggs vectors used production pseudoviruses described cdna encoding human tmprss<NUMBER> nm<NUMBER> ohu<NUMBER>d obtained genscript cdna fused cterminal ha tag subcloned pqxcih clontech noti paci sites obtain pqxcihtmprrs<NUMBER>ha vector verotmprss<NUMBER> cells produced retroviral transduction produce retrovirus <NUMBER> Î¼g pqxcihtmprrs<NUMBER>ha cotransfected polyethylenimine pei <NUMBER> Î¼g pbsgagpol addgene <NUMBER> <NUMBER> Î¼g pmd<NUMBER>g <NUMBER> cm dish <NUMBER> confluent hek<NUMBER>t cells optimem <NUMBER>x glutamax retroviral particles harvested <NUMBER> hours posttransfection cleared centrifugation <NUMBER> x g filtered <NUMBER>Î¼m low proteinbinding filter millipore used transduce vero cells polybrene sigma added concentration <NUMBER> Î¼gml enhance transduction efficiency transduced cells selected hygromycin b invitrogen hek<NUMBER>t cells maintained dulbeccos modified eagles medium dmem gibco supplemented <NUMBER> fetal bovine serum fbs <NUMBER>x nonessential amino acids lonza <NUMBER>mm sodium pyruvate gibco <NUMBER>mm lglutamine lonza <NUMBER> Î¼gml streptomycin lonza <NUMBER> uml penicillin vero verotmprss<NUMBER> veroe<NUMBER> cells maintained dmem supplemented <NUMBER> fbs <NUMBER> mgml sodium bicarbonate lonza <NUMBER>mm hepes lonza <NUMBER>mm lglutamine <NUMBER> Î¼gml streptomycin <NUMBER> uml penicillin cell lines maintained <NUMBER>Â°c <NUMBER> co<NUMBER> humidified incubator protocol vsvg pseudovirus rescue adapted whelan colleagues <NUMBER> briefly <NUMBER> confluent <NUMBER> cm dish hek<NUMBER>t cells transfected <NUMBER>Âµg pvsvegfpdg <NUMBER>Âµg pcagvsvn nucleocapsid <NUMBER>Âµg pcagvsvl polymerase <NUMBER>Âµg pmd<NUMBER>g glycoprotein vsvg <NUMBER>Âµg pcagvsvp phosphoprotein <NUMBER>Âµg pcaggst<NUMBER>opt t<NUMBER> rna polymerase using pei ratio <NUMBER> dnapei optimem <NUMBER>x glutamax fortyeight hours posttransfection supernatant transferred onto new plates transfected <NUMBER> hours prior vsvg <NUMBER> hours plates retransfected vsvg <NUMBER> hours resulting pseudoviruses collected cleared centrifugation <NUMBER> x g <NUMBER> minutes stored <NUMBER>Â°c subsequent vsvg pseudovirus batches produced infecting vsvg transfected hek<NUMBER>t cells vsvg pseudovirus moi <NUMBER> titres determined preparing <NUMBER>fold serial dilutions optimem <NUMBER>x glutamax aliquots dilution added monolayers <NUMBER> Ã <NUMBER> <NUMBER> vero cells medium <NUMBER>well plate three replicates performed per pseudovirus stock plates incubated <NUMBER>Â°c overnight scanned using amersham typhoon scanner ge healthcare individual infected cells quantified using imagequant tl software ge healthcare pseudovirus work performed class ii biosafety cabinet bsl<NUMBER> conditions erasmus medical center production merscov sarscov sarscov<NUMBER> pseudovirus hek<NUMBER>t cells transfected <NUMBER> Âµg expression plasmids twentyfour hours posttransfection medium replaced optimem <NUMBER>x glutamax cells infected moi <NUMBER> vsvg pseudotyped virus two hours postinfection cells washed three times optimem replaced medium containing antivsvg neutralizing antibody clone <NUMBER>g<NUMBER>f<NUMBER> absolute antibody dilution <NUMBER> block remaining vsvg pseudovirus supernatant collected <NUMBER> hours cleared centrifugation <NUMBER> x g <NUMBER> minutes stored <NUMBER>Â°c use within <NUMBER> days coronavirus pseudovirus titrated veroe<NUMBER> cells described transduction experiments carried incubating pseudovirus imatinib concentrations ranging <NUMBER>nm optimem <NUMBER>x glutamax <NUMBER> hour <NUMBER>Â°c pseudovirusimatinib mixes added monolayers <NUMBER> Ã <NUMBER> <NUMBER> vero verotmprss<NUMBER> cells <NUMBER>well plate plates incubated <NUMBER> hours quantifying gfppositive cells using amersham typhoon scanner imagequant tl software determine toxicity profile imatinib performed mtt assay using <NUMBER>hr <NUMBER>hr design briefly serial dilution imatinib prepared incubated vero cells <NUMBER> hr <NUMBER> c subsequently cells washed cultured eight hrs <NUMBER>hr design cells incubated serial dilution imatinib eight hours without washing step tested serial dilutions imatinib ability neutralize sarscov<NUMBER> german isolate gisaid id epiisl <NUMBER> european virus archive global <NUMBER>v<NUMBER> using plaque reduction neutralization test prnt previously described <NUMBER> fifty Î¼l virus suspension <NUMBER> spot forming units added well incubated <NUMBER>Â°c either <NUMBER> hr following incubation mixtures added vero cells incubated <NUMBER>Â°c either <NUMBER>hr <NUMBER> hrs cells incubated <NUMBER> hr washed incubated medium <NUMBER> hrs incubation cells fixed stained polyclonal rabbit antisarscov antibody sino biological <NUMBER> staining developed using rabbit antisarscov serum secondary alexafluorlabeled conjugate dako number infected cells per well counted using imagequant tl software binding kinetics imatinib sarscov<NUMBER> rbd protein studied using blitzÂ® system fortÃ©bio experiments conducted using advanced kinetics mode room temperature buffer system consisting <NUMBER>x kinetics buffer fortÃ©bio <NUMBER> anhydrous dimethyl sulfoxide dmso sigma aldrich recombinant histagged sarscov<NUMBER> rbd protein <NUMBER>v<NUMBER>h sino biological concentration <NUMBER> Âµgml loaded antipentahis his<NUMBER>k biosensors fortÃ©bio followed washing step assay buffer block unoccupied sensor surface association dissociation profiles imatinib sigma aldrich measured various concentrations fourpoint serial dilutions <NUMBER> Âµm <NUMBER> Âµm reference biosensor loaded manner <NUMBER> Âµm imatinib used baseline correction assay final binding curves analyzed blitz pro <NUMBER> software fortÃ©bio using <NUMBER> globalfitting model assay repeated twice validate binding constants data represented mean Â± sd wuhan hubei province china december <NUMBER> death toll rose <NUMBER> among <NUMBER> confirmed cases around globe april <NUMBER> <NUMBER> <NUMBER> virus causing covid<NUMBER> named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> based phylogenetic studies sarscov<NUMBER> categorized member genus betacoronavirus lineage includes sars coronavirus sarscov <NUMBER> caused sars severe acute respiratory syndrome china <NUMBER> <NUMBER> recent studies showed sarscov<NUMBER> close relationship bat sarslike covs <NUMBER> <NUMBER> <NUMBER> interestingly glycoprotein characterized critical determinant viral entry host cells consists two functional subunits namely s<NUMBER> s<NUMBER> s<NUMBER> subunit recognizes binds host receptor receptorbinding domain rbd whereas s<NUMBER> responsible fusion host cell membrane <NUMBER> <NUMBER> <NUMBER> merscov uses dipeptidyl peptidase<NUMBER> dpp<NUMBER> entry receptor <NUMBER> whereas sarscov sarscov<NUMBER> utilize ace<NUMBER> angiotensin converting enzyme<NUMBER> <NUMBER> abundantly available lung alveolar epithelial cells enterocytes suggesting glycoprotein potential drug target halt entry sarscov<NUMBER> <NUMBER> according recent reports neutralizing antibodies generated response entry fusion surfaceexposed protein mainly rbd domain predicted <NUMBER> important target vaccine candidates <NUMBER> <NUMBER> <NUMBER> however sarscov<NUMBER> emerged remarkable properties like glutaminerich <NUMBER> aa long exclusive molecular signature dsqqtvgqqdgsednqtttiqtivevqpqlemeltpvvqtie position <NUMBER> polyprotein <NUMBER>ab pp<NUMBER>ab <NUMBER> diversified receptorbinding domain rbd unique furin cleavage site prrarâsv s<NUMBER>s<NUMBER> boundary glycoprotein could play roles viral pathogenesis diagnosis treatment <NUMBER> date genomic variations sarscov<NUMBER> reported <NUMBER> <NUMBER> growing evidence spike protein <NUMBER> amino acid long glycoprotein multiple domains possibly plays major role sarscov<NUMBER> pathogenesis viral entry host cell initiated receptorbinding domain rbd s<NUMBER> head upon receptorbinding proteolytic cleavage occurs s<NUMBER>s<NUMBER> cleavage site two heptad repeats hr s<NUMBER> stalk form sixhelix bundle structure triggering release fusion peptide comes close proximity transmembrane anchor tm tm domain facilitates membrane destabilization required fusion virushost membranes <NUMBER> <NUMBER> insights sequence variations glycoprotein among available genomes key understanding biology sarscov<NUMBER> infection developing antiviral treatments vaccines study analyzed <NUMBER> genomic sequences sarscov<NUMBER> identify mutations available genomes followed amino acid variations glycoprotein foresee impact viral entry host cell structural biology viewpoint available sequences <NUMBER> whole genome surface glycoprotein sequences sarscov<NUMBER> related covid<NUMBER> pandemic retrieved ncbi virus variation resource repository httpswwwncbinlmnihgovlabsvirus <NUMBER> addition <NUMBER> glycoprotein sequences different coronavirus families retrieved phylogenetic <NUMBER> analysis ncbi reference sequence sarscov<NUMBER> glycoprotein accession number yp<NUMBER> used canonical sequence analyses spike protein variants variant analyses sarscov<NUMBER> genomes performed genome detective coronavirus typing tool version <NUMBER> specially designed virus httpswwwgenomedetectivecomapptypingtoolcov <NUMBER> multiple sequence alignment msa genome detective coronavirus typing tool uses reference dataset <NUMBER> whole genome sequences wgs <NUMBER> wgs known nine coronavirus species dataset aligned muscle <NUMBER> entropy hx plot nucleotide variations sarscov<NUMBER> genome constructed using bioedit <NUMBER> mega x version <NUMBER> used construct msas phylogenetic tree using pairwise alignment neighborjoining methods clustalw <NUMBER> <NUMBER> tree structure validated running analysis <NUMBER> bootstraps <NUMBER> replications dataset evolutionary distances calculated using poisson correction method <NUMBER> variant sequences sarscov<NUMBER> modeled swissmodel <NUMBER> using cryoem spike protein structure sarscov<NUMBER> pdb id <NUMBER>vsb template overall quality models assessed rampage server <NUMBER> generating ramachandran plots supplementary table <NUMBER> pymol biovia discovery studio used structure visualization superpose <NUMBER> <NUMBER> <NUMBER> multiple sequence alignment available <NUMBER> genomes sarscov<NUMBER> performed <NUMBER> variations found throughout <NUMBER> bp long sarscov<NUMBER> genome total <NUMBER> variations utr region <NUMBER> synonymous variations cause amino acid alteration <NUMBER> nonsynonymous variations causing change amino acid residue <NUMBER> indels <NUMBER> variations noncoding region supplementary table <NUMBER> among <NUMBER> variations <NUMBER> variations <NUMBER> synonymous <NUMBER> nonsynonymous mutations one deletion observed region orf encodes glycoprotein responsible viral fusion entry host cell <NUMBER> notable sarscov<NUMBER> genome sequences deposited usa <NUMBER> china <NUMBER> supplementary fig <NUMBER> positional variability sarscov<NUMBER> genome calculated msa <NUMBER> sarscov<NUMBER> whole genomes measure entropy value hx <NUMBER> excluding <NUMBER>â² <NUMBER>â² utr ten hotspot hypervariable position identified seven located orf<NUMBER>ab <NUMBER>ct <NUMBER>ct <NUMBER>ct <NUMBER>ct <NUMBER>ct <NUMBER>ag <NUMBER>ct one orf <NUMBER>ag orf<NUMBER>a <NUMBER>gt orf<NUMBER> <NUMBER>tc respectively variability position <NUMBER> <NUMBER> found highest among hotspots fig <NUMBER> phylogenetic analysis total <NUMBER> sequences <NUMBER> unique sarscov<NUMBER> <NUMBER> different coronavirus glycoprotein sequences performed evolutionary distances showed sarscov<NUMBER> spike proteins cluster node phylogenetic tree confirming sequences similar refseq yp<NUMBER> fig <NUMBER> bat coronaviruses close evolutionary relationship different strains found nearest outgroups clades bat coronavirus bm<NUMBER> bat hpbeta coronavirus bat coronavirus hku<NUMBER> conferring <NUMBER> coronavirus vast geographical spread bat prevalent host fig <NUMBER> clades clusters speculated different hosts may describe evolutionary changes surface glycoprotein due cross species transmission viral hosts reported different spots different times indicative possible recombination glycoprotein sequences sarscov<NUMBER> retrieved ncbi virus fig <NUMBER> <NUMBER> alterations amino acid residual charge positive neutral h<NUMBER>y r<NUMBER>i h<NUMBER>q negative neutral d<NUMBER>n d<NUMBER>g d<NUMBER>y negative positive d<NUMBER>h d<NUMBER>h neutral positive n<NUMBER>k s<NUMBER>r seen variants qhw<NUMBER> qhs<NUMBER> qis<NUMBER> qis<NUMBER> qik<NUMBER> qis<NUMBER> qis<NUMBER> qis<NUMBER> qio<NUMBER> qhr<NUMBER> respectively due substitution amino acid differ charge remaining <NUMBER> variants mutated amino acids similar charge fig <NUMBER> sarscov<NUMBER> spike protein variants superposed cryoelectron microscopic structure sarscov<NUMBER> spike protein <NUMBER> l<NUMBER>f n<NUMBER>k e<NUMBER>d f<NUMBER>l g<NUMBER>v s<NUMBER>r g<NUMBER>s v<NUMBER>a d<NUMBER>h d<NUMBER>h variants excluded superposition due absence respective residues <NUMBER>d structure template pdb <NUMBER>vsb superposition showed residual change causing incorporation bulky amino acid residues t<NUMBER>i h<NUMBER>y l<NUMBER>f s<NUMBER>w a<NUMBER>t h<NUMBER>q a<NUMBER>s a<NUMBER>v d<NUMBER>y a<NUMBER>v place smaller size residue except y<NUMBER>n d<NUMBER>n r<NUMBER>i d<NUMBER>g f<NUMBER>c fig <NUMBER> bp fig <NUMBER> s<NUMBER> subunit spike protein especially heptad repeat region <NUMBER> fusion peptide domain transmembrane domain cytoplasmic tail found highly conserved sarscov sarscov<NUMBER> variants s<NUMBER> subunit diverse specifically nterminal domain ntd receptorbinding domain rbd covid <NUMBER> one contagious pandemics world ever <NUMBER> confirmed cases date april <NUMBER> <NUMBER> cases increased high <NUMBER> times less month <NUMBER> phylogenetic analysis showed sarscov<NUMBER> unique coronavirus presumably related bat coronavirus bm<NUMBER> hpbetacoronavirus study <NUMBER> <NUMBER> <NUMBER> <NUMBER> likewise number studies targeting sarscov<NUMBER> spike protein undertaken therapeutic measures <NUMBER> unique structural functional details sarscov<NUMBER> spike protein still scrutiny also found variant r<NUMBER>i receptor binding domain rbd mutated positively charged arginine residue neutral smaller sized isoleucine residue fig <NUMBER> change might alter interaction viral rbd host receptor r<NUMBER> residue sarscov<NUMBER> known interact ace<NUMBER> receptor viral entry <NUMBER> similarly alterations rbd g<NUMBER>s v<NUMBER>a h<NUMBER>q a<NUMBER>s also could affect interaction sarscov<NUMBER> spike protein molecules require investigations qia<NUMBER> qis<NUMBER> variants found alteration alanine valine a<NUMBER>v aspartic acid tyrosine d<NUMBER>y respectively alpha helix hr<NUMBER> domain previous reports indicated hr<NUMBER> domain plays significant role viral fusion entry forming helical bundles hr<NUMBER> mutations including alanine substitution valine a<NUMBER>v hr<NUMBER> region predominantly responsible conferring resistance mouse hepatitis coronaviruses hr<NUMBER> derived peptide entry inhibitors <NUMBER> study hypothesizes mutation a<NUMBER>v found sarscov<NUMBER> might also role emergence drugresistance virus strains also mutation d<NUMBER>h found heptad repeat <NUMBER> hr sarscov<NUMBER> could play vital role viral pathogenesis sarscov<NUMBER> protein contains additional furin protease cleavage site prrars s<NUMBER>s<NUMBER> domain conserved among <NUMBER> sequences revealed study supplementary fig <NUMBER> unique signature thought make sarscov<NUMBER> virulent sarscov regarded novel features viral pathogenesis ref <NUMBER> according previous reports host cell protease process coronavirus accelerate viral tropism accordingly influenza virus <NUMBER> <NUMBER> <NUMBER> <NUMBER> apart could also promote viruses escape antiviral therapies targeting transmembrane protease tmprss<NUMBER> clinicaltrialsgov nct<NUMBER> well reported protease cleave s<NUMBER>s<NUMBER> glycoprotein <NUMBER> comparative analyses sarscov sarscov<NUMBER> spike glycoprotein showed <NUMBER> similarity diverse region sequences proteins sarscov<NUMBER> sarscov aligned fulllength alignment shown accession numbers sequences used analysis found methods section supplementary figure <NUMBER> sequence alignment s<NUMBER>s<NUMBER> region sarscov<NUMBER> representatives betacoronavirus lineages protein sequence <NUMBER> isolates sarscov<NUMBER> aligned representatives four betacoronavirus lineages lineages denoted letters b c sequence alphacoronavirus hcov<NUMBER>e also included alignment displayed region corresponding s<NUMBER>s<NUMBER> cleavage site red border indicates insert basic arginines identified sarscov<NUMBER> sequences Î± alphacoronavirus Î² betacoronavirus accession numbers sequences used analyses found methods section coronaviruses zoonotic pathogens well known evolve environmentally infect many mammalian avian species <NUMBER> diverse viruses often effective transmission immune evasion strategies especially outbreaks occur within dense human populations past two decades coronavirus outbreaks arisen human populations around world unique features also sharing several similarities severe acute respiratory syndrome coronavirus sarscov emerged <NUMBER> guangdong province china causing outbreak spread <NUMBER> countries <NUMBER> infections <NUMBER> deaths case fatality rate <NUMBER> <NUMBER> recently ongoing middle east respiratory syndrome coronavirus merscov outbreak originated <NUMBER> saudi arabia spread <NUMBER> countries <NUMBER> infections <NUMBER> deaths case fatality rate <NUMBER> <NUMBER> recent surfacing novel coronavirus sarscov<NUMBER> first identified december <NUMBER>th <NUMBER> initially detected wuhan hubei province china spread globally via travelers breached boundaries <NUMBER> countriesregions <NUMBER> <NUMBER> march <NUMBER>th <NUMBER> world health organization officially declared global pandemic rapidly evolving situation prompted affected countries impose tight restrictions border movements unprecedented statewide lockdown measures time writing april <NUMBER>th <NUMBER> <NUMBER> million cases approximately <NUMBER> fatalities reported globally <NUMBER> similar sarscov merscov sarscov<NUMBER> infections early stages outbreak observed family clusters hospital personnel <NUMBER> <NUMBER> <NUMBER> <NUMBER> outbreak occurring winter another commonality sarscov sarscov<NUMBER> <NUMBER> currently sustained communitybased spread occurring would make sarscov<NUMBER> communityacquired respiratory coronavirus along less pathogenic human communityacquired respiratory coronaviruses <NUMBER>e oc<NUMBER> hku<NUMBER> nl<NUMBER> <NUMBER> clinical signs associated sarscov<NUMBER> include pneumonia fever dry cough headache dyspnea may progress respiratory failure death <NUMBER> <NUMBER> <NUMBER> incubation period sarscov<NUMBER> seems longer sarscov merscov mean incubation time <NUMBER> <NUMBER> days leading challenges contact tracing <NUMBER> preexisting conditions comorbidities hypertension diabetes cardiovascular disease kidney disease affect severity pathogenesis attributed sarscov merscov thus far similar patterns seem exist sarscov<NUMBER> <NUMBER> <NUMBER> sarscov merscov seem exhibit deleterious morbidity mortality elderly population n <NUMBER> years age deaths occurring age group sarscov<NUMBER> currently portraying comparable trend <NUMBER> coronaviruses belong coronaviridae family orthocoronaviridae subfamily divided four genera alphacoronavirus betacoronavirus gammacoronavirus deltacoronavirus sarscov merscov sarscov<NUMBER> betacoronaviruses genus includes many viruses infect humans bats domesticated wild animals <NUMBER> betacoronaviruses many similarities within orf<NUMBER>ab polyprotein structural proteins however spike protein accessory proteins portray significant diversity <NUMBER> merscov maintained stable genome since emergence <NUMBER> unlike coronaviruses readily evolve undergo notable recombination events <NUMBER> alphacoronaviruses betacoronaviruses including sarscov merscov sarscov<NUMBER> human coronaviruses like hcovnl<NUMBER> thought originated bats <NUMBER> <NUMBER> <NUMBER> gammacoronaviruses deltacoronaviruses reported avian origin known infect mammals avian species <NUMBER> human infections batorigin viruses typically occur intermediate hosts sarscov hosts palm civets paguma larvata racoon dogs nyctereutes procyonoides merscov known host dromedary camel camelus dromedarius <NUMBER> <NUMBER> sarscov antibodies first detected palm civets animal handlers wet markets <NUMBER> merscov thought circulating least <NUMBER> years within dromedary camel population based retrospective antibody testing serum <NUMBER> <NUMBER> source sarscov<NUMBER> outbreak linked huanan seafood wholesale market wuhan initially confirmed majority cases onset prior january <NUMBER>st <NUMBER> linked market <NUMBER> market sells many species including seafood birds snakes marmots bats <NUMBER> market closed january <NUMBER>st <NUMBER> sampling decontamination occurred order find source infection origination sarscov<NUMBER> bats strongly supported presumed intermediate host remains identified recent reports suggested malayan pangolins manis javanica possible intermediate host sarscov<NUMBER> putative recombination signals found pangolin bat human coronavirus sequences <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however direct precursor sequence currently circulating human sarscov<NUMBER> putative intermediate host remain identified coronavirus spike protein primary determinant viral tropism responsible receptor binding membrane fusion large approx <NUMBER> kda glycoprotein present viral surface prominent trimer composed two domains s<NUMBER> s<NUMBER> <NUMBER> s<NUMBER> domain mediates receptor binding divided two subdomains nterminal subdomain ntd often binding sialic acid cterminal subdomain also known cdomain binding specific proteinaceous receptor <NUMBER> receptor sarscov identified angiotensinconverting enzyme <NUMBER> ace<NUMBER> similar recently identified sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> hela cells transfected express ace<NUMBER> receptor either human chinese horseshoe bat mouse civet pig infected sarscov<NUMBER> reported virus able use receptors except mouse ace<NUMBER> <NUMBER> sarscov<NUMBER> found use dipeptidyl peptidase <NUMBER> dpp<NUMBER> receptor merscov <NUMBER> <NUMBER> <NUMBER> following receptor binding s<NUMBER> domain mediates viralmembrane fusion exposure highly conserved fusion peptide <NUMBER> <NUMBER> fusion peptide activated proteolytic cleavage site found immediately upstream s<NUMBER>â² common coronaviruses many coronaviruses additional proteolytic priming occurs second site located interface s<NUMBER> s<NUMBER> domains s<NUMBER>s<NUMBER> <NUMBER> use proteases priming activation combined receptor binding ionic interactions eg h ca <NUMBER> together control viral stability transmission modulate conformational changes protein dictate viral entry process host cells <NUMBER> <NUMBER> <NUMBER> specifically sarscov merscov infect type ii pneumocytes vivo however individually infect ciliated bronchial epithelial cells nonciliated bronchial epithelial cells respectively <NUMBER> sarscov<NUMBER> infect ex vivo range cell culture lines sarscov merscov eg vero e<NUMBER> huh<NUMBER> cells though primary human airway epithelial cells reported preferential cell type <NUMBER> <NUMBER> <NUMBER> overall cell tropism sarscov<NUMBER> reflects balance receptor binding endosomal environment protease activation specifics mechanisms remain determined rapid dissemination sharing information sarscov<NUMBER> pandemic surpassed merscov sarscov latter virus identified several months genome available month later <NUMBER> sarscov<NUMBER> identified genome sequence available within month initial surfacing agent patients <NUMBER> initial reports identified sarscov<NUMBER> contains six major openreading frames viral genome various accessory proteins <NUMBER> sarslike sl virus batcovratg<NUMBER> also named batslratg<NUMBER> observed remarkably high degree genomic sequence identity sarscov<NUMBER> <NUMBER> overall sequence identity two bat sarslike viruses batslcovzc<NUMBER> batslcovzxc<NUMBER> around <NUMBER> sequence identity compared sarscov<NUMBER> genomewide level <NUMBER> sarscov<NUMBER> compared clinically relevant human coronaviruses sarscov merscov pairwise percent identities fall around <NUMBER> <NUMBER> genomic level respectively <NUMBER> <NUMBER> protein sarscov<NUMBER> found approximately <NUMBER> homologous sarscov spike <NUMBER> <NUMBER> study perform phylogenetic bioinformatic homology structural modeling analyses sarscov<NUMBER> comparison closely related viruses identify distinct four residue insert featuring two arginine residues maps s<NUMBER>s<NUMBER> priming loop sarscov<NUMBER> missing sarscovrelated viruses present merscov many coronaviruses discuss importance extended basic loop proteinmediated membrane fusion implications virus transmission comparison amino acid identity spike protein sarscov<NUMBER> human sarscov obtain initial assessment shared andor specific features sarscov<NUMBER> spike envelope glycoprotein protein sequence alignment performed compare sequence wuhanhu<NUMBER> strain novel coronavirus closely related human sarscov strain tor<NUMBER> sequence supplementary figure <NUMBER> overall percent protein sequence identity found alignment <NUMBER> figure <NUMBER>a breakdown functional domains protein based sarscov sequence reveals s<NUMBER> receptorbinding domain less conserved <NUMBER> identity s<NUMBER> fusion domain <NUMBER> identity within s<NUMBER> ntd found less conserved <NUMBER> identity compared receptor binding domain rbd <NUMBER> identity part cterminal subdomain figure <NUMBER>a relatively high degree sequence identity rbd consistent view sarscov<NUMBER> like sarscov may use ace<NUMBER> host cell receptor <NUMBER> <NUMBER> <NUMBER> interestingly defined receptor binding motif rbm analyzed ie region sarscov containing residues shown directly contact ace<NUMBER> receptor identity two sequences drops <NUMBER> figure <NUMBER>a case hinting possible differences binding residues involved interaction receptor andor binding affinities <NUMBER> <NUMBER> <NUMBER> expected within wellconserved s<NUMBER> domain subdomain identities high fusion peptide region fp <NUMBER> identity high heptadrepeat <NUMBER> region hr<NUMBER> <NUMBER> identity identical hr<NUMBER> <NUMBER> identity high transmembrane cterminal endodomain tm <NUMBER> identity e <NUMBER> identity figure <NUMBER>a early phylogenetic studies sarscov<NUMBER> genomic sequences revealed clustered closely sequences originating sarslike sequences bats within lineage b betacoronavirus genus lineage groups prototypical coronaviruses murine hepatitis virus mhv human coronaviruses hcovhku<NUMBER> hcovoc<NUMBER> highly pathogenic coronavirus merscov found within lineage c along related camelderived merscov lineage c also groups viruses bats mammals hedgehogs lineage contains viral species infecting bats gain better understanding shared specific features sarscov<NUMBER> protein phylogenetic analysis centered protein sequences representatives four betacoronavirus lineages carried figure <NUMBER>b fifteen sequences sarscov<NUMBER> sequences obtained ncbi gisaid china various export locations worldwide analyzed along representative members lineages ad betacoronaviruses analysis confirmed sarscov<NUMBER> sequences clustered closely bat sarslike sequences closest matching sequence corresponding bat coronavirus batcov strain named batslratg<NUMBER> closely related sequences found batslcovzc<NUMBER> batslcovzxc<NUMBER> subclade groups sarscov<NUMBER> batslratg<NUMBER> batslcovzc<NUMBER> batslcovzxc<NUMBER> distinct one grouping human civet sarscov along related bat sarslike viruses batsllyra<NUMBER> bat coronaviruses established reservoir sarscov<NUMBER> presumed intermediate host remains determined based high degree sequence identity rbd sequences found malayan pangolins javanica proposed mammals could intermediate hosts <NUMBER> <NUMBER> <NUMBER> subsequent wholegenome analysis revealed <NUMBER> identity sarscov<NUMBER> less observed batslratg<NUMBER> <NUMBER> <NUMBER> explore relationship pangolin covs sarscov<NUMBER> performed phylogenetic analysis spike gene pangolin covs isolated animals smuggled china <NUMBER> guangxi province gx <NUMBER> guangdong province gd compared sarscov<NUMBER> batcovratg<NUMBER> betacoronaviruses figure <NUMBER> pairwise comparison sarscov<NUMBER> protein batcovratg<NUMBER> representative sequences guangxi pangolin <NUMBER> abbreviated gx guangdong pangolin <NUMBER> abbreviated gd confirm overall batcovratg<NUMBER> highest identity <NUMBER> overall <NUMBER> <NUMBER> s<NUMBER> s<NUMBER> respectively figure <NUMBER>a analysis reveals pangolin protein sequences divergent overall <NUMBER> identity gx <NUMBER> identity gd divergence concentrating s<NUMBER> domain notably ntd domain gx gd pangolin sequences fell <NUMBER> <NUMBER> identity respectively rbd domain gd domain confirmed remarkably well conserved compared sarscov<NUMBER> <NUMBER> identity compared <NUMBER> identity gx pangolin <NUMBER> batcovratg<NUMBER> observations line previously reported putative recombination events occurring pangolin bat human betacoronavirus sequences <NUMBER> phylogenetically pangolin spike sequences <NUMBER> gx form subclade groups ratg<NUMBER> figure <NUMBER>b interestingly <NUMBER> pangolin gd sequence appears branch early ie could represent protein sequence diverged earlier forms subclade distinct ratg<NUMBER>pangolin sarscov<NUMBER>environmental subclades protein sequence alignment focusing rbd region sarscov<NUMBER> sarscov batsarsrelated viruses reveals nterminal half rbd relatively well conserved whereas cterminal half contains rbm exhibits variation figure <NUMBER>a notably batslcovzc<NUMBER> batslcovzxc<NUMBER> two deletions <NUMBER> <NUMBER> residues within rbd composition residues found two known coronavirus cleavage sites performed using alignment data figure <NUMBER>b c region around arginine <NUMBER> r<NUMBER> sarscov s<NUMBER>s<NUMBER> cleavage site aligned well sarscov<NUMBER> bat sarsrelated sequences <NUMBER> notably arginine position corresponding sarscov r<NUMBER> conserved five sequences analyzed alignment shows sarscov<NUMBER> contains four amino acid insertion <NUMBER> prra <NUMBER> found sequences analyzed including closely related batslratg<NUMBER> figure <NUMBER>b together conserved r<NUMBER> amino acid found sarscov<NUMBER> putative s<NUMBER>s<NUMBER> cleavage site insertion introduces stretch three basic arginine residues could potentially recognized members proprotein convertase family proteases <NUMBER> <NUMBER> insertion conserved <NUMBER> sarscov<NUMBER> sequences analyzed supplementary figure <NUMBER> within betacoronavirus genus presence basic stretch residues s<NUMBER>s<NUMBER> site found number species lineages hcovhku<NUMBER> mhv hcovoc<NUMBER> c merscov batcovhku<NUMBER> fouraminoacid insertion feature appears unique among lineage b viruses species analyzed extended alignment none contained stretch basic residues identified sarscov<NUMBER> supplementary figure <NUMBER> expected previous analyses s<NUMBER>â² cleavage site located immediately upstream fusion peptide corresponding residue position r<NUMBER> case sarscov strictly conserved sarscov<NUMBER> closely related bat sarsrelated sequences figure <NUMBER>c note leucine l residue found position <NUMBER> sarscov sequence substituted serine residue sarscov<NUMBER> well bat sarsrelated sequences fusion peptide sequence found well conserved sequences analyzed notably protein alignment analyses show pangolin sequences viruses betacoronaviruses lineage b show presence predicted proteolytically sensitive s<NUMBER>s<NUMBER> fusion activation site present sarscov<NUMBER> figure <NUMBER> environmental samples taken huanan seafood market appear also harbor s<NUMBER>s<NUMBER> insert interestingly <NUMBER> pangolin sequence shares motif immediately upstream s<NUMBER>s<NUMBER> insert found sarscov<NUMBER> <NUMBER> qtqtns <NUMBER> sarscov<NUMBER> numbering also shared batcovratg<NUMBER> pangolin sequences <NUMBER> harbor distinct motif <NUMBER> hsmsslf <NUMBER> betacovpangolinguangxip<NUMBER>l <NUMBER> epiisl<NUMBER> numbering gain deeper understanding common possibly distinguishing structural features found sarscov<NUMBER> protein homology modeling undertaken analysis modeled proteins provides powerful tool identify predicted structural characteristics translate structurefunction changes studied protein laboratory previously taken advantage tools structurefunction studies covs proteins <NUMBER> <NUMBER> <NUMBER> perform modeling first necessary identify suitable protein structure used template determine accuracy predicted model protein structure several covs including following reported previously alphacoronavirus hcovnl<NUMBER> feline coronavirus uu<NUMBER> fcovuu<NUMBER> betacoronavirus hcovhku<NUMBER> mhv sarscov merscov gammacoronavirus infectious bronchitis virus ibv deltacoronavirus porcine deltacoronavirus pdcov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> considering genome protein alignments showed sarscov<NUMBER> belongs betacoronavirus genus focused analysis structures viruses belonging genus select template structure figure <NUMBER> amino acid composition s<NUMBER>s<NUMBER> region sarscov<NUMBER> related sequences bats pangolins environmental samples protein sequences sarscov<NUMBER> sarscov closely related environmental pangolin bat coronaviruses aligned using mafft region corresponding s<NUMBER>s<NUMBER> cleavage site red arrow shown accession numbers sequences used analyses found materials methods section protein amino acid sequences four representative betacoronaviruses hcovhku<NUMBER> mhv sarscov merscov aligned solved protein structures compared determine amino acid identity overall structural organization similarities among proteins supplementary figure <NUMBER>a observed average of<NUMBER> identity among four viral proteins amino acid level exception hcovhku<NUMBER> mhv share amino acid identity <NUMBER> protein supplementary figure <NUMBER>a despite differences amino acid level overall structure four betacoronavirus proteins showed similar folding pattern supplementary figure <NUMBER>b major differences spotted specific sections functional domains flexible loops abundant eg rbd cleavage sites considering used modeller v <NUMBER> university california build first set models sarscov<NUMBER> protein based abovementioned structures supplementary figure <NUMBER> interestingly found major differences secondary structures among sarscov<NUMBER> proteinpredicted models depending structure used template modeling construction however extended flexible loops rbd andor clashes monomers s<NUMBER> domain level observed sarscov<NUMBER> models based hcovhku<NUMBER> mhv merscov supplementary figure <NUMBER> first three panels contrast predicted sarscov<NUMBER> model based sarscov structure displayed much better organized folding major clashes observed monomers supplementary figure <NUMBER> last panel described previously identity sarscov<NUMBER> sarscov protein amino acid level <NUMBER> phylogenetic analyses grouped sarscov<NUMBER> lineage b betacoronavirus genus closely related sarscov well covs originating bats figure <NUMBER>b two considerations addition preliminary modeling results suggested sarscov suitable template modeling sarscov<NUMBER> protein taking alternative approach protein sequence sarscov<NUMBER> submitted two structure homology modeling servers phyre <NUMBER> raptorx <NUMBER> <NUMBER> cases structural models highest homology scores based sarscov template structure pdb id <NUMBER>x<NUMBER> data shown confirming choice using sarscov template generating structural models sarscov<NUMBER> better compare predicted structural characteristics sarscov<NUMBER> also performed homology modeling four proteins batcovs belonging lineage b phylogenetic analysis closely related sarscov<NUMBER> modeled proteins batcovs ratg<NUMBER> covzc<NUMBER> covzxc<NUMBER> lyra<NUMBER> compared predicted structure sarscov<NUMBER> template structure sarscov figure <NUMBER> amino acid homology modeled proteins comparison template sarscov was<NUMBER> batcov exception lyra<NUMBER> shares homology <NUMBER> template overall modeled proteins shared similar folding pattern comparison sarscov s<NUMBER> s<NUMBER> domains showed uniform organization figure <NUMBER> expected differences mostly observed flexible loops forming head s<NUMBER> domain especially ntd region rbd region amino acid variation observed figures <NUMBER>a <NUMBER> protein amino acid identity among batcov including sarscov<NUMBER> ranged <NUMBER> <NUMBER> lyra<NUMBER> ratg<NUMBER> proteins lowest highest identity sarscov<NUMBER> respectively despite amino acid variability major changes secondary structures overall folding proteins observed among modeled structures viruses suggesting conserved organization proteins lineage b including sarscov<NUMBER> nevertheless differences flexible loops domains observed impact sarscov<NUMBER> protein function must studied recently reported sarscov<NUMBER> binds ace<NUMBER> receptor infect target cells <NUMBER> <NUMBER> <NUMBER> <NUMBER> finding appears agree previous reports describing ability batcovs successfully bind use ace<NUMBER> cellular receptor infection <NUMBER> <NUMBER> <NUMBER> conservation receptor usage among sarscov sarslike batcovs contrasts high variability observed amino acid sequence rbm figure <NUMBER>a considering high variability compared predicted rbm structure sarscov<NUMBER> batcovs one sarscov interestingly despite variability modeled sarscov<NUMBER>predicted rbm displayed similar organization sarscov figure <NUMBER> top panel also observed ratg<NUMBER> lyra<NUMBER>predicted rbm structures figure <NUMBER> middle left bottom right panels suggesting rbm organization well conserved among viruses contrast predicted rbm covzc<NUMBER> covzxc<NUMBER> viruses showed different folding region comparison sarscov figure <NUMBER> middle right bottom left panels two last viruses showed <NUMBER>and <NUMBER>aminoacid deletion respectively rbm sequence figure <NUMBER>a explain differential folding modeled proteins alignment figure <NUMBER> b shows fouraminoacid insertion <NUMBER> prra <NUMBER> well conserved arginine corresponding r<NUMBER> s<NUMBER>s<NUMBER> site sarscov<NUMBER> insertion appears unique among lineage b betacoronaviruses suggests differential mechanism activation sarscov<NUMBER> compared sarscov sarslike batcov structural level s<NUMBER>s<NUMBER> site shown difficult solve covs structures resulting either incomplete structures missing complete s<NUMBER>s<NUMBER> site structures altered ie mutated s<NUMBER>s<NUMBER> site <NUMBER> <NUMBER> <NUMBER> solving structure s<NUMBER>s<NUMBER> site also found issue sarscov structure used modeling analyses previously shown s<NUMBER>s<NUMBER> site modeled cov proteins appears organized flexible exposed loop extends structure suggest could easily accessible proteolytic activation <NUMBER> better study s<NUMBER>s<NUMBER> site structural organization modeled sarscov protein based structure mhv s<NUMBER>s<NUMBER> site mutated structure merscov sarscov s<NUMBER>s<NUMBER> site missing structure see predicted structure s<NUMBER>s<NUMBER> site similar despite template structure observed differences modeled sarscov protein s<NUMBER>s<NUMBER> site predicting exposed flexible loop three models data shown based proceeded compare s<NUMBER>s<NUMBER> site well major functional elements s<NUMBER> domain ie s<NUMBER>â² site fusion peptide predicted structure sarscov sarscov<NUMBER> batcov models figure <NUMBER> remarkably two features appear exhibit distinctive characteristics sarscov<NUMBER> model fusion peptide predicted organized compact conformation sarscov<NUMBER> sarscov figure <NUMBER> surface models region corresponding s<NUMBER>s<NUMBER> cleavage site contains r<NUMBER> case sarscov figure <NUMBER> s<NUMBER>s<NUMBER> alignment box ribbon models sarscov batcov proteins s<NUMBER>s<NUMBER> site forms short loop appears flanking closely side trimeric structure case sarscov<NUMBER> s<NUMBER>s<NUMBER> site predicted form extended loop protrudes exterior trimer figure <NUMBER> feature suggests s<NUMBER>s<NUMBER> loop sarscov<NUMBER> could exposed proteolytic processing host cell proteases mentioned solving structure s<NUMBER>s<NUMBER> site appears present difficulties reported cov structures figure <NUMBER> top panel however exposed loop feature demonstrated modeled cryoem cov structures similar amino acid sequences s<NUMBER>s<NUMBER> site ie fcov ibv respectively figure <NUMBER> top panel interestingly fcov viruses always display s<NUMBER>s<NUMBER> site figure <NUMBER> figure <NUMBER> sarscov<NUMBER> batcovs protein models modeled protein sarscov<NUMBER> ratg<NUMBER> covzc<NUMBER> covczxc<NUMBER> lyra<NUMBER> compared sarscov structure amino acid homology modeled proteins sarscov noted red amino acid differences blue models identity scale amino acid identity sarscov<NUMBER> batcovs also noted black identity scale figure <NUMBER> sarscov<NUMBER> batcovs modeled rbm surface view sarscov structure sarscov<NUMBER> ratg<NUMBER> covzc<NUMBER> covczxc<NUMBER> lyra<NUMBER> models sarscov rbm red flanking residues yellow noted rbm modeled structures also noted according amino acid homology red differences blue sarscov top panel results distinct cell entry mechanisms also performed analysis s<NUMBER>â² site sarscov<NUMBER> comparison sarscov batcov proteins expected differences modeled s<NUMBER>â² site structure predicted studied spikes figure <NUMBER> s<NUMBER>â² ribbon models agrees fact s<NUMBER>â² site appears conserved studied sequences figure <NUMBER> s<NUMBER>â² alignment box described previously sarscov functional r<NUMBER> residue cleavage position <NUMBER> p<NUMBER> well serine position <NUMBER> cleavage position p<NUMBER>â² conserved sarscov<NUMBER> among compared batcovs feature also appears conserved covs figure <NUMBER> bottom panel however mutations residues immediately upstream sarscov r<NUMBER> residue equivalent virus shown result changes proteolytical requirements covs <NUMBER> observed mutations l located upstream p<NUMBER> arginine positions p<NUMBER> p<NUMBER> s<NUMBER>â² site sarscov<NUMBER> comparison sarscov mutations predicted alter structure s<NUMBER>â² sarscov<NUMBER> figure <NUMBER> s<NUMBER>â² ribbon models current covid<NUMBER> pandemic caused sarscov<NUMBER> evidence potential coronaviruses continuously evolve wild reservoirs jump new species study aims contribute understanding sarscov<NUMBER> phylogenetic structural point view focusing functional proteolytically sensitive sites protein using phylogenetic analysis showed sarscov<NUMBER> protein closely related sarslike viruses figure <NUMBER> sarscov<NUMBER> s<NUMBER>s<NUMBER> s<NUMBER>â² activation sites s<NUMBER>s<NUMBER> s<NUMBER>â² activation sites sarscov sarscov<NUMBER> models shown surface ribbon views s<NUMBER>s<NUMBER> s<NUMBER>â² sites batcovs shown ribbon view amino acid homology sarscov noted follows s<NUMBER>s<NUMBER> site homology red differences blue s<NUMBER>â² site homology yellow differences magenta amino acid alignments s<NUMBER>s<NUMBER> s<NUMBER>â² sites shown homology also noted sarscov<NUMBER> spike protein distinct activation loop originating bats figure <NUMBER>b agrees early similar reports <NUMBER> identity protein batcovratg<NUMBER> strain bat coronavirus shown <NUMBER> suggesting virus closest relative sarscov<NUMBER> origin novel coronavirus appears bat reservoirs still definitive evidence possible intermediate host could transmit virus humans recent reports suggested malayan pangolins intermediate host sarscov<NUMBER> analysis found pangolin spike sequences grouped subclade branching ratg<NUMBER> additionally observed <NUMBER> guangdong pangolin sequence appeared branch early distinct subclade ratg<NUMBER> based findings hypothesize despite common origin bats phylogenetic relationship pangolin covs sarscov<NUMBER> sufficient support claim pangolins harbor direct precursor currently circulating human sarscov<NUMBER> fact analysis suggests humans pangolins could considered final hosts respective coronavirus study show presence distinct insert maps s<NUMBER>s<NUMBER> priming loop sarscov<NUMBER> spike protein shared sarscov sarsrelated viruses betacoronavirus lineage b preparation manuscript cryoelectron microscopy structures sarscov<NUMBER> recently determined <NUMBER> <NUMBER> <NUMBER> studies revealed detail structure sarscov<NUMBER> spike rbd contacts ace<NUMBER> host cell receptor notable differences compared sarscov <NUMBER> described sarscov rbm conformation packs closely ntd protein <NUMBER> report sarscov<NUMBER> rbd shown angled center trimmer conformation differs sarscov rbm structure interestingly observed models rbd predicted pack similarly sarscov rbm also predicted organize flexible loop similar structure despite lower amino acid identity two proteins figure <NUMBER> recent report shown ace<NUMBER>binding mode sarscov sarscov<NUMBER> rbds nearly identical supports claim flexibility rbm key compensate amino acid differences two covs proteins agrees predicted models <NUMBER> one common difficulties covs protein cryoem studies difficulty solve proteolytically sensitive regions protein <NUMBER> <NUMBER> since s<NUMBER>s<NUMBER> region proteolytically sensitive common introduce mutations site prevent proteolytic priming allow efficient heterologous expression purification <NUMBER> resulted difficulty solve s<NUMBER>s<NUMBER> region available cov protein structures exceptions figure <NUMBER> covs s<NUMBER>s<NUMBER> s<NUMBER>â² site s<NUMBER>s<NUMBER> s<NUMBER>â² activation sites fcov merscov ibv models shown ribbon views amino acid homology sarscov noted follows s<NUMBER>s<NUMBER> site homology red differences blue s<NUMBER>â² site homology yellow differences magenta amino acid sequences s<NUMBER>s<NUMBER> s<NUMBER>â² sites shown proteins viruses belonging alphacoronavirus gammacoronavirus genera <NUMBER> <NUMBER> considering region proteolytically sensitive shown play major role protein function covs use silico modeling tools become useful alternative study region context structural organization protein <NUMBER> <NUMBER> sarscov<NUMBER> protein exception issue recently reported structures allow resolution s<NUMBER>s<NUMBER> priming loop loop mutated used structural modeling approach better understand organization region suggested functionally active reported one major differences sarscov<NUMBER> closest relative ratg<NUMBER> <NUMBER> <NUMBER> observed sarscov<NUMBER> s<NUMBER>s<NUMBER> site predicted organized exposed flexible loop suggesting site easily available protease cleavage suggesting major role sarscov<NUMBER> function figure <NUMBER> significance sarscov<NUMBER> spike protein s<NUMBER>s<NUMBER> priming loop yet explored experimentally consider may fundamentally change entry pathway virus compared known viruses betacoronavirus lineage b presence extended s<NUMBER>s<NUMBER> priming loop containing paired basic residues predicts sarscov<NUMBER> would likely cleaved golgiresident proprotein convertases furin virus assembly delivery cell surface indeed analysis western blots vsvpseudoparticles containing sarscov<NUMBER> shown presence cleaved contrast pseudoparticles containing sarscov <NUMBER> case merscov sarscov known priming precleavage occurs s<NUMBER> s<NUMBER> site giving sarscov<NUMBER> cleavage activation properties line merscov sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> extended structural loop may also allow enhanced priming trypsinlike proteases ttsps even cathepsins sarscov<NUMBER> currently believed highly sarscovlike respect receptor binding modeling studies reported broadly line finding despite relatively low amino acid identity rbm however important remember changes protease usage may allow coronaviruses undergo receptorindependent entry viruscell fusion well affect syncytia formation cellcell fusion tissue pathology <NUMBER> <NUMBER> <NUMBER> study provides structural context s<NUMBER>s<NUMBER> insert also reported others <NUMBER> <NUMBER> presence distinct insert containing paired basic residues s<NUMBER>s<NUMBER> priming loop common many coronaviruses betacoronavirus lineage c eg merscov well lineage eg mouse hepatitis virus mhv lineage universally found gammacoronavirus eg ibv <NUMBER> noticeably absent alphacoronaviruses clear exception type canine feline coronaviruses <NUMBER> <NUMBER> one feature distinct insert sarscov<NUMBER> warrants attention relates potential changes virus evolves equivalent loop present influenza ha case adjacent fusion peptide insertions basic residues loop primary marker conversion low pathogenicity highly pathogenic avian influenza virus eg h<NUMBER>n<NUMBER> <NUMBER> coronaviruses loop modifications known affect mhv pathogenesis modulate neurovirulence neuroinvasiveness hcovoc<NUMBER> <NUMBER> <NUMBER> fcov another example s<NUMBER>s<NUMBER> loop modifications appear lead directly changes viral pathogenesis <NUMBER> <NUMBER> <NUMBER> case fcov equivalent proteolytically sensitive structural loop within hypervariable region spike gene suggesting region spike significant driver virus evolution <NUMBER> present sarscov<NUMBER> behaving distinct manner compared sarscov believe findings special importance considering available data indicates ace<NUMBER> suitable cellular receptor sarscov<NUMBER> entry <NUMBER> <NUMBER> modeling analysis observed rbm sarscov<NUMBER> predicted similar organization sarscov deletions rbm region batcovs reported impact ability bind ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> suggests instead receptor binding s<NUMBER>s<NUMBER> loop distinctive feature relevant sarscov<NUMBER> pathogenesis marks unique similarity merscov would predict distinct insert sarscov<NUMBER> would give virus biological properties line merscov sarscov especially regard cell entry pathway however may also impact virus spread transmission many epidemiological features sarscov<NUMBER> still need resolved many features transmission appear align merscov sarscov one component transmission reproductive number r <NUMBER> currently thought approximately <NUMBER> sarscov<NUMBER> broadly line sarscov merscov low r <NUMBER> humans b <NUMBER> high camels outbreak situations n <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> another study reported serial interval time disease onset patient onset disease secondary case estimated <NUMBER> days suggesting transmission occur onset clinical signs <NUMBER> two parameters highlight high transmissibility sarscov<NUMBER> one notable feature protein s<NUMBER>s<NUMBER> cleavage site first observed purification mhv protein structural analysis <NUMBER> mhv intact cleavage loop unstable expressed consider s<NUMBER>s<NUMBER> loop controls virus stability likely via access downstream s<NUMBER>â² site regulates fusion peptide exposure activity interesting monitor effects s<NUMBER>s<NUMBER> loop insertions proteolytic cleavability context virus transmission addition virus entry pathogenesis evolution sequences severe acute respiratory syndrome coronavirus<NUMBER> sars cov<NUMBER> currently associated global pandemic causing coronavirus disease first noted december <NUMBER> wuhan province china resultant disease termed covid<NUMBER> coronavirus disease<NUMBER> characterized acute respiratory disease pneumonia sars cov<NUMBER> infected nearly <NUMBER> million people caused nearly <NUMBER> <NUMBER> deaths worldwide predilection older people andor people health issues including hypertension diabetes obesity comorbidities <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> third human coronavirus appeared first time <NUMBER>st century one two coronaviruses sars appeared november <NUMBER> china caused nearly <NUMBER> <NUMBER> infections worldwide <NUMBER> deaths sars effectively contained virus although causing high degree mortality infected people apparently effectively transmitted one person <NUMBER> <NUMBER> second human coronavirus middle east respiratory syndrome coronavirus mers cov appeared <NUMBER> caused limited epidemic thousand people high death rates approximately <NUMBER> predominantly middle east saudi arabia primary source infection found dromedary camels although virus transmitted person person close contact hospital settings <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronaviruses specify spike glycoprotein embedded viral envelopes trimeric forms giving characteristic corona structures glycoprotein major antigen responsible receptorbinding membrane fusion properties <NUMBER> angiotensinconverting enzyme <NUMBER> ace<NUMBER> identified cell receptor sars <NUMBER> also sars cov<NUMBER> unknown human receptors may responsible wider infectious spread sars spike cleaved two major components s<NUMBER> s<NUMBER> cellular proteases virus entry cells mediated binding receptorbinding domain rbd located within s<NUMBER> ectodomain cleavage glycoprotein produce s<NUMBER> s<NUMBER> proteins mediated cellular proteases s<NUMBER>s<NUMBER> junction well s<NUMBER>â² site located downstream s<NUMBER>s<NUMBER> proteolytic cleavage fusion viral envelope cellular membranes mediated s<NUMBER> protein contains putative fusion peptide region mechanism membrane pore formation leads membrane fusion involves formation sixhelix bundle fusion core two heptad repeats hr<NUMBER> hr<NUMBER> domains found monomer forming initial pore results membrane fusion <NUMBER> cellular serine protease tmprss<NUMBER> implicated priming s<NUMBER>â² cleavage well ace<NUMBER> cleavage required initiation membrane fusion event <NUMBER> <NUMBER> <NUMBER> also sars spike glycoprotein cleaved cellular protease cathepsin l low ph endosomes thereby exposing s<NUMBER> domain spike protein membrane fusion <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cell surface expression mediates sinduced cell fusion formation syncytia phenomenon similar virus entry requiring presence ace<NUMBER> virusinduced cell fusion mechanism virus spread celltocell phindependent mechanism avoiding extracellular space potentially evading neutralizing antibody <NUMBER> <NUMBER> demonstrated rbd domain sars cov<NUMBER> spike snew sn higher binding affinity ace<NUMBER> receptor sars spike sold s<NUMBER> proteins two viruses nearly <NUMBER> identical <NUMBER> <NUMBER> <NUMBER> nelfinavir mesylate developed antihuman immunodeficiency virus hiv protease inhibitor <NUMBER> <NUMBER> also reported nelfinavir mesylate inhibited sars replication cytopathic effects cell culture <NUMBER> addition potent activity hiv protease nelfinavir mesylate found produce multiple effects cellular processes including induction apoptosis necrosis well induction cellprotective mechanisms including cell cycle retardation unfolded protein response <NUMBER> <NUMBER> <NUMBER> nelfinavir mesylate effects exploited anticancer purposes <NUMBER> <NUMBER> <NUMBER> previously investigated structure function sars glycoprotein transient transfectionmembrane fusion assays <NUMBER> <NUMBER> based initial studies undertook screening number compounds may inhibit smediated fusion transient expression african green monkey kidney cells vero report herein sars cov<NUMBER> sn causes extreme smediated membrane fusion comparison cell fusion caused transient expression sars importantly report nelfinavir mesylate inhibited smediated fusion micromolar ranges insilico docking experiments revealed possibility nelfinavir binds s<NUMBER> amino terminus within trimer thus may directly inhibit formation heptadrepeat complex causes smediated membrane fusion based results research nelfinavirs effect human covid<NUMBER> patients warranted african green monkey kidney vero cells maintained dulbeccos modified eagles medium dmem <NUMBER> fetal bovine serum fbs <NUMBER> primocin invitrogen inc carlsbad ca parental vector plasmids respectively s<NUMBER> subunit sn expression construct contained amino terminus aa<NUMBER> gly nterminal domain sn s<NUMBER> subunit engineered exactly s<NUMBER> containing nmyc tag amino terminus encompassing s<NUMBER> sn amino acid sequence <NUMBER> nelfinavir mesylate dissolved dmso <NUMBER> mm concentration stock series dilutions made serumfree dmem following transfection <NUMBER> Î¼l nelfinavir mesylate solution added well vero cells transfected either sn incubated drug <NUMBER> hours <NUMBER>Â°c <NUMBER> co <NUMBER> tissue culture plates observed fused cells phase contrast fluorescent images taken either formalin methanol fixed conditions docking nelfinavir mesylate spike protein sars cov<NUMBER> performed using autodock <NUMBER> crystal structure nelfinavir obtained complex hiv protease nelfinavir crystal structure protein data bank pdb id <NUMBER>q<NUMBER> <NUMBER> structure protein sars cov<NUMBER> reported wrapp et al <NUMBER> pdb id <NUMBER>vsb trimer structure spike protein used docking protein structure spike protein exists dynamic condition binding receptor fusion host cell grid docking created spike protein structure particular docking site center covering grid box <NUMBER> <NUMBER>Ã¥ x z directions center grid one grid site created around protease cleavage site s<NUMBER>s<NUMBER> another covering hr<NUMBER> region protein trimer figure s<NUMBER> docking calculations performed using lamarckian genetic algorithm <NUMBER> starting conformations <NUMBER> million energy evaluations olympus ix<NUMBER> fluorescent microscope used live phase contrast images using cellsens software zeiss axio observer z<NUMBER> fluorescent microscope used fluorescent images using zen software figure <NUMBER>a bef addition s<NUMBER> s<NUMBER> domains sn cloned independently transient expression vector pcmv<NUMBER> encompassing amino acid domains s<NUMBER> aa<NUMBER>aa<NUMBER> s<NUMBER> aa<NUMBER>aa<NUMBER> s<NUMBER> s<NUMBER> domains expressed myc epitope tag amino termini figure <NUMBER>cd s<NUMBER> domain included s<NUMBER>s<NUMBER> cleavage site figure <NUMBER>c figure <NUMBER>b coexpression s<NUMBER> s<NUMBER> performed test whether snmediated cell fusion could reconstituted coexpression domains expression either s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> domains sn readily detected immunohistochemistry antinmyc antibody however f g u r e <NUMBER> schematics spike glycoproteins recombinant gene constructs structure sarscov<NUMBER> spike <NUMBER>aa glycoprotein showing s<NUMBER> s<NUMBER> domains cleavage sites s<NUMBER>s<NUMBER> s<NUMBER>â² b structure pcmv<NUMBER>spnmyc sn sarscov<NUMBER> spike aa<NUMBER>aa<NUMBER> cloned plasmid expression vector kpnl xbal restriction sites nterminal <NUMBER> amino acids replaced signal peptide spâ² nmyc sequence c structure pcmv<NUMBER>s<NUMBER>nmyc s<NUMBER>n s<NUMBER> domain aa<NUMBER>aa<NUMBER> cloned plasmid expression vector kpnl xbal restriction sites nterminal <NUMBER> amino acids replaced signal peptide spâ² nmyc sequence structure pcmv<NUMBER>s<NUMBER>nmyc s<NUMBER>n s<NUMBER> domain aa<NUMBER>aa<NUMBER> cloned kpnl xbal restriction sites nterminal contains signal peptide spâ² nmyc sequence e structure sars spike <NUMBER>aa glycoprotein showing s<NUMBER> s<NUMBER> domains cleavage sites s<NUMBER>s<NUMBER> s<NUMBER>â² f structure p<NUMBER>xflagcmvs sars spike cloned plasmid expression vector previously described fp fusion peptide hr<NUMBER> heptad repeat <NUMBER> hr<NUMBER> heptad repeat <NUMBER> ntd nontranslated domain rbd receptorbinding domain sars cov severe acute respiratory syndrome coronavirus sp sars signal peptide spâ² signal peptide cell fusion observed <NUMBER> hpt evidenced welldefined single cells stained antimyc antibody figure <NUMBER> well later times shown suggesting s<NUMBER> s<NUMBER> domains part entire molecule processed correctly induction smediated cell fusion f g u r e <NUMBER> expression sars cov<NUMBER> spike sn domains vero cells transfected pcmv<NUMBER>spnmyc plasmid expressing either s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> domains sn tagged nmyc epitopes amino termini expression detected mabs epitope tags <NUMBER> hours posttransfection compared vehicle containing equivalent amount lipofectamine <NUMBER> reagent methanol fixed cells incubated mouse antimyc antibody stained hrp staining followed goat antimouse secondary antibody incubation images taken Ã<NUMBER> magnification hrp horseradish peroxidase sars cov severe acute respiratory syndrome coronavirus sn snew recently shown peptide targeted sn hr<NUMBER> domain inhibited sarscov<NUMBER> virus replication virus entry virusinduced cell fusion <NUMBER> therefore performed insilico docking experiments investigate possibility nelfinavir may directly bind near region theoretical docking experiments revealed nelfinavir may bind near hr<NUMBER> helix hr<NUMBER> hr<NUMBER> helices figures s<NUMBER> s<NUMBER> <NUMBER> cellular tubulin stained rabbit antialpha tubulin abcam <NUMBER> antirabbit secondary antibody conjugated alexa fluorophore <NUMBER> dapi used stain nuclei cells fluorescent images taken Ã<NUMBER> magnification dapi <NUMBER>â²<NUMBER>diamidino<NUMBER>phenylindole dmso dimethyl sulfoxide sn snew sold uncleaved form may proteolytically processed either within endosomes cell surfaces proteases tmprss<NUMBER> known required spike activation virus entry <NUMBER> utilized sn transient expression system screen currently available drugs may inhibit smediated cell fusion formation syncytia drugs included cardiac glycosides ouabain digoxin antihiv fusion inhibitor fuzeon enfuvirtide kinase inhibitors including gleevec imatinib mesylate drugs substantially inhibit smediated cell fusion even concentrations <NUMBER> Î¼m however found id<NUMBER> therefore may possible nelfinavir used even lower concentrations prescribed patients hiv results significant nelfinavir appear inhibit overall sn synthesis cell surface expression considered possibility nelfinavir may act protease inhibitor direct inhibitor spikemediated membrane fusion computational modeling revealed nelfinavir may directly bind trimeric form sn near putative fusogenic domain thus may directly inhibit smediated cell fusion figures s<NUMBER> s<NUMBER> nelfinavir reported pleotropic effects multiple cellular processes including inducing apoptosis er stress certain conditions investigated anticancer purposes <NUMBER> <NUMBER> <NUMBER> thus possible cellular signaling processes affected alter posttranslational processing sn without affecting cell surface expression also possible nelfinavir may inhibit cellular proteases including tmprss<NUMBER> may required sn fusion activation protease inhibitors currently investigated ability inhibit sars cov<NUMBER> replication spread however concrete results obtained clinical trials yet <NUMBER> preliminary experiments indicate sn may cleaved vero cells presence nelfinavir although currently known whether cleavage occurs efficiently addition transfected cells expressing sn presence nelfinavir appear exhibit morphologies indicating cellular cytotoxicity suggesting nelfinavir cytotoxic concentrations used study overall experiments suggest nelfinavir used combat sars cov<NUMBER> infections early first symptoms exhibited infected patients minimize virus spread give sufficient time infected patients mount protective immune response coronavirus belongs large family viruses ie coronaviridae family order nidovirales cui et al <NUMBER> kumar et al <NUMBER> phan et al <NUMBER> genomic structures phylogenetic relationship reveals subfamily coronavirinae contains four genera alpha coronavirus betacoronavirus restricted mammals responsible respiratory illness humans middle east respiratory syndrome coronavirus merscov sars coronavirus sarscov cui et al <NUMBER> kumar et al <NUMBER> payne <NUMBER> phan et al <NUMBER> two genera gamma coronavirus delta coronavirus infect birds mammals cui et al <NUMBER> kumar et al <NUMBER> payne <NUMBER> phan et al <NUMBER> sarscov merscov show severe respiratory diseases humans four others hcovnl<NUMBER> hcov<NUMBER>e hcovoc<NUMBER> hku<NUMBER> cause normal upper respiratory illness hosts immunocompetent even though induce severe infections elders young children infants cui et al <NUMBER> cascella et al <NUMBER> alpha betacoronaviruses give rise intense burden animals include recently emerged swine acute diarrhea syndrome coronavirus sadscov porcine transmissible gastroenteritis virus porcine enteric diarrhea virus pedv cui et al <NUMBER> banerjee et al <NUMBER> continuous development urbanization increases frequent integration many different animals crowded populated places may made easy emergence reemergence number viruses lau chan <NUMBER> httpswwwncbinlmnihgovbooksnbk<NUMBER> hand high mutation recombination rates reported coronaviruses may allow coronaviruses cross barrier species adopt new hosts lau chan <NUMBER> httpsclarivatecomwpcontentuploadsdlmuploads<NUMBER>coronavi rus report<NUMBER>pdf liu et al <NUMBER> <NUMBER> sars epidemic awakened worlds researchers scientists transmission capability coronaviruses animals humans primary reservoir sarscov horseshoe bat lau chan <NUMBER> wang et al <NUMBER> current sequence databases revealed animal origin human coronaviruses merscov sarscov hcov<NUMBER>e hcovnl<NUMBER> considered originated bats cui et al <NUMBER> wang et al <NUMBER> sarsassociated coronaviruses found bats china worldwide continuously lau chan <NUMBER> recently <NUMBER> sarscov<NUMBER> novel coronavirus emerged china affect globally total <NUMBER> confirmed cases <NUMBER> deaths march <NUMBER> <NUMBER> kampf et al <NUMBER> httpswwwwhointdocsdefaultsource coronavirusesituationreports<NUMBER>sitrep<NUMBER>covid<NUMBER>pdfsfvrsnÂ¼dcd<NUMBER> <NUMBER> figure <NUMBER> <NUMBER> represents total reported confirmed cases deaths due novel coronavirus httpswwwwhointemergenciesdiseasesnovelcoronavirus<NUMBER>situ ationreports current pandemic coronaviruslinked acute respiratory disease known coronavirus disease <NUMBER> covid<NUMBER> third recognized spillover humans animal coronavirus last two decades httpsdoiorg<NUMBER> <NUMBER>s<NUMBER>z kampf et al <NUMBER> table <NUMBER> <NUMBER> represents discovery human coronaviruses viruses family coronaviridae contain enveloped positivestranded rna coutard et al <NUMBER> coronaviruses largest <NUMBER> kilobase kb positivesense rna genome kumar et al <NUMBER> shoeman fielding <NUMBER> four major structural proteins membrane envelope e spike nucleocapsid n create complete virus particle encoded genome kumar et al <NUMBER> wu et al <NUMBER> guo et al <NUMBER> evolution emergence novel coronaviruses mostly due lack proofreading mechanism rna recombination among present coronaviruses kumar et al <NUMBER> gene encodes viral spike glycoprotein proposed higher frequency recombination kumar et al <NUMBER> <NUMBER> longer spike protein <NUMBER>ncov remarkable difference compared bat sarscov sarslike coronaviruses kumar et al <NUMBER> chapter discuss emergence reemergence sars coronaviruses genetic variations sarscov sarscov<NUMBER> <NUMBER> sarscov sarscov<NUMBER> rna recombination antigenic shift antigenic drift reported phylogenetic analysis revealed close relationship covid<NUMBER> bat sarslike coronavirus kumar et al <NUMBER> although emerged sars coronavirus suggesting newly spread <NUMBER>ncov human much related sarscov kumar et al <NUMBER> figure <NUMBER> <NUMBER> represents evolutionary relationship different lineage betacoronavirus respective cellular receptors interact host cell per sequence alignment data sequence spike glycoprotein covid<NUMBER> sarscov shows <NUMBER> individuality <NUMBER> resemblance <NUMBER> gaps data indicates covid<NUMBER> spike glycoprotein exhibits higher sequence similarity <NUMBER> variation sarscov study performed kumar et al <NUMBER> variation sequences minimal receptorbinding domain rbd revealed <NUMBER> uniqueness <NUMBER> matches <NUMBER> gaps suggesting difference <NUMBER> tertiary structure minimal receptorbinding domain covid<NUMBER> may changes virusbinding capacity shift infectivity receptors host cell due notable deviation minimal rbd sglycoprotein viruses belong coronaviridae family enclosed envelope positivestranded rna coronaviruses largest <NUMBER> kilobase kb positivesense rna genome genome coronaviruses contains open reading frames orfs variable number <NUMBER> first orf two thirds total viral rna located upon infection two large precursor polyproteins namely pp<NUMBER>a pp<NUMBER>ab translated viral genome host cells translated precursor polyproteins get processed <NUMBER> mature nonstructural proteins nsp<NUMBER>nsp<NUMBER> viral proteinases nonstructural proteins numbered according position n c terminus kumar et al <NUMBER> narayanan et al <NUMBER> figure <NUMBER> <NUMBER> depicts structure coronavirus representing essential proteins accessory proteins nsp<NUMBER> remaining orfs encode accessory proteins remaining part viral genome encodes spike glycoprotein small envelope e protein matrix protein nucleocapsid protein n four essential structural proteins protein attached host receptor ace<NUMBER> including two subunits s<NUMBER> s<NUMBER> cellular tropism rbd virus host range determined s<NUMBER> virus cell membrane fusion determined s<NUMBER> pradhan et al <NUMBER> belouzard et al <NUMBER> du et al <NUMBER> transmembrane nutrient transport formation envelop performed protein n protein e protein along several accessory proteins obstruct host immune response pradhan et al <NUMBER> nonstructural proteins play vital function time viral rna replication transcription kumar et al <NUMBER> narayanan et al <NUMBER> assigned functions <NUMBER> mature nonstructural proteins mentioned table <NUMBER> <NUMBER> several nsps unique enzymes implicated one important steps viral replication nsps appear entirely involved virushost interactions de groot et al <NUMBER> coronavirus sarscov<NUMBER> positive ssrna enveloped virus genome encodes <NUMBER> nonstructural proteins nsps <NUMBER> essential structural proteins several accessory proteins comparison glycosylation sites covid<NUMBER> sarscov spike glycoproteins unveiled presence novel glycosylation sites covid<NUMBER> ngtk nfti nltt ntsn kumar et al <NUMBER> presence novel glycosylation sites covid<NUMBER> might due variation sequence along deviation reported four glycosylation sites ie ngtk nfti nltt ntsn covid<NUMBER> spike glycoprotein exhibits similar glycosylation sites also present sarscov nitn ngti nitn nfsq nesl nctf nntv possibility interaction covid<NUMBER> host receptor novel glycosylation sites may effect process internalization linked pathogenesis kumar et al <NUMBER> study carried determine antigenicity comparing antigenic variations spike glycoproteins covid<NUMBER> sarscov revealed individuality ctl epitopes covid<NUMBER> compared sarscov however six identical epitopes risncvady cvadysvly rsfiedllf rvdfcgkgy mtsccsclk lkgvklhy present spike glycoprotein covid<NUMBER> sarscov kumar et al <NUMBER> covid<NUMBER> epitopes identified difference single amino acid change per available information research data antigenicity covid<NUMBER> shows little antigenic similarities sars coronavirus possible antigenic similarity may cause similar antigenic response therefore used one precautionary approach variation similarity spike glycoprotein epitopes may useful design newer effective vaccines kumar et al <NUMBER> length encoded proteins covid<NUMBER> sarslike coronaviruses found nearly however longer spike protein covid<NUMBER> showed notable difference compared bat sarslike coronaviruses sarscov whole <NUMBER> difference sequences glycoprotein difference minimal rbd <NUMBER> may cause structural differences spike glycoproteins covid<NUMBER> sarscov kumar et al <NUMBER> studies performed measure average distance molecules superimposed proteins ie rmsd depict <NUMBER> Ã¥ local rmsd value two glycoproteins illustrates regardless <NUMBER> sequence variation insignificant structural divergence among spike glycoproteins sarscov covid<NUMBER> absence structural divergence spike glycoproteins sarscov covid<NUMBER> raises hope treatment brutal covid<NUMBER> structural similarity sarscov covid<NUMBER> previously trialed tested attachment inhibitor used sarscov used present choice treatment covid<NUMBER> kumar et al <NUMBER> genetic recombination important evolutionary mechanism positivestrand rna viruses recombination drives toward diversity viral genome creation novel chimeric genomes bentley evans <NUMBER> loriere holmes <NUMBER> irrespective singleor multiplesegment genome rna recombination may occur entire rna viruses loriere holmes <NUMBER> crossspecies transmission rna viruses common approach get entered new host process recombination assists entry viruses facilitates viruses explore larger proportion sequence area mutation increases probability finding genetic configuration assists host adaptation loriere holmes <NUMBER> replicative nonreplicative recombination mechanism works viruses replicative recombination major role played viral polymerase however viral cellular proteins may exist contrary cellular components solely responsible nonreplicative recombination bentley evans <NUMBER> recently emerged many human diseases originated rna viruses three mechanisms viruses go evolutionary changes mutations also known antigenic drift reassortment antigenic shift recombination shao et al <NUMBER> emergence viral diseases human exhibits active viral genome recombination reassortment coronavirus emerged turkey recombinant infectious bronchitis virus attained spike proteinencoding gene coronavirus <NUMBER> loriere holmes <NUMBER> possibility emergence covid<NUMBER> rna recombination â¢ third epidemic twentyfirst century sarscov reported first epidemic twentyfirst century <NUMBER> following merscov <NUMBER> covid<NUMBER> caused sarscov<NUMBER> third epidemic declared pandemic â¢ severe acute respiratory syndrome sars coronavirus disease <NUMBER> covid<NUMBER> portray number similarities virus homology per sequence alignment data spike glycoprotein sequence covid<NUMBER> sarscov shows <NUMBER> resemblance sequences minimal receptorbinding domain rbd show <NUMBER> similarity presence similar glycosylation sites similar epitopes routes transmission viruses ie contact droplets fomite â¢ along similarities severe acute respiratory syndrome sars coronavirus disease <NUMBER> covid<NUMBER> depict number dissimilarities also <NUMBER> difference glycoprotein sequence difference minimal rbd <NUMBER> behavioral differences rate transmission severity covid<NUMBER> much higher sarscov â¢ emergence novel coronavirus <NUMBER> covid<NUMBER> might due rna recombination positivesense rna viruses well reported ability rna recombination make potent cross species barrier â¢ structural similarity covid<NUMBER> sarscov could encashed terms use available treatment inhibition attachment host cell could effective way control spread disease use drugcompound block entry host cell binding receptor newly emerged coronavirus sarscov<NUMBER> strongly related predecessor sarscov sarscov becoming pandemic declared public health emergency global concern presence novel glycosylation sites sarscov<NUMBER> makes possible become pandemic due antigenic divergence time important understand educate mass follow instructions given authorities avoid social gathering least delay transmission widespread community slowdown transmission rate provide time researchers scientists prepare well develop vaccine treatment novel coronavirus similarity sarscov<NUMBER> sarscov terms antigenic sites proposes scope sarslinked peptidebased vaccine prevent covid<NUMBER> structural similarity sarscov<NUMBER> sarscov suggests use attachment inhibitor specific coronavirus current option treatment although mechanism species species transfer sars coronavirus difficult understand sarscov <NUMBER> epidemic makes clear animal coronaviruses budding threats human community still researches going covid<NUMBER> limited information novel coronavirus makes boundaries explain complete antigenicity structure covid<NUMBER> complete genome analysis required understand similarities differences sarscov<NUMBER> previously reported viruses complete genome analysis also helps development vaccines medicines covid<NUMBER> required understand complete research emergence reemergence coronaviruses understand change proteins genome transmission crossing species barrier another area focus sarscov<NUMBER> spike type <NUMBER> fusion machine responsible viruscell entry via <NUMBER> ace<NUMBER> receptor interactions tmprss<NUMBER> protease activation endosome <NUMBER> substantially <NUMBER> glycosylated <NUMBER> also divergent betacoronavirus pathogens known infected <NUMBER> humans <NUMBER> continues diversify <NUMBER> cryoem structures sarscov<NUMBER> spike <NUMBER> reveal <NUMBER> two prevalent conformations singleup conformation alldown conformation related <NUMBER> <NUMBER> orientations receptorbinding domains rbds however extent spike <NUMBER> glycosylation sequence diversity conformational heterogeneity impact antibody elicitation <NUMBER> antibodymediated neutralization unclear <NUMBER> accumulating data indicates individuals recover covid<NUMBER> often <NUMBER> high levels neutralizing antibody activity <NUMBER> worrisome reports reinfection <NUMBER> recovered individuals <NUMBER> <NUMBER> <NUMBER> moreover reports antibody cr<NUMBER> disassembling spike <NUMBER> suggest <NUMBER> unusual fragility <NUMBER> facilitate molecular understanding sarscov<NUMBER> spike evasion <NUMBER> antibody measured unfolding enthalpy spike well binding cr<NUMBER> <NUMBER> antibody ace<NUMBER> receptor function ph also determined cryoem structures <NUMBER> spike alone complex ace<NUMBER> receptor physiological endosomal phs <NUMBER> delineated molecular mechanism mediates raising closing rbds utilizes <NUMBER> refolding region multiple aspartic acid residues phdependent switch fully <NUMBER> protonated locks rbds position overall findings suggest phdependent <NUMBER> mechanism conformational masking whereby reduced folding physiological ph underlies <NUMBER> ease antibodies like cr<NUMBER> bind spike prevalent elicitation recognition <NUMBER> ace<NUMBER> however leads endosomal entry resulting reduction ph induction antibody <NUMBER> shedding phdependent conformational changes spike <NUMBER> <NUMBER> spike physiological ph minimum unfolding enthalpy <NUMBER> provide insight stability spike course viruscell entry used <NUMBER> differential scanning calorimetry dsc measure unfolding enthalpy soluble trimeric <NUMBER> ectodomain spike included gsas pp mutations t<NUMBER> phage fibritin <NUMBER> <NUMBER> trimerization domain <NUMBER> function ph notably physiological ph observed spike <NUMBER> minimum unfolding enthalpy <NUMBER> kcalmol <NUMBER> normalized unfolding enthalpy <NUMBER> average globular protein <NUMBER> fig <NUMBER>a left amount folding energy increased rapidly <NUMBER> ph dropped increasing <NUMBER>fold ph <NUMBER> decreasing ph reduced analysis <NUMBER> melting curves fig <NUMBER>a right indicated three distinct peaks peak <NUMBER>Â°c dominated <NUMBER> basic conditions decreased acidic conditions peak <NUMBER>Â°c barely <NUMBER> present physiological ph rapidly increased dominate ph dropped <NUMBER> <NUMBER> peak <NUMBER>Â°c first appeared shoulder ph <NUMBER> increased dominate <NUMBER> shifted lower temperature ph lower <NUMBER> <NUMBER> sharp contrast spike analysis spike nterminal domain ntd rbd <NUMBER> separate proteins indicated typical unfolding enthalpies <NUMBER> <NUMBER> average normalized globular protein extended data fig <NUMBER> <NUMBER> understand reduced folding enthalpy might influence spike structure used <NUMBER> negative stainelectron microscopy em visualize spike function ph extended <NUMBER> data fig <NUMBER> ph <NUMBER> observed spike mostly disordered however ph <NUMBER> decreased observed wellformed trimers showed clustering ph <NUMBER> <NUMBER> resolving separate particles ph <NUMBER> overall observed concordance <NUMBER> presence wellformed trimers folding enthalpy measured dsc mostly unfolded <NUMBER> trimers physiological ph substantially increased folding endosomal ph enter endosome <NUMBER> used isothermal titration calorimetry itc determine whether <NUMBER> binding cr<NUMBER> spike compatible ace<NUMBER> interaction chose use monomeric <NUMBER> version ace<NUMBER> test sensitively impact antibody inhibition first titrated ace<NUMBER> <NUMBER> soluble spike observed <NUMBER> ace<NUMBER> molecules bind per spike trimer affinity <NUMBER> <NUMBER> nm fig <NUMBER>b left next fully titrated antigenbinding fragment fab cr<NUMBER> <NUMBER> soluble spike extended data fig <NUMBER>a titrated ace<NUMBER> spikecr<NUMBER> complex <NUMBER> formed observe <NUMBER> ace<NUMBER> molecules bind spikecr<NUMBER> complex affinity <NUMBER> <NUMBER> nm fig <NUMBER>b right sarscov<NUMBER> spike thus appears capable recognizing ace<NUMBER> even <NUMBER> presence antibody cr<NUMBER> indicating cr<NUMBER>bound spikes could enter <NUMBER> endosomal compartment <NUMBER> gain insight impact ph ace<NUMBER> cr<NUMBER> interactions spike <NUMBER> characterized affinities spike rbd expressed separate molecule <NUMBER> physiological endosomal ph chose use dimeric ace<NUMBER> closely mimic native <NUMBER> interactions spike endosomal phs surface plasmon resonance sprdetermined ace<NUMBER> <NUMBER> binding affinities spike rbd somewhat reduced <NUMBER> nm <NUMBER> nm <NUMBER> <NUMBER> nm <NUMBER> nm ph <NUMBER> spike rbd respectively extended data fig <NUMBER>b <NUMBER> cr<NUMBER> igg affinities high spike rbd physiological ph though <NUMBER> fold difference <NUMBER> <NUMBER> nm spike rbd respectively fig <NUMBER>c ph <NUMBER> <NUMBER> fold difference affinity retained <NUMBER> <NUMBER> nm respectively however ph <NUMBER> <NUMBER> cr<NUMBER> still bound rbd <NUMBER> nm affinity spike dramatically reduced k <NUMBER> <NUMBER> nm affinity difference least <NUMBER>fold fig <NUMBER>c extended data fig <NUMBER>c <NUMBER> cr<NUMBER> still bound strongly isolated rbd attribute dramatically reduced affinity <NUMBER> cr<NUMBER> spike low ph conformational constraints spike fig <NUMBER>d cryoem structures sarscov<NUMBER> spike ace<NUMBER> physiological endosomal ph <NUMBER> structures ace<NUMBER> cr<NUMBER> determined complex rbd separate <NUMBER> domain <NUMBER> less known interactions trimer provide structural insight <NUMBER> recognition ace<NUMBER> spike trimer mixed soluble ace<NUMBER> spike trimer <NUMBER> <NUMBER> molar ratio ph <NUMBER> collected singleparticle cryoem data titan krios <NUMBER> observed spike binding ace<NUMBER> stoichiometries <NUMBER> <NUMBER> <NUMBER> prevalences <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively fig <NUMBER>a membraneproximal region spike <NUMBER> complexes remained <NUMBER>fold symmetric ace<NUMBER>binding regions showed asymmetry <NUMBER> example superposition doubleace<NUMBER>bound complex onto based membrane<NUMBER> proximal regions leading displacement ace<NUMBER> molecules almost <NUMBER> Ã¥ fig <NUMBER>b however <NUMBER> could see evidence coordinated movement rbd domain protomer <NUMBER> appearing engage ace<NUMBER> without significantly impacting motion <NUMBER> neighboring protomers thus ace<NUMBER> receptor engagement required rbd movement <NUMBER> appear destabilize spike trigger substantial structural rearrangement beyond raising <NUMBER> rbd <NUMBER> provide insight impact endosomal ph mixed soluble ace<NUMBER> <NUMBER> spike trimer <NUMBER> molar ratio time ph <NUMBER> determined structure <NUMBER> complex using cryoem similar physiological ph observed spike binding ace<NUMBER> <NUMBER> stoichiometries <NUMBER> <NUMBER> <NUMBER> prevalences <NUMBER> <NUMBER> <NUMBER> respectively fig <NUMBER> <NUMBER>c superposed tripleace<NUMBER>bound complexes determined ph <NUMBER> ph <NUMBER> observed <NUMBER> membraneproximal regions spike align closely ace<NUMBER> molecules showed <NUMBER> displacements <NUMBER> <NUMBER> <NUMBER> Ã¥ fig <NUMBER>d overall structures spike ace<NUMBER> showed <NUMBER> <NUMBER> equal distribution single double tripleace<NUMBER>bound states physiological <NUMBER> endosomal ph <NUMBER> <NUMBER> ligandfree cryoem structures sarscov<NUMBER> spike low ph <NUMBER> light similarity ace<NUMBER> complexes ph <NUMBER> <NUMBER> fig <NUMBER> substantial <NUMBER> differences phs observed ligandfree spike negative stain em extended data fig <NUMBER> <NUMBER> analyzed structure spike ph <NUMBER> singleparticle cryoem determined <NUMBER> consensus structure <NUMBER> particles resolution <NUMBER> Ã¥ spike <NUMBER> well resolved except lone rbd reconstruction density poor fig <NUMBER>a fig <NUMBER>c panel b interestingly <NUMBER> unlike ace<NUMBER>bound complexes doubleor triplerbdup conformations observed <NUMBER> two classes prevalences <NUMBER> conformation <NUMBER> <NUMBER> Ã¥ resolution <NUMBER> conformation spike ph <NUMBER> remaining classes rbd assume defined position <NUMBER> suggesting mobility domain even endosomal ph <NUMBER> determine even lower ph affected conformational heterogeneity since <NUMBER> cr<NUMBER> retained binding spike ph <NUMBER> sought obtain cryoem structure ligand<NUMBER> <NUMBER> free spike ph <NUMBER> single particle analysis dataset comprising <NUMBER> particles resolved <NUMBER> allrbddown conformation fig <NUMBER>b extended data fig <NUMBER>ab map refined <NUMBER> Ã¥ <NUMBER> resolution enabling individual water molecules observed fig <NUMBER>c <NUMBER> additional residues <NUMBER> modeled undefined published cryoem structures <NUMBER> fig <NUMBER>b region reasons described named switch region fully <NUMBER> defined protomer b partially resolved protomer residues <NUMBER> <NUMBER> <NUMBER> protomer c residues <NUMBER> <NUMBER> notably region almost entirely unresolved <NUMBER> structures ace<NUMBER> published spike structures <NUMBER> fig <NUMBER>a bottom <NUMBER> asymmetry distribution refolding regions trimer singleup all<NUMBER> structures fig <NUMBER>b suggested rbd require concerted adjustments throughout tyr<NUMBER> unprotonatedswitches fig <NUMBER>a left recognizing backbone carbonyl protonated<NUMBER> switches fig <NUMBER>a right test impact mutation unfolding enthalpy performed <NUMBER> dsc measurements ph <NUMBER> <NUMBER> <NUMBER> fig <NUMBER>c enthalpies ph <NUMBER> <NUMBER> <NUMBER> similar wildtype spike unfolding enthalpy ph <NUMBER> dramatically increased <NUMBER> appearance high melting temperature peak variant fig <NUMBER>d seen wild<NUMBER> type low ph dramatic difference melting enthalpy demonstrated substantive <NUMBER> energetic effect altering interprotomerswitch interface test influence increased <NUMBER> unfolding enthalpy ace<NUMBER> interaction performed biolayer interferometry bli dimeric <NUMBER> ace<NUMBER> recognizing spike asp<NUMBER>gly variant ph <NUMBER> observed higher binding <NUMBER> wildtype spike asp<NUMBER>gly variant dimeric ace<NUMBER> fig <NUMBER>e left consistent dsc <NUMBER> showing unfolding enthalpy variant spike thereby reducing ability bind dimeric <NUMBER> ace<NUMBER> avidity <NUMBER> next tried understand impact asp<NUMBER>gly mutation switchbased <NUMBER> mechanism locking rbd position low ph switches disorder region <NUMBER> contacting sd<NUMBER> associated rbds hypothesized mutation asp<NUMBER> gly <NUMBER> would closely mimic loss interaction sd<NUMBER> switch exemplified <NUMBER> rbd b switch c indeed bli measurements ph <NUMBER> showed dimeric ace<NUMBER> bind <NUMBER> asp<NUMBER>gly variant greater apparent affinity fig <NUMBER>e right consistent higher <NUMBER> probability rbds adopting position providing explanation increased <NUMBER> infectivity <NUMBER> test impact antibody binding used bli measure affinity <NUMBER> cr<NUMBER> spike asp<NUMBER>gly variant similar observed dimeric ace<NUMBER> <NUMBER> cr<NUMBER> bound wildtype spike tightly gly variant physiological ph <NUMBER> behavior inverting low ph folding ph switch induced antibody shedding wild<NUMBER> type less variant spike fig <NUMBER>f lastly tested ability antibody cr<NUMBER> <NUMBER> neutralize asp<NUMBER>gly variant using pseudovirus format asp<NUMBER>gly variant showed <NUMBER> modest increase neutralization sensitivity cr<NUMBER> fig <NUMBER>g indicating conformational <NUMBER> <NUMBER> masking mostly intact observed increase spike binding cr<NUMBER> low ph <NUMBER> perhaps compensated respect neutralization altered spike interactions ace<NUMBER> howin face spike conformational masking neutralize sarscov<NUMBER> <NUMBER> envision three scenarios first antibodies block ace<NUMBER> interaction spike prevented <NUMBER> binding ace<NUMBER> able start endosomal entry pathway second antibodies <NUMBER> <NUMBER> extremely high affinity show conformational masking reduces affinity cr<NUMBER> <NUMBER> ph <NUMBER> <NUMBER>fold longer neutralizes however antibodies orders magnitude <NUMBER> tighter affinity might still bind neutralize despite <NUMBER>fold reduction affinity low <NUMBER> endosomal ph context note cr<NUMBER> <NUMBER>fold higher affinity <NUMBER> sarscov spike able neutralize sarscov virus <NUMBER> third antibodies bind cryoem data processing structural refinement individual spikes <NUMBER> dataset divided subsets initially processed independently <NUMBER> parallel using frederick research computing environment frce computing cluster later <NUMBER> combined final refinement movie frame alignment performed using motioncorr<NUMBER> <NUMBER> <NUMBER> ctffind<NUMBER> used determine parameters ctf <NUMBER> remaining processing steps <NUMBER> performed using relion <NUMBER> ref <NUMBER> unless otherwise stated spike ph <NUMBER> small particle <NUMBER> set selected manually used obtain <NUMBER>d classes utilized templates select <NUMBER> larger set particles initial <NUMBER>d model obtained using eman <NUMBER> <NUMBER> <NUMBER>d classes <NUMBER> generated extended particle set <NUMBER>d model subjected <NUMBER>d auto<NUMBER> refinement resulting map used generate lowpass filtered picking templates <NUMBER> entire dataset spike ph <NUMBER> particle picking performed cryolo <NUMBER> <NUMBER> using <NUMBER> general network model initial <NUMBER>d model obtained eman <NUMBER> subset <NUMBER> resulting <NUMBER>d classes following steps included rounds <NUMBER>d classification <NUMBER>d auto<NUMBER> refinement ctf refinement particle polishing map resolutions calculated using late endosomeearly lysosome shed antibodies longer bind spike activated lowph protease tmprss<NUMBER> binding ace<NUMBER> facilitates endocytosis ph drops spike folds begins shed antibodies like cr<NUMBER> recognize cryptic epitopes physiological ph weak folding constraints spike enable antibodies like cr<NUMBER> bind avidity antibody Âµgml <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several key residues including r<NUMBER> q<NUMBER> y<NUMBER> switched interactive partners upon refolding asp<NUMBER> colored orange purple blue ph <NUMBER> ph <NUMBER> respectively surrounding residues interacting switch labeled italics hydrogen bonds shown dashed lines b schematic phswitch locking rbd position c unfolding enthalpy measured dsc spike asp<NUMBER>gly variant ph <NUMBER> <NUMBER> <NUMBER> melting curves ph <NUMBER> left <NUMBER> right e bli measurements ace<NUMBER> binding spike asp<NUMBER>gly variant ph <NUMBER> <NUMBER> f bli measurements cr<NUMBER> binding spike d<NUMBER>g variant different phs g pseudovirus neutralization sarscov<NUMBER> d<NUMBER>g variant antibody cr<NUMBER> <NUMBER> orientations receptorbinding domains rbds however extent spike <NUMBER> glycosylation sequence diversity conformational heterogeneity impact antibody elicitation <NUMBER> antibodymediated neutralization unclear <NUMBER> accumulating data indicates individuals recover covid<NUMBER> often <NUMBER> high levels neutralizing antibody activity <NUMBER> worrisome reports reinfection <NUMBER> recovered individuals <NUMBER> <NUMBER> <NUMBER> moreover reports antibody cr<NUMBER> disassembling spike <NUMBER> suggest <NUMBER> unusual fragility <NUMBER> facilitate molecular understanding sarscov<NUMBER> spike evasion <NUMBER> antibody measured unfolding enthalpy spike well binding cr<NUMBER> <NUMBER> antibody ace<NUMBER> receptor function ph also determined cryoem structures <NUMBER> spike alone complex ace<NUMBER> receptor physiological endosomal phs <NUMBER> delineated molecular mechanism mediates raising closing rbds utilizes <NUMBER> refolding region multiple aspartic acid residues phdependent switch fully <NUMBER> protonated locks rbds position overall findings suggest phdependent <NUMBER> mechanism conformational masking whereby reduced folding physiological ph underlies <NUMBER> ease antibodies like cr<NUMBER> bind spike prevalent elicitation recognition <NUMBER> ace<NUMBER> however leads endosomal entry resulting reduction ph induction antibody <NUMBER> shedding phdependent conformational changes spike <NUMBER> <NUMBER> spike physiological ph minimum unfolding enthalpy <NUMBER> provide insight stability spike course viruscell entry used <NUMBER> differential scanning calorimetry dsc measure unfolding enthalpy soluble trimeric <NUMBER> trimerization domain <NUMBER> function ph notably physiological ph observed spike <NUMBER> minimum unfolding enthalpy <NUMBER> kcalmol <NUMBER> normalized unfolding enthalpy <NUMBER> average globular protein <NUMBER> fig <NUMBER>a left amount folding energy increased rapidly <NUMBER> ph dropped increasing <NUMBER>fold ph <NUMBER> decreasing ph reduced analysis <NUMBER> melting curves fig <NUMBER>a right indicated three distinct peaks peak <NUMBER>Â°c dominated <NUMBER> basic conditions decreased acidic conditions peak <NUMBER>Â°c barely <NUMBER> present physiological ph rapidly increased dominate ph dropped <NUMBER> <NUMBER> peak <NUMBER>Â°c first appeared shoulder ph <NUMBER> increased dominate <NUMBER> shifted lower temperature ph lower <NUMBER> <NUMBER> sharp contrast spike analysis spike nterminal domain ntd rbd <NUMBER> separate proteins indicated typical unfolding enthalpies <NUMBER> <NUMBER> average normalized globular protein extended data fig <NUMBER> <NUMBER> understand reduced folding enthalpy might influence spike structure used <NUMBER> negative stainelectron microscopy em visualize spike function ph extended <NUMBER> data fig <NUMBER> ph <NUMBER> observed spike mostly disordered however ph <NUMBER> decreased observed wellformed trimers showed clustering ph <NUMBER> <NUMBER> resolving separate particles ph <NUMBER> overall observed concordance <NUMBER> presence wellformed trimers folding enthalpy measured dsc mostly unfolded <NUMBER> trimers physiological ph substantially increased folding endosomal ph <NUMBER> binding ace<NUMBER> receptor cr<NUMBER> antibody physiological endosomal ph <NUMBER> variation ph course virus entry impact binding antibody <NUMBER> antibody would need allow spike recognition ace<NUMBER> receptor thereby enabling virus <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> enter endosome <NUMBER> used isothermal titration calorimetry itc determine whether <NUMBER> binding cr<NUMBER> spike compatible ace<NUMBER> interaction chose use monomeric <NUMBER> version ace<NUMBER> test sensitively impact antibody inhibition first titrated ace<NUMBER> <NUMBER> soluble spike observed <NUMBER> ace<NUMBER> molecules bind per spike trimer affinity <NUMBER> <NUMBER> nm fig <NUMBER>b left next fully titrated antigenbinding fragment fab cr<NUMBER> <NUMBER> soluble spike extended data fig <NUMBER>a titrated ace<NUMBER> spikecr<NUMBER> complex <NUMBER> formed observe <NUMBER> ace<NUMBER> molecules bind spikecr<NUMBER> complex affinity <NUMBER> <NUMBER> nm fig <NUMBER>b right sarscov<NUMBER> spike thus appears capable recognizing ace<NUMBER> even <NUMBER> presence antibody cr<NUMBER> indicating cr<NUMBER>bound spikes could enter <NUMBER> endosomal compartment <NUMBER> gain insight impact ph ace<NUMBER> cr<NUMBER> interactions spike <NUMBER> characterized affinities spike rbd expressed separate molecule <NUMBER> physiological endosomal ph chose use dimeric ace<NUMBER> closely mimic native <NUMBER> interactions spike endosomal phs surface plasmon resonance sprdetermined ace<NUMBER> <NUMBER> binding affinities spike rbd somewhat reduced <NUMBER> nm <NUMBER> nm <NUMBER> <NUMBER> nm <NUMBER> nm ph <NUMBER> spike rbd respectively extended data fig <NUMBER>b <NUMBER> cr<NUMBER> igg affinities high spike rbd physiological ph though <NUMBER> fold difference <NUMBER> <NUMBER> nm spike rbd respectively fig <NUMBER>c ph <NUMBER> <NUMBER> fold difference affinity retained <NUMBER> <NUMBER> nm respectively however ph <NUMBER> <NUMBER> cr<NUMBER> still bound rbd <NUMBER> nm affinity spike dramatically reduced k <NUMBER> <NUMBER> nm affinity difference least <NUMBER>fold fig <NUMBER>c extended data fig <NUMBER>c <NUMBER> cr<NUMBER> still bound strongly isolated rbd attribute dramatically reduced affinity <NUMBER> <NUMBER> cryoem structures sarscov<NUMBER> spike ace<NUMBER> physiological endosomal ph <NUMBER> structures ace<NUMBER> cr<NUMBER> determined complex rbd separate <NUMBER> domain <NUMBER> less known interactions trimer provide structural insight <NUMBER> recognition ace<NUMBER> spike trimer mixed soluble ace<NUMBER> spike trimer <NUMBER> <NUMBER> molar ratio ph <NUMBER> collected singleparticle cryoem data titan krios <NUMBER> observed spike binding ace<NUMBER> stoichiometries <NUMBER> <NUMBER> <NUMBER> prevalences <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively fig <NUMBER>a membraneproximal region spike <NUMBER> complexes remained <NUMBER>fold symmetric ace<NUMBER>binding regions showed asymmetry <NUMBER> example superposition doubleace<NUMBER>bound complex onto based membrane<NUMBER> proximal regions leading displacement ace<NUMBER> molecules almost <NUMBER> Ã¥ fig <NUMBER>b however <NUMBER> could see evidence coordinated movement rbd domain protomer <NUMBER> appearing engage ace<NUMBER> without significantly impacting motion <NUMBER> neighboring protomers thus ace<NUMBER> receptor engagement required rbd movement <NUMBER> appear destabilize spike trigger substantial structural rearrangement beyond raising <NUMBER> rbd <NUMBER> provide insight impact endosomal ph mixed soluble ace<NUMBER> <NUMBER> spike trimer <NUMBER> molar ratio time ph <NUMBER> determined structure <NUMBER> complex using cryoem similar physiological ph observed spike binding ace<NUMBER> <NUMBER> stoichiometries <NUMBER> <NUMBER> <NUMBER> prevalences <NUMBER> <NUMBER> <NUMBER> respectively fig <NUMBER> <NUMBER>c superposed tripleace<NUMBER>bound complexes determined ph <NUMBER> ph <NUMBER> observed <NUMBER> membraneproximal regions spike align closely ace<NUMBER> molecules showed <NUMBER> equal distribution single double tripleace<NUMBER>bound states physiological <NUMBER> endosomal ph <NUMBER> <NUMBER> ligandfree cryoem structures sarscov<NUMBER> spike low ph <NUMBER> light similarity ace<NUMBER> complexes ph <NUMBER> <NUMBER> fig <NUMBER> substantial <NUMBER> differences phs observed ligandfree spike negative stain em extended data fig <NUMBER> <NUMBER> analyzed structure spike ph <NUMBER> singleparticle cryoem determined <NUMBER> consensus structure <NUMBER> particles resolution <NUMBER> Ã¥ spike <NUMBER> well resolved except lone rbd reconstruction density poor fig <NUMBER>a fig <NUMBER>c panel b interestingly <NUMBER> unlike ace<NUMBER>bound complexes doubleor triplerbdup conformations observed <NUMBER> two classes prevalences <NUMBER> conformation <NUMBER> <NUMBER> Ã¥ resolution <NUMBER> conformation <NUMBER> <NUMBER> <NUMBER> Ã¥ resolution corresponded two different single rbdup conformations third <NUMBER> prevalent class representing <NUMBER> particles rbds three <NUMBER> prevalent classes unlike consensus structure density rbd domains well <NUMBER> resolved extended data fig <NUMBER>c panel c indicating multiple different orientations rbd <NUMBER> spike ph <NUMBER> remaining classes rbd assume defined position <NUMBER> suggesting mobility domain even endosomal ph <NUMBER> determine even lower ph affected conformational heterogeneity since <NUMBER> cr<NUMBER> retained binding spike ph <NUMBER> sought obtain cryoem structure ligand<NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> free spike ph <NUMBER> single particle analysis dataset comprising <NUMBER> particles resolved <NUMBER> allrbddown conformation fig <NUMBER>b extended data fig <NUMBER>ab map refined <NUMBER> Ã¥ <NUMBER> resolution enabling individual water molecules observed fig <NUMBER>c <NUMBER> additional residues <NUMBER> modeled undefined published cryoem structures <NUMBER> fig <NUMBER>b region reasons described named switch region fully <NUMBER> defined protomer b partially resolved protomer residues <NUMBER> <NUMBER> <NUMBER> protomer c residues <NUMBER> <NUMBER> notably region almost entirely unresolved <NUMBER> structures ace<NUMBER> published spike structures <NUMBER> fig <NUMBER>a bottom <NUMBER> asymmetry distribution refolding regions trimer singleup all<NUMBER> structures fig <NUMBER>b suggested rbd require concerted adjustments throughout <NUMBER> trimer delineate determined angles rigidbody translations <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> notably refolding regions observed reside critical interprotomer contacts <NUMBER> key joints domains especially sd<NUMBER> sd<NUMBER> joint cradles switch <NUMBER> neighboring protomer sd<NUMBER> b joint uprbd b made refolding residues <NUMBER> b <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> tyr<NUMBER> unprotonatedswitches fig <NUMBER>a left recognizing backbone carbonyl protonated<NUMBER> switches fig <NUMBER>a right test impact mutation unfolding enthalpy performed <NUMBER> dsc measurements ph <NUMBER> <NUMBER> <NUMBER> fig <NUMBER>c enthalpies ph <NUMBER> <NUMBER> <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> <NUMBER> similar wildtype spike unfolding enthalpy ph <NUMBER> dramatically increased <NUMBER> appearance high melting temperature peak variant fig <NUMBER>d seen wild<NUMBER> type low ph dramatic difference melting enthalpy demonstrated substantive <NUMBER> energetic effect altering interprotomerswitch interface test influence increased <NUMBER> unfolding enthalpy ace<NUMBER> interaction performed biolayer interferometry bli dimeric <NUMBER> ace<NUMBER> recognizing spike asp<NUMBER>gly variant ph <NUMBER> observed higher binding <NUMBER> wildtype spike asp<NUMBER>gly variant dimeric ace<NUMBER> fig <NUMBER>e left consistent dsc <NUMBER> showing unfolding enthalpy variant spike thereby reducing ability bind dimeric <NUMBER> ace<NUMBER> avidity <NUMBER> next tried understand impact asp<NUMBER>gly mutation switchbased <NUMBER> mechanism locking rbd position low ph switches disorder region <NUMBER> contacting sd<NUMBER> associated rbds hypothesized mutation asp<NUMBER> gly <NUMBER> would closely mimic loss interaction sd<NUMBER> switch exemplified <NUMBER> rbd b switch c indeed bli measurements ph <NUMBER> showed dimeric ace<NUMBER> bind <NUMBER> asp<NUMBER>gly variant greater apparent affinity fig <NUMBER>e right consistent higher <NUMBER> probability rbds adopting position providing explanation increased <NUMBER> infectivity <NUMBER> test impact antibody binding used bli measure affinity <NUMBER> cr<NUMBER> spike asp<NUMBER>gly variant similar observed dimeric ace<NUMBER> <NUMBER> cr<NUMBER> bound wildtype spike tightly gly variant physiological ph <NUMBER> behavior inverting low ph folding ph switch induced antibody shedding wild<NUMBER> type less variant spike fig <NUMBER>f lastly tested ability antibody cr<NUMBER> <NUMBER> neutralize asp<NUMBER>gly variant using pseudovirus format asp<NUMBER>gly variant showed <NUMBER> modest increase neutralization sensitivity cr<NUMBER> fig <NUMBER>g indicating conformational <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> masking mostly intact observed increase spike binding cr<NUMBER> low ph <NUMBER> perhaps compensated respect neutralization altered spike interactions ace<NUMBER> howin face spike conformational masking neutralize sarscov<NUMBER> <NUMBER> envision three scenarios first antibodies block ace<NUMBER> interaction spike prevented <NUMBER> binding ace<NUMBER> able start endosomal entry pathway second antibodies <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> extremely high affinity show conformational masking reduces affinity cr<NUMBER> <NUMBER> ph <NUMBER> <NUMBER>fold longer neutralizes however antibodies orders magnitude <NUMBER> tighter affinity might still bind neutralize despite <NUMBER>fold reduction affinity low <NUMBER> endosomal ph context note cr<NUMBER> <NUMBER>fold higher affinity <NUMBER> sarscov spike able neutralize sarscov virus <NUMBER> third antibodies bind certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> cloned pvrc<NUMBER> vector described previously <NUMBER> expressed purified <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> estimation carried cryosparc <NUMBER> ref <NUMBER> <NUMBER>d reconstructions performed <NUMBER> using c<NUMBER> symmetry complexes ace<NUMBER>bound region showed flexibility prohibited <NUMBER> typical symmetry operations triplebound complex however rbdace<NUMBER> region <NUMBER> assessed greater detail particle expansion c<NUMBER> symmetry used build <NUMBER> region model <NUMBER> coordinates sars cov<NUMBER> spike ectodomain structures pdb entries <NUMBER>vxx <NUMBER> <NUMBER>m<NUMBER>j <NUMBER> employed initial models fitting cryoem map theace<NUMBER> bound structures cov<NUMBER> concentration <NUMBER> mgml diluted target buffer <NUMBER> times <NUMBER> diluted sample incubated ice <NUMBER> min immediately negative staining sample <NUMBER> diluted <NUMBER> times following buffer <NUMBER> mm sodium acetate <NUMBER> mm nacl <NUMBER> ph <NUMBER> <NUMBER> mm hepes <NUMBER> mm nacl ph <NUMBER> <NUMBER> mm trizmahcl <NUMBER> mm nacl <NUMBER> ph <NUMBER> <NUMBER>Âµl drop diluted sample applied glowdischarged carboncoated <NUMBER> copper grid <NUMBER> drop removed filter paper grid washed <NUMBER> applying consecutively three <NUMBER>Âµl drops buffer used diluting sample removing <NUMBER> filter paper protein molecules adsorbed carbon negatively stained <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> applying consecutively three <NUMBER>Âµl drops <NUMBER> uranyl formate manner grid <NUMBER> airdried screened staining quality particle density using hitachi h<NUMBER> <NUMBER> transmission electron microscope tem datasets collected using fei t<NUMBER> tem <NUMBER> equipped eagle ccd camera microscope operated <NUMBER> kv pixel size certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> cryoem data processing structural refinement individual spikes <NUMBER> dataset divided subsets initially processed independently <NUMBER> parallel using frederick research computing environment frce computing cluster later <NUMBER> combined final refinement movie frame alignment performed using motioncorr<NUMBER> <NUMBER> <NUMBER> ctffind<NUMBER> used determine parameters ctf <NUMBER> remaining processing steps <NUMBER> performed using relion <NUMBER> ref <NUMBER> unless otherwise stated spike ph <NUMBER> small particle <NUMBER> set selected manually used obtain <NUMBER>d classes utilized templates select <NUMBER> larger set particles initial <NUMBER>d model obtained using eman <NUMBER> <NUMBER> <NUMBER>d classes <NUMBER> generated extended particle set <NUMBER>d model subjected <NUMBER>d auto<NUMBER> refinement resulting map used generate lowpass filtered picking templates <NUMBER> entire dataset spike ph <NUMBER> particle picking performed cryolo <NUMBER> <NUMBER> using <NUMBER> general network model initial <NUMBER>d model obtained eman <NUMBER> subset <NUMBER> resulting <NUMBER>d classes following steps included rounds <NUMBER>d classification <NUMBER>d auto<NUMBER> refinement ctf refinement particle polishing map resolutions calculated using <NUMBER> goldstandard approach <NUMBER> fsc curve threshold <NUMBER> resmap <NUMBER> used asses <NUMBER> local resolution <NUMBER> local map sharpening performed using phenixautosharpen <NUMBER> spider <NUMBER> <NUMBER> used map conversion resizing <NUMBER> correlations cryoem maps atomic <NUMBER> models assessed using phenixmtriage <NUMBER> ucsf chimera used docking <NUMBER> visualization <NUMBER> despite fact c<NUMBER> symmetry imposed reconstruction spike <NUMBER> ph <NUMBER> dataset resulting map displayed asymmetrical features regions <NUMBER> around residue <NUMBER> therefore three chains atomic model built <NUMBER> refined individually coordinates sars cov<NUMBER> spike ectodomain structures pdb entries <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> <NUMBER>vxx <NUMBER>vyb used initial models fitting cryoem map spike structures <NUMBER> ph <NUMBER> ph <NUMBER> structures iterative model building real space refinement carried <NUMBER> using coot <NUMBER> phenix accurately fit coordinates electron density map <NUMBER> molprobity <NUMBER> used validate geometry check structure quality videos <NUMBER> <NUMBER> structural heterogeneity consensus ph <NUMBER> map rbd region analyzed <NUMBER> using local <NUMBER>d classification obtain accurate mask encompassing conformational space <NUMBER> dynamic rbd four <NUMBER>d variability volumes corresponding beginning end <NUMBER> trajectories defined eigenvectors <NUMBER> <NUMBER> first aligned consensus cryoem <NUMBER> map four volumes density corresponding dynamic rbd isolated <NUMBER> performing volume segmentation ucsf chimera <NUMBER> rbd subvolumes added <NUMBER> together soft mask created resulting composite volume lowpass filtering <NUMBER> density <NUMBER> Ã¥ extending resulting volume <NUMBER> pixels adding soft edge <NUMBER> pixels <NUMBER> using relionmaskcreate local <NUMBER>d classification consensus dataset within mask <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint <NUMBER> performed without particle alignment relion <NUMBER> <NUMBER> followed global <NUMBER>d refinement <NUMBER> resulting six maps <NUMBER> <NUMBER> identification sarscov<NUMBER> spike refolding regions ph <NUMBER> ph <NUMBER> structures <NUMBER> used sliding window <NUMBER> amino acids <NUMBER> amino acids respectively align biolayer interferometry bli <NUMBER> fortÃ©bio octet htx instrument fortÃ©bio used assess binding wide ph <NUMBER> range experiments setup tilted black <NUMBER>well plates geiger bioone <NUMBER>mm <NUMBER> corresponding buffer plus <NUMBER>mm nacl <NUMBER> tween<NUMBER> <NUMBER> bsa <NUMBER> sodium azide <NUMBER> buffers used ph <NUMBER> <NUMBER> described dsc section plates agitated <NUMBER> <NUMBER> rpm temperature set <NUMBER>Â°c antihuman igg fc capture biosensors fortÃ©bio <NUMBER> used immobilize <NUMBER>nm cr<NUMBER> igg dimeric ace<NUMBER>fc <NUMBER> seconds ph <NUMBER> <NUMBER> following loading cr<NUMBER> igg sensors placed ph <NUMBER> buffer <NUMBER> seconds <NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> late endosomeearly lysosome shed antibodies longer bind spike activated lowph protease tmprss<NUMBER> binding ace<NUMBER> facilitates endocytosis ph drops spike folds begins shed antibodies like cr<NUMBER> recognize cryptic epitopes physiological ph weak folding constraints spike enable antibodies like cr<NUMBER> bind avidity antibody cr<NUMBER> spike also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint antibody Âµgml <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several key residues including r<NUMBER> q<NUMBER> y<NUMBER> switched interactive partners upon refolding asp<NUMBER> colored orange purple blue ph <NUMBER> ph <NUMBER> respectively surrounding residues interacting switch labeled italics hydrogen bonds shown dashed lines b schematic phswitch locking rbd position c unfolding enthalpy measured dsc spike asp<NUMBER>gly variant ph <NUMBER> <NUMBER> <NUMBER> melting curves ph <NUMBER> left <NUMBER> right e bli measurements ace<NUMBER> binding spike asp<NUMBER>gly variant ph <NUMBER> <NUMBER> f bli measurements cr<NUMBER> binding spike d<NUMBER>g variant different phs g pseudovirus neutralization sarscov<NUMBER> d<NUMBER>g variant antibody cr<NUMBER> also made available use cc<NUMBER> license certified peer review authorfunder article us government work subject copyright <NUMBER> usc <NUMBER> copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi biorxiv preprint pandemic coronavirus disease covid<NUMBER> sarscov<NUMBER> virus caused tremendous suffering tens millions people around world even though quite clinical studies involving different approaches undergoing treatment disease effective cure yet date vaccines therefore urgently needed preventing spread covid<NUMBER> corona virus sarscov<NUMBER> consists large rna genome four structural proteins <NUMBER> nonstructural proteins accessory proteins four structural proteins include spike envelope membrane nucleocapsid proteins spike glycoprotein particular interest popular vaccine target corona virus antibodies targeting spike glycoprotein sarscov merscov especially receptorbinding domain rbd found efficiently neutralize virus infection <NUMBER> <NUMBER> antibodies sarscov sarscov<NUMBER> patients however showed limited cross neutralization spite high sequence similarity two viruses <NUMBER> vaccine approaches include production live attenuated whole virion vaccines inactivated whole virion vaccines recombinant protein vaccines mrna based vaccines <NUMBER> sarscov<NUMBER> found enter cells binding host cellular receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> via spike glycoprotein soon outbreak china <NUMBER> later cryoem revealed structure sarscov<NUMBER> srbd complexed receptor human ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> s<NUMBER> subunit spike glycoprotein undergoes hingelike conformational transition conformation conformation binding ace<NUMBER> <NUMBER> receptorbinding motif rbm <NUMBER> amino acid total spike glycoprotein close contact ace<NUMBER> receptor identified sequence <NUMBER> <NUMBER> <NUMBER> rbm consistent identified srbd <NUMBER> conformational transition state become target antibodymediated neutralization atomiclevel understanding transitional state identification srbm would facilitate vaccine design development sarscov<NUMBER> ferritin <NUMBER>mer protein assembly consisting heavy chain <NUMBER> kd light chain <NUMBER> kd cagelike structure way similar sarscov<NUMBER> unique structure ferritin promising nanoplatform antigen presentation immune stimulation <NUMBER> <NUMBER> <NUMBER> <NUMBER> spherical architecture outer diameter <NUMBER> nm suitable rapid tissue penetration draining lymph node <NUMBER> work engineered human ferritin heavy chain hftn fusing presenting rbm spike glycoprotein potential vaccine sarscov<NUMBER> human ace<NUMBER>his tag <NUMBER>h<NUMBER>h ï¼ace<NUMBER> rabbit antibody <NUMBER>rp<NUMBER>ï¼ goat antirabbithrp secondary antibodyssa<NUMBER> sarscov<NUMBER> <NUMBER>ncov rbd spike glycoprotein mfc tag<NUMBER>v<NUMBER>h purchased sino biological beijing china refolding solution concentrated buffer exchanged <NUMBER> mm trishcl buffer ph <NUMBER> millipore lab scale tangential flow filter tff system buffer exchange rbmhftn found typical soluble ferritin structure fusion protein right space structure purified using anion exchange chromatography flow mode followed sizeexclusion chromatography remove aggregates low molecule impurities physicochemical properties fusion rbmhftn analyzed sechplc overnight blocking <NUMBER> bsa ace<NUMBER> protein concentration <NUMBER> Î¼gml allowed bind surface coated proteins <NUMBER> h <NUMBER>ï°c followed washing washing buffer three times antiace<NUMBER> antibody dilution <NUMBER> incubated <NUMBER> hours <NUMBER>ï°c followed washing three times secondary antibodyhrp <NUMBER> dilution <NUMBER> bsa incubated <NUMBER>ï°c <NUMBER> h followed washing three times tmb substrate added incubated <NUMBER> min absorbance read <NUMBER> nm wavelength ferritin heavy chain protein found many biological applications nanomedicines molecular diagnostics <NUMBER> <NUMBER> <NUMBER> lately constructs based ferritin developed antivirus anticancer vaccines <NUMBER> <NUMBER> <NUMBER> ferritin heavy chain protein derived natural occurring protein human low immunogenicity <NUMBER>mer assembly cagelike structure four different symmetries six <NUMBER>fold axes eight <NUMBER>fold axes twelve <NUMBER>fold axes twentyfour c<NUMBER>c<NUMBER> interfaces presenting fusion protein <NUMBER>fold axes ferritin able display eight trimers fused protein resulting enhanced immunogenicity protein display <NUMBER> work engineered human ferritin heavy chain fused rbm spike glycoprotein sarscov<NUMBER> nterminus ggggs<NUMBER> short peptide linker figure <NUMBER>a chose short polypeptide sequence <NUMBER> amino acid spike glycoprotein rbm srbm based latest <NUMBER>d cryoem studies spike glycoproteinace<NUMBER> complex <NUMBER> <NUMBER> sequence doesnt appear stable <NUMBER>d structure engineered nterminus fused srbm subunits distant wont affect formation <NUMBER>mer assembly reason chose minimal size rbd properly displayed surface ferritin spite considerations rbmhftn fusion protein found mainly inclusion bodies instead soluble form hypothetically designed rbmhftn fusion protein may involve two different pathways virus infection first importantly rbmhftn may act vaccine sarscov<NUMBER> antibodies responsive spike glycoprotein rbm may subsequently neutralize sarscov<NUMBER> followed removal virus immune system figure <NUMBER>b upper pathway two antibodies found covid<NUMBER> patients shown block binding virus sprotein rbd cellular receptor ace<NUMBER> <NUMBER> therapeutic effect validated mouse model reducing virus titer infected lungs <NUMBER> findings supported hypothesis properly presenting sprotein rbdrbm designed rbmhftn great potential antisarscov<NUMBER> vaccine thus inducing production antivirus antibodies second pathway obvious direct block cellular entry sarscov<NUMBER> preoccupy ace<NUMBER> receptor rbmhftn suppress virus proliferation figure <NUMBER>b lower pathway first pathway effective prevention virus infection second pathway valuable treatment virus infection antagonist ace<NUMBER> receptor expressed rbmhftn found form inclusion bodies bacteria lysis precipitates supplementary figure s<NUMBER> rbd spike glycoprotein mfc tag rbmhftn varied concentration <NUMBER> ï­l incubated maxisorp plate ace<NUMBER> allowed bind surface coated proteins binding detected ace<NUMBER> antibody followed secondary antibody indirect elisa maximum binding intensity correlates binding site surface indicated results figure <NUMBER> srbd showed higher plateau rbmhftn suggesting binding sites available srbd coated wells rbmhftn coated wells ec<NUMBER>s binding ace<NUMBER> srbd rbmhftn estimated <NUMBER> nm <NUMBER> nm respectively apparently rbmhftn higher binding affinity sprotein binding ace<NUMBER> receptor apparent higher binding affinity may attribute cagelike structure rbmhftn presents multiple copies <NUMBER> copies rbm surface result suggested rbm properly presented surface heavy chain human ferritin recognizable ace<NUMBER> receptor potential sarscov<NUMBER> vaccine antagonist ace<NUMBER> receptor studied animal experiments receptorbinding motif rbm sarscov<NUMBER> <NUMBER>amino acid polypeptide fused nterminus human heavy chain ferritin hftn proper linker constructed rbmhftn found inclusion bodies bacterial lysis able refold gradual dialysis purified rbmhftn found good purity expected size morphology biological activity towards ace<NUMBER> receptor confirmed elisa fusion protein rbmhftn bodes well potential vaccine therapeutics sarscov<NUMBER> ace<NUMBER> receptor antagonist ke holds ownership interest including patents kunshan xinyunda biotech co ltd potential conflicts interests disclosed authors lactoferrin lf versatile glycoprotein plays key role many biological functions <NUMBER> work focus lf crucial player natural immunity since proposed play strong antiviral activity wide range rna dna viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> lf composed single chain <NUMBER> residues folded two symmetrical lobes lobe possesses metalbinding site able bind iron also ions like cu <NUMBER> zn <NUMBER> n <NUMBER> <NUMBER> <NUMBER> protein present saliva tears seminal fluid white blood cells milk mammals <NUMBER> discovery <NUMBER> <NUMBER> <NUMBER> lactoferrin identified important ironbinding protein milk besides recent years lactoferrin found involved multitude biological processes fact despite name iron cargo capacity lf prominent activity exerted molecule instead performs antioxidant antiinflammatory anticancer activities <NUMBER> <NUMBER> together broad antimicrobial action bacteria fungi latter activity particular due lfs ability reversibly bind two atoms iron high affinity presence bicarbonate ironfree form lf apolactoferrin apolf deprives bacteria iron thus inhibiting metabolic activities vivo besides aforementioned activities lf demonstrated prevent infection wide range diverse viral species <NUMBER> many viruses make use glycans sialic acid sia glycosaminoglycan like heparan sulfate hf attachment factors see example <NUMBER> details glycans contact virus particle receptors established roll toward specific viral receptor subsequently enter host cell instance fusing host cell membrane <NUMBER> interaction lf hf observed <NUMBER> studies interaction sialic acid derivatives still missing hand lf reported interact virus structural proteins e <NUMBER> general depending specifics virus lactoferrin prevents infection target cell either interfering attachment factor ii binding host cell molecules virus uses receptor coreceptor competition iii direct binding virus particles described herpesvirus <NUMBER> polioand rotavirus <NUMBER> <NUMBER> possibly human immunodeficiency virus <NUMBER> see example <NUMBER> detailed discussion writing article novel virus first observed autumn <NUMBER> rapidly become pandemic virus called sarscov<NUMBER> belongs coronavirus family causes severe acute respiratory syndrome <NUMBER> <NUMBER> somewhat similar caused two coronaviruses sarscov merscov crossed species <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> fact sarscov<NUMBER> similarly sarscov merscov attacks lower respiratory system thus provoking viral pneumonia however infection also lead effects gastrointestinal system heart kidney liver central nervous system <NUMBER> <NUMBER> <NUMBER> sarscov <NUMBER> <NUMBER> <NUMBER> recent vivo experiments confirmed also sarscov<NUMBER> cell entry mediated highaffinity interactions receptorbinding domain rbd virus glycoprotein humanhost angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor <NUMBER> spike protein located arxiv<NUMBER>v<NUMBER> qbiobm <NUMBER> jul <NUMBER> virus envelope promotes host attachment fusion viral cellular membrane <NUMBER> <NUMBER> structural studies determined structures protein free form bound ace<NUMBER> <NUMBER> studies investigate possible interaction sarscov<NUMBER> sialic acids <NUMBER> <NUMBER> <NUMBER> <NUMBER> heparan surfate receptors <NUMBER> considered involved sarscov<NUMBER> well coronavirus infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> use lf antiviral previous coronaviruses infections poorly investigated except <NUMBER> evidence effect attachment process shown new studies proving antiviral effect lactoferrin novel sarscov<NUMBER> infection particular administration liposomal formulation lf significant sample covid<NUMBER> positive patients shown provide immediate beneficial effect <NUMBER> computationally investigate possible molecular mechanisms behind observed antiviral action lactoferrin particular make use recently developed computational protocol based <NUMBER>d zernike polynomials able rapidly characterize shape conformation given protein regions <NUMBER> framework using simple pairwise distance possible evaluate similarity <NUMBER> protein pockets shape complementarity binding regions <NUMBER> interacting proteins order assess whether lactoferrin could influence attachment factors investigated ability lt bind sialic acid sia heparan sulfate hs receptors <NUMBER> considered involved sarscov<NUMBER> infection <NUMBER> <NUMBER> <NUMBER> <NUMBER> well coronavirus infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover checked possible direct interaction lf ace<NUMBER> receptor could inhibit interplay spike ace<NUMBER> binding necessary virus infection finally investigate possible interaction lf <NUMBER> proteins present sarscov<NUMBER> membrane ie spike membrane envelope e proteins entry virus inside host cells requires occurrence sequence molecular interactions sialoside sia andor heparan sulfate hf chains mediate attachment virion cell surface proximity cellular receptor ace<NUMBER> sarscov<NUMBER> spike protein binds receptor initiates internalization process figure <NUMBER>a shows sketch mechanism observed antiviral action lf may consist interference one steps thus investigate next three sections possibility direct binding lactoferrin sia ace<NUMBER> sarscov<NUMBER> spike protein respectively see figure <NUMBER>b possible binding regions sialic acid terminal molecule sia receptors human lactoferrin investigated basis procedure described <NUMBER> ie select portion molecular surface merscov spike protein interaction sialic acid experimentally solved <NUMBER> figure <NUMBER>a search similar patches lf molecular surface within strategy search similar patches surface human lactoferrin <NUMBER>d zernike framework geometrical shape protein surface patch compactly summarized set ordered numerical descriptors whose number <NUMBER> case modulate detail description dealing ordered numerical descriptors comparison different protein patch performed euclidean distance figure <NUMBER>b c show four geometrically similar patches identified apo holo form lf posteriori check electrostatic potential patches allows us select possible solutions identified based shape comparison analysis ie ones also similar electrostatic surface sia binding site merscov spike region lf surface identified similar mers region interacting sialic acid shape electrostatics one centered val <NUMBER> check whether action lactoferrin ascribed competition virion spike proteins binding directly ace<NUMBER> receptor figure <NUMBER> performed blind search molecular surfaces ace<NUMBER> human lf identify possible binding regions meaningful shape complementarity hypothesis interaction lf ace<NUMBER> receptor occurs lf could hinder molecular binding spike protein sarscov<NUMBER> corresponding ace<NUMBER> receptor figure <NUMBER> shows molecular surface ace<NUMBER> receptor colored according propensity bind regions lf protein redder region greater shape complementarity region another one found surface putative molecular partner ie holo lactoferrin one see figure <NUMBER> complementary region indeed present however located far binding site spike grey figure part ace<NUMBER> looks toward membrane better visualize result represented two points view binding spike ace<NUMBER> one rotated <NUMBER> respect hand see ace<NUMBER> region interacting sarscov<NUMBER> spike protein low shape complementarity lf regions <NUMBER> competition binding glycan chains andor <NUMBER> competition binding ace<NUMBER> receptor andor <NUMBER> direct interaction one proteins virion envelope ie e proteins third possible mechanism basis observed antiviral activity lf could ascribed direct interaction membrane proteins present virion envelope particular sarscov<NUMBER> presents three different kinds proteins membrane ie e proteins <NUMBER> <NUMBER> <NUMBER>d structure protein determined even loop regions s<NUMBER> subunit solved unfortunately structures available e proteins thus molecular surfaces lf compared three proteins order check whether interaction lactoferrin possible analysis adopted computational procedure used previous paragraph e proteins sample whole molecular surface compared possible patches lf way molecular surfaces membrane proteins lf ones colored according corresponding binding propensity e presented possible region interactions located intramembrane region data shown robust relevant result analysis regards compatibility spike lactoferrin according findings lf presents two regions high complementarity one portion cterminal domain spike s<NUMBER> subunit another located nterminal part test reliability found signals performed molecular dynamics simulation spike trimer see methods details sampled <NUMBER> configurations three chains equilibrium see particular chain performed principal component analysis pca frames dynamics thus projected plane identified two principal components upon clustering points obtain <NUMBER> subgroups subgroup extract centroidal configuration since distant points pca plane correspond different <NUMBER>d structure picking one point identified cluster assured selected configurations high structural differences explored configuration space see figure <NUMBER>b remarkably repeating blind search complementarity regions <NUMBER> surfaces extracted spike monomers found conservation signal conformational noise figure <NUMBER>c shows identified regions conservation different sampled frames among found regions one involving spike cterminal domain one higher shape complementarity particular according method human lactoferrin could interact spike protein surface region centered residue ala <NUMBER> alternatively spike protein may interact lf protein using molecular patch centered residue phe <NUMBER> must pointed complementarity achieved patches comparable experimentally solved complexes indeed analyzing shape complementarity <NUMBER> xray proteinprotein complexes see methods details distribution shown figure <NUMBER>d lower distance higher complementarity binding region red dotted line shows complementarity found spike lt evident proposed patch characterized values shape complementarity typical experimental complexes finally support result independent external methodology approach performed completely blind molecular docking analysis spike protein lf protein end zdock server used state art molecular docking software <NUMBER> per default settings first <NUMBER> docking poses selected predicted contacts analyzed particular five ten poses show bindings involving spike region involve region found protocol residues defined contact calpha atoms distance less <NUMBER>Ã¥ last decade zernike formalism widely applied characterization molecular surfaces <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> recently developed new representation based <NUMBER>d zernike polynomials allows extremely efficient fast completely unsupervised description local geometrical shape allowing easy comparison different regions molecules compact description possible analyze similarity <NUMBER> different regions suggesting example similar ligand binding regions study complementarity interacting surfaces <NUMBER> used novel method shed light molecular mechanisms ruling observed antiviral action human lactoferrin exerts sarscov<NUMBER> infection <NUMBER> particular focused early stages infection ie attachment entry virus host cell lactoferrin interfere virushost interaction without need internalized cell thus tried establish whether lactoferrin could compete virus binding sialic acid sticky end sialoside chains suggested mediate attachment sarscov<NUMBER> host cell interestingly comparing binding region sialic acid merscov coronavirus patches lactoferrin surface found possible spots apo holo forms lf could compete forming low affinity high avidity interactions proceeded test hypothesis interaction lactoferrin primary sarscov<NUMBER> protein receptor ace<NUMBER> blind search complementarity regions highlighted hotspot region physiological conditions oriented toward membrane significative complementarity present ace<NUMBER> region involved interaction virus spike protein last analyzed three membrane proteins virus envelope ie e ones similarly ace<NUMBER> e presented possible interacting regions portions surface buried virion membrane normal conditions data shown hand spike protein showed two main hot spots one nterminal domain s<NUMBER> subunit another cterminal one two regions robust molecular noise signal endures using different configurations sampled molecular dynamics simulation three chains trimer notably complementary region one cterminal region one involved spikeace<NUMBER> interaction thus finding suggests possible competition ace<NUMBER> lactoferrin binding sarscov<NUMBER> spike may explain observed antiviral action protein whose structures analyzed paper â¢ human lactoferrin apo pdb id <NUMBER>cb<NUMBER> holo pdb id <NUMBER>lfg forms â¢ ace<NUMBER> apo state pdb id <NUMBER>r<NUMBER> â¢ sarscov<NUMBER> protein modeled using itasser <NUMBER> â¢ sarscov<NUMBER> protein modeled using itasser <NUMBER> â¢ sarscov<NUMBER> e protein modeled using itasser <NUMBER> set reference measured complementarities dataset proteinprotein complexes experimentally solved xray crystallography taken <NUMBER> selected pair interactions regarding chains <NUMBER> residues proteinprotein dataset therefore composed <NUMBER> complexes complex binding region identified portions two protein molecular surfaces distant less <NUMBER>Ã¥ protein dataset xray structure pdb format <NUMBER> use dms <NUMBER> compute solventaccessible surface using density <NUMBER> points perÃ¥ <NUMBER> trimer chains rmsd residue proteins colored white red according increasing shape complementarity partner comparison complementarity score red dashed line best binding site zernike disks distribution complementarity scores belonging <NUMBER> binding regions experimental complexes water probe radius <NUMBER>Ã¥ unit normals vector point surface calculated using flag ân molecular surface represented set points threedimensional space define surface patch group points fall within sphere radius r <NUMBER>Ã¥ centered one point surface patch selected â¢ fit plane passes points reorient patch way zaxis perpendicular plane going center plane â¢ define angle Î¸ largest angle perpendicular axis secant connecting given point c zaxis point patch c set order Î¸ <NUMBER> â¢ r distance c surface point â¢ build square grid associate pixel mean r points inside <NUMBER>d function expanded basis zernike polynomials see next section patch represented term zernike descriptors similarity patch another one simply measured euclidean distance invariant vectors relative orientation patches projection unitary circle must considered fact search similar regions must compare patches orientation projected <NUMBER>d plane ie solventexposed part surface must oriented direction patches example positive zaxis instead want assess complementarity two patches must orient patches contrariwise ie one patch solventexposed part toward positive zaxis toward negative zaxis function two variables f r Ï polar coordinates defined inside region r <NUMBER> unitary circle decomposed zernike basis  expansion coefficients complex functions z nm r Ï zernike polynomials polynomial composed radial angular part radial part n given since couple polynomials following relation holds z nm z n Ï n <NUMBER> Î´ nn Î´ mm <NUMBER> complete set polynomials forms basis knowing set complex coefficients c nm allows univocal reconstruction original image resolution depends order expansion n maxn since modulus coefficient z nm c nm depend phase ie invariant rotations around origin unitary circle shape similarity two patches assessed comparing zernike invariants associated <NUMBER>d projections particular measured similarity patch j euclidean distance invariant vectors ie starting structure sarscov<NUMBER> spike trimeric complex taken model structure proposed itasser server <NUMBER> steps simulation performed using gromacs <NUMBER> <NUMBER> topologies system built using charmm<NUMBER> force field <NUMBER> protein placed dodecahedric simulative box periodic boundary conditions filled <NUMBER> tip<NUMBER>p water molecules <NUMBER> checked atom trimer least distance <NUMBER> nm box borders addition <NUMBER> sodium counterions rendered systems electroneutral final system consisting <NUMBER> atoms first minimized <NUMBER> steps steepest descent relaxation water molecules thermalization system nvt npt environments run <NUMBER> ns <NUMBER> fs timestep temperature kept constant <NUMBER> k vrescale algorithm <NUMBER> final pressure fixed <NUMBER> bar parrinellorahman algorithm <NUMBER> guarantees water density <NUMBER> kgm <NUMBER> close experimental value lincs algorithm <NUMBER> used constraint hbonds finally systems simulated <NUMBER> fs timestep <NUMBER> ns periodic boundary conditions using cutoff <NUMBER>Ã¥ evaluation shortrange nonbonded interactions particle mesh ewald method <NUMBER> longrange electrostatic interactions recent pandemic <NUMBER> novel coronavirus also known severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> zhou yang et al <NUMBER> resulted <NUMBER> deaths fatality rate <NUMBER> infected total <NUMBER> individuals around globe <NUMBER> cest <NUMBER> may <NUMBER> world health organization <NUMBER> spectrum sarscov<NUMBER> infection found wide range severity asymptomatic carriage mild respiratory tract infection severe fatal pneumonia singhal <NUMBER> besides sarscov<NUMBER> characterized high morbidity high mortality emphasizes urgent medical well public health need validation development approval effective prophylactic therapeutic interventions covid<NUMBER> coronaviruses cov singlestranded enveloped positivesense rna largest genome size ranges approximately <NUMBER> <NUMBER> kilobases observed till date cov uses spike glycoprotein <NUMBER> kda bind receptor mediate membrane fusion virus entry indeed proteins typical homo trimeric class fusion proteins protease cleavage required activation fusion potential protein twostep sequential protease cleavage starts activation proteins covs involves prime cleavage two subunits ie s<NUMBER> s<NUMBER> activates cleavage s<NUMBER> site belouzard et al <NUMBER> cotten et al <NUMBER> ou et al <NUMBER> wan et al <NUMBER> depending virus strains cell types cov proteins may cleaved one several host proteases including furin trypsin cathepsins transmembrane protease serine protease<NUMBER> tmprss<NUMBER> tmprss<NUMBER> human airway trypsinlike protease hat availability proteases largely mediating attachment membrane fusion target cells upon entry viral particle encoded ready translation orf <NUMBER>a <NUMBER>b polyproteins pp<NUMBER>a <NUMBER> amino acids pp<NUMBER>ab <NUMBER> amino acids processed proteases <NUMBER>clike protease <NUMBER>cl pro papainlike protease pl pro subsequently polyproteins cleaved least <NUMBER> nonstructural proteins nsps assembles form replicationtranscription complex importantly homology modelling revealed sarscov<NUMBER> sarscov share functional host cell receptor ie angiotensinconverting enzyme <NUMBER> ace<NUMBER> besides sarscov<NUMBER> rbdsd<NUMBER> <NUMBER> fragment residues <NUMBER> reported ace<NUMBER> binding site wrapp et al <NUMBER> affinity ace<NUMBER> bounds sarscov<NUMBER> ectodomain <NUMBER>to <NUMBER>fold higher ace<NUMBER> binding sarscov due high binding affinity sarscov<NUMBER> human ace<NUMBER> sarscov<NUMBER> exhibits greater ability transmit persontoperson wan et al <NUMBER> furthermore genomic rna acting messenger rna mrna found play critical role initial rna synthesis infectious cycle template replication transcription also act substrate packaging ricagno et al <NUMBER> snijder et al <NUMBER> nsp<NUMBER> nidoviral rna uridylatespecific endoribonuclease nendou possess cterminal catalytic domain specific uridine acting singleand doublestranded rna elfiky <NUMBER>a reports reveal nendou activity nsp<NUMBER> main contributor protein interference innate immune response thus said nsp<NUMBER> plays pivotal role biological progression coronavirus bhardwaj et al <NUMBER> therefore drugs investigation targets conserved sites likely block entry replication proliferation virus thus may exhibit wide spectrum activity adeoye et al <NUMBER> elfiky <NUMBER>b joshi et al <NUMBER> pan et al <NUMBER> prajapat et al <NUMBER> tian et al <NUMBER> wu et al <NUMBER> although scientific fraternity interdisciplinary research groups putting sincere efforts combat pathogenic sarscov<NUMBER> applying variable holistic approaches understand possible features pathogenesis effective prognosis early identificationdetection cases along development effective therapeutic interventions including prevention prophylactics vaccines treatment measures covid<NUMBER> public health emergency international concern principle costeffective timeefficient computational technique provides powerful networkbased tool cheng et al <NUMBER> test novel hypotheses conceptualizing systematic drug repositioning strategy rapid identification therapeutic lead andor potential leads combinations effective <NUMBER>ncovsarscov<NUMBER> existing approved andor preclinical drugs kandeel alnazawi <NUMBER> serafin et al <NUMBER> sinha et al <NUMBER> zhou hou et al <NUMBER> promising published report glycyrrhizin bioactive constituent liquorice glycyrrhiza glabra l family fabaceae key medicine traditional chinese medicine tcm system indicates role treatment patients suffering infection caused sarscov cinatl et al <NUMBER> moreover according tcm theory liquorice primarily effective fatigue debilitation asthma coughing excessive phlegm respiratory infections relieving drug toxicity grienke et al <NUMBER> wang et al <NUMBER> bioactive compounds liquorice reported antimicrobial antiviral immunoregulatory features brief glycyrrhizic acid reported efficacy hiv<NUMBER> chronic hepatitis c virus coxsackievirus a<NUMBER> enterovirus <NUMBER> kaposi sarcomaassociated herpesvirus curreli et al <NUMBER> de clercq <NUMBER> sabouri ghannad et al <NUMBER> wang et al <NUMBER> licochalcone isoliquiritigenin effective preventing acute lung injury induced pathogenic origin liu et al <NUMBER> liquiritin also reported antiviral potential hiv grienke et al <NUMBER> application computational resource power drug discovery research screen molecular databases become faster less expensive approach towards scientific community worldwide okimoto et al <NUMBER> structurebased screening chemical phytochemical databases already reached new height due availability large numbers crystal target help excellent algorithms pharmacoinformatics tools molecular docking predict almost true conformational state proteinligand complex predicts binding affinity small molecules correctly meng et al <NUMBER> current investigation conceptualized structurebased antiviral screening natural products liquorice aim obtained structurally potential inhibitors targeting crystal structure prefusion sarscov<NUMBER> spike glycoprotein nsp<NUMBER> endoribonuclease sarscov<NUMBER> expedites discovery leads treatment covid<NUMBER> initially phytochemicals screened molecular docking approach molecular dynamics md simulation study carried explore dynamic behavior molecules finally affinity small molecules checked mmpbsa molecular mechanics poissonboltzmann surface area based binding energy calculation virtual screening phytochemicals pharmacoinformatics approach become pivotal tool drug discovery research availability crystal structure protein molecules given new dimension towards structurebased screening small large chemical databases explore promising anticovid molecules set <NUMBER> reported bioactive compounds liquorice glycyrrhiza species retrieved pubchem database kim et al <NUMBER> brief names search bioactive compounds glycyrrhiza glabra documented antitumor antimicrobial antiviral immunoregulatory efficacies viz glycyrrhizinic acid cid<NUMBER> licochalcone cid<NUMBER> licochalcone b cid<NUMBER> licochalcone c cid<NUMBER> licochalcone cid<NUMBER> licochalcone e cid<NUMBER> licochalcone f cid<NUMBER> licochalcone g cid<NUMBER> glyasperin cid<NUMBER> glyasperin b cid<NUMBER> glyasperin c cid<NUMBER> glyasperin cid<NUMBER> isoliquiritinapioside cid<NUMBER> <NUMBER>methoxyphaseollidin cid<NUMBER> dehydroglyasperin c cid<NUMBER> kanzonol q cid<NUMBER> liquiritin cid<NUMBER> hedysarimcoumestan b cid<NUMBER> <NUMBER>tetrahydro<NUMBER>dimethylquinoline cid<NUMBER> <NUMBER>tetrahydro<NUMBER>methylquinoline cid<NUMBER> bode dong <NUMBER> jiang et al <NUMBER> kim <NUMBER> liu et al <NUMBER> prajapati patel <NUMBER> yang et al <NUMBER> carried pubchem database resulting <NUMBER>d structures sdf file format directly used generation input pdbqt files autodock vina <NUMBER>d format molecules downloaded transformed <NUMBER>d coordinates subsequently optimized openbabel<NUMBER> gui molecular docking simulation study performed autodock vina program trott olson <NUMBER> select binding site proteins already available information considered region around bound citric acid nsp<NUMBER> considered active site case spike glycoprotein mentioned amino acid residues range <NUMBER> <NUMBER> recombinantly expressed measures ace<NUMBER> binding using biolayer interferometry wrapp et al <NUMBER> hence coordinate ser<NUMBER> amino residue considered position grid box confine active site protein molecule grid box information obtained adt help information case pdb id <NUMBER>w<NUMBER> grid box generated around bound citric acid coordinate Ã <NUMBER> <NUMBER> <NUMBER> x zaxis respectively hand pdb id <NUMBER>vsb grid coordinate considered <NUMBER> <NUMBER> <NUMBER> <NUMBER> along x yand zaxis respectively grid box size crystal structures determined manual inspection set <NUMBER>x<NUMBER>x<NUMBER> configuration file created adding grid receptor ligand information execution molecular docking adjudge molecular docking study two standard drug molecules lopinavir rivabirin cao et al <NUMBER> considered control molecules throughout study recent past number findings reported efficacy lopinavir protease inhibitor ribavirin nucleoside analogue suppressing shedding sarscov<NUMBER> hung et al <NUMBER> lim et al <NUMBER> sheahan et al <NUMBER> <NUMBER> phytochemicals along two drug molecules also prepared adding polar hydrogen gasteiger charges adt molecule saved pdbqt format autodock vina input detection set torsion angles molecular docking outcomes analyzed based binding energy binding interactions profile highest binding energy among drugs used threshold select best phytochemicals receptors binding interactions ligands receptor assessed proteinligand interaction profile plip salentin et al <NUMBER> molecular dynamics md simulation study one crucial effective tools explore dynamic nature proteinligand complex relative stability highest binding affinity scorer ligand respect protein ie glycyrrhizic acid spike glycoprotein glyasperin nsp<NUMBER> endoribonuclease complex respective protein selected md simulation study md simulation done gromacs<NUMBER> software tool wwwgromacsorg installed lengau chpc server cape town south africa study performed <NUMBER> ns <NUMBER>fs time step <NUMBER> atm constant pressure <NUMBER> k constant temperature generate protein topology allatoms charmm<NUMBER> force field considered study proteinligand complex system created within cubic box <NUMBER> Ã¥ center system system solvated tip<NUMBER>p water model sufficient numbers na Ã¾ cl Ã  ions added neutralize simulation system minimized system employing steepest descent algorithm <NUMBER> steps address longrange distances van der waals electrostatic interaction cutoff range set <NUMBER> <NUMBER> nm respectively swissparam tool daina et al <NUMBER> used generate ligand topology <NUMBER>ps interval trajectory information saved analysis entire system equilibrated nvt constant number particles volume temperature followed npt constant number particles pressure temperature ensemble approaches distribute solvent ions equally around proteinligand complex rootmeansquare deviation rmsd rootmeansquare fluctuation rmsf radius gyration rg calculated determine molecular complex stability terms conformation performance binding free energy determined molecular mechanics poissonboltzmann surface area mmpbsa method help gmmpbsa tool islam pillay <NUMBER> <NUMBER> theory details method given previous publication bhowmick et al <NUMBER> parida et al <NUMBER> structurebased screening one crucial approaches explore small large molecular databases find promising molecules specific target current study effort taken find antispike glycoprotein nsp<NUMBER> endoribonuclease molecules set <NUMBER> phytochemicals molecular docking md simulation studies flow diagram work given figure <NUMBER> binding site sarscov<NUMBER> spike glycoprotein considered around ser<NUMBER> already reported active site residue case nsp<NUMBER> endoribonuclease binding site selected around cocrystal ligand <NUMBER> phytochemicals along lopinavir ribavirin docked spike glycoprotein nsp<NUMBER> endoribonuclease details phytochemicals binding energies spike glycoprotein nsp<NUMBER> endoribonuclease given table s<NUMBER> supplementary file binding energy lopinavir ribavirin found Ã <NUMBER> Ã <NUMBER> kcalmol respectively docked spike glycoprotein moreover lopinavir ribavirin docked nsp<NUMBER> endoribonuclease binding energy found Ã <NUMBER> Ã <NUMBER> kcalmol respectively select best phytochemical threshold binding energy spike glycoprotein nsp<NUMBER> endoribonuclease considered Ã <NUMBER> Ã <NUMBER> kcalmol respectively table s<NUMBER> supplementary file seen cid<NUMBER> cid<NUMBER> cid<NUMBER> cid<NUMBER> satisfied criteria spike glycoprotein nsp<NUMBER> endoribonuclease moreover cid<NUMBER> cid<NUMBER> found binding energy less Ã <NUMBER> docking nsp<NUMBER> endoribonuclease hence cid<NUMBER> cid<NUMBER> cid<NUMBER> cid<NUMBER> found promising molecules enzymes addition cid<NUMBER> cid<NUMBER> found promising nsp<NUMBER> endoribonuclease twodimensional representation six promising molecules given figure <NUMBER> proposed final molecules found structurally diverse molecules consist several pharmacophoric features including hydrogen bond hb acceptor hba hb donor hbd hydrophobic hy etc might crucial potential binding interactions catalytic amino acids active site brief hbd hba features cid<NUMBER> figure <NUMBER> found crucial hydrogen bond interactions gln<NUMBER> his<NUMBER> gln<NUMBER> arg<NUMBER> hy region found important interaction ile<NUMBER> val<NUMBER> residues spike glycoprotein case nsp<NUMBER> endoribonuclease sarscov<NUMBER> hbd hba features revealed important interactions residues tyr<NUMBER> his<NUMBER> his<NUMBER> hydrophobic interactions formed residues tyr<NUMBER> likewise hbd hba aromatic ring features five compounds figure <NUMBER> found crucial interactions similar residues binding site proteins assess binding interactions molecule explored respective enzymes stability molecules inside protein explored allatoms md simulation finally binding free energy calculated mmpbsa approach binding interaction profile proposed molecules explored analyze catalytic amino acid residues responsible holding molecules inside receptor cavity spike glycoprotein nsp<NUMBER> endoribonuclease proteinligand interaction profiler plip webserver salentin et al <NUMBER> used explore twodimensional binding interactions binding mode surface view proposed phytochemicals considered drug molecules explored using pymol binding energies six proposed molecules considered drug molecules given table <NUMBER> four proposed spike glycoprotein inhibitors along lopinavir ribavirin docked spike glycoprotein binding interactions given figure <NUMBER> successful docking complex spike glycoprotein lopinavir explored found lopinavir properly positioned catalytic site assembled arg<NUMBER> asp<NUMBER> his<NUMBER> ala<NUMBER> val<NUMBER> val<NUMBER> val<NUMBER> gln<NUMBER> tyr<NUMBER> ile<NUMBER> phe<NUMBER> pro<NUMBER> amino acids binding energy Ã <NUMBER> kcalmol amine group tetrahydro pyrimidine lopinavir showed hbonding asp<NUMBER> carboxyl arg<NUMBER> amide his<NUMBER> ala<NUMBER> phenyl ring lopinavir formed pp parallel stacking his<NUMBER> triazole nitrogen ribavirin showed hbonding his<NUMBER> hydroxymethyl group tetrahydrofuran glu<NUMBER> ser<NUMBER> hydroxyl group tetrahydrofuran ala<NUMBER> amino acid binding energy Ã <NUMBER> kcalmol triazole ring ribavirin formed pp perpendicular stacking his<NUMBER> docking study sarscov<NUMBER> spike glycoprotein revealed glycyrrhizic acid cid<NUMBER> exhibited best binding mode among ligand standard drugs properly positioned binding pocket spike glycoprotein constructed his<NUMBER> glu<NUMBER> arg<NUMBER> gln<NUMBER> gln<NUMBER> val<NUMBER> tyr<NUMBER> thr<NUMBER> ile<NUMBER> asn<NUMBER> amino acids binding energy Ã <NUMBER> kcalmol glycyrrhizic acid two oxane tetrahydropyran ring substituted five hydroxyl two carboxyl groups buried properly binding pocket s<NUMBER> subunit showed hbonding his<NUMBER> glu<NUMBER> arg<NUMBER> gln<NUMBER> val<NUMBER> three pcation interaction his<NUMBER> also <NUMBER> methyl groups provide proper grip hydrophobic pockets equal distribution polar ie <NUMBER> oh <NUMBER> cooh group nonpolar ie <NUMBER> methyl group provide good balance hydrophilicity hydrophobicity cid<NUMBER> figure <NUMBER> hydroxyl group chromenone ring glyasperin cid<NUMBER> showed hbonding val<NUMBER> val<NUMBER> carboxy chromenone ring gln<NUMBER> hydroxyl groups phenyl ring glu<NUMBER> amino acid residue binding energy Ã <NUMBER> kcalmol cid<NUMBER> figure <NUMBER> liquiritin cid<NUMBER> chromenone ring substituted hydroxyl group showed hbonding gln<NUMBER> carboxyl group chromenone ring val<NUMBER> hydroxyl group oxane moiety cys<NUMBER> his<NUMBER> amino acid residues binding energy Ã <NUMBER> kcalmol cid<NUMBER> figure <NUMBER> phenyl ring substituted hydroxyl group showed hbonding gln<NUMBER> val<NUMBER> hydroxyl group oxane ring glu<NUMBER> his<NUMBER> hydroxyl group furan ring glu<NUMBER> carboxyl group isoliquiritinapioside cid<NUMBER> showed hbonding val<NUMBER> amino acid residue binding energy Ã <NUMBER> kcalmol cid<NUMBER> figure <NUMBER> observations explained proposed molecules spike glycoprotein hold similar better binding interactions comparison lopinavir ribavirin binding mode threedimensional space molecules extracted given figure <NUMBER> seen molecules perfectly fitted inside receptor cavity spike glycoprotein important amino residues involvement binding interactions spike glycoprotein inhibitors given table <NUMBER> best six phytochemicals found virtual screening docked nsp<NUMBER> endoribonuclease binding energy given table <NUMBER> important amino acids found binding interaction formation proposed molecules given table <NUMBER> standard lopinavir ribavirin docked binding energy found Ã <NUMBER> Ã <NUMBER> kcal mol respectively lopinavir properly positioned catalytic site constructed his<NUMBER> thr<NUMBER> glu<NUMBER> tyr<NUMBER> trp<NUMBER> lys<NUMBER> amino acids binding energy Ã <NUMBER> kcalmol pyrimidine lopinavir showed hbonding glu<NUMBER> carboxyl his<NUMBER> thr<NUMBER> phenyl ring lopinavir formed pp parallel stacking trp<NUMBER> pp perpendicular stacking tyr<NUMBER> figure <NUMBER> ribavirin found interact binding pocket binding energy Ã <NUMBER> kcalmol figure <NUMBER> simulation study crystal structure nsp<NUMBER> endoribonuclease revealed glyasperin cid<NUMBER> chromenone ring substituted three hydroxyl <NUMBER>methylbut<NUMBER>enyl group phenyl ring substituted hydroxyl <NUMBER>methylbut<NUMBER>enyl group showed hbonding tyr<NUMBER> lys<NUMBER> leu<NUMBER> asn<NUMBER> lys<NUMBER> binding energy Ã <NUMBER> kcalmol figure <NUMBER> glyasperin showed highest stable binding mode ie lowest binding energy among docked test ligand standard drug lopinavir ribavirin glyasperin b c <NUMBER> <NUMBER>dihydroxy phenyl ring attached chromen ring glyasperin one hydroxy phenyl substituted <NUMBER>methylbut<NUMBER>enyl group <NUMBER>rd position showed additional hydrophobic interaction phe<NUMBER> val<NUMBER> due glyasperin exhibited better binding affinity isoliquiritinapioside cid<NUMBER> furan ring substituted hydroxyl group showed hbonding glu<NUMBER> asp<NUMBER> ser<NUMBER> showed p stacking hydrophobic interaction isoliquiritinapioside figure <NUMBER> Ã <NUMBER> kcalmol hydroxyl group chromenone ring liquiritin cid<NUMBER> showed hbonding leu<NUMBER> asn<NUMBER> leu<NUMBER> lys<NUMBER> gln<NUMBER> two pcation interactions lys<NUMBER> his<NUMBER> amino acid residues Ã <NUMBER> kcalmol figure <NUMBER> hydroxyl group chromene ring dehydroglyasperin c cid<NUMBER> showed hbonding ser<NUMBER> val<NUMBER> thr<NUMBER> his<NUMBER> binding energy Ã <NUMBER> kcalmol phenyl ring dehydroglyasperin c formed pp parallel stacking tyr<NUMBER> pp perpendicular stacking trp<NUMBER> figure <NUMBER> structure dehydroglyasperin c resembled glyasperin due lack one <NUMBER>methylbut<NUMBER>enyl group phenyl ring decreases hydrophobic interaction also binding affinity protein glycyrrhizic acid cid<NUMBER> oxane ringsubstituted hydroxyl carboxyl groups exhibited hbonding ser<NUMBER> cys<NUMBER> his<NUMBER> thr<NUMBER> amino acids binding energy Ã <NUMBER> kcalmol three pcation interactions lys<NUMBER> his<NUMBER> his<NUMBER> figure <NUMBER> licochalcone showed hbonding lys<NUMBER> asn<NUMBER> gly<NUMBER> leu<NUMBER> his<NUMBER> pro<NUMBER> Ã <NUMBER> kcalmol phenyl ring formed pp parallel stacking trp<NUMBER> figure <NUMBER> isoliquiritinapioside glycyrrhizic acid oxan ring liquiritin dehydroglyasperin c chromenone ring showed good binding active site located two bsheets carries residues lys<NUMBER> tyr<NUMBER> his<NUMBER> lys<NUMBER> his<NUMBER> proposed constitute catalytic triad tyr<NUMBER> believed govern uridyl specificity moreover us patent us<NUMBER>a signifies use pyranchromenone compounds inhibiting growth replication viruses limited herpes simplex virus types <NUMBER> <NUMBER> hiv<NUMBER> hiv<NUMBER> cytomegalovirus varicella zoster virus papillomavirus feline leukaemia virus avian sarcoma viruses like hepatitis types ae rous sarcoma virus influenza virus measles rubella mumps viruses baker <NUMBER> position binding pose threedimensional space figure <NUMBER> clearly explained six molecules perfectly fitted inside receptor cavity nsp<NUMBER> endoribonuclease order check stability glycyrrhizic acidglycoprotein glyasperin ansp<NUMBER> endoribonuclease complexes allatoms md simulation time span <NUMBER> ns performed successful completion md simulation entire trajectory complex considered explore rmsd rmsf rg average maximum minimum value rmsd rmsf rg obtained entire frames given table <NUMBER> protein backbone rmsd one critical parameters obtained proteinligand complex gives overall information stability insight structural conformation dynamic states md simulation system equilibration terms stability explained rmsd analysis lower range rmsd along consistent variation throughout simulation inferred stability protein backbone hand higher rmsd high fluctuation native structure indicates comparatively low stability proteinligand complex always preferable accept protein biomolecule lower range rmsd higher deviated rmsd also acceptable might indicate protein probably undergoing large sort conformational change simulation rmsd frame complexes calculated given figure <NUMBER> average maximum minimum rmsd values complexes given table <NUMBER> average rmsd value found <NUMBER> <NUMBER>nm backbone spike glycoprotein nsp<NUMBER> endoribonuclease respectively also important note single frame glycoprotein nsp<NUMBER> endoribonuclease backbone deviated higher <NUMBER> <NUMBER> nm comparison respective native structure bound glycyrrhizic acid glyasperin respectively close inspection seen spike glycoprotein backbone bound glycyrrhizic acid fluctuated beginning <NUMBER> ns afterwards equilibrated end simulation similar pattern also observed case nsp<NUMBER> endoribonuclease backbone bound glyasperin observation clearly explained stability proteinligand complexes allatoms md simulation individual amino residue proteinligand complex plays critical role complex stability fluctuation amino residues inferred rmsf parameter explains average deviation amino residue time reference position precisely said analyzes specific part protein structure fluctuating mean structure amino acid group amino acids high rmsf value indicate greater flexibility attained complex whereas lower rmsf indicates lesser flexibility complex rmsf individual amino residues glycoprotein nsp<NUMBER> endoribonuclease bound glycyrrhizic acid glyasperin given figure <NUMBER> average maximum minimum rmsf values given table <NUMBER> average rmsf found <NUMBER> <NUMBER> nm spike glycoprotein nsp<NUMBER> endoribonuclease respectively case spike glycoprotein bound glycyrrhizic amino acids found consistent except range <NUMBER> <NUMBER> fluctuation amino acids might due lack interand intramolecular binding interactions hand rmsf plot amino acids belongs nsp <NUMBER> endoribonuclease bound glyasperin found consistent due free end proteins end amino acid found fluctuate highest comparison others compactness rigidity proteinligand complexes assessed rg parameter obtained md simulation trajectory defined massweighted rootmeansquare distance collection atoms common center mass baig et al <NUMBER> therefore overall dimensions alteration macromolecular structure md simulation explored rg parameter rg values frame complexes calculated plotted time simulation given figure <NUMBER> moreover explore details average maximum minimum rg values calculated showed table <NUMBER> rg value varied <NUMBER> <NUMBER> nm <NUMBER> <NUMBER> nm spike glycoprotein nsp<NUMBER> endoribonuclease respectively rg parameter spike glycoprotein system bound glycyrrhizic acid gradually decreasing <NUMBER> nm finally equilibrated around <NUMBER> nm case nsp<NUMBER> endoribonuclease bound glyasperin rg consistent throughout simulation except fluctuations around <NUMBER> ns hence trend rg plot time simulation low fluctuation undoubtedly explain residual backbone folding spike glycoprotein nsp<NUMBER> endoribonuclease remained consistent binding glycyrrhizic acid glyasperin respectively binding energy calculated mmpbsa approach considered accurate binding energy calculated means including molecular docking binding energy small molecule give idea affection towards macromolecule explore affinity glycyrrhizic acid glyasperin towards glycoprotein nsp<NUMBER> endoribonuclease respectively binding free energy calculated entire trajectory md simulation mmgpbsa approach higher negative binding energy explains affinity towards receptor binding free energy molecule plotted time simulation given figure <NUMBER> average minimum maximum binding energy frames also calculated given table <NUMBER> table <NUMBER> seen average binding free energy found Ã <NUMBER> kjmol Ã <NUMBER> kjmol glycyrrhizic glyasperin respectively case glycyrrhizic frames beginning md simulation found positive binding energy <NUMBER> ns frames showed high negative value new orientation conformation gained complex <NUMBER> ns might reason change binding energy molecule binding free energy glyasperin found almost constant throughout simulation single frame found positive binding free energy hence binding energy molecules suggests glycyrrhizic glyasperin possess strong affinity inhibit spike glycoprotein nsp<NUMBER> endoribonuclease respectively pharmacoinformatics approaches molecular docking md simulation studies carried explore set molecules belong natural products selected molecules including two antiviral drugs lopinavir rivabirin docked covid<NUMBER> targets spike glycoprotein nsp<NUMBER> endoribonuclease binding energies molecular docking study binding interaction explored details several crucial amino residues found interact molecules total six phytochemicals found promising compounds based comparative analysis binding interactions binding energy lopinavir ribavirin spike glycoprotein nsp<NUMBER> endoribonuclease high binding energy scored one molecule spike glycoprotein glycyrrhizic acid nsp<NUMBER> endonuclease glyasperin used md simulation complex respective target molecule many parameters calculated md simulation found molecules retained inside protein dynamic states finally binding free energy molecules calculated md simulation trajectories high negative binding free energy value molecules substantiated strong affinity towards target molecule concluded glyasperin might block nsp<NUMBER> endoribonuclease activity uridine specificity glycyrrhizic acid connect well widespread binding pocket spike glycoprotein due bulky nature moreover said glycyrrhizic acid disturbed connection virus ace<NUMBER> receptor entrylevel entry host cell glyasperin inhibits replication process virus hence proposed molecules might important molecules control covid<NUMBER> subjected experimental validation covid<NUMBER> pandemic situation tremendously turned entire world place horrible death tragedy sarscov<NUMBER> initially named <NUMBER> novel coronavirus <NUMBER>ncov world health organization causative agent recent serious respiratory complications resulting covid<NUMBER> pandemic <NUMBER> <NUMBER> <NUMBER> <NUMBER> though symptoms covid<NUMBER> infection appear incubation period approximately <NUMBER> days period onset covid<NUMBER> symptoms death ranged <NUMBER> <NUMBER> days median <NUMBER> days <NUMBER> <NUMBER> already completed world tour around <NUMBER> countries experiencing deadly scene occurred covid<NUMBER> including <NUMBER> <NUMBER> infected patients <NUMBER> <NUMBER> global death cases till <NUMBER>th may <NUMBER> <NUMBER> scientific community racing explore effective remedy severe health complications till date potential therapeutics approved clinical use <NUMBER> key proteins sarscov<NUMBER> could targeted vaccine drug surface <NUMBER> similar sars mers nonstructural proteins eg <NUMBER>chymotrypsinlike protease coronavirus main protease papainlike protease helicase rnadependent rna polymerase structural proteins eg spike glycoprotein accessory proteins investigated genome sarscov<NUMBER> nonstructural proteins constitute twothirds entire genome <NUMBER> among structural proteins nucleocapsid n protein prerequisite rna genome assembly membrane envelope e proteins associated viral assembly host environment <NUMBER> moreover spike protein mainly responsible viral entry host cell spike protein considered major therapeutic target drug vaccines sarscov<NUMBER> <NUMBER> protein interaction human ace<NUMBER> interface revealed atomic level efficiency ace<NUMBER> usage found main factor coronavirus transmissibility human human <NUMBER> contrary coronavirus main protease pro <NUMBER>clike proteinase <NUMBER>clp reported ability cleave polyproteins individual polypeptides required replication transcription <NUMBER> <NUMBER>clp autocleaved initially polyproteins become mature enzyme leading translation messenger rna <NUMBER> <NUMBER>clp cleaves <NUMBER> downstream nonstructural proteins <NUMBER>clp plays vital role replication cycle virus host reported attractive target human sars virus <NUMBER> rnadependent rna polymerase key target protein sarscov<NUMBER> catalyses synthesis viral rna possibly support nonstructural proteins cofactors <NUMBER> <NUMBER> <NUMBER> computational drug repurposing method could allow immediate search potential antiviral therapy case reemergence viral infections like covid<NUMBER> pandemic situation <NUMBER> <NUMBER> <NUMBER> computational drug repurposing already used identify promising drug candidates virus associated diseases like dengue ebola zika influenza infections <NUMBER> <NUMBER> importantly sarscov<NUMBER> shown evolutionary convergent relations sarscov merscov drug repurposing methods also applied sarscov merscov <NUMBER> <NUMBER> <NUMBER> hence extensive silico studies performed identify potential drug candidates example prulifloxacin bictegravir nelfinavir tegobuvi identified repurposing candidates covid<NUMBER> looking drugs high binding capacity sarscov main protease <NUMBER> nelfinavir hiv<NUMBER> protease inhibitor also predicted potential inhibitor covid<NUMBER> main protease another computationalbased study <NUMBER> however secondary metabolites plant origin found show effective defence mechanism different deadly pathogens widely used conventional remedy treat wide range human diseases since ancient period human civilization <NUMBER> <NUMBER> <NUMBER> pandemic situation researchers trying find effective solution covid<NUMBER> plant metabolites could promising wings screening potential drug candidates even plant secondary metabolites already reported effective coronaviruses <NUMBER> <NUMBER> present study total <NUMBER> plant based drug compound screened check potentiality blocking three important key proteins sarscov<NUMBER> main protease proteins rnadependent rna polymerase spike protein sarscov<NUMBER> employed molecular docking study repurposed drug candidates plant origin find better drug option towards covid<NUMBER> pandemic protein acquisition potential natural therapeutics pdb structures sarscov<NUMBER> main protease proteins <NUMBER>lu<NUMBER> <NUMBER>y<NUMBER>e rnadependent rna polymerase <NUMBER>m<NUMBER> spike protein <NUMBER>vyb retrieved rcsb protein data bank <NUMBER> moreover total <NUMBER> plant based drugs collected pubchem database supplementary table <NUMBER> alphaketoamide cid <NUMBER> also retrieved pubchem database database httpspubchemncbinlmnihgov ncbi <NUMBER> molecular docking effective approach screening potential therapeutics specific drugtargets deadly pathogens <NUMBER> <NUMBER> crystal structure retrieved sarscov<NUMBER> proteins complexed inhibitors refined pymol v<NUMBER> software <NUMBER> unwanted molecules ie water ions inhibitors removed viral retrieved viral protein employed molecular docking experiment <NUMBER> natural therapeutics autodock vina software <NUMBER> analyse binding affinity interactive amino acids alphaketoamide inhibitor sarscov<NUMBER> main protease protein used positive control study <NUMBER> also docked target proteins sarscov<NUMBER> default parameters grid box set <NUMBER> aÂ° x <NUMBER> aÂ° x <NUMBER> aÂ° x z center <NUMBER> aÂ° x <NUMBER> aÂ° x <NUMBER> aÂ° x z perform action moreover <NUMBER>d ligandprotein interaction diagrams generated ligplot find involved amino acids interactive position identified docked complexes <NUMBER> ligand molecules interactions viral proteins visualize analyzed discovery studio <NUMBER> pymol v<NUMBER> software <NUMBER> drug surface hotspot sarscov<NUMBER> proteins identified analysing docked structures protein top natural therapeutics ligplot pymol v<NUMBER> discovery studio software binding patterns azobechalcone rifampin isolophirachalcone tetrandrine fangchinoline sarscov<NUMBER> proteins results allowed comparative structural analysis screened natural therapeutics furthermore interactions alphaketoamide studied proteins also investigated adme absorption distribution metabolism excretion properties top drug candidates analysed swissadme server <NUMBER> pharmacokinetics druglikeness property medicinal chemistry assessed <NUMBER> default parameters used evaluate various physiochemical parameters molar refractivity molecular weight tpsa lipophilicity log pow wlogp log pow mlogp log pow xlogp<NUMBER> log pow silicosit log pow ilogp consensus log pow pharmacokinetics parameters log kp skin permeation water solubility probable drug candidates <NUMBER> inhibition effects natural therapeutics different cytochromes p<NUMBER>s cyp<NUMBER>c<NUMBER> cyp<NUMBER>c<NUMBER> cyp<NUMBER>a<NUMBER> cyp<NUMBER>a<NUMBER> cyp<NUMBER>d<NUMBER> also studied addition admetsar osiris property explorer employed evaluate toxic undesired effects ie mutagenicity tumerogenecity compounds <NUMBER> <NUMBER> <NUMBER> retrieved natural therapeutics employed molecular docking mpp rdrp spike protein sarscov<NUMBER> supplementary table <NUMBER> scoring function autodock vina utilized predict interaction ligands therapeutics proteins top five inhibitors protein identified based free binding energy results showed rifampin highest negative binding energy <NUMBER> kcalmol among top mpp inhibitors table <NUMBER> azobechalcone <NUMBER> kcalmol isolophirachalcone <NUMBER> kcalmol amentoflavone <NUMBER> kcalmol cepharanthine <NUMBER> kcalmol docked mpp sarscov<NUMBER> also exhibited topmost place higher negative binding energy <NUMBER> kcalmol well table <NUMBER> interacting rdrp sarscov<NUMBER> negative binding energy scored azobechalcone <NUMBER> kcal mol following rifampin <NUMBER> kcalmol tetrandrine <NUMBER> kcalmol biflavone <NUMBER> kcalmol biflavone <NUMBER> kcalmol table <NUMBER> moreover azobechalcone rifampin isolophirachalcone fangchinoline tetrandrine found top natural inhibitors spike protein sarscov<NUMBER> azobechalcone required lowest energy <NUMBER> kcalmol interact spike protein rifampin isolophirachalcone fangchinoline tetrandrine scored <NUMBER> kcalmol <NUMBER> kcalmol <NUMBER> kcalmol <NUMBER> kcalmol respectively table <NUMBER> however azobechalcone rifampin isolophirachalcone tetrandrine fangchinoline found effective inhibitory natural compounds docking results compared three sarscov<NUMBER> proteins figure <NUMBER> table <NUMBER> plant based natural inhibitors required minimum energy <NUMBER> kcalmol interact studied protein molecules docking pattern interacting amino acid residues respective position analyzed unravel binding sites studied sarscov<NUMBER> proteins rifampin involved amino acid h<NUMBER> n<NUMBER> s<NUMBER> c<NUMBER> h<NUMBER> m<NUMBER> e<NUMBER> d<NUMBER> r<NUMBER> q<NUMBER> mpp sarscov<NUMBER> figure <NUMBER> position h<NUMBER> c<NUMBER> m<NUMBER> also crucial binding amentoflavone however additional residue t<NUMBER> involved case isolophirachalcone table <NUMBER> p<NUMBER> d<NUMBER> t<NUMBER> p<NUMBER> f<NUMBER> f<NUMBER> also critical binding pattern rifampin sarscov<NUMBER> spike protein potent mpp rdrp spike protein inhibitors azobechalcone rifampin isolophirachalcone tetrandrine fangchinoline investigated spheres physicochemical parameters lipophilicity pharmacokinetics water solubility table <NUMBER> lipophilicity partition coefficient noctanol water log pow also calculated using five widely available predictive models xlogp<NUMBER> wlogp mlogp silicosit ilogp gi absorption lower drug candidates azobechalcone rifampin isolophirachalcone tetrandrine fangchinoline molecules repressive action p<NUMBER> cyp isoforms cyp<NUMBER>a<NUMBER> cyp<NUMBER>c<NUMBER> cyp<NUMBER>c<NUMBER> cyp<NUMBER>d<NUMBER> cyp<NUMBER>a<NUMBER> moreover permeant bbb exists among protein inhibitors mpp rdrp spike compounds sowed water solubility moderate high level ie <NUMBER>e<NUMBER> mgml <NUMBER>e<NUMBER> mgml <NUMBER>e<NUMBER> mgml <NUMBER>e <NUMBER> mgml <NUMBER>e<NUMBER> mgml respectively table <NUMBER> toxicity analysis inhibitors showed carcinogenic effect organ toxicity however rifampin tetrandrine fangchinoline slightly positive terms mutagenesis though azobechalcone isolophirachalcone inhibitors completely negative among top five inhibitors azobechalcone listed acute oral toxicity category <NUMBER> rest listed category <NUMBER> global pandemic caused sarscov<NUMBER> become major concern due excessive infection rate lethality <NUMBER> <NUMBER> <NUMBER> <NUMBER> despite huge research regarding pathogen drugs vaccine proven satisfactory combat infections caused sarscov<NUMBER> <NUMBER> <NUMBER> several investigational drugs exist however none could treat patients unquestionably moreover lack rapid detection procedures made sarscov<NUMBER> diagnosis troublesome <NUMBER> computational approach drug repurposing strategies hold promise face challenges caused sarscov<NUMBER> hence present study attempts taken suggest probable drug candidates checking efficacy natural inhibitors inhibit key proteins sarscov<NUMBER> race covid<NUMBER> pandemic allowed drug repurposing virtual finding drugs could used treatment covid<NUMBER> recent studies prioritized mpp inhibitors sarscov<NUMBER> ie alphaketoamide hydroxy remdesivir chloroquine favipiravir evaluate potency drug <NUMBER> <NUMBER> <NUMBER> several silico approach also adopted screen putative drug candidates sarscov<NUMBER> <NUMBER> <NUMBER> however experiments used either main protease proteins rnadependent rna polymerase sarscov<NUMBER> probable drug targets study screened potential natural therapeutics sarscov<NUMBER> mpp rdrp spike protein molecular docking approach rifampin azobechalcone azobechalcone determined top drug candidates interacted sarscov<NUMBER> mpp rdrp spike protein lowest negative binding energy highest negative binding energy <NUMBER> kcalmol <NUMBER> kcal mol <NUMBER> kcalmol respectively however comparative analysis revealed superiority <NUMBER> drug candidates ie azobechalcone rifampin isolophirachalcone tetrandrine fangchinoline sarscov<NUMBER> table <NUMBER> common drug surface hotspots analyzed along modeling pharmacophore important step drug discovery three amino acid residues ie h<NUMBER> c<NUMBER> m<NUMBER> played crucial role interaction mpp inhibitors ie rifampin amentoflavone cepharanthine table <NUMBER> azobechalcone top scorer among rdrp inhibitors position f<NUMBER> l<NUMBER> l<NUMBER> a<NUMBER> w<NUMBER> l<NUMBER> y<NUMBER> vital binding rdrp tetrandrine biflavone fangchinoline table <NUMBER> importantly binding patterns spike protein isolophirachalcone fangchinoline tetrandrine significantly similar study revealed possibility amino acids efficiently interact drugs though requires validation wet lab trials adme analysis top drug candidates reveled undesirable consequences compounds various physicochemical parameters lipophilicity pharmacokinetics properties water solubility determined table <NUMBER> addition bbb permeant identified among top inhibitors mpp rdrp spike protein consequence association natural inhibitory drugs three key proteins cytochrome p<NUMBER> cyp suggests substantial inhibition occur however toxicity analysis revealed rifampin tetrandrine fangchinoline slightly mutagenic though possibility organ toxicity results suggest azobechalcone rifampin isolophirachalcone tetrandrine fangchinoline could option treat sarscov<NUMBER> infections however study employed various computational approaches screen potent natural therapeutics involve invivo assay currently investigational drugs sarscov<NUMBER> immense experimental evaluation therefore suggest clinical trials experimental validation findings covid<NUMBER> pandemic situation going worst condition throughout world rapid detection social distancing encouraged stage need search immediate therapeutic options effective vaccine candidates battling serious health crisis drug repurposing approaches could screened already approved drugs reusing serious causative agents causing health complications plant metabolites based repurposed drug molecules could promising options sarscov<NUMBER> present study five plantr based therapeutics azobechalcone rifampin isolophirachalcone tetrandrine fangchinoline suggested potential inhibitors main protease protein rna dependent rna polymerase spike protein sarscov<NUMBER> using molecular docking based virtual screening study study initiated window towards thinking plant based therapy covid<NUMBER> though extensive research wet lab validation needs make usable patient coronaviruses large group highly diverse enveloped positivesense singlestranded rna viruses infect many mammalian avian species currently six coronavirus strains able infect humans identified among alphacoronaviruses hcov<NUMBER>e hcovnl<NUMBER> lineage betacoronaviruses hcovoc<NUMBER> hcovhku<NUMBER> usually cause mild selflimiting upper respiratory tract infection <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus sarscov lineage b betacoronavirus identified infected <NUMBER> <NUMBER> persons including nearly <NUMBER> related deaths worldwide <NUMBER> sars pandemic <NUMBER> <NUMBER> <NUMBER> ten years later another highly pathogenic lineage c betacoronavirus named middle east respiratory syndrome coronavirus merscov emerged saudi arabia <NUMBER> <NUMBER> <NUMBER> since discovery merscov infected <NUMBER> <NUMBER> persons including <NUMBER> related deaths according data august <NUMBER> two deadly coronaviruses extensively studied epidemiology virology clinical features aspects <NUMBER> <NUMBER> <NUMBER> <NUMBER> however still approved antiviral drugs vaccines treat prevent infections sarscov merscov spike glycoprotein coronavirus envelope responsible host cell attachment receptor binding mediating host cell membrane viral membrane fusion infection synthesized precursor single polypeptide chain <NUMBER> <NUMBER> amino acids cleaved host furinlike proteases amino nterminal s<NUMBER> subunit carboxyl cterminal s<NUMBER> subunit <NUMBER> <NUMBER> s<NUMBER> subunit contains domains host cell attachment recognizing cell surface sugar molecules binding specific cellular receptors <NUMBER> <NUMBER> therefore s<NUMBER> subunit especially receptorbinding domain rbd critical determining cell tropism host range zoonotic transmission coronaviruses <NUMBER> <NUMBER> s<NUMBER> subunit contains hydrophobic fusion loop two heptad repeat regions hr<NUMBER> hr<NUMBER> suggest coiled helix structure s<NUMBER> subunit <NUMBER> previous studies suggested three monomers assemble form homotrimer spikes anchoring outmost viral envelope <NUMBER> binding rbd cellular receptors triggers conformational changes s<NUMBER> s<NUMBER> subunits leading exposure fusion loop insertion target cell membrane <NUMBER> hr<NUMBER> hr<NUMBER> regions glycoprotein trimer form sixhelix bundle fusion core bridges viral host cell membranes close apposition facilitate fusion <NUMBER> highly pathogenic sarscov merscov rbd s<NUMBER> subunit postfusion core s<NUMBER> subunit structurally functionally studied separate domains <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> previous study sarscov virions singleparticle cryoelectron microscopy cryoem reported structure glycoprotein trimers virion low resolution <NUMBER> Ã¥ <NUMBER> recently prefusion structures mouse hepatitis virus mhv human coronaviruses hku<NUMBER> hcovnl<NUMBER> glycoprotein trimers determined cryoem <NUMBER> <NUMBER> <NUMBER> Ã¥ resolutions respectively <NUMBER> <NUMBER> <NUMBER> however highresolution structures highly pathogenic sarscov merscov glycoprotein trimers still missing addition intermediate states coronavirus glycoprotein trimer also required better understanding molecular mechanisms underlying receptor binding membrane fusion report cryoem structure determination sarscov glycoprotein trimer four different conformations structural analyses revealed conformations different position one cterminal domain <NUMBER> ctd<NUMBER> functions rbd glycoprotein trimer structural comparisons indicated positional change ctd<NUMBER> switches glycoprotein trimer receptorbinding inactive active state prerequisite binding sarscov receptor ace<NUMBER> neutralization monoclonal antibodies using bactobac insect cell system expressed purified mutant sarscov glycoprotein ectodomain residue arg<NUMBER> s<NUMBER>s<NUMBER> cleavage site mutated alanine enhance sample homogeneity strep tag added cterminus facilitate purification <NUMBER> figure <NUMBER>a purified sarscov glycoprotein subjected cryoem structural analysis using fei titan krios electron microscope equipped gatan k<NUMBER> summit direct electron counting camera supplementary information figure s<NUMBER>a projected secondary structure features clearly visible <NUMBER>d classification analysis boxed particles supplementary information figure s<NUMBER>b <NUMBER>d classification refinement four major different conformational states conformations <NUMBER> determined supplementary information figure s<NUMBER>a sarscov spike overall mushroomlike shape one conformation states closely threefold symmetric whereas three conformation states show significant asymmetric features mushroom head region calculation processing performed c<NUMBER> symmetry imposed symmetric conformation <NUMBER> without symmetry imposed asymmetric conformations <NUMBER> supplementary information figures s<NUMBER> s<NUMBER> resolution final c<NUMBER> symmetric conformation <NUMBER> calculated <NUMBER> <NUMBER> particles <NUMBER> Ã¥ supplementary information figure s<NUMBER> atomic model sarscov built based c<NUMBER> symmetric density map supplementary information table s<NUMBER>a sarscov glycoprotein Î²strandrich s<NUMBER> subunit composed nterminal domain ntd residues <NUMBER> three cterminal domains ctd<NUMBER> residues <NUMBER> ctd<NUMBER> residues <NUMBER> ctd<NUMBER> residues <NUMBER> figure <NUMBER>a <NUMBER>b ctd<NUMBER> functions rbd sarscov glycoprotein specifically binds cellular receptor ace<NUMBER> <NUMBER> <NUMBER> ctd<NUMBER> immediately followed ctd<NUMBER> ctd<NUMBER> ntd connected ctd<NUMBER> long linker residues <NUMBER> figure <NUMBER>a <NUMBER>b ntds mhv hku<NUMBER> glycoproteins structurally similar adopt galectinlike Î²sandwich fold model map correlation values <NUMBER> mhv ntd <NUMBER> hku<NUMBER> ntd supplementary information figure s<NUMBER>a s<NUMBER>b fitting mhv hku<NUMBER> ntd structure corresponding sarscov glycoprotein density map gave relatively low resolution map correlation values <NUMBER> mhv ntd <NUMBER> hku<NUMBER> ntd supplementary information figure s<NUMBER>c s<NUMBER>d indicating sarscov ntd different local conformations although may still adopt galectinlike Î²sandwich fold relatively low resolution region also allow us perform ab initio model building ntd therefore two strands short Î±helix built residues <NUMBER> included atomic model figure <NUMBER>a <NUMBER>b Î±helixrich s<NUMBER> subunit begins s<NUMBER>s<NUMBER> cleavage site residue <NUMBER> figure <NUMBER>a atomic model s<NUMBER> subunit includes functionally important fusion peptide residues <NUMBER> hr<NUMBER> residues <NUMBER> figure <NUMBER>a <NUMBER>b cterminal hr<NUMBER> residues <NUMBER> <NUMBER> <NUMBER> built due relatively poor density region figure <NUMBER>a <NUMBER>b conformation <NUMBER> threefold symmetry three glycoprotein monomers intertwine around form closely packed mushroomshaped homotrimer figure <NUMBER>c <NUMBER>d triangular head trimer spike composed ntds ctd<NUMBER>s three s<NUMBER> subunits three ctd<NUMBER>s locate center triangular head arranged around <NUMBER>fold symmetry axis figure <NUMBER>c <NUMBER>d three ntds locate outside triangular head ntd interacts one ctd<NUMBER> neighboring s<NUMBER> subunit figure <NUMBER>c <NUMBER>d stem trimer spike consists core helix bundle formed long helices three s<NUMBER> subunits core helix bundle surrounded ctd<NUMBER>s ctd<NUMBER>s three s<NUMBER> subunits figure <NUMBER>c <NUMBER>d three ctd<NUMBER>s head lay cover top s<NUMBER> subunits figures <NUMBER>c <NUMBER>d <NUMBER>a observed three conformations <NUMBER> showing asymmetric features ctd<NUMBER> triangular head figure <NUMBER>b<NUMBER>d symmetric conformation <NUMBER> ctd<NUMBER>s head position covering s<NUMBER> subunits stem figure <NUMBER>a angle long axis ctd<NUMBER> projection horizontal plane perpendicular <NUMBER>fold axis <NUMBER> degree figure <NUMBER>a conformations <NUMBER> two ctd<NUMBER>s still adopt conformation conformation <NUMBER> whereas one ctd<NUMBER> rotates outward position longer covers s<NUMBER> subunit figure <NUMBER>b<NUMBER>d angles long axes ctd<NUMBER>s projections horizontal plane increased <NUMBER> <NUMBER> <NUMBER> degrees respectively figure <NUMBER>b<NUMBER>d note ntd ctd<NUMBER> around rotated ctd<NUMBER> significant conformational changes supplementary information figure s<NUMBER>a therefore rotation ctd<NUMBER> hinge motion around loops connecting ntd ctd<NUMBER> ctd<NUMBER> ctd<NUMBER> close proximity supplementary information figure s<NUMBER>b s<NUMBER>c suggesting two loops would play key roles conformational switch positions ctd<NUMBER> although position ctd<NUMBER> affected within monomer ctd<NUMBER> adopts conformation ctd<NUMBER> may become liable undergo conformational changes expose fusion loop underneath rbd sarscov glycoprotein trimer ctd<NUMBER> specifically binds cellular receptor ace<NUMBER> prerequisite host cell attachment virion subsequent membrane fusion <NUMBER> <NUMBER> superimposed previously determined ctd<NUMBER>ace<NUMBER> complex crystal structure onto one ctd<NUMBER> glycoprotein trimer figure <NUMBER>a conformation <NUMBER> ctd<NUMBER>s positions numerous steric clashes observed ace<NUMBER> neighboring ctd<NUMBER> volume steric clashes reaches <NUMBER> <NUMBER> Ã¥ <NUMBER> figure <NUMBER>b <NUMBER>c therefore sarscov glycoprotein trimer ctd<NUMBER>s positions would able bind cellular receptor ace<NUMBER> suggesting threefold symmetric conformation <NUMBER> represents receptorbinding inactive state spike contrast similar structural superimpositions showed ace<NUMBER> binds ctd<NUMBER> well without steric clashes regions glycoprotein trimer figure <NUMBER>d <NUMBER>f supplementary information figure s<NUMBER>a s<NUMBER>b suggesting spikes one ctd<NUMBER> position able bind receptor ace<NUMBER> asymmetric conformations <NUMBER> represent receptorbinding activate state spike notably position ctd<NUMBER> also exposes one covered s<NUMBER> subunits leaving space largescale conformational change s<NUMBER> subunit expose insert fusion peptide target cell membrane conformation ctd<NUMBER> also required binding neutralizing antibodies several neutralizing antibodies targeting ctd<NUMBER> m<NUMBER> <NUMBER>r f<NUMBER>g<NUMBER> shown potent inhibition activity cell infection pseudotyped live sarscov antibody binding epitopes elucidated crystal structure determination antibodyctd<NUMBER> complexes <NUMBER> <NUMBER> <NUMBER> antibodies binds receptorbinding site ctd<NUMBER> thereby directly inhibiting engagement ace<NUMBER> receptor structural superimpositions showed antibodies steric clashes regions glycoprotein trimer conformation <NUMBER> state figure <NUMBER>a <NUMBER>c contrast glycoprotein trimer conformations <NUMBER> would allow antibodies bind ctd<NUMBER> inhibit interaction ace<NUMBER> receptor figure <NUMBER>d<NUMBER>f results indicated receptorbinding inactive active state transition glycoprotein trimer required successful infections sarscov virions also efficient neutralization antibodies targeting ctd<NUMBER> known largest class viral fusion protein coronavirus glycoprotein trimer recognizes variety host cell receptors ntd ctd<NUMBER> s<NUMBER> subunit subsequently mediates viral cell membrane fusion fusion peptide two heptad repeats s<NUMBER> subunit since discoveries highly pathogenic sarscov <NUMBER> merscov <NUMBER> studies focused rbd green one monomer pink conformation <NUMBER> trimer ctd<NUMBER> conformation b binding receptor ace<NUMBER> green conformation <NUMBER> trimer three ctd<NUMBER>s conformations steric clashes neighboring ctd<NUMBER> grey ace<NUMBER> green colored blue c model trimer density map presented boundary profile bound ace<NUMBER> shown green lines better view clashes volume <NUMBER> <NUMBER> Ã¥ <NUMBER> binding receptor ace<NUMBER> green conformation <NUMBER> monomer pink ctd<NUMBER> conformation e binding receptor ace<NUMBER> green ctd<NUMBER> pink conformation <NUMBER> trimer showing steric clashes neighboring ctd<NUMBER> grey f model trimer <NUMBER>d density map presented models generated superimposing ctd<NUMBER>ace<NUMBER> complex crystal structure onto ctd<NUMBER> corresponding sarscov monomer trimer ntd models shown ntd ctd<NUMBER> s<NUMBER> subunit binds host receptors also main target neutralizing antibodies infection knowledge structures complete sarscov merscov spike trimers prefusion postfusion states still limited present study determined structure sarscov glycoprotein trimer four different conformational states recently reported cryoem structures mhv hku<NUMBER> glycoprotein trimers simi lar conformation <NUMBER> sarscov glycoprotein trimer receptorbinding inactive state three ctd<NUMBER>s s<NUMBER> subunit positions figure <NUMBER>a sarscov glycoprotein trimer conformations <NUMBER> receptorbinding active state figure <NUMBER>b<NUMBER>d one ctd<NUMBER> position observed mhv hku<NUMBER> glycoprotein trimers protein receptor hku<NUMBER> identified ntd s<NUMBER> subunit shown bind oacetylated sialic acids host cells <NUMBER> rbd mhv glycoprotein ntd s<NUMBER> subunit structural alignment revealed mhv protein receptor ceacam<NUMBER>a binds ntd glycoprotein trimer without steric clashes supplementary information figure s<NUMBER>c <NUMBER> therefore mhv hku<NUMBER> glycoprotein trimer may need prerequisite receptorbinding inactive active state transition receptor binding intrinsic receptorbinding difference among coronavirus glycoprotein trimers may one reasons previous studies able reveal conformations rather conformation <NUMBER> mhv hku<NUMBER> glycoprotein trimers nevertheless conformational change ctd<NUMBER> may still needed subsequent exposure conformational changes s<NUMBER> subunit membrane fusion infection mhv hku<NUMBER> protein receptorbinding site ctd<NUMBER> also confirmed merscov bat coronavirus hku<NUMBER> lineage c betacoronaviruses host receptor dpp<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> structural superimposition dpp<NUMBER> complexed ctd<NUMBER> merscov hku<NUMBER> onto sarscov glycoprotein trimer also showed conformation ctd<NUMBER> required binding dpp<NUMBER> two betacoronaviruses supplementary information figure s<NUMBER> therefore suggest receptorbinding inactive active state transition observed sarscov spike would also occur spikes betacoronaviruses bind host receptors ctd<NUMBER> receptorbinding inactive state three ctd<NUMBER>s positions would allow efficient binding receptors figure <NUMBER> transition one ctd<NUMBER> position would release steric clashes enable binding one receptor molecule figure <NUMBER> whether binding first receptor molecule enough binding second third receptors required trigger conformational changes s<NUMBER> s<NUMBER> subunit necessary membrane fusion interesting question future studies human codonoptimized gene coding sarscov spike glycoprotein ectodomain ncbi accession np<NUMBER> residues <NUMBER> <NUMBER> r<NUMBER>a mutation enhance sample homogeneity cterminal strep tag purification cloned inserted pfastbacdual vector invitrogen construct transformed bacterial dh<NUMBER>bac competent cell extracted bacmid transfected sf<NUMBER> cells using cellfectin ii reagent invitrogen lowtiter viruses harvested amplified generate hightiter virus stock used infect <NUMBER> l sf<NUMBER> cells density <NUMBER> Ã <NUMBER> <NUMBER> cellsml supernatant cell culture containing secreted sarscov glycoprotein harvested <NUMBER> h infection concentrated bufferexchanged binding buffer <NUMBER> mm hepes ph <NUMBER> <NUMBER> mm nacl sarscov glycoprotein captured streptactin sepharose high performance ge healthcare eluted <NUMBER> mm ddesthiobiotin binding buffer eluted protein purified gel filtration chromatography using superose <NUMBER> column ge healthcare preequilibrated hbs buffer <NUMBER> mm hepes <NUMBER> mm nacl fractions containing sarscov glycoprotein pooled concentrated electron microscopy analysis aliquots <NUMBER> Âµl purified sarscov glycoprotein applied glowdischarged holey carbon grids quantifoil cu <NUMBER> mesh r<NUMBER> grids layer continuous ultrathin carbon film withwithout glowdischarge treatment ted pella inc protein concentration <NUMBER> mgml holey carbon grids <NUMBER> mgml continuous carbon grids grids blotted plunged liquid ethane using fei vitrobot grids checked fei f<NUMBER> microscope operating <NUMBER> kv gatan <NUMBER> <NUMBER> k Ã <NUMBER> k ccd camera small data set collected generating initial model data final classification refinement collected fei titan krios microscope operating <NUMBER> kv using k<NUMBER> summit camera gatan inc superresolution mode nominal magnification <NUMBER> <NUMBER>Ã yielding calibrated pixel size <NUMBER> Ã¥ image fractionated <NUMBER> movie frames total exposure time <NUMBER> dose rate <NUMBER> counts per physical pixel per second <NUMBER> electronsÃ¥ <NUMBER> ucsfimage<NUMBER> used data collection <NUMBER> image processing procedures summarized supplementary information figure s<NUMBER>a initial map generated using program eman<NUMBER> images collected f<NUMBER> microscope <NUMBER> total <NUMBER> <NUMBER> movie stacks collected using k<NUMBER> camera movie frames aligned using program motioncorr ctf parameters determined ctffind<NUMBER> <NUMBER> <NUMBER> total <NUMBER> <NUMBER> particles manually picked <NUMBER>d classifications performed relion <NUMBER> <NUMBER> four representative class averaged images selected references automatic particle picking whole data set using relion <NUMBER> <NUMBER>d <NUMBER>d classifications refinements performed using relion <NUMBER> autopicked particles visually inspected selected several rounds referencefree <NUMBER>d classifications <NUMBER>d classification particles classes showing clear secondary structure features deleted finally yielding <NUMBER> <NUMBER> selected particles selected particles subjected initial <NUMBER>d refinement c<NUMBER> symmetry imposed followed two runs <NUMBER>d classifications total <NUMBER> <NUMBER> particles best class selected subjected <NUMBER>d autorefine final stage refinement <NUMBER> <NUMBER> particles higher loglikelicontribution value used resolution final c<NUMBER> symmetric density map <NUMBER> Ã¥ post processing relion initial <NUMBER> <NUMBER> selected particles also subjected <NUMBER>d refinements classifications without symmetry imposed central parts different classes similar classes showed obvious asymmetric features one three ctd<NUMBER> domains protruding asymmetric particles could grouped three major classes according tilt angle ctd<NUMBER> particles classes separately subjected <NUMBER>d autorefine resolutions final density maps <NUMBER> <NUMBER> <NUMBER> Ã¥ three classes handedness density maps verified docking crystal structure sarscov glycoprotein ctd<NUMBER> maps reported resolutions based goldstandard fsc <NUMBER> criterion local resolution variations estimated using resmap <NUMBER> crystal structure sarscov glycoprotein rbd ctd<NUMBER> residues <NUMBER> pdb accession code <NUMBER>d<NUMBER>g structures hku<NUMBER> glycoprotein pdb accession code <NUMBER>i<NUMBER> ctd<NUMBER> residues <NUMBER> ctd<NUMBER> residues <NUMBER> s<NUMBER> domain residues <NUMBER> initially fitted sarscov density map using ucsf chimera <NUMBER> sequence alignment sarscov fitted structures performed using dnaman lynnon corporation quebec canada clustalx <NUMBER> fitted model rebuilt using rosettacm c<NUMBER> symmetry imposed best output model selected according energy fitness model em density map <NUMBER> model ctd<NUMBER> ctd<NUMBER> s<NUMBER> region refined using rosettarelax phenix realspace refinement <NUMBER> <NUMBER> crystal structure ctd<NUMBER> domain fitted em density refined rigid body real space using phenix two models merged manually adjusted coot refined phenix reference model restrains secondary structure restrains geometry restrains <NUMBER> crossvalidation overfitting performed following procedures described <NUMBER> <NUMBER> briefly atom coordinates model including ctd<NUMBER> ctd<NUMBER> ctd<NUMBER> s<NUMBER> randomly displaced <NUMBER> Ã¥ using phenix pdb tools displaced model refined one two half maps reciprocal space using phenix fsc curves calculated refined model corresponding half map used refinement half<NUMBER> fsc work refined model half map half<NUMBER> fsc test used model refinement big gaps observed work test fsc curves supplementary information figure s<NUMBER>d indicating model overfitted molprobity used evaluate final refined model models three asymmetric conformations built fitting symmetric model sarscov density maps using ucsf chimera fitted models refined rigid bodies real space using phenix subunit ctd<NUMBER> subunit split two rigid bodies refinement including ctd<NUMBER> rest part subunit structural comparisons different density maps density maps models performed using ucsf chimera measure correlation phenix getccmtzmtz get ccmtzpdb cross correlation values listed supplementary information figure s<NUMBER>as<NUMBER>d table s<NUMBER>b sarscov rbdreceptor complex pdb accession code <NUMBER>r<NUMBER>d sarscov rbdfab complexes pdb accession code <NUMBER>ghw <NUMBER>dd<NUMBER> <NUMBER>bgf superimposed onto models sarscov rbd structure reference using match command ucsf chimera calculate angles ctd<NUMBER>s figure <NUMBER> horizontal plane perpendicular <NUMBER>fold axis long axis ctd<NUMBER> generated using ucsf chimera define command angle axis plane calculated using ucsf chimera angle command overlap volumes fitted receptor spike also calculated using ucsf chimera two atoms considered overlapped overlap score <NUMBER> overlap score defined sum two vdw van der waals radii minus distance minus allowance <NUMBER> Ã¥ potentially hydrogenbonded pairs overlap atoms used generation steric clash area volume steric clashes calculated using ucsf chimera measure volume command figures generated ucsf chimera pymol pymol molecular graphics system version <NUMBER> schrÃ¶dinger llc cryoem maps related materials deposited em data bank accession codes emd<NUMBER> emd<NUMBER> emd<NUMBER> emd<NUMBER> atomic coordinate deposited protein data bank accession code <NUMBER>wrg february <NUMBER> <NUMBER> <NUMBER> samples suspected cases referred different states travel history wuhan china sarscov<NUMBER>affected countries screened viral rna extracted ts sample using magmax rna extraction kit applied biosystems usa per manufacturers instructions extracted rna immediately used testing presence sarscov<NUMBER> using realtime rtpcr protocol published <NUMBER> detection rdrp <NUMBER> rdrp <NUMBER> e gene n gene rnase p gene used internal control analysis confirmatory laboratory tests performed per whorecommended test protocols <NUMBER> samples also sequenced using ngs approach retrieve complete genome virus total rna three positive ts specimens kerala extracted <NUMBER> Âµl sarscov<NUMBER> realtime rtpcr positive samples qiaamp viral rna extraction kit qiagen hilden germany used according manufacturers instructions extracted rna quantified using qubit rna highsensitivity kit invitrogen usa rna libraries prepared per earlierdefined protocol quantified using kapa library quantification kit kapa biosystems roche diagnostics corporation usa per manufacturers protocol individual libraries neutralized loaded miniseq platform illumina usa detailed protocols steps undertaken published earlier <NUMBER> <NUMBER> data generated machine analyzed using clc genomics workbench version <NUMBER> clc qiagen germany referencebased mapping performed retrieve sequence sarscov<NUMBER> fulllength genome sequences sarscov<NUMBER> downloaded gisaid database <NUMBER> supplementary table available httpwwwijmr orginarticles<NUMBER>imagesindianjmedres <NUMBER>sm<NUMBER>pdf multiple sequence alignment performed using mega software version <NUMBER> <NUMBER> retrieved sequences two three positive cases available gisaid sequences phylogenetic tree generated using neighbour joining method kimura<NUMBER>parameter nucleotide nt substitution model <NUMBER> bootstrap replications implemented mega software <NUMBER> per cent nucleotide divergence amino acid aa divergence calculated using pdistance method <NUMBER> mutations specific indian sarscov<NUMBER> viruses identified comparing coding regions respect sarscov<NUMBER> wuhan china wuhan hu<NUMBER> threedimensional <NUMBER>d model spike protein epitope prediction prefusion structure indian case <NUMBER> sarscov<NUMBER> spike glycoprotein modelled using swissmodel server httpsswissmodelexpasyorginteractive corresponding protein wuhanhu<NUMBER> <NUMBER>vsbpdb template <NUMBER> identity sequential linear bcell epitopes predicted using bepipred<NUMBER> server httpwwwcbsdtudkservicesbepipred abcpred prediction tool httpcrddosddnet raghavaabcpred also used identify bcell epitopes indian sarscov<NUMBER> sequence epitope prediction probability <NUMBER> set increase specificity peptide stretch overlapping epitopes predicted bepipred<NUMBER> online server abcpred prediction tool identified antigenicity shortlisted peptide sequences predicted using vaxijen online server httpwwwddgpharmfacnetvaxijen vaxijenvaxijenhtml default threshold <NUMBER> discontinuous epitopes modelled structure indian case <NUMBER> sarscov<NUMBER> spike protein predicted using online servers ellipro httptoolsiedborgellipro discotope <NUMBER> httptoolsiedborgdiscotope integrated immune epitope database ellipro predicts epitopes based protusion index pi wherein protein shape approximated ellipsoid ref ellipro discotope ellipsoid pi value <NUMBER> indicates <NUMBER> per cent residues within ellipsoid <NUMBER> per cent outside residues outside <NUMBER> per cent ellipsoid score <NUMBER> residues larger scores associated greater solvent accessibility pi value set score <NUMBER> discotope predicts epitopes using <NUMBER>d structure halfsphere exposure surface measure novel spatial neighbourhood definition method default values set sensitivity <NUMBER> specificity <NUMBER> selecting amino acids forming discontinuous epitopes sensitivity <NUMBER> means <NUMBER> per cent epitope residues predicted part epitopes specificity <NUMBER> means <NUMBER> per cent nonepitope residues predicted part epitopes outputs methods combined final regions mapped modelled <NUMBER>dstructure probable conformational epitopes addition also predicted nlinked glycosylation sites protein using netnglyc <NUMBER> server httpwwwcbs dtudkservicesnetnglyc spike proteins also screened presence potential epitopes presented major histocompatibility complex mhc class molecules cytotoxic lymphocytes ctls online netctl<NUMBER> server httpwwwcbsdtu dkservicesnetctl based machine learning techniques artificial neural network ann support vector machine svm used predict tcell epitopes prediction made human leucocyte antigen hla supertypes available human alleles c terminal cleavage weight transportassociated protein tap efficiency threshold identification kept default vaxijen v<NUMBER> tool used predict antigenicity predicted epitopes httpwwwddgpharmfac netvaxijenvaxijenvaxijenhtml sequences screened potential epitopes using ctlpred online server httpcrddosddnetraghava ctlpred ability predicted linear bcell tcell epitopes mount interferongamma ifnÎ³ response assessed using ifnepitope httpcrddosddnetraghavaifnepitopeindexphp detection sarscov<NUMBER> suspected samples three <NUMBER> tsnasal swab ns specimens suspected cases tested positive sarscov<NUMBER> using realtime rtpcr specific e gene rdrp <NUMBER> rdrp <NUMBER> n gene ct value e gene ranged <NUMBER> <NUMBER> tsns specimens detailed ct values realtime rtpcrs specific abovementioned genes positive specimens given table blood samples found negative sarscov<NUMBER> case <NUMBER> travelled wuhan china reached india january <NUMBER> <NUMBER> travelled final destination kerala january <NUMBER> individual developed cough january <NUMBER> experienced sore throat mild fever admitted general hospital thrissur kerala second case travelled wuhan close contact case <NUMBER> travel final destination india case <NUMBER> developed similar symptoms along fever diarrhoea january <NUMBER> collected ts specimens referred icmrniv january <NUMBER> second case hospitalized january <NUMBER> medical college alappuzha kerala clinical sample ts collected january <NUMBER> <NUMBER> case <NUMBER> travelled china india developed runny nose january <NUMBER> admitted general hospital kasaragod kerala january <NUMBER> <NUMBER> ts specimens collected january <NUMBER> <NUMBER> ngs sarscov<NUMBER> india phylogenetic analysis molecular characterization ngs analysis ts specimens retrieved two complete genome sequences case <NUMBER> case <NUMBER> complete genomic sequence data case <NUMBER> could recovered due lower kappa concentration sample hence included study analysis fastq files reference mapped available wuhan seafood pneumonia virus wuhan hu<NUMBER> complete sarscov<NUMBER> genome accession number nc <NUMBER> total reads mapped percentage genome recovered two cases summarized table analysis complete genome sequences sarscov<NUMBER> positive cases india revealed percentage nt aa differences case <NUMBER> case <NUMBER> <NUMBER> <NUMBER> per cent respectively sequences case <NUMBER> case <NUMBER> diverged wuhanhu<NUMBER> sequence <NUMBER> per cent nt <NUMBER> per cent aa respectively indian sarscov<NUMBER> clustered sarbecovirus subgenus betacoronavirus genus closest batcov ratg<NUMBER> sequence <NUMBER> nt <NUMBER> phylogenetic comparison showed clustering genome sequences case <NUMBER> case <NUMBER> existing sequences sarscov<NUMBER> sequences fig <NUMBER> phylogeny revealed emerging heterogeneity within sarscov<NUMBER> sequences globally indian sarscov<NUMBER> viruses positioned different clusters indian sarscov<NUMBER> sequences showed two changes <NUMBER> argâile <NUMBER> alaâval spike protein compared wuhan hu<NUMBER> sequence mutations mapped spike protein model indian sequence supplementary fig <NUMBER> available httpwwwijmrorginarticles<NUMBER>images indianjmedres<NUMBER>sm<NUMBER>pdf deletion threenucleotide stretch encoding tyrosine residue position <NUMBER> spike gene also observed indian sarscov<NUMBER> case <NUMBER> compared sarscov<NUMBER> sequences noted earlier sarscov<NUMBER> sequences indian sequences possessed polybasic cleavage site rrar spike protein junction s<NUMBER> s<NUMBER> two subunits spike protein <NUMBER> epitope predictions thirty one linear bcell epitopes predicted bepipred indian sarscov<NUMBER> three found length <NUMBER> amino acids hence considered linear epitopes also predicted using abcpred prediction tool predicted <NUMBER> epitopes based threshold <NUMBER> regions common prediction methods n<NUMBER> identified manually <NUMBER> epitopes screened antigenicity using vaxijen v<NUMBER> tool httpwwwddgpharmfac netvaxijenvaxijenvaxijenhtml nine epitopes shortlisted epitopes screened ability elicit ifnÎ³ response predicted using ifnepitope tool finally five epitopes four s<NUMBER> domain one s<NUMBER> domain predicted could possibly generate immune response suppress ifnÎ³ response table ii nlinked glycosylation site prediction revealed two putative glycosylation sites low value jury agreement present within epitope stretch <NUMBER> discontinuous epitopes spike protein indian sarscov<NUMBER> identified using multiple methods ellipro discotope conformational epitopes based methods mapped prefusion structure modelled indian sarscov<NUMBER> spike protein newly released structure sarscov<NUMBER> spike protein used template modelling indian spike protein ramachandran plot statistics revealed <NUMBER> per cent residues core region <NUMBER> per cent additionally allowed region <NUMBER> per cent disallowed region four epitopes predicted ellipro based pi threshold <NUMBER> supplementary table ii mapped conformational epitopes depicted figure <NUMBER> purpose comparison indian protein sequence also modelled using prefusion structure sarscov<NUMBER> <NUMBER>accpdb <NUMBER> identity results conformational epitopes predicted supplementary tcell epitope prediction revealed <NUMBER> strong binding epitopes capable binding different hla types using netctl<NUMBER> software based threshold <NUMBER> twelve shortlisted considering binding efficiency <NUMBER> nm capable eliciting ifnÎ³ response table iii till february <NUMBER> <NUMBER> three positive cases sarscov<NUMBER> reported india <NUMBER> suspected cases tested icmrniv pune three cases travel history wuhan china january <NUMBER> although ngs performed specimens three positive cases complete genome sequence could retrieved case <NUMBER> case <NUMBER> three cases recovered hospitalization home quarantined per guidelines ministry health family welfare government india <NUMBER> epitopes predicted using combination bepipred server abcpred prediction server antigenicity predicted using vaxijen v<NUMBER> tool ifnÎ³ response predicted using infepitope server values bracket show prediction score given software threshold <NUMBER> nm used increased specificity prediction peptides reconfirmed using ctlpred server using default parameters peptides classified epitopes checked antigenicity score using vaxijen v<NUMBER> tool yadav et al low viral copy number ts specimen case <NUMBER> could possible reason lesser viral reads retrieved ngs run leading fragmented genome recent study china serial samples tss sputum urine stool two patients followed days <NUMBER> days <NUMBER> post onset <NUMBER> n genespecific realtime rtpcr assay showed viral loads ts sputum samples peaked around <NUMBER> days symptom onset ranging around <NUMBER> <NUMBER> <NUMBER> <NUMBER> copies per ml time <NUMBER> another study virus detected saliva specimens <NUMBER> <NUMBER> patients serial saliva testing showed declines viral rna levels <NUMBER> two indian sarscov<NUMBER> sequences found nonidentical <NUMBER> nt divergence result phylogenetic analysis indicated two different introductions country recent study using <NUMBER> published genbank sequences showed evidence substantial genetic heterogeneity estimated time recent common ancestor december <NUMBER> <NUMBER> <NUMBER> confidence interval november <NUMBER> december <NUMBER> <NUMBER> <NUMBER> continuous monitoring analysis sequences affected countries would vital understand genetic evolution rates substitution sarscov<NUMBER> comparison amino acid sequences nonstructural nsp<NUMBER>nsp<NUMBER> structural polyproteins undertaken reference wuhanhu<NUMBER> strain molecular characterization human betacoronaviruses including hcovhku<NUMBER> lineage polybasic cleavage site well predicted olinked glycans near s<NUMBER>s<NUMBER> cleavage site spike protein published recently polybasic cleavage site previously observed related lineage b betacoronaviruses unique feature sarscov<NUMBER> noted indian sarscov<NUMBER> mutation arg<NUMBER>ile spike protein one indian sequences noted rbd ala<NUMBER>val located s<NUMBER> domain however away ace<NUMBER> receptorbinding interface <NUMBER> <NUMBER> mutations spike protein sequences sarscov<NUMBER> observed currently localized s<NUMBER> s<NUMBER> domains far found ace<NUMBER>binding interface alignment spike protein sequences sars cov<NUMBER> sarscov<NUMBER> wuhanhu<NUMBER> india observed three nucleotidedeletion case <NUMBER> sarscov<NUMBER> india located close insert <NUMBER> region sars cov<NUMBER> supplementary fig <NUMBER> available httpwwwijmrorginarticles<NUMBER>images indianjmedres<NUMBER>sm<NUMBER>pd f notably case <NUMBER> case <NUMBER> close contact travelling india due absence complete genome case <NUMBER> genetic relatedness source infection could pinpointed among sarscov structural proteins spike protein found elicit neutralizing antibodies <NUMBER> study observed five bcell linear epitopes predicted four epitopes present s<NUMBER> domain one s<NUMBER> domain prediction conformational bcell epitopes revealed one residue positions <NUMBER> spike protein incorporates two predicted linear epitopes <NUMBER> <NUMBER> good antigenicity along favourable ifnÎ³ response enables differentiation proliferation bcells <NUMBER> notably equivalent epitope <NUMBER> predicted model generated using sarscov<NUMBER> protein template cases epitope lies within rbd <NUMBER> although epitope two putative nlinked glycosylation sites within positions <NUMBER> <NUMBER> probability sites actually glycosylated low major immunodominant epitope reported sarscov residues <NUMBER> <NUMBER> <NUMBER> hence predicted bcell conformational epitope identified present study may play important role initiating bcell response among five linear epitopes predicted study epitopes <NUMBER> <NUMBER> conserved sarscov<NUMBER> sarscov<NUMBER> epitopes <NUMBER> <NUMBER> <NUMBER> found variations spike protein sarscov also reported immunogenic elicit high ifnÎ³specific tcell response <NUMBER> prediction results study revealed nine possible ctl epitopes possessing good antigenicity inducing ifnÎ³ response present protein recent report <NUMBER> also predicted tcell epitopes protein based similar annsvm method antigenicity score although ifnÎ³ response considered authors noted two predictions found common among tcell epitopes predicted present study four epitopes <NUMBER> <NUMBER> s<NUMBER> domain <NUMBER> <NUMBER> s<NUMBER> domain found good ctl prediction scores broad hla allele coverage b supertypes hla supertypes predominant indian population predicted epitopes may considered suitable future experiments towards vaccine design conclude prompt intervention government india health authorities state kerala ensured said cases become secondary foci transmission timely identification sarscov<NUMBER> suspected cases icmrniv pune helped isolation patients containment enhanced surveillances virus restricted movement availability genomic sequences identified cases contribute public repositories help towards development diagnostics vaccines antivirals sequence data would also help tracking virus origin evolution transmission time monitoring mutation dynamics sarscov<NUMBER> critical development effective approaches contain <NUMBER> pathogen analyzing <NUMBER> sarscov<NUMBER> <NUMBER> sars genome sequences provided direct genetic evidence <NUMBER> sarscov<NUMBER> much lower mutation rate sars minimum evolution phylogeny analysis revealed putative <NUMBER> original status sarscov<NUMBER> earlystage spread history discrepant phylogenies spike protein <NUMBER> receptor binding domain proved previously reported structural rearrangement prior emergence sars despite found spike glycoprotein sarscov<NUMBER> particularly conserved identified mutation <NUMBER> leads weaker receptor binding capability concerns sarscov<NUMBER> sample collected <NUMBER> th january <NUMBER> <NUMBER> india represents first report significant sarscov<NUMBER> mutant raises alarm ongoing vaccine <NUMBER> development may become futile future epidemic mutations identified <NUMBER> <NUMBER> evolutionary rate assessment <NUMBER> ratio nonsynonymous mutations dn synonymous mutations ds calculated using codeml paml <NUMBER> version <NUMBER> package <NUMBER> cds sequences protein encoding gene filtered remove redundant identical <NUMBER> sequences codonbased cds sequence alignment performed using muscle program individual nj <NUMBER> tree generated using mega<NUMBER> <NUMBER> pdistance model obtained sequence alignment phylogenetic tree <NUMBER> files used paml inputs dn ds calculations <NUMBER> protein structural analyses <NUMBER> <NUMBER>d structure sarscov<NUMBER> spike glycoprotein complex pdb <NUMBER>vw<NUMBER> <NUMBER>vw<NUMBER> determined recently <NUMBER> <NUMBER> <NUMBER> genetic diversity analyses identified single amino acid mutation rbd spike protein sarscov<NUMBER> <NUMBER> <NUMBER> th march <NUMBER> total <NUMBER> nucleotide sequences sarscov<NUMBER> ncbi database restricting <NUMBER> complete nearcomplete genomes <NUMBER> sequences <NUMBER> countries obtained used analyses <NUMBER> encompasses <NUMBER> records usa <NUMBER> china rest countries australia <NUMBER> brazil <NUMBER> finland <NUMBER> <NUMBER> india <NUMBER> italy <NUMBER> nepal <NUMBER> spain <NUMBER> south korea <NUMBER> sweden <NUMBER> <NUMBER> based gene model reference sarscov<NUMBER> genome genebank nc<NUMBER> total <NUMBER> proteinencoding <NUMBER> open reading frames orfs plus <NUMBER>utr <NUMBER>utr annotated figure <NUMBER>a overall gene sequences <NUMBER> different samples highly homologous sharing <NUMBER> identity exception <NUMBER>utr <NUMBER> <NUMBER>utr <NUMBER> table <NUMBER> relatively divergent sequence alignment showed mutation orf<NUMBER> orf<NUMBER>a <NUMBER> orf<NUMBER>b genetic diversity profile across <NUMBER> genomes displayed figure <NUMBER>a nucleotide sites <NUMBER> within orf<NUMBER>a orf<NUMBER>b orf<NUMBER>a orf<NUMBER> exhibiting high genetic diversity identified figure <NUMBER>a <NUMBER> protein critical virus infection vaccine development shown figure assess mutation rate genetic diversity sarscov<NUMBER> ratio nonsynonymous mutations dn <NUMBER> synonymous mutations ds calculated proteinencoding orf based <NUMBER> sarscov<NUMBER> <NUMBER> sars <NUMBER> genomes sarscov<NUMBER> highest dn observed orf<NUMBER> <NUMBER> followed orf<NUMBER>a <NUMBER> orf<NUMBER> <NUMBER> <NUMBER> orf<NUMBER> <NUMBER> table <NUMBER> indicating genes may likely accumulate nonsynonymous mutations <NUMBER> contrast orf<NUMBER>b <NUMBER> gene <NUMBER> encoding spike protein orf<NUMBER> <NUMBER> relatively conserved <NUMBER> terms nonsynonymous mutation noteworthy orf<NUMBER> orf<NUMBER>ab orf<NUMBER> strictly conserved <NUMBER> nonsynonymous mutation compared sarscov<NUMBER> sars displayed higher mutation rates orfs <NUMBER> virus genome table <NUMBER> suggesting overall higher levels genetic diversity mutation rate particular dn <NUMBER> ds values gene sarscov around <NUMBER> <NUMBER> times higher sarscov<NUMBER> contrast mutation <NUMBER> rate differences orf<NUMBER>a orf<NUMBER>b sarscov<NUMBER> sars relatively milder varying <NUMBER> times <NUMBER> <NUMBER> times contrast sarscov<NUMBER> strictly conserved orf<NUMBER> orf<NUMBER>a orf<NUMBER>b sars displayed <NUMBER> mutation rates different levels notably ds orf<NUMBER> comparable two genomes <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> trace potential spread history sarscov<NUMBER> across world unrooted minimum evolution tree <NUMBER> <NUMBER> genomes developed based wholegenome sequence alignment clustering pattern phylogeny <NUMBER> spike glycoprotein critical virus infection recent study suggested protein sarscov<NUMBER> may <NUMBER> underwent structural rearrangement<NUMBER> investigate hypothesis two separate phylogenies developed <NUMBER> based fulls rbd sequences respectively overall two phylogenies displayed similar clustering patterns <NUMBER> separating three major clades figure <NUMBER> sarscov<NUMBER> identified major clade clustered <NUMBER> closely two bat sars covs highlighted purple green colors figure <NUMBER> human sarscov orange <NUMBER> color figure <NUMBER> phylogenies sarscov<NUMBER> closely related batcovratg<NUMBER> suggesting sars <NUMBER> may originated bat however evolutionary positions human sarscov batslcovz<NUMBER> <NUMBER> swapped fulls rbdonly phylogenies fulls phylogeny batslcovz<NUMBER> relatively similar <NUMBER> human sarscov<NUMBER> whilst human sarscov closer sarscov<NUMBER> batslcovz<NUMBER> taken together results suggested rbd sarscov<NUMBER> likely originated human sarscov whilst rest part <NUMBER> protein sarscov<NUMBER> may originated batslcovz<NUMBER> supporting potential structural rearrangement <NUMBER> protein sarscov<NUMBER> batcovratg<NUMBER> similar sarscov<NUMBER> indicating proposed structural <NUMBER> rearrangement may occurred bat first transmission human rbd virus protein binds receptor host cells responsible first step cov infection <NUMBER> thus <NUMBER> amino acid mutation rbd may significant impact receptor binding vaccine development <NUMBER>d structure <NUMBER> spike protein rbd sarscov<NUMBER> pdb <NUMBER>vw<NUMBER> recently determined complex human ace<NUMBER> <NUMBER> receptor <NUMBER> one the<NUMBER> amino acid mutations rbd protein r<NUMBER>i identified among <NUMBER> sars<NUMBER> cov<NUMBER> genomes sequence alignment showed <NUMBER>r strictly conserved sarscov<NUMBER> sarscov bat sars<NUMBER> like cov figure <NUMBER>a based determined cov<NUMBER>rbdace<NUMBER> complex structure <NUMBER>r located interface <NUMBER> rbd ace<NUMBER> positioned relatively far away ace<NUMBER> thus direct interaction ace<NUMBER> <NUMBER> figure <NUMBER>b however determined rbd<NUMBER>ace<NUMBER> structure showed <NUMBER>r forms hydrogen bond <NUMBER> Ã¥ length <NUMBER> glycan attached <NUMBER>n ace<NUMBER> figure <NUMBER>c <NUMBER> hydrogen bond may contributed exceptionally <NUMBER> higher ace<NUMBER> binding affinity contrast despite arginine residue also conserved human sarscov <NUMBER> corresponding <NUMBER>r pdb <NUMBER>ajf positioned relatively distant <NUMBER> Ã¥ glycan bound <NUMBER>n ace<NUMBER> <NUMBER> figure s<NUMBER> interestingly <NUMBER>rglycan hydrogen bond seem disrupted r<NUMBER>i mutation one sarscov<NUMBER> results clearly showed distribution linear epitopes related nglycosylation subtle call highly immunogenic peptides criteria set averagesignal intensity larger <NUMBER>cutoff<NUMBER> response frequency larger <NUMBER> see methods definitions total <NUMBER> peptides obtained surprisingly outside rbd significance rbd lowered criteria e response frequency larger <NUMBER> keep averagesignal intensity larger <NUMBER>cutoff<NUMBER> <NUMBER> consecutive peptides moderate immunogenicity e s<NUMBER> s<NUMBER> s<NUMBER> selected table s<NUMBER> interestingly peptides locate within rbm receptor binding motif binding interface spike protein ace<NUMBER> immunogenic peptides dispersed spike protein two linear epitope hot regions could immediately recognized aa<NUMBER> aa<NUMBER> one ctd cterminal domain another covers s<NUMBER> cleavage site fusion peptide fp immunogenic peptides table s<NUMBER> solubility <NUMBER> pi range <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively indicates overall immunogenicity spike protein correlated solubility pi several sarscov<NUMBER> epitope related studies involving small sample sets <NUMBER> <NUMBER> immunogenic epitopes partially consistent studies table s<NUMBER> relative high consistency observed data rescan phage display based strategy <NUMBER> <NUMBER> known immune response may related key clinical parameters gender disease severity age final outcome <NUMBER> <NUMBER> test whether linear epitope landscape correlates parameters divided linear landscape fig <NUMBER>a according parameters ie male vs female gender fig s<NUMBER> mild vs severe severity fig s<NUMBER> <NUMBER> vs <NUMBER> age fig s<NUMBER> recovered vs death final outcome fig s<NUMBER> unexpectedly overall obvious difference observed suggest linear epitope landscape highly robust consistent among covid<NUMBER> patients illustrate location distribution <NUMBER> immunogenic peptides table s<NUMBER> mapped <NUMBER>d structure spike protein <NUMBER> fig s<NUMBER>a s<NUMBER>b clear peptides locate surface spike protein consistent ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> <NUMBER> doi medrxiv preprint common notion <NUMBER> however s<NUMBER> s<NUMBER> s<NUMBER> surface trimeric spike protein surface monomer plausible explanation monomer spike protein could exposed immune system certain yet undiscovered stage well known rbd highly immunogenic <NUMBER> <NUMBER> however according selection criteria highly immunogenic peptide obtained rbd lowered selection criteria <NUMBER> peptides selected ie s<NUMBER> s<NUMBER> s<NUMBER> fig <NUMBER>a rbd compared regions spike protein obvious rbd poor linear epitopes seems contradictory knowledge rbd highly immunogenic possible epitopes rbd region conformational test possibility collected set <NUMBER> high affinity monoclonal antibodies rbd spike protein see methods antibodies obtained memory b cell isolation covid<NUMBER> recovered patients <NUMBER> analyzed antibodies individually spike protein peptide microarray <NUMBER> fig <NUMBER>b among antibodies <NUMBER> highest affinity <NUMBER> nm rbd expected strong bindings observed s<NUMBER> protein rbd however negative signals obtained peptides including rbd peptides aa<NUMBER> also peptide bindings observed rest rbd specific antibodies data shown antibody <NUMBER> strong binding obtained s<NUMBER> protein rbd interestingly <NUMBER> binds s<NUMBER> high affinity indicating epitope <NUMBER> recognized around aa<NUMBER> actually <NUMBER> immunogenic peptides e s<NUMBER> s<NUMBER> s<NUMBER> also identified related studies <NUMBER> <NUMBER> three peptides consecutive locate rbm region least partially overlapped close binding epitopes variety sarscov<NUMBER> neutralization antibodies eg b<NUMBER> <NUMBER> cb<NUMBER> <NUMBER> p<NUMBER>b<NUMBER>f<NUMBER> <NUMBER> illustrate locations peptides mapped <NUMBER>d structure spike protein open state closed state fig <NUMBER>c closed state aa<NUMBER> s<NUMBER> locate contact area among three monomers probably difficult accessed aa<NUMBER> <NUMBER> form Î²strand covered could accessed sides aa<NUMBER> exposed ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint present flexible sequence fig <NUMBER>c fig s<NUMBER> open state spike protein residues s<NUMBER> exposed highly accessible fig s<NUMBER> analyze immunogenicity s<NUMBER> neutralization antibodyrbd complexes used fig s<NUMBER> antibodies cb<NUMBER> <NUMBER> p<NUMBER>b<NUMBER>f<NUMBER> <NUMBER> bd<NUMBER> <NUMBER> cr<NUMBER> <NUMBER> s<NUMBER> <NUMBER> among structures cb<NUMBER> p<NUMBER>b<NUMBER>f<NUMBER> interact directly residues within s<NUMBER> cb<NUMBER>rbd complex fig s<NUMBER>d several residues within s<NUMBER> direct interactions antibody e y<NUMBER> l<NUMBER> f<NUMBER> r<NUMBER> k<NUMBER> s<NUMBER> n<NUMBER> y<NUMBER> q<NUMBER> p<NUMBER>b<NUMBER>f<NUMBER>rbd complex fig <NUMBER>e residue direct interaction antibody l<NUMBER> broad neutralization antibody vaccine effective sarscov<NUMBER> human coronaviruses high interest <NUMBER> performed homology analysis s<NUMBER> among sarscov<NUMBER> <NUMBER> human coronaviruses bat coronavirus btcovratg<NUMBER> <NUMBER> high homologies observed <NUMBER> peptides among sarscov<NUMBER> sarscov btcovratg<NUMBER> high homology indicate antibodies elicited s<NUMBER> may least effective sarscov<NUMBER> sarscov results strongly suggest rbd rich conformational epitopes poor linear epitopes underlying mechanism worth investigation taken together results suggest s<NUMBER> could serve promising candidate development broadly neutralization antibodies vaccine first hot region linear epitopes ctd whole domain densely covered linear epitopes fig <NUMBER>a according selection criteria <NUMBER> highly immunogenic epitopes ie s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> identified peptides evenly distributed cross ctd asked whether <NUMBER> highly immunogenic peptides epitopes also revealed studies showed s<NUMBER> identified rescan <NUMBER> table s<NUMBER> covidep <NUMBER> s<NUMBER> rescan s<NUMBER> covidep s<NUMBER> s<NUMBER> locate ctd<NUMBER> aa<NUMBER> s<NUMBER> aa<NUMBER> s<NUMBER> present loop region surface trimeric spike protein s<NUMBER> s<NUMBER> s<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint s<NUMBER> locate ctd<NUMBER> s<NUMBER> almost loop present surface s<NUMBER> Î²strand loop buried inside aa<NUMBER> loop region could accessed s<NUMBER> nearly s<NUMBER>s<NUMBER> cleavage site although aa<NUMBER> invisible spike protein structure residues could exposed surface induce antibody response prevent s<NUMBER>s<NUMBER> hydrolysis fig <NUMBER>b s<NUMBER> also surface s<NUMBER> inner surface underlying mechanism s<NUMBER> triggers strong igg reaction many patients worth study homology analysis performed <NUMBER> highly immunogenic peptides fig <NUMBER>c except s<NUMBER> high homologies observed <NUMBER> peptides among sarscov<NUMBER> sarscov btcovratg<NUMBER> high homology indicate antibodies elicited s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> may effective sarscov<NUMBER> sarscov antibody targeting s<NUMBER> may specific sarscov<NUMBER> d<NUMBER>g mutant current dominant strain europe <NUMBER> <NUMBER> times higher infection efficiency cell assay wild type strain <NUMBER> d<NUMBER> within s<NUMBER> peptide moderate immunogenicity close highly immunogenic peptide s<NUMBER> block d<NUMBER> region may cause functionally significant effect second region highly enriched linear epitopes spans aa<NUMBER> fig <NUMBER>a according selection criteria <NUMBER> highly immunogenic peptides obtained ie s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> interesting see whether <NUMBER> highly immunogenic peptides epitopes also identified related studies revealed s<NUMBER> identified peptide microarray study <NUMBER> four peptides s<NUMBER> s<NUMBER> s<NUMBER> s<NUMBER> identified rescan <NUMBER> <NUMBER> peptides s<NUMBER> s<NUMBER> predicted covidep <NUMBER> peptides s<NUMBER> one identified predicted studies since s<NUMBER> covers s<NUMBER> cleavage site fp speculate antibody targeting s<NUMBER> may block cleavage disturb function fp thus potent neutralization activity interestingly strong s<NUMBER> specific igg reaction also elicited mrna vaccine study <NUMBER> demonstrated high immunogenicity high potential neutralization activity s<NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> check similarity peptides among human coronaviruses performed homology analysis s<NUMBER> s<NUMBER> s<NUMBER> high homologies observed peptides among sarscov<NUMBER> sarscov btcovratg<NUMBER> fig <NUMBER>c interestingly s<NUMBER> highly homologous among coronaviruses almost identical among sarscov<NUMBER> sarscov btcovratg<NUMBER> peptide elicit strong neutralization activity may could serve promising candidate making broad neutralization antibody vaccine except immunogenic peptides belong rbd two hot regions also highly immunogenic peptides dispersed across spike protein fig <NUMBER>a s<NUMBER> locates ntd part residues e aa<NUMBER> form Î²strand surface trimeric spike protein aa<NUMBER> form loop partially covered region s<NUMBER> s<NUMBER> s<NUMBER> locate unobserved regions cterminal spike protein applied modeling structure present unobserved regions fig <NUMBER>b s<NUMBER> predicted Î±helix s<NUMBER> predicted loop s<NUMBER> cterminal end spike protein fig <NUMBER>b locates cytoplasm host cell checked whether <NUMBER> highly immunogenic peptides epitopes also revealed studies showed s<NUMBER> identified peptide microarray study <NUMBER> s<NUMBER> identified rescan <NUMBER> <NUMBER> peptides s<NUMBER> s<NUMBER> s<NUMBER> predicted covidep <NUMBER> functional role s<NUMBER> specific antibodies may worth investigation s<NUMBER> adjacent hr<NUMBER> antibody targeting site may block conformational change essential effective viruscell fusion <NUMBER> surprising see high immunogenicity s<NUMBER> s<NUMBER> since cterminal ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint end spike protein theoretically localize cytoplasm study necessary explore underlying mechanism functional roles peptides epitopes high homologies observed peptides among sarscov<NUMBER> sarscov btcovratg<NUMBER> fig <NUMBER>c interestingly s<NUMBER> s<NUMBER> highly homologous among coronaviruses almost identical among sarscov<NUMBER> sarscov btcovratg<NUMBER> s<NUMBER> high homology also observed merscov s<NUMBER> s<NUMBER> potential serve promising candidate developing broad neutralization antibody vaccine herein aim reveal igg responses triggered sarscov<NUMBER> spike protein systematic level adopted newly developed peptide microarray full coverage spike protein <NUMBER> analyzed <NUMBER> covid<NUMBER> sera <NUMBER> control sera set highly immunogenic peptidesepitopes revealed comprehensive igg linear epitope landscape constructed one limitation study short peptides involved though linear epitopes nicely represented conformational epitopes may example rbd region highly immunogenic <NUMBER> linear epitopes moderate immunogenicity identified overcome limitation one way synthesize longer peptides may retain conformational information <NUMBER> necessary point linear epitopes identified highly physiologically relevant since revealed analysis sera covid<NUMBER> patient study presents first igg linear epitope landscape spike protein could enabled analyzing large cohort samples using systematic approach peptide microarray full coverage spike protein according landscape obvious spike protein highly immunogenic many epitopes protein epitopes evenly distributed across spike protein among <NUMBER> immunogenic peptides table s<NUMBER> may good candidates developing neutralization antibodies vaccines may cause ade rest peptides may direct biological function serve neutral immunodominant epitopes ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint could trigger neutralization activity ade believe <NUMBER> immunogenic peptides table s<NUMBER> worth testing animal model identify peptides specifically trigger neutralization activities use intact spike protein vaccine development take precise way deleting mutating peptides correspond ade neutral immunodominant epitopes thus assure efficacy minimize side effect alternatively peptides elicit neutralization activity potential applied directly neutralization antibody generation applied peptide vaccine way avoid many challenges working intact spike protein rbd linear epitope landscape highly immunogenic peptides identified study could serve solid base guide precise development prophylactic therapeutic antibodies vaccines combating covid<NUMBER> high homology may also effective human coronaviruses including sarscov merscov since highly immunogenic peptides outside rbd believe antibodies vaccines based peptidesepitopes could used alone least complementary rbd centered antibodies vaccines nterminal amidated peptides synthesized gl biochem ltd shanghai china peptide individually conjugated bsa using sulfosmcc thermo ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint peptidebsa conjugates well s<NUMBER> protein rbd protein n protein sarscov<NUMBER> along negative bsa positive controls antihuman igg igm antibody printed triplicate path substrate slide grace biolabs oregon usa generate identical arrays <NUMBER> x <NUMBER> subarray format using super marathon printer arrayjet uk microarrays stored <NUMBER>Â°c use table s<NUMBER> sera control group healthy donors lung cancer patients patients autoimmune diseases collected ruijin hospital shanghai china tongren hospital shanghai china sera stored <NUMBER>â use ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint jackson immunoresearch pa usa diluted <NUMBER> <NUMBER> <NUMBER>Ãpbst incubation carried room temperature <NUMBER> h microarrays washed <NUMBER>Ãpbst dried centrifugation room temperature scanned luxscan spot signal intensity defined meanforeground subtracted meanbackground signal intensities triplicate spots peptide protein averaged overallmeanbackground overallstandard deviation sdbackground arrays probed covid<NUMBER> sera calculated cutoff<NUMBER> defined overallmeanbackground <NUMBER>overallsdbackground according array data cutoff<NUMBER> calculated <NUMBER> control arrays meanforground sdforeground peptide protein calculated cutoff<NUMBER> set controlmeansingal intensity <NUMBER>controlsd signal intentisy peptide protein sarscov<NUMBER> specific positive response called averagesignal intesnty larger cutoff<NUMBER> cutoff<NUMBER> response frequency defined number peptides positive response divided total number peptides microarray spike protein structures pdb id <NUMBER>x<NUMBER>p <NUMBER>vyb rbdace<NUMBER> structure pdb id <NUMBER>m<NUMBER>j antibodiesrbd complex structure pdb id <NUMBER>c<NUMBER> <NUMBER>bwj <NUMBER>byr <NUMBER>w<NUMBER> <NUMBER>wpt used analyze structural details epitopes identified peptide microarray c terminal <NUMBER> structure spike protein modeling structure qhd<NUMBER>pdb generated citasser httpszhanglabccmbmedumicheducovid<NUMBER> aligned c terminal spike ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> signal intensities <NUMBER> covid<NUMBER> sera <NUMBER> peptides obtained using peptide microarray peptides listed xaxis aligned corresponding locations spike protein control signal intensities s<NUMBER> protein also presented missing spots peptides either could synthesized failed bsa conjugation see table s<NUMBER> details cohort <NUMBER> controls sera also analyzed microarray addition known nglycosylation sites nglyco aligned spike protein peptides regions significant binding marked blue peptide s<NUMBER> specifically labeled significant bindings also observed controls ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint figure <NUMBER> rbd lack highly immunogenic linear epitope rbd region linear epitope landscape b peptide microarray results two spike protein specific monoclonal human antibodies active motif co ltd one <NUMBER> specific rbd <NUMBER> c detailed structures significant peptides s<NUMBER> aa<NUMBER> red rbd closed state spike protein trimer side view pdb id <NUMBER>x<NUMBER>p locations significant peptides s<NUMBER> aa<NUMBER> red cocrystal structure rbd ace<NUMBER> pdb id <NUMBER>m<NUMBER>j e homology analysis significant peptides among <NUMBER> known human coronaviruses bat coronavirus btcovratg<NUMBER> highly homologous sarscov<NUMBER> amino acids consistencies <NUMBER> among <NUMBER> coronaviruses marked red loop Î²strand region shown line arrow sequences respectively ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint specifically s<NUMBER> aa<NUMBER> red s<NUMBER> aa<NUMBER> blue s<NUMBER> aa<NUMBER> yellow s<NUMBER> aa<NUMBER> green s<NUMBER> s<NUMBER> <NUMBER> orange c homology analysis significant peptides among <NUMBER> known human coronaviruses bat coronavirus btcovratg<NUMBER> amino acids consistencies <NUMBER> among <NUMBER> coronaviruses marked red loop Î±helix Î²strand region shown line coil arrow sequences respectively unobserved structure shown dotted line ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> figure <NUMBER> highly immunogenic linear epitopes <NUMBER> significant peptides belong two hot regions see figure <NUMBER> figure <NUMBER> b significant peptides locate spike protein s<NUMBER> aa<NUMBER> red s<NUMBER> aa<NUMBER> red s<NUMBER> aa<NUMBER> red c homology analysis significant peptides among <NUMBER> known human coronaviruses bat coronavirus btcovratg<NUMBER> amino acids consistencies <NUMBER> among <NUMBER> coronaviruses marked red loop Î±helix Î²strand region shown line coil arrow sequences respectively unobserved structure shown dotted line ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint figure s<NUMBER> peptide microarray layout peptide microarray used study please see table s<NUMBER> details peptides array b example array probed covid<NUMBER> patient serum c example array probed control serum ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint figure s<NUMBER> igg linear epitope landscape sarscov<NUMBER> spike protein age <NUMBER> vs <NUMBER> linear epitope landscape separated two sublandscapes according age ie <NUMBER> age <NUMBER> vs <NUMBER> age <NUMBER> b correlation age <NUMBER> age <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint contacting residues shown stick significant peptides s<NUMBER> aa<NUMBER> marked red ae table s<NUMBER> serum samples tested study ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint table s<NUMBER> highly immunogenic peptides ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted july <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint catastrophic coronavirus disease <NUMBER> covid<NUMBER> pandemic caused novel coronavirus referred severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> brought world standstill afflicted global public health abraham et al <NUMBER> bhardwaj et al <NUMBER> elasnaoui chawki <NUMBER> paniri et al <NUMBER> virus infected six million people ruthlessly claimed nearly four hundred thousand lives till date per updates june <NUMBER> <NUMBER> httpswwwworldometers infocoronavirus covid<NUMBER> surpassed two coronavirusrelated outbreaks associated severe acute respiratory syndrome sars middle east respiratory syndrome mers occurred recent past terms frequency infected individuals number deaths lu et al <NUMBER> though overall casefatality rate remains lower sars mers wu mcgoogan <NUMBER> patients infected covid<NUMBER> diagnosed mildtosevere respiratory illness symptoms like high fever cough dizziness shortness breath might advance pneumonia acute respiratory distress causing death lu et al <NUMBER> wu mcgoogan <NUMBER> sarscov<NUMBER> positivestranded rna virus represents genus betacoronovirus belongs family coronaviridae benvenuto et al <NUMBER> sarma et al <NUMBER> novel coronavirus significantly distant sarscov around <NUMBER> identify merscov around <NUMBER> identity lu et al <NUMBER> despite novelty sarscov<NUMBER> significant advancements made elucidating complex genomic features understanding codon usage signatures evolutionary enigma andersen et al <NUMBER> tort et al <NUMBER> unraveling riddles infectivity epidemiology lu et al <NUMBER> rothan byrareddy <NUMBER> intimidating virus viral genome encodes several structural nonstructural proteins nsp play crucial roles attaching virus host cellular receptors regulating viral replication facilitating subsequent infection tai et al <NUMBER> spike protein vital structural protein component forms prominent spikes outer surface virus helps viral attachment successful fusion subsequent entry host cells sinha et al <NUMBER> tai et al <NUMBER> imperative main protease enzyme pro also referred <NUMBER> clike protease sarscov<NUMBER> plays pivotal role proteolytic cleavage processing large viral polyprotein orf<NUMBER>ab combination papainlike proteases facilitates viral replication alkhafaji et al <NUMBER> gyebi et al <NUMBER> islam et al <NUMBER> jin et al <NUMBER> joshi et al <NUMBER> mittal et al <NUMBER> efficient replication spread sarscov<NUMBER> host cells largely dependent proper functioning rnadependent rna polymerase rdrp ziebuhr <NUMBER> nonstructural protein <NUMBER> nsp<NUMBER> catalytic subunit rdrp mediates viral replication enhances template binding processivity combination nsp<NUMBER> nsp<NUMBER> subissi et al <NUMBER> te velthuis et al <NUMBER> pivotal roles viral proteins attachment virus host cell receptors subsequent replication infection establish promising drug vaccine candidates aanouz et al <NUMBER> adeoye et al <NUMBER> das et al <NUMBER> lobogalo et al <NUMBER> mahanta et al <NUMBER> pant et al <NUMBER> sk et al <NUMBER> tai et al <NUMBER> yin et al <NUMBER> several methods like drug repurposing ciliberto cardone <NUMBER> elmezayen et al <NUMBER> administration convalescent plasma transfusion usage sarscov merscov antibodies presently employed combat covid<NUMBER> combination hydroxychloroquine azithromycin observed effective treatment disease gautret et al <NUMBER> hydroxychloroquine antimalarial drug facilitates endosomal acidification blocks viral entry fusion inhibiting glycosylation host cellular receptors bind viral proteins sanders et al <NUMBER> though hydroxychloroquine efficiently arrests viral growth toxic side effects concerns drug poisoning remain major bottlenecks using covid<NUMBER> therapy enmozhi et al <NUMBER> drugs like arbidol targeted sarscov<NUMBER> spike protein sanders et al <NUMBER> lopinavir ritonavir targeted sarscov<NUMBER> pro reported effective menacing pathogen antiviral drugs like remdesivir favipiravir inhibit rdrp activity hendaus <NUMBER> li et al <NUMBER> nejadi babadaei et al <NUMBER>have observed arrest sarscov<NUMBER> replication currently clinical trials despite relentless attempts researchers medical practitioners struggling limit rapid transmission combat calamitous health hazards posed sarscov<NUMBER> due lack specific effective therapeutics prophylactics though several drugs vaccines clinical trials world effective therapeutic remedy specifically targeted treat cure covid<NUMBER> yet achieved since time immemorial phytochemicals natural compounds employed medicinal agents towards effective treatment grave ailments quest natural therapeutic remedy covid<NUMBER> several studies designed explore inhibitory prospects phytochemicals various important conventionally used medicinal plants herbs world boopathi et al <NUMBER> clerodendrum perennial shrub member lamiaceae family prevalent tropical regions asia including india myanmar bangladesh malayasia indonesia thailand bhutan nepal also temperate tibet chathuranga et al <NUMBER> various medicinally important species clerodendrum frequently used treat respiratory ailments like common cold bronchitis pneumonia chathuranga et al <NUMBER> patel et al <NUMBER> crude extract clerodendrum trichotomum reported actively inhibit respiratory syncytial virus rsv without cytotoxic effects towards normal tissues chathuranga et al <NUMBER> considering fact clerodendrum spp often finds widespread applications treating respiratory disorders chathuranga et al <NUMBER> patel et al <NUMBER> house repertoire phytochemicals obtained gcms analysis twelve clerodendrum species assessed explore inhibitory prospects imperative spike pro rdrp proteins sarscov<NUMBER> employing silico molecular interactionbased approach present work also involves comprehensive investigation physicochemical features screened phytocompounds accordance general rules druglikeness viz lipinskis rule five ro<NUMBER> vebers rule purpose assess potential druglikeness leaves twelve species clerodendrum collected <NUMBER> table s<NUMBER> supplementary material different localities north bengal garden medicinal plants department botany university north bengal jalpaiguri roadside sites azra guwahati assam plants identified plant taxonomist department botany university north bengal deposited herbarium department reagents chemicals used present study purchased himedia laboratories pvt ltd mumbai india merck mumbai india sigmaaldrich usa milliq ultrapure water departmental facility used experiments chemicals analytical grade fresh disease free leaves selected plants washed twice double distilled water shade dried room temperature <NUMBER> days pulverized fine powder using mechanical grinder powdered leaves selected plants <NUMBER> g extracted soxhlet apparatus using absolute methanol ratio plant material solvent <NUMBER> mv <NUMBER> h extracts concentrated reduced pressure controlled temperature <NUMBER> <NUMBER> c using rotary evaporator buchi rotavapor r<NUMBER> switzerland extracts lyophilized using eyela freeze dryer fdu<NUMBER> usa obtain dry powder stored <NUMBER> c use lyophilized methanolic extracts centrifuged <NUMBER> rpm <NUMBER> min clear supernatants thus obtained utilized gcms analysis identify different phytochemical compounds thermo scientific make trace <NUMBER> gc attached tg<NUMBER>ms column <NUMBER> Ã¢ <NUMBER> mm Ã¢ <NUMBER> lm equipped isqqd thermo scientific single quadrupole mass analyzer conditioned ion trap <NUMBER> c transfer line <NUMBER> c electron energy <NUMBER> ev vacuum pressure<NUMBER>e<NUMBER> torr employed present study kar et al <NUMBER> one microlitre sample injected thermo scientific ai<NUMBER> autosampler splitless mode split flow <NUMBER> mlmin splitless time <NUMBER> min helium selected carrier gas constant flow <NUMBER> mlmin samples run thrice minimize error results plotted compounds identified three runs essential compounds identified retention times mass fragmentation patterns using reference parent compound using ms interpreter version <NUMBER> also matching reference database national institute standards technology nist ms library version <NUMBER> external standards used study prominent active compounds present selected species clerodendrum detected gcms analysis subjected robust molecular docking analysis imperative sarscov<NUMBER> proteins currently serve promising targets effective drug development namely receptorbinding domain rbd sarscov<NUMBER> spike protein sarscov<NUMBER> main protease enzyme pro sarscov<NUMBER> rdrp tai et al <NUMBER> highresolution xray diffraction crystal structures receptorbinding domain rbd sarscov<NUMBER> spike protein pdb id <NUMBER>lzg chain b <NUMBER> Ã¥ resolution sarscov<NUMBER> main protease enzyme pro pdb id <NUMBER>lu<NUMBER> chain <NUMBER> Ã¥ resolution jin et al <NUMBER> sarscov<NUMBER> rdrp pdb id <NUMBER>bv<NUMBER> chain <NUMBER> Ã¥ resolution retrieved pdb inhibitor water molecules removed pdb files prior analysis polar hydrogen atoms kollman charges added corresponding pdb files using autodock tools structures concerned phytocompounds retrieved ncbi pubchem httpspubchemncbinlmnihgov respective threedimensional structures generated open babel software oboyle et al <NUMBER> energyoptimization structures achieved using prodrg server schâ¬ uttelkopf van aalten <NUMBER> gromos <NUMBER> force field applied process energy minimization gasteiger charges added corresponding ligand structures using autodock tools molecular docking achieved using autodock vina software naidoo et al <NUMBER> trott olson <NUMBER> thorough information active site residues rbd sarscov<NUMBER> spike sarscov<NUMBER> pro sarscov<NUMBER> rdrp proteins obtained recent reports structure interactioninhibition binding pockets andersen et al <NUMBER> jin et al <NUMBER> wang et al <NUMBER> yin et al <NUMBER> ligands docked active binding pockets concerned proteins employing gridbased docking method opting rigid protein receptor flexible ligand docking protocol naidoo et al <NUMBER> grid boxes coordinates <NUMBER> <NUMBER> <NUMBER> x z dimensions involving active site residues generated carry molecular docking binding pockets viral proteins naidoo et al <NUMBER> dinc server used validate results autodock vina antunes et al <NUMBER> ligandreceptor complexes lowest binding scores rmsd <NUMBER> Ã¥ naidoo et al <NUMBER> used robust interaction profiling employing pymol software version <NUMBER> proteinligand interaction profiler plip webserver salentin et al <NUMBER> compounds displaying binding energy scores Ã <NUMBER> kcalmol selected next phases analysis naidoo et al <NUMBER> physicochemical features selected phytocompounds thoroughly estimated using swissadme server results validated pkcsm server daina et al <NUMBER> pires et al <NUMBER> panassay interference structures pains medicinal chemistry analysis performed employing swissadme fafdrugs<NUMBER> lagorce et al <NUMBER> servers toxicity parameters like mutagenicity ames mutagenesis cytotoxicity phytochemicals assessed using protoxii webserver banerjee et al <NUMBER> validated vnnadmet server schyman et al <NUMBER> molecular mechanicsgeneralized born surface area mmgbsa used estimate free energies binding dg bind selected proteinligand complexes employing default parameters prime mmgbsa modules vijayakumar et al <NUMBER> implemented schrâ¬ odinger software prime mmgbsa approach uses optimized potential liquid simulations opls force field combination molecular mechanics energies emm surface generalized born sgb solvation model polar solvation gsgb nonpolar solvation term gnp calculation purpose alkhafaji et al <NUMBER> mittal et al <NUMBER> sarma et al <NUMBER> total free energy binding concerned proteinligand complex calculated molecular dynamics md simulations allow proper validation molecular docking results offer reliable assessment potential stability proteinligand complex muralidharan et al <NUMBER> complexes ligands displaying best interaction terms binding energy values sarscov<NUMBER> spike pro rdrp proteins subjected md simulation timescale <NUMBER> nanoseconds ns using gromacs software version <NUMBER> abraham et al <NUMBER> md simulations executed per protocols opted equilibration steps set constant pressure temperature npt ensemble elfiky azzam <NUMBER> enayatkhani et al <NUMBER> umesh et al <NUMBER> md simulations carried standard temperature <NUMBER> k pressure level <NUMBER> bar umesh et al <NUMBER> md trajectories estimated analyzing root mean square deviation rmsd root mean square fluctuation rmsf complexes timescale <NUMBER> ns md simulations followed detailed interaction profiling proteinligand complexes using ligplot software wallace et al <NUMBER> <NUMBER> investigation pertaining gas chromatographymass spectrometry gcms current study intended identification active compounds present twelve species clerodendrum using gcms method evident thorough analysis gcms chromatograms twelve concerned clerodendrum spp figures s<NUMBER>s<NUMBER> among <NUMBER> commonly shared phytocompounds table s<NUMBER> supplementary material <NUMBER> unique accordingly molecular docking analysis performed employing <NUMBER> unique phytocompounds tables <NUMBER> concerned sarscov<NUMBER> proteins taraxerol friedelin betulin identified gcms analysis triterpenoid chemical compounds mainly found various higher groups plants compounds shown possess antiinflammatory anticarcinogenic antiobesity antimicrobial activities significant therapeutic potential giweli et al <NUMBER> takasaki et al <NUMBER> tang et al <NUMBER> yao et al <NUMBER> fatty acids like linoleic acid la hexadecanoic acid profiled present study essential fatty acids human beings require diet kar et al <NUMBER> deficiency linolenic acid reported associated infertility skin kidney degeneration abrupt changes fatty acid composition lipids dobryniewski et al <NUMBER> addition squalene stigmasterol identified present gcms analysis reported potent antioxidants effective oxidative stress related disorders amarowicz <NUMBER> yoshida niki <NUMBER> sarscov<NUMBER> infection initiates attachment spike protein human receptor angiotensin converting enzyme <NUMBER> ace<NUMBER> via receptorbinding domain rbd abdelli et al <NUMBER> basit et al <NUMBER> tai et al <NUMBER> wahedi et al <NUMBER> molecular docking phytochemicals clerodendrum spp performed active pocket rbd sarscov<NUMBER> spike protein pdb id <NUMBER>lzg light prior knowledge active site residues bind human receptor ace<NUMBER> andersen et al <NUMBER> hasan et al <NUMBER> tai et al <NUMBER> wan et al <NUMBER> detailed binding energy scores concerned phytocompounds provided table <NUMBER> compounds displaying binding energy scores Ã <NUMBER> Â± <NUMBER> leu<NUMBER> glu<NUMBER> pro<NUMBER> gln<NUMBER> hydrophobic interactions marked italics hydrogen bonds highlighted bold Ã <NUMBER> kcalmol table s<NUMBER> supplementary material compounds displaying binding energy scores Ã <NUMBER> kcalmol compounds taraxerol friedelin stigmasterol found exhibit best binding energy scores <NUMBER> Â± <NUMBER> kcalmol Ã <NUMBER> Â± <NUMBER> kcalmol <NUMBER> Â± <NUMBER> kcal mol respectively among concerned phytochemicals table <NUMBER> thorough inspection revealed taraxerol interacted leu<NUMBER> glu<NUMBER> tyr<NUMBER> residues rbd figure <NUMBER> table <NUMBER> inferred play vital roles attachment sarscov<NUMBER> spike protein human ace<NUMBER> receptor andersen et al <NUMBER> ortega et al <NUMBER> wan et al <NUMBER> molecular interactions friedelin involved residues lys<NUMBER> tyr<NUMBER> asn<NUMBER> whereas stigmasterol interacted residues tyr<NUMBER> phe<NUMBER> receptorbinding domain sarscov<NUMBER> spike protein table <NUMBER> present study mode binding drug arbidol currently used targeting sarscov<NUMBER> spike protein inhibit viral attachment human ace<NUMBER> receptor sanders et al <NUMBER> also analyzed compared binding patterns concerned phytochemicals arbidol displayed binding energy score <NUMBER> Â± <NUMBER> kcalmol rbd sarscov<NUMBER> spike protein table <NUMBER> striking note compounds taraxerol friedelin stigmasterol exhibited significantly higher p <NUMBER> binding potential relative drug arbidol evident binding energy scores table <NUMBER> observations provide opportunities validate inhibitory potential compounds vitro vivo towards development effective therapeutics targeted sarscov<NUMBER> spike protein proper inhibition sarscov<NUMBER> pro arrests viral replication jin et al <NUMBER> recently michael acceptor inhibitor n<NUMBER> observed exhibit significant inhibitory efficacy sarscov<NUMBER> pro proposed promising drug lead compound jin et al <NUMBER> robust molecular docking inhouse phytochemicals clerodendrum spp revealed interesting facts regarding inhibitory prospects detailed account binding energy scores provided table <NUMBER> compounds displaying binding energy scores Ã <NUMBER> kcalmol table s<NUMBER> supplementary material compounds displaying binding energy scores Ã <NUMBER> kcalmol compounds taraxerol friedelin stigmasterol found display significantly higher p <NUMBER> binding potential binding energy scores <NUMBER> Â± <NUMBER> kcalmol Ã <NUMBER> Â± <NUMBER> kcalmol <NUMBER> Â± <NUMBER> kcalmol respectively table <NUMBER> inhibitor n<NUMBER> <NUMBER> Â± <NUMBER> kcal mol active binding pocket sarscov<NUMBER> pro reported glu<NUMBER> pro<NUMBER> residues sarscov<NUMBER> pro crucial binding inhibitor n<NUMBER> jin et al <NUMBER> interestingly taraxerol also involved two imperative residues interaction figure <NUMBER> table <NUMBER> indicated towards potential inhibitory efficacy sarscov<NUMBER> pro enzyme compounds friedelin stigmasterol interacted residue pro<NUMBER> active binding pocket sarscov<NUMBER> pro table <NUMBER> binding efficacy drugs lopinavir ritonavir currently employed inhibit sarscov<NUMBER> pro activity sanders et al <NUMBER> estimated molecular docking binding energy scores observed <NUMBER> Â± <NUMBER> kcalmol <NUMBER> Â± <NUMBER> kcalmol lopinavir ritonavir respectively interesting note taraxerol exhibited significantly higher p <NUMBER> binding energy score sarscov<NUMBER> pro currently used drugs table <NUMBER> present observations confer scopes evaluate inhibitory efficacy taraxerol vitro vivo sarscov<NUMBER> vital catalytic component nsp<NUMBER> combination nsp<NUMBER> nsp<NUMBER> sarscov<NUMBER> rnadependent rna polymerase rdrp mediates viral replication host cells subissi et al <NUMBER> ziebuhr <NUMBER> proper inhibition rdrp activity reported arrest sarscov<NUMBER> replication thus limit infective prowess sanders et al <NUMBER> yin et al <NUMBER> binding energy scores phytocompounds clerodendrum spp active binding pocket sarscov<NUMBER> rdrp detailed table <NUMBER> compounds displaying binding energy scores Ã <NUMBER> kcalmol displaying binding energy scores Ã <NUMBER> kcalmol compounds taraxerol friedelin stigmasterol displayed highest binding potential scores <NUMBER> Â± <NUMBER> kcalmol Ã <NUMBER> Â± <NUMBER> kcalmol <NUMBER> Â± <NUMBER> kcalmol respectively sarscov<NUMBER> rdrp table <NUMBER> taraxerol observed involve residues lys<NUMBER> arg<NUMBER> figure <NUMBER> table <NUMBER> whereas friedelin interacted sarscov<NUMBER> rdrp residue asp<NUMBER> table <NUMBER> stigmasterol found interact residues lys<NUMBER> arg<NUMBER> thr<NUMBER> ala<NUMBER> sarscov<NUMBER> rdrp table <NUMBER> remdesivir favipiravir antiviral drugs inhibit viral rdrp activity arrest growth replication sanders et al <NUMBER> drugs reported exhibit significant viral inhibition presently clinical trials prospects effective treatment covid<NUMBER> sanders et al <NUMBER> accordingly binding patterns drugs sarscov<NUMBER> rdrp compared modes binding concerned phytocompounds clerodendrum spp remdesivir favipiravir noted display binding energy scores <NUMBER> Â± <NUMBER> kcalmol <NUMBER> Â± <NUMBER> kcalmol respectively sarscov<NUMBER> rdrp table <NUMBER> intriguing note compounds taraxerol friedelin stigmasterol exhibited significantly higher p <NUMBER> binding energy values drugs table <NUMBER> thus present findings provide opportunities explore inhibitory potential concerned phytocompounds vitro vivo towards effective deployment inhibitors sarscov<NUMBER> accurate account physicochemical features therapeutic compound compliance general rules druglikeness imperative step initial phases drug development paul gleeson et al <NUMBER> decent binding affinities binding energy scores Ã <NUMBER> kcalmol compounds taraxerol friedelin stigmasterol sarscov<NUMBER> spike pro rdrp proteins conferred appropriate scope evaluate physicochemical attributes related druglikeness lipinskis rule five proposes drug candidate logarithm partial coefficient log p <NUMBER> molecular weight <NUMBER> dalton number hydrogen bond acceptors <NUMBER> number hydrogen bond donors <NUMBER> exhibits decent gastrointestinal absorption enhanced membrane permeability lipinski et al <NUMBER> thorough investigation revealed three compounds table <NUMBER> accordance lipinskis rule five ro<NUMBER> slightly higher log p logarithm partial coefficient values optimum pretext worth mentioning oral drugs frequently used treatment cancer log p values higher optimum range proposed lipinskis rule five oneill twelves <NUMBER> vebers rule suggests potential therapeutic molecule number rotatable bonds <NUMBER> topological polar surface area tpsa <NUMBER>Ã¥ <NUMBER> tends display decent oral bioavailability veber et al <NUMBER> compounds taraxerol friedelin stigmasterol noted agreement vebers rule observation correlated well decent bioavailability score <NUMBER> table <NUMBER> naidoo et al <NUMBER> physicochemical features compounds compared relevant drugs like arbidol lopinavir ritonavir remdesivir favipiravir presently employed sarscov<NUMBER> motive infer potential druggability compounds relevance drugs striking note drugs lopinavir molecular weight <NUMBER> dalton number rotatable bonds <NUMBER> ritonavir molecular weight <NUMBER> dalton number rotatable bonds <NUMBER> tpsa <NUMBER>Ã¥ <NUMBER> remdesivir molecular weight <NUMBER> dalton number rotatable bonds <NUMBER> tpsa <NUMBER>Ã¥ <NUMBER> violated rules druglikeness compounds taraxerol friedelin stigmasterol predicted possess structural alerts associated toxic consequences pains toxicophore estimation table <NUMBER> naidoo et al <NUMBER> pouliot jeanmart <NUMBER> however drug arbidol observed possess <NUMBER> structural alert phytocompounds found display relatively better physicochemical druglikeness features compared drugs presently employed sarscov<NUMBER> silico toxicity estimation revealed compounds potentially nonmutagenic noncytotoxic table <NUMBER> observations found consistent previous reports demonstrating nontoxic nature alsnafi <NUMBER> ayaz et al <NUMBER> boldrin et al <NUMBER> borges et al <NUMBER> subashbabu et al <NUMBER> surapaneni prakash <NUMBER> thus concerned phytocompounds exhibited promising druglike features provide scopes validated vitro vivo towards development effective therapeutics covid<NUMBER> blomme <NUMBER> decent binding energy scores Ã <NUMBER> kcalmol compounds taraxerol friedelin stigmasterol sarscov<NUMBER> spike pro rdrp proteins offered scopes estimate free energies binding concerned proteinligand complexes using mmgbsa method suggested mmgbsa provides apt estimates free energies binding proteinligand complexes negative value indicates stronger binding alkhafaji et al <NUMBER> detailed investigation mmgbsa binding free energy scores dg bind selected proteinligand complexes revealed compound taraxerol displayed higher binding potential respective sarscov<NUMBER> proteins comparison compounds friedelin stigmasterol p <NUMBER> evident dg bind mmgbsa scores taraxerol sarscov<NUMBER> spike <NUMBER> kcalmol pro <NUMBER> kcalmol rdrp <NUMBER> kcal mol proteins table <NUMBER> observations signified better binding efficacy taraxerol concerned sarscov<NUMBER> proteins relative friedelin stigmasterol compound taraxerol exhibited better binding potential sarscov<NUMBER> spike pro rdrp proteins terms binding energy tables <NUMBER> dg bind mmgbsa scores table <NUMBER> comparison phytochemicals friedelin stigmasterol accordingly complexes taraxerol respective sarscov<NUMBER> proteins selected md simulations along timescale <NUMBER> ns validate results molecular docking assess conformational stability taraxerolrbd sarscov<NUMBER> spike protein complex displayed fluctuations rmsd values ca atoms <NUMBER> ns attained stability thereafter figure <NUMBER> taraxerolsarscov<NUMBER> pro complex noted experience initial fluctuations rmsd values ca atoms <NUMBER> ns attained equilibrium remained stable figure <NUMBER> taraxerolsarscov<NUMBER> rdrp complex exhibited significant dynamicity rmsd values ca atoms initial phases md simulation however attained considerable stability <NUMBER> ns remained equilibrium figure <NUMBER> observations reflected conformational stability complexes indicated towards decent binding potential taraxerol sarscov<NUMBER> spike pro rdrp proteins analysis root mean square fluctuation rmsf residues proteinligand complex effective addressing local changes along protein chain deciphering conformational stability muralidharan et al <NUMBER> extensive analysis rmsf pertaining complexes revealed average rmsf values <NUMBER> Ã¥ <NUMBER> Ã¥ <NUMBER> Ã¥ complexes taraxerolrbd sarscov<NUMBER> spike protein figure <NUMBER>a taraxerolsarscov<NUMBER> pro figure <NUMBER>b taraxerolsarscov<NUMBER> rdrp figure <NUMBER>c respectively peaks rmsf plot depict residues experience major fluctuations md simulations muralidharan et al <NUMBER> evident analysis residues active binding pockets sarscov<NUMBER> proteins interacted taraxerol tables <NUMBER> conformational stability proteinligand complex inferred considerable changes interaction patterns complex prior md simulations extensive analysis interaction profiles complexes taraxerolrbd sarscov<NUMBER> spike protein taraxerolsarscov<NUMBER> pro taraxerolsarscov<NUMBER> rdrp md simulations <NUMBER> ns revealed suffer change binding patterns interacting residues prior md simulations <NUMBER> ns found figure <NUMBER>ac tables <NUMBER> thus evident complexes conformationally stable supported initial observations molecular docking studies covid<NUMBER> pandemic afflicted human population worldwide calamitous impact rapid spread transmission infectivity utmost demand development specific drugs vaccines targeted sarscov<NUMBER> causal agent covid<NUMBER> present research venture aimed exploring inhibitory prospects phytocompounds clerodendrum spp revealed taraxerol indubitably promising inhibitory candidate sarscov<NUMBER> spike pro rdrp proteins followed friedelin stigmasterol evident binding energy scores fact taraxerol displayed decent binding potential concerned sarscov<NUMBER> proteins included present analysis might provide foundation deployed universal target sarscov<NUMBER> vitro vivo validations required draw final inference <NUMBER> neutralizing antibodies fully block viral entry host cells however general <NUMBER> location binding antibodies would strongly affect bodys ability <NUMBER> produce neutralizing antibodies <NUMBER> date coronavirus vaccine approved <NUMBER> <NUMBER> inactivated sarscov demonstrated offer incomplete protection <NUMBER> whereas purified coronavirus spike protein nanoparticles found induce <NUMBER> coronavirus neutralizing antibodies mice <NUMBER> therefore full exposure neutralizing <NUMBER> epitopes b cell epitopes likely represent important factors coronavirus <NUMBER> vaccine design high homology protein sarscov<NUMBER> sarscov resulted <NUMBER> design subunit vaccine sarscov<NUMBER> focused rbd region <NUMBER> vicinity purpose vaccine design analyzed biological <NUMBER> characteristics eg homology analysis b cell epitope prediction advanced b cell epitopes sarscov<NUMBER>spl predicted online disctope<NUMBER> <NUMBER> <NUMBER> iedb <NUMBER> disctope score peak chart subsequently constructed using <NUMBER> <NUMBER> rbd region whereas two located tail region expected <NUMBER> also five motifs sarscovspl thr<NUMBER>gln<NUMBER> thr<NUMBER> <NUMBER> thr<NUMBER> <NUMBER> <NUMBER> leu<NUMBER>leu<NUMBER> arg<NUMBER> <NUMBER> val<NUMBER>asp<NUMBER> val<NUMBER> <NUMBER> thr<NUMBER>trp<NUMBER> <NUMBER> ala<NUMBER> <NUMBER> thr<NUMBER>lys<NUMBER> asp<NUMBER> <NUMBER> fig <NUMBER>b furthermore two <NUMBER> discotope score peaks almost mirror images fig <NUMBER> according maria percentiles possible <NUMBER> mer peptide sequences <NUMBER> netmhcpan<NUMBER> percentiles possible <NUMBER> mer peptide sequences sarscov<NUMBER>spl <NUMBER> broad coverage defined presented <NUMBER> mhc alleles <NUMBER> found <NUMBER> <NUMBER> cd<NUMBER> epitopes <NUMBER> cd<NUMBER> cell epitopes met requirement overlapping <NUMBER> integration nine potential cd<NUMBER> <NUMBER> potential cd<NUMBER> cell antigenic <NUMBER> determinants table <NUMBER> rbd region possessed seven cd<NUMBER> epitopes nine cd<NUMBER> <NUMBER> cell epitopes whereas tail region two cd<NUMBER> epitopes two cd<NUMBER> cell epitopes <NUMBER> moreover comparing epitopes verified cd<NUMBER> cd<NUMBER> cell epitopes <NUMBER> sarscovspl <NUMBER> onetoone correspondence observed eg ser<NUMBER>asn<NUMBER> <NUMBER> lys<NUMBER>val<NUMBER> sarscov lys<NUMBER>val<NUMBER> sarscov<NUMBER> amino acid identity <NUMBER> sarscov<NUMBER>spl sarscovspl <NUMBER> fig <NUMBER> <NUMBER> amino acid differences <NUMBER> located <NUMBER> receptorbinding motif rmb ser<NUMBER>gln<NUMBER> accounting <NUMBER> <NUMBER> <NUMBER> empirically biological characteristics amino acids eg arglys thrser <NUMBER> gluasp ileleu similar taking biological similarity amino acids <NUMBER> appear similar goldfish rmb head rbd trunk remainders <NUMBER> tail fig <NUMBER>a <NUMBER>b rmb head critical receptor binding <NUMBER> sarscov<NUMBER>spl completely exposed surface fig <NUMBER>a also <NUMBER> crucial production neutralizing antibodies homotrimer sarscov<NUMBER>spl <NUMBER> arranged barrel three rbms top fig <NUMBER>a might represent <NUMBER> natural state sarscov<NUMBER>spl structure 